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Preface 
Philip SCOTTa and Louis  PAPE-HAUGAARD b 
a
 School of Computing, University of Portsmouth, United Kingdom 
b
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This volume presents the proceedings of the 30th Medical Informatics Europe 
conference (MIE), organized in Geneva, Switzerland, in April 2020. This collection of 
papers offers a wealth of knowledge and experience across the full spectrum of digital 
health and medicine.  
MIE conferences have been hosted by the European Federation for Medical 
Informatics (EFMI) since the 1970s. Over those decades, we have been privileged to 
share in a growing community of expertise in health and care informatics and seen the 
advancement of the field from a few pioneers to a diverse international network. 
The overarching concept of Digital Personalized Health and Medicine is elaborated 
under the six programme themes as the structure of this volume: 
 Biomedical data, tools and methods 
 Supporting care delivery 
 Health and prevention 
 Precision medicine and public health 
 Human factors and citizen centered digital health 
 Ethics, legal and societal aspects 
 
The topics of the conference proceedings demonstrate that crucial scientific work is 
still in progress across this scientific continuum and that much existing knowledge is yet 
to be widely adopted in routine practice. For example, recent years have seen 
unprecedented leaps forward in data science and machine learning, yet important work 
still continues on basic prerequisites such as data quality and computable semantic 
interoperability. Further excellent work continues in human-computer interaction, policy, 
workforce development, ethics and regulation. Increasing attention is being paid to 
citizen and patient concerns, whether it be trust in computerised clinical guidance, 
privacy and consent or issues of safety and accountability. 
Helpfully, the Learning Health System is increasingly seen as a unifying concept for 
basic and translational health and care informatics, incorporating standards for 
representing biomedical knowledge, machine learning, precision medicine, clinical 
decision support systems, quality improvement and behaviour change. 
We commend this body of papers to readers as a powerful educational resource. 
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MIE 2020 was organized in partnership with the World Health Organization (WHO), 
the International Telecommunication Union (ITU), the State of Geneva (Geneva), the 
University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG). The 
local team would particularly like to acknowledge the work of Dr Vasiliki Foufi PhD 
and Christophe Gaudet-Blavignac BSc CS MMed. The editors would like to express 
thanks to our doctoral student assistants, Taiwo Adedeji MSc and Obinwa Ozonze MSc. 
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A FHIR-Based eConsent App for the
Digital Hospital
Manuela WEBER a,b,1, Alexandra GRIESSBACH c,d, Regina GROSSMANN c and
Ju¨rg BLASER a,b
aFaculty of Medicine, University of Zurich, Switzerland
bDirectorate Research and Education, University Hospital Zurich, Switzerland
cClinical Trials Center, University Hospital Zurich, Switzerland
dFaculty of Science, University of Zurich, Switzerland
Abstract. Research projects with humans is a highly regulated field that is currently
undergoing rapid changes due to developments in eHealth and mHealth. While a
patients data and samples must be thoroughly protected, they are also an invaluable
source for fundamental and cutting edge research. There are processes in place to
obtain a patient’s consent for the use of their data and samples for research. These
approaches could be more flexible, user-friendly and modernised. There is a high
demand among all parties for a unified, yet differentiated, dynamic and person-
alised eConsent. An Android app has been developed that brings any existing con-
sent form to mobile devices, including the integration of the process into existing
hospital IT using established data standards, such as FHIR and the ResearchStack
open source framework.The app is user-tested and shown to work in a hospital
setting. Lack of eIdentification and legal drawbacks were determined as the main
obstacles for immediate implementation.
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1. Introduction
Research projects with humans is a complex and highly regulated field [1], evolved
through insight gained by trial and error over the recent decades. This research is subject
to new challenges, where large collections of health data and biological samples stored
in biobanks and databases, come in conflict with current ethical, legal, and societal im-
plications. The number and size of these repositories is set to increase significantly over
the coming years [2].
In Switzerland, the Human Research Act (HRA) [1] allows the use of these data
and samples when consent by the patient is present. Consent may be given in form of
the traditional informed consent (IC), tailored to a specific project, or general consent
(GC), in which patients allow the use of their data and samples for future, previously
unspecified research projects. The HRA as well as the data protection laws give strict
instruction on how to handle these highly sensitive medical data and samples.
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Recent?developments? in?eHealth?and?mHealth? research?applications?show?demand?
for? a? consent? system,? attainable? on? a? patient’s? own? device? (eConsent)[3],?which?may?
prove?profitable?to?both?patient?and?institution.?An?eConsent?process?can?simplify?a?hos-
pitals?consent?process,?as?well?as?allow?patients?to?consent?and?withdraw?at?any?time;?de-
fine? the? terms? and? conditions? for? projects? using? their? data? and? samples? (dynamic?
consent);?and?help?patients?investigate?projects?their?data?and?samples?are?being?used?in.?
Simplified?hospital?processes?and?increased?patient?autonomy?are?not?the?only?benefits?of?
eConsent;? Consent? forms? are? often? very? complex? and? riddled?with?medical? or? legal?
jargon,? which? may? be? better? explained? through? explanatory? images? and? videos.?
Electronic?consent?pro-cesses?can?inform?patients?sufficiently?about?research?studies?[4],?
as? interactive? elements? of? eConsent? lead? to? better? understanding? and? recall? of? key?
information?[5,6].?Addition-ally,?Switzerland?is?a?multi-cultural?country?with?four?native?
languages,?this?excluding?many?other?languages?present?due?to?migration.?There?is?a?dire?
need?for?quick,?accessible?and?up-to-date?consent?forms?in?different?languages.
The?eConsent?concept?is?not?without?its?challenges.?It?is?well?known?that?older?pa-
tients?visit? the?hospital?more?frequently?and?make?out?a? large?sub-population?who?may?
have?difficulties?navigating?the?application.?Furthermore,?it?may?be?seen?that?the?eCon-
sent? is? treated? less? seriously? than?a?paper-based?consent,?even? though?both?are? legally?
binding.?Nevertheless,?current?developments?in?the?health?system?demand?for?more?dy-
namic,?differentiated,?and?personalised?consent?solutions.
The?prototypes?used? in? the?various? studies?were? rather?pragmatic?and? isolated? so-
lutions? [7]?and?when?authors?mentioned? the?chosen?platform,? it?was?mostly? iOS?based?
[5,6,8].?This?may?be?due?to?Apple’s?initial?lead?in?providing?programming?tools?for?the?
health? sector? i.e? ResearchKit? (http://researchkit.org).? Android? developers,? however,?
caught?up?by? releasing?ResearchStack? (http://researchstack.org).?There? are?now? estab-
lished?data?standards?like?FHIR?(https://www.hl7.org/fhir)?and?open?source?frameworks?
available? to? create? an?unified? eConsent?process? for?different?needs?on?both?platforms,?
such?as?C3-PRO?(https://github.com/C3-PRO).
In? this?context,? the?goal?of? this?paper? is? the?research?and?development?of?an?eCon-
sent?technology?available?on?Android?and?exploring?the?user?acceptance?in?different?pa-
tient?populations.?To?our?knowledge,?we?are?one?of?the?first?team?of?researchers?not?only?
equipped?with?a?prototype,?but?an?eConsent?app?user?tested?and?readily?applicable.?The?
project?focus?is?technological?feasibility,?user?acceptance,?and?reusability?of?existing?pa-
per?consent?forms.?Our?work?concentrates?on?a?simple?design?which?allows?novice?pro-
grammers?to?set?up?eConsent?processes?for?any?paper-based?consent?form.
2.?Methods
Our?research?consists?of?two?main?parts:?the?design?of?an?easily?constructed?app?and?the?
evaluation?of?the?app’s?acceptance?amongst?patients.
In? the?first?step,?we?conducted?a? literature?search?of?previous?attempts?and?experi-
ences?with?eConsent?(PubMed,?Google?Scholar),?deciding?on? the? implementation?envi-
ronment.?We? chose? the? platform? for? the? app? and? determined? existing? frameworks? to?
make?the?implementation?as?easy?and?versatile?as?possible.?The?app?was?then?developed,?
incor-porating?feedback?from?different?stakeholders,?such?as?thorough?research?into?the?
techni-cal? and? legal? possibilities? and? challenges? of? connecting? it? to? the? existing? IT?
environment ?of ?the ?hospital.
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For?the?user?acceptance?evaluation,?the?consent?forms?for?the?collection?of?data?and?
samples?was?integrated?into?the?app?and?evaluated?with?patients?of?the?dermatology?and?
the?visceral?and?transplant?surgery?department.?So?far,?52?patients?were?asked?to?partici-
pate?of?which?33?patients?agreed.?Patients?of?different?ages?were?included?whether?or?not?
they?had?previously?signed?the?paper-based?form.
The?administrator?selected? the?document?on? the?eConsent?app,?scanned? the?patient?
label?or?filled? in? the?patient?data?manually.?The?administrator?gave?a?brief?standardised?
introduction?and?handed?the?tablet?to?the?patient.?The?patient?read?through?the?document?
by?clicking?through?the?frames,?followed?by?their?consent?or?refusal.?When?refusing,?the?
process?ended?and?returned? to? the?home?screen,?while?consenting? led? to?a?frame?where?
patients?signed?on?screen?with?a?stylus?pen.?After?signing?and?clicking?”next”,? they?re-
turned?the?tablet?to?the?administrator.?In?the?last?step,?patients?filled?out?a?user?acceptance?
evaluation?questionnaire?consisting?of?9?questions?concerning? their?age?group,?compre-
hension,?user?friendliness,?readability,?signature,?font?size,?amount?of?content?per?frame,?
preference?for?eConsent?or?paper?consent?as?well?as?general?comments?and?overall?expe-
rience.? Due? to? current? legal? restrictions,? a? paper-based? consent? form? always?
accompanied?the?electronic?version.
3.? Results
3.1.? Implementation
With?over?80%?of?mobile?devices?running?worldwide?on?Android?[9]?with?no?restrictive?
licensing?requirements,?Android?was?our?operating?system?of?choice.?The?eConsent?app?
was?programmed?in?Android?Studio?using?Java?code.?ResearchStack?for?Android?offered?
an?easy?to?use?open?source?framework?for?implementation?of?research?apps,?including?a?
user?interface?for?a?consent?process?that?allows?the?signing?of?a?consent?document?on?the?
screen?of?mobile?devices.? Integration?of? the?app? into?existing?clinical? IT? infrastructure?
was?made?possible?by?C3-PRO,?an?open?source?toolchain?to?connect?ResearchStack?apps?
to?clinical? research? IT? infrastructure? through? the?established? standard? for?medical?data?
FHIR?[10].
The?consent?document,?structured?into?subsections?defined?and?provided?by?the?Re-
searchStack,? is?stored? in?a? json?file?as?a?FHIR?contract?resource.?Among?others,? it?pro-
vides?sections?for?introductions,?study?information,?privacy,?usage?of?collected?data?and?
information?on?withdrawal?of?consent.?Each?section?is?displayed?on?screen?for?the?patient?
to?read?and?scroll?through.?Every?section?can?show?a?”learn?more”?link?,?which?navi-gates?
the? patient? to? a? different? screen? for? more? information.? The? json? file? containing? the?
consent?document?is?loaded?into?the?app?using?the?C3-PRO?framework?and?passed?on?to?
the?ResearchStack?framework?to?be?presented?to?the?user.?To?start?the?consent?process,?a?
custom? label? reader?was? implemented? to? read?a? standard?patient?bar?code?and? retrieve?
patient?data?needed?for?the?consent?document,?such?as?name,?date?of?birth?and?patient?ID.?
The?patient? is? then?guided? through? the? sections?of? the?consent?document?and?asked? to?
agree?to?the?terms?by?signing?his?signature?on?the?screen?of?the?device.?After?signing,?a?
PDF?of?the?consent?form,?complete?with?the?patient?information?and?signature?is?created?
and? transmitted? to? the?hospital?IT?system?by? the?C3-PRO?framework,?either?as?a?FHIR?
resource?or?as?plain?PDF.
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3.2.? User?Acceptance?Evaluation
The?designed?app?can?be?set?up?for?different?consent?forms?with?minimal?effort.?It?can?
run?on?different?Android?devices?and?adjusts? to?different?screen?sizes.?For? the?user?ac-
ceptance? study,? the?app?was? installed?on?a?10.5”?Samsung? tablet.?From?all?33?patients?
who?completed?the?consent?process?and?questionnaire,?the?app?was?generally?positively?
received?and? found?easy? to?navigate.?The?eConsent?was?generally?determined?superior?
over?the?paper-based?version.?Results?of?the?questionnaire?can?be?seen?in?Table?1.?A?few?
issues?arose?during? the?eConsent?process.?In?some?cases,? the?navigation?buttons?for? the?
app?were?not?big?enough,?the?amount?of?text?per?section?was?too?much?and?some?patients?
expressed?the?need?for?a?bigger?signature?area.?Some?users?also?experienced?difficulties?
when?resting?the?palm?on?the?screen?when?signing.?Over?all,?patients?reflected?positively?
about?their?experience?with?a?few?minor?and?adaptable?issues.
Table?1.? User?Acceptance?Questionnaire?Results?(?n=33)
characteristic comprehension user friendliness readability signature
mean score* 4.6 4.2 4.2 3.2
improvement integration of media,
adjust text per frame
increase button size,
swipe function
zoom function,
larger font size
increase signature
platform
*1 lowest score, 5 highest score
4. Discussion
This project creates a solution that allows a standardised eConsent process for various
types of consents with minimal effort or programming knowledge. Due to the use of
established data standards, the proposed app can easily be integrated into existing hos-
pital IT infrastructures. The user acceptance evaluation has shown that patients of all
ages navigated the technology easily and even prefer the digital version. If further re-
quirements arise in the future, the technology offers plenty of options for adaptation and
improvement.
Possible integration of different media types could allow for a more differentiated,
dynamic and personalised experience for patients with different preferences. Numerous
field tests show that there is wide acceptance and preference of eConsent among patients,
medical professionals and researchers [4], which is corroborated by our results. Elec-
tronic forms instead of paper forms can lead to greater satisfaction for all parties [7] and
field tests have shown that eConsent result in the same or higher consent rate [11,12].
Although the app is ready for implementation, there are some challenges concerning
the integration of the app into the IT infrastructure of the institution. The main concern
being legal and safety matters. Swiss law does not accept electronic hand-written signa-
tures, with exception of the postal service. eSignatures such as Swiss Post’s SwissID can
be costly, are not widely accepted, and do not easily integrate with third party software,
such as ResearchStack. No Federal law on recognized eIdentification is yet in force. Fur-
thermore, data protection laws are very strict about patient data being stored on mobile
devices and transmitted through potentially vulnerable networks. However, despite strict
laws and best efforts, eHealth data has become more attractive to hackers over the re-
cent years and are stored in less secure systems [13,14,15]. Substantial initial investment
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would?be?necessary?to?establish?a?secure?yet?accessible?infrastructure?for?a?secure?unified?
eConsent?system.
5.? Conclusion
It?is?time?to?supplement?or?replace?paper-based?consent?forms?with?a?unified?yet?dynamic?
and?personalised?eConsent?process.?The?solution?presented? is?accepted?among?patients?
and?researchers,?and?easily?integrated?into?existing?and?future?health?networks.?The?lack?
of?options?for?eIdentification?and?legal?drawbacks?were?determined?as?the?main?obstacle?
for?immediate?implementation.
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Abstract. The cryptographic method Secure Multi-Party Computation (SMPC)
could facilitate data sharing between health institutions by making it possible to 
perform analyses on a “virtual data pool”, providing an integrated view of data that 
is actually distributed – without any of the participants having to disclose their 
private data. One drawback of SMPC is that specific cryptographic protocols have 
to be developed for every type of analysis that is to be performed. Moreover, these 
protocols have to be optimized to provide acceptable execution times. As a first step 
towards a library of efficient implementations of common methods in health data 
sciences, we present a novel protocol for efficient time-to-event analysis. Our 
implementation utilizes a common technique called garbled circuits and was 
implemented using a widespread SMPC programming framework. We further 
describe optimizations that we have developed to reduce the execution times of our 
protocol. We experimentally evaluated our solution by computing Kaplan-Meier 
estimators over a vertically distributed dataset while measuring performance. By 
comparing the SMPC results with a conventional analysis on pooled data, we show 
that our approach is practical and scalable.
Keywords. secure multi-party computation; healthcare data; patient privacy; 
operational confidentiality of information
1.?Introduction
The increasing abundance of digital health data holds great potential for medicine and 
healthcare. Paired with standardized data formats and analytic tools, this wealth of data 
can help to improve diagnosis, treatment and prevention as well as efficiency of 
care. However, health data is distributed across a large number of institutions, and the 
knowledge to be gained from these isolated data repositories is limited. This has led to 
the creation of a wide range of national and international data sharing initiatives. But 
laws and regulations such as the EU General Data Protection Regulation often prevent 
the disclosure and sharing of health data for privacy reasons.
Secure Multi-Party Computation (SMPC) is a cryptographic approach that can help 
to overcome this limitation and facilitate data sharing between health institutions. SMPC 
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makes it possible to perform analyses on a virtual data pool, providing an integrated 
view of data that is actually distributed – without any of the participants having to 
disclose their private data [1].  
Prior work on SMPC in healthcare includes a protocol for genome-wide association 
studies that keeps underlying geno- and phenotypes private [2], as well as a study that 
uses SMPC to investigate drug-target interactions in large pharmacological datasets [3].
Other applications include a disease surveillance system that ensures patient and provider 
privacy [4] and a method for privacy-preserving health record linkage [5]. 
2.?Objective
Despite its potential as a privacy-preserving approach to health data sharing, SMPC is 
not yet widely used in health analytics. One reason for this is that SMPC is 
computationally demanding, and protocols therefore have to be highly optimized for 
acceptable performance. 
As a first step towards a library of efficient SMPC implementations of common 
methods in health data sciences, we studied the problem of time-to-event analysis over 
vertically distributed data. In this scenario, one participant (e.g. a hospital) holds relevant 
clinical data (e.g. the primary diagnosis) while another participant (e.g. a medical 
practice or death register) holds data on relevant events (e.g. time of death or 
(re-)admission to hospital) of the same patient group. As a showcase, we present an 
efficient SMPC implementation of the Kaplan-Meier estimator for survival probabilities.
3.?Methods
3.1. Secure Multi-Party Computation 
Our implementation uses the Obliv-C framework [6], which provides an abstraction 
layer for the garbled circuits technique. With this widespread approach, two-parties can 
evaluate a common function without disclosing their inputs by mapping the function to 
a Boolean circuit [1]. Furthermore, we used a library providing additional primitives for 
sorting and secure memory that hides access patterns (ORAM) [7–9].
Obliv-C provides an abstraction layer that imitates a Trusted Third Party (TTP). As 
illustrated in Figure 1, both parties A and B push their data a and b to the TTP, which 
calculates the function f and returns the output c. In reality, however, there is no TTP;
Figure 1. Example for the abstraction layer provided by Obliv-C.
L. Vogelsang et al. / A Secure Multi-Party Computation Protocol for Time-To-Event Analyses 9
the computation and its inputs are encrypted and computations are executed 
distributively between both parties. 
3.2. Efficient SMPC Protocol for Kaplan-Meier Estimators 
One major drawback of SMPC is its computational overhead. To reduce this
overhead, we split our problem into two phases: In the first, SMPC-based phase, 
computation is minimized and as much computation as possible is offloaded to the 
second, non-SPMC-based phase. As intermediate results from the SMPC program are 
revealed to the subsequent non-SMPC programs, special care has to be taken to make 
sure that these intermediate results do not leak private information. 
In the particular case of the Kaplan-Meier estimator, the survival probabilities of 
individual patients should not be leaked, as this would create a direct mapping between 
the result and each patient’s private information. Instead, values have to be aggregated 
so that only cumulated distinct data points are revealed. To aggregate time points in the 
SMPC phase, we used the secure memory (ORAM) mentioned above. 
Figure 2. Schematic view of our algorithm implementing the Kaplan-Meier estimator. 
One challenge with this approach is that the ORAM has to be initialized with a
maximum size. While the number of patient records could be used as an upper bound, 
this adversely impacts performance, as ORAMs do not scale well. However, the length 
of the result is typically lower because time points get aggregated and not every patient 
has an event. The size of the ORAM can thus be limited to the number of distinct time 
points. We achieve this by iterating over the dataset in two (sub-) phases: first, we 
aggregate the values without storing them, only counting the number of distinct time 
points, revealing the count afterwards; then we initialize the ORAM and perform the 
calculations again, this time storing the results as shown in Figure 2. This does not impact 
privacy in any way, as the count is leaked at the end of the protocol anyway. 
The source code of our SMPC protocol for Kaplan-Meier estimators is available at
https://github.com/LevitatingOrange/secure-kaplan-meier.
3.3. Experimental Setup 
In  our  experiments  we  used  two  datasets:  (1)  A synthetic  dataset  including  patient 
demographics (date of birth, gender and postal code), case information (case number, 
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admission and discharge dates), coded diagnoses (ICD-10-GM) and procedures (German 
OPS codes); (2) a simulated dataset from a death registry. The datasets included a total 
of 3,927 patients with 5,110 cases. The patients shared a common identifier across both 
datasets (e.g. a social security or health insurance number).
We performed two experiments: (1) a “conventional” analysis in R (www.R-
project.org) on the pooled datasets on one machine; (2) an analysis on distributed data 
with our SMPC protocol simulating two machines connected with a local area network 
(LAN, bandwidth: 119 Mbits/s, average latency: 0.347ms) and a wide area network 
(WAN, bandwidth: 31.3 Mbits/s, average latency: 5.11ms). We used two laptops for the 
LAN scenario: a six core Intel Core i7-8850H processor and 32 GB RAM machine and
another with a four core Intel Core i7-4960HQ and 16 GB RAM. In the WAN scenario, 
we connected the former laptop to a virtual machine on a hosting provider with 12 GB 
RAM and a six core Intel Xeon E5-2680 processor.
Figure 3. Kaplan-Meier plots obtained using (A) pooled data and (B) the SMPC protocol. 
4.?Results
Figure 3 shows the Kaplan-Meier graphs comparing patients with (vs. without) a 
diagnosis of heart failure (ICD-10 code: I50*), atherosclerosis (ICD-10 code: I70*) and 
myocardial infarction (ICD-10 code: I21*). As can be seen, the results obtained in both 
experiments were in high agreement.
Figure 4. Execution times of the SMPC Kaplan-Meier estimator in the LAN and WAN scenario.
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Figure 4 shows the execution times of the SMPC protocol. Both scenarios (LAN 
and WAN) showed a linear increase in computation time in relation to the number of 
records processed. The complete dataset of nearly 4,000 records was processed in about 
five minutes in the WAN scenario. 
5.?Discussion and Conclusion
In this article, we have presented an efficient SMPC implementation of the Kaplan-Meier 
estimator over vertically distributed data. 
Slight differences in the survival probabilities resulting from the SMPC and the 
conventional implementation can be explained by the fact that Obliv-C only supports 32-
bit single precision floating point arithmetic (rather than the 64-bit precision floating-
point operations of the conventional analysis). Moreover, the experiments showed that 
our approach provides practical execution times. Even with very large datasets 
(>1,000,000 records), we expect computations to take not more than several hours or 
maximally a few days. This is acceptable in typical research projects, especially when 
considering that the alternative, in many cases, would be not to do the project at all. 
In future work, we plan to implement additional SMPC protocols for common
statistical methods in health analytics and test them in real-world scenarios. An 
interesting candidate would be an SMPC implementation of a Cox proportional hazard 
model for more advanced statistical analyses of survival times. In the long-term, SMPC 
protocols could be made available in an open source library, providing a collection of 
methods that researchers can choose from for their specific projects. 
For long, SMPC remained a largely academic field, especially due to its sub-par 
performance compared with traditional analysis methods. With recent progress towards 
efficient SMPC protocols and the focus on data privacy and security, SMPC can play a 
large role in advancing analysis across distributed healthcare data. 
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Abstract. Healthcare 4.0 demands healthcare data to be shaped into a common 
standardized and interoperable format for achieving more efficient data exchange. 
Most of the techniques addressing this domain are dealing only with specific cases 
of data transformation through the translation of healthcare data into ontologies, 
which usually result in clinical misinterpretations. Currently, ontology alignment 
techniques are used to match different ontologies based on specific string and 
semantic similarity metrics, where very little systematic analysis has been 
performed on which semantic similarity techniques behave better. For that reason, 
in this paper we are investigating on finding the most efficient semantic similarity 
technique, based on an existing approach that can transform any healthcare dataset 
into HL7 FHIR, through the translation of the latter into ontologies, and their 
matching based on syntactic and semantic similarities. 
Keywords. Healthcare, Ontology alignment, Semantic similarity, HL7 FHIR 
1.Introduction 
In the last decade, there has been a transition from a data-poor to a data-rich world, with 
the aim of improving the quality of transport, governance, environment, communication 
and health. Much of this unprecedented increase in data generation can be attributed to 
the abundance of thousands of mobile devices, wearables, and sensors. Most of these 
devices are typically characterized by a high degree of heterogeneity, in terms of having 
different characteristics, capabilities, or network specifications, needing to be easily 
manageable in particular with regard to the management of the heterogeneous data they 
generate. Especially for the Internet of Medical Things (IoMT) devices it is undeniable 
that vast amounts of heterogeneous medical data are becoming available, thus completely 
reshaping the Healthcare 4.0. In order for these heterogeneous medical data to be 
exchanged with multiple stakeholders, and to be a key driver of providing personalized 
and efficient medical care to patients and citizens, interoperability is the only way. 
Taking into consideration these challenges, in [11] a holistic approach has been 
presented for achieving interoperability through the transformation of healthcare data 
into its corresponding HL7 FHIR structure. Shortly, the provided mechanism was 
building the healthcare ontologies that were stored into a triplestore, in order to identify 
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and compare their syntactic and semantic similarity with the HL7 FHIR Resources. 
According to the aggregation of the syntactic and semantic similarity results, the 
alignment and translation to the HL7 FHIR was taking place. In this paper, we are going 
to fill the gap of the semantic similarity of the aforementioned mechanism, as there has 
been little systematic analysis on which semantic similarity techniques perform well 
when applied to ontology alignment. 
The remainder of this paper is organized as follows. In Section 2, some semantic 
similarity techniques are illustrated, while Section 3 depicts the overall approach. Section 
4 includes the evaluation of the derived results, presenting our concluding remarks. 
2.Semantic Similarity Techniques 
Several methods for determining semantic similarity between terms have been proposed 
in the literature. Word2Vec [2] is a two-level neural network that processes text. Its input 
is a body of text and its output is a set of vectors. The purpose and utility of Word2Vec 
is to group similar word vectors together in the vector space, detecting mathematical 
similarities. Word2Vec creates vectors that are distributed arithmetic word 
representations, such as the single word context, without human intervention. Given 
enough data, usage, and the current environment, Word2Vec can make very accurate 
guesses about the meaning of a word based on impressions of the current word in other 
situations in the past. WordNet [3] is a great English based dictionary. Nouns, verbs, 
adjectives, and adverbs are grouped into sets of synsets, each of which expresses a 
separate meaning. Synsets are interrelated through conceptual-semantic and lexical 
relationships. The resulting network of related words and concepts can be navigated with 
the browser. The structure of WordNet makes it a useful tool for computational 
linguistics and NLP. WordNet looks superficially like a treasure trove because it groups 
words according to their meanings. Cortical.io [4] proposes a new way of understanding 
the natural language that transcends the limitations of other artificial intelligence 
approaches. Semantic Folding [5] is inspired by the most recent findings on how the 
brain processes information. This theory introduces the Semantic Fingerprint, which 
explicitly codifies the concept, including all concepts and frameworks. The system 
understands the affinity of two elements by measuring the overlap of their fingerprints. 
3.Proposed Approach 
In the context of ontology alignment of healthcare data, several techniques are presented 
that lead to better decision making, and interoperable exchange and use of data, providing 
solutions that are adapted to deliver results under specific scenarios. To address this gap, 
in [1] a holistic approach is proposed that is capable of identifying common links 
between healthcare ontologies and the ontologies that represent the HL7 FHIR Resources. 
The preliminary steps of the developed approach were dealing with the automatic 
transformation of the healthcare dataset and the HL7 FHIR Resources into their 
ontological structure. As soon as the ontologies had been constructed, they were stored 
into a triplestore. Afterwards, two sub-mechanisms had occurred, providing the syntactic 
and the semantic similarity between two different ontologies, based on their syntactic 
representations and their semantic knowledge accordingly. The final stage of the 
mechanism implemented an additional sub-mechanism that aggregated and merged the 
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outcomes of the aforementioned sub-mechanisms, providing the overall alignment 
results, for the final transformation of the healthcare dataset into HL7 FHIR. Henceforth 
based on this developed mechanism, in our case, we assume that healthcare ontologies 
have already been constructed for both the ingested healthcare dataset and the different 
HL7 FHIR Resources. Consequently, the three described semantic similarity techniques 
are going to be implemented, for measuring the semantic similarity of the built ontologies. 
3.1.Semantic Similarity Identifier 
The objective of the Semantic Similarity Identifier is to provide the means for aligning 
and matching the different healthcare dataset and HL7 FHIR Resources ontologies, 
according to their semantic meaning (Fig. 1). 
 
 
Figure 1. Semantic Similarity Identifier. 
4.Evaluation 
In our case, in order to evaluate the three different semantic similarity techniques, we are 
going to implement them under the same use case scenario where we will calculate their 
precision, recall, F-measure, and total errors [6], with respect to a UMLS-based reference 
alignment [7]. After this calculation, a comparison between the results will take place in 
order to conclude to the semantic similarity technique that is more suitable for aligning 
ontologies and calculating their semantic similarity in the healthcare domain. 
4.1.Application of Semantic Similarity Techniques 
The use case exploits a healthcare dataset structured in CSV format, covering all the 
previous steps, consisting of 5000 different instances of the personal information of 
certain citizens about their: (i) personal identifier (subject), (ii) gender (gender), (iii) date 
of birth (dateOfBirth), and (iv) cause of death (causeOfDeath). After performing the 
steps introduced into the Semantic Similarity Identifier, the following tables are being 
created (Table 1, Table 2, and Table 3), depicting the HL7 FHIR Resources with higher 
semantic similarity degrees, compared with the concept names of the use case dataset, 
through the three different semantic similarity techniques. 
A. Kiourtis et al. / A Semantic Similarity Evaluation for Healthcare Ontologies Matching 15
Table 1. Semantic Similarity Identifier Top Results for Cortical.io 
Use Case Dataset Attribute HL7 FHIR Resources Cortical.io 
 
subject 
 
Patient.identifier 
 
0.947 (~95%) 
 
gender 
 
Patient.gender 
 
0.863 (~86%) 
 
dateOfBirth 
 
Patient.birthDate 
 
0.971 (~97%) 
 
causeOfDeath 
 
Patient.deceased 
 
0.458 (~46%) 
 
Table 2. Semantic Similarity Identifier Top Results for Word2Vec  
Use Case Dataset Attribute HL7 FHIR Resources Word2Vec 
 
subject 
 
Patient.contact.address 
 
0.357 (~36%) 
 
gender 
 
Patient.gender 
 
0.663 (~66%) 
 
dateOfBirth 
 
Patient.birthDate 
 
0.891 (~89%) 
 
causeOfDeath 
 
- 
 
0 (0%) 
 
Table 3. Semantic Similarity Identifier Top Results for Wordnet 
Use Case Dataset Attribute HL7 FHIR Resources Wordnet 
 
subject 
 
Patient.gender 
 
0.772 (~77%) 
 
gender 
 
Patient.gender 
 
0.861 (~86%) 
 
dateOfBirth 
 
Patient.multipleBirth 
 
0.561 (~56%) 
 
causeOfDeath 
 
Patient. deceased 
 
0.619 (~62%) 
4.2.Conclusions & Discussion of Results 
In order to evaluate these results with regards to the metrics of precision, recall, F-
measure, and errors, the specific use case dataset was translated manually in HL7 FHIR, 
so as to compare the results of the developed mechanism, with the actual outcomes. In 
Fig. 2, a visualization of the aforementioned results is depicted through a bar chart, 
showing how the three different semantic similarity techniques behave in the total 
semantic similarity identification, with regards to the manually provided results which 
did not contain any errors (0% of errors), while their precision, recall and F-measure had 
the value of 100%.  
It is clear that there was not any semantic similarity technique that provided 100% 
accurate results. As it can be seen through Fig. 2, among the different techniques, the 
Cortical.io behave better since it provided less errors (13%) compared with the other 
semantic similarity techniques (31%, and 23% accordingly). Moreover, the F-measure 
(a result of both the precision and recall) of the Cortical.io had the greatest value (84%) 
in comparison with the other semantic similarity techniques (77%, and 65% accordingly). 
Consequently, this lead us to the conclusion that for the Semantic Similarity Identifier 
the most convenient semantic similarity technique to use is the Cortical.io, since it 
provides more efficient and reliable results. 
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Figure 2. Visualization of Comparison Results. 
In the field of healthcare interoperability, semantic similarity has to be identified, 
for which there has been little systematic analysis on which techniques perform well 
when applied to ontology alignment. For addressing this gap, in this paper a previous 
research was considered, about a healthcare ontology matching mechanism that has the 
ability of transforming healthcare data to HL7 FHIR format. Therefore, based upon this 
research, in order to identify the required semantic similarity, three of the most well-
known semantic similarity techniques were used under the same scenario, in order to 
result to the most efficient technique of semantic similarity in the cases of healthcare 
ontologies alignment, and consequently to the most efficient HL7 FHIR transformation.  
To this context, we will continue working on the evaluation of the Semantic 
Similarity Identifier mechanism with additional semantic similarity techniques, to 
identify the technique that is most suitable for the case of healthcare ontologies alignment. 
In addition, we will continue on this evaluation with datasets of different sizes, standards 
and formats, respecting privacy issues, based on the mechanism developed in [8]. 
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Abstract. The aim of this study was to develop a simple method to map the French 
International Statistical Classification of Diseases and Related Health Problems, 
10th revision (ICD-10) with the International Classification of Diseases, 10th 
Revision, Clinical Modification (ICD-10 CM). We sought to map these 
terminologies forward (ICD-10 to ICD-10 CM) and backward (ICD-10 CM to ICD-
10) and to assess the accuracy of these two mappings. We used several terminology 
resources such as the Unified Medical Language System (UMLS) Metathesaurus, 
Bioportal, the latest version available of the French ICD-10 and several official 
mapping files between different versions of the ICD-10. We first retrieved existing 
partial mapping between the ICD-10 and the ICD-10 CM. Then, we automatically 
matched the ICD-10 with the ICD-10-CM, using our different reference mapping 
files. Finally, we used manual review and natural language processing (NLP) to 
match labels between the two terminologies. We assessed the accuracy of both 
methods with a manual review of a random dataset from the results files. The overall 
matching was between 94.2 and 100%. The backward mapping was better than the 
forward one, especially regarding exact matches. In both cases, the NLP step was 
highly accurate. When there are no available experts from the ontology or NLP 
fields for multi-lingual ontology matching, this simple approach enables secondary 
reuse of Electronic Health Records (EHR) and billing data for research purposes in 
an international context. 
Keywords. ICD-10, Clinical terminologies, Interoperability, Multilingual matching 
1. Introduction 
The International Statistical Classification of Diseases and Related Health Problems, 10th 
revision (WHO-ICD-10) one of the most popular terminologies used in around the world. 
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It is a standard diagnostic terminology created and maintained by the World Health 
Organization (WHO) since 1990 for diagnostic coding[1]. The French healthcare system 
uses a French version of the WHO-ICD-10 (Classification Internationale des Maladies, 
10e version, CIM-10) since 1997[2], while the United States created and implanted their 
own adaptation of the terminology (International Classification of Diseases, 10th 
Revision, Clinical Modification, ICD-10-CM) on October, 1st, 2015[3]. There are far 
more codes in the ICD-10 CM than in the CIM-10, even though they share the same 
common denominator: the WHO-ICD-10[3]. 
Multilingual ontology matching is the process of finding correspondences between 
ontologies of different languages to allow them to interoperate[4]. This enables 
secondary reuse of Electronic Health Records (EHR) and billing data from different 
healthcare systems for research purposes, especially if data from the United States is 
involved in the study. We can use two main strategies for multilingual ontology 
matching: direct and indirect alignment. The direct alignment is translation-based and 
uses external resources to help with translation, while the indirect alignment uses 
intermediary mappings between the source and target ontologies. Furthermore, mapping 
two ontologies can be an automated or manual process. Manual mapping is still the 
prevalent choice for ontology matching, but necessitates a large team of experts, is time-
consuming, and is prone to errors[5]. On the other hand, automated approaches use 
public terminology resources such as the Unified Medical Language System (UMLS)[4] 
or Bioportal[6] but those sources are extremely incomplete outside of the English 
speaking world[7]. Therefore, when the purpose of a study is not the mapping itself but 
a necessary step to join databases, it should be possible to overcome the semantic 
interoperability issue by combining different automated matching techniques to conduct 
the study, even with limited resources or experts from the ontology matching field.  
The aim of this study was to develop and evaluate a simple method to link the French 
ICD-10 (or any version of the WHO ICD-10) with the ICD-10 CM. We sought to map 
these terminologies forward (ICD-10 to ICD-10 CM) and backward (ICD-10 CM to 
ICD-10). 
2. Methods 
2.1. Terminology resources 
Since there were no direct mapping files for our study, we used all the intermediate 
mapping files available online. We used four data sources: i) the UMLS Metathesaurus, 
which integrates and assigns a unique identifier to synonymous concepts from several 
standard biomedical technologies (including ICD-10 CM, WHO-ICD-10 and a 1998 
version of the CIM-10)[4], ii) Bioportal, which is a comprehensive repository of standard 
terminologies created by the National Center for Biomedical Ontology (NCBO), with an 
ontology alignment tool, called Lexical OWL Ontology Matcher (LOOM)[6], iii) the 
latest version of the CIM-10, which is mainly a translation of the WHO-ICD-10 with 
more children, and is publicly available on the national billing agency website (Agence 
Technique de l’Information sur l’Hospitalisation, ATIH)[2] and iv) different existing 
mapping files with forward and backward mapping such as: the General Equivalent 
Mapping (GEM) Files from the National Center for Health Statistics (NCHS)[8], the 
New-Zealand mapping files from the Ministry of Health (ICD-10 Australian 
Modification and ICD-9 Australian Modification)[9] and the mapping files between the 
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ICD-10 AM and ICD-10, from the Australian Consortium for Classification 
Development (ACCD)[10].  
2.2. Mapping method 
We decided to map only the first 4-character codes of the CIM-10, because the WHO-
ICD-10 is mainly 4-character codes, except for chapters XIII, XIX, XX, which means 
that after this position, there was a bigger risk of mapping codes with a different 
signification between the two languages. 
Our strategy used three main steps (Figure 1). First, we used the NCBO API to retrieve 
the mapping between the ICD-10 CM and the WHO-ICD-10 and the partial mapping 
between the CIM-10 and the WHO-ICD-10 from the UMLS Metathesaurus and LOOM 
algorithm, which is available through the NCBO API. Then, we matched each 
terminology using the different mapping files mentioned above. And finally, we used 
manual review and natural language processing (NLP) to recognize labels between the 
two terminologies with custom R scripts. The NLP process was only used on unmatched 
codes after the two first steps. For each set, one native-speaking investigator from each 
language extracted the two or three main words of the ICD or CIM label, then they built 
together a translation dictionary and used rules-based NLP to match the labels and codes. 
For the remaining unmatched codes, we mapped them to their three-character codes 
parent. After all these steps, we considered the code unmatched if we could not find an 
exact or approximate match. 
 
Figure 1. Forward and backward mapping methods 
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Since the automated mapping was based on official mapping files, we did not review 
those matched codes. However, we reviewed manually all NLP-based matches before 
confirming their match or un-match status. Uncertain pairs were reviewed again by two 
other medical investigators. 
3. Results 
The ICD-10 CM included 91,737 codes and the French ICD-10 included 39,928 codes, 
including the 3-charcters codes parents. The ICD-10 CM had 9835 (11%) of 4-characters 
codes while the ICD-10 had 12,345 (31%) of 4-character codes.  
Among the 39,928 codes of the CIM-10, 8,477 (21.2%) were exact matches to the ICD-
10 CM and 29,131 (73 %) were partial matches. 264 of those partial matches were based 
on the NLP-based step. There were 2,320 (5.8%) missing codes. 
Among the 91,737 codes of the ICD-10 CM, 9,082 (9.9%) were exact matches and 
82,655 (90.1 %) partial matches with no unmatched codes. 226 of those partial matches 
were based on the NLP-based step. There were no missing codes. 
All the NLP-based matches were true positives with no false negatives. Overall, the 
backward mapping was 94.2%, while the forward mapping was 100%. (Table 1) 
 
Table 1. Characteristics of all matches after the forward and backward mappings 
Mapping Exact Match Partial Match* No match 
  
>4-characters code 
to one 4-character 
code 
>4-characters code 
to more than one 
4-characters code 
4-characters code 
to more than one 
4-characters code 
4-characters codes 
(or more) to the 3-
characters parent 
 
ICD-10 to 
ICD-10 CM 8,477 (21.2%) 4,832 (12.1%) 23,345 (58.5%) 932 (2.3%) 22 (0.1%) 2,320 (5.8%) 
ICD-10CM 
to ICD-10 9,082 (9.9%) 41,518 (45.3%) 33,893 (36.9%) 1,797 (2%) 5,447 (5.9%) 0 (0%) 
*The partial match includes the codes matched using the Natural Language Processing (NLP) step 
4. Discussion 
Our method showed a very high matching score, especially regarding the backward 
mapping (ICD-10 CM to ICD-10) with 100% of codes matched. However, the exact 
match was far better in the forward mapping (21% versus 10% in the backward). The 
manual evaluation confirmed the accuracy of the rules-based NLP algorithm. 
Our study has several limitations. First, we only tested the method with two 
languages (French and English). However, we only had native speaking experts in 
French and English available for the manual review and most countries use either the 
ICD-10 CM, or a fairly close version of the WHO ICD-10 for reimbursement and 
billing[1]. Therefore, we knew that if our mapping process was accurate it would be 
relatively easy to adapt it to other languages. Second, our NLP was rather basic because 
we wanted first and foremost to use already existing reference files. Previous 
studies[11,12] showed that NLP based on modern machine-learning methods is the most 
pertinent method to match a diagnostic to an ICD-10 code or to translate a terminology 
to another language, but it is a very specific field with few experts, especially outside of 
the English language. The idea here was to propose an alternative when NLP specialists 
are not available to implement automatic translation and/or matching algorithms. Finally, 
most of our matches are partial. A majority of exact matches would have been ideal, 
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especially since the ICD-10 is not always very precise regarding some diagnoses[13], 
but since the WHO-ICD-10 and the ICD-10-CM have a vastly different number of 
codes[3], this outcome was predictable.  
Manual mapping for multilingual ontology alignment is still the gold standard today, 
but it requires several experts of the healthcare and ontology fields and is a very time-
consuming work that can take years[14]. This method cannot make the same claims of 
precision as official manual mapping files, but it could become a fairly quick and reliable 
process for international studies based on secondary reuse of EHR and billing data 
(including legacy data coded in ICD-9 CM, thanks to the GEM files from the NCHS[8]) 
without any ontology or translation experts.  
5. Conclusion 
Our study demonstrated that semi-automated mapping based on reference mapping 
files (in standard format) and basic NLP could be considered for secondary reuse of EHR 
and billing data from different countries when there are no existing reference files. Next, 
we would like to replicate this study with ICD-10 in other languages and use more 
automated NLP resources, like the Google Translate API, to confirm the accuracy of this 
method. This work could also serve as a basis for semi-automated mapping of the ICD-
10 to the ICD-11, once the official ICD-10 to ICD-11 mapping files are available. 
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Abstract. The acquisition of medical images from multiple medial institutions has 
become important for high-quality clinical studies. In recent years, electronic data 
submission has enabled the transmission of image data to independent institutions 
more quickly and easily than before. However, the selection, anonymization, and 
transmission of medical images still require human resources in the form of 
clinical research collaborators. In this study, we developed an image collection 
system that works with the electronic data capture (EDC) system. In this image 
collection system, medical images are selected based on EDC input information, 
patient ID is anonymized to a subject ID issued by the EDC, and the selected 
anonymized images are transferred to the research institute without human 
intervention. In the research institute, clinical information registered by the EDC 
and clinical images collected by the image collection system are managed by the 
same subject ID and can be used for clinical studies. In October 2019, our image 
collection system was introduced to 13 medical institutions and has now begun 
collecting medical images from the in-hospital picture archiving and 
communication system (PACS) of those institutions. 
Keywords. Multicenter clinical study, Electronic data submission, Medical image  
1. Introduction 
Assessments of medical images are often needed in multicenter clinical studies. To 
ensure the quality of image analyses, imaging core labs that collect medical images 
taken at multiple medical institutions in one place and analyze them in a defined way 
are needed [1, 2]. Regarding image analyses by artificial intelligence (AI), a large 
amount of medical images are required [3, 4]. For this reason, a system that supports 
efficient image collection from independent institutions is required. 
For the protection of patient information, medical images used for clinical research 
must be anonymized at each medical institution. Medical images stored in the digital 
imaging and communications in medicine (DICOM) standard can be anonymized by 
rewriting the DICOM tag information. However, in a non-DICOM image, patient 
information is described in the image, and it is necessary to erase patient information 
by image processing for anonymization. 
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Clinical information must be collected in addition to images for subsequent 
analyses. Such clinical information is often collected via an electronic data capture 
(EDC) system [5, 6]. In EDC system, anonymization is usually performed by replacing 
the patient ID with the subject ID. For efficient data analyses in a research institute, the 
anonymization of clinical images is also performed using the same subject ID. 
In recent years, electronic data submission has enabled the transmission of image 
data to independent institutions more quickly and easily than before [7]. However, 
research collaborators in each institution still need to select the medical images, 
anonymize the patient information, and perform the electronic transfer itself. When it is 
difficult to replace the patient ID with the subject ID, a correspondence table must be 
created between the image anonymization ID and the subject ID and sent to the 
relevant research institute. These tasks require substantial effort from research 
collaborators, who are already busy with their clinical work. 
We developed an EDC system that collects clinical information in cooperation 
with electronic medical records (EMRs) [8]. The doctors in each collaborating 
institution enter clinical information via template of the EDC system which can retrieve 
the data recorded in the EMR. The EDC system outputs narrative text of input data to 
the progress note of the EMR. The EDC system also maps the input data to the 
operational data model (ODM) developed by Clinical Data Interchange Standard 
Consortium (CDISC) and sends to the research institute. The EDC site server 
anonymizes the patient ID and issues a subject ID, maintaining a correspondence table 
of the patient and subject IDs.  
In the present study, we developed an image collection system that works with our 
EDC system. In this image collection system, medical images are selected based on 
EDC input information, a patient ID is anonymized to a subject ID issued by the EDC 
system and the selected anonymized medical images are transfer to the research 
institutes. 
2. System Overview 
The image collection system is divided into image acquisition from the picture 
archiving and communication system (PACS) and that from non-DICOM server. The 
EDC site server and the image acquisition gateway were set up in each collaborating 
institution (Figure 1), while the EDC center server and image-receiving server were set 
up in the research institute. A virtual private network (VPN) internet connection was 
used for connections between the research institute and each medical institution. 
 
 
 Figure 1. System overview  
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3. Collection of images stored in the DICOM standard in prospective studies 
3.1. Image acquisition and anonymization by the image acquisition gateway 
The image acquisition gateway asks the EDC site server about image information to be 
acquired. This information includes the patient ID, observation date, modality, and 
observation area. The subject ID is also obtained at this time. Next, the gateway 
searches the PACS for the target images using a query and retrieve (Q/R) connection. 
The patient ID described in the DICOM tag of the acquired images is then anonymized 
by replacing it with the subject ID issued by the EDC system. Finally, the gateway 
transfers the anonymized images to the image receiving server in the research institute. 
3.2. Transmission of information from the EDC to the image acquisition gateway 
Our EDC system is designed to enter clinical information using templates for each 
event. For the image to be collected, the item of “observation date” is set in the 
template. When a study using collected images is registered to the EDC, the EDC 
outputs the ODM files of the input template data to the predetermined folder at a time 
fixed by the scheduler (Figure 2). The output ODM file name is composed of the 
“patient ID”, “Study OID”, “Event OID”, “ODM file output date and time”. ?Subject 
ID”, and input data, including the “observation date”, are described in the ODM file. 
 
 
Figure 2. Transmission of information from the EDC to the image acquisition gateway 
 
We defined the configuration file for collecting images beforehand and registered 
it to the image acquisition gateway. In the configuration file, information about the 
location of the “observation date” described on the template are defined. The location is 
identified by the “Study Code”, “Study Event OID”, “Form OID”, “Item Group OID”, 
and “Item Data OID”. In the configuration file, the “modality”, “observation area”, and 
“search period” based on the “observation date” are also defined. The image 
acquisition gateway acquires search conditions for images to be acquired from the 
ODM file output by the EDC system and the configuration file registered beforehand 
and searches for images stored in the in-hospital PACS. Figure 3 shows an example of 
a configuration file for extracting images from the in-hospital PACS. 
 
 
Figure 3. The EDC template and its configuration file for collecting images 
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4. Collection of images stored in the non-DICOM standard 
For the collection of non-DICOM images, the research collaborators must select the 
images and output them to a specific folder (Figure 1). Next, the patient information 
described in the selected images is masked using the image acquisition software 
program. This program can set a plurality of masking patterns in advance, and one of 
them is set as the main masking pattern for each project. After masking the patient 
information, the images are converted to the DICOM format, and the patient IDs in the 
DICOM tag are anonymized to the subject IDs issued by the EDC system. The images 
are then transferred to the image-receiving server placed in the research institute. 
The application can collect the image information from the image folder and file 
name. There are two patterns for collecting image information: (1) a pattern that sets a 
delimiter and corresponds to variable-length information, and (2) a pattern that does not 
set a delimiter and corresponds to fixed-length information. Figure 4 shows an example 
of the image information collected from a folder and file name. 
 
Figure 4. Collection of the non-DICOM image information 
5. Collection of images stored in the DICOM standard in retrospective studies 
Images obtained in the past may need to be collected in bulk, such as for image 
analyses using AI. However, as the PACS is designed to be used on a per-patient basis, 
the selection and download of images must be performed by launching the PACS 
viewer for each patient. The image collection system can batch download medical 
images, anonymize the patient ID to the subject ID, and send the images to the research 
institute according to the acquisition conditions defined in the csv format file. 
6. Introduction status of our image collection system 
On October 1, 2019, our image collection system was introduced to 13 medical 
institution, and medical images began to be collected from these centers’ in-hospital 
PACS, which had been developed by 4 PACS manufacturers. 
7. Discussion 
As discrepancies may occur between the image analysis results assessed by an imaging 
core lab and those obtained by study sites, it is necessary to collect images at a single 
institute to maintain the quality of clinical research involving image analyses [1]. 
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Although the submission of imaging data in an electronic format has begun to spread, 
the tasks of selecting, anonymizing, and transferring data still pose a substantial burden 
to research collaborators. This results in a limited number of medical institutions 
cooperating in image collection. Our image collection system selects the images to be 
collected, anonymizes the patient information, and transfers them to the research 
institute. Since the images to be collected are determined on a study-by-study basis, the 
modality and observation area of the images are entered into the configuration file and 
registered in the image acquisition gateway, so that research collaborators only need to 
add the observation date of the images to the EDC template. This image collection 
system may facilitate multi-center clinical studies. 
For images stored in the DICOM format, patient information is only described in 
the DICOM tag. Therefore, automatic anonymization can be easily achieved. In 
contrast, the images stored in the non-DICOM format may include sensitive patient 
information, so image processing is necessary for anonymization. To ensure reliable 
anonymization, automatic anonymization should not be performed. However, setting 
the masking area and performing the automatic acquisition of image information from 
the folder and file names will assist in collecting non-DICOM images. 
8. Conclusion 
We developed an image collection system that automatically selects, anonymizes, and 
transfers medical images based on the EDC input information. 
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Abstract. We here describe the evolution of annotation guidelines for major clini- 
cal named entities, namely Diagnosis, Findings and Symptoms, on a corpus of ap- 
proximately 1,000 German discharge letters. Due to their intrinsic opaqueness and 
complexity, clinical annotation tasks require continuous guideline tuning, begin- 
ning from the initial definition of crucial entities and the subsequent iterative evo- 
lution of guidelines based on empirical evidence. We describe rationales for adap- 
tation, with focus on several metrical criteria and task-centered clinical constraints 
Keywords. Clinical text corpus, German discharge summaries, Annotation 
guideline 
1. Introduction 
The annotation of clinical documents is a challenging task due to the intrinsic opaque- 
ness and complexity of the clinical domain. Clinical experts do not necessarily agree on 
fundamental judgments relevant for annotation decisions, e.g., the distinction between 
symptoms, diagnoses and other medically relevant phenomena. Reports of medical 
annotation campaigns often disregard this lack of conclusiveness insofar as the pain-
staking adaptive processes underlying the vernier adjustment of annotation guidelines 
are hidden from the scientific community. Most often only the final outcome of 
consensus-seeking processes is made publicly available. Annotated clinical text corpora 
focusing on diagnoses came up with clinical shared tasks, e.g., I2B2 [1], CLEF EHEALTH 
[2], and SEMEVAL [3]. The annotation of major clinical entities is typically considered 
as a very hard decision task, with agreement scores (F-scores, -or -values) usually in 
the range between 0.7 and 0.8, even after several modification rounds for annotation 
guidelines (see Table 1 for an overview of previous annotation campaigns related to 
clinical documents). 
We here want to shed light on the impact of different annotation policies and propose 
robust metrical decision criteria in order to find out which kinds of adaptive steps have 
particular impact on annotators’ (dis)agreement and how such factors can be controlled 
by empirical evidence. We illustrate an evolutionary approach to the development of 
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annotation guidelines for major clinical named entities, namely Diagnoses, Findings and 
Symptoms, on a corpus of roughly 1,000 German discharge summaries.  
Table 1. Overview of clinical annotation studies, incl. annotated entities and agreement scores (F-score, 
Cohen’s (c), Siegel and Castellan’s (s&c) or Krippendorff’s ) 
Authors Data Annotated Entities Agreement 
	

		
	
Wang et al. [4] 300 clinical notes SNOMED-CT concepts F 088 
Savova et al. [5] 273 clinical notes UMLS semantic groups c 0727 
Dog˘an et al. [6] 793 PubMed abstracts diseases F 09 
Albright et al. [7] 13K pathol. report sentences UMLS semantic groups F 07075
Hahn et al. [8] 200 Medline abstracts diseases, symptoms, anatomy s&c 0708
Patel et al. [9] 5K different documents UMLS semantic groups c 068097

		
			
	
	

	
Min˜arro- 
Gime´nez et al. [10] 
60 short texts terminology terms SNOMED-CT and 
UMLS 
0409
Kors et al. [11] 800 Medline titles, 500 drug 
labels, 150 patent claims 
biomedical concepts based on UMLS 
semantic groups 
F 079 
	

		
	
Toepfer et al. [12] 140 German ECG reports fine grained information extraction F 0955 
Skeppstedt et al. [13] 1,148 Swedish EPR reports disorders, findings, pharma F 069088
Campillos et al. [14] 500 French clinical notes entities derived from 
UMLS semantic groups 
F 0793 
He et al. [15] 138 Chinese documents F 0992 
 
2. Methods 
Data and Annotation Setup. This work was carried out on the Jena part of the 3000PA 
text corpus [16]—1,106 German discharge summaries from the Jena University 
Hospital’s information system given the following constraints: patients had stayed for at 
least five days on a ward for internal medicine or in an intensive care unit between 
2010 and 2015, and were already deceased. These criteria were approved by the local 
ethics committee (4639-12/15). The corpus consists of approx. 170K sentences and 
1.5M tokens. The documents were annotated (using the Brat Rapid Annotation Tool) 2by 
eight medical students who all had passed their first medical licensing exam. We ran 
through four iterations of guideline revisions, tool configuration, team instruction, 
annotation work, agreement computation, error analysis and subsequent team discussion. 
This process was supervised by one annotation manager. In each iteration, 5 to 10 
documents and 50 in the final round were annotated by each student (for agreement 
values see Table  2). 
Evaluation Measures. A challenging problem for medical annotations is posed by de- 
termining the proper text span of named entities. We thus calculate inter-annotator agree- 
ment (IAA) by using the pair-wise average F-score [17] of instances and tokens. An 
instance is a single composite annotation unit that consists of one or more tokens (e.g., 
“renal insufficiency” denotes an instance with two tokens, “renal” and “insufficiency”). 
Instance agreement is a strong criterion, as annotations with only slightly differing spans 
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count as non-matching. Token-based agreement describes the overlap of individual to- 
kens for annotations of the same instance type3.  
Table 2. Inter-annotator agreement (IAA; pair-wise average F-score incl. standard deviation ()) of training 
iterations and the final annotation round (incl. the number of documents being used per iteration (in brackets)), 
for each document over all eight annotators w.r.t. instances (inst.) and tokens (tok.) 
 Iteration 1 (10) Iteration 2 (5) Iteration 3 (10) Iteration 4 (10) Final (50) 
Category inst. tok. inst. tok. inst. tok. inst. tok. inst. tok. 
Diagnosis .504 .633 .534 .630 .593 .705 .614 .688 0.637 0.758 
Findings .354 .545 .698 .896 .682 .887 .628 .864 0.684 0.860 
Symptoms .583 .617 .441 .657 .424 .729 .532 .669 0.611 0.718 
Anatom. Loc. .455 .624 .735 .876 – – – 
Procedures .252 .301 .527 .580 – – – 
Avg. F-score .410 .563 .671 .832 .653 .873 .621 .837 .648 .839 
(F-score) .079 .076 .056 .030 .064 .027 .065 .036 .056 .032 
 
Annotation Schema. We started our annotation campaign with five types of medical 
entities: Diagnosis as diseases as listed in the ICD-10 (excluding symptom chapter ‘R’); 
Findings as the summary of all information about a patient’s medical status reported  
by medical staff based on the results from physical examination or the use of medical 
devices (e.g., x-ray); Symptoms as the summary of all health affecting information and 
complaints reported by the patients or their relatives; Anatomical Location as the sum- 
mary of all anatomical parts of the body excluding body fluids and body secretions; Pro- 
cedures as the summary of all medical interventions like surgery, non-surgical therapeu- 
tic measures, etc. The administration of (new) medication belongs to the latter category, 
but was excluded here since medication had already been annotated elsewhere [16]. 
Iterative Process. The average agreement value (F-score) of the first iteration reached 
.410 on instances and .563 on tokens which is clearly below expectations. During the sec- 
ond iteration Anatomical Locations were automatically pre-annotated based on the Ger- 
man part of the Foundational Model of Anatomy (FMA) of the UMLS using the JUFIT 
tool. This step increased the IAA for Anatomical Location up to .735 on instances and 
.876 on tokens. Still, it was removed from further annotation rounds because of its 
overlap with mentions of Diagnoses, Findings or Symptoms. Also discussions with the 
annotators pointed at a painfully large number of single decisions and double annotations 
to be made resulting in an average annotation time of one hour per document. In par- 
ticular, distinguishing Procedures from Medications (e.g., “long-term oxygen therapy”) 
and Diagnoses was considered a difficult task—a previous intervention can be coded as 
Procedures and Diagnoses (e.g., Z98.8—Other specified postsurgical states). As a clear 
criterion to minimize the overlap between Diagnoses and Procedures could not be found 
we eliminated Procedures from the current annotation project and will deal with it sepa- 
rately. Following the approach of Hahn et al. [8] for annotating long and short text spans, 
we required the attribute Complexity to be tagged for all entities containing more than 
one piece of annotation-relevant information (e.g. “Pupils middle and isocor”). Diagno- 
sis, Symptoms and Findings were assigned two attributes: Time with the value set previ- 
ous, recurrent, uncertain and Modality with the value set suspected, excluded, uncertain. 
Negations or vague descriptions were defined to be part of the long annotation span. 
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

Baseline Classifier. We trained a (CRF-based) JCORE pipeline for named entity recog- 
nition of Diagnosis, Findings and Symptoms; evaluation with 10-fold cross-validation. 
Table 3. Instances and tokens of entity types Diagnosis, Findings, Symptoms, with the percentage distribution 
of their attributes Complexity, Modality, Time; baseline classifier (BC) results (avg. token distribution depend- 
ing on all of the 1.863M tokens; all other percentage values depending on the total number of entity instances) 
3. Results 
The final average IAA values were .648 on instances and .839 on tokens (see Table 2). 
Table 3 illustrates the distribution of the different entities and their attributes. About one 
third of the entire corpus consists of Findings. Diagnoses added up to around 6.6%, 
whereas Symptoms were rare with less than 2%. Around 13% of all annotations were 
marked as complex; roughly every fifth instance of Findings and Symptoms contained 
more than one information unit. Compared to Findings and Symptoms, Diagnoses were 
more precisely described. 10–20% of all annotations were negated. The majority of 
negated entities were Symptoms and Findings ( 20%). The attributes suspected and 
uncertain were rarely used, only about 5% of Diagnosis annotations were marked as 
suspected. Temporal annotations of Findings and Symptoms were hardly used,    7%    
of Diagnoses were previous. The average F-score results of our (admittedly simple) 
CRF-based classifier are .805 for Findings, .475 for Diagnosis and .143 for Symptoms. 
4. Discussion 
The final IAA values (0.7–0.8) could be improved and are comparable to, if not higher 
than, annotation campaigns covering the listed entity types in languages other than 
German (cf. Table 1). Category overlap or hard to disentangle semantic 
interdependencies must be resolved for the sake of acceptable IAA values—either by 
generalizing cate- gory definitions, by stretching the granularity of annotation spans, by 
adding complexity markers (thus delegating finer distinctions to future annotation 
studies), or, in the worst case, by eliminating sloppy named entity types from the 
current annotation process. 
5. Conclusion 
We presented an evolutionary approach to an annotation scheme for Diagnoses, Findings 
and Symptoms and its application to German discharge summaries. We struggled with 
 
 
 
Inst. Tokens Avg. 
span 
Com- 
plexity 
Modality 
sus. exc. unc. 
Time 
rec.    unc. pre. 
BC 
Entity type freq. freq. % tok. % % % % % % % F 
Diagnosis 55K 123K 6.6 2.2 3.46 4.44 9.31 1.49 0.67 0.01 6.66 .475 
Findings 150K 663K 35.6 4.4 17.15 1.24 17.36 1.40 0.13 0.02 1.81 .805 
Symptom 8K 26K 1.4 3.3 14.21 0.10 22.16 0.13 0.96 – 1.57 .143 
Annotations 163K 812K 43.40 3.8 13.50 2.02 15.45 1.38 0.30 0.01 3.05 – 
C. Lohr et al. / An Evolutionary Approach to the Annotation of Discharge Summaries 31
criteria that control the number of iterations and the directions of adaptations. 
Generalizing from the our annotation task, we found that IAA is a solid metrical 
indicator for task complexity or inconclusive annotation guidelines. Both parameters 
have to be tuned in case of too low IAA values. Annotation time is a metrical indicator 
for task complexity. 
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Abstract. Development of vascular collaterals in a lesion area is one of the key 
factors that determine not only the choice of treatment for ischemic stroke (IS) 
patients, but also outcome and therapy effectiveness. The main method for 
examining the vessels’ ramification is CT angiography (CTA). CTA analysis may 
be improved by incorporating filters designed to extract more features about vessels 
and quantify their level of development. This work suggests the usage of radiomics 
methods in the analysis of vesselness measure calculated from CTA images. 
Vesselness measurement is based on the analysis of the Hessian matrix with a few 
modifications dictated by practical aspects of this issue. The developed algorithm 
was implemented as a filter that generates a new 3D image, every voxel of which 
has the probability of belonging to a vessel-like structure. Further analysis of the 
distribution of vesselness in the lesion area and in the intact contralateral area was 
conducted with the methods from the open library PyRadiomics. A set of radiomics 
features was calculated. Preliminary analysis on a sample of 30 IS patients showed 
the presence of significant differences between afflicted and intact hemispheres. 
Keywords. Collaterals, imaging biomarkers, ischemia, tomography 
1. Introduction 
Ischemic stroke (IS) is one of the leading causes of death and disability in the world [1]. 
The outcome of IS depends not only on the timeliness of the reperfusion therapy but also 
on the intensity of collateral flow [2]. The absence of well-developed collaterals leads to 
an increase in the volume of necrotized tissue and to a decrease in the effectiveness of 
treatment [3]. In daily practice, CT angiography (CTA) is used as the main method for 
visualizing of vascular anatomy. However, it is very common among radiologists to 
analyse CTA images manually, resulting in subjectivity of the assessment. Cutting-edge 
methods of image processing, including vesselness calculation algorithms, may be of 
help in addressing this problem, by providing an automatic measure of collateral status. 
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Vesselness calculation involves assessment of the probability of each voxel 
belonging to a vessel-like structure [4]. According to literature, there is a possibility of 
using vesselness to resolve some clinical challenges in treatment of IS patients [5-7]. 
Currently, most of studies include analysis of variables based only on the volume of 
vessel-like structures, but not on their spatial behavior and other characteristics. At the 
same time, one of the most perspective directions of modern medicine is the analysis of 
radiological images, specifically radiomics [8-10]. It allows extracting numerous 
features including those that describe shape and texture from radiological images. So, in 
the line with the above, the aim of the presented work was the application of radiomics 
methods in the analysis of vascular behavior calculated from the CTA images of the 
patients with IS. 
2. Methods 
This pilot study included data of 30 patients (74 years old (IQR 57-80), 18 males, 12 
females) admitted to the N.V. Sklifosovskiy Scientific Research Institute of Emergency 
Care with IS in the territory of the middle cerebral artery (up to 5 hours from stroke 
onset). The examination of the patients was performed with multi-slice CT-scanner (GE 
Medical Systems), with pixel spacing of 0.44 x 0.44 mm, and slice thickness of 0.5 mm. 
We used CTA images obtained on the admission of a patient to the hospital, and images 
from non-enhanced CT conducted on the second day after IS onset, when the ischemic 
region was already visible as a hyperdensive area. The last ones were used for contouring 
of the regions of interest (ROI) that was conducted by two radiologists (Figure 1, A). 
Each of them had more than 20 years of experience. 
Brain normalisation was conducted to build a symmetrical area and to transfer both 
areas (with damaged and intact brain tissues) onto the CTA series (Figure 1, B and D). 
It was performed with the set of instruments described in the Advanced normalisation 
tools (ANTS) [11] that allowed coregistration of a brain to a template image using linear 
affine and warp transformations.  
Then, CTA images were processed through the vesselness filter (Figure 1, C). The 
vesselness calculation was based on the following key concept: if we look at every voxel 
of a 3D image and evaluate the function of the derivative of intensity along three 
orthonormal directions, then it is possible to establish criteria for a voxel belonging to a 
tubular structure. The mathematical representation of this is the Hessian matrix 
calculation with second-order partial derivatives, and the assessment of its three 
eigenvalues λ1, λ2, λ3 sorted in ascending order [4]. This method successfully identifies 
vessels, but it causes a decline of vesselness value in vessel bifurcation points. To address 
this issue, [7] proposed using λp as a regularized value, which is computed depending on 
the maximal value of λ3. 
Based on the latter, we developed a vesselness filter, but made some changes to 
adaptation to further clinical research work. First, as the original CT images are noisy, it 
was necessary to smooth them to make them better suited for vessel analysis. The 
minimisation of noise is determined by the size of vessels that we are looking for and by 
the resolution of the CT scanner (0.7-1.4 mm). Thus, we applied the Gaussian filter with 
σ=0.7 mm. This allowed us to determine the Hessian matrix more robustly while keeping 
information about small vessels. Second, we adapted the approach proposed in [7] to λp 
regularization. λp depends on the maximal value of λ3 throughout an image. In this case, 
even if we have a fairly smooth image with relatively meagre vascularity, we find a lot 
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of vessel-like structures. So, the results of vesselness analysis for different images and 
patients are not comparable. To avoid this, we decided to exclude the dynamic nature of 
λp and fix the maximum value of λ3 at 400 HU/mm2. The filter was implemented in our 
previously developed platform for medical images analysis [12].  
The initial CTA images of 30 patients were processed through it, and new 3D images 
were generated. Each voxel has a vesselness value which measures the similarity of the 
voxel to a vessel-like structure. As the total sum of vessel-like voxels is very sensitive to 
the threshold of vesselness, we decided to implement the calculation of other features of 
the filtered images, describing other morphometric and distribution aspects of vesselness. 
The open library PyRadiomics was used to calculate 75 features of damaged and intact 
areas [13-14]. They included first-order statistics (FO) and second-order statistics which 
were based on analysis of the grey-level co-occurance (GLCM), grey-level size zone 
(GLSZM), and grey-level run-length (GLRLM) matrices. 
 
Figure 1. Scheme of the image processing for the calculation of radiomics features of vesselness (A – 
semiautomatic segmentation of ROI with damaged tissue on non-enhanced CT, B – automatic segmentation 
of ROI in the intact area, C – Application of vesselness filter on CTA images, D – copy of two ROIs to the 
filtered CTA images) 
3. Results 
Comparative analysis of 75 features in damaged and intact areas of 30 patients showed 
the presence of statistically significant differences in 57 parameters (р<.05, the Wilcoxon 
signed-rank test). For 48 of them these differences were highly significant (p <.001). We 
evaluated their relative change against the intact side to select the most informative 
features. It the confidence interval of a feature’s relative change contained zero, the 
feature was excluded. Thus, the following list of features with the most pronounced and 
stable changes was formed (Table 1). 
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Table 1. The magnitude of the features’ relative change in comparison with intact area. 
Feature Group Feature Name Relative change P-value 
FO Energy ?79.3 (IQR 12.3-91.0) % <<0.001 
Variance ?79.6 (IQR 11.1-91.2) % <<0.001 
Entropy ?34.9 (IQR 11.1-91.2) % <<0.001 
GLCM Contrast ?81.4 (IQR 21.9-47.7) % <<0.001 
Difference Variance ?81.5 (IQR 21.0-91.0) % <<0.001 
Joint Entropy ?34.5 (IQR 23.3-47.3) % <<0.001 
GLRLM High Grey Level Run Emphasis ?72.0 (IQR 10.0-84.6) % <<0.001 
GLSZM Large Area Emphasis ?133.2 (IQR 10.9-228.1) % <<0.001 
Size-Zone Non-Uniformity ?71.9 (IQR 14.9-84.9) % <<0.001 
Zone Variance ?133.1 (IQR 10.9-228.0) % <<0.001 
As you can see in the table 1, the damaged areas show a decrease in energy and 
variance as a result of reduction in the number of vessel-like voxels. GLCM features 
indicated a decrease in the homogeneous patterns in the image. Changes in size-zone 
non-uniformity and zone variance of GLSZM reflect the fact that the distribution of 
zones with the same intensity level was modified in the damaged ROIs. 
4. Discussion 
One of the most effective ways to improve the quality of treatment for IS patients is to 
implement the advanced technologies of intellectual analysis and image processing into 
interpretation of the results of neuroimaging examinations. Assessment of the collateral 
status on the CTA allows predicting effectiveness of revascularization surgeries and 
long-term outcome of a clinical case, hence providing the decision support in the 
choosing of the treatment tactics for patients. 
In this work we detected a large difference between damaged and intact areas in 10 
features describing vesselness behavior. An interesting aspect of these preliminary 
results was that some of these features indirectly described the volume of vascular tree 
or a number of bright voxels (e.g., energy, variance, root mean squared), but others 
outlined the homogeneity of regions of interest (e.g., entropy, contrast of GLCM, size-
zone non-uniformity and zone variance of GLSZM). 
It is important to note that with the application of radiomics methods to the initial 
images of CTA it is difficult to explain whether the discovered differences in the features 
are caused by the changes in vessels or in the brain tissue. At the same time, the 
physiological interpretation of the images resulting from the use of the vesselness filter 
is simpler as all changes are only related to voxels of vessels. 
Limitations to this study include its retrospective design and a small sample size. 
Also, we didn’t have a control group to investigate the behavior of the features for 
healthy people. In the future work we will try to address these limitations. 
5.  Conclusion 
In this paper, we presented a method of quantitative assessment of collaterals based on 
the analysis of vesselness measure. The suggested procedure includes the calculation of 
vesselness with an algorithm developed by Jerman et al, modified by using Gaussian 
filters and fixing the maximum value of λ3. The result of the application of the vesselness 
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filter is proposed to analyse with the radiomics methods, effectively investigating not 
only the volumetric characteristics of vesselness, but also the pattern of its distribution. 
Comparison analysis of extracted features of vesselness between the afflicted and the 
intact ROIs had shown that there are significant differences in a number of parameters. 
This makes it possible to develop clinically relevant measures for assessment of 
collaterals and prediction of treatment outcomes in further work.  
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Abstract. Nursing Minimum Data Sets (NMDS) intend to systematically describe 
nursing care. Until now NMDS have been populated with nursing data by manual 
data ascertainment which is inefficient. The objective of this work was to evaluate 
an automated mapping pipeline for transforming nursing data into an NMDS. We 
used LEP Nursing 3 data as source data and the Austrian and German NMDS as 
target formats. Based on a human expert mapping between LEP and NMDS, an 
automated data mapping algorithm was developed and implemented in an automatic 
mapping pipeline. The results show that most LEP nursing interventions can be 
matched to the NMDS-AT and G-NMDS and that a fully automated mapping 
process from LEP Nursing 3 data to NMDS-AT performs effectively and very 
efficiently. The shown approach can also be used to map different nursing 
classifications and to automatically transform point-of-care nursing data into 
nursing minimum data sets.  
Keywords. nursing minimum data sets, data mapping, secondary use of nursing data, 
electronic health record, standardized nursing terminology, health informatics 
1. Introduction 
Nursing data must be documented in a standardized and structured way in Electronic 
Health Records (EHR) to allow meaningful data exchange in an eHealth environment. 
Structured electronic documentation also enables reuse of data from the nursing process 
for multiple purposes such as quality management or research ("Collect once, use many 
times" paradigm) [1]. LEP Nursing 3 (“Leistungserfassung in der Pflege”, i.e. nursing 
workload measurement) is a classification of around 500 nursing interventions. It allows 
structured care planning and documentation, together with nursing workload 
measurements [2]. At the moment, around 650 health care services in Germany, 
Switzerland, and Austria are using LEP in their EHR and for statistical evaluations of 
nursing data. LEP is semantically based on International Classification for Nursing 
Practice (ICNP) and is structured according to ISO-18104 [3].  
Nursing Minimum Data Sets (NMDS) have been proposed to systematically 
describe nursing care and defined as ‘systematic registration of the smallest possible 
number of unequivocally coded data, with respect to or for the purpose of nursing 
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practice, making information available to the largest possible group of users according 
to a broad range of information requirement’ [4].  
NMDS aim at supporting nursing managers, health policy decision-makers, public 
health experts, and nursing researchers [5]. They may lead to following benefits: access 
to comparable nursing care data on a local, regional, national, and international level; 
description of nursing care in different populations and variety of settings; availability 
of data for research activities; evaluation of costs and outcomes of nursing care; 
benchmarking of nursing quality indicators; extrapolation of trends in nursing care; and 
allocation of resources of hospitals [6, 7, 8]. 
In Austria, the NMDS-AT [8, 9, 10] and in Germany the G-NMDS [11] have been 
developed in recent years. However, up to now these NMDS were only theoretical 
constructs and weren’t populated with nursing data due to two main reasons: First, as 
terminologies used in EHRs may be different from NMDS elements, a mapping between 
different terminology systems is necessary. Second, the usual way to populate NMDS 
by manual data ascertainment is time- and resource-intensive. 
The objective of this work was to evaluate an automated mapping pipeline for 
transforming nursing data documented via LEP Nursing 3 into the Austrian and German 
NMDS. This pipeline should comprise an automated mapping process for transforming 
LEP Nursing 3 data into an NMDS representation and then loading it into the respective 
Nursing Minimum Data Set. 
2. Methods and Materials 
2.1. Human Expert Mapping between LEP and NMDS 
For the manual expert mapping, three raters with LEP and NMDS expert knowledge 
were recruited. First, a training session was held to brief the mapping method. In the 
following first mapping round the source terminology, LEP Nursing 3.3.1, was matched 
to the target formats NMDS-AT and G-NMDS independently by all three raters. After 
that, questions which emerged during the first round and uncertainties concerning special 
mapping rules were discussed and solved in a further briefing session. Then, in a second 
mapping round, the expert mapping was finalized independently by all experts. Resulting 
discrepancies were clarified in a subsequent consensus process [12]. 
LEP nursing interventions offer sufficiently structured information for the mapping 
because LEP is based on ISO reference terminology. The NMDS nursing interventions 
provide additional structural elements compared to LEP and ISO. For example, LEP 
defines the intervention “Performing a full body wash” which related to the NMDS term 
“Body care washbasin/bed/incubator, partial assistance”; in this case, NMDS 
distinguishes the degree of dependency as an additional attribute. Therefore, the mapping 
was supplemented with data describing the patient condition using ICNP and the 
International Classification of Diseases (ICD). For example, nursing assessment data, 
nursing diagnoses or medical information were added to guide the mapping. 
As the mapping of LEP to NMDS includes 1:n matches, interrater reliability was 
assessed using a specially defined metric. The metric for each mapped concept ranged 
from 0 (no match) to 1 (full match). Following scores were assigned: (a) In cases of 
identical mappings including the cases where the rater did not find a mapping, the 
agreement score was set to 1; (b) in cases of partial agreement or the case where one rater 
did not find a mapping but the other did, a score of 0.5 points was assigned; and (c) if 
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the ratings are completely distinct, 0 points were assigned. Intra- and interrater reliability 
were defined as the average of these scores. 
2.2. Automated Data Mapping Algorithm 
Based on the human expert mapping, an algorithm for an automated process for a 
mapping from LEP to NMDS-AT was defined [12]. NMDS-AT was chosen here as a 
first step, it is planned to extend the algorithm to G-NMDS later on. This algorithm 
comprised a five-stage mapping cascade and was implemented using Talend Open 
Studio (TOS, www.talend.org).  
In the first stage, all the cases in which a clear 1:1 mapping between LEP and 
NMDS-AT was possible, were implemented (LEPNMDS-AT). In the second stage, 
medical information (ICD-10 codes of the primary and all secondary diagnoses of the 
respective patient case) was used to make the mapping decision (LEP + ICDNMDS-
AT). For example, the NMDS category “Care of urinary stoma” will be triggered by LEP 
“Attending to stoma” and ICD-10 “N00-N99: Diseases of the genitourinary system”, 
“Z43.5 Attention to cystostomy” or “Z43.6. Attention to other artificial openings of 
urinary tract”. In the third stage, the nursing information of the remaining cases (all 
relevant ICNP codes of the patient case) was evaluated to make the mapping decision 
(LEP + ICNPNMDS-AT). In the fourth stage, a decision was made if certain 
combinations of LEP codes, e.g. “Monitoring cuff pressure/tube” together with 
“Attending to the tracheal cannula” or “Attending to the tracheal catheter” were observed 
in a given patient case (LEP + LEP’NMDS-AT). In the last stage, all remaining LEP 
elements that were not assignable to a corresponding NMDS-AT category were logged 
as ‘not-mappable’. 
2.3. Test Data Set and Automated Mapping  
To test the mapping, an anonymized data set comprising 4,390 patient cases from 7 
hospital wards (from 6 different special fields) was sampled. This dataset included 
789,723 documented LEP interventions (329 different instances of LEP interventions). 
As this dataset, due to anonymization and other organizational requirements, did not 
comprise other patient data such as demographic information, ICD diagnoses or ICNP 
data, a set of 2,000 fictitious test-patients was created. Age, ranging from 0 to 100 years, 
was randomly assigned and gender proportion was set to 50:50. The 4,390 real, 
anonymized cases were then randomly assigned to the test-patients. One primary 
diagnosis from the ICD-10 catalogue was randomly assigned to each case and 3,000 
secondary diagnoses, as well as 3,000 ICNP codes, were randomly assigned to all cases. 
The test cases were stored in a PostgreSQL database for extraction and further processing. 
The automated mapping procedures were compiled and exported from TOS as 
runnable jar files and executed on a MacBook Pro (15-inch, 2017) with 2.9 GHz Intel 
Core i7 CPU, 16 GB of RAM (2,333MHz LPDDR3) and macOS Mojave. The mapped 
cases were collected in a separate PostgreSQL database holding the NMDS-AT. 
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3. Results 
3.1. Human Expert Mapping, Intra- & Interrater Reliability 
A total of 68.8% (369/536) respectively 71.5% (383/536) instances of LEP Nursing 3 
interventions could be matched to 100% of the NMDS-AT (80/80) and G-NMDS (91/91) 
nursing interventions.  
Table 1 shows the intra- and interrater reliability of the NMDS-AT and G-NMDS 
mappings. The intra-rater reliability from the NMDS-AT is somewhat higher than that 
of the G-NMDS (e.g. Intra-rater, Rater 3: NMDS-AT 94.0% > G-NMDS 85.5%). The 
reason for this may be the lower number of nursing interventions in NMDS-AT (NMDS-
AT, n=80 < G-NMDS, n=91). The results of the interrater reliability from mapping round 
2 suggest good agreement with 88.4% at the NMDS-AT and 88.3% at the G-NMDS.  
Table 1. Average percentage of agreement (%) from the NMDS-AT and the G-NMD in consideration of partial 
matches (identical mapping = 1; partial mapping = 0.5; distinct mapping = 0) by 3 raters and 2 mapping rounds 
 Intra-rater Rater 1 
Intra-rater 
Rater 2 
Intra-rater 
Rater3 
Interrater 
Round 1 
Interrater 
Round 2 
NMDS-AT 77.0% 75.3% 94.0% 72.8% 88.4% 
G-NMDS 68.0% 80.5% 85.4% 66.8% 88.3% 
3.2. Automated Mapping, Outcomes & Performance  
The test data set comprised 4,390 real patient cases that had been randomly assigned to 
2,000 fictitious patients. The average number of cases per patient was 2.5 ( 1.3). 
Approximately 50 percent of the cases had at least one secondary ICD-10 diagnose 
(2,355/4,390) respective one ICNP code at least (2,215/4,390).  
All LEP Nursing 3 interventions were aggregated to instances per case and counted. 
The aggregation resulted in 104,278 distinct interventions for all 4,390 patient cases. Of 
these cases, 91 percent could be mapped (3,998/4,390) and were found in the NMDS-
AT. The number of patients that were mapped to the NMDS-AT was slightly lower at 
86 percent (1,729/2,000). The mapping of interventions resulted in a successful match of 
47 percent of all instances (49,188/104,278). From these, 98% (48,204/49,188) were 
mapped in stage 1 (LEPNMDS-AT). Stage 2 (LEP + ICDNMDS-AT) accounted 
for 40 matches, 681 matches were done at stage 3 (LEP + ICNPNMDS-AT) and stage 
4 of the mapping (LEP + LEP’NMDS-AT) yielded 84 matches. 
The execution time of the whole mapping pipeline including data extraction, 
aggregation, mapping, loading and logging was below one second. 
4. Discussion 
In our study, we could show that a fully automated mapping process from LEP Nursing 
3 intervention data to elements of an NMDS-AT does work. 
The manual expert mapping built a solid base for the implementation of the 
automated mapping algorithm. However, just under a third of the LEP Nursing 3 
interventions could not be mapped to NMDS elements by the experts. Mostly, these cases 
were special nursing interventions not covered by the NMDS, such as “Performing 
acupuncture”, indirect nursing interventions, e.g. “Carrying out surgical hand 
disinfection”, or nursing interventions, such as “Organising discharge”. Such nursing 
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interventions without assignment will be reviewed for future developments of the NMDS. 
The automated mapping performed best in the first stage where direct 1:1 mapping was 
possible. In the following mapping stages that require additional medical and nursing 
data the mapping success was suboptimal. This was caused by the fact that sex, age, ICD 
and ICNP codes had been randomly assigned to the fictitious patients. This shows that 
the mapping in these stages is very context-specific. With real patient cases and plausible 
combinations of LEP nursing interventions and medical and other nursing information, 
we would expect significantly improved mapping results.  
5. Conclusion and Outlook 
We successfully implemented and tested an automated mapping from LEP to NMDS-
AT. We expect that it would be equally successful for mapping LEP to G-NMDS and 
comparable NMDS. Our approach is not only feasible for mapping LEP to NMDS, but 
also for other classification systems. All that has to be done is to define the mapping rules 
by human experts and then to implement the mapping cascade algorithm. Our mapping 
pipeline supports the transformation of nursing data from EHRs into a minimum data set 
representation for multiple reuse purposes on a fully automated basis.  
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Automated Spelling Correction for Clinical 
Text Mining in Russian 
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Abstract. The main goal of this paper is to develop a spell checker module for 
clinical text in Russian. The described approach combines string distance measure 
algorithms with technics of machine learning embedding methods. Our overall 
precision is 0.86, lexical precision - 0.975 and error precision is 0.74. We develop 
spell checker as a part of medical text mining tool regarding the problems of 
misspelling, negation, experiencer and temporality detection. 
Keywords. clinical texts, electronic health records, natural language processing, 
spellchecker, Russian, anamnesis, misspelling correction, word embeddings 
1. Introduction 
Predictive modeling in medicine and healthcare is developing rapidly, and the 
quality of modeling results crucially depend on the quality of the input data. In 
these domains, a significant proportion of the information is presented with texts 
in natural language. Feature extraction from medical texts is challenging due to 
the following problems: misprints in medical terms, negation, temporality, and a 
person (experiencer) that have experienced an event (it could be a patient or his 
or her relative. In the present study, our goal is to develop module of spelling 
correction to more accurately process and extract knowledge from clinical 
records in natural language.  
2. Related works 
Processing of clinical texts in natural language is a well-studied problem, mainly 
for the English language. There are many tools for labeling text, extracting 
entities, disease’s cases, temporal and negation detection (UMLS, UIMA, IBM 
Watson, Apache Ruta, etc.), but their require collection of language corpus [1–
4]. In some other countries, scientists develop their own corpus-free machine-
learning tools or tools that can solve problems which are very specific to their 
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language [5, 6, 7]. To our knowledge, for the Russian language, a corpus of 
medical texts has not yet been compiled. There is a small case based on 120 
records with labeled diseases and their attributes (complications, severity, 
treatment, etc.) [8,9]. Machine learning and artificial intelligence are 
increasingly used in medicine and healthcare. As a result, new methods and 
models are developed in NLP to obtain additional features from texts [2,4]. 
To extract knowledge from medical texts it is necessary to cope with many 
challenges: expansion of acronyms and abbreviations, interpretation of domain 
specific words, handling spelling mistakes, temporal tagging, negation detection 
[10,11], etc. There are many solutions for above mentioned problems regarding 
English language (UMLS, UIMA, OHNLP, etc.). However, NLP instruments for 
Russian are very limited and there is no generally accepted system to process 
clinical texts in Russian.  
 
Figure 1. Modules of spelling correction and negation detection. Green blocks indicate methods described in 
this paper. Pink blocks are developed and implemented by colleagues. 
We are developing corpus-independent modules with a spellchecker and a 
negation detector trained on Russian medical texts. Figure 1 shows the scheme 
of language processing application. And it also can be used for similar languages. 
In this research, we used a set of 3434 electronic health records (EHRs) of ACS 
patients who admitted to Almazov National Medical Research Centre (Almazov 
Centre) during 2010-2015. EHRs includes disease and life anamnesis, doctor’s 
reports, discharge report, etc. in natural language. Disease anamnesis are the 
most unstructured records and we used them to demonstrate our approach.  
In order to correct misspelled words, we need to solve three main tasks: find 
incorrect words in text, define the type of mistake and correct the word (Figure 
1). To identify misspelled words, we use external dictionaries of russian words, 
medical terms, drugs, abbreviations, etc. We also broaden the pool with specific 
non-dictionary words of a high frequency from clinical records. Our module 
works with the following types of mistakes.  
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Table 1. Types of misspelled words. 
Type of mistake Incorrect text Corrected text
Word reduction anem anemia 
Missing/ misspeled 
symbols 
anmia anemia 
Multiple words separation hemolyticanemia hemolytic anemia 
 
In current realization we can automatically identify only multiple words mistake 
type by dividing the word sequence into all possible subsequences and evaluating 
if each part is an existing word and their probability to stand next to each other 
in a sentence is high. The basic idea of correction is to replace the incorrect word 
with the most similar correct word from the dict. Our approach combines 
machine learning technics for the word-to-vector representation with more 
traditional approaches of string distance calculations. To measure the 
performance of spell checker, we use lexical precision (which is treated as a 
measure of incorrect words identification), error precision and overall linguistic 
performance. 
3. Method 
The classical approaches to measure words similarity is Levenshtein distance or edit 
distance and its extensions (Damerau-Levenshtein-DL) [13]. It is often used for spell 
correction [15]. It calculates words similarity according to the minimal number of 
basic operations required to get the target word from the other. However, this 
approach doesn’t consider the context provided by the sentence.  
  
Figure 2. Most similar words for word 'patient' based on FastText vector representation (on the right). And 
Most similar words for the word ‘diabetes’ based on Word2Vec vector representation (on the left) 
In order to map words into numerical vectors we use the following word-
embeddings: Word2Vec [12] and also FastText [14] on SG and CBOW. We 
chose Word2Vec and FastText, since they are widely and efficiently used in 
different NLP problems, including spell correction, and leverage context of the 
target word. In simple words both methods build a vector representation using a 
hidden layer of the Neural Network. The difference between models is in token 
representation: FastText treats each word as a vector of n-grams, whether W2V 
uses the whole word. Using such representation, we can easily calculate distance 
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between words with cosine similarity. The example of finding close words is on 
the Figure 2.  
4. Results and discussion 
The methods were evaluated on hold-out sample of randomly sampled 200 
correct medical words and 200 incorrect medical terms. All results are performed 
in Table 2. According to the results, we may conclude that both string distance-
based algorithms and vector-based methods perform poorly when used 
separately. Lev. distance and DL distance are lacking context information and 
the ‘meaning’ of tokens. However, embedding-based approach may confuse 
correct word for the synonym or other related words. That is why our final model 
combines these approaches in the following way. 
Table 2. Results of spell checker experiments 
Method Lexical Precision Error Precision Overall 
Precision 
Levenshtein dist. 0.975 0.52 0.7475 
Damerau–Levenshtein (DL) 
dist 
0.975 0.545 0.76 
Cos. dist. on Word2vec 0.975 0.42 0.6975 
Cos. dist. on FastText CBOW 0.975 0.375 0.675 
Cos. dist. on FastText SG 0.975 0.405 0.69 
FastText + DL dist 0.975 0.745 0.86 
Mean(CBOW, SG, W2V)+DL 
Dist 
0.975 0.745 0.85 
At the first stage, we get top-n similar words according to our word-model 
trained on anamnesis text, then we select m words from the dictionary and top-n 
words, by minimal DL distance. We also tried different ensembling approaches 
(voting, bagging, etc.), however it outperformed the others. The error analysis 
allows us to suggest, that, in general, Levenshtein distance and DL distance when 
used separately perform better for misprints and the words with missing letters. 
However, vector-based methods are better at reduced word spelling (anem, 
anemia). That is why it could be more precise to use independent approaches for 
each mistake type in future works. 
5. Conclusion 
We may conclude that in terms of incorrect words detection our approach works 
steadily and is quite precise 0.975 lexical precision. In terms of error precision it 
is 0.745, which is high for texts with specialized language, but still there is a 
room for advancement. The output data can be used for more accurate knowledge 
extraction from medical texts for the further processing and modelling. In order 
to improve our approach concerning the problem of spell checking, we are going 
to expand external dictionaries for more medicine names, rare medical terms, 
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etc. Also, we want to build ML classifier to separately work with different types 
of mistakes (Table 1). And our main goal in the future is to expend module’s 
functionality towards negation, experiencer and temporality detection and make 
a tool for clinical text mining in Russian. 
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Automatic Classification of Discharge 
Letters to Detect Adverse Drug Reactions 
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Abstract. Adverse drug reactions (ADRs) are frequent and associated to significant 
morbidity, mortality and costs. Therefore, their early detection in the hospital 
context is vital. Automatic tools could be developed taking into account structured 
and textual data. In this paper, we present the methodology followed for the manual 
annotation and automatic classification of discharge letters from a tertiary hospital. 
The results show that ADRs and causal drugs are explicitly mentioned in the 
discharge letters and that machine learning algorithms are efficient for the automatic 
detection of documents containing mentions of ADRs.   
Keywords. Adverse drug reaction, pharmacovigilance, text mining, document 
classification, supervised machine learning 
1. Introduction 
Adverse drug reactions (ADRs) affect 7 to 17% of hospitalized patients [1,2] and 
can result in serious morbidity, mortality and high costs. They are largely underreported, 
making active pharmacovigilance useful. The detection of ADRs can be performed 
through the review of electronic medical records (EMR) [3] or regular ward visits by a 
trained health professional [4], which can be time-consuming. In this context, data 
mining techniques, focusing on the automated identification of ADRs from the patient 
EMR can be helpful [5,6]. These techniques include structured data analysis as well as 
text mining, including natural language processing (NLP) [7,8]. In this context, 
techniques for the automatic classification of clinical documents have been proven 
effective [9–11]. 
The aim of this study is to assess the feasibility of using NLP techniques to detect 
the presence or absence of ADRs in discharge letters written in French and extracted 
from patients hospitalized in a tertiary hospital via a hybrid –machine learning and rule-
based– method. In this paper, we will present the supervised learning method. 
Particularly, three machine learning algorithms for document classification have been 
applied and evaluated. For the creation of the training and test datasets, manual 
processing of 300 discharge letters was performed. The results show that ADRs are 
reported in the documents and that NLP tools are efficient for their automatic detection. 
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2. Method 
2.1. Data collection 
Our study was approved by the local ethics committee (study number: 2016-02107). 
Hospitalized adults for whom a specialized consultation from clinical pharmacologists 
(in 2015 and 2016) had identified the occurrence of serious ADRs, during or leading to 
hospitalisation, were included in the study. Out-patients and cases of non-serious ADRs 
were not included. Based on these criteria, a dataset of 100 positive discharge letters 
(presence of ADR) and 200 negative letters (absence of ADR) was constituted.  
2.2. Data processing 
2.2.1. Manual annotation 
For the creation of the training and test datasets, an expert manually annotated 100 
discharge letters (positive dataset) and validated 200 letters (negative dataset). Based on 
specific guidelines, sequences of the following categories were annotated: 
1. Drugs 
The drugs category is divided in 3 sub-categories: a) commercial names, b) international 
nonproprietary names (INN), c) therapeutic class. 
2. ADRs 
Occurrences of ADRs and their consequences, symptoms, laboratory values are 
annotated. ADRs are divided in 3 sub-categories: a) names (hépatite/hepatitis), b) 
periphrases (perturbation des tests hépatiques/liver test abnormalities), c) characteristics 
(hémoglobine à 75 g/l/haemoglobin at 75 g/l).  
3. Trigger words  
Words like imputabilité/causality, stoppé/stopped, suspect/suspect that imply the 
presence of an ADR are annotated.  
4. Drug indications 
Indications for drugs entailed in ADRs are annotated.  
2.2.2. Automatic classification of discharge letters 
For the automatic classification of the discharge letters into positive or negative, a 
supervised learning approach was followed. The dataset is composed of the positive 
letters containing at least one annotation of ADR and the negative letters validated by 
the expert. For this task, three machine learning algorithms widely used for text 
classification tasks were applied: Support Vector Machine (SVM), Naïve Bayes 
Classifier, and Linear Classifier. From the whole dataset, 80% was used for training and 
20% for testing. 
V. Foufi et al. / Automatic Classification of Discharge Letters 49
3. Results 
3.1. Manual annotation 
Out of 100 letters of the positive dataset, 87 letters contained at least one annotated 
sequence. The mean length of a discharge letter is 785 words. In total, 1471 sequences 
were annotated. These results are summarized in Table 1:  
 
Table 1. Number of occurrences per annotation category. 
Annotation category Number of occurrences Unique occurrences 
Commercial name 170 76 
International nonproprietary name 210 87 
Therapeutic class 126 59 
Trigger word 293  156 
ADR 441 217 
Characteristic 130 103 
Drug indication 37 28 
Periphrasis 64 35 
 
From the 200 discharge letters considered as negative (absence of ADR), 47 reported an 
ADR and 2 were empty. Therefore, the final negative dataset consists of 151 letters.  
3.2. Automatic document classification 
Three well-known classification methods implemented in the Scikit-learn python library 
[12] were applied and compared: Support Vector Machine, Naive-Bayes, and Linear 
Classifier. For the SVM model, the radial basis function was selected with a ‘scale’ 
gamma. The Multinomial Naive-Bayes was trained with default parameters. Eventually, 
the Linear Classifier is based on a stochastic gradient descent with a lower stopping 
criterion than default (tol=1e-6). Figure 1 represents the classification accuracy of each 
model after 50 iterations. For each iteration, the test set represents 20% of the whole 
corpus, i.e. 17 positive documents and 30 negative documents (k-fold = 0.8). The training 
time is ~100ms for each SVM iteration whereas it takes 2mn for both the Naïve Bayes 
and the Linear Classifier. 
 
  
Figure 1. Mean accuracy over 50 iterations. 
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The SVM classifier achieved 0.83 accuracy, Naïve Bayes achieved 0.94 accuracy and 
the Linear Classifier 0.94. Complete results are shown in Table 2: 
 
Table 2. Evaluation results of the automatic classification. 
Classification 
method 
Class Precision Recall F1 score Test set 
SVM Positive 0.80 0.97 0.88 17 
Negative 0.92 0.60 0.73 30 
Naïves Bayes 
Positive 0.93      0.97       0.95 17 
Negative 0.95 0.88 0.91 30 
Linear Classifier 
Positive 0.97 0.93 0.95 17 
Negative 0.90 0.95 0.92 30 
 
The confusion matrices in Figures 2-4 display the performance of each classifier at the 
classification task: 
 
                                                                                              
          Figure 2. SVM.                                Figure 3. Naïve Bayes.                    Figure 4. Linear Classifier. 
4. Discussion 
The manual annotation of positive discharge letters by an expert showed that ADRs were 
explicitly mentioned in most cases (>80%). A significant bias is that the test population 
were patients who had already received a specialized pharmacology consultation that had 
identified the ADR, thereafter mentioned in the discharge letter. Drugs were almost 
equally mentioned as commercial names, INN and therapeutic classes, and this has to be 
taken into account for their automated detection, especially given the diversity of 
commercial names in different countries. Trigger words were frequently present (293 
occurrences); therefore, they constitute useful tools for the automatic detection of ADRs. 
ADRs were most frequently mentioned as plain terms, such as MedDRA (Medical 
Dictionary for Regulatory Activities) derived terms (i.e. hepatitis), but were also 
described as periphrases or as laboratory characteristics in many cases (approximately 
200 occurrences) which makes their automatic detection challenging given the fact that 
the distinction between the 3 sub-categories was not always straightforward even for the 
human annotator.  
For the automatic classification task into positive and negative discharge letters, 
three machine learning algorithms were applied and evaluated on the dataset. Naïve 
Bayes and Linear Classifier achieved the same mean accuracy over 50 iterations (0.94) 
and high precision and recall (Table 2).  
A major limitation of this study is that the dataset was manually processed by only 
one annotator. Also, the classifiers should be applied and evaluated on a larger dataset. 
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5. Conclusion 
In this study, we presented the methodology used for the manual and automatic 
processing of discharge letters generated in a tertiary hospital in the aim to automatically 
detect the presence or absence of ADRs. A dataset of 300 discharge letters written in 
French was manually processed and the output was used to train and test three machine 
learning algorithms for document classification. After comparison, we concluded that 
Naïve Bayes and Linear Classifier performed better than SVM at this task.  
The manual annotation of the dataset from another expert will serve to create a gold 
standard corpus. In a next step, the trigger words and sequences describing the presence 
of ADRs identified during the manual annotation will be included in the rules that are 
being developed for the automatic identification and extraction of ADRs and their 
relations with causal drugs. Then, the hybrid method –machine learning and rule-based– 
will be applied and evaluated on the gold standard dataset.   
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Automatic Extraction of Risk Factors for 
Dialysis Patients from Clinical Notes Using 
Natural Language Processing Techniques 
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Abstract. Studies have shown that mental health and comorbidities such as de- 
mentia, diabetes and cardiovascular diseases are risk factors for dialysis patients. 
Extracting accurate and timely information associated with these risk factors in the 
patient health records is not only important for dialysis patient management, but also 
for real-world evidence generation. We presented HERALD, an natural language 
processing (NLP) system for extracting information related to risk factors of dialysis 
patients from free-text progress notes in an electronic dialysis patient management 
system. By converting semi-structured notes into complete sentences before feeding 
them into the NLP module, the HERALD system was able achieved 99%, 83% and 
80% accuracy in identifying dementia, diabetes and infarction, respectively. 
Keywords. Natural language processing, Text data mining, Real-world data, 
Dialysis patient risk factor 
1. Introduction 
The amount and complexity of data amassed in electronic health records (EHR) are enor- 
mous. EHR data are not only a vital part of providing patient care but a rich source for a 
wide range of secondary uses, including quality control, real world evidence generation 
and clinical research. Although great progress in the standardization of medical terminol- 
ogy has been made [1], semi-structured or unstructured text data still constitute a large 
portion of EHR data. Thus, one of the challenges facing real-world evidence generation 
is the automatic extraction of high quality information from narrative data. However, rapid 
advances in the field of Natural Language Processing (NLP) could offer viable so- lutions 
in extracting information from complex clinical text. NLP toolkits such as cTakes 
[2] was capable of recognizing Unified Medical Language System (UMLS) concepts 
in clinical texts. NLP algorithm was shown to be effective in identifying breast cancer re- 
currence from clinical notes with above 90% accuracy [3]. Furthermore, Berrios et al. 
[4] used a method that involved tokenization, syntactic parsing and noun phrase iden- 
tification to identify UMLS concepts associated with infectious diseases.  
These studies demonstrated the feasibility of using NLP techniques to significantly 
reduce the work of manual annotation of clinical data. Therefore, the ability to identify 
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key information such as events of interests and risk factors in the vast amount of narrative 
EHR data will be increasingly important in personalizing treatment or decision support 
systems [5]. 
HERALD is an NLP-based data extraction system, collaboratively developed by a 
team of clinicians at the Grand River Hospital (Kitchener, Ontario) and researchers of the 
University of Waterloo.  
The HERALD system used the clinical notes of patients in the EHR system to 
identify relevant information associated with their potential risk associated with 
withdrawal from the dialysis treatment. More specifically, the EHR data were used to 
determine whether a patient’s progress notes contain documentation related to dementia, 
diabetes and infarction [6]. In this paper, we present the design and the validation results 
of the HERALD system. We demonstrated the feasibility of the HERALD system to 
process non-standardized narratives of progress notes, as well as semi-structured text ,i.e. 
templates embedded in the free-text progress notes.  
This study provided insights on the utilities and limitations of the open-source NLP 
toolkit cTakes in processing dialysis content, as well as strategies of adapting the 
HERALD system to a specific clinical domain. 
The study used clinical notes extracted from the renal patient management in-
formation system, Nephrocare® from 1st January 2012 to 30th September 2017 in a 
large tertiary care hospital in Ontario, Canada. The hospital provides a full spectrum of 
Chronic Kidney Disease services, including nephrology clinics, pre-dialysis, 
hemodialysis, peritoneal dialysis, home hemodialysis, and pre-transplantation for eligible 
patients living in Waterloo Region and Wellington County. The Tri-Hospital Research 
Ethics Board (THREB) and the University Human Research Ethics Committee approved 
the research project (THREB File # 2016-0619) along with the waiver for “the 
requirement to obtain patient informed consent”. The notes can be divided into two 
categories: 
(i) free-text notes: free text narratives generated by multi-disciplinary care team 
members (ii) semi-structured data: data in a predefined template (e.g., “History of 
falling; within 3 months [x] NO,[ ]YES”). Full chart review were performed by three 
medically trained personnel to extract risk factors associated with dialysis withdrawal. 
Our study was focused on three specific risk factors: dementia, diabetes and infarction. 
The statistics for the positive and negative classes for each risk factor can be found in 
Table 1. 
Table 1.  statistics of the dataset 
risk factor positive class negative class 
Dementia 39 644 
Diabetes 447 236 
Infarction 195 488 
2. Method 
The HERALD system consists of three main modules: prepossessing module; NLP 
module and Rule module. The process pipeline is depicted in Fig 1. 
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Figure 1.  Pipeline of the HERALD system 
The function of the prepossessing module is to remove the information that was not 
tagged as correct due to the semi-structured format of the notes. We tracked the number 
of repetitions of the sentences between the patients and only removed the sentences that 
were not connected with a filled box and can be observed for multiple patients. The logic 
behind this policy is that, in structured data, the sentences need to be repeated between 
the patient forms and cannot change over multiple patients. Therefore, unique sentences 
are intentionally added by a physician for a specific patient. 
For the extraction of information from the unstructured notes, we developed an NLP 
module with the open-source Apache clinical Text Analysis and Knowledge Extraction 
System (cTakes) [2]. cTakes is a natural language processing tool, whose components are 
specifically trained for the clinical domain. Our NLP pipeline was composed of (i) A 
concept coding module where we tried to identify terms of interest for which a concept 
unique identifier (CUI) exists in UMLS [1]. In this module, the sentences were split into 
tokens and the tokens were normalized to their based form. A POS tagging sub– module 
was then used to tag the normalized tokens to their part-of-speech and finally   a named-
entity recognition algorithm used this information to identify terms of interest that exist 
in the UMLS library. (ii) An assertion status annotation module where additional 
information for each CUI were discovered in the texts, such as whether a term is negated 
or whether it expresses uncertainty (iii) A coreference annotation [7] module which 
provides information about whether the person of interest for a specific CUI is the patient 
or a family member or someone irrelevant. Finally, after reviewing the initial results with 
only the terms from the UMLS dictionary, our expert examined the notes of patients that 
were flagged as false-negative and he provided new terms that are indicators of a specific 
risk factor. We created a new custom dictionary with the additional CUI that were 
determined to be relevant to the identification of different risk factors. 
In the Rule module, different rules were created in order to determine the existence 
of a connection between a patient and a specific risk factor. Our first rule was that a patient 
is diagnosed with a specific risk factor only if all the conditions below were true: 
(i) A term/s that was/were connected to this risk factor was found in his notes (ii) The 
term/s was/were not negated (iii) The term/s did not express uncertainty (iv) The subject 
of the term/s was/were the patient. Finally, we investigated if a term was connected to the 
following sentences by using the dependency parser, which was provided by cTakes[8]: 
(i) can cause, (ii) risk of, (iii) voicing concerns about, (iv) raising concerns about, (v) 
no prior history of, and (vi) free. We chose these sentences as they express uncertainty or 
negation but cTakes failed to identify them. By analyzing the structure of the dependency 
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tree, our system could understand the terms that were connected to the above sentences 
and if they were indeed connected to one of them, then we did not consider these terms 
as proof that a patient is connected to a specific risk factor. Python 3.7 was used for the 
creation of this module and the prepossessing module. 
3. Results 
Cardiac disease [9] and dementia [10] were found to be associated with increased risk of 
death and dialysis withdrawal. Based on the quality of source data, number of patients for 
each risk factor and the definition of each risk factor, we tested how accurately the 
HERALD system could determine the connection of dialysis patients with dementia, 
diabetes, infarction in the progress notes. HERALD processed the notes of each patient 
in order to identify each risk factor and the results were compared with the manual chart 
review in order to calculate the classification accuracy. The accuracy of our system was 
reported in Table 2. 
Table 2.  Results of experiments 
risk factor Accuracy Sensitivity Specificity 
Dementia 0.9941 0.8333 1.000 
Diabetes 0.8375 0.8318 0.8481 
Infarction 0.8038 0.7077 0.8422 
4. Discussion 
The HERALD system identified a patient with dementia with high sensitivity and good 
specificity. Given dementia was considered as a contraindication for dialysis treatment, 
dementia was not as common as other risk factors such as diabetes and infraction in the 
dialysis population. The HERALD system was able to identify accurately the presence of 
of dementia in a clinical note, which could help care providers to provide needed support 
for patients or their families. 
One of the limitations of the HERALD system, or any NLP systems in general, is the 
ability to create generalizable rules that could capture the experience of a medical ex- pert. 
For example, one false-negative case in our experiment is due to the more complex 
reasons associated with the inference of the presence of dementia, such as: (i) The patient 
had delirium (ii) No reversible causes of cognitive and motor decline (iii) Overall history 
suggestive of dementia. Furthermore, it should be noted that during his chart review, in 
cases of uncertainty, our medical expert also consulted other clinical reports available in a 
regional EHR system. These cases were kept as a reminder that, in a real-world scenario, 
relevant information can be absent from clinical notes and a decision support system 
should take into consideration multiple sources - structured and unstructured data. 
5. Conclusion 
Our study demonstrated the feasibility of using an NLP-based system to identify the 
association of a patient with specific risk factors. This study also proved that the NLP 
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technique could be a useful tool for identifying passages containing relevant information 
of interests. However, we also showed that an NLP system could not fully replace the 
judgment of a clinical expert. Since it is possible to automatically extract structured data 
from the dialysis program’s EHR system (e.g. NephroCare), combining structured data 
and features extracted from notes, could be a promising future direction to improve the 
performance of the HERALD system. Also, we aim to combine all available data ex- 
tracted from the EHR system, including structured and non-structured data in order to 
build machine learning models to predict if a patient is likely to withdraw from a dialysis 
treatment. Finally, our future plan is to investigate different feature selection techniques 
as it is a crucial process for the performance of machine learning models [11]. 
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Abstract. Radiology reports describe the findings of a radiologist in an imaging 
examination, produced for another clinician in order to answer to a clinical 
indication. Sometimes, the report does not fully answer the question asked, despite 
guidelines for the radiologist. In this article, a system that controls the quality of 
reports automatically is described. It notably maps the free text onto MeSH terms 
and checks if the anatomy and disease terms match in the indication and 
conclusion of a report. The agreement between manual checks of experienced 
radiologists and the system is high with automatic checks requiring only a fraction 
of time. Being able to quality control all reports has the potential to improve report 
quality and thus limit misunderstandings, loosing time for requesting more 
information and possibly avoid medical mistakes. 
Keywords. Radiology Reports, Quality Control, Text Analysis 
1. Background 
Radiologists routinely document, report and communicate diagnostic information to the 
referring clinicians through structured standardized reports (SSRs). Different from 
unstructured documents, a typical radiology report is divided into the following 
sections: type of examination, clinical indication, technique, findings and conclusion 
[1,2]. A referring clinician conveys any identified clinical question requesting a 
radiology examination. This clinical question is repeated in the indication section of a 
report and the aim of a radiologist is to clearly communicate the answer to this clinical 
question through the conclusion section [3]. Despite guidelines for structuring reports, 
several problems can prevent clear communication between a radiologist and a 
clinician. One of the most frequent problems found in reports is a difference between 
the content of the indication and the conclusion sections whereby a report either fails to 
answer the clinical question of the referring clinician or has an unclear answer [4]. For 
example, we identified a report where a clinician requested a MRI (Magnetic 
Resonance Imaging) scan upon indications of tendinopathy and bursitis 
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(comorbidities). The conclusion section confirmed tendinopathy but failed to validate 
or contradict the clinicians’ question about bursitis. 
Such human errors could be avoided through automated quality control (Q.C.) of 
reports. The work of this article describes a Java-based software prototype that employs 
data integration and semantic comparison to identify the reports with potential 
differences in reporting and informs the concerned radiologist by flagging them. We 
assess prototype performance by measuring overall concordance between the indication 
and conclusion sections using a data set of radiology reports by comparing the results 
of automated evaluation with human evaluation. 
2. Methods 
2.1 Data set used 
A set of 200 randomly chosen, anonymized, French-language reports was obtained 
from Institut de Radiologie de Sion (IRS), a private radiology center located in the 
French speaking part of Switzerland. An individual report comprises the following 
sections: indications, description and conclusions (see Figure 1).  
 
 
Figure 1. Picture showing the processes followed in the developed prototype. 
The data set was not only used to assist prototype development but was also used to 
evaluate the prototype. 
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2.2 Medical Subject Headings 
Medical Subject Headings (MeSH) are a hierarchically-organized terminology mainly 
used for organization and cataloguing of the biomedical information and literature. It   
is organized into a tree structure with its root node branching into 16 broad thematic 
categories like “Anatomy”, “Diseases”, “Chemical and Drugs”, etc. These categories 
are further divided into subcategories or MeSH headings. In this way, MeSH enforces 
uniformity and consistency across the terminology in a way that articles corresponding 
to a particular topic are indexed under a particular MeSH heading. For example., all the 
studies about benign cancer are indexed under MeSH heading Neoplasm2. Each MeSH 
heading in the MeSH tree has a code indicating its location in the tree and a unique 
MeSH ID [5]. 
2.3 MeSHSim 
MeSHSim is an R-package with ”nodeSim” functionality that measures semantic 
similarity between any two MeSH codes as a function of their length and their position 
in the MeSH tree. The similarity values range between 0 and 1 [6].  
2.4 HeTOP 
HeTOP (Health Terminology/Ontology Portal)3is a portal, housing 70 health 
terminologies in 32 languages including MeSH and Radiology Lexicon (RadLex). It 
comprises  a semantically interoperable network of 2 million cross-lingual, health-
domain related concepts. For example, querying the French term radiologie leads to its 
MeSH counterpart ”Radiology” from other multi-lingual terminologies4. This rich 
multilingual content is available for research and can be programmatically accessed via 
authenticated Representational State Transfer (REST) or Simple Object Access 
Protocol (SOAP) requests [7]. 
2.5 ECMT 
L’Extracteur de Concepts Multi-Terminologique (ECMT) combines a rule-based and 
an NLP (Natural Language Processing)-based approach to extract health-related 
concepts from French-language texts using French-language terminologies in HeTOP. 
ECMT service can be programmatically accessed via authenticated REST or SOAP 
requests [7,8].  
3. Results 
3.1 Prototype developed 
The developed prototype fetches a non-empty, radiology report file from internal 
storage followed by rule-based extraction of free text from the indication and 
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conclusion sections (see Figure 1). An authenticated REST request to ECMT then 
extracts French-language health-related concepts from the free text. ECMT returns an 
XML (eXtensible Markup Language) file that is parsed to extract only the MeSH 
Headings and unique ID’s corresponding to Anatomy [A] and Disease [C]. Then, an 
authenticated REST request to HeTOP returns an XML file with MeSH codes and 
paths corresponding for the requested MeSH headings. Next, weighted-link semantic 
similarity between individual anatomy and disease codes is calculated from indication 
and conclusion using the nodeSim functionality from MeSHSim. If every anatomy and 
disease code in indication has a similarity score of 0.85 or more with their counterparts 
in conclusion, the report is considered as 
Q.C. passed, otherwise it is flagged. A threshold of 0.85 was chosen, as it pertains 
to path length three or less between MeSH codes being compared, based on 
experiments with a few validation cases. This threshold accounts for the conceptual 
similarity between the MeSH headings being compared. [6]. For example, a similarity 
score between MeSH anatomy terms “knee” and “toes” is 0.815, but between “toes” 
and “hallux” it is 0.948. 
3.2. Prototype evaluation 
To evaluate the performance of the prototype, overall percentage concordance between 
indication and conclusion for all the radiology reports in the data set was automatically 
assessed. Out of the 200 reports in the data set, a small subset were flagged by the 
prototype because the text corresponding to the conclusion section was missing in these 
reports. The conclusion text from these reports was deliberately removed for testing 
this scenario. Of the remaining reports, MeSH terms and codes for the anatomy and 
diseases were extracted from the indication and conclusion free-texts using ECMT and 
HeTOP. Only 93 and 143 reports respectively contained MeSH terms corresponding to 
anatomy and disease. Of these 143 reports, semantic similarity between indication and 
conclusion MeSH terms was obtained using nodeSim and total concordance was 
calculated. To establish a ground truth, two expert radiologists repeated the above 
procedure manually and calculated the total concordance. 
Upon total concordance assessment between the indication and conclusion, the 
prototype reported 45% concordance for the anatomy information, while manual 
evaluation reported a 61% concordance. For disease information, the prototype 
reported 80% concordance versus 88% with the peer review. Based on ground truth, 
the algorithm accuracy for anatomy was 84% and for disease 92%. It took the 
experience radiologists about 1.5 hours to conduct manual quality checks, but the 
prototype did it in a matter of seconds. 
4. Discussion and Conclusion 
Reports with perfect match for the anatomy and disease MeSH terms between 
indication and conclusion correctly passed Q.C, multiple reports were flagged when a 
particular anatomy term (e.g. knee) was mentioned in indication, but was missing in the 
conclusion. The prototype success, however, is subject to ability of ECMT to 
accurately extract the concepts from free texts and also upon availability of a particular 
concept in the MeSH vocabulary. Currently, the prototype accounts only for the MeSH 
terminology, which lacks some radiology-specific terms [9]. For example, a report 
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mentioned epicondyle in indications section, but not in the conclusion section. This 
report passed Q.C. because no MeSH term corresponding to epicondyle was identified 
from indications. Indeed, this term was absent in MeSH, but present in RadLex5 and 
hence complementing the two can likely improve the results for the missed radiology 
terms. However, only a part of RadLex is currently available in French. In another 
instance, a disease term ”Déchirure” from free text indication was not identified by the 
ECMT, but a standardized, English counterpart for ”Déchirure” existed in MeSH as 
”Rupture”. This instance was reported to the ECMT team and the term was later added 
and semantically linked to its MeSH counterpart. Overall prototype performance 
should also be improved with lexical standardization of disease terms in radiology 
reports, and further developments in ECMT algorithm. 
In conclusion, the automated prototype showed good performance compared to the 
expert radiologists for assessment of indication and conclusion concordance in the 
radiology reports. It also reduces time and cost required for the quality control. The 
prototype additionally identified the lack of systematic reporting of relevant anatomy 
information in the conclusion sections, a fact that can be highlighted in guidelines for 
radiologists. 
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Abstract. Drugs information systems, prescription support softwares, and drug 
decision support systems need to reason on drug properties. Combined 
pharmaceutical products need to be considered specifically because they may 
require a specific processing. Hence, they also need to be identified to automate the 
population of databases with up-to-date property values. We defined a set of digital 
filters designed for the identification of antibiotics in a public database. Four 
different filters are proposed, to be combined to extract the relevant information. 
Evaluation was conducted to combine filters and retrieve information about rand 
combined antibiotics with success. However, information provided in the structured 
files of the French drug database is limited; information provided in the HTML files 
suffers from a lack of quality. Hence, reuse of this data and this information should 
be performed very cautiously.  
Keywords., Drug Combinations, Information Retrieval, Drug databases, 
Antibiotics 
1.Introduction 
World Health Organization defines combined drugs as “pharmaceutical products 
containing two or more active ingredients (incl. combination packages).  Stereoisomeric 
mixtures are regarded as plain products.  Medicinal products which in addition to one 
active ingredient contain auxiliary substances intended to increase the stability of the 
product (e.g. vaccines containing small amounts of antibacterials), increase the duration 
(e.g. depot formulations) and/or increase the absorption (e.g. different solvents in 
various dermatologicals) are considered as plain products”. It is assumed that “the 
classification of combination products is a challenge in any classification system”. For 
instance, any support decision tool processing dose information should be able to have a 
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specific processing of combined products, and, thus, should be able to distinguish plain 
to combined medication. These automated tools are used to generate alerts and/or 
decision or recommendation [1].  
Public databases provide information about drugs. French public Drug Database [2] 
provides information for each drug on the market either in structured Excel files, or as 
HTML pages including the Summary of Product Characteristics provided by the national 
drug agency and the medication package insert, provided by the pharmaceutical industry, 
which markets the medication. These HTML pages can be processed as text documents. 
None of the fields of the structured files can be used to decide whether a medication 
is a combination or not. The world health organization has provided guidelines for 
combination products, but there is no standard rule that may be used on the basis of the 
ATC code to identify combined products. ATC Classification system is provided by the 
World Health Organization  to classify active substances in a hierarchy with five different 
levels [3]. The system has fourteen main anatomical/pharmacological groups or 1st 
levels.  Each ATC main group is divided into 2nd levels which could be either 
pharmacological or therapeutic groups.  The 3rd and 4th levels are chemical, 
pharmacological or therapeutic subgroups and the 5th level is the chemical 
substance.  The 2nd, 3rd 5](]and 4th levels are often used to identify pharmacological 
subgroups when that is considered more appropriate than therapeutic or chemical 
subgroups. 
Drug information retrieval has been investigated in recent years. Adam S. Brown et 
al. have worked on information retrieval to design a database for drug repositioning [4]. 
Martin Kralinger et al. have worked on information retrieval for Chemistry, including 
drugs, using text mining methods [5]. Serkan Ayvaz et al. have worked on information 
retrieval about drug-drug interaction from publicly available sources [6]. 
Our paper aims at providing a knowledge-based automated tool to identify 
combination drugs from information provided onto a public database in the domain of 
antibiotherapy. Section 2 will describe methods. Results will be presented in section 3 
and discussed in section 4.  
2.Methods 
Our method used to distinguish combined and plain pharmaceutical product uses a bank 
of successive filters. In our case, four consecutive filters have been designed and 
implemented. 
All pharmaceutical specialties are listed in a file called CIS_bdpm.txt. Each 
pharmaceutical specialty is identified by a code called CIS. This file allows to constitute 
the starting list of products from which we want to extract and isolate combined products. 
It contains 14 906 specialties. 
2.1.Homeopathic medicines filter 
According to World Health Organization, homeopathy is a system of medicine born in 
Europe in the last part of the eighteenth century. In some  cases,  the  dilution  is  so  high  
that  it  is  almost  impossible  to  find  one  molecule  of  the  original  raw  material [7]. 
By definition, homeopathic medicines may contain several active ingredients. They 
are referenced, in the Summary of Product Characteristics as homeopathic medicines, or 
as medicines dedicated to homeopathy. As a consequence, searching for the terms 
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"homeopathy" or "homeopathic" in the Summary of Product Characteristics HTML 
pages allows to identify homeopathic medicines.  
2.2.Antibiotics filter 
Antibiotics are recognized from their “J01” ATC Class. ATC code is given in the 
Summary of Product Characteristics in HTML pages, which can be obtained by using a 
regular expression and basic text processing methods. Regular expressions allow to 
search for a string in a text document by describing their character composition. The 
ATC code is described as a seven characters string that starts by a capital letter, followed 
by two numbers, followed by two capital letters followed by two numbers. We observed 
that some ATC codes used in the HTML pages were misspelled using the O character 
instead of the 0 number. We integrated this possible misspelling in our regular 
expression, and used a post-processing step to correct the found ATC Code.  
Antibiotics were defined to belong to the “J01” ATC Class. It means that their ATC 
Code starts with “J01” string.  
2.3.Brand vs generic product filter 
An interesting information is to be able to distinguish between the brand products and its 
generics. This information is provided in a text file called CIS_GENER_bdpm.txt. 
Generic groups are defined, identified by a code and a label. For each specialty, identified 
by a CIS code, the associated generic groups is given; it is also mentioned whether the 
drug product is an originator brand, a generic, a generic by dosage complementarity, or 
a substitutable generic. The aim of this filter is to select from a start list of specialties 
those that are a kind of generic product.  
2.4.Single-substance filter 
The entire composition of a specialty is listed in a file called CIS_COMPO_bdpm.txt. 
For each specialty, identified by its CIS code, the different pharmaceutical forms are 
listed separately. For each of them, the whole composition is detailed. Each substance is 
identified by an identifier, and tagged as active substance or therapeutic fraction. Indeed, 
the therapeutic fraction is defined as part of an active substance that carries 
pharmacological activity. Hence, the dose of the therapeutic fraction is different from the 
dose of the active substance, and both are provided in the file in two different lines, with 
a key value allowing to associate corresponding active substance and therapeutic 
fraction. If the therapeutic fraction is the same as the active substance, then only the 
information about the active substance is provided.  
The aim of this filter is to remove from the initial list all specialties that have only 
one active substance in their composition. To perform that, therapeutic fractions should 
not be considered. 
3.Results 
Our method was evaluated to filter all specialties present in the CIS_bdpm.txt file.  
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Table 1 gives the number of specialties remaining after using each of the filters defined 
in the previous section. The initial list contained 14 906 specialties. From all there 
entities, we aim at finding those that are combined products. A chain of combined filters 
is used for each test; number and percentage of specialties remaining after the filters is 
provided in the second and third column of the table. 
 
Table 1. Results of the different filters, used separately of combined to each other 
Combination of  used Filters Number of remaining 
specialties 
Percentage of removed 
specialties 
Single substance filter 2 245 84.94% 
Antibiotics filter 779 94.77 % 
Homeopathic medicines filter 14 806 0.67% 
Originator brand filter 1 261 91.54% 
Single substance + Antibiotics 
filters 
123 99.17 % 
Single substance + Homeopathic 
medicines filters 
2 161 85.50% 
Single substance + originator 
brand product filter 
176 98.82% 
Antibiotics + Homeopathic 
medicines filters 
779 94.77% 
Single substance + Antibiotics + 
homeopathic medicine filters 
123 99.17% 
Single substance + Antibiotics + 
homeopathic medicine + 
originator brand product filters 
11 99.93% 
 
As we see, filters can be combined to retrieve the desired drug. From this drug 
associated characteristics can also be retrieved from the structured text files, like the price, 
or the reimbursement rate. Natural language processing methods can also be used to 
retrieve other data like the drug schema, or the contraindications.  
4.Discussion 
We proposed a method for retrieving combined antibiotic drug based on various filters. 
The method allows to considerably reduce the number of specialties, and can easily be 
extended to other types of drugs. Information provided in structured files of the French 
public drug database is limited, which may prevent from exploiting it in a clinical use 
purpose. For example, ATC codes, drug schema, contraindications, adverse reactions, 
excipients, and information about pregnancy and breast feeding are not provided in the 
structured files. Hence, they should be retrieved from the HTML pages using web 
connection and natural language processing methods. Web connection is time consuming 
and makes it very long a mass processing of a database. Natural language processing 
method are highly dependent of the quality of the data [8]. 
Moreover, the quality of the HTML pages is also limited. Instead of nesting HTML 
tags hierarchically, they follow each other in a listed way, making it more difficult to 
work with section header identifiers. In addition, information may be wrong. For 
example, we observed that the ATC code was written using the “O” character instead of 
the “0” number. Once it has been retrieved, it needs to be corrected to be used. For some 
specialties, the ATC code was absent from the web pages, and it was thus impossible to 
exploit it to generated and infer other data and information. 
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Finally, we observed that structured files were inconsistent. For instance, 7 497, i.e. 
50.30% of all specialties, were absent of the structured file providing generic groups 
information. For those specialties, we were not able to infer any result related to the 
generic groups.  
Identifying combined drug products could facilitate the design of decision support 
systems for alerting drug-drug interactions [9,10].  
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Abstract. Modern biomedical research is increasingly data-driven. To create the
required big datasets, health data needs to be shared or reused, which often leads to
privacy challenges. Data anonymization is an important protection method where
data is transformed such that privacy guarantees can be provided according to for-
mal models. For applications in practice, anonymization methods need to be in-
tegrated into scalable and reliable tools. In this work, we tackle the problem of
achieving reliability. Privacy models often involve mathematical definitions us-
ing real numbers which are typically approximated using floating-point numbers
when implemented as software. We study the effect on the privacy guarantees pro-
vided and present a reliable computing framework based on fractional and interval
arithmetic for improving the reliability of implementations. Extensive evaluations
demonstrate that reliable data anonymization is practical and that it can be achieved
with minor impacts on executions times and data utility.
Keywords. data protection, anonymization, reliable computing
 	
	
Modern?data-driven?biomedical? research,?e.g.? in? the?field?of?precision?medicine?which?
tailors? healthcare? to? the? characteristics? of? individuals,? increasingly? leverages? data? sci-
ence?methods? such? as?machine? learning? [1].?However,?when? creating? the? required?big?
datasets,?laws?and?regulations?mandate?stringent?privacy?protection.?Hence,?a?wide?range?
of?safeguards?has?to?be?applied,?ranging?from?organizational?to?technical?measures.
Data?anonymization?is?an?important?technical?building?block?for?implementing?pri-
vacy?protection.?In?this?process,?data?is?transformed?in?such?a?manner?that?formal?guar-
antees,?e.g.?regarding?the?risk?of?singling?out,?linkage?or?inference,?can?be?provided.?Tra-
ditional?models?of?privacy?protection? such?as?k-anonymity,? -diversity?and? t-closeness?
specify?syntactic?constraints?on?output?datasets,?while?more?recent?models?like?differen-
tial?privacy?formulate?requirements?for?data?processing?methods?[2].
2.? Objective
All?methods?for?implementing?privacy?models?require?performing?changes?to?data?which?
inevitably?leads?to?a?decrease?of?its?utility.?To?balance?a?decrease?in?privacy?risks?with?a
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decrease?of?utility,?models?for?quantifying?both?aspects?have?been?developed.?When?im-
plementing?privacy?models?in?practice,?an?important?challenge?lies?in?the?need?to?reflect?
their?mathematical?definitions?in?software.?Privacy?models?are?often?formulated?over?real?
numbers,?which? in? software? are? approximated? by?floating-point? numbers?with? limited?
precision?(typically?64?bits).?Computations?can?therefore?yield?results?that?differ?signifi-
cantly?from?the?exact?mathematical?results?[3].?This?can?make?output?data?of?anonymiza-
tion?tools?vulnerable?to?privacy?breaches.?For?example,?it?has?been?shown?that?straight-
foward?implementations?of?a?common?method?for?achieving?differential?privacy?can?be?
exploited?to?extract?the?entire?content?of?a?(presumably?protected)?dataset?[4].?However,?
studies?of?the?effects?of?floating-point?errors?on?the?privacy?guarantees?provided?by?other?
methods?for?data?anonymization?are?still?lacking?in?the?literature.
In?this?article,?we?aim?to?fill?this?gap,?with?a?focus?on?investigating?further?meth-ods?
which? are? truthful? (i.e.? non-perturbative)? and? hence? particularly? well-suited? for? the?
biomedical?domain?[5].?For? this,?we?discuss? the?numerical?stability?of? implementations?
of?various?privacy?models,? including? k-anonymity,? -diversity,? t-closeness? and? further?
methods?for?achieving?differential?privacy?[2].?Moreover,?we?present?a?reliable?comput-
ing?framework,?which?we?have?integrated?into?the?open?source?data?anonymization?tool?
ARX?[6]?to?mitigate?vulnerabilities?resulting?from?the?use?of?floating-point?operations.
3.?Methods
3.1.? Data?Anonymization?and?Floating-Point?Arithmetic
Figure?1? shows?an?example? transformation?of?an? input?dataset?using?a?combination?of?
generalization?(i.e.? the?replacement?of?values?with?more?general,?but?semantically?con-
sistent?values),?suppression?(i.e.?the?removal?of?values)?and?aggregation?(i.e.?the?replace-
ment?of?values?with?an?aggregate,?such?as?their?mean).?The?example?output?dataset?satis-
fies?2-anonymity,?which?means?that?each?combination?of?attribute?values?appears?at?least?
twice?(see?[2]?for?further?details).?Whether?or?not?k-anonymity?is?satisfied?is?easy?to?de-
termine?by?simply?counting?the?size?of?groups?of?indistinguishable?records.?Implement-
ing?other?privacy?models,?such?as?-diversity,?t-closeness?or?differential?privacy,?requires?
evaluating?mathematical?expressions?over?real?numbers,?though?(cf.?Section?3.2).
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Figure 1. Example of input data and transformed output data.
In computers, real numbers are typically approximated using floating-point num-
bers. The number of floating-point values which can be represented with a fixed number
of bits (typically 64) is finite. Hence, there exists an infinite number of unrepresentable
real numbers. Most implementations of floating-point arithmetic adopt the IEEE stan-
dard 754 [7]. It specifies that all floating-point operations have to be performed as if it
was possible to perform the corresponding operation with infinite precision, and then to
round the result to a representable number. This inevitably introduces rounding errors
which add up during sequences of calculations [3].
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3.2.? Numerical?Stability?of?Common?Privacy?Models
Implementing? some?privacy?models? supported?by?ARX,? e.g.? k-anonymity? [2],?doesn’t?
require?decimal?numbers?at?all.?Implementing?others?requires?significant?amounts?of?dec-
imal?arithmetic,? though.?Examples?are? (1)? t-closeness?which?basically? requires? that? the?
distribution?of?sensitive?attribute?values? in?a?set?of? indistinguishable?data?records? is?not?
too?different?from?the?corresponding?distribution?in?the?overall?dataset?or?(2)?(entropy)?-
diversity?which?requires?the?distribution?(p1, ...,?pm)?of?sensitive?attribute?values?in?each?
group?of? indistinguishable? records? to? satisfy?−∑i? 1?pi? ln(pi)?≥? ln()? [2].?However,?by?
studying?possible?effects?of?floating-point?error?propagation?using?forward?analyses?(see?
e.g.?[3]?for?details),?we?were?able? to?derive?upper?bounds?for? the?resulting?additive?ex-
ceedances?of? the?privacy?parameters?of? these?models.?While?a?detailed?presentation?of?
these?analyses?is?beyond?the?scope?of?this?article,?they?showed?that?the?resulting?privacy?
violations?are?negligible?in?practice?for?all?syntactic?privacy?models?supported?by?ARX.
Differential? privacy? is? not? a? property? of? a? dataset,? but? a? property? of? a? data? pro-
cessing?method.? It?basically?guarantees? that? the?probability?of?any?possible?output?of?a?
probabilistic?algorithm?does?not?change?“by?much”?if?data?of?one?individual?is?added?to?
or? removed? from? the? input? dataset.? The? Laplacian? mechanism? and? the? exponential?
mechanism? are? important?building?blocks? for? implementating?differentially?private? al-
gorithms?[8].?In?[9],?we?have?presented?a?process?for? implementing?k-anonymity?while?
fulfilling?(ε,δ?)-differential?privacy.?This?approach?uses? random?sampling? to? introduce?
non-determinism?and? the?exponential?mechanism? to?optimize? the?utility?of?output?data.?
Consequently,?unlike? the?majority?of?differentially?private?algorithms,? it? is? truthful?and?
therefore?well-suited?for?processing?health?data?[5].
We?were?able?to?calculate?an?upper?bound?on?the?rounding?error?induced?by?straight-
forward? floating-point? implementations? of? the? exponential? mechanism.? For? this,? we?
applied?conservative?methodologies?described?e.g.?in?[3]?followed?by?an?extension?of?the?
original?proof?of? the?privacy?guarantees?provided? [8]?which? takes? rounding?errors? into?
account.?While?a?detailed?presentation?of?this?analysis?is,?again,?out?of?the?scope?of?this?
article,? it? showed? that? the? additive? exceedance? of? the? expected? privacy? loss? ε? is?
negligible,?with?values?of?about?10−10?or?less?in?practical?settings.
However,?the?implementation?of?differential?privacy?in?ARX?requires?complex?cal-
culations? to?determine? the?sampling? fraction?β?and? the?parameter?k? for?k-anonymity? to?
guarantee?the?requested?degree?of?privacy?protection.?Investigating?our?floating-point?im-
plementation,?we?found?that?the?deviations?of?ε?were?in?the?order?of?10−16?using?common?
values?of?ε?(e.g.?0.01,?0.1,?0.5,?ln(2),?0.75,?1,?ln(3),?1.25,?1.5?and?2).?The?actual?values?
calculated?for?the?parameter?δ?,?however,?deviated?drastically,?as?is?shown?in?Table?1.
Table?1.?Relative?error?of?δ?for?ε?=?ln(2)?using?a?floating-point?implementation.
Requested value of δ 10−2 10−3 10−4 10−5 10−8 10−9
Error of δ [%] 13.3 11.1 17.2 28.4 10.0 27.9
3.3.? Design?of?ARX’s?Reliable?Computing?Framework
To? solve? this? problem,?we? implemented? a? framework? comprising? different? computing?
technologies?that?are?reliable,?i.e.?offer?strict?guarantees?for?the?accuracy?of?the?calculated?
results:?(1)?Arithmetic?using?exact?arbitrary-precision?floating-point?numbers.?This?can?
be?used?for?calculations?involving?numbers?with?a?finite?amount?of?digits?only.?(2)?Using?
representations?as?fractions?with?arbitrarily?long?integer?enumerators?and?denominators.?
This?approach?can?be?used?to?perform?exact?calculations?over?rational?numbers?but?it?can
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become?very?slow.?(3)?Interval?arithmetic?[3],?which?dynamically?computes?strict?bounds?
on?the?errors?of?mathematical?operations.?The?basic? idea?is?not? to?operate?on?(approxi-
mations?of)?real?numbers,?but?rather?on?intervals?which?enclose?the?respective?exact?real?
numbers.?Functions?operating?on?such?intervals?yield?intervals?which?are?guaranteed?to?
include?the?exact?result.?For?example,?addition?can?be?performed?by?calculating
[x1,x2]?+?[y1,y2]?=?[x1?+?y1,x2?+?y2].
ARX? is? implemented? in?Java?and?arbitrary?prevision?arithmetic?and? fraction?arith-
metic?is?well?supported?by?common?programming?libraries.?The?number?of?Java?libraries?
for?performing?interval?arithmetic?is,?however,?known?to?be?limited?[10].?Hence,?we?im-
plemented?a?basic?interval?arithmetic?framework?from?scratch?while?focusing?on?a?mini-
mal?amount?of?easily?understandable?and?verifiable?code.?We?implemented?various?oper-
ators,?including?the?basic?arithmetic?operators.?For?more?complex?functions?such?as?exp,?
pow,? log? and? sqrt?we? invoke? the? respective? implementations? for?floating-point? values?
pro-vided?by? the? Java? standard? library?which?have?clearly?defined?accuracies.?We?also?
imple-mented? various? comparison? operators? such? as? ≤? which? allow? for? reliable?
comparisons?by?returning?the?result?of?comparing?the?upper?and?lower?endpoint?of?their?
operands.?These?operators?are?guarded?by?checks?which?raise?an?error? if? the?relation?of?
their?operands?is?not?decidable,?i.e.?if?the?intervals?are?overlapping.
We?used? the?methods?and?operators?provided?by? this? framework? to? implement? the?
parameter?calculation?process?for?differential?privacy?reliably?so?that?the?actual?degree?of?
privacy?protection?provided?can?be?at?most?more?conservative?than?specified?by?the?uer.

To?evaluate? the? impact?of? the?reliable?parameter?calculation?on? the?strictness?of? the?de-
rived?parameters?we?have?compared?it?with?a?straight-forward?floating-point?implemen-
tation?using?common?values?of?ε?ranging?from?0.01?to?2?and?δ?=?10−i?for?i?=?1, ...,9.
The?differences?between?the?values?of?β?obtained?using?both?implementations?were?
very?small?with?values?of?about?10−16?in?all?cases.?All?values?obtained?for?k?were?identi-
cal?except?for?ten?configurations?using?irrational?parameters.?This?is?because?these?num-
bers?have?more? significant?figures? than? the?other?values? considered,?which? resulted? in?
higher?rounding?errors?and?hence?larger?intervals?during?calculations.?In?these?cases,?the?
values?of?k?obtained?reliably?were?(slightly)?higher.?Using?ε?=?ln(3),?the?values?of?k?com-
puted?differed? for?δ?=?10−5?and?δ?=?10−6? (k?=?63?vs.?k?=?66?and?k?=?78?vs.?k?=?82,?
respectively).?The?results?obtained?when?using?ε?=?ln(2)?are?listed?in?Table?2.?As?can?be?
seen,?the?absolute?differences?were?at?most?two.?Consequently,?for?decreasing?values?of?
δ?,?which?correspond?to?increasing?degrees?of?privacy?protection,?the?relative?differences?
between?the?values?of?k?obtained?by?both?implementations?tended?to?become?smaller.
Table?2.?Values?of?k?derived?from?various?values?of?δ?and?ε?=?ln(2).
δ 10−1 10−2 10−3 10−4 10−5 10−6 10−7 10−8 10−9
Floating-Point 7 18 30 42 54 67 81 93 105
Reliable 8 20 32 44 56 68 81 95 107
In?contrast?to?results?obtained?using?the?floating-point?implementation?(cf.?Table?1),?
the?actual?values?of?ε?and?δ? resulting?from?reliably?calculated?parameters?k?and?β?were?at?
most?more?conservative?than?the?privacy?parameters?specified?by?the?user.?In?particular,?
increasing?k?was?necessary?to?mitigate?the?violations?of?δ?reported?in?Table?1.?At?the?same?
time,?the?impacts?on?the?intensity?of?data?transformations?applied?and?hence?the?potential?
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We? also? evaluated? the? execution? times? of? both? implementations? on? a? PC?with? a?
quad-core?3.1?GHz?CPU,?Ubuntu?Linux?and?an?Oracle?JVM.?The? results?are?shown? in?
Figure? 2.?When? decreasing? both? ε? and? δ? (which? corresponds? to? stronger? degrees? of?
protection),?the?relative?execution?times?tended?to?increase.?Using?typical?values?of?ε?≈?1?
and?δ?≈?10−6,? the?execution? time?of? the? reliable? implementation?was?about? four? times?
higher?than?the?time?used?by?the?floating-point?implementation.?In?all?experiments?with?ε?
≥? 0.1,? the? calculation? of? parameters? terminated? in? less? than? one? second? using? both?
implementations.? This? contains? the? range? of? parameters? which? is? practical? for? the?
approach?(cf.?[9]).
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Figure 2. Execution times for deriving β and k from various values of δ and ε reliably relative to the float-
ing-point implementation.
5. Conclusion
In this article, we studied how privacy violations resulting from floating-point implemen-
tations of anonymization algorithms can be mitigated. We discussed reliability issues re-
sulting from arithmetic operations for a variety of privacy models including k-anonymity,
-diversity and t-closeness as well as an implementation of differential privacy specif-
ically suited for applications to health data [9]. Moreover, we presented a framework
comprising reliable computing techniques, including interval and fractional arithmetic.
All results have been integrated into the open source tool ARX. Finally, we examined the
impacts of the reliable implementation on output data utility as well as execution times
and found both to be negligible in practice when realistic parameters are being used.
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Abstract. Blood lactate concentration is a reliable risk indicator of deterioration in 
critical care requiring frequent blood sampling. However, lactate measurement is 
an invasive procedure that can increase risk of infections. Yet there is no clinical 
consensus on the frequency of measurements. In response we investigate whether 
machine learning algorithms can be used to predict blood lactate concentration from 
ICU health records. We evaluate the performance of different prediction algorithms 
using a multi-centre critical care dataset containing 13,464 patients. Furthermore, 
we analyse impact of missing value handling methods in prediction performance for 
each algorithm. Our experimental analysis show promising results, establishing a 
baseline for further investigation into this problem. 
Keywords. machine learning, deep learning, clinical decision support, critical care 
1. Introduction 
Blood lactate concentration is frequently measured in critical care as it is used as an 
indicator of risk of patients’ deterioration. Presence of increased lactate levels is correlated 
with increased risk of morbidity and mortality. In healthy individuals there is a continuous 
cycle of lactate production and clearance (metabolised primarily in the liver), while    in 
critically ill patients lactate metabolism is impaired, resulting in elevated lactate 
concentration. Several clinical conditions have been associated with impaired clearance 
of lactate, such as liver dysfunction and sepsis. Therefore frequent lactate measurements 
are necessary to track and assess patients’ state. However, lactate concentration cannot be 
measured without drawing arterial or venous blood, which is an invasive procedure that 
can increase risk of infections. As a consequence, blood gas analysis may not be ordered 
as frequently leading to sub optimal rates of lactate measurements [1]. 
In this respect, there is ample potential for machine learning methods to play a 
significant role in lactate guided clinical decision making. Such role is especially important 
when considering that lactate-guided therapy significantly reduced hospital mortality and 
length of stay as evidenced by several multicentre randomised controlled trials [2,3,4]. 
However, this potential has not been explored thus far. Addressing the evident need for 
prediction of blood lactate concentration in ICU, we are the first to compare performance 
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 of several machine learning methods in lactate concentration prediction. Furthermore, we 
evaluate several strategies to handle missing values using a dataset of 13,464 patients, 
containing 12,196,798 clinical records from the eICU critical care database [5]. Our 
results show that blood lactate concentration prediction could become a useful tool during 
clinical decision making process in critical care, that may reduce unnecessary blood 
sampling, while meeting recommendations of Surviving Sepsis Campaign (SSC) on serial 
lactate testing [6]. 
2. Methods 
We formally define the problem of lactate concentration prediction as follows: For each 
patient with the set of clinical parameters     	
   , where l represents 
blood lactate concentration, X represents the set of all other clinical measures, and t is 
the time index, we want to predict ltbased on     	
      , where Xˆ  
is the selected set of clinically relevant measurements out of X. Therefore, we 
formulate a regression problem using Eq.(1). 
                !
"
#$%% & '( 
                                                            (1) 
In other words, the objective of lactate prediction is to predict the blood lactate 
concentration of a patient in the next β hours using a selected set of their measurements 
taken in the past αhours. 
For our work we use eICU Collaborative Research Database [5], a multi-center 
intensive care unit database with high granularity data. The eICU database comprises 
200,859 patient unit encounters for 139,367 unique patients admitted between 2014 and 
2015 to hospitals located throughout the US. The final patient cohort contained 13,464 
patients (14,477 ICU stays) with 12,196,798 clinical records, where we grouped these 
records into 2 hour windows. Patient’s mean age was 618 ) 157 years (45% female). 
For our case study, the relevant clinical features for the selected cohort are chosen 
based on advice from the clinician and outlined in Table 1. 
Critical care data suffers from several limitations with missing data as one of the 
main challenges. In the eICU dataset, the percentage of missingness per feature is between 
0 to 96 which needs to be addressed properly. Addressing missing values is typically 
dependent on the cause of missingness. Statistically speaking, there are three types of 
missing values: missing completely at random (MCAR) which happens on an unrelated 
cause, missing at random (MAR) which implies a relation between missing value and 
other present values, and missing not at random (MNAR) which implies a relationship 
between the value of the variable and its missingness [7]. On the other hand, there are 
several imputation methods to handle missingness. Mean and forward imputations are 
basic single-value imputation methods, which only consider the information in the past 
values of the variable and work best under MCAR assumption. Multiple imputation [8], 
Matrix Factorisation [9], PCA [10], SoftImpute [11] and Random Forest [12] are the most 
known traditional machine learning methods that find the substitute for missing values 
based on the relation between observed and missing features. These methods perform best 
when handling MAR cases. Finally, MNAR cases are the hardest to manage. A helpful 
solution to capture the information behind missingness of variables is to use missing 
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Table 1. List of selected variables from eICU tables (in bold) based on clinical relevance 
 
Patient, gender, age, ethnicity, admissionweight, apacheadmissiondx 
Lab, Respiratory Rate, O2 Saturation, FiO2, glucose, potassium, sodium, Hgb, chloride, creatinine, BUN, 
bicarbonate, LPM O2, calcium, Hct, platelets x 1000, anion gap, WBC x 1000, lactate, RBC, RDW, paO2, 
pH, paCO2, magnesium, HCO3, Total CO2, Base Excess, phosphate, Pressure Support, albumin, -lymphs, 
-polys, -eos, -basos, -bands, -monos, bilirubin, AST (SGOT), ALT (SGPT), total protein, alkaline phos. 
NurseCharting, Heart Rate, Respiratory Rate, Temperature (C), Invasive BP Mean, Invasive BP Systolic, 
Invasive BP Diastolic, Non-Invasive BP Mean, Non-Invasive BP Systolic, Non-Invasive BP Diastolic, O2 
Saturation, glucose, CVP, LPM O2, Total CO2 
RespiratoryCharting, Heart Rate, Respiratory Rate, FiO2, Total CO2, Tidal Volume, Inspiratory Pressure, 
LPM O2, Vent Rate, Plateau Pressure, Mean Airway Pressure, Pressure Support, Inspiratory Pressure 
VitalPeriodic, Heart Rate, Respiratory Rate, Temperature (C), Invasive BP Mean, Invasive BP Systolic, 
Invasive BP Diastolic, CVP 
VitalAperiodic, Non-Invasive BP Mean, Non-Invasive BP Systolic, Non-Invasive BP Diastolic 
IntakeOutput, Urine 
indicators. These indicators can either be used directly aside data or inside the prediction 
model structure. Note that indicators can also be useful in MAR and MCAR, since they 
differentiate the imputed values from the observed ones and the prediction method can 
use this information to ignore bad imputations. 
There are a vast number of successful regression methods used for healthcare data 
which could be grouped into three categories: the statistical regression methods, the 
traditional machine learning methods and the rising deep learning methods. Here we 
investigate one method from each category: Lasso regression(LR) as linear regression, to 
benefit from its feature section capabilities, Random Forest(RF) as nonlinear model with 
an ensemble of decision trees, and Long Short-term Memory(LSTM) as temporal deep 
learning model to learn complex temporal relation in data. 
3. Results 
Data preparation. Data is prepossessed in six steps. (1) Patient cohort is selected 
based on three inclusion criteria; adult patients (age > 18), with at least two measured 
lactate levels, and with at least 18 hours length of stay in ICU. (2) The relevant 
variables are selected based on advice from the clinician. For our case study, the 
relevant clinical features for the selected cohort are outlined in Table 1. A detailed 
description of each variable is provided in the original eICU paper [5]. (3) Some 
features exist in more than one table under different names. These features are aligned 
to a unique feature in time. (4) The selected data is aligned in time since each feature is 
measured in an arbitrary time and frequency. We resampled time-series data into 
regularly aligned periods where each feature is sampled every 2 hours. In case a feature 
is measured more than once during each two hour interval, the last record is used. (5) 
Noise and outliers are addressed as follows: for each feature, the valid interval is 
defined based on clinical knowledge and the values out of the valid scope are 
considered as missing values. (6) The data is split into training and testing parts, which 
is done using five-fold cross validation where at each fold 80% of the data is 
considered as training and the rest is test data. 
Settings. All the imputation methods are applied using python based on 
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 fancyimpute, predictive imputer, and sklearn open-source libraries. Also for all the 
machine learning methods, the default parameters proposed by their authors are used. 
The LSTM network has 2 layers of 1024 units with Glorot normalisation and tanh 
activation, each followed by a drop out layer of 0.6. Adam optimizer is used with 
learning rate starting from 0.0001 and the model is trained for 20 epochs with batch 
size 100. To ease LSTM convergence, data is normalised to have zero mean and a 
standard deviation of one. The LSTM model is implemented using Keras and 
Tensorflow as backend and one GTX 2080 Ti as GPU. 
All combinations of introduced prediction models and imputation methods are ex- 
amined on eICU data and their results are reported in Table 2. To measure the quality 
of imputation methods regarding lactate prediction while preserving the structure of 
data, we report Mean Absolute Error (MAE), Root Mean Squared Error (RMSE), and 
R-squared (R2) as indicators of the predictive performance of the regression models. 
The mean  and standard deviation of each measure on five fold cross-validation of data 
is reported. The best results are shown in bold. As the results suggest, both regression 
model and imputation method affect the prediction results. LSTM performed 
significantly better compared to LR an RF using the same imputation method. 
Therefore, it can be concluded that the data contains complex relations not only 
between measurements but also across their values in time that were captured by the 
LSTM model. 
Table 2. The results of all combinations of prediction models and imputation methods. The mean and standard 
deviation of various metrics on five fold cross validation of data is provided. MAE, RMSE, and R2 stand for 
Mean Absolute Error, Root Mean Squared Error, and R-squared respectively. LR, RF, and LSTM stand for 
Linear Regression, Random Forest, and Long Short Term Memory. 
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 4. Conclusion 
Considering the importance of monitoring blood lactate levels, the ability to predict blood 
lactate concentration may provide clinicians sufficient time to devise interventions for 
rapidly deteriorating patients. At the same time it may decrease the frequency (and the 
associated cost) of invasive lactate measurements in stable patients. Therefore, we defined 
the problem of lactate prediction from ICU data in details and offered solutions with 
well-known prediction and imputation methods. 
Our results show that LSTM-based method can predict lactate level with a Mean 
Absolute Error of 0.665 across 13,464 patients from different hospitals and ICU units. 
Furthermore, we show that indicator imputation method achieves highest performance 
in our dataset, suggesting that a missing value indicator is informational and increases 
predictive power over other, mean-based imputation methods. Future work will investigate 
prediction of lactate levels in patient sub-populations and its impact on critical care at 
patient as well as organisational level. 
 
This work was partially supported by the European Union’s Horizon 2020 research and 
innovation program under grant agreement #769765. 
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Abstract. The present work provides a real-world case of the connection process of 
a hospital, 12 de Octubre University Hospital in Spain, to the TriNetX research 
network, transforming a compilation of disparate sources into a single harmonized 
repository which is automatically refreshed every day. It describes the different 
integration phases: terminology core datasets, specialized sources and eventually 
automatic refreshment. It also explains the work performed on semantic 
normalization of the involved clinical terminologies; as well as the resulting benefits 
the InSite platform services have enabled in the form of research opportunities for 
the hospital. 
Keywords. I2B2, ICD, LOINC, ATC, SNOMED-CT, Clinical research, Secondary 
use of EHR, Semantic interoperability, Clinical data integration. 
1. Introduction
The adoption of Electronic Health Record (EHR) systems for storing clinical data has 
been trending upwards in the last decades, especially in larger hospitals where record 
tracking has become increasingly difficult as they grow. However, the formats used by 
each department or area for recording and storing these data are rarely consistent. The 
process of extracting and combining information from several sources within a hospital 
in order to, for instance, allow observational studies on broad cohorts of patients, can be 
anything but trivial. 
This scenario is where resources such as the InSite platform [1] come into play. 
InSite is a secure service platform which enables healthcare organizations across Europe 
to harmonize their clinical data sources in order to increase data availability and its 
efficient reuse for research. InSite, as the European branch of TriNetX [2], has helped 
establish a global Clinical Research Network, with over 130 healthcare providers across 
23 countries and almost 4.200 clinical trial opportunities already delivered. 
When a new hospital joins the network, InSite integrates its clinical sources to a 
local node, an I2B2 [3] repository where all this data is homogenized, which is linked to 
the central InSite platform. Other common data models such as OMOP or PCORnet 
could have been chosen as well, but I2B2 was selected for being a flexible and widely 
used standard [4, 5, 6]. Federated analytics technology ensures that patient data never 
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leaves the hospital and remains under local control, while providing aggregated results 
to research questions. 
The present paper provides a real example of the complete connection process of 12 
de Octubre University Hospital [7] in Spain to the InSite network, transforming a 
compilation of disparate sources into a single harmonized repository which is 
automatically refreshed on a daily basis.  
2.Methods
During the data loading process for new hospitals, integration is not performed 
simultaneously for all sources. It is divided in iterations or phases: a historical data load, 
integration of specialized sources and lastly automation of incremental updates.  
In the case of 12 de Octubre, the complete process required around 2 years of work, 
starting April 2017. Details on the specific steps taken and data sources involved in each 
of the phases are presented below. 
2.1. Phase I – Minimum Basic Data Set (MBDS) 
The initial phase consisted on a historical data load of the essential domains from the 
EHR system of the hospital (HP-HCIS, [8]). This includes Demographics (age, gender 
and vital status related data), Providers (e.g. physicians, nurses, etc.), Visits (any 
clinical transaction generating a set of data), Diagnoses, Procedures, Laboratory 
tests and Medication. This data was extracted from the source database and 
transformed, directly through series of queries, to fit the I2B2 structure of its target 
table. 
When local coding systems do not match the reference terminologies used in InSite, 
specific mappings have to be developed and loaded into the hospital’s I2B2 node in this 
step. The mapping effort to standard clinical terminologies has been performed by a 
multidisciplinary team from both 12 de Octubre and InSite.  
For diagnoses and procedures, the hospital had generated mappings from their local 
coding to ICD9CM [9] or, for recent data, to ICD10CM and ICD10PCS [10]. In the 
interest of a joint exploitation of both historical and recent information in a single 
terminology, codes stored in ICD9CM were also mapped to ICD10CM or PCS 
respectively by InSite, using internally developed mappings to increase reliability and 
maintain legacy data [11, 12]. 
Translation of most local laboratory tests into LOINC [13] was provided by the 
hospital. For those local codes not present in the hospital’s internal mapping, InSite 
developed a manual mapping to LOINC. 
Finally, for medication data, AEMPS (Spanish Agency of Medicines and Medical 
Devices) codes were translated to ATC [14] using the official mapping [15], which was 
further refined by 12 de Octubre. 
2.2. Phase II – Specialized Sources & Expansion of Previous Data 
The second phase involved two main extensions of the harmonized data. Firstly, the 
integration of four new sources: cancer registry, anatomic pathology, clinical findings 
and oncological medication. Secondly, an update of the preexisting sources and the 
inclusion their additional visit types: inpatients, outpatients, ambulatory surgery or 
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emergency room. Two of the new sources were processed through exports of their 
original systems instead of direct database connections. These export files were then 
integrated with the rest of the collected information. 
Regarding the terminologies assigned to the new sources, cancer registry and 
anatomic pathology data had been coded using a local terminology. Before entering the 
I2B2 repository, all topology and most morphology information was mapped by InSite 
to ICD-O-3 [16] while the remaining morphology information, together with specific 
cancer registry concepts such as TNM staging data, were mapped to SNOMED-CT [17]. 
Clinical findings data, similarly to what had been done for laboratory tests in phase 
I, was mapped automatically to SNOMED-CT through the hospital’s internal mapping 
tables before extraction. Oncological Medication was locally already in ATC. 
2.3. Phase III – Data Load Automation 
The first step taken during this phase of the integration process was to perform a load 
from all data sources in order to bring historical data completely up to date, bridging the 
time gap since the latest manual refreshment. This was followed by the introduction of 
automatic incremental updates, which begun by the implementation of HL7 (Health 
Level 7, [18]) channels for ingesting fresh data from the different sources. 
The new loading process entails a two-step ETL. Whenever fresh data is recorded, 
individual HL7 messages are sent through a channel implemented by the hospital, 
connected to the source systems. Subsequently, these messages are processed in a 
channel implemented by InSite, which models the information in the format required by 
the I2B2 repository. 
After each channel has been implemented, InSite continues to provide technical 
support and validation tasks as requested by the hospital to ensure its stability, such as 
filtering of duplicate messages, detection of empty fields or local unit errors. 
There are currently eight channels ingesting messages periodically from the 
following data domains: diagnoses, procedures, laboratory tests, medication, oncology 
and clinical findings. These incremental updates occur daily. Fresh data extraction 
requires an average of 10 minutes, after which the steps of processing, quality checking 
and load take place. The I2B2 repository and InSite applications for the hospital’s 
internal use remain accessible at all times during this process. 
3.Results
Tables 1 and 2 summarize the outcome of the integration process for phases I and II. 
Table 1. Details on the historical data load of the Minimum Basic Data Set (MDBS) – Phase I. 
Data domain Visit type Period # Records Target I2B2 Table 
Demographics Inpatients –  2.672.821 PATIENT_DIMENSION 
Providers – – 43.053 PROVIDER_DIMENSION 
Visits Inpatients 01/1999 - 02/2017 22.462.945 VISIT_DIMENSION 
Diagnoses Inpatients 01/2010 - 02/2017 1.990.697 OBSERVATION_FACT 
Procedures Inpatients 01/2010 - 02/2017 1.036.653 OBSERVATION_FACT 
Laboratory tests All 01/2016 - 02/2017 148.761.307 OBSERVATION_FACT 
Medication Inpatients 01/2011 - 02/2017 1.996.671 OBSERVATION_FACT 
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Table 2. Details on the load of specialized sources and additional visit types – Phase II. Visit types include 
Inpatients (IN), Outpatients (OUT), Ambulatory Surgery (SUR) and Emergency Room. 
Data domain Visit type Period # Records Target I2B2 Table 
Demographics All – 2.698.508 PATIENT_DIMENSION 
Providers – – 43.700 PROVIDER_DIMENSION 
Visits – 01/1999 - 07/2017 23.579.551 VISIT_DIMENSION 
Diagnoses IN,OUT,SUR 01/2010 - 07/2017 3.142.581 OBSERVATION_FACT 
Procedures IN,SUR 01/2010 - 07/2017 1.730.628 OBSERVATION_FACT 
Laboratory tests All 01/2015 - 07/2017 226.872.641 OBSERVATION_FACT 
Medication IN,OUT,SUR 01/2008 - 07/2017 2.371.452 OBSERVATION_FACT 
Cancer registry All 01/1980 - 07/2017 66.966 OBSERVATION_FACT 
Anat. pathology All 01/2014 - 07/2017 783.894 OBSERVATION_FACT 
Clinical find. All 01/2010 - 07/2017 11.492.325 OBSERVATION_FACT 
Oncology med. All 01/2002 - 07/2018 252.267 OBSERVATION_FACT 
After the implementation of incremental updates during phase III, the volume of 
harmonized data has continued to grow as fresh information is automatically included in 
the repository. Figure 1 illustrates the evolution of the volume per data domain over the 
integration process. 
Figure 1. Snapshot of the data volume per domain through the different phases of the integration process. 
Quality assurance processes were undertaken in parallel to the described ETL 
processes and a number of expected fluctuations have been identified in collaboration 
with the hospital’s IT team. As a future line of work, time series analyses of volume 
variations in the different data domains are being designed, in order to extract patterns 
of data peaks and drops, and to forecast its evolution for detecting unexpected variations. 
As an example of this evolution of data volume over time, figure 2 shows the number 
of new laboratory records loaded per month in the period of January 2015 to August 
2019. Indicator 1 marks the moment in which the hospital’s coding team implemented a 
filter to remove redundant laboratory records, thus reducing the mean monthly volume 
of new data. The second indicator marks the period in which laboratory data load 
migrated to the appropriate HL7 channel and automatic updating of this source began. 
Figure 2. Monthly evolution of laboratory data. Grey: manually loaded. Black, dashed: with automatic updates. 
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4. Conclusions
The InSite team, in collaboration with the IT department of 12 de Octubre University 
hospital, have managed to integrate a number of heterogeneous, dissociated clinical data 
sources into a single, harmonized repository where information is refreshed daily, 
without manual intervention, on a record-to-record basis. Not only does this help the 
hospital’s physicians access patient information from several data domains easily and 
efficiently, but thanks to incremental updates it also allows the hospital to perform 
clinical trial recruitment protocols with the least possible data availability delay. Keeping 
harmonized data up to date implies physicians can look for suitable patients including 
those currently under treatment. 
Apart from the numerous clinical trial opportunities offered through the InSite 
platform, joining the network has enabled the participation of 12 de Octubre in a number 
of European research projects in collaboration with prominent healthcare and research 
institutions, including EHR2EDC[19], ECRIN[20], RIS[21], CDISC[22] or ICHOM[23]. 
Regarding future courses of action, complementary clinical information sources are 
continuously being identified and integrated within the hospitals of the InSite network. 
In the case of 12 de Octubre, new data sources currently considered are microbiology, 
genetics, HIV registry, medication posology and specialized parameters from breast and 
lung cancer. Further iterations of integration will provide essential data to drive the 
current clinical research more efficiently. 
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Character-Level Neural Language
Modelling in the Clinical Domain
Markus KREUZTHALER a,b,1, Michel OLEYNIK a and Stefan SCHULZ a
a Institute for Medical Informatics, Statistics and Documentation,
Medical University of Graz
bCBmed GmbH — Center for Biomarker Research in Medicine
Abstract. Word embeddings have become the predominant representation scheme
on a token-level for various clinical natural language processing (NLP) tasks. More
recently, character-level neural language models, exploiting recurrent neural net-
works, have again received attention, because they achieved similar performance
against various NLP benchmarks. We investigated to what extent character-based
language models can be applied to the clinical domain and whether they are able
to capture reasonable lexical semantics using this maximally fine-grained represen-
tation scheme. We trained a long short-term memory network on an excerpt from
a table of de-identified 50-character long problem list entries in German, each of
which assigned to an ICD-10 code. We modelled the task as a time series of one-hot
encoded single character inputs. After the training phase we accessed the top 10
most similar character-induced word embeddings related to a clinical concept via
a nearest neighbour search and evaluated the expected interconnected semantics.
Results showed that traceable semantics were captured on a syntactic level above
single characters, addressing the idiosyncratic nature of clinical language. The re-
sults support recent work on general language modelling that raised the question
whether token-based representation schemes are still necessary for specific NLP
tasks.
Keywords. Neural Networks, Electronic Health Records, Natural Language
Processing
1. Introduction and Motivation
So-called word embeddings have become popular for various natural language process-
ing (NLP) tasks. They capture the semantics of a word to a certain degree and have re-
placed term-weighted vector-based representation schemes from the pre-deep learning
era. For building such embeddings, a critical amount of textual data is needed to obtain
stable vector representations with different surrounding contexts. The excellent perfor-
mance of such representations, in combination with different neural network architec-
tures were demonstrated in various clinical NLP tasks.
In most cases, character-based input representations were handled as a merely sup-
portive information layer for word-level embeddings in different NLP problem domains.
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The?idea?that?character-level?neural?language?models?(CNLM)?alone,?based?on?recurrent?
neural? networks? (RNN)? and?more? specifically? long? short-term?memories? (LSTM)? are?
able? to? sufficiently?capture? the? information?needed? for?a?given? task? recently?got?again?
attention?by?various?research?groups.?The?main?motivation?behind?these?experiments?—
Google?named? them?“tokenizer-free? language?models”? [1]?—? is? to?address?NLP? tasks?
using?only?single?characters?as?input?representations,?thus?capturing?human?language?on?
its?most?granular?representation?level?[2].
In? this?work?we? investigated? the? possibility? of? character-based? clinical? language?
modelling?in?order?to?address?its?well-known?idiosyncrasies?(telegram-style,?single-word?
composition,?spelling?variants,?and?typing?errors)?with?the?purpose?of?optimally?capturing?
the?meaning?of?real-world?textual?data.
The?paper? is?structured?as?follows:?Section?2?gives?an?overview?of?recent?work?on?
CNLMs.?Section?3?describes? the?clinical?data?set? for? the? investigation?as?well?as?used?
methods?and? language?models.?Section?4?exemplifies? the?results,?gives? insight? into? the?
lexical?semantics?of?the?obtained?embeddings?and?discusses?the?results.?Finally,?Section?5?
concludes?the?paper?and?provides?an?outlook?for?further?investigation.
2.? Background?and?Related?Work
Zhang?and?LeCun?[3]?applied?convolutional?neural?networks?(CNN)?on?a?single?character?
input?level?for?ontology?classification,?sentiment?analysis?and?text?categorization.?They?
stacked?six?convolutional? layers?and? three?fully-connected? layers?for?the?specific?tasks.?
The?experimental?design?reached?a? test?set?based?accuracy?of?0.98?for?ontology?classi-
fication?(DBpedia),?0.95?for?sentiment?analysis?using? the?Amazon?review?polarity?data?
set,?and?0.60?exploiting?the?Amazon?review?full?score?data?set.?An?accuracy?of?0.71?was?
reached?for?the?Yahoo!?Answers?topic?classification?data?set.
Kim?et?al.?[4]?applied?single?character-level?inputs?to?a?deep?neural?network?model?
consisting?of?a?CNN,?a?highway?network?over?characters,?and?an?LSTM?at?the?end.?They?
tested?their?model?on?the?Penn?Treebank?for?different?languages?and?achieved?state-of-
the-art?results?with? less?parameters? in?comparison? to? the?other?machine? learning?based?
approaches.?They? reported?a?perplexity?of?78.9?on? the?English?Penn?Treebank? test?set.?
Their?character-level?input?models?outperformed?word/morpheme-based?input?represen-
tation?schemes?in?general.?The?model?was?also?shown?to?be?able?to?capture?different?lev-
els?of?semantics?on?a?token?level?constituted?by?a?time-series?based?input?representation?
scheme?of?single?characters.
More?recently,?Choe?et?al.?[1]?from?Google?showed?that?tokenizer-free?CNLMs?are?
competitive?with?current? state-of-the-art? language?models?using? the?One?Billion?Word?
benchmark? in?combination?with?a?deep? transformer?neural?network?containing?40?self-
attention?layers.?By?using?several?semantic?benchmarks,?they?showed?the?ability?of?their?
network? to?capture? layer-wise?word-level? semantics?even? though? the? input? representa-
tion?was?character-based.?This?work?corroborates?another?recent?work?from?Stanford?and?
Facebook? [5],?which?concluded? that?CNLMs?based?on? recurrent?neural?networks? (e.g.?
LSTMs)?are?able?to?capture?upper-level?semantics.
Motivated?by? the? research?mentioned?above,?we?explored? to?what?degree?CNLMs?
can?capture? token-level? lexical?semantics?from?clinical? texts.?We?accomplished? that?by?
fetching?embeddings?out?of?an?RNN,?after?training?it?on?a?critical?mass?of?real-world?data,
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viz. ICD-10 coded problem list entries from a clinical information system, modelled as
a time series of one-hot encoded single characters. With a nearest neighbour search on
selected clinical narrative content we fetched word types within the embedding space and
hypothesized that they were semantically connected to the given input. To the best of our
knowledge, this is the first investigation on the extent of CNLM-based lexical semantics
that can be obtained from clinical narratives.
3. Methods and Data
The initial data set is composed of ∼1.9 million unique 50 characters long problem list
descriptions in German, annotated with ICD codes. These annotations had been done by
physicians on in-patient discharge, the ICD codes being relevant for billing. To have a
sufficient number of initial samples per class we took the top-100 most frequent three-
character ICD-10 codes from a 90% split and up-sampled them to the most common one
to balance the whole data set. The final data consisted of ∼6 million coded problem list
entries used for CNLM training downstreamed to their corresponding disease code.
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Figure 1. Schematic description of the LSTM network in use [6].
After having prepared the training data set, we fed it to an LSTM network as depicted
in Figure 1. The problem list entry is represented as a series of one-hot encoded input
vectors of dimensionality 122 (number of alphabetic characters in the training corpus) to
the recurrent neural network. We refrained from any pre-processing and used all strings
as they were in the raw data. The neural network was trained for 5 epochs (∼73 hours)
using the deeplearning4j2 framework on an NVIDIA Titan V GPU with the following
parameters: mini-batch size: 512; learning rate: 1.0; L2 regularisation: 1E-6; weight ini-
tialisation: XAVIER; updater: RmsProp; LSTM hidden state vector size: 128; number of
LSTM cells: 60; LSTM activation: TANH; output layer activation: SOFTMAX; output
layer loss function: MCXENT; total number of network parameters: 141,412, which is
about a factor of 40 less than available training observations.
2https://deeplearning4j.org/
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In?order? to?obtain?a? specific?character-induced?word?embedding,?we?accessed? the?
hidden?state?ht−1?out?of?the?cell?at?step?t?−1?for?a?given?token?X?of?length?t.?Using?the?k-d?
tree?data?structure?we?built?a?searchable?k?=?128?dimensional?index?for?all?occurring?types?
in?the?training?corpus?to?get?back?the?top?n?nearest?neighbours?given?an?input?vector.?The?
input?vector?was? inferred? the?same?way?using? the? trained?LSTM?network?as?described?
before.?With?the?trained?LSTM?network?and?the?k-d?tree?data?structure,?we?could?obtain?
the?nearest?neighbours?in?reasonable?time?by?exploiting?the?cosine?similarity?measure?in?
the?embedding?space.?This?space?was?used?to?test?our?hypothesis?that?nearest?neighbours?
to? a? given? input? vector? contain? verifiable? semantics?with? respect? to? the? initial? search?
vector.
4.? Results?and?Discussion
Table?1?lists?the?top?10?nearest?neighbours?to?a?given?concept?in?descending?order.?The?
first?column?contains? the? results? for? the?disorder?“Nikotinabusus”? (nicotine?abuse).? In-
terestingly,?most?of?the?nearest?embeddings?to?the?given?token?contain?variations?of?the?
clinical?quantification?of?smoking?cigarettes? in?pack?years?(py),?a? level?of?detail? that? is?
irrelevant? for? ICD.?The?pack?year? (py)? is? the?unit? in?which? the? inhaled?smoke?dose?of?
a?cigarette?smoker?is?approximately?described.?Moreover,?the?quantitative?values?corre-
spond?to?the?manifestation?of?a?harmful?use?of?nicotine?via?some?smoking?behaviour.
“Nikotinabusus” “Handverletzung”
Word type Sim. Word type Sim.
chronisch 1.00 Handverletzung 1.00
(15/die) 0.99 Strecksehnendurchtr 0.91
abuse) 0.99 Fingernagelbruch 0.81
(20Stk./d) 0.99 Zeigefingergrundgliedfraktur 0.80
(25/d) 0.99 ausw.kons. 0.80
Z/d) 0.99 Handwurzelkontusion 0.79
(135 0.99 eingestauchte 0.79
(Abstin.seit 0.98 Daumenendphalanxstauchungsfraktur 0.78
(30pys) 0.98 Handwurzelknochen-Fraktur 0.78
(50pj) 0.98 4.links 0.77
Table 1. Top 10 nearest neighbors with corresponding similarity scores for two example words.
The second column contains the most similar character-level-induced word embed-
dings for “Handverletzung” (hand injury). The majority of the top 10 results contain dif-
ferent types of injuries of the body structure hand, and anatomical locations which are
part of the hand. A remarkable result is the semantic response “Daumenendphalanxs-
tauchungsfraktur” (thumb end phalanx compression fracture). Semantically obviously
related to each other, the lexical representation of “Handverletzung” and “Daumenend-
phalanxstauchungsfraktur” has nearly nothing in common with a Levenshtein distance
of 25.
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5.? Conclusion?and?Outlook
In?this?paper?we?investigated?to?what?extent?a?CNLM?with?an?LSTM?network?architec-
ture? is?able? to? induce?meaningful? lexical?semantics? in? the?clinical?domain.?We? trained?
the?network?on?∼6?million? ICD-10? coded?problem? lists,? a? critical? amount?of? training?
data?for?language?modelling.?After?the?training,?we?fetched?the?embeddings?by?access-
ing? the?hidden?state?ht−1?within? the?cell?at? the? last?step?of?an? input?word?of? the?LSTM?
network.?We? then? indexed? the? resulting?128-dimensional?character-level-induced?word?
embeddings?using?a?k-d? tree?data?structure?and,?via?a? top?10?nearest?neighbour?search,?
obtained?the?most?similar?whitespace?separated?tokens?given?an?input?word.?We?showed?
that?meaningful?lexical?semantics?could?be?captured?at?this?representation?level?using?an?
exploratory?evaluation.
Our?results?support?recent?investigations?that?single?character-level?representations?
to?RNNs?are?able?to?fetch?semantics?in?contrast?to?the?most?low-level?fine-granular?input?
scheme.?The?work?presented?here?uses?a?single?LSTM?network?in?contrast?to?more?com-
plex?models?from?recent?research?on?deep?transformer?models?like?BERT?[7]?or?stacked?
Bi-LSTMs?like?ELMo?[8]?for?contextual?embedding?modelling.
Furthermore,? this?preliminary?evaluation?was?done?purely?on?a?human? interpreta-
tion?level?on?selected?examples.?Future?investigations?of?CNLMs?in?the?clinical?domain?
should?consider?objective?evaluation?measurements?for?semantic?similarity?and?language?
model?quality.?Besides?the?mentioned?limitations,?the?work?presented?in?this?paper?sup-
ports?the?promising?potential?of?CNLMs?in?processing?raw?clinical?language?in?a?robust?
but?nevertheless?semantically?precise?manner.
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Clinical Abbreviation Disambiguation Using 
Deep Contextualized Representation 
Mingkai PENGa,1 and Hude QUANa 
aDepartment of Community Health Sciences, University of Calgary, Calgary, Canada 
Abstract. The objective of this study is to develop a method for clinical abbreviation 
disambiguation using deep contextualized representation and cluster analysis. We 
employed the pre-trained BioELMo language model to generate the contextualized 
word vector for abbreviations within each instance. Then principal component 
analysis was conducted on word vectors to reduce the dimension. K-Means cluster 
analysis was conducted for each abbreviation and the sense for a cluster was 
assigned based on the majority vote of annotations. Our method achieved an average 
accuracy of around 95% in 74 abbreviations. Simulation showed that each cluster 
required the annotation of 5 samples to determine its sense.   
Keywords. clinical abbreviations, deep contextualized representation, cluster 
analysis 
1. Introduction 
Abbreviations are ubiquitous in clinical notes as they are a convenient way for health 
care providers to record clinical concepts such as diseases and procedures within limited 
time. However, ambiguity of clinical abbreviations is very common. It was reported that 
33.1% of abbreviations in the Unified Medical Language Systems (UMLS) have more 
than one sense[1]. Abbreviation disambiguation is the process of identifying the correct 
sense of an abbreviation within a given context and is an important step to automate 
information extraction from clinical notes. Understanding clinical abbreviations still 
remains a challenging task for current clinical natural language processing (NLP) 
systems due to two major reasons: lack of a complete sense inventory of abbreviations, 
and efficient methods to disambiguate abbreviations with multiple senses[2].  
Overall, supervised learning performs well in clinical abbreviation 
disambiguation[3]. These methods usually build a classifier for each abbreviation using 
an annotated corpus with a large number of instances. However, the annotation process 
to create training data is expensive and time-consuming, which limits the scalability of 
supervised learning approaches. Many studies have explored different ways to reduce 
the annotation efforts for abbreviation disambiguation. Semi-supervised approaches 
have been explored to generate training data by submitting the long forms with their 
corresponding abbreviations and then training a classifier on the generated data[3]. The 
semi-supervised approach can achieve up to 90% of classification accuracy. To build the 
sense inventory, instances of an abbreviation were clustered into different sense clusters 
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and selected instances from each cluster were manually annotated to create the final list 
of senses[4]. The clustering-based method significantly reduced the annotation cost and 
increased the sense inventories. 
Previous studies have demonstrated the usefulness of word embedding for 
abbreviation disambiguation. Pooled neighbor word embedding of the abbreviations 
were used to train support vector machine classifiers for each abbreviation and the 
classifiers achieved good results on two clinical abbreviation datasets[5]. Use of deep 
contextualized word representation from pre-trained language model on large corpus has 
achieved state of the art performance on many NLP tasks, including abbreviation 
disambiguation[6][7].  
In this study, we explored the use of deep contextualized word representations as the 
input features and the cluster analysis to divide instances into clusters for annotation. The 
annotated cluster would be used for subsequent classification. 
2. Data and Methods 
In this study we used the clinical abbreviation sense inventories from University of 
Minnesota (UMN)[8]. The inventory was derived from 352,267 clinical notes including 
admission notes, consultation notes and discharge summaries and included 74 
abbreviations. For each abbreviation, 500 instances were randomly selected and 
annotated. For each instance, 10 words pre and post the abbreviations were extracted and 
used in this study. 
The pre-trained BioELMo was used to get the contextualized representation of an 
abbreviation within each instance. Embedding from Language Models (ELMo) is a deep 
bidirectional long short-term memory (LSTM) language model with two hidden layers 
and achieves the state of the art results in several NLP problems (e.g. word sense 
disambiguation) due to its deep contextualized representation[6]. Embedding 
representation of each token in ELMo is a function of the entire input sentence. We used 
the BioELMo that was trained on the PubMed corpus with 10 million abstracts[9]. The 
first and second layers from BioELMo and summation of the two layers were used as the 
feature presentation in our study. 
Instances from each abbreviation were divided into training (400) and test (100) data. 
Principal component analysis (PCA) was conducted on the word vectors of training data 
for dimension reduction. The PCA retained 95% of the total variance. The K-Means 
cluster algorithm was applied to extract 10, 15, and 20 clusters respectively. The senses 
of clusters were determined based on the majority vote of its cluster members. The 
trained PCA and cluster models were applied to test data to classify its sense. Simulation 
was conducted to evaluate the number of samples to be reviewed to determine the sense 
for a cluster. After the cluster analysis on the training data, we randomly sampled 1, 3 or 
5 instances for each cluster per abbreviation to determine the sense of the cluster based 
on the majority vote. See Figure 1 for an overview of preprocessing and analysis process. 
The accuracy of classification was used to assess the performance of method. 
3. Results  
There were 74 abbreviations in the clinical sense inventory. Half of them had 3 senses 
ad 8 abbreviations had more than 4 senses (Figure 2). Most of abbreviations had 
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unbalanced distribution of senses. 68 abbreviations had a sense accounting for over 50% 
of instances and 35 abbreviations had a dominant sense for more than 80% of instances. 
 
Figure 1. An overview of the method for clinical sense disambiguation. 
 
Figure 2. Distribution of senses for the abbreviations. 
Table 1. Accuracy of the method using different bioELMo layers and the number of clusters   
Layer Number of cluster Accuracy on training data Accuracy on test data 
Layer 1 10 0.912 (0.072) 0.916 (0.087) 
Layer 1 15 0.921 (0.065) 0.924 (0.076) 
Layer 1 20 0.927 (0.064) 0.929 (0.076) 
Layer 2 10 0.936 (0.060) 0.943 (0.065) 
Layer 2 15 0.943 (0.057) 0.949 (0.062) 
Layer 2 20 0.946 (0.051) 0.954 (0.059) 
Sum of layer 1 and 2 10 0.930 (0.066) 0.935 (0.070) 
Sum of layer 1 and 2 15 0.938 (0.056) 0.944 (0.058) 
Sum of layer 1 and 2 20 0.943 (0.053) 0.948 (0.058) 
Impact of ELMo layer and number of cluster on classification accuracy are presented 
in Table 1. Overall, use of layer 2 achieved better accuracy than use of layer 1 or sum of 
layer 1 and 2, and 20 clusters in the cluster analysis achieved the highest overall accuracy. 
Due to the nature of unsupervised learning used in our study, the differences in 
performance between training and test data were minimal.  
Detailed results for each abbreviation are shown in Figure 3. For abbreviation with 
only 2 sense, there were minimal increases in accuracy when the number of clusters 
increased from 10 to 20. However, increasing the number of clusters improved the 
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classification accuracy in abbreviation with multiple senses. There were slight decrease 
of accuracy with the increase of senses, in particular for abbreviations with > 4 senses.  
Simulation was conducted to evaluate how many instances were needed to be 
reviewed to determine the sense of a cluster. As expected, the increase of number of 
reviewed instances improved the classification accuracy. Use of 5 instances to determine 
the sense of a cluster achieved comparable overall accuracy to the use of all 400 instances.   
 
Figure 3. Impact of layer and number of cluster on the classification accuracy in test data. Each line 
represents one abbreviation. 
4. Discussion 
Our study showed that use of deep contextualized representations as features and cluster 
analysis to disambiguate clinical abbreviations achieved similar accuracy as supervised 
learning methods. Use of layer 2 of BioELMo and 20 clusters achieved the best 
performance. Simulation analysis demonstrated the potential cost-efficiency for sense 
disambiguation as it only required 5 samples per cluster without the loss of accuracy. 
Use of word embeddings from pre-trained language models can capture rich 
semantic and contextual information for abbreviations and improve the accuracy of 
abbreviation disambiguation. The previous study used a bag of word representation, 
position information, and section name of clinical notes where the abbreviation occurs 
as the input features for cluster analysis and achieved an average accuracy of 93.7% on 
12 abbreviations[4]. The use of deep contextualized representation as the input for a 
neural network model achieved an average accuracy of 98.1% on 11 clinical 
abbreviations[7]. This clearly shows the benefit of deep contextualized representation 
for abbreviation disambiguation.  
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Our method shows promising results on abbreviation disambiguation while 
requiring around 100 instances (20 clusters x 5 instances) for annotation to achieve 
comparable results to the supervised learning approaches. This could significantly reduce 
the cost of annotation. A recent study proposed the use of interactive learning algorithms 
to train abbreviation disambiguation classifiers using human created features[10]. During 
the annotation process, an expert was required to specify the sense of the indicated word 
and highlight the supporting evidence in a labeled instance. The algorithms achieved 
90% accuracy using only 15 labels on the UMN dataset. Our method can achieve 
comparable results without the use of expert domain knowledge and steps to manually 
create the features for classification. This will speed up the development of new 
abbreviation disambiguation methods for new data sources.  
Our study only applied the method in one corpus. Further investigation is required 
to test the generalizability of the method to other corpuses. 
5. Conclusion 
We proposed the use of pre-trained language to extract deep contextualized 
representations for cluster analysis to disambiguate clinical abbreviations. The results 
show that with minimal annotation effort to determine the sense of each cluster, our 
method can achieve comparable accuracy as supervised learning methods.  
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Clinical Concept Normalization on Medical 
Records Using Word Embeddings and 
Heuristics 
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Abstract. Electronic health records contain valuable information on patients’ clin- 
ical history in the form of free text. Manually analyzing millions of these docu- 
ments is unfeasible and automatic natural language processing methods are essen- 
tial for efficiently exploiting these data. Within this, normalization of clinical enti- 
ties, where the aim is to link entity mentions to reference vocabularies, is of utmost 
importance to successfully extract knowledge from clinical narratives. In this paper 
we present sieve-based models combined with heuristics and word embeddings and 
present results of our participation in the 2019 n2c2 (National NLP Clinical 
Challenges) shared-task on clinical concept normalization.  
Keywords. natural language processing, clinical information extraction, clinical 
concept disambiguation, word embeddings, sieve-based model 
1. Introduction 
Electronic health records (EHRs) hold great value for the correct understanding of pa- 
tient trajectories since they combine the multimodality in medical data with the tempo- 
ral aspect that is embedded in the clinical history, rendering it as a vital component to 
correctly understand how symptoms, findings, diagnoses and diseases evolve [1]. 
Textual data is highly relevant and can be found in EHRs in (semi-)structured and 
unstructured formats, the latter being commonly referred to as free text. Medical narra- 
tives (e.g. discharge or admission reports) are stored as free text since natural language 
provides a flexible convoy for physicians to track and report each medical situation, over- 
coming the limitations from ambiguous and unspecific terms that physicians can find 
when using coding standards such as RxNorm or SNOMED-CT. Owing to that, it is reck- 
oned that free text frequently contains plenty of information otherwise not obtainable 
from other data sources [2]. However, it is unfeasible to manually analyze large scale 
medical datasets. Despite the intricacies inherent to free text that make it very challeng- 
ing to process and interpret, the process of automatically annotating clinical narratives is 
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an important way to summarize or extract relevant data from medical text. This typically 
requires the text processing tasks of named entity recognition (NER) and named entity 
normalization (NEN) to extract relevant concepts and to standardize their referencing. 
The latter is a necessary step to combat ambiguities since clinical text contains many 
abbreviations, misspellings, and domain-specific expressions. 
In this paper we describe an approach for normalization of clinical entity mentions 
using sieve-based models combined with heuristics and word embeddings. The proposed 
method was used in the 2019 n2c2 shared task on clinical concept normalization3, where 
the aim was to link clinical entities to SNOMED CT or RxNorm vocabularies through 
UMLS Concept Unique Identifiers (CUIs) [3]. 
2. Materials and Methods 
The aim of the n2c2 clinical concept normalization task was to normalize medical entities 
to standard medical vocabularies. For simplicity purposes, the task focused only in NEN, 
bypassing the NER step by providing relevant clinical mentions identified a priori. 
In this section, we describe the dataset used as well as the three different 
methodologies applied, namely a method based on concept embeddings, an improved 
version of a baseline sieve approach, and a final rule-based method. 
2.1 Dataset 
The Medical Concept Normalization (MCN) corpus proposed by Luo et al. [1] was used. 
It comprises a wider set of clinical concepts in contrast to previous NEN challenges that 
only evaluated the normalization of disease mentions [4,5]. 
Each annotated clinical entity is associated with a single CUI from the UMLS 
2017AB version. For example, “hypertension” and “HTN”, or “blood pressure” and “BP” 
are two examples of expressions that refer to the same concepts and are therefore 
identified by the same CUIs (C0020538 and C0005824, respectively). Although UMLS 
encompasses several vocabularies, only two were used for annotation. RxNorm was used 
to annotate clinical drugs and medications, whereas SNOMED-CT, an extensive vocabu- 
lary of clinical terminology, was used for normalizing the remaining concepts (disorders, 
procedures, body structures, and others). 
Table 1.  Detailed dataset statistics. 
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The dataset contains a total of 100 annotated discharge summaries and is split in 
training and test subsets (Table 1). This allowed model development in the training set 
and a blind official challenge evaluation using withheld test data (the gold standard an- 
notations for the test data were only available after the official evaluation).
J.F. Silva et al. / Clinical Concept Normalization on Medical Records94
 2.2 Developed Methodologies 
2.2.1 Concept Embeddings Similarity 
This method involves two sequential steps: (1) text pre-processing and (2) similarity 
computation. In the first step, certain text rewrite rules were handcrafted by inspecting 
the clinical named entities in the training set (Table 2) with the aim of cleansing the sur- 
face representation of these mentions. In addition to the text replacements made, HTML 
entities and other superfluous symbols were also discarded. 
Table 2. Examples of text rewrite rules handcrafted according to the training set. 
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In the second step we represented the clinical named entities (from training and test 
sets) and UMLS concept names by using pre-calculated biomedical word embeddings. 
We employed the publicly available BioWordVec model [6] that was created applying 
the fastText library [7] and was generated from over 30 million documents from PubMed 
articles and clinical notes from the MIMIC-III database. 
From these representations we created a direct mapping between terms and CUIs 
where each term was defined by the embedding vector average of  its  constituent words 
[8]. This mapping was built using (i) text mentions from the train set and (ii) concept 
names from the UMLS CUIs corresponding to the SNOMED-CT and RxNorm 
vocabularies. 
At last, for making the predictions in the test set, the cosine similarity was calculated 
between each test mention embedding vector and all pre-calculated term embeddings [8]. 
The CUI corresponding to the most similar term was chosen. 
A simplified overview of this method is shown in Figure 1. Due to its ability to 
correctly capture text mentions with similar semantics, this method was also used as a 
final sieve to predict remaining (unclassified) entities in the next two pipelines. 
2.2.2 Improved Sieve-Based Approach 
The sieve-based approach by Luo et al. [1] was firstly deployed, containing exact match- 
ing with the training set annotations and with UMLS, along with MetaMap sieves [9]. 
This pipeline was performed in two stages, firstly using raw text mentions and secondly 
using clean text mentions. This approach yielded a 5-fold accuracy on the training set of 
0.783. An error analysis showed that MetaMap generated too many incorrect identi- fiers, 
limiting the number of unclassified mentions passing to the second sieve stage, thus 
capping the maximum attainable accuracy. 
The pipeline was reworked by shifting the MetaMap sieve from stage 1 to the end 
of the pipeline, right before the MetaMap sieve from stage 2. Further improvements 
involved performing a Monte Carlo simulation to select an optimal threshold for CUI 
classification with MetaMap, greatly reducing false positives. Remaining unclassified 
men- tions were classified using the concept embeddings approach described in Section 
2.2.1. The final pipeline is presented in Figure 1.   
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2.2.3 An Orchestrator for Combining Simple and Complex Rules 
This approach applies a 4-step pipeline combining rules and dictionary lookup, followed 
by previously computed concept embeddings. 
The initial step processes mentions containing ambiguous terms that map to multiple 
CUIs in the training set. For each mention, several rules are applied that consider specific 
words from the respective sentence and section heading if applicable. In steps 2 and 3, the 
system performs an exact match using dictionaries created from the training set and the 
UMLS database, respectively. This three step pipeline is invoked twice: in a first phase 
it is applied to raw mentions, which was essential to detect certain patterns that could 
match concepts annotated in the training set; in a second phase, the remaining mentions 
are pre-processed as described in Section 2.2.1 before the pipeline is applied. 
Finally, we combined this workflow with the concept embeddings from Section 2.2.1 
by having a final stage where concepts that completed the previous workflow without an 
Figure 1. Final system architecture composed of three different approaches. 
3. Results and Discussion 
Table 3 shows the results, obtained in the training and test sets, of the three previously 
described methodologies. 
Concept embeddings achieved an accuracy of 0.812 and 0.801 in the training and 
test sets. However, a posterior evaluation without using handcrafted replacements proved 
that the created text patterns were biased into the training set and led to overfitting, since 
simpler text pre-processing resulted in a lower training accuracy (0.807) and similar test 
accuracy (0.800). 
The rule-based approach combined with the concept embeddings method obtained 
the highest accuracy in the test set with a value of 0.806, corresponding to a 4 percentage 
points improvement compared to the baseline sieve-based model proposed by Luo et al. 
[1] that obtained an accuracy of 0.764 in the test set. 
attributed CUI were processed using the concept embeddings. 
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Table 3. Obtained accuracy results with the three distinct methodologies. Results in the training set achieved 
by 5-fold cross-validation (10 repetitions in the concept embeddings method). 
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4. Conclusions and Future Work 
In this paper, we proposed three methodologies to normalize clinical concepts from pa- 
tient clinical reports automatically. The development of such methods applied in health- 
care data migration pipelines is essential to increase data value and have harmonized 
datasets. 
As future work, we intend to improve each methodology individually by using in- 
formation from the surrounding context and section heading of each mention. Also we 
intend to incorporate UMLS concept definitions to enrich the semantic knowledge re- 
garding each concept. These improvements may reduce concept ambiguity issues. As a 
final refinement, we aim to apply deep neural network models to predict the correct CUI 
embedding vector. 
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Abstract. Chronic fatigue syndrome (CFS) is a long-term illness with a wide range 
of symptoms and condition trajectories. To improve the understanding of these, 
automated analysis of large amounts of patient data holds promise. Routinely 
documented assessments are useful for large-scale analysis, however relevant 
information is mainly in free text. As a first step to extract symptom and condition 
trajectories, natural language processing (NLP) methods are useful to identify 
important textual content and relevant information. In this paper, we propose an 
agnostic NLP method of extracting segments of patients’ clinical histories in CFS 
assessments. Moreover, we present initial results on the advantage of using these 
segments to quantify and analyse the presence of certain clinically relevant concepts. 
Keywords. Natural Language Processing, Chronic Fatigue Syndrome; Electronic 
Health Records; Clinical Informatics 
1.Introduction 
Chronic fatigue syndrome (CFS) is a debilitating illness characterised by extreme 
tiredness, with a wide range of related symptoms, including muscle fatigue and sleep 
disturbance [1]. Given that the origin of the condition is still unknown, analysing large 
amounts of patient data is an important step towards an improved understanding of its 
aetiology and clinical trajectories. Clinical assessments of CFS provide a comprehensive 
overview of patients’ symptoms and functional limitations, and are usually conducted 
when a patient is referred to a specialist clinic. These assessments include past history as 
well as current situation, thus representing a valuable source of data for large-scale 
analysis. In electronic health records (EHRs), however, clinical assessments are often 
primarily documented in an unstructured form (free text), which cannot be easily 
analysed on a large scale. To allow the automatic analysis of such texts, natural language 
processing (NLP) methods are becoming increasingly popular [2]. 
During a CFS assessment, an extensive amount of patient information (e.g., 
demographic data, medication history, treatment plans) is gathered. To automatically 
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process these different input texts, capturing only information specifically on factors that 
may have contributed to or are associated with symptom and condition trajectories is 
helpful. For downstream tasks such as clinical concept extraction and trajectory 
modelling, NLP methods that identify useful segments within the text are needed, and 
these are usually found in paragraphs related to clinical history. Automatically extracting 
these relevant segments for large patient cohorts is a challenging task, especially due to 
the variability of EHR document structures across healthcare institutions. In initial 
clinical assessments, most clinicians document the presenting (or primary) complaint 
first, and then less strictly ordered are the history of present illness, past medical and 
psychiatric history, family history, social history, personal history and assessment & 
management plan [3]. However, these sections are not necessarily documented under 
specific headings. There have been several efforts to develop NLP approaches that 
automatically extract document sections from various types of clinical documents, e.g., 
discharge summaries and admission reports [3–5]; family history [6–8], or patient 
histories [9]. However, most of these studies rely on using section and subsection 
heading information, which is often not available in a predefined way. 
As a crucial initial step to modelling symptom and condition trajectory patterns in 
CFS patients, extracting clinical history segments from initial assessments - regardless 
of the structure of the documents - is needed. In this work, we develop an agnostic 
method of extracting temporal segments of text that convey clinical history information. 
The method is evaluated against a small set of manually annotated CFS assessments. We 
also perform an initial experiment of the potential benefit of using these segments to 
analyse the presence of certain clinically relevant concepts in a larger CFS patient cohort. 
 
 
2.Materials and Methods 
 
This study is based on mental health records from the Clinical Record Interactive Search 
database [10] from the South London and Maudsley NHS Foundation Trust (Ethical 
approval: Oxford REC C, reference 18/SC/0372). The first clinical assessment for CFS 
patients usually consists of a comprehensive letter written by the clinician, including 
information on past and recent history. To develop and evaluate our segment extraction 
approach, we used “first” assessment letters for all patients diagnosed with CFS - based 
on the date, length (character count) and title of the documents. 1201 patients (one 
document per patient) were identified. Only 49.7% of the documents had some form of 
section headings. 36 CFS assessments were randomly extracted and manually annotated 
by two annotators (medical students, native English speakers). Annotators were asked to 
mark sentences that indicated history information (clinical, family, personal and social 
history). Here, we only focus on sentences marked as clinical history. This annotated 
dataset was randomly split into a training (20 docs) and blind test (16 docs) set. 
For our segment extraction algorithm, we hypothesised that historical segments 
contain more time expressions (e.g. in 2012, two years ago) than other parts of the 
document. Time expressions were obtained using SUTime [11]. The segment extraction 
algorithm divides each document in sentences using a regular expression sentence 
tokenizer. Then, it flags each sentence as 1 if the sentence contains a time expression 
(date or duration), 0 otherwise. The first and last sentence of each document are always 
considered as unflagged (0) because of document headings and end signatures. To 
generate larger segments, additional sentences are then flagged 1 if the length of the 
segment flagged as 0 between two sentences marked 1 is shorter than the average length 
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of segments with sentences flagged as 0. Finally, flagged segments that are too short are 
deleted, based on calculating the average length of flagged segments. 
Inter-annotation agreement (IAA) was calculated with f-measure on the sentence 
level, which approaches the statistic when the number of negative cases is large and 
unknown [12]. For the algorithm performance, recall (sensitivity) was the main 
quantitative evaluation metric, calculated at a sentence level as compared to the 
annotators (A1 and A2). To assess whether the extracted segments retained clinically 
relevant information, we searched for a set of pre-defined concepts relevant to CFS 
disease trajectories within these segments and in the entire text (using exact string 
match). We considered the following concepts, known to be related to CFS: stress, virus, 
depression, anxiety and suicidal thoughts/ideation. The number of concepts were counted 
and compared in extracted segments vs. entire documents. In addition, two clinicians 
analysed the qualitative nature of the extracted segments for 10 randomly extracted CFS 
documents, assessing whether they retained the key clinical information. False positives 
and false negatives from the temporal segmentation algorithm were also analysed, to gain 
more insight into how temporal information is documented in CFS assessments. 
 
 
3.Results 
 
IAA on the CFS dataset was 
70.6 and 74.9 f-measure on 
the training and test set, 
respectively. Overall, the 
temporal segmentation 
algorithm resulted in an 
average recall of 72.3% on the 
training set. Results on the 
final test set were: 64.1%. 
Figure 1 is a visualisation 
of a random subset of the 
segments (training set) found 
by the temporal segmentation 
algorithm (black) compared to 
the manually annotated 
sentences (pink). Each 
document is divided into 
sentences. When a sentence 
 
 
Document 1 Document 6 
 
 
Document 2 Document 7 
 
Document 3 Document 8 
 
 
 
Figure 1: Visualisations of the temporal segmentation algorithm 
output as compared to manually annotated sentences (annotator A1) 
of clinical history on 6 documents from the CFS training set 
(x-axis) has been marked as clinical history either by the algorithm (black) or the 
annotator (pink), it is marked as 1, 0 otherwise (y-axis). As can be observed, the 
algorithm tended to cover most annotations (i.e. high recall), but also captured sentences 
not annotated as clinical history (i.e. low precision). In the qualitative evaluation, the 
clinicians generally agreed that the extracted segments usually contained symptom and 
condition onset information, and that they represented clinical histories. 
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Figure 2 shows results of 
the concept search on the 
entire set of CFS 
assessments (n=1,201). For 
94%  (1,133/1,201)  of  the 
patients (i.e. documents), at 
least one concept was 
found. ‘Stress’ was found 
in most assessments (69%, 
832/1,201), and was, in the 
majority of cases, either in 
the extracted history 
segment  (43%)  or  in both 
the history segment and outside (36%), i.e. in 21% the concept was documented only 
outside of the segment. ‘Virus’ was documented almost exclusively in the extracted 
history segments (11% were found outside of the segments). ‘Anxiety’ and ‘suicidal 
thoughts/ideation’ were more often reported outside of the history segments (30% and 
34% respectively). ‘Suicidal thoughts/ideation’ was rarely found both within and outside 
the extracted segments (7%), and only found in 26% of the patients’ assessments (316). 
A manual analysis of 10 randomly extracted examples for ‘Anxiety’ and ‘Virus/viral’ (5 
each) revealed some potential patterns. For ‘Anxiety’, all but one related either to 
speculations about the patient suffering from chronic anxiety disorder rather than chronic 
fatigue, or to anxiety related to work or health. For ‘Virus/viral’, 4/5 examples related to 
concepts that would be clinically relevant, and were all found at the beginning of the 
document, where the algorithm had failed to capture a segment. However, the segments 
in those documents contained synonym concepts such as ‘shingles’. The fifth example 
was a negation and was correctly excluded by the algorithm. 
 
 
4.Discussion 
 
To address the goal of finding population-level patterns in symptom and condition 
trajectories for CFS patients from their initial clinical assessments using NLP, selecting 
segments of the text describing the disease history is crucial. We have developed an 
algorithm that extracts temporal segments based on a simple approach relying on 
identifying time expressions (dates and durations) in sentences, and automatically 
expanding to segments by calculating patterns of consecutive sentences. As this method 
is agnostic to the data and does not make use of document section information, it can be 
extended to different types of clinical documents. In this approach, there is no assumption 
on the number of segments found per document. As shown in Figure 1, clinical history 
sentences can be either spread out across the document or gathered in one single segment. 
IAA agreement results were promising (within the ‘Substantial’ agreement range [13]), 
but further analysis and adjudication is needed. Most importantly, our current findings 
are based on a very small dataset – to generate more conclusive results, we will extend 
our study to larger datasets and perform additional experiments. 
Previous studies on identifying segments in clinical narratives have heavily relied 
on the presence of pre-defined sections [3–5]. Only 50% of our data had section titles, 
thus such approaches would miss important information. We focused on improving 
recall, as our goal was to reduce the amount of irrelevant information in each document, 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Coverage of pre-defined list of clinically 
relevant concepts in the entire set of CFS assessments 
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whilst ensuring we did not miss key clinical information. Generally, the algorithm covers 
the manual annotations (and more), but it also misses some sentences (Figure 1). False 
positives included examples of personal history rather than clinical history (#1 and #6) 
or current symptomology (#2). Several documents contained clinical history annotations 
at the end of the document (e.g. #6 and #7), that were missed by the current algorithm 
(false negatives). These corresponded to a brief overall summary which were repeating 
the information contained in previous segments. The algorithm also missed a few 
symptom-related sentences following a long social history paragraph (document #7). We 
plan to study alternative methods for automatically generating temporal segments based 
on larger datasets, as well as compare results with previously published approaches. 
When searching for pre-defined clinically relevant CFS concepts, most documents 
had at least one (94%), and most concepts were found inside the extracted segments 
(90%). Concepts only found outside of segments were either mentioned in a different 
context than clinical history (e.g. the concept anxiety was used to describe the patient’s 
current state) or used in the first sentence of the document (mainly for ‘virus/viral’). We 
plan to extend this analysis by looking at additional concept mapping techniques such as 
word embeddings, clustering and topic modelling approaches. 
Our main contributions in this study are: an agnostic method of extracting segments 
of EHR text that convey history information, and an initial experiment of the benefit of 
using these segments to analyse the presence of certain clinically relevant concepts in a 
CFS cohort. This is a first step towards large-scale studies on CFS disease trajectories. 
 
 
References 
 
[1] A. Avellaneda Fernández, A. Pérez Martín, M. Izquierdo Martínez, et al., Chronic fatigue syndrome: 
aetiology, diagnosis and treatment, BMC Psychiatry. 9 Suppl 1 (2009) S1. 
[2] S. Sheikhalishahi, R. Miotto, J.T. Dudley, et al., Natural Language Processing of Clinical Notes on 
Chronic Diseases: Systematic Review, JMIR Med. Inform. 7 (2019) e12239. 
[3] Y. Li, S. Lipsky Gorman, and N. Elhadad, Section Classification in Clinical Notes Using Supervised 
Hidden Markov Model, in: Proc. 1st ACM Int. Health Inform. Symp., ACM, New York, NY, USA, 
2010: pp. 744–750. 
[4] J.C. Denny, A. Spickard, K.B. Johnson, et al., Evaluation of a method to identify and categorize section 
headers in clinical documents, J. Am. Med. Inform. Assoc. JAMIA. 16 (2009) 806–815. 
[5] P.J. Haug, X. Wu, J.P. Ferraro, et al., Developing a section labeler for clinical documents, AMIA Annu. 
Symp. Proc. AMIA Symp. 2014 (2014) 636–644. 
[6] R. Bill, S. Pakhomov, E.S. Chen, et al., Automated Extraction of Family History Information from 
Clinical Notes, AMIA. Annu. Symp. Proc. 2014 (2014) 1709–1717. 
[7] J. Friedlin, and C.J. McDonald, Using a natural language processing system to extract and code family 
history data from admission reports, AMIA Annu. Symp. Proc. AMIA Symp. (2006) 925. 
[8] S. Goryachev, H. Kim, and Q. Zeng-Treitler, Identification and Extraction of Family History 
Information from Clinical Reports, AMIA. Annu. Symp. Proc. 2008 (2008) 247–251. 
[9] W. Lee, and J. Choi, Temporal Segmentation for Capturing Snapshots of Patient Histories in Korean 
Clinical Narrative, Healthc. Inform. Res. 24 (2018) 179–186. 
[10] G. Perera, M. Broadbent, F. Callard, et al., Cohort profile of the South London and Maudsley NHS 
Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent 
enhancement of an Electronic Mental Health Record-derived data resource, BMJ Open. 6 (2016). 
[11] A.X. Chang, and C. Manning, SUTime: A library for recognizing and normalizing time expressions, 
in: Proc. Eighth Int. Conf. Lang. Resour. Eval. LREC-2012, European Languages Resources 
Association (ELRA), Istanbul, Turkey, 2012: pp. 3735–3740. 
[12] G. Hripcsak, and A.S. Rothschild, Agreement, the f-measure, and reliability in information retrieval, J. 
Am. Med. Inform. Assoc. 12 (2005) 296–298. 
[13] J.R. Landis, and G.G. Koch, The Measurement of Observer Agreement for Categorical Data, 
Biometrics. 33 (1977) 159. 
S. Priou et al. / Clinical History Segment Extraction from Chronic Fatigue Syndrome Assessments102
Clinico-Environmental System for Personal 
Monitoring 
Filipe PIRES1a,b,, André PEDROSAa,b , João ALEGRIAa and Carlos COSTAa,b , 
a Department of Electronics, Telecommunications and Informatics, University of Aveiro 
b Institute of Electronics and Informatics Engineering of Aveiro 
Abstract. The ever-growing use of information and communication technologies in 
the past decades and the proliferation of mobile devices for monitoring vital signs 
and physical activity is enhancing the emergence of a new healthcare paradigm. 
More recently, citizens are becoming more sensible to the necessity of monitoring 
environmental health indicators and to its direct impact on personal health. This 
article proposes and describes the development of a clinico- environmental system 
for personal monitoring. The result is ContinuousCare, a personal healthcare 
information system that integrates personal smart devices with air quality monitors. 
The solution helps citizens to better understand their health and body activity with 
environmental context, aiding professional doctors with analysis tools and making 
available valuable data for external systems. 
Keywords. clinico-environmental monitoring, health monitoring, personal health 
record, geolocation tracking 
1.Introduction 
The use of science and technology in medicine has been explored by mankind 
throughout the last decade more than ever. Information and communication 
technologies brought a proliferation of mobile devices for monitoring vital signs and 
physical activities of citizens and, consequently, the emergence of a new paradigm of 
medical monitoring is growing in the research communities. 
On one hand, there already exists software to integrate distinct types of health 
monitoring devices and make available useful tools for injury detection and alert, 
amongst other purposes. Its target audiences are mostly specific groups like elderly 
people or athletes. On the other hand, the environmental conditions surrounding human 
life is often neglected by these healthcare technologies. Health disorders, painful 
conditions or even diseases can be directly correlated with local environmental 
conditions such as, for instance, high carbon dioxide levels. Current software solutions 
do not integrate environmental indicators, neglecting in consequence an important 
source of data than has tremendous potential to increase the prevention and diagnosis 
capabilities. 
In this paper, we propose a personal monitoring solution called ContinuousCare that 
is able to integrate traditional personal health monitoring devices and environmental 
data sources, including home devices for air monitoring. Our system approaches the 
problem considering both the human activity and the environment it is exposed to and 
proposes powerful forms of data aggregation and visualization. 
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2.Background 
A market research and literature reviewing process was performed for evaluation of 
actual proposal in the scope of ContinuousCare solution. It is possible to find a 
tremendous number of products, services and reports related to personal health 
monitoring, including geolocation recording. Due to the article size restrictions, we just 
report the ones that were more inspiring to the proposed system. An android  application 
[1], developed by Turkish researchers, was the first product that takes advantage of 
geolocation to improve its service’s quality. The  application allowed users to keep track 
of elderly family members and be notified in case of emergencies, providing the closest 
hospitals. Health Tracking system [2] used GPS coordinates and other metrics to 
provide insights on the physical conditions of cyclists. The offered services seems very 
interesting and were inspiring for our proposal, being adapted to a more generalized 
target audience. Other solutions such as the Angel-Echo [3] or the UPHSM [4] provided 
us with perspectives on the potential of the subject and on the variety of use-cases and 
target audiences that could benefit from robust and intuitive health monitoring systems. 
Finally, the evaluation of key characteristics of already existing products, for similar 
problems, were taken in consideration during the design of ContinuousCare. A group of 
students from SSPACE college [5], in India, gave us valuable insights on what are the 
best metrics to take in consideration when monitoring body status.  
3.System Architecture 
The architecture of proposed personal monitoring system is shown in the Figure 1. The 
key design decisions aimed to ensure the robustness and scalability of ContinuousCare 
and its accessibility to any user with an internet connection. These regarded the 
collecting of data from our different sources, the appropriate storage strategy and the 
database load and access-time optimizations. It follows a modular structure where each 
module is replaceable and updates to one component do not imply the refactoring of 
others. The main component is the Monitoring Server that is divided into 3 functional 
units: 
• Processing – it is responsible for gathering the information from supported devices 
and public data source APIs. This operation is scheduled, which means that it is 
executed many times per day. This unit is responsible for doing this scheduling and 
for processing the data collected (filtering it, assigning labels, and more); 
• Persistence – it is responsible for storing all data after processing. It interacts with 
the database interface and ensures that every field is persisted correctly; 
• REST API – it is the component responsible for supporting a REST 
(REpresentational State Transfer) interface for the system, serving as the entry 
point for every client application. 
The second module is the GPS Service that was implemented since many personal 
monitoring devices do not provide access to its locations. Since geolocation is a crucial 
aspect in our proposal, it was necessary to implement from scratch a service responsible 
for receiving the users’ locations and a mobile application that tracks them. 
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 Figure 1. Architecture diagram. 
In the persistence layer, we adopted a strategy based on a hybrid database. It was 
designed a relational database model in MySQL for the structured and interconnected 
data: accounts information, permissions between users, and devices. For the bulk data 
received from the devices and external sources, it was used a time series driven 
database, implemented with InfluxDB. This second one was found the best technology 
for our case as it is dedicated to continuous data streams and queries with time intervals. 
It is this database that feeds most of our web application’s features. A system like 
ContinuousCare faced problems of big-data and some optimizations were performed, 
namely keeping in cache the values for a given time interval and periodically writing  
all the values stored with a batch process. In the long run, the database will hold a big 
load of data, some of it turning irrelevant as time passes. For this reason, the storage 
module supports the aggregation data after a defined period of time. 
The platform provides a web application that runs on the UI Server and is our main 
interface with the end-users. It interacts with a public REST API (through the 
Monitoring Server) and makes use of the supported devices. It was developed with the 
NuxtJS framework, over VueJS, helping to maintain an intuitive website organization 
and giving us the possibility of deploying either a Single Page App or a Universal App 
(where pages are rendered on the server side for a smoother user experience). Several 
libraries for graphical elements, cookies and web-sockets were used, as well as an 
HTML template from Colorlib [6] for design purposes. 
Finally, the system supports at this moment three types of data providers: 1) 
personal monitoring device – it was used the Fitbit Charge 3 [7], an advanced fitness 
tracker that has many health-related metrics. We focused on collecting calories, heart 
rate and sleep stages, as these present more interesting information for analysis 
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purposes; 2)  air quality monitor – it was used Foobot [8], an indoor device able to 
detects invisible and odorless pollutants that fall into 3 categories (volatile compounds, 
particulate matter  and carbon dioxide), calculates temperature and humidity levels and 
alerts users about unhealthy activities; 3) public portal with environment indicators – it 
was used the Waqi2 public API that allows us to know the level of pollution of a given 
place on earth. By tracking the geolocation of our users, the system is able to decide 
whether to collect information from a Foobot or from Waqi according to the distance 
between the users and their respective air quality monitors. 
4.Results 
A Web platform was deployed on the Cloud with all functionalities described in this 
article. The system was continuously used by  a  user  during  one  month  for  
validation purposes. The platform supports two distinct user profiles, patients and 
doctors. Doctor accounts, once permitted by patients, have access to the profile 
information and to all records, grouped by Health Status, Environment, Sleep or Events. 
In each group, the user can see a particular metric in detail throughout time with the 
help of the line graphic. Users are able to add, remove or update monitoring devices. 
For instance, they can have many home devices in different places of common use 
(home, workplace, etc.). 
Figure 2. History Page 
Users have also available a timeline with relevant events that occur throughout the 
days. The users can add descriptive markers (annotation)  to  those  events  to  keep 
track of their health progress. They include  situations  like,  for  instance,  heart  rate 
out of the healthy range, presence of high levels of carbon dioxide or other harmful 
particles, sedentary behaviors (not enough daily steps), few hours of sleep, etc.  
Figure 2 presents one of the most emblematic functionalities implemented, the 
History Page. Here the user can see the places he/she has been, the current location of 
his/her device(s) and the markers of events that occurred throughout the defined time 
window. This allows the pairing of events to locations and understand what places 
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affect him/her the most.  
The first version of ContinuousCare application provides 7 main functional areas 
and presents data related to 20 metrics. Its public API provides 26 public endpoints (i.e. 
services). The results of the scalability tests executed show that the backend supports 
comfortably  100  users   online,   each   making   300   requests,   ensuring all of the 
performance requirements established. 
5.Conclusions 
Modern society is becoming very sensible to the necessity of monitoring environmental 
conditions and study its impact on personal health. This paper proposes an innovator 
clinico-environmental system for personal monitoring. ContinuousCare presents itself as 
a healthcare tool for any person, empowering both people concerned with their own 
health and medical personnel looking for innovative analysis tools. It has potential to 
aid any user interested in perfecting their lifestyle and monitoring the surroundings. It 
combines data collected by air quality monitors with vital signals form personal health 
devices, and it makes all data collected easy to read, process and consume in an 
integrated way. Users can also annotate detected events and register daily moods and 
behaviors. In the future, the efforts will focus on a new system module for data mining 
aiming to extract key information from events and offer tools to predict diseases and 
notify users of dangerous behaviors and hazardous environments. 
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Abstract. Grenoble Alpes University Hospital (CHUGA) is currently deploying a 
health data warehouse called PREDIMED [1], a platform designed to integrate and 
analyze for research, education and institutional management the data of patients 
treated at CHUGA. PREDIMED contains healthcare data, administrative data and, 
potentially, data from external databases. PREDIMED is hosted by the CHUGA 
Information Systems Department and benefits from its strict security rules. 
CHUGA’s institutional project PREDIMED aims to collaborate with similar 
projects in France and worldwide. In this paper, we present how the data model 
defined to implement PREDIMED at CHUGA is useful for medical experts to 
Keywords. Complex and massive data, medical informatics, health data 
warehouse, cohorts, data visualization
1. Introduction
Selecting a cohort of patients and gathering associated medical data for research 
usually involves bringing together information from different sources, potentially 
isolated from each other in a hospital's information system.
It is thus necessary, for all patients that are likely to be members of a research 
cohort, to combine their clinical notes with the local information of a clinical 
department of the hospital, then to enrich them with those distributed in the various 
hospital databases, to gather all the documents containing demographic, clinical, 
biological, pharmacological information concerning these patients. This phase often 
interactively build a cohort of patients and to visualize this cohort.
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involves the cooperation with the IT department to transform the potentially complex 
needs expressed by the research team into querying language to extract the expected 
information from the hospital’s multiple databases. Several iterations of this process 
between researchers and data managers may be necessary to ultimately lead to the 
expected data set. However, in this way no interactivity on data exploration is offered 
to researchers, though it would allow them to obtain or approach faster the best 
possible result. It is then necessary to organize these data in a coherent and easily 
explorable form for researchers to select the members of the final cohort that will 
constitute the data set to be used for the study.
The whole process of collecting the data set associated with a cohort of patients is 
therefore expensive in terms of mobilizing different health and IT specialists for 
several months. This paper describes methods and tools implemented as a proof of 
concept in the framework of the health data warehouse called “PREDIMED” of the 
Grenoble Alps University Hospital, to enable hospital authorized medical specialists to 
navigate interactively and in a fluid way through the whole data lake or through their 
own data set, to create and explore their own cohorts of patients.
PREDIMED is a data lake platform designed to integrate and analyze for research, 
education and institutional management, the data of patients treated at CHUGA since 
1998. PREDIMED contains administrative data (patients and visits), healthcare data 
(diagnoses, prescription, images, etc.) and, potentially, data from external databases. 
PREDIMED is hosted by the CHUGA Information Systems Department and benefits 
from its strict security rules. PREDIMED has several views on the data facilitating its 
exploration and usage according to the specific needs. In this paper, we specifically 
present the graph model and the associated tools dedicated to its real-time exploration 
and data visualization of millions of heterogeneous information.
2. Methods and implementation
Here we describe methods and implementation choices that we used to provide 
healthcare professionals with an environment allowing them to simply and graphically 
manipulate the concepts and relationships of their expertise domain to navigate through 
the hospital's data lake without knowledge of any computer language.
Figure 1: Graph data model of the data lake and interactive cohort construction interface.
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The data lake is modeled in an intuitive form that allows each member of the 
research project, regardless of their profession, to understand its semantics [3]. Figure 1 
gives an idea of the graphical visualization of the lake data model. Graph nodes are 
common medical concepts and graph edges represent the relationships between them.
Patients data from various hospital databases is linked in PREDIMED via an 
internal key. This technical key is different from the patient number used for care to 
separate medical information from directly identifying data. The same approach is used 
for the visit numbers.
Using the graph data model, the team in charge of cohort constitution works with 
the clinician to build the cohort for the study. The graph model allows starting from 
any entity since the selection is made by choosing a concept from the model and 
following an edge that links it to another concept. The traversal can thus start from 
diagnostic codes (ICD10), periods of hospitalization, administered treatments  or any 
other graph node. The user can then progress in traversing the graph edges by hops, 
possibly expressing constraints at different levels. Interactively, at each movement 
through the graph, the system provides the volume of collected data. In Figure 1, one 
can see that at this intermediate stage, the selected data concerns the entities marked in 
yellow (here diagnostics, patient_did, document, venue_did and treatment). The 
attributes associated with venue_did can be filtered (a filter can be set on the 
hospitalization period (dt_debut_prestation for example)).
Behind this graphical selection mechanism is a query language [4] specifically 
developed for the project that allows the user to query the associated graph database. 
The query basic hop is built as follows:
“source objects class”[filters]—named relationship[filters]—>“target objects class”, ...
The complete query string that traces the graphical navigation path is associated 
with the current cohort, which allows the user to relaunch it if the lake content gets 
richer or to trace what has been done during the exploration phase.
Figure 2 illustrates the expression language of a textual query for the first move 
through the graph. The presented query is based on a proof-of-concept study building a 
cohort of patients with diabetes (first move in Figure 2: patients over 20 years old, 
hospitalized in 2016 and whose biological measurements and received treatments 
corresponded to the chosen characteristics).
3. Results
Through the interactive iterations on this graph, the clinician can visualize the 
information on the obtained cohort in different ways. Graphical visualization tools 
associated with the cohort make it possible to highlight the dispersion of patients over 
the territory or to construct a dashboard with various indicators (see Figure 3).
Based on the same data structure, a visual exploration of the cohort being built 
provides access to a “360° view” of the cohort elements. The visualization interface in 
a web browser interacts with the graph database through a software layer (REST API) 
Figure 2: Generated query hop during navigation
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that gives an abstraction of the model. This architecture thus limits a strong adherence 
with the database. 
 
Figure 3: Interactive views describing the current selected data-set 
 
This “360° view” of the patient allows to visualize the different sides of the patient 
file. The first facet resumes the diagnoses based on the ICD10 codes and the timeline 
provides the chronology of these diagnoses. Those codes are projected onto a body 
silhouette highlighting the affected organs or body parts. An oval-shaped representation 
gives a synthesis of the pathological classes concerned. Other facets provide access to 
the various documents available in the patient's file. As with diagnoses, a timeline is 
associated with the list of documents such as drug prescriptions. An equivalent view is 
available for pharmaceutical prescriptions giving both the list of drugs administered or 
prescribed (therapeutic class, name of the drug, etc.). 
 
 
4. Discussion 
4.1. Flexibility, evolutivity of the model, code genericity. 
Graph modeling allows similar concepts to be grouped together and is well-suited to 
represent flexible and evolving structures. Graph data model implementation with a 
Figure 4: Different views on the patient's file. 
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graph database is almost straightforward and the high level of manipulated objects is 
appropriate for the development of generic code, independent of the future data 
variants.
4.2. Implementation and interoperability
The application environment we have built to operate PREDIMED is based on an open 
source property graph database, ArangoDB. This in-memory system enables to 
navigate seamlessly in such complex, highly-connected, massive data organizations. 
The native JSON-centered data application environment provides both the ability to 
comply with normative health data standards, to deal with complex objects' attributes 
(lists, matrices...) and the ability to distribute processing on different and evolutive 
applications of the PREDIMED architecture. Interoperability is also facilitated by the 
ability to interconnect with other graphs, using online APIs provided by evolving 
global data standards for health information such as ICD11.
4.3. Scalability
Unlike a conventional relational database system whose complete request must be 
written in advance, PREDIMED's alternative request system allows researchers to 
navigate easily through the data and record the path corresponding to a “built-on-the-
fly” request. As the request is executed step by step, even when it is eventually 
relaunched entirely, there is potentially no limit to the number of steps that constitute 
the response path to a request. The size of the request and therefore its complexity have 
no impact on the processing infrastructure.
5. Conclusion
PREDIMED Data Warehouse allows non-IT specialists to use complex and massive 
data mining tools to effectively and rapidly design patient cohorts for research projects. 
PREDIMED provides agility and auto-improvement ability in data navigation while 
making the work traceable, reproducible, and transferable to other data-sets. 
This work has been performed as proof-of-concept. The independent supervisory 
authority in terms of the GDPR (CNIL in France) has authorized the CHUGA to 
proceed to the operational phase of PREDIMED, on October 10 2019.
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Abstract. The use of Artificial Intelligence (AI) technologies within the healthcare
sector is growing. However, there are differences in the speed of commercial 
adoption of AI across sub-sectors. We employ a dataset including news mentions 
and executive communications of all S&P500 Health Care Index companies to 
explore these differences. Pharmaceutical and medicine manufacturing companies 
had the earliest AI-linked news presence, yet they appeared to be among the slowest 
commercial implementers of AI. Ambulatory health care services and hospitals, as 
well as insurance carriers, received media coverage later, but were the quickest to 
take AI into commercial use. From the theory perspective our results indicate that 
the classical innovation diffusion theory might not fully explain these differences.
Keywords. Artificial Intelligence, Technology Transfer, Health Technology
1. Introduction
Artificial intelligence (AI) technologies are expected to significantly impact or even 
transform healthcare provision. Value of goods and services produced by 12 developed 
economies in the healthcare sector alone is estimated to exceed baseline growth by USD 
400 billion in 2035 thanks to the use of AI [1]. However, such value creation and capture
can take place only when the technology is translated into action [2]. To understand this 
transition, information technology (IT) diffusion and assimilation has been one of the 
central areas of investigation in healthcare informatics [3], information systems [4], and 
innovation literature [5]. Due to the increasing applications of AI in healthcare, there is
a need for studies exploring the status of commercial adoption of AI within that sector.
This paper reports results from an exploratory analysis focusing on the adoption and 
commercial use of AI technologies by large healthcare companies. We investigate AI 
and machine learning (ML) related keyword appearances in two contexts for the sample 
of 62 healthcare sector companies, which were constituents of S&P500 index as of May 
2019. The first context is news and media items that relate to the sample companies and 
include AI or ML keywords. The second context is earnings calls and other investor 
presentations of the sample companies, where top executives make statements regarding 
commercial applications of AI and ML technologies. 
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2. Data and Methods
Sample of companies selected for this study consisted of S&P500 Health Care Index 
constituents included in the index as of May 2019. These companies represent some of 
the largest healthcare companies in the world and are thoroughly covered by news and 
media, as well as financial analysts. Consequently, there is a large body of publicly
available information regarding these companies, which makes a research design
leveraging content analysis a feasible approach. The sample companies were divided into 
six sub-sectors based on their NAICS codes (manufacturing companies were further 
divided into two subgroups). Following [6], we do not intend to provide explicit 
definition of AI, but rather rely on implicit definitions embedded in the examples covered 
in the analyzed content. Nevertheless, our work was guided by an inclusive definition as 
follows, “Artificial Intelligence . . . is intended to make computers do things, that when 
done by people, are described as having indicated intelligence” [7].
For each company, we collected data from two sources. News and media items were 
collected from ProQuest ABI/INFORM Collection using the following search query: 
("artificial intelligence" OR "machine learning") AND stype.exact("Magazines" OR 
"Trade Journals" OR "Newspapers" OR "Reports" OR "Blogs, Podcasts, & Websites" 
OR "Wire Feeds") AND la.exact("English"). Transcripts of management presentations 
were retrieved from Thomson Reuters Eikon database. The types of items searched 
included not only transcripts of quarterly earnings calls, but also other conferences, 
media events, financial analyst days and investor events. The case insensitive search 
query used for that database was: “artificial intelligence” OR “machine learning”. The 
time period covered in this exploratory analysis was 1 January 2004 – 10 May 2019.
Preliminary qualitative analysis focused on the transcripts of management 
presentations. For each company, the transcripts were analyzed by two researchers to 
determine whether a commercial application of AI technologies has been mentioned. The 
definition of commercial application was either (1) reference to a current commercial use 
of AI or ML technologies (as part of customer offering or internal processes, which are 
“business as usual”), or (2) commercial launch or implementation utilizing AI or ML 
technologies in the near future (specific details provided).
The subsequent exploratory analysis had two objectives: (1) to establish the current 
status of AI use by healthcare sector companies and (2) to inspect the pattern of diffusion 
of the technology over time with the intention of identifying aspects requiring scrutiny.
3. Results
Nearly all companies (91.9%) included in the sample have been mentioned in news and 
media in the context of AI, and 43.5% of companies have mentioned commercial use of 
AI technologies during their investor presentations given by top executives (Table 1).
It appears that news and media coverage in relation to AI and healthcare companies 
increased sharply starting from 2015. Major increase in number of companies 
mentioning commercial use of AI during their investor presentations started in 2017. 
Figure 1 provides more detail on the cumulative percentage of companies covered in 
news and media items related to AI, as well as those mentioning commercial use of AI.
First mentions of AI in news and media items covering healthcare companies, in 
many cases, have been far ahead of the recent wave of AI technology implementation by 
the companies. This is particularly the case for manufacturing companies (sub-sectors 1 
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and 2). Figure 2 illustrates the publication timings of news and media items. 98% of the 
items were published during the last four years.
Table 1. Summary statistics for news and media items mentioning sample companies and AI technologies, and 
top executive investor presentations mentioning AI technologies.
News and media items Top executive presentations
Sub-sector Count
Mean 
count per 
company
Mean date of 
1st mention
of AI/ML
Count
Mean date of 
1st commercial 
use mention
Share (ratio) of 
companies with 
commercial use
1. Manufacturing (excl. 
Pharmaceutical and 
Medicine)
721 28.8 2014-11-11 81 2018-08-17
48.0%
(12/25)
2. Pharmaceutical and 
Medicine
Manufacturing
1 661 127.8 2013-04-02 14 2019-11-12
15.4%
(2/13)
3. Professional,
Scientific, and 
Technical Services
254 31.8 2016-05-04 28 2018-11-27
37.5%
(3/8)
4. Ambulatory Health 
Care Services and 
Hospitals
327 36.3 2016-12-19 18 2017-10-21
66.7%
(6/9)
5. Merchant 
Wholesalers 148 37.0 2017-09-02 4 2019-11-17
25.0%
(1/4)
6. Insurance Carriers 214 71.3 2015-07-16 23 2013-07-09 100.0%(3/3)
Total 3 325 53.6 2015-03-27 168 2018-08-21 43.5%(27/62)
Figure 1. Comparison of cumulative percentage of companies mentioned in AI related news and media items
with cumulative percentage of companies mentioning commercial use of AI in executive presentations.
A sub-sector level comparison of cumulative percentage of companies mentioned in 
news and media in relation to AI, and those whose top executives mention commercial 
use of AI reveals stark differences. Manufacturing (1 and 2) and Professional, scientific 
and technical services (3) companies started appearing in news and media items in a 
relatively even manner over time. The remaining sub-sectors started receiving news and 
media coverage much later, yet they caught up or even exceeded early-comers. See 
Figure 3 (left). This pattern is nearly reversed when mentions of commercial uses of AI 
are considered. See Figure 3 (right). Insurance carriers (6) and Ambulatory health care 
services and hospitals (4), which received news and media attention later, were not only 
the first ones to mention commercial uses of AI, but these sub-sectors present also the 
highest rate of disclosure regarding commercial use of AI. Contrary to the news and 
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media coverage, Pharmaceutical and medicine manufacturing (2) companies appear to 
have the lowest rate of commercial utilization of AI.
Figure 2. Timing of AI related news and media mentions of healthcare companies. Each row in the chart 
represents a single company.
Figure 3. Left: Cumulative percentage of companies mentioned in AI related news by sub-sector. Right: 
Cumulative percentage of companies with commercial AI mentions in executive presentations by sub-sector.
4. Discussion and Conclusions
Companies from pharmaceutical and medicine manufacturing subsector had the longest 
and most prominent news and media presence, yet they were among the slowest 
commercial implementers of AI. Ambulatory health care services and hospitals, as well 
as insurance carriers received news and media coverage much later, although more 
rapidly, and were the quickest to take AI technologies into commercial use. Larger media 
coverage might be a result of pharmaceutical companies having typically a long product 
developmental timescale, resulting in relatively larger overall fixed costs and possibly 
also driving larger marketing budgets, thus leading to increased press coverage. AI 
solutions developed for pharmaceutical companies are also found to attract more venture 
capital funding than other healthcare-related AI solutions [8].
Classical diffusion of innovations theory (DOI) [5] predicts that new technologies, 
such as AI, do not spread evenly across the whole population. Instead, a typical 
cumulative adoption curve takes an “S-shape”– the sample companies taken as a single 
group appears to follow such pattern (Figure 1). However, sub-sector level analysis and 
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comparison of news and media coverage (approximating diffusion of information and 
awareness) with mentions of commercial uses of AI by top executives (approximating 
diffusion of commercial adoption) indicate that DOI might not fully explain the sub-
sector level differences. Disparity between these two diffusion patterns indicates that 
factors beyond those recognized by DOI might be at play, which is a phenomenon 
requiring further investigation. From media perspective, the solutions for e.g. insurance 
carriers might be seen as having less public impact potential than pharmaceutical 
products [9]. Furthermore, organizational characteristics such as IT intensity and 
absorptive capacity or use case of AI, such as those illustrated by quotes in Table 2, might 
explain AI adoption rates [4]. In our future research we intend to further investigate 
factors driving AI adoption by healthcare companies.
Table 2. Quotes illustrating organizational characteristics and use cases, which might impact AI adoption.
Sub-sector Quote
1. Manufacturing (excl. 
Pharmaceutical and 
Medicine)
“Tempus combines Illumina's sequencing with machine learning to provide 
physicians a comprehensive report that highlights key findings to support 
clinical decision-making.”
2. Pharmaceutical and 
Medicine
Manufacturing
“[…] many different kinds of data sciences we had to bring together. So add to 
this list graph theory, non-linear machine learning, lot of combinatorial 
methods, and I'm even going to show you how we've used elements of 
cryptography in some of the analysis…”
3. Professional,
Scientific, and 
Technical Services
“[W]e will leverage […] machine learning, human genetics and functional 
genomics to create disease models for NASH and discover relevant drug 
targets…”
4. Ambulatory Health 
Care Services and 
Hospitals
“We use real-time machine learning. We know the demand patterns that are 
coming into our patient service centers, so we can make real-time staffing 
decisions and we can take some of the staffing decisions out of the hands of the 
supervisors and tell them exactly what they're going to need at that facility next 
Tuesday at 9:00 in the morning.”
5. Merchant 
Wholesalers
“[W]e're basically using machine learning, artificial intelligence to do online 
claims adjudication, which will make us so much more efficient and so much 
more scalable…”
6. Insurance Carriers
“[W]e process about 2 billion claims a year, about $0.5 trillion in medical spend 
and we transmit about $130 billion in funds electronically every year and we do 
so to about 1 million care providers across the country. […] all of that represents 
data and […] increasingly, we're applying machine learning…”
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A Computational Adverse Event Detection 
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Abstract. Harms caused during healthcare encounters are pervasive and occur at an 
alarming rate; therefore, building a set of computational detection methodologies in 
the adverse event area is urgently needed to address this problem. To understand the 
entire range of adverse event detection methods currently in practice we have 
developed a computational adverse event detection matrix. This structure is made of 
methods used presently at US hospitals to detect patient safety events. It contains 
adverse event 1) concepts and 2) synthesized detection strategies as well as 
calculations of overlap of coded data in the subset of algorithms implemented 
completely computationally. Most importantly, this matrix provides a clear 
picture of coverage gaps in the detection of adverse events. 
Keywords. Patient safety, Data quality
1.Introduction
Harms or Adverse events (AE)s caused during healthcare encounters are pervasive,
have a significant impact on patient wellbeing, and occur at a staggering rate.
Specifically, one of every ten hospitalized patients develops a healthcare-acquired
condition, and twelve million outpatients experience a diagnostic error, which may
result in harm, every year. [3]AEs can be categorized as unavoidable (e.g. part of the
patient’s condition), potential (near miss or never events) or preventable and can come
from active medical errors at the point of care or latent causes present within care
settings. [9; 13] The Institute for Healthcare Improvement uses a definition for AEs as 
"Unintended physical injury resulting from or contributed to by medical care (including
the absence of indicated medical treatment), that requires additional monitoring, 
treatment, or hospitalization, or that results in death”.
This study is designed to determine which of the events designated as harms, or 
AEs, are currently 1) identifiable algorithmically, 2) which are identifiable using 
other methods, and 3) which are likely going undetected due to the methodology used. 
AEs are typically tracked and quantified using incident reporting, medical record review 
or claims data, although other methods are also available, as shown in Table 1. 
None of these processes captures all AEs.[10] Comparative studies suggest that the 
most effective methodology is the Medical record review (MRR).[9] As this process is 
time-consuming,  efforts have been made to increase the efficiency of this work with 
instruments like the Institute for Healthcare Improvement (IHI) Global Trigger Tool. 
[3; 7]. To ensure as many AEs are detected as possible while at the same time not 
overloading healthcare staff automation has been introduced in several of the 
methodologies listed in Table 1. Detecting AEs using rule-based algorithms makes
automation possible. [8] But this 
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automation is only as good as the combination of the phenotype definition and the data it 
consumes. Not all AE will be detectable using rule-based algorithms. Active errors occur 
at the point of contact between the patient and the healthcare system and are typically 
observable whereas latent errors are process errors, where no single event is the source 
of the problem. AEs arising from active errors are more detectable than those arising 
from latent causes, and direct process observation or data mining are the best solutions 
to finding these types of situations. In general, the methods listed in Table 1 can miss as 
much as 90% of all AE types. [5] 
Table 1. AE Detection Methods Currently in Use 
Medical Record Review (w/ and w/out Trigger Tools) 
Studies based on interviews w/ healthcare providers 
Direct Observation 
Incident Reporting Systems 
External Audit 
Studies of legal claims and complaints 
Administrative Data 
Computational Methods using EHR 
Autopsy 
We are currently in need of common terminology to quantify the occurrence of and 
detection methods for AEs. In the US, governmental organizations and Patient safety 
organizations (PSO), regulated by the US Agency for Healthcare Research and Quality 
(AHRQ), collect data and do analysis and reporting on patient safety concerns. Many of 
these organizations have designed approaches to describe, classify and detect patient 
safety events. Methods used include retrospective surveillance with administrative coded 
data, observation and voluntary reporting as well as MRR. All of these methods are 
flawed in that they miss AEs or are excessively expensive so cannot be conducted at 
scale. [12; 14] Additionally, large scale detection methods are not sensitive enough to 
show improvement over time. [3] 
In an effort to find common ground among the methods currently in practice, we 
have developed a computational AE detection matrix. This matrix provides a clear picture 
of what is available and what is missing in the detection of AEs. As part of this process 
we have also investigated the overlap in computationally implemented algorithms.  
2. Methods
In order to understand where there is overlap in current AE detection methodologies and
to discover which AE are not the subject of in practice methodologies, we have classified 
currently accepted PSO AE detection algorithms into the International Classification for 
Patient Safety categories from the World Health Organization (WHO). Patient safety 
information is categorized into standardized concepts that represent descriptions that are 
valid internationally and can be used for comparison, measurement, monitoring, analysis 
and interpretation of information for improved patient safety.[15] This framework breaks 
patient safety events into ten high-level classes which are broken down into very specific 
but generalizable concepts two of which are directly comparable to the PSO terminology, 
incident type and patient outcomes. Although, some incidents may be classified in more 
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than one category in the WHO framework we have kept to a one to one relationship with 
detection algorithm. 
Right now, there are a few standard approaches to AE detection and none are both 
highly efficacious and also computational. Some are completely computational and can 
detect roughly half of AE [1], and some use MRR, which is very through but limits the 
number of cases evaluated due the time required. In previous studies commonalities 
among detection strategies were synthesized and found to be predominantly focused in 
the areas of surgery and care management.[11] This study seeks to extend the previous 
work by including areas in healthcare where AE are recognized, but no external detection 
method is currently in place to identify them. This work includes the extraction of the 
rule-based definitions. For the computational approaches, the extraction of International 
Statistical Classification of Diseases, Injuries and Causes of Death (ICD) codes used in 
the detection of AEs from organizational source documents was necessary to build an 
understanding of the degree of overlap between computational methodologies. 
Commonalities have arisen between the ICD codes coming from government bodies The 
Centers for Medicare and Medicaid Services (CMS) and PSOs (AHRQ). AEs are 
detected for Patient Safety Indicators (PSI) coming from AHRQ and Human Acquired 
Conditions (HAC) coming from CMS.  
The manual and hybrid approaches to AE detection were extracted from the 
organization website sources. These cannot be compared directly with the computational 
methods in terms of data points due to the incorporation of human judgment. The most 
effective method with respect to efficiency as well as thoroughness is the hybrid 
approach. Together, review of medical records with computerized monitoring capture 
conditions that are associated with more preventable and potential AEs than any singular 
method. [4; 6; 9]  
The sources used for these algorithms are (a) CMS, hospital-acquired conditions, (b) 
IHI, Global Trigger Tool (c) The Agency for Healthcare Research and Quality (AHRQ, 
PSI), (d) The Joint Commission (TJC, Sentinel Event definitions) and (e) The National 
Quality Forum (NQF, serious reportable event (SRE) definitions). 
3. Results
Both the CMS HAC codes and the AHRQ PSI rates use ICD codes to detect patient harm. 
As shown in Figure 1 - 5,702,505 ICD codes are used, and 70,384 are shared. AHRQ 
uses a large portion of the CMS set plus a great deal more.  
Figure 1. AHRQ and CMS detections methods which use ICD codes exclusively. 
This large overlap exists due to the use of the Medicare Severity Diagnosis Related 
Group (MS-DRG) system for financial considerations by the Centers for Medicare and 
Medicaid Services. This system, in effect, determines the definition of an AE by 
associating payment penalties with the code combinations that represent harm conditions. 
The idea of patient safety and the prevention of AEs was the impetus for the MS-DRG 
CMS
5,121
AHRQ
5,556,616
70,384
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system. That being the case, any computational AE detection methodology in the US will 
need to also incorporate information from this system. 
The AE detection matrix shown in Table 2 classifies rule-based algorithms according 
to the WHO Patient Safety Conceptual Framework. The WHO incident types are in the 
leftmost column. The binary patient outcome severity, listed as present or not, is across 
the top. Both CMS and AHRQ use the MS-DRG system which provides grouping 
information about severity of an inpatient stay in order to facilitate payment for services. 
The methodology used in detection is the column title in Table 2 listing the spectrum of 
methodologies in 
Table 2. Computational AE Detection Matrix 
Level of Harm Specified No Yes 
EHR Data EHR Data Trigger w/ 
MRR 
Observation 
or MRR 
Behavior 
Blood/Blood Products 
Clinical Administration 
Clinical Process/Procedure 
Healthcare Associated 
Infection 
Infrastructure/Building/Fixtures 
Medical Device/Equipment 
Medication/IV Fluids 
AHRQ 
AHRQ 
AHRQ/CMS 
AHRQ/CMS 
AHRQ/CMS 
IHI 
IHI 
IHI 
IHI 
IHI 
NQF/TJC 
NQF/TJC 
NQF/TJC 
NQF/TJC 
NQF 
NQF 
NQF 
NQF 
Oxygen/Gas/Vapor IHI NQF 
Patient Accidents AHRQ/CMS IHI NQF/TJC 
 Increasingly difficult and time consuming to complete  practice from completely 
computational to completely manual.  
4. Discussion
This work lays out detection strategies currently in use against an international conceptual 
framework of AEs, thereby exposing the sparseness of computational solutions in today’s 
healthcare environment. Each of the fundamental patient safety events in the framework 
has many subtypes, and out of these 10 categories only 5 are computationally 
implemented, and one of these doesn’t indicate severity. That leaves half of AE types to 
voluntary reporting and record review with no external means of being discovered.  
Moreover, the computationally implemented detection algorithms rely on coded 
administrative data. There are concerns about accuracy in this type of data because not 
all cases of a complication will be captured, leading to both false positives and negatives. 
Lastly, data quality is a problem in any data source and missing information is the most 
prominent issue in healthcare data resulting in codes that may not fully reflect the clinical 
case.[2]  
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While gaps exist in computational methods, there is good coverage in the application 
of medical record review. This approach addresses the false positive and false negative 
concerns but it is intensely laborious and not practical for truly safeguarding patients. The 
combination of review using a data-driven trigger tool approach has potential as well but 
is not yet in common practice due to the complexity of the process. [12] 
5. Conclusion
Harms caused during healthcare encounters are ubiquitous and occur at an alarming rate 
and building a complete set of computational detection methodologies in the AE space is 
urgently needed to address the problem. This is a many-dimensional problem due to 
multiple organizations, terminologies, detection methodologies and levels of harm. The 
matrix of patient safety events developed in this study and the resulting synthesis of 
associated detection algorithms provides a clear picture of areas where coverage gaps 
exist in AE detection. 
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Abstract. Iodine-containing contrast agents (CA) are important for enhanced image 
contrast in CT imaging especially in CT angiography (CTA). CA however poses a 
risk to the patient since it can e.g. harm the kidneys. In clinical routine often a standard 
dose is applied that does not take differences between individual patients into account. 
We propose a method that as a preliminary stage determines excessive image contrast 
and CA overdosing by assessing the image contrast in CTA images obtained with the 
ulrich medical CT motion contrast media injector with RIS/PACS interface. A 
resulting CA dose recommendation is linked to a set of clinical parameters collected 
for each assessed patient. We used the established data set to implement an automatic 
classification for individual CA dose adjustment. The classification determines 
similar cases of new patients to take on the associated CA dose adjustment 
recommendation. The computation of similar patient data is based on the previously 
collected patient-individual parameters. The study shows that as basis for a 
recommendations the largest proportion of patients receive too much CA. A first 
evaluation of the automatic classification showed an overall error rate of 22% to 
recognize the correct class for CA dose adjustments using a k-NN-Classifier and a 
leave-one-out method. The classification’s positive predictive value for correctly 
assigning a CA overdosing was 85.71%. 
Keywords. CT Angiography, Contrast Agent, Personal Health Care 
1. Introduction 
Radiological examinations using contrast agents (CA) belong to the basic methods of 
image diagnostics and interventional therapy. CA used in CT angiography (CTA) gains 
the contrast enhancing ability through the contained iodine. Iodine-containing CA is 
however known for being harmful to the renal system with contrast-induced nephropathy 
being the third leading cause of hospital acquired acute renal failure [1]. However, a 
standard CA dose is administered to patients in clinical practice. A few methods were 
proposed to simulate the CA flow based on hemodynamic models [2, 3] that consider 
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physiological parameters of individual patients. Nevertheless, the focus there is on the 
optimization of the CTA scan and not on the determination of a patient-individual CA 
dose. In [4] a method was proposed to adjust the CA dose based on the patient’s body 
weight and the CT’s tube potential. In our approach we propose a method to perform an 
automatic quality assessment of CTA data (Fig. 1 (blue box)) as a ground truth for CA 
dose adjustment recommendations for individual patients. Similar to [5, 6] case-based 
reasoning a Nearest-Neighbor approach is applied, since it showed convincing results in 
tasks with medical backgrounds and is transparent to a high degree. The automatic 
classification based on the k-NN uses a multitude of patient-individual parameters to 
determine the most similar already assessed patient data for a particular case and takes 
over the corresponding CA dose adjustment recommendation (Fig. 1 (yellow box)). 
Figure 1. Quality assessment (blue box) and automatic classification (yellow box). 
2. Study 
The required CTA data is sourced from a study at the radiology department of the UKSH 
Lübeck. The goal of the acquiring stage is to collect 400 CTA data sets evenly subdivided 
into four scan protocols: aortic angiography, pulmonary angiography, pelvic-leg 
angiography and abdomen angiography. In addition, a multitude of patient-individual 
parameters are collected. These include parameters like age and height, laboratory 
parameters (e.g. creatine content) and non-invasive physiological parameters (e.g. blood 
pressure). To this state 226 CTAs featuring 75 aortic angiographies as the largest share 
were transferred. Therefore, in this paper we focused on the analysis of CTA data with the 
aortic scan protocol. 
3. Methods 
3.1 Quality Assessment of Image Contrast 
To enable CA dose adjustments an automatic quality assessment of existing CTA images is 
implemented. The image contrast is assessed based on selected regions of interest (ROI) 
in diagnostically relevant locations affected by the CA. The assessment serves as a 
classification implying whether the applied CA dose is optimal or can be decreased. Three 
ROIs for each aortic CTA image are evaluated and were defined with the aid of 
radiological experts: 
 ROI 1: Aorta, level: pulmonary artery bifurcation 
 ROI 2: Aorta, level: front or lateral outflows of the aorta respectively 
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 ROI 3: Vessels of the periphery, level: last slice of CTA image 
At first the medical practitioner must choose a slice of interest (SOI) for each ROI. 
Then, an algorithm is implemented to automatically detect the aorta and the peripheral 
vessels in the SOIs, respectively. To locate the aorta for ROI 1 and 2 an algorithm based 
on the Circle Hough Transformation (CHT) [7] was used. Based on the resulting Hough 
space we made the empirical decision to consider the six most probable circles. Because 
there are more circular shaped structures e.g. the vertebral body, a cost function was 
implemented similar to [8] to identify the aorta. The cost function assesses the variance, 
differences in radii and distances of the centers of multiple consecutive circles positioned in 
adjacent axial slices with a dynamic programming approach. The radius of the starting 
circle that accumulates the lowest costs is decreased by four pixels to evade calcifications 
and is declared as the ROI. For detection of ROI 3 the vesselness filter by [9] is applied to 
the last four slices of the CTA Image to mark the peripheral vessels. The vesselness filter 
can extract bright lines in 3D based on the Hessian Matrix and their eigenvalues. To 
remove partially segmented bone structures and calcifications a thresholding with the 
values [660, 3100] Hounsfield units ( HU ) was applied to the last slice of the CTA image 
and subtracted from the corresponding filtered slice to determine the ROI 3. Each ROI is 
then assigned a category from Tab. 1 with respect to the mean HU value of the particular 
ROI. The thresholds for the target area were similarly chosen to [10]. 
Table 1. Definition of the categories of image contrast. The range refers to the mean HU value in the ROI. 
Category Range [HU] Definition 
A ≤ 180 HU value too low 
B 181 – 240 Lower tolerance area 
C 
D 
E 
241 – 300 
301 – 360 
>360 
Target area 
Upper tolerance 
area Excessive HU 
value 
Aided by radiological experts rules were formulated to describe the image quality as 
ground truth for the automatic classification. Applying the rules to the combination of the 
three ROIs results in one of the three possible classes from Tab. 2. 
Table 2. The quality assessment results in one of the following classes and recommendations. 
Class Definition Rule 
1 Image contrast insufficient At least one ROI is in category A 
2 Optimal CA dose Left over combinations 
3 Decrease CA dose At least one ROI is in category E, the two remaining are at 
least in category D 
3.2 Automatic Classification 
The main objective of our project is to enable patient-individual adjustments of the CA 
dose based on the previously classified CTA data. As a mean to achieve this a k-Nearest 
Neighbor classification was implemented as a first approach which is suitable if only small 
training sets are available. The k-NN classification identifies the ??most similar already 
classified patient data. The according class is then adopted using majority vote and the 
recommendation for the dose adjustment can be applied. As features nine clinical 
parameters were considered based on their previously assessment in literature [2]: age, 
weight, height, body mass index (BMI), gender, glomerular filtration rate (GFR), ankle 
brachial index (ABI), oxygen saturation and blood pressure (systolic). For gender we 
assumed a non-ordinal distribution however further possibilities will be considered. 
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4. Experiments and Results 
4.1 Data 
For our experiment we used 75 CTA volumes scanned with an aortic angiography protocol. 
The CA was administered with a programmed injection rate of 5 ????. 
4.2 Quality Assessment – Experiments and Evaluation 
To test the algorithm’s ability to locate the aorta in the selected slice the number of cases 
where the aorta was manually corrected was considered. The same approach was used to 
evaluate the vesselness filter to determine ROI 3. 
4.3 Quality Assessment – Results 
69 cases were processed successfully. The aorta was located correctly in 71.01 % cases. 
The vesselness filter was corrected in 50.72 % cases. Using the definition of the rules six 
CTA volumes were assigned to class one, 18 to class 2 and 45 to class 3. As a first insight 
the quality assessment confirms that there is a CA overdosing in clinical routine 
examinations. The algorithm proved to be successful for detecting the aorta rarely 
resulting in failures mostly when confronted with major aortic deformations and 
dissections (s. Fig. 2). The correction rate of the vesselness filter for ROI 3 was rather high 
but given the variance in the CTA data, the smallness of the peripheral vessels and the 
high effort caused by manually determining the vessels, the use of the filter was still rated 
as a success. 
Figure 2. Images of the found aorta and peripheral vessels (red) and the corrections (green) respectively. 
4.4 Automatic Classification – Experiments and Evaluation 
For the k-NN classification all 29-1 combinations of normalized clinical parameters were 
tested with k ??[1, 3, 5, 7]. We used leave-one-out validation to evaluate each classifier 
resulting in a failure rate. In addition, the positive predictive value for classifying a CA 
overdose was determined. The Euclidean and the Mahalanobis metric were used as 
distance measures. 
4.5 Automatic Classification – Results 
The lowest overall failure rate was 22 % meaning that in 47 cases the determined class 
matched the prior classification. The rate was achieved with the Mahalanobis metric as 
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the distance measure and ?? ???neighbors. The optimal combination of clinical parameters 
used was: ABI, height, BMI, oxygen saturation and blood pressure. 
Considering the clinical parameters some (BMI, height) were expected due to their 
examined correlations with contrast enhancement in literature [2, 4]. Others like ABI, 
oxygen saturation and blood pressure can be considered as indicators for the vessel 
condition and therefore influence the CA flow and distort the CTA scan. The positive 
predictive value of the automatic classification after merging class 1 and 2 to correctly 
assign class 3 (Tab.2), which is crucial for dose reductions in the use case is 85.71 % and 
showed a rather high prediction quality. 
5. Discussion and Conclusion 
In this paper we presented a method for an automatic quality assessment of CA-induced 
contrast enhancement in CTA images with an application for patient-individual dose 
adjustment. By considering clinical parameters of a new patient the examiners could 
decrease the CA dose in the use case to lower the risks of CA-induced side effects. While 
the implemented algorithm is robust for locating the aorta the need of user-determination 
for the SOI could also be automated. Furthermore, it is debatable how feasible it is to 
choose the last available slice for the ROI. Therefore, a fixed landmark for the ROI 3 e.g. 
the aorta femoralis communis will be set. As a next step we will consider deep learning 
approaches to replace the k-NN classifier for more precise results based on the increased 
number of patients in our ongoing study. In addition, the presented system will be applied 
to returning patients for validation. 
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Abstract. The paper presents a sensor network system implemented to continuously 
monitor and detect cardiovascular diseases experienced in patients at high-risk. The 
device is designed to capture and transmit the ECG signals and pulse to the patient´s 
mobile phone. Later interpretation of the single-lead ECG signals will result into a 
HRV analysis and heart-rate detection that is compared with the pulse oximeter 
results for validation. The fastest alert will be issued to doctors, relatives and 
hospitals, using the proposed data processing algorithm implemented in the patient´s 
mobile phone. The continuous usage of this monitoring system provides an effective, 
efficient and fast health care service to patients at risk, even if the doctors or relatives 
are not near the patients. 
Keywords. sensor, electrocardiogram, alert, emergency, wavelet transform 
1. Introduction 
In the past, it was difficult to use sensors and front-end electronics in wearable 
technology to gather physiological and movement data because of their size. But now, 
wearable sensors are available at a much lower cost and utilized in digital health 
monitoring systems with miniature circuits.  
Prevention is especially critical for cardiovascular diseases and electrocardiogram 
(ECG) is the most undisputed and widely accepted tool to detect and diagnose them. 
Apart from their enormous impact in older people life expectancy, cardiovascular 
diseases are also the main cause of death for the population among 44 and 64 years and 
detecting their symptoms in time is critical to avoid irreparable damages or death. Our 
solution comprises of an integrated system module that captures the physiological ECG 
and SpO2 data that is measured using a single board computer card, a micro-controller 
and an e-health sensor platform. 
Timely access to emergency cardiac care and survival is partly dependent on early 
recognition of heart-attack symptoms and immediate action by calling emergency 
services. In a 2016 study [1], most persons (95%) recognized chest pain as a heart-attack 
symptom, but only 11% correctly classified all symptoms and knew to call 1-1-2 when 
someone was having a heart-attack. This proved the need of medical devices that 
continuously monitor and record the physiological parameters of patients outside the 
clinical environment as part of a care pathway. 
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[2] presents a mobile healthcare application for self-diabetes management. The 
application synchronizes data with hospital’s EMR database to provide accurate data. 
[3] presents a mobile app integrated into a hospital workflow to achieve medication 
list portability via Fast Healthcare Interoperability Resources. 
[4] presents FHIRbox which is a distributed system under development by the 
authors of the paper for integrating data from various diagnosis devices and uses FHIR 
for exchanging clinical information. 
Still an important issue is the continuity of healthcare, the communication standards 
will lead to a better patient healthcare activity. The exchange of information between 
different medical unit’s information systems and devices, and understanding each other 
means that the interoperability request is satisfied. In this paper the standard which will 
be used is HL7 Fast Healthcare Interoperability Resources (FHIR) [5]. This standard 
provides access to medical data via a RESTful API which uses XML and JSON. The 
benefits of using FHIR are: real-time, query-able, patient – centric interface to EHR 
Resources; HTTP/REST greatly strengthens interoperability, the specification of this 
standard provides all the needed data and modern code libraries and architecture. 
2. System description 
The system is designed to capture the physiological ECG signals and detect the heart-
rate using wavelet decomposition and fixed thresholding of wavelet coefficients. The 
following components were integrated in the system capturing module:  
 Pulse Oximeter module, designed to capture patient-specific pulse and 
saturation oxygen signals, digitize and send them to the e-Health Sensor shield. 
 ECG electrodes, diagnostic tools that are routinely used to assess the electrical 
and muscular functions of the heart further useful in the diagnosis of a myriad 
of cardiac pathologies. 
 GSM shield: In order to make calls on threshold events, the system includes a 
GSM shield for the Arduino Uno, connected directly throughout the pins. 
 Arduino + Raspberry Pi module, connected by using the I2C communication 
protocol. 
The captured data is further processed for diagnosis, treatment or both. It also 
enables the patient to be more engaged and auto-monitor their health status by regularly 
or continuously checking the values of the vital parameter stated above.  The data 
collected is stored in a database which further can be accessed by an API for creating a 
file in the HL7 FHIR standard format. The API used in this system is Azure API for 
FHIR [6]. The data sent using FHIR for our particular case is accessed by the Obstetrics-
Gynecology Department Information System previously developed and in use by the 
medical staff [7]. The Obstetrics-Gynecology Department Information System (OGD IS) 
was developed using Visual Studio.NET 2015, ASP.NET pages and C# language, it is a 
responsive web application, and may be accessed by the doctors using a tablet. OGD IS 
has a statistical component which allows the medical staff tracking of health parameters 
and draw different charts related to treatments, or IoT systems. 
 Figure 1 presents the general architecture of the solution presented in this paper. 
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 Figure 1. Overview of the system 
2.1.  Mobile application  
The client mobile application is designed specifically to be accessed from personal 
smart-phones and it permanently displays the patient status and time evolution illustrated 
by graphs and alarms in case of threshold events. The application is built using PHP, 
HTML, Ajax and JavaScript technologies. This client application can be easily accessed 
from mobile Android devices to provide healthcare professionals with the ability to 
check their patients´ status when not near them, and can receive alarms when a patient´s 
condition is critical. 
In figure 2 we present the mobile application user interface, called RpiHm 
(Raspberry Heart Monitor) build using Apache Cordova, an open-source mobile 
development framework. The template used is Gentelella, a free to use Bootstrap admin 
template. It uses Bootstrap 3 styles along with a variety of powerful jQuery plugins and 
tools to develop a powerful framework for creating admin panels and back-end 
dashboards. 
The app can be downloaded on the phone and used by both the patient and the 
physician for continuous monitoring. It displays information regarding the beats-per-
minute, the oxygen saturation (SpO2) and a graph. Upon launching, the ECG graph 
begins collecting data from the MySQL database and constructs the waveform. 
3. Statistical analysis 
By loading the data set into Tableau, we can perform a statistical analysis and derive 
models and patterns in our values. In Figure 3 we can see the preprocessed ECG data 
that is being used to detect the heart-beat rate. The detection is performed by using 
discrete wavelet transform (DWT) in order to obtain the amplitude and duration of the 
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characteristic ECG waves and to determine the RR interval time series. The 
programming language used for the heart-rate variability (HRV) analysis is R, a free 
software environment for statistical computing and graphics. 
  
Figure 2. Mobile app   Figure 3. Preprocessed ECG data 
 
By further refining, we conclude that roughly all the values from our dataset are 
situated in the 70-80 bpm interval, a healthy distribution since any resting value outside 
this range can be considered a threat. We further want to predict the probability of having 
a heart disease and we compare the accuracy of three different algorithms: k-nearest 
neighbors, logistic regression and decision trees by using 230 observations in the training 
set and 40 in the test set. The accuracy scores for the selected algorithms are very similar 
and are more or less 85%. After plotting the ROC curves and calculating the area under 
the curve, we can finally conclude that the logistic model is the most accurate for our 
study set. 
 
 
Figure 4. Comparison of ROC curves 
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4. Conclusions 
Since the monitoring of hospitalized patients is currently being carried out only in critical 
cases, especially in intensive care units, using inflexible and costly systems, it has been 
considered useful to the medical world to demonstrate the construction of a system that 
highlights the technological advance in recent years in the field of monitoring the heart 
health, bringing benefits in terms of cost, flexibility, interoperability and usability. In 
order to meet these factors, it was chosen to monitor the heart´s activity redundantly to 
enhance patients´ comfort, provide a reliable set of data and building an accessible client 
application from mobile devices for quasi-real-time viewing of the patients´ situation. 
The doctors and caregivers monitor the patient in real time using the data received 
through the server. Ensuring the interoperability between the mobile application and 
other medical units using FHIR, as in our particular system is presented the 
communication with an Obstetrics-Gynecology Department, improves the patient health 
and the doctor has a better support for a better treatment, due to continuity of healthcare 
records. 
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Abstract. Analysis of consumptions has proved a misuse of antibiotics, despite the 
existence of national requirements. To be able to compute drugs consumption 
quantities of highly heterogeneous drugs expressed in various doses units, the World 
Health Organization has defined a defined daily dose. A methodology has been also 
defined from previous work to compute manually the drugs consumptions in daily 
defined dose. We automated this methodology by using data fusion on data retrieved 
from different sources including a French public database and the World Health 
Organization website. Evaluation proved the efficiency of the approach, except for 
inconsistency cases. We identified these cases and proposed a solution to avoid them.  
Keywords. Drug database, Health Information Interoperability, Automatic data 
processing, Drug misuse 
1.Introduction 
French authorities in public health study and publish regularly results about antibiotics 
consumption in France and in the world [1]. More generally, drug consumption trends 
are observed [2]. Due to a misuse of antibiotics, it is thought that “Antimicrobial 
resistance could become one of the leading causes of death in the world” [3]. To obtain 
these results it is necessary to compute automatically measures reflecting the 
consumption of antibiotics. World Health Organization (WHO) has defined a unit to 
express to consumptions, called daily defined dose (DDD). Drug Defined Dose is defined 
by WHO as “The assumed average maintenance dose per day for a drug used for its main 
indication in adults.” [4]. It was first introduced by S. Natsch et al [5]. It was observed 
that, despite the existence of national requirements, hospital antibiotic stewardship 
programs are not fully implemented in France [6] Hence, it is necessary to automate the 
computation of the drugs consumption, and more precisely antibiotics consumption, in 
DDD using data and information stored in the clinical information systems. 
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The ATC (Anatomical Therapeutic Chemical) Classification system hierarchically 
classifies therapeutic drugs into 5-level groups, considering the organ or system on which 
they act and their chemical, pharmacological and therapeutic properties. Each group is 
identified by a code. 
WHO provides a DDD, for each ATC code, and administration route, and sometimes 
pharmaceutical form, as a dose expressed with a value and a unit.  They can be retrieved 
from a website using text mining methods [7]. Hence, the computation of  drug 
consumption quantity can be considered as a unit conversion. Methodology to measure 
antibiotic consumption has been proposed in previous work [8] but needs to be automated. 
Drug information is provided by French public database [9] under heterogeneous 
formats. Structured information are provided in text files following the tabula separated 
values format. Information on specialties is given in a first file called CIS_bdpm.txt . 
Each specialty is identified by a CIS (French for “Specialty Identifier Code”) code, and 
described with the name, the administration route, or the pharmaceutical form and other 
administrative information about the specialty. Each specialty can be sold in different 
presentations, each being identified by a CIP (French for “Presentation Identifier Code”). 
All presentations are provided in a file called CIS_CIP_bdpm.txt, providing CIP code, 
CIS code, presentation name, price and other administrative information about 
presentation. A third file, called CIS_COMPO_bdpm.txt provides information about the 
substances that are part of a medicinal product, among which the name of the substance, 
the dose, the nature (active substance or therapeutic fraction). In addition of this 
information, HTML pages provide other textual information that can parsed with text 
mining method. The ATC Code needs to be retrieved from these HTML pages. 
This papers aims at designing a tool to automate the computation of the drugs 
consumption in DDD using information provided by a French public drug database. 
Section 2 will describe the methods. Results will be provided in section 3. Finally a 
discussion will be proposed in section 4.  
2.Methods 
Our approach is based on data fusion. It has been proved that symbolic approaches are 
efficient to fuse heterogenous, and eventually multimodal data coming from various 
scattered sources [10]. The system is composed of two consecutive steps: (1) data 
retrieval (2) data fusion.  
2.1.Data retrieval 
To be able to compute the consumptions in DDD, it is necessary to retrieve all necessary 
data. In the clinical information systems, consumed drugs are identified by their CIP 
code, which is given in the CIS_CIP_bdpm.txt file. Then, we need to know the dose of 
all substances that compose the drug, which is provided in the CIS_COMPO_bdpm.txt 
file. The link between the two files is the CIS, identifying a specialty, provided in the 
two files. With this information, from these two files, it is thus possible to retrieve the 
dose of all substances that compose a drug. 
To retrieve the DDD defined by the WHO, it is necessary to have the administration 
route, which is provided in the CIS_bdpm.txt file given the CIS Code. The ATC Code 
can be retrieved from the HTML page, given a CIS Code and using a regular expression. 
Because of errors in the ATC Code – some of them used the “O” character instead of the 
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“0” number – it was necessary to use an adapted regular expression to find all ATC codes 
for a given CIS code. Hence, we used the following regular expression: “[A-Za-z][0-
9O]{2}[A-Za-z]{2}[0-9O]{2}”. It is then possible to retrieve the DDD value and units 
by parsing the ATC/DDD Web page for a given ATC Code.  
 
 
Figure 1. Data dependencies 
 
Figure 1 shows the relationships between the different required data. In a yellow 
rectangle is represented the CIS code, which is the key data allowing to link all other 
data. In a brown rectangle is represented the data provided in the CIS_CIP_bdpm.txt file; 
in blue rectangles are represented data provided by CIS_COMPO_bdpm.txt file; in red 
rectangle is represented the data provided by CIS_bdpm.txt file; in pale green rectangle 
is represented the data provided by HTML pages of the public drug database; in forest 
green is represented the data provided in the WHO ATC/DDD Webpage. 
  
2.2.Data fusion 
Respecting the principles of high-abstraction-level symbolic fusion [11], all data is 
represented as a list of multimodal data, indexed by an identifying code. Fusion strategies 
are defined to fuse data considering the relationships pointed out in Figure 1.  
 
 
Figure 2. High-abstraction-level fusion strategies  
 
Figure 2 shows how high-abstraction-level fusion strategies are defined considering 
the data model presented in Figure 1. Multimodal data is represented by conceptual 
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graphs allowing the fusion. By applying fusion strategies, we can enrich information 
about a medicinal product identified by a CIP code.  
Once we have got the DDD provided by the WHO and the dose of all substances of 
a drug, we are able to compute their value expressed in DDD by dividing each substance 
dose by each DDD associated with a specialty. As a consequence, one value will be 
computed for each substance of the drug. 
3.Results 
The method was applied to the 20 479 drugs, identified by a different CIP code, from the 
CIS_CIP_bdpm.txt file, present in the French public drug database; we were able to 
compute the dose expressed in DDD for 9 264 of them (45.23 %). We were unable to 
compute the DDD for 249 drugs for inconsistency reasons which will be discussed in the 
next section. The main encountered problem was that for 11 027 drugs (53.8%), the 
DDD was not defined by WHO.  
By focusing on antibiotics, we found 966 entities, among which we were able to 
compute the dose expressed in DDD for 780 (80.8%) of them.  
4.Discussion 
Several inconsistencies were observed in data and information provided by the French 
drug public database, making sometimes impossible to compute the DDD. 
First, we observed missing data. Although information was provided for a CIP code, 
information about corresponding CIS code was missing, either about the composition of 
the drug, or about the administration route. This should be solved by checking the 
completeness of the information provided in the database. 
Second, only one ATC Code is given – at most –  on the web page of the French 
public drug database, which does not reflect some cases where a drug can have several 
ATC codes. This is the case, for instance, of the prednisolone, which has seven ATC 
codes; the only that can be retrieved from the web page is H02AB06. This can be solved 
by adding all the ATC codes to the structured files. 
Third, as already mentioned, they can be errors in the ATC code, which can be 
missing, or can be shorter than expected, or containing spaces and containing the “O” 
character instead of a “0” number. For these reasons, text mining methods using a regular 
expression are not efficient to retrieve all ATC codes. This should be solved by providing 
a clean value of the ATC codes in the structured files.  
Fourth, there is no alignment of administration routes representation in the drug 
database and in the WHO ATC/DDD webpage. To be able to compute the consumption 
in DDD, it is necessary, in a preliminary step, to align manually the different values used 
in the two sources. Standardizing the expression of administration routes would allow to 
prevent this issue. 
Fifth, doses are sometimes expressed under a form that is impossible to process 
automatically. For instance, doses like “2ch to 30ch and 4dh to 60dh”, or “75 mg 
equivalent to 69,6mg of risedronic acid” cannot be processed automatically.  
Sixth, sometimes substance doses and WHO DDD are expressed in incompatible 
units : micrograms and Thousand Units, milliliters and milligrams. Constraints on the 
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dose data format, combining a numeric value to a unit would allow to avoid the two last 
presented issues. 
Finally, there exists some ATC codes without any DDD by the WHO. For instance, 
“J01DA33”, “G04CA05” or “R02AA19” have no DDD by WHO. 
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Abstract. Data integration is an important task in medical informatics and highly 
impacts the gain out of existing health information data. These tasks are using 
implemented as extract transform and load processes. By introducing HL7 FHIR as 
an intermediate format, our aim was to integrate heterogeneous data from a German 
pulmonary hypertension registry into an OMOP Common Data Model. First, 
domain knowledge experts defined a common parameter set, which was 
subsequently mapped to standardized terminologies like LOINC or SNOMED-CT. 
Data was extracted as HL7 FHIR Bundle to be transformed to OMOP CDM by using 
XSLT. We successfully transformed the majority of data elements to the OMOP 
CDM in a feasible time.  
Keywords. ETL, OMOP, HL7 FHIR, LOINC, SNOMED-CT 
1. Introduction 
International collaborative research faces a variety of challenges. One includes 
integrating data from different heterogeneous data sources into a data repository or data 
registry. Such registries can serve a lot of different purposes such as drug safety analysis 
[1], longitudinal analysis of certain cohorts [2] or as in our, and many other cases [3] a 
disease specific registry to promote research in that field. As part of the Pulmonary 
Vascular Research Institute, a collaboration of healthcare professionals and researchers 
working in the field of pulmonary hypertension (PH), an international PH registry/data 
repository needs to be established. 
We chose the OHDSI OMOP Common Data Model [1] to be the foundation of this 
registry. The OMOP CDM is a database specification, based on standardized 
vocabularies like SNOMED-CT, LOINC or RxNorm, with the aim to provide an 
analytic-friendly non-complex representation of medical data [1]. 
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To populate a registry with data from existing databases, usually, Extract-
Transform-Load tools (ETL) are used to transform and transfer data to the target schema. 
Popular tools in this regard are Talend Open Studio or Pentaho, which are used to define 
the ETL process as a dataflow from source to target system. However, by using such 
software a complete ETL process needs to be implemented for each source separately. 
This is also the recommended way of designing ETL processes for the OMOP CDM. 
Because we want to connect multiple heterogeneous databases, a common parameter set 
was predefined. We plan to use HL7 FHIR [4] as an intermediate format for the local 
data extraction. The FHIR resource will be fed into an XSLT processor to generate CSV 
files in the OMOP schema. Similar international and national approaches using 
intermediate formats or HL7 FHIR together with OMOP CDM have led to good results 
[5–7].  
Therefore, our aim is to evaluate the feasibility of HL7 FHIR Bundle and XSLT as 
a generic ETL process to populate an OMOP CDM. Feasibility will be assessed by the 
computation time and coverage of source data in the target CDM. 
2. Method 
2.1. Common data set 
To integrate data from multiple registries into a single data warehouse, a common data 
set is needed. A meeting of domain experts from two large PH registries from both the 
UK and Germany was scheduled to discuss all data items and produce a common data 
set definition. In a second step, this data set is annotated with international standard 
terminology (LOINC, SNOMED-CT, etc.) by documentation experts. 
2.2. Source data 
As source data, we used a German PH registry database. Its data is stored in a Microsoft 
Access database with 22 proprietary tables and 18 user forms. Additionally, two EXCEL 
sheets are used to collect data about specimen and echocardiography. All tables are 
exported to CSV format using MS Access’s standard export functionality. For ETL-
preparation, we used HIStream-import to convert the proprietary CSV files to a standard 
FHIR Bundle collection. For this purpose, an XML configuration file is written which 
includes mapping of source field names to standard terminology as defined by the 
common data set. The resulting HL7 FHIR Bundle resource contains Patient, Encounter 
and Observation resources and conforms to the latest FHIR standard 4.1.0 [4]. An 
example of the Bundle structure containing the source data is depicted in Figure 1. 
 
Figure 1. Example FHIR Bundle structure of provided input data 
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2.3. Mapping to OMOP domains 
The OMOP CDM splits data into different domains depending on their scope. Condition, 
Drug, Procedure, Measurement are common medical domains, which are mapped to 
separate tables in the OMOP CDM. We used Athena [8] to browse the complete OMOP 
vocabularies to find the correct target table for the data elements of our defined data set. 
We did so by searching for the respective SNOMED-CT, LOINC or ATC code and 
retrieving the OMOP domain of the resulting concepts, as well as the concept ids. 
2.4. Extending OMOP vocabularies 
There are many subtypes of pulmonary hypertension depending on the etiology or 
comorbidities of the patient. Those subtypes are classified using the clinical classification 
of the World Symposium on Pulmonary Hypertension of 2013, which is also referred to 
as PH Nice Classification [9]. Since the Nice classification is not part of the standardized 
vocabularies already included to OMOP, we had to add it manually.  
By using the hierarchical classification and the ER model of the OMOP standardized 
vocabularies [10], we generated CSV files to bulk load the Nice classification to OMOP.  
2.5. Data transformation using XSLT and XPath 
To transform the source data, provided as HL7 FHIR Bundle, to the OMOP schema we 
used XSLT (v2.0) [11] and XPath (v2.0) [12] to generate CSV for each used OMOP 
target table. The resulting CSV files contain all required information for the respective 
table, e.g. Measurement or Patient. 
3. Results 
3.1. Mapping to standard terminology 
The predefined common dataset consists of 141 distinct data elements all represented by 
a specific code. Out of the 141 elements, 36 have been mapped to SNOMED-CT, 38 to 
LOINC, 27 to ATC and one to ICD-10. 27 of the remaining 39 data elements belong to 
the PH Nice classification, while no standard code was found for 12 parameters. 
3.2. Algorithm 
The transformation is split up into different files, one for each table that will be 
populated. Currently our approach populates the following OMOP tables with all 
required fields: PERSON, OBSERVATION_PERIOD, CONDITION_OCCURRENCE, 
DRUG_EXPOSURE, PROCEDURE_OCCURRENCE, OBSERVATION and 
VISIT_OCCURRENCE 
The transformation structure is in principle the same for each table. A generic XSLT 
template is defined, to generate one row for each entry to the respective table. This 
generic template also extracts metadata about the entry like the date time or references 
to patients or encounters. Additionally, we defined parameter-specific templates, which 
map one parameter to its correct concept id in OMOP. Those parameter-specific 
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templates call the generic template with the correct parameter specific data like concept 
id, status ids or type ids for the respective parameter.  
The resulting CSV files are then bulk loaded to the database. A schematic illustration 
of the ETL process is shown in Figure 2. 
 
Figure 2. Schematic illustration of ETL process, showing involved software, including configurations and 
temporary result files 
3.3. Transformation results and performance 
Except for the 12 data elements of the common data set, where no standard concept in 
the standardized vocabularies could be found, every element was successfully mapped 
to the OMOP domains resulting in an overall coverage of about 91.5 %. We applied for 
new codes within LOINC for five data elements [13]. Additionally, we added 34 new 
concepts, 54 concept relationships and 68 concept ancestor entries to the vocabularies 
and therefore achieved 100 % coverage of the PH Nice classification in OMOP. 
In total, data of 3,887 patients was transformed to OMOP in 15 minutes and 29 
seconds using Saxon-HE v9.9.1 XSLT processor (on Intel Core i7-8550U with 256 GB 
SSD). To populate all required fields, we assigned default values for the parameters, 
which were not available in the source data. Those fields were for example: visit_type, 
admitted_from, discharged_to and others. In addition, fields like ethnicity and race have 
been set to default values for the first prototype, but those will be correctly mapped in 
the future as well. 
4. Discussion 
Based on the achieved results we conclude the feasibility for HL7 FHIR Bundle and 
XSLT as part of a generic ETL process. The majority of data elements were successfully 
transformed to the target scheme in reasonable time. Additionally, the customization of 
the available ETL process to connect new source databases reduces to only adjusting the 
data extraction process and HIStream configuration to provide data as HL7 FHIR Bundle. 
Therefore, providing a HL7 FHIR export for a local data source can increase 
interoperability of the included data, not only for data warehousing, but also for 
communication with other systems. 
Limitations of this work include the necessary synchronization between HIStream 
configuration and XSL transformations in order to transform all available data elements 
to OMOP. Additionally, the mapping of standard concepts is currently hard coded, by 
leveraging the rich vocabularies provided as CSV the mapping can be designed in a more 
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generic way. We also plan to reduce the computational time, even though 15 minutes for 
the transformation is already feasible because data will only be loaded periodically. 
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Abstract. This paper discusses the topic of data quality, which concerns the global 
research and business community and constitutes a challenging task. The data 
quality prerequisite becomes even more critical when it pertains to critical and 
sensitive data, such as the healthcare domain data. To begin with, the paper outlines 
the basic definitions and concepts of data quality and its dimensions. The related 
research work on data quality assessment is presented and our approach for data 
quality assurance is introduced. This approach is implemented in our designed cloud 
platform, called MODELHealth, which is intended for supporting clinical work and 
administrative decision-making process. 
Keywords. data quality, health data, ehr, quality assurance  
1. Introduction 
Today’s world is entirely data-driven. Enormous amounts of data are generated at every 
point of interaction. Therefore, how this data can be used effectively is a matter of great 
importance. For this data to be utilizable, they have to meet some requirements and be 
reliable, up-to-date, and of high quality. Thus, data quality is one of the biggest 
challenges in the digital world. The high volume and complexity of data collected across 
multiple sources create an enormous task in terms of data quality management. It is 
essential to mention that the issues in data quality can directly affect analytics and 
decision-making.  
For these reasons, data quality is recognized as widely considered to be a critical 
factor, especially in the healthcare sector. This paper outlines the basic definitions and 
concepts of data quality and proposes a new approach for data quality assurance. 
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2. Quality of Health data 
2.1. Data Quality Definition and dimensions 
Data are real-world objects, with the property of storing, retrieving and elaborating 
through an algorithmic process and can be communicated between two entities. Data 
quality has a distinct definition in various fields and periods. Multiple definitions of data 
quality have been proposed, but data is generally considered high quality if they are fit 
“for intended uses in operations, decision making, and planning” [1] or, more 
generally, “for the purposes data consumers want to apply them” [2]. Indeed, the 
quality of data is critical for improvement process activities, and it can be addressed in 
various fields inclusive of finance, statistics, computer science, and medicine.  
The primary phase in any data quality process is to define the properties of data 
quality; those properties are defined as data quality dimensions (DQDs). A Data Quality 
Dimension is a term used to define a data quality measure that can describe numerous 
data elements including attribute, record, table, system or more abstract groupings, such 
as business unit, company or product range [3]. Researchers have recognized various 
numbers of dimensions for data quality, but the most important are the six following core 
dimensions: Accuracy, Completeness, Consistency, Timeliness, Uniqueness and 
Validity. 
Accuracy of the data is the degree to which data is correct, reliable and certified. In other 
words, data are accurate in case of data values stored in the database are equivalent 
to real-world values. It is a measure of the correctness of the content of the data. 
Completeness of the data concerns the extent to which values appear in a dataset. With 
regard to a separate datum, only two conditions are potential: The attribute under 
consideration has a value or not.  
Suraj Juddoo et al. suggested that the two common most significant DQDs to consider 
in the context of big datasets for the health domain are accuracy and completeness 
[4]. 
Consistency of the data is the extent to which information is presented in the identical 
format and compatible with previous data. 
Timeliness of data regards only the interval between an alteration of a real-world state 
and the outcoming modification of the information system state. Timeliness has 
two constituents: age and volatility, which are a measure of how old the 
information is and a measure of information instability, respectively.  
Uniqueness of data determines the extent to which there are no duplicate values. 
Validity of data refers to data that have been collected in conformity with any rules or 
definitions that apply to that data. This will enable benchmarking between 
organizations and over time. 
According to the “Harmonized Data Quality Assessment Terminology and 
Framework for the Secondary Use of Electronic Health Record Data” [5], an initiative 
aimed at providing a solution to the inconsistency of data quality terminology used 
throughout the relevant scientific literature, the main proposed categories of healthcare 
data quality are: 
Conformance: The data should be compliant as far as format, relational reference, and 
computational accuracy are concerned. The subcategories of conformance are: 
 Value Conformance: Values and format of the data should adhere to all given 
prespecified data architecture constraints. 
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 Relational Conformance: Data should be consistent with the given structural 
constraints (nullability, referential integrity, etc.). 
 Computational Conformance: If there are computed values derived from 
existing data, they should be correct and consistent between computations based 
on the same specifications (internal or external programs). 
Completeness: In accordance with the respective dimension mentioned above, data 
should be complete, i.e., conforming to the expected frequencies of every data 
attribute value presence. In this context, completeness is not concerned with the 
data values, structure or plausibility. 
Plausibility: The data values should be believable/truthful when put in context (other 
variable values, temporal sequences, state transitions etc.). Plausibility 
subcategories are: 
 Uniqueness Plausibility: Objects represented by data should not appear 
multiple times where duplication is not explicitly justified. 
 Atemporal Plausibility: Observed data values and/or distributions should 
agree with domain knowledge, trusted external sources or established “gold 
standards”. 
 Temporal Plausibility: Time-dependent variable values should change as 
expected, taking under consideration established temporal properties. 
2.2. Importance of Data Quality in Electronic Health Record 
E-health constitutes a recognized term and is close related to the usage of Electronic 
Health Records (EHRs), so as to achieve adequate communication between healthcare 
sectors. Specifically, various sources of healthcare data exist, such as the internet, 
electronic patient records, data analysis tools, communication between health experts 
and patients, electronic health devices. Data management and analysis tools aim to 
improve healthcare organizations operation in terms of obtaining useful information and 
knowledge via conversion of the aforementioned vast resources [6].  
It is crucial that the collected data are precise, comprehensive, reliable, 
comprehensible and available to all stakeholders such as patients, health experts, legal 
authorities, and government authorities [7]. Therefore, data quality issue constitutes a 
significant challenge concerning health records and is able to provoke pivotal effects on 
every health sector operation. A considerable amount of lethal medical errors concerns 
the result of missing or incomplete data about medication, instructions, and treatment 
plans [8].  
In addition, adequate data quality plays a significant role in the successful 
implementation of machine learning methods, and it presents one of the significant 
challenges, especially in the healthcare domain [9], [10]. Poor quality input data are, 
most of the times, a critical liability in the machine learning process as, in essence, they 
carry an altered state of the underlying patterns that represent the “truth” of the data, 
leading to an altered “reality” perceived by the algorithm. It’s self-evident that regarding 
a learning process, if the foundation -the learning material- is critically impaired, one 
should not have many expectations of the outcome. 
The most common source of data used in machine learning processes of medical 
significance is operational software systems in clinical environments, mainly EHR 
transactions. This secondary analysis setting, meaning the use of the data for research 
analytics, which is not their original purpose of collection, has been researched 
M. Sarafidis et al. / Data Quality Challenges in a Learning Health System 145
extensively towards assessing and dealing with the factors that affect data quality [11]–
[13]. It has been found that “EHR data from clinical settings may be inaccurate, 
incomplete, transformed in ways that undermine their meaning, unrecoverable for 
research, of unknown provenance, of insufficient granularity, and incompatible with 
research protocols” [11]. 
3. Health Data Quality in MODELHealth 
MODELHealth is a cloud platform that facilitates the application of Machine Learning 
methods, towards processing health data, in order to support clinical work or/and the 
administrative decision-making process, in all levels of health services provision. It is a 
“holistic” approach to the subject of developing and exploiting Machine Learning 
algorithms. It covers the whole lifecycle of the respective process, from querying, 
homogenizing, anonymizing and enriching raw data, to the final provision of the 
resulting algorithms via Application Program Interfaces, in order for them to be 
consumed by any authorized Information System. For projects like MODELHealth, data 
retrieval is a critical step, as the raw data that are produced by querying a real-world 
database need to be handled on various levels for a number of reasons before they end 
up on the central data repository, in order to participate in the training and validation of 
machine learning algorithms.  
To this end, the ETL (Extract, Transform & Load) mechanism of the MODELHealth 
platform contains a dedicated Quality Assurance (QA) module, as well as an Entity 
Mapping module that handles ontologies and central database homogeneity and an 
anonymization module that handles patient privacy and regulatory compliance. Both 
latter modules lie outside the scope of this text. 
Regarding the data quality Assessment, the QA module of the ETL system is capable 
of performing a number of tests on the incoming data, based on a customizable and 
extendable rule-set that quantifies data quality in the form of test success-failure 
percentages. There will be rules covering the whole aforementioned spectrum of 
healthcare data quality: atemporal completeness, value conformance, and atemporal 
plausibility. These are the factors that are primarily investigated through data quality 
checks by the organizations which are currently engaged in data quality assessment [14]. 
Via centrally defined customizable thresholds for each active rule, the administrators can 
set the quality tolerance of the data retrieval process, thus controlling the minimum 
quality requirements of the data that actually make it to the central data repository. This 
is accomplished by “instructing” the decentralized ETL mechanisms to reject data that 
do not meet the desired criteria.  
More specifically, in order to pursue the quality standards, the developed QA 
module will be based on the research conducted by Nicole G. Weiskopf et al. [15]. The 
tool’s core framework takes into account three different forms of data: complete, correct, 
and current data. Data quality assessment issues diversify from one another forms of data. 
Furthermore, the operationalization of the above forms varies depending on the three 
main types of HER data: patients, variables, and time. As a result, the combination of the 
aforementioned 3x3 elements produces nine constructs that lead to different 
methodological recommendations, in other words guideline-based best practices, for 
EHR data quality assessment. 
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4. Conclusions 
This paper has described a spectrum of issues associated with the quality of health-care 
data. Because contemporary EHR systems suffer from many shortcomings, the medical 
data that they produce are also often flawed. Data-quality problems can compromise the 
value of databases for scientific research, quality assessment, public health, and other 
purposes. Analytical insights in healthcare should always be probed for data quality 
problems. Also, the value derived from the use of analytics should dictate the 
requirements of data quality. This is emphasized because most analytical tools assume 
that the data are of very high quality. Based on this premise, MODELHealth attempts to 
apply contemporary data quality checks, towards a systematic approach to data quality, 
in order to ensure a reliable and viable developed asset for healthcare organizations for 
the holistic implementation of machine learning processes.   
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Abstract. Sensitive data is normally required to develop rule-based or train ma-
chine learning-based models for de-identifying electronic health record (EHR) clin-
ical notes; and this presents important problems for patient privacy. In this study,
we add non-sensitive public datasets to EHR training data; (i) scientific medical text
and (ii) Wikipedia word vectors. The data, all in Swedish, is used to train a deep
learning model using recurrent neural networks. Tests on pseudonymized Swedish
EHR clinical notes showed improved precision and recall from 55.62% and 80.02%
with the base EHR embedding layer, to 85.01% and 87.15% when Wikipedia word
vectors are added. These results suggest that non-sensitive text from the general
domain can be used to train robust models for de-identifying Swedish clinical text;
and this could be useful in cases where the data is both sensitive and in low-resource
languages.
Keywords. EHR, clinical text, de-identification, deep learning, wiki word vectors
1. Introduction
De-identifying health data is an important problem for health data reuse, and the topic
has generated significant scholarly interest because of increased use of electronic health
records (EHR). Re-use of the data in research could give us unique insights into disease
etiology and progression, as well as a greater understanding of patient care processes and
pathways. Current de-identification methods rely on sensitive health data for training.
This presents a number of data-sensitivity problems, such as when there is need to trans-
fer or adapt the models to new target data. In this study, we investigate the usefulness of
non-sensitive training data from the general domain.
Two main approaches have so far been used for de-identification namely, rule-
based and machine learning-based methods [1]. Studies show that more successful de-
identification systems use a hybrid of both these approaches [2]. On the one hand, rule-
based methods can go as far as using name lists from the economy/administration soft-
ware to match against the clinical text [3]. While this can be an effective solution, it is
not robust enough for simple variations or for use outside the specified datasets or orga-
nizations, and could entail serious risks to patient privacy. On the other hand, machine
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learning?approaches,?while?more? robust? since? they? learn?patterns,? instead?of?matching?
specific?instances,?still?require?a?large?amount?of?sensitive?data.
Machine?learning?approaches?require?a?lot?of?training?data?or?examples?to?learn?from.?
Creating?examples?by?annotating?the?data?is?an?expensive?proposition?because?it?requires?
specialist? knowledge,? and? the? amounts? of? data? are? enormous.?Unsupervised?methods?
which?can?be?used?to?discover?discriminating?features?in?new?target?datasets?are?emerg-
ing.?These?emerging?deep?learning?architectures?do?not?require?any?feature?engineering?
to?produce?state?of?the?art?results?[4].?So?far?however,?these?architectures?have?only?used?
embeddings?from?sensitive?data?or?scientific?medical?publications?like?PubMed?[5].?Out-
of-domain?sources?such?as?Wikipedia?or?newer?general?language?models?like?BERT?[6]?
have?not?been?extensively?explored?for?this?task?on?medical?text.
Exploring?use?of?non-sensitive?data,? the?validity?of?using?pseudonymised? clinical?
text?for?de-identification?is?studied?in?[7]?where?the?Stockholm?EPR?PHI?Pseudo?Corpus?
[8]? is? used? and? compared?with?Stockholm?EPR?PHI?Corpus,? the? non-pseudonymised?
corpora.? It? is?shown? that? the? results?using?pseudonymised?corpora?as? training?data?are?
slightly?decreased,?suggesting?limited?potential.
In?another?approach,?McMurray?et?al.? [3]?used?both?EHR? text?and? text? from?pub-
licly?published?medical?journals?for?training?purposes.?The?authors?argued?medical?pub-
lications?will? generally? not? contain? enough? protected? health? information? (PHI)? infor-
mation,? and? this? could?be? a?discriminating? factor.? In? contrast,? a? recent? study?by?Berg?
et?al.? [9]? found?no?additional?benefits?of?using?out-of-domain? training?material? for?de-
identification?using?deep?learning?approaches.
Whether?non-sensitive?medical?text?such?as?scientific?medical?publications?or?even?
text?from?the?general?domain?is?useful?for?de-identification,?is?still?a?matter?without?fully?
resolved? clarity.? In? this? study?we? test?both? these?non-sensitive? sources? and? contribute?
evidence?to?help?answer?the?question.
2.?Method
Experiments?will?compare? the?effect?of?adding?medical?scientific? text?versus? text?from?
the?general?domain? to? the? training?set?for?a?de-identification?deep? learning?model.?The?
comparisons? are?with? (i)? the?base? embedding? layer? from? the?EHR? text,? (ii)?EHR? text?
plus?medical?scientific?text,?and?(iii)?EHR?text?plus?Wikipedia?word?vectors.?These?data?
sources?are?detailed?in?the?succeeding?subsections.
2.1.? Stockholm?EPR?PHI?Psuedo?Corpus
Stockholm?EPR?PHI?Pseudo?Corpus2? is? a?Swedish?EHR? corpus,?which?has?been?de-
identified?and?pseudonymized?[8],?and?where?the?tokens?are?annotated?with?PHI?informa-
tion.?Stockholm?EPR?PHI?Psuedo?Corpus?is?part?of?the?Health?Bank?[10],?the?Swedish?
Health?Record?Research?Bank3.?The?Health?Bank?encompasses?structured?and?unstruc-
tured?patient?records?data?from?512?clinical?units?from?Karolinska?University?Hospital?
collected?from?the?years?2007?to?2014?encompassing?over?2?million?patients.?The?dataset?
uses?a?less?fine-grained?annotation?scheme?(IOB),?indicating?[I=inside?token],?[B=begin?
token],?and?[O?=?not?PHI?token].
2Research approved by the Regional Ethical Review Board in Stockholm; permission no. 2014/1607-32.
3Health Bank, http://www.dsv.su.se/healthbank
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2.2.? Scientific?medical?journal?and?Swedish?Wiki?word?vectors
Scientific?medical? text? is?based?on? the?La¨kartidningen?corpus? (The?Swedish? scientific?
medical? journal? from?1996? to?2005).?La¨kartidningen?has?publicly? available? articles? at?
Spra˚kbanken4.?Wiki?word?vectors?are?pre-trained?word?vectors?created?with?fastText?from?
Swedish?Wikipedia?text?[11],?and?are?publicly?available?at?fastText5.?They?are?designed?
with?no?specific?downstream?task?in?mind,?but?what?makes?them?interesting?is?their?use?
of?character-level?n-grams,?where?a?single?word?can?be?represented?by?several?character?
n-grams.
2.3.? Deep?recurrent?neural?networks
A?state?of?the?art?deep?learning?algorithm?previously?used?on?health?data?[5],?the?Bidirec-
tional?Long?Short-Term?Memory?algorithm?with?conditional?random?fields?(BI-LSTM-
CRF),?was?used?in?the?experiments,?as?implemented?in?TensorFlow/Keras6.?For?the?scien-
tific?medical?text,?we?used?another?state?of?the?art?method,?Word2Vec,?to?create?the?word?
embeddings.?Wikipedia?word?vectors?are?made?available? to? the?public?pre-trained?and?
ready?for?downstream?tasks.?Both?sources?have?300?dimensional?vector?representation.
3.? Results
The? results? in?Table? 1? show? a? clear? improvement? in? results,? from? adding?Wiki?word?
vectors? to? the?base?embedding? layer?with?EHR?data?only.?We?also?observe? that?adding?
scientific?medical?text?improves?performance,?but?falls?short?of?Wiki?word?vectors.
PHI EHR EHR + Scientific medical text EHR + Wikipedia
P % R % F1 P % R % F1 P % R % F1
Age 66.67 40.00 50.00 100.00 80.00 88.89 100.00 80.00 88.89
Date Part 62.87 83.24 71.63 92.09 91.06 91.57 87.76 96.09 91.73
First Name 72.22 87.39 79.09 89.83 66.81 76.63 95.78 95.38 95.58
Full Date 50.00 85.54 63.11 67.23 96.39 79.21 80.41 93.98 86.67
Health Care U. 40.39 77.15 53.02 67.10 77.15 71.78 71.43 82.4 76.52
Last Name 91.61 97.26 94.35 77.01 98.63 86.49 92.95 99.32 96.03
Location 21.15 18.64 19.82 87.50 11.86 20.90 100.00 15.25 26.47
Phone Number 17.39 42.11 24.62 66.67 31.58 42.86 92.86 68.42 78.79
Avg 55.62 80.02 65.62 77.83 77.21 77.52 85.01 87.15 86.07
Table 1. De-identification results based on the three comparisons, P=Precision, R= recall, both percentage
There are a number of reasons that could explain why the Wikipedia text performed
better than medical text. First, Wikipedia is a rich source of information which contains
both general text and medicine-related text as well. In addition, a number of PHI informa-
tion such as first and last names, ages, year, and location are present in the text. Also, the
scientific medical journal corpus in Swedish (La¨kartidningen) produced 118,683 vectors
while Wikipedia, on the other hand, produced 1,143,274 vectors.
Further, we observed that the scientific medical text start’s out with a relatively high
error loss in each epoch, while initial error loss is much lower for Wikipedia. In terms of
4La¨kartidningen, https://spraakbanken.gu.se/swe/resurs/lakartidn-vof
5fastText, https://fasttext.cc
6TensorFlow, http://www.tensorflow.org
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the?improvement?in?F1?measures?(see?Figure?1),?there?was?significant?performance?gain?
for?Age?and?Phone?Number.?For?scientific?medical?text,?we?noted?poorer?performance?for?
some?PHI?information?like?first?names?and?last?names,?compared?to?the?EHR?baseline.
Figure 1. The graph shows the PHI differences in F1 measures between scientific medical text and the EHR
baseline (MED-EHR) and between Wikipedia and the EHR baseline (WIKI-EHR) respectively.
4. Discussion
It appears the general consensus in scholarship is that training on general-domain text is
not appropriate for tasks on clinical text, since clinical text is so different that it represents
a unique linguistic genre. The language in clinical notes is meant for other healthcare
professionals. Clinicians and nurses write these notes under time pressure, therefore the
text has abbreviations, misspellings, unusual grammatical constructs and other errors and
ambiguities.
Our results support a counter-argument that PHI information is distinct from clinical
text since PHI information is general, as opposed to clinical procedures, medication or
medical concepts that are present in clinical text. Therefore, it could be appropriate to use
non-sensitive text in the general domain as training data for detecting PHI information.
Also, deep learning architectures have been reported to show good performance under
different domains and languages.
The poor results obtained with scientific medical text is consistent with previous as-
sertions made in the literature, that is, scientific text is not likely to contain names and
surnames in meaningful contexts [3]. However, the significant improvement in Age and
Phone Number suggest that scientific medical text could still be useful for detecting spe-
cific PHI information. Therefore, combining this medical text with other sources could
be a viable option.
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5.? Conclusion
Current? results?suggest? that?non-sensitive? resources? in? the?general?domain?can?be?use-
ful? for?de-identification? tasks?on?clinical?notes.?Even? though?deep? learning?models?are?
generally?thought?of?as?data-hungry,?current?results?raise?the?prospect?of?creating?robust?
models;?where?the?primary?training?data?is?sensitive?and?low?resourced.?In?the?future,?we?
will?test?non-sensitive?resources?and?language?models?to?adapt?and?transfer?deep?learning?
models?for?de-identifying?clinical?notes?between?closely?similar?Nordic?languages;?such?
as?between?Swedish?and?Norwegian?clinical?notes.
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Glaucomatous Optic Neuropathy Using 
Digital Fundus Image: A Meta-Analysis 
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Abstract: We conducted a study to evaluate the algorithms based on deep learning 
to automatically diagnosis of GON from digital fundus images. A systematic 
articles search was conducted in PubMed, EMBASE, Google Scholar for the study 
that investigated the performance of deep learning algorithms for the detection of 
GON. A total of eight studies were included in this study, of which 5 studies were 
used to conduct our meta-analysis. The pooled AUROC for detecting GON was 
0.98. However, the sensitivity and specificity of deep learning to detect GON were 
0.90 (95% CI: 0.90-0.91), and 0.94 (95%CI: 0.93-0.94), respectively.  
Keywords: Glaucoma, glaucomatous optic neuropathy, deep learning, artificial 
intelligence, fundus image. 
1. Introduction 
Glaucoma has already been emerged as one of  primary cause of blindness, affecting 
approximately 66.8 million people worldwide [1]. It is often considered as a 
progressiveness neurodegenerative, multifactorial disease, characterized by the 
continuous loss of ganglion cells (RGCSs) and damage of optic nerve atrophy and the 
visual cortex [2]. Most cases of GON are asymptomatic until to be reached in late stage. 
Since the diagnosis of GON is very subjective and qualitative, and early detection of 
GON can help to improve treatment plan, monitoring of the quality of life and to 
prevent visual impairment. Screening of GON is always achieved by manually assessing 
optic nerve structure in the digital fundus image. However, this process is labor-
intensive, time-consuming and the performance of GON detection solely depend on the 
skill and experience of ophthalmologists [3]. A fully automated system would enhance 
the quality of existing care by providing diagnostic support to ophthalmologists and 
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 could contribute to the accessibility of patients care by generating large-scale automated 
screening systems [4]. 
Deep learning algorithm has already appeared as a cutting-edge solution for 
successful detection of diabetic retinopathy [5], glioma [6], macular degeneration [7]. 
An automated system could also play an important role in the diagnosis of GON early 
that could improve patients care. It would contribute to strengthening the treatment 
adherence and by providing the importance of GON medications and surgeries. Here, 
we conducted a systematic review with meta-analysis to evaluate the performance of 
deep learning for detecting GON using digital fundus images. It can help to establish 
evidence of the ability of deep learning model for detecting GON. 
2. Methods 
This study followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) that is based on Cochrane’s Handbook for Systematic Reviews [8]. 
Databases Search A systematic search was conducted in PubMed, EMBASE, Scopus, 
Google Scholar for relevant studies between 2010 and 2019. Some control 
keywords: “deep learning”, “Convolutional neural network”, “CNN”, “DL”, 
“glaucoma”, “glaucomatous optic neuropathy”, “GON” were used as a search term. 
To ensure comprehensiveness, the reference lists of retrieved articles were checked 
carefully to get additional relevant studies. 
Eligibility Criteria Eligibility was restricted to studies that evaluated the performance 
of deep learning algorithms to detect glaucoma. Studies were excluded if they were 
not published in English, and published as review, short report, editorial, letter to 
editors. 
Selection Process Two authors (MMI, TNP) independently screen the titles and 
abstracts of all retrieved relevant studies. They selected studies based on the pre-
specified selection criteria. Any disagreement between them during the screening 
process was resolved by the main investigator (YCL). 
Data Extraction Data collection forms were used to extract the required information 
from included studies retrieved initially. Two authors first removed duplication by 
checking author name, publication date, sample size. Afterwards, they collected 
author name, publication year, total sample size, number of images, methods, 
external validation information, the performance of deep learning, sensitivity, 
specificity, true positive, true negative, false positive and false negative. 
Assessment of Risk Bias Same two authors independently used QUADAS-2 for 
assessing the individual quality of each study. The QUADAS-2 tool is 
recommended for evaluating the risk of bias and applicability of primary diagnostic 
accuracy studies. QUADAS-2 tool consists of four areas such as patient selection, 
index test, reference standard and flow and timing.  
Statistical Analysis The meta-analysis was performed on qualifying studies that 
reported the performance of deep learning for detecting GON with sensitivity and 
specificity, and a total number of images. We then calculated the true positive, false 
positive, true negative and false negative to generate area under the receiver 
operating characteristic curve. A random-effect model was used to generate the 
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 pooled sensitivity, specificity, positive- and negative likelihood ratio and diagnostic 
odds ratio. All the analyses were performed using Meta-Dise (V-1.4) software. 
3. Results  
The literature searches of the electronic databases yielded 150 articles. After screening 
of the titles and abstracts, 137 studies were excluded due to lack of inclusion criteria. 13 
articles went for full-text review; a total of 8 articles were then selected for our study [3, 
9-15]. 5 out of 8 studies were included in the meta-analysis. Publication years ranged 
from 2018-2019. Three studies were from China, 2 from Japan, 1 from India, 1 from 
South Korea and 1 from the United States. All the studies were used the CNN model to 
detect GON from digital fundus images. The QUADAS-2 tool assessment showed that 5 
studies had moderate applicability, and the concerns about the applicability of the 
remaining studies were considered as low. 
Table 1: Characteristics of included studies. 
Author Country Method  Total Image  Data source 
Liu 2019 China CNN 274,413 CGSA* 
Asaoka-2019 Japan CNN 1,364 MRCH 
Shibata-2018 Japan CNN 1,364 MRCH 
Li-2018 China CNN 48,116 LabelMe 
Raghavendra- 2018 India CNN 1,426 KMC 
Ahn-2018 S Korea CNN 1,542 KEH 
Christopher- 2018 USA CNN 14,822 ADGES & UCSD 
Chai-2018 China CNN 2,554 NR 
# Note= CGSA: Chinese Glaucoma Study Alliance *other dataset also used. MRCH: Matsue Red Cross 
Hospital, KMC= Kasturba Medical College, Kim’s Eye Hospital, The African Descent and Glaucoma 
Evaluation Study and the University of California, San Diego (UCSD), NR= Not reported. 
 
Five studies evaluated the performance of deep learning model for accurate 
detection of GON. The deep learning model showed the higher performance to 
accurately detect GON. The overall pooled AUROC for deep learning algorithms to 
detect GON was 0.98 (Figure 1). The sensitivity and specificity were 0.90 (95% CI: 
0.90-0.91), and 0.94 (95%CI: 0.93-0.94), respectively. 
Furthermore, the pooled positive likelihood ratio and negative likelihood ratio were 
16.77 (95%CI: 6.42-43.79), and 0.06 (95%CI: 0.02-0.15). The heterogeneity among the 
studies was I2 =99.8% and I2= 99.4%, respectively. Moreover, the diagnostic odds ratio 
was 292.53 (50.13-1706.94. 
4. Discussion 
In this study, we evaluated the performance of deep learning algorithms for detecting 
GON from the digital fundus images. Our findings suggest that deep learning model has 
immense potential to detect GON with high sensitivity and specificity in a diverse 
population. The diagnosis accuracy, sensitivity and specificity of traditional computer  
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Figure 1: Classification performance of deep learning model. a) Receiver operating characteristic curve b) 
sensitivity c) specificity d) diagnostic odds ratio 
vision methods are close to 60% [16], whereas the pooled AUROC, sensitivity, and 
specificity of deep learning model are 0.98, 0.90, and 0.94, respectively. The 
performance of the deep learning model can help to make an automatic screening tool to 
detect GON early for better patient’s care. Improved sensitivity and specificity of tests 
increase the feasibility of GON screening programs by reducing the burden of false-
positive [12].  Early diagnosis of GON using automated tools could have a crucial role 
in supporting ophthalmologist, as patients with glaucoma are unaware of their condition 
until central visual acuity is damaged. An automated technique would help to improve 
performance, reduce the healthcare cost, and give the same performance in different 
digital images. 
There are several advantages of using deep learning for the detection of GON from 
digital fundus images. First, no need to do conventional steps such as feature extraction, 
dimensionality reduction and feature ranking [17]. Second, it does not require data 
preprocessing which usually influence in traditional machine learning techniques. 
However, there are several challenges to use deep learning techniques in GON 
diagnosis. First, it takes a higher number of GON images to train the model for getting 
the optimum performance. Second, generalizability problem, it means the model would 
perform the same in different databases.   
5. Conclusion  
Findings of our current study showed that deep learning model has immense potential to 
detect GON (high sensitivity and specificity). Implementation of deep learning-based 
automated tools could be cost-effective and improve the accessibility of GON screening 
in a remote setting. Having ensured the generalization of automated diagnosis of GON, 
a dataset with different ethnicities could be tested.  
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Abstract. The MIRACUM consortium is developing a Clinical Trials Recruitment
Support System to support the data-driven recruitment of patients for clinical trials.
The design of the prototype includes both open source solutions (OMOP CDM,
Atlas) and open standards for interoperability (FHIR). The aim of the prototype is
to create a patient screening list of potential participants for a clinical study. The
paper shows the modular structure and functionality of the prototype building the
foundation for the practical implementation of the CTRSS and, at the same time,
demonstrating the use of open source solutions and standards for the development
of clinical support systems.
Keywords. clinical trial recruitment support system, FHIR, OMOP, OHDSI,
secondary use of electronic health records, automation, open standards, decision
support systems
1. Introduction
Clinical trials are fundamental in clinical research and in evidence based medicine since
they are needed to evaluate new treatment methods, the effectivity of drugs, or new di-
agnostic tools [1]. However, many studies fail during the recruitment phase for the fol-
lowing two reasons: either the minimum necessary number of patients is not reached or
the recruitment process takes too much time and effort to find enough eligible patients
to participate [2] [3]. One option to overcome those issues is the specific reuse of al-
ready observed data during inpatient treatment. Since the availability of digital health
care data is growing rapidly it offers high potential for reuse in clinical research [4]. The
idea of automated screening electronic health care data is not new. During the last ten
years the number of publications on clinical trial recruitment support systems (CTRSS)
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is?continuously?increasing.?This?trend?demonstrates?the?importance?and?need?of?such?sys-
tems? to?allow?faster?and?more?efficient?patient?screening?[5].?Ko¨pcke?et?al.?[5]?pointed?
out? the? lack?of? standards?and?missing? interoperability?of?CTRSS?as?well?as?a?missing?
formalisation?of?eligibility?criteria? for? the?definition?of?a?potential? trial?cohort.?Thus?a?
major?goal?of?the?MIRACUM?consortium?[6]?is?to?provide?a?modular?CTRSS?based?on?
open?standards.?This?approach?shall?ensure?interoperability?and?flexibility?to?connect?to?
other?systems?such?as?study?registries?and?hospital?information?systems.?As?one?of?four?
consortia?MIRACUM? is?part?of? the?German?Medical? Informatics? Initiative? (MII).?The?
MII?brings?together?30?university?hospitals?and?a?number?of?industry?partners?to?estab-
lish?data?integration?centres.?The?aim?is?to?provide?clinical?health?care?data?from?various?
source?systems?in?one?place?to?ensure?to?”prove?their?benefit?for?researchers,?doctors?and?
patients”?[7].?To?demonstrate?the?benefits?of?integrated?data?one?use?case?the?MIRACUM?
consortium?is?responsible?for? is?“Alerting? in?care?-?IT?support?for?patient?recruitment”.?
This?paper?illustrates?how?to?build?a?CTRSS?concept?that?consists?of?separate?modules,?
can?be?transferred?to?other?locations,?make?use?of?existing?open?source?tools?and?benefit?
from?open?standards.
2.?Methods
To?address?the?topics?modularity,?transferability,?open?source?tools?and?open?standards,?
a?heterogeneous?group?of?computer?scientists,?medical? information?scientists,?data?sci-
entists?and?physicians?joined?forces?to?developed?the?CTRSS?prototype.?The?team?eval-
uated?how?the?communication?between?loose?coupled?modules?of?the?prototype?can?be?
done?based?on?Representational?State?Transfer? (REST)?over?HTTP?protocol?and?what?
is?needed?to?represent?data?using?the?Fast?Healthcare?Interoperability?Resources?(FHIR)?
developed? by?Health?Level?Seven?Organization? (HL7)? standard? for? data? exchange.?A?
common?data?model?was?needed?to?store?data?that?gets?searched?for?potential?trial?par-
ticipants?by?the?CTRSS?prototype.?The?Observational?Health?Data?Sciences?and?Infor-
matics? (OHDSI)?organization? consists?of? a? rapidly?growing?worldwide? community?of?
universities?to?foster?worldwide?medical?scientific?community?and?to?improve?scientific?
research? [8].?Thus? they?developed?a?common?data?model? (CDM)?Observational?Med-
ical?Outcomes?Partnership? (OMOP)? including? a? set? of? standardized? vocabularies(e.g.?
SNOMED,?LOINC,?rxNorm,?ICD10)?and?their?translations?between?each?other?to?allow?
researches?to?speak?a?common?language?when?exchanging?data.?To?validate?OMOP?CDM?
is? a?proper?patient?data? storage?needed?by? a?CTRSS?we? installed? it?on? a?PostgreSQL?
database?and?added?standardised?vocabularies?using?the?OHDSI?Athena?web?application.?
Athena?is?a?service?that?provides?regular?updates?of?the?vocabularies?to?ensure?utilization?
of? the?most? recent?vocabulary?versions.? In?Germany?a?modified?version?of? the? ICD10?
world?health?organization?(WHO)?vocabulary?is?in?place?to?serve?local?billing?purposes.?
Thus?the?ICD10GM?vocabulary?has?been?added?as?an?additional?vocabulary?to?the?OMOP?
database?based?on?the?work?done?by?Maier?et?al.?[9].?In?a?next?step?the?patient?data?based?
on? the?MII?core?data?set?were? imported? into?OMOP.?All?data? included? in? the?MII?core?
data?have?been?mapped? into? the?OMOP?CDM?successfully.?Afterwards? the?Atlas?web?
application?was?used?to?define?cohorts?based?on?the?eligibility?criteria?of?a?clinical?trial?
using?a?web? interface?for?several?clinical? trials.?The?exchange?of?cohort?definitions?be-
tween?different? locations?was?done?with? the? import?and?export?capability?of? the?Atlas
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web?application.?All?information?of?defined?cohorts?was?stored?in?the?OMOP?database.?
Furthermore?OHDSI?provides?a?Web?Application?Programming? Interface? (API)?based?
on?REST?for? the?OMOP?CDM.?The?REST?Web?API?was?used? to?realize? the?access? to?
already? defined? cohorts.?This? included? the? execution? of? cohort? definitions? against? the?
OMOP?database,?status?checks?of?a?cohort?execution?and?the?call?of?a?result?list?of?patient?
ids?for?a?certain?cohort?definition.?To?implement?the?notification?of?research?teams?about?
any?changes?on?the?patient?screening?lists,?we?evaluated?the?functionality?offered?by?the?
FHIR?HL7?standard.?FHIR?provides?subscription?resources? that?allows?us? to?register?a?
certain?resource? to?act?on?any?event?such?as?change,?create?or?delete.?The?subscription?
resource?was?configured?to?use?a?certain?communication?channel?such?as?e-mail,?REST?
post?request?and?others.
3.? Results
The?CTRSS?prototype?consists?of?separate?modules?based?on?an?architecture?proposed?
by?Trinczek?et.?al.?[10].?Each?module?targets?a?small?set?of?similar?features?and?is?imple-
mented?as?a?REST?based?micro-service?with?well-defined?service?boundaries.?All?module?
interfaces?have?a?properly?documented?API.?As?shown?in?Figure?1?the?prototype?CTRSS?
is?composed?of?the?following?five?modules:
• patient data module
• Atlas web application
• query module
• notification module
• screening list module
Figure 1. Architecture of the CTRSS
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The process of creating a patient screening list consists of the following five main steps:
1. cohort definition using the ATLAS web application
2. generation of a cohort and retrieval of its contents from the OMOP database done
by the query module
3. generation or update of the screening list with retrieved patients as a FHIR list-
resource done by the query module
4. notification based on any event on a FHIR list-resource done by the notification
module
5. screening list module receives new or changed screening lists
The patient data module is based on the OMOP CDM (version 5) and it stores all obser-
vational data of a patient. In the first step the Atlas web application is being used for co-
hort definition. On successful cohort definition an unique identifier of the defined cohort
is returned. All cohort definitions built with Atlas can be exported to other locations. The
query module is a custom implementation using REST calls to send and retrieve data.
In step two the query module generates the patient list using the cohort identifier that is
handed over after cohort definition with Atlas. Based on a defined scheduling or on noti-
fication when patient data changes, the query module runs a REST POST query against
the OMOP Web API to generate the list of potential trial participants in the database. The
query module uses another REST call to check the current status of a cohort generation.
After successful cohort creation the query module retrieves the patient list. In step three
the list of patients for a particular trial is sent using a FHIR list-resource that contains all
patient ids. There has been a subscription resource created for the list-resource that sends
e-mail messages to recipients when a list of patient ids gets created or changed on the
FHIR server. The patient screening list module is a custom web application that reads
the list-resources data from the FHIR server. It displays all potential patients for a trial
of interest based on the cohort id. The screening list module is implemented as a web
application based on HTML 5 and the java script framework Vue.js.
4. Discussion
The CTRSS prototype is based on separate modules that consist of a strong encapsula-
tion to hide the details of the implementation that ensure a loose coupling between each
other and thus addresses the lack of missing interoperability [11]. Our approach provides
great advantages in terms of technology heterogeneity, resilience, scalability, deployment
efficiency, composability, and optimization for replacement as stated by Sam Newman
[12]. Hence compared to monolithic software, the modular CTRSS prototype introduced
by us allows to accelerate development cycles, reduce deployment efforts, and provide
improved scalability. Development teams can exchange single modules without affect-
ing others as long as the interfaces are the same and thus flexibility of the whole system
increases. Additionally the scaling of each module can be done based on performance
requirements individually instead of scaling the whole prototype. As stated by Ko¨pcke
et. al. [5] ”many CTRSS are designed to fit the existing infrastructure of a clinical care
provider or the particularities of a trial” and therefore most existing CTRSS are limited
to local environments and conditions that cannot be transferred to other locations nor
adapted to trials with different characteristics. Our CTRSS prototype was built to over-
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come? those? limitations?as? it? is?a? transferable?solution? that?can?be?used?across?different?
locations.?Additionally?the?usage?of?FHIR?for?the?exchange?of?electronic?healthcare?data?
using?web? technologies? enables? the?prototype? to?be? extended? and? connected? to?many?
other?health?care?systems.?In?the?future?the?prototype?can?be?extended?to?send?back?noti-
fication?on?new?potential?trial?participants?to?existing?health?information?systems?(HIS).?
With? the?OMOP?CDM? the?used?patient?data? is? transformed? into?a?standardized?format?
that?allows? scientists? to? search? for?potential?participants?at?multiple? locations?national?
wide?and?with? the?option?for?extension? to?an? international? level? in?future?projects.?The?
usage?of?OHDSI?Atlas?allows?scientists? to?share?defined?cohorts?with?others.?This?ex-
tends?the?range?of?coverage?when?searching?for?potential?participants?and?thus?increases?
the?chance? to?meet?set?expectations? in? terms?of?number?of?participants.?Our?prototype?
is?currently? limited? in? terms?of?usage?and? result? reporting.?Therefore?no? results?on? the?
success?of?patient?recruitment?can?be?provided.?The?exchange?of?data?between?different?
locations?has?to?be?done?in?a?next?step.?The?test?and?deployment?of?the?prototype?within?
the?MIRACUM?consortium?including?reporting?of?the?results?and?outcomes?needs?to?be?
addressed?in?follow-up?publication?as?suggested?by?Ko¨pcke?et.?al.?[5].
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Abstract. Identifying adverse events in clinical documents is demanded in 
retrospective clinical research and prospective monitoring of treatment safety and 
cost-effectiveness. We proposed and evaluated a few methods of semi-automated 
muscle weakness detection in preoperative clinical notes for a larger project on 
predicting paresis by images. The combination of semi-expert and machine learning 
methods demonstrated maximized sensitivity = 0.860 and specificity = 0.919, and 
largest AUC = 0.943 with a 95% CI [0.874; 0.991], outperforming each method used 
individually. Our approaches are expected to be effective for autoshaping a well- 
verified training dataset for supervised machine learning. 
Keywords. Electronic Health Records, Neurosurgery, Natural Language 
Processing, Adverse Events, Logistic Regression, ROC-analysis 
1.Introduction 
Identifying adverse events in clinical documents is highly demanded in retrospective 
clinical research and monitoring of treatment safety and cost-effectiveness [1]. 
However, these entities are described using free text in medical records. To extract 
information on complications following neurosurgery, the examination of narrative 
medical texts is likely needed. These activities are time-consuming for experts and 
almost impractical when dealing with big data collected through decades. Despite the 
effective machine learning implications in natural language processing, the absence of 
formalized ground truth variables in unstructured data makes the use of supervised 
techniques challenging. Thus, the text annotation would benefit from effective 
automation. Recently, our group proposed an information extraction algorithm (IEA) for 
detecting adverse events in neurosurgery using documents written in a natural rich-in- 
morphology language [2]. This study aimed to test our IEA in the identification of 
preoperative extremity muscle weakness in patients with glial tumors and to compare its 
feasibility with supervised machine learning. 
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2.Methods 
The task of any extremity weakness (paresis) detection in medical texts originated from 
the project on muscle strength prediction by deep learning on medical images (supported 
by Russian Foundation for Basic Research (RFBR) grant 19-29-01154). The technical 
problem we tried to solve was a classification of patients as having paresis or not. The 
relevant data were obtained for a cohort of 429 patients with accessible magnetic 
resonance images (average age 39.8 ± 17.9 y.o., 194 (45.2%) males) who underwent glial 
tumor resection at N.N. Burdenko National Medical Research Center of Neurosurgery in 
a period between 2009 and 2018. In this sample, the narrative description of the 
preoperative neurological status in the Russian language was supplemented with the 
quantitative (0 to 5 scores) estimation of muscle strength for each extremity, which 
allowed us to create a ground truth binary variable (0 – no paresis, 1 - any paresis) [3]. 
That dataset was used in testing of our algorithm’s performance and comparing it to 
supervised machine learning. All the data extracted from electronic health records (EHR) 
were processed and analyzed within the R programming environment (version 3.5.0) in 
RStudio IDE for MacOS (version 1.1.453) using rsample, drlib, broom, yardstick, 
glmnet, doMC, dplyr, tidyr, stringr, tidytext, tidyverse, quanteda, qdapRegex, tm, scales, 
and cutpointr packages. 
2.1.Event detection in EHR 
Source text documents related to neurological examination upon admission were selected 
to build the initial corpus of 429 medical cases, which was preprocessed as follows: 
• words transformed to lower case; 
• all the characters and symbols except for letters and single spaces removed; 
• texts tokenized with a space separator; 
• stop-words and meaningless words (single letters, artifacts, etc.) removed; 
• spelling corrected and tokens lemmatized. 
The unique lemmas were screened by an expert to select those likely related to or 
certainly used in the paresis description. The selected lemmas shaped the “paresis 
lexicon” list. The context of each selected term was defined from n-grams containing 
it. Considering the importance of prepositions in the Russian language, we have seen 5- 
grams sufficiently interpretable. Those 5-grams were rated by 0.5 (if indicating any 
paresis with uncertainty), 1 (if indicating any paresis obviously), or 0 (if no paresis was 
mentioned) by the expert. We tested two modes of using the scores to decide whether 
muscle weakness is present in the source documents containing the rated 5-grams. The 
first option considered paresis in only those medical records in which at least one 5-gram 
received 1 point (IEA1, “utmost confident algorithm”). In the second mode, the presence 
of paresis was decided considering the sum of scores for all rated 5-grams found in each 
case history based on an optimal cutpoint (IEA2, “highly suspicious algorithm”). 
2.2.Logistic regression with LASSO regularization 
The subset of 429 clinical records containing a narrative and digital preoperative 
assessment of muscle strength was used to build a supervised logistic regression model 
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(LR1) on a “bag of words” text representations (sparse vectors). The target binary 
variable indicated the presence/absence of paresis. The model was evaluated with 5-fold 
validation (within training data consisted of 75% of the initial sample) and LASSO 
regularization, 300 times repeatedly using resampling. We rebuilt the LR1 model with 
the same technique adding more textual data referring to preoperative neurological 
status, however, written postoperatively (LR2). Finally, IEA1 was used in combination 
with LR2 to find whether it improves the prediction (IEA1+LR2). In the latter approach, 
all the cases of paresis confidently identified by IEA1 were automatically accepted, and 
LR2 predicted the rest. 
2.3.Performance evaluation 
The quality of the IEA, the logistic regression models, and their combination was 
evaluated using ROC-analysis. The sensitivity (SENS, also referred to as recall), 
specificity (SPEC), accuracy (ACC), positive predictive value (PPV, also referred to as 
precision), negative predicted value (NPV), F-measure (F), cutoff value (COV) and area 
under ROC-curve (AUC) were computed for all methods on test sets in each iteration of 
resampling. The bounds of 95% AUC confidence interval were calculated at each 
iteration using bootstrapping techniques. The cutoff point was chosen on the training sets 
to maximize the sum of sensitivity and specificity for every method. All the metrics were 
averaged across 300 iterations. 
3.Results 
3.1.Evaluation of the paresis detection algorithms 
We selected 122 terms to shape “paresis lexicon” out of unique 854 lemmas for 1199 
original tokens from 429 cases. These 122 concepts were represented in 491 5-grams 
screened by the expert. The paresis was suspected with uncertainty by 72 and more 
confidently by 92 n-grams. The IEA1 showed the best accuracy, positive predictive 
value, and specificity operating with an only binary (0 or 1) output (Table 1). The output 
of IEA2 ranged from 0 to 8.5. However, the cutoff point maximizing the sum of 
sensitivity and specificity treated all cases of 0.5 scores and above as paresis (Table 1). 
AUC for both cases was estimated above 0.8 on average, with IEA2 outperforming IEA1 
(Table 1, Figure 1, A). 
Table 1. The quality metrics of information extraction algorithms, logistic regression models and combined 
approach. 
Method COV* SENS SPEC ACC PPV NPV F ROC AUC [95% CI] 
IEA1 1 0.633 1 0.907 1 0.889 0.775 0.817 [0.771; 0.863] 
IEA2 0.5 0.789 0.897 0.869 0.723 0.926 0.754 0.875 [0.833; 0.914] 
LR1 0.267 0.668 0.906 0.846 0.723 0.892 0.673 0.860 [0.757; 0.945] 
LR2 0.272 0.762 0.925 0.877 0.815 0.904 0.777 0.911 [0.831; 0.972] 
LR2 + IEA1 0.268 0.860 0.919 0.902 0.821 0.942 0.837 0.943 [0.874; 0.991] 
* for all algorithms, ‘paresis’ cases were considered when output ≥ cutoff point. 
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3.2.Evaluation of logistic regression and combined approach 
The LR1 and LR2 algorithms showed better performance than semi-automated expert 
dependent IEA1 and IEA2, with LR2 superior to LR1 (Table 1, Figure 1, B and C 
respectively). Regularization led to the selection of words most significant for paresis 
detection. However, the combination of IEA1 and LR2 simultaneously resulted in the 
largest AUC in our tests (Table 1, Figure 1, D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. ROC curves superimposed after 300 times of resampling. A – model IEA2, B – model LR1, C – 
model LR2, D – model IEA1+LR2. The improvement of performance is observed from A to D. 
4.Discussion 
Natural language processing with machine learning machine learning has occasionally 
been applied in neurosurgical adverse events detection. J. Gaebel et al. (2015) suggested 
using semantic preprocessing for adverse events extraction in neurosurgery [4]. B. 
Campillo-Gimenez et al. (2013) identified surgical site infections with the NOMINDEX 
tool and text similarity in vector space [5]. N. Tvardik et al. (2018) detected healthcare- 
associated infections in clinical notes [6]. However, the idea of adverse events extraction 
from texts is challenged in other medical domains (e.g., infections or drug trials) and 
with other technologies (e.g., word embeddings, neural networks, etc.) [1], [7]. 
In our study, the IEA1 method appeared to be robust in the detection of paresis 
A B 
C D 
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with 100% specificity and positive predictive value (which still needs verification on a 
larger dataset). Despite the moderate sensitivity, this semi-expert method might be 
required in retrospective research when a sufficient number of ‘paresis’ cases should be 
obtained for clinical study, and no quantified muscle strength assessment is provided 
for supervised machine learning. However, collecting more data available for IEA1 and 
a combination of it with logistic regression provides a more flexible instrument to 
enroll true positive cases and true negative cases in the main and control study groups 
with stronger confidence at a large number. The other implication of these methods is 
in prospective adverse events monitoring. IEA1+LR2 favoring maximal sensitivity 
might be preferable. In general, we consider this methodology feasible for other 
adverse events detection. IEA1 and IEA2 may be especially efficient in detecting rare 
cases. 
The most important limitation of this work is a relatively small dataset. All 
methods described above will be further tested on a significantly larger data volume. It 
would also be valuable to estimate all the models on the dataset with no quantitative 
muscle strength assessment. The more resource-intensive expert verification will be 
required in future studies. 
5.Conclusion 
The method for paresis detection in unstructured medical records showed its efficiency, 
however testing on a larger dataset is required. The event detection algorithms based on 
the combination of expertise and machine learning outperformed each approach used 
independently.  
This project was supported by the RFBR grant 18-29-22085. The extraction of data for 
glial tumors was also supported by the RFBR grant 18-29-01052. 
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Abstract. The disease multiple sclerosis (MS) is characterized by various 
neurological symptoms. This paper deals with a novel tool to assess cognitive 
dysfunction. The Brief Visuospatial Memory Test-Revised (BVMT-R) is a 
recognized method to measure optical recognition deficits and their progression. 
Typically, the test is carried out on paper. We present a way to make this process 
more efficient, without losing quality by having the patients using a tablet App and 
having the drawings rated with the use of a machine learning (ML) algorithm. A 
dataset of 1’525 drawings were digitalized and then randomly split in a training 
dataset and in a test dataset. In addition to the training dataset the already trained 
drawings from a preliminary paper were added to the training dataset. The ratings 
done by two neuropsychologists matched for 81% of the test dataset. The ratings 
done automatically with the ML algorithm matched 72% with the ones of the first 
neuropsychologist and 79% of the ones of the second neuropsychologist. For a semi-
automated rating we defined a threshold value for the reliability of the rating of 
78.8%, under which the drawing is routed for manual rating. With this threshold 
value the ML algorithm matched 80.3% and 86.6% of the ratings of the first and 
second neuropsychologists. The neuropsychologists have in that case to manually 
check 17.4% of the drawings. With our results is it possible to execute the BVMT-
R Test in a digital way. We found out, that our ML algorithms have with the semi-
automated method the similar matching as the two professional raters. 
Keywords. BICAMS; BVMT-R; Convolutional neural network; Machine Learning, 
Multiple Sclerosis, digitalize 
1. Introduction 
The disease multiple sclerosis (MS) is characterized by various neurological symptoms, 
including motor weakness and spasticity, coordination problems, fatigue, sensory, 
bladder and cognitive dysfunction [1]. This paper deals with a novel tool to assess 
cognitive dysfunction. The Brief Visuospatial Memory Test-Revised (BVMT-R) [2], 
which is part of the Brief Internation Cognitive Assessment for MS Test Battery 
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(BICAMS) is a validated instrument to assess cognition in MS patients [3]. Currently, 
the BVMT-R is carried out on paper in the presence of a neuropsychologist. Briefly, the 
patient is presented a page with six geometric figures for ten seconds to memorize them. 
Then he tries to redraw them from memory considering the correctness and position of 
each figure. These drawings are then evaluated by a neuropsychologist. A figure, which 
is both correct in details and position on the paper receives a rating of 2 points. If the 
drawing is not correct but similar to the original or correct but in the wrong position, the 
rating is 1. If the drawing is wrong the rating is 0 points. This is a time-consuming 
procedure for both players. 
 In this paper, we present a way to make this process more efficient, without losing 
quality by having the patients using a tablet App to look at, memorize and draw the 
figures and having the drawings rated automatically or semi-automatically with the use 
of a machine learning (ML) algorithm. We have therefore defined the following research 
question: “Can the drawings of the BVMT-R be rated by a Convolutional Neural 
Network (CNN) with the same accuracy as a neuropsychologist?”. 
2. Method 
First of all, a mobile app was developed to digitalize the 294 (page of six drawing of 
geometric figures) paper-based patient data, which were provided by the COGITO 
GmbH in Düsseldorf and evaluated by their neuropsychologist (N1). Those patient data 
contain only the form A (see Table 1 below) of the BVMT-R. After eliminating 239 
empty drawings, from the total of 294 patient’s data at 6 drawings per page, a total of 
1’525 drawings remained and were included in this patient dataset. 
This dataset was then randomly split in 1’220 drawings (=80%) for the training 
dataset and 305 (=20%) for the test dataset. In addition to the training dataset the already 
trained drawings from the preliminary paper [4] were added, which resulted in a total 
training dataset of 1’790 drawings (see table 1). 
Table 1. Number of training data (m) and test data (n) per figure. 
Number Figure Data 
1------ 
 
m = 352, n = 57 
2------ 
 
m = 309, n = 52 
3------ 
 
m = 320, n = 54 
4------ 
 
m = 267, n = 47 
5------  m = 281, n = 48 
6------ 
 
m = 261, n = 47 
Total  m = 1’790, n = 305 
 
For the ML algorithm a CNN was chosen, because this algorithm has been developed for 
visual object classifications [5]. The CNN gives as an output a rating of the image with 
a probability value of the reliability of the rating [6]. 
Furthermore, the test dataset was revaluated by a second neuropsychologist (N2) 
from the University Hospital Zurich, to compare the evaluation between two 
neuropsychologists from different centers. The evaluation of the neuropsychologist from 
the University Hospital Zurich is also used as external validation unit. 
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Since the manual rating procedure of a single neuropsychologist is not representing 
a clear gold standard for the ML algorithm, its rating results cannot rely on the ratings of 
a single neuropsychologist. Therefore, in order to answer the research question, we use 
the result of the comparisons between the ML algorithm and the two individual 
neuropsychologists and consider these results with the comparison between both 
neuropsychologists among themselves.  
Various statistical methods were used to evaluate the ML algorithm: Sensitivity, 
specificity, the positive and negative prediction value [7], the significance test [8] and 
the Cohen’s kappa test to evaluate the interrater reliability of assessments between the 
neuropsychologists themselves and the ML algorithm [9]. 
In a second step, a semi-automated rating methodology was used, keeping the rating 
of the ML algorithm when the rating reliability was above a defined threshold value and 
otherwise redirecting the drawing to the neuropsychologist for manual rating. 
3. Results 
The two neuropsychologists (N1 and N2) rated the test data and they were compared 
with each other. Their rating was identical for 81% of the drawings. Cohen's Kappa (K) 
was 0.62. 
We can see that our neuropsychologists have an equal match with a Kappa of 0.62 
like the scientists of Brazilian study [10]. 
The agreement between N1 and ML is by 72% (K = 0.45) and between N2 and ML 
79% (K = 0.56). 
With the second method (semi-automated rating) in order to set the threshold value, 
a ROC curve was generated per label and comparison from the sensitivity and the 
specificity. 
 
Figure 1. ROC curve per label from the comparison between N1 and ML. 
 
Figure 2. ROC curve per label from the comparison between N2 and ML. 
 
The area below the ROC curve is a measure of the quality of the evaluation per label 
[11]. This means that if the ML algorithm cannot detect labels, the ROC curve forms a 
diagonal (50% area below the ROC curve). The better the ML algorithm, the larger the 
area below the ROC curve. The area below the ROC curve can also be seen as the 
probability that a label will actually be evaluated from the ML as the label from the 
neuropsychologist. 
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Table 2. Area below the ROC curve. 
 N1 <-> ML N2 <-> ML 
Label 0- 71.5% 75.6% 
Label 1- 72.0% 81.3% 
Label 2- 82.6% 89.7% 
Average 75.4% 82.2% 
Average total 78.8% 
 
This threshold value was used again to calculate the agreement in percent and in 
kappa. In addition, the number of drawings that must be checked manually for each 
threshold value was specified. This shows how the agreement changes and how many 
drawings have to be checked manually by a neuropsychologist. 
With the threshold, the N1 and ML has an agreement of 80.3% (Kappa = 0.62) and 
the agreement between N2 and ML was 86.6% (Kappa = 0.73). N1 and N2 have to 
manually check 53 drawings (of the 305). 
The significance test is intended to show how many ratings of the ML algorithm do 
not match with the ratings of N1 and N2 and are not submitted to them for a manually 
check (β = 20%, error type 2) and how many ratings matched, but are submitted to the 
N1 and N2 for a manually check (α = 5%, error type 1). Follow hypothesis was defined 
for the significance test: H0: the ML rated the drawing equal to the neuropsychologist. 
H1: the ML rated the drawing not equal to the neuropsychologist. 
Table 3. Significance test of N1 <-> ML (left) and N2 <-> ML (right). 
 H0 H1   H0 H1 
H0 63.0% 19.7%  H0 68.9% 13.4% 
H1 9.5% 7.9%  H1 9.8% 7.9% 
 
The error type 1 (cell H1 / H0) is on both significance tests over the 5% and not 
significant. The ML rated 9.5 / 9.8% of the drawings equal to N1 / N2, but with a 
reliability below the threshold. So those drawings have to be rated manually from a 
neuropsychologist. 
The error type 2 (cell H0 / H1) should be as low as possible, because these drawings 
are not submitted to the neuropsychologist for a manually rating, although they are 
wrongly assessed. But as we can see, the error type 2 is in both cases under 20%, so β is 
significant. 
Table 4. Overview comparison N1 with ML algorithm and N2 with ML algorithm with threshold of 0% and 
78.8%. 
 N1 <-> ML N2 <-> ML 
Threshold (%) 0 78.8 0 78.8 
Agreement (%) 72 80.3 79 86.6 
Agreement (Κ) 0.45 0.62 0.56 0.73 
4. Discussion 
With our results is it possible to execute the BVMT-R Test in a digital way. The rating 
of the drawings is given by a trained ML algorithm either in a full automated way, or in 
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a semi-automated way with the possibility to set a threshold value for the reliability of 
the rating under which the drawing is manually rated by a neuropsychologist. 
The biggest challenge to answer the research question was to determine the quality 
of the ratings received in the test data because there are no rated reference data sets (gold 
standard rating). With our solution, to measure the matches of the ratings of the test data 
performed by the COGITO GmbH with the ratings of the University Hospital Zurich, 
and find out it was 81%, we were then able to compare the results obtained in automated 
or semi-automated way with our ML algorithm with the results of either one of two 
neuropsychologists (N1 and N2), results with N1 showing the internal and N2 the 
external validation.. Consequently, to answer the research question positively the rating 
of the ML algorithm had to reach at least the same matching as the two professional 
raters.  
With this result it is conceivable to create further projects in this area of science. A 
more detailed consideration could be a completion of the entire digital BICAMS test set 
using ML.  
In summary, a semi-automated rating with the use of ML algorithms of patient-
drawn drawing is possible. The deviation of this solution (matching 80.3% and 86.6% 
with the two neuropsychologists) is in the same range as the deviation between those two 
independent professionals (matching of 81%).  
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Abstract. Social determinants of health (SDoH) are the complex set of 
circumstances in which individuals are born, or with which they live, that impact 
their health. Integrating SDoH into practice requires that information systems are 
able to identify SDoH-related concepts from charts and case notes through 
vocabularies or terminologies. Despite significant standardisation efforts across 
healthcare domains, SDoH coverage remains sparse in existing terminologies due 
to the broad spectrum of this domain, ranging from family relations, risk factors, to 
social programs and benefits, which are not consistently captured across 
administrative and clinical settings. This paper presents a framework to mine, 
evaluate and recommend new multidisciplinary concepts that relate to or impact the 
health and well-being of individuals using a word embedding model trained from a 
large dynamic corpus of unstructured data. Five key SDoH domains were selected 
and evaluated by domain experts. The concepts resulting from the trained model 
were matched against well-established meta-thesaurus UMLS and terminology 
SNOMED-CT and, overall, a significant proportion of concepts from a set of 10,000 
candidates were not found (31% and 28% respectively). The results confirm both 
the gaps in current terminologies and the feasibility and impact of the methods 
presented in this paper for the incremental discovery and validation of new SDoH 
concepts together with domain experts. This sustainable approach facilitates the 
development and refinement of new and existing terminologies and, in turn, it allows 
systems such as Natural Language Processing (NLP) annotators to leverage SDoH 
concepts across integrated care settings. 
Keywords. Social Determinants of Health, Terminologies, Vocabularies 
1. Introduction 
Throughout human societies, health and illness are not homogeneously distributed due 
to disparities in social and economic aspects. The aspects that underpin such disparities 
are commonly referred to as the Social Determinants of Health (SDoH) and examples 
include intangible factors such as “political, socioeconomic, and cultural constructs, as 
well as place-based conditions including accessible healthcare and education systems, 
safe environmental conditions, well-designed neighbourhoods, and availability of 
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healthful food” [1]. The significant impacts on health and costs associated with SDoH 
have been reported [2] and in order for social aspects to be best utilised for service 
evaluation or outcome assessment and improvement, this information should be 
routinely collected by organisations across the integrated care continuum. However, 
despite technological advances, SDoH information is neither routinely nor systematically 
collected in Electronic Health Records (EHRs) and lacks standardisation [3,4]. The US 
Institute of Medicine was among the first to identify SDoH domains and recommend 
they be routinely collected and made available in EHRs [3]. When available, SDoH 
information is often stored in natural language as part of unstructured case notes which 
further hinders efforts to identify cases and select cohorts. Terminologies and meta- 
thesaurus such as SNOMED-CT and UMLS can be used to encode health-related 
observations or activities into a canonical form. A recent exploratory analysis [5] has 
confirmed the limitations of current healthcare vocabularies in documenting SDoH- 
related information and has called for more comprehensive, coherent, and user-friendly 
SDoH code sets [6] to support and facilitate the rapidly evolving health care use cases[5]. 
Techniques for bridging clinical and social domains using word embeddings have been 
proposed to explore cross-domain spaces [7] and calls for action to create standards for 
representing SDoH data have been suggested [3]. Recent initiatives include Health 
Level Seven’s (HL7) Gravity Project [8] and LOINC’s models for the representation of 
screening assessments and measures of SDoH [9]. Healthcare terminologies have begun 
adopting concepts in social domains through consultation with expert groups but 
sustainable processes and methodologies to support these efforts are lacking. 
This paper proposes a computational approach to facilitate the process of seeking 
new terminology concepts as well as refreshing existing terminologies. The framework 
proposed in this paper leverages existing word embedding techniques [10, 11, 12] in 
order to mine new candidate terms from large corpora of unstructured data. Other 
approaches have focused on developing ontologies and taxonomies [11] yet the work 
presented in this paper aims to incorporate expert humans-in-the-loop in order to 
recommend new concepts not included in existing terminologies. This approach can also 
be used to refine existing terminologies with categories for specific domains. 
2. Methods and Experiments 
The proposed framework takes a list of seeded terms as input and returns a list of 
relevant concepts with domain categories assigned. This process relies on training a 
model to discover relationships between terms in relevant corpora and is supported by a 
human-in-the-loop evaluation step to ascertain the relevance of the discovered terms. 
Framework steps are summarised in Figure 1 and described in detail in the next sections. 
 
Figure 1. Proposed framework for recommending new terminology concepts. 
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Training a comprehensive SDoH model requires a list of relevant seeded term(s) for 
the first iteration of the process. Together with domain experts (DEs), 57 distinct seeded 
terms were selected for our experiments. The terms were extracted from relevant 
literature definitions of SDoH (WHO, Marmot & Wilkinson [13], CDC, Wikipedia). 
2.1. Data Sources and Preprocessing 
The first step consists of obtaining a corpus of unstructured data suitable for model 
training. A collection of case notes may be obtained from EHRs, case notes, books, or 
other sources of knowledge. Data sources should ensure coverage of the relevant domain 
areas in the seeded terms and this can be achieved in consultation with the DEs. 
In order to train the comprehensive SDoH model presented in this paper, we 
prepared a corpus of text by crawling the set of Wikipedia pages hierarchically linked 
through DBpedia’s taxonomy to the seeded terms. We curated the collected corpus by 
removing irrelevant pages, and obtained 2,134 distinct pages, with 3,282,508 non-unique 
terms. Finally, we pre-processed the collected corpus by removing metadata, images, and 
tables, and by applying lemmatisation and filtering of non-textual characters. 
2.2. Model Training and Model Evaluation 
This step focuses on the application of word embedding techniques on the prepared 
corpus of text. The purpose is to train a model able to capture contextual similarities 
between terms and term classes. The SDoH model was built using state-of-the-art 
embedding techniques to discover domain-specific n-grams from the corpus of text [10]. 
We trained a skip-gram model with negative sampling and subsampling of the frequent 
words in the training corpus. Experiments to tune the model hyperparameters were 
undertaken and found 100-dimension embeddings, computed with a context window of 
5, and n-grams of size 3, provided a rich domain representation for our task. Other 
techniques such as pre-trained word embedding models may be used in this step yet these 
typically only yield unigrams. The resulting trained model contained 77,232 terms. 
For evaluation, the DEs selected five terms each defining specific SDoH domains of 
interest: Housing, Criminal Justice, Financial Services, Health Behaviours and 
Homeless. For each of the five terms, a set of similar (candidate) terms was computed by 
selecting the closest 2000 neighbours in the model’s high-dimensional space using 
Euclidean distance. The ranked set of 2000 candidate terms was considered large enough 
to be evaluated by DEs in a timely manner. The set was later randomised for the DEs. 
2.3. Filtering and Expert Validation 
In the filtering step, candidate terms from each of the five domains of interest were 
programmatically checked against UMLS and SNOMED-CT terminology. Each term 
was labelled as matching when either a partial or exact match was found in the 
terminology (via its API), or no match. It is possible to use more complex matching 
algorithms and to filter out terms that already exist in terminologies (e.g. synonyms), 
however, for the purpose of developing and evaluating the framework proposed in this 
paper, no filters were applied, and partial and exact matching were combined. 
The Expert Validation step consists of gathering information from DEs about the 
candidate terms’ relevance in their specific domains. This was achieved by carrying out 
J.H. Bettencourt-Silva et al. / Discovering New Social Determinants of Health Concepts 175
90 minute workshop sessions with social workers where at least 3 different DEs of the 
same specialty evaluated the same set by responding accept, reject or pass for each term. 
2.4. Inter-Rater Evaluation and Recommendation of New Concepts 
In this step the results are analysed in order to determine consensus among DEs (inter- 
rater agreement based on simple majority was used due to small number of DEs, however, 
other methods are possible). Decisions are made for all candidate terms and a curated list 
of recommended new concepts is the output of the framework (Figure 1). This list may 
serve to refine the input list of seeded terms in order to further build or refine models. 
3. Results and Discussion 
The framework proposed in this paper enabled the training of a model based on SDoH 
seeded terms. The model was evaluated on five key SDoH domains through workshops 
with DEs (each domain seen by 3 distinct DEs with the exception of Housing). Figure 2 
summarises the DEs evaluation results for each domain and depicts a trend where lower 
ranked terms were accepted less often than those nearest to each of the five domain terms. 
 
Figure 2. Proportion of terms accepted by DEs. For each domain, terms were ranked using Euclidean  
distance in the SDoH embedding model high-dimensional space.  
Table 1 shows the results of matching each of the terms against SNOMED-CT and 
UMLS. Overall our findings show a large number of new terms that did not match either 
(on average 76% in SNOMED-CT and 83% in UMLS), with SNOMED-CT showing a 
better coverage throughout. Across all domains, on average, 40% of terms are accepted 
by DEs consensus of which 30% of them were not found in either (no match). Financial 
Services was the domain with most new relevant terms found across both SNOMED-CT 
(48%) and UMLS (50%) suggesting this area may be most lacking. Housing and 
Homeless are the two domains with the least number of new terms found and accepted 
by DEs (respectively 16% and 23% for SNOMED-CT, and 19% and 30% UMLS). Out 
of all 10,000 terms evaluated in this paper, the framework yielded 30% as concepts to be 
suggested for inclusion in terminologies and highlights terms from other terminologies 
of relevance to this domain. A limitation of the modelling approach is yielding less 
relevant n-gram combinations (e.g. ‘housing provides’ versus ‘housing programs’). 
However, the human-in-the-loop step helps filter out such cases. A subset of the concepts 
found could also be synonyms of existing terminology concepts and terms could appear 
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in both UMLS and SNOMED-CT. Since no partial or exact matches were found, 
however, it is still relevant to suggest bringing these terms in to terminologies. 
Table 1. Results of matching terms against SNOMED-CT and UMLS. 
SNOMED-CT UMLS 
 Match % (N) No Match % (N) Match % (N) No Match % (N) 
Domain Accepted Rejected Accepted Rejected Accepted Rejected Accepted Rejected 
Housing 8.50% (170) 25.75% (515) 16.15% (323) 49.60% (992) 6.05% (121) 17.80% (356) 18.60% (372) 57.55% 
(1151) 
Criminal Justice 9.95% (199) 5.75% (115) 24.30% (486) 60.00% 
(1200) 
7.55% (151) 3.75% (75) 26.70% (534) 62.00% 
(1240) 
Financial Services 9.40% (188) 3.40% (68) 47.80% (956) 39.40% (788) 7.65% (153) 4.20% (84) 49.55% (991) 38.60% (772) 
Health 
Behaviours 
10.85% (217) 11.15% (223) 27.70% (554) 50.30% 
(1006) 
6.80% (136) 7.50% (150) 31.75% (635) 53.95% 
(1079) 
Homeless 19.30% (386) 17.25% (345) 23.05% (461) 40.40% (808) 12.75% (255) 10.90% (218) 29.60% (592) 46.75% (935) 
Total (Average) 
11.60% 12.66% 27.80% 47.94% 8.16% 8.83% 31.24% 51.77% 
24.26% 75.74 % 16.99 % 83.01% 
4. Conclusions 
The lack of standardisation, terminologies and code sets in complex multidisciplinary 
domains remains a barrier to the successful documentation and use of SDoH in practice. 
This work assessed the coverage of existing terminologies in selected SDoH domains 
using expert humans-in-the-loop and proposed a framework for the discovery of SDoH 
concepts from unstructured data. Further work is needed to refine model training, to 
include additional categories for DEs to assign to terms and allowing new term/code sets 
to be defined in the process, and to inspect SDoH in other terminologies (e.g. ICD-11). 
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Abstract
This paper presents an original machine learning method for extracting diagnos-
tic medical information from heart sound recordings. The method is proposed to
be integrated with an intelligent phonocardiography in order to enhance diagnostic
value of this technology. The method is tailored to diagnose children with heart
septal defects, the pathological condition which can bring irreversible and some-
times fatal consequences to the children. The study includes 115 children referrals
to an university hospital, consisting of 6 groups of the individuals: atrial septal de-
fects (10), healthy children with innocent murmur (25), healthy children without
any murmur (25), mitral regurgitation (15), tricuspid regurgitation (15), and ven-
tricular septal defect (25). The method is trained to detect the atrial or ventricular
septal defects versus the rest of the groups. Accuracy/sensitivity and the structural
risk of the method is estimated to be 91.6%/88.4% and 9.89%, using the repeated
random sub sampling and the A-Test method, respectively.
Keywords. Time growing neural network, Intelligent phonocardiography, A-Test
method, septal heart defects, heart sound signal
1. Introduction
Since the last few decades when extracting medical information from heart sound has be-
come a topic of study, several machine learning methods have been proposed for learning
details of the heart sound signals for the classification purposes [1][2][3]. Although deep
learning methods initiated a considerable change in the processing methods sophisticated
for medical signals including heart sound signal [4][5], several research questions should
be answered in terms of both the theoretical and the applicative contents. PhonoCardio-
Gram (PCG) is a device for recording of mechanical activity of heart, as reflected by the
heart sound. The term Intelligent PhonoCardioGraphy that has recently appeared in this
contexts, implies on a computerised PCG supported by the intelligent machine learning
1Corresponding Author: Arash Gharehbaghi, Department of Innovation, Design and Technology,
Ma¨lardalen University, Va¨stera˙s, Sweden; E-mail: arash.ghareh.baghi@mdh.se.
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methods?to?extract?medical?information?from?the?signal?[6][7][8].?Time?Growing?Neural?
Network?(TGNN)?has?been?introduced?as?a?powerful?learning?method?either?for?classi-
fying?cyclic? time?series? [4],?or? for?extracting?medical? information? from? the?non-cyclic?
stochastic?time?series?[5],?in?parallel?to?the?hybrid?methods?[9][10][11].?Effectiveness?of?
TGNN?has?been?investigated?for?symptom?detection?of?PCG?signals,?and?also?for?screen-
ing?a?certain?heart?abnormality?among?other?possible?pathologies?[11][12][5].?An?impor-
tant?applicative?aspect?of? IPCG? is? its?potential? in?patient?prioritisation? in? terms?of? the?
disease?severity.?For?example,?a?valvular?regurgitation?in?children?is?managed?differently?
from?septal?leakage,?as?the?former?might?not?effect?growth?of?the?children,?whereas?the?
later?which?can?effect?growth?of?the?patient.
This?paper?presents?a?method?for?diagnosing?a?group?of?paediatric?patients?with?sep-
tal?defect?from?the?other?group?of?valvular?leakage,?the?two?pathological?conditions?man-
ifested?by?systolic?murmur.?Similarity?of?the?disease?manifestations?in?auscultation?make?
the?diagnosis?a?complicated? task,?which?neccessiates?expensive? investigations?even?for?
those?with?mild?defects.?It?is?important?to?note?that?timely?detection?of?septal?defects?can?
prevent? further?complications? including?pulmonary?artery?defect,?ventricular?hypertro-
phy?and?dilatation,?pulmonary?hypertension,?and?heart?failure,?each?can?put?negative?im-
pact?on?the?growth?of?the?children?suffering?from,?which?is?sometimes?irreversible.?The?
presented?method?employs?TGNN?for?extracting?medical?information?from?a?heart?sound?
recording?regarding?the?heart?septal?defects,?showing?an?important?application?of?medical?
informatics.?The?resulting? technology?can?be?easily? incorporated? into?an?IPCG? to?help?
practitioners?or?nurses?at?primary?healthcare?centres?to?detect?and?prioritise?the?patients?
for?further?investigation.?The?resulting?IPCG?can?provide?valuable?medical?information?
even?for?a?paediatric?cardiologist? to?be?oriented? in? the?echocardiographic? investigation?
[13].
2.?Material?and?Methods
2.1.? Data?Collection
Heart?sound?signals?of?10?second?duration?were?recorded?from?the?children?referrals?to?
Tehran?University?of?Medical?Sciences,?using?a?WelchAllyn?Meditron?Analyzer?in?con-
junction?with?a?portable?computer?with?44100?Hz?of?sampling?frequency?and?16?bit?res-
olution.?All?the?referrals?or?their?legal?guardians?gave?the?informed?consent?for?participa-
tion?in?the?study,?which?was?conducted?according?the?Good?Clinical?Practice,?and?com-
plied?with?the?World?Medical?Association?and?Helsinki?Declaration.?The?referrals?were?
investigated?by?a?paediatrician?as?well?as?paediatric?cardiologist?who?used?echocardiogra-
phy?as?the?gold?standard?along?with?complementary?tests?like?chest?X-Ray,?in?accordance?
to?the?guideline?of?Tehran?University?of?Medical?Sciences.?Six?groups?of?paediatric?indi-
viduals?were?included?in?the?study:?healthy?children?with?no?audible?murmur?(NM),?and?
with?audible?innocent?murmur?(IM),?as?well?as?abnormal?children?with?Ventricular?Sep-
tal?Defect?(VSD),?Atrial?Septal?Defect?(ASD),?Mitral?Regurgitation?(MR)?and?Tricuspid?
Regurgitation?(TR).?The?patient?population?is?listed?in?Table?1.
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Table 1. Study population.
Heart condition Number of Age Range Average age ± SD
Patients (years) (years)
ASD 10 5 − 15 9.3 ± 3.2
IM 25 2−14 6.7 ± 3.7
NM 25 4 − 15 8.6 ± 3.4
MR 15 4 − 18 11.8 ± 4.1
TR 15 6 − 18 12.6 ± 4.4
VSD 25 1 − 9 3.9 − 2.4
Figure 1. The flowchart of the learning method.
2.2. The processing algorithm
The signals are first down-sampled to 2 KHz using the antialiasing low-pass filter and
then normalised. The processing method is based on our deep learning method, in which
spectral contents of heart sound signal is calculated using three fashions of growing win-
dows. In this technique, the systolic part of PCG signals are characterised by its spectral
contents calculated over three different schemes of temporal windows: the forward, the
backward and the mid-growing windows. Details of the growing method can be found in
[4]. The number of the growing windows for each scheme is selected to be 3 based on the
medical considerations. Figure 1 illustrates the growing time schemes. We used Fisher
criteria for finding the most discriminative frequency bands for spectral calculation. This
is performed at the deep learning layer in which the most discriminative frequency band
is found for each temporal window, and the spectral energies are used by a three layer
perceptron neural network with a hidden/output layer of 10/1 neurone for the ultimate
learning process. The neural network is trained using back propagation error method in
which the output layer performs the binary classification of septal defect against the rest
of the classes .
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Figure 2. Results of the A-Test method for different index of k-value.
2.3. The validation method
The method is validated by using repeated random sub-sampling method as well as the
A-Test for the structural risk evaluation. In the repeated random sub-sampling, 30% of
data is randomly selected for testing and the rest for training the method, and the two per-
formance measures, accuracy and sensitivity, are calculated, where the former is defined
the percentage of the correctly classified samples whereas the later which is defined as
the percentage of the correctly classified samples from the patient group (those patients
with septal defect). This procedure is repeated several times and the statistical descrip-
tive of the performance measures are found. The A-Test method is based on using K-fold
validation method with different values of K, spanning from 2 to half of the minimum
group size [4].
3. Results
The repeated random sub-sampling with 100 iterations was applied to validate perfor-
mance of the method. Average of the accuracy and the sensitivity is estimated to be 88.4
and 91.6 with and standard deviation of±3.9 and±5.7, respectively. In order to evaluate
structural risk of the method, the A-Test method is employed. The average classification
error is estimated to be 9.89% using the A-Test method. Figure 2 shows results of the
A-Test method, exhibiting a decreasing trend for the classification error, which implies
on a good capacity of enhancement with larger training data. As can be seen, the method
performance is by far better than a paediatric cardiologist who relies on the conventional
auscultation, as the studies show the average screening accuracy is less than 80% [3].
4. Discussion
This study suggested a method for distinguishing two important cardiac abnormalities,
the septal defects and valvular regurgitation. Ventricular septal defects must be diagnosed
at the early ages, and the diagnosed patients should undergo appropriate disease man-
agements, in contrast with the valvular regurgitation which are found at the later ages of
the childhood. An important aspect of this study is the use of sophisticated time grow-
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ing?neural?network? for?characterising?heart? sound? signal,?and?hence?extracting? impor-
tant?medical? information?from? the?signals.?This? innovative?method?allows? the?IPCG? to?
provide?a?more?comprehensive?information?to?practitioners?or?family?doctors?at?primary?
healthcare?centres,?resulting?in?a?more?efficient?patient?prioritisation.?This?avails?access?
to?paediatric?cardiologists?to?those?of?rather?urgent?need?sooner?than?those?of?need?to?a?
regular?supervision,?and?also?improves?automatic?extraction?of?medical?information?from?
IPCG.
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Abstract. In general, small-mid size research laboratories struggle with managing 
clinical and secondary datasets. In addition, faster dissemination, correlation and 
prediction of information from available datasets is always a bottleneck. To address 
these challenges, we have developed a novel approach, Document Oriented 
Graphical Analysis and Prediction (DO-GAP), a hybrid tool, merging strengths of 
Not only SQL (NoSQL) document oriented and graph databases. DO-GAP provides 
flexible and simple data integration mechanism using document database, data 
visualization and knowledge discovery with graph database. We demonstrate how 
the proposed tool (DO-GAP) can integrate data from heterogeneous sources such as 
Genomic lab findings, clinical data from Electronic Health Record (EHR) systems 
and provide simple querying mechanism. Application of DO-GAP can be extended 
to other diverse clinical studies such as supporting or identifying weakness of 
clinical diagnosis in comparison to molecular genetic analysis.
Keywords. Data integration, clinical trials, data quality, data processing
1. Introduction
Traditionally, to develop a relational database or data repository, first, the data 
requirement is analyzed and then data structure is designed based on the requirements
[1]. The data structure remains rigid and can only hold the data elements that it was 
designed for [2]. Then, data integration is performed by feeding-in data from various 
sources into a data warehouse and processing it after wards. Fixed source to target Extract 
Transformation and Load (ETL) processes are used to load data into a data repository 
[3]. Drawback of using relational databases is that it is difficult to keep up with changing 
data requirements and it takes months to modify source to target mapping and implement 
ETLs. Not only SQL (NoSQL) databases were developed to overcome fixed data 
structure limitation of relational data models [4].
1 Corresponding Author, Shorabuddin Syed, University of Arkansas for Medical Sciences, Little Rock, 
AR, USA; E-mail: ssyed@uams.edu.
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200147
183
The schema-less design of NoSQL allows flexibility and scalability to add 
information to any field without a need to define the structure in advance compared to 
SQL databases [5-7]. One of the common NoSQL database is document-oriented
database that uses documents as the structure for data storage and queries, document is 
a block of XML or JSON [7, 8]. Each document can have the same or different structure.
MongoDB is one of the document-oriented database system, it is highly flexible, 
partition tolerant and consistent [4, 9].
Graph database models their schema as graphs, using nodes and edges. Each node 
represents an entity (patient, physician etc.) and they are connected by edges, 
representing relationship between the nodes[10]. Graph database is queried by traversing 
through the connected links. The graph database are expressive and can be easily 
conceptualized making them an ideal choice to adopt for data analysis[10]. Moreover, 
“graph databases excel in traversal-type queries ”[11], they facilitate deep knowledge 
discoveries using simple-to-mid complex queries. Neo4j (www.neo4j.com) is a graph 
database designed to manage information with graph-like nature.
DO-GAP attempts to take advantages of both the models (Document and Graph DB) 
and solves challenges (i) flexible schema that enables faster and more iterative
development, and scalable databases (ii) clean and readily available data for graph 
database. DO-GAP uses MongoDB as document-based data repository and Neo4j graph 
database for simple analysis and easy visualization.
2. Methods
To address our hypothesis, a pipeline was built for processing of the incoming data, store 
it in primary data repository, cleansing and transferring study specific data to graph 
database for analysis and knowledge discovery as shown in Figure 1.
Figure 1. DO-GAP Architecture.
+*,* 
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The flow starts by collecting and assembling data from multiple sources, extract patient’s 
longitudinal data from the source files and create a JSON document for each patient. The 
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JSON files created will be merged into primary data repository, MongoDB. On-demand, 
study-specific data from MongoDB is cleansed and transferred to graph database, Neo4j.
Laboratories may receive clinical and biological data from multiple sources in 
different format, frequency and file types. Metadata, a mapping document, for each 
source file is created to standardize the source data elements. JSON conversion tool 
creates a JSON document based on source and metadata files. The conversion is 
independent of source file format, thereby minimizing data pre-processing time. Figure
2, shows an example of patient demographic Comma Separated Values (CSV) file and 
its equivalent JSON file created using the JSON conversion tool. A master metadata file 
is maintained during the process.
Figure 2. A sample demographic file and its equivalent standardized JSON file.
The JSON documents created are loaded into NoSQL document database i.e. 
MongoDB, using its native data import tool. To inform researchers on the available data 
fields in DO-GAP, a list of all field names (i.e. Keys) present in the MongoDB and their 
description is available. This list is updated when new data elements are imported into 
the database. Researchers can select from the available fields for data extraction and 
analysis.
Based on user selection, Hybrid adapter cleanses the selected data elements. The 
cleansing process includes applying standard rules such as removing potential duplicates 
and null values etc. This cleaned data set will be fed to Connector, it unwinds JSON 
documents and stores it as deconstructed array document using $unwind, $project, $out
MongoDB operators[4]. The deconstructed array document is then written to CSV file 
using mongoexport utility. Connector uses the generated CSV files to create nodes in 
Graph database i.e. Neo4j, and builds relationship between the nodes. By this approach 
only required data elements for a study is selected on-demand, cleansed and made 
available as a new study in graph database. Thereby overcoming Graph database’s data 
quality and volume limitations[12]. In Graph database component, the data extracted 
from MongoDB is loaded into Neo4j and is analyzed using native tools such as Neo4j 
browser and Bloom [13].
3. Application
About 2,300 patients with any type of lung cancer disease[14] were chosen for the study. 
Selected patient’s clinical facts, genomic profiles, comorbidities, social and family 
history were loaded into DO-GAP for knowledge discovery, resulting in 2,760 nodes and 
9,683 relationships. We ran a Cypher query to find the common gene alterations in our 
sample. As shown in Figure 3, most patients have gene TP53 and LRP1B, TP53 and 
SPTA1 alterations. Cypher queries are simple to learn as non-technical users can query 
the database by conceptualizing the graphs, which is difficult with relational databases.
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Figure 3. Partial graph showing links between Patient and their Gene alteration.
The output of graph analysis heavily depends upon connectivity between nodes [15],
in DO-GAP we can click on any two gene nodes and can ask for common patterns 
(clinical facts) between them. Graph traverse through all links and displays every node 
(clinical facts) that is connected to these two gene nodes, hence the data or knowledge 
discovery.
Graph database can be queried using native visualization tools of Neo4j. In our case, 
we have used Bloom [16] to demonstrate the ease of querying. As shown in Figure 4, a 
simple English-like querying language syntax is used to find all patients with any gene 
alterations and are smokers. In addition, it displays the profile of query results, for 
example in Figure 4; we have 43 patients that are smokers with at most 10 gene 
alterations. Graph database query can be expanded to include other clinical facts along 
with gene information.
Figure 4. Very simple query to find patients who are smokers and has gene alteration.
4. Discussion and Conclusion
DO-GAP offers hybrid and flexible data integration, expansion, productive data analysis 
and prediction with minimal coding. Advantage of using DO-GAP is twofold (1) flexible 
schema that enable faster and more iterative development, and scalable NoSQL 
databases. (2) As strength of graph data analysis heavily depends on quality of data, we 
have achieved it by using hybrid adapter that automatically cleanse user selected data 
and import to graph database. Graph databases reduces query complexity compared to 
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both relational and MongoDB databases. Use of graph database reduces data analysis 
and data inference time; we have demonstrated this by two basic use cases (i) common 
gene alteration, and (ii) simplicity of querying heterogeneous data. As this was a pilot 
study, we selected the use cases that profile the data, which is the first step in research 
data analysis. 
There are several limitations in this study that we wish to acknowledge. First, to 
resolve identity of individuals, i.e. entity resolution, which is a complex process in itself
and is beyond the scope of this paper. Currently, DO-GAP process these records as 
separate subjects, in future, an entity resolution systems such as OYSTER [17], can be 
employed to resolve this limitation. Second, the cleansing component of hybrid adapter 
only checks for null values and duplicate clinical facts, but can be expanded to 
incorporate in-depth data quality checks. Finally, results of selected use cases can be 
easily reproduced using relational databases by technical users. However, DO-GAP was 
designed to be a data management and analysis tool for non-programmers such as lab 
technicians, for whom conceptualizing relational database schema and building 
appropriate queries is challenging task. This pilot project, paves way for future work that 
will seek to address in-depth graph queries for better findings and correlations. We 
envision to address aforementioned limitations in our future work that will empower 
users to explore critical insights which is currently not available.
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Electronic Whiteboard in the Inpatient 
Care Management: Nurses' Perceptions        
About the Use  
Liliana GIRALDOa,1 Bibiana SCHACHNERa, Daniel LUNAa, Sonia BENITEZa 
aDepartment of Health Informatics, Hospital Italiano de Buenos Aires 
Abstract. In the hospital setting, the traditional method of information for nurses 
is to consult the Electronic Health Records (EHR) on several occasions to check 
the continuous updates of the prescriptions. This process, in practice, involves time 
and multiple setbacks such as: availability of equipment (there is no computer per 
nurse in the office), number of patients assigned (it involves entering each EHR 
one by one). This is how the implementation of the tool known as electronic 
whiteboard (e-whiteboard) came about. The aim of this study was to explore 
perceptions of nurses after implementation of e-whiteboard, recently introduced at 
Hospital Italiano de Buenos Aires. A Qualitative study, which consisted of 5 group 
interviews with a total of 27 participants.  A convenience sampling was used 
(selection of nurses from different shifts), corresponding to 4 sectors of adult 
patient admissions and 1 sector of pediatric patients. The main findings were 
positive aspects such as: it was a simple, intuitive and easy to navigate interface, it 
allowed communication with other health professionals (physicians, nutritionists 
and kinesiologists), and it facilitated the visualization of real time information that 
favors the fulfillment of tasks in scheduled time. This tool is considered of great 
clinical importance for coordinated patient care because the visibility and 
availability of clinical information improves communication between professionals, 
streamlines workflow, and consequently accelerates shared decision making. 
Keywords. Perceptions, nursing, electronic whiteboard, inpatient 
1. Introduction 
Advances in health have led organizations to incorporate technologies for patient care 
planning [1]. In the hospital setting, during the hospital stay, nursing work regarding 
patient care planning requires continuous updates. The traditional method, which 
consists of accessing the Electronic Health Records (EHR) involves multiple setbacks 
[2] such as: availability of equipment (there is not one computer per nurse in the office), 
or the number of patients assigned (it implies gaining access to every EHR one by one). 
Unlike EHR, electronic whiteboards (e-whiteboards) are being used as a tool to 
monitor [3,4] and improve the quality and safety of care [4]. 
Previous research has shown that e-whiteboards have certain advantages over 
traditional dry erase white-boards [5,6] (which have been and continue to be used in 
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our local environment). These advantages include automated updating of patient 
information, the ability to visualize information in real time, and integration with other 
clinical information systems, and reduction of the workload of nurses [2,7]. While the 
use of tablets and mobile solutions in hospitals is currently being discussed, in our 
environment we are using more precarious tools and are just introducing e-whiteboards 
[4]. The aim of this study was to explore perceptions of nurses after implementation of 
e-whiteboard, recently introduced. 
2. Methods 
The Hospital Italiano de Buenos Aires (HIBA) is an institution with more than 1200 
nurses and 750 beds in Buenos Aires, Argentina. The e-whiteboards, large electronic 
screens located on the nurse’s station wall and out of sight of patients and visitors, were 
implemented in October 2017. This implementation were restricted to the adult and 
pediatric inpatient wards. 
The e-whiteboard was developed with a user-centred design methodology, with a 
system that makes "retrieval information" in real time, addressed to nursing care staff. 
Categorization of information are displayed in around 84 icons in a horizontal 
distribution. The categories are: hospitalization data (patient's patronymic data, bed 
number, gender, age), alerts (for example: new prescriptions and/or changes in 
medication, isolation status, allergies), risks (pain scale assessment, pressure ulcers) 
and tasks (laboratory requests, patient transfers). The system interacts with the data 
from the admission, discharge and transfer (ADT) system, operating room agenda, 
EHRs, medical prescriptions and Computerised Physician Order Entry (CPOE) for 
complementary tests, nursing e-chart.  (See Figure 1). 
 
 
Figure 1: e-whiteboard screen 
 
2.1 Design 
A qualitative study to explore perceptions of nurses after implementation of e-
whiteboard [8] was performed using group interviews. The data obtained, were 
homogeneous in terms of the institutional hierarchical position, there were not an 
inhibition of free expression by power relations and / or hierarchy, and it was achieved 
a greatest diversity of possible opinions. 
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A convenience sampling was carried out that included the selection of nurses from 
different shifts (morning, afternoon, evening and Saturday, Sunday or holiday). These 
Nursing staff belonged to four adult wards and one pediatric ward.  From March to 
April 2018, 5 group interviews were conducted, with a duration of 90 minutes each one 
following an open-ended questionnaire. Grounded theory was used to analyze the 
transcribed data and build convergent themes. The relevance and importance of themes 
was constructed by examining frequency, convergence, and intensity. The presentation 
of results is oriented by these categories.  
3. Results 
A total of 27 nurses, with no age limit, from both genders, and from the general 
hospitalization area, participated in different shifts. Those nurses who carried out 
administrative management tasks (not patient care) were excluded.  Six dimensions 
emerged from this study: use, communication, workflow, data quality, training and 
technical support.  Each dimension is detailed with its respective findings (See Table 1).  
 
Table 1.  Dimensions and findings 
 
Dimension Description Example 
 
Dimension one: 
Use 
 
Two components were identified: interface design and 
information availability. Nurses’ perceptions were 
positive in relation to a simple and intuitive interface, 
simple navigation based on user-centered design 
guidelines, and the interaction with other systems of the 
institution. Likewise, it was highlighted that the 
iconography used facilitates its interpretation and use. 
In this sense, the most used icons were: assessment of 
pain scale, fall risk, isolation status, early warning, diet 
and the status of pharmacological prescriptions (new, 
modified, and suspended). 
 
“I use the e-whiteboard to 
visualize the pending tasks 
and for patient care 
planning” 
 
"It's very complete, 
because it shows 
everything you need to 
plan  patient's care" 
 
Dimension two:  
Communication 
 
Four structural elements of communication were 
determined using group interviews: the e-whiteboard 
properties, its physical location, permanent 
visualization, and the health personnel that must 
interact with the e-whiteboard (nurses, nutritionists, 
kinesiologists, stretchers, physicians, among others). 
Although they expressed positive perceptions related to 
the communication established with other health 
professionals (physicians, nutritionists and 
kinesiologists), it was not useful for the communication 
between them (nursing staff) to perform the shift pass. 
 
"It is very useful for 
communication with 
nutritionists and 
kinesiologists who come  
to evaluate  patients" 
 
"Allows easy 
identification of the nurse 
in charge of the patient" 
 
Dimension 
Three:  
Workflow 
 
A perception of a workflow improved was identified, 
related to: decrease of constant EHR access, 
visualization of relevant information and pending tasks 
in real time, and facilitates fulfilling tasks in scheduled 
time (without delays, improving timely patient care). 
 
"When there are changes 
in medical indications, 
they are immediately 
visualized, this helps to 
better plan our routine" 
 
 
Dimension 
Four: Data 
The interviewees expressed positive aspects related to: 
the accuracy, reliability and quality of the information 
"It is reliable and secure 
data that are displayed on 
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quality displayed. They emphasized the capability to carry out 
patient care planning (due to the accessible and timely 
information), without generating complex processes to 
understand and assimilate the meaning of the data 
through iconography and colors. 
the e-whiteboard" 
 
 
Dimension 
Five: Training 
 
The nurses mentioned as a positive aspect, the 
brochures provided with the information of the e-
whiteboard. However, they consider negative the lack 
of training or follow-up during the implementation. 
 
"The information 
displayed is easily 
understood, but I would 
have liked accompaniment 
in my hospital sector" 
 
Dimension Six: 
Support 
They mentioned as a negative aspect the lack of a help 
desk support that would allow the resolution of 
problems related to the e-whiteboard, and difficulties 
when the board failed. 
 
"When a e-whiteboard 
failed, we didn't know 
what to do" 
4. Discussion 
This research proposed to explore the perceptions of nurses in relation to the 
implementation of the e-whiteboard. The main findings were positive aspects such as: 
the e-whiteboard was a simple, intuitive and easy to navigate, allowed communication 
with other health professionals (physicians, nutritionists and kinesiologists), and 
facilitated the real time visualization of information that favors the fulfillment of tasks 
in a scheduled time. The most used icons were: pain scale assessment, fall risk, 
isolation, early warning, diet and the status of pharmacological prescriptions. 
This system is considered important for a coordinated patient care because the 
visibility and availability of clinical information improves communication between 
professionals, streamlines workflow [8], and consequently speeds up shared decision-
making. Consistent with other studies [3,9], the e-whiteboard represents a technology 
that improves communication and coordinated patient care. On the other hand, the 
interviewees expressed certain negative aspects such as: it was not useful for 
communication between nursing staff to carry out the shift pass, the lack of training or 
coaching in its use, or the lack of a convenient support. In view of these findings, 
training and information dissemination should be planned in order to proceed in case of 
failure or to mitigate the risk.  
The e-whiteboard could not be incorporated in the nursing pass workflow due to its 
physical location in the nursing office. The system could be viewed from the corridors 
by family members. Because information that must be hidden to maintain patient 
confidentiality (for example: sex, gender and other important clinical history), and after 
a consultation with the legal department, it was decided to use the bed numbers instead 
of the patient's name or initials. 
Despite this is a unicentric study, the user-centered design methodology used 
facilitated the resolution of some specific needs of the end user, providing satisfaction 
and a good experience [10].  Post-implementation, the acceptance of the system by the 
staff is decisive [11], which has a direct impact on its use. 
We believe that our findings can provide an approach to the understanding the 
complex factors related to the implementation of health technology, looking at staffs 
needs and concerns that are still present post-implementation [12], and which will be 
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worked on in future studies. This information is useful and can be expanded through a 
multi-hospital study. 
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Abstract. Biomedical research has become data-driven. To create the required big
datasets, health data needs to be shared or reused out of the context of its initial pur-
pose. This leads to significant privacy challenges. Data anonymization is an impor-
tant protection method where data is transformed such that privacy guarantees can
be provided according to formal models. For applications in practice, anonymiza-
tion methods need to be integrated into scalable and robust tools. In this work, we
focus on the problem of scalability.
Protecting biomedical data from inference attacks is challenging, in particular for
numeric data. An important privacy model in this context is t-closeness, which has
also been defined for attribute values which are totally ordered. However, directly
implementing a scalable algorithmic representation of the mathematical definition
of the model proves difficult. In this paper we therefore present a series of opti-
mizations that can be used to achieve efficiency in production use. An experimen-
tal evaluation shows that our approach reduces execution times of anonymization
processes involving t-closeness by up to a factor of two.
Keywords. data protection, anonymization, inference attacks, scalability
1. Introduction
Biomedical research, e.g. in the field of precision medicine which tailors healthcare to
characteristics of individuals, is increasingly data-driven and leveraging methods from
data science such as machine learning [1]. However, when creating the required big
datasets, stringent privacy protection is mandated by laws and regulations. Hence, a wide
range of safeguards has to be applied, including organizational and technical measures.
Data anonymization is an important building block for implementing technical pri-
vacy protection. The basic idea is to transform data in such a manner that formal guar-
antees, e.g. regarding the risk of singling out, linkage or inference, can be provided [2].
These formal guarantees are captured by so called privacy models. t-Closeness is a state-
of-the-art model for protecting data from inference attacks. The model requires that the
distribution of sensitive attribute values in a set of indistinguishable data records is not
too different from the distribution of sensitive information in the overall dataset [3].
1Corresponding Author: Raffael Bild, Institute of Medical Informatics, Statistics and Epidemiology,
University Hospital rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675 Munich,
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2.? Objective
The?ARX?Data?Anonymization?Tool? is?among? the?few?software?solutions?for?quantita-
tive?data?anonymization,? that?have? found?wide-spread?adoption.?ARX? focuses?on?data?
transformation?methods?which?have?been?specifically?recommended?for?applications?to?
health?data?and?it?implements?models?for?protecting?data?from?singling?out,?linkage?and?
inference?[4].?t-Closeness?is?amongst?the?models?supported.
t-Closeness?has?been?specified?in?different?variants?that?apply?to?variables?with?dif-
ferent? scales?of?measure.?One?of? these?variants? focuses?on?variables?which?are? totally?
ordered.?This?model? is?particularly? relevant? in?practice,?as? it? is?one?of? the? few?privacy?
models?which?have?been?proposed?for?protecting?sensitive?numeric?variables.
When?using?ARX?to?protect?complex?datasets?using?the?t-closeness?model,?however,?
we?realized?that?the?initial?implementation?is?not?scalable.?Upon?further?inspection,?we?
realized? that?directly? implementing?a?scalable?algorithmic?representation?of? the?mathe-
matical?definition?of?the?model?t-closeness?proves?difficult?in?general.?In?this?paper?we?
therefore?present?a?series?of?optimizations?that?we?have?developed?to?achieve?efficiency?
in?productive?use.?All?of?them?have?been?integrated?into?ARX.
3.?Methods
3.1.? Problem?Definition
t-Closeness?is?a?condition?that?applies?to?equivalence?classes,?i.e.?groups?of?records?which?
are? indistinguishable? regarding? attributes? that? could? be? used? for? linking? records.? Let?
P(e)?=?(p1,?p2, ...,?pm)?be?the?relative?frequency?distribution?of?sensitive?values?in?a?given?
equivalence?class?e?and?let?Q?=?(q1,q2, ...,qm)?be?the?relative?frequency?distribution?of?
sensitive?values?in?the?whole?dataset.?D[P(e),Q]?is?the?distance?between?the?distributions?
P(e)?and?Q?[3].?It?is?defined?as?follows?[3]:
D[P(e),Q] =
1
m−1
m
∑
i=1
∣
∣
∣
∣
∣
i
∑
j=1
(p j −q j)
∣
∣
∣
∣
∣
.
A dataset fulfills t-closeness with numerical ground distance if for all equivalence
classes e, D[P(e),Q]≤ t holds.
Age Sex LoS AdmQrtr Charge 
[25, 50[ Male [1, 5[ 3 50.000 
[25, 50[ Male [1, 5[ 3 60.000 
[50, 75[ Female [5, 10[ 1 60.000 
[50, 75[ Female [5, 10[ 1 60.000 
[50, 75[ Female [5, 10[ 1 70.000 
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Figure 1. Example discharge dataset. ”LoS” = Length of stay, ”AdmQrtr” = Admission quarter.
Figure 1 shows an example dataset with a sensitive attribute ”Charge” and two equiv-
alence classes e1 and e2 defined by the values of the other attributes. The distribution
of sensitive values is Q = ( 15 ,
3
5 ,
1
5 ) since the values 50.000, 60.000 and 70.000 appear
1, 3 and 1 times in the whole dataset, respectively. For the equivalence classes, we get
P(e1) = ( 12 ,
1
2 ,0) and P(e2) = (0,
2
3 ,
1
3 ). Consequently, we have
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.
Hence, we can conclude that the dataset satisfies t-closeness with t =max{ 14 , 16}= 0.25.
A straight-forward implementation of t-closeness for fully ordered attributes would
implement this by checking if the following inequality holds:
|r1|+ |r1+ r2|+ |r1+ r2+ r3|+ ...|r1+ ...+ rm−1| ≤ t(m−1)
Each ri has the form ri = pi − qi, where pi is the frequency of the attribute value
number i in the currently considered equivalence class e of the transformed data set, and
qi the frequency of the attribute value number i in the entire input dataset.
As we will show in Section 4 this process is highly inefficient. The main reason is
that it needs to iterate over all sensitive attribute values contained in the overall dataset.
Given that this process needs to be executed for all equivalence classes, the worst-case
complexity is O(n2) where n is the number of records in the dataset.
3.2. Optimization Approaches
In this section, we present three optimizations that we used to improve our initial,
straight-forward implementation of the model.
Optimization 1 – Fibonacci hashing: The first optimization adresses the imple-
mentation level. One of the most time-consuming aspects of implementing a check for t-
closeness is to dynamically group the sensitive attribute values in each class to determine
their frequency. The standard data structure used for this purpose are hash tables. ARX
already used an efficient implementation provided by the High Performance Primitive
Collections for Java library [5]. However, these collections are still much more complex
than required, as they for example support updating the data stored in a map. We there-
fore implemented a simplified hash table using Fibonacci hashing based on the golden
ratio to reduce the number of CPU cycles required for adding and querying elements.
Optimization 2 – Check pruning: The second optimization addresses the mathe-
matical definition of the model. Let us assume that the attribute values number 1...k in
the equivalence class currently under consideration do not occur at all, then p1 = p2 =
...= pk = 0 holds and the first k summands in the above condition have the form:
|−q1|+ |−q1−q2|+ ...+ |−q1− ...−qk|.
This partial sum depends only on the input dataset and can therefore be pre-
calculated for every possible value of k before the individual equivalence classes of the
transformed dataset are checked.
These precalculations can be performed in an initialization step, for ascending values
of k until the corresponding subtotal is greater than the threshold, i.e. the following holds:
|−q1|+ |−q1−q2|+ ...+ |−q1− ...−qk|> t(m−1).
Let us denote the smallest value of k for which this inequality is fulfilled with x.
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When?checking?whether?t-closeness?holds?for?a?specific?equivalence?class,?as?a?first?
step,?we?calculate?the?smallest?index?of?any?attribute?value?occurring?in?the?class.?We?call?
this?index?y.?When?y?>?x?it?can?be?inferred?that?the?following?summands?are?included?in?
the?relevant?sum:
|?−?q1|?+?|?−?q1?−?q2|?+?...?+?|?−?q1?−?...?−?qx|.
It?follows?that?the?threshold?t(m?−?1)?will?definitely?be?exceeded?and?computations?
can?already?be?stopped?at?this?point?(concluding?that?privacy?guarantees?are?not?fulfilled).
Optimization?3?–?Summand?pruning:?The? third?optimization?adds?an?additional?
pruning?mechanism?using?pre-computations.
It?can?be?used?in?cases?where?the?pruning?strategy?described?above?is?not?applicable,?
i.e.?if?y?≤?x?holds.?It?works?by?starting?the?summation?at?position?y,?using?an?appropriate?
sum?which?has?been?pre-calcuated?ahead?of?time?for?all?k?≤?x?as?a?starting?point:
|?−?q1|?+?|?−?q1?−?q2|?+?...?+?|?−?q1?−?...?−?qk|.
3.3.? Experimental?Design
To?evaluate?our?approach,?we?used?the?following?data?from?registries?and?health?surveys?
from?the?U.S.:?100,937?records?about?traffic?accidents?from?the?NHTSA?Fatality?Anal-
ysis?Reporting?System? (FARS),?539,253? records? from? the?American?Time?Use?Survey?
(ATUS)?and?1,193,504?records?from?the?Integrated?Health?Interview?Series?(IHIS).?More-
over,?we?analyzed?a?subset?of?a?synthetic?discharge?dataset?which?is?particularly?hard?to?
protect?from?sensitive?attribute?disclosure?(SPD)?[6].?We?also?included?two?de-facto?stan-
dard?datasets?for?benchmarking?anonymization?methods:?30,162?records?from?the?1994?
U.S.?Census?(ADULT)?and?63,441?records?from?the?1998?KDD?competition?(CUP).?For?
a?detailed?specification?of?the?datasets?we?refer?to?[7].
We?anonymized?the?datasets?with?attribute?generalization?and?record?suppression?to?
produce?output?datasets?which?fulfill? t-closeness?for?fully?ordered?attributes.?We?varied?
the?risk?threshold?t?(0.5?≥?t?≥?0.1)?to?study?the?effect?of?our?optimizations?on?different?
parameterizations.?As?a?baseline,?we?used?our?original,?unoptimized?implementation.?In?
the?software,?both?pruning?strategies?are?combined? into?a?common? implementation?and?
we?therefore?present?one?measurement?capturing?both?of?them.
4.? Results
Figure?2? shows? the? results?of?our?experiments.?As?can?be? seen,?our?optimizations? im-
proved?execution? times?by?up? two?a?factor?of?more? than? two.?Each?optimization?had?a?
positive?effect?in?all?setups?while?the?degree?of?effectiveness?of?each?optimization?varied?
between?setups.?Pruning?was?possible?in?between?69%?and?99%?of?the?checks?performed,?
but?the?effect?on?execution?times?varied.
The?differences?in?the?impact?of?optimizations?on?execution?times?can?be?explained?
by?considering?the?distribution?of?sensitive?attributes?values?in?the?different?datasets.?The?
impact?was? lower?for?datasets?with?a?small?number?of?distinct?values,? i.e.?ADULT?(7),?
ATUS?(7)?and?IHIS?(10),?higher?for?datasets?with?more?distinct?sensitive?values,?i.e.?CUP?
(81)?and?FARS?(20).?We?measured? the?strongest?effect?for? the?SPD?dataset,?which?has?
101?different?sensitive?attribute?values.?When?the?number?of?sensitive?attribute?values?is?
high,?execution?times?are?also?higher,?implying?the?our?optimizations?are?more?effective?
exactly?in?the?cases?where?they?are?needed?the?most.
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Figure?2.? Execution?times?relative?to?the?original?implementation?for?various?datasets?and?risk?thresholds.
5.? Conclusion
Due? to? its?usability,?flexibility?and?scalability,?ARX? is?actively?used? in?many?areas,? in-
cluding?commercial?big?data?analytics?platforms,?medical?research?projects,?clinical?trial?
data?sharing?and? for? training?purposes.?An? important? reason? for?ARX’s?scalability?are?
the?many?optimizations? that?have?been? integrated? into? the? software.? In?prior?work?we?
have,? for?example,?presented?methods? to? improve? the?scalability?of?optimization?algo-
rithms?for?trading?off?risks?vs.?utility?[8]?and?a?versatile?optimized?runtime?environment?
for?anonymization?algorithms?[9].
In? this? paper,?we? have? presented? an? optimization? affecting? a? specific? and? impor-
tant? privacy? model? only.? Our? approach? addresses? the? implementation? level? as? well?
as? the?mathematical?definition?of? the?model? implemented.?Our? solution?utilizes?high-
performance?data?structures?as?well?as?pre-computation?techniques.?The?model?is?partic-
ularly?relevant?in?practice,?as?it?is?one?of?the?few?approaches?which?can?be?used?to?protect?
sensitive?numeric?data.
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Abstract. The paper presents a review of current research to develop predictive 
models for automated detection of drug-induced repolarization disorders and shows 
a feasibility study for developing machine learning tools trained on massive 
multimodal datasets of narrative, textual and electrocardiographic records. The goal 
is to reduce drug-induced long QT and associated complications (Torsades-de-
Pointes, sudden cardiac death), by identifying prescription patterns with pro-
arrhythmic propensity using a validated electronic application for the detection of 
adverse drug events with data mining and natural language processing; and to 
compute individual-based predictive scores in order to further identify clinical 
conditions, concomitant diseases, or other variables that correlate with higher risk 
of pro-arrhythmic situations. 
Keywords. Machine Learning, Clinical Decision Support System, 
Pharmacovigilance, Adverse Drug Events, Electrocardiography, Long QT, 
Torsades-de-Pointes, Repolarization Disorders, Analytic-Decision Modelling. 
1. Introduction 
Drug-induced ventricular arrhythmia is a major cause of iatrogenic morbidity and 
mortality [1], particularly in circumstances, where a wide range of psychotropic and 
illicit drugs are consumed (e.g. people who inject drugs, living in detention or with 
mental illness). Electrocardiographic (ECG) screening is a widely available method for 
detecting repolarization abnormalities. Long QT (LQT), defined as a QT interval 
duration of >470 ms for men and >480 ms for women, is the main surrogate marker for 
Torsades-de-Pointes (TdP), a pathognomonic, drug-induced polymorphic ventricular 
arrhythmia [2]. The probability to develop a TdP increases with the extent of the 
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corrected QT interval (QTc) prolongation. Most TdP are transient and unsustained, but 
can degenerate to malignant ventricular fibrillation (VF) and sudden cardiac death (SCD). 
Machine Learning (ML) based techniques are expected to support clinicians by 
allowing more accurate detection of abnormalities that would be missed using traditional 
diagnostic criteria (QT duration, axis, visual T-wave morphology). In the past decade, 
algorithms for pattern recognition and classification using learning techniques have 
become interesting in health applications for two main reasons; firstly, the digital 
information stored in Electronic Health Records (EHRs) is massively increasing [3], and 
there are available open databases, such as the MIT-BIH Arrhythmia Database [4]; 
secondly, the performance of ML algorithms have reached a point where either the task 
is better achieved by automatic systems, or further hidden underlying physiological 
phenomena can be re-addressed from a new analytical perspective. Recent research 
groups have tackled the problem of ECG-based heartbeat classification in order to detect 
arrhythmias [5]. ECG-based ML approaches include several steps after the acquisition 
of the ECG signals; preprocessing, segmentation, feature extraction, selection, and 
classification with learning algorithms [6]. 
2. Scope 
Virtually all medications inducing LQT act by blocking the outward IKr current, which 
is mediated by the potassium channel encoded by the KCNH2 gene [7].The measured 
QT value is further corrected according to a calculation based on heart rate (most 
frequently Bazett and Fridericia formulas), i.e. the QTc. Long QTc interval is a sensitive 
marker for TdP, but it is not specific since drug-induced QTc. More importantly, the lack 
of LQT specificity causes the discontinuation of valuable patients’ treatment and new 
drug development [8]. Separate analysis of J-Tpeak and Tpeak-Tend intervals helps to 
identify medications which prolong the QTc interval with counterbalancing inward 
current block and limited risk of arrhythmias. Automated measurement methodology and 
algorithm for the evaluation of the early repolarization J-Tpeak and late repolarization 
Tpeak-Tend intervals were proposed to assess drug-induced proarrhythmia propensity, 
using a two-step T-wave delineation method [9]. A wide range of illicit substances and 
medications are associated with repolarization abnormalities. In psychiatry, risk factors 
for developing drug-induced TdP include chronic hepatitis C infection, HIV, electrolyte 
abnormalities, renal or hepatic dysfunction, pre-existing coronary heart disease, 
treatment with more than one QT-prolonging drug, older age, female sex, and genetic 
predisposition [10,11]. Abnormal electrocardiographic (ECG) recordings are reported in 
27.3% of psychiatric inpatients at hospital admission and repolarization disorders were 
the most prevalent abnormal findings (11.8%). 
3. Methodology 
In the University Hospitals of Geneva (HUG), since 2017, all ECG devices (n=220) have 
been replaced by the same electrocardiographic devices (Philipps TC-70) and all records 
are automatically converted into a DICOM® [12] file (>8’000 ECGs per month 
performed in all care settings at HUG) and stored in the Picture Archiving 
Communication System (PACS) [13]. Computerized ECG health records with structured 
metadata in XML format are available to be extracted from the hospital DPI (Dossier 
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Patient Intégré) [14] secured servers for research purposes. All records can be analyzed 
with socio-demographic, clinical, laboratory, genetic, and drug prescription data at the 
individual patient level, using an agreed protocol and database structure. The latter 
cardiac information combined with electronic prescription systems and natural language 
processing (NLP), allow ECG feature extraction and drug imputability assessment, based 
on interactions, dose variations, and chronological relationship with drug exposition. 
Moreover, it stores all measurements from the recordings, meaning it includes boundary 
detection, epoch extraction, and characteristic measurements for each lead. In the 
proposed methodology (see Figure 1), electrographic, structured, and unstructured text 
data is collected and stored in a multimodal database, which will first pass a quality 
control, and then be used to extract and select relevant features to build models for RD 
prediction. 
 
Figure 1. Research Methodology. Database (DB), Repolarization Disorders (RD), LQT (Long QT), Torsades 
de Pointe (TdP), Machine Learning (ML). 
A feature set proposed in the literature include ECG-intervals, morphological (e.g. 
amplitude), Vector Cardiographs (VCG) [15], Temporal VCG (TVCG) [16], different 
transforms, including temporal polynomial fitting with Hermite Basis decompositions 
[17], and different versions of time-frequency representations, such as Discrete Wavelet 
Transforms (DWT) [18]. The classification, according to the resulting feature vectors is 
done using classifiers such as linear discriminant (LD), support vector machines (SVM) 
[19], Random Forests [20], and ensemble classifiers with the advantage of bagging both 
temporal and morphological feature-based classifiers [21]. Long-short-term memory 
(LSTM) networks, combined with a wavelet sequence (WS) [22], and algorithms with 
deep learning (DL) architectures [23] have been investigated. For inter-patient 
classification convolutional neural networks (CNN) and recurrent neural networks 
(RNN) give very promising results [24]. 
4. Feasibility study 
There are no a priori exclusion criteria. Nonetheless, ECG of insufficient quality (not 
present QT measurements) or with inverted electrodes will not be included. With a 
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minimum 70'000 ECG recorded and saved in the hospital's database (PACS), the 
estimated amount of available ECG over the target period (three years) is 200'000 EC. 
Figure 2 shows estimations, over a four week period, of QT density distributions 
depending on age and sex. 
Figure 2. Left: density distributions estimation (based on a four-week period in 2019) of patient age and 
QT/QTc (Bazett's formula, in red) values of patients at HUG. Right: QTc (Bazett's formula) distributions 
over a four-week period in 2019 at HUG. For children (under the age of 15 years), women (above 15 years 
old, female sex), and men (above 15 years old, male sex). From green to dark red; normal, intermediate, and 
long QTc [ms]. 
5. Discussion 
Approximately 30% of the inpatients are taking QT prolonging drugs, out of which 50% 
will have additional QT prolonging drugs [25]. In our preliminary analysis of ECG 
structured data (early 2019), RD prevalence and QT interval variability increased with 
patient age and the number of medications. The proposed research will exploit large 
databases to answer the central question of the influence of drugs on RD, particularly 
LQT and related severe complications. This question is of major importance since QT 
prolongation may lead to iatrogenic life-threatening arrhythmia, whose indicators could 
be detected to prevent consequences by instant electronic alert systems. ML-based 
approach could bring about innovation opportunities and new dimensions to comprehend 
iatrogenicity. Applied ML will influence decision-making processes (at individual and 
more global levels, such as health authorities), education, and training (including general 
practitioners, cardiologists, and medicine students). Additionally, CDSS can potentially 
decrease the number of misdiagnosed patients, the extra costs of non-suitable 
hospitalizations (40% of patients oriented to specialists for LQTS are misdiagnosed) [26], 
and prevent patients from severe cardiac events, such as arrhythmias or, possibly, sudden 
cardiac death. 
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Abstract. Radiology reports include various types of clinical information that are 
used for patient care. Reports are also expected to have secondary uses (e.g., clinical 
research and the development of decision support systems). For secondary use, it is 
necessary to extract information from the report and organize it in a structured for-
mat. Our goal is to build an application to transform radiology reports written in a 
free-text form into a structured format. To this end, we propose an end-to-end 
method that consists of three elements. First, we built a neural network model to 
extract clinical information from the reports. We experimented on a dataset of chest 
X-ray reports. Second, we transformed the extracted information into a structured 
format. Finally, we built a tool that enabled the transformation of terms in reports to 
standard forms. Through our end-to-end method, we could obtain a structured radi-
ology dataset that was easy to access for secondary use. 
Keywords. Natural Language Processing, Radiology Report, Information Extrac-
tion 
1.Introduction 
Radiology reports are created by radiologists to communicate with referring clinicians, 
and play an important role in patient care. Radiology reports are usually written in free-
text format. It has been reported that the ambiguity of terminology or style in free-text 
can reduce the clarity of the report, causing inaccurate communication [1]. European 
Society of Radiology has taken the initiative in developing structured reporting to im-
prove the quality of radiology reports [2]. They mention structured reporting also has the 
potential to facilitate clinical research and the development of radiological applications.  
There are a lot of studies on information extraction from radiology reports [3]. Some 
studies examined Japanese radiology reports [4,5]. In recent years, extraction method 
using a deep learning has drawn much attention [6]. However, most studies have only 
focused on the extraction process and did not refer to the structuring process.  
In this study, we propose an end-to-end approach for structuring radiology reports. 
Our aim is utilizing massive amounts of unstructured reports as training data for a lesion 
detection system [7]. Specifically, we take three steps: extraction, structuring and nor-
malization. In the first step, we build a recurrent neural network-based model for entity 
recognition. In the second step, we organize the extracted information for storage in a 
database. The data is stored in a tabular database for accessibility. It is well-known that 
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radiology reports contain heterogeneous writing styles, including non-standard terminol-
ogy and abbreviations [8]. In the third step, we transform non-standard terms in the report 
to a standard form.  
2.Material and methods 
2.1. Radiology dataset 
In this study, we used chest X-ray reports from 2000 to 2017 that were stored in the 
radiology information system at Osaka University Hospital. The dataset consisted of 
319,130 reports, most of which were written in Japanese. This study was approved by 
the institutional review board of Osaka University Hospital (Permission number: 17166). 
2.2.Entity recognition 
2.2.1.Gold Standard 
We randomly sampled 5,000 reports for a gold standard dataset. A report was segmented 
into a single sentence and word tokenization was implemented using MeCab [9].  
One non-medical expert was responsible for the annotation process. Two medical 
experts (a clinician and a radiological technologist) reviewed the results. 
A previous study defined 5 semantic classes (Anatomy, Anatomy Modifier, Obser-
vation, Observation Modifier, and Uncertainty) [10]. Another defined 4 semantic classes 
(Clinical Finding, Body Location, Descriptor and Medical Device) [6]. With reference 
to previous studies, we defined 3 semantic classes: Clinical Finding (CF), Body Location 
(BL), and Body Location Modifier (BLM). CF includes terms related to observation and 
abnormalities in the report. BL includes terms related to the anatomical area. BLM en-
compasses terms that modify the BL. To differentiate the certainty of the Clinical Find-
ings, they were split into three labels: Clinical Finding Positive (CFP), Clinical Finding 
Suspicious (CFS), Clinical Finding Negative (CFN). Figure 1 shows an example of an-
notation. 
 
 
 
Figure 1. annotation example 
2.2.2.Neural Network Architecture 
Our deep learning model is based on the architecture described by Ma and Hovy [11]. 
The encoder part of this model is composed of the Bidirectional Long Short Term 
Memory (BiLSTM) [12] layers. The character representation of each word computed by 
convolutional neural networks (CNNs) is concatenated with the word representation. Fi-
nally, the output of  BiLSTM is fed to the CRF [13] layers to decode the label sequence. 
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2.3.Structuring 
Entities from the report need to be transformed to tabular format records. We created 
simple rules using position information of the entities. In the common word order of 
radiology reports written in Japanese, BL appears after BLM, before CF. Based on this 
assumption, pairs of BLM and BL, BL and CF were created (Figure 2). 
 
 
 
Figure 2. an example of pairs in the report  
 
 
When transforming, a pair of BLM term and BL term was concatenated as one term, 
and a CF was divided into CF and Certainty. Multiple records were created from one 
sentence when BL and CF had a one-to-many (many-to-one) relationship (Figure 3). 
 
 
 
Figure 3. an example of creating records from the extracted entities.  
2.4.Normalization 
Each term needs to be normalized automatically. We created a concept table from scratch 
since there is no comprehensive radiology vocabulary in Japan. This table has 2 columns; 
mention and concept. Values of mention column are terms that occurred in the radiology 
reports, and they were collected from the outputs of our entity extraction model (As we 
described in 2.2.2). Value of concept column is the standard form of its mention column. 
3.Results 
3.1.Entity recognition 
Five thousand reports were divided into 4,000 for training, 500 for development, and 500 
for validation. Hyper-parameters were tuned by using a development dataset. We used 
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pre-trained word vectors to help the learning process. Pre-trained word vectors were ob-
tained using Contiguous Bag of Words (CBOW) [14] from 317,130 unlabeled radiology 
reports. We used the RMSProp algorithm [15] with a batch size of 32. A 0.5 dropout rate 
was applied to avoid overfitting. 
Our experimental results are shown in Table 1. Our model achieves 0.938 in the F1-
score, which shows that the model can accurately extract target entities. 
 
Table 1. Performance metrics of each semantic class 
Semantic classes Precision Recall F1-score No. of entities 
Body Location Modifier 0.953 0.968 0.960 4,024 
Body Location 0.952 0.959 0.955 7,205 
Clinical Finding Positive 0.904 0.920 0.912 7,574 
Clinical Finding Suspicious 0.874 0.902 0.888 1,672 
Clinical Finding Negative 0.992 0.932 0.961 2,818 
Total               0.937 0.941 0.938 23,297 
3.2.Structuring 
We manually created 453 records from 200 reports. We evaluated the accuracy of the 
structuring process assuming that all entities were correctly extracted. Our structuring 
processer was able to correctly transform 436 records (Accuracy is 0.96). 
3.3.Normalization 
We created a concept table for normalization. This table was created by some medical 
experts (clinicians and radiological technologists). We created 21 concept terms for BL 
by dividing chest X-ray images. And, the concept for CF was decided by picking up 
frequently occurring words that were extracted as CF entity. We then combined similar 
concepts into one concept term. Finally, we defined 121 concept terms. 
4.Discussion 
In Table 1, we show the performance metrics of each semantic class. The F1-score of 
semantic classes exceeded 0.9, excluding CFS. The lower F1-score in CFS was related 
to the number of entities in the training dataset. Table 1 shows the number of entities in 
the CFS group was lower in comparison to other semantic classes.  
As we described in 3.2, the simple rule-based method is applicable for structuring 
reports. This result may be due to the high similarity of the writing style of the reports. 
The present study was associated with some limitations. First, some important in-
formation could not be covered in our semantic classes. For example, the size and shape 
of the lesions were not included, even though they are valuable for clinical research. 
Second, we only used an in-house dataset, which means that the performance of our 
method might differ if a dataset from a different hospital was used. Third, although our 
concept terms of BL and CF were 21 and 121, respectively, the granularity is not general 
and may not be appropriate for some secondary uses. 
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5.Conclusion 
In this paper, we built an end-to-end method for transforming unstructured radiology 
reports into a structured format. We combined machine learning for entity recognition 
with a rule-based method for structuring and normalization to pursue a better approach. 
While our method leaves room for improvement of versatility, the present study shows 
the way to facilitate secondary use of radiology reports. 
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Evaluation of Document Retrieval Systems 
on a Medical Corpus in French: Indexation 
vs. Feature Learning 
Arnaud ROBERTa,1, Francis DAMACHIa,1, Mina BJELOGRLICa,1, Jean-Philippe 
GOLDMANa,1, and Christian LOVISa,1 
a
 Division of Medical Information Sciences, University Hospitals of Geneva and 
University of Geneva, Geneva, Switzerland 
Abstract. This paper presents five document retrieval systems for a 
small (few thousands) and domain specific corpora (weekly peer-
reviewed medical journals published in French) as well as an 
evaluation methodology to quantify the models performance. The 
proposed methodology does not rely on external annotations and 
therefore can be used as an ad hoc evaluation procedure for most 
document retrieval tasks. Statistical models and vector space 
models are empirically compared on a synthetic document retrieval 
task. For our dataset size and specificities the statistical approaches 
consistently performed better than its vector space counterparts. 
Keywords. Medical Information Retrieval, Document Retrieval, 
Natural Language Processing, Word Embedding. 
1. Introduction 
The field of Information Retrieval (IR) is a well-studied and yet still critical field of 
research. In the last few decades, additional effort has been made in the biomedical 
domain with the digitalization of medical data and the multiplication of biomedical 
scientific literature [1,2]. The goal of the present paper is to give a clear methodology in 
evaluating several IR systems on small (few thousands) and domain specific corpora 
(medical literature in French). For a specific query, document ranking is determined by 
a numerical score assigned by the IR system [3]. On the one side, early IR systems in the 
early 60’s were based on Boolean and statistical approaches [4]. In term-based 
approaches documents are represented by a predefined arbitrary feature with no encoded 
semantic information (words are represented by an index in a vocabulary). On the other 
side, vector space (VS) models represent documents as a composition of vector 
representation of terms [5]. In VS each word is encode as a vector in a high dimensional 
space allowing to encode semantic information. Independently of the representation 
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used, most Document Retrieval systems compute a ranking between a query and all the 
documents in the corpus [3]. The documents with the highest score (rank) are considered 
most relevant and are returned [6,7]. Statistical models (Boolean and Weighted), vector 
space models (Word2Vec-Mean and Word2Vec-Weighted, Word2Vec-Max), are 
compared on a dataset consisting of 4,201 articles of weekly peer-reviewed medical 
journals published in French. All models are evaluated empirically on the same 
document retrieval task.  
2. Data/corpus 
The source of the dataset is the Revue Medical Suisse (RMS). The dataset consists of 
4,201 articles of weekly peer-reviewed medical journals published in French in XML 
format spanning from years 2014 to 2019. Sections of the document such as the abstract, 
title, body, conclusion and references can be distinguished by specific XML tags. In 
order to evaluate the models performance we kept articles for which title, abstract and 
body were available and in French, which resulted into 1,401 documents. All models 
benefited from the same preprocessing steps. The first step consists into the extraction 
of the documents from the XML format to plain text. Then, each document is converted 
into lemmatized tokens (49,573 unique terms). Lemmatization is done by Spacy’s pre-
trained statistical models for French [8]. Stopwords are removed (they do not add any 
semantic information), verbs are removed (add small semantic information), and word 
that occurs less than 2 were removed (to filter out mostly misspellings and extremely 
rare terms). Following this procedure, approximately 42% of words were filtered out, 
leaving a vocabulary size of 28,791 terms. 
3. Methodology 
We investigate different methodologies to rank documents according to a query. The 
proposed models fall in one of the two following categories: Term-based or VS models. 
The term-based models evaluated (Boolean and Weighted models) represents words as 
an index in a reference vocabulary while VS models represent words as vector in a high 
dimensional space [5], which encode semantic properties of the word. The evaluated VS 
models (Word2Vec-Mean, Word2Vec-Weighted, Word2Vec-Max) represent each term as 
a -dimensional vector  using the well-known Word2Vec algorithm [5], where  is a 
user chosen parameter (called embedding size). 
3.1. Term-based Models 
In the Boolean model, for a vocabulary size of n words, the model encodes a text as an 
n-dimensional vector containing a ‘1’ for each word present in the text and ‘0’ otherwise. 
In order to evaluate the similarity between a query q and a document d the model first 
normalizes the two vectors:   =     ,   =  
	
 	  , and then compute the cosine 
similarity between  and , where the cosine similarity between two vectors 
 and  is 
defined as follow: 
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(
, ) =    
   
     (1) 
The main drawback of the Boolean model is that it gives the same importance to all the 
words in a document. To include the word importance, the Weighted model uses the TF-
IDF (for term frequency - inverse document frequency) metric that weight the 
importance of a term in a document. More formally TF-IDF will compute the weight of 
a term as follow: 
 
	() = 	()  ( 	(!) + 1), 
	() = "#(!) "#$% (!%) , with 	()  = 	()  (

	(!) + 1) (2) 
 
 
where 	() denotes the number of times the term t appears in the document , i.e 
the term frequency and () denotes the number of documents that contain the term , 
i.e. the document frequency. Query and documents are compared using cosine similarity 
(see eq. 1) [9]. 
3.2. Vector Space Models 
For all VS models word representation was computed with Word2Vec algorithm, with 
an embedding size of 32, a context window size of 7, and 64 negative samples. 
In Word2Vec-Mean model, documents are represented as the mean of their word vectors: 
& =  '	*'  --.	*  , where - is the -dimensional vector representing word i. Queries 
are represented with the same methodology. For a given query, the relevance of a 
document is computed with the cosine similarity (see eq. 1). The main drawback of the 
previous method is that it assigns the same weight to all words of the document. An 
alternative (Word2Vec-Weighted model) is to use the TF-IDF weights (see eq. 2), and 
represent a document as follow: & =   "#*(-)  	*()--.	*  
When representing a document with the above methods, the mean can involve a 
potentially large number of vector (several hundreds), hence drowning the information 
in the mass. The Word2Vec-Max model solves this problem by focusing on the few words 
that are the most relevant regarding the query. For each term of the query  the algorithm 
find the closest term (w.r.t. the cosine similarity, see eq. 1) in the document and average 
them to compute the final similarity score:  
/	* . 	((-, &)).  . 
4. Experiments 
The dataset for testing consists of 1400 medical articles from RMS Journal. In order to 
evaluate the above information retrieval systems we used an article’s title as a query. The 
precision of the model is then evaluated, by looking if the corresponding article appears 
in the top-N most relevant documents (N=1, 5, 10). Performance of some methods might 
fluctuate depending on the length of the documents composing the corpus, therefore, 
experiments were conducted on 3 different corpuses:   
 Corpus A, contains only the abstracts of the articles (25 to 184 words); 
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 Corpus B, contains only the body of the articles (431 to 8,839 words); 
 Corpus A+B, contains both the abstract and the body of the articles. 
Titles, used as queries, have from 1 to 29 words (mean=9.7 words) and the total number 
of words is the whole corpus is 1,853,939 (in titles + abstracts + bodies). 
 
 
Figure 1. Performance according to query length. From left to right, it shows the top1, top5, and top10 
performance. Models are color coded, and the size of the marker is proportional to the support size (i.e. 
number of queries). 
 
For all the documents, all models, and the three different corpuses, the top1, top5, and 
top10 performances are shown in Table 1. The best performance for almost all sub-tasks 
is obtained by the Weighted model. In order to quantify the impact of the query length, 
Figure 1 shows the performance of each model according to the query length. The 
dominance of the Weighted model (in dark blue) is confirmed by this new perspective. 
The performance is the ratio between the number of queries where the correct document 
was in a specific ranking (i.e. top1, top5, top10) and the total number of queries. We 
achieve up to 94.5% of retrieval with top10 metric for 7 concept long queries. 
Table 1. Shows the top1/top5/top10 performance of the five models on 1400 different queries 
Method Abstracts only Bodies only Abstracts + bodies 
Boolean 801/1071/1138 564/963/1084 595/979/1092 
Weighted 876/1186/1240   838/1195/1276   861/1218/1295   
Word2Vec- Mean 422/785/920 405/749/900 421/766/915 
Word2Vec- Weighted 486/804/949   458/812/941   474/831/955   
Word2Vec-Max 882/1135/1192 572/982/1098 598/1004/1114
 
5. Discussion 
First, it is important to note that the task is prone to advantage index-based methods since 
it is very likely that words that appear in the query (title) will occur in the target article. 
Hence, it might explain the very good results obtain by index based methods. Secondly 
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it seems that VS space models that compute document representation using all terms in 
the documents fail to provide a good representation, as suggested by the poor results 
obtained by Word2Vec-Mean and Word2Vec-Weighted models. This is also confirmed 
by the performance gain seen with Word2Vec-Max (which use less terms to represent 
documents). 
6. Conclusion 
This paper shows and evaluates how various document representations can impact the 
performance of a Document Retrieval system. The presented models are separated into 
two groups: term based and vector space models. In total we described and evaluated 5 
models: Boolean, Weighted, Word2Vec-Mean, Word2Vec-Weighted, Word2Vec-Max 
models. The relevance of a document with respect to a query was computed using the 
cosine similarity between their appropriate representations. By varying the query length 
we see how the models perform in retrieving the top 1/5/10 documents. 
Future work should focus on: (i) evaluating the presented methods against a much larger 
corpus (rather than only 1400 articles); (ii) investigating more in depth document 
representation (the Word2Vec Max use only a small subset of words, as many as the 
query length, to represent a document, this information loss impact the severely the 
document representation); (iii) efficient implementation of those systems to scale to 
larger database. The methodology proposed in this paper can be used as an ad hoc 
evaluation procedure for most document retrieval tasks in small and medium size text 
databases, in order to adopt the most effective IR strategy. 
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Abstract. The aim of our validation study was to assess the quality of hospital data 
for perinatal algorithms on a national level. In each hospital, we selected 150 
discharge abstracts of delivery (after 22 weeks of gestation), in 2014, and their 
corresponding medical records. Overall, 23 hospitals were included and 3,246 
discharge abstracts were studied.  
This first national validation study of several case-funding algorithms using 
various perinatal variables suggests that the French national hospital discharge 
abstracts database is an appropriate data source for epidemiological studies. 
Keywords: hospital data, perinatal indicators, validation study. 
1. Introduction 
Administrative data, such as hospital or care consumption, that are collected primarily 
for reimbursement, contain several clinical diagnoses and procedures, which can be 
used to provide epidemiologic information (1). In France, 99.6% of the 800,000 annual 
births in France take place in hospitals (2). This renders  the French hospital database 
particularly interesting for the investigation of perinatal Nonetheless, the researchers 
using the medico-administrative databases are required to evaluate data quality via a 
validation study (3–7). In validation studies of case-finding algorithms, validity indices 
are used to assess data quality by comparing an algorithm in the simpler and easier-to-
use data set versus a more elaborate, robust and reliable data set that is considered to be 
a “gold standard”. Furthermore, other validity indices are used to aid the selection of 
the best algorithms. In contrast to the less frequently conducted national surveys, the 
use of routinely collected health data in hospitals saves time and money when 
identifying infrequent and unfavorable delivery outcomes and improves health 
surveillance of women and their offspring (1). 
The aim of our validation study was to assess the hospital data quality  for 
perinatal algorithms on a national level. 
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2. Methods 
The principle of this transversal multicenter study was to compare discharge abstract 
data entered into the French hospital database with the corresponding data from 
medical records, where we considered the latter to be the gold standard.  
2.1. Population 
Fifty health hospitals with a maternity unit were randomly selected in metropolitan 
France (other than Paris and Paris region), irrespective of the level of the unit. We 
developed a software program to randomly select 150 perinatal discharge abstracts per 
hospital ( 22 weeks of gestation) in 2014, from all discharge abstracts that contained a 
Z37 code and/or a delivery procedure. The same investigator collected data in each 
hospital from hospital paper-based or electronic medical records of pregnancy (prenatal 
care, the delivery and the post-delivery stay, and a discharge letter). Then, a 
comparison between data from medical records and data from discharge abstracts was 
made.   
2.2 Statistical analysis 
We explored several algorithms, including different combinations of codes in discharge 
abstracts from delivery stay, pregnancy stay, or hospitalization over the past 2 years 
before delivery. To evaluate the quality of the hospital database of discharge abstracts 
versus the hospital medical records (our gold standard), two validity indices the 
positive predictive value (PPV) and the sensitivity were calculated for dichotomous 
data. Continuous data were assessed by the concordance rate as the validity index. The 
rates of false negatives (FN) and false positives (FP) were also calculated in order to 
select the best algorithms with regards to the likelihood ratio (balancing specificity and 
sensitivity). This study was approved by the French National Committee for Data 
Protection (registration number 9132091). To meet the requirement of the data 
protection agency, the family names and first names were removed, the date of birth 
was replaced by the age at delivery, and the dates of admission and discharge were 
replaced by the length of stay. 
3. Results 
Twenty-two hospitals were finally included. Among them, 5 maternity units had less 
than 1,000 deliveries, 4 units had between 1,000 and 2,000 deliveries, 5 units had 
between 2,000 and 3,000 deliveries and 8 maternity units had more than 3,000 
deliveries. Overall, 3,246 discharge abstracts were compared with their corresponding 
medical records. 
3.1. Maternal indicators 
The concordance rate of maternal age at delivery was 94.8%, with a 95% confidence 
interval (CI) [93.8-95.4]. The maternal characteristics and several types of morbidity 
are presented in Table 1.  
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Table 1: Quality of the hospital database of discharge abstracts versus the hospital medical records 
 
 
The pregnancy-related disorders are presented in Table 1. The concordance rate of 
gestational age at delivery was 91.8% [90.9-92.7]. Rounding up or down to the nearest 
whole number of WG (< 1 week), the concordance rate increased to 98.3%.  
n % n % % 95% CI n % n % % 95% CI 
Maternal characteristics and 
comorbidities
Parity
Primiparous women 981 40.2 971 39.8 93.3 92.3-94.3 65 2.7 75 3.1 92.4 91.3-93.5
Multiparous women 1,459 59.8 1,458 59.8 95.5 94.7-96.3 66 2.7 67 2.7 95.5 94.7-96.3
Overweight or obesity  ≥ 25 kg/m² * 1,104 37.6 220 7.5 98.6 98.2-99.0 3 0.1 887 30.2 19.7 18.3-21.1
Obesity≥ 30 kg/m² * 507 17.3 216 7.4 91.7 90.7-92.7 18 0.6 309 10.5 39.1 37.3-40.9
Uterus scar** 464 14.4 384 11.9 94.8 94.0-95.6 20 0.6 100 3.1 78.5 77.1-79.9
Diabetes Mellitus
Type 1 diabetes *** 98 3.0 143 4.4 50.4 48.7-52.1 71 2.2 26 0.8 73.5 72.0-75.0
Type 2 diabetes *** 51 1.6 31 1.0 67.7 66.1-69.3 10 0.3 30 0.9 41.2 39.5-42.9
Type 1 or type 2 diabetes 148 4.6 170 5.2 65.9 64.3-67.5 58 1.8 36 1.1 75.7 74.2-77.2
High blood pressure 29 0.9 34 1.0 32.4 30.8-34.0 23 0.7 18 0.6 37.9 36.2-39.6
Pregnancy-related disorders
Gestational diabetes
Code O24.4 482 14.9 469 14.5 80.6 79.2-82.0 91 2.8 104 3.2 78.4 77.0-79.8
Codes O24.4-O24.9 482 14.9 474 14.6 80.8 79.4-82.2 91 2.8 99 3.1 79.5 78.1-80.9
Hypertensive disorders 
Previous or during pregnancy 213 6.6 239 7.4 69.5 67.9-71.1 73 2.3 47 1.4 77.9 76.5-79.3
Moderate or severe pre-eclampsia  96 3.0 106 3.3 70.8 69.2-72.4 31 1.0 21 0.6 78.1 76.7-79.5
Eclampsia 2 0.1 8 0.2 12.5 11.4-13.6 7 0.2 1 0.0 50.0 48.3-51.7
Premature labor*** (O60.0) 141 4.3 87 2.7 57.5 55.8-59.2 37 1.1 91 2.8 35.5 33.9-37.1
Premature labor***¥ 141 4.3 326 10.0 32.5 30.9-34.1 220 6.8 35 1.1 75.2 73.7-76.7
Premature delivery 434 13.4 295 9.1 85.8 84.6-87.0 42 1.3 181 5.6 58.3 56.6-60.0
Placental abruption 41 1.3 40 1.2 75.0 73.5-76.5 10 0.3 11 0.3 73.2 71.7-74.7
Delivery
Type of pregnancy
Singleton 3,134 96.5 3,179 97.9 98.3 97.9-98.7 54 1.7 9 0.3 99.7 99.5-99.9
Twin 105 3.2 106 3.3 94.3 93.5-95.1 6 0.2 5 0.2 95.2 94.5-95.9
Triple 5 0.2 8 0.2 50.0 48.3-51.7 4 0.1 1 0.0 80.0 78.6-81.4
Delivery -
Vaginal 2,508 77.3 2,51 77.3 99.5 99.3-99.7 13 0.4 11 0.3 99.6 99.4-99.8
Operative 343 10.6 373 11.5 88.2 87.1-89.3 44 1.4 14 0.4 95.9 95.2-96.6
Caesarean 731 22.5 738 22.7 98.5 98.1-98.9 11 0.3 4 0.1 99.5 99.3-99.7
Emergency caesarean 450 13.9 516 15.9 83.0 81.7-84.3 88 2.7 22 0.7 95.1 94.4-95.8
Planned caesarean 238 7.3 250 7.7 80.4 79.0-81.8 49 1.5 37 1.1 84.5 83.3-85.7
Episiotomy*** 350 14.0 334 13.4 90.1 88.9-91.3 33 1.3 49 2.0 86.0 84.6-87.4
Perineal tears*** 1,231 49.3 1,092 43.7 86.2 84.8-87.6 151 6.0 290 11.6 76.4 74.7-78.1
Postpartum hemorrhage*** (PPH) -
Immediate (O72.0, O72.1) 286 8.8 278 8.6 77.7 76.3-79.1 62 1.9 70 2.2 75.5 74.0-77.0
Diagnosis codes 
+ manual removal of the placenta*
191 5.9 31 1.0 80.7 79.3-82.1 6 0.2 166 5.1 13.1 11.9-14.3
Severe PPH -
Relevant advanced interventional 
procedures
120 3.7 143 4.4 67.8 66.2-69.4 46 1.4 23 0.7 80.8 79.4-82.2
Relevant or general advanced 
interventional procedures
120 3.7 158 4.9 68.4 66.8-70.0 50 1.5 12 0.4 90.0 89.0-91.0
Medical abortion 153 4.7 153 4.7 91.5 90.5-92.5 13 0.4 13 0.4 91.5 90.5-92.5
Medical abortion, fetal pathology 137 4.2 117 3.6 88.9 87.8-90.0 13 0.4 33 1.0 75.9 74.4-77.4
Stillbirth -
 Relevant Z37 codes¥¥, or O36.4 or 
O31.2
239 7.4 255 7.9 89.4 88.3-90.5 27 0.8 11 0.3 95.4 94.7-96.1
 Relevant Z37 codes + P95 239 7.4 391 12.0 60.6 58.9-62.3 154 4.7 2 0.1 99.2 98.9-99.5
Tranfer in utero 61 1.9 30 0.9 56.7 55.0-58.4 13 0.4 44 1.4 27.9 26.4-29.4
PPV (Pos it ive p red ict ive value), FP (false pos it ives), FN(false negatives), CI(confidence Interval) ; * Miss ing  Data (MD) = 309  ; **  MD=24  ; *** MD<10
¥ codes  O60 .0 , O60 .1, O60 .2 , O47.0  ; ¥¥ codes  Z37.1, Z37.3 , Z37.4 , Z37.6 , Z37,7
Medical records Discharge abstracts PPV FP FN Sensitivity
K. Goueslard et al. / Evaluation of the Quality of French Hospital Data 215
The indicators of delivery are presented in Table 1. Regardless of the algorithm 
explored, the PPV for vaginal delivery was over 99%. In order to select severe 
postpartum hemorrhage, we explored advanced interventional procedures which 
indicated a second-line therapy (arterial embolization, uterine or hypogastric artery 
ligation, hemostasis hysterectomy).  
The concordance rate between the vital status and the diagnosis codes for stillbirth 
from newborn discharge abstracts was 95.4% [94.7-96.1] for singleton pregnancy. For 
multiple pregnancies, the rate was 99.7% for the first- or the second-birth child, and 
100% for the third-born child. 
3.2. Newborn indicators 
The concordance rate of newborn weight was 91.3% [90.3-92.3] in singleton 
pregnancy. The rate was 79.1% [70.5-87.5] for first- and second-born in cases of 
multiple pregnancies. As regards the first-born child, the median gap between the 
newborn weight mentioned in the medical record and the weight specified in the 
discharge abstract was 100g.  
4. Discussion 
4.1. Main findings  
Our study has shown that the French hospital perinatal discharge abstracts database, 
when compared with hospital medical records (our gold standard), regarding parturient 
women, pregnancy and delivery is highly accurate. Gestational diabetes had a higher 
metrological quality than the other types of diabetes. Several algorithms were studied 
using the data of hospital stay during pregnancy or during delivery. They did not 
improve the identification of women who had gestational diabetes. The algorithm 
including one of two gestational diabetes diagnosis codes (O24.4, O24.9) from the 
hospital stay of delivery remains the most performant. The algorithms for stillbirths and 
termination of pregnancy for medical reasons were found to be accurate.  
4.2. Strengths and limitations 
Our national study included maternity units of all types and all volumes of deliveries. 
Moreover, in France almost all deliveries occur in a hospital. We explored a large 
number of perinatal indicators: 70 items were collected for each hospital stay by a 
single technician specialized in clinical studies. Some limitations also have to be 
acknowledged. The data collection was performed by a technician, perfectly trained, 
but not by a health professional. The maternity units included in our study were 
geographically not distributed uniformly throughout the French territory. It is very 
important to assess the data quality in case-finding algorithms so that the design of an 
envisaged study can be adjusted according to the quality of data (4,8). Our results 
suggest that it seems possible and worthwhile to conduct studies on women with a 
history of gestational diabetes. The use of a complementary French database for 
ambulatory care (treatment, biology) has been suggested as a means to identify women 
with gestational diabetes or pre-existing diabetes, but it is necessary to assess the data 
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quality of this algorithm (9,10). The quality of the French hospital database for 
stillbirth and medically indicated abortion was high. Thus, it seems possible to use 
these two indicators not only for descriptive studies, but also for longitudinal studies. 
Conclusion 
This first national validation study of a large set of perinatal algorithms has shown that 
French hospital database is an appropriate data source for subsequent epidemiological 
studies. The choice of the algorithm may vary, depending on the aim of the study. 
Nevertheless, the data quality of the algorithms should be taken into account to define 
the design of the study. 
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Abstract. Managers, physicians and researchers need to study patient’s path for 
purposes of management, quality of care and research. We present the proof of 
concept of the use of a flow diagram, the Sankey diagram, to visualize the trajectory 
of a population that experienced an event. This representation was tested with two 
case studies in populations from the anesthesia data warehouse of Lille University 
Hospital. For the 551 patients undergoing a pancreaticoduodenectomy, Sankey 
diagram helped us identify atypical care paths of patient being transferred too late in 
an intensive care unit. For 473953 patients who have had anesthesia procedure, 
Sankey diagram highlighted that mortality and re-operation rates increase with the 
number of operations. This preliminary work has been well received by end-users 
and allowed managers, physicians and researchers to visualize the paths of patients 
and to provide visualization support for research questions. This work will be 
followed by generalization. 
Keywords. Data Visualization, Data Reuse, Patient Path, Sankey Diagram 
1. Introduction 
To display complex information in a most effective way, graphical representations are 
more appropriate than tables and figures [1, 2]. In healthcare facilities, to have access  to 
visual representations of patients’ path would be of great value for assessing quality of 
care (e.g. to detect atypical care paths) and for management purpose [ 3]. From a 
research perspective, studying patient flows may generate hypotheses about patient care 
that can be assessed later with classical biostatistics methods. 
Designing and providing clear and efficient visualization of patients’ paths faces 
several issues: 
• Hospital Information Systems (HIS) generate a huge amount of data and the 
patient path is documented by many variables (admission and discharges 
modes, type of units, succession of interventions and re-interventions, medical 
acts, diagnostics, etc). This makes it difficult to extract relevant information ;  
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• Patients’ stays differ in complexity and may represent a large number of 
patterns (e.g. one patient went through two care units and underwent one 
operation while another went through 6 units and underwent two operations). 
Several kinds of diagrams are commonly used to represent flows. From a practical 
point of view, a flow is a succession of steps, each one defined by an initial state, a  final 
state, and a quantity. From a graphical point of view, it is represented by links carrying 
information about quantity from start nodes to end nodes. Table 1 compares 8 types of 
flows diagrams [4]. Most of these representations enable to visualize only one step of a 
process. On the contrary, the Sankey diagram enables to represent several steps along 
with the information about flows’ volumes, and to manage the complexity of the patient 
paths. 
This work aims to assess whether the Sankey diagram is feasible to represent patient 
paths, in a way that would be readable and understandable by clinicians. With this goal 
in mind, two cases were used: (i) paths of patients with the pancreaticoduodenectomy 
and (ii) association between re-operation and mortality. 
Table 1. Comparison of flow diagrams 
 
2. Materiel and methods 
We worked on two different cases to illustrate the design of the Sankey diagram used to 
represent patient paths. Each case aimed to answer a question: (i) in the digestive surgery 
department, what is the patient volume in each care unit after surgical operation for 
pancreaticoduodenectomy and what are the atypical patient paths? (ii) how mortality is 
related to the number of surgical operations during an hospital stay?  
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To design the Sankey diagrams and representing answers to those questions, we 
used data from the anesthesia data warehouse of Lille University Hospital. This data 
warehouse stores and organizes data about surgery and anesthesia procedures (drugs, 
vital signs, steps of surgery) with administrative data (hospital stay characteristics, 
medical unit, entry and discharge modes, medical and surgical acts, diagnoses) [5,6]. 
The Sankey diagrams were designed following three stages. The first stage is crucial 
and consists in determining information needed to answer the question. The information 
are summarized in Table 2. 
Table 2. Aggregated data to upload in the graphical library 
 
The second stage consists in aggregating the data and compute the count of patients 
in each step between two successive states of the path. For each link, we had to provide a 
source node, a target node and the quantity between the two nodes. Finally, these 
aggregated data are loaded into graphical libraries (D3.js and D3sankey [7]). 
The resulting Sankey diagrams were presented to clinicians to get their feedback on 
the readability, the understandability of this visual representation and its impact.  
3. Results 
3.1 Case study 1 : Patient flow for pancreaticoduodenectomy 
Operations of pancreaticoduodenectomy were selected based on the code HNFA007 of 
the French medical act classification (CCAM, Classification Commune des Actes 
Médicaux). For operations between 2010 and 2018, 551 patients were included. We 
selected two significant states of the hospital stay for pancreaticoduodenectomy: the 
post-operative unit and the last unit before discharge from the hospital. These two states 
were characterized with the type of unit (conventional, continuous care or intensive care 
unit) and final discharge status (mortality) was reported. The Figure 2 is the Sankey 
representation for this population. 
Two managers and two physicians examined the Sankey diagram. They were able to 
describe patient flows in each unit after operation. Moreover, physicians highlighted 
atypical paths: some patients were transferred from conventional care unit to critical care 
after operation, and some patient died even thought they did not go through critical care 
beforehand. They reported that this Sankey diagram was intuitive to read, more 
understandable than a table but that they needed contextual information when the graph 
is accessed for the first time. Physicians will now investigate why these patients were not 
treated earlier in an appropriate care unit. 
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Figure 1. Patient flow for pancreaticoduodenectomy 
 
3.2 Case study 2: Mortality rates after re-operation 
Between 2010 and 2018, 473953 patients underwent operation. For each patient, we 
computed the number of operations, and final discharge status (death). In order to get the 
most out of the diagram, two key points were relevant. First, we had to define a 
maximum number of operations to be covered. Secondly, we had to display results in 
percentages to compare modalities with small numbers (3rd and 4th surgical procedures) 
with larger modalities (1st and 2nd surgical procedures). With the Sankey diagram in 
Figure 2, we can see that mortality and re-operation rates increase with the number of 
operations performed during the same hospital stay. This diagram has been shown to 2 
managers and 2 physicians, and they all agreed on the intuitiveness of the information 
displayed. They only asked for contextual information to know the source of the data. 
According to them, this result will be the starting point of research program about how 
going through multiple operations could impact mortality rates. 
 
Figure 2. Sankey diagram representing the mortality and re-operation rates 
according to the number of operations during 
a hospital stay 
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4. Discussion 
In this paper, we offer a way of visualizing patients’ path with the Sankey diagram. This 
representation allowed managers, physicians and researchers to visualize the paths of 
patients, to detect atypical patient flows between units and to provide visualization 
support for research questions. We will now investigate which signals in operating room 
and post-anesthesia care unit could be use to detect patients prone to complications and 
refer them to an intensive care unit as soon as possible. 
Usually, end-users are provided with data in a table format, on a case-by-case basis, 
or for a single step of the patient path. With the Sankey diagram, the benefits reported by 
users are that this representation is easily understandable, gives a useful overview of 
patient path and offers the opportunity to identify atypical paths that they may not have 
seen otherwise. It could also be used as a way to validate their hypotheses and further 
investigate. 
However, the implementation of such diagrams might be challenging as patient 
paths have more than two steps and are complex. Thus, the data aggregation must be 
adapted to the specific issue to deal with. Morevover, the steps displayed must be 
selected to highlight important facts and avoid overload of information. 
A limitation of the Sankey diagram, with its current implementation, is that it is not 
possible to follow an individual path from the first to the last node. The next step is to 
improve the current Sankey representation by adding a traceable multi-level feature. This 
would represent a more precise way to highlight a specific path. 
Another perspective would be to offer an online Sankey visualisation tool, in which 
the users would select the targeted population (e.g. a surgical act) and predefined steps 
(e.g. surgical complication) to have a display of the corresponding patients’ path.  
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Abstract. The increasing demand for territorial services requires the improvement 
of the coordination and cooperation among stakeholders in planning and delivery 
of integrated health and social services. In this scenario, to improve the 
communication among stakeholders there is a need of a formal conceptual model 
that facilitates the interoperability between organizations and professionals. This 
paper presents the methodology adopted by a UNINFO working group established 
in Italy to extend the ContSys standard with social care concepts to integrate health 
and social care contexts in a continuity of care perspective. An example of this 
extension is also provided considering the definition of patient’s care plans. 
Keywords. Continuity of Care, Integrated Care, ContSys standard, Semantic 
interoperability, Health and social care services  
1. Introduction 
In recent decades there has been a change in the provision of health services privileging 
home care over hospitalization [1]. This is considered a sustainable approach that not 
only leads to significant cost savings, but also allows optimal results to be achieved in 
providing high-quality health services as well as offering an improvement in the 
individual’s quality of life [2]. Furthermore, the rapid development of medical and non-
medical technologies facilitates the provision of home care services, supports care 
coordination among professionals as well as allows remote patient monitoring [3]. 
However, a critical aspect considering the provision of services both in the home 
environment and in the community is their fragmentation that leads to scarce outcomes 
and wasted resources [4]. Thus, in this perspective, an important target to be 
accomplished is the improvement of the coordination and cooperation among 
stakeholders considering the different needs of the target population both between 
primary and secondary care (vertical perspective) and between health and social care 
settings (horizontal perspective). In this scenario, one of the first issues to be tackled to 
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improve the communication among stakeholders is the definition of a formal 
conceptual model that defines the concepts needed to facilitate the interoperability 
between organizations and professionals. Among the standards developed in healthcare 
ContSys (A system of concepts for the continuity of care, formally ISO 13940 [5]) 
represents a suitable starting point to accomplish our task. It is focused on semantic 
interoperability that is one of the major requirements to achieve the continuity of care. 
ContSys has the advantage of considering continuity as the integration of different 
health services provided by formal and informal carers belonging to different types of 
organizations such as primary care, hospital, territorial, community. Moreover, this 
standard provides a comprehensive conceptual framework to describe generic concepts 
that represent both the content and context of the health services with well-defined 
relationships among a large set of classes that describe in details the healthcare process 
[6]. However, even if ContSys states that also social care has the objective to influence, 
restore and maintain health, this standard only indirectly include social care within the 
wider spectrum of health concepts. This paper starts from a previous work [7,8] where 
we introduced a preliminary idea of an integrated model that collates healthcare, social 
care and assistive domotics elements to define the conceptual model of an interoperable 
open platform, called H@H, that organizes the provision of a set of home care services. 
The resulting conceptual model was confined on the portion of the ContSys standard 
fitting with the purposes of the H@H project. Starting from the results achieved in 
these papers a working group was launched at the UNINFO, the branch of the Italian 
National Unification (UNI) Standardization body that tackles the Information and 
Communications Technology (ICT) activities, to put in practice the idea of extending 
the ContSys standard as a whole.  
The aim of this paper is to describe the methodology adopted by the working 
group to extend the ContSys standard with social care concepts to establish an overall 
schema that models the integration between care professionals in a continuity of care 
perspective. The steps of the methodology are described in Section 2, while Section 3 
reports the application of these steps to define patient’s care plans.  
2. Methodology  
The extension of the ContSys model was performed on the basis of the following steps.  
Step 1. Analysis of the ContSys concepts in the light of the social context. Given 
the structure of the ContSys standard and the relevant technical document, each clause 
of the conceptual schema was analysed taking into account its concepts as well as the 
related classes. Each concept was analysed considering its definition, the relationships 
with the relevant classes (type, name and cardinality) as well as notes and examples. 
On the basis of this analysis the working group determined whether the concept can be:  
a. Included as it is. This category refers to universal concepts that already 
include in their definition, notes and examples references to social care. 
Examples are: subject of care, health resources such as funds;  
b. Included but extending the vocabulary with social references. These concepts 
need to be revised in terms of notes and/or examples or slightly modified in 
their definition. Examples are: health matter, contact.  
c. Included identifying a new specific concept. These concepts explicitly describe 
the clinical process but have a counterpart within the social context and can be 
integrated within the model. This required the creation of a new concept 
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targeted to the social model. This can imply the redefinition or the 
introduction of new relationships. Examples are: clinical process, health issue. 
d. Excluded given that these concepts describe the clinical side of care and are 
not needed for the social context, such as adverse event.  
Step 2. Definition of the combined model. Once all concepts were analysed a 
conceptual schema describing the social side of care and its relationships with the 
clinical side of care was defined. The resulting model was composed of three main 
sections. The first two sections describe separately the healthcare and the social care 
contexts, while the third one concerns concepts that are shared between the two above 
mentioned sections. Moreover, additional associations are determined to capture the 
relationships between the health and the social parts of the schema.  
Step 3. Definition of the integrated model. Once the model that combines both the 
healthcare and the social care perspectives is defined, the final step of the methodology 
concerned the identification and modelling of the part of the model where services are 
delivered in a professional collaboration and integration perspective. This is mainly 
applied considering the assessment and planning activities that can be carried out by a 
multidisciplinary team of specialists belonging to health and social care organizations.  
The analysis carried out during each step of the methodology can facilitate the 
refinement of the models defined in the previous steps in an iterative approach. In the 
following paragraph an example of the application of the methodology is described 
analysing the healthcare planning clause of the ContSys standard [5].  
3. Results  
Figure 1 shows the combined model (see step 2 of the methodology described in the 
previous paragraph).  
 
Figure 1. Combined model highlighting classes defined in the ContSys Healthcare Planning clause (white) 
and those defined in other clauses (grey). <<Stereotype>> highlights health and social care classes.  
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The core class of the social section is the Individual Care Plan (ICP) (also known 
as Piano Assistenziale Individuale (PAI) in Italy) that is focused on one or more social 
needs. It is composed of a set of needed social care activities and a set of planned or 
delivered social care activities. The plan is stored in a social record that concerns a 
specific subject of care. A similar description can be seen considering the healthcare 
section of the schema, while in the common section a set of goals and objectives that 
are in common in both contexts are associated with health and social care plans. 
Similarly, the health thread, that is in common with the two sections of the schema, is 
adopted to associate both health issues and social needs of the relevant subject of care. 
As introduced in the methodology, the integration of health and social care contexts 
does not only imply that a subject of care accesses to these services separately, but also 
to a set of activities that are carried out by a multidisciplinary team in an integrated 
approach in a continuity of care perspective. This may occur especially during the 
planning activities. In case of an integrated context, a set of activities may be provided 
by a team on the basis of a collaborative and continuity of care approach. For this 
reason, the planning clause of the model was additionally extended by including the 
integrated plan of care concept. It is important to stress that an integrated plan cannot 
be considered only as a composition of health and social care plans because it has to:  
 Incorporate a set of needed and provided health, social care and integrated 
care activities;  
 Target a set of objectives and goals, that are shared between contexts; 
 Be stored in an integrated care record;  
 Be applied by different actors involved in the health and social care sectors; 
 Plan a healthcare process that describes both health and social care contexts;  
 Address a health thread that links both health issues and social needs;  
 Be planned during a set of integrated activities involving both health and 
social care professionals (integrated planning); 
On the basis of these features an additional model that describes the healthcare 
integrated planning clause is defined and shown in Figure 2. 
 
Figure 2. Integrated model highlighting classes defined in the ContSys Planning clause (white) and those 
defined in other clauses (grey). <<Stereotype>> highlights health, social and integrated care classes.  
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4. Discussion  
This paper describes the methodology proposed by the UNINFO Working Group in 
Italy to extend the ContSys standard to social concepts. It provides an example of the 
definition of the individual care plan established in the social context to track the 
activities (both needed and provided) related to one or more social needs of a specific 
subject of care. Moreover, as different services can be planned and provided by a 
multidisciplinary team composed of both health and social care professionals, an 
integrated plan is envisioned. The adoption of the integrated model could facilitate the 
interoperability between systems as well as the coordination and cooperation activities 
of the different actors involved in the provision of services in a comprehensive 
continuity of care process.  
At the moment the UNINFO team has analyzed the different concepts of the 
standard identifying an extension of the model as well as capturing the part of the 
model where an integrated view of the care can be modelled. Moreover, thanks to the 
interdisciplinary composition of the team, that also comprises researchers and 
professionals belonging to social care, a set of scenarios have been collected to capture 
and assess the completeness of the extended model. The debate set up within the 
UNINFO group can be a starting point to provide suggestions to the established ISO 
working group for the revision of the ContSys standard.  
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Abstract. Introduction:  Computable phenotypes are gaining importance as 
structured and reproducible method of using electronic health data to identify people 
with certain clinical conditions. A formal standard is not available for defining and 
formally representing phenotyping algorithms. In this paper, we have tried to build 
a formal representation of such phenotyping algorithm. Methods: We built EN 
13606 EHR standard for building clinical archetypes to represent the computable 
phenotyping algorithm for ‘diagnosis of cardiac failure’. As part of this work, we 
created a set of new clinical archetypes for defining ‘cardiac failure diagnosis’. The 
EN13606 editor called Object Dictionary Client was used which was in-house 
developed by University College London. We evaluated the ability of EN 13606 to 
provide clinical archetypes to define EHR phenotyping algorithms using the 
predefined desiderata for the purpose [Mo et al]. Results: EN 13606 archetypes 
could represent phenotype components grouped and nested based on their logical 
meaning. It was possible to build the EHR phenotyping algorithm with the clinical 
elements and their interrelationships along with hierarchical structure and temporal 
criteria. But the specific mathematical calculation and temporal relations involved 
in the algorithm was difficult to incorporate. These will need to be coded and 
integrated within the clinical information system. These archetypes can be mapped 
for comparison with the openEHR models. Binding to external clinical terminology 
is fully supported. However, it does not satisfy all the desiderata defined by Mo et 
al. A possible way could be an approach using phenotype ontologies and its 
architectural representation integrated with ISO interoperability. Conclusion: The 
EN13606 archetypes can be used to define the phenotype algorithm that basically 
identifies patients by a set of clinical characteristics in their records. Phenotype 
representations defined in EN 13606 do not satisfy all the desiderata proposed by 
Mo et al. and thus currently has a limited ability to define the computable 
phenotyping algorithms. Further work is required to make the EN13606 standard to 
fully support the objective. 
Keywords. computable phenotypes, EN13606, archetypes, EHRs, algorithms. 
1. Introduction 
A computable phenotype refers to a clinical condition or characteristic that can be 
determined with a computerised query to an Electronic Health Record (EHR) system or 
clinical data repository using a defined set of data elements and logical expressions 
(https://rethinkingclinicaltrials.org/resources/ehr-phenotyping/). Standardised 
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computable phenotypes can promote efficient and reliable recruitment in clinical trials 
across various clinical faculties and health systems.  
A formal standard is not available for defining and formally representing 
phenotyping algorithms in a standardized way. Hence the automatic or computerized 
translation of phenotyping algorithms to computational implementation code is not 
possible. In this paper, we have tried to build a formal representation of such phenotyping 
algorithm using EN 13606 EHR standard. Similar work has been done to evaluate 
openEHR standard for building computable phenotyping algorithms [1]. This attempt 
shall add to the learning process. 
 
1.1 CEN/ISO EN13606 and Clinical archetypes: 
The CEN/ISO EN13606 is a European norm from the European Committee for 
Standardization also approved as an international ISO standard [2] intended to support 
the interoperability of systems and components that need to communicate EHR data: 
EN13606 follows an innovative Dual Model architecture. The former is structured 
through a reference model (RM) [3] that is an object-oriented model used to represent 
the generic and stable properties of health record information and the later is based on 
clinical archetypes [4,5]. Figure 1 shows the building blocks or classes of EN13606 RM, 
such as Folder, Composition, Section, Entry, Cluster and Element. 
An archetype is a formal and standard way of representing the clinical data structures 
and their inter-relationships for a given clinical domain. They are content specifications 
expressed in terms of constraints on a specific reference model [6]. Archetypes specify 
EHR clinical data hierarchies and the kinds of data values used within each entry [7].  
Figure 1: Structure of the reference model of EN13606 and EHR extract hierarchy [8]  
2. Methods 
2.1. Clinical condition/characteristic and its algorithm chosen for phenotyping: 
We chose ‘cardiac failure’ as the clinical condition, diagnosis of which would need a 
computable phenotyping algorithm.?We used a previously validated EHR phenotyping 
algorithm for identifying and diagnosing patients with cardiac failure. 
(https://www.mdcalc.com/framingham-heart-failure-diagnostic-criteria) The algorithm 
as shown in Fig. 2, represents clinical information that contributes towards the diagnosis 
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of cardiac failure. The algorithm was designed to 
identify patients with cardiac failure. Identification 
of various types of cardiac failure is not taken into 
consideration here.  
2.2. Building Clinical Archetypes: 
Archetypes relevant to ‘cardiac failure diagnosis’ 
were not found in the publicly available archetype 
repositories or libraries like the ‘Clinical Knowledge 
Manager’ by the openEHR foundation 
(https://www.openehr.org/ckm/|) or ‘Ocean 
Informatics’ (https://www.openehr.org/ 
industry_partners/ocean_informatics). As part of this 
work, we created a set of new archetypes for defining ‘cardiac failure diagnosis’ 
underpinned by the EHR standard EN 13606. The EN13606 editor called Object 
Dictionary Client (ODC) was used which was in-house developed by University College 
London, which is recently published, and the information models built with it are open 
source for use [9].  
The EN 13606 Archetype describes the definitive semantic model of archetypes. It 
defines data types, constraints, and a reference mechanism allowing one archetype to 
reference another (slot). Archetypes are usually built and implemented with the help of 
templates, that help to combine the various archetypes together in a logical manner. EN 
13606 uses the Archetype Definition Language (ADL) for building the archetypes and 
Archetype Query Language (AQL) for querying the data. 
2.3. Desiderata for assessing clinical archetypes: 
We used the desiderata published by Mo et al [10] to evaluate the ability of EN 13606 to 
build clinical archetypes to define EHR phenotyping algorithms.  Mo et al. reviewed 
common features for multisite phenotype algorithms and proposed 10 desired 
characteristics for a flexible, computable Phenotype Record Model.  
3. RESULTS  
a) Archetypes created for computable 
phenotyping algorithm: Archetypes 
created were organized into a single 
composition with subgroups composed of 
number of elements (Fig. 3). Each node 
represents a data element, which is bound 
to external clinical terminologies (Read 
Codes, ICD-10 and SNOMED CT). 
Additional constraints are added to each 
data element including, the cardinality, 
optionality, datatype, value range and 
units for a physiological quantity, internal  
Figure 2. Cardiac failure EHR 
phenotyping algorithm for the diagnosis 
of Heart failure  
Figure 3 Clinical archetype built in ODC, an EN 
13606 archetype editor 
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codes, etc. With EN 13606 archetypes, the components of a phenotype algorithm 
could be grouped or nested based on their clinical semantics into Symptoms, Signs, 
Investigation Results, Diagnoses, Treatment or Procedures. It can very well define 
the hierarchy of the data elements and the interrelationships between the data 
elements with the help of its Record Model (RM) properties along with the archetype 
slot mechanism. Still, it provides a very limited way to express the actual logic of the 
phenotype algorithm (especially the relational algebraic operation).  
b) Dessiderata for assessing clinical archetypes: (here we have partly followed the 
pattern used by Papez et. Al, to represent the desiderata for assessing clinical 
archetypes for phenotyping algorithms) [1] Here we represent the desired desiderata 
[8] and where EN 13606 standard stands to satisfy it, to define phenotyping 
algorithms. 
Table1: Summary of the feasibility of EN13606 archetypes in in defining EHR phenotyping 
Desiderata by Mo. 
et al 
 
Evaluation of EN 13606 EHR standard in defining computable 
phenotype algorithms 
1. Human-readable 
and computable 
representation 
Fully supported: Clinical Archetypes are defined in ADL and templates are stored 
as XML. EN 13606 editors can transform the archetypes (in ADL) into human-
readable format such as Hypertext Markup Language (HTML) and vice versa.  
2. Set operations and 
relational algebra 
Not supported: Need to be coded and integrated with the EN 13606 clinical 
information model/system  
3. Structured rules 
Not supported: These need to be coded and integrated into the clinical information 
system  
4. Temporal 
phenotype criteria 
Partially supported: Archetypes support temporal criteria using points in time or 
time intervals. Temporal relations need to be coded within the clinical information 
system  
5. Standardized 
nomenclature 
Fully supported: Supports binding of the names/values of the data elements with 
external standardized controlled clinical terminology or classification systems 
(e.g. ICD-9, ICD-10, Read Codes v2/v3, SNOMED CT) 
6. External 
interfacing 
Partially supported: The entire EN13606 model can be viewed in the AWB RM 
schema and Class tools, and comparisons can be made with classes in the 
openEHR reference model.  
7. Backward 
compatibility 
Fully supported: The tracking of changes during their development and evaluation 
is feasible and older versions can be referred to.  
4. Discussion 
Since EN 13606 archetypes define the characteristics/attributes of a set of data elements 
and phenotyping algorithms are primarily based on identifying patients satisfying a list 
of criteria (e.g. signs, symptoms, investigation results, diagnosis, etc.), archetypes could 
be used for defining the computable phenotyping algorithms especially for their content, 
hierarchical structure, interrelationships of data, and temporal criteria. EN 13606 
however does not satisfy all the desiderata defined by Mo et al in defining the EHR 
phenotyping algorithms, especially the algebraic operations and temporal relations. 
Natural language processing is not provided by EN 13606 and external interfacing is 
limited. The example of ‘cardiac failure diagnosis’ is fairly simple but more complex 
diagnostic criteria for various diseases would require algebraic and temporal relations to 
be operated and some would demand external interfacing as well.  
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A possible way could be an approach using phenotype ontologies and its 
architectural representation. The most recent published version of ISO 13606 (late 2019) 
refers to this approach by integrating the ISO Interoperability and Integration Reference 
Architecture [2] that formalizes the relationship between clinical domains and their 
information representation. Without that formalization, there is a risk that archetypes will 
proliferate to formalize pieces of a domain in disconnected and ad hoc ways. Ontologies 
can successfully formalize the representation of a domain, and therefore be an 
appropriate semantic anchor for the development of archetypes. With that starting point, 
an implementation of computable and easily searchable phenotype definitions 
implemented as FHIR resources is a feasible way. Furthermore, a phenotype ontology 
also offers rich logical relationships including the consideration of relevant context., and 
the desiderata defined by Mo et al. such as the delivery of structured rules, temporal 
criteria, etc. could be better met by the described alternative approach. By deploying the 
Interoperability Reference Architecture part of ISO/EN 13606, transformation between 
the different representation styles including archetypes can be easily performed. 
5. Conclusions 
EN 13606 archetypes could be used for defining the computable phenotyping algorithms 
especially for their contents, hierarchical structure, interrelationships of data, and 
temporal criteria to identify patients with a set of clinical criteria. However, it does not 
satisfy all the desiderata defined by Mo et al. and hence further attempts are required to 
achieve the objective, especially for more complex phenotyping algorithms. Clinical 
archetype editors underpinned by EN13606 EHR standard might need to be used along 
with some other programmes to make it completely feasible to represent the phenotyping 
algorithms. Thus, EN 13606 currently has an ability to define the computable 
phenotyping algorithms but has its limitations.  
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Generation?of?Fine?Grained?Demographic
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Abstract.?Cancer?risks?may?be?influenced?by?local?exposures?such?as?working?con-
ditions?or?nuclear?waste?repositories.?To?find?influences,?local?accumulations?of?can-
cer?rates?are?used,?for?which?finely?granulated?data?should?be?utilized.?In?particu-
lar,?high-resolution?demographic?data?for?a?reference?population?are?important,?but?
often?not?available?for?data?protection?reasons.?Therefore,?estimation?methods?are?
necessary?to?approximate?small-scale?demographic?data?as?accurately?as?possible.?
This?paper?presents?an?approach?to?project?existing?epidemiological?and?public?data
to?a?common?granularity?with?respect? to?attribute?characteristics?such?as?place?of?
residence,?age?or?smoking?status?to?allow?for?analyses?such?as?local?accumulations?
and?consistently?falls?below?an?average?relative?error?of?5%.
Keywords.?Health?Data?Science,?Data?Analysis,?Population?Synthesis,?Microsimulation
1. Introduction
The risk of cancer can be increased by the degradation of nuclear waste repositories and
the associated radiation exposure of the immediate environment. Local accumulations
are a type of analysis in cancer epidemiology to correlate geospatial impact with cancer
risk and requires finely granular data from cancer incidences and a reference popula-
tion. In epidemiological cancer registries, the reference population is often more coarsely
granular than the incidences due to data protection, making an approximation of the pop-
ulation at the incidence level desirable. This paper presents an approach for the genera-
tion of fine-grained data using iterative proportional fitting (IPF) combined with cellular
automata (CA) for exemplary application in analyses of epidemiological cancer registra-
tion (ECR) in Lower Saxony and evaluates the accuracy and reliability of the generation.
In the ECR, data is evaluated pseudonymised by the registry unit, which as a re-
sult of the analysis for the verification of a suspicion can request the underlying not
pseudonymised data from the confidentiality unit [1]. In order to form a suspicion, exact
results are therefore not necessary at first, since the analysis is finally carried out on the
1Corresponding Author: Timo Wolters, OFFIS - Institute for Information Technology, Escherweg 2,
Oldenburg, Germany; E-mail: timo.wolters@offis.de.
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data of the confidentiality unit. However, too large an approximation error leads to false
suspicions and should therefore be minimized.
Incidences are present in the ECR for Lower Saxony in a geometric grid with an
edge length of 1km (1km grid) while the reference population is present at municipal-
ity level. Figure 1 shows the difference between the municipality level and a 1km grid,
while the actual distribution of the population is shown in a 100m grid using the mu-
nicipality of Oldenburg. The 1km grid has a much finer resolution than the municipality
and better reflects the spatial distribution of the population, especially with respect to the
temporal stability of a grid in contrast to frequently changing administrative boundaries
of municipalities [1].
Figure 1. Granularity comparisons between a municipality, an 1km grid and an 100m grid for Oldenburg in
Lower Saxony.
After Section 2 has outlined related work on population synthesis and microsimu-
lations, Section 3 describes our approach to generate fine-granular data. Section 4 ex-
plains the implementation details and Section 5 evaluates the generation of the popula-
tion, while Section 6 describes future work and summarises this contribution.
2. Related Work
Ballas et.al. investigate in [2] location-based microsimulation systems for population
synthesis. Population synthesis usually combines fine granular census data with coarse
granular data to approximate a synthetic population between two censuses or to add
missing attributes. Population synthesis can be divided into population reconstruction,
probabilistic reweighting and deterministic reweighting.
Iterative Proportional Fitting (IPF) is according to Moretti et.al. [3] a method for
deterministic reweighting to map the distribution of coarse granular data (deaggregated
data) to fine granular data (aggregated data). For this a unambiguous mapping between
deaggregated and aggregated data is necessary. This mapping does not exist between a
1km grid and administrative boundaries of municipalities, so that IPF alone would not
be sufficient to synthesize a reference population.
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Basse et.al. [4] deal with exactly this problem using cellular automata (CAs) and
neural networks. Cellular automata are used to simulate land use for grid cells in border
regions, while neural networks are used as a probabilistic model. However, the applica-
tion of neural networks requires a large demographic database, which is not available in
ECR. Therefore, the combination of IPF and CA in this paper is necessary for population
synthesis in order to counteract problems in border regions and insufficient data volumes.
3. Concept
For the concept, the data basis should first be considered. The aggregated data for IPF
contain the demographic information with 10-year age classes and without reference
to the two gender classes in a 100m grid of the 2011 census. The deaggregated data
contain demographic data at municipality level with 1-year age classes with reference to
the gender classes and sparsely smoker status or occupation as cancer specifc attributes.
Additional data are information from the census on households and families and are used
in the integration of CA with IPF. From the deaggregated data, statistical ratios such as
the proportion of a 1-year class in a 10-year class are extracted as additional information.
This results in a vector U = {U1,U2, . . .} of attributes that are to be generated with
a function PU,C by assigning a probability pi, j to each attribute characteristic ui, j ∈Ui,
taking into account the deaggregated data as context C. PU,C gets as argument a vector
A = {a1,a2, . . .} of the aggregated data so that a random number π ∈ [0;1] together
with A calculates a vector u = {u1,u2, . . . |ui ∈ Ui} representing a single person with
all required attributes. A CA then checks the conformity of the generated data with the
family, household and demographic data and gradually adapts the demography so that the
information on families and households is reflected in the demographic data, but meets
the constraints of the municipality demography.
In the application, U = {age,gender,residence} is used with 1-year age groups
up to 80 and the 100m grid of the census as a place of residence. The vector A =
{age10,residence,gendern,households, f amilies} contains the 10-year age groups up to
80 of the census, the same place of residence and the number of men and women living
in the grid cell together with the information on families and households for the CA.
Other attributes such as smoker status or hormone receptor information for lung cancer
or breast cancer, for example, are also possible forU and A if the necessary data are avail-
able. Based on epidemiological cancer registration, smoking status information is rare
and hormone receptor information is not available, but hormone receptor information
should be reported in the clinical cancer registration for estrogen in breast cancer.
After generation, an additional function p¯ is applied, which can serve as a bias. p¯ is
particularly useful if generation is to be carried out for years other than the census year,
since population changes and changes in administrative boundaries can be modelled here.
On the other hand, this function can be used to correct inconsistencies between different
data sources.
4. Implementation
The data of the census are available in tables with about 6 columns, but 61 million entries.
Partitioning based on characteristics (age, gender) is essential to shorten access times
T. Wolters et al. / Generation of Fine Grained Demographic Information 235
to the data. The geo references of the census are used to link the sub-data sets of the
aggregated data and a mapping to municipalities is used to link the deaggregated data.
Population synthesis uses IPF for an initial statistical distribution of personal char-
acteristics in the grid cells of the municipality. On the basis of this distribution, CA is
used to generate people probabilistically until the statistical distribution is approximated,
taking into account household and family data, or a certain number of iterations has been
reached. However, the average number of persons per grid cell is 6, so that the empiri-
cal law of large numbers cannot be applied to the probabilistic method to approximate
the statistical distribution. An adaptation of probability from [5] helps to achieve faster
convergence despite small numbers of people. For this purpose, logistic growth is used
as an adaptation function with the turning point (1, pi) for the basic probability of a fea-
ture, and the limits are defined by pu = 1.5 · pi and pl = 0.5 · pi. The abscissa x counts
the occurrence of an event and the higher x is, the greater the probability of the counter-
event, whereby the occurrence of the counter-event x can either be set to 1 (hard reset) or
reduced by 1 (soft reset). p¯ is trained with municipality data from the census year 2011
and a target year, e.g. 2017, so that the generation can also be used for other years.
5. Evaluation
The evaluation of the data quality on the 1km grid is not possible, because data with
comparable accuracy are missing. Instead, the generated 100m grid cells of the map step
are aggregated at the municipality level and compared with the previous municipality
data for the year 2011. p¯ thus has no influence on the data quality, since the identity
function is used for 2011. Since the procedure is probabilistic, several iterations should
be considered for evaluation. The influence of probability adaptation (PA) should also
be measured to determine the necessity and contribution to stability of the adaptation.
A total of 12 iterations with and without probability adaptation were performed, with
Figure 2 showing the best results of the iterations based on the relative error for the
generated gender distribution in the municipality average.
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Figure 2. Relative error in Lower Saxony in 2011 with and without probability adaptation.
The total plots in Figures 2a and 2b are identical and reflect the relative error of the
number of persons generated between the 100m grid and the municipality level. The aim
of the procedure should be to distribute the error as evenly as possible over the individ-
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ual characteristics in order to achieve stable convergence. The generation without PA in
Figure 2a shows a clearly higher variance, in particular the even distribution of the er-
ror on the characteristics does not take place, because a low error for one gender results
in a high error for the other gender. Without PA, for example, the maximum error can
vary between 4% and 12%, while with PA it can vary between 7% and 8% as Figure 2b
indicates. Overall, PA is necessary as a factor for the stabilization and reliability of the
procedure, whereas the synthesized population for Lower Saxony deviates from the ac-
tual population by an average of 2.7% and can therefore be used for the analysis of local
accumulations.
6. Conclusion
Currently, p¯ is used for 2011 as an identity function or to represent the population for
other years. It is conceivable that this function can also be trained to minimize errors, so
that overall errors and thus also the generation error of the characteristics decrease and
can lie within the 99% confidence interval. In addition, the procedure can also be used
for regions other than Lower Saxony or for data with other granularities. Furthermore,
the method can also be applied for the approximation of health information described in
[6], e.g. supply chain company networks on different levels (personnel, specialist groups,
company groups) for drug research or for clinical studies, in order to dissolve clusters if
necessary and to reduce study costs by data approximation in preliminary studies.
This paper has given an overview of various granularities of demographic data in
epidemiological cancer registration and a probabilistic procedure for approximating ac-
tual demographics for a 1km grid using a combination of Iterative Proportional Fitting
(IPF) and cellular automata (CA). For this purpose, municipality-level data were com-
bined with data from the 2011 census for Lower Saxony, so that a statistical distribution
was created by IPF as a framework for the actual generation of the population by CA
in a 100m grid. The generation error in relation to known data is on average 3%, but a
detailed evaluation on 100m or 1km grids was not possible because no reference data
were available.
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Abstract. One major obstacle to developing precision medicine to its full potential
is the privacy concerns related to genomic-data sharing. Even though the academic
community has proposed many solutions to protect genomic privacy, these so far
have not been adopted in practice, mainly due to their impact on the data utility. We
introduce GenoShare, a framework that enables individual citizens to understand
and quantify the risks of revealing genome-related privacy-sensitive attributes (e.g.,
health status, kinship, physical traits) from sharing their genomic data with (poten-
tially untrusted) third parties. GenoShare enables informed decision-making about
sharing exact genomic data, by jointly simulating genome-based inference attacks
and quantifying the risk stemming from a potential data disclosure.
Keywords. genomic privacy, privacy-conscious tools, risk quantification, inference
1. Introduction
The growing number of health data breaches [1] and the recent revelations about the use
of free genealogical databases for law enforcement purposes [2] are increasingly eroding
public trust in social media, genealogy websites (e.g., 23andMe and Ancestry.com) and
personalized medicine initiatives (e.g., the U.S. All of Us Research Program and the
U.K. 100,000 Genomes Project), worldwide. Guaranteeing individuals’ genetic privacy
is becoming a major challenge for those who want to encourage sharing of medical data
for research purposes and better personalized medicine. In response to this demand, the
computer security community has made a remarkable effort in providing solutions to
secure the storage [3], and the processing of genetic data [4,5,6,7,8]. Yet, the issue of trust
goes beyond the provision of secure storage and processing. It is also intimately related
to the question of control over what data is shared and what information it conveys. In
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Figure 1. High-level representation of the GenoShare framework.
this paper, we introduce GenoShare, the first decision-support framework that provides
individuals with guidance at the time of deciding what data can be shared without risking
the undesired disclosure of sensitive information.
2. Methods
Let’s assume an individual wishes to share part of her genetic profile with a public or
private third party in order to join a personalized medicine study or obtain some genetic-
related services, but she is concerned about her genetic privacy. Upon reception of a re-
quest for genetic data sharing, such an individual can use GenoShare to quantify the risk
of sensitive attribute disclosure associated to revealing those data. To this end, GenoShare
simulates the combination of inference attacks relevant to the privacy concerns of the in-
dividual (e.g., revealing the participation in a sensitive study, revealing undisclosed kin-
ship, revealing predisposition to certain health conditions) and, based on the information
available to the adversary, measures the risk of a potential privacy breach. We consider
that a realistic adversary could have access to: (i) part of the individual’s genetic profile
obtained in the past, (ii) the statistical regularities within the genetic population to which
the individual belongs (e.g., linkage disequilibrium, allele frequencies), (iii) the effect-
size statistics of the genotype-phenotype association, (iv) the genetic profiles of the indi-
vidual’s relatives who might have already joined the study, and the (v) aggregate statistics
from other studies in which the individual might have participated. GenoShare is a mod-
ular framework and enables different parameterizations (i.e., different levels of adversar-
ial prior knowledge) and the instantiations of different inference attacks, according to the
data-sharing context (Fig. 1). Furthermore, GenoShare provides a mechanism, based on
the generation of synthetic genomes called avatars, to protect individuals’ genetic pri-
vacy from inferences stemming from decision to not release the requested data. Details
about the algorithms underpinning GenoShare are described in the extended version of
this paper [9].
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3.? Results
To? show? how?GenoShare? can,? in? practice,? support? privacy-conscious? decisions?when?
sharing?genetic?data,?we?implement?an?operational?prototype?in?Python?with?a?Web?user?
interface.?We?instantiate?it?with?three?of?the?most?important?genomics-oriented?inference?
attacks?that?we?re-adapted?to?work?on?a?joint?manner?and?on?adversarial?partial?knowl-
edge:?the?phenotype?inference?attack,?the?membership?inference?attack?and?the?kinship?
inference?attack.?For?our?experiments,?we?used?individual?genetic?profiles?from?the?1,000?
Genomes?Project?[10]?and?considered?different?data-sharing?use?cases?where?the?adver-
sary?has? access? to? an? increasing? amount?of? information? about? the? targeted? individual.?
For?example,? for?a?given? individual,?GenoShare?shows? that? revealing?her?genetic?vari-
ants?related?to?schizophrenia?(400?variants)?introduces?a?risk?of?almost?100%?of?leaking?
the?value?of?her?predisposition?to?bipolar?disorder?and?her?participation?in?a?study?with?
less?than?50?people,?and?a?risk?of?60%?of?leaking?her?kinship?with?a?first-degree?relative?
who?might?be?known?by?the?adversary.?Details?and?figures?about?the?experiments?run?to?
validate?GenoShare?are?described?in?the?extended?version?of?this?paper?[9].
4.? Discussion
Academic?solutions? for?privacy-preserving?sharing?of?genetic?data? that?provide? formal?
guarantees?of?privacy,?such?as?differential?privacy,?have?mostly?focused?on?data?pertur-
bation?(e.g.,?differential?privacy).?Such?solutions,?however,?have?not?been?adopted?by?the?
medical?sector?as?(i)?they?are?only?suitable?for?protecting?genetic?privacy?when?aggregate?
information? is?shared?and? (ii)? they?damage? the?utility?of? the?data?such? that? is? then?un-
usable?by?practitioners.?As?opposed?to?these?solutions,?GenoShare?quantifies?the?risk?of?
sensitive?attribute?disclosure?when?individual?and?exact?genetic?data?is?released?by?using?
novel?meaningful?sensitive?attribute-oriented?metrics?and?by?considering?realistic?adver-
saries?with? limited?and?parametrizeable?background?knowledge.?Finally,? to? the?best?of?
our?knowledge,?GenoShare?is?also?the?first?framework?to?jointly?consider?relevant?attacks?
in?genomic?privacy?in?presence?of?incomplete?information.?Therefore,?it?provides?a?prin-
cipled?answer?to?the?privacy?concerns?that?affecting?the?genomic?community,?and?thus?it?
is?a?firm?step?forward? to?enable? the?responsible?and?privacy-respecting?use?of?genomic?
data?in?research?and?medical?environments.
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Abstract. As widely known, regular accuracy is a misleading and shallow indica- 
tor of the performance of a predictive model, especially in real-life domains like 
medicine, where decisions affect health or life. In this paper we present and dis- 
cuss a new accuracy measure, the H-accuracy, as a more conservative alternative to 
regular accuracy, which we claim is more informative in the medical domain (and 
others of similar needs) for the elements it encompasses. In particular, the proposed 
measure takes into account important information such as the complexity of the 
cases and the case prevalance in the population. We also provide proof that the H- 
accuracy is a generalization of the balanced accuracy and illustrate the descriptive 
power of this score. 
Keywords. Accuracy, Machine Learning, Medical Artificial Intelligence, 
Validation 
1. Introduction 
Statistical and machine learning communities have developed many metrics to assess and 
report the predictive performance of a model [1]: some metrics are common and easy- 
to-comprehend, like accuracy, recall (also known as sensitivity), specificity, the F1 score 
(i.e., the harmonic mean of sensitivity and specificity), and the area under the ROC curve 
(AUROC); others are less common and less straightforward, like the Cohen’s Kappa, the 
Gini coefficient, cross-entropy and Hamming loss.  
However, in the non-specialist literature, like medicine, one measure of model per- 
formance is much more common than the others: accuracy, that is the proportion of cor- 
rect predictions with respect to the total number of predictions made. Despite its apparent 
simplicity, accuracy scores can be misleading. For instance, it is generally well known 
that on imbalanced datasets high values of the accuracy of a model could mirror over- 
fitting with respect to the majority class. In case of datasets where classes are unevenly 
represented, an alternative measure has been proposed instead of regular accuracy: bal- 
anced accuracy, that is defined as the average accuracy obtained on each class individ- 
ually. It can easily be shown that increasing the difference in the prevalence of the two 
classes of a binary discriminative task makes regular and balanced accuracy diverge pro- 
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gressively, so that the meaningfulness of the former and more common type of accuracy, 
which is blind to class prevalence problems, can be disputed1 [2]. 
We also believe that regular accuracy is only a partial way to convey meaningful 
information on the usefulness and practical value of a predictive model, mainly because 
it overestimates the model performance and does not take into account important 
characteristics of the test set, like the class (im)balance, the complexity of the cases 
correctly identified or the importance of rightly detecting one class at the expense of the 
other(s), according to the users’ preferences. 
In this paper we present a new accuracy measure, the H-accuracy, or Ha, which  we 
claim is more informative in the medical domain (and other domain with similar 
requirements) as it covers all of the aspects mentioned above. 
2. Method 
In the following we deal with a classification task in which the set of classes (or labels) 
is C = {l1, ..., lk}; we have a dataset of instances S = {x1, ..., xn} sampled from the space 
of all possible observations X and the real class of instance x is given by a function c : X 
→C. We consider, without loss of generality, only scoring models: that is, models m 
defined as m: X → [0, 1]k where, given m(x) = (l1m (x), ..., lkm (x)), where lim (x) 
represents the confidence attached to the event c(x) = li. We also define m(x) = argmaxli 
lim (x) as the prediction of m. Accuracy of a model m is defined as a(m) =   	
	
 , while Balanced accuracy is defined as Bam   
  	
	

  
We then introduce the formula for the H-accuracy of a model m as:  
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It is easy to prove that Ha is a proper generalization of the balanced accuracy (Ba) 
and, thus, a proper accuracy measure: IJK#KLMNMKO&PQ&&RST&E %& ("U " (V&! D& "&Wi.p(li) =  &XY&W5  ZQ $5
 % [  9:"1;Q 
Then W\Q]
 % !" #"$
. 
3. Discussion 
In this section, we will share some reflections on the different kinds of accuracy scores 
that Formula 1 allows to produce, and on the methods that can be applied to set the τ, p 
and dxparameters. 
3.1. Confidence, for reliability 
First, let us consider confident accuracy (i.e. Ha(τ) = !"  " [
), according to values 
of  !, that is the accuracy of a system that is at least !, confident of its output, such that 
we can claim that “it does not take guesses”. 
This measure finds motivation in how human experts behave: in situations of 
uncertainty they “don’t usually toss a coin” (τ = 50%) but rather abstain, at least 
temporarily, and either look for stronger clues or evidence [3], or refer to the second 
opinion of a more expert colleague [4]. When multiple options are available (i.e., in 
multi-class tasks), experts can choose the option (e.g., the diagnosis) that is more likely 
or plausible among the ones available, but they would still act as the option were true 
only when the plausibility is high enough (otherwise, at least in medicine, a “wait and 
see” attitude is generally recommended [5]). 
Although there are some machine learning applications that apply abstention in 
conditions of uncertainty [6], this approach is not commonly adopted, and hence it is 
common that decision support systems have users considering recommendations that are 
associated with low prediction scores and have a higher chance to be wrong, often 
without their knowledge, and hence mislead them. Setting a τ, and reporting a 
corresponding confident accuracy (Ha(m!)), can help users evaluate this risk. 
Setting a high τ and relying on Ha instead of regular accuracy raises the bar for the 
performance of machine learning in real-world settings and reflects the requirement to 
have really accurate models that minimize “guessing” behaviors in a sensitive context. 
3.2. Priority, for tailorability 
Prioritized accuracy (i.e., Ha(p) = &  " #" [
) is defined according to p values. These 
can be set naively: if &^) must express a clear preference for specificity, p could be 
associated with 0.75 (and 0,25 with respect to sensitivity); and vice versa in case of a 
preference for sensitivity. Otherwise, if no preference is expressed, a balanced 
weighting p = .5 can be adopted.  
On the other hand, priority p can be set empirically in two ways: either explicitly or 
implicitly. The explicit way entails to collect the preferences of a panel of experts for 
the classification task at hand by means of a psychometric questionnaire. The implicit 
case occurs when experts are involved as dataset labelers, and p is set according to their 
performance.  
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3.3 Complecity, for usefulness 
With the term complexity, as hinted above, we refer to decision effort and difficulty to 
classify an instance for the test set. 
But  how  should  dxbe  determined,  and  hence  the  practical  accuracy  (i.e. 
Ha(d) = &  "  " $
) score? Here, we recall that dx is a function returning a 
complexity score for each case x, that is how hard it is to correctly classify the case. 
This function can be determined in different ways, among which we can distinguish 
between direct and indirect methods. In regard to the former approach: we can ask the 
doctors involved to express whether they found a case x difficult or not (0 or 1), as if we 
asked them if that case deserves to be shared with a class of residents or trainees, or 
even with the specialist community, as a case report [7]. Similarly, we could ask them to 
rate how difficult they perceived the case x on an ordinal scale. 
Alternatively, once a gold standard is available or has been established, also indirect 
methods are possible; for instance dxcan be set on the basis of the error rate of the 
raters involved for that specific case x: the higher, the more difficult the case is; or on the 
basis of the confidence the raters express in assessing the case, irrespective of whether 
their answer was correct or not. 
Why assessing complexity is important, and therefore practical accuracy is? Think 
of a very accurate decision support for trivial or easy cases: the medical experts would 
not consult it, or if they do, would neglect and override it with no regret or doubt in case 
they disagreed with it3. Conversely, complex cases are those for which even experts 
would like to receive confirmation or, if lost about them, a proper aid. In these cases, 
right advice can have a strong impact on the final decision, and wrong advice can 
mislead the decision makers, a situation that could be worsened by automation bias (i.e., 
over-reliance on the support, which could be induced by a higher, almost oracular, 
accuracy exhibited by the system on the easy cases). 
For these reasons, we deem the practical accuracy an important measure to compute 
and report, to understand the real utility of a decision support in naturalistic (i.e., real- 
world) decision making by expert practitioners. 
4. Conclusions 
In this paper we aimed to raise awareness that the medical community (like many others 
that increasingly rely on predictive models and decision support systems) must have sin- 
gle, summative but yet comprehensive and informative ways to report and communicate 
model performance and skills. Other contributions have discussed the limits of common 
performance measures (e.g., the AUC [8] and accuracy itself [9]) and proposed how to 
minimize the odds of misinformation about model performance. In addition to this body 
of literature, we make the claim that the current use of the accuracy indicator for under- 
standing and reporting how well a model works (even assuming a proper testing process 
producing such an indicator) falls short of communicating the most important feature of 
a decision support, that is being useful in daily practice. 
                                                   
3Let us just hint at the impact of these ”easy misses” on doctors’ trust and on the perceived reliability of the 
support. 
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Different research groups and companies across the world in the domain of 
machine-learning based decision support struggle to surpass competitors even by a few 
percentage points in accuracy (or related measures), with a common “psychological” 
threshold to interest the medical stakeholders set to 80% at least [10]: besides these 
figures, in this paper we make the point that is more important to inform stakeholders 
and practitioners by also showing them alternative and more conservative accuracy 
measures, with a clear clinical and practical meaning. 
For this reason, in this paper we proposed a general formula that takes into account 
the reliability and relevance of the advice given; we also pointed out meaningful areas of 
the resulting function to focus on specific aspects of the model performance, like 
reliability (cf. ), practicality (cf. d) and priority (cf. p), and some empirical values to 
report a set of accuracy measures that could inform the users adopting a model 
exhibiting such skills, namely confident, prioritized, and practical accuracy. 
These measures regard a static assessment of the accuracy of a prediction model, 
evaluated holistically on a whole test dataset, as an indicator of the usefulness of the 
model. Our future work will explore a more dynamic and case-dependent assessment, 
yielding indicators of the reliability of the model’s predictions: this is the case of a sort 
of local accuracy metrics, that is related to the single new case to classify, evaluated on 
the basis of the performance of the model on the n (e.g., 10) most similar cases in the test 
set, as a function of their similarity to the new case at hand. 
Once more comprehensive static metrics and convenient dynamic metrics have been 
made available to the users, further research should be aimed at evaluating as the user 
experience could change and possibly improve when decision makers can learn these 
additional information about their decision support [11], to mitigate automation bias and 
increase meaningful use and the overall accuracy of a community of decision makers in 
real-world settings. 
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Abstract. Introduction. Electronic health records (EHR) comprehend structured and 
unstructured data, that are usually time dependent, enabling the use of timelines. 
However, it is often difficult to display all data without inducing information 
overload. In both clinical usual care and medical research, users should be able to 
quickly find relevant information, with minimal cognitive overhead. Our goal was 
to devise simple visualization techniques for handling medical data in both contexts. 
Methods. An abstraction layer for structured EHR data was devised after an informal 
literature review and discussions between authors. The “Heimdall” prototype was 
developed. Two experts evaluated the tool by answering 5 questions on 24 clinical 
cases. Results. Temporal data was abstracted in three simple types: events, states 
and measures, with appropriate visual representations for each type. Heimdall can 
load and display complex heterogeneous structured temporal data in a 
straightforward way. The main view can display events, states and measures along 
a shared timeline. Users can summarize data using temporal, hierarchical 
compression and filters. Default and custom views can be used to work in problem-
oriented ways. The evaluation found conclusive results. Conclusion. The “Heimdall” 
prototype provides a comprehensive and efficient graphical interface for EHR data 
visualization. It is open source, can be used with an R package, and is available at 
https://koromix.dev/files/R. 
Keywords. Electronic health records, Visualization, Timeline, Feature extraction. 
1. Introduction 
Electronic health records data usually contain structured data, such as administrative data, 
diagnoses (e.g. ICD10 codes [1]), procedures, administered drugs, medical devices, 
laboratory results, and non-structured data, such as free-text medical records and medical 
imaging. All of them are characterized by their temporal aspects (e.g. the date of a 
measurement, the period of a diagnosis, etc.), and relate to one patient. Structured data 
often take the form of multivalued qualitative variables, encoded using terminologies, 
and supported by a hierarchical tree of sections and codes. 
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Data visualization is interesting within 2 contexts. “Transactional” visualization 
relates to visualization of one patient’s data, in order to provide the patient with 
appropriate care. “Decisional” visualization relates the visualization of several patient’s 
data, for management or research purposes [2,3], notably in the frame of data reuse.  
In both contexts, the main objective of data visualization is to provide the user with 
a comprehensive view, and to enhance the mental process of feature extraction [4], by 
making it easy to detect temporal associations. For instance, in case of INR elevation and 
red cells decrease, a physician infers the patient encountered a hemorrhage. However, 
data complexity may overload the user, leading to interpretation errors [5]. 
Many visual interfaces have been developed for transactional EHR data 
visualization [6], such as LifeLines [7], MultiMedia Stream System (MMSS) TimeLine 
[8], KNAVE-II [9] , TimeLine [10] HARVEST [11], or other prototypes [12–14]. However, 
to our knowledge, such representation methods are rarely implemented in commercial 
hospital information systems. Some visual interfaces have also been developed for 
decisional EHR data visualization, such as OutFlow [15], Care Pathway Explorer [16], 
EventFlow [17], or other prototypes [18–25]. Many of them are dedicated to specific 
tasks. The objective is to propose a visualization method that could either be used for 
transactional or decisional visualization of EHR data, and to evaluate it. 
2. Method 
An abstraction layer for EHR data was first defined, based on an informal literature 
review, and discussions between authors, taking profit from their experience in clinical 
care and data reuse. The prototype was intended to be embeddable in C++ programs, R 
[26], and web pages. 
To evaluate the tool, two medical experts (not involved in the development) were 
asked to retrieved medical information over 24 cases of acute kidney injury (AKI, 
according to the KDIGO criteria [27]). The 24 cases were represented through 3 
interfaces: the classical interface (“classical”: 1 page per type of information, with 
tables), the manually optimized interface (“manual”: the same, but manually filtered, to 
present only relevant data), and the Heimdall interface (“Heimdall”: developed in this 
project, without any prior data filtering). Expert A used “classical” to evaluate records 
#1-8, “manual” for records #9-16, and “Heimdall” for records #17-24. Expert B used the 
same interfaces respectively for records #17-24, then #9-16, then #1-8. Both experts were 
asked to answer five questions for each case (“d0” relates to the date of AKI, which was 
intentionally not explicit): (Q1) Was a nephrotoxic treatment discontinued, at d0 or d1? 
(Q2) Was there a urine dosage of sodium and potassium, at d0 or d1? (Q3) Was there a 
search for proteinuria, at d0 or d1? (Q4) Was there a urinary tract imaging at d0, d1 or 
d2? (Q5) Was a there an ICD10 code of AKI? Number of errors and time required to 
answer were compared using an analysis of variance. 
3. Results 
3.1. EHR data abstraction 
We identified 3 types of information: (1) events, which occur at a single point in time, 
and have a label and a date (e.g. a medical procedure, a document), (2) States, which are 
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characterized by a label, a start date and a stop date (e.g. a hospital stay, a diagnosis), 
and (3) Measures, which are characterized by a date, a label and a value (with or without 
normality range; e.g. a laboratory result, a clinical parameter). 
For each of kind of information, the label could be part of a hierarchical tree. In such 
case, the hierarchy folding had to result in the merging of the symbols. Moreover, 
additional information could be provided, e.g. the content for a document, which is a sort 
of event, or the unit for a laboratory result, which is a sort of measure. 
3.2. Prototype development 
Heimdall is a read-only visualization tool, developed in C++, using OpenGL, and Dear 
ImGui. It is available for MS Windows and GNU/Linux. It can be used through its R 
package, which enables data loading and terminology handling, and can also be 
integrated inside web pages (through WASM and WebGL). 
Pieces of data relating to the same data type are grouped into a component (e.g. 3 
values of blood potassium  a unique curve of kalemia). Each component follows a time 
axis from the left to the right. Components are designed to be stacked vertically. 
Figure 1 shows the representation of components according to their type, and their 
behavior in case of combination (e.g. in case of terminology folding or temporal 
compression). Events are represented as triangles, states as transparent rectangles, and 
measures as curves. When folded, measures are transformed into red events in case of 
abnormal values (outside normality range), or blue events elsewise. The interpolation 
method can be set as Last Observation Carrier Forward, linear, or cubic spline. 
 
 Event State Measure 
Unfolded 
     
Folded      
Figure 1. Unfolded and folded representation of 3 types of components 
 
Figure 2. Example of a medical record (partially unfolded view) 
Figure 2 illustrates a medical record. The main window principally looks like a stack 
of components, with a unique time axis. The components are organized according to their 
hierarchy: (1) patient, then (2) data type (e.g. diagnoses, laboratory results, etc.), then (3) 
the hierarchical tree of the relevant terminology, if so (e.g. ICD10). This organization is 
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compatible with both transactional (one patient) and decisional (several patients) usage. 
In case of multi-patient view, the time axis can be aligned with real dates, or with a 
chosen event (e.g. birthdate, first inpatient stay, or specific surgical procedure). The 
representation of big amount of data is made easier by 3 mechanisms: (1) the time axis 
can be rescaled using control key plus mouse wheel, (2) the top-bottom axis can be 
compressed, resulting in components folding, and (3) a dropdown menu enables for 
quick use of problem-oriented filtered views. For instance, the “renal” view only shows 
diagnoses, procedures, laboratory results and drugs in relation with the kidneys or the 
renal function. The user can create custom views. 
3.3. Prototype evaluation 
Loading data from 3,500 patients, including 360,000 values, in Heimdall from R took a 
couple seconds on a workstation equipped with an old Intel® Core 2 Duo CPU (2009), 
and required about 50 MB of memory (40% for non-character data, 30% for character 
data, and 30% for terminologies/graphic interface/polices). 
The results of the evaluation are presented in Table 1. For both users, the manually 
optimized interface and the Heimdall interface were faster to use than the classical 
interface. The number of errors did not significantly differ. 
Table 1. Results of the evaluation (2 experts * 24 clinical cases * 5 questions) 
Expert Measure “Classical” “Manual” “Heimdall” p val. 
#1 Time required (sec, mean & SD) 54.25 (5.42) 35.00 (2.62) 40.88 (5.22) < 0.001 
 Errors (n & %) 0.38 (0.74) 0.12 (0.35) 0.25 (0.46) 0.662 
#2 Time required (sec, mean & SD) 57.75 (6.82) 42.25 (5.23) 45.38 (4.47) < 0.001 
 Errors (n & %) 0.38 (0.74) 0.12 (0.35) 0.12 (0.35) 0.546 
4. Discussion and conclusion 
In this work, we designed a data visualization prototype called “Heimdall”, and evaluated 
it. The Heimdall interface takes profit from combining foldable hierarchical view with a 
timeline. Alignment, filtering and custom views enhance data exploration. Heimdall is 
very fast and easy to use. However, this tool is still not able to display non-temporal data 
(e.g. birthdate), or data with imprecise timing (e.g. ancient medical history). Non-
structured data can be displayed as document icons. Unlike EventFlow [17], Heimdall 
only provides rudimentary tools for querying and filtering data. The problem-oriented 
filtering seems to be the most powerful part. Heimdall provides a comprehensive and 
efficient graphical interface for EHR data visualization. It is open source, and the current 
R package (alpha version) can be downloaded at https://koromix.dev/files/R. 
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How Have Experimental Cancer 
Interventions Evolved over Time? 
Ziran LIa, Huanyao CHENa, Chi YUANa, Chunhua WENGa 
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Abstract. We performed a trends analysis of experimental cancer interventions. The 
complete records of 32,623 interventional neoplasm clinical trials involving 454 
types of neoplasms from 2000 to 2017 were downloaded from the AACT database. 
The conditions and drug concepts were normalized using MetaMap. The normalized 
frequencies (NF) for each type of intervention were calculated and compared. 
Among 95,440 interventions, 77.4% were drugs, 5.3% were radiation, 6.6% were 
surgery and 10.6% were other therapies. Among 47,754 arms, 82.8% were mono-
type interventions and 17.2% were multi-type interventions. Among 73,889 drug 
interventions, immunologic factor drugs increased rapidly over the last five years. 
Both breast cancer and pancreatic cancer have been testing new drugs in clinical 
trials; however, more drugs have been tested in phase 3 or 4 trials and employed in 
comparator arms for breast cancer compared to pancreatic cancer. Breast cancer 
trials showed a more even drug NF distribution than pancreatic cancer trials. The JS 
Distance among three periods (2000-05 vs. 2006-11 vs. 2012-17) showed 
unidirectional research progress trend for breast cancer, but reverse trend for 
pancreatic cancer. This study contributes a large-scale landscape overview of the 
trends in cancer experimental interventions and a methodology for using public 
clinical trial summaries for understanding the evolving cancer research. 
Keywords. Clinical Trials, Trend Analysis, Data Science 
1. Introduction 
The World Health Organization predicted that worldwide cancer cases are projected to 
increase by 50% by 2030, from 14 million to 21 million. Well-identified progress in 
cancer research is pivotal for our understanding of the cancer research direction. Many 
systematic reviews have uncovered the unbalanced medical advances across different 
cancers. While prior studies reviewed the evolution of cancer treatment and highlighted 
the advances in specific cancer types, they are unable to spark more far-reaching insight 
due to several potential study limitations. Firstly, these studies have largely focused on 
one cancer at a time. Secondly, only a qualitative description of the milestones in the 
cancer treatment history is given based on the reports of domain experts. A longitudinal 
quantitative analysis is needed to investigate multiple cancer types together to help us 
better understand the progress in a big picture, compare advances in cancer treatment 
across different interventions, and guide the future development of cancer therapies. The 
ClinicalTrials.gov houses all trials including eligibilities, conditions, study design, 
interventions, result and outcome information. In this study, we propose quantitative 
methods to answer two questions: (1) What types of interventions have consistent 
patterns across cancers? (2) What are the trends of intervention research across cancers?  
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2. Methods 
2.1. Dataset  
As of July 2018, the record of 271,514 distinct clinical trials were all downloaded from 
the database of Aggregate Analysis of ClinicalTrials.gov (AACT) [1]. First, 
interventional studies with primary purpose of treatment conducted within 2000 to 2017 
were extracted. Then, an oncology interventional clinical trial dataset was created by 
selecting clinical trials whose condition MeSH term has the semantic type of “neoplastic 
process”. The information of treatment arms and interventions were extracted. Each 
intervention in the clinical trial was recognized as an instance that we focused on.  
2.2. Data Preprocessing 
Clinical trial conditions were mapped to MeSH concepts. Then all free-text drugs 
extracted from table of interventions with either “Drug” or “Biological” intervention type 
were mapped to NCIt concepts using MetaMap. All neoplastic trials were assigned to 
one of three time periods including 2000-2005 (1st period), 2006-2011 (2nd period), and 
2012-2017 (3rd period). The phases of clinical trials were modified as “Phase 1/2” or 
“Phase 3/4”. Each treatment arm was modified as “experimental” or “comparator” arm 
type based on the value of group_type field. The interventions were classified into four 
intervention types, including drug (“Drug” or “Biological”), surgical procedure, 
radiation, and other therapies (includes “Dietary Supplement”, “Behavioral”, “Device”, 
“Genetic”, and “Other”). Mapped drug concepts were classified into three drug types 
based on the UMLS semantic type of the concept, which are immunologic factor 
(semantic type is “Immunologic Factor”), other bioactive substance (“Hormone”, 
“Enzyme”, “Vitamin”, “Receptor”, or “Biologically Active Substance”), and 
conventional drugs (“Pharmacologic Substance” or “Antibiotic”). All interventions in 
our dataset were stamped with the time period, cancer type, modified phase, modified 
arm type, modified intervention type, and drug type (only for drug intervention). 
2.3. Trend analysis of Intervention Pattern and Drug  
We defined the normalized frequency (NF) as the number of interested intervention 
divided by the total number of interventions for studied condition(s) during a certain time 
period. The NF of each type of intervention in each year were calculated and compared. 
We interpreted the change of NF along time as the trends of intervention types. Two 
types of interventional patterns were defined based on the combination of different types 
of intervention:  mono-pattern includes one type of intervention, such as drug, surgery, 
radiation or other therapies, while multi-pattern includes the combination of at least two 
different types of intervention.  
We took breast neoplasm and pancreatic neoplasm as examples to demonstrate the 
different drug research trends across different neoplastic diseases. Breast neoplasm was 
identified by collecting condition concepts with UMLS CUI including C0006142, 
C0242788, C0021367, C0206692, C0677776, C0278601, C4018978, C3539878, and 
C1458155; Pancreatic neoplasm was identified by collecting condition concepts with 
UMLS CUI including C0030297, C0242363, C1328479, and C0887833. For each trial, 
we first removed drugs in comparator arms from the drugs in experimental treatment 
arms to extract research drugs for each trial. The NFs of all research drugs were 
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calculated in each period. All NFs in each period formed a density distribution of drug 
tested times in clinical trials. Jensen-Shannon (JS) distance was used to quantify the 
change of drug distribution among three periods. The density distributions for most 
popular research drugs were visualized and compared. The number of tested times for 
most popular research drugs stratified by arm types or trial phase were also visualized 
and compared between two types of neoplasm. 
3. Results 
3.1. Clinical trial retrieval and concept recognition 
A total of 32,623 neoplastic clinical trials with 47,754 treatment arms encompassing 
95,440 interventions were identified, with 73,889 (77.4%) being drugs, 5,048 (5.3%) 
being radiation, 6,330 (6.6%) being surgery and 10,137 (10.6%) being other therapies. 
Among 47,754 treatment arms, 39,530 (82.8%) arms were mono-pattern, 8,224 (17.2%) 
were multi-pattern. The number of newly registered neoplasm clinical trials from 2000 
to 2017 displayed an overall increasing trend, corresponding to 454 unique “neoplastic 
process” concepts and 3439 unique drug concepts. The number of drug intervention was 
much greater than the number of the other three interventions.  
3.2. Interventional Trend analysis 
The number of drug interventions far exceeded other types of intervention. It is notable 
that the ratio among drug, surgery and radiation interventions kept steady since 2000, 
whereas the number of other therapies had surpassed surgery and radiation after 2006. 
The multi-pattern (e.g., combining drugs and surgery) has displayed an increasing trend 
in years after 2010 as opposed to mono-pattern. Figure 1 illustrates the temporal trend of 
three drug types including immunologic factors, other bioactive substance and 
conventional drugs. Conventional drugs outnumbered the rest of drug types but exhibited 
a decreasing trend and the immunologic factor drugs showed an increasing trend. 
 
Figure 1. The temporal trend of three types of drug 
We took breast neoplasm and pancreatic neoplasm as two examples to compare the 
drug research trends in different types of neoplastic disease. 3,418 breast neoplasm 
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clinical trials and 1,271 pancreatic neoplasm clinical trials were extracted from our 
database. The NFs of all experimental drug were calculated in each period and the result 
for the top popular research drugs were visualized in Figure 2.  
 
Figure 2. NF distribution of the most popular drugs for (a) breast neoplasm and (b) pancreatic neoplasm. 
The drugs were ranked by an increasing order of the NFs in the 3rd period. We 
observed three different drug NF distributions in three periods for breast neoplasm 
(Figure 2a). As new drugs studies appeared, the peaks of NF distribution dropped and 
kept moving rightward to these new drugs from 2000 to 2017. The JS distance of drug 
NF distributions are 12.4 between the 1st and the 2nd period, 20.5 between the 2nd and 
the 3rd period, and 21.4 between the 1st and the 3rd period. Thus, the drug research focus 
showed a unidirectional progress trend for breast neoplasm. In contrast to breast 
neoplasm, the pancreatic neoplasm has significantly different NF distributions as shown 
in Figure 2b. However, the NF distributions for pancreatic neoplasm among three periods 
are pretty similar. Over the past three periods, the drug gemcitabine took the lead with a 
consistent NF for three periods, and is almost thrice as high as the dominant drugs for 
breast neoplasm, which indicates the relatively limited drug options for pancreatic 
neoplasm. The JS distance of NF distributions between the 1st and the 3rd period (8.2) 
is even closer than the distance between the 2nd and the 3rd period (11.8), which implies 
a reversing research progress trend for pancreatic neoplasm. For breast neoplasm, all 
popular research drugs have been tested in phase 3/phase 4 clinical trials to gather more 
information about the effectiveness by studying different populations with different 
dosages and by using the drug in combination with other drugs.  
4. Discussion  
The ratio between drug, surgery and radiation has leveled off since 2000, indicating the 
popularity of research of three intervention types have stabilized, while drug studies are 
dominating majority in neoplasm trials. Although drug, surgery and radiation remain the 
major interventions to treat neoplastic disease, the number of other therapies (supportive 
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care, dietary supplement, behavioral, observation etc.) tested in clinical trials had 
surpassed surgery and radiation during recent years. This trend reflects the fact that 
researchers are paying more attention to supportive care and improving quality of life for 
cancer patients except for radical cure and prolonging OS [2].  
The multi-intervention patterns showed an increasing trend after 2010, which is 
consistent with the popularity of the concept of multimodality therapy in cancer 
treatment area. The increasing trend of immunologic factor drugs also implies what 
current drug research focuses on. This trend can be explained by the fact that 
immunotherapies generally have fewer side effects than chemotherapies because it 
boosts the body's natural defenses to fight the disease. Most of immunologic factor drugs 
are referred as monoclonal antibodies. Among them, we recognize several blockbuster 
drugs such as Avastin, Rituxna, Herception, and Erbitux. These popular cancer 
treatments target a wide range of conditions and diseases. 
We found that neoplastic diseases whose treatment drugs have steadily progressed, 
like breast neoplasm, present a more even NF distribution and a unidirectional progress 
trend between distributions. This unidirectional change implies more new drugs 
introduced into clinical trials that gradually receive more attentions due to their potential 
of better efficacy. Neoplastic disease whose drug development is stagnant, such as 
pancreatic neoplasm, present an uneven distribution and a fluctuating trend, implying 
researchers encountered difficulty developing more effective substitutes for old drugs.  
We further integrated diverse data sources to find evidence supporting our findings. 
For instance, Bevacizumab, a new drug for breast neoplasm, has a peak frequency in 
2006-2011, but its frequency drops drastically within the next period. This result can be 
attributed to the fact that Bevacizumab was once approved by FDA for metastasis breast 
neoplasm treatment in 2008 but then revoked in 2011 due to safety concerns including 
severe high blood pressure and hemorrhaging.  
5. Conclusions 
This study shows interesting trends in the development of interventions for neoplastic 
disease in clinical trials and interprets the trends with regard to the corresponding medical 
contexts and literature. It may generate meaningful insight for the cancer research 
community so that the medical researchers can quantify the progress of cancer research 
and utilize prior knowledge of trend. The methodology from this study can also be 
applied to a diversity of medical fields other than neoplastic diseases. 
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Impact of Altering Data Granularity Levels 
on Predictive Modelling: A Case Study of 
Fall Risk Prediction in Older Persons 
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Abstract. Classification systems are widely used in medicine for knowledge 
representation. The hierarchical relationships between concepts in a classification 
system can be exploited in prediction models by looking for the optimal predictive 
granularity level. In this study, we used the Anatomical Therapeutic Chemical 
(ATC) classification system to cluster medications in the context of predicting 
medication-related falls in older persons. We compared the performance of fall risk 
prediction by describing medications at varying granularity levels of the ATC 
classification system. We found that the level of abstraction significantly affects the 
predictive performance in terms of both discrimination (measured by the receiver 
operating characteristic curve AUC-ROC) and calibration. An implication of these 
findings to the researchers is that data representation at different granularity levels 
can influence the predictive performance. The optimal granularity level can be 
determined by experimentation. 
Keywords. classification system, data abstraction, feature selection, prediction, 
granularity, hierarchy. 
1. Introduction 
Classification systems describe concepts and relationships between them. They are 
widely used for knowledge representation. The hierarchical relationship between 
concepts describes the relationship between a class and its sub-class. For example, the 
Anatomical Therapeutic Chemical (ATC) classification system [1] describes classes in 
terms of anatomy, therapy, and chemical compounds of medications and generalization-
specialization relationships between medications. Hence a medication can be described 
at various granularity levels. The choice of the appropriate level of abstraction to describe 
a class (here medication) depends on the task at hand. 
When the task is prediction of an event (such as fall of a person), the problem can 
be stated as: at which level of granularity should medications be described in order to 
optimize the prediction of that event. This is not a trivial problem, as the error of a 
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prediction model is governed by the bias-variance trade off [2]: using a too coarse level 
of medications to predict falls may lead to parsimonious models with high bias, while 
using a too detailed level may lead to high variance. This necessitates search within the 
hierarchy to find the granularity level that leads to the best prediction model. In essence 
this is a feature selection strategy in prediction models. 
Research studies have linked certain medications with an increased risk of falls in 
what is called fall-risk-increasing drugs (FRIDs) [3]. FRIDs are grouped in fall risk 
prediction models to ease interpretation [4, 5]. To exemplify the different granularity 
levels of these medications, consider “paroxetine”, this medication lies on the leaf level 
of the ATC hierarchy, and is a sub-class of a group called “selective serotonin reuptake 
inhibitors”. This group has a super-class named “antidepressants” which belongs to the 
“psychoanaleptics” class and further to the “nervous system” as the main anatomical 
level. In studies using medication as predictors, the decision on which level of abstraction 
to use them has often been arbitrary. In addition, little is known about the impact of 
medication abstraction on fall risk prediction performance. 
The aim of this study was to understand the effect of describing medications at 
different granularity levels on the performance of fall risk prediction. We achieve this by 
comparing the predictive performance of models using various granularity levels of the 
ATC classification system.  
2. Materials and methods 
2.1. Study approach 
In this cross-sectional study, we evaluated six prediction models which included the 
features pertaining to demographics, comorbidity; and home medications. Medications 
in the dataset are described at ATC level five (leaf level), which can be grouped at 
different levels of the ATC classification system. We created six prediction models: 
ATC-5 a model that uses individual medications; ATC-1 to ATC-4 are models that group 
medications at the respective ATC level; and one model with only demographic and 
comorbidity features (No-Med). 
2.2. Population, patient inclusion and clinical outcome 
Data were obtained from the Medical Information Mart for Intensive Care (MIMIC-III, 
Version 1.4) [6] database. The MIMIC-III is a publicly available database containing de-
identified data from more than 40,000 patients admitted to intensive care settings at the 
Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA, USA, between 2001 
and 2012. The dataset comprises demographic elements such as age, gender and 
ethnicity, clinical elements including vital signs, laboratory data, diagnostic codes (in 
International Classification of Diseases 9th Edition, Clinical Modification [ICD-9-CM] 
format) and outcome values. Beside these it contains various types of clinical notes, 
including discharge summaries and nursing notes.  
We included first admissions of older persons (≥65 years of age) with complete 
discharge summaries. 
The clinical outcome was falls before hospital admission. Fallers were identified by 
the presence of an ICD-9 code that starts with “E88” which represent accidental falls, or 
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the existence of any of the words (fall, fell, fallen) in the text of the reason of hospital 
admission field. 
2.3. Data extraction and processing 
The extracted demographic features were age, gender, ethnicity and marital status. We 
composed an algorithm to extract home medications and comorbidity features from the 
discharge summaries. The algorithm utilized RxNorm [7] and the Systematized 
Nomenclature of Medicine Clinical Terms (SNOMED CT) in order to match the 
medications and the comorbidities in the text. Data processing involved the mapping of 
the extracted medications into ATC codes (level five) using the Observational Health 
Data Sciences and Informatics (OHDSI) [8] and obtaining all the super (parent) groups 
for each medication code. 
2.4. Statistical analysis 
We used the Least Absolute Shrinkage and Selection Operator (LASSO) with logistic 
regression to allow for feature selection as part of fitting the model and to avoid over-
fitting [9]. LASSO trades off an increase in bias with a decrease in variance, by adding 
a penalty against model complexity. This penalty term (lambda) is usually chosen by 
cross-validation. The analysis was performed using the R programming language, 
version 3.4 and data extraction was performed using Python. We used the 
implementation in the R glmnet package to perform LASSO regression. 
We assessed the performance of the models in terms of discrimination (with the area 
under the receiver operating characteristic curve: AUC-ROC); calibration via calibration 
plots; and the relative goodness of fit with the Akaike Information Criterion (AIC). To 
internally validate the results, we applied bootstrapping [10] with 200 recommended 
repetitions and we calculated the optimism-corrected AUC-ROC. To get an honest 
assessment and to address LASSO instability of model performance all modelling steps 
(lambda-tuning) were repeated for each bootstrap sample. To test for statistical 
significance of the differences in the median between each of the models and the model 
with medications without grouping (ATC-5), we used Wilcoxon signed-rank test. A p-
value < 0.05 was considered to indicate statistical significance. 
3. Results 
The total number of patients was 46,520 in the MIMIC-III database. The number of 
patients which met the inclusion criteria was 23,034 (49.5%). The number of fallers was 
1,721 (7.5% of the included patients). The number of different medications extracted 
from the discharge summaries was 939. 
Figure 1 depicts the relationship between the AUC-ROC and the level of ATC 
grouping. It can be seen that the AUC-ROC initially increases when climbing up the 
hierarchy of the ATC, peaks at level two and then drops at the first level of the ATC. 
The calibration performance of the models is shown in Figure 2. All the models 
showed acceptable calibration except the No-Med and ATC-4 models which had 
miscalibration. As shown in Table 1, the lowest AIC estimate (lower is better) was for 
the model ATC-2 followed by the model ATC-3. The number of selected features for 
these two models were 65 and 110 respectively. 
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Figure 1. The relationship of AUC-ROC with different levels of grouping using the ATC. Note that the y-axis 
does not start from zero. 
 
Figure 2. Bootstrap bias-corrected calibration curves of the models.  
 
Table 1. Akaike Information Criterion and the number of selected features after applying LASSO regression. 
Models AIC #Total Features #Selected Features 
No-Med -16,406.67  38 28 
ATC-1 -16,615.84  52 37 
ATC-2 -16,838.66  118 65 
ATC-3 -16,655.52  212 110 
ATC-4 -16,444.1  465 121 
ATC-5 -16,369.3  977 196 
4. Discussion and conclusion 
This study investigated the effect of leveraging hierarchical relationships of concepts in 
classification systems for predictive modelling. Our experiments indicate that significant 
improvement in predictive performance can be achieved by altering granularity levels. 
This is demonstrated by the ATC-2 model having the highest discrimination performance, 
acceptable calibration and the lowest AIC. 
The strengths of our approach include a systematic evaluation of the performance of 
the prediction models and the use of bootstrapping to validate the results. The main 
limitation lies in the fact that the ICD-9 codes were generated for billing purposes at the 
end of the hospital stay and may not always represent falls before admission. Although 
the inspection of a random sample of the discharge summaries revealed that most of the 
patients fell before admission, there still is uncertainty in the definition of fall and the 
exact moment of its occurrence. This limitation may have affected the overall estimation 
of falls risk and prediction performance because we considered only home medications 
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registered on admission and not during hospital stay. Furthermore, we could not validate 
the accuracy of the algorithms used to extract medications on admissions and 
comorbidities because of the lack of an annotated dataset. We however, believe these 
limitations should not qualitatively affect our findings as we evaluated the models under 
the same conditions. 
The utilization of granularity in classification systems was also investigated in other 
domains. A recent study evaluated the impact of altering bacterial taxonomy on disease 
prediction [11]. The authors found that describing bacteria at different granularity levels 
influenced the predictive performance. This finding corroborates what we observed in 
this work. Another recent study evaluated how different levels of data granularity of 
medications and diagnoses would affect prediction of diabetic kidney disease (DKD) 
prediction [12]. The authors showed that different data granularity may not necessarily 
influence the predictive performance. However, this differs from the findings presented 
here and this discrepancy could be attributed to the differences in the domains on which 
the approach was evaluated.  
On the basis of this work, we conclude that describing features at different levels of 
granularity can significantly affect the predictive performance. So far, we considered the 
same level of granularity to describe medications. A possible interesting extension to our 
work is to apply tree-lasso [13] or a (greedy-based) search strategy to select a subset of 
nodes in the tree-structured medication hierarchy. Another important work that warrants 
further investigation is validating our results on another dataset. Our findings have 
implications for researchers: we showed that prediction performance can be enhanced by 
altering the granularity of the data, and the optimal level of granularity can be obtained 
by experimentation. 
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Abstract. The IT- and data protection concept of the FAmiliäres Risiko für das 
KOloRektale Karzinom (FARKOR) project will be presented. FARKOR is a risk 
adapted screening-project in Bavaria, Germany focusing on young adults with 
familial colorectal cancer (CRC). For each participant, data from different sources 
have to be integrated:  Treatment records centrally administered by the resident 
doctors association (KVB), data from health insurance companies (HIC), and 
patient reported lifestyle data. Patient privacy rights must be observed. Record 
Linkage is performed by a central independent trust center. Data are decrypted, 
integrated and analyzed in a secure part of the scientific evaluation center with no 
connection to the internet (SECSP). The presented concept guarantees participants 
privacy through different identifiers, separation of responsibilities, data 
pseudonymization, public-private key encryption of medical data and encrypted 
data transfer. 
Keywords. Data integration, HIC data, pseudonymization, data encryption  
1. Introduction 
The FAmiliäres Risiko für das KOloRektale Karzinom (FARKOR) project assesses the 
efficacy and safety of a risk adapted screening-program focusing on familial colorectal 
cancer (CRC) in young adults (aged 25-50 years of age) [1]. It is implemented in 
Bavaria, Germany [2]. The project integrates individual data from different sources: (1) 
individual diagnostic and treatment data from medical practitioners, (2) individual 
patient-reported lifestyle data, and (3) individual outcome data from health insurance 
companies (HIC).  
FARKOR has two parts: (1) Efficient selection of persons with familial colorectal 
cancer risk within a population of 3 million people, (2) offering safe and efficient 
screening approaches for the selected high risk population. FARKOR is a prospective, 
population-based cohort study. Its efficiency is assessed by (1) the number of advanced 
adenoma or carcinoma detected in the selected high-risk population, (2) a health 
economic evaluation that estimates avoided morbidity and mortality.   
A large number of practices enrolled into the project. All 35 health insurance 
companies working within Bavaria participate. They provide individual outcome data 
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regarding CRC mortality and morbidity. This allows to have control outcome of 
persons not enrolled in FARKOR.   
To implement and to run this project successfully, a reliable IT infrastructure and 
robust data protection concept has to be established that is also compliant with the new 
European General Data Protection Regulation (EU-GDPR) [3]. 
2. Methods  
2.1. Several institutions and responsibilities 
The FARKOR project integrates data from multiple sources and exchanges the data 
between different institutions (see Figure 1).   
 
2.2. Specific challenges and used methods  
 
Specific challenges regarding the data protection concept are:  1.) Integrating data from 
different sources; 2.) Protecting the privacy of participating individuals 3.) Protect 
business issues between the participating HICs (which patient is insured by which 
HIC); 4.) Providing the legal reasons for collecting the data (informed consent for 
subjects enrolled in FARKOR, permission to use individual data of persons not 
enrolled in FARKOR – the controls); 5.) Performing person rights: Informing about 
collected data or deleting the records on request; 6.) Providing a 24/7 availability of the 
IT-infrastructure.  
The FARKOR IT- and data protection concept is built on several strategies [4-10]: 
Informational separation of powers (Informationelle Gewaltenteilung [11]) by using 
different identifiers for data of different origin [4]; Pseudonymization of identifiers [5] 
and encryption of personal health information [6]; a trust center [7] and concepts of 
asymmetric encryption and pseudonymization [8-10]. 
Integration of HIC data over multiple databases uses standardized terminologies 
like the International Classification of Diseases, 10th Revision (ICD-10), Operationen- 
und Prozedurenschlüssel (OPS) and Einheitlicher Bewertungs Maßstab (EBM). 
3. Results 
3.1. IT- and data protection concept with data flow 
The program started in October 2018. By end of December 2019 about 9000 persons 
were enrolled. The data capturing, data encryption, data flow (see Figure 1), 
pseudonymization and data decryption work appropriately.  
A specific data service by the resident doctor’s association (1) KVB data service 
administrates the individual project data. It is separated from the institution’s routine 
data and general activities. The (2) trust center pseudonymizes the data identifiers. 
The KVB data service provides an internet portal to document the medical data: 
demographic, diagnostic, and treatment data of individuals enrolled in FARKOR. After 
informed consent, participants are enrolled by their primary care physician who does a 
basic familial CRC risk assessment. In case of a positive assessment, the participant 
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will be referred to specialists for further staging and potential screening measures. The 
KVB data service encrypts the data and makes it available to the trust center for 
download.  
Record linkage between the medical data and the individual health insurance data 
uses the social security numbers (KVNR). The trust center downloads the medical data 
from the KVB data service, removes the specific HIC IDs, pseudonymizes the 
individual IDs, and makes the data available for download to the secure evaluation 
environment (SECSP). The SECSP is a secure part in the secure evaluation center 
(SEC) with no connection to the internet. 
 
 
Figure 1. Data flow in the FARKOR project. 
 
The trust center provides at scheduled points in time, the social security numbers 
(KVNR) and a pseudonym of the KVNR of the FARKOR participants to the HICs for 
download. The HICs match individual data with related ICD-10, OPS and EBM codes 
according to the specified identifiers. The HICs pseudonymize the data accordingly, 
remove the KVNR and deliver the pseudonymized data back to the trust center. The 
trust center pseudonymizes the HIC data, performs the record linkage and allows to 
download the data to the SECSP. The HICs data is now doubly pseudonymized. 
The concept of informational separation of powers requests, that all medical data is 
encrypted by the KVB data service and has to be decrypted in the SECSP. Encryption 
uses public-private-key RSA encryption. Patient-related data are encrypted with the 
public key. The identifying variables are not encrypted for pseudonymization purposes. 
It was requested by the LMU’s IRB that the trust center cannot read the medial data.  
The SECSP downloads the data and decrypts the individual medical data with the 
private key. Then the SEC performs data storage, data integration and analysis.  All 
data transfers are transport-encrypted. 
Furthermore, lifestyle data are important for the analysis. The SEC created 
individual FARKOR-IDs, which are delivered to the KVB data service. These IDs are 
provided to the participants when they enroll and allows login to the lifestyle 
questionnaire website. Participants use their internet browser to answer the lifestyle 
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questionnaire. The corresponding server is hosted in the SEC. These data will be 
transferred to the SECSP and integrated to the project data with the FARKOR-ID.  
The health economic evaluation is carried out by partners at the Private University 
for Health Sciences, Medical Informatics and Technology (UMIT). They perform their 
analysis within the SEC. No data leaves the SECSP. 
3.2. Warranty of the participants rights  
Participants may request at any time a copy of their individual data stored. They can 
also withdraw their consent of participation in FARKOR at any time. Their requests are 
handled in a standardized manner. The process for withdrawal is shown in Figure 2. To 
date, four participants have withdrawn their consent. The corresponding data was 
deleted from the analysis data. So far, no participant has requested access to their data 
records. 
 
 
Figure 2. Data flow when participants withdraw their consent. 
4. Discussion 
The FARKOR IT- and data protection concept enables the integration of multi-source 
data. To our knowledge, this paper describes for the first time an EU-GDPR conform 
simultaneous integration of individual HIC as well as project data during the course of 
the study. The integration of HIC data allows to have control groups of persons not 
enrolled in FARKOR, as well as data for subjects enrolled that supplements data 
documented during medical examinations. This makes it necessary to collect and store 
social security numbers (KVNR). This record linkage process is complex. The KVNR 
is stored and pseudonymized in the trust center and communicated to the HICs. The 
KVNR is not transmitted to the SECSP. The medical data will be encrypted in the 
KVB data service and decrypted in the SECSP. The medical data and the FARKOR-ID 
are only available in encrypted form to the trust center. 
5. Conclusion 
To integrate the multi-source data, a strong IT infrastructure as well as an appropriate 
data protection concept is needed to guarantee participating persons privacy. This is 
achieved by using different identifiers for data of different origin, pseudonymization of 
identifiers in a trust center, encrypted data transfer and encryption of patient-related 
data.  
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Integrating the Comparative 
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Abstract. Information relevant to pharmacogenomics studies is available in several 
open databases, which makes it difficult to synthetize the available data. Within the 
PractikPharma project, several databases were integrated to PGxLOD, a resource 
dedicated to the generation and verification of pharmacogenomic influence on drug 
responses. The Comparative Toxicogenomic Database (CTD) describes the toxic 
effects of many chemicals on living species based on the literature. Since drugs are 
peculiar chemicals and side effects are peculiar toxic effects, we aimed at extracting 
information from CTD that matches drug side effects in the human specie. 
Keywords. Pharmacogenomics, biomedical genomics, Data interoperability and 
data integration, Quality of data, 
1. Introduction 
Pharmacogenomics is a branch of pharmacology that studies how drug responses may be 
influenced by the genome. As information relevant to discovering and explaining such 
responses are available in several databases, the consortium of the PractikPharma project 
implemented methods to extract state of the art knowledge from these databases and the 
literature. First, PGxO [1], an ontology covering the pharmacogenomic domain was pro- 
posed, which focuses on human and drug relative information. Second, this model was 
implemented in PGxLOD, a pharmacogenomic LOD i.e. a semantic entry (a SPARQL 
endpoint) to access and query pharmacogenomic data. 
The Comparative Toxicogenomic Database (CTD) [2] is a premier public resource 
for literature-based, manually curated associations between chemicals, gene products, 
phenotypes, diseases, pathways and environmental exposures. Considering drug as par- 
ticular chemicals and pharmacogenomic relations as particular toxicogenomic relations, 
we identified CTD as a potentially interesting pharmacogenomic information resource. 
In this paper, we describe the method applied to extract data relevant to pharmacoge- 
nomic studies from CTD to prepare its integration to PGxLOD. 
 
1Corresponding Author: Franc¸ois-E´ lie Calvier, CIM 42, chemin de la marandie`re, CHU de Saint-e´tienne 
Hoˆpital Nord 42055 SAINT-E´ TIENNE CEDEX 2, France; E-mail: francois.calvier@chu-st-etienne.fr 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200164
267
2. Material and Method 
We first describe CTD data. Then, we explain how we selected and extracted data from 
CTD. Finally, we integrated these data to PGxLOD by mapping elements from the same 
classes that were previously imported in PGxLOD from other databases. 
 
2.1 Data representation in CTD 
CTD provides a collection of biological links documenting toxicogenomic connections. 
An initial set of links is gathered through a semi-automatic systematic review of pubmed 
articles. This task consists first, in identifying the elements (i.e. chemicals, genes or dis- 
eases) involved in those links. Then, in associating a link with the pubmed IDs of the 
articles that mention co-occurring elements. Links validated by CTD curators are anno- 
tated using controlled vocabularies. In a latter step, these links are integrated with data 
from external reference databases. For example, chemicals are mapped to the Chemical 
Abstract Service (CAS) [3], Medical Subjects Headings (MeSH) [4], and DrugBank [5] 
databases. Genes are mapped to the NCBI gene database [6]. Diseases are mapped to the 
MeSH, and pathways are mapped to Kyoto Encyclopedia of Genes and Genomes 
(KEGG) [7] and Reactome [8] databases. Finally, additional links are inferred by reason- 
ing over the curated set of links. 
Regularly updated, 164,640 chemicals, 470,706 genes, 12,784 diseases, and 2,363 
pathways over several species and their known biological links were represented in 2017 
(version 14932). Biological links represented in CTD can be either documented knowl- 
edge from the literature or inferred knowledge. We detail these links in table 1. When 
links are inferred, the inference node is specified in parenthesis. 
 
Table 1.  Biological links statistics 
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2.2 Data extraction from CTD 
In order to extract human pharmacogenomic data from CTD, drugs should be distin- 
guished from other chemicals, and human genes should be distinguished from genes be- 
longing to others species. We filtered biological links in order to discard those involving 
non-human genes and non-drug chemicals. Finally, we removed pathways and diseases 
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without a biological link involving a drug or a human gene. Identification of Drugs was 
the main difficulty of the extraction process. 
Chemical are described in CTD by their names, and some external databases IDs. 
These external IDs, in particular DrugBank ID and CAS RN, were exploited to identify 
drugs among the chemicals. As DrugBank is a drug database, a chemical in CTD with a 
DrugBank ID is necessarily a drug. The CAS number is a unique identifier defined by 
the American Chemistry Society (ACS). It is widely used in several databases, and can 
be found in DrugBank and in KEGG. 
2.3 Direct Exploitation 
56,536 chemicals in CTD have a non empty CAS number field which is available for 
4,789 drugs in DrugBank. This information is also available for 8,760 within the 10,467 
drugs present in KEGG. An identification of chemicals which are actually drugs was 
performed using the CAS number as a pivot. 
2.4 Indirect Exploitation 
Several databases relative to drugs do not mention the CAS number. Moreover, this in- 
formation is often incomplete like in DrugBank and KEGG. Therefore, we also exploited 
the Pharmacogenomics database (PharmGKB) [9] as a reference drug database. KEGG 
and PharmGKB provide more cross-references than DrugBank (resp. 5 and 19), that can 
be exploited thanks to web services to reinforce mappings using the CAS number: 
• Unichem [10] provides mappings between 38 databases including CAS but was 
not updated since 2014. 
• Chemical Identifier Resolver (CIR) [11] is a NIH web service that includes map- 
pings between CAS, InChI, and chemSpider identifiers. 
2.5 Integration of selected data from CTD to PGxLOD 
Many databases for life sciences already have been integrated in the Bio2RDF project 
[12]. Several databases (e.g.DrugBank, KEGG, and PharmGKB) have been integrated to 
PGxLOD thanks to a mapping between their respective ontologies. Nevertheless, as 
Bio2RDF has not been updated since 2014, we integrated CTD data to PGxLOD by using 
a script written by following the Bio2RDF guidelines. 
3. Results 
3.1 Extraction Results 
4,944 drugs were identified within CTD chemicals. DrugBank IDs of 1,710 chemicals 
are available in CTD which makes identification straightforward for these chemicals. 
Thanks to the CAS number as a common foreign key 4,363 drugs were identified among 
CTD chemicals (resp. 1,235 from DrugBank and 3,328 from KEGG). 1,731 of the drugs 
from KEGG were not identified thanks to DrugBank. Finally, Exploiting web services 
lead to the identification of 268 additional drugs. From the identified drugs, it is possible 
to extract biological links that are relevant for human pharmagenomics. We provide, in 
F.-É. Calvier and C. Bousquet / Integrating the Comparative Toxicogenomic Database 269
table  2,  the   number   of   extracted   links   with   respect   to   CTD   existing   links. 
A gene is involved in a relation with a drug if there is a relation with a chemical from CTD 
that has been identified as a drug. Thus, 31,559 genes are involved in the 631,143 drug-
gene links. Moreover, 19,780 genes of this subset belong to the human genome. 
Following the same rule, diseases and pathways relevant to human 
pharmacogenomics are extracted. The respective numbers are shown in table 3. 
 
Table 2. Extracted Biological links statistics   Table 3. Extracted linked elements 
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3.2 Integrating CTD Data to PGxLOD 
Even if all extracted biological links are relevant to human pharmacogenomics, we have 
chosen to integrate to PGxLOD only those that were manually curated. Since PGxLOD 
is a semantic resource, all inferred links from CTD could be retrieved by adding an infer- 
ence rule when using a reasoner. We represented Biological links as objects in order to 
keep the documentation link information. Thus, a biological link between two biologi- 
cal elements was represented by two properties between each element and the biological 
link object. Pubmed ID was then added as a property of a biological link in PGxLOD. 
4. Discussion 
We conducted the extraction of data relevant to pharmacogenomics studies from CTD. 
This extraction was first expected as an easy task because of the existence of cross ref- 
erences between CTD and DrugBank. But, later, we realised there was a lack of interop- 
erability between data provided by the chemistry and biomedical communities, and that 
most of the cross references were missing (less than 10% of the DrugBank drug IDs are 
found in CTD and the CAS RN information is available for less than 50% of DrugBank 
drugs). Our extraction task is complete with respect to the limitations of our approach. 
The integration of CTD in PGxLOD lead to an update of PGxO. Since biological 
links were relations between two elements and PGxO expects ternary relations, we rep- 
resented links as an object property in PGxO. CTD enables the possibility to provide the 
literature link referencing a biological link evidence. To take advantage of this resource, 
biological links should be represented as a concept with the linked biological elements 
and the literature references as properties. 
Our approach is mainly manual and requires much time to understand chemical and 
biomedical knowledge. The gap between both communities obstruct our reconciling ef- 
forts. Moreover, many database cross-references are out-dating and can lead to uncertain 
results. Nevertheless, the CTD project is still providing updates and particularly CAS 
number information for more and more chemicals. As only a third of CTD chemicals 
were studied in our extraction due to CAS number availability, the process can be 
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reproduced to improve the extraction with the updated data. Finally, we chose to exploit 
only invariable information such as IDs to perform an automatic extraction. Information 
like the name of the chemicals could also be exploited in a semi-automatic process. 
Thanks to the integration of CTD to PGxLOD, experiments could be conducted to 
explore the link between averse drug reactions and molecular characteristics of the drugs 
[13]. 
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Integration of Unstructured Data 
into a Clinical Data Warehouse 
for Kidney Transplant Screening 
-Challenges & Solutions
Maximilian ZUBKEa,1 , Matthias KATZENSTEINERa and Oliver J. BOTTa
aUniversity of Applied Sciences Hannover, Hannover, Germany 
Abstract. After kidney transplantation graft rejection must be prevented. Therefore, 
a multitude of parameters of the patient is observed pre- and postoperatively. To 
support this process, the Screen Reject research project is developing a data 
warehouse optimized for kidney rejection diagnostics. In the course of this project 
it was discovered that important information are only available in form of free texts 
instead of structured data and can therefore not be processed by standard ETL tools, 
which is necessary to establish a digital expert system for rejection diagnostics. Due 
to this reason, data integration has been improved by a combination of  methods 
from natural language processing and methods from image processing.  Based on 
state-of-the-art data warehousing technologies (Microsoft SSIS), a generic data 
integration tool has been developed. The tool was evaluated by extracting Banff-
classification from 218 pathology reports and extracting HLA mismatches from 
about 1700 PDF files, both written in german language.  
Keywords. NLP, image processing, information extraction, data warehouse, graft 
rejection, kidney transplant
1. Introduction
Due to demographic change an increasing number of severe kidney disease cases and, as 
a result, an increasing need for kidney transplants can be expected. Early detection of 
graft rejection is therefore of particular importance in the therapy of kidney transplanted
patients. 
The joint project “Screen-Reject: A lateral flow test for rejection diagnostics” 
focuses on innovative diagnostics for the aforementioned purpose and is stratified into 
three subprojects. The subproject "Screen-Reject: Clinical data warehouse for graft 
rejection diagnostics" of the project network is concerned with the provision of a clinical
data warehouse (CDWH) as a starting point for the development of an expert system to
support rejection diagnostics based on clinical data. [1]
In the course of the medical monitoring of patients, both structured treatment-
relevant data and unstructured findings texts are recorded. These unstructured findings 
texts pose special challenges for data extraction. 
1 Corresponding Author, Maximilian Zubke, University of Applied Sciences Hannover, Expo Plaza 12, 
30539 Hannover, Germany; E-Mail: Maximilian.zubke@hs-hannover.de.
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1.1. Requirements of clinical practitioners and scientists 
Our clinical partners are especially interested on the Banff classification [2,3] as well as 
several information from examinations of human leukocyte antigens (HLA). A
requirement analysis resulted in the following four requirements for the CDWH:
 Obtaining the distribution of Banff classification for all the patients
included in our study.
 Selecting patients by Banff classification and coding results.
 Estimating the most common HLA mismatches.
 Selecting donor/receiver pairs having certain HLA mismatches.
However, since that information are only described in narrative instead of structured
reports, it is not yet possible to select certain variables and filter them by value.
Thus methods are needed to extract the relevant information from the narrative 
reports.
2. Method
2.1. Data Staging
Initially, reports from the local pathology lab and the clinic for transfusion medicine were 
acquired. While the pathology reports could be provided as plaintext block from another 
clinical data warehouse [4], the findings from transfusion medicine were only available 
as PDF files. Thus the data staging environment have been extended by a data lake. Any 
information that could not be imported directly into the data warehouse was temporarily 
stored in the data lake. 
2.2. Extracting Banff classification from staged plaintext blocks 
The extraction, transformation and loading of defined information from narrative 
plaintext was realized by a SSIS 2 package.  This package requires a source table 
containing plaintext resp. file paths to text data and processes the rows sequentially by a 
JSON-based communication with external text mining functionality.  In detail, one or 
several external text mining tools can be connected with the SSIS package by 
corresponding script tasks.  Finally, the data provided by the script task is written to 
previous designed tables of the data warehouse. Figure 1 illustrates this workaround. 
2 SQL Server Integration Services (https://docs.microsoft.com/en-
us/sql/integration-services/sql-server-integration-services?view=sql-server-ver15 )
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Figure 1. Workflow of the SSIS based ETL package: A central component coordinates the data flow and 
communicates with external NLP Pipelines via corresponding SSIS Script Tasks.
In the present case, the determined Banff categories [2,3] including optional comments 
as well as the  Banff coding [2,3] should be extracted from pathology reports.
Considering that, two script tasks have been created, getting the same input but 
interacting with different NLP pipelines (one for each information to be extracted) and 
sending the output to two different tables in the destination database. The NLP pipelines 
can be any executable program which generates structured JSON output that is 
interpretable by the corresponding script task. In our use case, all NLP pipelines where 
represented by compiled python3 scripts. The information extraction functionality was 
realized using regular expressions. 
2.3. Reverse engineering of HLA mismatch table from unstructured PDF files 
In contrast to pathology findings, reports about HLA mismatches could not be made 
available in form of plaintext blocks, provided by another data warehouse. Instead, the 
only available descriptions were PDF files generated by third-party software or a scanner. 
For this reason, the first step was the transformation of PDF files to text files. A 
preprocessing step that converts each PDF file to a text file without losing information 
like headlines or line breaks has been integrated. However, this approach was not able to 
recognize tables: Visual lines that separate rows and columns were not extracted and thus 
the whole table was transformed to a text block, whereby internal borders between rows 
and columns as well as external borders to previous and following document content. 
Even conversions to Word Documents or other formats failed in most cases.  
However, from a visual perspective, tables are obvious and clearly delimitable parts of a 
document. Due to this, we decided to read the table of mismatches by image processing 
instead of natural language processing. Therefore, the PDF is considered as an image and 
the first step of this approach is the detection of horizontal and vertical lines [5]. Next, 
intersections of these lines are calculated. Thereafter, reading the document from left to 
right, each recognized intersection marks the border between columns and horizontal 
lines having intersection with the same vertical lines mark the rows. 
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Figure 2. Sample image of a HLA table: Cell values are antigen stereotypes that extend the HLA name in the 
headline of the same column. Each row describes a sample from a patient.  
Finally, the image regions surrounded by the intersection points become extracted and 
analyzed by an OCR component, OCR errors are prevented by comparing the results 
with the plaintext of the PDF. Geometric coordinates about the position of lines and 
intersection points are used to associate regions with each other and deriving the semantic 
information; For example, in Figure 2 the cell containing “HLA-A” and the cell 
containing “*02,*03” are surrounded by the same vertical lines and located in the same 
geometric region on Y-axis. Image regions having the same coordinates on the X-axis 
are interpreted as fields of the same row. 
Overall, using visual features instead of linguistic or keyword based approaches, 
works fine to recognize the sematic structure of a mismatch table within a PDF-based 
report. 
The extraction of the remaining content of interest, which is represented as a section 
or list is done by the same approach as described in section 2.2.
3. Result
As illustrated in Figure 3, the requirements mentioned in the introduction were fulfilled 
by extending ETL-pipelines with methods from natural language processing and image 
processing.
Figure 3. Requirements (green) were fulfilled by providing detailed information tables (yellow). 
Technically, the described process was implemented by a generic SSIS package, which 
can be reused for further, similar data integration projects. 
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3.1. Evaluation
The described data integration approach was used for 218 pathology reports and 1700 
HLA reports, both in German, given by the source dataset provided for this research 
project. 
The correctness of our ETL approach was checked by manual verification of the 
mapping results. Our approach reaches a precision of 100% and a recall of 100% for 
pathology reports and 85% for the HLA reports.  The latter recall of only 85% has been
caused by unexpected document structures. After appropriate modifications, also the 
NLP Pipeline for the HLA reports reached a recall of 100% and finally all requirements 
were accomplished.
4. Conclusions
Even this work has confirmed that clinicians tend to document crucial information in 
form of free texts.  Thus, clinical information systems shall be able to extract information 
of interest from such documentations and transform it into structured representations 
required for secondary use in research and care. The transformation of information from 
free text to structured formats is typically done using natural language processing. 
However, it has been shown, that methods from image processing can outperform
traditional NLP in some specific tasks like the extraction of coherent document parts 
which are marked visually like e.g. tables. 
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Abstract. We propose mini-batch top-n k-medoids to sequential pattern mining to 
improve CGM interpretation. Mecical workers can treat specific patient groups bet- 
ter by understanding the time series variation of blood glucose results. For 10 years, 
continuous glucose monitoring (CGM) has provided time-series data of blood glu- 
cose thanks to the invention of devices with low measurement errors. We conducted 
two experiments. In the first experiment, we evaluated the proposed method with a 
manually created dataset and confirmed that the method provides more accurate 
patterns than other clustering methods. In the second experiment, we applied the 
proposed method to a CGM dataset consisting of real data from 163 patients. We 
created two labels based on blood glucose (BG) statistics and found patterns that 
correlated with a specific label in each case. 
Keywords. continuous glucose monitoring, subsequence time-series clustering 
1. Introduction 
In this paper we propose an interpretation method for extracting characteristic sequential 
patterns from given pairs of labels and continuous glucose monitoring (CGM) value 
sequences, facilitating better interpretation of CGM values. The label shows a patient’s 
state such as blood glucose level. The key technology is mini-batch top-n k-medoids that 
provides accurate cluster centers. By clustering the data, we group similar elements of 
data to find patterns more effectively. 
Device makers provide analysis software for CGM logs2. The International Dia- 
betes Center created an analysis schema, the “Ambulatory Glucose Profile,” consisting 
of more than 10 metrics, including mean glucose [1]. This analysis schema handles one 
patient’s CGM logs and does not compare them with other patient’s logs. We provide 
sophisticated scheme for comparing patient’s logs. 
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Figure 1. Overview of proposed interpretation method: In this case, the two labels 
are orange or blue. Our interpretation method extracts the pattern that highly 
correlates with the blue label. 
Medical service workers have to understand patient lifestyles to determine a thera- 
peutic strategy. Thanks to technological advancements in medical devices, we can mea- 
sure glucose by the minute for weeks using CGM. CGM provides time-series data and 
has been available since devices with low measurement errors appeared 10 years ago. 
The review study about CGM [2] reported that there is an urgent need for a standardized 
interpretation of glucose data and patterns akin to automated electrocardiogram interpre- 
tation. 
We conducted two experiments, one with a manually created dataset and one with a 
dataset consisting of actual CGM data. In the first experiment, we evaluated mini-batch 
top-n k-medoids and determined if our method outperforms other related methods. In 
the second experiment, we applied our interpretation method to a CGM dataset, that is 
created through clinical trials, containing 223 waves from 163 real patients over a 2-week 
period. We extracted interesting patterns from the CGM dataset. 
 
2. Methodology 
 
Our interpretation method consists of the four steps shown in Figure 1. First, we extract 
subsequences from given sequences by using a sliding window. Next, we apply mini- 
batch top-n k-medoids to transform CGM value sequences into cluster ID sequences. By 
clustering the data, we group similar elements of data to reduce noise. Then, we apply 
sequential pattern mining to extract sequential patterns that correlate with a specific label. 
Finally, we interpret a label-specific pattern by replacing a cluster ID with a cluster center 
sequence and obtaining a CGM value sequence. 
The procedure of mini-batch top-n k-medoids basically follows the partitional clus- 
tering method, but the novel extension uses a mini-batch and n centers in one cluster 
and runs faster with large-scale data while maintaining clustering accuracy. Some stud- 
ies have reported that k-means with an Euclidean distance metric for subsequence time- 
series clustering is useless because the cluster centers are similar to a sine wave [3][4], 
which is unfavorable to our interpretation task. To address this issue, we use a k-medoid- 
based method that can use any distance metric and does not create cluster centers based 
on the Euclidean space. 
Let X denote a set of elements in Rd  and dist denote a function that returns the 
distance between two elements. Let C denote a set of cluster centers and Cidenote 
centers in i-th cluster. Let n denote the number of centers in a cluster and k denote the 
number of clusters that is predefined. The method finds a set of cluster centers Ci in 
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cluster of x  X′, we select cluster centers Cithat minimizes the loss x, which is the 
sum of the distance between x and Ci. When we assign the i-th cluster’s centers, we 
sort the i-th cluster’s elements in ascending order based on the loss c, the averaged 
distance to the elements in the same cluster, and select the top-n elements. At the end of 
each iteration, we calculate the loss  to determine whether the loss  is converged. 
If the loss is converged, we stop the iteration. Otherwise, we randomly update mini-
batch X′and start the next iteration. 
3. Experimental Results 
Experiment with the manually created dataset: We created a dataset that contains 
500 waves with 16 dimensional attributes. Since the real data has no clear definition for 
cluster centers, we evaluate our method on the basis of the manually created dataset. 
First, we created four base waves B with four dimensions. An element of a wave is a 
random integer in the half-open interval [0, 20). Second, we created one wave W by 
randomly combining the four base waves and multiplying a noise. Let wiW and 
g∼N(µ = 1.0, σ2 = 0.15) be i-th value of the wave and the noise, respectively. Then we 
define the value with the noise as wi⋅g. Finally, by repeating the previous steps, we 
created a dataset with 500 waves. 
We evaluated the clustering performance by measuring the average Earth Mover’s 
Distance (EMD) between the four base waves and the cluster centers. EMD is a distance 
metric designed to handle time-series data, and lower average EMD indicates a better 
clustering performance. Let C be the cluster centers. Let emd be the function that returns 
the EMD between a pair of waves. The criterion is formulated as 

 $%&'()$* +,- .  We applied a clustering method one hundred times with 
different initial cluster centers and used the average as the clustering performance. We 
used k-means, k-medoids, DBA [5], and k-shape [6] as baselines. Since k-medoids-
based methods can use any distance metric, we applied multiple distance metrics: 
Manhattan distances (L1), Euclidean dis- tances (L2), EMD, and dynamic time 
warping (DTW). We set 10 as the number of clus- ters and 5 as the number of centers 
in mini-batch top-n k-medoids (n = 10, k = 5).  
Table 1 shows the evaluation results. We do not list the performance of k-shapes 
be- cause the performance of k-shapes was over 10 times worse than other clustering 
meth- ods. We evaluated the performance of mini-batch top-n k-medoids by comparing 
#2 and #6, #3 and #7, #4 and #8, and #5 and #9. Except for cases with DTW, mini-batch 
top-n k-medoids performed better than k-medoids. Based on the comparison, the mini-
batch top-n k-medoids outperformed the other clustering methods in this evaluation. 
Distance metrics defined in Euclidean space were better than EMD and DTW dis- 
tance metrics designed for time-series data. EMD and DTW handle shift-invariances, 
one of the biggest issues in time-series data processing. We handle shift-invariances by 
using a sliding window, not a distance metric. Therefore, EMD and DTW would not 
interact well with this evaluation. 
M. Ono et al. / Interpretation Method for Continuous Glucose Monitoring 279
Table 1. Clustering performance when the number of clusters was 10 (k=10). In this case the clustering per- 
formance is the average EMD between cluster centers and four base waves. 
 
Experiment with the real CGM dataset: We applied our interpretation method to 
a CGM dataset (created through clinical trials) containing 223 waves from 163 real 
patients over a 2-week period. We targeted patients diagnosed with type 2 diabetes 
mellitus living in Japan. The target device was Abott Freestyle Libre3. 
We created two labels based on the patients’ blood glucose (BG) statistics. The 
first label was created from the average of BG and separated the waves into three 
groups: the average BG is (1) less than 110, (2) more than 110 but less than 140, and 
(3) more than 140. The numbers of the waves were 129, 80, and 13. The second label 
was created from the standard deviation of BG and separates the waves into three 
groups: the standard deviation of BG is (1) less than 30, (2) more than 30 but less than 
50, and (3) more than 50. The numbers of waves were 142, 51, and 29. In the 
experiments, we applied this method by changing the number of clusters, as shown in 
Tables 2. We set 5 as the number of the centers in mini-batch top-n k-medoids (n = 5) 
and uses L1 as a distance metric. We used p-value to measure correlation between a 
label and a pattern. We investigated patterns that occurred more than 100 times and 
assumed that a pattern whose p-value was less than 0.1 was label-specific. 
In the first label, the average of BG, we obtained 686 patterns, and the p-values of 
58 patterns were less than 0.1 when there were 30 clusters. When there were 20 clusters, 
the number of patterns was the largest. In the second label, the standard deviation of BG, 
we obtained 691 patterns, and the p-values of 58 patterns were less than 0.1 when the 
number of clusters was 40. 
Figure 2 is two examples of label-specific sequential patterns in each label. In both 
examples, the waves were not observed in group 3, and they highly correlated with 
groups 1 and 2. When replacing a cluster ID with a cluster representative wave, we se- 
lected one that had minimum loss x in the cluster. Our aim is to propose an interpretation 
method rather than give medical insight, so we do not discuss the patterns. 
4. Conclusion  
In this paper, we focused on a better interpretation of CGM values. We propose an inter- 
pretation method of extracting characteristic sequential patterns using mini-batch top-n 
k-medoids that provides accurate cluster centers. By clustering the data, we group similar 
elements of data to find patterns more effectively. 
 
                                                   
3
https://www.freestylelibre.us 
ID Method Loss ID Method Loss 
#1 k-means 8.949 #6 Mini-batch top-n k-medoids + L1 5.185 
#2 k-medoids + L1 6.519 #7 Mini-batch top-n k-medoids + L2 5.821 
#3 k-medoids + L2 6.000 #8 Mini-batch top-n k-medoids + EMD 7.292 
#4 k-medoids + EMD 7.850 #9 Mini-batch top-n k-medoids + DTW 15.061 
#5 k-medoids + DTW 14.535 #10 DBA [5] 9.277 
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Table 2. Results of the first label created from the BG average (AVG) and the second label created from the 
standard deviation of BG (STD) 
 
 
 
 
 
 
Figure 2. Examples of label-specific sequential patterns produced from the CGM dataset. The waves  on the 
right side were created from the label based on the BG average. The waves on the left side were created from 
the label based on the standard deviation of BG. 
We conducted two evaluations. In the first experiment on manually created dataset, 
we show that mini-batch top-n k-medoids outperformed the baselines. In the second ex- 
periment, we applied our interpretation method to a CGM dataset containing 223 waves 
created from 163 real patients over a 2-week period. We created two labels based on 
blood glucose statistics, and extracted label-specific sequential patterns. 
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Abstract. In this paper, we present and discuss two new measures of inter- and
intra-rater agreement to assess the reliability of the raters, and hence of their la-
beling, in multi-rater setings, which are common in the production of ground truth
for machine learning models. Our proposal is more conservative of other exist-
ing agreement measures, as it considers a more articulated notion of agreement by
chance, based on an empirical estimation of the precision (or reliability) of the sin-
gle raters involved. We discuss the measures in light of a realistic annotation tasks
that involved 13 expert radiologists in labeling the MRNet dataset.
Keywords. inter-rater agreement, reliability, Ground Truth, Machine Learning
1. Introduction
Data science research needs valid and reliable data to enable the comprehension of the
represented phenomena, and sound statistical inference and prediction about those phe-
nomena, that is the definition of predictive models, e.g., by machine learning methods
that can help human decision makers classify and interpret the reality of interest.
In many domains, like medicine, phenomena are increasingly measured by sensors,
but are still to a large extent described by human observers, who are supposed to produce
data in the endeavor to provide accurate and complete representations, by which to detect
effects, trends and differences and build reliable prediction models out of them, what is
then called Ground Truth.
In the light of the unavoidable fallibility of human observers in providing an ever true
representation, in domains characterized by high uncertainty, ambiguity and variability of
relevant conditions, like medicine, ground truth datasets are built by combining multiple
observations and ratings (i.e., labels), and averaging between them, to associate “the one
best” label to each case or object of interest. This is the process by which data scientists
can bring together subjective ratings (that is how a single rater sees and interprets a given
phenomenon) and create a reliable inter-subjective labelling, which is intended to be the
most objective representation of the reality of interest [1].
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Assessing?observer?variability,?that?is?the?extent?multiple?raters?agree?(or?disagree)?
in?providing?a?unique?interpretation?(that?is?label,?or?evaluation),?is?then?important?to?as-
sess?the?reliability?of?the?ground?truth?by?which?to?build?predictive?models?from?empiri-
cal?observations.?In?the?literature?there?are?many?measures?(e.g.,?Fleiss’?Kappa,?Cohen’s?
Kappa,?Krippendorff’s?α)?and?any?of? them?present?pros?and?cons? [2].? In?particular,? to?
assess?inter-rater?agreement,?the?Krippendorff’s?α?is?particularly?indicated?(although?sel-
dom?used?in?medicine?and?by?ML?scholars)?as?it?is?robust?with?respect?to?chance?effects?
and?missing?values.
However,?this?measures,?as?the?other?ones,?adopts?a?naive?model?of?chance,?by?which?
to? assess? the? degree? by?which?multiple? observers? agree?with? each? others? beyond? the?
extent?they?do?so?by?chance.?In?particular,?no?measure?considers?the?expertise?of?the?raters?
involved,?nor? their? confidence? in? their? specific? ratings:? in? short? the? reliability?of? their?
ratings.?This?brings?us?to?consider?an?aspect?that?is?seldom?considered:?how?to?assess?the?
reliability?of?the?raters?involved,?beyond?self-assessment??This?can?be?evaluated?in?many?
ways:?we?investigated?the?relationship?between?this?construct?and?the?extent?raters?agree?
with?themselves?in?judging?the?same?phenomenon?multiple?times?over?time,?and?hence?
they?do?not?take?guesses.?We?call?this?degree,?self-agreement,?while?others?refer?to?it?with?
the?expression?intra-rater?agreement?(e.g.,?[3]).
In? this?paper,?we?will?present? two?new?metrics? to?assess?both? self-agreement?and?
inter-rater?agreement?in?order?to?contribute?to?the?existing?literature?and?provide?a?better?
tool?to?assess?the?reliability?of?multi-rater?labeled?datasets.
2.?Method
In?this?Section?we?first?provide?a?decision-theory?based?derivation?of?a?measure?for?self-
agreement,?intended?as?the?probability?that?a?decision-maker?gives?the?same?interpreta-
tion?of?the?same?phenomenon?consistently.?Next,?we?use?the?self-agreement?indicator?to?
define?a?novel?chance-adjusted?measure?of?inter-rater?reliability?that?we?denote?as?ρ .?Let?
C?=?{0,1, ...,n?−?1}?be? the?set?of?possible?class? labels,? p?=?〈p(0), ...,?p(n?−?1)〉?be? the?
proportion?of?0s,?1s,?...,?n?−?1s?in?the?actual?labelings?by?multiple?raters?(we?assume?that?
these?reflect?the?real?class?proportions?in?the?reality?of?interest).
We?assume?a?two-step?decision?procedure:?first?the?decision?maker?flips?a?biased?n+1?
faced?coin?to?choose?between?random?choice?(x)?and?peaked?choice?(y0, ...,yn−1).?Then:
• If the decision maker chose random choice, then she selects one class according
to distribution p;
• Otherwise, if she chose peaked choice, she reports one value (which depends
on the specific peaked distribution chosen) with probability 1. Notice that while
each peaked distribution assigns probability 1 to a single alternative, the specific
peaked distribution is chosen according to (y0, ...,yn−1), which allows to encode
possible degree of uncertainty of the rater when she does not guess completely at
random.
This decision-making model conforms to standard decision-theory where a decision
maker is usually modeled as a probabilistic device in particular, our model represents a
generalization of the decision model proposed by Krippendorff as a justification for his
α metrics [4], in which raters possess different and unrelated probabilities of selecting
among the alternatives at random (e.g. due to their different expertise levels).
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How?can?we?find?x?and?y0, ...,yn−1? given?m?o1, ...,om? observations?of?the?decision-
maker?repeating?the?same?annotation?task?(i.e.?annotating?multiple?times?the?same?case)?
Let?d(0),? ...,?d(n?−?1)?be? the?observed?proportion?of?0,?1,? ...,?n-1? labels,? respectively,?
among?o1, ...,om?(notice?that?this?is?a?maximum?likelihood?estimation?of?the?parameters?of?
a?nominal?distribution).?We?can?find?x,y0, ...,yn−1? selecting?the?solution?to?the?following?
system?by?maximizing?the?entropy:
⎧
⎪⎨
⎪⎩
∀i.d(i) = x∗ p(i)+ yi
x+∑i yi = 1
∀i.x,yi ≥ 0
(1)
We define the self-agreement of the observer on label class i as SAi = [x ∗ p(i) +
yi]2 = d(i)2 and their overall self-agreement as SA = ∑i SA. Notice that SAi is the proba-
bility that the observer gives the same label i when it is asked to give a label to the same
object twice and thus it coincides with the Gini impurity.
Starting from our definition of self-agreement, we want to define a measure of inter-
rater reliability, i.e. a measure of the extent a set of raters agree in labeling a set of cases
or objects. Specifically, we want to define a measure ρ that takes into account the fact
that, because that raters do not have perfect self-agreements, mutual agreements may
arise due to chance; thus, we want ρ to properly discount this case.
Given two raters i, j and a case x we can find the probability
P((i, j) genuinely agree on x|(i, j) agree on x) (2)
by a direct application of Bayes’ rule. Denoting as yik(x) the value of yk for rater i on
case x, we note that this represents the probability that rater i genuinely asserts label i on
case x. Denoting as ci(x) the labeling provided by rater i on case x and supposing that
ci(x) = c j(x), we can see that, assuming that the raters i, j annotate case x independently:
P((i, j) genuinely agree on x) = yici(x)(x)∗ y
j
c j(x)
(x) (3)
and
P((i, j) agree on x) = P((i, j) genuinely agree on x)+P((i, j) agree by chance on x) =
yici(x) ∗ y
j
c j(x)
+ p[ci(x)]∗ xi ∗ y jc j(x) + p[c j(x)]∗ y
i
ci(x)
∗ x j + p[ci(x)]∗ p[c j(x)]∗ xi ∗ x j
(4)
Then, denoting the ratio of the probabilities in Equations 3, 4 as Genuine Agreement
Effect (GAE), we can express the ρ measure as:
ρ =
1
|U |∑x
1
(|D|
2
) ∑
i= j∈D
δ (ci(x),c j(x))∗GAE(i, j) (5)
where δ (x,y) =
{
1 x = y
0 otherwise
,U is the set of cases and D the set of raters. Notice
that when the sample size to estimate the values of the yik factors is small, the estimate
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obtained?via?the?exact?methods?is?not?robust?when?computing?the?value?of?ρ ,?especially?
if? the? value?were? computed? on? only? a? small? set? of? cases? and? then? propagated? to? the?
remaining?ones?(e.g.?by?averaging).?In?these?cases?a?more?robust?but?approximate?estimate?
can?be?obtained?by?considering? ignoring? the?specific?probability?of?getting?a?particular?
peaked?choice?distribution?and?only?considering?∑k?yik? as?a?measure?of?the?ability?of?rater?
i?of?providing?self-consistent?annotations.
3.? Results
In?order? to? test?our?proposed?measures?we?considered?a?dataset?obtained?by?a? realistic?
esperiment? of? knee?Magnetic?Resonance? Imaging? (MRI)? annotation.? Specifically,?we?
asked? 13? radiologists? from? the? IRCCS?Orthopedic? Institute?Galeazzi? of?Milan? (Italy)?
to?annotate?417?MRIs?from?the?well-known?MRNet?dataset?2:?in?particular,?the?doctors?
were?asked?to?assess,?for?each?of?these?images,?the?presence?of?abnormalities?(thus,?the?
considered?problem?was?a?binary?classification?setting,?i.e.?C?=?{0,1}).?Furthermore,?the?
doctors?were?also?asked?to?assess?the?complexity?of?each?case?and?the?confidence?in?their?
annotations,?on?a?4-?and?5-value?scale,?respectively.
In?order?to?apply?our?measure,?we?first?had?to?estimate?the?self-agreement?of?each?of?
the?raters.?In?order?to?do?so,?we?first?chose?two?cases?randomly?among?the?ones?consid-
ered?of?medium?to?high?difficulty?(between?2?and?3?in?a?1?to?4?scale)?by?one?of?the?most?
experienced? radiologist? in? the?panel?of? experts? involved.?Then,?we? inserted? these? two?
cases?multiple?times?in?the?dataset?of?cases?to?be?labelled,?replicating?them?for?6?times?
each:?in?so?doing,?the?dataset?had?10?more?cases.?These?replicated?images?were?placed?
randomly?in?an?annotation?sequence?(encompassing?more?than?200?cases)?to?make?more?
difficult?for?the?radiologists?to?understand?that?they?had?already?examined?and?assessed?
those?cases.?Considering? the?spread,? in? terms?of? interquartile?range?(IQR),? in? the?com-
plexity? rating?and? the?varying?confidence? in? the? interpretation?of? these? identical?cases,?
we?can?conjecture?that?the?replicated?cases?were?likely?considered?different?cases?by?all?
of? the? radiologists? (First?case:?complexity? IQR?=?0.63,?confidence? IQR?=?0.5;?Second?
group:?complexity?IQR?=?0.5,?confidence?IQR?=?0.4).
In? regard? to? the?first? case,?we?obtained? an? average? self-agreement?of?0.58?±?0.03?
(95%?confidence?interval,?min?=?0.5,?max?=?0.72)?For?the?second?group?of?images,?we?
obtained? an? average? self-agreement? of? 0.51?±?0.01? (min?=?0.50,?max?=?0.56):? notice?
that? these?values? are? close? to? the?minimal?value? for?SA?which,? for? the?binary? case,? is?
0.50.?Averaging? between? the? two? groups? the? average? self-agreement?was? 0.54?±?0.02?
(min?=?0.5,?max?=?0.64).
In? the? computation? of? the? ρ ,? for? each? agent? i,?we? considered? the? values? yi0?+?y
i
1?
estimated?on?the?whole?group?of?12?repeated?images.?We?obtained?a?value?of?ρ?=?0.46,?
while?for? the?same?dataset?we?obtained?a?value?of?Fleiss’?k?=?0.63?and?Krippendorff’s?
α?=?0.63.
4.? Discussion
The?above?results?show?how?our?measure?is?much?more?conservative?than?the?others?pro-
posed?to?assess?inter-rater?agreement.?The?small?difference?between?the?latter?measures
2https://stanfordmlgroup.github.io/competitions/mrnet/
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can?be?explained?by? the?fact? that? there?was?a?near?perfect?class?balance:? indeed?both?k?
and?α?consider?the?class?balance?in?order?to?model?chance?effects.?Furthermore,?the?large?
difference?between?the?ρ?and?the?values?of?the?other?metrics?can?be?explained?observing?
that? the?observed?self-agreement?were? indeed?very? low?and? the?same?holds?for? the?ob-
tained?yik?value?(in?most?cases?the?value?of?x
i?was?near?to?0.5).?In?fact,?to?obtain?a?value?of?
ρ?∼?0.63?on?the?dataset,?an?average?GAE?around?0.75?would?be?needed.?This?shows?that,?
differently?from?α? (and?k),?the?ρ? takes?into?account?a?model?of?the?rating?reliability?of?
the?raters?involved,?and?hence?it?yields?a?more?realistic?measure?of?their?agreement:?for?
example,?if?all?raters?exhibited?a?perfect?self-agreement?(thus?GAE?=?1)?we?would?obtain?
a?value?ρ?=?0.82?while?the?values?for?α?and?k?would?not?change.
Moreover,? one? could?wonder?what? threshold? should? be? set? to? assess?whether? the?
agreement? is?sufficient? to?consider? the?data?reliable,? that? is?what? the?so-called?smallest?
acceptable?reliability? is? [4].?Unfortunately,?any?proposal?of?such?a? threshold?would?be?
laden?with?some?extent?of?arbitrariness.?Krippendorff?suggests?to?“not?accept?data?with?
reliabilities?whose?confidence?interval?reaches?below?the?smallest?acceptable?reliability?
[.?.?.?],?for?example,?of?.8?00,?but?no?less?than?.667”?[4](p.?242).?An?α?or?an?ρ?below?0.667?
would?mean?that?only?two?thirds?of?the?data?are?labelled?to?a?degree?better?than?chance”.?
This?recommendation?challenges?a?much?more?popular?way?to?interpret?agreement?scores?
since? the?1970s?by? [5],? that? is?much?more? indulgent? (a? score?of? .21? is? considered? an?
indicator?of?fair?agreement;?.41?moderate;?.61?substantial).
As?said?above,?differently? from?α ,? the?ρ? takes? into?account?a?model?of? the? rating?
reliability,?and?hence? it?yields?a?more?realistic?measure?of? their?agreement.?In? this?first?
formulation,?we?have?considered?self-agreement?as?a?proxy?of?the?rater?reliability.?Since?
measuring?self-agreement?with?surreptitious?repetitions?can?be?intricate,?Formula?5?can?
alternatively?be?integrated?with?a?measure?of?the?raters’?confidence?in?the?interpretations?
given? (the?higher? the?confidence?on?a? rating,? the?higher? the? reliability?of? that? rating?as?
the?rater?is?stating?they?are?not?taking?a?guess).?Although?this?sounds?reasonable,?yet?we?
did?not?find?confidence?to?be?highly?correlated?with?self-agreement?(correlation?=?0.22,?
p?−?value?=?0.46).
In?this?regard,?however,?we?should?emphasize?that?low?ρ?or?SA?scores?should?not?be?
used?as?proxy?of?rating?skills,?or?to?judge?how?good?the?raters?are:?in?the?MRNet?study,?the?
13?radiologists?achieved?a?remarkable?average?performance?of?.82?(min:?.78,?max:?.86)?in?
re-annotating?the?original,?low-res?dataset?on?standard?monitors?and?with?no?incentives.?
Rather,?what? low?ρ? or?SA?scores? in?ground? truthing?by?experts? indicate? is? the? intrinsic?
ambiguity?and?complexity?of?medical?phenomena;? the?over-ambition? to?pinpoint? them?
with?clear-cut?labels;?and?the?reckless?risk?to?delegate?judgment?or?advice?to?classifying?
machines?that?interpolate?those?labels?as?a?way?to?resolve?uncertainty.
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Abstract. Eye tracking studies have demonstrated deficits in attention in 
individuals with Autism Spectrum Disorder (ASD) for a range of different social 
attention-based tasks. Here we examined social attention skills in a large sample of 
ASD participants (n = 120), using eye tracking data from a social information 
processing task, and compared them with a typically developing (TD) group (n = 
35). Assuming eye movement parameters are random variables generated by an 
underlying stochastic process, we modeled the fixation sequences of participants in 
ASD and TD groups with a Hidden Markov Model. The Regions of Interests 
(ROIs), modeled as hidden states, corresponded to the true ROIs with a prediction 
accuracy of >90% for each group. The transition between ROIs revealed bias 
towards a specific area in the scene in ASD group, which deviated from the TD 
group. Objective time-dynamic measures of gaze patterns can potentially serve as
useful endpoints in ASD diagnosis. Clinical Trial Registration: NCT02299700.
Keywords. Autism Spectrum Disorder; eye tracking; Hidden Markov Model.
1. Introduction
Tracking of eye movements allows collection of high-density spatiotemporal data that 
can provide a rich source of information related to underlying cognitive processes.
Several studies have proposed different computational methods to infer observers’ 
characteristics during tasks such as counting, searching, memorizing, or viewing static 
artificial or natural scenes, that are informative of cognitive processes. These methods 
broadly range from extracting eye tracking parameters like fixation duration, number, 
dispersion etc. directly from the data [1]; incorporating spatial information by creating 
heatmaps, which are 3-D objects (x-coordinate, y-coordinate, fixation density) 
representing spatial distribution of eye position at a given time [2]; converting eye 
movement trajectory to a chronological sequence of fixations within pre-defined 
regions of interest followed by using geometric-based distances metrices to compare 
scan paths [3]; or using probabilistic approaches to model eye movement [4].
Eye tracking data has been studied as an indicator of social attention in Autism 
Spectrum Disorder (ASD). Attention to social information is impaired in individuals 
with ASD, including limited attention to eyes and faces, increased attention to non-
social stimuli, increased attention to detail and difficulty with shifting attention 
compared to typically developing (TD) controls [5]. Commonly, Regions of Interests
(ROI) are identified on static images or sequentially on dynamic videos and time spent 
viewing a prespecified ROI is used to study gaze differences between ASD and TD 
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groups. Although simple and intuitive, this approach does not capture the dynamic
nature of gaze and involves a labor-intensive process of manual labeling of ROIs.
Using data obtained from an observational study collected from the Janssen 
Autism Knowledge Engine® (JAKE®) [6,7], here we present findings on measurement 
of eye tracking data from a Social Information Processing task. We propose a Hidden 
Markov Model (HMM) based approach, a time-series probabilistic model, to analyze 
complex gaze trajectories in ASD and TD groups. Since eye fixation during a task is 
conditioned on previous fixations, eye movements can be represented as a Markov 
process. HMM is a natural fit for this problem - it models the specific ROIs participants 
look at as hidden states (eliminating the need to manually label ROIs) and captures the 
transition among those ROIs (incorporating the temporal dynamics of eye movement).
2. Study design
2.1 Participants: This study was a part of large prospective, 10-week long 
observational clinical trial conducted at 9 study sites in the US and enrolled 144 ASD 
and 41 TD participants in total aged between 6 and 64 years [7]. At the study sites, 
participants completed multiple passive viewing tasks presented on a 23-in. computer 
screen (1920-by-1024 pixels). Table 1 shows the characteristics of participants for 
which valid data was available when performing the social information processing task.
Table 1. Characteristics of ASD and TD participants.
2.2 Social information processing task: Here we focus specifically on the results from 
a viewing task called the social information processing task. Participants viewed a
video of a female actor engaged in child-directed speech against a background of 
objects, such as toys and an iPad. Detailed description of the video can be found in [8]. 
The length of the video was 73 seconds with 4 predefined conditions presented over 
multiple episodes, designed to reflect important aspects of social interaction requiring 
different demand characteristics: a) Activity: where the actor is making a snack. No
direct actor’s gaze or speech cues is present; b) Dyadic Bid: where the actor faces and 
speaks directly to the camera; c) Joint Attention: where a walking toy robot suddenly 
begins to move towards the actor, which distracts her from her activity and makes her 
turn toward that toy; d) Moving Toy: where the toy robot is moving, but the actor looks 
away at a different toy placed on a wooden stand, located diametrically opposite to the 
moving toy robot. Figure 1 shows snapshots from the 4 conditions.
Figure 1. Representative snapshots from 4 predefined conditions in social information processing task.
Participants freely viewed the video while sitting in a comfortable chair ~60 cm from
the screen. Tobii X2 eye tracker, mounted below the screen, collected participants’ eye
movement data at a sampling rate of 30 Hz. iMotions Biometric Research Platform was
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used for stimulus presentation, synchronization and automatic calibration. Before start 
of the task, a cartoon was placed on a center of the screen to cue participant’s attention.
3. Analyses
3.1 HMM for eye movement analysis: A Markov process is a memory-less stochastic 
process where the probability distribution of the next event or state (in a sequence of 
events) depends only on the current state and not on the sequence of states preceding it. 
An HMM is based on augmentation of a Markov process where the system to be 
modeled has unobservable or hidden states. HMMs are suitable for modeling sequential 
data varying over time and is specified by the following components:
a set of ? states
a transition probability matrix , being the probability of
moving from state to state , s.t
a sequence of observations
emission probabilities, each representing the probability of 
an observation being generated from a state 
Prior/initial probability distribution of states, s.t.
In the context of eye movement modeling, the fixation 
sequence of a participant constitutes a sequence of 
observation for the HMM. The hidden states of HMM 
represent Regions of Interest (ROIs) when the participant 
is viewing the video. The possible ROIs that participants
could be viewing during the video is shown in Figure 2.
Here we assumed that the distribution of eye fixations on
each ROI follows a Gaussian distribution, so the 
emission densities corresponding to the fixations 
distribution in each ROI was modeled as two-
dimensional Gaussian distribution:
is the center, is the covariance of state emission.
We modeled the three ROIs: hair, eye and mouth as a single hidden state and called it 
face. The transition from one ROI (hidden state) to another represents a saccade, and 
the probabilities of these transitions are summarized in the transition matrix. The prior 
specifies the probability distribution of the first fixation. The fixation sequences of all 
participants in each group (ASD and TD) were modeled using a single HMM. To avoid 
convergence to local minimum, the ASD (and TD) model was trained 100 times with 
different initial parameters for Gaussian distributions of ROIs, and the model with the 
highest log-likelihood of the data was selected. The resultant model parameters 
obtained were the transition matrix, emission densities and priors. From the transition 
matrix, we quantified the randomness associated with transitioning among different 
ROIs, by computing the entropy of trajectories of a Markov process as derived in [9]. 
3.2 Validation of predicted hidden states with Regions of Interest (ROI): To assess if 
the hidden states or the ROIs predicted by the model for each group correspond to the 
true ROIs (Figure 2), normalized confusion matrices were generated. Confusion matrix 
visualizes the performance of HMM model where the rows and columns represent the 
instances in true and predicted ROIs respectively. 
Figure 2. ROIs manually drawn
on areas of scene.
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4. Results
Figure 3 shows the accuracy of predicted ROIs when validated with true ROIs for the 
ASD group (Figure 3A) and the TD group (Figure 3B). Overall prediction accuracy for 
all ROIs taken together were 92.73% and 94.55% for ASD and TD groups respectively.
Figure 3. (A) True ROIs (left), predicted ROIs (middle), normalized confusion matrix (right) for ASD group. 
(B) True ROIs (left), predicted ROIs (middle), normalized confusion matrix (right) for TD group.
Figure 4. (A) Transition matrices for ASD (left) and TD (right) group; each cell contains probability values 
multiplied by 100; (B) Markov entropy matrices for ASD (left) and TD (right) group.
All 3 toys in the video array, iPad, face and hands were predicted with high 
accuracy (>85%) in each group, however accuracy for prediction of body fell to 75.5%
and 70.9% for ASD and TD groups respectively. The model automatically splits the 
hands into 2 regions of interest: the left hand, hand-L and the right hand, hand-R (for 
the purpose of an easy visualization, hand-L and hand-R are combined and represented 
as hands only in Figure 3). The probability distribution of first fixation indicated that 
body is the most probable initial fixation both for the ASD group (prior probability = 
0.95) and TD group (prior probability = 1), with iPad being the next most likely initial 
fixation for ASD group. The fact that both groups initially fixate on body could 
possibly be a manifestation of the experimental design, wherein participants’ gaze 
could still be directed at the cartoon on center of the screen (shown at the beginning of 
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the task) which falls within the body ROI, even slightly after task has started. Figure 
4A shows the transition matrix for each group. The TD group exhibited a higher 
probability to continue fixating at the face when they are already fixated at the face.
ASD group also deviated from the TD group in the way they scanned the hands- when 
participants in the ASD group fixate at the right hand, they are likely to next shift their 
gaze to the left hand. Similarly, when ASD participants fixate at the left hand, they are 
likely to next shift their gaze to the right hand. Thus, ASD group was more likely to 
switch between the two hands than TD group. This stereotypic nature of scanning the 
hands was also captured by the entropies of the transition matrices (Figure 4B), where 
the entropies of switching between two hands (as well as entropies of switching to 
hands from any other ROI) were much lower in ASD group than that in TD group.
5. Conclusion & Future Work
Here we presented a simple methodological framework based on Markov chain and 
information theory to cut complex eye tracking trajectories into interpretable 
elementary measures with the least amount of data manipulation or introduction of free 
parameters as possible. This approach identified the ROI observers look at without 
requiring manual pre-specification and captured the dynamic nature of gaze patterns by 
modeling the transition probabilities of the ROIs. One HMM was built for each group,
hence could not capture the variability in viewing patterns across participants which 
can be relevant particularly in ASD group. The ASD group also spent significant time 
viewing the stimulus background which could bias the choice of hidden states of the 
model. Finally, the primary focus of the main study was to maximize collection of data 
in the ASD group, which led to a smaller and unbalanced TD group. Future work will 
augment the model by introducing a prior to HMM that will model spatial distribution 
of the moving ROIs, incorporating time spent viewing non-stimulus, building an HMM
for each participant and correlating the participant level measures with clinical scales.
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Abstract. Acronyms frequently occur in clinical text, which makes their identi-
fication, disambiguation and resolution an important task in clinical natural lan-
guage processing. This paper contributes to acronym resolution in Spanish through
the creation of a set of sense inventories organized by clinical specialty containing
acronyms, their expansions, and corpus-driven features. The new acronym resource
is composed of 51 clinical specialties with 3,603 acronyms in total, from which we
identified 228 language independent acronyms and 391 language dependent expan-
sions. We further analyzed the sense inventory across specialties and present novel
insights of acronym usage in biomedical Spanish texts.
Keywords. Acronym resolution, Clinical specialties, Natural Language Processing,
PubMed, Sense inventory, Spanish
1. Introduction
An important normalization task in clinical Natural Language Processing (NLP) is
the identification and resolution of short forms, e.g. “Human Immunodeficiency Virus
(HIV)”. Existing approaches can be distinguished between those that focus on documents
where the expansion is explicitly contained (e.g. in scientific articles) and those where
the resolution of the acronym is left to the reader (e.g. in clinical narratives). While the
former case is mostly addressed by rules, heuristics, and statistical analyses, the latter is
usually addressed by using external dictionaries. In both cases, ambiguity arises when an
identified acronym may have different expansions (e.g. RA for Right Atrium or Rheuma-
toid Arthritis). The problem of ambiguity has been addressed by analyzing the contexts
in which the acronym may exist; however, acronym dictionaries in which expansions are
linked with possible contexts rarely exist [1].
Several studies have proposed sense inventories that are automatically obtained
from MEDLINE or other openly accessible corpora by exploring acronym-definition
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pairs?commonly?found?in?scientific?texts.?Some?of?the?strategies?considered?for?English?
abstracts? include?manually-created? pattern?matching? rules? [2,3];? statistics-based?word?
collocations[4,5];?or?a?mix?of?both?[6].?A?seminal?study?on?this?topic?has?been?pre-sented?
by? Schwartz? and? Hearst? [7]? who? proposed? a? simple? algorithm? in? which? possible?
candidates? identified?using? length?heuristics?are?used? to?map?parenthesized?short?form-
definition-pairs?with?an?alignment-based?strategy.
Languages?other? than?English?came? into? focus? for? short? form?expansion?more? re-
cently.? In?Spanish,? the?2018?BARR2?Task? [8]? explored? clinical? acronym?disambigua-
tion,?with?a?focus?on?acronym? identification?on? the?first?subtrack.?The?winning? team?of?
Sánchez-León?[9]?proposed?the?application?of?regular?expressions?on?content?of?biomed-
ical?websites,?while?Montalvo?et?al.? [10]?applied? the?Schwartz?&?Hearst?algorithm?on?
SNOMED?CT?to?biomedical?websites.
This?paper?contributes? to?acronym? resolution? in?Spanish?clinical? texts? through? the?
semi-automatic?creation?of?acronym?repositories?from?non-clinical?texts?using?a?resource?
that?guides?disambiguation.?This?resource? is?composed?of?a?set?of?acronym? inventories?
classified?by? clinical? specialty? and? characterized?by? specialty-specific? acronym? expan-
sions.?Our?main?goal?is?to?demonstrate?that?the?generation?of?a?sense?inventory?classified?
by?specialty?helps?acronym?resolution?by? reducing?sense?ambiguity.?To? the?best?of?our?
knowledge,?we?are?the?first?to?apply?the?Schwartz?&?Hearst?algorithm?to?the?full?Spanish?
subset?of?MEDLINE?and?provide?our?results?stratified?by?clinical?specialty.
2.?Method
Figure?1?depicts?the?construction?of?the?sense?inventory?classified?by?clinical?specialty.
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Identification of data source for acronym extraction: We firstly identified specific
branches of the MeSH thesaurus2 related to each clinical specialty (step 1). We consid-
ered MeSH terms denoting clinical specialties (step 2) and other terms extracted from the
“See Also” section of the MeSH hierarchy (step 3) and, from them, only the specialties
in the first two levels of the MeSH hierarchy (step 4). Finally, we excluded duplicated
2https://meshb.nlm.nih.gov
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specialties?(e.g.?gynecology?as?“Specialties,?Surgical”?and?as?“Reproductive?Medicine”)?
and?specialties?with?less?than?250?Spanish?titles?in?their?MEDLINE?record?(step?5).
We?explored?the?MeSH?thesaurus?and?automatically?queried?documents?in?PubMed?
using?Biopython3?for?matches?on?either?(a)?affiliation,?(b)?title,?or?(c)?MeSH?tags.
Identification? of? acronym? pairs? by? clinical? specialty:?Once?we? obtained? the? relevant?
documents,?we?pre-processed?their?titles?and?abstracts?(step?6)?and?applied?the?Schwartz?
&?Hearst?algorithm?(step?7).
We? normalized? all? acronym? expansions? to? lower? case? and? characterized? each?
acronym/expansion?pair?by? the? following? features? (step?8):? (i)? intra-frequency,? the? fre-
quency?of?the?acronym?within?a?clinical?specialty;?(ii)?inter-frequency,?the?frequency?of?
the?acronym?across?all?specialties.?(iii)?uniqueness?across?specialties,?the?number?of?spe-
cialties?where? the?acronym?was?found;?(iv)? intra-specialty?and?(v)? inter-specialty?ambi-
guity,? the?number?of?different?senses?found?for? the?same?acronym?within?a?specialty?or?
across?all?specialties,?respectively.
We?finally? (step?9)?analyzed? the? level?of? language-independence?of?acronyms?and?
their?expansions?because?we?observed?acronyms?that?derived?from?a?different?lan-guage?
(mostly?English? and?Latin)? together?with?Spanish? expansions.? In? these? articles?where?
acronyms?and?expansions?were?identified?in?both?languages,?we?performed?a?lan-guage?
independence? analysis? and? classified? acronyms? automatically? into? three? groups:? (i)?
language-independent?acronyms,?acronyms?and?their?corresponding?expansion?are?used?
indistinctly?in?any?language,?e.g.,?“NEWSQOL”?(“Newcastle?Stroke-specific?Quality?Of?
Life?measure”);? (ii)? language-dependent? acronym,? acronyms?whose? value? and? expan-
sion?are?different?for?each? language,?e.g.,?“MS”?(“Multiple?Sclerosis”,?English)?and? its?
corresponding?“EM”?(“Esclerosis?Múltiple”,?Spanish);?and?(iii)?language-dependent?ex-
pansion?of?acronyms?used? indistinctly? in?any? language?with?expansions? translated? into?
the?document? language?(the? translation?does?not?necessarily?coincide?with? the?acronym?
creation? rules),? e.g.,? “ANCA”? (“Anti-Neutrophil? Cytoplasmic? Antibodies”)? and?
“ANCA”?(“anticitoplasma?de?neutrófilos”).
3.? Results
The?resource4?generated?is?composed?of?51?dictionaries?with?3,603?acronyms?identified?
from?the?Spanish?subset?of?MEDLINE.?Figure?2?illustrates?the?number?of?acronyms?vs.?
the?number?of?titles?analyzed?per?specialty.?The?analysis?of?this?relationship?showed?that?
out?of?the?group?of?specialties?with?more?than?1,000?titles?available,?pediatrics,?rehabili-
tation,?radiology,?psychiatry,?and?orthopedics?are?the?specialties?with?the?higher?ratio?of?
acronyms?per?title.?For?instance,?pediatrics?has?approximately?one?acronym?in?every?22?
titles?/?abstracts.
We?analyzed? the?ambiguity?of?acronyms?by?comparing? the?number?of?possible?ex-
pansions? in? the?corpus?and? their? reduction?when? they?were?analyzed?by?specialty? (Fig-
ure?3).?The?x?axis?shows? the?number?of?possible?expansions? in?a?specialty-independent?
inventory,?while?the?y?axis?shows?the?average?number?of?expansions?in?the?specialties?in?
which?the?acronym?was?used.?The?dot?size?represents?the?number?of?acronyms?with?the
3https://biopython.org/
4Available at https://github.com/plubeda/spanish-acronyms-pubmed.
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Figure 2. Acronyms per specialty and number of source document titles.
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same behavior. We found that the acronyms DE (12), EC (12), CC (11), II (10) are the
most ambiguous acronyms as they have ten or more possible expansions. We reduced
the overall ambiguity from 1.32 to 1.06 senses/acronym, a reduction of 81% ambiguity
(excess over 1) on average. Considering only ambiguous acronyms, we reduced it from
2.71 to 1.28 senses/acronym, a mean reduction of 84%.
Figure 3. Number of expansions before and after specialty classification.
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Finally, Figure 4 depicts the similarity of the specialties with respect to the acronyms
they use. The height at which any two specialties merge indicates the joining order: a
smaller height represents a stronger relationship; e.g., “obstetrics” and “perinatology”
are the most similar because they share 92% of their acronyms.
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Figure 4. Similarity among specialties according to the used acronyms.
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4. Discussion and Conclusion
The generated resource supported the hypothesis that creating a sense-inventory of
acronyms classified by specialty reduces the level of ambiguity when compared to a
specialty-independent sense inventory. Therefore, it can be used to improve contextual
knowledge about an acronym and thus better disambiguate its meaning during the res-
olution process. The development of this resource also made it possible to identify the
specialties in which more acronyms are used and those specialties with stronger links in
terms of the acronyms used.
The proposed method can be expanded to any other language that has available
resources in PubMed. In the future, we plan to use the generated resource for pre-
processing electronic health records. We also would like to extract contextualized word
embeddings for each acronym and make them available as features together with the
dictionary resource.
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Abstract. Iris is a system for coding multiple causes of death in ICD-10 and for the 
selection of the underlying cause of death, based on a knowledge base composed by 
a large number of rules. With the adoption of ICD-11, those rules need translation 
to ICD-11. A pre-project has been carried out to evaluate feasibility of transition to 
ICD-11, which included the analysis of the logical meta-rules needed for rule 
translation and development of a prototype support system for the expert that will 
translate the coding rules. 
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1. Introduction
With its adoption by the 72th World Health Assembly in May 2019, ICD-11 
(International Classification of Diseases, Revision 11) will become the new standard for 
coding diseases and health problems. For mortality statistics, the ICD coding is 
performed with the use of semi-automated coding systems, mainly Iris [1].  
Iris is a system for coding multiple causes of death in ICD-10 and for the selection 
of the underlying cause of death. Iris is based on the international death certificate form 
and coding rules provided by WHO (World Health Organisation). The core component 
of Iris are the decision tables, currently based on ICD-10 codes. For the transition of Iris 
to ICD-11, it will be necessary to translate the decision tables and to allow them to 
include all the features of the new revision. 
This transition is expected to have a big impact on the system transition and use. 
Periodic revision of the ICD is essential to stay abreast of advances in medical science 
and changes in medical terminology [2,3]. Institutionally, revision of the ICD requires 
an enormous investment of national resources to revise software, training, publications, 
edit procedures, etc [4]. For the Iris transition to ICD-11, classification and coding 
experts are needed. To support their work, formal procedures are needed to ensure the 
correctness of the transition and validation of the system.  
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A pre-project has been carried out to evaluate feasibility of transition to ICD-11, 
which included the analysis of the logical meta-rules needed for rule translation and 
development of a prototype translation support system aimed at the expert [5]. This paper 
describes the logical rules identified for translating from ICD-10 to ICD-11 with their 
consequences from the point of view of automation and human expert intervention, with 
an overview of the prototype, and evaluation of efforts needed. 
1.1.Decision tables 
The decision tables form a knowledge base of relations between pairs of codes 
(representing the causes of death reported on the death certificate) that must be taken into 
consideration during the application of the steps for the selection of the underlying cause. 
This knowledge base was first developed by the NCHS (US National Center for 
Health Statistics) for the ACME system [6]. Successively it has been embedded in the 
new automated coding system Iris and updated on the basis of the recommendations of 
the Mortality Reference Group, which operates in the network of the WHO Collaborating 
centers for the Family of International Classifications (WHO-FIC) [7]. 
In practical terms, the decision tables are a list of possible kind of relations between 
pairs of terminal code. The relation between the codes are specified as “rule type”, which 
are used in the different steps of selection. 
1.2.Mapping between classification versions 
Along with ICD-11, the WHO releases the mapping table between the ICD-10 and ICD-
11 classification. The mapping table contains the mapping of both terminal codes and 
higher categories which can be used to add detail. 
The mapping between the ICD-10 and ICD-11 entities can be specified by 
cardinality as: 1x1 (equivalent), 1xn, nx1 and nxn (structure of the classification change 
and the categories intersect each other) with axb where a is the cardinality of the ICD-
10 codes and b is the cardinality of ICD-11 codes. 
2. Methods
For this analysis the 2019 decision tables are considered, since they include the most 
recent ICD-10 updates. The most represented rule is the DUETO, with more than 27 
million records (90.1% of the total rules). The analysis thus focused on the DUETO rules. 
These rules represent the vast majority of the rules and are the most critical for coding. 
2.1.Translation method 
From former evaluations of the transition between the ICD-9 and ICD-10, it is known 
that the transition to ICD-11 will have an impact and the mapping will not be enough to 
completely automate the transition. The mapping table gives the possibility to translate 
single codes, but when it comes to the rules, we need to translate relationships between 
codes. Due to the relation between the pair elements, we cannot translate codes separately, 
but we need to interpret the relation from a logical point of view and the impact that the 
diverse mapping cardinality has on the two codes involved. 
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2.2.DUETO rule-type translation 
The DUETO relation can shortly be described as: 
Code A DUETO B if B is an acceptable cause of A (according to ICD provisions); in 
IRIS terminology, A is called codeDef and B is called subcodeDef. 
The goal of the translation is to identify all the possible translation rules that can be 
automated. Afterwards we define the DUETO rule-type in combination with the mapping 
cardinality of the two codes that can be automated, and which needs expertise support.  
The decision tables are based on pair of codes, but since the DUETO rules may 
include many consecutive pairs, the conditions can be represented also as ranges of codes. 
Using ranges, it is possible to achieve better results but also to reuse part of the translation 
of the subcodeDef. 
Given a rule, the basic idea is to verify whether a mapping exists between single 
codes for both codeDef and subcodeDef and of which kind. A rule can be translated 
automatically if both sides can be translated automatically. In some cases, we may need 
a different translation of codes for codeDef and subcodeDef, since the consequences of 
the rule-type could be different. So we want to always suggest the translation codes based 
on the mapping but, basing on the mapping type and the implications of the relation, the 
system also suggest which are the codes that can be accepted or need expert supervision. 
Since the disease knowledge evolves, some ICD-10 codes may have no mappings 
to the ICD-11 classification since the concept is no longer used, or ICD-11 codes may 
have no mapping from the ICD-10 since they are new. Those codes are problematic and 
need expert supervision. Sometimes, using ranges for the translation, some of those 
codes could be handled. Since the classification is hierarchical, translating the higher 
levels could avoid manual intervention on some of the terminal codes with no mapping, 
since the results would be covered by the parent translation. 
Figure 1. Summary of translation cases. 
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3. Results
Basing on the cardinality of the mappings on both sides, we can distinguish between 
manual and automatic translations.  
The equivalent mapping (1x1), when found on both sides of the rule, is the basic 
case of automation, applicable to all the rule types. On the other side, when a mapping 
with cardinality of nxn is present, translation will always be manual. Rules where 
mapping of type nx1 and 1xn appear are those that provide some chance of automated 
translation, as depicted in Figure 1.  
The key for the DUETO rule translation is to remember that is not representing 
causality, but the possibility of causality. Thus, whenever aggregated conditions are 
present in the ICD-11 translation, such causality could not be excluded and thus the 
mapped rule is valid as obtained from the mappings. Let’s examine two examples of 
automated translation in table 1. 
Table 1. Automated translation examples.     
case ICD-10 rule Mappings involved ICD-11 rule 
(a) A01.0 (Typhoid fever)
DUETO C33 (Malignant 
neoplasm of trachea)
A01.0 ≡ 1A07 
C33 ≡ 2C24 
1A07 (Typhoid fever) 
DUETO 2C24 (Malignant 
neoplasms of trachea) 
(b) F03 (Unspecified
dementia) DUETO R54
(Senility)
But also: 
F01 (Vascular dementia
DUETO R54 (Senility)
F03 6D8Z  
R54 ≡ MG2A 
But also:  
F00 (Dementia in Alzheimer 
disease) 6D8Z  
F01 (Vascular dementia)6D8Z  
6D8Z (Dementia, 
unknown or unspecified 
cause) DUETO MG2A 
(Old age) 
(c) J96.9 (Respiratory
failure, unspecified) 
DUETO F03
J96.9 ≡ CB41.2 
F03 6D8Z 
But also: 
F00 6D8Z 
F01 6D8Z 
CB41.2 (Respiratory 
failure, unspecified  
as acute or chronic) 
DUETO 6D8Z  
Let’s now examine the cases that need expert intervention in table 2. In this case, 
since ICD-11 conditions are recorded with greater detail, we cannot ensure all of them 
are reasonably part of a DUETO rule (but the expert will know and decide). No example 
is provided for mixed situations involving nxn because too complex to be shown here. 
Table 2. Examples of rules translation needing expert intervention. 
case ICD-10 rule Mappings ICD-11 rule 
(d) I46.9 (Cardiac
arrest, unspecified
DUETO R26.3
(Immobility) 
I46.9 MC82 (Cardiac arrest)  
I46.9 MC82.0 (Ventricular tachycardia and 
fibrillation cardiac arrest) 
I46.9 MC82.1 (Bradycardic cardiac arrest) 
I46.9 MC82.2 (Asystolic cardiac arrest) 
I46.9 MC82.3 (Cardiac arrest with pulseless 
electrical activity) 
R26.3 (Immobility) ≡ MB44.3 (Immobility) 
We cannot 
ensure that all 
types of cardiac 
arrest can be due 
to immobility 
(e) I27.9 (Pulmonary
heart disease,
unspecified)
DUETO B44.1
(Other pulmonary
aspergillosis)
I27.9 ≡ BB0Z (Pulmonary heart disease or diseases 
of pulmonary circulation, unspecified) 
B44.1 CA82.4 (Aspergillus-induced allergic or 
hypersensitivity conditions) 
B44.1 1F20.12 Chronic pulmonary aspergillosis) 
We cannot 
ensure that both 
CA82.4 and 
1F20.12 can 
cause Pulmonary 
heart disease.  
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In cases like (d) and (e), the expert should be given the list of mappings that map to 
the same ICD-11 entity, to let him decide which ones generate valid DUETO rules. 
Using this method for the translation the expert has a tool to quickly get an overview 
of the suggestions for the translation, but also has the possibility to focus more on the 
results that are suggested as manual after the validation of the method.  
CodeDef and subcodeDef can be translated separately, and for the translation of the 
subcodeDef we can reuse the same translation in different rules. A further improvement 
is the translation reuse of a sub-range, that can be used for the translation of ranges that 
incorporate the translated range. Both techniques help in reducing human intervention. 
Further details on the translation methodology can be found in [5]. 
By exploring the distribution of mapping types in the coding rules, we evaluated in 
about 3.2 million pairs those needing manual intervention, out of about 27 millions. With 
the reuse of the validated range translation we estimated a relevant reduction, where the 
cases that still need manual support are about 87000 codes (considering manual 
translation of codeDef and subcodeDef). 
3.1.Prototype 
The prototype is aimed at providing decision support in the translation of mortality rules 
from ICD-10 to ICD-11. For the implementation, we choose a web-based model where 
experts can work collaboratively from a different location but also for the consistency of 
the results. It has a full implementation of the visualization and editing of the “DUETO” 
translation rules of the decision tables. Rules are grouped where possible with the same 
subcodeDef to ease the translation and facilitate maintenance over time. 
4. Conclusion
The presented method and prototype seem suitable for supporting the process of 
transition of Iris from ICD-10 to ICD-11, however it further needs expert validation to 
correctly estimate the workload needed. Adaption of results obtained on the DUETO 
rules is being carried out for the other rules, in particular those describing direct sequels 
of conditions. 
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Abstract. Evidence-based practice is highly dependent upon up-to-date systematic 
reviews (SR) for decision making. However, conducting and updating systematic 
reviews, especially the citation screening for identification of relevant studies, 
requires much human work and is therefore expensive. Automating citation 
screening using machine learning (ML) based approaches can reduce cost and labor. 
Machine learning has been applied to automate citation screening but not for the 
SRs with very narrow research questions. This paper reports the results and 
observations for an ongoing research that aims to automate citation screening for 
SRs with narrow research questions using machine learning. The research also 
sheds light on the problem of class imbalance and class overlap on the performance 
of ML classifiers when applied to SRs with narrow research questions. 
Keywords. Systematic reviews, Automation, Natural language processing, Machine 
learning 
1. Introduction 
Summarizing evidence in a specific domain through the process of conducting 
systematic reviews (SR) becomes increasingly difficult with an exponential increase in 
the number of primary research publications and an increasing variety of publishers. 
With this increased publication rate, citation screening for conducting the SRs has 
become time-consuming and labour intensive. The core of citation screening involves 
manually categorizing the studies found in literature search into relevant or non-
relevant depending upon predefined criteria for the research question at hand [1]. This 
screening is usually performed by two independent reviewers, who often cannot keep 
up with the manual process of screening the studies and constantly updating outdated 
SRs [2]. 
In the area of physiotherapy and rehabilitation such an exponential increase in the 
number of publications is also observed2. For an ongoing review on exercise and non-
exercise interventions in reducing cancer-related fatigue retrieved over 30,000 
references, about 2,000 of which were published in 2017 alone. It took more than 200 
hours for each of the two independent reviewers to manually assess the titles and abstracts 
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for relevance to the research question before the studies were taken for further meta-
analysis [3]. Supervised machine learning based classification approaches are 
successfully applied for automation of citation screening but either only for broad and 
shallow SRs [4] or SRs that retrieved fewer than 6,000 studies [5]. However, there are 
SRs that address very specific research questions leading to narrow, predefined 
criteria for selection of relevant studies to be included for meta-analysis. For such 
narrow SRs, inclusion prevalence becomes as low as 10%, which means that out of all 
the studies retrieved during the search phase, 90% are excluded as non-relevant. A 
narrow research question combined with a low inclusion prevalence leads to class 
imbalance and class overlap problems for classification tasks that generally reduce 
classifier performance [6]. Class overlap cannot be artificially controlled but class 
imbalance can be tackled using oversampling or undersampling [7]. In this work, we 
aim to explore machine learning and natural language processing to assist citation 
screening in SRs with a narrow research question and low inclusion prevalence using 
word embeddings and random oversampling. 
2. Methods 
2.1 Datasets 
Data sets from the open access literature were used in the work is described below. 
a) Word embedding Titles and abstracts (TA) of 2.09 million studies included in the 
PubMed Central Open-Access subset (PMC-OA) were used to generate semantic 
word embedding using the two most common architectures: word2vec and 
fastText [8,9]. 
b) Data for the screening process The data set used to test automation approaches 
included the studies identified for citation screening in an update to the 
systematic review by Hilfiker et al. [3]. The data set included TA from 31,279 
studies identified during the search phase of this SR. These studies were already 
manually assessed for relevance and labelled by two reviewers into two mutually 
exclusive labels. 4,066 studies assessed as relevant were labelled “include” and 
the rest were labelled “exclude”. The inclusion prevalence for this case is only 
about 13% leading to class imbalance. 
2.2 Screening Automation 
To automate the screening and explore the effect of class imbalance, six supervised 
binary classifiers were trained to classify documents into “include” (relevant) vs. 
“exclude” (non-relevant) using the data set of Section 2.1 represented using corpus-
specific static word embedding. This approach follows steps enumerated below. 
1. Word embedding generation To generate embedding, the PMC-OA data were 
lower-cased and all punctuation except the hyphens were removed. Phrase 
generation was then performed using the word2phrase tool 3 to identify 
frequently occurring bi-grams. The output of phrase generation along with the 
unigrams was fed to gensim’s word2vec 4  and to fastText 5 using the 
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hyperparameters in Table 1 to obtain two dense, semantic, real-valued word 
embeddings [10]. 
 
Parameter Value Parameter value Parameter value 
Size 300 Alpha 0.05 bucket* 2000000 
Window 5 min alpha 0.0001 minn* 3 
min count 5 sample 0.0001 maxn* 6 
sg 1 iter/ epoch 5 seed 1 
hs 1 negative 5  
Table 1. Hyperparameter values used to generate word embeddings using gensim’s word2vec and the 
fastText functionality. (*) means that these parameters were available only for the fastText embeddings. 
2. Data set for text pre-processing Post deduplication and removal of non-
English language studies led to 25,540 studies remaining. For these remaining 
studies, the text was lower-cased and tokenized into words using NLTK 
(Natural Langauge ToolKit). Irrelevant tokens were removed using a 
predefined set of stop-words provided by NLTK and PubMed. Additional 
corpus-specific stop-words identified during the experiments with the training 
set were removed accordingly. The text normalization process converted 
British English terms into American English. After token lemmatization, a 
corpus vocabulary was constructed from all the unique unigram and bigram 
tokens. To scale this vocabulary down, uninformative short tokens with fewer 
than five characters and the tokens with vocabulary count lower than five were 
removed assuming they were not representative of the classes. 
3. Random oversampling Class imbalance often deteriorates the classifier 
performance, so in the present data set it was addressed using naive random 
oversampling. This method randomly duplicates data points from the minority 
class and brings the total number of instances in the minority class equal to the 
majority class [6]. 
4. Feature extraction Feature extraction was performed to generate real-valued, 
dense feature vectors from text. These features were used as input to train the 
supervised ML classifiers. For non-neural ML classifiers, from each of the 
25,540 studies word vectors were extracted for each token using both 
generated word embeddings. All vectors for each token in the individual study 
were averaged over the entire study normalized by study length to produce a 
single 300-dimensional vector representing a particular study. For the 
Convolutional Neural Network (CNN), feature extraction was part of the 
model, where a static, non-trainable weight matrix generated from the word 
embedding was provided with the embedding layer to extract token word 
vectors during training. 
5. Classifier training and evaluation Six classifiers including Logistic 
Regression (LR), Support Vector Machines (SVM), k-nearest neighbor (KNN), 
Decision Trees-CART (DT), Random Forest (RF), and CNNs were trained 
and evaluated over the generated text feature to perform binary classification. 
Hyperparameter tuning was performed using GridSearch. A CNN was trained 
using hyperparameters loosely based on suggestions from Zhang et al. [11]. 
Classifier performance before and after oversampling was evaluated on an 
unseen validation data set and metrics pertinent to imbalanced classification 
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like precision, recall, F1 and precision-recall AUC (PR-AUC) score were 
tracked [7].  
 
Figure 1. A t-SNE projection for 25,540 studies labelled “include” vs. “exclude” before and after 
oversampling. 
3. Results and Discussion 
The data set used for training and evaluating the classifiers comprised 2,259 relevant 
studies labelled “include” and 23,281 labelled “exclude”. Cosine similarity between class 
centroid vectors for the “include” and “exclude” classes before and after oversampling is 
0.985814 and 0.985824 respectively. A high cosine similarity is indicative of high class 
overlap even after tackling the class imbalance using oversampling (see Figure 1). 
The results obtained by applying classifiers on the data set before and after random 
oversampling are summarized in Table 2 and 3. Before oversampling, the classifiers 
focused on improving the performance for the majority class but in reality they are 
simply predicting the majority class as noticeable from the relatively high F1 score for 
the exclude class. Upon oversampling, the overall classifier performance drastically 
improves for the minority class especially the precision (see Table 3), while the 
precision for the majority class is reduced with a small improvement in recall. 
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Table 2. Classifier performance before random oversampling for the “include” and “exclude” classes 
If the task is considered a classification task, a high class overlap still leads to 
unacceptable precision and recall values for citation screening implying the inclusion 
of false-positive studies and exclusion of false-negative studies. Our future work has two 
directions: Firstly, experimenting with systematic oversampling techniques like 
Synthetic Minority Over-Sampling Technique (SMOTE) and Adaptive Synthetic 
(ADASYN) and considering this task as data extraction rather than classification [12].  
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 Classifier 
 
embedding 
 
Precision 
Class 
Recall 
“include” 
F1 
 
PR-AUC 
Class “exclude” 
Precision   Recall F1 
LR word2vec 0.8981 0.8850 0.9116 0.9342 0.8951 0.9090 0.8816 
SVM fastText 0.8914 0.8818 0.9012 0.9378 0.8990 0.8792 0.8890 
KNN word2vec 0.8860 0.8303 0.9500 0.9321 0.9418 0.8055 0.8682 
DT fastText 0.8348 0.8201 0.8510 0.8734 0.8285 0.8463 0.8126 
RF word2vec 0.8695 0.8918 0.8488 0.9279 0.8966 0.8757 0.8560 
CNN word2vec 0.9034 0.7480 0.8183 0.9318 0.7850 0.9200 0.8471 
Table 3. Classifier performance after random oversampling for the “include” and “exclude” classes. 
4. Conclusion 
To the best of our knowledge, this is the first attempt to explore citation screening 
automation for a narrow systematic review topic using domain-specific word 
embedding on a range of ML classifiers. The research specifically sheds light on the 
impact of class imbalance and class overlap on the classifier performance before and 
after oversampling as also discussed by [6,7]. Knowledge of these challenges is useful 
for further development of automation approaches for citation screening. 
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Abstract.?Machine?Learning?(ML)?can?improve?the?diagnosis,?treatment?decisions,?
and?understanding?of?cancer.?However,?the?low?explainability?of?how?“black?box”?
ML?methods?produce?their?output?hinders?their?clinical?adoption.?In?this?paper,?we?
used?data?from?the?Netherlands?Cancer?Registry?to?generate?a?ML-based?model?to?
predict?10-year?overall?survival?of?breast?cancer?patients.?Then,?we?used?Local?In-
terpretable?Model-Agnostic?Explanations?(LIME)?and?SHapley?Additive?exPlana-
tions? (SHAP)? to? interpret? the?model’s?predictions.?We? found? that,?overall,?LIME?
and?SHAP?tend?to?be?consistent?when?explaining?the?contribution?of?different?fea-
tures.?Nevertheless,?the?feature?ranges?where?they?have?a?mismatch?can?also?be?of?
interest,?since?they?can?help?us?identifying?“turning?points”?where?features?go?from?
favoring?survived? to? favoring?deceased? (or?vice?versa).?Explainability? techniques?
can?pave?the?way?for?better?acceptance?of?ML?techniques.?However,?their?evaluation?
and?translation?to?real-life?scenarios?need?to?be?researched?further.
Keywords.?Artificial?Intelligence,?interpretability,?oncology,?prediction?model
1.? Introduction
Although? it?has?been?shown? that?Machine?Learning? (ML)?methods?are?able? to?predict?
oncological?outcomes?[1],?there?are?still?a?few?factors?that?hinder?their?widespread?clinical?
adoption.?One?of? these? factors? is? the? lack?of? trust? in? the?models.?Often,?ML? tools?are?
considered?black?boxes.?If?decisions?need?to?be?made?that?are?based?(at?least?partially)?on?
predictions?made?by?ML?algorithms,?users?need?to?be?able?to?understand?how?and?why?
the?algorithm?has?come?up?with?that?decision?[2].
In?the?last?couple?of?years,?ML?explainability?has?gained?considerable?interest.?Re-
cently,? two? techniques?have?been?proposed? and?developed? to?make?ML?models?more?
interpretable:?Local?Interpretable?Model-Agnostic?Explanations?(LIME)?[3]?and?SHap-
ley?Additive?exPlanations?(SHAP)?[4].?However,?evaluation?of? these? tools?remains?rel-
atively?unexplored.?Although?some?studies?have?attempted? to?evaluate?explanations?of
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model predictions by letting users test which explanations are more understandable or
intuitive [5], more analytical, standardized evaluations are needed.
In this paper, we used data from the Netherlands Cancer Registry (NCR) to generate
a predictive model of 10-year overall survival (OS) after curative breast cancer surgery.
Then, we applied LIME and SHAP to the obtained model to explain its predictions.
Finally, we evaluated said interpretability methods by analysing their explanations and
the agreement between them, which allowed us to identify features’ turning ponts.
2. Materials & Methods
We used NCR data granted under data request K18.999. It consisted of demographic,
clinical, and pathological data of patients in the Netherlands diagnosed between 2005
and 2008 with non-metastatic breast cancer who underwent surgery. Features included
age, tumor characteristics, hormonal receptor statuses, clinical and pathological TNM-
staging, and number of removed and positive lymph nodes. We imputed missing values
using Deep Learning and K-Nearest Neighbor (KNN). We defined 10-year OS as the tar-
get variable for our model. The final dataset consisted of 46,284 patients and 31 features.
We performed feature selection using a combination of 21 different filter and wrap-
per methods. Each of them output a ranking ordering feature predictiveness. Then, we
computed the median of these rankings and chose the six best ranked features: 1. age,
2. ratio between the number of positive and removed lymph nodes (ratly), 3. number
of removed lymph nodes (rly), 4. tumor size in millimeters (ptmm), 5. pathological
TNM stage (pts), and 6. tumor grade (grd).
We experimented with a variety of ML tools: Random Forest, Extreme Gradient
Boosting (XGB), KNN, Artificial Neural Networks, Naı¨ve Bayes, and Logistic Regres-
sion. We performed a randomized grid search to train, test, and optimize each of them.
Since our target variable had a class distribution of roughly 75% (survived) versus 25%
(deceased), we used stratified 10-fold cross-validation to optimize the models’ hyperpa-
rameters. Then, we evaluated their performance using the Area under the Curve (AUC)
as a metric, with XGB yielding the highest value (0.78). Therefore, we used XGB for the
rest of this study.
In order to better understand the model’s predictions, we used LIME and SHAP. On
the one hand, LIME approximates individual predictions of a (black box) model with
a local (interpretable) surrogate model that is as close as possible to the original one.
Explanations are produced by minimizing a loss function between the predictions of both
of them. The complexity of the surrogate model is used to explain the original model [3].
On the other hand, besides offering local interpretability, SHAP allows to explain a model
globally by expressing it as linear functions of features [4]. In other words, it explains
how much the presence of a feature contributes to the model’s overall predictions.
To assess the consistency of LIME in explaining individual predictions, we applied
it to each of the predictions of the test set (20% of the data) 100 times. We defined con-
sistency when LIME assigned values with the same sign in all cases. Then, we evaluated
global variable importance using SHAP. Finally, we tested agreement between LIME
and SHAP values by comparing their instances (i.e., local) explanations in the test set.
We defined agreement when both methods assigned either a positive or a negative con-
tribution to the same feature of the same data instance.
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3. Results
Figure 1 shows five representative data instances (i.e., patients) picked at random of the
LIME consistency test. The x-axis shows the values for a particular feature, while the y-
axis denotes the feature weight assigned to that value by LIME. A positive weight means
it contributed to survived, while a negative one contributed to deceased. Across all plots,
the position of each box is the same for each patient. For instance, the first box of each
plot corresponds to the same patient, who was 51 years old, had a ratly value of 0, a
rly value of 1, etc. LIME was consistent in >98% of the cases of age, pts, and grd.
However, for ratly, rly, and ptmm LIME was consistent in 74%, 8%, and 55% of the
cases, respectively. These cases correspond to the boxes in Figure 1 that cross 0 (dotted
line), which means that LIME yielded contradictory weights.
Figure 2 shows the SHAP values of the six features used by the global model. The
x-axis shows the SHAP values that correspond to the features shown on the y-axis. The
color scale indicates the feature values, which range from low (blue) to high (red). Simi-
larly to LIME, a positive SHAP value contributes to survived, while a negative one con-
tributes to deceased.
Figure 1. LIME consistency of five representative data instances (i.e., patients) picked at random. Contradic-
tory explanations correspond to boxes that cross the dotted line at 0. Practically, age, pts, and grd had consistent
LIME values, while the opposite can be said for ratly, rly, and ptmm.
The percentage of instances where LIME and SHAP agreed on their explanations
for each feature was as follows: age, 97.5%; ratly, 95.9%; rly, 87.8%; ptmm, 91.9%;
pts, 99.6%; grd, 99.9%. Figure 3 shows the individual feature weights for age (since it
was the best-ranked feature) and for rly (since it was the feature with the largest dis-
agreement). The x-axis denotes the feature values, while the y-axis denotes the feature
weights assigned by the interpretability methods. Circles indicate an agreement between
them, while crosses indicate the opposite.
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Figure 2. Summary plot of all SHAP values. Globally, age has the biggest impact on the model output.
Figure 3. Feature weights assigned by LIME and SHAP to all test set instances for age and rly. The shaded
area shows clear age’s clear “turning point”. SHAP markers were shifted slightly along the x-axis for clarity.
4. Discussion
Figure 1 shows that LIME tends to assign consistent values to categorical features. For
example, a pts of 1 is assigned almost identical feature weights in different patients. A
similar thing occurs for a grad of 2. However, LIME has more difficulties with numer-
ical features. For instance, there is very little difference in the impact that having 1 or
16 lymph nodes removed has on the model predictions. We think this is because LIME
discretizes continuous features by binning them and treating them as categorical, losing
information. Figure 1 also shows that LIME weights can be contradictory. For example,
in the rly case, LIME values for the same patient are often inconsistent. It has been sug-
gested that LIME’s uncertainty can be explained by randomness in the sampling proce-
dure and the variation of interpretation quality across different data instances [6], which
is in line with the presented results.
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Figure?2?combines?the?features’?effects?(x-axis)?with?their?importance?(y-axis).?At?a?
global?level,?age?is?the?most?important?feature,?while?rly?is?the?least?important.?This?could?
be?explained?by? its?non-monotonic?behaviour?(i.e.,? low?rly?values?are?assigned?positive?
and?negative?weights).
Although?LIME?and?SHAP?values?show?a?similar?trend?overall?for?both?age?and?rly?
(Figure?3),?we?can?also?distinguish?specific?regions?of?mismatch.?These?are?of?particu-lar?
interest,? since? they? can? help? us? identify? “turning? points”? in? the? features’? values.? For?
example,?in?the?case?of?age,?mismatches?occur?approximately?between?65?and?68?years?
(shaded?area).?This?could?explain?where? the?model?considers?age? to?contribute? towards?
survived?or?towards?deceased.
5.? Conclusion
In?this?study,?we?used?breast?cancer?data?from?the?NCR?to?generate?an?XGB-based?model?
for?predicting?10-year?OS.?We?explained?the?model’s?predictions?using?LIME?and?SHAP?
and?compared?their?performance.?In?few?cases,?LIME?showed?inconsistent?and?contradic-
tory?explanations?of? individual?predictions.?Furthermore,?comparing?LIME?and?SHAP?
showed?agreement?between? them? in?95.4%?of? the? instances.?The? regions?of?mismatch?
allowed?us?to?identify?“turning?points”?in?the?features’?values,?which?indicate?where?fea-
tures?go?from?favoring?survived?to?favoring?deceased?(or?vice?versa).
Methods?like?LIME?and?SHAP?are?a?first?step?to?provide?a?more?interpretable?way?of?
explaining? complex? models? than? what? the? models? are? capable? of? themselves.? It? is?
important?to?keep?in?mind?that?perfect?explanations?are?also?infeasible,?since?there?is?no?
gold? standard? to? which? the? explanations? can? be? compared.? This? also? makes? the?
evaluation?of?these?methods?a?challenge.?These?type?of?methods?pave?the?way?for?larger?
use? and? acceptance? of?ML? techniques? for? digital? health? applications.?However,? their?
evaluation?and?translation?to?different?fields?need?to?be?researched?further.
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Abstract. The encoding of Electronic Medical Records is a complex and time-
consuming task. We report on a machine learning model for proposing diagnoses 
and procedures codes, from a large realistic dataset of 245 000 electronic medical 
records at the University Hospitals of Geneva. Our study particularly focuses on the 
impact of training data quantity on the model’s performances. We show that the 
performances of the models do not increase while encoded instances from previous 
years are exploited for learning data. Furthermore, supervised models are shown to 
be highly perishable: we show a potential drop in performances of around -10% per 
year. Consequently, great and constant care must be exercised for designing and 
updating the content of such knowledge bases exploited by machine learning. 
Keywords. Medical coding, machine learning, text mining. 
1. Introduction 
The coding, or encoding, of medical records with standard classifications serves multiple 
purposes for healthcare actors, including billing and reimbursement, quality control, 
epidemiological surveillance, or cohort identification for clinical trials [1,2]. This task is 
usually performed by professional coders, at the term of an episode of care (EOC). These 
coders have to master knowledge in the field of medicine, along with the handling of 
large code sets, coding rules and local guidelines [3]. For these reasons, manual coding 
is expensive and time-consuming. The amount of available electronic medical records 
(EMRs), potentially exploitable by computers, has steadily grown in recent years [4]. 
Hence, machine learning algorithms are today likely to produce accurate and effective 
tools for assisting human coders [5]. 
We report on the development and evaluation of a machine learning – or supervised 
– model for suggesting codes, from a large dataset of EMRs.  
A citation attributed to Peter Norvig, Google’s Chief Scientist, claims that "more 
data beats clever algorithms" [6]. Several reported works on text categorization tend to 
support this idea, and incite to direct efforts towards increasing the size of annotated 
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learning collections [7,8]. Our study has particularly focused on the impact of exploiting 
growing amounts of learning data on the algorithm’s performances. The figure below 
illustrates the global workflow of the automatic encoding process. 
 
 
Figure 1. Global workflow of the machine learning encoding. The input is all textual documents from an EOC. 
The algorithm compares it with past coded episodes contained in the Knowledge Base, and retrieves the k most 
similar instances, based on statistical textual similarity. From the encoding of these similar episodes, the 
algorithm infers rankings of candidate CIM and CHOP codes, along with probability scores. 
Our study was conducted in the University Hospitals of Geneva (HUG), with a real 
dataset ranging from 2011 to early 2016 (245 000 EOCs). In Switzerland, EOCs are 
encoded with two medical classifications derived from the International Classification 
of Diseases (ICD). Diagnoses are encoded with the CIM classification, issued from ICD-
10, German modification; procedures are encoded with the CHOP classification, issued 
from the ICD-9-CM in 2008 but having evolved since. In Switzerland, both 
classifications are available in German, French and Italian, but all medical records in 
Geneva are written in French. 
This encoding task is a multi-label automatic text categorization problem [9]. Most 
reported systems in the literature rely on the popular Support-Vector Machines (SVM). 
Yet, for large multi-label categorization, SVM has been reported to scale with difficulties 
[10], requiring the usage of data reduction or feature selection [1]. In our study, with our 
objectives, we chose to exploit a simple, yet powerful classification algorithm: the k-
Nearest Neighbors (k-NN). From a Knowledge Base (KB) containing past encoded 
instances, this algorithm retrieves the instances that are the most similar to a new instance, 
and assigns to it the most common codes among these neighbors.  
2. Data 
At the HUG, encoding is performed by professional coders after an EOC. Coders have 
limited contacts with the healthcare personnel, but they review all produced documents. 
There are 4 318 different types of documents, including admission notes, exam or 
operative reports, progress notes, or discharge letters. Coders have to detect disorders 
that were addressed during the EOC, and to encode them into CIM codes. For example, 
for a patient admitted for an alcoholic cirrhosis of liver, the episode will be encoded with 
the CIM code K70.3 “Cirrhose alcoolique du foie”. The coders also have to detect 
procedures that were performed. In our example, if a liver biopsy was performed, the 
coder has to encode it with the CHOP code 50.13.10 “Biopsie du foie transveineuse”. 
Thus, the whole dataset consists in 245 000 encoded EOCs, from 2011 to early 2016. It 
is worth noting that what is encoded is EOCs, not documents. In this perspective, all 
experiments were conducted at the EOC level. For each experiment, a test set of 
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randomly selected 250 EOCs was submitted to the tool. The algorithm is judged on its 
capacity to output the codes that were effectively assigned to these episodes by 
professional coders.  
3. Methods 
The investigated algorithm is a k-Nearest Neighbors (k-NN). This algorithm performs 
instance-based learning; it does not learn any discriminative function, but rather exploits 
a Knowledge Base (KB), containing previously labelled instances, in order to infer real-
time decisions [10]. For such text categorization problems with numerous and multiple 
labels, k-NN has been reported to efficiently scale and to perform comparably with 
Support Vector Machines [11]. 
In this study, the KB contains previously encoded EOCs. A similar search engine is 
designed for retrieving nearest neighbors (i.e. EOCs), based on textual similarity. The 
Terrier information retrieval platform was used for this purpose [12]. The k parameter 
sets the number of neighbors exploited for making decisions. Once similar EOCs are 
retrieved, the second step of the k-NN is to infer encoding for the input episode. For this 
purpose, the algorithm simply computes what are predominant codes among the retrieved 
learning instances. The algorithm hence outputs ranked lists of disorders (CIM) and 
procedures (CHOP) codes, along with confidence scores. 
The algorithm is judged on its capacity to output the codes that were effectively 
assigned to these episodes by professional coders. The evaluation relies on metrics issued 
from information retrieval [13]. As the tool potentially outputs hundreds of codes – along 
with decreasing scores – evaluated lists are limited to the top 10 predicted codes. In a 
semi-automatic workflow, ten is a convenient number of codes easily checkable by the 
coder. Hence, the recall at rank 10 curves presented in the Results section is the 
proportion of actual codes that were outputted by the tool in the top 10 ranks. Precision 
curves are not presented for clarity concerns, but show similar shapes. 
4. Results 
Preliminary studies (not reported) were conducted with a dataset limited to 2014 EOCs. 
For both disorders and procedures, the performances of the tool increased with the size 
of the KB. The most promising observation is that more data leads to better results: for 
2014 EOCs, when the size of the KB doubles, the recall is improved by approximately 
10%. Thus, with the complete dataset (2011 - 2016), higher performances were expected. 
 
Figure 2. Performances (Recall at rank 10) of the encoding with 2015 queries, for disorders (CIM codes) and 
procedures (CHOP codes), depending on the k parameter. The KB is populated by previously encoded EOCs, 
from 52 000 for 2015 only, to 230 000 for the 2011 to 2015 range. 
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A first set of experiments was conducted for assessing the impact of training data 
quantity on the model’s performances (Figure 2). The test set was a sample of EOCs 
from 2015, while we progressively increased the number of past EOCs for populating 
the KB. For both disorders and procedures, all curves are interwoven: the performances 
of the model do not increase while encoded EOCs from previous years are injected in 
the KB – yet the past EOCs do not damage the model. 
 
Figure 3. Performances (Recall at rank 10) of the encoding with 2015 KB, depending on the k parameter. 
Different test sets, containing EOCs sampled in a single year ranging from 2011 to 2016, were used. 
A second set of experiments focused on the durability of the model (Figure 3). This 
time, the KB did not vary and only contained 50 000 encoded episodes from 2015. The 
model was evaluated with different test sets, each sampled in a single year ranging from 
2011 to 2016. The different curves are this time remarkably distinct. With a KB 
containing previously encoded EOCs from 2015, the best results are reached for input 
EOCs from 2014 and 2015. Older episodes, from 2013 to 2011, obtain progressively 
weaker results. These results show that the encoding is considerably year-dependent, and 
suggest that a model built on a single year is highly perishable – with a potential drop in 
performances of around -10% per year. 
Table 1. Final performances reached for KB and queries from 2015. F-measure is the harmonic mean of 
precision and recall. This study focused on optimizing recall values. 
Coding F1 at rank 10 P at rank 10 R at rank 10 R at rank 20 
Diagnoses 39 % 32 % 51 % 62 % 
Procedures 29 % 18 % 72 % 78 % 
5. Discussion 
The F-measure at rank 10 reached by the tool for 2015 data is 39.3% (see Table 1). This 
is competitive with F-measures (39.5% [14], 42% [5]) reported in other studies dealing 
with such large-scale data. Beyond state-of-the-art comparisons, the recall values – 62% 
for diagnoses and 78% for procedures at rank 20 – must be considered in the light of the 
inter-annotator agreement, which is a theoretical upper bound. In 2006, this agreement 
was reported about 79% in the University Hospitals of Geneva [15].  
However, the results indicate that the performances of the machine learning model 
are considerably year-dependent. This could be explained by two main reasons. First, the 
classifications used for medical encoding in Switzerland evolve over time: every two 
years for diagnoses, every year for procedures. Codes can be created, merged, or 
migrated. Second, the coding guidelines proper to each hospital also evolve over time. 
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Indeed, on the top of diagnoses and procedures codes, rules defining reimbursement are 
applied by Swiss authorities based on DRGs (Diagnosis Related Groups), unknown from 
facilities. As two different accurate encodings of the same EOC can lead to differences 
in the reimbursement, each facility aims at continuously improving its proper coding 
guidelines, in order to better encode provided healthcare. The consequence is a typical 
case of concept drift in medical encoding. 
6. Conclusion 
Are more data better for automatic encoding of EMRs by machine learning? In 
University Hospitals of Geneva, the answer is mixed. For a unique year, injecting more 
data in the knowledge base leads to progressively better performances for the algorithm. 
Yet, injecting encoded episodes from past years does not improve – while does not harm 
– the performances. Another essential result is that KBs are considerably year-dependent, 
and a model built on previous years’ EOCs appear to be perishable. In this study, a 
potential drop in performances of around -10% per year has been brought to light. 
Consequently, great and constant care must be exercised for designing and updating the 
content of such knowledge bases exploited by machine learning. As Peter Norvig has 
refined: “More date beats clever algorithms, but better data beats more data”. 
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Abstract. Medical studies are usually time consuming, cumbersome and extremely
costly to perform, and for exploratory research, their results are also difficult to
predict a priori. This is particularly the case for rare diseases, for which finding
enough patients is difficult and usually requires an international-scale research. In
this case, the process can be even more difficult due to the heterogeneity of data-
protection regulations, making the data sharing process particularly hard.
In this short paper, we propose MedCo2 (pronounced MedCo square), a dis-
tributed system that streamlines the process of a medical study by bridging and
enabling both data discovery and data analysis among multiple databases, while
protecting data confidentiality and patients’ privacy. MedCo2 relies on interactive
protocols, homomorphic encryption and differential privacy. It enables the privacy-
preserving computations of multiple statistics such as cosine similarity and vari-
ance, and the training of machine learning models, on patients that are obliviously
selected according to specific criteria among multiple databases.
Keywords. data discovery, data analysis, privacy, confidentiality, homomorphic
encryption
1. Introduction
The current trend towards personalized medicine requires researchers to access increas-
ingly larger cohorts of subjects [1], the size of which often exceeds the amount of data
available at the researchers’ facility. This results in an urgent need for efficient and auto-
matic data sharing mechanisms between medical institutions. Medical data, however, are
particularly sensitive, and attempting to share them poses significant threats to the sub-
jects’ privacy, as it increases the risk of leaks to ill-intentioned persons or organizations.
Medical institutions often refrain from sharing their data due to the increasing number
of breaches [2,3], and to their derived reputation and financial implications [4]. Finally,
national and international regulations (e.g., HIPAA [5] in the U.S. and the GDPR [6]
in the E.U.) impose strong requirements in terms of both confidentiality and restriction
of data access that are commonly not met by the existing sharing-solutions [7]. In this
environment, in order to access the data, researchers are faced with complex challenges
throughout the whole process. Cohort exploration is usually the first step of a medical
study; when performed across several medical institutions, it becomes very difficult, as
obtaining the necessary legal authorizations and signing agreements between institutions
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can take months. This becomes almost impossible when hospitals are in different coun-
tries because of the incompatibility of national legal frameworks. Finally, researchers can
be left with data of limited value to perform the desired analyses, as they cannot get a
priori information (e.g., size, availability and statistical properties such as distribution or
moments) to assess the suitability of the data before actually gaining access to them. We
propose MedCo2, a novel system featuring privacy-preserving cohort exploration and
advanced cohort analysis. It enables a researcher to assess the presence of subjects with
specific traits and features, compute statistics, and/or train and evaluate machine-learning
models on subjects’ records, over distributed databases. By relying on distributed and
interactive protocols, homomorphic encryption and differential privacy, our system en-
sures that these queries can be executed yet still protect the confidentiality of data and
the privacy of subjects. Finally, MedCo2 distributes the trust and avoids single points of
failure, as both the storage and the computations are distributed among multiple nodes.
2. System and Threat Models
MedCo2 supports a network of mutually distrustful medical institutions that act as data
providers (DPs) and hold subjects’ records. An authorized researcher (see Figure 1) can
run queries without threatening the data confidentiality and subjects’ privacy. The DPs
are considered semi-honest and the researcher is considered malicious. If required, our
system can also use zero-knowledge proofs and an immutable distributed ledger to cope
with malicious DPs.
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Figure 1. System Model.
3. Proposed Solution
The two main building blocks in MedCo2 are MedCo [8] and Drynx [9]. MedCo is an
operational distributed system that enables authorized researchers to explore cohorts dis-
tributed across several institutions, by filtering subjects with inclusion/exclusion of clin-
ical and genetic criteria. Drynx enables the computation of statistics, such as standard
deviation or extrema, and the training and evaluation of machine-learning models on dis-
tributed data. In order to ensure data confidentiality and individuals’ privacy, both sys-
tems rely on distributed interactive protocols, homomorphic encryption and differential
privacy. In MedCo2, we combine MedCo’s capabilities to privately identify a set of sub-
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jects matching precise criteria with Drynx’s ability to perform computations on the iden-
tified subjects’ records. As a result, we provide a fully-decentralized system that enables
multiple functionalities and enforces privacy and security guarantees that are stronger
than in any (to the best of our knowledge) existing solutions [10,11].
We now briefly describe the MedCo2 data model, before explaining how a query is
executed. DPs have two separate databases: (1) the local database, that is in cleartext and
is only accessible from within the institution, and (2) a research database, open to ex-
ternal queries, in which data are encrypted. We define a micro-ETL (extract, transform,
load) process that encrypts selected data from the local database and transfers them to the
research database. In our system, the data stored in the research databases and all those
involved in the query execution are homomorphically encrypted under the DPs’ collec-
tive key, as described in [9]. A researcher creates a query containing the subjects’ selec-
tion criteria along with the computation she wishes to perform on the selected subjects’
records (step 1 in Figure 1). This query is broadcast to the DPs who privately retrieve
the list of subjects satisfying the query and initiate a local data retrieval process (step 2).
In this process, each DP stacks the received query and the retrieved subjects’ identifiers
inside its research database. This stack is periodically emptied by the local operating
database that pulls the waiting queries and authorizes them (e.g., based on regulations,
local policies). If the query is accepted, each DP performs some query-dependent pre-
computation on its local database, before encoding and encrypting its contribution to the
secure protocol (step 3). These contributions are then collectively aggregated under ho-
momorphic encryption, to obtain the encrypted results (step 4). At this point, the results
are obliviously switched from the collective key to the researcher’s private key (Collec-
tive Key Switching protocol), and sent back to her (step 5). MedCo2 executes, in paral-
lel to the query execution, a micro-ETL in which it encrypts the attributes involved in
the query and stores them in the research database. This means that when a DP receives
another query on the same attributes, it can directly answer from the research database,
thus reducing its workload for upcoming queries.
4. Evaluation
We implement and showcase MedCo2 within a representative scenario that involves clin-
ical and genetic data sharing. We integrate it in MedCo by enhancing its data model
and query language/interpreter to seamlessly enable an authorized researcher to execute
operations on a cohort built from MedCo.
We present MedCo2 performance for a worst-case scenario: a query that it has not
seen before, i.e., we assume that all the computation happens on the fly, with no pre-
computation. Figure 2 shows the timeline of a query execution in MedCo2, comprising
the steps of (a) query creation at the client, (b) query broadcast to the DPs, (c) collective
query reencryption at the DPs (in order to enable matching queries [8]), (d) local DB
execution and result retrieval at each DP, (e) local encoding of the matching patients’
data at each DP, (f) collective aggregation of the target function across all DPs, (g) col-
lective key switching of the results to the querier’s key, and (h) decrypting and decoding
at the querier. In this case, 18132 patients satisfy the filtering criteria and are retrieved
among 150,000 patients distributively stored in 12 databases. As shown in [8,13], the
overhead time for data discovery (including Step 1, which comprises Query Creation,
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Figure 2. MedCo2 Query Execution Timeline. LC =Local Computations, CC =Collective Computations.
Query Broadcast and Query Reencryption, and Step 2, composed of Database Execu-
tion and Result Retrieval) when executed on encrypted data is negligible, in this case
2 seconds, with respect to the same operation executed on cleartext data. Figure 2 also
shows that MedCo2 can perform a logistic regression on a distributed dataset with 100
features in less than 23 seconds. The distributively trained models achieve accuracy re-
sults similar to their centralized, non-secure counterparts, as shown in [9]. We observe
that the whole MedCo2 process is performed in less than 98 seconds if 18132 patients
out of 150000 satisfy the selection criteria. The DPs’ local query execution in MedCo
(DB execution in Figure 2) is the most expensive operation, as it linearly depends on the
number of selection criterias in the query and on the total number of observations in the
database (each patient has thousands of observations).
Finally, MedCo2 enables a researcher to train and evaluate linear and logistic re-
gression models on a chosen cohort without accessing the actual subjects’ records. This
makes the task more cost-effective and streamlines a process that is at the core of many
common medical workflows such as GWAS.
5. Conclusion
MedCo2 addresses the privacy and security challenges of highly distributed medical-data
sharing networks by avoiding single points of failure and by providing the following
unparalleled functionalities and properties: (a) privacy-preserving cohort exploration and
analysis over distributed databases held by distrustful DPs, (b) distributed training of
simple machine learning models, (c) data confidentiality and individuals’ privacy through
collective keys and distributed protocols, and (d) a usable example scenario through its
integration in a deployed system featuring a modern graphical user interface [8]. MedCo2
aims at enabling the promises of personalized health by facilitating and streamlining the
data discovery and analysis processes.
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Abstract. The use of augmented reality (AR) in the medical field has grown since
2007-2013 and was first introduced in surgical departments. AR and mixed real-
ity (MR) allow us to explore complex structures, observe phenomena that are dif-
ficult or impossible to see otherwise, and interact with the virtual structures they
display. Recently, they are beginning to be adopted for education. This work ex-
amines whether new AR and MR technological tools, when used in the context of
anatomical teaching, can allow for strengthening of teaching quality - for example
by overcoming new or existing constraints such as the limited availability of dis-
section specimen. This work also considers how these technologies are to be ap-
plied efficiently and practically in teaching. An attempt is made to answer these
questions in three stages: i) a non-systematic review of the literature ii) a review of
augmented reality solutions for anatomy available on four different platforms iii) a
30-person study of the usability of augmented reality. The results show that there
is potential for AR and MR to supplement anatomical teaching, but that traditional
methods remain indispensable.
Keywords. augmented reality, mixed reality, anatomical teaching, e-learning,
digital tools for supplementing medical teaching
1. Introduction
Anatomy is a fundamental branch of the medical curriculum. As the human body is the
target of daily interventions and investigations, this discipline is a cornerstone of physi-
cians’ medical skills. Anatomical knowledge allows for safe and quality medical prac-
tice, through the understanding of decisions and actions taken and the fact that it con-
tributes to effective communication between health professionals [1]. Given its impor-
tance, its teaching should be as effective as possible, in terms of accuracy of the acquired
knowledge, and its resilience.
Since the Renaissance, the study of corpses and their dissection have been the main
means of teaching anatomy [2]. Today, this discipline is traditionally taught in the pre-
clinical years and provides basic knowledge in the four fields of macroscopic anatomy
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(including?dissection),?neuroanatomy,?histology?and?embryology.?Course?material?gen-
erally?includes?slideshows?with?verbal?explanations,?bodies?for?dissection,?presentations?
of?already?dissected?body?parts?and?books?with?two-dimensional?images?[3].
Since? its? inception,? the? field? of? anatomical? teaching? faces? several? practical? con-
straints.?These?include?the?time?allocated?within?the?medical?curriculum,?the?practicality?
of?using?human?bodies?and? the?ethical?and?emotional?dimension?surrounding? the?han-
dling?of?corpses?by?students.?Some?of? those?constraints?are? relatively?new,?or?are?cur-
rently?increasing?in?severity.?The?evolution?of?the?constraints?which?apply?to?the?field?of?
anatomical? teaching,?raises? the?question?of?whether? the? tried?and? true?methods?are?still?
optimal.? In? addition,? technological? advances?make?previously?unavailable?medias? and?
modalities?possible.?This?raises?the?questions?of?how?modern?technologies?could?be?used?
to?supplement? the? teaching?of? this?discipline,?whether?applying? these? tools?would? lead?
to?improved?efficiency?in?practice,?and?what?additional?challenges?technologically?aug-
mented?anatomical?teaching?might?present.?Previous?work?[3]?shows?that?anatomy?learn-
ing? is?most?effective?when? the?desired?structures?can?be?examined?from?all?angles?and?
at?any?time.?Recent?technological?advances?in?the?field?of?virtual,?mixed?and?augmented?
reality?have? led? to? the?emergence?of?widely?available?consumer?software,?academic?or?
commercial,?which?focus?on?anatomy?learning.
One?aspect?of?this?work?consisted?in?evaluating?the?already-available?tools?and?solu-
tions?in?the?academic?and?commercial?field,?through?a?literature?review?and?application?
inventory.?In?a?second?stage,?two?of?the?most?promising?mixed-reality?applications?were?
selected?in?order?to?conduct?a?usability?study,?with?the?participation?of?medical?students.?
This?usability? study? focused?on? the?hands-on? evaluation?of? two? applications? available?
on?Microsoft’s?mixed?reality?headset,?”Hololens”.?The?results?collected?throughout?this?
study?are?evaluated?in?order?to?extract?recommendations?in?proposing?an?evolution?in?the?
teaching?of?this?discipline.
2.?Methodology
2.1.? Nonsystematic?Literature?Review
A?literature?search?was?conducted?on?the?following?search?engines?and?knowledge?bases:?
PubMed?,?Google?scholar?,?Embase/Elsevier/ScienceDirect?,?Wiley?Online?Library?,?Web?
of?science,?and?more.?The?inclusion?criteria?for?literature?was:?The?article?must?discuss?
the?topic?of?AR/MR?in?the?general?field?of?medicine?OR?the?article?must?discuss?the?topic?
of?AR/MR?in?the?teaching?of?anatomy.
2.2.? Study?of?Available?Solutions
Presently,?the?most?widely?used?AR?devices?are?consumer?smartphones?and?tablets?[4].?
In?the?pursuit?of?studying?available?AR?and?MR?solutions,?the?three?most?promising?AR?
and?MR?platforms?were?identified,?and?software?available?on?those?platforms?was?tested?
and?evaluated.?Selection?criteria:?Software?was?selected?for?evaluation?according?to?the?
following?criteria:? i)? the?software?must?focus?on?human?anatomy? ii)? the?software?must?
present?significant?AR?or?MR?capabilities.?iii)?the?software?must?be?available?for?use?on?
the?Hololens,?Apple?device,?or?Google?Play?device?platforms.?Of?the?selected?software,?a
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sub-selection?was?made?based?on?available?user-review?ratings.?Finally,?a?small?portion?of?
the?selected?software?was?excluded?due?to?practical?limitations.?Each?remaining?software?
solution?was?tested?in-person,?and?evaluated?according?to?a?consistent?evaluation?scheme.?
The?evaluation?scheme?was?formed?to?include?as?much?potentially?relevant?information?
as?possible?for?anatomical?teaching?providers.
2.3.? Usability?Study
The?usability?study?conducted?in?the?course?of?this?work?can?be?modeled?in?three?parts.?
The?experiment?set-up:?the?target?demographic?for?the?study?was?medical?students,?in?the?
2nd? to?5th?year.?1st?and?6th?year?students?were?not? targeted?due? to?a? lack?of?complete?
ongoing?anatomical?curriculum.?30?medical?students?signed-up? for?and?participated? in?
the?study.?The?hands-on?experiment:?two?solutions?were?selected?based?on?their?ease-of-
use,? relevance?and?completeness:?”Dynamic?Anatomy”?and?”Holoanatomy”,?both?MR?
applications?intended?for?and?tested?on?the?Hololens.?Hands-on?experimentation:?during?
30?minutes,?participants?were? to? interact?with?both? selected?MR? solutions,? in? a? semi-
supervised?manner.?Structure?was?given,?but?not?imposed?in?the?participants’?interaction?
with?each?application.?Assistance?was?available?and?given?on?request.?Then?a?usability?
questionnaire,?developed?based?on?the?standard?set?by?[5],?was?filled? in?by?participants?
after?they?had?completed?all?other?tasks.?The?questionnaire?contained?4?sections:?1)?state-
ments?concerning?their?experience?with?MR,?2)?perceived?positive?and?negative?aspects,
3) a multiple-choice question regarding their preferred mode of anatomy teaching, and
4) arguments supporting their choice on the multiple-choice question.
3. Results
3.1. Nonsystematic Literature Review
Using the criteria outlined in Subsection 2.1, 27 existing articles were selected for review.
8 of the reviewed articles relate to describing evolution in the topic of AR in anatomical
teaching. 19 of the reviewed articles concern tools presently available to apply AR and
MR technologies.
Work by [6] describes the evolution of AR use in medical scenarios, and identifies a
rise in activity for these topics in the years 2007-2013. The terms MR and AR are used
inconsistently in the literature. As a result, tracing back the evolution for MR specifically
is challenging. Technical limitations have contributed to hindering the introduction of AR
to the medical field [7] Despite this, research projects involving the use of AR in medical
scenarios, and specifically in anatomical teaching were identified. Previous works look
at the use of AR in surgery [6], neurosurgery [8], and oto-rhino-laringology [9] Research
towards the use of AR for anatomical teaching dates back at least as far as 1997 [10].
Since then, several works [11] have focused on applying AR in medical teaching.
3.2. Available AR and MR Solutions
52 applications were selected, 26 of those available on the Apple ecosystem, 16 on the
Google Play ecosystem, and 10 on the Hololens. Of those, 35 applications (respectively
17, 8, and 10 for Apple, Google Play, and Hololens) could be tested in person.
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Table 1.: Open-ended 3-positive-3-negative-aspects questionnaire results
Hololens for anatomy teaching MR for anatomy teaching
Positive % Negative % Positive % Negative %
Ease of use 26% Discomfort 35% 3D Visualization 22% Discomfort 30%
Adjustability 10% Field of view 22% Practicality 18% Missing touch 17%
Convenience 9% Price 19% Super-real Space required 17%
Comfort 9% Software bugs 10% visualization 15% Little benefit
Low weight 9% Availability 7% Stimulating 12% compared to PC 10%
Interactivity 9% Non-trivial Interactivity 10% Lack of realism 8%
Portability 7% learning curve 7% Increased No social aspect 8%
Intuitiveness 7% understanding 9% Lack of real body 5%
Image quality 7% Innovative 8% Non-mature tech. 5%
Voice, gesture Add, remove, and
recognition 7% isolate structures 6%
The overall resulting impression is as follows: At the time of this study, MR/AR
applications exist which could be used as tools to supplement anatomy teaching. How-
ever commercial solutions do not yet exist for every body part, or are not suited for all
specific teaching modalities. A knowledge base of these evaluations was compiled and is
made freely available (www.dugas.ch/public/realite-mixte-app-evaluation-data). Based
on these evaluations, the Hololens platform was selected for the usability study described
in Subsection 2.3.
3.3. Usability Study
The usability questionnaire contained 4 sections. The results obtained for each section
are as follows:
The statements supplied in the questionnaire were graded on a scale from 1 (worse)
to 7 (best). The mean score by category was 5.03 for the usefulness, 5.42 for ease of use,
6.2 for ease of learning and 5.63 for satisfaction. The overall grade was 5.47. Full results
are available on request.
Responses to the open-ended 3-positive-3-negative-aspects questionnaire were
grouped into conceptual categories, semantics aside. Those categories, and the frequency
at which participant responses fell into the relevant category are shown in Table 1.
As shown in Table 2, in the concluding multiple-choice poll, following hands-on
testing of MR tools and existing software, an overwhelming majority of students ex-
pressed a desire for both classical methods and technological tools to be used in the
teaching of anatomy in the medical curriculum.
In the open-ended supporting arguments question, participants were asked to moti-
vate their choice. Responses to this open-ended question were grouped based on concep-
tual similarity. Arguments for using MR in anatomical teaching fell into the following
categories: i) Access to specimens, and in particular the ability for home-work, which
is difficult with real specimens. ii) Access to otherwise-impossible (referred to as super-
real in this work) visualizations, such as dynamical properties, hidden structures, etc.
Arguments for traditional methods fell into the following categories: i) realism, and the
ability to show details which digital media can not practically capture ii) the psycholog-
ical impact of real bodies on professional maturity iii) the importance of all senses in
anatomy learning.
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Table 2.: Preferred modality to be used in anatomical courses
Proposed general statement selected %
Only MR methods, with Hololens 3%
Only currently used, traditional methods 11%
A combination of traditional and MR methods 86%
4. Conclusion
It has been shown that practical factors such as a high number of students, passive par-
ticipation, difficult concepts [12], and a large quantity of material to be learned, can
lead to sub-optimal or superficial learning for students in medical anatomy. Proper spac-
ing of study sessions is important for optimal long-term memorization [13]. Use or AR
and MR anatomical teaching could pose several advantages, such as the possibility of
increasing the frequency of leaning instances, interaction with models and specimens
which are rare in practice, and super-real visualizations. This work shows that medical
students are open to the introduction of technological tools to supplement, though not
replace, traditional anatomy teaching. Potential future work involves extending the scope
of the present study, and conducting a feasibility study from the perspective of anatomy
teachers.
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Abstract. Introduction: We describe an analysis that modulates the simple 
population prevalence derived likelihood of a particular condition occurring in an 
individual by matching the individual with other individuals with similar clinical 
histories and determining the prevalence of the condition within the matched 
group. Methods: We have taken clinical event codes and dates from anonymised 
longitudinal primary care records for 25,979 patients with 749,053 recorded 
clinical events. Using a nearest neighbour approach, for each patient,  the 
likelihood of a condition occurring was adjusted from the population prevalence to 
the prevalence of the condition within those patients with the closest matching 
clinical history. Results: For conditions investigated, the nearest method 
performed  well  in  comparison  with  standard   logistic   regression.  
Conclusions: Results indicate that it may be possible to use histories to identify 
‘similar’ patients and thus to modulate future likelihoods of a condition occurring. 
 
Keywords. EHR; machine learning; clinical terminologies 
 
 
1. Introduction 
 
The advent of electronic information systems in recent decades has enabled a rapid 
increase in data creation and collection in many disciplines, not least in healthcare, 
where we now have large amounts of data stored in individuals’ electronic health 
records. These data have been acquired during the care of individuals with a variety of 
aims: to improve the care of the individuals; to improve communications between 
individuals’ care givers; to maintain records of care; and to enable appropriate charging 
to payers [1]. Electronic records generally now hold data dating back 30 years or more 
and exist in various healthcare enterprises and departments for a variety of purposes – 
e.g. booking systems, GP systems, lab test results, imaging – and contain a number of 
data items, such as demographic information, test results, diagnoses, treatments, clinic 
appointments and charging information. In the work presented here, a set of 
longitudinal primary care records was analyzed to see if patients with similar recorded 
histories of symptoms and diagnoses were likely to share similar future diagnoses. The 
analysis of Electronic Health Records (EHR) data for risk prediction is an active area of 
research [2] however scant work using solely primary care records data for general 
future conditions likelihood was found. Miotto et al [3] used secondary care EHR data 
to make such predictions for a number of conditions using deep learning, achieving an 
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F-score of 0.236 for their predictions. Weng et al [4] tested four machine learning 
algorithms (random forest, logistic regression, gradient boosting machines, neural 
networks) to predict cardiovascular risk. McCormick et al [5] describe a Bayesian 
hierarchical model for the selection of association rules, predicting future medical 
histories for individuals on the basis of common clinical histories. Wang et al [6] 
developed a multilinear sparse logistic regression for risk prediction with patient EHRs 
for joint risk prediction (two or more diseases that are related to each other in terms of 
sharing common comorbidities, symptoms, risk factors). In summary, other work to 
date has primarily been on secondary care records for patients being treated in hospital 
settings as part of single episodes; the work we describe here investigates the use of 
primary care records that record events over many years. 
2. Objective 
With many symptoms being common to multiple diseases, there is a challenge in 
producing an initial diagnosis or recommendation for diagnostic tests from a set of 
symptoms that could have been produced by a number of diseases. Often the initial 
choice of diagnosis or testing is based on a clinician's impression of the likelihood of 
that condition in a general population; however the opportunity may exist for 
modification of these likelihoods based on individuals' recorded histories. In this work 
we aim to investigate the potential of applying machine learning methods to medical 
histories, in order to see if we can predict whether an individual’s chances of being 
diagnosed with a particular condition are modulated from general population 
prevalence by comparison of their previous diagnosis and symptom histories with 
others’ diagnosis and symptom histories. Jenssen and Kenyon note that ‘medical 
decision-making is about assessing risk and weighing competing probabilities in the 
setting of imperfect information’ [7]. We used coded histories from primary care 
records as the basis for this work. Primary care records, in general, utilize coding 
systems to store diagnosis and other information about patients. Common coding 
systems used for these records include ICD9, the dominant system in primary care in 
the USA and now being replaced by ICD10; and the Read Code system, the dominant 
system in the UK but now being replaced by SNOMED CT. Data used in this study 
were derived from UK patients, coded using Version 3 of the Read Codes (CTV3), and 
US patients, coded using ICD9. We chose CTV3 as the primary coding system. Some 
data required translation from ICD9 to CTV3 using a look-up table created from 
existing look-up tables for ICD9 to SNOMED 
CT from NIH [8] and for SNOMED CT to 
Read CTV3 from NHS Technology Reference 
Data Update Distribution Service [9]. 
Each CTV3 term is associated with a single 
concept and consists of a 5 byte code with an 
optional 2 byte. Codes comprise letters, 
numbers and trailing decimal points and fall 
into one of three categories: findings and 
diagnoses; processes; and medications. All 
codes are arranged in a hierarchy with a table 
listing all parent-child relations. 
Figure 1 shows a small extract from the 
Figure 1. An example of codes in the 
CTV3 hierarchy. 
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CTV3 hierarchy, illustrating the relationship between codes relating to bacterial chest 
infections. This Figure shows that Acute haemophilus influenza bronchitis is a 
Haemophilus influenzae infection; there are four other codes that are child codes of 
Haemophilus influenzae infection. Haemophilis influenzae infection itself is a 
Haemophilus infection, which in turn is a Bacterial disease. Bacterial disease is an 
Infective disorder, a child code of Clinical findings, a category coming under the root 
node of the CTV3 tree. 
3. Methods 
The data sources were sets of longitudinal clinical records derived from general 
practice data across the UK and USA, de-identified prior to being made available to us 
for this work. Data were presented as a set of records of events, including patient age, 
gender, and codes of events including diagnoses, symptoms, administrative events and 
prescriptions, together with the year of the event and history of smoking and alcohol 
consumption. There were 25,979 patients in the full data set (49.3%M, 50.7%F), with a 
total of 749,053 recorded items, of which 375,312 items were diagnostic events. Age 
distribution and prevalence of common conditions (as determined by [10]) in the full 
data set was not different to that present in the general population. For this work, only 
diagnosis and symptom codes and those codes giving information about smoking and 
alcohol consumption were retained from the records in the data set. The Konstanz 
Information Miner (KNIME) [11] was used to prepare the data and merge the data sets; 
statistical analysis was performed using R [12]. All software was run on an Asus 
N56VM laptop with Intel Core i7-3610QM 2.30 GHz CPU with 8GB RAM running 
64-bit Windows 10. 
For each record, the codes retained were used to determine its k nearest neighbour 
(KNN) records by use of the binomial method [13] using a program written in R for 
this work. Optimum values for k, the number of nearest neighbours, were established 
for each condition by experimentation on a training set of records removed from the 
complete data set, where the F-measure of accuracy was optimized over a range of 
values for k. The most effective depth in the CTV3 tree at which to aggregate codes 
from deeper levels was similarly determined by experiment. Calculations were repeated 
for a set of medical conditions. The process was run separately for each condition, with 
the condition of interest hidden from the information used for the distance calculation. 
For each record, the prevalence of the condition in the KNN was compared to the 
prevalence in the remainder of the data set; those records where the prevalence in the 
neighbours was significantly (p < 0.05) higher than in the remaining records, were 
assigned a prediction of positive for the condition of interest, otherwise the prediction 
was negative. Predictions were then compared to the actual presence in each record. 
4. Results 
An example is given for a single condition, allergic rhinitis. A Fagan nomogram [14] of 
the changed probability of an individual having the condition is illustrated in Figure 2. 
The prior probability of an individual having the condition, i.e. the population 
prevalence, is 0.178. After implementing the nearest neighbours algorithm, (the ‘test’) 
those predicted to have the condition had a probability of having the condition of 0.252. 
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Figure 2. Results for allergic rhinitis using k-
nearest neighbours. 
The sensitivity of the test was 0.599; the 
specificity was 0.614. Results for six 
conditions are shown in Table 1. The 
results include comparison with a simple 
logistic regression (LR) method, chosen as 
an established prediction method [2]. 
KNN generally performed better than 
LR when judged by F-score, sensitivity and 
specificity, for all conditions. Low 
prevalence conditions performed poorly 
with LR, predicting no positive cases. 
Because of LR’s better performance in 
positive likelihood ratio, it also gave higher 
results for odds ratio than KNN, suggesting 
that if LR predicts positive for a condition 
then there is greater confidence in the 
record containing that condition than if 
KNN predicts positive. However, if LR predicts negative for a record then there is less 
confidence that the record does truly not contain the condition than if the KNN 
predicted negative. F1 scores achieved for the more common conditions compared well 
with those achieved by Miotto et al [3]. Additionally, the KNN method presents an 
explainable method that may be more convincing than other machine learning methods 
in a clinical setting [4]. 
Table 1. Comparison of KNN and LR prediction methods for six conditions. 
5. Conclusions and Future Work 
The results of our analysis indicate that it is possible to apply nearest neighbour 
techniques using medical histories to modulate future likelihoods of a condition 
occurring in individual patients. The technique employed in this work showed 
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Allergic Rhinitis 2297 KNN 0.354 0.469 0.599 0.614 1.550 0.654 2.37 
LR 0.113 0.080 0.067 0.974 2.518 0.959 2.626 
Bronchitis 2004 KNN 0.328 0.433 0.552 0.661 1.625 0.679 2.394 
LR 0.139 0.981 0.223 0.164 7.240 0.881 5.146 
Obesity 2000 KNN 0.334 0.443 0.566 0.670 1.713 0.648 2.643 
LR 0.409 0.326 0.287 0.979 13.422 0.729 18.420 
Gastroparesis 26 KNN 0.017 0.039 0.286 0.944 5.06 0.757 6.684 
LR 0 0 0 0.999 0 0 0 
Autism 25 KNN 0.016 0.034 0.167 0.970 5.493 0.854 6.392 
LR 0 0 0 1 0 0 0 
Eczema 670 KNN 0.229 0.369 0.623 0.791 2.984 0.476 6.265 
LR 0.137 0.095 0.079 0.996 21.649 0.925 23.413 
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performance improvements over logistic regression methods particularly for conditions 
of low prevalence, although there were limitations due to the relatively small data set 
size. This method is suggested as a useful low-cost screening tool. Early discovery of a 
condition can often improve the chances of successful treatment or of mitigation of the 
effects of the condition and many conditions can be detected through screening tests on 
asymptomatic individuals. Disadvantages of conventional screening tests include risks 
of harm to the individual if the screening test is invasive; inconvenience and/or stress to 
the individual; and financial cost to the individual and/or the health care system. It is 
therefore advantageous to perform screening tests on subsets of the population selected 
to be at great risk of the condition being screened for [15]. 
We intend to extend our analysis in a number in a number of areas. We will repeat 
the analysis using the existing methods but translating event codes to SNOMED CT 
and comparing results to those described here. We intend to optimize the methods used 
to address the slow run time experienced in this analysis. Run time has implications for 
use in clinical practice: currently the system takes around 30 minutes to run on a 
sample of 5,000 records. This is likely to be too long for opportunistic likelihood 
predictions for an individual arriving in a clinic, although acceptable for use in 
identification of individuals appropriate for screening or invitation to consultation. 
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Abstract. Physical health records belong to healthcare providers, but the information 
contained within belongs to each patient. In an increasing manner, more health-related 
data is being acquired by wearables and other IoT devices following the ever-
increasing trend of the Quantified Self.  Even though data protection regulations (e.g., 
GDPR) encourage the  usage of privacy-preserving processing techniques,  most of 
the current IoT infrastructure was not originally conceived for such purposes. One of 
the most used communication protocols, MQTT, is a lightweight publish-subscribe 
protocol commonly used in the Edge and IoT applications. In MQTT, the broker must 
process data on clear text, hence exposing a large attack surface for a malicious agent 
to steal/tamper with this health-related data. In this pa per, we introduce  MQT-TZ, a 
secure MQTT broker leveraging Arm  TRUSTZONE, a popular Trusted Execution 
Environment (TEE). We define a mutual TLS-based handshake and a two-layer 
encryption for end-to-end security using the TEE as     a trusted proxy. We provide 
quantitative evaluation of our open-source PoC on streaming ECGs in real time and 
highlight the trade-offs. 
Keywords. wearables, mHealth, secure broker, MQTT, mosquitto, TrustZone 
1. Introduction 
Personalized health and medicine has the potential of being the next revolution in health- 
care. It is also referred as the P4 medicine (Predictive, Preventive, Personalized, and Par- 
ticipatory), and provides the opportunity to benefit from more targeted and effective di- 
agnoses and treatments [1]. One of the driving forces behind this tendency is the increas- 
ing medicalization of wearable technology [2] and mobile health (mHealth) apps [3]. In 
order to enable these technologies, complex processing IoT pipelines are gradually be- ing 
deployed or repurposed. When the data-in-motion are vital signs, protecting user’s privacy 
becomes a topic of crucial importance. Recent data protection regulations (e.g., GDPR [4]) 
stress the importance of protecting sensitive information against malicious attackers or 
untrusted cloud providers. 
Message Queuing Telemetry Transport (MQTT) [5] is one of the most commonly- 
used communication protocols in IoT. In spite of that, it is not included in some of the most 
extended Medical-Grade data exchange standards [6,7]. It follows a publish- subscribe 
architecture specially designed for environments with limited memory and reduced 
network bandwidth. In such circumstances, MQTT has proven to be more adapted to the 
IoT than classical protocols such as HTTP [8]. In MQTT, a client publishes data to a topic 
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 and the broker forwards it to each client that previously subscribed to it. The pro- tocol is 
currently used in a variety of settings: data generation by sensors, pre-processing on the 
edge, and forwarding to the cloud. Examples include live heart-rate data [9,10], smart-
grids [11], or building management systems [12]. Most MQTT implementations support 
TLS for transport security in the client-broker link, preventing malicious actors from 
spoofing application data. However, the broker itself still exposes a great attack surface 
[13]. 
In order to protect the privacy of health-related data, we present MQT-TZ, a secure 
implementation of the MQTT broker leveraging Arm TRUSTZONE, a Trusted Execution 
Environments (TEE), widely available on edge devices [14]. TRUSTZONE is a security 
feature available in recent Arm processors that enables system-wide hardware isolation 
for trusted software [15]. Our prototype builds atop mosquitto (https://mosquitto. 
org), a popular MQTT broker implementation, and includes persistent storage of client’s 
keys in Arm’s tamper-proof secure storage, as well as TEE-protected re-encryption of 
application data. These security enhancements make our ecosystem compliant with 
the ”Services Secure Interface” [6] described by the Personal Connected Health Alliance, 
and address several attack vectors listed [7] by the IHE. We also consider linking our secure 
broker to a larger storage utility where data-at-rest is encrypted and its origin authenticated 
by MQT-TZ. 
The paper is organized as follows. In Section 2, we describe the technical architec- 
ture and implementation of MQT-TZ. Then, in Section 3, we evaluate its performance and 
robustness at processing 1-lead ECGs in real time. Finally, in Section 4 we expose our 
main conclusions and propose further lines of research. 
2. MQT-TZ: Securing the MQTT Broker 
2.1 Architecture & Component Description 
TRUSTZONE splits the system in a hardware-protected trusted part (the TEE) and an 
untrusted one (also called Rich Execution Environment, or REE). We add an encryp- tion 
layer in MQTT’s payload using client-specific keys stored in Arm’s secure storage. This 
way, application data is only processed in clear inside the TEE. For the additional key-
provisioning, we redefine the client authentication in the mutual TLS handshake to prevent 
the REE from gaining access to clients’ keys. 
The overall workflow looks as follows. Data travels two-fold encrypted from the 
client to the broker (Fig.1: part 1). Once the client access is confirmed, Fig. 1: part 2, the 
subscribers for the given topic are retrieved and the payload forwarded (Fig 1: part 3). Then, 
encrypted data is transferred to the TEE (Fig.1: part 4). The origin and destination client 
keys are retrieved (fig. 1: part 5-7), the payload is re-encrypted, and sent back to the REE 
(Fig. 1: part 8) and to the subscriber (Fig.1: part 9). 
Two-Step Handshake. MQT-TZ defines and uses a two-step handshake that realizes 
broker and client authentication with end-to-end encryption from the client to the TEE. 
The handshake protocol requires minimal pre-provisioned cryptographic material. The 
broker (server in TLS nomenclature) authentication is done through TLS’ handshake, 
supported by default in mosquitto. The client authentication is done through MQTT. It 
publishes its symmetric key, encrypted with the broker’s TEE public  key,  to  a  specific 
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 write-only topic. This TEE key-pair is generated at device start-up  time  (secure boot) and 
derived from a Hardware Unique Key (HUK). 
 
Layered    Encryption   & Access  
Control  Mechanisms. Once the initial 
handshake is finished, MQT-TZ uses a 
two-layer encryption mechanism. First, 
the client-broker link is protected by TLS 
within MQTT. Second, MQTT’s 
payload field is encrypted using the 
clients’ symmetric key. Then, data is re-
encrypted in the TEE (explained next) 
and sent to destination over MQTT-TLS. 
Doing so, we achieve end-to-end 
security relying on TRUSTZONE as a 
secure proxy.   
Payload Re-encryption. The core 
secure functionality implemented in 
MQT-TZ is the payload re-encryption. 
We link MQTT with a Trusted 
Application (TA) running inside the TEE that transfers the encrypted data to the Secure 
World, retrieves the origin and destination keys from secure storage, and re-encrypts the 
information. Currently, topic subscription lists and MQTT metadata are stored in a 
dedicated database (MQTT DB) in the REE. We plan on shadowing these structures and 
keeping them in the TEE. 
Lightweight Cache. MQT-TZ embeds a lightweight cache that keeps the most re- cent 
keys in the TA’s heap memory, and evicts the least used to persistent secure storage.  
2.2 Implementation Details 
MQT-TZ is implemented in C. The current version of MQT-TZ adds 400 SLOC to 
mosquitto and the TA amounts to 1184 SLOC. The MQT-TZ TA relies on OP-TEE 
(https://www.optee.org), an open-source framework with native support for TRUST- 
ZONE. Our implementation will be publicly available (https://github.com/mqttz). 
Client and Server Authentication. The server-side authentication is done through 
vanilla TLS. We deploy MQT-TZ’s secure broker in a device with  a  static IP ad- dress. 
Then, we bound the address to a domain name and use a certificate. We rely on Let’s 
Encrypt (https://letsencrypt.org/) to get one and to authenticate the bro- ker. The client-
side authentication uses MQTT as communication layer, and openssl (v1.1.1a) for 
cryptographic primitives and operations. The integration with mosquitto exploits custom 
callbacks for each packet processing. In addition, we use MQTT Re- quest/Response (RR) 
features (since v5) for the client’s key exchange. To control access and R/W permissions 
to topics, we use mosquitto’s ACLs. 
Trusted Application. We use OP-TEE to implement the payload re-encryption TA. 
Code developed within this framework has two parts: (1), a host app that runs in the REE 
and acts as entry point and bridge to the TEE, and (2) a trusted API in the TEE that ex- poses 
different functions. MQT-TZ intercepts all MQTT packets being forwarded to the recipients, 
and feeds our host app with both client’s IDs, and the encrypted data. We then perform the 
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 payload re-encryption using OP-TEE’s storage and cryptographic libraries. TRUSTZONE not 
only provides isolation between worlds, but also between different TAs. Hence, we use the same 
secure API to store new keys during the handshake. For the key retrieval, we plan to implement 
a small LRU cache to store the most frequently used keys in the TA’s heap, and the rest in 
persistent secure storage. 
3. Evaluation & Discussion 
In this section, we perform an evaluation of MQT-TZ. First, we benchmark the TA re- 
encryption with random data in order to understand the overhead introduced by the re- 
encryption; and then, we analyze the CPU and network throughput when monitoring vital 
signs in a real setting. For all experiments, we virtualize a Raspberry Pi 3 using QEMU- 
V8 (https://www.qemu.org/) running mosquitto v1.6.3 and OP-TEE v3.5.0. 
3.1 TA Re-encryption 
In Fig. 2, we show the breakdown of the time required to re-encrypt a single block of data 
for different sizes. The time is split in the time to retrieve each key (retrieve dec key, 
retriev enc key), encrypt, and decrypt. We can observe that AES is two orders of 
magnitude slower in the TEE. This is a consequence of OP-TEE not using hardware ac- 
celerators in contrast to openssl in the REE. Moreover, we observe sensible slowdowns 
when switching from in-memory to secure persistent storage. 
 
Figure 2. Re-encryption TA microbenchmark 
3.2 Realtime ECG processing 
In this case, we test the resilience of MQT-TZ at sustaining the workloads that can be 
encountered in a hospital. For the experiments, we use the LTMS-S [16] platform de- 
veloped by CSEM for the European Space Agency (ESA). In particular, we simulate 50 
patients streaming in real-time 1-lead 
electrocardiograms (ECGs) at a frequency of  
321.25 Hz. All ECGs are streamed toward a 
single MQT-TZ broker. In Fig. 3, we depict the 
outbound throughput generated by each publisher 
measured using nethogs 
(https://github.com/raboof/nethogs). We observe 
that at any given time only a subset of the 
publishers actually emits data. A single subscriber 
streams at 350 Bytes/s in the worst case, and the 
full collective generates between 3 to 5 kBytes per 
second. During the experiment, we recorded using Figure 3. Workload test: Network 
throughput (top) and CPU usage (bottom) 
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 dstat (https://github.com/dagwieers/dstat) the CPU load at the broker, shown in Fig. 3. We 
observe that after the initial peak, the overall CPU usage (both for usr and sys processes) 
stabilizes at 60%. 
4. Conclusion and Future Work 
Motivated by the lack of secure-by-design communication protocols for the Edge, we 
presented MQT-secure implementation of the MQTT broker using TRUST-ZONE and 
showed its direct application in a in-hospital setting. The proposed system is robust and 
capable of managing 50 patients in real-time with a CPU usage of 60%. We plan to extend 
this work along the following directions. First, we will compare MQT-TZ against other 
publish-subscribe protocols and messaging queues. Second, we will study the performance 
overhead of MQT-TZ when deployed on large-scale scenarios. Finally, we intend to look 
into the energy footprint, an aspect of paramount relevance for edge deployments. 
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Abstract. Extraction and use of Electronic Health Record (EHR) data is common 
in retrospective observational studies. However, electronic extraction and use of 
EHR data is rare during longitudinal prospective studies. One of the reasons is the 
amount of processing needed to assess data quality and assure consistency in 
meaning and format across multiple investigational sites. We report a case study of 
and lessons learned from acquisition and processing of EHR data in an ongoing 
basis during a clinical study. 
 
Keywords. Data integration, clinical trials, data quality, data processing 
 
 
1. Introduction 
 
Large sets of electronic health record (EHR) data present an exciting possibility for 
research such as epidemiologic and observational research, real-time data collection, 
safety surveillance and regulatory uses and prospective clinical research. [3,4,6] 
Although this data has much potential, there are many issues that must be addressed in 
order to produce consistent and reliable findings. [10] EHR data are data collected in 
the process of care. Since the primary purpose of EHRs is to support activities such as 
clinical workflow and billing, the resulting data format, structure and quality often 
differ from the carefully scheduled, collected and formatted data required for research. 
In addition, EHR data changes over time reflecting (1) changes in the health status of 
the patient, and (2) changes in technology, data representation formats, regulatory 
incentives and institutional factors. [5] These variations in expected data versus 
collected data (e.g., timeliness, accuracy) are collectively referred to as data quality 
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dimensions. [8,11] 
EHR data provide useful information about a patient and their healthcare only if the 
data quality is high and correspond to the real world. This correspondence varies 
widely, as do the measurement methods employed in the published literature. [1; 9] 
Further, the reasons for observed inconsistencies are rarely reported. To address this 
deficit in our understanding of data quality in healthcare data, the Patient Centered 
Outcomes Research Institute (PCORI) EHR Data Quality Study compares EHR and 
patient self-reported data for 34 conditions, 8 medical procedures, hospitalizations, and 
smoking status in cohorts from two southern U.S. states (Arkansas and North Carolina). 
This report outlines the data acquisition and processing of EHR data for this study. 
Briefly, the study required near real time acquisition and processing of EHR data to 
facilitate the comparison of EHR with self-report data to (1) identify discrepancies 
between these sources, and (2) support subsequent EHR data investigations and patient 
interviews on a weekly basis. 
2. Methods 
We report on the common aspects of data acquisition and processing between the two 
regions. Inpatient data from large hospitals were extracted from institutional data 
warehouses. Data from outpatient clinics were obtained either directly from the clinic 
EHR (North Carolina) or from an institutional data warehouse (Arkansas). Patient self-
report data were compared with phenotypes derived from EHR data for the conditions, 
procedures, hospitalizations and smoking status from Arkansas and conditions from 
North Carolina. 
For each phenotype, computational algorithms were developed to render a “self-
report” answer and an “EHR answer”. Each was classified as “yes/confirmatory”, 
“don’t know/possible”, or “no/no evidence” in the self-report and EHR data 
respectively. Mismatches between EHR and self-reported phenotypes were considered 
a discrepancy. A subset of study participants were interviewed about their 
discrepancies. In the Arkansas cohort, participants were prospectively enrolled and the 
study required acquisition and processing of data on a weekly basis. In North Carolina, 
participants from a longitudinal community registry and biorepository, the 
Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis 
(MURDOCK) Study, have provided self-report data with annual updates as well as 
consent to access their EHR data. [2] 
3. Results 
For the North Carolina cohort, self-report data were managed in a custom-developed 
system. Existing self-report data were compared to newly acquired EHR data and 
discrepancy reports. For the Arkansas cohort, participants were prospectively enrolled 
at six clinics throughout the state. In Arkansas, self-report data were collected only 
once for the purpose of the PCORI EHR Data Quality Study. Data for the Arkansas 
cohort were managed in the open-source Community Edition of the OpenClinica 
Electronic Data Capture (OC-EDC) system. Discrepancies for both cohorts were 
double coded for root cause and correct data source in the OC-EDC system. The 
orchestration of these sources was accomplished with carefully timed data transfers and 
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SQL queries running over the entirety of the combined patient populations with 
1,061,999 patients and 23,839,223 encounters. 
Research Staff had real time access to EHR Data. For the Arkansas cohort, 
participant healthcare data were captured in either the Epic® EHR or various versions of 
Centricity®. These data were directly accessed through the EHR user interface by the 
research assistants (RAs) at enrollment to obtain participant medical record numbers 
(MRN) to for patient matching between self-report and EHR data. The RAs also used 
Epic to look up diagnostic information (1) prior to the telephone discrepancy interview 
when a discrepancy appeared likely due to clinical charting under the wrong patient or 
record linkage errors; and (2) for post interview attempts to confirm root cause. 
Because the study was operationalized differently in North Carolina due to previously 
existing EHR and self-report data, and because the clinics were separate institutions 
from the MURDOCK Study, EHRs in North Carolina were not accessed through the 
EHR user interface. 
Acquisition of EHR data required substantial preprocessing. For the Arkansas 
cohort, all data were extracted from the institutional data warehouse for enrolled 
participants. The extracted data were stored in Microsoft SQL server and required 
several layers of conversion processing in order to integrate the regional program data 
with the hospital data. For the North Carolina cohort, EHR data were obtained from 
five local healthcare facilities with the following EHRs: Athena Health®, Allscripts®, 
Practice Fusion® and Epic®. The data from the different facilities were standardized and 
transformed to a common data model by the MURDOCK Study team. These data were 
linked with the self-report data, de-identified and sent to the study coordinating center 
for further processing. Record linkage between the incoming self-report data and EHR 
data was a deterministic match for both cohorts using the MURDOCK Study Number 
(North Carolina) and the MRN (Arkansas). Any linkage errors discovered in the EHR 
were collected as part of the study. 
Following record linkage, each participant’s EHR data were phenotyped. 
Phenotypes are rule-based definitions used for classification. Combinations of 
standardized controlled coded terminologies for healthcare (the International 
Classification of Diseases (ICD) and Current Procedural Terminology (CPT)), along 
with a few other non-coded data points identified from the existing literature and from 
practicing physicians, were used to develop the rule- based definitions. These were run 
over the entire dataset. 
The phenotyping process was completed using stored procedures and each 
processing step was logged in case of failure. Overall, 140 phenotypes (70 
“confirmatory” and 70 “possible”) were specified and programmed. A total of 7,405 
unique ICD-9 and ICD-10 codes were used in the process. Due to the long list of codes, 
a flexible design was necessary. Value sets for all phenotype definitions were kept in one 
table to be read by stored procedures, providing a quick and easy way to address 
unexpected phenotype results with simple table insertions/deletions as opposed to time 
consuming and risky code alterations. Records returned from the EHR for each 
phenotype run were compared with those from the self-report dataset. Each condition, 
procedure and event of interest for each participant was classified as “discrepant”, 
“possibly discrepant” or “not discrepant”. Discrepancies were then output to reports for 
RAs to use in the interview process. In addition to the discrepancy details, 
supplemental information such as ICD code descriptions were included to help 
characterize each discrepancy. Discrepancies were also imported into the OpenClinica 
system for post- interview coding (root cause and most likely correct data source) and 
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adjudication. Finally, coded and adjudicated discrepancies were exported from the 
OpenClinica system back to the Microsoft SQL Server for final post-interview 
discrepancy reports which were made available to participants. 
To date, 2,151 participants have been enrolled in Arkansas. Of those, 1,096 
participants have been successfully processed through discrepancy identification. Of 
the North Carolina cohort, 3,927 MURDOCK Study participants had EHR data and 
have been processed through discrepancy identification, of which 373 participants have 
been interviewed. The study is ongoing at this time. 
4. Discussion 
The lack of information about the level of correspondence between healthcare data and 
the real world is an impediment to various types of research. Data quality must not be 
an unknown. The PCORI EHR Data Quality Study is an effort to test dimensions of 
healthcare data quality over multiple phenotypes simultaneously in order to reveal data 
quality issues at scale and establish general measures and methods for characterization 
of data quality problems in health record data. 
Modifications were needed in response to both internal and external changes. 
Some phenotypes were especially challenging, such as obesity, kidney disease and 
chronic obstructive pulmonary disease (COPD). Initially phenotypes were developed 
with broad definitions and code sets. Through iterations of ICD code tuning they were 
refined to more conservative sets that reflected the intent of the phenotype. In addition, 
an inherent dependency on data source systems provided challenges. Changes to 
institutional software along with a national migration from ICD version 9 to version 10 
affected our design and led to reanalysis, redefinition and reprogramming. During 
system development, a new EHR system for the Arkansas regional clinics was 
implemented which required additional programming to access the data that had not yet 
been integrated into the institutional data warehouse. Additionally, some specific ICD 
codes were also updated during this time period. System changes are inevitable, as 
institutions maintain EHR systems and controlled terminologies evolve. Due to 
flexibility of the system design, we were able to resolve phenotype tuning issues and 
adapt to external and internal environmental changes smoothly. 
Several concrete lessons were learned that are unique to comparing EHR with self- 
report data. First, record linkage can be problematic, even in cases where id numbers 
are used. [7; 8] Linked data should always be fact checked to make sure errors have not 
occurred. Second, phenotype definitions will evolve and change based on data source, 
date of collection and workflow or process of collection. Third, comparisons for events 
will cause a multiplicity of “no match” conditions (e.g. hospitalizations and procedures 
can easily lead to a large all possible combinations problem if the date windows are not 
sufficiently tolerant). Lastly, the permutations of possible outcomes (discrepant, 
possible, and not discrepant) must be very carefully considered. These conditions were 
discussed on multiple occasions as new information came in from phenotype runs and 
were compared directly against data in Epic®. 
This work has provided a window into the quality of EHR data through the design 
and implementation of a near-real-time data quality measurement system while 
supporting study operations for informatics and research. While the architecture was 
designed for the University of Arkansas’ environment it may be adapted and 
generalized to work at other institutions and for other data sources. 
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5. Conclusion 
It is well-known that the quality of EHR data varies from institution to institution. The 
implementation reported here identified additional challenges in acquisition and 
assessment of discrepancies between EHR data and patient self-report data. Even with 
well-defined approaches a significant amount of effort to adapt and keep up with 
institutional changes and handle unpredictable quality issues was needed. The work 
reported here required a team- based approach with the technical staff, informaticists, 
clinicians and other subject matter experts. Observations and lessons learned from this 
implementation may inform others as they embark upon use of EHR data during and to 
support clinical and informatics studies. 
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Abstract. Developing predictive modeling in medicine requires additional features 
from unstructured clinical texts. In Russia, there are no instruments for natural 
language processing to cope with problems of medical records. This paper is 
devoted to a module of negation detection. The corpus-free machine learning 
method is based on gradient boosting classifier is used to detect whether a disease 
is denied, not mentioned or presented in the text. The detector classifies negations 
for five diseases and shows average F-score from 0.81 to 0.93. The benefits of 
negation detection have been demonstrated by predicting the presence of surgery 
for patients with the acute coronary syndrome. 
Keywords. clinical texts, medical records, electronic medical records, natural 
language processing, negation detection, Russian, anamnesis  
1. Introduction 
An electronic medical record (EMR) contains records in natural language, for example, 
life and disease anamnesis, protocols of surgeries, examination or discharge reports. 
Developing predictive modeling in medicine requires additional features, and not only 
strictly structured ones, such as blood tests, patient metrics, etc. For the English 
language, there are many tools for labeling text, extracting entities, disease’s cases, 
temporal and negation detection (UMLS, UIMA, IBM Watson, Apache Ruta, etc.) [1–
4]. However, most of the tools are now impossible to adapt to the Russian language 
because a word corpus of medical texts has not yet been compiled. There is a small one 
based on 120 records with labeled diseases and their attributes (complications, severity, 
treatment, etc.) [5,6]. But this corpus is compiled on the records of one medical centre 
and for patients with a limited set of diseases, and therefore it is difficult to use it for 
automatic text labeling of other medical centres. Thus, our team aims to develop a 
system of four modules to solve problems of misprints in medical terms, negation, 
temporality, and experiencer detection (see Figure 1). This paper is devoted to a 
module of negation detection.  
It is accepted that any condition or disease is sought by the occurrence of 
synonyms-terms in medical history, anamnesis, etc. However, the presence of such a 
term may also indicate that the patient denies the disease. In Russia, healthcare 
providers often ask patients after admission to the hospital about strokes, heart attacks, 
 
1 Corresponding Author, ITMO University, 49 Kronverksky Pr., St. Petersburg, 197101, Russia; E-
mail: funkner.anastasia@itmo.ru, funkner.anastasia@gamil.com.  
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200179
342
and high blood pressure in the past, as this may affect the course of treatment. As a 
result, in disease anamnesis, phrases like “MI in the past denies” (Myocardial 
Infarction), “there was no increase in blood pressure”, “without a history of 
hypertension”, “diabetes denies” can be often found. 
The above-mentioned problem is called negation detection in texts. One of the first 
algorithms NegEx was proposed by Chapman et al. in 2001 and was based on rules [7]. 
Subsequently, syntax-based methods for the English language were developed [8,9]. 
Goryachev et al. implemented four methods for detecting negations and compared them 
using three sets of clinical records in English [10]. NegEx showed the best accuracy 
[7]. Thus, most of the approaches found for identifying negations are developed with 
grammatical rules for the English language. 
 
 
Figure 1. Modules of spelling correction and negation detection. Pink blocks indicate methods which are 
described in this paper. Green blocks are developed and implemented by colleagues. Dashed blocks indicate 
methods that are just being developed. 
2. Method 
In this research, we used a set of anonymized 3434 EMRs of patients with the acute 
coronary syndrome (ACS) who admitted to Almazov National Medical Research 
Centre (Almazov Centre) during 2010-2015. Disease anamneses are one of the most 
unstructured records (free text without any tags; each physician writes as he/she wants), 
and therefore we used them to demonstrate our approach. 
Our approach to detect negations is machine learning based on multi-class 
classification. In Figure 1 the main steps are presented on how to train a negation 
detector and use for new data sets. Firstly, clinical texts should be annotated with 3 
labels for each specific disease: ‘-1’ means ‘the disease is denied’, ‘0’ means ‘the 
disease is not mentioned in the text’ and ‘1’ means ‘patient has this disease’. We 
suppose to annotate the whole anamnesis with these labels because the classifier will be 
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able to learn an additional context which follows the disease. The two problems are 
possible: the disease can relate to a patient’s family members (label with 0) and there 
can be two descriptions about patient’s condition in different moments of her or his life 
(label with 1). We use semi-automated labeling with phrase search because the 
provided anamneses can be written in a similar format by the same doctor and it is 
possible to find repeated phrases.  
Secondly, annotated anamnesis is normalized with pymorphy2 module which can 
be used for Russian and Ukraine [11]. Term frequency – Inverse document frequency 
(TF-IDF) transformation makes commonly used words less weighted in word corpus 
(prepositions, pronounce, etc.). TF-IDF vectors are used to train, tune and chose the 
best classifier. In consequence of cross-validation experiments, based on decision trees 
a gradient boosting classifier shows the best result with F-score. Thus, we trained five 
classifiers for detecting arterial hypertension (AH), myocardial infarction (MI), stroke, 
diabetes mellitus (DM) and angina pectoris (AP) (see Table 1). Using negation 
classifiers is crucial for stroke, MI and AH. For MI and AH, the classifiers learn 
context and help find additional cases of these conditions. Table 2 includes the most 
import phrases for detecting MI which are disease terms and possible treatment 
(surgery and medications).   
When the negations are detected, each sentence of the anamnesis is labeled as 
containing or not containing negation using a logistic loss [12]. Sentences or their parts 
with negations are removed from anamnesis so that these texts can be used to build 
other models and consider only the patient's existing conditions, for instance, for topic 
modeling. 
Table 1. The comparative results for negation classifiers (F1 – F-score). False positives are anamneses which 
were detected with ‘1’ and ‘-1’ using a term search and a negation classifier respectively. False negatives 
were detected with ‘0’ (terms not found in a text) and ‘1’ with the same methods. 
Disease Number 
of 
annotated 
anamneses 
F1 for 
‘-1’ 
labeled 
F1 for 
‘0’ 
labeled 
F1 for 
‘1’ 
labeled 
Macro 
average 
F1 
Total 
accuracy 
Number 
of false 
positives 
(%) 
Number 
of false 
negatives 
(%) 
stroke 648 0.96 0.96 0.78 0.9 0.93 0.15 0.00 
MI 897 0.95 0.5 0.97 0.81 0.96 0.07 0.15 
AH 1167 0.88 0.59 0.96 0.81 0.93 0.08 0.20 
DM 239 0.95 0.93 0.91 0.93 0.93 0.02 0.00 
AP 864 0.67 0.91 0.98 0.85 0.95 0.02 0.01 
 
Table 2. Feature importance (FI) of words and phrases which are used to define the presence of disease in an 
anamnesis. 
Russian phrase English phrase FI Class Comments 
оим AMI 0.052 1 Abbreviation: Acute Myocardial Infarction 
ибс оим IHD AMI 0.042 1 Abbreviation: Ischemic Heart Disease. 
IHD includes myocardial infarction. 
миокард 
отрицать 
myocardial deny 0.041 -1 Patient denies MI 
отрицать deny 0.035 -1 Patient denies an acute condition 
миокард ранее myocardial early 0.027 1 Indicates myocardial problems previously 
нижний low 0.022 1 Indicates the localization of AMI 
провести 
стентирование 
perform stenting 0.016 1 Stenting is a surgery performed after AMI. 
ознакомить provide 0.015 0 Indicates anamnesis without a medical 
history 
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передний anterior 0.014 1 Indicates the localization of AMI 
анальгин 
трамадол 
analgin, tramadol 0.013 1 Medicines that are used to treat AMI 
3. Results 
To evaluate how the application of negation detection module affects predictive model 
performance we conduct experiments on 2 tasks: clinical episode outcome prediction 
and prediction of surgery for the patients suffering from ACS [13]. Usually, all 
information medics have about a patient by the time of arrival is clinical anamnesis in 
the natural text format. Therefore, we use it as input data to train machine learning 
models.  
During experiments all the models parameters remain constant (for XGBoost: num. 
estimators = 500, max depth = 100, learning rate = 0.1, objective = binary logistic; for 
Random Forest: max depth = 100, num estimators = 500, criterion = ’gini’, min. 
samples split = 2, min. samples leaf = 1; for k-nearest neighbors model (KNN): num. 
neighbours =  10, weights = 'uniform'). The only change is in the input data for the 
fixed feature set: we use diagnosis features collected from clinical texts using regular 
expressions without negation detector and with the help of negation detector. 
We evaluate the results on 33% test sample using the F1 score as a quality metric. 
The results are performed in Table 3. 
Table 3. Evaluation of the negation detection (ND) performance on predictive tasks.  
Task Model F1 without ND 
Text features 
F1 with ND 
Text features  
F1 without ND 
Text + other 
features 
 
F1 with ND 
Text + other 
features 
Surgery 
prediction 
XGBoost 0.3755 0.5234 0.6941 0.6992 
Random Forest 0.3948 0.7110 0.7038 0.7128 
KNN 0.5091 0.5234 0.5851 0.5870 
Outcome 
prediction 
XGBoost 0.3234 0.3233 0.5208 0.5113 
Random Forest 0.3234 0.4229 0.4402 0.4569 
KNN 0.3234 0.3233 0.3428 0.3428 
4. Discussion 
According to the experiment results, we may conclude that the use of negation detector 
significantly improves the performances of XGBoost, Random Forest and KNN on the 
task of surgery prediction based on only text features. On the task of the outcome 
prediction, only Random forest improves. All other algorithms’ results do not change. 
One of the reasons could be the need for additional information for the outcome 
prediction to improve since on current feature sample models predict the constant class 
for all instances and can’t properly distinguish classes. For this reason, we conduct 
additional experiments and add other numerical features based on the first lab test the 
patients had. Lab tests for models are more significant than texts, therefore, the effect 
from the negation detection application is not such significant in this experimental set. 
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5. Conclusion 
We demonstrated the procedure for training and using the negation detector on the 
example of disease anamnesis of patients with ACS. For five treatment-relevant 
diseases and conditions, the negation detector showed average F-score from 0.81 to 
0.93 on the test sample. Also, the benefits of the negation detection were demonstrated 
with predicting the presence of surgery for patients with ACS. The developed and 
implemented module for detecting and removing negations is part of the application for 
processing clinical text. In the future, we plan to develop additional modules and make 
this application an indispensable part of data preparation and feature extraction for any 
predictive modeling. 
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and?Matthias?GANZINGER? a,1
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Abstract.?The?amount?of?digital?data?derived? from?healthcare?processes?have? in-
creased?tremendously?in?the?last?years.?This?applies?especially?to?unstructured?data,?
which?are?often?hard? to?analyze?due? to? the? lack?of?available? tools? to?process?and?
extract?information.?Natural?language?processing?is?often?used?in?medicine,?but?the?
majority?of?tools?used?by?researchers?are?developed?primarily?for?the?English?lan-
guage.?For?developing?and? testing?natural? language?processing?methods,? it? is? im-
portant? to?have? a? suitable? corpus,? specific? to? the?medical?domain? that? covers? the?
intended?target?language.?To?improve?the?potential?of?natural?language?processing?
research,?we? developed? tools? to? derive? language? specific?medical? corpora? from?
pub-licly?available?text?sources.n?order?to?extract?medicine-specific?unstructured?
text?data,?openly?available?pub-lications? from?biomedical? journals?were?used? in?a?
four-step? process:? (1)?medical? journal? databases?were? scraped? to? download? the?
articles,?(2)? the?articles?were?parsed?and?consolidated? into?a?single?repository,?(3)?
the?content?of? the? repository?was?de-scribed,?and? (4)? the? text?data?and? the?codes?
were?released.In?total,?93?969?articles?were?retrieved,?with?a?word?count?of?83?868?
501?in?three?different?languages?(German,?English,?and?Spanish)?from?two?medical?
journal? databasesOur? results? show? that? unstructured? text? data? extraction? from?
openly?available?medical?journal?databases?for?the?construction?of?unified?corpora?
of?medical? text?data?can?be?achieved?through?web?scraping?techniques.
Keywords.?Natural?Language?Processing,?Data?Mining,?Information?Storage?and?
Retrieval,?Medical?Informatics,?Linguistics
1.? Introduction
The? amount?of?digital?data?derived? from?healthcare?processes?have? increased? tremen-
dously?in?the?last?years?[11].?Data?available?from?healthcare?sources?can?be?roughly?di-
vided? into? two? types:? (1)?structured?data,?namely? information?already?organized? into?a?
known?data?model,? for? instance,? results? from?psychological?surveys?or? results?of? labo-
ratory?tests;?and?(2)?unstructured?data?in?the?form?of?free-text?data,?medical?images,?or?
physiological?signals.?Examples?for?such?free-texts?are?anamnesis?records?or?discharge
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notes?and?they?are?commonly?written?by?healthcare?professionals?[7].?Dalianis?et?al.?es-
timated?that?over?40%?of?healthcare?data?are?unstructured?[3].?It?is?often?hard?to?use?such?
unstructured? texts? for? research?and?other?analyses?due? to? the? lack?of?available? tools? to?
process?and?extract?information.?These?tools?must?be?tailored?specifically?for?the?medical?
field,?and?moreover,?tailored?for?a?specific?language?[3].
Nowadays,? the?way? to? analyze? texts? is? using? large? corpora? from?which? comput-
ers?can? learn? the?meaning?of?a?word?from? its?context,?replacing?former?rule-based?and?
feature-selection-based?approaches?[5].?However,?availability?of?medical?records?for?such?
research?purposes? is?usually? restricted?due? to?privacy? issues.?Consequently,? collecting?
biomedical?texts?extracted?from?journals?have?been?proposed?as?a?possible?solution?for?
the?lack?of?resources?[1,?12].
Natural? language?processing? (NLP)? is?a? sub-field?of?computer? science,?concerned?
with? interactions?between?computers?and?human? languages? [4].?Some?of? the?most? im-
portant?NLP?applications? in?medicine?are? (1)?detection?of?patterns? in?electronic?health?
records?(EHR)?(e.g.?detection?of?healthcare?associated?infections,?adverse?drug?events?or?
cancer?symptoms);?(2)?text?summarizing?and?translation?of?EHR;?and?(3)?automatic?cod-
ification?[2].?While?there?are?successful?applications?of?NLP?in?the?medical?field?[6,?13,?
9],?the?majority?of?tools?used?by?researchers?are?developed?for?the?English?language?[8].?
Therefore,?creating?tools?and?training?corpora?for?languages?different?to?English?are?valu-
able?contributions? to?empower?NLP?of?clinical?sources? in?non-English?speaking?coun-
tries.?To? improve? the?potential?of?NLP?research,?especially?for?non-English? languages,?
we?developed?tools?to?derive?language?specific?medical?corpora?from?publicly?available?
text?sources.?Specifically,?we?focus?on?Spanish?and?German?texts.
2.?Methods
In?order?to?extract?medicine-specific?unstructured?text?data,?openly?available?papers?from?
biomedical?journals?were?used.?The?general?process?was?divided?into?(1)?web?scraping?of?
the?database?to?download?each?of?the?articles?contained?in?the?website,?(2)?parsing?of?the?
raw?downloaded?data?to?consolidate?it?into?a?local?standardized?repository,?(3)?descriptive?
analysis?of? the?content,?and? (4)? the? release?of? the?data? to? the? scientific?community.?A?
general?overview?of? the?workflow? is?summarized? in?Figure?1.?The?entire?pipeline?was?
developed?in?the?Python2?programming?language.
Figure 1. Overview of our proposed workflow to generate corpora from medical journal databases.
2Python - https://www.python.org/
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2.1.? Web?scraping
Web?scraping? is?a? technique? to?extract?automatically?data? from?websites.?The?package?
Scrapy3?was?used?to?develop?a?script,?which?navigates?trough?the?database?and?downloads?
every?article?in?XML?format.
The? recursive? algorithm? first? searched? for? a?medical? journal? in? the? index? of? the?
database,? then? inside? the? journal? looked?up? for? the?volumes? available,? and?finally? the?
script?searched?for?all?the?articles?inside?that?volume?and?downloaded?the?XML?file?asso-
ciated?with?the?article.
2.2.? Parsing?of?the?raw?data?and?corpora?consolidation
For?parsing?raw?XML?files,?the?package?BeautifulSoup4?was?used.?Additionally,?we?ex-
tracted? the? following? attributes:? title,? language,? abstract,? day? of? release? and? journal? /
meeting?name.
The?parsed?articles?were?then?consolidated?into?separate?corpora?based?on?the?lan-
guage?in?which?the?article?was?written.?Each?corpus?was?word?tokenized?using?the?NLP?
framework?Spacy5.
2.3.? Descriptive?analysis
For? the?exploration?of? the?corpora,?each?corpus?was?summarized?by?(1)? the?number?of?
articles?that?is?composed?of,?(2)?number?of?word?tokens,?and?(3)?vocabulary?size?counted?
as?the?number?of?different?words.?To?compare?each?of?the?corpora,?we?first?deleted?stop-
words?from?the?text?using?the?list?provided?in?Spacy?and?then?frequency?of?appearance?of?
each?word?in?each?corpus?was?calculated.
2.4.? Release
The? corpora? are?made? available? to? the? research? community? as? a?package,?which? con-
tains?each?article?labeled?with?the?language?of?the?content.?The?code?used?to?retrieve?the?
corpora?is?available?on?a?git?repository?6?and?the?corpora?in?a?hosting?platform?7.
3.? Results
In? total,?95?737? articles?were? retrieved? from? the?German?Medical?Science?Database? 8?
(GMS)?and?the?Chilean?Scientific?Electronic?Library?Online?9? (SciELO).?After?parsing?
the? raw?data,?1?762?empty?articles?were?discarded.?A?division?by? language?was?made,?
finding?that?63%?of?the?articles?were?written?in?German,?24%?in?English,?13%?in?Spanish?
and?<1%?in?French.?The?metrics?of?each?corpus?are?described?in?Table?1.
A?word?frequency?analysis?was?made?for?each?corpus?and?ten?of?the?most?frequent?
words?are?summarized?in?Table?2.
3Scrapy: A Fast and Powerful Scraping and Web Crawling Framework - https://scrapy.org
4Beautiful Soup - https://www.crummy.com/software/BeautifulSoup
5Spacy: Industrial-Strength Natural Language Processing - https://spacy.io
6https://github.com/fvillena/multilingual-medical-nlp
7https://zenodo.org/record/3463379.XY4RsUEzaV4
8https://www.egms.de
9https://scielo.conicyt.cl
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Table 1. Summary statistics of the corpora
corpus
Metric German English Spanish
Articles count 59 539 22 372 12 058
Number of word tokens 20 437 502 12 093 145 51 337 854
Vocabulary size 497 256 144 550 374 877
Table 2. Most frequent words in the corpora
corpus
Rank German English Spanish
1 patienten (patients) patients pacientes (patients)
2 ergebnisse (results) results estudio (study)
2 methoden (methods) study an˜os (years)
3 schlussfolgerung (conclusion) treatment casos (cases)
4 einleitung (introduction) methods tratamiento (treatment)
5 fragestellung (research question) clinical diagno´stico (diagnostic)
6 studie (study) medical riesgo (risk)
7 material (material) group figura (figure)
8 hintergrund (background) used enfermedad (disease)
9 therapie (therapy) years resultados (results)
10 durchgefu¨hrt (carried out) time forma (form)
4. Discussion
Current research on NLP in medicine mainly focuses in the English language; never-
theless there is an increasing effort in closing the gap of the development of NLP in
languages beyond English [8]. Our work is a building block of a framework to retrieve
medical unstructured text by the construction of biomedical corpora to support clinical
text mining. Similar work was published by Soares et al. [10], but only SciELO database
was scraped.
The toolset we describe in this manuscript has shown to be suitable for establish-
ing generic medical corpora for multiple languages. To validate our approach we have
queried a public Chilean and German database for medicine related publications. While
we were focusing on German and Spanish texts, we retrieved a considerable amount of
English texts because many the German site publishes in English as well.
Analysis has shown that the most frequent words conform across the corpora only
partially (cf. Table 2). This result is to some extent unexpected, since scientific texts,
as they are provided by the the underlying collections, typically share a very similar
structure (IMRaD – Introduction, Methods, Results, and Discussion). While the reason
for this finding needs further investigation, it might be due to differing focus areas in the
collections. This result is supported by the figures shown in Table 1. Obviously, the GMS
database contains shorter texts, possibly due to a large amount of conference abstracts
published by them.
With a large amount of medical text data, the simplest model we can develop is a
probability distribution, where we can predict upcoming words given a sentence. These
models are essential in tasks where we have noisy and ambiguous inputs [4], as they oc-
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cur, for instance, in spelling and syntax correction of clinical texts or speech recognition
tasks for electronic health records (EHR).
5. Conclusion
The unstructured text data extraction from openly available medical journal databases
for the construction of unified corpora of medical text data can be achieved through web
scraping techniques.
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Abstract. Processes like the care of type 2 diabetes mellitus patients require support 
by information systems considering the heterogeneity of the actors from different 
domains involved, enabling harmonization and integration of their specific 
methodologies and knowledge representation approaches towards interdisciplinary 
cooperation. Currently, the development of systems starts from the simplified 
information world, ignoring the aforementioned heterogeneity and specificity of 
real-world processes. This paper aims to demonstrate the feasibility of developing 
an adaptive, interoperable and intelligent system that supports the major aspects of 
type 2 diabetes mellitus care based on the Generic Component Model as formal 
methodology for modelling universal systems. The result is a deployable solution 
based on a formal representation of the diabetes care system, its objectives, and the 
intended business process. The implemented system enables reasoning over the data, 
inferring medical diagnosis. The effectiveness of the inference was evaluated, 
obtaining an F-measure of 0.89. The methods presented in this paper helps to build 
high quality models based on computation-independent aspects, which enable the 
construction of knowledge-based adaptive, intelligent and interoperable eHealth 
systems. 
Keywords. Diabetes mellitus, Health information management, Ontology-based 
Systems, Systems architecture, Knowledge-based systems 
1. Introduction 
Currently, numerous software applications have been developed and implemented to 
support health care services. Few of them aim at achieving data interoperability, mapping 
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the structure of their data to different standards. Even fewer systems consider the 
concepts and contexts of the data represented, i.e., the knowledge of the actors and the 
interoperability problems associated with the heterogeneity of this knowledge. Therefore, 
most of the systems have difficulties to “understand” the data and to adapt them 
consistently and correctly to the different stakeholders. Improving health care services 
by interpreting data to perform conclusions and actions requires a specific level of system 
intelligence, especially needed in low and middle income countries where skilled human 
resources are limited.  
The deployed methodology, i.e. the architectural model and framework, for 
designing and implementing a type 2 diabetes mellitus (T2DM) software system is based 
on the Generic Component Model (GCM) [1]. GCM allows the representation of any 
system architecture and the analysis and design of information systems. The GCM has 
been explained, discussed, used and compare in several papers, e.g. [1-4]. However, most 
of those papers focus on the principles GCM, without evaluating concrete software 
implementations. The proposed method allows the harmonization of the diversity of 
terms and concepts involved in health services by abstracting them. Thus, 
interoperability, collaboration and decision-making between health systems actors are 
demonstrated for a T2DM care scenario in the Colombian context. The paper’s main 
objective is to demonstrate the feasibility of developing an adaptive, interoperable and 
intelligent T2DM care system based on a formal methodology for modelling of systems 
and their ontological representation. The T2DM scenario was considered because of its 
high prevalence, 8.5% in 2014 [5], and its complex management due the required 
collaboration of many health professionals from different domains. 
2. Methods 
The methodology followed in this work is based on the GCM framework for analysis, 
design and implementation of the systems, providing a generic abstract architecture for 
each domain-specific aspect of the system instantiated by domain-specific ontologies. 
The obtained model addresses three domains, viz. the medical, policy and resource 
domain. The upper-level ontology BioTopLite [6] was deployed to harmonize the 
different domains’ concepts and knowledge. It provides high compatibility with the top-
level ontology BFO [7], and it additionally considers some relevant and general aspects 
of the biological domain.  
Ontology languages such as the Web Ontology Language (OWL) were used to 
represent architectural and static aspects of the system such as the generic system 
description and the description of the glycaemic control use case. Functional or dynamic 
aspects of the system are modelled by the Business Process Modeling Notation (BPMN) 
[8]. The business process model describes the expected behaviour of a business system 
and allows controlling, monitoring or implementing the ongoing processes.  
Policies and rules governing the system for the glycaemic control use case were 
formally described using the SPARQL Inference Notation (SPIN) [9]. SPIN is a general 
purpose, standardized, and broadly accepted rule language that allows the definition of 
rules related to ontology classes. Now, the computation-independent T2DM care system 
was completely modelled. Based on this description, the software development process 
was performed according to the ISO 10746 RM-ODP [10] and its viewpoints as defined 
in the GCM. The output of this process is the specification of the information technology 
(IT) solution and, finally, the running application system. 
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3. Results 
Generic and specialized architectural models of the system have been explained in [11-
13]. For each GCM viewpoint, the models are adapted according to some inputs required 
for the development process [1, 13]. The Business View corresponds to the architectural 
models expressed using OWL and SPIN, and semi-formal models of the behaviour 
represented using BPMN. The Enterprise View defines the roles, activities and policies 
statements of the specified system [10]. The actors' roles in the system can be classified 
into: the categories of health organization staff, the self-care actor, the organizational 
administrator, and the resource chief. The roles have been derived from the International 
Standard Classification of Occupations [14]. The Information View represents in a 
platform-independent way the semantics of information [10]. It is defined in the ontology, 
but the datatypes of the information are not. In our approach, the entities representing 
data are btl2:InformationObject individuals. These entities are the only ones that use 
datatypes in a computational sense. The Computation View describes the functional 
decomposition of the system [10]. A functional decomposition was performed according 
to the general information cycle for any collaboration [13]. Five generic components has 
been defined: the data storage, the data interpreter (processing the data according to the 
formalized knowledge), the data mapper (maps the information to the knowledge of 
specific actor), the planner (decide the plan to be followed), the execution controller 
(assist the actors in the plan execution), and the execution listener (obtains new data after 
the plan execution). Additionally, some support components an execution engine, the 
reasoner, and the user interfaces are defined. The Engineering View describes the 
platform-specific infrastructure that supports the computational view. In our 
implementation, the system was deployed in four devices, the self-care device, the health 
professional device, a node including most of the computational components, and a node 
including the data storage. All are connected by Internet Protocol version 4 and HTTP. 
Finally, the Technology View describes the implementation of the system in terms of a 
configuration of technology objects representing the hardware and software components 
of the implementation [10]. In this view, the technologies used to implement the 
functional components are selected. For the execution engine functional component, the 
CamundaBPMN version 7.3 was selected. For the reasoner component the SPIN Rule 
Reasoner in its version 1.4 was deployed, and for the data storage the Virtuoso Openlink 
Server version 6.1 was used. The other functional components have been implemented 
using the Spring Framework version 4.1.7, available as open-source projects [15]. 
For evaluating the proposed system, a quantitative formal experiment was 
performed. Effectiveness is quantified using precision, recall and F-measure metrics. The 
hypothesis of the experiment is that the F-measure of the system’s diagnosis is higher 
than 0.71, it is the average of the algorithms C4.5 and CART evaluated for the diagnosis 
of diabetes [16]. The specialist provided 20 anonymized medical records including its 
observations and decisions made for these patients. The medical records were structured 
according with the proposed information model, and then 1200 medical observations 
were obtained [15]. The prototype developed operates as an expert system for glycaemic 
control. after entering the 20 medical records, the system provides diagnostic suggestions. 
Table 1 compares the outcomes for one medical record. Some diagnoses corresponding 
to non-diabetic complications (e.g. chondromalacia of patella, mild malnutrition) were 
not included in the system. Other diagnoses have not been asserted due to the difficulty 
to infer them using the aforementioned rules, such as no chronic complications, 
uncomplicated diverticular disease colon, or probable primary hypothyroidism. Some 
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correct states about the patient have been added by the designed system (bolded in Table 
1). These diagnoses were considered irrelevant by the specialist because they are not 
included in ICD10, which is used to classify the relevant medical diagnoses in Colombia. 
The mean F-measure obtained was 0.89, with a minimum value of 0.57 and a maximum 
value of 1. The F-measure has a standard deviation of 0.13. The mean precision is 1 and 
recall is 0.82. The significance of the results was evaluated with a one-sample T-test. 
The one-sample T-test resulted in an F-measure significantly higher than the threshold 
value (0.71) with a value of p=0.00. 
Table 1. Diagnoses by physicians versus diagnoses by the system (underlined and bolded the differences) 
Diagnosis by Physician Diagnosis by the System 
Type 2 diabetes mellitus Type 2 diabetes mellitus 
Peripheral diabetic neuropathy Peripheral diabetic neuropathy 
Overweight Overweight 
Metabolic syndrome Metabolic syndrome 
Hypertriglyceridemia Hypertriglyceridemia 
Raised fasting plasma glucose Raised fasting plasma glucose 
Scleral and hypertensive cardiopathy South Asian central obesity 
Congestive heart failure stage II – C Decreased ankle reflex 
Coronary artery disease Medical alert – hyperglycemia 
 Hypoesthesia 
 Medical alert – hypertension 
4. Discussion 
The correct and formal description of domains and contexts through rules allows the 
adaptability of the system. For example, the presented system was developed using a 
description of the context of the Colombian health system, but it can be adapted to other 
health systems by the definition of their specific context. Furthermore, the software 
system is able to adapt to the physician's preferred language and methodologies including 
internal guidelines, measurement units, etc. 
Contrary to the presented proposal, traditionally, the development team models the 
system by abstracting the types of information generated and shared during the business 
process. The resulting models are semi-formal descriptions of the system and are not 
intended to formally describe the system domains’ knowledge, thereby preventing 
knowledge sharing and management including the deployment of best-of-breed expertise. 
Therefore, at least the following problems arise in traditional development processes:  
1. The models are highly dependent on the knowledge of the development team. 
Different development teams provide heterogeneous models without a clear 
way of harmonization. 
2. The models ignore essential concepts and knowledge of the business domain, 
as domain experts are usually not part of the team. 
3. The models cannot guarantee correct inferences using logic rules.  
4. Most parts of the models are specific for the correspondent business process, 
limiting the re-usability of components and reducing the chance of 
interoperability. 
5. There is no a clear separation between the business domain description and the 
description of the information objects. That makes interoperability between 
information models difficult. 
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One limitation of the presented proposal is the medically relevant diagnoses of 
absence conditions, e.g. the diagnoses “No chronic complications” and “Uncomplicated 
diverticular disease colon”. 
5. Conclusions 
This paper presents the development of a software system and its evaluation process, 
starting from an abstract description of the real system considering computation-
independent aspects up to a concrete ontology-based web application. This application 
follows medical guidelines, includes the data of the patients and suggests a precise 
diagnosis. 
The paper testifies the feasibility to develop an adaptive, interoperable and 
intelligent T2DM Care System based on the GCM methodology and framework. The 
resultant software is available as open source in [15]. 
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Optimization of Entropy-Based Automated 
Dyslalia Screening Algorithm 
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Abstract. This paper presents the current state of progress of a project aimed at 
achieving an automated information entropy-based discrimination of phoneme 
mispronunciations in utterances of early school-age children. The introductory part 
briefly describes the dyslalia symptomology and the incidence of dyslalic 
disorders. This section also reviews the current challenges posed by the main 
research objective in other similar projects sharing the same objective and 
summarizes the current results thereof. The Material and Method section presents 
the conditions, the technology and the feature-extraction technique used in the 
experiment. The same section also describes the computation of the information 
entropy values of each analyzed speech sample. The highest match rate of 93.33% 
was achieved in the classification of words containing the phoneme /r/ in the initial 
position. A synthesis of the achieved results is provided in the Results section 
based on which conclusions are drawn and exposed in the Discussion and 
Conclusions section.  
Keywords. Dyslalia, Information Entropy, Polynomial Trendline 
1. Background 
Dyslalia is the most frequent Speech Sound Disorder (SSD) among early-school aged 
children affecting mainly the phonetic tier of communication and it consists in the 
mispronunciation (distortion, omission, inversion or substitution) of speech sounds 
(phonemes). Its prevalence indicator for Romanian children is 13% [1] and its 
incidence is on a global ascending trend. Unless diagnosed and treated in due time, 
dyslalic disorders may have a dramatic impact on children’s school performance and 
even lead to behavioral disorders. From a neuroscience perspective dyslalia has been 
linked to right-brain dominance and left-handedness and roughly a quarter of dyslalic 
subjects are affected by dyslexia-dysgraphia [2]. 
Phonological assimilation, which is both progressive and regressive within an 
utterance, poses a major challenge to the attempts to devise mathematical models for 
phoneme classification. It follows that the phonetic context of a given target consonant 
is of utmost importance for rigorous analysis of its articulation.  
There are several projects aiming to provide a computerized solution for the 
discrimination of misarticulated phonemes. Logomon [3] is a complex speech therapy 
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software for Romanian equipped with a fuzzy-logic based expert system dedicated to 
pronunciation assessment. No specific pronunciation assessment results are provided 
by the authors, but human intervention (phoneme scores assigned by the Speech 
Therapists) is massively required to achieve such objective. Intelligent System for 
Impaired Speech Evaluation [4] focuses on the pronunciation of consonant /r/ in 
Romanian in an attempt to generate real-time numerical information on 
mispronunciations by analyzing Mel-Cepstral coefficients extracted from phonemes 
and by computing, for each item of the unclassified classes (test data), the (Euclidian) 
distance to each item in the known (learning) data classes (manually selected correct or 
incorrect pronunciations). The related distances are ordered and the final decision is 
made by using a K-Nearest Neighbor (KNN) algorithm. This study reports a 78% 
match rate for a K of 11.  Self-Organizing Maps for Identifying Impaired Speech [5] 
describes an automated method for the discrimination of heavily impaired 
pronunciations of /r/ in Romanian based on Kohonen neural networks. The algorithm 
uses the parameters extracted from the alternating component of the signal envelope as 
feature vectors in a neural network-based classification stage. The study reports an 
82.5% match rate with the best mispronunciation classification results within the 1000-
1500 training ages range and concludes that mispronounced speech sounds have a 
tendency to organize on a single neuron while correct pronunciations spread on several 
map nodes. Vocaliza [6] is a computer-based speech therapy application for Spanish 
speaking children. Its phoneme mispronunciation module proposes a detection method 
based on feeding single phonemes (segmented from words uttered by children) to a 
phonetic decoder (automatic speech recognition algorithm). The speech sound 
discrimination scenario consists of 3 stages: identifying the phoneme-level confidence 
measure by using posterior probabilities resulting from a confusion network (CN) 
generated from the phone lattices (lattice compression algorithm), adapting the acoustic 
model by using Hidden Markov Models (HMM) trained on a Spanish language audio-
record database containing 63193 words (Albayzin) and non-linear mapping of CN 
posteriors (confidence measures) to improve prediction as compared to the 
classification performed by non-expert human labelers. The authors conclude that the 
decision made by an expert (speech pathologist) will invariably have a subjective 
component. The study reports a match rate of 85.81% for the human labeling tasks. 
Human intervention is still required to a significant extent in order to reach efficient 
SSD assessment match rates enabling rigorous detection of phoneme 
mispronunciations.  
The main objective of our research project is the development of a software 
solution for the fully automated entropy-based screening of dyslalic disorders in early 
school-age children. The screening system architecture is presented in [7]. 
2. Material and Method 
An observational experiment was conducted on a target population of 30 children aged 
5-7 from the Banatean National College in Timisoara (Romania), focusing on the 
pronunciation of the vibrant lateral consonant /r/ in initial, median and final position 
within the Romanian words: “RAFT” (shelf), “PARĂ” (pear) and “FAR” (headlight). 
The audio samples were recorded in the speech therapy practice using an Olympus 
LSP1 Linear PCM Recorder (PCM 44.1 kHz/16 bit). Each pronunciation was assessed 
by the speech language pathologist (SLP) so as to be compared with the results of the 
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screening application. The application was built in C# (Microsoft.NET) using 
Accord.NET audio processing libraries to display the polynomial trendline based on 
the positive amplitude values of the audio signal (Figure 1). 
 
Figure 1. Dyslalia Screening Application 
 
 
The algorithm extracts the polynomial trendline of a variable order (from 9 to 12) 
from the audio signal and describes its evolution by assigning 3 possible values to its 
peaks and troughs: A (ascending), D (descending) or S (stable, i.e. curve variation from 
previous value remains within a predefined range, in percentages of the max. amplitude 
value). A transition matrix shown in Figure 2 (Markov process) [8] is then filled in 
with such values (letters) for the reference signal (SLP’s pronunciation whose 
corresponding polynomial trendline has the highest R-squared value) and the test signal 
(subject’s pronunciation of the same word) taken together, e.g.: SLP’s pronunciation 
and Subject’s pronunciation. The probability of each alphabet letter is given by the 
quotient of the number of occurrences of the specific letter n+1 given another previous 
letter n (numerator) and the total number of occurrences of the specific letter in the 2 
segments combined (denominator) [9]. The corresponding information entropy values 
for each segment are then calculated based on the probabilities provided by the 
transition matrix and compared. To have a drastic assessment of the test signal, the 
similarity threshold was set to a maximum value of 0.00099, therefore the test-signal 
entropy values belonging to the [0-0.00099] range were deemed to match the reference-
signal entropy value, whereas test-signal entropy values of higher magnitude orders (i.e. 
in the [0.001 – 1] range) were labeled as mismatch (false positive or false negative 
cases).  
 
Figure 2. Transition matrix and alphabet 
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3. Results 
Calculations were made based on the algorithm described above for 1440 values in all 
possible configurations (combinations of polynomial orders and S-letter ranges).  
Table 1. Highest match rates for initial /r/ 
Initial /r/ Poly 9-S 15 Poly 10-S 2  Poly 10-S 5 Poly 11-S 10 Poly 12-S 15 SLP Opinion 
Subject 1 -0.0099 -0.0614 -0.0125 0.0163 0.0049 Pararhotacism (/iaf-/) 
Subject 2 0.0043 -0.0194 -0.0194 0.0102 0.0019 Rhotacism (/Raft/) 
Subject 3 0.0057 -0.0617 -0.0703 -0.0218 -0.0137 Polymorphic (/rarf/) 
… 
      
Subject 30 0.0019 -0.1449 -0.018 0.0341 0.0086 Rhotacism (/Ra:ft/) 
Match Rate 86.66% 90% 90% 93.33% 86.66% 
 
The resulting match rate was compared to the SLP’s opinion on each analyzed 
utterance. The highest match rates achieved were: 93.3% for initial /r/, 80% for median 
/r/ and 83.3% for final /r/ as shown in Figures 3 and 4. 
 
Figure 3. Initial /r/ results. 
The highest match rate for the pronunciation containing the phoneme /r/ in the 
initial position (93.33%) was obtained using a polynomial order of 11 and an S-letter 
range of 10, while the best results for median /r/ (80%) were achieved using a 
polynomial order of 10 and an S-letter range of 5. 
   
Figure 4. a) Median /r/ results b) Final /r/ results 
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For final /r/ the highest match rate (83.33%) was obtained by setting the 
polynomial order to 10 and the S-letter range to 10 or 15. It can be inferred from the 
synthetic diagrams (Figures 3 and 4) that an S-letter range of 2 produces the most 
stable results across the polynomial order range [9-12] in all three cases. The S-letter 
range of 15 generates the largest variation in the initial and final /r/ cases, while it 
remains fairly stable for the median /r/ case. 
4. Discussion and Conclusions 
The application computes and stores the R-squared value for each polynomial trendline 
to measure the goodness of fit of the model. Further analysis of such stored values is 
required to establish useful correlations. Higher polynomial orders (12 and above) 
generate poor match rates (33.33% to 70%) across the 3 cases, i.e. initial, median and 
final /r/.  
The algorithm produced better results than previous studies and requires little 
human intervention.  
Future work will focus on optimizing the audio signal quality (noise filtering) and 
segmentation by performing a normalized correlation of the pair of analyzed signals 
and using logatomes (monosyllabic pseudowords) with specific structures in terms of 
vowels (V) and consonants (C): VCV/CVC/CVV/VVC, where C stands for the target 
consonant. The inflection points of the polynomial trendline will also be considered for 
assignment of additional letters or sub-letters to be used in the transition matrix, by 
computation of the first and second derivatives. 
Formant frequencies of the analyzed signals will also be explored to assess the 
possibility of devising alternative means to validate the segmentation described above. 
References 
[1] E. Verza, Tratat de logopedie, Editura Semne, Bucuresti, Romania 2000. 
[2]  J. Law, J. Boyle, F. Harris, A. Harkness and C. Nye, Prevalence and natural history of primary speech 
and language delay: Findings from a systematic review of the literature, International Journal of 
Language and Communication Disorders 2 (2000).  
[3] S.Gh. Pentiuc, O. A. Schipor, M. Danubianu, D.M. Schipor, Automatic Recognition of Dyslalia 
Affecting Pre-scholars, arXiv:1406.0495v1 [cs.CY] (2014). 
[4] O. Grigore, C. Grigore, V. Velican, Intelligent System for Impaired Speech Evaluation, Recent 
[5] Advances in Circuits, Systems and Signals, Book Series: International Conference on Circuits Systems 
Signals (2010). 
[6] O. Grigore and V. Velican, Self-Organizing Maps For Identifying Impaired Speech, Advances in 
[7] Electrical and Computer Engineering (AECE) 3 (2011). 
[8] S.C. Yin, R. Rose, O. Saz and E. Lleida, A study of pronunciation verification in a Speech 
[9] Therapy Application, IEEE International Conference on Acoustics, Speech and Signal Processing 
(2009). 
[10] E.E. Mahmut, S. Nicola, V. Stoicu-Tivadar, A Computer-based Speech Sound Disorder Screening 
System Architecture, Proceedings of the 17th International Conference on Informatics, Management 
and Technology in Healthcare (ICIMTH) (2018). 
[11] S. Meyn and R.L. Tweedie, Markov Chains and Stochastic Stability, Second Edition, Cambridge 
University Press, 2009. 
[12] M. Della Ventura, The Influence of the Rhythm with the Pitch on Melodic Segmentation, Proceedings 
of the Second Euro-China Conference on Intelligent Data Analysis and Applications (Springer) (2015). 
 
 
E.E. Mahmut et al. / Optimization of Entropy-Based Automated Dyslalia Screening Algorithm 361
	
			


Re´mi?CARDON?aand?Natalia?GRABAR?a
a?UMR?CNRS?8163?–?STL,?F-59000?Lille,?France
Abstract. Parallel sentences provide semantically similar information which can
vary on a given dimension, such as language or register. Parallel sentences with
register variation (like expert and non-expert documents) can be exploited for the
automatic text simplification. The aim of automatic text simplification is to better
access and understand a given information. In the biomedical field, simplification
may permit patients to understand medical and health texts. Yet, there is currently
no such available resources. We propose to exploit comparable corpora which are
distinguished by their registers (specialized and simplified versions) to detect and
align parallel sentences. These corpora are in French and are related to the biomed-
ical area. We treat this task as binary classification (alignment/non-alignment). Our
results show that the method we present here can be used to automatically generate
a corpus of parallel sentences from our comparable corpus.
Keywords. sentence alignment, text simplification, classification
1. Introduction
Parallel sentences provide semantically similar information which can vary on a given
dimension. The dimension on which the parallelism is positioned can come from many
levels, here we are concerned with expert and non-expert register of language. The fol-
lowing pair of sentences illustrates this:
– Expert : Drugs that inhibit the peristalsis are contraindicated in that situation
– Non-expert : In that case, do not take drugs intended for blocking or slowing
down the intestinal transit
Pairs differentiated by their degree of technicality can be used for text simplification.
The purpose of text simplification is to provide simplified versions of texts, in order to
remove or replace difficult words or information.
Automatic text simplification can be used as a preprocessing step for NLP applica-
tions or for producing suitable versions of texts for humans. In this second case, sim-
plified documents are typically created for children [1], or for people with mental or
neurodegenerative disorders [2].
Helping patients to better understand medical and health information is an important
issue, which motivates our work[3].
In order to perform biomedical text simplification, we propose to collect parallel sen-
tences, which align difficult and simple information. We can exploit an existing monolin-
gual comparable corpus with medical documents in French [4]. The corpus is composed
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of?documents?created?for?medical?professionals?and?documents?created?for?patients.?The?
purpose?of?our?work?is?to?detect?and?align?parallel?sentences?from?this?comparable?cor-
pus.?We?also?propose?to?test?what?the?impact?of?imbalance?on?categorization?results?is:?
imbalance?of?categories?is?indeed?a?natural?characteristic?in?textual?data.
The?existing?work?on?searching?parallel?sentences?in?monolingual?comparable?cor-
pora?indicates?that?the?main?difficulty?is?that?such?sentences?may?show?low?lexical?over-
lap?but?be?nevertheless?parallel.?This?task?is?usually?explored?in?general-language?corpora?
and?performed?as?assigning?a?similarity?score?from?0?to?5[5].?Among?the?exploited?meth-
ods,?we?can?notice?lexicon-based?methods?which?rely?on?similarity?of?subwords?or?words?
from?the?processed?texts?or?on?machine?translation?[6];?knowledge-based?methods?which?
exploit?external?resources,?such?as?WordNet?[7];syntax-based?methods?which?exploit?the?
syntactic?modelling?of?sentences.?[8];?or?corpus-based?methods?[9].There?is?no?existing?
work?on?building?a?corpus?for?text?simplification?in?the?biomedical?domain.
2. Method
We?use? the?CLEAR? comparable?medical? corpus? [4]? available?online1? which? contains?
three?comparable?sub-corpora?in?French.?Documents?within?these?sub-corpora?are?con-
trasted?by?the?degree?of?technicality?of?the?information?they?contain?with?typically?spe-
cialized?and?simplified?versions?of?a?given?text.?These?corpora?cover?three?genres:?drug?
information,?summaries?of?scientific?articles,?and?encyclopedia?articles.?The?Drugs?cor-
pus?contains?drug?information?such?as?provided?to?health?professionals?and?patients.?This?
corpus?is?built?from?the?public?drug?database2?of?the?French?Health?ministry.?The?Scien-
tific?corpus?contains?summaries?of?meta-reviews?of?high?evidence?health-related?articles,?
such? as?proposed?by? the?Cochrane? collaboration? and? the? simplified?versions? that? they?
provide[10].?This?corpus?has?been?built?from?the?online?library?of?the?Cochrane?collab-
oration3.?The?Encyclopedia?corpus?contains?encyclopedia?articles?from?Wikipedia4? and?
Vikidia5.?Wikipedia?articles?are?considered?as? technical? texts?while?Vikidia?articles?are?
considered?as?their?simplified?versions?(they?are?created?for?children?from?8? to?13?year?
old).?Only?articles?indexed?in?the?medical?portal?are?exploited?in?this?work.
We?exploit?a?reference?dataset?with?sentences?manually?aligned?by? two?annotators?
within?this?corpus.
2.1.? Automatic?Detection?and?Alignment?of?Parallel?Sentences
Automatic?detection?and?alignment?of?parallel?sentences? is? the?main?step?of?our?work.?
The?objective?is?to?assess?whether?two?given?sentences?have?the?same?meaning.
The?reference?data?with?aligned?sentence?pairs,?which?associate?technical?and?sim-
plified?contents,?are?created?manually.?We?have?randomly?selected?39?documents?from?
the?corpus.?The?sentence?alignment? is?done?by? two?annotators.?This?alignment?process?
provides?a?set?of?238?equivalent?sentence?pairs.?The? inter-annotator?agreement? is?0.76
1http://natalia.grabar.free.fr/resources.php#clear
2http://base-donnees-publique.medicaments.gouv.fr/
3http://www.cochranelibrary.com/
4https://fr.wikipedia.org
5https://fr.vikidia.org
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[11],?before?consensus.?In?order? to?perform? the?automatic?categorization,?we?also?need?
negative?examples,?which?are?obtained?by? randomly?pairing?all?sentences? from?all? the?
document?pairs?except?the?sentence?pairs?that?are?already?found?to?be?parallel.?Approxi-
mately?590,000?non-parallel?sentences?pairs?are?created?in?this?way.?That?high?degree?of?
imbalance?is?the?main?challenge?in?our?work?and?we?address?it?in?the?experimental?design?
(sec.?2.2).
For? the? automatic? alignment? of? parallel? sentences,?we? use? a? binary? classification?
model?that?relies?on?the?random?forest?algorithm?[12].?The?implementation?we?use?is?the?
one?that?is?available?in?scikit-learn?[13].?The?features?we?use?are?the?following:?number?
of?common?non-stopwords;?percentage?of?words?from?one?sentence?included?in?the?other?
sentence,?computed?in?both?directions;?sentence?length?ratio;?average?word?length?ratio,?
total?number?of?common?character?bigrams?and?trigrams,?word-based?similarity?measure?
exploits? three?scores?(cosine,?Dice?and?Jaccard)?character-based?minimal?edit?distance,?
word-based?minimal? edit? distance? [14],? syntactic? token-based?minimal? edit? distance;?
number?of?common?CUI? (we?generate?all? the?possible?subsequences?of?words? in?both?
sentences?and?check?whether? they?have?a?corresponding?CUI? in? the?UMLS/SNOMED?
lexicon[16].?We?count?the?number?of?times?that?a?same?CUI?appears?in?both?sentences);?
WAVG?and?CWASA?[17].
2.2.? Experimental?Design
We?work?on? sentences? that?are?equivalent? (they?both?express? the? same?meaning).?238?
equivalent?pairs?were?obtained.
We performed two sets of experiments:
1. We train and test the model with balanced data (we randomly select as many non-
aligned pairs as aligned pairs), and then we progressively increase the number of
non-aligned pairs until we reach a ratio of 3000:1, which is close to the real data
(∼4000:1).
2. Then, for each ratio, we apply the obtained model to the whole dataset and eval-
uate the results. Note that the training data is included in the whole dataset, we
proceed this way because of the low volume of available data.
This means that each model is evaluated twice : once on the test set, and once on the
whole dataset. We only report scores for the aligned category. The results that are pre-
sented correspond to the mean values over the fifty runs. Finally, we apply the best model
on another 30 randomly selected documents and manually evaluate the output.
3. Results
We present the results in Figures 1 and 2: The x axis represents the growing of imbalance
(the first position is 1 and corresponds to balanced data), while the y axis represents the
values of Precision, Recall and F-measure. Figure 1 presents the results for the experi-
ments where we evaluate the model on the test set, Figure 2 presents the results for the
experiments where we evaluate the model on the whole dataset.
We can observe that the use of balanced data provides very high results, both for
Precision and Recall, which are very close to the reference data (> 0.90 performance).
These good results in an artifical setting cannot be applied to the real dataset, as is indi-
cated by the starting point in Figure 2
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Figure 1. Evaluation on the test set.
Figure 2. Evaluation on the whole dataset.
4. Discussion
When the model is learned on a substantial degree of imbalance, the Precision score is
high when that model is applied to the real data, which has a ratio of about 4,000:1. The
recall value is also high, but since two thirds of the aligned sentences have been used for
training, that good score should be considered cautiously.
For further evaluation, we randomly selected 30 pairs of documents to evaluate the
performances of the models. We used the model that was trained at a ratio of 1200:1. In
terms of precision, the model shows 98.75% on all the sentence pairs aligned (80 sen-
tence pairs), including equivalence, inclusions and intersection. Only one result showed
two unrelated sentences. Those results show that we have a model that can be used to
automatically generate a parallel corpus with reduced noise, from highly imbalanced
comparable corpora, for text simplification purposes.
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5. Conclusion
We?addressed? the? task?of?detection?and?alignment?of?parallel? sentences? from?a?mono-
lingual? comparable? French? corpus.?We? use? the?CLEAR? corpus,? that? is? related? to? the?
biomedical?area.
We?made?observations?on?the?effect?of?imbalance?during?training?on?the?performance?
on? the? real?data.?We? show? that? increasing? the? imbalance?during? training? increases? the?
Precision?of?the?model?while?still?maintaining?a?stable?value?for?Recall.
We?will?use?that?model?to?generate?a?corpus?of?parallel?sentences?in?order?to?work?
on?the?development?of?methods?for?biomedical?text?simplification?in?French.
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Abstract. Clinical trial data collection still relies on a manual entry from 
information available in the medical record. This process introduces delay and error 
risk. Automating data transfer from Electronic Health Record (EHR) to Electronic 
Data Capture (EDC) system, under investigators’ supervision, would gracefully 
solve these issues. The present paper describes the design of the evaluation of a 
technology allowing EHR to act as eSource for clinical trials. As part of the 
EHR2EDC project, for 6 ongoing clinical trials, running at 3 hospitals, a parallel 
semi-automated data collection using such technology will be conducted focusing 
on a limited scope of data (demographic data, local laboratory results, concomitant 
medication and vital signs). The evaluation protocol consists in an individual 
participant data prospective meta-analysis comparing regular clinical trial data 
collection to the semi-automated one. The main outcome is the proportion of data 
correctly entered. Data quality and associated workload for hospital staff will be 
compared as secondary outcomes. Results should be available in 2020.  
Keywords. Data collection; Health Information Interoperability; Clinical trial as 
topic; Clinical Trial Protocols as Topic; eSource. 
1.Introduction 
Pharmaceutical industry is facing increasing costs for drug development [1]. The 
automatic transfer of data from Electronic Health Records (EHR) to Electronic Data 
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Capture System (EDC) has been identified as one partial solution to address this issue 
by reducing the burden of data entry and associated activities, like data monitoring and 
review by sponsor [2]. Moreover, such solution would drastically reduce the time to 
entry, which is still too high, even with incentive [3]. 
A recent literature review [4] identified multiple initiatives towards automated 
transfer from EHR to EDC systems. Most of these initiatives being monocentric, 
retrospective or based on only one EHR, the authors also stress out the need for further 
research to better evaluate the impact of eSource solutions on data quality and workload: 
some burdens might decrease (entry, quality assessment…) but some others will increase 
(application maintenance, semantic interoperability maintenance).  
The EHR2EDC project [5] has received funding from European Institute of 
Innovation and Technology (EIT) Health. This project is led by Sanofi R&D, include in 
a consortium 3 other pharma companies (see Tab 1), one Clinical Research Organization 
(ICON), one health data technology company (InSite, a TriNetX company), 4 hospitals 
(see Tab 1), the French National Institute for Medical Research (Inserm) and the 
European Institute for Innovation through Health Data (i~HD, a not for profit 
organization). The aim of this project was making such transfer a reality, by overcoming 
technical, organizational and regulatory difficulties. Building on the already existing 
InSite solution (developed by InSite), that allows feasibility studies and provides support 
for recruitment, a new module was developed, that prefills the concomitant medication, 
local laboratory, vital signs and demographic sections of the eCRF, and sends this 
information, under the investigator control, to the trial sponsor EDC. After unit, 
component and usability testing, it is now necessary to evaluate this tool’s performances 
(data transfer capacity, error rate in comparison with manual entry, acceptability with 
regard to process evolution). This work focusses on the design of the evaluation protocol 
allowing to assess the performance of an eSource solution and the application of this 
evaluation protocol in the EHR2EDC context within the TransFAIR study. 
2.Methods 
2.1.Individual participant data – prospective meta-analysis (IPD–PMA) 
IPD meta-analysis is recognized by the Cochrane collaborative group as a ‘gold standard’ 
of systematic review [6], and some authors strongly advocate for prospective meta-
analysis [7]. Even if this study is a proof-of-concept technology evaluation study, and 
not a clinical trial, it was decided to design it like an IPD–PMA, following as much as 
possible PRISMA-P [8][9] and MOOSE [10] statements. This design will ease later 
inclusion of data from other tests in other hospitals using an eSource solution.  
A preliminary protocol was developed by Sanofi R&D and submitted for review and 
validation to the whole EHR2EDC consortium. Each hospital was allowed to modify the 
template in order to customize this protocol but agreed to share patient level data to the 
statistician in charge of the meta-analysis (not the data collected in itself, but rather the 
result of the comparison of paired data sets collected, either manually or semi-
automatically).  
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2.2.Study design 
The main idea of this evaluation is to take advantage of real ongoing clinical trials 
(support CT), by performing a semi-automatic data collection in addition, and 
independently, to the usual manual data collection (see Fig 1). Support CT will be 
conducted in a completely usual way, and will not be affected by the TransFAIR study. 
The data collected in this way are named "Manual Data". All the patient included in the 
support CT are eligible for inclusion in the TransFAIR study. 
In parallel of each support CT, the EHR2EDC transfer module will be installed 
allowing direct use of EHR data under the supervision of clinical investigators or study 
personal in a mirror study. As support CT are ongoing, patients may have been included 
before the beginning of the TransFAIR study. To increase the amount of data collected, 
both prospective and retrospective data will be collected using the EHR2EDC transfer 
module according to the following steps:  
1. The study coordinator / investigator will supervise the automated data collection. 
Through the module interface, (s)he will review, validate and transfer the data 
required by the protocol to the sponsor eSource database. 
2. The sponsor will then reconciliate the manual and eSource database to identify 
discrepancies and provide them to the study coordinator / investigator. 
3. For each discrepancy identified, the study coordinator / investigator will go back 
to the source documents of both eSource and support CTs data in order to collect 
the real value of the information collected.  
4. To the best of his/her knowledge and skills, (s)he will try to identify error causes 
amongst: (i) rounding error, (ii) transcription error, (iii) wrong data entry for 
Manual Data, and (a) modification of information during the transfer, (b) wrong 
information transferred, (c) user error with the new module (wrong patient, 
wrong visit or wrong data selection) for the eSource data. 
For data outside EHR2EDC scope (e.g. pathology, medical history), Manual Data 
will only be counted – and considered correct.  
 
Figure 1. Support CT and TransFAIR study designs. 
N. Griffon et al. / Performances of a Solution to Semi-Automatically Fill eCRF 369
2.3.Outcomes 
The main objective of the TransFAIR study is to assess the percentage of data accurately 
transferred (the number of data correctly transferred divided by the whole number of 
correct data – either manually or automatically entered). Secondary outcomes are:  
1. Assessment of the percentage of target data points that can be accurately 
processed by the eSource solution. Computed like main outcome besides the 
denominator, that is restricted to data transferred.  
2. Descriptive analysis of the identified types of inconsistency  
3. Comparison of data management activities between the two processes assessed 
by the number of queries 
Subgroup analysis will be performed on study site, type of protocol, medical 
specialty and data domain. For exploratory analysis, we will: 
1. Compare entry error rates between arms, based on the discrepancy analysis, and 
try to identify some determinants of error rate: datatype (Boolean, text, date…), 
CDISC domain, data quality… 
2. Explore more thoroughly the differences in queries between semi-automated and 
manual data entry.  
2.4.Statistical analysis 
We won’t assess publication bias because of the prospective design of this meta-analysis. 
The heterogeneity between sites will be assessed using Cochran’s Q and I square statistic. 
For primary outcome and 1st secondary outcome, proportion will be computed using a 
multi-level model to take account of inter site variance. A conditional logistic regression 
model will be used to compute OR estimate for entry error between arms. Once again, 
the inter site heterogeneity will be handled by a multi-level model.  
2.5.Ethical concerns 
Patients included in the support clinical trials will be asked if they consent to the reuse 
of their data in the context of the TransFAIR study. All the data shared between partners 
are shared with respect to the EU General Data Protection Regulation (GDPR). 
3.Results 
The TransFAIR study is being conducted using the proposed study protocol at 3 hospitals 
in parallel of 6 support clinical trials between mid-September and end-November, 2019 
(see Tab 1). The 3 IRBs of the hospitals involved in the project approved both TransFAIR 
and support CT.  
4.Discussion 
Making the data interoperable between pharma and hospital world is a huge work that 
has been accomplished for demographic, local laboratory, medication and vital signs data 
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during the EHR2EDC project. It required the creation – to be published – of: (i) a FHIR 
common information model (CIM) – each hospital must be able to provide data in the 
CIM way, and, (ii) an important set of mappings between this CIM and pharma standards 
– derived from CDISC. This model makes different EHR and EDC systems interoperable.  
Table 1. Description of support clinical trials 
Running hospitals Registration number1 Sponsor Indication Phase 
APHP2, 12Oct NCT03767244 Janssen Advanced prostate cancer 3 
APHP, IRST-IRCCS NCT03390504 Janssen Advanced urothelial cancer 3 
APHP NCT03315143 Sanofi Diabetes/cardiology 3 
12Oct NCT03284957 Sanofi Advanced breast cancer 1b 
12Oct NCT03619213 Astra Zeneca Heart failure 3b 
IRST-IRCCS NCT02516241 Astra Zeneca Urothelial cancer 3 
1: ClinicalTrials.gov identifier; 2: four APHP hospitals involved (Mondor, HEGP, Bichat, Lariboisière) 
This study will allow the identification of data quality gaps in EHR, highlighting the 
data quality dimensions, as described by Khan et al., to put the focus on for the 
EHR2EDC scenario. The idea is to enhance the i~HD quality seal for Research 
Platforms [12] and to make it a requirement for any hospital to deploy and use any data 
transfer application between EHR and EDC.  
This paper focused on the design of an evaluation protocol allowing the assessment 
of eSource solutions implementing large-scale connectivity between EHR and EDC 
systems. Results will be available in 2020.  
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Abstract. We propose an approach to decision support systems (DSS) that starts 
with the user first making their own unassisted decision αU and providing this 
decision as an input to the algorithm. Then, if the decision based of machine 
learning (ML) disagrees with the user’s initial decision, it iteratively works with 
the user to converge to a common decision or at least make the user reconsider 
input values that are inconsistent with αU. We provide a detailed description of this 
approach along with examples, and then discuss potential benefits and limitations 
of this approach.   
Keywords. decision support; machine learning; user interaction 
1. Introduction 
Success of artificial intelligence systems in medicine are amazing. However, the 
greater the accuracy of machine learning algorithms (ML), the greater the user’s 
exclusion from participation in these decision-making processes. The danger of this is 
not only in the loss of responsibility for making the decision, but also in its correctness. 
The point is that machine learning uses a training sample collected in the past, while 
decisions are made in the present. But the past may be radically different from the 
present and the speed of changes may exceed the speed of additional training. 
Moreover, the machine’s decision in any case is based on the patient's data provided by 
the physician, and therefore there is a danger of the preliminary physician decision’s 
influence on the accuracy of this data. In psychology, this effect is called “Cognitive 
bias” [1]. Even in the absence of subjectivity in the assessment of the attribute’s value 
there could be an error in the instrument’s reading, in the measurement method itself, 
and in the natural fluctuations of the meter’s readings. The best defense against these 
threats (the effect of detachment and non-availability of data) is seen in automating the 
explanation of the machine solution and the obligatory responsibility of a physician in 
the final decision [2]. These measures are indeed very helpful, but justification remains 
challenging, particularly for complex ML models.  
Additionally, the better ML systems become, the more likely users will stop 
putting much effort into analyzing or critically evaluating the algorithms’ decisions, 
even if automated explanations are also provided. Here we propose an approach that 
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introduces a meta-agent or decision support system (DSS) between the user and the ML 
algorithm [3]. This DSS restructures the interaction between a user and the ML to 
mitigate the potential loss of expertise and restore a fuller sense of responsibility to 
users. Central to this is that it requires the user to first make an unassisted decision and 
provide this as an input parameter to the algorithm before the algorithm generates its 
own automated decision. The DSS is trying to find "weaknesses" in the decision of the 
user. If the decision of the user continues to differ from the decision of the ML, the 
DSS helps the user to find the reasons for these discrepancies.  
2. The Algorithm Overview  
2.1 Definitions: 
Let X be the set of strings of length n of numerical or Boolean values and D = {αj }, 
j=1,...,k,  is the set of possible decisions that could be made by the user or ML. Each 
string represents n parameter values. We define the decision function f: (X, D)→ [0,1], 
that maps an input x=[x1,...,xn] and a decision α to a confidence interval [0,1].  
Let v = [v1 , …,vn] be the input provided by the user and αU  is the initial unassisted 
decision made by the user. The user also singles out parameters [v1 , …,vm],  m ≤ n, as 
being particularly important for making the decision αU. ML finds max(f(v, α)) for all α 
that belong to D. Let αml be the ML algorithm decision based on the user-provided input 
v= [v1 , …,vn]. The values xi   that are entered into the ML algorithm may be biased or 
erroneous, so we define Ω(xi), i=1,…,n as the set of values which are considered within 
the error bounds for xi. The bias includes the uncertainty of a patient and the physician 
(i.e. the user). (the level of a patient headache or the degree of paleness are examples of 
a possible bias). When there is an uncertainty in assessing a parameter, we have a 
phenomena of “confirmation bias” and “selective perception” [1].  
We introduce a parameter normalization xinorm for each i, based on four thresholds: 
а0i, а1i, а2i , а3i, а4i that are defined by a group of expert physicians. 
xi < а0i         : strong deviation xinorm = 0 + xi /а0i 
а1i  < xi < а2i : abnormal: xinorm = 1 + (xi -а1i)/(а2i-а1i) 
а2i  < xi < а3i : normal: xinorm = 2 + (хi -а2i)/(а3i-а2i) 
а3i  < xi < а4i : abnormal: xinorm = 3 + (хi -а3i)/(а4i-а3i) 
а4i  < xi  : strong deviation: xinorm = 3 + хi /(а4i) 
Thus, normalized parameters will belong to five intervals: [0,1], [1,2], [2,3], [3,4], 
and the interval of numbers greater than 4. 
Using this normalization we substitute [x1,…,xn] for [x1norm,…,xn norm]. Now we 
define the distance between strings x and y  in a standard way as 
 
To define a range of sub-normal (deviated) values, a team of experts empirically 
establishes acceptable parameter limits. They are determined for a certain combination 
of parameters and certain patients. If a parameter stays within the defined abnormal or 
normal range, no action is required. The strong deviation range covers all the sets of 
possible values beyond the abnormal values [4]. For example, if the body temperature 
is less than 350 C, then it is a strong deviation. If it is in the range 350-360, then it is 
considered abnormal. If it is in the range 36.10-37.50, then it is normal. If the range is 
37.60-38.30, then it is abnormal, and if it is more than 38.30, then it is a strong deviation. 
2 2
1 1( ) ... ( )n nx y x y x y− = − + + −
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 2.2 The Algorithm [5]:  
Step 1. The user enters a string of data, v = [v1 ,…, vn]  X into the ML algorithm.  
Step 2. The user makes an unassisted decision αU and enters it into the ML.  
Step 3. The user explains his or her decision αU. The user singles out m out of n input 
values as being particularly important in making the decision αU.    
Step 4. DSS tests the physician decision. In this step the DSS checks whether αU is 
stable when the input parameters are perturbed within the error bounds Ω (vi).  
If ML comes up with the decision αML that is not equal to αU, then go to Step 5.  
If ML comes up with the decision αML that is equal to αU, then go to Step 7. 
Step 5. DSS selects one or more “suspicious” parameters relied on by the user in 
making the initial decision. Since αU ≠ αml, DSS iteratively works with the 
physician. DSS could, at this point, just show the value of αml to the physician, but 
DSS specifically avoid doing this to prevent the physician from automatically 
changing his or her decision to αml. Instead, DSS use an indirect approach where 
it tries to find the parameter whose value vi deviates the most from the typical 
value for the given αU.  
There are some subtle details about this approach intended to make the user more 
willing to review his or her initial decision αU. The First, DSS takes the user’s 
point of view as the starting point and works from there. The Second, DSS tries to 
only select parameters i that are greater than m, because the user doesn’t consider 
them as particularly important to αU, so it may be more productive to point the 
user to inconsistency in these parameters rather than to inconsistency in 
parameters 1,..,m which the user marked as supporting αU.  
Step 6. DSS explains ML decision. As at this point the user’s decision still differs from 
the ML’s decision, the DSS attempts to explain the difference between the ML’s 
decision αml and the user’s decision αU in a way that is intuitive for a user rather 
than in a way that is based on the ML’s internal representation. For this purpose, 
the DSS determines which input parameters were the most important for the 
ML’s decision. This can be done by finding the input vector z' which is the 
closest to the user’s input values v and which prompts the ML to change its 
decision from αml to αU. A critical part of this step is that the distance between 
points v and z' is computed in the normalized parameter space (Xnorm). The DSS 
can use a grid search to find points on the boundary between αml and αU. Once z' 
is found, the parameters in which z' and v differ the most are recognized as the 
parameters being the most important to explain the difference between αml and αU.  
Step 7. A physician tests the ML decision and makes the final decision. 	
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3. Example Application  
Some features of the proposed approach were implemented in the decision support 
system “Dinar-2” for the Center for Child Air-Ambulance Services in Yekaterinburg, 
Russia.  One of the goals of the Center was to provide a remote consultation to doctors 
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in regional medical centers who treated seriously ill children. The Center has served the 
large geographic area, so for its air-ambulance services it would often take a long time 
to reach regional centers. A computerized decision support system had been key to the 
efficient operation of the Center. This system helped in diagnosing the type of 
pathology and in determining its severity. It has also assisted in selecting the best 
course of action and the healthcare center that is best suited for treating patients. 
Besides test results, the system had to consider a significant amount of subjective 
information about the patient's’ condition. This made the decision support task more 
complicated because the subjective information was susceptible to conscious and 
subconscious biases on the part of the reporting physicians. Specifically, these biases 
tended to skew the provided information toward making a patient’s condition appear 
either severe than it was. Because of that, the Dinar-2 decision support system assigned 
an a-priori confidence interval to every input parameter that was based on subjective 
information. Then, the system perturbed the inputs within the bounds of these 
confidence intervals and checked whether its diagnosis was consistent with the 
diagnosis initially proposed by a physician. If, under these perturbations, Dinar-2’s 
diagnosis of the patient’s condition did not match that of the user, Dinar-2 would 
follow the proposed interaction flow (described in section II above) to clarify the 
diagnosis. After its initial deployment, several years ago, Dinar-2 was soon adopted by 
39 air-ambulance centers across former Soviet Union, and has been use since then. For 
example, available statistics for the Yekaterinburg region for 2017 indicate that during 
that year the system assisted in evaluating 537 cases. In 131 of these cases (24%), 
effective remote diagnosis and consultation proved sufficient for resolving the patient’s 
crisis, and the need to dispatch an air-ambulance was avoided [6].  
4. Discussion 
Can it be of interest to have only a user testing the machine or the machine testing a 
user?  In our opinion, it can be. There are situations in which the degree of 
responsibility is so big that it is not desirable to directly indicate the machine’s views. 
For example, this may occur when critical decisions about the patient care are to be 
made. Then, the parameters in which the ML and physician opinions differ are 
presented to the DSS for an increased scrutiny without ML being mentioned. A similar 
approach was used in [7]. Explaining an ML classifier’s decision while treating the 
classifier as a black box was proposed before. However, our approach serves to provide 
explanations that are more intuitive to a physician because it uses the normalization of 
input parameters to map them into a space that is based on the way experts naturally 
think about these parameters. We would like to emphasize the importance of a 
physician to reach a conclusion before following up on a machine’s suggestion. 
Requiring physicians to first reach their own decision serves to counteract the loss of 
physician’s expertise and sense of responsibility that often occurs when users delegate 
decisions to the DSS. It prevents physicians from becoming complacent and motivates 
them to give more thought to their initial decision. It provides continued opportunity 
for users to revisit and refresh their domain knowledge. When a physician decision is 
different from the algorithm’s, he or she reconsiders that decision considering 
parameters highlighted by the algorithm. In the end, it makes it more likely that the 
user will critically evaluate the machine’s decision. Finally, if some of the inputs 
provided by the user are based on subjective information, it is likely that these will 
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contain biases that support the user’s unassisted decision. By having access to this 
decision, the algorithm can take steps to correct these biases. Of course, all these 
benefits and the user-machine dialogue itself will not work if a user’s solution is just a 
formality and a user will be waiting for a machine’s solution before resorting to any 
actions. If the original decision is recorded, a physician will think twice before making 
it to avoid possible accusations of incompetency. Gaining experience of such a 
communication with the machine seems to significantly benefit each expert, but it also 
is useful for improving the quality of ML when working with an expert. Ongoing work 
involves testing this approach in medical diagnostic applications. 
5. Conclusions 
In conclusion, there are several benefits to structuring decision support systems in a 
way that makes the user provide their own unassisted decision to a decision support 
system as a first step. We expect this approach will increase the accuracy of the final 
decision and will serve to maintain and possibly even improve the expert users’ domain 
knowledge.  
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Abstract. Predicting a patient’s hospital length of stay (LoS) can help manage 
staffing. In this paper, we explore LoS prediction for a large group of patients 
admitted non-electively. We use information available at admission, including 
demographics, acute and long-term diagnoses and physiological tests results. Data 
were extracted from the electronic health records (EHR), so that the LoS prediction 
would not require additional data entry. Although the data can be accessed, the 
system does not present a unified view of the data for one patient: to resolve this we 
designed a process of cleaning and combining data for each patient. The data was 
used to fit semi-parametric, parametric and competing outcomes survival models. 
All models performed similarly, with concordance of approximately 0.7. Calibration 
results showed underestimation of predicted discharges for patients with high 
discharge probabilities and overestimation of predicted discharges for those with 
low discharge probabilities. The main challenges in operationalizing LoS 
predictions are delays in entering admissions data into EHR and absent data about 
non-medical factors determining discharges. 
Keywords. Length of Stay, Bed management, Survival analysis, Medical data 
transformation. 
1. Introduction 
We develop and evaluate a Length of Stay (LoS) predictive model and use the prediction 
of individual patients’ LoS from daily admitted cohorts to estimate levels of bed 
occupancy in the following days. Given the potential of LoS prediction to optimise 
hospital operations, many methods have been used to predict LoS including machine 
learning techniques, such as neural networks, logistic regression and regression trees [1] 
[2] [3], as well as statistical methods including negative binomial regression [4]. Here, 
we use survival models to obtain the probabilities of discharge of individual patients 
from daily admissions. Whereas many earlier studies have focussed on a restricted 
patient group, our aim is a model that can be applied to a wide range of patients. 
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2. Background 
The Acute Care Unit (ACU) in the Royal London Hospital provides short term treatment 
of patients aged 16 or older, admitted non-electively from Emergency Department (ED) 
or specialist clinics. After 48 hours patients are typically moved to specialist units or 
discharged. Patients are admitted to the ACU with a wide range of conditions, including 
injuries, acute health conditions and acute episodes of chronic conditions. 
We used the data of the admissions to the ACU in the period 2013-17, consisting of 
35,792 admission records for 20,836 unique patients – 52% women and 48% men, with 
a median age of 65 years. Median LoS was 4 days, with a mean of 8.4 days. 4.8% 
admissions ended with the death in hospital. There were 6,246 unique ICD-10 diagnostic 
codes in the sample. Patients’ LoS was defined as the time interval between admission 
to ACU and discharge from hospital or death.  
3. Methods 
3.1. Data transformation 
The Barts Health NHS Trust stores information about patient encounters in a Cerner Data 
Warehouse. Although the stored data is comprehensive, there are several challenges for 
building a data set for predictive modelling.  
 Multiple identifiers are used: although there is a unique patient ID, every 
admission to a separate unit, including moves between units during a stay, is 
recorded with a unique encounter ID. The encounters that make up a hospital 
stay are not linked: a way to do this was found to assemble a patient’s diagnoses, 
physiological results and treatment data for one admission.  
 Data is entered at different times. Some data are entered into the electronic 
system in real-time during admissions but other data are recorded on paper and 
only entered into EHR at the end of patient’s admission to the hospital. This can 
result in some of the data not entered into system or data recorded with errors.  
 Codes and descriptions of diagnoses are stored together and there is no 
commonly used system to group individual diagnoses into clusters of clinically 
similar categories. A patient’s diagnoses and physiological tests are often 
recorded with ED encounter ID, instead of ACU encounter ID. 
We extracted demographic data from the ACU unit using patient and admission IDs 
and cleaned duplicates and errors. We extracted diagnoses data from all hospital’s units 
using the patients ID in the demographic data. For each admission, multiple diagnoses 
were recorded. To obtain information about comorbidities, we extracted ICD-10 codes 
from all admissions before the current one, counting as comorbidities diagnoses that 
were recorded at least once in an earlier admission, excluding any from the latest hospital 
stay. However, only 33% of admissions were repeats; other patients were assumed free 
of serious comorbidities. We used the R icd package to classify ICD codes into 
comorbidities and calculated Charlson scores.  
To cluster acute diagnoses, we extracted ICD codes and descriptions from current 
admissions and used R erm package, that groups clinically similar diagnoses. For the 
codes that could not be matched automatically, manual comparisons and corrections 
were made, from the ICD-10-CM 2014 to the ICD-10-CM-2019 codes, compatible with 
erm package. This method enabled all the common acute diagnoses to be clustered. 
Physiological tests results (blood tests and NEWS score), were extracted from all 
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hospital units from time interval admission date minus one day and admission date plus 
two days, to account for the tests performed in ED for patients admitted overnight and 
for repeated tests e.g. when the first sample has been compromised. This procedure 
resulted in missing values of 3%-5% for the most common tests (e.g. Hemoglobin, 
RBCDW) and up to 30% for less common ones (e.g. Bilirubin, Albumin). The missing 
values were imputed with population normal values.  
In the last stage, we derived additional variables from the extracted data. For 
example, for Kidney_problem variable, we calculated for repeated admissions median 
Creatinine for patients’ previous admissions and extracted dialyses and kidney transplant 
codes. We assigned the category 3 for admissions with kidney transplant recorded, 2 for 
ones with dialyses, 1 with the Creatinine level at a given admission at least 1.5 higher 
than median Creatinine from previous admissions and 0 if none applied. 
Admission_number and Readmission_within_year variables were derived to indicate if 
an admission was a consecutive one and if a given patient was often readmitted. The final 
data set consisted of 49 predictors.  
3.2. Survival analysis  
We developed and evaluated semi-parametric (Cox) and parametric (log-normal) models 
and Fine and Gray competing outcomes model. We set the evaluation time for 30 days 
and we defined the ‘event’ as discharge from hospital. Deaths during admission were 
right-censored for Cox and parametric models and a competing outcome for the Fine and 
Gray model. For Cox and parametric models, we fitted splines for continuous variables 
to account for non-linear relationships with LoS and we used backward variable selection 
algorithm to select significant predictors (p-value <=0.05 for a global model). 
4. Results 
The hazards in the global Cox model for the selected variables were not proportional, 
and stratifying on non-proportional predictors did improve the proportionality result. Full 
Fine and Grey model did not converge, so this model was developed with the variables 
selected for Cox model. All models had similar concordance, presented in Table 1. 
Table 1 Comparison of models’ concordance. 
Model Concordance Index (AUC) 
Cox 0.705 
Log-normal 0.706 
Fine and Gray model 0.703 
Given the similar performance, we chose the Cox model for further analysis, as hazard 
ratios for discharge event could be directly obtained for Cox model regression 
coefficients, but not from Fine and Gray model [5] [6]. Validation of Cox model with 
resampling showed there was little overfitting. Predicting discharges by day 4 showed a 
mean prediction error of 0.033, with underestimation of discharges for the groups with 
high discharge probability and overestimation of discharges for groups with low 
discharge probability. Prediction on day 11 showed a slight overestimation of discharges 
for patients with medium probabilities of discharge, but the mean error decreased to 
0.014. Figure 1 shows Cox model calibration performance on days 4 and 11.  
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We calculated means of individual patients’ discharge predictions with confidence 
intervals (CI) to obtain the number of beds released from daily admissions. Figure 2 
shows the predicted output for days 2, 3, 10,15 and 30 from admission of 14 patients. In 
the external sample of 180 admissions, for days 2 and 3, 66% of observed numbers of 
beds released were within predicted CI, day 10 - 81%, day 15 - 79% and day 30 - 75%. 
 
 
Figure 1 Calibration of predictions on 4th and 11th day - Cox function. 
 
  
Figure 2 Predicted and observed number of beds released on days 2,3,10,15 and 30. 
 
 
Figure 3 Predicted and observed number of beds occupied from 3 consecutive admissions. 
We used the model to predict bed occupancy from several consecutive daily admissions. 
Figure 3 shows the predicted and observed occupancy after 3 days from the admission 
on a given day, and the previous 2 days, for 180 admission days. The model predictions 
match the trends in the observed data. Perhaps because the Cox model does not account 
for deaths during the admission, the variation in larger in observed than predicted values. 
4.1. Bed estimation 
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5. Conclusions and future work 
We have shown that patient information stored in EHR is sufficient for predicting LoS 
for a large group of patients with varying diagnoses admitted non-electively. This opens 
the way to make such predictions routinely without requiring additional data generation. 
Building a data sets for modelling is challenging due to the form in which data is 
stored, but we showed that the necessary linking of records can be achieved so that a 
uniform dataset can be derived for all patients. We used LoS predictions for patients from 
daily admissions to estimate the bed occupancy on chosen days post-admission. Despite 
the suboptimal calibration group of patients with more extreme discharge probabilities, 
the model performed well for the prediction of beds released from daily admissions.  
The next steps in operationalizing the model will be to investigate ways to facilitate 
real-time entry and access to data. Notably, the ICD-10 codes on which we rely are 
currently coded manually, but the use of machine learning methods (e.g. [7]) to automate 
coding has already been investigated and need not be perfectly accurate for LoS 
prediction. Sourcing comorbidity data for patients admitted to hospital for the first time 
also needs to be resolved; we plan to investigate the possible use of GP records for this. 
We will work to extend the prediction to elective admissions and investigate the hospital 
units to which patients are transferred when they are not discharged from the ACU. We 
will also investigate ways to incorporate the social factors in LoS analysis, as they can 
strongly influence a patient’s discharge times and cannot be estimated from purely 
medical records. Finally, to transform the model into a decision tool, senior nurses and 
bed managers will be consulted on what predictions outputs are useful to support 
effective bed management.  
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Predicting Postoperative Hospital Stay in 
Neurosurgery with Recurrent Neural 
Networks Based on Operative Reports 
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Abstract. This study aimed to predict the duration of the postoperative in-hospital 
period in neurosurgery based on unstructured operative reports, natural language 
processing, and deep learning. The recurrent neuronal network (RNN-GRU) was 
tuned on the word-embedded reports of primary surgical cases retrieved for the 
period between 2000 and 2017. A new test dataset obtained for the primary 
operations performed in 2018-2019 was used to evaluate model performance. The 
mean absolute error of prediction in the final test was 3.00 days. Our study 
demonstrated the usability of textual EHRs data for the prediction of postoperative 
period length in neurosurgery using deep learning. 
Keywords. Neurosurgery, Electronic Health Records, Operative Report, Machine 
Learning, Deep Learning, Recurrent Neuronal Networks, Artificial Intelligence 
1. Introduction 
Although machine learning is gaining special attraction in neurosurgery during the last 
years, the text analysis and natural language processing have rarely been used [1], [2]. 
The operative report is a document describing the details of surgical procedures in a 
patient's medical records. Written narratively in the majority of clinics, it undoubtedly 
provides certain knowledge when appropriately explored. 
In-hospital stay duration is an indirect estimate of disease severity and healthcare 
expenses. We hypothesized that the information stored in operative reports could be 
sufficiently meaningful to predict the duration of the postoperative in-hospital period. To 
test that hypothesis in a pilot study the predictive model (recurrent neuronal network 
(RNN) - gated recurrent unit (GRU)) was previously built on 75 531 and tested on 26 
123 operative reports [2]. We have shown that the postoperative period could be (to a 
certain extent) reasonably predicted using the textual description of the surgery, natural 
language processing, and deep learning. However, our study was limited by the data 
collected in a period between 2000 and 2017 years [2]. This study aimed to update the 
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model developed previously and validate it on a new set of operative reports never seen 
by the model before.   
2. Methods 
In our previous study, the EHRs of N.N. Burdenko Neurosurgery Center was queried to 
select all operative reports with the corresponded length of in-hospital stay following 
surgery in the period between 2000 and 2017 [2]. In February 2018 the Hospital 
information system at N.N. Burdenko Neurosurgery Center was changed. The data on 
operative reports for a period between January 2018 and June 2019 were obtained from 
two sources: the old EHR (named “e-Med”; January - February 2018) and the new one 
(named “Asclepius”; February 2018 – June 2019) [3]. All the incomplete reports and 
cases with an inaccessible length of in-hospital stay were excluded. 
In the current study, all the operative reports dated to 2000-2017 were split into 
primary surgical cases (the operations performed at our Center for the first time for 
patients) and repeated surgery, and the training samples were randomly generated from 
75% of each subset. The testing samples constituted of the remaining 25% of documents 
in each category. The model was trained on primary and repeated surgery subsets 
independently, and its performance was compared in two testing samples accordingly. 
Finally, the model built on primary cases was fine-tested on operative reports for primary 
operations dated to January 2018 - June 2019. We did not consider the cases of repeated 
surgery for the final test due to the reasons explained in section 3.1. 
 
2.1 Text preprocessing 
All neurosurgical operative reports typed by neurosurgeons on computer keyboards were 
retrieved from EHRs. Corpus preparation was done using R programming environment 
(version 3.5.0) in RStudio IDE for MacOS (version 1.1.453). Raw textual data were 
preprocessed before fed into deep learning procedure as input: 
• Transformed to lower case 
• Tokenized with a space separator 
• Proceeded by word embeddings 
All the tokens generated from the original texts were mapped into numeric vectors 
from Euclidean space Rd when d = 400. These vectors were assumed to capture hidden 
information about a language, like word analogies or semantic relations between them. 
Distributed word representation was obtained from operative reports using the FastText 
library [4], [5]. The idea of that approach was in learning to predict a word from its context 
or vice versa. We considered the basic vector representations of character trigrams and 
expanded each word as the sum of the vectors of its trigrams. Then we built the 
constructions of skip-gram (a set of tokens that imply other tokens between them in an 
amount not exceeding the preset number) on these sums. Unlike the classic Word2vec and 
Glove, FastText provides the invariance of embedded tokens to word morphology since 
N-grams of characters are more common than whole words. As a result, the vector 
representations we obtained were expected to work efficiently with the rich-in- 
morphology Russian language. 
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2.2 The model architecture 
The target variable was the postoperative period duration (number of days stored in EHR 
as integers). To process the operative reports, we RNN-GRU architecture proposed in 
our previous study [2], [6]. The logarithm of the hyperbolic cosine of the prediction error 
was used as a loss function since it is resistant to outliers and the second derivative of it 
exists. The adaptive gradient method RmsProp was utilized as the optimizer with the cut- 
off gradient value of the maximum norm equal to 1, and the cut-off gradient value 
outlying the range [-1,1] [4]. The activation function used was Exponential Linear Unit 
(ELU) [4]. The hyperparameters of the model were set by the grid search as: 
• Batch size = 256 texts 
• Dropout (for regularization) = 0.3 
The model was trained using a Keras framework (keras.io) on the first 500 vector-
represented tokens corresponding to documents. When the number of tokens was < 500, 
the sequence was padded with a fixed token complementing sequence to 500. 
2.3 The evaluation of model performance 
Mean Absolute Error (MAE) was used to measure the quality of model prediction: 
(1) 

where – was the number of operative reports, 

– true length of the postoperative in-
hospital period, 

– the predicted duration of postoperative in-hospital stay [7]. 
The model was trained and evaluated within the Python (version 3.6) environment 
Jupyter Notebook for MacOS. 
3. Results 
In the period between 2000 and 2017, a total of 77 876 patients (avg. age 39 ± 20 years, 
males – 55%) underwent 104 506 neurosurgical operations. Initially, we obtained the 
complete uncorrupted operative reports for 101 664 operations and could verify the 
duration of postoperative period in 101 654 cases eligible for the inclusion. These texts 
consisted of 163 316 unique words or 36 438 unique tokens excluding stop-words and 
words appeared five and fewer times in all reports. The “primary surgery” subset 
included 75 652 reports (of which 56 739 documents were selected as a training sample). 
The “repeated surgery” subset included 26 002 reports (with 19 501 used for training). 
 
3.1 Training and validation of the models 
The characteristics of samples subsetted for this study and the corresponding measures 
of deep learning performance are presented in Table 1. The RNN-GRU was applied to 
“primary surgery” and “repeated surgery” datasets, resulted in MAE of 4.83 and 14.25 
days respectively. The model trained on the first dataset outperformed the model 
previously built on the whole set of data for the period 2000-2017 (Table 1, primary 
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surgery vs. all reports). However, the result of prediction in the “repeated surgery” 
dataset appeared to be three times worse. Thus, the RNN-GRU built on the primary 
surgery dataset was considered as the final model.   
3.2 Testing the final model 
A total of 2034 operative reports for neurosurgical procedures was obtained from “e- 
Med” and 11 460 reports were retrieved from “Asclepius” for the period between January 
2018 and June 2019. The test of a final model was performed on 11 968 complete 
operative reports for primary surgery with the known length of the postoperative period 
(a new testing dataset). The final model demonstrated MAE = 3.00 days (Table 1). The 
distinct result for “e-Med” data (n = 1 829, MAE = 2.85 days) appeared to be similar for 
that from “Asclepius” (n = 10 139, MAE = 3.03 days). 
Table 1. The results of RNN (bidirectional GRU) testing on operative reports for primary and repeated surgery 
(n – number of operative reports, AE – absolute error). 
 
* the results obtained from our previous study [2] 
** a new testing dataset containing operative reports for primary surgery performed in Jan 2018 - June 2019 
The absolute prediction error in the new testing dataset did not exceed three days in 
78.5% of cases. 
4. Discussion 
To the best of our knowledge, this is the first study in neurosurgery aimed at prediction 
of the postoperative period based on unstructured medical texts. We chose the operative 
report for a pilot study to test the utility of textual records. A real-world model production, 
however, should consider the maximum structured and unstructured data available. 
W. Muhlestein et al. (2017, 2018) predicted the length of in-hospital stay after brain 
tumor surgery using machine learning on non-textual data [8], [9]. Non-elective surgery, 
preoperative pneumonia, sodium abnormality, or weight loss, and non-White race were 
found the strong predictors of the prolonged in-hospital stay [8], [9]. In contrast, the results 
we obtained demonstrate the meaningfulness of narrative medical texts in these non-
trivial predictions. The worse predictive capability of repeated surgery reports may 
indicate that the information essential for prognosis was not captured compared to 
primary surgery descriptions. 
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The lower MAE shown in the new testing dataset could be related to the shorter range 
of the target variable (compared to the development datasets). The high range of AE in 
all samples was caused by the broad initial range of postoperative periods due to outliers. 
The outliers in the training samples appeared to be extremely rare and better explained 
by occasional factors not related to the initial surgery directly, such as severe 
complications and repeated interventions. The EHR software change was not supposed 
to affect the results since the operative reports remained in textual format invariant to the 
system's interface. 
The RNN-GRU model was efficient to predict the postoperative period with an 
acceptable error for the pilot study. However, the rationale for its efficiency should be 
unraveled in more details, e.g., applying the other machine learning methods, combining 
it with structured data analysis and considering neurosurgeon’s expectation of a 
postoperative period length. Nevertheless, initial surgical exposure to the human brain 
appears to be a sophisticated factor itself which might determine the postoperative course 
and its length. The proposed model may still be improved by text preprocessing (e.g. 
lemmatization), adding convolutional neural networks layers, optimizing the architecture 
and training, testing alternative word embeddings (GloVe, Word2vec) [10]. 
5. Conclusion 
Unstructured operative reports served as an informative source for prediction of in- 
hospital postoperative period in neurosurgery using deep learning. Our study 
demonstrated the usability of data stored in EHR as texts. This research was supported 
by the Russian Foundation for Basic Research (grant 18-29-01052). 
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Abstract. Integrating data from different sources into homogeneous dataset 
increases the opportunities to study human health. However, disparate data 
collections are often heterogeneous, which complicates their integration. In this 
paper, we focus on the issue of content heterogeneity in data integration. Traditional 
approaches for resolving content heterogeneity map all source datasets to a common 
data model that includes only shared data items, and thus omit all items that vary 
between datasets. Based on an example of three datasets in Systemic Lupus 
Erythematosus, we describe and experimentally evaluate a probabilistic data 
integration approach which propagates the uncertainty resulting from content 
heterogeneity into statistical inference, avoiding the need to map to a common data 
model. 
Keywords. Probabilistic data integration, content heterogeneity, missing data, 
biomedical data harmonisation 
1. Introduction 
Integrating data from different sources into a homogeneous data resource creates 
powerful opportunities to study human health. However, disparate data collections are 
often heterogeneous, which complicates their integration. 
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease of unknown 
aetiology, affecting approximately 16,000 people in the UK. Through the MASTERplans 
programme [1] we have gained access to data from three cohort studies: Aspreva Lupus 
Management (ALMS), Lunar, and Exploratory Phase II/III SLE Evaluation of Rituximab 
(Explorer). 
Content heterogeneity refers to the situation in which data items that are not equally 
represented across different data sources [2]. In the MASTERplans example, content 
heterogeneity occurs because Lunar and Explorer did not record age at onset of disease, 
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smoking status, white blood cells (WBC), platelets and lymphocytes, creating missing 
variables problems. Another form of content heterogeneity occurs because ethnicity was 
not recorded using the same categories across the three studies. 
Traditionally, people solve these problems by mapping all datasets to a common 
data model. This model would only include variables that are present in all datasets, and, 
in case of granularity problems, categories that exist in all datasets. 
2. Data and Method 
First, we select all the datasets that are available and can enable us to answer the research 
question based on the description in the metadata. For the datasets that do not satisfy all 
the selection criteria concerning content heterogeneity we build predictive models that 
estimate the probability that these criteria are present based on other information that is 
available, using more complete datasets. The probabilistic relationship selection criteria 
are learned from other datasets. Our approach aims to preserve all the available 
information in the original datasets by translating content heterogeneity problems into 
missing value problems, and then solving these missing value problems using established 
methods (multiple imputation). The method assumes that naming differences are 
resolved beforehand, that the original datasets were sampled from the same population 
and that data are missing at random. 
We applied our method to the three SLE datasets, to answer the research questions 
“does ethnicity predict response to treatment?” and “Finding the set of variables that best 
predict drug response”. For the first question a granularity problem occurred, and for the 
second question a missing variables problem occurred. For both solutions, we applied 
imputation using multivariate imputation by chained equations (MICE) [3] and a random 
forest approach called missForest [4]. 
In order to answer both questions, we included only ALMS-M (maintenance) 
information from the ALMS study data since we required patients to have a 12-month 
follow-up visit (with disease severity evaluated) which was not available in the ALMS-
I set (which followed patients for only 6 months). We rescaled the first visit as zero days 
and calculated days for each following visit relative to that. For both questions were used 
datasets that included patients from all the three studies together, with multiple visits per 
subject. For the response measure only, in order to have only one visit per patient, we 
kept the visit that had the least absolute difference from 365 days (12 month). First 
question’s dataset consists of the 545 patients and 9 variables i.e., gender, age, ethnicity, 
height, weight, drug response (BILAGScore total), creatine, body mass index (BMI), and 
current treatment. Content heterogeneity occurs because ethnicities’ levels are not the 
same across all the sources. Ethnicity in ALMS has 4 levels, i.e., ‘Caucasian’, ‘Asian’, 
‘Black’, and ‘Other’, where ‘Other’ are also different levels of ethnicity. On the contrary, 
ethnicity’s levels in Lunar and Explorer are ‘Caucasian’ and ‘Black or African 
American’. Therefore, in ALMS, ethnicity’s granularity is very high. For the granularity 
problem we add a categorical variable that classifies patients based on the ‘Other’ 
ethnicity. With this additional variable we eliminate misclassification. 
The dataset with the missing variables problem contains not only the initial variables 
mentioned earlier but also smoking status, lymphocytes, WBC, and platelets. Missing 
variable problem occurs because these extra variables were included only in Lunar and 
Explorer data. We remove records for 7 patients with missing value for height and 9 with 
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missing creatine leading to 530 patients. This way makes it better and clearer to 
understand how the method works in application.  
The chosen parameters for missForest imputation are 100 trees and a maximum of 
50 iterations for both research questions. For MICE the chosen parameters are 30 and 20 
imputed datasets, 50 and 40 iterations, and 10,000 and 15,000 seed for the research 
questions respectively. At the end, we fit linear regression models to the complete 
datasets that resulted from both imputation methods. 
3. Results 
In Table 1, we see the coefficients for the linear regression model that estimates the drug 
response based on ethnicity. We compare the coefficients from both imputation methods; 
MICE and random forest. Table 2 shows the coefficients for the linear regression model 
that estimates the drug response based on ethnicity, gender, smoking status, BMI, 
treatment, creatine, lymphocytes and platelets. Figure 1. shows the distributions  
 
Table 1. Coefficients for linear regression model in granularity problem 
 estimate std error pvalue 
 MICE MissForest MICE MissForest MICE MissForest 
Intercept 1.1917 1.0000 4.9643 6.1870 0.8104 0.8720 
Asian 3.8140 4.6710 5.0076 6.2090 0.4467 0.4520 
Black or African American 5.8783 6.0200 5.0009 6.2180 0.2404 0.3330 
Cape Coloured -0.9833 -1.0000 7.5161 8.7500 0.8960 0.9090 
Caucasian 6.9757 7.2210 4.9789 6.1990 0.1618 0.2450 
East Indian 10.3623 5.0000 5.4224 8.7500 0.0567 0.5680 
Eritrean 12.4797 11.0000 5.7933 8.7500 0.0319 0.2090  
Hispanic 4.1158 4.5000 6.2853 7.5780 0.5129 0.5530 
Mexican Mestizo 2.8448 3.2610 5.0588 6.3200 0.5741 0.6060 
Middle Eastern -0.8167 -1.0000 7.5825 8.7500 0.9143 0.9090 
Mixed 2.7500 1.0000 6.5575 8.7500 0.6751 0.9090 
Moroccan 5.9950 5.0000 7.4419 8.7500 0.4210 0.5680 
Native American 4.0167 2.0000 6.9421 8.7500 0.5632 0.8190 
Nicaraguan 9.7708 6.0000 6.7114 7.1440 0.1462 0.4010 
 
Table 2. Coefficients for linear regression model in missing variables problem 
 estimate std error pvalue 
 MICE MissForest MICE MissForest MICE MissForest 
(Intercept) 5.4982 6.2212 1.89E+00 1.9747 5.76E-03 0.0017 
Caucasian 1.2472 1.2619 7.47E-01 0.7485 1.22E-01 0.0924 
Other -0.5385 -0.5426 8.00E-01 0.7867 4.37E-01 0.4907 
Male -2.0917 -1.9727 8.64E-01 0.8238 1.89E-02 0.017 
Never smoker -0.4917 -0.2473 8.73E-01 0.8431 5.57E-01 0.7694 
Previous smoker -1.0473 -1.0190 1.02E+00 0.9793 3.10E-01 0.2986 
BMI 0.0402 0.0465 4.33E-02 0.0421 4.17E-01 0.2692 
Placebo + MMF OR MMF -0.2093 0.1268 7.95E-01 0.6919 8.74E-01 0.8547 
Placebo + MTX OR MTX 3.4207 3.8444 1.54E+00 1.5080 2.73E-02 0.0111 
RITUX + AZA 1.4513 1.5648 1.18E+00 1.1227 2.00E-01 0.1634 
RITUX + MMF 0.6037 0.8455 9.02E-01 0.7961 5.08E-01 0.2888 
RITUX + MTX 2.0002 2.2410 1.24E+00 1.1906 1.20E-01 0.0604 
Creatine 1.0438 1.0278 9.24E-01 0.8998 3.23E-01 0.2539 
Lymphocytes -2.3277 -2.9186 5.60E-01 0.5525 2.40E-05 1.89E-07 
Platelets 0.0090 0.0068 3.40E-03 0.0036 1.11E-02 0.05723 
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Figure 1. Density plots for year of SLE diagnosis, WBC, lymphocytes and platelets, in missing variables 
problem. Blue line shows the observed data and the red lines the imputed data from each of the imputations 
in MICE. 
4. Discussion 
The impact of ethnicity on drug relationship has the huge potential of achieving and 
improving the efficacy of results in precision medicine and differences in recommended 
drug doses [5, 6]. In table 1 we see that ‘Eritrean’ is significant and it implies that 
ethnicity is associated with drug response. Concerning the imputation methods, MICE 
did not have any misclassifications. However, missForest misclassified 1 patient as 
‘Caucasian’ and 2 as ‘Black of African American’. Further analysis is suggested such as 
application of our method to other data sources. 
In Table 2, the coefficients of linear regression models, after imputation using MICE, 
show that all the variables included in the model are significant. Nonetheless, imputed 
values with missForest imputation show less significance. Gender, treatment and 
lymphocytes are the most significant with missForest imputation. Figure 1 also shows 
the distributions of the observed and imputed values for missing variables problem. As 
we see in figure 1 extreme values affect the shape of the plots. However, the central 
tendencies of the density plots of imputed data appear relatively similar to the observed 
ones. 
In general, our approach contains a number of important ingredients. First, it insists 
on the future existence of health data heterogeneity. Therefore, our approach strives for 
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post alignment rather than pre-alignment of Big-health/bio datasets. Second, as a post-
alignment of heterogeneous data sources will be always imperfect and it is not a problem 
that datasets are not content equivalent, if they estimate the probability that they are. 
Third, this approach is pragmatic in the sense that always provides an answer- although 
it might not better when the source datasets do not provide useful information to answer 
the research question. However, the results of the probabilistic data integration would be 
the same as those that would result from analysing an integrated dataset. 
5. Conclusion 
Existing methods for dataset integration rely on mapping to common data models, often 
resulting in a substantial loss of information that is present in the source datasets. One 
promising alternative relies on probabilistic methodologies. This paper has illustrated 
this approach using a real-world example from Lupus cohort studies. Rather than relying 
on perfectly harmonised data items, our method propagates the uncertainty that results 
from imperfect harmonisation into the statistical analysis, thus obviating the need for 
data integration through a common data model. 
Ideally, shared data models would be implemented at source, enabling uniform data 
collection at different sites and studies. But in reality, data standardisation is always 
imperfect, and our approach embraces this imperfection rather than trying to extinguish 
it. Future work includes expanding of the general applicability of the method, and 
comparing results of the proposed integration techniques with gold standard results 
through statistical simulation studies. Moreover, to demonstrate its utility the developed 
approach will be applied to real world biomedical and health datasets such as the studies 
in SLE that were used for our examples. 
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Abstract. Despite their young age, the FAIR principles are recognised as  
important guidelines for research data management. Their generic design, 
however, leaves much room for interpretation in domain-specific application. 
Based on practical experience in the operation of a data repository, this article 
addresses problems in FAIR provisioning of medical data for research purposes in 
the use case of the Leipzig Health Atlas project and shows necessary future 
developments. 
Keywords. FAIR data, Research data management, Data sharing 
1.Introduction 
The FAIR Guiding Principles for scientific data management have been widely 
accepted since their publication in 2016 [1]. Nevertheless, their practical 
implementation is difficult, especially in the area of particularly sensitive personal 
medical data. While many data repositories and data management solutions claim to be 
FAIR, the qualitative implementation of the FAIR principles varies [2]. A typical 
university hospital supports various types of research projects in addition to patient 
care, such as clinical trials for the approval of new drugs or therapy optimization, 
disease-specific registries for the most complete possible registration of all patients 
suffering from a specific disease, population-based cohorts for epidemiological long- 
term monitoring of the population, biomaterial banks, molecular genetic analysis 
(OMICS) and much more. Most of these research projects generate high quality data in 
terms of completeness, consistency and accuracy. Data is collected, curated, analyzed; 
but rarely used again. The objective of this contribution is to show the problems that 
arise when building a research data repository in accordance with the FAIR principles, 
with special emphasis on the health research domain. 
2.Method 
Medical research on humans is resource-intensive and ethically challenging, so it 
should be made possible to get the maximum out of the data. The Leipzig Health Atlas 
is a research data repository that has been built up over the last few years [3] and is 
now constantly being filled with content. Based on the SEEK platform [4], not only 
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data sets but also other types of research artefacts such as systems biology pipelines, 
bioinformatics models or medical ontologies will be managed. In addition to the core 
task of long-term archiving data are to be made available to other researchers ("Data 
Sharing“) and analyses of data should be repeatable by third parties 
("Reproducibility“). The method empirical-analytical approach used here is based on 
our experience in operating the portal and the consulting and feedback of scientists 
when uploading their results. 
3.Results 
This chapter outlines various FAIR hurdles for biomedical research, broken down 
according to the main axes of the FAIR principles, which have arisen several times and 
for which proposals are made for dismantling them. 
3.1.Considerations for FAIR axis 1: Findability 
Findability deals with the problem of recognising the existence of resources and 
referencing them. Many data repository software systems or content management 
systems assign (locally) unique numbers by themselves, which could be made globally 
unique by a suitable prefix. However, the required "eternal persistence" cannot be 
guaranteed with regard to updates or system changes. This results in the need for 
special digital identifier registry software. Such systems already exist in the medical 
field, e.g. the HL7 Object Identifier (OID) Registry as defined in the recommendation 
ITU-T X.660 and ISO/IEC 9834 series. Unfortunately, the OID system [5] is only one 
of many possible handle systems, Digital Object Identifiers (DOI) are widely used in 
scientific journals, and Uniform Resource Identifiers (URI) are used in distributed web- 
based software systems. While each of these systems can be designed to be resolvable 
in principle, there is no agreement on other desirable characteristics [6] such as 
descriptive human readable designation as part of identifiers. 
Another problem is the granularity at which data is to be assigned its own 
identifiers. It is undoubtedly important, for example, to provide a data set that was the 
basis of a scientific publication in one version with its own identifier.  However, 
medical databases are characterized by frequent and extensive changes, whereby data is 
not only added, but also updated. A continuous versioning would be impracticable 
here. A further problem is that it is desirable with regard to the use of data by external 
systems to also be able to reference only parts of data sets or single data elements. In  
the sense of the idea of a Semantic Web, each information atom would get its own 
URI, which is, however, insufficiently supported in practice by existing software. 
While the actual search can be very well supported by existing software using 
keywords, ontologies, or categorical filters, there is a lack of community accepted 
metadata vocabularies for describing data sets (such as MIAME – Minimum 
information about a microarray experiment or the WHO Clinical Trial Registration 
Data Set) for many areas of biomedical research, which often makes it difficult for 
users to navigate within a repository. Furthermore, due to the growing number of 
repositories, it would be desirable if these were federatively linked so that a user does 
not have to formulate a request several times in different places and aggregate the 
results. Here, too, there is a lack of a unifying data catalog specification for available 
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health data describing the content of data collections and the location. Ultimately, 
individual data elements must be described very precisely in order to prevent 
misinterpretation. Simple designations cannot do this. Metadata repositories (MDR) 
allow semantic specification of clinical concepts through annotation with medical 
terminologies, as well as the precise specification of units of measurement, formats, 
data types, and reference ranges. Different systems exist, but their use is very complex 
and does not fit into the regular work processes, which limits their application [7]. 
3.2.Considerations for FAIR axis 2: Accessibility 
Accessibility enables a researcher to actually retrieve data. To have metadata 
permanent available, even when the data are no longer available, is quite easy to 
achieve technically but harder to enforce culturally because some researchers have not 
yet fully embraced the meaning of this criterion. Access via a standardized 
communication protocol is also not a technical problem since Representational State 
Transfer (REST) interfaces based on the HTTP protocol have established themselves 
and current open standards such as HL7 Fast Healthcare Interoperability Resources 
(FHIR) [8] are based on them. The difficulties with access to personal medical data lie 
rather in their sensitive nature for the individual patient. Comprehensive regulations 
such as the European General Data Protection Regulation (GDPR) regulate in detail the 
conditions and restrictions for their collection and further processing. In general, the 
use of such data for research purposes requires the informed consent of the patient or 
proband. The declaration of consent must be sufficiently specific with regard to the 
research objective, the persons accessing the data and the circumstances of the data 
processing, which can prevent subsequent data sharing. Also, identifying data must not 
be stored together with other research data, which makes subsequent data collection or 
record linkage more difficult. Furthermore, participation in research projects is always 
voluntary and can be recalled at any time. Anonymisation procedures for individual 
medical data can remove these restrictions, but are accompanied by a great loss of 
information entropy. For this reason, it is necessary to create and use further 
harmonised metadata vocabularies on topics such as the legal basis for data collection 
or the different variants of Informed Consent. 
Since such data will rarely be automatically accessible, the process of requesting 
data access and secure data retrieval plays an important role. In practice, a simple 
reference to a contact person for each data record represents a major hurdle for both the 
data holder and the interested party, since medical researchers are not always fully 
aware of the legal framework. The establishment of a Data Access Board for checking 
and approving data use proposals according to a usage concept is strongly 
recommended. The data repository should provide an authentication service for internal 
and external users based on a rights and roles concept. To address the concerns of data 
owners about possible breaches of data privacy during data sharing, contact points for 
questions regarding data sharing, data protection, etc. should be established. 
Further problems regarding permanent accessibility are contradictory rules for the 
storage of data. While individual funders consider a storage period of at least 10 years 
as part of good scientific practice to be appropriate, some data usage agreements state 
that the shared data must be deleted immediately after the end of the project, which has 
already led to data records no longer being available shortly after the publication of a 
scientific article. A regulatory harmonisation must take place here. 
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3.3.Considerations for FAIR axis 3: Interoperability 
Interoperability is the ability of distributed, heterogeneous systems to exchange 
information in an unambiguous and exploitable manner. There are countless standards, 
conventions and best practices in biomedical research, but in many cases researchers 
take advantage of the freedom of science to act according to their own ideas. For the 
operators of research data repositories, this often means that only minimal ideas about 
data structures can be enforced (e.g. a tabular format with character-separated values). 
Since technical and semantic interoperability are generally subject to higher 
requirements, operators should support data owners in transforming the data into a 
widely applicable format for knowledge representation. Such a FAIRification process 
requires the definition of a rich target data model. Various common data models are 
suitable for this; the selection can be influenced by later intentions of use. The latest, 
but also most universally applicable model is the already mentioned HL7 FHIR. It 
covers practically all areas of medicine, even if some resources are not yet finally 
specified. In the area of clinical trials, the standards of the CDISC organization are of 
importance, especially the Operational Data Model (ODM) [9] in conjunction with the 
Study Data Tabulation Model (SDTM). For large, distributed data analyses, the OHDSI 
Observational Medical Outcomes Partnership (OMOP) [10] model has gained great 
popularity. For all these models, however, rudimentary ETL tools are available at best. 
International medical terminologies such as ICD-10, LOINC or SNOMED CT are 
very suitable for describing clinical concepts in detail. They only partially meet the 
requirement that vocabularies should also comply with FAIR principles. Terminology 
services can aid the linking process. 
3.4.Considerations for FAIR axis 4: Reusability 
Reusability describes the application of data for secondary purposes independent of the 
original use. With regards to medical data, provenance is the most important topic of 
the FAIR reusability metric. While provenance is a broad topic and the demarcation to 
data acquisition is not sharp, data owners should specify in detail the circumstances of 
the data collection and processing, i.e. data sources, data validation rules, format 
conversions, data cleansing, derived or aggregated data, measuring instruments, scripts, 
software libraries, observers. This greatly increases the confidence of external 
researchers in the data sets. A further recommendation is the provision of simple web- 
based visual analysis tools such as tranSMART [11], which give potential interested 
parties an overview of the depth of the available data and so enhances reusability. 
3.5.Additional considerations for medical FAIR data 
Some aspect does not fit into one of the FAIR data categories but are nevertheless part 
of our recommendations: 1) Data quality is a primary concern when one relies on 
external data. All procedures to ensure high data quality (technical validations, manual 
curation) should be made explicit. 2) If datasets are not eligible for sharing (privacy, 
volume), privacy-preserving data analysis techniques could be an option. 3) Repository 
operators should provide additional services to facilitate sharing and usage of data e.g. 
pseudonymization, de-identification, anonymization, record linkage. 4) The effort and 
benefit of FAIR verification of data is generally unevenly distributed at the expense of 
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the data owner. However, an incentive for them may be to receive feedback on 
improved or additionally calculated data and to add it to the original data source. 
4.Discussion and conclusion 
The FAIR data principles can well be applied to medical data repositories, yet some 
restrictions will apply, mostly with regard to accessibility/data privacy. The LHA 
project is work in progress; not all of our recommendations are solved, implemented 
and evaluated yet. Even through some of our findings lack a broad, independent 
evaluation, we expect most of them to be translatable to similar projects. A first draft of 
a guideline for implementing a general FAIR open data policy in health research was 
developed as part of the FAIR4Health project [12]. 
The greatest difficulties for FAIRification currently lie in the lack of availability of 
community-consented vocabularies and powerful tools for transforming data to 
common data models like HL7 FHIR. While several initiatives (e.g. FORCE11, 
GOFAIR, Research Data Alliance) assess the coverage of the FAIR principles of 
different systems and publish FAIR metrics onto how these principles should be put 
into practice, effort and costs are currently too high for many common data collection 
projects. Incentives are needed to take on the challenge of FAIRification. Furthermore, 
there should be more standardization on processes for data access and data extraction. 
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Abstract. Next generation sequencing (NGS) technologies allow improved 
understanding of pathogens. In the upstream processing of generating genomic 
data, there is still a lack of process-oriented tools for managing corresponding 
meta data. In this paper, we provide a description of how a process-oriented 
software prototype was developed that allowed the capture and collation of 
metadata involved when doing NGS. Our question was: How to develop an 
interactive web application that supports the process-oriented management of 
genetic data independent of any sequencing technique? 
Keywords. data management; microbiological data; ngs; web application 
1. Introduction
Modern microbiological laboratories use next generation sequencing (NGS) for 
understanding the genomes of pathogens. This allows, for example, the detection of 
outbreaks and the determination of antibiotic resistance mechanisms. In order to 
generate annotated genomic data, bioinformatic and biomedical knowledge are 
necessary. For NGS analysis, software solutions such as Ridom Seqsphere+ [1], CLC 
Genomics Workbench [2] or UGENE [3] can be used and facilitate the analysis of 
sequence data, annotation, alignments, and visualization such as phylogenetic trees. 
However, there is more information involved in the upstream processing of generating 
genomic data, which are often not fully considered in such approaches [4].  
The collection and reliable storage of metadata relating to the sample is critical, 
particularly in an ISO accredited clinical microbiology laboratory, but also of relevance 
to other laboratories performing NGS. Three steps for generating a genome-based 
laboratory typing report from a clinical sample can be distinguished: sample 
preparation, sequencing and analysis. In the sample preparation step, clinical samples 
or isolates are subject to DNA extraction. In this stage, relevant data relating to the 
patient, the sample, and the extraction are collected. In the sequencing step, data on the 
concentration of DNA, the library method, the sequencing platform used, and a quality 
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control of the resulting sequences are annotated. In the analysis step, the sequences are 
interpreted, for which biomedical information is indispensable.  
The workflow of capturing and collating metadata during NGS was analyzed in the 
Division of Bacteriology at the University Hospital Basel. The processes for capturing 
the data associated with NGS were examined before starting the process of software 
development. At baseline, Excel worksheets on a server were used with no established 
workflow of how and when to commit changes or new entries. Our central goals were 
to facilitate NGS metadata management in order to reduce the likelihood of errors in 
the database and allow for parallel editing of different parts of the database. The 
guiding research questions was: How to develop an interactive web application that 
allows an efficient process-oriented management of genetic data independent of any 
sequencing technique? 
2. Methods
With a Pubmed and Google Scholar research using the keywords “metadata 
microbiology”, “ngs metadata”, “pathogen ngs metadata”, “metadata management 
system” and “metadata management system genome” we checked if an external tool for 
our goals is available. Next, we iteratively created a mockup together with the 
laboratory staff using the Figma mockup tool [5] in order to define an optimal 
workflow. The subsequent requirement engineering process was based on IEEE 830-
1998 [6] and lead to the definition of the software architecture.  
In the development phase, we used the agile SCRUM technique [7] with seven 
sprints lasting one week each. We made use of the JavaScript node.js (loopback) 
framework for the backend and the Vue.js framework for the frontend. The REST-
based philosophy of many JavaScript frameworks is not designed for multiuser systems 
that require isolated updates and deletion of common resources. Therefore, we used 
socket.io as a JavaScript library for real-time web applications that enables bi-
directional communication between web clients and servers, ensuring that locks on 
datasets can be propagated beyond one session within a REST-based access [8]. For 
usability tests based on a structured questionnaire and for final modifications according 
to the anwers, two more weeks were scheduled.  
3. Results
In our analysis of the management of genetic meta data, we identified six central 
process steps concerning the weekly sample preparation workflow. Initially, a 
laboratory order from internal or external customers arrives together with the material 
to be sequenced. The order is validated and prioritized. In step 2, the sample type 
(isolate or DNA) is checked. Step 3 selects the necessary DNA extraction process with 
respect to the material, if required. Step 4 selects the number of samples (4, 24, 48, or 
96 depending on the sequencing device and cartridge). After performing the DNA 
extraction, the sequencing can be planned with the information generated during 
extraction (step 5). Finally, the samples for the next NGS run are selected, a sequencing 
run is performed, and sequencing data is saved for later analysis and reporting (step 6). 
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These process steps are divided into four different views according to the data 
input required. For steps 1-2, it is the view “Planned” with data on the requesting 
facility, the patient, the type of the material, the date of receiving the order, the type of 
the pathogen, the priority of the order (from “A”: high to “D”: low); the view for step 3 
is “extracted” with the same data as in the former view and DNA concentration; the 
view for steps 4 and 5 is “Preparing run” with data on the finalized DNA extracts to be 
sequenced; for the last step the view is “Sequenced” with data on the sequencing device 
used, date of sequencing and some of the sequencing properties, e.g. adaptor 
oligonucleotides ligated to fragments of the DNA for forming the DNA library.
During the requirements analysis, we also identified the original data management 
workflow based on Excel worksheets, which showed several disadvantages:
 Lack of information on the order of inserting data into the Excel
worksheets
 No import options for pre- formulated orders, potentially leading to errors
in manual entries
 No export options for selected data, which could lead to errors in manual
copy/paste operations during report generation
 No support for batch processing of the data
 No possibility of representing a complete repetition of a sequence run by
shifting metadata from the view “sequenced” to former views
To implement a web application that addresses these disadvantages and provides 
an affirmative answer to our research questions (see introduction), we considered 
additional functional and non-functional requirements, e.g. a table view for general 
overview or ubiquitous access to the system from everywhere within the laboratory, 
which mandates a web interface that is compatible with current browsers. The main 
non-functional requirement was user guidance through the metadata management 
process by prompting only for relevant fields in each step and by providing help 
functions, sorting options, search functions as well as tooltips. The prototype is called 
“Red Maple”, and the start page is given in Figure 1. The UML sequence diagram for 
our solution using web sockets is presented in Figure 2.  
Figure 1. Start page of the prototype Red Maple with the four views “Planned”, “Extracted”, “Run”, 
“Sequenced” and a summary of datasets included in them. The bubbles in the right column represent 
the links for details within these views.  
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Figure 2. The UML sequence diagram shows how data is accessed via the frontend (VueClient). In 
case of manipulation of the data, tokens are used, which allow manipulation of data in the backend 
(MongoDB is the NoSQL database used by the loopback Server). Locks are necessary in order prevent 
anomalies possible when the same data is tried to be manipulated simultaneously.
4.?Discussion
Typically, laboratory analyses are associated with clear diagnostic procedure steps 
described in medical guidelines. The NGS processes within microbiological 
laboratories are different in that they are often not directly based on a medical guideline 
but are necessary to gain information on transmission and outbreaks, thus affecting 
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more than one single patient. This is one of the reasons why such NGS analysis 
processes are difficult to integrate into the workflow of existing laboratory information 
systems. Hence, instead of stretching existing LIS solutions, it seems desirable to 
develop a modular solution that is useful for many microbiological laboratories.
Therefore, we implemented and described an exemplary web application that supports 
an efficient process-oriented management of NGS-related meta data.
One important advantage of our REST-based prototype is the increasing number of 
RESTful applications and clients that can be easily interfaced in future, for example the 
biobank software OpenSpecimen [9]. HL7 FHIR is an important standard for RESTful 
medical software applications that makes RESTful service-oriented architectures 
increasingly attractive for the data management of a variety of “non-standard” clinical 
data.  
Due to project time constraints, there are some limitations. Today, the prototype is 
not yet in routine use. We collected positive reactions from future users and measured 
decreased processing time, but no systematic study of the effects of the new solution 
has been conducted. Future work will also concentrate upon more sophisticated 
statistical reports for the data.  
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Abstract. The integration of health data systems is an open problem. Most of the
active initiatives are based on the use of standards, each one proposed for a concrete
use, without integrating other needs or standards allowing on homogenous use. We
propose an alternative to get an unified view of health related data, valid for several
uses, that can integrate heterogeneous sources. The proposal set the framework to
integrate the developments made so far to automatically learn the extraction and
conversion of the data. All the sources are integrated under a single access point.
We present the main concepts of EHRagg as a middleware between systems that can
incorporate several sources giving an unified access following the FAIR principles.
Keywords. Health Data, Interoperability, DataMining, Natural Language Processing
1. Introduction
Nowadays the need for interoperability between Hospital Information Systems is obvi-
ous, as it enables patient mobility, not only geographically, but also between medical
services and health care providers.
Many efforts have been made to achieve this interoperability, starting with standard-
ization initiatives (e.g. [9,10]). The main issues with these standards are two: first, there
is no agreement about which one to choose; and second, it is going to take long before
all the systems comply with these standards and become effectively interoperable, due to
the huge efforts required to adapt current ad hoc hospital information systems.
This is a problem that also affects data accessibility, especially in health research,
where data science offers very promising and useful tools ([1,2,3]), but has limited data
to work with. This is due to the lack of integrated and standardized datasets for health
data. Many initiatives to improve the quality and number of sources for research have
been proposed (e.g [4,5,6]). For example, both USA ([7]) and Europe ([5]), have devel-
oped catalogues where researchers can add references to datasets and look for others, but
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Figure 1. Architecture for EHRagg systems
they need to adapt the data or methods to work with each of the datasets. As Schulz et
al. indicate ([8]), although several standards have been developed, they are not generic
enough to be valid for different uses.
Moreover, there is a third variable to add to the current landscape. New personal de-
vices are emerging every day, which gather very useful information about people’s way
of life, but they are developed by private companies under different ad-hoc implementa-
tions, and completely disconnected from the rest of the systems and datasets.
In sum, we are faced with the following circumstances: (1) several sources of infor-
mation, not only from medical institutions, that should be integrated; (2) different access
needs with distinct requirements (personal use, medical use, research purposes,...), espe-
cially regarding privacy protection; and (3) the need for a homogeneous access point for
all this data, with adaptation capabilities (to fit new systems, standards and needs), but
without the need to transfer the ownership of the data.
The main idea is to build what we call an EHR Aggregator (EHRagg) that integrates
the developments made so far (and upcoming ones) to automatically learn how to convert
current information systems into standard systems. This system also includes a layer
that operates as a homogeneous access point to the information stored in all the sources,
without necessarily having to transfer the data, but enabling its processing.
Here we present the concept of EHR Aggregator and the conditions that each ele-
ment should comply with in section 2. Our purpose here is to present the general struc-
ture. In section 3 we put forward our conclusions about how it aims to solve these issues.
2. General Structure
In this section we cover the concept of Electronic Health Record Aggregator. We first
present the idea and the general structure, while the following subsections are dedicated
to describing each of the elements in the structure.
An EHR aggregator (EHRagg), in Figure 1, is a system that acts as middleware be-
tween EHR systems and others with health-related data (e.g. activity, sleep analytics,
etc.) and the users that want to access the information (which can be people or other
systems). It provides a unified view of the underlying Health Data Systems, in the Data
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Layer,?by? learning?automatically,?and? in? the?Extraction?Layer,?by?converting? the? infor-
mation? stored?within.?This?uniform?access?point?allows? the?user? to?query?and? retrieve?
information? from?all?of? the? systems?without?adapting? the?access? to? the?architecture?of?
each?one,?which? is?possible? through? the? Integration?Layer.?This? layer?acts?as?a?unique?
access?point? to?all? the?collected?data? for?external?applications.?To? improve? reusability,?
there?are?platforms?in?this?Access?Layer?that?collect?and?update?the?generic?functions?to?
facilitate?the?implementation?of?external?applications.?Each?of?these?layers?are?discussed?
in?the?following?sections.
2.1.? Data?Layer?(DL)
One?of?the?main?elements?of?the?structure?are?the?sources?of?information.?From?each?one?
we?have? to?obtain?not?only? the?data,?but?also? the?metadata.?We? then?need? to?convert?or?
translate?this?information?in?order?to?integrate?it?into?the?aggregator.
Depending?on?the?type?of?data,?we?can?use?different?functions?to?perform?this?con-
version.?For?example,?the?functions?to?convert?metadata?may?be?different?from?those?to?
convert?data,?and? those?used? for? images?may?be?different? from? those?used? for?medical?
analysis?information.?Each?of?these?functions?are?called?extraction?function?(e?f?).
During? this? process? it? is? essential? to? consider? the? quality? of? the? conversion.? In? a?
perfect?situation,?we?will?translate?the?information?without?any?loss?of?data?or?metadata.?
In?this?case?we?will?consider?a?value?ci
j?=?1,?indicating?a?perfect?conversion.?However,?
in?most?of?cases?we?will?not?have?perfect?conversions,?so?we?shall?indicate?this?using?a?
value?in?the?[0,1]?range.?The?nearer?to?1?the?value,?the?better?the?conversion?is,?and?the?
less?information?is?lost.
2.2.? Extraction?Layer?(EL)
The?most?critical?part?is?to?retrieve?the?data?from?the?source?systems?and?transform?it?so?
that?the?API?(application?programming?interface,?see?next?section)?can?access?all?the?in-
formation.?The?components?in?charge?of?this,?called?e?f? (extraction?functions),?transform?
the?information?stored?in?the?source?systems,?to?allow?the?API?to?work?with?it.
If?the?source?is?based?on?a?health?standard?(e.g.?[9,10]),?the?conversion?may?be?di-
rect?but?not? always? is? so? ([8]).?Most?of? the? current?health?data? systems? are?not? com-
pletely?based?on?standards,?so?we?need?to?adapt?the?data.?So?far,?great?advances?have?been?
achieved?in?standards?compliance.?However,?system?standardization,?in?most?situations,?
is?very?complicated?or,?under?the?best?circumstances,?is?costly?in?time?and?effort.?This?is?
why?we?propose?here?to?get?the?most?of?these?advances?by?using?methods?that?automat-
ically?learn?how?to?perform?the?conversion?from?any?system?to?one?of?the?standards?and?
between?the?standards?themselves.
This?automatic?learning?process?allows?us?to?(1)?directly? integrate?systems?that?al-
ready?comply?with?one?standard;?(2)?reuse?the?learned?transformations?to?apply?them?in?
the? integration?of?other?non-standard?compliance?systems,?and? (3)?keep?open? to? future?
standards,?sources?or?advances?in?integration?or?interoperability.
Depending? on? the? type? of? data,?we?may? define? different? e?f? functions.? For? non-
standard?systems,?the?e?f? need?to?learn?the?structure?of?the?data?(and?metadata)?and?trans-
form?it?to?be?used?by?the?EHRagg.?Most?EHR?systems?are?based?on?semi-structured?do-
cuments?and?we?can?find?several?proposals?in?the?literature?using?Text?Mining?to?extract
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data? from?EHR? (see? [11]).?Other?approaches?are?based?on?Natural?Language?Process-
ing?(NLP)?([12,13,14]).?These?processes?can?be?applied?to?extract?not?only?data?but?also?
metadata.?In?both?cases,? the?proposed?solutions?can?be? tested? to?obtain? information?re-
garding?confidence? in? the?conversion,?and? the?best?algorithm?for?each?concrete? type?of?
data?will?be?chosen.?This?value,?normally? in? [0,1],?provides? the?user?with? information?
regarding? the? confidence?of? the?data?offered?by? the? aggregator.?We? can?define? the? e?f?
function?combining?several?proposals?according?to?the?data?to?be?transformed.
2.3.? Integration?Layer?(IL)
The? IL?has? three?components.?First,? the?API? itself,?with? the?methods? to?access?and/or?
retrieve?the?data?from?EL?and?providing?access?to?the?functions?and?the?working?environ-
ment.?The?authentication?module,?which?controls?and?registers?the?accesses,?configures?
privacy?restrictions,?and?ensures?compliance?with?regulations.?The?last?one?is?the?working?
environment,?where?the?access?platforms?can?process?all?the?data?without?having?to?leave?
the?system,?and?avoiding?the?transfer?of?the?data?to?other?layers.
Through?the?API,?the?user?has?access?to?the?information?stored?in?each?and?all?of?the?
data?sources? integrated? in? the?EHRagg.? It?maximizes?accessibility? to? information,?with?
the?only? restrictions?being? those? imposed?by? regulations? and?privacy?protection? rules.?
Using?this?API?to?develop?their?applications,?users?can?run?queries?over?all?the?data?and?
metadata?available?in?a?homogeneous?way,?regardless?of?where?it?comes?from?or?how?it?
is?stored.?It?is?possible?because?the?API?makes?use?of?the?extraction?functions?to?retrieve?
the?data.
The?second?element?is?the?Authentication?module.?It?has?the?following?functions:?To?
register?all?of? the?data?retrievals,?regardless?of? the?API?used?(authentication?module? in?
Auth?block?(AB));? to?control?privacy?protection?restrictions? imposed?by? the?source? that?
provides?the?data?or?according?to?how?the?data?will?be?used?(privacy?in?AB);?to?adapt?the?
access?point?to?different?regulatory?frameworks?(regulation?configuration?in?AB).
Finally,?we?have?the?working?module,?that?enables?direct?processing?of?data?without?
really?having?the?data.?The?idea?is?to?offer?a?work?space?where,?for?example,?researchers?
can?use? the?API?to? launch? their?methods?and?perform?calculations?on? the?data,?without?
retrieving?the?data?or?transferring?it?from?the?source?institution.
2.4.? Access?Functions?(AF)
The?access?layer?is?used?to?run?queries?in?the?system.?Since?we?are?referring?to?a?large-
scale? system,?we? have? taken? into? account? that? there?will? be? different? access? require-
ments,?depending?on?how? it?will?be?used.?For?example,?research?activities?may?require?
anonymized?data?and?statistical?methods,?while?a?medical?EHR?system?needs?access?to?
detailed? information?of? the?EHR?of?a?concrete?patient?homogeneously,?when? the?data?
in?the?original?sources? is?spread?out?and?fragmented.?Therefore,?as?a?starting?point,?we?
have?identified?at?least?five?types?of?data?use?with?distinct?needs.?These?are:?personal?use?
of?data,?medical?use,?use? for? research,? for?management?and?governance?purposes,?and?
industrial?use.?This?is?not?a?closed?classification,?since?new?needs?may?arise?in?the?future.
Here?we?propose? to?build?an?access?platform?per?use?or?purpose?where,? in?a?simi-
lar?way?to?software?as?a?service?(SaaS)?platforms,?the?most?frequent?operations?will?be?
implemented?for?each?given?use.?This?way,?as?shown?in?figure?1,?they?can?be?reused?by?
external?functions,?applications?and?systems?of?users?with?similar?needs.
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Finally,?external?functions?can?only?access?the?system?through?the?access?platforms,?
which?in?turn?have?access?from?the?working?module?or?directly?through?the?API.?Let?us?
remark?that?in?any?case,?all?of?the?access?points?pass?through?the?authentication?module.
3.? Conclusions
With?the?EHRagg?we?propose?to?address?the?interoperabity?and?accessibility?problem?us-
ing? the?same?pragmatic?approach:? instead?of? trying? to?have?all? the?systems?agree?with?
the?same?standard,?we?propose?a? translation?between?standards,?and?of?systems? to?any?
standard,?reducing?effort?and? time.?It? includes?an? integration? layer? that?acts?as?a?single?
access?point,?offering?an?unified?view?of?the?underlying?data?sources.?This?layer?also?en-
sures?access?control,?privacy?protection?and?adaptation?and?compliance?with?regulations.?
In?addition,? it?has?an?access? layer?especially?designed? to? facilitate? the?development?of?
external?access?functions,?based?on?the?principle?of?reusability.
It? is?an?ambitious?proposal? that?aims? to?centralize?current?efforts? to?accelerate?un-
derstanding?between?health-related?systems.?Here?we?present?the?general?structure?of?the?
EHR?aggregator,?establishing? the?first? steps? to?build?a?unified? framework,?but? there? is?
still?a?lot?of?work?to?be?done.?Some?of?the?current?and?future?lines?of?work?focus?on?the?
study?of?access?time?requirements,?feedback?on?the?e?f? used?to?improve?the?system,?the?
classification?of?access?functions?and?their?assessment?to?be?integrated?in?the?access?plat-
forms.?Nevertheless,?we?believe?this?practical?and?open?approach?can?give?great?results?
in?the?short?and?medium?term.
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Abstract. The geographical imbalance of the healthcare workforce is a social 
problem in Japan. Except for big cities, hospitals have difficulties in securing a 
sufficient workforce to offer healthcare services stably. For local government, 
hospital service suspensions are potentially an essential indicator to figure out the 
capacity of the regional healthcare supply. This paper proposes an algorithm that 
automatically identifies and classifies hospital service suspensions from insurance 
claims data, based on periodicity and similarity. To verify the effectiveness, we have 
applied the algorithm to the insurance claim dataset, which has been provided 91 
regional public insurers in Japan. The case studies have confirmed that the proposed 
algorithm has presented an evidential picture of hospital service suspensions, which 
is potentially useful to understand the actual capacity of healthcare service supply 
in regions.
Keywords. Hospital service suspension, insurance claims data
1. Introduction
The geographical imbalance of the healthcare workforce is a common problem in many
countries. Japan is no exception [1-2]. To tackle this problem, the Ministry of Health, 
Labor and Welfare of Japan has been executing several healthcare policies from 2008
[3]. As a result, the number of health workforce (especially physicians) has been 
increasing. However, a recent study showed that the supply capacity of the health 
workforce was still imbalanced between urban and rural areas in Japan [4]. In addition, 
this study showed that the supply capacity of the health workforce was decreasing in 
rural areas. Except for limited big cities, hospitals have difficulties in securing a 
sufficient workforce to offer healthcare services stably. Hence, understanding the 
balance supply capacity and healthcare demands is crucial for local governments to 
design their healthcare policies effectively.
To figure out the capacity of the regional healthcare supply, hospital service 
suspensions are potentially an essential indicator for local governments. In this paper, 
we present our idea of identifying hospital service suspensions from healthcare insurance 
claims data. Japan has established the universal health insurance system since 1961 [5];
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all the medical services are covered by the public healthcare insurance programs. The 
healthcare insurance claims have the great potential to reveal the hospital service 
suspensions thoroughly and precisely. 
In this study, we propose an algorithm that automatically detects and classifies the 
hospital service suspensions from a large amount of insurance claims data, based on 
periodicity and specificity and present case studies to demonstrate the effectiveness of 
the algorithm. The remainder of the paper is organized as follows. Section 2 describes 
the proposed algorithm, Section 3 presents case studies using four and half years of 
insurance claims dataset, and finally, Section 4 presents conclusions and discussions. 
2. Method 
The algorithm proposed in this paper detects and classifies hospital service suspensions 
from healthcare insurance claims data. The algorithm can be roughly divided into the 
following two steps: Step1; scans the given healthcare insurance claims data and then 
identifies services suspensions of each hospital based on the daily occurrence of medical 
services, and Step2; classifies service suspensions based on the periodicity and the 
similarity of suspension occurrences and the heuristic rules. The following two sections 
describe these steps in detail. 
2.1. Identify hospital service suspension from the healthcare insurance claims data 
Healthcare insurance claims data (standardized in Japan) does not directly contain the 
information of hospital service suspension. Instead, the claims data contain detailed 
information of medical service provision from hospitals to patients. That is, each claim 
records a date, a hospital identifier, a patient identifier and one or more medical service 
codes. Firstly, the algorithm aggregates a large amount of healthcare insurance claims to 
predict off (non-consultation) days of each hospital. Specifically speaking, the algorithm 
calculates, from the insurance claims, a service provision function for each hospital, y(t),  
which denotes the number of patients that the hospital consulted on a date t. Obviously, 
the date t? satisfying y(t) = 0 is highly likely to be an off day for the hospital. Our 
algorithm thoroughly scans the healthcare insurance claims to list all the off days for 
each hospital; if four and more consecutive days are off for a concerned hospital, these 
off days are recognized as a service suspension2. 
2.2. Classify hospital service suspensions 
The proposed algorithm classifies the hospital service suspensions into the following 
four types based on the periodicity and the similarity of suspension occurrences and the 
heuristic rules: (a) apparent service suspensions before hospital open, (b) apparent 
service suspensions after hospital close, (c) anormal service suspensions, and (d) regular 
service suspensions (planned, including weekends and holidays). 
First, by the heuristic rules, the algorithm classifies the suspensions into the before 
hospital open or the after hospital close. If the duration of the suspension is over a month 
                                                          
2 In Japan, many organizations including hospitals are off on Saturday and Sunday, and national holidays 
are often placed on Monday. After intensive exploration, we came to define four and more consecutive off 
days as a suspension to distinguish such weekend off days. 
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and started from the first data of given claims data, the algorithm classifies the suspension 
as the before hospital open. Likewise, if the duration of the suspension is over a month 
and ended on the last date of the given claims data, the algorithm classifies the suspension 
as the after hospital close. 
Next, based on the periodicity and the similarity of suspension occurrences, the 
algorithm classifies the remaining suspensions into the anormal or regular service 
suspensions. Generally, scheduled hospital suspensions would occur at regular intervals 
(weekly, annually)2. Therefore, the algorithm calculates the periodicity pw(t) by using 
the trends and cycles model [7] as follows: 
 y(t)?=?g?t??+?s?t??+?εt,              pw?t??=? ?
yfitted?t?,  ?t ??y?t??=?0?
0,            ?t ??y?t??≠?0?
 (1) 
Where y(t) is the time-series data calculated in Step1, g(t) denotes a constant 
up/down trend, and s(t) denotes the weekly/annually periodic changes. εt denotes error 
terms. yfitted(t) represents a fitting result of the trends and cycles model. 
Furthermore, in Japan, many hospitals schedule their day off around August 14 
(called the “Obon” holidays), despite not national holidays. Such as the “Obon” holidays, 
the suspensions when many hospitals were suspended similarly can be considered as 
scheduled suspension. Hence, the algorithm calculates the similarity sw(t) referring to 
the idf (inversed document frequency) index, which can measure whether a suspension 
is similar (common) or rare: 
 sw(t) = ?
log2 ?
# of suspended hospitals on each date:?t 
# of total hospitals
? ,  ?t ? y?t? = 0?
0,                                        ?                ?t ? y?t? ≠ 0?
 (2) 
Our algorithm classifies the remaining suspension, which contains the four and more 
consecutive days that satisfy pw(t) + sw(t) > 16, as the anormal service suspension. 
Finally, the algorithm classifies the remaining suspension as the regular service 
suspension. 
3. Result 
In our study, we used the insurance claims dataset of 91 regional public insurance 
providers in the Mie prefectural area in Japan. This dataset contained 71.53 million 
claims (1.676 billion records) from March 2013 to November 2017. 
3.1. Case study1: detecting and classifying service suspensions 
First, we applied the proposed algorithm to the dataset. Figure 1 shows an example of 
the visualization result of the suspended dates for each hospital. In Figure 1, the 
horizontal axis represents date t, the vertical axis represents each hospital, and each 
column shows the number of patients who provided medical services on each date. The 
no service provided dates are shown in colored. As shown in Figure 1, in many hospitals, 
the no service provided dates appeared at a cycle of a week. In addition, early May, which 
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has many national holidays, “Obon” holidays and New Year’s holidays showed that 
many hospitals were suspended at the same time.
Table 1 shows the details of the number of suspends detected and classified by the 
algorithm. The algorithm identified 12,813 service suspensions in total, which were 
classified into (a) 12,217 regular service suspensions, (b) 523 anormal service 
suspensions, (c) 26 hospital opens, and (d) 47 hospital closes. The number of service 
suspensions the highest in the urban areas (populations are> = 100K), second in the 
medium areas (populations are <100K and > = 10K), third in the rural areas (populations 
are <10K) for each suspension type.
Figure 1. Example of the visualization of the suspended days (the no service provided dates are colored).
Table 1. Details of the number of suspend detected and classified by the algorithm.
Regular service 
suspension
Anormal service 
suspension Hospital open Hospital close
Urban areas 8,741 428 20 32
Medium areas 3,358 89 6 13
Rural areas 118 6 0 2
Total 12,217 523 26 47
Figure 2 shows the average duration of the regular and anormal service suspensions.
The average duration of the regular service suspensions was 5.37 days in the urban areas, 
being significantly longer than that of the medium areas (5.21 days (p<0.01)) and the 
rural areas. (4.81 days (p<0.05)). On the other hand, there was no significant difference 
in anormal service suspensions (the urban areas: 8.51 days, the medium areas: 10.04 days, 
the rural areas: 8.17 days). Figure 3 shows the average frequency of the regular and 
anormal service suspensions. The average frequency of the regular service suspensions
was 5.90 times in the rural areas, being significantly lower than that of the urban areas 
(11.52 times (p<0.01)) and the medium areas (11.82 times (p<0.05)). On the other hand, 
there was no significant difference in anormal service suspensions (the urban areas: 2.30 
times, the medium areas: 1.93 times, the rural areas: 2.00 times).
Figure 2. The average duration of the service 
suspensions (*: p<0.05, **: p<0.01).
Figure 3. The average frequency of the service 
suspensions (*: p<0.05, **: p<0.01).
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These results show that regular service suspensions tend to shorter and fewer in rural 
areas. This trend indicates that the number of hospitals in rural areas is limited, and there 
are no alternative hospitals in their regions. 
3.2. Case study2: the relationship between the service suspensions and the demand 
behavior 
Next, we analyzed the relationship between the service suspensions and the demand 
behavior of patients. In the dataset, 55 hospitals provided consecutive dialysis treatment 
to 5,450 patients. In these hospitals, regular and anormal service suspension did not occur.
From this result, we confirmed that a stable supply system was established in the 
hospitals that provided continuous dialysis. On the other hand, 144 hospitals provided 
consecutive rehabilitation treatment to 29,513 patients. Of these, anormal service 
suspension occurred in 12 hospitals. 412 patients affected by the service suspensions, of 
which 406 patients were not receiving rehabilitation during the suspensions and 6 
patients were receiving rehabilitation from other hospitals. 
This result shows that the anormal service suspensions could occur even in the 
hospitals that provide consecutive treatments, excepting the hospitals that provide 
treatments, which have a high impact on life support such as the dialysis. 
4.Discussion and Conclusion
In this study, we have proposed an algorithm for detecting and classifying hospital 
service suspensions from healthcare insurance claims data, and then presented the case 
studies, which confirm that the algorithm has effectively presented an evidential picture 
of hospital service suspensions. The present study has been performed with the dataset 
provided by 91 regional public insurers in Japan. We would like to extend the study to 
other regions including metropolitan areas. 
The next possible challenge is to reveal the resilience of the regional healthcare 
system, such as how neighboring hospitals compensate suspended healthcare services. 
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Abstract. In this paper, we propose a new approach for performing privacy-
preserving genome-wide association study (GWAS) in cloud environments. This
method allows a Genomic Research Unit (GRU) who possesses genetic variants
of diseased individuals (cases) to compare his/her data against genetic variants of
healthy individuals (controls) from a Genomic Research Center (GRC). The orig-
inality of this work stands on a secure version of the collapsing method based on
the logistic regression model considering that all data of GRU are stored into the
cloud. To do so, we take advantage of fully homomorphic encryption and of secure
multiparty computation. Experiment results carried out on real genetic data using
the BGV cryptosystem indicate that the proposed scheme provides the same results
as the ones achieved on clear data.
Keywords. GWAS, security, homomorphic encryption, cloud computing
1. Introduction
Nowadays, a large amount of genetic data is available enabling the better understanding
of the human genome, especially by means of genome-wide association studies (GWAS).
The main objective of GWAS is to identify genetic variants associated with some dis-
eases. These studies are mainly based on the statistical analysis of genomic data shared
between a genomic research unit (GRU) who possesses genetic variants of affected indi-
viduals (cases) and a genomic research center (GRC) who has genetic variants of unaf-
fected individuals (controls). Today, GWAS aims at taking advantage of cloud computing
which allows data owners to store and process large amount of data. However, genetic
data externalization raises up many questions in terms of data privacy and confidentiality.
Indeed, with outsourcing an owner loses the control over his data. Even if a service level
agreement has been signed with the cloud service provider (CSP), the user has actually
no other choice than trusting him. In addition, the human genome is a very sensitive. It
is unique to its owner and can give information about his or her relatives, from a clinical
and behavioral point of view. Thus, there is a need for protecting genetic data during
their storage or processing in the cloud. In this work, we are interested in securing the
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collapsing?method?[1],?a?case-control?study?GWAS,?with?as?objective?to?test?whether?the?
proportions?of?individuals?with?rare?variants?in?case?sample?and?control?sample?differ.
Several?solutions?have?been?proposed?so?as? to?perform?privacy-preserving?GWAS.?
The?first?ones?were?based?on?data?anonymization? techniques?such?as?k-anonymity,?but?
have?been?shown?vulnerable?to?many?attacks?[2].?Methods?based?on?differential?privacy?
(DP)? [3]?overcome? these? issues.?DP?adds?a? random?noise? to? real?data? so?as? to?ensure?
individuals’?privacy?but?at?the?same?time?reduces?data?usability.?Homomorphic?encryp-
tion?(HE)?and?secure?multiparty?computation?(SMC)?are?also?used.?HE?makes?possible?
performing?linear?operations?on?encrypted?data?without?decrypting?them?with?the?guar-
antee?that?the?decrypted?result?equals?to?the?one?computed?on?clear?data?[4].?SMC?allows?
several?parties?to?jointly?compute?a?function?over?their?data?while?keeping?them?private?
[5].?There?exist?several?approaches?based?on?secret?sharing,?oblivious? transfer?and?HE?
[6].?Many?HE?and?SMC?based?methods?have?been?proposed? to?secure?GWAS?statisti-
cal?algorithms?used?such?as?χ2−statistic?without?compromising?data?usability?[5,7,8].?In?
this?paper,?we?present?the?first?scheme?that?allows?the?secure?computation?of?collapsing?
method?based?on?the?logistic?regression?model.?It?takes?advantage?of?fully?homomorphic?
encryption,?and?especially?of?the?BGV?cryptosystem?which?allows?encrypting?and?pro-
cess?blocks?of?data,? in?combination?with?SMC.?Contrarily? to? the?previous? schemes,? it?
considers?that?all?user?data?are?outsourced?and?only?returns?to?the?users?whether?the?test?
is?significant?or?not?making?our?solution?more?secure.
The?rest?of? this?paper? is?as? follows.?Section?2?comes?back?on?some?cryptographic?
preliminaries? and?on? the? collapsing?method.?Section?3?presents?our? secure? collapsing?
method.?Experimental?results?and?conclusion?are?given?in?Section?4?and?5,?respectively.
2.? Cryptographic?and?Collapsing?method?preliminaries
2.1.? Homomorphic?encryption?and?secure?multiparty?computation
Homomorphic?encryption?(HE)?allows?performing?linear?operations?(e.g.,?”+”,?”×”)?over?
encrypted?data.?Formerly,? if?E? and?D?denote? the?encryption?and?decryption? functions,?
and?Kp? and?Ks? are? the?public?and? the? secret?keys? respectively,? then? the?homomorphic?
property?states:?D(E(m1,Kp)??E(m2,Kp),Ks)?=?m1?◦?m2?where:??and?◦?are? two?oper-
ators?in?the?encrypted?and?the?clear/decrypted?domains;?m1? and?m2? are?two?plain-texts.?
There?are?three?types?of?HE?cryptosystems:?partially?HE?cryptosystems?(allow?computing?
additions?or?multiplications?unlimitedly);?somewhat?HE?cryptosystems?(allow?a?limited?
number?of?additions?and?multiplications);?and,?fully?HE?cryptosystems?(allow?unlimited?
number?of?additions?and?multiplications).?In?this?work,?we?opted?for?BGV?[9],?a?fully?HE?
cryptosystem?because?of?its?homomorphic?and?batching?properties.?Batching?consists?in?
encrypting?multiple?messages?in?one?with?the?capacity?to?process?each?message.?These?
properties?are?of?importance?in?our?scheme.
2.2.? Collapsing?method
This?method?involves?collapsing?genotypes?across?variants?in?a?specific?gene?and?apply-
ing?a?statistical? test?such?as? logistic?regression.?It? is?a?powerful? tool?for?analyzing?rare?
variants.?Let?us?consider?a?sample?of?N? individuals?constituted?of?N1? cases?and?N2? con-
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trols.?Let?Yj?be?the?disease?status:?Yj?equal?1?if?an?individual? j?is?a?”case”?or?0?if?he/she?is?a?
”control”.?To?perform?the?test,?k?sites?of?the?studied?gene?where?the?variants?of?interest?ex-
ist?are?chosen?by?GRC?and?GRU.?After?this?selection,?a?variable?Xi? is?defined?for?each?in-
dividual.?It?equals?to?1?if?the?individual?i?has?at?least?one?variant?allele?on?any?of?the?k?sites?
or?0?otherwise.?The?detection?of? the?association?consists? in? testing? if? the?proportion?of?
individuals?in?cases?and?controls?differ.?To?do?so,?a?logistic?regression?model?[10]?can?be?
used?where?the?outcomes?are?{Yj} j=1...N? and?the?predictors?are?the?variables?{Xj} j=1...N?.
The?simplified? logistic?regression?model? is?defined?as? logit(p)?=?ln(?1−
p?
p?)?=?β0?+?β1X ,?
where? p? is? the?probability? that?Yj? occurs?and?{βl?}l=0,1? are? the? regression?coefficients.?
These?ones?are?estimated?using?the?log?of?the?maximum?likelihood?function?such?that
l(β ) = log(L(β )) =
N1+N2
∑
i=1
yi(β0+β1xi)−
N1+N2
∑
i=1
ln(1+ exp(β0+β1xi)) (1)
To conduct the collapsing method, two hypothesis tests are considered. The null hypoth-
esis (H0) states that the studied gene is not associated to the disease. In that case, β1
equals to 0 and logit(p) = β0. The alternative hypothesis (H1) informs that there is an
association. β1 is not null and and the logit model remains logit(p) = β0+β1X . Let us
define a, b, c and d as the number of individuals that: have at least one variant allele on
any of the k sites in controls; have at least one variant allele on any of the k sites in cases;
have non variant allele on the k sites in controls and have non variant allele on the k sites
in cases, respectively. In that case, (1) becomes
l(β ) = dβ1+b(β1+β2)− [(a+b)ln(1+exp(β1+β2))]− [(c+d)ln(1+exp(β1))] (2)
This function has a global maximum only if a, b, c and d are different from 0. The
maximization of (2) under H1 gives us βˆH1 = (βˆ0, βˆ1) = (ln(
d
c ), ln(
b∗c
a∗d )) while under
H0, it leads to βˆH0 = βˆ0 = ln(
b+d
a+c ). After estimating regression coefficients, the statistic
test result is given by Stat = 2(l(βˆH1)− l(βˆH0)). This value being distributed according
to the χ2 distribution with 1 degree of freedom (χ2(1)), if Stat > χ2(1), H0 is rejected,
otherwise, we can not decide whether the gene is associated to disease or not.
3. Secure collapsing method
Our framework considers three entities: a Genetic Research Unit (GRU) who owns N1
cases; a Genomic Research Center (GRC) who has N2 controls and a Cloud Service
Provider (CSP). We assume that: i) all data are BGV encrypted and stored by CSP, GRU
and GRC possess their own pair of keys, respectively i.e., (KUp ,K
U
s ) and (K
C
p ,K
C
s ) and ii)
GRU and GRC ask CSP to perform collapsing method on their data. CSP is considered
as ”honest but curious”. It follows the processing steps but may try to infer information
about GRU and GRC data. Herein, we only focus on protecting data confidentiality and
individual privacy. Other data threats are out of the scope of this paper due to space limi-
tation. Because the collapsing method is based on some nonlinear operations that cannot
be achieved with BGV (e.g., division and ln(.) function), a third party entity (TPE) is
introduced. It has also a pair of key (KTp ,K
T
s ). Case data of GRU and control data of
GRC correspond to VCF files. To roughly sum up, one VCF file contains a table the lines
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Cloud Service 
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 Genomic Researcher Center (GRC) 
1. Request: • Collapsing  method
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4. Computation of????? ? ?and????? ?
7. Computation of ???? ? , ???? ?  and
encrypted result ????????? 
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9. Decryption 
GRU public key 
GRC public key 
TPE public key 
 ??? 
5. ?????? ? ??
6. ?????? ? ??
5. ?????? ? ??? 6. ?????? ? ???
8. ?????????
Figure 1. Different steps of our secure collapsing method
of which correspond to the variants and the columns to individuals. Each table element
contains binary values. To benefit of the BGV batching property and of the fact it allows
binary operations, one line is encrypted as a single message. For a test of M variants, we
have two sets of encrypted vectors {EKUp [vcasn ]}n=1...M and {EKCp [vconp ]}p=1...M . As shown
in the Figure 1, our secure collapsing method is conducted in 9 steps as follows.
1. GRU sends a request to the CSP and GRC to initialize the test, specifying the
gene he is interested in.
2. GRU and GRC choose their respective sites of interest and send them to
CSP. They correspond to positions into the vectors {EKUp [vcasn ]}n=1...M and
{EKCp [vconp ]}p=1...M .
3. CSP selects the sites of interest in the stored samples of GRC and GRU and
constructs two encrypted vectors of binary values EKUp [CU ] and EKCp [CC] from
{EKUp [vcasn ]}n=1...M and {EKCp [vconp ]}p=1...M , respectively.
4. CSP computes EKCp [a] = EKCp [∑kCC(k)] and EKUp [b] = EKUp [∑kCU (k)].
5. CSP selects two random values r and r′, computes EKCp [r] and EKUp [r
′] and sends
EKCp [a+r] =EKCp [a]+EKCp [r] to GRC and EKUp [b+r
′] =EKUp [b]+EKUp [r
′] to GRU.
This process corresponds to an additive data masking operation.
6. GRU decrypts EKCp [a+r] and GRC decrypts EKUp [b+r
′]. Both of them re-encrypt
these values using KTp and send the results to CSP.
7. CSP computes EKTp [N1] and EKTp [N2]. With EKTp [a], EKTp [b], it calculates EKTp [c]
and EKTp [d], and interacts with TPE to SMC computes EKTp [Stat] (see Section 2).
8. Thanks to BGV, CSP computes the encrypted sign EKTp [Res] of the encrypted
difference EKTp [Stat−χ2(1)] and sends it to TPE.
9. TPE decrypts Res and sends the decrypted value to the GRU.
As stated in Section 2, the computation of Stat requires the computation of ln(.), a non-
linear function. To secure it, our solution combines homomorphic encryption with an
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original?multiplicative?data?masking.? It?adds?a?noise? that?can?be? removed? thanks? to? ln?
property:?ln(ab)?=?ln(a)?+?ln(b).?Due?to?space?limitation?we?cannot?detail?this?approach.
4.? Experimental?results
Experiments?were? conducted?on? a?genetic? sample?of?57? individuals? (20? cases? and?37?
controls).?These?data?are?extracted?from?a?real?genetic?database.?Data?are?encrypted?using?
the?BGV?cryptosystem?implemented?with?HElib?library.?Our?choice?of?HElib?stands?on?
the?fact?it?optimizes?the?size?of?encrypted?data?to?store?in?the?cloud?thanks?to?batching.?
We? ran? the?proposed?solution?on?a?machine?equipped?with?4?GB?RAM,? Intel?Core? i5-
5200U,?2.7GHz,?running?on?Ubuntu?18.04?LTS.?Execution?time?is?about?15?minutes?with?
no?errors?in?the?test?results?compared?to?the?same?tests?conducted?on?clear?data.
5.? Conclusion
In? this?paper?we?have?proposed? the?first?privacy-preserving?collapsing?method?using?a?
logistic?regression?model.?It?takes?advantage?of?fully?homomorphic?encryption,?of?SMC?
and?multiplicative?data?masking? in?order? to?allow? two?entities? to?compute? this? test?on?
encrypted?data;?data?they?store?in?the?cloud?without?decrypting?them.?This?solution?is?se-
cure?under?the?honest?but?curious?adversarial?model.?Because?our?scheme?makes?no?ap-
proximations,?it?achieves?exactly?the?same?results?as?working?on?clear?data.?Future?works?
will?focus?on?minimising?computation?complexity?by?exploiting?parallel?computing.
Acknowledgement:?This?work?was?granted? to? the?Labex?CominLabs?and?managed?by?
the?French?ANR?in?the?”Investing?for?the?future”?program,?ref.ANR-10-LABX-07-01.
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Semantic Querying of Hospital Data Using an 
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Abstract. This paper focusses on the question of knowledge-based modeling of 
discharge summaries for semantic requesting in the context of hospital reporting 
process. An ontology was designed and implemented to capture patient data and 
required expert knowledge. The modeling process was carried out manually using 
Protégé after an initial reverse engineering of the official format of discharge 
summaries. An OWL 2 model was built integrating discharge summaries ontology 
and ICD 10 hierarchy. The framework is operationalized using the OpenLink 
Virtuoso database system (RDF store), enabling SPARQL queries and basic 
reasoning features. The evaluation was performed by implementing a use case based 
on patient comorbidities. 
 
Keywords. Ontologies, OWL, RDFS, RDF, ICD 10, Protégé, OpenLink Virtuoso 
 
 
1. Introduction 
 
Hospital stakeholders need business reports for medical activity analysis, decision- 
making and strategic planning of care. Although data analytics are valued when they are 
simple, concise and relevant, their production remains a complex task, requiring 
manipulation of referential data such as diseases and procedures that are coded using 
standard terminologies. ICD 10 codes [1], used in this context to express principal and 
secondary diagnosis, refer to detailed descriptions of disorders. These fine-grain codes 
are inappropriate for business reporting because they do not respond to the “summary” 
feature of hospital indicators. In order to overcome this issue, data scientists map ICD 
10 codes to high-grain terms that are more relevant to describe care chains and in-hospital 
pathways. One example of such a situation is medical activity reporting according to the 
acuteness/chronicity of diseases or their anatomical location. Such reporting processes 
require concrete substantial intervention of domain experts to build code glossaries. The 
weaknesses of this process consist in: (1) the dependence on domain expert knowledge 
and points of view; (2) the deprecation of used codes that require verification over time; 
and (3) the lack of semantic mapping between different glossaries. This observation led 
us to consider that building sustainable reporting services cannot rely solely on data 
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management strategies. A better and simpler method should take a comprehensive 
approach covering the management and formalization of underlying knowledge. The 
objective of this work is to build and operationalize a knowledge-based model of 
discharge summaries that enables semantic queries regarding basic properties of disease 
terminology such as their hierarchical organization. 
 
 
2. Material and methods 
 
2.1. Discharge summaries data and ICD 10 hierarchy 
 
Discharge summaries are created for each hospitalization [2]. Collected data cover 
administrative information such as date of entry and discharge, diagnosis information 
coded with ICD 10, procedures information coded using CCAM [3], and finally the 
Groupe Homogène de Malade (GHM), which is the equivalent of the diagnosis-related 
group. These data are uploaded monthly to a government agency named the Agence 
Technique de l’Information sur l’Hospitalisation (ATIH) to issue activity-based 
payments. Data are also stored in local databases for hospital reporting and evaluation 
studies. An official format of data is published by the ATIH providing a technical 
description of data to be transmitted: position, definition, type and sometimes range of 
possible values. Two types of data elements are distinguishable: referential data to be 
coded according to defined terminologies; and non-referential data that refer to 
elementary data type values such as integer, date or string. 
This work focuses particularly on ICD 10, as it is the standard resource for disease 
coding. The strengths of this terminological resource are: (1) the amount of data coded 
with this resource; (2) its complete coverage; and (3) the hierarchical granularity of dis- 
ease descriptions. The weaknesses of ICD 10 are: (1) some inconsistencies in chapters 
and subchapters as grouping nodes; (2) the lack of defining properties of terms; (3) in- 
sufficient semantic mapping procedures between different terms (i.e. etiology/manifes- 
tation) pertaining to its hierarchical nature; and (4) periodic updates possibly modifying 
the hierarchy and/or the meaning of terms [4]. 
 
2.2. Ontological modeling principles of discharge summaries using OWL 2 
 
Ontologies provide a formalized and shared vision about domain concepts, properties 
and their semantic relations [1]. They provide a modeling framework to simultaneously 
express data and knowledge. Their usefulness consists in enabling reasoning features on 
complex assertions about properties and consistency checking. The ontological 
principles assumed in our modeling process are: (1) considering data elements in the 
official format as domain concepts expressed with “owl classes”, (2) discharge 
summaries data as instances expressed with ‘owl individual’, (3) elementary data types 
as ‘owl data properties’ and (4) referential data as ‘owl data object properties’. We started 
by reverse engineering data formats. This generated a raw OWL ontology containing the 
classes and object properties. This ontology was then refactored manually to add 
definition domains and ranges. 
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Figure 1 the OWL 2 model of discharge summaries description visualized using Protégé. 
 
 
2.3. Intermediate model of the ICD 10 
 
While terminology modeling has been addressed in detail [4,5], we focused on using the 
ICD 10 for its semantic information, e.g. its hierarchy, articulated with the data and al- 
lowing for semantic queries [6]. To this end, several issues had to be overcome: not only 
is the ICD 10 adapted for the French prospective payment system with extended codes, 
but this variant is also updated annually on March 1st, so an annual report should take 
into account two versions, not to mention multi-annual reporting. 
Building on the current model of the ICD 10 released by the Organisation Mondiale 
de la Santé (OMS) [7] and expressed in SKOS [8], we designed an intermediate model 
by combining it with the French specific material: 
• We retained only the hierarchical structure of the OMS (skos:broaderTransitive 
and skos:narrowerTransitive), stripping all other information (i.e. icd:classKind 
icd:CodingHint) apart from skos:preflabel, replaced by its French translation; 
• Two elements were added as properties: the ICD 10 code (icdfr:code) formatted 
according to the French convention (code without dot); and the hierarchical 
level of the code (icdfr:nivH), starting from 1 for the chapter level. This infor- 
mation was grouped as properties of a resource <info>, <info> being itself a 
property of the ICD term resource; 
• Starting from the 3 digit codes, we appended the French codes (e.g. including 
their extensions) and their hierarchical level. At this stage we had a complete 
French version of the ICD 10; 
• Finally, we implemented a resource <version>, as a property of the <info> re- 
source. <version> was designed with a start date, an end date and a version 
identifier. It was then possible to manage validity periods of the versions. 
It is possible with Virtuoso to implement skos:broaderTransitive and skos:narrower- 
Transitive through “rule sets” associated to graphs [9]. We implemented the ICD 10 hi- 
erarchy using this functionality. 
Discharge 
summaries 
instances 
Property 
assertions 
Inferred 
types 
Diagnosis Classes 
Inferred property 
assertions 
Data Properties 
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2.4. Ontology population, data querying and reporting framework 
 
The reporting framework was implemented based on OpenLink Virtuso, installed on a 
Windows 2012R2  Server running on an Intel  Xeon E5 processor with 16 Go of 
RAM.  
       We uploaded around 340,000 triplets corresponding to the 70,000 discharge sum- 
maries of the Nîmes University Hospital for the first semester of 2019, which required 
querying both ICD 10 French version 2018 and 2019. 
As an example, the following query retrieves in less than a second the number of 
discharge summaries by the ICD 10 codes of hierarchical level 2 their principal diagnosis 
is related to: 
SPARQL DEFINE input:inference <http://localhost:8890/HIER> 
PREFIX icdfr: <http://simmer.chu-nimes.fr/icd-fr-schema#> 
PREFIX rss: <http://simmer.chu-nimes.fr#rss-schema> 
SELECT DISTINCT ?ch ?lh (COUNT(DISTINCT ?NumRSS) AS ?NbRSS) 
FROM <http://localhost:8890/RSS2019M06> 
FROM <http://localhost:8890/REF> 
WHERE 
{ 
?x rss:hasValue_NumRSS ?NumRSS . 
?x rss:has_DP ?d . 
?d icdfr:info ?i . 
?i icdfr:code ?c . ?i skos:prefLabel ?l . 
?i icdfr:version ?v . ?v icdfr:ddv ?dd . ?v icdfr:dfv ?df . 
?i skos:broaderTransitive ?ih OPTION (TRANSITIVE) . 
?ih icdfr:code ?ch . ?ih skos:prefLabel ?lh . 
?ih icdfr:nivH 2 . 
?x rss:hasValue_DS ?ds 
FILTER 
(?dd <= ?ds && ?ds <= ?df) 
} 
GROUP BY ?ch ?lh 
ORDER BY DESC(?NbRSS) 
The combination of the skos:broaderTransitive property and the icdfr:nivH property 
ensures the determination of the level of aggregation. We used the R software to query 
the Virtuoso server and format and deliver the results. 
 
 
3. Results and discussion 
 
An ontology model of French discharge summaries was developed and expressed in 
OWL 2 formalism. This model is populated with large datasets available for requesting 
through SPARQL endpoint. SKOS model is used to implement the ICD 10 hierarchy. 
The whole framework supports hospital automatic reporting according to multiple 
criteria. Requesting data according to ICD 10 chapters or subchapters (intermediate 
codes that are not directly used in coding) was carried out taking advantages of reasoning 
features such as relation transitivity and “is-a”-property heritage. 
This first step work shows the technical feasibility of the framework and lays out a 
path for sustainable hospital reporting services, through a sound methodology of data 
and knowledge management. Nevertheless, achieving such a purpose requires handling 
subsequent issues such as knowledge acquisition and knowledge sources consistency 
management. 
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To take into account the deeper properties of diseases will need the formalization 
of a knowledge-acquisition process. This raises the question of available disease 
knowledge sources and their evolution over time.  
Protégé™ and OpenLink Virtuoso™ database systems are useful tools that help 
respectively to build the model and to operationalize the RDF database system. It would 
be useful if all Protégé reasoning features were implemented in Virtuoso™ and inversely 
if Virtuoso™ OWL model could be visualized via Protégé™ without ad-hoc 
developments. 
 
 
4. Conclusion 
 
Envisioning hospital reports through knowledge-engineering techniques has proven very 
fruitful, with already actionable results after this first round of exploration and 
development. This work enables us to identify the issues we need to explore further: 
enhance and refine the ontology of the discharge summaries in order to take into account 
not only the medical dimension but also other aspects (e.g. geographical origin of the 
patients and information about the hospitals); and expand the terminology modeling (e.g. 
procedure terminology) using the strategy we have defined to take into account the 
different versions. 
Finally, we plan to study the national database using this approach in order to explore 
its capacity as an instrument for health resource usage analysis. 
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Supervised Bayesian Statistical Learning to 
Identify Prognostic Risk Factor Patterns 
from Population Data 
Colin J. CROOKSa,1 
a University of Nottingham, UK 
Abstract. Current methods for building risk models assume averaged uniform 
effects across populations. They use weighted sums of individual risk factors from 
regression models with only a few interactions, such as age. This does not allow 
risk factor effects to vary in different morbidity contexts. This study modified a 
supervised Bayesian statistical learning method of topic modelling, allowing 
individual factors to have different effects depending on a patient's other 
comorbidity. This study used topic modelling to assess more than 71,000 unique 
risk factors in a population cohort of 1.4 million adults within routine data. The 
model learnt prognostically important risk factor patterns that predicted 5 year 
survival, and the resulting model achieved excellent calibration and discrimination 
with a C statistic of 0.9 in a held out validation cohort. The model explained 92\% 
of the observed variation in 5 year survival in the population. This paper validates 
using survival supervised Bayesian topic modelling within large routine electronic 
population health data to identify prognostically important risk factor patterns. 
Keywords. Latent Dirichlet allocation, topic modelling, Bayesian modelling, 
electronic health records, co-morbidity 
1. Introduction 
To understand the effects of large numbers of individual factors, and how these vary in 
different combinations, requires a different approach from weighted linear summations 
of small numbers of individual factors common in current prediction models. Methods 
are needed in which risk factors are modelled by their observed patterns, rather than as 
individual factors. Bayesian statistical learning methods using topic modelling provide 
a more interpretable alternative to current machine learning methods for identifying 
unknown patterns in data[1] By using mixtures of risk factor patterns, risk factor 
effects can vary in different patients depending on the co-occurrence of other factors. 
This reflects the heterogeneity observed in the general population. Importantly, it has 
an advantage of transparency through the interpretable intermediate step of topics 
constructed from risk factor patterns. Topic modelling also has computational 
advantages through Bayesian learning, as it can process larger numbers of codes, whilst 
it incorporates priors to reduce over fitting where the data is sparse. Importantly, topic 
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modelling can be supervised by outcomes, including survival time [2, 3]. The aim of 
this study was to assess the feasibility of using survival supervised topic modelling to 
predict mortality from unselected population based routine health data through learning 
prognostically important morbidity patterns. 
2. Methods 
The study cohort consisted of all adults in the English population over 18 years who 
were alive and registered on 1st January 2010 to the Clinical Practice Research 
Datalink (CPRD, protocol number 16_269R was approved by the Independent 
Scientific Advisory Committee (ISAC)). All their routine primary care (diagnostic 
Read codes from the CPRD clinical file) and secondary care (ICD 10 diagnostic codes 
from linked Hospital Episodes Statistics (HES)) data recorded prior to 1st November 
2009 were included in the study with no filtering. The two month exclusion window 
avoided including codes related to a final illness event. All deaths from this cohort 
were identified for the study outcome between 1st January 2010 and 1st January 2015. 
Each diagnostic code was weighted with the frequency with which it was recorded in 
the data for the year prior to 1st November 2010.  Age was adjusted within the baseline 
hazard by setting age as the origin of follow up time. The cohort was divided randomly 
into a 50% training cohort, 25% testing cohort and 25% validation cohort using simple 
random sampling.  
2.1.  Bayesian statistical learning model - Survival Supervised Topic Modelling 
Blei et al developed the initial Latent Dirichlet allocation method for categorising 
documents based on associating word frequency combinations with unobserved (or 
latent) topics[1], and observed topics (supervised allocation)[2]. For this study topic 
modelling was supervised by censored survival data, using cumulative risks predicted 
from survival models as previously described [3]. However, to scale this up to large but 
noisy and sparse electronic health record data, with tens of thousands of unique codes, 
this study integrated 2 further modifications into the algorithm: 1) An asymmetric 
Dirichlet prior that was learnt from the data, promoting uninformative but frequently 
occurring codes to be allocated into uninformative baseline topics, 2) A penalised Cox 
proportional hazards model fitted via a coordinate descent algorithm to improve 
stability, with automated centering of topics based on the current topic allocations.  
2.2. An asymmetric Dirichlet Prior learnt from the data 
High frequency but uninformative terms can, by their association with other terms, 
become allocated to informative topics. To reduce this an asymmetric prior for 
document level topic distributions was learnt from the word topic allocations [5]. This 
allowed some topics within the model to automatically form baseline topics with a 
higher prior Dirichlet probability, thus promoting patients with few or uninformative 
risk factors to be allocated to these baseline topics along with their uninformative risk 
factor combinations. This topic prior was given a Dirichlet distribution learnt using the 
Newton-Raphson method [5]. The baseline topic with the highest prevalence, i.e. the 
highest number of words assigned to it was allocated a zero coefficient in the Cox 
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model for each iteration. This aided the convergence of the Cox model by keeping the 
topic simplex centered. 
2.3. A penalised proportional hazards model via a coordinate descent algorithm 
To improve stability a penalty was introduced to the Cox model, shrinking coefficients 
towards the null, reducing instability, and preventing over-fitting where the data are 
sparse. Within the learning algorithm each topic is required to retain some level of 
probability, therefore L2 regularisation (or ridge regression) rather than L1 (Lasso) 
weighting was used [4]. Cyclic coordinate descent was used to fit the Cox model and 
the latent Dirichlet algorithm, as the large number of parameters was prohibitive for 
matrix inversion [4]. This also allowed coarse parallelisation of the document level 
updates.  
3. Results 
The topic model algorithm described above was applied to an unselected population 
cohort of training 712,868 patients derived from linked primary and secondary cared 
data from the English Clinical Practice Research Datalink for a range of numbers of 
topics from 10 to 200. The model was fitted to predict five year survival from patients 
alive on the 1st January 2010 using over 71,141 unique diagnostic codes available prior 
to 1st November 2009. The model converged on average in under 20 iterations. In 
addition to varying the topic number, a range of L2 penalties was assessed from 10
−4
 
to10
4
, with the best fitting selected by out of sample likelihood in cross validation 
during the maximisation step. 
 
3.1. Model parameter selection 
The model learnt in the training cohort was applied to the testing cohort of 356,482 
patients, and the perplexity calculated as a measure of model fit perplexity is shown in 
figure 1. Perplexity is an average of the inverse likelihood per code, and the lower the 
perplexity the better the model fit. Figure 1 shows that model fit increased rapidly with 
an increase in topic number, but after 90 topics this plateaued. A fixed penalty of 0.01 
was the minimal value that aided convergence in the test data and was selected as the 
L2 penalty. Fifty three of the topics were significantly associated with survival (p<0.05 
likelihood ratio test), and the remainder were null and uninformative.  
The topics generated by the latent Dirichlet allocation demonstrated recognisable 
combinations of risk factors that cut across different disease categories to define 
clinically recognisable frailty and multi-morbidity types. Summaries of three of 
selected topics that were strongly associated with survival are shown in (table 1).  
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 Figure 1. Model fit by number of topics in the testing dataset (lower is better) 
 
Table 1. ICD and Read code descriptors with high probabilities for three example learnt topics that were 
strongly associated with survival 
Summary  Cardiac disease, 
housebound, limited 
mobility and constipation 
Cataract, falls, 
osteoporosis, fractures and 
UTI, 
Chronic leg ulcers and 
nursing care 
  Congestive 
heart failure 
 Hypertension  Dressing of wound 
Read and 
ICD 10 
code 
descriptors 
 
 
 
 
 
 
 Syncope and 
collapse 
 Cataract  Nursing care - 
dressing 
 AF & flutter  High BMI  Leg ulcer NOS 
 COPD  Fall-accidental  Cellulitis NOS 
 Senility  Dementia   Dressing of ulcer 
 Living alone  UTI  Wound healing 
 Constipation  Osteoporosis  Change of dressing 
 Housebound  Fracture neck 
of femur 
 Wound 
observation 
3.2. Validation and calibration 
The 90 risk factor topics that were learnt by the model in the training cohort were 
applied to the held out validation cohort (n=356,473 patients) using the inference 
algorithm as described by Blei et al [1], adjusted for age (in 10 year age bands) and 
gender. This model demonstrated a 1 year discrimination with a C statistic of 0.925 
(95% confidence interval 0.921-0.929), which reduced to 0.908 (0.906-0.910) by 5 
years. The average observed survival for each centile of the predicted topic model is 
plotted in figure 2. This showed excellent calibration across the range of predicted 
survival. 92% of the observed variation in 5 year survival was explained by the model 
(R
2
 adjusted for censoring).  
4. Conclusion 
Topic modelling provides a novel Bayesian statistical learning approach to learn 
prognostic patterns of risk factors from routine health data, and this study demonstrates 
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it can be successfully adapted to censored electronic health records. This study 
confirmed the importance of using risk factor patterns to model risk rather than 
individual risk factors, and demonstrated how these different patterns of coding can be 
captured automatically. One limitation is the model assumed learnt patterns were 
independent from each other, and further work will incorporate a correlated topic 
model. However, the current method identified clinically recognisable risk factor 
patterns of multi-morbidity and frailty that would not be included in standard co-
morbidity scores. This approach could be applied to identify cross cutting morbidity 
patterns that are necessary for prediction models with the increasing complexity of 
multi-morbidity in the population. The C++ code underlying this paper can be accessed 
at doi.org/10.5281/zenodo.1045521 or 
github.com/ColinCrooks/SurvivalSupervisedLDA.  
 
  
Figure 2: Calibration curve of the fitted model to the held out validation cohort 
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Abstract. Automatic detection of ICD-10 codes in clinical documents has become
a necessity. In this article, after a brief reminder of the existing work, we present
a corpus of French clinical narratives annotated with the ICD-10 codes. Then, we
propose automatic methods based on neural network approaches for the automatic
detection of the ICD-10 codes. The results show that we need 1) more examples
per class given the number of classes to assign, and 2) a better word/concept vector
representation of documents in order to accurately assign codes.
Keywords. ICD-10 coding, clinical NLP, clinical narratives, French
1. Introduction
Automatic coding of clinical narratives in French with the International Classification of
Diseases, 10th revision (ICD-10) has become a necessity, as ICD-10 is used for billing,
epidemiology survey and many other tasks. In this work, we present 1) a corpus with
French clinical documents annotated with the ICD-10 codes, and 2) methods relying on
neural networks for document-level classification. Given the difficulty of this task, the
aim of our work is to create a tool that suggests relevant codes to human coders.
Several shared tasks are related to the ICD coding. The first of the kind, Computa-
tional Medicine Challenge [1] in 2007, was dedicated to the assignment of the ICD-9-
CM codes to clinical narratives (radiology reports). While [2] is the first work on ICD
coding in French, since 2016, CLEF eHealth offers a clinical information extraction chal-
lenge which aim is to extract ICD-10 codes from health reports. Recently [3,4,5], the
Ce´piDC task consisted in extracting ICD-10 codes from death reports in several lan-
guages (French in 2016, French and English in 2017, French, Hungarian and Italian in
2018). In 2019 [6], the task involved the automatic annotation of German non-technical
summaries of animal experiments with ICD-10 codes. The 2020 task will focus on ICD-
10 coding for clinical narratives in Spanish. As we are working with French clinical
documents, we next describe the 2018 French data and the most efficient systems.
The French death certificates are stored in two files: one raw text file in which the
physician writes the report (raw causes) and one file containing the corresponding ICD
codes (computed causes). The computed causes file might contain the text supporting
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line text normalized text ICD codes
1 choc septique choc septique A41.9
2 peritonite stercorale sur perforation colique peritonite stercorale K65.9
2 peritonite stercorale sur perforation colique perforation colique K63.1
3 Syndrome de de´tresse respiratoire aigue¨ syndrome de´tresse respiratoire aigue¨ J80.0
Table 1. A sample document from the Ce´piDC French Death Certificates Corpus: aligned dataset [5]
Aligned Raw
Team Precision Recall F-measure Team Precision Recall F-measure
IxaMed-2 .841 .835 .838 IxaMed-1 .872 .597 .709
IxaMed-1 .846 .822 .834 IxaMed-2 .877 .588 .704
IAM-2 .794 .779 .786 LSI-UNED-1 .842 .556 .670
IAM-1 .782 .772 .777 LSI-UNED-2 .879 .540 .669
Table 2. Best CLEF eHealth 2018 results on the raw and aligned French dataset [5]
the coding decisions. Two datasets were provided for this task: one raw and one aligned.
The raw dataset contains the original death certificates and the corresponding computed
causes. The aligned dataset contains per line: raw text, normalized text and the corre-
sponding ICD code, as exemplified in Table 1.
The IxaMed team [7] used a language-independent solution in which a neural
sequence-to-sequence modeling system encodes a variable-length input sequence of to-
kens into a sequence of vector representations, and decodes those representations into
a sequence of output tokens (the ICD10 codes). As shown in Table 2, IxaMed got the
best results on the aligned and raw datasets. The IAM-ISPED team [8] used a dictionary-
based approach to assign ICD-10 codes to each text line, and Levenshtein distance and
synonym expansion system to detect typos. IAM-ISPED got the second best score on the
aligned dataset and third on the raw dataset. The LSI-UNED team [9] submitted two runs
for each dataset. Their best run used a multilayer perceptron and an One-vs-Rest (OVR)
strategy supplemented with IR methods. The models were trained with the training data
and dictionaries of Ce´piDC, estimating the frequency of terms weighted with Bi-Normal
Separation (BNS). LSI-UNED was the second best system on the French raw dataset.
The task addressed during this challenge is interesting although the death certifi-
cates cannot be considered as free-text but rather as controlled text documents. This is
especially true for the aligned dataset, which makes it very convenient for the methods
proposed during the challenge. In this work, we use clinical narratives containing mostly
free-text, therefore, the methods used during the challenge are not appropriate.
2. Method
Dataset. Our dataset contains 28,000 clinical documents from the Rennes university
hospital. Each document contains one or several notes for a single patient issued from a
single stay at the hospital. Table 3 presents statistics on our corpus. As it shows, although
the tokenization methods might differ, our documents are much longer than death certifi-
cates. Indeed, the latter only contain on average 3 lines, 10 tokens and 4 ICD codes per
document while our clinical narratives have on average 1,345 tokens per document and
twice as many codes. It also shows that a majority of ICD codes have very few examples
in the corpus which will be an issue for the deep learning methods. A typical document
describes the patient’s medical history, reasons for hospitalization, laboratory measure-
ments, findings, treatment and conclusion. Our set of data also contains some noise (e.g.
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Training Development Test Total
Documents 22,400 2,800 2,800 28,000
Tokens 30,307,091 3,718,715 3,654,599 37,680,405
Total ICD codes 182,112 23,010 22,561 227,683
Unique ICD codes 5,735 2,824 2,887 6,116
Unique unseen ICD codes - 191 212 -
Codes with less than 10 examples 3,885 2,320 2391 -
Codes with 100 examples or more 382 32 31 -
Table 3. Descriptive statistics of the Rennes University Hospital dataset
phone numbers, names, email addresses, titles, etc.) which was not preprocessed. As our
data contain confidential medical information, we cannot show any examples.
Tasks. The first task addressed is the multi-label classification done on a document level
for all codes. As Table 3 shows, there are 6,116 different classes (ICD codes) to identify:
5,735 codes are present in the training set among which 3,885 examples have less than
10 examples. For the second task, we reduced the hierarchical level of the ICD-10 codes.
All codes with 3 digits and more were reduced to 2 digits: A01.3 Paratyphoid fever C
becomes A01 Typhoid and paratyphoid fevers. Therefore, only codes A00 to Z99 are
exploited, which decreases the number of classes to 1,549 overall, among which 1,501
are present in the training set.
Methods. The purpose of our work is to design an approach for the automatic and ef-
ficient detection of the ICD codes. The approaches proposed and tested rely on specifi-
cally trained word embeddings and supervised learning techniques. In the existing work,
various methods have been used to represent words as vectors. Recently, several machine
learning-based approaches have been introduced for a better representation of semantic
relations between words. We experiment with fastText vectors [10], which use subword
information to represent words missing in the training vocabulary. Each word is repre-
sented as a bag of all possible n-grams of characters it contains. Our model is trained
on our dataset with the Skip-Gram algorithm, 300 dimensions, a window of 5 words be-
fore and after each word, a minimum count of five occurrences for each word and nega-
tive sampling. Besides, we experiment with two neural network architectures: recurrent
and convolutional. A recurrent neural network is a class of network which is capable of
adapting its decision by taking into account the previously seen data, in addition to the
currently seen data. This operation is implemented thanks to the loops in the architec-
ture of the network, which allows the information previously seen (previous words) to
persist in memory. In our experiments, we used a bidirectional recurrent neural network
with long short-term memory cells (BiLSTM). Convolutional neural networks (CNN)
are widely used in Computer Vision and Natural Language Processing. The convolution
layer consists of a set of filters, where each filter is convolved with the input forming
feature maps. These filters are randomly initialized and become parameters that will be
learned by the network.
Experiments. We trained several CNN models based on the architecture proposed in
[11] for 30 epochs. We used four filter windows (2, 3, 4 or 5 width) with either 100, 500,
1,000 or 2,000 feature maps each (ReLU activation), 0.5 dropout, global max pooling and
a fully connected layer with ReLU activation of either 100, 1,000 or 2,000 dimensions
for a more compact representation. Regarding our BiLSTM, the dimensionality of the
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output?space?was?set?to?600?units?per?layer?(backward/forward)?with?0.5?dropout.?Both?
architectures?use?our?pre-trained?fastText?vectors?with?0.5?dropout?and?a?fully?connected?
sigmoid?layer?for?prediction.?Performance?was?measured?with?the?standard?metrics:?pre-
cision,?recall?and?F-measure.
3.? Results
As?Table?4?shows,?on?both?tasks,?our?CNN,?even?at?the?lowest?settings,?performs?better?
than? our?BiLSTM.?Our? experiments? also? show? that? increasing? the? number? of? feature?
maps?per?convolution?filter?and?hidden?units?in?the?fully?connected?layer?both?improves?
the? results.? Indeed,?we?get?an?8.21?point? increase?at? the?most?expensive?settings?when?
compared?to?the?lowest?settings.?We?might?be?able?to?slightly?improve?the?results?if?we?
raise?parameters? further.?However,? it?would?be?a? low? increase?with?a?great?computing?
cost.? Indeed,? the? results? on?Task? 2? show? a? very? low? improvement? (0.28? point)?when?
doubling?the?value?of?the?parameters.
System Feature maps Hidden units Precision Recall F-measure
Task 1
BiLSTM - 600 0.6513 0.1387 0.2287
CNN 100 100 0.6510 0.2091 0.3165
CNN 100 1,000 0.4916 0.2491 0.3306
CNN 500 100 0.5624 0.2652 0.3605
CNN 500 1,000 0.4935 0.3042 0.3763
CNN 1,000 100 0.5353 0.2597 0.3498
CNN 1,000 1,000 0.5052 0.3200 0.3918
CNN 2,000 2,000 0.5029 0.3301 0.3986
Task 2
BiLSTM - 600 0.6309 0.2837 0.3914
CNN 1,000 1,000 0.6306 0.4427 0.5202
CNN 2,000 2,000 0.6018 0.4625 0.5230
Table 4. Results for the ICD coding tasks. The results are given in terms of Precision, Recall and F-measure.
The best scores are in bold.
4. Discussion
As expected, we get better results on our second task which shows that the reduction of
the number of classes is efficient. However, as we can only assign each class once to a
document, we might lose some information as a document can have multiple codes be-
longing to the same hierarchically higher class. Besides, we get much lower results than
the systems presented at CLEF eHealth 2018. This can be explained by the nature of the
documents: short, structured death certificates cannot be compared to clinical narratives
with free text. The tasks are therefore different. Another explanation is that some codes
might not be explained by the textual data but rather by the structured data in the hospital
database.
5. Conclusion
The interest for the automatic detection of ICD-10 codes has increased in recent years.
Yet, the data used in previous shared tasks do not seem representative of real clinical
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narratives.?In?our?work,?after?a?brief?reminder?of?the?existing?work,?we?presented?a?new?
body?of?French?clinical?narratives?annotated?with?the?ICD-10?codes.?Another?contribu-
tion?of?our?work?is?the?exploitation?of?fastText?vectors?and?neural?networks?for?the?auto-
matic?ICD-10?coding.?The?experiments?are?conducted?and?evaluated?on?French?clinical?
narratives? (free-text),?which?have?not?been?experienced?much? in? the?previous?work?of?
this?type.?From?a?more?technical?point?of?view,?our?work?also?indicates?that?the?convo-
lutional?neural?architectures?are?more?efficient?than?the?recurrent?neural?architectures?for?
the?multi-label?classification.?We?plan? to? improve?our?neural?network?performance?by?
providing?a?richer?feature?set.?Indeed,?adding?available?structured?data?and?using?recent?
embedding?techniques,?such?as?BERT?[12],?may?provide?more?accurate?representation?of?
the?documents.
	
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Abstract. Recent studies in the biomedical domain suggest that learning statistical 
word representations (static or contextualized word embeddings) on large corpora 
of specialized data improve the results on downstream natural language processing 
(NLP) tasks. In this paper, we explore the impact of the data source of word 
representations on a natural language understanding task. We compared embeddings 
learned with Fasttext (static embedding) and ELMo (contextualized embedding) 
representations, learned either on the general domain (Wikipedia) or on 
specialized data (electronic health records, EHR). The best results were obtained 
with ELMo representations learned on EHR data for the two sub-tasks (+7% and 
+4% of gain in F1-score). Moreover, ELMo representations were trained with only 
a fraction of the data used for Fasttext. 
Keywords. Natural Language processing, Contextual word embeddings, Natural 
language understanding 
1.Introduction 
The recent advances in language representation such as static word embeddings [1,2], 
and contextual word embeddings (e.g. ELMo[3]) led to a significant performances 
improvement in natural language understanding (NLU). These methods can take 
advantage of large text corpora to learn a representation of the vocabulary in the vector 
space according to words semantics and syntactic use[1]. These approaches are 
unsupervised: they do not require learning datasets with manual annotations. However, 
the training corpus must be large enough to learn a correct representation. For example, 
it is customary to use a full dump of Wikipedia® to learn the models[1–3]. In the 
biomedical domain, the vocabulary is very specific. Moreover, when looking at clinical 
reports in electronic health records (EHRs), the syntax is also different from articles from 
sources similar to Wikipedia. A recent study from Wang et al.[4] evaluated the 
performances of embeddings learned on Wikipedia, biomedical publications and clinical 
notes in English : learning embeddings using clinical notes from EHRs increased the 
performances. Would this improvement also be true for contextual word embeddings? 
Nonetheless, it may be challenging to have access to the large number of documents 
requested (e.g. more than 100k patients in the study of Wang et al.) or even have 
access to embedding matrices learned on such corpus, due to privacy issues. It is 
possible that using more advanced methods to learn the word representations such as 
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ELMo compared to static embeddings would allow researchers to use embeddings 
learned on general domain corpora and still obtain good performances. 
The aim of this work is to explore the impact of the method and data source of 
embeddings in the context of a weakly supervised NLU task in French. For this task in a 
restricted domain (biomedicine), we focused on the two NLU tasks: slot-filling and intent 
classification. 
More specifically, this task aims at providing NLU in a virtual assistant in French 
for clinicians to explore biological tests results information in the patient’s record in 
natural language (e.g. Donne moi le dernier résultat de créatinine ‘Give me the last result 
of creatinin’). The set of queries that a physician may have about characteristics and 
results of a patient is broad and diverse. Therefore, enabling queries in natural language 
may help accessing information more efficiently. Given that no public dataset is available 
for this task in French, we used a weakly supervised approach by generating training data 
from question templates, terminologies and paraphrases as described in a previous work 
[5]. 
We compared the performances of two types of word representations: static word 
embeddings (Fasttext) and contextualized word embeddings (ELMo). For each method, 
we also compared two different learning sets in French: #1 Wikipedia or #2 a set of 1M 
clinical notes from our local EHR. 
2.Methods 
2.1.Embeddings 
We compared two types of embeddings: #1 continuous skip-gram model with sub-
word information as implemented in fastText[2], #2 embeddings from language models 
(ELMo) where the vectors are learned from the internal states of a deep bidirectional 
language model[3]. As a baseline, we use a continuous skip-gram model learned only on 
the training set (no external dataset). 
We also compared the performances of these methods when learned on either a 
general domain dataset or a specialized dataset. The general domain dataset (hereafter, 
Wiki) is made of a dump of the French version of Wikipedia plus the French dataset of 
CommonCrawl. For this dataset, we used pre-learned models for French downloaded 
from fasttext website1 for Fasttext and from github2 for ELMo. 
The specialized dataset (hereafter, EHR) is constituted of a random set of 1M clinical 
notes from the clinical data warehouse of Necker – Enfants malades hospital, a French 
AP-HP childrens hospital in Paris[6]. This dataset contains 162M tokens and a 
vocabulary of size 92k. For Fasttext, we used vectors of 300 dimensions and a window- 
size of 5. For ELMo, we kept only a subset of the EHR data (24M tokens) due to the high 
training time of ELMo. To compare embeddings from different sources, we kept the 
hyper-parameters as described in [3]. 
 
 
 
 
1 https://fasttext.cc 
2 https://github.com/HIT-SCIR/ELMoForManyLangs 
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2.2.Task 
We evaluated the impact of the different embeddings approaches on the task of NLU in 
a virtual assistant (VA task). Given that no public dataset is available for this task in 
French, we used the dataset generated from templates, terminologies and paraphrases as 
described in a previous work [5]. The training dataset contains 16,000 questions, 144k 
words (mean length of a question is 9), the development set of 4,000 questions for the 
tuning of the models. For the evaluation, we collected from physicians in our hospital, a 
set of 178 questions that they would like to ask in such a system. This set of questions 
has been manually annotated. 
The slot filling task (VA-sequence) consists of a sequence labeling task aiming at 
identifying, in the question, the labtest mention (e.g créatinine ‘creatinin’) and the 
date- related information (e.g. 22/04/2012, depuis 4 semaines ‘for 4 weeks’). In the 
training set, the number of distinct lab mentions was 336 with a length ranging from 1 
to 11 tokens and a median length of 2. In terms of vocabulary, there is only an overlap 
of 28% between the training set and the test set for labtest mentions. The date labels 
include exact dates, relative dates and time ranges.[5] 
The intent classification task (VA-classification) is divided into 4 sub-tasks 
corresponding to 4 axes of classification. For each utterance, we assign one label per axis. 
Two axes concern the results of the lab exams (i.e. the type of result (5 categories) and 
interpretation of the result (5 categories). The two latter concern temporal aspects (i.e. 
the time of result (3 categories) and constraints on time (4 categories)).[5] 
2.3.Models 
We evaluated 5 different configurations of embeddings: continuous skip-gram model 
of 300 dimensions (D) learned on the training set; fasttext of 300D learned on Wiki; 
fasttext of 300D learned on EHR; ELMo of 1024D learned on Wiki; ELMo of 1024D 
learned on EHR. 
For the sequence labeling task (VA-sequence), we used a recurrent neural network 
(RNN) based on bidirectional long short term memory units (biLSTM)[7]. We used two 
layers of biLSTM of size 256. 
For the classification tasks we used a convolutional neural network (CNN)[8]. The 
model contains a 1D convolutional layer of 250 units, kernel size of 3, ReLU activation, 
followed by a max pooling layer and a dense fully connected layer. 
All the models were implemented using Keras, with a Tensorflow backend, and 
the optimizer was Adam. We used dropouts after the embedding layer and before the 
final dense layer as well as L2-regularization on the convolutional layers to limit 
overfitting. We used a weighted F1-score (harmonic mean of the precision and the 
recall) to evaluate the results of the different models. To estimate the variability of the 
performances, we used 10 repetitions of 5 fold cross-validation on the test set. 
3.Results 
All the results are presented in Table 1. For the sequence labeling task (VA-sequence), 
the best results are obtained with ELMo learned on EHR with a F1-score of 0.76 (95%CI 
[0.74-77]) compared to Fasttext on EHR (0.67, 95%CI [0.61-0.73]). Interestingly, we 
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show similar results between ELMo on Wiki (0.69, 95%CI [0.67-0.70]) and Fasttext on 
EHR (0.67, 95%CI [0.61-0.73]). To note, the distance between the training set and the 
test set, estimated using the perplexity of the n-gram model, is 194. 
Table 1. Results for the NLU task for the virtual assistant: sequence labeling (Bi-LSTM) and intent 
classification (CNN) 
 
For the intent classification task (VA-classification), again, the best results come 
from the ELMo model learned on EHR (F1-score 0.70, 95%CI [0.67-0.73]) compared to 
the second-best Fasttext on EHR (F1-score 0.66, 95%CI [0.63-0.69]). In this task, the 
models learned on Wiki performed poorly: Fasttext on Wiki with a F1-score of 0.52 
(95%CI [0.49-0.55]) and ELMo on Wiki 0.49 (95%CI [0.46-0.52]) with a baseline at 
0.62 (95%CI [0.58-0.65]). 
4.Discussion 
The use of pre-learned embeddings may improve substancially the results on certain 
downstream tasks. As shown by Wang et al. [4] on various tasks in English, we show 
increased performances on two of three tasks in French when using pre-learned 
embeddings on a large corpus of clinical notes. The higher improvement was obtained 
on the VA-sequence task suggesting that tasks requiring extended lexicons may benefit 
the most of the pre-embeddings. Indeed, the identification of labtest mentions highly 
depends on the vobabulary available during training and we show that 72% of the 
mentions in the test set are absent from the training set. In this scenario, the 
representations learned on a large specialized dataset helped the model to obtain a better 
generalization when dealing with previously unseen mentions. 
The test set shows 29% of out of vocabulary words overall. It may also partly explain 
the improvements observed on the classification task also (VA-classification). 
Interestingly, in the VA-classification task, both embeddings (Fasttext and ELMo) 
learned on Wiki did worsen the results compared to the baseline. This noise might come 
from the lack of specialized vocabulary in the Wiki corpus and a different usage of 
specialized words that may vary depending on the biomedical context and that are not 
taken into account in the general domain. 
Sheikhshab et al.[9] evaluated ELMo embeddings on named entity recognition tasks 
in the biomedical domain. They also showed improved results when using an in-domain 
corpus to train ELMo (i.e. articles from Pubmed). It would be interesting to evaluate 
ELMo embeddings learned on a corpus of biomedical article in French but collecting 
such a corpus may be challenging. 
This study has some limits. First, the embeddings learned on EHR came from a 
single hospital. This may cause some bias in the results given that the semantic 
particularities of the different practices may have an impact on the suitability of the 
embeddings for the different tasks. One possible solution to tackle this issue would be to 
Method Sequence labeling 
F1-score [95%CI] 
Intent classification 
Mean F1-score [95%CI] 
Baseline (only training set) 0.62 [0.61-0.64] 0.62 [0.58-0.65] 
Fasttext on Wiki 0.69 [0.67-0.70] 0.52 [0.49-0.55] 
Fasttext on EHR 0.67 [0.61-0.73] 0.66 [0.63-0.69] 
ELMo on Wiki 0.69 [0.67-0.70] 0.49 [0.46-0.52] 
ELMo on EHR 0.76 [0.74-0.77] 0.70 [0.67-0.73] 
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learn embeddings from multiple sites. However, due to privacy issues, it is not possible 
to transfer massive amount of hospital data. Two other approaches might be used to 
workaround this issue and should be explored for the biomedical domain: #1 the use of 
federated learning to train the models without moving the data[10]; #2 learning one 
embedding per site and aligning the different embeddings using unsupervised 
techniques. Finally, it is not obvious to determine the size of the training corpus for an 
embedding. It is a common practice to use all the articles from Wikipedia for example. 
But do we need that amount of data in a specialized domain? Comparing the impact of 
the size of the embedding corpus on downstream task will be of great interest. 
5.Conclusions 
Depending on the task, embeddings learned on large corpora can have a significant 
impact on NLP tasks in the biomedical domain in French. Moreover, learning these 
embeddings on clinical notes will increase the performances compared to general 
domain. As it may not be feasible to access a large corpus of clinical notes, it is still 
profitable to use advanced methods such as ELMo learned on general domain and obtain 
reasonable results. When the task does not rely on a large specialized vocabulary, the 
impact of external embeddings might be reduced. 
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The LOINC Content Model 
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Abstract. To unambiguously encode the semantic meaning of laboratory tests, the 
LOINC terminology is widely used. With regard to the constantly changing and 
diverse requirements of the laboratory domain, LOINC’s long-established content 
model and related publications are reviewed conjointly, revealing some obstacles 
for flexible adaptation in terms of new or varying application needs as well as 
issues regarding the comprehensive reusability of lab data. In a concise overview, 
four specific limitations are identified that require adaptation or the usage of other 
terminologies. 
Keywords. Terminologies, Semantic Interoperability, Clinical Laboratory 
1. Introduction 
Logical Observation Identifiers Names and Codes (LOINC) is one of the most notable 
and well-known terminologies in medicine and widely used for standardized coding of 
laboratory data in electronic health records [1]. LOINC’s content model has remained 
unchanged since its beginnings [2] but is confronted with varying needs and 
requirements in modern healthcare. Here, the significance of laboratory diagnostics 
entails a great diversity of tasks in digitalized lab environments including order/entry of 
tests and reporting of their results. Distributed laboratory data often needs to be 
integrated as well, for example to compare a patient’s test results for clinical 
monitoring or to aggregate and analyze data on a larger scale in a data warehouse. In all 
of these aspects, economic considerations are highly relevant as well, with the billing 
of lab procedures being part of everyday clinical practice [3]. Like all subdomains of 
medicine, the laboratory field is subject to constant change, but here the rapid 
emergence of new diagnostic tests and methods, for example in molecular genetic 
analysis, speeds up this process in particular [4]. 
In this paper, LOINC’s properties are analyzed regarding the current challenges in 
the laboratory domain to identify present limitations of its appliance. Related recent 
research is incorporated to bring together individual insights for a thorough and 
accurate overview. This evaluation shall not be misunderstood as criticism of LOINC – 
its usefulness in coding lab tests is undeniable; instead we identify potential for 
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improvement and cases in which another coding system such as the comprehensive 
ontology SNOMED CT is needed to fully cover the complex demands of laboratory 
medicine. 
2. Material and Methods 
Based on the authors’ extensive knowledge gained in previous projects, the LOINC 
content model and the features of its current version 2.66, as well as related literature, 
are critically reviewed in the context of requirements in modern laboratory diagnostics. 
2.1. LOINC content model 
Since its inception, LOINC is published biannually by the Regenstrief Institute as a 
database of unique codes associated with human-readable terms. Each code 
corresponds to a distinct lab test (currently 55,844 out of 91,388 codes) or another 
clinical observation explicitly defined by five mandatory main dimensions plus an 
optional method part. Therein, LOINC’s referenced properties are restricted to those 
required for a correct test result interpretation so that each combination represents the 
minimal set of values needed to distinguish this test from all others. For most axes, 
some further information can be included in specific subcomponents if needed for a full 
definition. 
Component describes the kind of substance or analyte measured stating the test’s most 
basic information with an immense variety of possible values (currently 24,707 
part codes) and complexity of contents (up to three subcomponents). 
Property denotes in which characteristic or type of property the component was 
measured, e.g. as number, as substance concentration or the qualitative presence. 
Obviously, this value is highly correlated with the test result’s unit which is not 
specified in the LOINC term [5]. With 135 different options, the property axis is 
known to cause misunderstandings and therefore issues while mapping to 
LOINC [6]. 
Time is used to differentiate measurements at a single point of time from those over a 
(specified) interval of time with an optional subcomponent. 
System defines the specimen or material sample used for testing as the second most 
distinct characteristic. Further refinement is typically needed by other properties 
(e.g. 32 LOINC codes for “creatinine” in “urine”) or a subcomponent. 
Scale broadly differentiates between quantitative, ordinal and nominal measurements, 
forming an interrelation to the Property part. Answer options for qualitative tests 
shall be coded with SNOMED CT; for quantitative results exemplary value 
ranges and units are partially mentioned but not explicitly defined. 
Method information is only included if the measurement technique is clinically 
significant by affecting the test’s result or reference range. So, most terms 
(63.32%) lack this dimension. 
Table 1. Some exemplary LOINC codes with their defining characteristics of six dimensions. 
Subcomponents are divided by the ^ sign. 
LOINC code Component Property Time System Scale Method 
14682-9 Creatinine SCnc Pt Ser/Plas Qn  
14684-5 Creatinine SRat 24H Urine Qn  
5802-1 Nitrite PrThr Pt Urine Ord Test strip 
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14754-6 Glucose^1H post 
50 g glucose PO 
SCnc Pt Ser/Plas Qn  
14578-9 AB0 group Type Pt Bld^BPU Nom  
Structure and content of terms and subcomponents as shown in Table 1 reveal 
LOINC’s origin to work conjunctively with the syntactic interoperability standard HL7 
v2. Omitted information like result value, unit, reference range or context are meant to 
be communicated in other fields of the HL7 v2 message or the (newer) HL7 FHIR 
Observation resource. Another design principle states to only add sensible 
combinations required in practice [2,7], limiting availability to existing pre-coordinated 
terms. 
2.2. Related research 
In a previous project, we investigated the mapping of laboratory services contained in 
an internal catalog of a German hospital to a standardized terminology. Internal 
catalogs capture the local range of services and are thus used for billing purposes. This 
leads to a primary focus on methods and environmental information, whereas 
measurement parameters like specimen or property are seldom mentioned. Because of 
this, we found it impossible to map the heterogenous contents to LOINC due to the 
small overlap of included information and the prerequisite to use complete pre-
coordinated terms. As a solution, SNOMED CT could be utilized based on its concepts 
of diverse granularity and ability for post-coordination [8]. 
In a literature review, we found 929 publications since 2017 mentioning the terms 
‘LOINC’, ‘laboratory’ plus ‘limitations’ or ‘challenges’ and further investigated 25 of 
these classified as most relevant by Google Scholar. Two articles covered the most 
relevant aspects for our review. Bietenbeck et al. assessed three terminologies 
including LOINC and SNOMED CT for their ability to encode laboratory results of 
different complexity and correlated evaluation parameters. Whereas LOINC was found 
to be easily usable, interpretive comments like measurement uncertainty or reference 
intervals could not be expressed adequately. With SNOMED CT more content could be 
encoded although full coverage remained elusive. Another issue concerning LOINC 
was detected in the non-existent formal definitions – and explicit hierarchies in 
particular – resulting in unclear (subclass) relations between terms and limited 
possibilities of computational analysis [9]. Stram et al. conducted a comprehensive 
evaluation of current challenges in LOINC usage in pathology laboratories. Among 
other results, an increased risk for mismatches between laboratories due to inconsistent 
mapping, especially of method properties, was revealed. Additionally, molecular 
genetic diagnostics were identified to pose serious problems on the current content 
model regarding the vast quantities of singular tests with heterogeneous features 
involved, e.g. for 22,000 genes. Rapidly evolving subdomains like this were also 
mentioned to be challenging for keeping LOINC up to date [10]. 
3. Results 
Putting LOINC content model characteristics into the context of current challenges in 
lab diagnostics reveals four types of limitations and their underlying causes: 
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3.1. Billing 
Although the billing of laboratory procedures is highly correlated with the creation of 
test results and thus combined evaluations may be of interest, both applications require 
different sets of attributes and can not easily be integrated with the same terminology 
as shown in [8]. These results can be transferred to the general scope because LOINC’s 
usage-specific content model offers no means to reasonably represent billing data, 
primarily because of its limitation to precoordinated combinations. The enforced usage 
of five axes that are partially irrelevant for economic purposes whereas intentionally 
omitting billing-relevant methods lead to an unsuitable data model. 
3.2. Context and interpretive comments 
By examining the historic origin as an addition to HL7 standards and the coverage of 
its accordingly developed content model, LOINC turns out to be not intended as a 
standalone format to fully describe laboratory test results. Additional information 
referring to test environment, device characteristics or result specific comments are 
meant to be communicated with relation to but outside of the term. So, the attempt to 
interpret laboratory data exclusively based on LOINC code and result value is 
inherently futile. 
3.3. Aggregation of test results 
Test results sharing the same LOINC code cannot ensure a simple and correct 
integration for combined analysis due to some distorting factors. As explained in 
section 3.2, LOINC terms are lacking some crucial information for complete result 
interpretation, e.g. different devices and reference ranges leading to incomparable 
results. Furthermore, seemingly identical tests specified by the same LOINC code may 
actually refer to different observations caused by an inaccurate mapping of 
idiosyncratic terms in the first place. Here, the (necessary) complexity of the content 
model with subcomponents and obscure Property values can be identified as a source 
of error. During mapping, another issue arises from non-existent formal definitions and 
explicit hierarchies so that easily locating related terms of different granularity (e.g. 
with a specified method) is prevented. The missing formal conceptualization further 
restricts advanced aggregation as well. Otherwise, LOINC terms differing only in the 
Property axis may be principally evaluated together when their units of measurement 
are convertible into one another but both unit defining relations and conversion support 
are currently missing. 
3.4. Molecular genetics and other rapidly changing domains 
Because of the limitation to reviewed pre-coordinated terms, LOINC can hardly keep 
up with newly developing tests and methods. Restricting contents to sensible 
combinations has obvious advantages in terms of data quality and error prevention but 
sacrifices any flexibility on the other hand. This rigid content model does not scale well 
for the numerous and diverse tests required for genetic diagnostics.  
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4. Discussion 
In a complex field of application like the laboratory domain, the presented list of 
limitations is obviously non-exhaustive, instead we focused on the apparently most 
urgent issues. An application of LOINC for billing purposes is clearly out of its 
predefined scope but has previously been discussed and is not far-fetched. For most of 
the above-mentioned challenges (billing, context, and aggregation), SNOMED CT 
provides an approach for improvement based on its larger coverage and ontological 
features, but no complete solution either [8,9]. A combined usage of both terminologies 
is explicitly favorable. Of course, improvements to LOINC are continually proposed 
and implemented as well, e.g. we recently developed an ontological representation 
including LOINC’s implicit hierarchies [11], Hauser et al. introduced an automated 
process for unit conversion of compatible codes [12], and the HL7 Clinical Genomics 
Work Group published an implementation guide for genetic test reporting with 
LOINC [13]. 
5. Conclusion 
The long-established content model of LOINC partially restricts the coding system’s 
usefulness for derived, originally not-intended applications needs, for changing 
demands as well as for test result interpretation and aggregation. This is due to its 
inflexibility, lacking formalization and incomplete information. LOINC is no all-
purpose, standalone format but can benefit largely from further specification, extension 
and combined usage with other terminologies, primarily SNOMED CT. 
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Abstract. Current high-throughput sequencing technologies allow us to acquire en-
tire genomes in a very short time and at a relatively sustainable cost, thus resulting
in an increasing diffusion of genetic test capabilities, in specialized clinical labora-
tories and research centers. In contrast, it is still limited the impact of genomic in-
formation on clinical decisions, as an effective interpretation is a challenging task.
From the technological point of view, genomic data are big in size, have a complex
granular nature and strongly depend on the computational steps of the generation
and processing workflows. This article introduces our work to create the openEHR
Genomic Project and the set of genomic information models we developed to catch
such complex structure and to preserve data provenance efficiently in a machine-
readable format. The models support clinical actionability of data, by improving
their quality, fostering interoperability and laying the basis for re-usability.
Keywords. genomic models, openEHR, mutations, variations, structured data
1. Introduction
Within the healthcare domain, Next Generation Sequencing (NGS) data sets are a po-
tential asset of clinically valuable information that, if properly read and deciphered, can
pave the way for life-enhancing applications such as personalised therapeutic treatments
or early detection of certain hereditary diseases, just to name a few. However, handling
genomic data is a very complex task from both clinical and technological perspectives.
Several initiatives are addressing the technological challenges [1,2], but they are mainly
focused on the exchange aspects, while many facets of the subject still remain unad-
dressed. In the first place, genomic information is composed of many levels, derived
from each calculation step, but usually the intermediate results are expressed in a wide
variety of text file formats (e.g., SAM/BAM, VCF, etc.), thus hindering the efficient re-
use, sharing and possible inclusion of data in an electronic health record (EHR). In addi-
1Corresponding Author: Cecilia Mascia, C/O CRS4, Loc. Piscina Manna - Edificio 1, 09050 Pula (CA),
Italia; E-mail: cecilia.mascia@crs4.it.
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tion,?bioinformatic?workflows?typically?rely?on?many?external?resources?(e.g.,?reference?
genome?sequences,?biological?annotation?databases,?analysis? tools)? that?evolve? rapidly?
and?have?a? significant? impact?on? the?final? results.?Hence,? it? is?essential? to?capture? the?
details?of?each?workflow?execution?to?ensure,?for?instance,?accurate?data?auditability?and?
reproducibility?or?to?make?results?comparable?when?a?different?pipeline?is?used.
The?availability?of?NGS?data? in?a? structured? and?machine-readable? format?would?
therefore?facilitate?their?integration?into?effective?clinical?actions,?thanks?to?the?possibil-
ity?of?capturing?granularity?and?provenance.?This?need?has?motivated?the?creation?of?ge-
nomic?models?in?the?form?of?openEHR?archetypes?[3,4],?fostering?the?foundation?of?the?
Genomics?openEHR?modelling?group?–?consisting?of?members?from? the?CRS4?(Italy),?
the?HiGHmed?Consortium?(Germany),?the?EUCANCan?project?(EU,?Canada),?the?CIN-
TESIS?group?(Portugal),?the?BigMed?project?(Norway)?and?the?international?openEHR?
Clinical?Modelling?Program?[5].?This?article?describes?how?our?collaborative?work?led?to?
the?launch?of?the?openEHR?Genomics?Project,?the?results?obtained?so?far?and?the?future?
directions.
2.?Method
2.1.? The?OpenEHR?Approach?and?the?OpenEHR?Clinical?Modelling?Program
OpenEHR?is?set?of?open?specifications?for?structured?data,?designed?to?represent?medi-
cal?knowledge?separating?domain?semantics?from?any?specific?technology?[6].?OpenEHR?
archetypes?are?the?maximum?set?of?attributes?describing?a?clinical?concept?in?a?machine-
readable?format.?They?enable? to?represent?concepts?of?different?scale?of?granularity,? to?
add? specific? constraints? on? elements? and? to? embed? their? semantics.?Conceptual?mod-
els? are? formalised? in? computable? entities? through? the?Archetype?Definition?Language?
(ADL),?which?can?be?easily?converted?to?a?number?of?other?popular?formats?like?XML.?
The?OpenEHR? framework? also? includes? a?mechanism? to? aggregate? archetypes? in?use?
case-oriented?structures?(i.e.,?templates),?a?query?language?optimised?for?archetypes?(i.e.,?
AQL-Archetype?Query?Language),?a?set?of?open?APIs?and?a?conformance?test?approach?
to?validate?real?implementations.
The?openEHR?Clinical?Modelling?Program?gathers?clinicians,?researchers?and? im-
plementers? in?an? international?collaborative?action?for? the?development?of?multilingual?
archetypes?and?templates.?The?direct?involvement?of?domain?experts?in?the?design?pro-
cess?is?one?of?the?key?strategies?adopted?to?obtain?high?quality?models,?whose?re-use?is?
encouraged.?Archetypes?are?collaboratively?reviewed?and?made?available?to?the?commu-
nity?through?the?international?Clinical?Knowledge?Manager?(CKM)?[7]?–?the?openEHR?
artefacts?repository?–?which?has?also?some?national?instances?developed?to?meet?specific?
demands.
2.2.? The?Initial?Genomic?OpenEHR?Archetypes?Collection
The?starting?point?was?the?set?of?11?archetypes?proposed?in?[3]?that?should?be?used?within?
the?Laboratory? test?result?archetype? to? represent?genetic? test? results,?developed?on? the?
basis?of? the?Variant?Calling?Format?(VCF)?file?specification?[8].?VCF?files?consist?of?a?
set?of?rows?each?describing?a?variation?that?occurred?in?a?sample?sequence?together?with
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customisable?functional?annotations?like,?for?instance,?’transcript?features’?and?the?’pre-
dicted?impact’.?Within?the?archetypes,?mutations?are?described?according?to?the?Sequence?
Variant?Nomenclature2? of? the?Human?Genome?Variation?Society?(HGVS)?[9].?Further,?
the?models?included?elements?like?the?’conservation?score’?and?the?’allele?frequency’?that?
are?usually?not? included? in? the?medical?report? itself,?but?are?potentially?relevant?on? the?
bioinformatics?research?side.?Finally,?each?tool?or?external?database?used?in?the?analysis?
can?be?tracked?by?explicitly?recording?their?name,?version?and,?where?appropriate,?URL,?
thus?integrating?provenance?within?the?data.
The?Design?Process
Two?use?cases?drove?the?creation?of?a?common?semantic?data?model?for?the?representation?
of?variant?information?derived?from?whole?genome?and?exome?sequencing?(WGS,?WES)?
data:
• Rare Diseases: to identify pathogenic variants responsible for rare diseases
through WES tests of patients and their parents.
• Oncology: to enable an evidence-based and better informed diagnostic and treat-
ment design, based on molecular stratification.
The whole design process has been guided by the co-chairs of the openEHR Clinical
Modelling Editorial Group (CMEG), responsible for the modeling governance within the
community.
The first step was the rethinking of content and structure, when the whole set of
nodes constituting the archetypes have been assessed from two opposing perspectives.
Starting from the overall picture, we prepared a mind map (using the collaborative tool
XMind3) to depict all the necessary pieces of information describing the use cases, to
detect possible repetitions or overlapping with existent archetypes and to simplify the
structure. Starting from the single nodes, we checked the adequacy of the concept name,
its adherence with standard nomenclatures and the consistence with the element’s de-
scription, adding examples to clarify the intended usage.
After reaching a good level of agreement, working with the Archetype Designer4,
we converted the mind maps into archetypes, taking further decisions on data types,
node occurrences and constraints and adding, when possible, bounds to external standard
ontologies.
3. Results
On April 2019, the Genomics Project5 was officially created in the openEHR CKM. The
project collects and makes publicly accessible the 13 archetypes developed in this work.
The Genetic variant is the core archetype designed to be nested within the Labora-
tory test result to report observations and annotations related to mutations found in the
genome as the result of a sequencing test. The morphological description of the muta-
2Guidelines available at: http://varnomen.hgvs.org/
3XMind 8: https://www.xmind.net/xmind8-pro/
4Archetype Designer: https://ehrscape.marand.si/designerv2/#/
5CKM Genomic project: https://ckm.openehr.org/ckm/#showProject=1013.30.50
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tions?–?i.e,?nucleotide?changes?and?genomic?coordinates?–?is?given?at?the?DNA?level?with?
reference? to?a?genomic? reference?sequence.?The?model?supports?all? the?simple?change?
types?identified?in?the?HGVS?guidelines?[9]?plus?translocations?and?copy?number?varia-
tions?–?two?structural?variations?that?are?often?relevant?in?cancer?studies.?In?addition,?fur-
ther?descriptions?of?the?mutations?are?possible?at?the?transcript?level?in?terms?of?changes?
in?the?coding?sequence?(’DNA?changes’)?and?in?the?protein?(’amino?acid?changes’).?The?
reference?sequence?used?to?annotate?the?variations?is?explicitly?recorded?too,?through?a?
dedicated? archetype? (Reference? sequence).?The?archetype?design? allows? the? recording?
of? annotations? for? each? transcript? affected? by? that? specific?mutation,? pointing? out? the?
one?with?the?highest?predicted?impact,?considered?relevant?for?the?clinical?evaluation.?In?
this?regards,? the?functional? interpretation?of? the?variants?can?be?specified?following? the?
ACMG?classification?[10]?or?by?citing?relevant?scientific? literature.?All? the?external?re-
sources?used?by?the?data?analysis?pipeline,?including?biological?databases?and?software,?
can?be?explicitly?recorded?by?giving?their?IDs,?version?and,?possibly,?a?unique?resource?
locator? (URL);?an?archetype? is?dedicated? to?capturing? this? information? in?a? structured?
manner?(Knowledge?base).?In?order?to?clearly?state?the?concepts’?semantic?and?improve?
data?quality?and?interoperability,?most?of?the?model’s?nodes?are?codified?using?LOINC6,?
an? international? standard?ontology? for? identifying?health?measurements,?observations,?
and?documents.
OpenEHR’s?flexibility?allows?to?project?the?archetype?data?onto?a?variety?of?different?
use?cases,?enabling? to?archive?all? the?elements?automatically?captured?during?pipeline?
execution,?but?presenting? to? the?final?user?only? those? relevant? to? the? task? at?hand.?To?
demonstrate?how?the?archetypes?can?be?combined?and?integrated,?an?example?template?
for?a?generic?sequencing?test?report?has?been?included?in?the?Project.
The?initial?review?round?of?the?Genetic?variant?archetype?started?on?April?26?2019,?
and,?afterwards,?we?commenced?in?staggered?steps?the?review?process?of?each?archetype,?
inviting?all?the?interested?domain?experts?in?the?project?to?give?their?opinions?and?com-
ments.?The?process?is?managed?by?the?project?editors?and?performed?completely?via?the?
CKM,?which?also?allows?the?tracking?of?archetypes?changes.?At?the?moment?of?writing,?
one?archetype?has?been?published?after?one?review?round?while?the?others?are?still?in?the?
consolidation?phase.?In?the?meantime,?the?Norwegian?translations?of?the?archetypes?are?
currently?being?refined.
4.? Discussion
The?focus?of?our?work?was?the?creation?of?information?models?to?capture?genomic?data?
for?clinical?and?research?applications.?The?openEHR?community?has?overall?expressed?
a?good?consensus?on? the?structure?of? the?models,? together?with?a?series?of?useful?feed-
backs.?For?instance,?a?series?of?suggestions?has?been?provided?to?improve?the?coverage?
of?the?genomic?domain,?particularly?with?respect?to?the?representation?of?complex?mu-
tations,?such?as?splicing?variants?affecting?RNA?sequences,?which?are?not?yet?supported?
by?model.?The?review?process?has?also?provided?important?hints?on?how?to?improve?and?
extend?the?usability?of?the?models?in?real?contexts,?as?a?set?of?suggestions?emerged?to?re-
fine?the?requirements?and?to?generalise?the?models?towards?different?use?cases?than?those
6Logical Observation Identifiers Names and Codes (LOINC): https://loinc.org/
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initially?considered.?The?feedback?will?be?integrated?in?the?next?versions?of?the?models?
while?trying?to?balance?the?different?perspectives.
More?generally,?the?number?of?reviewers?involved?in?this?specific?CKM?domain?tend?
to?be?fewer? than? those? involved? in?more? long-standing?ones.?We?believe? this? is?mainly?
due?to?the?novelty?and?the?specialised?nature?of?the?project,?and?that?the?situation?can?be?
improved?with?targeted?actions?to?disseminate?the?potential?of?the?obtained?results.
5.? Conclusion?and?Future?Work
In?this?work?we?presented?the?openEHR?Genomics?Project?and?its?first?results:?the?models?
to?represent?clinical?genomic?data?and?its?provenance?with?a?set?of?openEHR?archetypes.?
These? results? have? been? developed? through? a? collaborative? process? supported? by? the?
openEHR?Clinical?Modelling?Program.?Capturing?the?complexity?of?genetic?information?
remains?a?challenging?task,?but?the?results?presented?in?this?work?are?the?promising?start-
ing?point?for?an?ongoing?development?and?improvement?process.?Our?next?steps?include?
to?extend?the?models?to?cover?additional?concepts,?like?the?complex?genetic?variants,?and?
to? continue? the?ongoing? review?process? in? the? international?CKM.?Further,? additional?
model?reviews?at?the?Norwegian?and?German?repository?instances?are?already?planned,?
and?more?will?be?organized?in?due?time.
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Abstract. Traditionally, health data management has been EMR-based and mostly 
handled by health care providers. Mechanisms are needed to give patients more 
control over their health conditions. Personal Health Libraries (PHLs) provide a 
single point of secure access to patients' digital health information that can help 
empower patients to make better-informed decisions about their health care. This 
paper reports a work-in-progress on leveraging tools and methods from artificial 
intelligence and knowledge representation to build a private, decentralized PHL 
that supports interoperability and, ultimately, true care integration. We demonstrate 
how a social application querying such a decentralized PHL can deliver a tailored 
push notification intervention focused on improving self-care behaviors in diabetic 
adults from medically underserved communities. 
Keywords. Personal health library, digital health, privacy, interoperability. 
1. Introduction
Currently, patients receive important digital health information in multiple settings and 
through different communication modalities. Emerging evidence indicates that patients 
are frustrated by the lack of EMR interoperability among these fragmented systems and 
platforms [3-8] and want to have an active role in managing their data [1, 2]. Improved 
interoperability and support for patient-provider communication has the potential to 
improve patient satisfaction and, evidence suggests, could even help detect and prevent 
medical errors [8]. Table 1 summarizes some critical requirements of PHL from the 
patient perspective identified in the literature [1-8]. In digital health management, a 
health state is a digital representation of the state of someone’s health at a point in time, 
including their medications, test results, exercises, diets, insurance claims, vaccines, 
allergies, appointments, and their outcomes. Such data come from diverse sources, in-
cluding health care organizations, government agencies, and clinicians. It can also in-
clude digital health information from mass media and social networks. Health data also 
comes in different formats, including EMRs, family histories and genealogies, data 
streams from activity trackers, personal genome sequences, articles, videos, and public 
datasets. Health states change over time as data is acquired through ongoing health-
 Corresponding Author, E-mail: ashabann@uthsc.edu.1
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related processes and events embedded within those processes. A health-related inter-
vention is a process, which could either be therapeutic or preventive. For instance, an 
intervention for self-management of chronic diseases (e.g. diabetes) focused on pro-
moting health behavior change to improve clinical outcomes is an example of a preven-
tive intervention. In this paper, we describe a strategic implementation plan for a social 
application querying a decentralized PHL that can deliver a tailored push notification 
intervention focused on improving self-care behaviors in diabetic adults from under-
served communities. 
Table 1. Patient requirements (Req.) for a PHL. 
2. Method
We provide a solution for constructing and using a Personal Health Library (PHL) in-
spired by the Social Linked Data (Solid) framework [9]. Solid builds on the future vi-
sion of the decentralized Web by providing an infrastructure for separating data from 
applications that process that data. It provides users with true ownership of their data 
by storing it among several Personal Online Data stores (PODs) hosted wherever they 
Req. Description
Construction and Management (PODs)
R1.1 
R1.2 
R1.3
A mechanism to construct a PHL by bringing their data together  
in a trustworthy, usable, and useful library  
by gathering different types of knowledge into a single resource.
R2 Ability to manage the PHL by adding, editing, or removing resources 
Access Management and Privacy (PODs)
R3.1 
R3.2
Ability to decide what types of data should be kept,  
and who has access to that data
Knowledge Acquisition and Aggregation
R4.1 
R4.2
Ability to seek health information from constantly changing public sources,  
enriched with new streams and types of data
R5 Ability to decide what types of data is important enough to collect, manage, and share
R6 Ability to participate by sharing their data with citizen science and research initiatives 
Usage (Applications)
R7.1 
R7.2
Ability to search through the PHL  
using intelligent mapping for vocabulary used to describe resources in their profile.
R8 Ability to annotate their own results from participating in clinical trials  
to look for patterns
R9 Ability to receive alerts about new information related to topics covered in the PHL
R10 Ability to play an active role in staying healthy by monitoring their progress
R12 Ability to find and use information including text summarization, knowledge mapping.
R13 Ability to get digital assistance: personalized alerts, literacy aids, translations.
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desire, and selectively authenticating applications to access and process specific re-
sources within those PODs. The proposed Solid-based PHL manages distributed data 
storage in several PODs and enables interoperability between applications by reusing 
standard protocols, formats, and vocabularies, and by providing a common access 
RESTful API. Table 2 shows the main features supported by the proposed Solid-based 
framework.
Table 2. Features supported by the proposed Solid-based framework. 
Fn Description
F1 Agents: Solid defines standard vocabulary to describe the different entities that contribute to a 
user’s profile as Agents of different types (Person, Organization, Device, etc.)
F2 WebID: Each agent has a unique WebID, which links to a public RDF-based profile document that 
may link to other extended profiles. Extended profiles represent different user’s application profiles.
F3 Web of Trust: Extended profiles can be used to build a Web of trust using the FOAF vocabulary by 
allowing agents to link their profiles in a public or protected way.
F4 Web of Resources: Whether it is a person, an inbox, a document, an image, a notification, or a rela-
tionship, everything within a profile is represented as a resource.
F5 Hierarchical resource representation: Resources can be organized hierarchically in containers (di-
rectories), which allows for fine-grained access control lists (ACL). Solid uses the WAC Ontology. 
F6 Resource Management: RDF, the model driving the Linked Data Platform (LDP), follows REST 
principles of identifying resources by URIs. Users manage resources via HTTP operations on their 
URIs. SPARQL endpoints enable complex multi-pod data retrieval via link-following SPARQL.
F7 Linkability: Resources stored in different PODs are represented following LDP recommendations. 
LDP enables agents to dereference resource URLs to reach a resource from another. Links within 
LDP are typed, which enables agents to explicitly state how their linked resources are related.
F8 Live Notifications: are implemented following the W3C LDN protocol and ActivityStream Vocabu-
lary and enable users to interact with content on each other’s PODs and enable content owners to 
receive notifications in the appropriate inbox.
F9 Portability and Interoperability: The framework has a standard API that makes it easy for develop-
ers to write applications that allow users to use the same data in different applications instead of 
locking it inside different application data repositories
F10 Security: Authentication: The framework provides decentralized authentication, a global id space, 
and a global single sign-on through WebIDs. User has to register with an identity provider (their 
POD provider). The provider stores the users’ WebID profile document associated with a crypto-
graphic key.
F11 Privacy: Access Control Lists (ACL). Solid uses the WAC Ontology to define read, write, edit, etc. 
permissions on resources. Since resources are hierarchical this allows for fine-grained access con-
trol. A patient can grant fine-grained access permissions to the different agents, ranging from a 
single person or a group to everyone. The patient can also have a list of trusted applications and 
control their access to the different resources in his/her POD.
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3. Results
To showcase the proposed Solid-based PHL in action, we focus on one application sce-
nario, featuring a preventive intervention from the chronic disease self-management 
domain: 
Bob is an African American adult with diabetes equipped with a smart-phone that col-
lects physiological data (e.g. step counts) in real-time. The social application on his 
smartphone queries his decentralized PHL to deliver tailored push notifications to sup-
port behavior change related to chronic disease self-care. Depending on sensor read-
ings and other information in his PHL, the app provides personalized and tailored rec-
ommendations for healthy eating, physical activity, medication taking, and/or visiting 
healthcare providers. Alice is a cancer patient who is part of Bob’s social network and 
Mary is his primary care physician. 
      We leverage the Solid infrastructure and the relevant linked data principles to assist 
Bob in constructing and managing his PHL as well as interacting with other collabora-
tors in his health and social networks, through the Solid ecosystem.  
First, Bob generates unique WebID to securely login to his profile document (Table 
2, F2, F10), sets up his PODs, and keeps a list of vCard URIs of trusted (Table2, F3) 
agents and applications in his extended profile. He adds Alice and Mary as Person 
agents and he adds the monitoring app and his smartphone as device and 
software agents, respectively (Table2, F1). Bob is interested in gathering the latest 
blog posts about diabetes from a blogging app. He adds the app  under  the trusted  
apps section of his profile document. He grants each of the above agents a fine-grained 
access permis-sion to the corresponding containers under his POD with the 
proper access mode (Table2, F11). He can set up a chatting channel of type LongChat 
about Diabetes as a resource under the Diabetes folder under his public folder (Table2, 
F4,F5,F6).  
Alice and Mary can subscribe to the channel using their WebIDs and have message 
notifications pushed to their inboxes as resources with unique URIs and they can col-
laborate on assessing each other’s messages. Bob can also share blog posts that 
he receives from the blogging app to Alice’s inbox. Alice gets a notification in her 
inbox of the blog post (Table2, F8). She has several options to interact with the 
document, including replying to Bob, adding annotations to robustify links in the 
document by linking them to other concepts or sources of knowledge, and save either a 
copy of that document to her POD or a link to Bob’s copy. 
Resources generated by each of the three users is stored in their 
corresponding PODs, but can be linked to each other (Table2, F7). For example, 
message notifications get pushed by the messaging POD to the inboxes of the users 
who subscribed to the messaging app as resources with unique URIs. Assuming a 
message stored in Bob’s profile is identified by https://bob.solid/messages/
diabetes/1234, then Alice’s comment at https://alice.solid/comments/36756 links back 
to Bob’s message by the hasTarget Link Type defined in the Web Annotation 
Ontology (www.w3.org/ns/oa).

4. Discussion and Future Work
This paper has shown how a social application querying such a decentralized PHL can 
securely access, exchange, and use PHLs and deliver personalized and tailored push 
notifications to support chronic disease self-care. In this paper we employed a Solid-
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based framework to assist users in constructing their PHL by gathering different types 
of data, information, and knowledge into a single searchable resource. While there has 
been some effort to build similar systems, the novelty of the proposed approach lies  in 
i) providing a decentralized, yet linked architecture; ii) supporting interoperability,
portability, knowledge mapping, and reasoning by following protocol, format, and vo-
cabulary standards; iii) building trust with patients by facilitating true ownership over
their data, and appropriate reporting; and (4) giving them a fine-grained access control
mechanisms.
Future work will focus on further implementation of an end-to-end framework of 
intelligent recommendation and digital assistance tools, including text summarization, 
knowledge mapping, and personalized resource suggestions. In achieving this goal, we 
will incorporate AI techniques and knowledge representation methods that have been 
successfully used in our previous works [10, 11, 12]. Other ongoing tasks will include 
setting up a clinical trial of the social application and recruiting participants to fully 
evaluate the application. 
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Abstract. Electronic glasses use advanced assistive technology that can improve 
function for persons with visual impairments. This paper presents work in progress in 
the SmartSight project, where existing versions of electronic glasses are adapted and 
tested for persons with the visual impairments; macular degeneration and retinitis 
pigmentosa. The project aims are to adapt and innovate electronic glasses for persons 
with impaired fields of vision and study the impact on the daily function and quality of 
life. In a pilot test of the electronic glasses, promising results were found that imply a 
big difference for persons with impaired vision. The outcome of the SmartSight 
project might change the clinical practise on treatment and rehabilitation of persons 
with impaired fields of vision, and on how the support services are organised. 
Keywords. E-accessibility, Visual impairment, Augmented reality, E-glasses, 
Usability evaluation 
1. Introduction 
Two large patient groups have eye diseases that impair their fields of vision, inducing 
problems in everyday living and thus reduced function. Macular degeneration (MD) 
causes the central vison to deteriorate while the peripheral vision remains intact [1], see 
Figure 1 middle. One in ten older than 70 years of age have functional impairments due to 
MD [2]. In retinitis pigmentosa (RD) central and peripheral fields of vision are impaired, 
giving a “tunnel vision” for persons affected [3], see Figure 1 right. This is problematic 
for orientation and implies more impaired vision in dark surroundings [4]. The total 
prevalence of all different forms of retinitis pigmentosa is variably reported (one case for 
each 2500 - 7000 persons), but represents one of the most common causes of blindness or 
severe low-vision in people 20 to 60 years old [5]. 
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 Figure 1. The field of vision for normal vision (left), macular degeneration (middle) and retinitis pigmentosa 
(right). 
In this context, the SmartSight project (Electronic glasses to improve function for 
persons with impaired fields of vision) addresses research gaps connected to clinical 
studies of eHealth assistive technology aiming to improve function and quality of life for 
persons with impaired fields of vision. The software in existing technology of electronic 
glasses (eGlasses) will be adapted to improve function and coping for persons with 
impaired fields of vision. The effects of using eGlasses will be measured and tested for 
persons with macular degeneration and retinitis pigmentosa. 
The main hypotheses are that use of electronic glasses will have beneficial effects on 
individual, organisational and societal levels. The research questions (RQs) stated for the 
SmartSight project: 
RQ1: How can the functionality of existing eGlasses products be adapted to improve 
function and coping for persons with impaired fields of vision? 
RQ2: What benefits and effects of using such customised products can be 
measured for individuals and for the society? 
RQ3: What are the user experiences with such customised products? 
2. Methodology 
To address the user experiences, a mixed-methods research approach will be applied to 
evaluate the usefulness and user satisfaction with the eGlasses [6][7]. Initially, pilot tests 
will be made. User evaluations led by a cross-disciplinary research team, will be 
performed in a usability laboratory together with persons affected by macular degeneration 
and retinitis pigmentosa, followed by user satisfaction questionnaires and qualitative 
interviews [8]. By this systematic approach, real end-users get the opportunity to share their 
user experiences regarding the eGlasses and the results will be used for iterative 
refinements of the eGlasses. For each iteration in the technical development, 4- 6 test 
participants evaluate the functionality and usability of the eGlasses. All laboratory tests 
will be video-recorded for analysis purposes [9][10]. 
To evaluate the long-term experiences; a 6-12 months long field study will be made 
with 10-12 participants using a high-fidelity prototype of eGlasses. During the study, there 
will be regular contacts between the research team and the test participants for evaluating 
impacts on fields of vision and daily life. Recruitment of test participants is made in close 
collaboration with The Norwegian Association of the Blind and Partially Sighted [11], the 
Eye Clinic at Sørlandet Hospital Trust [12] and The National Centre for Optics, Vision 
and Eye Care, University of South-Eastern Norway [13]. 
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3. Results 
The SmartSight project is in an early study phase. A workshop was organised together 
with The Norwegian Association of the Blind and Partially Sighted, where pilot tests of 
eGlasses were made. The eGlasses had mounted cameras, and modified pictures from the 
cameras were projected in the glasses. 
 
Figure 2. The pilot test of different types of eGlasses. Photo: Mona Hauglid. 
 
The tests showed promising results using unmodified eGlasses that may imply great 
differences for persons with retinitis pigmentosa [14][15], see Figure 3. Unmodified 
eGlasses did not give any benefit for persons with macular degeneration, but the modified 
versions are promising, see Figure 4. 
 
Figure 3. A model of principle function of the eGlasses for retinitis pigmentosa. 
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Figure 4. A model of principle function of the eGlasses for macular degeneration. 
4. Conclusion 
The main contributions of the SmartSight study lie in the adaption and innovation of 
existing eGlasses technology, a detailed analysis of their usefulness, and user experiences 
from persons with visual impairments caused by macular degeneration and retinitis 
pigmentosa. These outcomes might change the clinical practise on examination and 
rehabilitation for persons with impaired field of vision, and improve quality of life by 
increasing employability and participation in social life. The outcomes might also have 
impact on the organisation of support services connected to this area of concern.  
 
4.1 Acknowledgement 
Thanks to The Norwegian Association of the Blind and Partially Sighted and to the persons 
that voluntarily participated in the pilot test. This study was funded by Research Grant no. 
16/00528-27 of December 21st, 2016, from the South-Eastern Regional Health Authority 
in Norway. 
References 
[1] A.C. Bird, N.M. Bressler, S.B. Bressler, I.H., Chisholm, G. Coscas, M.D. Davis, et.al., An international 
classification and grading system for age-related maculopathy and age-related macular degeneration, 
[2] Surv Opthhalmol 39:5 (1995) 367-374, doi:https://doi.org/10.1016/S0039-6257(05)80092-X 
[3] J.M Colijn, G.H. Buitendijk, E. Prokofyeva, D. Alves, D, M.L. Cachulo, A.P. Khawaja et.al., Prevalence 
of age-related macular degeneration in Europe: the past and the future, Ophthalmology 124:12 (2017), 
1753-1763, doi: 10.1016/j.ophtha.2017.05.035 
[4] C. Hamel, Retinitis pigmentosa, Orphanet J. Rare Dis 1:1, (2006), 40, doi:10.1186/1750-1172-1-40 
B.F. Smaradottir et al. / The SmartSight Project456
 
[5] D.T. Hartong, E.L. Berson, T.P Dryja, Retinitis pigmentosa, The Lancet 368:9549 (2006), 1795-1809, 
doi:https://doi.org/10.1016/S0140-6736(06)69740-7 
[6] F. Parmeggiani, Clinics, epidemiology and genetics of retinitis pigmentosam, Curr Genomics 12:4 (2011), 
236–237. doi:10.2174/138920211795860080 
[7] J.W. Creswell, V.L.P. Clark, Designing and conducting mixed methods research. SAGE Publications Inc, 
2007. 
[8] R.B. Johnson, A.J. Onwuegbuzie, L.A. Turner, Toward a definition of mixed methods research, J Mix 
Methods Res 1:2 (2007), 112-133. 
[9] M.W. Jaspers, A comparison of usability methods for testing interactive health technologies: 
methodological aspects and empirical evidence, Int J Med Inform 78:5 (2009), 340-353. 
[10] B. Smaradottir, J. Håland, S. Martinez, Å.R Somdal, R.W. Fensli, Recommendations on a test infrastructure 
for evaluation of touchscreen assistive technology for visually impaired users, Linköping University Press, 
2015. 
[11] B.F. Smaradottir, J.A. Håland, S.G. Martinez, User Evaluation of the Smartphone Screen Reader 
VoiceOver with Visually Disabled Participants, Mob Inf Syst (2018), Article ID 6941631, doi: 
https://doi.org/10.1155/2018/6941631 
[12] The Norwegian Association of the Blind and Partially Sighted. [cited 2020 Jan 1]. Available from: 
https://www.blindeforbundet.no/om-blindeforbundet/brosjyrer/muligheter-til-et-aktivt-liv-engelsk 
[13] The Eye Clinic at Sørlandet Hospital Trust. [cited 2020 Jan 1]. Available from: 
https://sshf.no/avdelinger/somatikk-arendal/oye/oyepoliklinikk 
[14] National Centre for Optics, Vision and Eye Care, University of South-Eastern Norway. [cited 2020 Jan 1]. 
Available from: https://www.usn.no/english/research/our-research/vision-science/national-centre- for-
optics-vision-and-eye-care/ 
[15] B. Borgersen J. Claesson, M. Grundetjern, Adapting smart glasses for persons with loss of peripheral vision. 
Bachelor thesis, University of Agder, 2018. [cited 2020 Jan 1]. Available from: https://flåttsenteret.no/wp-
content/uploads/2019/04/e-Glasses_bachelor_report_UiA_140518.pdf 
[16] K. Lorentzen, Manipulation of virtual pictures to compensate impaired fields of vision (In Norwegian 
Manipulering av virtuelle bilder for kompensering av tapt synsfelt), Bachelor thesis, University of Agder, 
2017. [cited 2020 Jan 1]. Available from: https://flåttsenteret.no/wp-content/uploads/2019/04/e- 
Glasses_Kenneth_Lorentzen_Short-form_Bachelorreport_UiA_sept_2017.pdf 
 
B.F. Smaradottir et al. / The SmartSight Project 457
Three-Dimensional Volumetric Renal 
Reconstruction Based on Geometrical 
Coefficients 
Tomasz LESa,1, Tomasz MARKIEWICZ a,b , Miroslaw DZIEKIEWICZ b and 
Malgorzata LORENT b 
a Warsaw University of Technology, Warsaw, Poland 
b Military Institute of Medicine, Warsaw. Poland 
Abstract. The article presents an innovative method of 3D computer tomography 
(CT) image reconstruction of kidney. Diagnosis based on CT scanning allows to 
obtain projections of multi-dimensional object, made from different directions in 
order to create cross-sectional (2D) slices. Standard techniques for identifying 
kidneys in CT images analyze each 2D slice separately. It causes different 
reconstruction accuracy for the same object at its different heights. This is the 
main problem of a machine-learning systems. Reconstruction error of end-slices of 
the kidney model is often greater than the error of the kidney’s middle part. The 
main idea of the technique presented in this paper is to analyze the largest coherent 
3D spatial-areas. This technique allows to increase the accuracy of kidney 
detection as well as to decrease the FP (false positive) error. An additional 
advantage of the developed algorithm is the possibility of obtaining a precise 
model representing the 3D view of an entire kidney. 
Keywords. renal, reconstruction, geometrical-coefficients 
1. Introduction 
Quick and effective diagnosis of kidney diseases is possible by usage of a precise X-
ray imaging. Increasingly more accurate projection, combined with novel methods of 
an automatic segmentation and visualization of the organs, e.g. kidneys, allows a better 
diagnosis of the disease and also a selection of a more appropriate treatment. An 
accurate kidney detection is particularly important for the cancer diagnosis. According 
to WHO Cancer Mortality Database, 400 000 new cases were diagnosed in 2018 [1]. 
Kidney cancer is the ninth most common cancer among men and 14th among women. 
The highest incidence rate covers the countries of Central and Eastern Europe (Belarus, 
the Czech Republic) and the Baltic States (Lithuania, Latvia and Estonia). 
Current techniques for diagnosis of kidney diseases are based on CT image 
analysis, followed by manual or semi-automatic segmentation in order to detect the 
kidney area. Although, a 3D reconstruction of the kidney is often used in diagnosis for 
a better visualization. Modern CT scanners generate large number of scans with high 
density. This is an advantage, however, it causes also that the manual analysis, 
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performed by specialists, of a large number of images, becomes time consuming and 
involves the risk of human error caused by, for example, tiredness. Therefore, there is a 
necessity to develop a new, more accurate and faster techniques for an automatic 
diagnosis and visualization of kidneys. Current kidney identification techniques are 
based on the analysis of each slice separately. The consequence is that the accuracy of 
recognition of an individual kidney contours on different slices can vary significantly. 
This is particularly important when analyzing the end-slices of a kidney where the 
accuracy of a detection is often worse than the accuracy of a kidney detection in the 
middle slices. This causes false positive error, difficult to decrease with standard 
techniques. 
In this article, a novel volumetric technique of a renal reconstruction is presented, 
based on an analysis of geometrical coefficients for 3D kidney model. Renal contour 
detection is performed on all scans together unlike in many popular methods which 
analyses each slice separately. The final 3D model generated using our technique is 
also more precise than model using standard techniques. 
2. Automatic renal segmentation technique 
In this section we present a complete system of the 3D kidney reconstruction. The 
starting point of the algorithm is a set of n images encoded as gray-scale images, 
representing individual slices of renal. Input images can be obtained, e.g. using 
morphological operations [2,3], segmentation methods [4-6] or methods based on 
machine learning [7-9]. Regardless of the used method, the key task is to calculate the 
appropriate threshold for binarization final mask. In our experiment we used U-Net 
multilayer network model to obtain the input data: raw CTA images of dimensions of 
512 x 512, frame size 48×48 (defined the input layer of U-Net), encoder depth equals 4 
and convolution filter size equals 3. Other neural network parameters we applied: 
initial learning rate: 0.07, momentum 0.9 and LZ regularization 0.0002, number of 
epochs: 20 and minimal batch size: 256. 
Output of the network frame classification is the gray-scale image. The value of 
each pixel c = [x, y] equals the number of votes that the pixel c belongs to the renal 
area when the sequential frames are classified by the network. 
It is difficult to calculate the optimal threshold value (t value) for a segmentation 
of renal area. Moreover, t value differs for different cases and also for each renal in one 
case. The main, novel contributions of this work include a method of calculating 
geometric coefficients for the entire 3D renal model, for different threshold levels. 
Following coefficients are calculated for each renal separately: fc - the circularity ratio 
(1) and fh – the compactness factor (2). 
 
?? ? ? ???
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   (2)  
Directly measured parameters are denoted by the following symbols: 
 
 A – real area of the renal 
 P – perimeter of the renal 
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Finally, the p factor is calculated by the formula (3): 
 
? ?
??
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(3) 
 
Next, the algorithm selected minimal p value and corresponding t value. Table 1 
presents the dependence of the p value and t value, as well as of the fc and fh factors for 
one case. 
Table 1. Dependence of the t, p, fc and fh factors for one case.  
t fc fh p t fc fh p 
17         10147.06 7.92 1281.095 28 2063.42 12.03 171.474 
20 9868.72 7.80 1265.137 29 2071.86 11.98 172.970 
22 9756.89 7.71 1265.934 30 2102.20 11.86 177.223 
23 2177.78 11.91 182.855 31 2116.63 11.79 179.543 
24 1987.00 12.39 160.358 40 2302.47 11.02 209.019 
25 1983.68 12.37 160.356 60 4774.24 5.88 812.425 
 
Fig. 1 presents plot of minimal p value range in relation to t value. 
 
Figure 1. Plot of minimal p value range in relation to t value. 
The minimal p value is obtained for t range from 23 to 40. For these values the 
reconstruction is the most precise. Our method allows a simple selecting the minimum 
value of p (which is equal: 160.356 in this case) and an optimal threshold value t 
(equals 25 in this case). The more general analysis of other cases allows to observe that 
the optimal t value ranges from 20 to 50. This technique is applied for each renal 
separately. Fig. 2 presents the results of a complete reins reconstruction using t value 
equals: [22,25,60]. 
 
 
Figure 2. Complete reconstruction of reins for t value of: [22,25,60], for one patient. 
In this case, the best reconstruction quality can be obtained for the threshold t = 25. 
This value was calculated automatically basing on coefficient factors fc, fh and p value. 
A full diagram of a complete system for 3D reconstruction of the reins is shown in 
fig 3. 
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 Figure 3. A full diagram of a complete system for 3D reconstruction of reins. 
3. Test and results 
In numerical experiments we have recognized 21 cases, each consisting of 60-250 
slices. In total, 1335 CT images were tested. For each case, automatically, a complete 
3D reconstruction of a renal was realized as well as the final binary masks for each 
individual slice were calculated. Each mask was compared to mask obtained by an 
expert from the Military Institute of Medicine and final Renal Sørensen-Dice 
coefficient was calculated. Detailed numerical results of recognition accuracy are 
presented in Table 2. 
Table 2. The accuracy of renal area recognition for 21 cases.  
Case Accuracy Case Accuracy Case Accuracy 
1 87.60 8 84.82 15 80.41 
2 92.45 9 59.91 16 85.66 
3 75.97 10 90.08 17 87.02 
4 90.70 11 78.36 18 91.02 
5 88.85 12 89.48 19 94.41 
6 96.60 13 94.29 20 95.24 
7 91.00 14 89.39 21 95.13 
  
  mean 87.54 
 
Experimental results show the good performance of the proposed system. The main 
accuracy of kidney reconstruction equals 87.54%. 
The results of renal boundary detection for exemplary slices were presented on fig 4. 
The green line represents the expert’s result and the red line represents the system’s 
result. 
Figure 4. Results of renal boundary detection for exemplary slices. The green line represents the expert’s 
outlines and the red line represents the system’s results. 
4. Conclusion 
This paper presents a novel method of the 3D renal reconstruction. The presented 
technique allows to obtain a precise boundary of the reins in both three-dimensional 
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and two-dimensional projections. Our algorithm allows for calculating the optimal 
thresholding value for gray-scale images. An automatic selection of threshold is a 
difficult task due to the very high variability of the intensity of each slice. The existing 
techniques for visualizing the correlation of threshold values and reconstruction results 
use the roc curve. However, those techniques do not allow for automatic selecting of 
one optimal value. The proposed technique was tested using a set of data generated by 
the U-Net network, however, many other techniques generating gray-scale images (e.g. 
basing on morphological operations or segmentation methods), can be used in our 
solution. The main novel idea used in the presented system is to analyze geometric 
coefficients (circularity and compactness) as volumetric factors. The result of the 
coefficient calculation allows selecting optimal threshold value, binarization and final 
renal boundary recognition. In order to assess the quality of the proposed system, 
numerical tests were performed. Each mask was compared to a mask obtained by an 
expert from a medical institute. The numerical results of this verification have been 
presented and discussed in this paper. The measurable benefit of the presented system 
is a practical tool for visualization and evaluation of very significant cancerous change. 
Despite satisfactory research results, it is necessary to constantly develop new methods 
to support medical diagnostics in order to improve treatment results. 
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Abstract. The web portal Medfloss.org lists over 360 medical free/libre and open 
source software (MEDFLOSS) projects. These projects are described with the help 
of a self-developed nomenclature. Due to inconsistencies, the nomenclature shall 
be replaced by HITO, the Health IT Ontology. HITO is developed iteratively 
based on different use cases. This paper aims to describe methods and results of 
the second HITO use case in which HITO is extended to improve the description, 
retrieval and comparisons of MEDFLOSS projects on Medfloss.org. We use a 
mixed-methods approach to add concepts and relationships to describe 
MEDFLOSS precisely. The resulting HITO version stresses functional 
descriptions based on features and supported enterprise functions, rather than just 
describing technical characteristics. However, describing a larger number of 
MEDFLOSS projects requires the commitment of the community.     
Keywords. Health Information Systems, Software, Semantics  
1. Introduction 
Medical free/libre and open source software (MEDFLOSS) is widely used in academia 
and in low-resource settings, but also in healthcare institutions of industrial countries 
such as the US and UK [1]. The web portal Medfloss.org gives an overview of 363 
MEDFLOSS projects, 111 professional service providers and 436 publications dealing 
with MEDFLOSS [2]. The portal is provided in cooperation with the FLOSS working 
groups of the European Federation of Medical Informatics, the International Medical 
Informatics Association and the International Society for Telemedicine & eHealth. 
About 3.350 visitors consult the website every month. 
To describe software projects, Medfloss.org uses a self-developed nomenclature 
describing software by categories such as “application type”, supported “enterprise 
functions” and “license”. Since the establishment of Medfloss.org in 2010, the 
uncontrolled growth of the nomenclature has led to inconsistencies such as 
misassignments of descriptors to characteristics (e.g. “Virtual Reality” is listed as 
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enterprise function) and the use of synonyms and homonyms for the descriptions of 
MEDFLOSS projects.  
The Austrian-German research project HITO aims at the development of a Health 
IT Ontology for the systematic description of application systems and software 
products used in healthcare [3]. Whereas software products are tailor-made or 
purchased pieces of software that can be installed on a computer system, application 
systems are already installed software products that are adapted to a certain 
organizational environment [4].  
HITO is developed iteratively by means of five use cases that currently lack 
precise application system and software product descriptions. Each use case is intended 
to add new concepts and relationships to HITO. In the first use case, we developed 
HITO V1 in order to improve the retrieval of evaluation studies examining application 
systems in healthcare settings [5]. HITO V1 systematically describes evaluated 
application systems by features, user groups and organizational units.     
In the second use case, HITO V1 is extended by concepts and relationships for the 
precise description of MEDFLOSS (HITO V2) to improve retrieval and comparisons of 
MEDFLOSS projects on Medfloss.org. 
This paper aims to describe methods and results of developing HITO V2.  
2. Methods 
We used a mixed-methods approach to identify important categories for the description 
of MEDFLOSS. The methods described in sections 2.1 to 2.4 were applied in parallel.  
2.1.  Surveying the Medfloss.org portal operators 
In semi-structured interviews, two of the Medfloss.org web portal operators were asked 
about their experiences with the current terminology used on Medfloss.org and their 
ideas for improvement. On a 4-point scale ranging from “unimportant” to “very 
important”, both rated 8 out of 11 categories of the current terminology (enterprise 
function, application type, status, license, standard, language, client type, and platform) 
as “important” or “very important” for the description of the projects. The categories 
“popularity”, “database” and “programming language/toolkit” were each rated “less 
important” and “important” by one of the interviewees. They pointed out that the 
importance of these categories also depends on the perspective of the MEDFLOSS 
portal user. While health professionals are interested in functional software descriptions, 
software developers are more interested in technical categories. 
However, from their point of view, the terminology currently lacks possibilities to 
describe the functionalities and application types more precisely. Therefore, the 
integration of existing terminologies such as WHO’s classification of digital health 
interventions [6] should be considered.      
2.2. Comparison of three terminologies for describing MEDFLOSS functionalities 
During the first HITO use case, we identified existing health IT taxonomies and 
ontologies [5]. To describe MEDFLOSS functionalities, we selected three of these 
taxonomies, which cover a broad range of health enterprise functions or application 
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system types systems, for a deeper analysis: (1) The reference model for the domain 
layer of hospital information systems (RDHIS) provides a hierarchy of enterprise 
functions (e.g. “medical admission”, “execution of nursing procedures”) [7]. Although 
it is originally developed for hospitals, many of these enterprise functions also fit in 
other healthcare settings. (2) The textbook “Health Information“ includes a list of 
application system types (e.g. radiology information system, patient administration 
system) used in healthcare and tries to avoid conceptual overlappings [4]. (3) Varshney 
et al. systematically developed a taxonomy of healthcare applications consisting of 
eight application system types [8]. 
For 356 projects listed on Medfloss.org, we counted how many of them could be 
described by the three taxonomies’ classes. The RDHIS gained best results in this 
comparison (Table 1). 71 % of the MEDFLOSS projects could be described by it. Only 
13 of the 68 RDHIS’ enterprise functions could not be used for any description. With 
the help of application system list and the taxonomy of healthcare applications, only 
42 % and 29 % of the projects could be described, respectively.   
Table 1. Comparison of three taxonomies to describe 356 projects listed on Medfloss.org 
 (1) Reference model for the 
domain layer of HIS [7] 
(2) Application 
system list [4] 
(3) Taxonomy of 
healthcare applications [8] 
Number of classes 68 16 8 
Number of Medfloss 
projects assignable 
to classes (n=356) 
253 (71%) 151 (42%) 105 (29%) 
2.3.  Analyzing the Architecture of a MEDFLOSS-based Laboratory Environment 
The MI-Lab at Leipzig University is a small computerized hospital information system 
architecture built up from several MEDFLOSS components [9]. Its analysis reveals that 
MEDFLOSS products can be provided as parts of other MEDFLOSS products. The 
Bahmni software used as electronic medical record (EMR) system in MI-Lab is 
composed of four other MEDFLOSS products providing a laboratory information 
system (LIS), an enterprise resource planning system (ERP), a patient management 
system and a picture archiving and communication system (PACS).   
2.4. MEDFLOSS Literature Review 
In order to find important characteristics for the description of MEDFLOSS products, 
we conducted a snowball search starting from a review on MEDFLOSS publications 
[1] which was complemented by a Pubmed and Google Scholar search on open source 
software characteristics and comparisons. Four out of seven articles providing 
structured descriptions of MEDFLOSS [10–13] list characteristics that are worth to be 
considered as HITO classes. However, the use of different self-developed lists of 
features or functionalities in the articles demonstrates the lack of a consented or at least 
organized terminology, but also unclear borders between features (e.g. “templates”) 
and supported enterprise functions (e.g. “billing”). Most of the categories used by 
Medfloss.org (2.1) can also be found in the articles: license, database, platform, 
programming language, language. Further categories describing privacy, security, 
usability, performance, customizability, user and developer support issues should be 
considered for inclusion into HITO.    
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3. Results 
Based on our mixed-methods approach, we made the following design decisions for 
HITO V2 and explain them referring to the well-documented Bahmni software [14]: 
(A) All categories for the description of MEDFLOSS used on Medfloss.org are 
integrated into HITO V2 as classes because of their importance rating (2.1) 
and their use in MEDFLOSS literature (2.4). For example, Bahmni uses the 
license “AGPL 3.0” and supports the platform “CentOS”.  
(B) Functionalities of software products are described by combinations of 
supported enterprise functions and features (2.2, 2.4), e.g., Bahmni supports 
the enterprise function “Patient Registration” for which it provides the features 
“Register patients with their demographics”, “Identification contact”, etc. In a 
further step, these citations of software descriptions can be linked to entries of 
established catalogues for enterprise functions (e.g. [6,7]), and features (e.g. 
[6]), respectively. The enterprise function “Patient Registration” can be linked 
to the RDHIS function “Administrative Patient Admission”, for example. See 
Figure 1 for the corresponding HITO classes and relationships. 
 
Figure 1. HITO V2: Relationships between functions and features as UML class diagram. Every citation of a 
MEDFLOSS description can be linked to a “classified” entry of a catalogue.   
(C) The RDHIS is transformed into a reference model for the domain layer of 
health information systems which includes enterprise functions for specific 
diagnostics and therapies, mobile health, research and public health (2.2).  
(D) The class “Software product” is linked with itself by a “part of” relationship 
(2.3). Thus, the relationship “Open MRS is part of Bahmni” can be expressed. 
HITO V2 is available as Linked Open Data as RDF on https://hitontology.eu [3]. 
4. Discussion and Conclusion 
Using a mixed-method approach, HITO could be extended by a variety of classes for 
the description of MEDFLOSS projects. Besides rather technical characteristics like 
platform or programming language, the precise description of software functionalities 
for medicine and health care plays an important role for the selection and comparison 
of MEDFLOSS. Thus, the domain-specific description abilities of HITO can be 
considered as one of its strengths and could, in the future, make it comparable to the 
EDAM ontology used in bioinformatics to describe operations and data [15]. However, 
due to the different terminologies for functionalities and application system types 
already in use, a unification of terms cannot be achieved in the short term. The HITO 
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project therefore integrates different existing terminologies for features and enterprise 
functions with the long-term goal of linking their terms. 
Although a user searching for a specific software often relies on allegedly 
established terms for application system types (e.g. EHR, EMR, PACS, LIS), these 
terms are not clearly defined. For example, an “electronic health record (EHR) software” 
might be developed for the use in practices, hospitals or healthcare networks. It may be 
the electronic collection of patients’ documents or it may provide full medical process 
support. For this reason, HITO currently focuses on functional descriptions. After 
describing a large number of software products, clustering might help to improve 
definitions of application system types. However, coming to a huge amount of 
meaningful MEDFLOSS descriptions by HITO depends on good documentation of the 
software projects and the commitment of the community. 
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Abstract.Multimorbidity is a major problem for patients and health services. How-
ever, we still do not know much about the common trajectories of disease accumu-
lation that patients follow. We apply a data-driven method to an electronic health
record dataset (CPRD) to analyse and condense the main trajectories to multimor-
bidity into simple networks. This analysis has never been done specifically for mul-
timorbidity trajectories and using primary care based electronic health records. We
start the analysis by evaluating temporal correlations between diseases to determine
which pairs of disease appear significantly in sequence. Then, we use patient tra-
jectories together with the temporal correlations to build networks of disease ac-
cumulation. These networks are able to represent the main pathways that patients
follow to acquire multiple chronic conditions. The first network that we find con-
tains the common diseases that multimorbid patients suffer from and shows how
diseases like diabetes, COPD, cancer and osteoporosis are crucial in the disease tra-
jectories. The results we present can help better characterize multimorbid patients
and highlight common combinations helping to focus treatment to prevent or delay
multimorbidity progression.
Keywords. multimorbidity, electronic health records, disease trajectory, multiple
disease progression model
1. Introduction
Multimorbidity (the coexistence of two or more chronic diseases in an individual) is a
growing health and healthcare challenge. There is significant evidence showing that the
prevalence of patients with multiple chronic conditions has increased over time [1]. Nev-
ertheless, we still do not know the temporal dynamics of disease accumulation over time
in the development of multimorbidity. In this paper we study which are the trajectories of
disease accumulation that patients follow to become multimorbid. Understanding what
are the characteristics of these trajectories can be helpful to better identify and predict
the disease progression of patients. We adapt the methodology proposed by Jensen et
al [2] and we apply it to primary care electronic health records (EHRs) instead of sec-
ondary care EHRs. If we want to study multimorbidity we need to use primary care data
since most chronic condition are treated in general practice. However, it is challenging
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Table 1. List of chronic conditions in scope
Atrial Fibrillation (AF) Anxiety Alcohol problems
COPD Coronary Heart Disease (CHD) Chronic Kidney Disease (CKD)
Cancer Chronic liver disease (CLD) Depression
Diabetes Dementia Diverticulitis of intestine (Div)
Epilepsy Glaucoma Hypothyroidism
Heart Failure (HF) Inflammatory Bowel Disease (IBD) Learning Disabilities (LD)
Multiple Sclerosis (MS) Motor Neurone Disease (MND) Osteoporosis (Osteo)
Osteoarthritis Peripheral Arterial Disease (PAD) Parkinson’s disease
Psychoactive substance misuse
(Substance) Prostate disorders Psoriasis
Rheumatoid Arthritis (RA) Stroke or TIA Severe Mental Illness (SMI)
to work with primary care data because it is not standardized between countries and the
disease coding system used in the UK cannot be directly mapped onto the ICD-10 coding
system. We are the first to apply this methodology to find trajectories of chronic disease
accumulation using this type of data.
2. Data
To perform the analysis we used the CPRD (Clinical Practice Research Datalink) dataset
[3] that contains EHRs from general practices across the UK. Our study included 1.1
million English people aged 45 and over, followed up from 2001 to 2010. Since there
is no clear definition of the chronic conditions that define multimorbid patients we com-
bined 3 different approaches to decide which were the diseases of interest: a systematic
literature review of the diseases included in multimorbidity studies, the NHS Quality and
Outcomes Framework disease list and expert advice from primary-care clinicians and
clinical epidemiologists. Our final list is shown in Table 1. The CALIBER platform [4]
provided the data extracts and phenotyped the disease codes.
3. Methods
The method used is based on Jensen et al [2] and we adapted some aspects of the imple-
mentation to the specific circumstances of this analysis.
First, we computed the Relative Risk (RR) between all the pairs of diseases. The
Relative Risk between disease A and B measures if A is a risk factor for B (i.e. a temporal
correlation measure): RRA→B =
P(Bt=T=1|At=0=1)
P(Bt=T=1|At=0=0) , where At and Bt are random variables
of being diagnosed or not with diseases A and B at time t. We estimated 5-year RRs by
matching each patient with At=0 = 1 (exposed group) to N comparison groups where
At=0 = 0. The comparisons groups were matched at baseline by sex, age and deprivation
index. We computed the P−values as the proportion of comparison groups where the
count of cases with Bt=5 = 1 is larger than in the exposed group. We selected all pairs
A → B with RRA→B > 1 and P-value < 0.05. In case of selecting both A → B and B →
A we checked which direction was more significant. To evaluate the directionality we
performed a Binomial test with the number of cases NA→B and NB→A in each direction.
We kept at most one direction if it had P-value < 0.05.
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Once?all?pairs?of?relevant?directions?were?obtained?we?went?through?the?dataset?to?
find?patient? trajectories?formed?only?by? these?pairs.?If?a?patient? is?diagnosed?with?A?→?
B?→?C?→?D?we?considered?that?trajectory?for?our?analysis?if?all?the?pairs?A?→?B,?B?→?C?
and?C?→?D?are?relevant.?We?only?selected?trajectories?with?at?least?4?diagnosed?conditions?
and?with?at?least?5?patients?going?through?that?trajectory.?Afterwards,?we?merged?all?these?
trajectories?to?form?a?network?where?each?node?represents?a?disease.?Finally,?we?clustered?
the?resulting?network?using?the?Markov?Cluster?Algorithm?[5].
4.? Results
We? used?RRs? to?measure? the? temporal? correlation? between? the? different? diseases.?To?
compute?the?RRs?we?used?1000?comparison?groups?for?each?exposed?patient.?In?Figure?
1?we?show?the?significant?5-year?RR?between?all?pairs?of?diseases.?From?the?870?pairs?of?
disease?we?find?that?648?have?RR>?1?and?P-value?<?0.05.?There?are?281?pairs?of?diseases?
(A,B)?where?RRA→B?>?1?and?RRB→A?>?1?and? the?P-values?are?under?0.05.?Therefore,?
we?checked?for?directionality?to?select? the?most?significant?directions?of?the?two.?After?
removing? the? less?significant?directed?pairs?we?obtained?367? relevant?directed?pairs?of?
diseases.
Figure 1. Relative Risks heatmap. The x-axis represents the baseline disease and the y-axis the follow-up
disease. The x-axis and y-axis follow the same numerical index. The black dots indicate that RR < 1 or
P-value< 0.05 so the relative risk is not significant. There are values with RR> 10 but for visualization pur-
poses we have limited the colorbar range.
We searched disease trajectories from patients in the CPRD dataset formed exclu-
sively by these significant pairs of diseases and with at least 4 diagnoses in the trajec-
tory. Then, we merged all trajectories that have at least 5 patients going through them
and we obtained a network of diseases where the diseases are the nodes and the edges
are the transitions in the trajectories. We applied the Markov Clustering Algorithm [5]
to the network and we obtain two clusters. The main cluster is shown in Figure 2 and
contains 16 diseases. To visualize the second cluster in Figure 3 we added 3 disease long
trajectories. There are some diseases that do not appear in any of the two clusters since
they do not appear in 3 long patient trajectories formed by RR significant pairs. These
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Figure 2. Main cluster of disease trajectories. The edge width represents the number of patients going through
that diagnose sequence
Alcohol problems
Diverticulitis of intestine
Parkinson
Motor neurone disease
Depression
Severe mental illness
PsoriasisChronic liver disease
50025010050
Number of patients:
Figure 3. Second cluster of disease trajectories or Depression cluster. The edge width represents the number
of patients going through that diagnose sequence
two clusters describe the most common trajectories of chronic disease accumulation. The
main cluster network was build using trajectories of 4 conditions. Consequently, there
are disease trajectories that start in a node with incoming edges.
5. Discussion
In this analysis we used EHRs from primary care to investigate the sequence in which
patients get multiple chronic conditions. When studying multimorbidity it is not clear
which are the chronic conditions that need to be taken into account. Thus, we decided
to focus on a relatively small but prevalent number of diseases to understand what are
the most common trajectories that multimorbid patients follow. We started by comput-
ing the RRs between diseases to evaluate the temporal correlation between any pair of
conditions. Previous studies have focused on studying RRs of specific pairs of diseases.
However, we were able to directly estimate 648 RRs thanks to the large dataset used.
Most RRs related to learning disabilities, multiple sclerosis and motor neurone disease
were found not significant due to the small amount of diagnosed cases. It is not possible
to compare directly these RRs to previous studies because the time frame and disease
definition can vary. Nevertheless, we found similar estimates for multiple pairs like CKD
and Dementia [6] or PAD and CHD [7].
The main cluster shown in Figure 2 condenses the most common trajectories to
multimorbidity into a single network. We can see how diseases like cancer, COPD, dia-
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betes?and?osteoporosis?are?central?in?the?progression.?We?also?can?observe?clinically?well?
known? trajectories? like?Diabetes?→?PAD?→?Stroke?[7].?The?second?cluster? in?Figure?3?
shows?reasonably?expected?alcohol?problems?related?trajectories?with?depression?as?the?
initiating?disease.?However,?there?are?many?other?trajectories?that?the?two?clusters?do?not?
cover.?A?dataset?with?a? longer? follow?up?period?would?help? improve? the? results? since?
we?would?be? able? to?observe?more? complete? trajectories.?Previous?work?have? applied?
this?methodology? to?Secondary?Care?data?and? ICD-10?codes? [2].?However,? secondary?
care?data?does?not?capture?most?of?the?long?lasting?chronic?conditions?that?multimorbid?
patients?suffer?from.
We?know?that?sex?and?deprivation?index?are?key?factors?to?understand?multimorbid?
patterns?[8].?Consequently,? in? the?future?we?should?focus?on?finding?specific? trajectory?
networks?for?different?population?subgroups.
6.? Conclusion
We?used?a?data?driven?method?to?obtain?networks?that?describe?the?main?trajectories?that?
patients?follow?to?become?multimorbid.?The?application?of?this?method?to?a?primary?care?
dataset? like?CPRD?confirms? some?of? the?already?know? temporal?correlations?between?
diseases?and?detects? longer? less?known?disease?sequences.?However,? this?method?does?
not?capture?all?the?complex?patterns?that?multimorbid?patients?follow.?A?main?limitation?
of? the?model? is? that? it?only?uses?a?directionality?between? the?pairs?of?diseases.? In? the?
future?we?should?focus?on?detecting?specific?trajectory?patterns?for?different?populations?
subgroups.
This?work?was? partially? supported? by? the?National? Institute? for?Health?Research?
Collaboration? for?Leadership? in?Applied?Health?Research? and?Care?North?Thames? at?
Bart’s?Health?NHS?Trust.?The?views?expressed? in? this?article?are? those?of? the?authors?
and?not?necessarily?those?of?the?NHS,?the?NIHR?or?the?Department?of?Health?and?Social?
Care.?The?NIHR?UCLH?Biomedical?Research?Centre?and?EPSRC?grant?M020533/1?also?
supported?this?work.
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Abstract. Social determinants of health (SDH) are a valuable source of health 
information which still are not fully utilized in the clinical space. Knowing that a 
certain patient has trouble finding transportation, has a potentially hazardous 
relationship with a family member or close relative, is currently unemployed, or 
various other social factors would allow providers to tailor treatment plans in a way 
to best help that patient. However, these SDH must be gathered, represented, and 
stored in a standardized way before they can be leveraged by informatics tools 
designed for health providers. This process of translating SDH to standardized 
clinical entities includes two main steps. The first is a collaborative effort to establish 
an ontology of medical terminology codes (i.e., ICD, SNOMED, LOINC, etc.) which 
can be used to uniformly represent SDH as coded concepts. The second is a 
collaborative effort to use the FHIR standard to create profiles and extensions which 
will allow FHIR resources to be used to store the coded SDH as clinical entities. 
Each of these steps has their own complexities that must be considered and 
accounted for in future efforts to create interoperable clinical informatics solutions 
which utilize SDH. 
Keywords. Social determinants of health, FHIR, interoperability, translational 
informatics 
1. Introduction 
The World Health Organization (WHO) recommends “systematically addressing” social 
determinants of health (SDH) to improve the health of the population as a whole [1]. 
Although there are many medical schools which provide training regarding SDH [2], 
some research has noted that current training strategies which “focus on knowing rather 
than acting cannot effect the change which will reduce health inequity in a meaningful 
way [3]. One recent study developed five categories of activities which should be used 
in tandem to fully address social needs. There, the authors describe the need of 
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developing an interoperable digital infrastructure that can easily share data between 
healthcare and social care organizations. The study also showed awareness as being just 
the first step in addressing a social issue; the other four categories include adjustment, 
assistance, alignment, and advocacy [4]. 
However, despite their potential implications in health, SDH are not a commonly 
utilized data source in most clinical workflows. Healthcare providers are already 
collecting some of this data, although this collection often occurs in an inconsistent and 
unstructured way. A structured, standardized method of SDH data collection by providers 
could inform individualized treatment, improve care coordination, and allow for a better 
population-level understanding of social and health equity for policy makers and 
healthcare system administrators. There are a few current informatics solutions that have 
sought to utilize SDH within the healthcare provider’s office [5-6]. However, these are 
specific use-cases implemented among relatively small populations. In order to increase 
the population sizes included in such studies, interoperability must be a priority. This 
will allow cross-site deployment and wider-scale evaluation. 
2. Background 
The translation of SDH to standardized clinical entities is a complicated process due to 
the sheer number of stakeholders (i.e., government organizations, hospital systems, 
providers, clinical vocabulary creators, etc.) involved in the standardization of any 
clinical process. However, the informatics solutions discussed here will provide a high- 
level overview of the domains that decision-makers in SDH clinical implementation 
projects require. 
The WHO defines SDH as “the conditions in which people are born, grow, work, 
live, and age, and the wider set of forces and systems shaping the conditions of daily life 
[1].” Marmot et al. summarized the relation of SDH to health as follows: “The poorest 
people have high levels of illness and premature mortality—but poor health is not 
confined to those who are worst off. At all levels of income, health and illness follow a 
social gradient: the lower the socioeconomic position, the worse the health [3].” 
Commonly assessed SDH include employment status, education level, food security, 
access to health services, housing status, income, discrimination, and social support [7]. 
The HL7 Fast Healthcare Interoperable Resources (FHIR) Specification is an 
ongoing effort to create a clinical data standard which enables the kind of interoperability 
which is necessary to fully utilize informatics tools and solutions. It abstracts clinical 
data concepts into separate resources. These resources are given unique identifiers which 
are used to string them together in order to represent all possible clinical scenarios [8].  
The branch of translational informatics is becoming an increasingly important aspect 
of health informatics research. As its name suggests, translational informatics is the 
process of translating data from its original form to another using informatics methods. 
In health informatics, this has enabled various data sources to be utilized by informatics 
solutions in the clinical space in a standardized way. A sampling of these data sources 
includes environmental sensors, wearable health tools, imaging devices, various -omics 
databases, and detailed drug pharmaceutical research resources. In each case, the data is 
not formatted for clinical use and must be translated to a common clinical data standard 
before it can be used for interoperable clinical informatics solutions. Because these data 
are so potentially useful in clinical use, translational informatics has been named as an 
important milestone in achieving a nationwide learning health system [9]. 
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3. Methods 
The first step in a translational informatics approach to standardize the clinical use of 
SDH is to establish a shared ontology which coordinates the representation of any single 
determinant as a coded concept. This ontology could draw from established clinical 
coding systems such as SNOMED CT or ICD-10. Creating an ontology would allow 
separate efforts to build on each other rather than duplicate work. 
One study worked to create a compendium of structured, codable social risk factors 
from common medical terminologies (i.e., SNOMED, LOINC, and ICD) [10]. 
Subsequent efforts should build upon such efforts in a collaborative way to achieve a 
robust common clinical data set (CCDS) of SDH which can be formally adopted and 
used for future SDH clinical solutions. Coding the determinants is the first step to various 
downstream interventions which enhance the value of care provided to patients. 
Standardizing the coding process with a shared ontology will result in a uniform 
knowledge source. 
While mapping SDH to clinical codes is an important first step, it must be coupled 
with a standardized approach to storing them as clinical data entities. The clinical 
standard most suited for this purpose is the HL7 FHIR specification which is comprised 
of detailed resources (e.g. Observation, Condition, etc...). These resources require 
concepts to be coded to medical terminologies. However, each of these base resources 
would need to be properly extended in order to ensure that different research efforts 
would be able to maintain interoperability. This extension process relies on FHIR profiles 
to be created and published which specify how the relevant resource would need to be 
adapted to accurately represent the specific new data type in question. These efforts are 
typically undertaken by coordinated working groups and result in a FHIR 
Implementation Guide (IG). The IG walks future implementers through the process of 
creating the specific resources and extensions. 
4. Results and Discussion 
As is the case in any informatics efforts, collaboration and standardization are the 
catalysts for real progress. The creation of a robust ontology of SDH medical terminology 
codes, and the utilization of the FHIR standard for the standardized clinical 
representation of SDH, is a vast undertaking. The following considerations are additional 
points which should be carefully considered by those who join this effort. 
A working group, known as the Gravity Project, has recently been announced which 
will tackle the complex issue of specifying FHIR profiles and extensions which can be 
used to store SDH [11]. Their coordinated efforts to profile various SDH will result in 
an IG to assist in the standardized adoption of FHIR resources to represent SDH. SDH 
are varied and many FHIR profiles may already exist for certain determinants in 
connection with other clinical use-cases. Care should be taken by researchers to ensure 
that existing work is built upon and only modified if necessary. FHIR can also provide 
important interoperability and standardization to the process of SDH collection. The 
FHIR Questionnaire resource is a versatile option for representing SDH-gathering 
questionnaires or question sets. It allows each question to be internally represented with 
a corresponding clinical code. SDH have historically been gathered through sets of 
questions which probe the patient’s lifestyle and other aspects typically associated with 
SDH. Due to the nature of SDH data, its collection often requires patient self-reporting. 
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For example, although patient addresses are frequently used to infer socio-economic 
standing from census tracts, ZIP codes, and other community area designations, this 
method is dependent on survey and census material which is often outdated [12]. To 
assume that the patient is poor, based on that address alone, would result in incomplete 
information for that determinant. Since most approaches to clinical SDH gathering will 
use direct questions to avoid that unreliability, using FHIR Questionnaire resources 
would allow questionnaires to be used across institutions. 
Responses to these questionnaires can be represented as FHIR 
QuestionnaireResponse resources. While using a FHIR Questionnaire ensures that the 
SDH are captured as coded concepts, an additional step is necessary to create a profiled 
FHIR resource for each relevant question response. For example, although a positive 
response to question on smoking history would result in a corresponding coded SDH 
within the QuestionnaireResponse, an additional step would be required to create a 
profiled FHIR Observation resource to represent that information. An informaticist 
querying for information on that patient’s smoking history will be guided by the smoking 
status profile and will look for that corresponding resource, not for an obscure response 
within a QuestionnaireResponse resource. Coding a patient's smoking history as a FHIR 
Observation resource would allow for the data to be queried by relevant CDS solutions 
for all subsequent patient interactions. This method also enables patient-level, system- 
level, or population-level analysis of both the questionnaires and the unique, standardized 
clinical concepts. 
The creation of an SDH ontology will be further complicated by the fact that there 
is a high level of overlap between the common medical terminologies. Reconciling this 
overlap will require collaboration and iterative feedback from relevant stakeholders. 
However, it is a crucial first step because despite the clinical standardization available 
through FHIR, the value is lost if the underlying representation of SDH is ambiguous. 
5. Conclusion 
Clinical informatics is a field which continues to present new opportunities for utilizing 
nontraditional medical data sources. Combining clinical informatics and translational 
informatics can be a powerful source of innovation. SDH represent a vast and varied 
source of data which can have important implications for health services. However, in 
order to use SDH in a clinical setting, they must be translated to standardized clinical 
entities. Following our approach will require a collaborative effort to curate a robust SDH 
ontology and to create the necessary FHIR profiles and extensions to store SDH in the 
clinical space. As this work moves forward, it will allow health professionals to provide 
more informed care for their patients and will likely inform later efforts to create new 
interoperable clinical informatics solutions which use other nontraditional data sources. 
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Abstract. Ballisto- and seismocardiography (BCG/SCG) are methods of studying 
blood circulation and cardiac function by using the vibration measurements at the 
body surface, e.g. via accelerometers. The aim of this work is to show the current 
relevance of BCG/SCG for the target medical diagnostics. To reach this goal and to 
examine the relevance, an overall search for all BCG and SCG articles in the databases 
PubMed and IEEEXplore was first carried out ("ballistocardiography OR 
seismocardiography") for the years till 2019. The results of this literature study show, 
overall 425 papers for the years from 2003 till 2019, with BCG (317) as significantly 
stronger represented than SCG (120). The distribution of the included subjects shows 
that a smaller group (n<=10) of mostly healthy people is more common. Last but not 
least, we examined which sensors have been included in the articles since 2003, with 
the result that accelerometers, whether as self-developed prototypes or installed in 
smartphones, were used in slightly less than 50% of the articles found. The differences 
in the numbers of publications between BCG and SCG may also be due to the 
distinction’s complexity between BCG, which is more intuitive, and SCG. Looking at 
the number and distribution of included subjects, it is noticeable that this is rather low 
and primarily healthy subjects are used. However, the publication increase indicates 
that we are at a threshold in this topic and actual benefit to medicine. 
Keywords. Review, Ballistocardiography, Seismocardiography 
1. Introduction 
Ballisto- and seismocardiography (BCG/SCG) are alternative methods for studying blood 
circulation and cardiac function. In this case, the BCG maps the pulse wave with its 
parameters via recording at the extremities, the head (often large vessels) or structures 
adjacent to the body [1,2]. The SCG is more likely to be recorded at the thorax and shows 
direct functional parameters of the heart, such as valve closure [1–3]. These methods can 
be used to perform long-term cardiovascular or respiratory illnesses, as a support or 
extension of common techniques such as the ECG. 
As early as 1877 J. W. Gordon published a treatise on "Certain Molar Movements of 
the Human Body Produced by the Circulation of the Blood" and thus a cornerstone of the 
BCG [4]. Over the years, BCG and other forms, such as SCG, have evolved. New feature 
parameters such as pulse transit time as a marker for blood pressure, have come into focus 
[3,5]. But what about today with these methods of cardiovascular diagnostics. 
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 Especially related to the improvement of technical devices, e.g. sensors, in terms of 
size, cost or performance, BCG/SCG could contribute to improve diagnostics and care. 
The motivation of this work is not only to show the current relevance of BCG/SCG 
for the target medical diagnostics, but also current research content, such as subject 
properties or measuring system setups. The aim is to be able to make a statement if the 
technology of BCG/SCG is really increasing and gaining importance in the research field 
of medical diagnostic. 
This includes the questions about the origin of articles since 2003, as well as the 
investigation of different research circumstances, such as the extent of the subjects, the set 
of subjects, used sensors. 
2. Method 
To answer these questions from the introduction and to examine the relevance of 
BCG/SCG, an overall search for all BCG and SCG articles in the databases PubMed and 
IEEEXplore was first carried out ("ballistocardiography OR seismocardiography"). For 
the investigation of the articles found, after elimination of duplicates, no limitations were 
made on the date of publication or the settings, e.g. Animal experiments or similar. 
 
Figure 1. Amount of BCG/SCG papers over the years. 
 
In Figure 1, the results of this overall search approach can be seen. We identified 2003 
as the start of the renewed upswing in BCG/SCG research. With the adaptation of the 
literature search from May 2019 to the period beginning with the year 2003 up to the date 
of the search, the Prisma method for the literature search was continued [6]. 
After analyzing the paper found between 2003 and 2019, it was filtered for use in 
human medicine. In addition, review articles were excluded. With the inclusion of the 
found articles, the first author's seat, sensor technology, subject structure, number of 
subjects, general setting and the focus of the described work were extracted. 
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 3. Results 
The results of this literature study show, overall 425 papers over the years 2003 till 2019, 
that BCG is significantly stronger represented within the article than SCG (317/120). 

Figure 2. Amount of publication of BCG (first) and SCG (second) sorted by country (only top 5). 
However, a slight increase after 2007 is to be noted, as can be seen in Figure 2, a 
rather linear, marked increase in publication figures overall. For the SCG, the number of 
releases increased since 2011. In both cases, the US is the country with the most 
publications over the years (see Figure 2). 
In addition to the general results on the distribution of the articles found by years and 
countries, with regard to the focus on BCG or SCG, it was further considered how the 
subjects in the respective publications composed. This includes not only the number of 
subjects, but also the composition of the groups of subjects, for example by the inclusion 
of healthy subjects or subjects with heart diseases (e.g., heart failure) or other disorders 
(e.g., sleep disorders). In Figure 3, we graphically analyzed the results of the subject 
analysis with regard to the articles found. The number of subjects in Figure 3 (left) is the 
distribution of the subjects used, considering the number of found items. The figure clearly 
shows an increase in the number of 1 to 5, 10 and 20 subjects. 
Looking now at the distribution of the subjects included in the articles found, Figure 3 
(top left), a clear majority of the inclusion of healthy or heart-healthy subjects is evident. 
Last not least, we examined which measurement technologies have been included in the 
articles since 2003, with the result that accelerometers, whether as self-developed 
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 prototypes or installed in smartphones, were used in slightly less than 50 percent of the 
articles found. The others were pressure sensors and weighing scales. Looking at the 
general focus of the articles found, the majority has a medical focus, such as  the  analysis  
of  signal  parameters  for  diagnostics  (total   of   338   articles).  Only 72 articles have a 
more technical focus, such as the usability of specific sensors  
 
4. Conclusion 
Considering the listed results of this literature review on ballisto- and seismocardiography 
with a focus on the distribution to the focus area as well as the examination of the included 
subjects and the used sensor technology, an increasing number of publications starting 
from the year 2003 are shown. As a limitation of the review it has to be mentioned, that 
Figure 3. Number of used subjects in publications (left), type of used subjects (top right) and used sensing 
technology (bottom right). 
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 we only used PubMed and IEEEXplore, which can be handled to mark a tendency and is 
not to be understand as complete. The publication slump which begins in the late 1970s 
can certainly be attributed to the development of image-based procedures, such as MRI 
and CT. The smaller peak in 2008 and the overall positive publication trend are certainly 
attributable to the smartphone as a new sensor system, as well as to technical developments 
(e.g., MEMS). 
The differences in the numbers of publications between BCG and SCG may also be 
due to the complexity differences between the two methods. So, the BCG is a more 
intuitive method with less difficult to identify features than the SCG. The increasing 
number of SCG publication figures can certainly be attributed to the increasingly sensitive 
sensor technology as well as the previous experience and findings in signal analysis. 
Moreover, Taebi et al. describe the challenges of the SCG, alone in the determination of 
the measuring position [7]. The distribution in the world shows the relevance of the topic 
worldwide, while North American, European and Asian research groups can be identified 
in the BCG area as well as in the SCG. 
Looking now at the number and distribution of included subjects, it is noticeable that 
rather low and primarily healthy subjects are used. This is certainly due to the still early 
stage of BCG/SCG research. Of course, it is still kind of basic research, with meanwhile 
reaching consensus on basic signal BCG/SCG structures [see 2]. 
It is moreover interesting that beside the more obvious subject group of healthy and 
heart related subjects, the field of sleep issues are a noticeable field. For sure in a supine 
position while sleeping is near an optimal setup for BCG/SCG measurements. 
But once again, SCG complexity shows itself (see also [7]). However, the increase in 
"diseased" subjects and in the number of papers in the recent years indicates that we are 
at a threshold in this topic and the actual benefit to the medicine, e.g. as diagnostic support, 
may be in the near future. 
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Abstract. Scarce literature exists as to the use of Petri Nets (PN) to model the 
dynamic evolution of health issues in a deterministic way. Starting from the HIN 
(Health Issue Network) approach, the paper aims at describing the suitability of 
PN in supporting the Case–Based Learning method for improving an educational 
simulation environment in which students can manage realistic clinical data  
related to the evolution of a patient's health state over time. 
Keywords. Health Issue Network, Case-Based Learning, Electronic Health 
Record, Petri Nets, Medical education 
1. Introduction 
The increase of both life expectancy and incidence of chronic diseases and disabilities 
in western societies that goes under the name of “epidemiological transition” [1] 
implies that nowadays physicians must provide healthcare activities over time to 
patients with multiple chronic diseases and, eventually, with an acute concomitant 
condition. Unfortunately, the concept of time is not present in current models of 
clinical reasoning [2-4], as they focus on the cognitive process of making a diagnosis 
and do not address the problem of how medical conditions evolve over time in a 
patient’s clinical history, and/or how each condition interferes with the evolution of the 
other co-existing conditions. Case–Based Learning (CBL) is one of the most effective 
methods for teaching/learning clinical reasoning [5]. CBL has been successfully 
implemented through computer-based simulations [6], but these “virtual patients” are 
generally acute cases rarely described under the perspective of health evolution over 
time. Although the clinical question “What is the diagnosis in this patient?” remains 
pivotal, our aim was to develop the ability to answer to three other important questions, 
that is: starting from the available information on a patient in his/her present state (i.e. 
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given a specific pathophysiology and treatment), (1) how health conditions may evolve 
in the future given the present patient’s health status? (2) which past health conditions 
have possibly evolved in the present health status? (3) which health conditions have 
influenced the evolution of other health issues?  
The HIN (Health Issue Network) approach was introduced [7] to improve CBL in 
a simulation environment for medical education. HIN allows: (i) reconstructing the 
implicit knowledge that lies behind and origins the physician’s way of thinking, turning 
it into an explicit knowledge that makes possible to extract real clinical cases from 
Electronic Health Records; (ii) formalizing the description of an evolution path of a 
health issue of a person, through the implementation of the Petri Nets (PN) formalism 
[8], which is capable of translating HIN’s key concepts in a graphical language. In HIN 
the PN marking represents the health status of a person, which evolves from one issue 
to another: each place node can only contain one token at a time. The transition from a 
HI (place node of the PN) occurs via a well-defined evolution (transition node of the 
PN) – PNs are bipartite graphs. Moreover, HIN model is a P/T safe net [8]. More 
details on the HIN model can be found in [7]. 
The present work investigates more in depth how Petri Nets, and therefore the HIN 
model, are an accurate way to represent the evolution of a patient's health state over 
time. The article summarizes the main features of the HIN model, discusses why PNs 
are suitable as a formal model underlying the HIN model and highlights the added 
value of HIN project. 
2. Basic concepts of Health Issue Network 
The guiding idea of HIN is a network of clinical problems as a basis for modeling a 
person’s medical history. Each episode of care starts with an initial clinical problem 
(e.g. a symptom) and is described by its evolution together with the healthcare 
activities that make up the care path implemented to solve the original issue. The HIN 
model is characterized by two key concepts underlying the evolution of a health state: 
(i) health issue (HI), that is any problem related to a patient's health (diagnosis, 
diagnostic hypothesis, symptom, sign, condition or risk factor, iatrogenic problem, 
general class of problems) [9], and; (ii) evolution, that is any change in a HI through 
which the patient moves from one health state to another. Five fundamental evolutions 
have been identified: examining in-depth, worsening, complication, recurrence and 
improvement. A HI can evolve for its own dynamics and/or – if more than one HIs 
occur in the same patient – be influenced by other HIs in its evolution. Both evolutions 
and influences are intended as probabilistic events, but in the real history of a patient, a 
HI evolution has occurred or not: alternative paths (evolutions in conflict) do not exist. 
3. The choice of Petri Nets 
In order to represent the evolution path of a person’s health state, the choice of the Petri 
Nets formalism is based on the characteristics of the evolution path, as these well 
match with the properties of the PNs. Moreover, PNs allow to reduce the complexity of 
real clinical cases of patients with chronic multimorbidity into a rather simple 
mathematical model, which allows a representation of cases suitable for an educational 
environment, in particular: realistic as to its ability to reproduce the concepts of 
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evolution of HIs and influence between HIs; customizable according different learning 
outcomes. Here following are some of the properties of PN related to their use in a 
HIN-based simulation environment to represent clinically meaningful situations: 
the PN is a linear system – the aim of the HIN approach is to extract real cases 
from medical records and let the students carry out exercises based on real/realistic 
data. The learning outcome is the ability to identify the HI evolutions that really 
occurred. A patient's clinical history is the “sum” of the evolutions of each HI and, at 
any given time, the patient’s health state is the “set” of the active HIs. The evolution 
over time of a patient's health state can then be represented as a linear system 
composed by a series of defined states. For example: in a patient with chronic 
pulmonary disease (COPD) and initial prostatic hypertrophy (BPH) these co-existing 
HIs make up the initial health state and the clinical history is composed by all the 
evolutions of these HIs. PNs represent a series of transitions in a deterministic manner. 
Moreover, in PNs the effect of a “sum” of input perturbations is equal to the “sum” of 
the effects produced by each individual perturbation, with the possibility of breaking  
up a linear problem; 
the PN is a discrete distributed system – not all HIs are connected to each other: 
this implies that the evolution of a patient’s health state actually comprises parts 
(subnets) that can be independent from each other. In the above example, the BPH can 
worsen and produce the need for surgery without any influence on COPD. A PN – as 
well as the system of the evolving health states; 
the PN (as evolution of a patient's health state) is an asynchronous system – the 
evolution concerns one HI at a time and not more HIs together. Since each health state 
can be interpreted as sum of several partial and independent subnets, an evolution only 
influences a part of the overall state; the firing of an evolution at a time preserves the 
locality of evolution of HIN diagram: two unrelated evolutions “never occur at the 
same time”. In the above example, surgery makes the HI BPH evolve into “operated 
BPH”. Because of the process of care (surgery) the HI COPD may evolve in “acute 
respiratory failure”. If the patient has another unrelated HI (for example a symptomatic 
uncomplicated diverticular disease), this can evolve or not, but in any case, its 
evolution is recorded in a different time than the other ones; 
a PN is a system without memory – when an evolution takes place, a new health 
state must be assessed to envisage potential health evolutions: new possible evolutions 
may have been enabled and some others disabled; the identification of the new 
potential evolutions doesn’t depend on how the new health state has been reached. 
Furthermore, for the educational purposes of HIN, the input to every single evolution 
of an HI is made up of all the HIs that make the firing of that evolution possible. In the 
above example, in managing the patient with a present state of BPH and COPD, a 
physician can only envisage through what series of evolutions the patient got to his 
present state. The set of previous evolutions are summarized in the actual state but 
cannot be detailed or inferred in any way. 
Table 1. The correspondence between evolution for a patient's health state and for Petri Nets 
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Tab.1 shows the kernel of the correspondence between the concepts of the 
evolution for a patient’s health state and those for a PN system.  
4. Results: the use of Petri net in the simulation environment 
The HIN method also deploys the computational properties of PNs. The three 
previously reported clinical questions can be solved in terms of the PN property of 
reachability [8]. These questions can be expressed as: (i) which HIs are achieved 
starting from a specific health state? (ii) which HIs are needed to reach a specific HI? 
(iii) what link exists between two identified HIs? Example: the learning outcome is the 
management of a patient with chronic co-morbidities (cardiac and renal failure) 
undergoing abdominal surgery for cancer and developing complications. The left box 
of fig. 1 shows the PN that represents the prototypical clinical condition, while the right 
box shows the HIN of a real case, selected from a database of medical record according 
to the selection criteria derived from the learning outcome. The real case has much 
more details and possibly slightly different paths of evolution. 
Figure 1. An example of HIN diagrams 
Examples of the above questions (right box of fig. 1) are the following: (i) which 
HIs are achieved starting from the health state {D', C, A}? (ii) which HIs are needed to 
reach the HI C'? (iii) what link exists between the HIs C' and A'? In modelling a health 
state as a set of HIs, and therefore as a marking in the HIN model, PNs allow solving 
these clinical questions by means of the reachability graph and of a firing sequence. 
Another use of PNs is to measure the “distance2” between two HIN diagrams. This 
problem is solved via a rewriting of a PN (e.g. deleting a place-HI or a transition- 
                                                   
2 We indicate with the term distance the difference in terms of places, transitions and edges, besides the 
possibility that the two diagrams can become equal after their rewriting. 
 
Learning outcome Real case: Mario 
 
 
 
Legend: 
A: GI cancer 
C: chronic heart failure 
C’: severe chronic heart failure 
D: chronic renal failure 
E: pleural effusion 
H: diffuse peripheral oedema 
F: peritoneal effusion 
Legend: 
A’: sub-occlusion 
B: pulmonary oedema by acute hearth failure 
D’: severe chronic renal failure 
G: urinary tract infection 
G’: urinary tract infection, second relapse 
Complicanza = Complication Aggravamento = Worsening 
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evolution, or an edge). The analysis of graph distance is useful in the following 
scenarios: 
• Choice of the real case – how far is the HIN diagram of a real case from the 
HIN diagram of the condition in the learning outcome? In the example of Fig. 
1 the “distance” was analyzed between the HIN diagram for a didactic goal, 
and the HIN diagram of a real case (Mario). 
• Given a set of HIs (without the related evolutions) with an indication of the 
initial and final health states, the learner is asked to envisage the possible 
evolutions of the health state, i.e. to draw the evolutions and influences and 
link them to the related HIs: how different will be the resulting HIN diagram 
drawn by the learner from the HIN diagram drawn by the teacher as correct 
solution of the exercise? 
5. Discussion and Conclusions 
Scarce literature exists as to the use of modelling tools for representing the evolution of 
a health issue. A number of papers describe modelling tools for  developing workflows 
[10], protocols [11], or guidelines [12], but in all these cases the focus is on a flow of 
clinical activities planned and executed so as to accomplish specific tasks, or to work 
out clinical issues. No mention is made for what concerns the way activities can change 
the health state, or how this evolves over time. From an educational point of view as 
well, few works have been produced to develop educational models and tools for the 
competence of clinical management of chronic and multimorbidity conditions. 
Basically, the indications are about practical training and the use of virtual cases, which 
are not based on a sound theoretical model [13]. The HIN project is developing an 
integrated environment of theoretically based technical solutions to design, implement 
and assess the simulation of clinical cases of chronic and multimorbidity patients [7]. 
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Abstract. Healthcare spending has been growing at an increasing rate in the US, 
due in part to medical malpractice costs. Dental malpractice is an area that has not 
been studied in depth. Using National Practitioner Data Bank (NPDB), we 
explored the extent of dental malpractice claims and sought to construct a 
predictive model that can help us identify dental practitioners at risk of performing 
medical malpractice. Over 1,500 dental malpractice claims were reported annually, 
and over $1.7 billion being paid out by medical malpractice insurers over the past 
15 years. Majority of claims resulted in minor injuries, and the number of major 
injury claims increased over years. In prediction, we randomly split the data into 
train (75%) and test (25%) datasets. We trained and tuned models using 5-fold 
cross validation on the training set. Then, we fitted the model on the test data for 
performance measures. We used Logistic Regression, Random Forest (RF) and 
XGBoost and tuned the hypermeters of models accordingly through grid search 
and cross validation. XGBoost was the best machine learning model to predict the 
risk of dentists having several malpractice reports. The best performing model had 
an accuracy of 72.8% with 30.6% F1 score. The NPDB database is a valuable 
dataset to study dental malpractice claims. Further analysis of information 
extracted from this dataset is warranted. 
Keywords. Data Science, Big Data Analytics, Machine Learning, Predictive 
Model 
1. Introduction
The United States currently ranks highest in health care spending among the developed 
nations of the world. In 2017, health care spending was $3.5 trillion in total, which 
accounted for a 17.9% share of the nation’s GDP. It has also increased over 50% in the 
past 10 years, compared to $2.3 trillion in 2007 [1]. One of the reasons for the 
increasing cost of health care is defensive medicine. Defensive medicine refers to 
physicians prescribe diagnostic test or medical treatment that depart from normal 
medical practice as a safeguard from litigation [2]. According to a recent study, there is 
a statistically significant correlation between specialists concerns regarding potential 
medico-legal disputes and the choice of defensive medical procedures [3].  
Although the number of malpractice claims has decreased since 2001, they are still 
very common in the United States. According to a 2016 Benchmark Survey, a third of 
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physicians have been sued at least once in their career [4]. In addition, the average 
costs of malpractice cases have increased year over year. The malpractice insurance 
premiums have also increased accordingly, due to the high cost of malpractice claims. 
As a result, physicians’ incomes may be affected by the rising cost of doing business as 
well.  
While physicians’ (MD, DO) malpractice cases have been frequently studied in 
recent years, there is little study on dental malpractice disputes and predictive models 
on future prevention are rarely constructed [5, 6]. In this article, using data from the 
National Practitioner Data Bank, we reported findings concerning the distribution of 
dental malpractices and the extent of dental malpractice risk. By studying malpractice, 
we hope to mitigate the high insurance premiums caused by the prevalence of 
malpractice claims. Our objectives were to review recent trends in dental malpractices, 
based on cost, number of claims, severity of injuries, physicians’ and plaintiffs’ 
information; and to create machine learning models predicting dentists with higher risk 
of frequent malpractices based on their first malpractice claim. 
2. Method
2.1. Dataset 
The dataset comes from National Practitioner Data Bank’s (NPDB) Public Used Data 
File [7]. National Practitioner Data Bank, started in 1990, is a database that contains 
information related to the professional competence and conduct of physicians, dentists, 
and other health care practitioners. We accessed the data in 2019, so it included reports 
received from September 1, 1990 through December 31, 2018. 
This analysis studied dental malpractice reports aiming to find important factors 
and to identify possible practitioners who could have repeat acts of malpractice in the 
future based on characteristics of their first offence. Due to several new variables added 
since January 31, 2004, and an average 4-year-gap between an incident and its payment, 
a 10-year-period (2005 – 2014), based on the report filing year (ORIGYEAR) was used 
in this study. In addition, only dentists (LICNFELD: 30) and dental residents 
(LICNFELD: 35) were included in this study. Records with missing data were deleted. 
Furthermore, only the first malpractice report of each practitioner was kept. 
2.2. Variable Selection 
Columns that are irrelevant to malpractice, such as Adverse Action Classification, 
Basis for Action, etc., were deleted from the dataset. After adjusting for inflation based 
on CPI-U for the U.S. City Average for All Items from the Bureau of Labor Statistics, 
we replaced Payment (PAYMENT) and Total Payment (TOTALPMT) by 
PAYMENT_ADJ and TOTALPMT_ADJ correspondingly. According to guidelines, 
we created a new variable ’STATE’, which equals Work State if a work state value was 
reported and Home State if no work state was reported [7]. Since, for most practitioners, 
their License States (LICNSTAT) and their work States (STATE) are identical, we 
created a new binary variable State Difference (STATEDIFF), which is 1 if license 
state is different from state, and 0 other wise. We counted the occurrences of each 
LICNSTAT, weighed against population of that state and rescaled those values to 
between 0.0001 and 0.9999. This information was stored in variable 
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‘STATWEGHT_ADJ’. Similar to States, we created a new variable Payment 
Difference (PAYDIFF) to track the difference between payment and total payment. In 
addition, we created a variable Years of Experience (YREXP), for years between 
Graduation (GRAD) and Year of Act or Omission 1 (MALYEAR1). We also added 
variable Duration for years between MALYEAR1 and Year of Original Report 
processed (ORIGYEAR). A binary prediction variable ‘RISK’ was created based on 
the number of malpractice reports a practitioner had. The risk is 0 for a practitioner 
with only one malpractice report on record and the risk is 1 if a practitioner has more 
than one malpractice reports.  
2.3. Statistical Methods 
In variable analysis, we calculated summary statistics, such as mean, median and 
quantiles of continuous variables using standard methods. For those variables with 
skewed distribution, the Mann-Whitney test was performed to compare the difference 
between two risk levels. For variables with normal distribution, a two sample t-test was 
used. In addition, Pearson’s Chi-Square test was used to identify differences between 
some categorical variables against the two risk levels.  
In prediction, we randomly split the data into train (75%) and test (25%) datasets. 
We trained and tuned models using 5-fold cross validation on the training set. Then, we 
fitted the model on the test data for performance measures. We used Logistic 
Regression, Random Forest (RF) and XGBoost and tuned the hypermeters of models 
accordingly through grid search and cross validation. Due to imbalanced data, we 
experimented with up sampling, down sampling and Synthetic Minority Over-sampling 
Technique (SMOTE). 
All analyses were performed in RStudio (R version 3.5.3). All tests were two-sided, 
with p < 0.05 being considered statistically significant. 
3. Results
3.1. Variable Analysis 
Between 2005 and 2014, there were over 9,000 new dental practitioners who had their 
first malpractice cases reported. Of those practitioners, 7,494 (83.22%) of them were 
identified as risk free for multiple malpractices in the near future (Risk 0), and 1,511 
(16.78%) of them were identified as at risk of multiple malpractices in the near future 
(Risk 1). Improper performance was the primary type of complaint. 
Despite some fluctuations, the total number of malpractice reports generally 
decreased from 2005 to 2014. There were over 1,000 cases in 2005; this decreased to 
857 cases in 2014 (Figure 1A). Although the number of cases decreased throughout the 
ten years being studied, mean payment amount after adjusting for inflation 
(PAYMENT_ADJ) increased for both risk free and at risk practitioners. This suggests 
that the cost of malpractice increased every year (Figure 1B). In addition, mean 
payment amount (Risk 0 = $70,360; Risk 1 = $105,660) and median payment amount 
(Risk 0 = $22,436; Risk 1 = $29,570) for at risk cases were higher than those for risk 
free cases (p value < 0.001). Average years of experience (YREXP) for the risk free 
group (mean = 24.17) was also significantly higher (P < 0.001) than that of the at risk 
group (mean = 22.96). Most practitioners have their first claim in their 40s. 
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Furthermore, there was a significant difference in the duration (DURATION) of each 
dispute between the two groups (p value < 0.001). The average duration of the risk free 
group was 3.27 years, in contrast to 3.93 years of the at risk group.  
 Figure 1. Malpractice reports trend. 
There was no significant difference for different levels of outcome (OUTCOME) 
between the two groups (p value = 0.1159). While the amount of minor injuries 
decreased gradually from 2005 to 2014, the amount of major injuries increased. The 
amount of emotional injury and death remained constant. Moreover, there was no 
significant difference for gender of patients (PTGENDER) between groups (p value = 
0.4). However, around two-third of the reports involved female patients and the 
proportion stayed consistent over the years. 
3.2. Predictive Models 
We used Logistic Regression as a baseline model. Prior to resampling the data, the 
logistic model categorized a significant amount of data to the risk free group, due to the 
imbalanced dataset. Thus, we experimented with up sampling, down sampling and 
SMOTE and compared the results. The result using Logistic Regression yielded a 
higher F1 score after resampling, increasing from 2.1% to 30.6%. However, the 
accuracy of the model decreased from over 80% to 60%. Thus, we would like to find a 
model that produced a high F1 score without the cost of accuracy. Both Logistic 
Regression and XGBoost produced relatively high F1 score. Up and down sampling 
methods also yielded better results than the SMOTE method (Table 1).  
Considering XGBoost has a faster model training time and is a robust model which 
is less subject to overfitting, we decided to use XGBoost as our primary model. We 
fine-tuned hyper parameters of XGBoost using grid search. We also combined both up 
sampling and down sampling techniques using the ROSE package in an attempt to find 
balance between these two methods. The final model accuracy was 72.8% and F1 score 
was 30.6%.  
Table 1. Predictive models results 
Logistic Baseline No Sampling (83.7%, 2.13%) 
Down (Accu, F1) Up (Accu, F1) SMOTE (Accu, F1) 
Logistic (59.1%, 30.7%) (60.6%, 30.9%) (74.3%, 24.5%) 
Random Forest (57.7%, 30.6%) (81.7%, 13.8%) (81.4%, 11.8%) 
XGBoost (58.5%, 31.0%) (61.6%, 30.0%) (82.8%, 10.6%) 
XGBoost (Best) Up and Down Sampling (72.8%, 30.6%) 
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4. Discussion
The final predictive model supports the previous discovery that payment amount, 
dentists’ years of experience and length of disputes are major variables in determining 
whether a dentist is at risk of multiple malpractice cases in the near future. In addition, 
allegation type, dentists’ working states and patient ages are also important factors for 
prediction. 
A highly imbalanced dataset and categorical variables with multiple levels are the 
two main challenges for constructing predictive models. We employed different 
sampling techniques and used robust models that are suitable for categorical data to 
solve these issues. In future studies, we plan to optimize the probability threshold to 
overcome the imbalanced class problem. Furthermore, summary information of the 
dataset will be passed into the XGBoost model as additional features to improve model 
accuracy and F1 score. 
5. Conclusion
In the past 15 years, over 1.7 Billion dollars of dental malpractice payments were 
awarded to patients. While the number of malpractices claims decreased through years, 
the payment amount per claim has increased. Practitioners’ age was also an important 
variable. Dentists with more years of experience and older age were subjected to higher 
risk of having multiple malpractice cases in the near future. Additional standardized 
training should be provided to overcome improper performance issue.  
XGBoost was the best machine learning model to predict the risk of dentists 
having several malpractice reports. The best performing model had an accuracy of 
72.8% with 30.6% F1 score. 
The NPDB database is a valuable dataset to study dental malpractice claims. 
Further analysis of information extracted from this dataset is warranted. 
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Using Business Intelligence Tools to Support 
Medical Validation of Laboratory Tests 
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Abstract. Modern clinical laboratories have to confirm that the procedures used 
for specific tests are reliable and valid. There are several sources of errors and 
interferences that can invalidate the results. Medical validation refers to the 
plausibility check of the test results. Implausible results indicate that something 
might went wrong with a sample retrieved from the patient, e.g., the blood sample 
got contaminated with another fluid, which requires re-examination. Here, we 
describe how an integrated R-based business intelligence (BI) tool can be 
developed that increase the efficiency of the medical validation at the Institute of 
Clinical Chemistry (ICC) of the University Hospital Zurich. A BI software 
environment allowed us to digitalize steps in the validation process that were 
manually done in Excel worksheets, e.g., importing the data, calculating 
percentiles, and producing graphical outputs. 
Keywords. Clinical validation; delta check; extreme value analysis; business 
intelligence; R 
1. Introduction 
It is indispensable for modern clinical laboratories to confirm that the procedures and 
methods used for specific tests are reliable and valid. There are several sources of 
errors and interferences that can invalidate the results. One important distinction in this 
regard is between technical and medical sources [1,2]. The former one relates to the 
quality of laboratory devices and instruments used, e.g., purity of chemicals or 
adequacy of materials. Whenever a test is introduced, changed or used in a new context, 
technical validation should be triggered. There are several guidelines and quality 
standards for ensuring technical validity [3]. Medical validation, on the other hand, 
refers to the plausibility of the test results. Assuming technical validity, implausible 
results indicate that something went wrong with a sample retrieved from the patient, 
e.g., a blood sample was contaminated with another fluid, which requires re-
examination.  
Medical validation consists of two parts: transversal and longitudinal assessments, 
addressing the plausibility of results with respect to a population or to an individual [4]. 
Transversal assessments can be based on all patients of a hospital, for which the same 
test procedure was executed. This allows to set limits on the values to be expected from 
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a test, for example in the form “the cardiac troponin values on our devices for 99% of 
all our patients in the last year range between 0.04 ng/L and 100 ng/L”. This type of 
validation is often called extreme value analysis. For longitudinal assessments, several 
measurements of the same parameter for the same patient are compared with each other. 
Plausibility in this context defines whether delta changes are within sensible limits or 
not. The phrase used for such assessments is “delta check”. 
Our working environment was the Institute of Clinical Chemistry (ICC) of Zurich 
University Hospital (USZ). Several tools were in use to calculate the percentiles and 
produce graphical outputs, mainly Excel based spreadsheets with added functionality. 
The workplace of the scientific staff responsible for the validation was separated from 
the laboratory premises. This physical distance creates a clear separation between the 
day-to-day business (laboratory examinations) and the validation process, allowing 
high flexibility in the adaptations of workflows. In this context, we were approached to 
tackle the question of whether it is possible to increase the efficiency of the medical 
validation at ICC by business intelligence tools. 
2. Methods  
2.1 Review of the literature  
Our literature research was based on the PubMed and Cochrane Library databases. The 
focus was on studies that use business intelligence and/or the statistical environment R 
for delta check procedures and extreme value analysis. Keywords were identified in 
particular through preliminary discussions with stakeholders. These were then entered 
into the database mask in various combinations: 
 
 ("medical validation") AND "r statistics" 
 ("medical validation") AND "business intelligence" 
 ("delta check") OR "r statistics" 
 ("delta check") OR "business intelligence" 
 ("extreme value analysis") AND "r statistics" 
 ("extreme value analysis ") AND "business intelligence" 
2.2 Approaches and tools considered 
For deriving requirements, we used user stories as well as uses case diagrams. The 
former technique stems from the agile development framework Scrum [5]. A user story 
informally describes features of a software system from the perspective of the user; 
hence, it focuses on what the user needs instead of what the system should deliver. One 
example in our context: User A (who) wants to calculate percentiles (what) to decide 
whether validation is necessary (goal). This made it possible to gain a better mutual 
understanding of the system [6]. Use Cases in contrast describe how the system will act. 
The creation of a use case was intended to concretize the functional and non-functional 
requirements of the system and to illustrate the interaction between user and system. 
Based on the results of our requirement analysis, we developed a business 
intelligence application (BIA) using on Microsoft Power BI (Desktop version August 
2018) and R (3.5.2). For user-system interactions and visualization, we used an 
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interactive HTML widget in order to improve the user experience. To implement this 
widget, additional R packages are required, namely ggplot2 and plotly. The availability 
Microsoft Power BI at the ICC and its connection to hospital wide data warehouse 
made it to a natural choice as BI environment.  
3. Results 
The results of our literature research demonstrated, albeit various methodological 
improvements were proposed (e.g. see [7]), that there is a gap between the availability 
of business intelligence tools and their usage for supporting the medical validation 
workflow in laboratories. In addition, information on the use of expert systems within 
the clinical laboratory [8], on automated validation for clinical laboratory test results 
[9], and on the usage of Microsoft Power BI and R for business intelligence 
applications could be collected [10, 11]. 
Together with our stakeholders, we defined different workflows to be supported in 
shape of user stories: 
 
 “As a research assistant, I need up-to-date clinical laboratory test data in order 
to perform medical validation.” 
 “As a research associate, I want graphical visualizations to give me a first idea 
of the data shape.” 
 “As a research associate, I need to calculate percentiles in order to decide 
whether validation is necessary.” 
 “As a research assistant, I need an intuitive user interface to get around 
quickly.” 
 “As a research assistant, I need a user manual so that I can inform myself 
about the individual functions of the application.” 
 
Discussing these user stories and use case diagrams developed in the requirement 
analysis phase allowed us to identify following functional requirements:  
 
i. Interfacing to stored clinical data; in our case to clinical data in the data 
warehouse of the hospital,  
ii. Support for two separate validation workflows: extreme value analysis and 
delta check,  
iii. Possibility to specify any time span,  
iv. Filter functions to specify age ranges and sex of the population,  
v. Summary statistics and interactive visualizations (e.g., histograms)  
vi. Automated computation of several percentiles (.01, .025, .05, .95, .975, .99) 
 
Implementing these requirements with a business intelligence software 
environment allowed us to digitize steps in the validation process that were previously 
done manually in Excel worksheets; especially, importing the data, calculating 
percentiles, and producing graphical outputs. In first validations of the tool, the average 
time for each validation was around two minutes in contrast to 30 minutes with the old 
solution. Due to the flexibility of the validation workflow, further adaptations can be 
realized rather quickly. The user interface for the extreme analysis uses filters for 
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selecting the population on the left panel of the page. The user can specify the 
laboratory test, the time period, sex and the age range. On the main panel, the results 
are interactively updated according to the specifications; the core result elements are an 
interactive histogram, the number of examinations considered, and percentiles. The 
user interface for the delta check was structured in the same way (see Figure 1). In 
addition, we included buttons for absolute (default) and relative values (the difference 
divided by the first value).  
 
 
Figure 1: The Delta Check page of our application with filters on the left panel and results on the main panel.  
Discussion 
We were able to increase the efficiency of the medical validation process at the ICC by 
automating many time-consuming validation steps that were performed manually 
before. Due to the automation, reduced error rates can be expected. One important 
advantage of using an R-based BI tool is related to the out-of-the-box functionalities it 
provides, e.g., for data import, for interactive visualizations and for statistical 
summaries. The functional requirements list in the result section describes key 
requirements that typically arise in such contexts.  
Development took place on a development environment. Before moving to the 
production environment, a few hurdles have to be considered. First, there are different 
Power BI versions: we used Power BI Service for development, but for security 
reasons (if cloud solutions are not permitted) Power BI Reporting Services should be 
used, which might require license update. Second, HTML widgets in one Power BI 
version might not work in another. Third, the graphics integrated into Power BI via R 
can only deal with data frames having at maximum 150,000 rows [12].  
Using R comes with a lot of functionality, stemming from an open research 
community [13,14], that can be used for advanced statistics and machine learning (ML). 
Although Python gains high attention for data science applications, for visualization 
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and scientific-based data analysis, R is still one of the most widespread and dynamic 
programming environments. The use of ML in a future version could lead to an even 
faster validation process. The whole process of plausibility checks based on different 
percentiles and patient characteristics can be automated and trained by a neural network, 
which can be enabled to integrate many different kinds of information. The keras-
package in R [15] is highly suitable for that purpose and its integration will be our next 
goal.  
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Abstract. Identifying subtypes of Alzheimer’s Disease (AD) can lead towards the 
creation of personalized interventions and potentially improve outcomes. In this 
study, we use UK primary care electronic health records (EHR) from the 
CALIBER resource to identify and characterize clinically-meaningful clusters 
patients using unsupervised learning approaches of MCA and K-means. We 
discovered and characterized five clusters with different profiles (mental health, 
non-typical AD, typical AD, CVD and men with cancer). The mental health cluster 
had faster rate of progression than all the other clusters making it a target for future 
research and intervention. Our results demonstrate that unsupervised learning 
approaches can be utilized on EHR to identify subtypes of heterogeneous 
conditions.  
Keywords. Phenotyping, Alzheimer’s disease, Electronic health records, machine 
learning 
1. Introduction 
Alzheimer’s disease (AD) is a highly heterogeneous disease. Any two individuals  with 
the disease display a different array of symptoms or  progression rate[1]. Progression 
rate can be increased by many factors such as higher education level and comorbidities 
like diabetes[2]. Gaining a complete view of a patient's profile of symptoms, 
comorbidities and demographic factors can enable the discovery of different 
progression patterns and to personalise treatments for AD patients. 
Almost all subtyping studies to date in AD focuses on two data types; cognitive 
tests[3] and brain scans[4], showing cluster(s) of hippocampal atrophy and more 
diffuse atrophy, corresponding to specific memory problems and more global cognitive 
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problems, leading to different patterns of progression[4]. Subtyping using electronic 
health records (EHR) has been carried out in many diseases[5][6] and are ideal data 
sets to apply these methods to due to the large sample size and the breadth of clinical 
information[7] they contain. Variables and outcomes are lifted directly from clinical 
data making them directly relevant to the patient’s clinical management. This work 
aims to identify subtypes of AD using a range of clinical information on the patients.  
2. Methods 
2.1. Data and cohort 
We used data from the Clinical Practice Research Datalink (CPRD)[8] which contains 
longitudinal primary care EHR from general practices in the United Kingdom[8]. Only 
patients from practices which have been marked up to standard are used and only data 
collected after the practice was found to be up to standard were used. Data were 
extracted and phenotypes defined using the CALIBER data resource[9,10]. We 
classified patients as cases if they had at least one AD Read code and no other future 
diagnosis indicating a different dementia subtype diagnosis[11]. Full case analysis was 
used. This study was approved to use CPRD data by the Independent Scientific 
Advisory Committee (ref. 18_111). 
2.2. Variables and Outcomes 
Three categories of variables were included in the analysis; symptoms, comorbidities 
and demographic and lifestyle factors. Symptoms and comorbidities were identified 
through a systematic literature review of studies identifying symptoms or finding 
associated comorbidities. There resulting symptoms found were memory problems, 
confusion, neuropsychiatric problems and motor problems. From them the disease that 
were identified where atrial fibrillation, anxiety, hyperglycaemia, rheumatoid arthritis, 
stroke, hearing loss, depression, kidney disease, heart failure, atherosclerosis and 
cancer.  Age of onset, gender, drinking status and smoking status were all included  as 
demographic variables in the analysis. The phenotypes for each symptom was ideally 
defined using previously defined and verified CALIBER phenotypes[9,10], if they 
were not available, using a definition from a previous studies.   
We defined five clinical outcomes which were used to evaluate clusters: a) length 
of time to treatment discontinuation[12], b) rate of progression measured by the Mini 
Mental State Exam[13], c) healthcare utilization defined as number of appointments 
and missed appointments per year, d) all-cause mortality and time to assisted living, 
and e) time to assisted living. For the latter two,  we created Kaplan-Meyer survival 
curves.  
2.3. Statistical analysis  
We used Multiple Correspondence Analysis (MCA) for dimensionality reduction[14]. 
K-means was used to identify clusters: First, k was decided through an elbow plots for 
the cluster entropy , silhouette coefficient and Bayesian Information Criterion (BIC). 
K-means was executed 100 times to establish the optimum solution determined by the 
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inter cluster variation. To evaluate the clusters silhouette score were used to measure 
cluster structure and cluster stability was measured through Jaccard index of cluster 
results based on a 100 X bootstrapped sample. 
3.  Results  
We identified 7,913 AD patients (66.2% female, mean age 82.1, 81.3-83 95% CI). 
Using the first five MCA principal components, we identified five clusters: mental 
health cluster which has the highest prevalence of anxiety and depression 
comorbidities, non-typical AD which had the lowest prevalence of memory symptoms 
and highest of other symptoms, typical AD which had high prevalence of memory 
symptoms and low other symptoms, cardiovascular disease (CVD) cluster with high 
prevalence of cardiovascular diseases such as atrial fibrillation and associated diseases 
such as diabetes and a cluster of men with cancer  (Table 1, Figure1) all with differing 
clinical outcomes (Figure 2). The clusters had a silhouette score of 0.19 (showing weak 
cluster structure) and mean Jaccard index of 0.78 indicating overall stability. 
Table 1. Each cluster name, key variables that characterise the cluster and their outcomes. Green - highest 
outcome. red - lowest outcome, * significant  
Cluster I.D Demographics 
Top Characteristics  
(figure 1) Outcomes (figure 2) 
1. Mental Health 
Cluster 
 n = 1528 
 80.1% female 
onset age = 75 
Diag MMSE = 
21.6 
Neuropsychiatric symptoms, 
(83.51%)  
Anxiety (62.11%) 
Depression (69.24%) 
Fastest rate of progression* (2.16 
mmse points per year, 2.06-2.26 
95% CI) 
2. Non- typical AD 
Cluster 
n = 1640 
81.3% female 
onset age = 86 
Diag MMSE = 
20.9 
Memory symptoms (44.15%) 
Confusion(71.04%) 
Neuropsychiatric symptoms 
(98.35%)  
Shortest time till treatments 
discontinuation 
(3.09 years, 3.19-2.99 95% CI) 
Lowest survival probability* 
Shortest time till assisted living * 
3. Typical AD Cluster 
n = 2026 
90.1% female 
onset age = 82 
Diag MMSE = 
21.7 
Memory symptoms (89.09%) 
Confusion(0.05%) 
Neuropsychiatric symptoms 
(18.85%)  
Fewest appointments per year* 
(16.6 apps per year, 16.15-17.1, 
95% CI) 
4. Cardiovascular 
disease Cluster 
n = 686 
45.9% female 
onset age = 81 
Diag MMSE = 
21.4 
Diabetes (84.26%)  
Hypertension(81.49%)  
Atrial fibrillation(20.41 %) 
Greatest number of  appointments 
per year* (24.8 apps , 23.7-25.9 
95% CI)  
and missed appointments per 
year* (0.96 missed apps, 0.84 - 
1.08 95% CI) 
5. Memory problems 
and Cancer Cluster 
n = 1710 
19.0% female 
onset age = 79 
Diag MMSE = 
22.6 
Memory symptoms (90.94%) 
Cancer(43.27%)  
Male (80.99%) 
Slowest progression rate (1.59 
mmse points a year, 1.5-1.68 95% 
CI)  
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 Figure 1:  Distribution of the variables included in the cluster analysis for each cluser a) symptoms, b) 
Comorbidities, c) age, d) gender, e) clinically-recorded smoking status, f) clinically-recorded drinking status  
 
Figure 2 : Outcomes difference for variables not included in the cluster analysis per cluster: a) mean number 
of appointments per year with CI, b) mean missed appointments per year with 95% CI, c)  mean MMSE 
score reduction per year with 95% CI, d)  mean time to treatment discontinuation with 95% CI, e) Kaplan 
Meyer curve of survival probability, f) Kaplan Meyer curve on time till assisted living. 
N. Alexander et al. / Using Unsupervised Learning to Identify Clinical Subtypes502
4.  Discussion 
Using unsupervised machine learning on a cohort of 7,913 AD patients defined through 
EHR, we identified five distinct clusters with different clinical profiles: a mental health 
cluster, a non-typical AD cluster, a typical AD cluster and clusters with mostly 
cardiovascular problems and a cluster with cancer. The mental health and early onset 
cluster had a faster rate of progression. Further research is needed to delineate the 
relationship between the mental health comorbidities, rate of progression and early 
onset. Identifying the CVD cluster can have clinical benefit as they have the highest 
healthcare utilization. The two clusters of typical and non-typical AD are similar to 
clusters found in previous research splitting patients with memory issues and patients 
with other cognitive issues[3]. The cluster with high prevalence of cancer, and men 
reported low prevalence of other symptoms aside from memory loss. There should be 
more investigation into whether the mechanism that leads cancer to protect against AD 
[2] also reduces the number of symptoms through less global atrophy. Using this data 
type uses a unique perspective on which to cluster patients as it offers a longitudinal 
and broad scope of a patient. The cluster results also have clinically relevant and 
impactful outcomes. There are however several weaknesses to the study such as there 
are some that are important but not or only partly recorded such as family history of 
AD recorded in EHR. Future work will look into validating these results through 
comparing this method with other cluster methods cluster results using imaging and 
cognitive test results. 
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Abstract. The aim of the present study was a comparison of prognostic accuracy 
assessment results for scores in different ways on the example of validity analysis 
of the prognostic model ISS-RTS-TRISS for assessing the severity of the condition 
in children with trauma. The prospective study was conducted using clinical and 
physiological data collected at the admission and during the first 24 hours of 
hospitalization from 414 children with trauma. We had three groups of patients, 
common group children with traumatic brain injuries, and two groups of patients 
were divided into the two following ways: 141 (34%) patients with isolated 
traumatic brain injuries and 273 (66%) patients with combined injuries with 
traumatic brain injuries The validity and prognostic accuracy of prognostic scores 
were assessed by determining there discrimination and calibration ability. Analysis 
of the discrimination ability of score was carried out by assessment the areas under 
the ROC curves. For analysis of the calibration ability of score was used three 
methods of the Hosmer-Lemeshow test (H- criterion, C-criterion in two variants). 
The ISS-RTS-TRISS score showed significantly outstanding predictive accuracy 
in studied groups (AUROC >=0.9) .However, estimation the calibration ability of 
score using the C-criterion, by dividing into groups with the same number of cases 
of patients (recommended for abnormal distribution) did not show an 
unambiguous results. It was shown that to obtain an unambiguous correct result, it 
was necessary to use the C-criterion method using the division of cases into groups 
with the same number of patients with the lethal outcome. When using this method, 
satisfactory results of study of calibration ability were shown for all the studied 
groups (p<0.05). 
Keywords. Prognostic score, validity of prognostic scores, prognostic accuracy of 
score, the Hosmer-Lemeshow test, score ISS-RTS-TRISS 
1. Introduction 
Modern medicine focuses on increasing the effectiveness of decisions taken during 
treatment, based on assessing the severity of the condition and the severity of injury in 
patients, predicting the likelihood of death in patients [1, 2]. One of the methods for 
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solving this problem is the using of numerous specialized prognostic scores for various 
nosologies and different age groups of patients [3, 6, 7, 8]. The prognostic scores, 
which are mathematical models that include basic demographic, clinical and laboratory 
data, are an example of the quantitative assessment of the severity state [8, 9, 10]. One 
of these scores is the ISS-RTS-TRISS (Injury Severity Score - Revised Trauma Score - 
Trauma Injury Severity Score) prognostic score for assessing the severity of injuries, 
proposed by Champion and colleagues in 1990.The score allows to assess the severity 
of a patient’s injury and determine the likelihood of death [11]. An important point in 
the use of scores is the quality and validity of the predictive model, which determines 
the validity and suitability of the application of the technique in specific conditions, 
and consequently - the correspondence of the possibility of prognostic scores to the 
tasks assigned [5, 12, 13] 
As is known, the validity and prognostic accuracy of prognostic scores can be 
assessed by determining its discrimination and calibration ability [3, 4, 5]. 
Determination discrimination ability at the moment is not difficult in the presence of 
matching the amount of data. 
However, the determination of the calibration ability is a more complicated 
process and depends on the approach chosen for calculating the Hosmer–Lemeshow 
test [4, 5]. 
The aim of the present work was a compare of prognostic accuracy assessment 
results for scores in different ways on the example of analysis the validity of the 
prognostic model ISS-RTS-TRISS for assessing the severity of the condition in 
children with traumatic brain injuries (TBI), located in the department of 
anesthesiology and resuscitation in the Clinical and Research Institute of Urgent 
Pediatric Surgery and Trauma. To achieve this aim we set following tasks to: 
investigate discrimination ability of the ISS-RTS-TRISS prognostic score in groups 
with TBI and investigate the calibration ability of the ISS-RTS-TRISS by three ways of 
Hosmer–Lemeshow test. 
2. Material and methods 
The prospective study was performed on basis of data collected from 414 patients 
(mean age 9.3 ± 5, m/f were 266/148 patients) with TBI from the age of 1 month to 18 
years old who had been admitted to the Department of Anesthesiology and 
Resuscitation between January 2008 and January 2012 of Clinical and Research 
Institute of Urgent Pediatric Surgery and Trauma. 38 (9.2 %) patients died. 
Criteria for including patients into the study were the following: traumatic brain 
injury, age till 18, availability of all necessary data for calculating results of prognostic 
scores, staying in the anesthesiology and resuscitation department not less than 24 
hours. 
We had three groups of patients, common group children with traumatic brain 
injuries, and two groups of patients were divided into the two following ways: 141 
(34%) patients with isolated traumatic brain injuries and 273 (66%) patients with 
combined injuries with traumatic brain injuries (Table 1). 
The assessment of severity of patient’s condition and injury severity and the death 
risk were determined with ISS-RTS-TRISS prognostic score; these data were collected 
from anamnesis, initial examination, parameters of physiological and neurological 
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status on admission and within the first 24 hours. Score was calculated using software 
tools published on the SociéteFrançaiseet de Réanimation community website [14]. 
Table 1. Characteristics of data for all patients and in different groups 
Group patients with N Age (m± δ) M/F (%/%) Died (%) Survived 
(%) 
TBI 414 9.3±5 266/148 (64.3/35.7) 38 (9.2) 376 (90.8)
Isolated  TBI 141 9.0±4.9 88/53 (62.4/37.6) 10 (7.1) 131 (92.8)
Combined injuries with TBI 273 9.1±4.8 171/102 (62.6/37.4) 25 (9.2) 248 (90.7)
N -sample’s size of group, m - average age in the group, δ - standard deviation of mean, M – man-child, 
F – female-child, Died – the number of deaths in the group of patients, Survived - number of surviving 
patients in the group, TBI - traumatic brain injuries. 
The validity and prognostic accuracy of prognostic score were assessed by 
determining its discrimination and calibration ability. The discrimination ability has 
shown a probability score to divide patients into two groups: with favorable outcomes 
and unfavorable (likelihood and lethal) outcomes. ROC-curve was used for evaluating 
the discrimination ability of the studied prognostic score [4, 5]. For analysis of the 
calibration ability of score was used three methods of the Hosmer-Lemeshow test. The 
first way was the H-criterion test with the division patients 10 groups by probability of 
lethal outcome. In this case, the number of patients in the intervals according to the 
probability of a lethal outcome wasn't the same; the number of patients who died in the 
intervals was also being different. The second way was the classic C-criterion of 
Hosmer-Lemeshow test with the division patients into probability groups of death with 
the same number of observed cases of patients. And the third way – the C-criterion of 
Hosmer-Lemeshow test with the division patients into probability groups of death with 
the same number of observed cases with lethal outcome of patients [5]. The data base 
statistical assessment and statistical description were done in Excel of Microsoft Office 
2013 and IBM SPSS Statistics 20 programs. 
3. Results 
The investigated prognostic score ISS-RTS-TRISS showed significantly outstanding 
discrimination ability in studied groups (AUROC>0.9). [14]. (Figure 1, Table 2). 
Table 1. Results of AUROC and cut-off of prognostic score Characteristics of data for all patients and in 
different groups 
Group patients with N AUROC p  
TBI 414 0.928±0.019  
<0.001 
) 
Isolated  TBI 141 0.985±0.012 
Combined injuries with TBI 273 0.899±0.029 
N - number of patient in the group, AUROC –area under ROC curve,  δ- standard deviation, TBI - 
traumatic brain injuries. 
Calibration ability for score ISS-RTS-TRISS determined by H-criterion of the 
Hosmer-Lemeshow test showed satisfactory calibration ability for all considered 
groups (p<0,05) (Table 3). The classic C-criterion of Hosmer-Lemeshow test (division 
group into the same number of cases of patients) didn’t show satisfactory calibration 
ability in all considered groups (p>0,05). The second C-criterion of Hosmer-Lemeshow 
test (division group into the same number of patients with a lethal outcome) showed 
satisfactory calibration ability for all groups (p<0,05). The second С-criterion of 
Hosmer-Lemeshow method proved to be insufficiently sensitive to assess the 
calibration ability of the scores with small number cases of study. Thus, the observance 
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of the conditions for the need for a sufficient amount of not only the general group, but 
also the need for a sufficient amount of the studied subgroups, taking into account 
favorable and unfavorable outcomes. 
In general, it can be concluded satisfactory calibrating ability for all considered 
groups of patients with TBI. 
Figure 1. ROC-curves for prognostic score ISS-RTS-TRISS in studied groups. 
 
Table 3. Results of assessment of calibration ability for prognostic score ISS-RTS-TRISS in studied groups. 
Studied groups 
of patients with 
N H-criterion C-criterion (the same 
number of cases of 
patients) 
C-criterion (the same 
number of patients 
with a lethal outcome) 
χ2 p f χ2 p f χ2 p f 
TBI 414 26.04 0.001 10 14.91 0.06 10 47.75 <0.001 10 
Isolated TBI 141 20.26 0.009 10 3.18 0.786 8 8.71 0.033 5 
Combined 
injuries with TBI 
273 26.68 <0.001 10 15.20 0.055 10 24.09 0.002 10 
N- number of patient in the study, χ2- χ2-value, p-p-value (Hosmer–Lemeshow test), f-degree of 
freedom, TBI- traumatic brain injuries. 
This analysis of the prognostic accuracy of scales in different ways by using three 
methods of the Hosmer-Lemeshow test on the example of assessing the validity of the 
prognostic model ISS-RTS-TRISS has shown, that for sufficient validity of the results 
there must be, not only the total number of survived patients, but also must be a 
sufficient number of dead patients in the study group. 
4. Discussion 
Modern scientific evidence-based medicine in its practice, more and more uses 
complex mathematical statistical methods of analyzes. 
Thus, for investigation of prognostic accuracy of prognostic scores used the 
determination of discrimination and calibration abilities of mathematical models. The 
aim of the present work was to compare of results of assessment and prognostic 
accuracy of scales in different ways on the example of analysis the validity of the 
prognostic model ISS-RTS-TRISS for assessing the severity of the in children with 
traumatic brain injuries. 
For validated prognostic score ISS-RTS-TRISS were defined discrimination ability 
(AUROC >0,9) and calibration ability by Hosmer-Lemeshow test in three ways in 
considered groups. 
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Our investigation has shown satisfactory calibrating ability for all considered 
groups by H-criterion of  Hosmer-Lemeshow test (p<0,05). 
The classic C-criterion of Hosmer-Lemeshow test with the division patients into 
probability groups of death with the same number of observed cases hasn’t shown 
satisfactory calibration ability in all considered groups (p>0,05. The C-criterion of 
Hosmer-Lemeshow test with the division patients into probability groups of death with 
the same number of observed cases with lethal outcome has shown satisfactory 
calibration ability for all groups (p<0,05). In general we could conclude calibrating 
ability for all considered groups was satisfactory. 
Thus, as a result of our study, it was shown that for assessment of calibration 
ability the Hosmer-Lemeshow test should be used, but one should take into account the 
number of dead and survived patients, as well as their distribution in the interval groups. 
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Abstract.  Based on the recent statistics published by the Stroke Association (UK), 
first-time incidence of stroke occurs almost 17 million times a year worldwide (one 
every two seconds), making Stroke as the second cause of death in the world. By 
the age of 75, 1 in 5 women and 1 in 6 men will have a stroke, which is one of the 
largest causes of disability, as half of all stroke survivors have a disability, making 
those persons dependent on others (1 in 5 are cared for by family and/or friends). 
People living longer is a cause for celebration, but older people are more vulnerable 
to mental health, cognition and physical problems, especially if they have already 
experienced a stroke (minor or mild). Depression is a main condition after a stroke 
and may be experienced in the form of sadness, unexplained pains, loss of interest 
in socializing, weight loss etc. The abovementioned conditions reduce the person's 
ability to remain active and independent, affecting their well-being and quality of 
living. Independent living of aging adults that have suffered a stroke is the key 
motivation for the VIVID project. 
Keywords. stroke; machine learning; personalization; virtual coach ; serious 
gaming; affective computing 
1. Introduction 
 
Over the past decade and based on the undeniable fact that Europe is an ageing continent, 
the ICT research community has responded with enthusiasm to the latest challenge: 
providing Europeans with healthier, safer, more independent and overall happier ageing. 
As Baby Boomers age, the need for adult care and assisted living continues to grow. As 
of February 2015, 16.4 million people in Europe receive support annually from five main 
long-term care service options: home health agencies, nursing homes, hospices, 
residential care communities, and adult day service centres. Outside these facilities, 43.5 
million family and informal caregivers currently provide care for someone aged 50+.  
Among the most severely disabled old persons living in Europe, about two-thirds rely 
solely on family members for assisted care, often resulting in great emotional stress for 
family caregivers. The aging population has greater chances to experience age related 
conditions, such as Stroke and the Post Stroke Depression. We aim to utilize intelligent 
multisensory and multimodal ICT devices to sense, monitor and understand human 
activity, in order to motivate the aging population to have a better quality of living, while 
improving their physical, cognitive, mental and social well-being, and furthermore to 
support them in their everyday living tasks. We are proposing a universal solution for 
any aged person in the form of a Personalized Virtual Coach (PVC) that will sense mood, 
activity, physical status and stress of the user (using smart environment sensors, wearable 
devices and voice analysis), and will interact with the user via intuitive Graphic User 
Interfaces and Voice Recognition. The PVC will reside in the Home Hub of the VIVID 
e
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platform, while it will be accessible via smartphone and/or tablet devices. Our solution 
will adopt the latest development in Human Machine Interaction and Affective 
Computing, to provide user-adapted and intuitive access to a multitude of enabling 
computer applications, designed to assist and support the welfare of the seniors. The PVC 
aims to reduce the decline of the physical status, the mental capacity and the cognitive 
abilities of seniors suffered a Stroke, including those having Post Stroke Depression 
symptoms, encouraging them to stay active and perform physiotherapy and speech 
therapy rehabilitation sessions, using body posture tracking devices and Augmented 
Reality headsets.  Going beyond any other similar solution, the proposed PVC prototype 
will incorporate an ontology-based adaptive learning system to improve machine-to-
machine learning, in order to enhance the identification of the user behaviour, patterns 
and preferences, and provide a highly customised virtual coaching experience. 
2. Objectives 
2.1. Develop the Smart Sensor Network (SSN) to capture the living environment and 
the health status of the user 
Under this objective, we will investigate how we can use Augmented Reality, Serious 
Games, Voice Analysis and Emotional Computing to monitor how the user interacts with 
the living environment in their everyday living conditions. The proposed framework will 
be capable of using Internet of Things (IoT) enabled commercial sensors to a) "sense" 
the home environment of the user, and b) measure physiological parameters to assess the 
health status of the user. SSN will adopt UniversAAL middleware to allow the IoT 
enabled devices to become available, searchable, accessible, and usable by the 
UniversAAL to enable applications of the system. 
2.2. Develop an intuitive Interaction Framework for the interaction between the user 
and the PVC 
This objective will focus on the adoption of the intuitive Human Computer Interaction 
(HCI) principle in the implementation of the PVC. The interaction will be performed 
using four of the user’s senses (sight, hearing, voice and touch). Portable devices with 
touch screens will be used to receive user's input, using simple and intuitive Graphic 
User Interfaces (GUIs). A Natural Language Processing (NLP) framework will be used 
to process voice commands and reply to user requests. The NLP framework will enable 
PVC to be built upon the use of conversational interfaces that understand and speak 
human language, leveraging the acceptance and maximising user friendliness.   
2.3. Develop a Serious Gaming Platform supported by Augmented Reality headset 
This objective will focus on the development of a Serious Gaming Platform (SGP) to be 
used by the elderly to perform physical and cognitive exercises. The SGP will be 
composed of standalone applications installed in the HH, which will update their content 
and exercises via internet connection. The updated content will be provided by the 
medical professionals and will be personalised to the individual player, supported by the 
IF. This module will also be used for the tele-rehabilitation (physiotherapy and speech 
therapy) of the users.  
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2.4. Improve prescription adherence along with medication compliance and 
persistence 
Successful treatment of disease with prescription medicines requires consistent use of 
the medicines as prescribed. Yet research shows that medicines commonly are not used 
as directed . Non-adherence to medicines is a major health care cost and quality problem, 
with numerous studies showing high rates of non-adherence directly related to poor 
clinical outcomes, high health care costs, and lost productivity. Many of the human and 
economic costs associated with non-adherence can be avoided, making improving 
patient adherence one of the best opportunities to get better results and greater value from 
our health care system [7]. Prescription adherence and medication compliance are crucial 
when targeting Depression and Stroke patients. Forgetfulness and complexity of regimen 
are the two parameters of adherence where PVC will focus. The proposed Medication 
Adherence Module (MAM) will be composed of a smart pill box (an IoT connected 
device to manage medication disposal) and a reminder connected to the user via the IF.  
2.5. Improve exercise compliance to improve physical well-being and reduce health 
related risks 
This objective will focus on the personalised provision of the exercise plan for the users, 
based on the individual preferences and needs. There is clear evidence that well-designed 
technology interventions can effectively change health-related behaviour, improve 
patient knowledge and confidence for self-management of health, and lead to better 
health outcomes. Embedding emerging technologies into health interventions afford a 
real opportunity to study, understand, and positively affect human behaviour through 
devices which monitor human behaviour and provide an ideal platform for delivering 
behavioural change interventions and feedback. By improving the physical health of the 
seniors via the executed activities, both musculoskeletal and mental well-being will be 
improved, as strong muscles can reduce the risks of potential falls, and as exercise can 
treat mild to moderate depression as effectively as antidepressant medication. Validation 
of the results will be performed using the International Physical Activity Questionnaires 
(IPAQ). 
2.6. Improve cognitive well-being to reduce memory decline, preserve language skills 
and maintain visual perceptual abilities 
Language and vocabulary are well retained throughout the lifespan. Vocabulary 
continues to improve into middle age. Recall of general knowledge acquired at a young 
age and well-practiced skills like arithmetic also peak in middle age and are resistant to 
age-related decline. To be able to recall an event or new information, the brain must 
register the information, store it, and then retrieve it when needed. The ability to recall 
new information, such as reading material, becomes more challenging after the age of 
40, particularly for visual material. To improve the cognitive skills of aging people, the 
PVC will challenge the users to play mini game, like quizzes or simple problem solving 
games, tailored for each individual. 
2.7. Maintain mental health of the aging population to enhance the everyday feeling of 
well-being 
Under this objective, the mental health of the seniors will be promoted, as it is an integral 
part of health. Good mental health is identified by WHO as a "state of well-being in 
which an individual realizes his or her own abilities, can cope with the normal stresses 
of life, can work productively and is able to make a contribution to his or her 
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community." With that in mind, VIVID will try and maintain the improvement of mental 
health via the guidance and the support of the PVC, the adoption of a healthy diet, the 
performance of regular moderate exercise , the adoption of patterns that offer good 
quality of sleep or manage stressful situations (via relaxation techniques). To achieve 
those targets, the PVC will encourage the user to comply with a minimum set of goals, 
including regular exercising, setting small incremental targets in everyday life (regarding 
exercise, sleeping patterns or participation in community activities) to help him/her 
maintain a competent mental health . 
2.8. Advance the social wellness of the seniors, to let them remain active and socially 
connected 
To maintain the social wellness of the seniors, the PVC will encourage their contribution 
to their environment and community. Social wellness incorporates making healthy living 
choices and initiating better communication with others. Social activities such as games 
(bingo, dominos, cards, and puzzles), parties/gatherings for family and friends or the 
local community, are part of the activities to improve social wellness. By helping seniors 
to be kept socially active, there is a decreased risk of diseases, social isolation as one of 
the key indicators leading to depression in seniors is avoided (the seniors maintain and 
continue to build new relationships). There is also proof that the immune system tends 
to be stronger in seniors who are active socially, while isolated seniors tend to have 
higher blood pressure, because the lack of social connections can lead to an elevated risk 
of diseases, such as cardiovascular disease .  
3. Concept and methodology 
The concept of the VIVID project is the development of a personalised solution, in the 
form of a PVC, that will use the latest advances in ICT, to motivate and support the aging 
adults in terms of medication and exercise adherence and their overall well-being. VIVID 
will develop a personalized solution in the form of a PVC, adapted to the needs of the 
Figure 1 VIVID PVC architecture outline 
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aging population, with focus on those with PSD and those who have suffered a SE and 
need rehabilitation. Our solution targets those that require rehabilitation (speech therapy 
or physiotherapy) after they have suffered a Stroke Episode. This will be done in such a 
way that will preserve the individual's dignity and will motivate him/her to re-learn basic 
skills that the stroke may have affected, such as speaking and walking. Figure 1 depicts 
the ICT tools that will be used in the proposed PVC solution offered by the VIVID 
project. 
4. Discussions 
VIVID can improve care and reduce the need to use health and care services by enabling 
more of our citizens to build up the knowledge, skills and capabilities they need to 
manage their own care and symptoms. VIVID will achieve this by engaging communities, 
supporting carers, and developing volunteering in and partnerships with the charitable 
and voluntary sector. VIVID will aid in Improvement of patients’ life-space mobility 
(Modified Ashworth scale, Tinetti Performance Oriented Mobility Assessment, High-
level Mobility Assessment Tool (HiMAT),in Permission of independent living (e.g. 
EQ5-D, SF-36, Interprofessional Socialization and Valuing Scale (ISVS), Care 
Dependency Scale, Bowel Control Scale (BLCS), Paced Auditory Serial Addiction Test 
(PASAT),in Improvement of patients’ autonomy and participation in society (Lkert 
scale),in Improvement of family living standards (self-reported questionnaire),in 
Improvement of quality of life (questionnaires of QoL – EQ 5D) and in reduction of costs 
for the management of the gait problems (Functional Gait Assessment). In the VIVID 
project the users’ participation is situated in the center of the development process. 
Innovative user-friendly interfaces of VIVID will increase the usability and adaptability 
of the systems. Taking into account seniors’ needs, an interactive game framework is 
developed and will be tested during the pilot phase. The science of behavior and 
personalization will help in order to build a really elderly-friendly and easily adopted 
VIVID system.  
 
5. References 
[1] T. S. Association, “State of the Nation,” Stroke Stat, no. January, pp. 1–40, 2016. 
[2] A. G. Karatepe et al., “Comorbidity in patients after stroke: Impact on functional outcome,” J Rehabil Med, 
vol. 40, no. 10, pp. 831–835, 2008. 
[3] M. Liu et al., “Comorbidities in stroke patients as assessed with a newly developed comorbidity scale.,” Am J 
Phys Med Rehabil, vol. 78, no. 5, pp. 416–24. 
[4] S. Paolucci et al., “Quantification of the risk of poststroke depression: the Italian multicenter observational 
study DESTRO,” Acta Psychiatr Scand, vol. 112, no. 4, pp. 272–278, Oct. 2005. 
[5] E. M. Whyte et al., “Post stroke depression: epidemiology, pathophysiology, and biological treatment.,” Biol 
Psychiatry, vol. 52, no. 3, pp. 253–64, Aug. 2002. 
[6] S. Asteriadis et al., “Towards Detecting Clusters of Players using Visual and Gameplay Behavioral Cues,” 
Procedia Comput Sci, vol. 15, pp. 140–147, 2012. 
[7] A. Anastasiou et al., “Monitoring of compliance on an individual treatment through mobile innovations,” XIV 
Mediterr Conf, 2016. 
A. Anastasiou et al. / VIVID: Independent Living of Aging Adults Suffered a Stroke 513
This page intentionally left blank
Section 2 
Supporting Care Delivery 
This page intentionally left blank
A Domain-Independent Semantically 
Validated Authoring Tool for Formalizing 
Clinical Practice Guidelines 
Jordi TORRESa, †, Garazi ARTOLAa, † and Naiara MUROa,b,c 
a
 eHeatlh and Biomedical Applications, Vicomtech, Donostia-San Sebastian, Spain 
b
 Biodonostia, Donostia-San Sebastian, Spain 
c
 Sorbonne Universités, UPMC Univ Paris 06, INSERM, Université Paris 13, Sorbonne 
Paris Cité, UMR S 1142, LIMICS, Paris, France 
† Equally Contributing Authors 
Abstract. Clinical Practice Guidelines (CPGs) are promoted as a powerful tool for 
standardization of the medical care quality and improvement of patients’ outcomes. 
However, CPGs need to be formalized in a computer interpretable format (i.e. as 
Computer Interpretable Guidelines or CIGs) for their implementation within 
Clinical Decision Support Systems (CDSS). But, maintaining the reliability of 
these guidelines when deploying them in different clinical settings is still a 
challenge. On the one hand, the complexity of the medical language complicates 
the adoption of the guidelines in different clinical institutions. On the other hand, 
the continuous discovery of new evidence needs to be included within CPGs, 
updating their contents and providing tools for evidence assessment. Furthermore, 
although nowadays’ clinical decision-making tends towards a personalized process, 
guidelines are designed for a general population. In this paper, we present an 
Authoring Tool (AT) that allows clinicians to take an active role in the process of 
CPG formalization. This AT enables them to introduce new clinical knowledge 
and create personalized CIGs for their local application, which best fits their 
clinical needs. The proposed system also allows the use of ontologies to facilitate 
the standardization and interoperability of the created guidelines. Finally, the 
content included in the CIGs can be evaluated using standard systems for grading 
clinical evidence. 
Keywords. Authoring Tool, Clinical Decision Support System, Clinical Practice 
Guidelines, Computer Interpretable Guidelines, Ontologies. 
1. Introduction 
Clinical Practice Guidelines (CPGs) are a set of criteria developed in a systematic way 
to help professionals in the decision-making process, providing the latest evidence-
based diagnostic or therapeutic options when dealing with a health problem or a 
specific clinical condition [1]. Over the past years, CPGs have been widely promoted to 
be implemented as Computer Interpretable Guidelines (CIGs) within Clinical Decision 
Support Systems (CDSS). Nevertheless, there is still work to be done in the 
maintenance and personalization of these guidelines in order to maintain their 
reliability when implementing them in different clinical settings. On the one hand, the 
complexity of medical language makes the comprehension and interoperability of the 
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CPGs a complicated issue, since different guidelines modeling the same clinical 
domain could differ in the provided knowledge. In this context, semantic web 
technologies such as ontologies are promoted for a standardized medical vocabulary. 
On the other hand, the evolving nature of medicine and the continuous discovery of 
new evidence needs to be included in CPGs, assessing the quality of the formalized 
evidence in a continuous way. To solve this issue, methodologies that assess the quality 
of the formalized evidence and the strength of the recommendations are promoted. 
Furthermore, CPGs are developed considering a population as target, not individuals, 
thus assuming the existence of a “standard” patient, which is not representative of all 
possible individual cases [2]. In this sense, personalizing guidelines using clinicians’ 
own experience, patient preferences or local protocols of institutions can be helpful to 
increase clinicians’ compliance to CDSS [3]. 
In this paper, an Authoring Tool (AT) that enables clinicians to formalize actively 
personalized CPGs in a user-friendly way by introducing new clinical knowledge and 
create CIGs that can be adapted to their local protocols is proposed. First, an approach 
for the semantic validation of the content in the guidelines leaning on an ontology is 
presented. Second, the methodology used for the CPG formalization process is 
described. Lastly, a use case in Gestational Diabetes Mellitus is shown to illustrate the 
proposed methodology. 
2. State of the Art 
The formalization process of CPG into CIGs is a complex, time-consuming task 
requiring technical and clinical skills to be done successfully. As a result of this, it is 
difficult for clinicians to create or edit the contents of existing CIGs, making necessary 
the involvement of a knowledge engineer for CIG management and implementation [4]. 
In order to solve this issue, Authoring Tools (AT) are proposed as tools for facilitating 
and actively taking part in the creation of CIGs by clinical domain experts. To avoid 
the technical encoding, clinicians are provided with user-friendly and interactive 
interfaces that ease the formalization process [5].  
For example, Dunsmuir et al. [6] developed an AT in order to enable 
anaesthesiologists to include their clinical knowledge in a rule-based CDSS. Their AT 
allows users to introduce and edit clinical rules, but requires the user to have 
knowledge about XML files in order to edit the terminology and parameters used by 
the AT. Furthermore, the format used to encode clinical rules is designed for its use in 
anaesthesiology, which makes it too specific for its adoption in other clinical domains. 
Another example would be in the case of Ali et al. [7], who propose a framework 
that makes use of HL7 standard and ontologies in order to generate shareable CIGs. 
Rules are created and edited using an ontology-linked AT, and Arden Syntax is used to 
represent them. While the constructed rules follow a standard to encode the clinical 
knowledge, no standard systems for grading clinical evidence are used. 
In this work, following the approach by Muro et al. [8], an AT for developing 
domain independent CIGs is presented. This proposal uses the Decisional Event (DE) 
structure to store the clinical information regarding the decision-making process. Using 
this structure it is possible to compute the quality of evidence and strength of 
recommendation for each of the rules, as described in [9]. As our platform is based on 
this DE concept, the strength of the recommendations in the CIG can be assessed. 
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3. Methodology  
The proposed AT, within the architecture shown in Figure 1, is composed by: 
 
(i) a module for interacting with external knowledge models, such as ontologies, 
to provide the needed clinical domain knowledge during the formalization 
process, 
(ii) a user-friendly Graphical User Interface (GUI) as the frontend of the system 
for introducing rules that will compose the final CIG, and 
(iii) a backend, which is responsible for creating the final CIG.  
 
To ease the technical comprehension of this chapter, it is supported by a use case 
in the management of gestational diabetes.  
 
Figure 1. General view of the framework. 
3.1. Interaction of the AT with ontologies 
Ontologies formalize the clinical knowledge in a standard, flexible and interoperable 
way. In this approach, ontologies are externally queried to provide the needed clinical 
domain knowledge during the formalization process. After a research on different APIs 
for the integration of ontologies with the CDSS, Apache Jena1 was selected, as it allows 
our development to integrate ontologies using RDF or OWL models in an easy way. 
For the interaction of the AT with the ontology, different web services are used to: 
 
(i) get the list of variables (classes) from the ontology for defining the variable 
names within a rule, 
(ii) obtain the possible values of the selected variables, and 
(iii) receive the list of recommendations for completing the consequent part of the 
rule. This interaction can be seen in Figure 2, where the possible values that a 
 
1 https://jena.apache.org/documentation/ontology 
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variable (“CurrentPhysicalActivityLevel”) can take (left) and a 
recommendation as the consequent part of a rule (right) are shown. 
 
 
Figure 2. Introduction of conditions (left) and recommendations (right) of rules in the AT. 
 
3.2. CPG formalization 
The process of CPG formalization is the result of a continues interaction between the 
frontend and the backend of the system. The proposed GUI allows the user to formalize 
rules following four simple steps (see example in Figure 2). First, the name of the rule 
is defined, which defines the clinical content in a textual way. Afterwards, the 
conditions of the rule are introduced, defining the statements to be accomplished by the 
studied patient. Next, the recommendation for the formalized rule is specified as the 
consequent part to be provided. Finally, the rule is sent to the backend where it is 
stored and added into the knowledge base of the CDSS to be triggered for new cases 
study. 
The backend supporting this AT is composed by (i) a knowledge layer linked with 
external knowledge models, such as ontologies, to provide the needed clinical domain 
knowledge during the formalization process, (ii) a structure layer that gathers all this 
clinical knowledge and formalizes it in a technology-independent way relaying in the 
DE concept explained in [9], (iii) a rule engine that integrates a rule file generator for 
automatic triggering of the formalized knowledge, and (iv) a database (DB) that stores 
the formalized rules. 
With the interaction between the frontend and the backend of the system, the rules 
in the formalized CIG can be retrieved for their edition and update. Moreover, the used 
DE structure allows to write down CIGs in any document-based format (e.g. .drl, .xml, 
.json), since the knowledge is built in a java-based structure [8]. Finally, using the 
information stored in the DE concept, it is possible to apply standard metrics for 
J. Torres et al. / A Domain-Independent Semantically Validated Authoring Tool520
grading clinical evidence such as GRADE 2  to assess the quality of the evidence 
included in the guidelines. 
4. Conclusions and Future Work 
In this paper an Authoring Tool (AT) for the formalization of CPGs into CIGs is 
presented. This AT allows clinicians to take an active role in this process, as it enables 
them to formalize CPGs and personalize them according to their own experience. Also, 
the system facilitates the maintenance and shareability of this knowledge, as the 
followed DE structure can be exported into other clinical standards. With the use of this 
DE concept, the clinical evidence of the recommendations obtained from the system 
can be evaluated. In addition, the proposed system is domain-independent, allowing to 
formalize CPGs from different domains using the same AT. The generated CIG can 
then be integrated in a CDSS to provide patient-specific recommendations. 
Furthermore, new clinical knowledge can be added to the CIG using the AT GUI in 
order to update its contents with the latest evidence-based clinical practice. 
Overall, the presented tool eases the formalization of CPGs into CIGs for 
clinicians or knowledge engineers, while also allowing to edit and update the 
introduced knowledge. Furthermore, tools for assessing the reported clinical evidence 
in the CIGs are provided, avoiding the inclusion of erroneous or low evidence-based 
knowledge. 
Future work will include a visualization of the constructed rules to aid the 
clinicians' understanding how the introduced knowledge is being formalized. Finally, 
an ontology editor will be implemented for visualizing its classes and easing the 
manipulation of the ontology’s contents. 
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Abstract. This article proposes the analysis of the admissions to hospital-at-home
service within the framework of process mining. In addition to conventional model-
ing in standard languages, relying on interviews and continuous improvement, we
propose the adoption of an automatic process discovery technique based on data
collected by the hospital information system. We focus on the patient admission
process, in which staff discriminate cases of interest for the service. Our method-
ological framework starts with the extraction of process information from the ex-
isting dataset. Once obtained meaningful data for an event log analysis, we propose
the adoption of a process discovery algorithm by using a specific tool for process
mining. In the context of Business Process Management, we suggest a practical
application to be explored in order to improve standard modeling, opening the way
to perform business process simulation with scenario analysis.
Keywords. Business Process Management, Process Mining, E-health, Hospital-at-
Home
1. Introduction
In Medicine, one of the important aspects to investigate is the organization of health
processes, by considering an holistic and systemic approach. In this direction, computer
science gained a relevant role for technical hardware and information systems improve-
ments [8]. This is the case of Business Process Management (BPM) [7], a discipline
combining data science and management studies to perform business process improve-
ment, modeling and simulation [19] for decision-making [2], also in healthcare [12,15].
Modeling usually adopt standard languages, e.g, BPMN2, as well as relevant data col-
lected from Process-Aware Information Systems [8], properly stored with the recent XES
format [3]. Such workflow analysis facilitates the detection of inefficiencies, bottlenecks,
constraints, and risks [20,5,18].
In this paper, we explore the adoption of a process discovery technique from Pro-
cess Mining [9], a recent and promising field of study, in order to automatically extract
1Corresponding?Author??????????????????????????????
2See?OMG,?Business?Process?Model?Notation:?https://www.omg.org/spec/BPMN/2.0/About-BPMN/
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relevant information from event log data concerning the patients workflow [1]. We focus
on a specific healthcare service, the Hospital-at-Home service (HaH) in Torino, one of
the largest city of Italy, to investigate the admission process3.
The availability of real data about the service is at the core of healthcare business
process mining perspective [13,16]. Nevertheless, the adoption of Process Aware Infor-
mation System (PAIS) in most hospitals is not yet achieved, and healthcare managers
more often deal with conventional aggregated information. A large part of hospital infor-
mation systems actually is not well equipped for process analysis, whereas data can be
difficult to extract, including several well-know problem concerning data quality [14].
This work focuses on two research problems: i. Can we derive digital information
even in the absence of an information system that accurately collects data? ii. On this
basis, can we automatically derive an healthcare process, e.g. the HaH admissions? We
improve similar works which addressed the specific topic of modeling home-care ser-
vices [17], by applying process discovery technique to data of the service.
In the following of the paper, we introduce our use case, dataset and the method-
ological framework in Section 2, while Section 3 includes the output of process mining.
We draw some conclusions in Section 4.
2. Use case, data and methodology
The scientific literature as well as the practical experiences have already recognized the
usefulness of domiciliary cares, pushing hospitals to operate with integrated territorial
services [21].
2.1. Description of the use case
In the context of HaH carried out since 1985 by the main hospital in Torino, one of the
biggest city in northern Italy, we focus on the experimental project of geriatric home hos-
pitalization, in Piedmont region. This service started in the Molinette Hospital within the
“City of Health and Science” of Torino, which actually is one of the largest public health
hub in Europe4. This innovative service ensures cares mostly for elderly and fragile peo-
ple in acute disease. In addition to institutionalized services for patients, HaH provides
a relevant support to caregivers and their relatives. This avoids the improper accesses to
Emergency services, contributing in the reduction of the consistency of waiting lists. The
main interest of hospital managers to investigate HaH by adopting a process-oriented
perspective relies in the evaluation of benefits to further extend this kind of service.
2.2. Business process modeling and data analysis
In Figure 1 we provide a brief overview of HaH service, focusing on admission process,
whose diagram is on the left part. Eligible patients for the service are interviewed by a
Case Manager (CM), to investigate and evaluate the existing conditions to apply for HaH.
3This research is part of the project “CANP - CAsa Nel Parco” of Regione Piemonte funded by POR FESR
PIEMONTE 2014-2020. Web site of the project: http://casanelparco-project.it.
4Cfr. City of Health and Science, http://www.cittadellasalute.to.it, as well as: http://
shorturl.at/bosz3
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Figure 1. On the left: business process analysis in BPMN. On the right: Arrivals of patients at the HaH service
in 2017 and 2018 in the different months.
The diagram describes the output of a conventional approach with BPMN. Due to lack
of relevance in this paper, we avoid to detail all the tasks and passages, better presented
in [4]. In addition, we perform traditional data analysis to contextualize the process of
interest. The histogram in the right side of Figure 1 summarizes the arrivals of patients
in last two years by months, with peaks corresponding to the periods of flu (January and
Autumn), and less requests near Italian festivity days (i.e. April for Easter festivities).
2.3. Log of the process
To promote a business process analysis, we need more information about the patients’
flow. An initial step in the construction of the admission process includes the exploitation
of data registered in the hospital information system. As in the log example presented
in the following paragraph, we extracted information including: patient’s numeber (ID),
corresponding case (SDO), provenience (PROV), first call to the CM for the evaluation
(CALL), admission date (HaH1), type (OUT) and date of dismission (END).
ID, SDO, PROV, CALL, HaH1, OUT, END
045, 2017500110, SPEC, 02/02/17, 06/02/17, ORD, 14/02/17
048, 002017500552, PS, 21/06/17, 27/06/17, TRASF, 09/07/17
045, 2018500025, MDB, 04/01/18, 04/01/18, DEC, 25/02/18
2.4. Process Mining in Health
To perform the discovery of the process from the log we adopted PALIA Process Discov-
ery algorithm [10]. In particular, we apply PALIA algorithm for discovering the process
of HaH events described in previous section. PALIA Algorithm has been successfully
used in several medical problems like surgery [10], Emergency Rooms [11], or Diabetes
[6], among other health solutions. Process Mining can support healthcare professionals
in the real understanding of the process, not only by discovering the process but also
performing assessments for enabling the application of Value based healthcare [11].
3. Results
The result of our process mining technique is the model presented in Figure 2, whereas
the admission process has been automatically extracted from raw data.
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Figure 2. Output of the admission process
The process starts with the patient admission (HaH1) preceded by a call by the Case
Manager (CALL0), and followed by three types of output: the ordinary management of
HaH activities (ORD) until the dismission (END), the transfer of the patient - e.g. surgery
or the recovery to an Hospital department (TRASF); or the patient’s death (DEC).
A second model is presented in Figure 3, describing also the amount of occurrences.
Here, the color reflect the frequency of each event: as occurrences increase, arrows and
circle tend to red color. As clearly stated by the figure, the most frequent output is patients
hospitalization (only once time) and then the ordinary discharged.
Figure 3. Process discovery from HaH admission dataset.
By investigating our dataset, we immediately observe how the service performs well,
in general, as most patients are discharged in an ordinary way. In fact, a further inves-
tigation identifies how most patients, once discharged, do not return to the hospital. In
addition, it can be observed that the number of re-hospitalization is not very relevant.
4. Conclusions
We applied process mining to data about the admission of patients in healthcare ser-
vice. One point of interest is to demonstrate the ability to perform an healthcare process
analysis, by automatically deriving information about processes from not well structured
data (i.e., data not registered in standard event log XES format), as actually most hos-
pital information systems are still not process-aware. We believe that the understanding
of the advantages of using process mining techniques will push towards a wider adop-
tion of PAIS in the near future, as it is actually happening in Industry. As a matter of
fact, the methodological framework here presented allows to compare traditional process
analysis with the emerging techniques of process discovery, opening the way to perform
conformance checking and enhancement.
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Abstract. In this paper we present work on creating and evaluating a Text-to-Speech 
system for the Albanian language to be used in the BabelDr medical speech 
translation system. Its quality was assessed by twelve native speakers who provided 
feedback on 60 prompts generated by the synthesizer and on 60 real human 
recordings across three dimensions, namely comprehensibility, naturalness and 
likeability. The results suggest that the newly created voice can be incorporated in 
the content creation pipeline of the BabelDr platform. 
Keywords. Text-to-Speech, Albanian, Tacotron 2, BabelDr 
1. Introduction 
The ever increasing movement of people worldwide poses new challenges for healthcare 
institutions across Europe in particular problems related to different language and 
cultural barriers experienced by the healthcare practitioners and their foreign patients [1], 
[2]. Most of the time experienced interpreters, relatives or friends try to bridge this 
communication gap. However, this solution is often less than satisfactory as trained 
medical interpreters are both scarce and expensive, family members might not 
communicate the exact meaning of the physician’s question or the patient’s response, 
while there are also privacy concerns. It is generally agreed that translation quality is of 
prime importance in this setting [3], while tools like Google Translate pose certain 
problems on reliability and data privacy. 
Since 2017 the Faculty of Translation and Interpreting of the University of Geneva 
and the Geneva University Hospitals (HUG) joined forces for building a medical speech 
translator, under the BabelDr project2 funded by the Fondation Privée des HUG. The 
system is a web based tool that has been specifically designed to assist in triaging of non-
French-speaking patients visiting HUG’s A&E department, and allows a medical 
                                                          
1 Nikos Tsourakis, TIM/FTI, University of Geneva, 40, boulevard du Pont-d'Arve 
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professional to perform a preliminary medical examination dialogue to determine the 
nature of the patient’s problem and the appropriate action to take. The system 
incorporates state-of-the-art technologies like speech recognition (ASR) and text-to-
speech (TTS) and supports translation for different language pairs [4]. It is also aligned 
with mainstream research findings [5] on the basis that it incorporates preset health 
related questions and declarative sentences (11.134 in total) that can be selected using 
around 1M variations of similar speech phrases. 
In the context of this work we created and evaluated a synthetic female voice for the 
Albanian language based on Tacotron 2, a neural network architecture for speech 
synthesis directly from text [6] that can be used for announcing the physician’s questions 
to an Albanian speaking patient. In this paper we present the data gathering process and 
the steps taken in order to train the TTS. Based on an evaluation with twelve native 
speakers we assessed the comprehensibility, naturalness and likeability of the newly 
created voice. According to our findings we can reasonably argue that the synthesized 
voice can be incorporated in the content creation pipeline of the BabelDr platform. 
Section 2 presents the methods used for gathering audio data, training the voice and 
evaluating its quality. Section 3 reports on the results of the training process and the 
feedback from the native speakers. Section 4 discusses the findings and different 
implications in more depth. The final section concludes. 
2. Method 
2.1. TTS training 
As in every training task that involves a neural network architecture the amount of data 
is a crucial factor. Using an in-house web-based recording tool and an intermediate 
fidelity microphone we asked a female subject to perform 10452 recordings from home 
using a sampling rate of 48 kHz. The text included questions from 13 diagnostic domains 
with phrases like: “Can you show me with the finger where the pain is?”, “Are you 
allergic to antibiotics?”, “How many cigarettes do you smoke per day?”, etc. The created 
corpus contained 2014 unique words, while the average length of the sentences was 14 
words (sd=6). The corpus was split into a training set consisting of 9500 sentences and 
an evaluation set with 952 sentences.  Approximately 9.5 hours of speech were recorded. 
2.2. Human evaluation 
Contrary to other evaluation tasks, where software systems can be assessed in terms of 
various objective measurements, evaluating a synthesized voice is highly subjective. For 
this reason we recruited twelve native Albanian speakers and asked them to provide their 
feedback across three dimensions typically encountered in TTS evaluations [7]. 
Specifically, they had to listen to a series of audio prompts and express their opinion in 
a five-point Likert scale (subjective mean opinion score - MOS) concerning how 
comprehensible the prompt is, how natural the voice sounds and how much they like the 
voice. The whole evaluation was set-up as a Google form3 so that the participants could 
provide their feedback easily, while the investigators of the study could acquire their 
responses immediately. The evaluation protocol was based on two hypotheses: 
 The TTS can be used in our content creation pipeline. 
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 The TTS works equally well for short and long sentences. 
For testing the two hypotheses we generated 60 audio prompts with the TTS and 
selected randomly 60 volume normalized recordings from the initial training corpus. For 
each of these two subsets we chose sentences of different word length according to this 
formula: 20 sentences with 1 to 3 words, 20 sentences with 4 to 9 words and 20 sentences 
with more than 9 words. The human recordings and the TTS prompts were merged and 
shuffled into a single set, so that participants were not aware of the source of each one. 
3. Results 
3.1. TTS training 
The TTS engine was trained based on a Tacotron 2 implementation4 using the following 
hyper-parameters: learning rate=0.0001, batch size=32 and epochs=1000. The model had 
to learn ~28M parameters and the process took place on a Linux server equipped with an 
NVIDIA GeForge GTX Titan X, 12GB GPU card. Figure 1 shows the average total loss 
(average of the linear loss, mel loss and stop loss) in respect to the training epochs, which 
reaches to 0.01 at the last one. 
Figure 1. Average total loss per number of epochs 
3.2. Human evaluation 
Table 1. Mean opinion score (MOS) for the three evaluation criteria: Comprehensibility (C), Naturalness (N) 
& Likeability (L) and for the two types of prompts 
 I understand the question 
(C) 
The voice sounds natural 
(N) 
I like the voice  
(L) 
TTS MOS 3.9 (sd=0.5) 3.0 (sd=1.0) 3.1 (sd=1.1) 
Recordings MOS 4.5 (sd=0.4) 4.2 (sd=0.9) 4.1 (sd=0.9) 
 
Table 1 summarizes the mean opinion score of all participants, for the three evaluation 
criteria and the two types of prompts. As expected human recordings outperform the TTS 
in all dimensions. Although the TTS might sound less natural and be less likeable it is 
still quite comprehensible 3.9/5 vs. 4.5/5 (statistically significant difference at p<0.002). 
We also examine the variation in comprehensibility, naturalness and likeability of the 
TTS based on the sentence length. As it can be observed in Table 2, our initial hypothesis 
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is correct and the TTS works equally well for short and long sentences (no statistically 
significant differences). 
Table 2. Mean opinion score (MOS) of Comprehensibility (C), Naturalness (N) & Likeability (L) of the TTS 
prompts based on the sentence word length 
 MOS (C) MOS (N) MOS (L) 
Sentences with 1-3 words 3.8 (sd=0.6) 3.0 (sd=1.0) 3.1 (sd=1.1) 
Sentences with 4-9 words 4.0 (sd=0.4) 3.1 (sd=1.0) 3.1 (sd=1.1) 
Sentences with more than 9 words 3.9 (sd=0.6) 3.0 (sd=1.0) 3.0 (sd=1.1) 
3.3. Qualitative analysis 
In order to qualitatively analyze the source of errors in the synthesized prompts we asked 
two experts to identify possible problems. Specifically, each expert had to assess each 
prompt based on possible intonation problems (e.g. not being able to distinguish if it is a 
question or a request) and whether the prompt included muffed or unnatural sounds. 
These criteria were selected on the basis of informal feedback by the participants of the 
evaluation task. We calculated the Cohen’s Kappa score for each one of the two pairs 
that expresses agreement corrected for chance, shown in Table 3. A kappa ranges 
between -1 and 1 and a value of 0.19 is defined as slight agreement whereas a value of -
0.27 as a poor one [8]. The last row shows the absolute number of sentences where the 
two experts agreed. 
 
Table 3. Cohen’s Kappa for the two kinds of possible problems (95% confidence intervals in parenthesis) and 
absolute sentence agreement  
 Intonation problems Muffed or unnatural sounds 
Cohen’s Kappa 0.19 (0.1,  0.34) -0.27 (-0.51,  -0.04)  
Agreement 30 out of 60 25 out of 60 
 
We also calculated the correlation between the MOS of comprehensibility 
(continuous variable) and the responses from each expert and for each one of the two 
criteria (categorical variables “0” or “1”). The appropriate method in this case is the point 
biserial correlation, which did not show any significant differences.  Both correlation and 
agreement suggest that using intonation and checking for unnatural sounds is not an 
appropriate method for assessing prompt comprehensibility, which should be determined 
on a case-by-case basis with other criteria. 
4. Discussion 
In the era of neural networks creating a new voice from scratch demands few human 
months of work something that a decade ago would require extensive expertise and 
commitment for much longer time. After the positive experience with the Albanian TTS 
we are capable of creating new voices according to the needs of the project. Resorting to 
a commercial TTS is not always an option due to the lack of support for certain 
languages; a typical example is Tigrinya, frequently encountered at HUG, for which no 
synthetic voice yet exists. Even for those languages where a commercial option is 
available it normally targets the most common dialect. Arabic is another typical example. 
On the other hand one might argue in favor of recording every new sentence from 
scratch. This option is well aligned with the BabelDr project which is strongly biased 
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towards quality assurance. Every translation is checked by experts to avoid possible 
errors and ambiguities. The sole difference, however, is that multiple people can perform 
the translation task but a single person can do the audio recordings. If this person is 
temporary not available the whole deployment pipeline is stalled. Even as a backup 
strategy having your own TTS presents many competitive advantages. Nonetheless there 
is always a human in the loop in our content creation pipeline that checks both 
translations and TTS prompts and decides if they are acceptable or not. 
A factor that was not properly addressed in this study concerns on how we measure 
comprehensibility. In essence by asking participants to quantify their understanding you 
risk obtaining a negative answer for a perfectly oralized prompt simply because the 
question was ambiguous or unclear in the first place (e.g. a medical term was used). In a 
future study two levels of comprehensibility should be scrutinized by carefully creating 
and testing a corpus that alleviates this deficiency. Conversely, even a perfect score in 
comprehensibility does not decisively mean that the prompt sounds perfect. The 
participants expressed concerns that sometimes they listened to sentences that did not 
sound completely right but were still comprehensible.  
5. Conclusion 
Language barriers often cause inconvenience but when medical issues are involved they 
cease to be mere inconvenience and can become life-threatening. In this work we include 
a new building block in our platform for creating synthesized voices. After evaluating its 
feasibility for the Albanian language with twelve native speakers we can include it in the 
BabelDr content creation pipeline. We have also found that there are no differences in 
quality between short and long sentences. 
In the future we plan to combine Tacotron 2 with a neural Vocoder like WaveNet5 
and WaveGlow6 that promise to ameliorate the output quality. We also intend to gather 
more data for Albanian, as 9.5 hours of training material puts us in the low end of 
complexity (e.g. in [6] around 25 hours of speech were used). We will also create a new 
voice for the Tigrinya language. 
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Abstract. Few, if any, of the Clinical Decision Support Systems developed and 
reported within the informatics literature incorporate patient preferences in the 
formal and quantitatively analytic way adopted for evidence. Preferences are 
assumed to be ‘taken into account’ by the clinician in the associated clinical 
encounter. Many CDSS produce management recommendations on the basis of 
embedded algorithms or expert rules. These are often focused on a single criterion, 
and the preference trade-offs involved have no empirical basis outside an expert 
panel. After illustrating these points with the Osteoporosis Adviser CDSS from 
Iceland, we review an ambitious attempt to address both the monocriterial bias and 
lack of empirical preference-sensitivity, in the context of Early Rheumatoid 
Arthritis. It brings together the preference data from a Discrete Choice Experiment 
and the best available evidence data, to arrive at the percentage of patients who 
would prefer particular treatments from those in the listed options. It is suggested 
that these percentages could assist a GRADE panel determine whether to produce 
a strong or weak recommendation. However, any such group average preference-
based recommendations are arguably in breach of both the reasonable patient legal 
standard for informed consent and simple ethical principles. The answer is not to 
localise, but personalise, decisions through the use of preference-sensitive multi-
criteria decision support tools engaged with at the point of care. 
Keywords: Clinical Decision Support System, guidelines, GRADE, multi-criteria 
decision support, osteoporosis, rheumatoid arthritis 
1. Introduction 
Clinical Decision Support Systems (CDSS) can approach the eponymous task in a 
variety of ways, but this variation is within the taken-for-granted assumption, 
understandable in the context of ‘informatics’, that the basic support for the clinical 
decision at the point of care is in the form of information. However, it is clear that this 
excludes information on patient preferences. The aim here is to question this practice 
and argue for a rethinking of CDSS that would bring them into line with recent moves 
toward patient- and person-centred care. To avoid any suggestion of misrepresentation 
we start with a mainstream definition [1], with which all the CDSS presented, as such 
at MIE and Medinfo conferences in the last five years are in line.  
                                                 
1 Corresponding author: Jack Dowie, LSHTM, 15-17 Tavistock Place, London, UK WC1H 9SH; 
email: jack.dowie@lshtm.ac.uk 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200217
532
Clinical decision support systems (CDSS) - defined as any system designed to 
improve clinical decision-making related to diagnostic or therapeutic processes of 
care… use specific parameters (such as diagnoses, laboratory results, medication 
choices, or complex combinations of clinical data) to provide information or 
recommendations directly relevant to a specific patient encounter at the point of care… 
CDSS address activities ranging from the selection of medications (e.g., the optimal 
antibiotic choice given specific microbiologic data) or diagnostic tests (e.g., the best 
blood test to evaluate a patient with possible pulmonary embolism) to detailed support 
for optimal drug dosing and support for resolving diagnostic dilemmas… Typical 
CDSS suggest default values for drug doses, routes of administration, and frequency, 
and offer more sophisticated drug safety features such as checking for drug allergies or 
drug–drug interactions[1]. 
The AHRQ summary goes on to suggest that the advent of advanced analytic 
methodologies for large, complex data sets and the development of machine learning 
techniques is likely to lead to the development of increasingly powerful and 
sophisticated CDSS. ‘These artificial intelligence approaches have tremendous 
potential for transforming diagnosis and therapy…. However… acceptance of artificial 
intelligence–based CDSS will require transparency around the methods used to develop 
recommendations… .’. Otherwise the spectre of ‘digital paternalism is raised. 
Crucially, there is no reference to preferences, which are necessary in any 
‘selection’, ‘optimization’, or ‘recommendation’ task. Confirming the basic point of 
this paper, Patient-centered clinical decision support systems (PCCDS) are regarded by 
AHRQ as a separate category of CDSS: ‘PCCDS refers to decision support systems 
that support individual patients, caregivers, and health care teams in health-related 
decisions and actions by leveraging patient-specific information (e.g., patient-generated 
health data) and patient-centered outcomes research findings… ‘. However, even here, 
the patient is only as a source of biomedically relevant information, not of preferences. 
We employ a simple three-level taxonomy. A basic CDSS confines itself to 
producing biomedical information to assist the clinician to arrive at the best possible 
diagnostic judgment and therapeutic decision recommendation for this patient, 
containing no further guidance or assistance.  This information can range from a single 
piece of data on a single parameter, such as this patient’s bone mineral density (BMD) 
as measured by a DXA scan, to the output of a multi-attribute model yielding a 
probability for this patient experiencing a hip fracture in the next ten years (e.g. Frax). 
A diagnostic CDSS goes further, applying embedded guidelines and/or algorithms to 
this data to help the clinician arrive at the best possible diagnostic judgment for this 
patient - such as whether they meet the criteria for a diagnosis of osteoporosis or 
osteopenia according to the BMD result. Finally, a therapeutic CDSS applies 
embedded guidelines and/or algorithms to the basic data and/or diagnostic 
suggestion/s to help the clinician arrive at the best possible therapeutic decision 
recommendation for this patient - such as applying the National Osteoporosis 
Guideline Group’s Frax thresholds for reassuring, treating without testing, or treating 
and testing. (‘Diagnostic judgment’ covers the entire range from a single diagnosis to a 
probabilistic differential diagnosis. ‘Therapeutic decision recommendation’ refers to 
any test and/or treatment option). 
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2. Osteoporosis Advisor: A conventional CDSS 
We have already used bone health and fragility fractures as examples and now explore 
Osteoporosis Advisor (OPAD), an Icelandic commercial product distributed through 
professional providers and exclusively for use in association with a clinical encounter 
[2,3]. To document what is, and what is not, in OPAD, we quote at length: 
… the Osteoporosis Advisor or OPAD (http:// www.expeda.is), a computerized 
clinical decision support system to assess and treat osteoporosis in a primary care 
setting… OPAD provides a patient’s 10-year fracture probability (with or without 
BMD values) using a speedometer-like output that users can easily understand. The 
OPAD also notes whether a patient would benefit from BMD measurement by DXA. 
OPAD provides patients with lifestyle and treatment recommendations to reduce their 
fracture risk, incorporating country-specific guidelines for therapy… OPAD not only 
gives the fracture risk, but also recommend clinical decisions based on guidelines… 
Further patient factors may be incorporated into the risk assessment model of OPAD, 
such as loss of height, history of falls and it is even possible to add individual 
genotypes to improve the fracture risk estimation [2] (pp. 2, 6, 7). 
Notably these ‘further patient factors’ do not include their preferences. The word 
‘preference’ does not appear in this paper or the earlier companion one. As in most 
therapeutic CDSS, the patient is a biological object to be subjected to a biomedical 
assessment, followed by the application of guidelines incorporating either population-
based thresholds  (NOGG) or, as in OPAD, local expert-based rules (unpublished). 
It seems fair to characterise OPAD as a good example of the ‘digital’ (i.e. data-
driven) paternalism’ that underlies many therapeutic CDSS. 
The busy clinician may have difficulties in interpreting the risk value figure for 
each patient in hectic daily clinical practice. With this in mind we have extended the 
information provided by OPAD, by giving a specific diagnosis, that is, osteoporosis or 
osteopenia, and specific recommendations on prevention, time of next DXA, and 
treatment options according to international guidelines and experts knowledge… The 
clinically relevant parameters and the computed risk for fracture are used as input into 
an expert system which gives specific recommendations for each case with respect to 
lifestyle changes and treatment options… the system predominantly relies on 
knowledge capture process of the expert panels, as guidelines never cover all cases. In 
the end a total of fifteen different treatment recommendations were initially identified 
as possible recommended treatment options for osteoporosis. The recommended 
treatments ranged from no treatment to specific recommendations for which drug class 
was the most appropriate, either as a preventive measure or as a treatment for manifest 
osteoporosis… [3] (pp. 5,2,3). 
There is nothing in any of these statements that would preclude the explicit 
mention of patients’, or patient’s,  preferences, but there is none. The taken-for-granted 
assumption is that the latter can - and by implication should be - left to be ‘taken into 
account’ by the clinician, subsequent to the clinician’s engagement with the CDSS. 
Why do CDSS feel justified in producing therapeutic decision recommendations 
without any reference to information on patient values and preferences?  
One answer is that, in line with the embedded algorithm or guideline, many CDSS 
assume the decision is monocriterial not multicriterial. OPAD assumes that the only 
criterion that matters is fragility fracture prevention, ignoring all other outcomes (and 
process considerations) involved in the options. The side effects and treatment burden 
of the various options are two criteria given significant weight by many patients. In the 
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piloting of a Danish decision support tool the weights given to avoiding fragility 
fracture in the next ten years was 43%, to avoiding (option?) side effects 37%, and to 
avoiding bother/burden 20% [4]. Other populations, settings, and methodologies are 
likely to produce different results, but highly unlikely to produce anywhere near 100% 
weight to fragility fracture prevention. It is not a convincing response that these criteria 
are also to be dealt with outside the CDSS. If a CDSS does not attempt to address a 
decision as the multi-criterial one it is - probably using some version of Multi-Criteria 
Decision Analysis [5] - it would be more appropriately called a Clinician Information 
Support System. 
The second answer is that, even absent ‘digital paternalism’, it is extremely 
difficult to deal with preferences ‘scientifically’, since this requires (a) their elicitation 
and (b) the integration of the results into the decision or guideline. It is not surprising, 
then, that only in 2019 have we seen a paper attempting it [6]. 
3. A multi-criterial, group preference-sensitive CDSS 
Hazlewood and colleagues accepted the challenge, acknowledging that ‘Research 
evidence alone cannot tell us which treatment is best for patients, and the reason is 
simple. Even where high-quality evidence is available, treatment choices inevitably 
involve trade- 	
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Incorporating patients’ preferences into treatment recommendations has been viewed 
as the next step in guideline development, but rarely occurs in practice’ [6] (p57).  
They argue that guideline panels should view the assessment and incorporation of 
patients’ preferences as a critical step in the evidence to decision process and 
accordingly seek to assist these panels in making the necessary judgments when 
translating evidence into a recommendation, using empirically derived data. 
In their application to Early Rheumatoid Arthritis (ERA) they ‘estimated the 
preferred treatment using patients’ preferences measured in a discrete-choice 
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analysis and other considerations (dosing, rare adverse events)… We applied this to 
treatment recommendations for ERA where there is disagreement over the preferred 
treatment. Thus, a secondary aim was to generate evidence that could be used to help 
inform patient-centered GRADE treatment recommendations for ERA’ [6] (pp.56, 57). 
Unfortunately, both the analysis and presentation of results confirm that any 
approach to the clinical decision through guideline recommendations, even if 
population-preference informed in this way, is not patient-centred. According to the 
authors, the patient’s preferences  - and decision aids - are to come into play only if the 
percentage of patients preferring a therapy is somewhere between 62% and 78%. Most 
patients would prefer triple therapy as initial treatment (78%) or after an inadequate 
response to methotrexate (62%). The probability of choosing triple therapy as initial 
treatment was further from 50% (the point of indifference) for more patients, making 
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made. After an inadequate response to methotrexate, the choice was more split, 
suggesting a decision aid may be helpful... [6] (p56). 
Both proposals - that there is a population percentage threshold for a strong 
recommendation and that it is at 50% - are arguably in breach of both the reasonable 
patient legal standard for informed consent and simple ethical principles.  
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Hazlewood et al. accept that preference studies may be very context-, so 
that existing studies may not be relevant to a guideline group’s target population. 
Hence, generating context-
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that may not be feasible. Nevertheless ‘Guideline developers could… use a central 
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‘globalizing evidence, but localizing decisions’’ [6] (p.64). 
4. Conclusion 
The difficulty of generating relevant group preference data is actually a blessing in 
disguise. The answer is to personalise, not localise, eliminating the irrelevant detour 
into group average preferences, and going direct to those of the individual patient in the 
clinic at the point of care. Conventional therapeutic CDSS should be abandoned, and 
basic and diagnostic CDSS re-labelled - and evaluated as - Clinician Information 
Support Systems. The best way for informaticians to support preference-sensitive 
clinical decision making is to redirect their efforts to producing the information (option 
performance ratings on each of the criteria) required in the Multi-Criteria Decision 
Analysis-based decision support tools essential for greater patient involvement and 
transparent preference-sensitivity. 
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Abstract.         !  has been 
"     -based reasoning principles. Our decision 
   #"   "    "!
who represents future users $%&enables its user to 
find   !""##
result of the potential coronary angiography '((
useful visualizations to the cardiologist, who is responsible for the final decision 
#"coronary angiography or not for the new patient. The first 
$"#(". 
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1. Introduction 
In the process of establishing an initial diagnosis of potential disease, a collection of 
relevant      significant difference that enables doctors to 
$    decisions. For doctors, it is nowadays hard to consider a 
"($"!""% 
The diagnostics   ("
$ (#   " % ) #  " # 
"!     that  '"    
$ $. *+-
based reasoning (CBR) [1] which associates  "  analogy. We 
   into an application that allows its users to reasonably 
("% The use of 
+2    $   (("% * " # $ 
"""!($$s. The fact that the CBR 
"(#3"""$$
+2[7]. Cardiovascular diseases are still the leading cause of 
4(#!#  [10]. It was expected, 
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  (( "   approaches were introduced, that 
##"$($%!
profile of population worsened in the course of last years. +(#
" (    #  $ early screening of patients, thereby 
speeding up patient selection for eventual intervention testing and indicating effective 
therapy. There is an unanswered question that properly indicated and evaluated new 
ethods could reduce further investigations that unnecessarily prolong the diagnostic 
$((-intervention strategies. 
      +2 " ?#$ #  
$"  =@! <" kEE  $ $"     $
*G!#"G4
?   $   "  (   H@% 
("$  (<%* $
(<!"%"%(<#+
?+@%4$(#(<
described in section 4.   
2. Methodology 
Case-based reasoning (CBR) is a #-solving " that is recognized and 
well-#  $    L=Q. To find a solution to a new 
#! '$dealing with ( and 
adapt the old answers to fit the current situation LHQ. Therefore, t of 
the CBR is the  #should also be %  
The CBR process consists $$ [4]; 
 RETRIEVE – finding one or several of ses to the current 
#, 
 REUSE/ADAPT – ""that was gained $$
(#! 
 REVISE – " $  and $" 
the solution if needed, 
 RETAIN – saving the currently solved case for potential future use.  
" k-Nearest Neighbors (kNN) $( 
cases. It is a versatile (  " " that can be applied to 
solve # leading to both classification and " % )!
" kNN [5]  that cases close to each other, <"  #
!% 
3. Application design 
The goal of this application is to  #$ <
data about real patients with cardiovascular diseases. It will serve as a decision support 
for cardiologists%*#$$application lies in helping the doctors 
to  diagnosis $   ly. Specifically, it should  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while deciding whether the current patient shows signs of potential cardiovascular 
disease and needs ''coronary angiography. 
The CBR cycle begins with the user entering data about a new patient who 
 ( '% "    ""   $ 
(, which represents the first phase of the CBR cycle called 
RETRIEVE. This step utilizes the  $     
!YY# % We considered regarding #
of   to be returned, the following ;   ! an arbitrary 
# $ ( \1;10>          a given 
threshold. In the third scenario, there could be a situation when all of the cases 
would be very different than the current one  that none $would be 
retrieved. Therefore, #ation of both to be the  appropriate. 
A, we also want to provide $#the calculated 
of the cases. 
* $" !     REUSE/ADAPT, uses the prevailing 
value of the target attribute as a solution for the new case. If the suggested value 
indicates that the new patient has a $$$"$ cardiovascular disease, 
the CBR cycle continues to the next phase.  
The third phase is called REVISE because of the verification of the suggested 
diagnosis. W$"%*he application selects ten 
new case for each of the existing classes 
(i.e. for all different values of the target attribute). The calculated distances of the 
nearest cases $are then for each of the classes of the 
target attribute            ( ""
solution. If the newly proposed solution is ly suggested diagnosis 
(utilizing kNN), the user can consider this so%  
We proposed also a different approach to the adaptation phase of the CBR cycle 
in [6]. Our approach there #$
 % $$  $   relevant decision rule are identified and 
subsequently adapted to the new case.  
4. Implementation 
The proposed application is being the R language with the help of the 
4 "% *    $  previously collected  
which are stored in a relational table in a “.csv” $$% 
The application currently consists of five different tabs. The user can navigate 
#"positioned at the top of the page. The first tab is called 
“The New Case” (see Fig. 1) and    $ $  pplication. 
The user has to enter necessary $!uch as year of birth and gender 
of the new patient, to start the process of findin"    """ the 
diagnosis. *#$  ##  the interval 
\1;10> with the default setting being the #j% *$#the current 
     # ' (   #  (d in a 
k%'m$$% 
There are also five different options concerning the  $   $
$#; 
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 ; Manhattan distance; Mahalanobis distance; 
 |fil - fiR| / |fmax - fmin|, where fi equals the value of the attribute i (fil for the new 
case and fiR $ "$@% fmax and fmin '
!%($#" [8]; 
 if fil < fiR ;1 – ( fil / fiR )!;1 – ( fiR / fil ). 
*## ""!
"$"k-%*(
#$## #"
tree leaf or cluster as the new case, respectively. |      $
'    $      # " 
(?%"%!#$#$
new case). The accuracy of prediction will be evaluated by 10-fold cross-validation, 
   $ $ $$ distance  ?  
#k-@% 
 
 
Figure 1. “The New Case” tab. 
The second tab, which is called “The Data”,  
cases. It also offers the sorting and filtering options to see only the relevant records that 
are of interest to the user. There is also an option to upload and preview a new dataset 
of cases in a “.csv” file $, which will be added to the current database of cases. 
The next tab shows the data classified into four different categories according to the 
severity of disease and their calculated 4+&. The following pages contain various 
visualizations of the records. The user can choose which of the available attributes 
should appear on the x and y-axis. Another attribute can be selected to divide the cases 
into groups of different colors. The default type of graph is scatterplot, but there are 
other options, such as barplot or boxplot. The first visualization consists of a "
depicting the new case along $$k*E+m#% 
The second graph portrays all the available records as data points. The last tab 
offers the visualizations of th     # the Principal 
 (PCA) – )"%=. +# #
($$[9]. In our case the two 
are shown on the x and y-axis in two separate scatterplots, divided 
into groups of different colors by the severity of the disease. The first graph consists of 
all the data plus the new case (i.e. only attributes provided for the new case are used for 
calculation of distances), the second one of all the data without a new case. The 
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difference between the two PCA visualizations is that in the second visualization the 
#$#$$+
% 
 
Figure 2. “PCA - +nalysis” tab. 
5. Summary 
      "    $ "!
#+2"%kEE"#! 
*G      G4 !   $    $$ %
Moreover, CBR cycle is supported by a set of visualizations, which have been designed 
 "  "!"%2 $# 
$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Abstract. The world population is dramatically ageing, resulting in an increase of 
the prevalence of older dependent adults living in nursing homes (NHs). Because 
of insufficient resources in NHs, and nurses’ lack of time and knowledge, adverse 
events, most of them being preventable, are often reported. Clinical decision 
support systems (CDSSs) have proven to improve the quality of care in various 
healthcare settings such as hospitals and primary care centers. However, the use of 
CDSSs in NHs is still limited and little is known about their influence on nursing 
practices and NH residents’ clinical outcomes. We conducted a scoping review of 
the literature to evaluate CDSS use in NHs.  Out of 1,231 retrieved papers, 15 
studies were retrieved which assess 10 CDSSs applied to pressure ulcers and 
malnutrition prevention, drug prescription, and disease management. This review 
showed CDSSs could be effective in NHs for improving routine clinical practice 
and patient outcomes, but research is still needed to implement effective CDSSs in 
NHs. 
Keywords. Clinical decision support systems, Nursing homes, Geriatrics, Clinical 
Outcomes, Evaluation, Quality of care 
1. Introduction 
Because of the ageing population and the rise in the prevalence of dependent older 
adults, an increasing number of aged people currently live in nursing homes (NHs). 
Studies have reported that NH residents are at risk of developing adverse events, many 
are preventable (e.g. pressure ulcers, urinary tract infections, falls, adverse drug events) 
[1]. This is often explained by insufficient staff and resources in NHs, and nurses’ lack 
of time and knowledge [2].  
Electronic Health Record systems (EHRs) contain patient’s data, including 
nursing records and care track. EHRs have proven to provide accurate, up-to-date, and 
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holistic information about patients at the point of care, enabling more coordinated and 
efficient care. The use of clinical decision support systems (CDSSs) connected to 
EHRs have demonstrated to improve the quality of care in both hospitals and primary 
care settings [3]. However, the use of CDSSs in NHs is still limited and little is known 
about their influence on nursing practices and NH residents clinical outcomes [4]. 
Teranga2 is a French vendor of an EHR called “NETSoins” used in about 40% of 
NHs nationwide. One objective is to develop a CDSS connected with NETSoins to 
improve the knowledge of nurses and support them in providing better care to NH 
residents. Prior to this development, we conducted a scoping review of the literature to 
analyze CDSSs used in NHs and assess the key factors of these systems regarding 
nurse satisfaction, care process improvement, and NH residents clinical outcomes. 
2. Methods 
PubMed was searched between 2010 and 2019 for studies describing CDSSs used in 
NHs. We used a combination of MeSH terms and key words to account for the 
management of elderly in NHs (i.e., “Geriatrics”,  “Long-Term Care”, “Nursing 
homes”, “Residential Facilities”, “Care homes”) and the use of CDSSs (i.e., “Decision 
support techniques”, “Decision support system, Management”, “Decision support 
system, Clinical”).  
Two of the authors (AA, DN) independently selected original articles describing 
and evaluating the implementation and use of CDSSs in NHs on the basis of titles and 
abstracts. The reference list of selected papers was also examined.  
Selected articles were analyzed according to (i) the specific clinical application of 
the CDSS, (ii) the design of the study (type, CDSS users, sample size), (iii) CDSS 
features (reasoning process and users’ interfaces), (iv) impact of the CDSS, and (v) 
CDSS users’ acceptance and adoption in routine practice beyond the intervention 
period. We included observational studies (OSs), randomized (RCTs), and non-
randomized controlled trials (NRCTs). 
3. Results 
The query used to search PubMed retrieved a total of 1,231 articles leading to 26 
potentially relevant publications for full-text review after the screening step. Eleven 
publications were excluded (CDSS was applied to primary care, no computerized 
CDSS was used, no outcome was assessed) leading to 15 articles [4–18] that met our 
criteria for review.  
The 15 selected studies assessed 10 different CDSSs that were gathered for the 
analysis according to their clinical application: CDSSs for prevention, CDSSs for drug 
prescription, and CDSSs for disease management. In all the retrieved studies, users’ 
adoption of CDSSs in routine practice beyond the intervention study period was not 
well described and was finally not analyzed in this paper. 
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3.1.  CDSSs for pressure ulcers and malnutrition prevention 
We retrieved five studies [4–8] assessing the implementation of three CDSSs to 
support pressure ulcers and malnutrition prevention. Two studies were OSs [5,8], two 
were RCTs [4,7], and one was a NRCT [6]. All studies enrolled nurses and nursing 
aides as primary CDSS users. All CDSSs were guideline-based and used the display of 
alerts automatically triggered when risk assessment instruments (e.g. the Risk 
Assessment Pressure Scale for pressure ulcer risk screening or the Mini Nutritional 
Assessment scale for screening nutritional status) exceeded predefined thresholds. One 
CDSS [4–6] is integrated into the NH EHR, the two others [7,8] are standalone systems 
that need to be activated by users. One CDSS [8] is a patient monitoring system to 
facilitate nursing staff implementation of standard care for pressure ulcer/injury 
prevention. The system operates from data on frequency and position of sensors worn 
on each resident's anterior chest, to estimate the nursing staff compliance with 
repositioning standard of care, before and after visual monitors were activated to cue 
staff. 
Globally, using the CDSS lowered significantly the prevalence of malnourished 
residents (reduction from 28.8 to 19.8%) [4], and pressure ulcers incidence (reduction 
from 15.1% to 7.1%) [7]. The three CDSSs were associated with an improvement of 
care processes (better compliance of nursing care with clinical practice guidelines, 
especially concerning NH residents repositioning, improvement of practitioners’ 
attitude and nursing culture) [5–8]. User reviews were mixed, diversely reporting ease 
of use, lack of training, and resistance to computer use. 
3.2. CDSSs for drug prescription: medication review and daily drug prescription 
We made the difference between CDSSs supporting daily drug prescription and those 
for “medication reviews”. A medication review is a structured analysis and re-
consideration of the entire patient’s drug treatment aiming at simplifying and 
optimizing it, usually performed at least once a year in geriatrics by both physician and 
pharmacist.  
Five studies [11,12,16-18] (among which four OSs and one NRCT), evaluated two 
CDSSs for medication review. Two studies [11,12] enrolled pharmacists as primary 
users of the CDSS whereas nurses were the CDSS principal users in the other studies 
[16-18]. Both CDSSs were guideline-based. One [11,12] is a standalone system and 
operates to support pharmacist review of physician orders. In case of drug mis-
prescription, alerts are automatically triggered and displayed to the pharmacist who 
contacts the prescriber and indicates how to revise the wrong prescription. The second 
CDSS [16-18] is connected to the NH EHR. It criticizes drug prescriptions and alerts 
nurses about drug-related problems. All studies measured the effects of using the CDSS 
on care processes such as prescriptions and observed clinical practices compliance with 
guidelines, as well as interpersonal collaboration. The use of the CDSS was beneficial 
in all studies. Users were mostly satisfied by the CDSS except in one study [12], where 
they reported alert fatigue. 
Three studies [13–15] (two OSs and one RCT) evaluated the implementation of 
three CDSSs to support daily drug prescription. The primary users of CDSSs were 
pharmacists in two studies [14,15], and physicians in the third study [13]. The 
knowledge bases of these systems are elaborated from clinical practice guidelines and 
expert opinion. All CDSSs display critics attached to non-compliant drug dosing or 
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prescription. One of the three CDSSs [9] is connected with the NH EHR and generates 
informative dosing messages or alerts for prescribers. The two other CDSSs are 
standalone systems where patient data have to be entered to obtain decision support. 
Warning messages are displayed to criticize physicians’ prescriptions. CDSSs work 
with emails or phone calls between physicians and pharmacists.      
CDSSs were successful in all studies to improve processes (e.g. increase of drug 
prescription compliance) and organizational aspects (e.g., time saving, team working). 
No clinical outcome was measured in any of the studies. Users of one study [13] 
expressed their dissatisfaction about unnecessary alerts (displayed in 50% of the cases). 
3.3. CDSSs for disease management 
Two studies (both were OSs) [9,10] assessed two CDSSs for disease management. The 
first CDSS [9] is applied to heart failure real time management. It includes several 
reporting tools to help data tracking and analysis to be used by physicians (tabular view 
for medications, weight-trending graph, and symptom analysis). The second CDSS [10] 
is applied to the management of urinary tract infections and is developed following 
Goal-Directed Design principles to support NH staff in differentiating urinary tract 
infections from asymptomatic bacteriuria, thus reducing antibiotic days.  
The first CDSS [9] is connected to the NH EHR. It relies on a guideline-based 
knowledge base. The second CDSS [10] is a web-based application. Four information 
needs were identified from focus groups (guidance regarding resident assessment, 
communication with providers, care planning, and urine culture interpretation) and 
encoded in the knowledge base of the system (also including clinical practice 
guidelines). Both CDSSs provided educational recommendations. Both CDSS were 
considered useful for symptom tracking, visual information, facility of data entry, and 
ease of use. 
4. Discussion and conclusion 
Health information technology tools such as EHRs and CDSSs have proven to improve 
the quality of care in hospital settings. However, our literature review showed that 
these tools are not yet widely used in NHs despite a great number of residents and 
insufficient staff and resources, e.g., lack of doctors. On the last decade, only 15 papers 
describing the NH use of 10 different CDSSs have been retrieved. Most of the CDSSs 
were stand alone systems (six out of 10), this lack of interoperability being reported as 
being an issue in previous studies. Systems were poorly described in the retrieved 
papers and it was difficult to understand how they were developed (data processing, 
user’s interfaces, etc.). For instance, we could not assess whether factors such as 
requiring practitioners to provide reasons when over-riding or providing advice 
concurrently to patients and practitioners, known to be winning factors to improve 
guideline compliance and care quality [3], were implemented. Only a few studies were 
RCTs (3 out of 15), evidencing positive clinical outcomes (significant reduction in the 
prevalence of malnourished residents and pressure ulcers incidence), and most of 
CDSSs were judged as satisfactory (ease of use, time saving, team working) even if 
some critics were also reported (alert fatigue). The number of health conditions 
addressed is currently quite limited although there is, undoubtedly, a great potential to 
expand CDSS applications, for instance to the management of osteoporosis or to fall 
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prevention. However, since elderly are more likely to experience adverse drug 
reactions, many studies were focused on drug prescription improvement. 
Whether they are linked or not to an EHR, used by physicians, nurses, or 
pharmacists, generating alerts at the point of care or not, this review suggests CDSSs 
can be effective in NHs to improve nurses’ daily practice and residents’ clinical 
outcomes in several domains. However, more research is still needed for implementing 
effective CDSSs in NHs.   
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Abstract. Anticipating unplanned hospital readmission episodes is a safety and 
medico-economic issue. We compared statistics (Logistic Regression) and 
machine learning algorithms (Gradient Boosting, Random Forest, and Neural 
Network) for predicting the risk of all-cause, 30-day hospital readmission using 
data from the clinical data warehouse of Rennes and from other sources. The 
dataset included hospital stays based on the criteria of the French national 
methodology for the 30-day readmission rate (i.e., patients older than 18 years, 
geolocation, no iterative stays, and no hospitalization for palliative care), with a 
similar pre-processing for all algorithms. We calculated the area under the ROC 
curve (AUC) for 30-day readmission prediction by each model. In total, we 
included 259114 hospital stays, with a readmission rate of 8.8%. The AUC was 
0.61 for the Logistic Regression, 0.69 for the Gradient Boosting, 0.69 for the 
Random Forest, and 0.62 for the Neural Network model. We obtained the best 
performance and reproducibility to predict readmissions with Random Forest, and 
found that the algorithms performed better when data came from different sources. 
Keywords. Medical Informatics, Data Warehousing, Supervised Machine 
Learning, Patient Readmission/statistics and numerical data 
1. Introduction 
Controlling the proportion of unexpected readmissions is important for patient comfort 
and safety and represents a medico-economic issue. In 2009, the 30-day readmission 
rate in the United States was about 20% (13.3% to 23.2%, depending on the state [1]), 
and the cost of these readmissions was estimated at 17.4 billion dollars. In France, the 
readmission rate varies between 12% and 14%, according to the methodology [2]. 
To comprehensively address this problem in the context of population ageing and 
the increasing prevalence of chronic diseases, it is important to take into account the 
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care pathway between hospital and primary care. Indeed, the days following the 
hospital discharge are at risk of adverse events [3–4], and therefore, a better 
communication between caregivers is essential. A systematic review highlighted that 
some 30-day readmission episodes are avoidable, but their proportion greatly varies 
partly in function of the (objective/subjective) criteria used to define such avoidability 
[5]. Nevertheless, the readmission rate is widely used as indicator to evaluate possible 
improvements in medical care. 
Public health policies have been put in place to control the 30-day readmission 
rates in the United States [6], France, Germany and Denmark [7]. Consequently, 
research has been focused on developing methods to anticipate unplanned readmissions, 
by identifying relevant clinical indicators, and by developing predictive models to 
integrate these indicators. 
The adoption of electronic health records (including laboratory data) represents an 
unprecedented source of data that must be exploited to better understand the patient 
care pathway, both descriptively and analytically. The emergence of automatic learning 
methods allows using these data to anticipate the patient trajectories. The most 
widespread predictive models [8–10] are based on classical statistical approaches that 
are widely used in medical research, such as logistic regression analysis. More recently, 
machine learning methods have started to be tested (e.g., Gradient Boosting, Random 
Forest, Neural Networks). Therefore, the contribution of each of these methods must be 
now assessed in similar conditions. 
The goal of this study was to compare different approaches to predict the 30-day 
readmission risk of hospitalized patients using massive hospital and geo-demographic 
data. 
2. Methods 
The included hospital stays had an admission date that ranged from January 1, 2013 to 
December 31, 2018. This dataset was then partitioned into a training set (admission 
date before December 31, 2016) and a test set (admission date after January 1, 2017). 
To ensure the results comparability with the French national indicator for 30-day 
readmission, the selection criteria were those of the ATIH RH30 national methodology 
(Agence Technique de l'Information sur l'Hospitalisation - Les réhospitalisations à 30 
jours) [11], except for the geolocation data that were used at the place of the 
geographical code. Specifically, the patients included were aged 18 years or over and 
received obstetrical, surgical or medical care. Patients with no geolocation in mainland 
France and patients in palliative care settings were excluded. Hospital stays with a 
different mode of entry than from home and iterative stays (chemotherapy session, 
radiotherapy, transplant context, renal dialysis sessions, cataract surgery) also were 
excluded. A readmission was defined as an unplanned hospital stay within 30 days 
after the end of the previous stay. 
Data were extracted from the Rennes clinical data warehouse [12] that contains 
most of the computerized medical records, including clinical notes, drug prescriptions, 
laboratory test records and administrative data. All information about a patient's 
hospital stay was de-identified and organized in structured and unstructured data in the 
electronic medical record. If the patient had several hospital stays, all hospital stays 
were combined in a single electronic medical record. Diagnoses were coded using the 
French version of the International Classification of Diseases, 10th Edition (ICD-10) 
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that incorporates the specific French adjustments. Medical and surgical procedures 
were coded according to the French classification of clinical procedures (CCAM 
classification) [13]. Drug prescriptions were coded using the Anatomical, Therapeutic 
and Chemical (ATC) code. The potentially significant covariates extracted from the 
clinical data warehouse were: age, sex, length of stay, number of previous 
hospitalizations, illness severity in the French version of diagnosis-related group 
(DRG) classification, major diagnostic categories, medical diagnosis and comorbidities 
(ICD-10), medical and/or surgical procedures (CCAM), hospital department and 
laboratory data (still organized according to a local thesaurus). 
Demographic data, aggregated at the municipal and sub-municipal level [14], were 
merged with the patient using the geometric map background and the corresponding 
geolocation: median pre-tax household income during the year, part of 15-year-old 
population, education level, unemployment rate for the 15 to 64-year-old population, 
and socio-professional categories for the 15 to 64-year-old population. 
Data handling and pre-processing were performed on R with 'tidyverse' (version 
1.2.1), 'data.table' (version 1.12.2) and 'recipes' (version 0.1.6). The compared 
algorithms were the most frequently found in the literature: logistic regression ('stats' 
version 3.5.0), random forest ('randomForest' version 4.6-14), gradient boosting ('gbm' 
version 6.1.1), and neural network ('nnet' version 7.3-12). 
The main outcome was the area under the ROC curve (AUC) and the secondary 
outcomes were sensitivity, specificity, positive and negative predictive value of cut-
point closest to the top-left corner of ROC space. As the models did not yet have a 
specific use, there was no reason to focus on sensitivity (to screen for stays at risk of 
readmission), and specificity (to target specifically stays with readmission). 
The importance of the different covariates (clinical/geo-demographic data) was 
assessed according to criteria adapted to each algorithm: odds ratio for logistic 
regression, relative influence for gradient boosting, Gini index for random forest, and 
Garson algorithm for neural network [15]. 
3. Results 
Among the 410 837 stays available in the clinical data warehouse, 259114 were 
retained (193913 for the training set and 65201 for the test set) based on the inclusion 
and non-inclusion criteria. The main non-inclusion criteria were patients younger the 
18 years (76670 stays excluded), absence of geolocation (18454 stays excluded), 
iterative stays (14477 stays excluded), and palliative care (5750 stays excluded). The 
30-day readmission rate was 8.8%. Readmitted patients were on average 4 years older 
than non-readmitted patients, and with a higher proportion of males (58.3% versus 
49.2%). Demographic data were comparable in readmitted and non-readmitted patients. 
The AUC was 0.61 for logistic regression, 0.69 for gradient boosting, 0.69 for 
random forest, and 0.62 for neural networks (Figure 1). Logistic regression and 
gradient boosting placed the most importance on post-emergency units, number of 
iterative hospitalizations, disease severity (DRG classification) and co-morbidities. The 
regression model became robust by adding a stepwise cross-validation. Random forest 
focused on other variables, including demographic data. In addition, random forest 
gave the most robust results, regardless of data sharing, with constant performance and 
use of covariates. 
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Table 1. Main characteristics of the patients of the included stays. 
Readmission YES NO 
N 22893 236221 
Age (mean (sd)) 60.30 (19.34) 56.46 (20.67) 
Sex, male (%) 13355 (58.3) 116329 (49.2) 
Length of stay (mean (sd)) 6.18 (10.47) 4.81 (8.14) 
Number of previous stays (mean (sd)) 2.58 (3.27) 1.82 (1.85) 
Median pre-tax household income (mean (sd)) 20654.29 (3274.12) 20643.86 (3210.86) 
Higher degree rate (mean (sd)) 0.30 (0.13) 0.30 (0.13) 
Unemployment rate (mean (sd)) 0.12 (0.06) 0.12 (0.06) 
 
Table 2. Prediction performances. 
Algorithm TP TN FP FN Se Sp PPV NPV AUC 
Logistic Regression 3011 37187 22325 2678 0.53 0.62 0.12 0.93 0.61 
Gradient Boosting 3531 39065 20447 2158 0.62 0.66 0.15 0.95 0.69 
Random Forest 3528 39075 20437 2161 0.62 0.66 0.15 0.95 0.69 
Neural Network 3467 33911 25601 2222 0.61 0.57 0.12 0.94 0.62 
 
 
Figure 1. ROC curve. 
4. Discussion 
This is the first comparison of 30-day predictive readmission models in France using 
clinical data warehouse and geo-demographic data. In addition, this study used a 
methodology as similar as possible to the definition of the French national 30-day 
readmission indicator, while taking advantage of data from different sources.  
There is a wide literature on the subject of 30-day hospital readmission prediction 
models. The AUC values of our prediction models are comparable to the 0.71 found in 
the literature [8]. The community state of health, healthcare delivery/access, hospital 
management, computerization of departments, data integration, and advancement of the 
data warehouse are among the many factors that affect the results of the obtained 
models. The inclusion criteria and the choice to focus on all-cause readmissions also 
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influence the prediction model performance. Indeed, the algorithm used is an end-of-
chain parameter that depends very strongly on the learning data quality. 
5. Conclusion 
In conclusion, the predictive models displayed comparable performances (AUC from 
0.61 to 0.69). Random forest showed the best and most reproducible performance 
compared with the other models. The importance of the included variables differs 
among models and merging external data can improve their performance. 
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Abstract. This paper proposes an approach and demonstrates its application for 
cross- border exchange of clinical documents oriented towards the use of archetype 
concepts and international patient summary standards adopted in the European 
Union. A novelty in this approach is the management of native XML instances of 
an archetype concept in the CEN 13606 standard by means of a native XML 
database and XML technologies. The computer experiments demonstrate that it is 
suitable for representing relatively small clinical datasets such as those describing 
rare diseases like the Acromegaly illness, where the semantic context in the 
relatively small number of symptoms is practicable to tag in terms of SNOMED-CT 
terminology codes. Additionally, we demonstrate that the semantically enriched 
information model can facilitate secondary use of clinical data by visualizing the 
execution of queries based on standard terminologies. Finally, the compatibility of 
the information model with the IPS standard enables sharing of clinical data among 
different information models. 
Keywords. international patient summary, semantic interoperability, CEN 13606 
archetype, e-health, rare disease register, native XML database, terminology   
1. Introduction
European citizens enjoy a variety of rights when it comes to intra-EU mobility, including 
the right to seek care in another Member State. Health systems in the European Union 
aim to provide high-quality, cost-effective care. Directive 2011/24/EU on patients’ rights 
in cross-border healthcare describes patients’ right to receive health treatment, including 
planned procedures, in another Member State (MS) and to then get reimbursed 
domestically up to the level that would have been covered by their home State [1] 
The realization of the full potential of the Directive’s provisions is still in 
development. In March 2017, the Commission launched the European Reference 
Networks (ERNs), creating cross-border virtual networks of healthcare providers across 
the EU to tackle rare diseases and conditions [2]. The ERNs are supported by Clinical 
Patient Management System (CPMS) in providing knowledge and resources for 
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improving the diagnosis and treatment of rare or low prevalence complex diseases [3]. 
CPMS establishes a common ground for collaboration between healthcare professionals 
in this subject area allowing them to upload patient cases in Rare Disease (RD) registers 
and share this way diagnosis, care and treatment procedures. However, only a Digital 
Imaging and Communications in Medicine (DICOM) Viewer for image consultations 
and a couple of IHE profiles for connection with Hospital Information Systems are 
provided, no other European or International standards for data exchange are 
implemented. A Central Metadata Repository (ERDRI.mdr) is established in 2019 in 
order to ensure semantic interoperability between existing RD registries [4].  It stores all 
data elements (metadata) used by the participating registries, including the names of the 
data elements (designations) and their definitions. Authorized users can create groups of 
hierarchical structures of new data elements in a limited number of languages (English, 
German, Spanish and French). This good principle of containerization is not related to 
any standard approved in the European Union like the CEN 13606 standard, where the 
reference model is composed of hierarchical structures. Moreover, the content of data 
elements may be represented with minor exceptions in an arbitrary way without a 
reference to external ontologies, terminologies or standards. This complicates 
substantially the exchange of data between European databases and national RD registers. 
The situation requires prompt and adequate solutions really helping the clinicians to 
exchange clinical information without wasting time to translate and transcribe the 
already registered medical records. In our point of view the clinical data sets for several 
rare diseases that were accumulated in the last decades as part of existing national 
registries are suitable to start the data exchange, maintaining the clinical context. These 
datasets are structured clinical records and include several important variables [5].  Their 
exchange using European health informatics standards between existing European data 
bases and National RD registries can foster the way for implementation of semantic 
interoperability.  
The objective of this study is to prove that the CEN 13606 Standard for Electronic 
Record Communication based on the Archetype paradigm and the International Patient 
Summary (IPS) together with the appropriate international nomenclatures and 
classifications successfully could provide a high degree of semantic interoperability. In 
the following section we present the methods we employ to achieve this objective. The 
results from computer experiments are discussed in Section 3 and the conclusions are 
outlined in Section 4. 
2. Methods 
In this paper we present an approach and demonstrate its application for cross- border 
exchange of pseudonymized clinical records between the Bulgarian Acromegaly register 
and the Liege acromegaly survey (LAS) database that aggregates the data from 14 
European RD registries [6]. This approach is oriented towards the use of archetype  
CEN 13606 concepts and maintenance of compatibility with the International Patient 
Summary (IPS) described in the preliminary standard (FprEN 17269 [7]) and the 
technical specification (FprCEN/TS 17288 [8]). 
International nomenclatures like SNOMED CT, LOINC, ICD 10 and ATC are used 
in the CEN 13606 Archetypes. A mapping is performed between the clinical concepts 
existing in the national databases and the respective codes in these nomenclatures for 
laboratory tests, procedures, diagnoses and medications. This allows to design an 
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archetype of the RD dataset compatible with the IPS standard enriched with semantic 
context (Fig. 1-left side) and describe it using the Archetype Description Language in 
CEN 13606. Unlike existing approaches that employ archetypes with relational 
databases we obtain a native XML instance of the obtained archetype(Fig. 1-right side). 
We refer to this XML instance as native because it is valid with respect to the CEN 13606 
Reference model [9]. It allows us to represent RD datasets in terms of such instances 
with native XML database like existDB [10] and execute queries on the such archetype 
instances with XML technologies. Note, that an archetype query language is not provided 
as part of the CEN 13606 standard. 
   
Figure 1. CEN 13606 Archetype of IPS sections(left) and its corresponding native XML instance (right). 
3. Results 
The methods described in the previous section have been applied to develop a client 
server web application with the NoSQL database existDB [10]. A dataset with real 
clinical data from the Bulgarian Acromegaly register is loaded as a “collection” of XML 
documents in this database. Each one of these documents is a native XML instance of 
the archetype shown in Fig.1. The client makes use of the web graphical interface on 
Fig.2 to create new native XML instances of the archetype and add data content in these 
instances. For example, Fig. 2 shows the recorded clinical data for symptoms observed 
during the Acromegaly therapy of a given Patient, where the semantic context is 
represented by SNOMED-CT codes [11]. 
The web application makes use of RESTful web services allowing the client to 
manage the collection of XML documents on existDB. It enables cross- border exchange 
of RD datasets for example, with the Liege acromegaly survey (LAS) database. Once the 
XML document is complete it can be uploaded in the LAS database. Moreover, this 
standard- based approach allows to query the RD dataset and visualize the results. For 
example, Fig. 3 shows visualization from two of the major Acromegaly symptoms during 
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the Acromegaly therapy of the selected Patient. This visualization allows us to conclude 
that therapy has been successful, and the Patient has fully recovered. 
 
 
Figure 2. Web interface for management of XML instances of the IPS archetype.  
 
Figure 3. Visualization of selected clinical data for Acromegaly Symptoms. 
4. Conclusion 
In this paper we have proposed an approach and discussed the results of its software 
implementation for cross- border exchange of clinical data for rare diseases like the 
Acromegaly illness. The implementation of the proposed approach employs EN 13606 
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archetypes to build a model of a clinical document compatible with the recently proposed 
IPS standard FprEN 17269. The novelty in this approach is the creation of a native XML 
instance of a CEN 13606 archetype concept representing a clinical document model in 
terms of the Archetype Description Language. It allows to achieve semantic 
interoperability in exchange of RD data sets compatible with the IPS standard by means 
of native XML databases and XML technologies. The computer experiments show that 
this approach and its implementation are quite suitable for representing relatively small 
clinical datasets such as those describing rare diseases. For example, the semantic context 
in the limited number of symptoms in the Acromegaly Register is practicable to tag with  
SNOMED-CT terminology codes. Additionally, we demonstrate that the semantically 
enriched information model can facilitate secondary use of clinical data by visualizing 
the execution of queries based on standard terminologies. Finally, the compatibility of 
the information model with the IPS standard enables sharing of clinical data among 
different information models. 
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Data Transfer Model for HIS and 
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Abstract. Hospital Information Systems (HIS) are used in every hospital in our 
country and these systems have been developed by different vendors. If there is a 
change in the HIS software used in a hospital for various reasons, all data must
be transferred from the current HIS to the new HIS. Accurate, complete,
consistent, reliable and rapid transfer of this transfer is important in order not to
interrupt the health care provided by the hospital. The aim of this study is to 
introduce a data transfer model standart (VEM) between independent HISs and 
to explain the validations that are applied to enforce the model work correctly. In 
addition, we share the opinions from HIS vendors who develop VEM compatible 
systems. In the development process of the model, studies with data transfer 
experts from the HIS vendors in Turkey were performed. A validation software 
has been developed to check the compatibility of VEM with HIS software. In 
addition, a questionnaire was sent to HIS developers via e-mail and their
opinions on VEM were received. Fourty six HIS developers voluntarily
participated in the study, and 70% said they thought VEM helped with solving 
data transmission problems. As a result, it can be said that VEM has been 
successful in solving many problems encountered for data exchange in HIS 
changes in hospitals.
Keywords: Data transfer model, data exchange, HIS.
1. Introduction
In our country and in the world, hospitals, which are the users of Hospital Information 
System (HIS), could change the system they are using, for the reasons of the negative 
elements of the important components (modules), usability problems, dissatisfaction,
etc. In such cases, hospital managers should prepare for a difficult transition and set 
realistic expectations [1]. Implementing a new Electronic Health Record (EHR) or 
switching to another is likely one of the most disruptive predictable events a hospital 
can experience, affecting practically every employee and workflow at a hospital [2].
Conceptually, most HIS operate on the same type of information (demographics 
medical history, medications, diagnosis, laboratory findings, billing, etc.). Since 
medical content standards of HIS were not determined when they were first used in 
hospitals, most of the HIS’ in Turkey have formed their own specific terminology for 
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medical data. This unstandardized terminology also was making it difficult to transfer 
data accurately and quickly in the HIS data transfer process. It may be a tremendous
challenge to understand and map the database architecture used in the current HIS to 
transfer the health history of each patient to a new HIS. Mapping of data at a high 
level of accuracy, a fully automated transfer while taking into account all the patient 
information in the hospital is not a big problem in only our country, but also in the 
world [3]. Accurate mapping of the data into the new system is vital because EHRs 
serve as the legal health record, containing individually identifiable information 
describing the healthcare services delivered during a patient’s clinic visit [4]. The 
process of transition from current HIS to new HIS can lead to long, exhausting efforts 
and data loss [5].
In our country, as the databases to be transferred are different in every HIS and
the data transfer process is completed in a longer period than it is anticipated. If there 
were a universal standard (or at least some kind of “universal translator” for EHR 
data), data conversion would be much simpler, and the process of switching EHRs 
would be easier [6]. Given the differences in HIS structures and the diversity of EHRs 
across countries, it may be premature to speak of a universal model for data 
transmission. However, a national model independent of the HIS structure may be 
successful for the data transfer problem. For this reason, a data model has been 
developed for data transfer and studies have been carried out to use this model as a 
standard in data transfer between HISs. Minimum Data Transfer Model (VEM) has 
been developed to be the model that defines the structure and minimum content of 
any HIS. The minimum here; expresses the data that need to be transferred to the new 
HIS as a priority.
The aim of this study is to introduce a data transfer model standart (VEM) 
between independent HISs and to explain the validations that are applied to enforce 
the model work correctly. In addition, we share the opinions from HIS vendors who 
develop VEM compatible systems.
2. Method
The model, which was developed as a standard for the use of HIS data transfers, was 
created by analyzing the database designs of HIS softwares used in the majority of the 
state hospitals in Turkey. The main purpose was to determine a minimum data 
transfer model which would cover necessary data elements and which should be able 
to be transferred primarily between HISs. In this context, a draft model is formed by 
working together with HIS vendors. VEM is designed as arelational structureusing 
relational database views. These standard views are created by HIS vendors and 
reflect the records from the original HIS database. HIS vendors have to follow VEM 
standards and provide VEM compatiable views (HIS-VEM) according to their 
database design. Because HIS vendors can adopt various software development 
pattern they are free to desing their own relational database models however they 
have to provide VEM views on each HIS database system. In some occasions vendors 
use multiple primary data tables to create certain views and in some occasions VEM 
to physical database mapping would be one to one. VEM views content is available as 
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XML at https://vem.saglik.gov.tr/. According to the validations made so far, two 
update studies have been done for VEM. In the first version, the number of views was 
63, while in the current version it is 84. All versions of VEM are available at the 
reference web site.
A validation software (VEM Analysis Program - VAP) has been developed to 
test the compatibility of VEM with HIS software. VAP was developed using the 
Delphi programming language in RAD Studio platform and it supports all of the 
databases (Oracle, MySQL, MsSQL, PostgreSQL etc.) used by HIS software in our 
country. HIS vendors are required to login to the VAP where they run the database 
connection information which they use to test the HIS-VEM data transfer model.
VAP checks if the data structure and content which are found as XML in 
https://vem.saglik.gov.tr/ are compatible with HIS-VEM.
It was seen that the validation process of the each HIS vendors via VAP was 
taking a long time. For this reason, a workshop was conducted in order to enable HIS 
developers to work with each other. In the workshop, HIS vendors were paired to 
work with another HIS vendor which was using same database system. For example, 
a vendor using Oracle has been paired with a vendor using Oracle. A test form was 
given to the software developers and they were able to work together for five days by 
analyzing each other's HIS-VEM views by analyzing the problems that might occur in 
case of data transfer.
During the HIS-VEM validation, the HIS developers who form the model 
expressed their opinions on VEM views in written form or verbally. However, in 
order to get the opinions of the developers who could not give face-to-face interviews 
because they were busy or they could not join the workshop, a web-based 
questionnaire was sent to 56 HIS developers via e-mail.
3. Results
The validation process via VAP is done in two steps. In the first step; the views of 
VEM, which is the standard model and HIS-VEM are compared (data elements in the 
view, reference codes of the view, SQL script information, comparing the number of 
records in the view etc.). In the second step; controls related to the quality of the data 
in the views (PK-Primary Key Control, Reference Table Name Control, Relational 
Data Control, Time Accuracy Control, Data Accuracy Control, Data Type Control) 
are performed. 
Majority of the HIS vendors tested their VEM compability using the VAP 
system, however, they all failed the tests initially. Later, we had organized a
workshop in which all HIS vendors were invited to attend and at the end of the 
workshop most the HIS vendors participating to the workshop made successful 
implementation of standard VEM in to their system and they manage to get 
compliance with our standards. 
A web-based questionnaire was prepared using a 5-point Likert-type scale and 
sent to 56 HIS developers. Forty-six of them responded. 41 of the participants were 
male, 5 were female and 94% were university graduates or higher. Their work 
experience was 12 ± 5 years (mean ± standard deviation) and the highest working 
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time was 23 years. 96% of the participants knew about the VEM standard and 91% of 
them said that they know how to transfer data in the hospitals where they work. The 
responses of the participants regarding VEM views are shown in Table 1.
Table 1. Opinions of HIS Developers about VEM
Considering the entire systematics generated for VEM, please express your opinion about the follow-
ing statements.
Questions
Certainly 
Disagree
(1)
n (%)
Disagree
(2)
n (%)
Undecided
(3)
n (%)
Agree
(4)
n (%)
Certainly 
Agree
(5)
n (%)
I think that the number of views
created in VEM is adequate for the 
purpose of the developed model.
4
(%8.7)
5
(%10.9)
8
(%17.4)
22
(%47.8)
7
(%15.2)
Views are sufficient to meet field 
requirements.
3
(%6.5)
7
(%15.2)
12
(%26.1)
14
(%30.4)
10
(%21.7)
I think the explanations of the creat-
ed views are clear and      under-
standable.
4
(%8.7)
5
(%10.9)
8
(%17.4)
18
(%39.1)
11
(%23.9)
VEM helps to solve problems with 
data transmission.
3
(%6.5)
4
(%8.7)
7
(%15.2)
15
(%32.6)
17
(%37)
With VEM, it is easier to collect data 
from the field.
1
(%2.2)
6
(%13)
5
(%10.9)
19
(%41.3)
15
(%32.6)
4. Discussion
Changing HIS can create a host of issues. These include practical issues, such as the 
sheer amount of time required to research, implement, and transition to a new HIS 
package; loss of productivity in the process; and changes in functionality from one 
HIS to another, which require retraining and perhaps may lead to a loss of some 
functions on which the physicians counted previously [6]. Patient demographics, 
billing, and other financial data that was stored in the previous HIS will need to be 
transferred to the new HIS [6]. When the HIS changes in Europe and the United 
States are examined, it can be seen that the HIS exchange takes a long time and a 
large part of this period is related to the data transfer part. When the proposed 
strategies to conclude the changes in electronic health record in the easiest way are 
examined, it is seen that the importance of using standard terminology of different 
HISs is emphasized [3].
The developed model has been used by various HIS companies in data transfer 
since 2015 in Turkey. The aim of the model is to determine the data (patient 
information, laboratory results, diagnostic information, etc.) that should be transferred 
in order to prevent disruption of the health care processes in the hospitals in order to 
ensure that these data are transferred accurately, completely and consistently. 
Therefore, the model is named as the minimum data model. The feedback received 
from the HIS developers using the model has shown that VEM has been successful in 
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data that needs to be transferred primarily. However, when all the data in the hospital 
need to be transferred from the existing HIS to the new HIS, it was seen that the HIS 
developers use traditional methods in addition to VEM. This necessitated the transfer 
process to be performed in two different ways and caused the HIS developers to 
perform two separate tasks. According to our experience of VEM validation study or 
feedbacks from HIS developers using the model, it was seen that the developed 
model-VEM gave faster results compared to the traditional method, but a model that 
would provide all the data to be transferred in a hospital would be more beneficial. 
For this reason, new studies have been planned to improve the scope of the VEM. 
Due to the success of many HIS vendors in our workshop, workshops create an 
effective learning environment for HIS developers. We also believe that the 
collaboration of HIS developers and their successful results increased the adoption of 
VEM. 
In Table 1, 70% of respondents responded positively to the question “VEM helps 
to solve data transfer problems, 15% stated that they did not agree and 15% stated that 
they were undecided. The majority of the participants think that the model is 
successful compared to the traditional method. 
Although VEM is a standard that was developed for data transfer, it has been 
learned that most HIS software developers have made changes to their database 
structure after VEM. It is considered that VEM shows a positive effect on data 
standardization. 
5.? Conclusion
As a result, the majority of HIS developers stated that VEM solves the problems in 
data transfer. In light of this information, it can be said that the model developed to be 
used as a standard in HIS changes in hospitals has been successful for the targeted 
aim. This fact also revealed the necessity of extending the model to a wider spectrum 
of the data in any hospital. By expanding the VEM, data transfer processes in hospi-
tals in our country can be completed more quickly and smoothly. 
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Abstract. The primary output of a decision making process is a decision and a key 
outcome measure is therefore decision quality. However, being a formative 
construct, ‘decision quality’ is both preference- and context-sensitive and 
legitimate alternative measures accordingly exist. A decision maker wishing to 
measure decision quality in the evaluation of a decision or decision making 
process needs to be aware of the attributes of the measures on offer. This paper 
establishes some of the key conceptual differences by examining two measures: 
Decision Quality Instruments and MyDecisionQuality. Four of their main 
conceptual differences relate to:  the timing of the measurement (at the point of 
decision or at follow-up when the ‘downstream’ outcome is known); (whether or 
not an objective assessment of the information state of the individual is included 
(as opposed to self-reported state); whether the instrument itself is preference-
sensitive; and whether the measure is to be used in the context of individualised 
clinical practice at the point of care or only in research to produce group level 
feedback. Establishing agreed measures of decision quality is  necessary and 
useful, so long as it is accepted that it is a preference- and context-sensitive 
construct, in the way that is widely acknowledged in relation to, for example,  
Health-Related Quality of Life, with its many measures. 
Keywords: decision quality, Decision Quality Instruments, MyDecisionQuality, 
formative construct, preference-sensitive. 
1. Introduction 
If the fundamental aim of informatics is to help decision makers make high-quality 
decisions, it might be expected that the measurement of ‘decision quality’ would be a 
major focus of interest. However, there is limited attention to this outcome in the 
literature, compared to the amount devoted to related input qualities: the quality of the 
information inputs being produced, the quality of the transmission and dissemination of 
information inputs, and the quality of the processing of the information inputs within 
decision making. In this paper we explore two specific approaches to the measurement 
of decision quality, an exploration which, while restricted in scope, is sufficient to 
throw significant light on the reasons for this relative paucity of attention. Among other 
things, it may help explain the surprising non-appearance of decision quality as a 
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Patient-Outcome Measure (PROM). In the comprehensive 2015 survey of the latter [1], 
the term ‘decision quality’ appears only within the section headed ‘Patient experience’ 
and not as a PROM. 
Among the underlying reasons for this marginalisation is that the latent 
unobservable construct (‘decision quality’) is a formative, not a reflective construct, 
and therefore preference- and context-sensitive [2]. This has both methodological and 
practical consequences. Among the methodological consequences are the psychometric 
standards appropriate for validating instruments seeking to measure it. ‘Decision 
quality’ is an ‘it’ that does not exist in the sense that a reflective construct (such as 
appendicitis) exists, where psychometric standards such as internal consistency are 
valid. The main practical consequence of its formative nature is that there are many 
possible and acceptable definitions of decision quality, none of which can be validated 
as the ‘gold standard’. The ambition to develop a universally agreed definition of a 
formative construct is understandable since widely-agreed definitions have their uses 
and in many senses are essential. The various formative measures of Health-Related 
Quality of Life exemplify acceptance of their intersubjective, value-based provenance. 
However, capitalising a construct as Shared Decision Making or Decision Quality 
cannot produce ontological transformation from formative to reflective, even if it is 
sometimes institutionally convenient to treat it as if it does. 
There are many meaningful distinctions which can and should be made between 
different proposed measures of decision quality, and the basic point being made here is 
that the decision on which measure of decision quality to select for use, from a set of 
alternative measures given this label, is both preference-sensitive and context-sensitive. 
Different instruments will measure different constructs and are not to be regarded as 
different measures of the same construct.  
A decision maker selecting the measure that is optimal for the particular evaluation 
they are undertaking needs to be informed about their content and construct validity. 
The limited aim here is to establish some of the key conceptual differences in measures 
of decision quality. We set aside most practical differences, the need for alternative 
versions or adaptations for contexts such as low literacy or ethnicity being taken for 
granted.  Examining two measures will be sufficient for our limited purpose: the 
Decision Quality Instruments (DQIs) [3-4] and MyDecisionQuality (MDQ) [5-6]. The 
concept is often used implicitly as an umbrella for a set of individual indicators [7]. 
2. The Decision Quality Instruments (DQIs) 
A generic DQI framework is used in the production of condition-specific instruments, 
14 of which are currently available, including ones for breast cancer surgery, prostate 
cancer screening and treatment, back pain and knee and hip osteoarthritis.   
(https://mghdecisionsciences.org/tools-training/decision-quality-instruments/) 
Since the DQIs are condition-specific, we will focus on that for Breast Cancer 
Surgery (BCS-DQI) [3-4]. The BCS-DQI comprises a set of 15 ‘objective’ knowledge 
questions ‘to determine whether patients are informed’ and a set of 8 questions about 
their ‘goals and concerns’. As a profile measure, it produces two scores. The DQI-
Knowledge Score is the number of correct responses divided by the number of items, 
resulting in scores from 0% to 100%. A threshold for considering a patient to be ‘well-
informed’ is set, using (if available) the mean knowledge score for a group of patients 
who have viewed a decision aid. The DQI-Concordance Score measures ‘the extent to 
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which patients received treatments that reflected what is most important to them’. It is 
derived from a multivariate logistic regression model in which the treatment received 
(e.g. surgery vs. non-surgical) is the dependent variable. The goals and concerns 
specified by the respondent are the independent variables, with other factors that 
should influence treatments (e.g. stage of disease for breast cancer surgery) included, 
as needed. The dependent variable is a predicted probability of treatment for each 
patient. Patients with a predicted probability of more than 50% who had the treatment, 
and those with a predicted probability equal to or less than 50% who did not have the 
treatment, are classified as having treatments that match their goals and are 
‘concordant’. (Dividing the number who matched by the total number in the sample 
then yields a summary percentage concordance score for the group.) A binary Decision 
Quality Composite Score can be created with a score of 1 for patients who were well-
informed [i.e. met the pass threshold] and received treatments matching their 
preferences, and 0 for all others. 
The interpretation of both the 2-score profile and the binary composite score is 
only at the group level and available only after follow-up, months after the decision.  
So the DQIs are essentially research tools for evaluating a decision process (which is 
assumed to be ‘shared decision making’, usually including a decision aid), for the 
purpose of improving future practice through group level feedback. They are not 
envisaged as tools to be used as the source of individual feedback in real time within 
clinical practice. 
3. MyDecisionQuality (MDQ) 
MDQ is a preference-sensitive instrument in which individuals provide their responses 
as soon as possible after a decision is made. The responses are of two distinct types - 
their personal ratings of the preceding decision- and decision-making process on 8 
criteria, and their weightings for those 8 criteria. The MDQ score is the weighted sum 
of the ratings (i.e. the expected value for each option). The abbreviated labels for the 8 
items are four which relate to the decision content - Options, Effects, Criterion 
Importance, and Effect Chances - and four which relate to the decision process - Trust, 
Support, Control, and Commitment [5-6]. 
MDQ is a self-reported, preference-sensitive (‘dually personalised’) multi-criterial 
index, generic across both conditions and contexts. Its primary purpose is to evaluate 
the quality of a decision and decision process and do so at the individual level. The 
evaluation is to occur as soon as possible after the decision is taken. This is to rule out 
reference to any downstream outcomes, for whatever reason. (Two common ones are to 
establish whether action or behaviour subsequent to the decision was in accordance 
with the person’s expressed ‘goals and values’ and to permit their experienced regret to 
affect the assessment of decision quality.) It also excludes ‘objective knowledge 
possession’ as a criterion. However, it addresses both the decision and the decision 
process, being designed to indicate whether the ‘reasonable patient’ legal standard for 
informed and preference-based consent has been met (items 1-4), as well as the 
‘subjective patient’ ethical standard for the care process (items 5-8). Where clinicians 
agree to complete an equivalent measure, it can provide decomposed measures of 
concordance (e.g. between patient and practitioner) and so establish which ratings or 
weightings are the source of any discordance.  A sub-analysis indicates the criteria 
which hold the greatest potential for improved future decision quality. It is possible to 
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aggregate MDQ scores across individuals and arms of trials [8], but the interpretation 
of these results must be approached with caution, given their individual preference-
sensitivity. 
4. Discussion 
A wide variety of constructs of decision quality are possible, with the main distinctions 
resting on why they are done, who is asked to provide which type of responses/s to 
what items, and when and where they are asked to do so. The answers determine 
whether the measure of decision quality is preference-sensitive in relation to the items 
in the instrument; whether the measure is useful in real time clinical practice or is 
essentially an output from evaluation research at a group level; and whether it is 
appropriate in evaluations of a decision, of a decision process, or a decision aid 
(including policy makers and regulators approving the last of these) .  
The timing of measurement is perhaps most important, because for many it 
impinges on the validity of the measure, as well as its use. Elwyn and Miron-Shatz 
report the  widespread view that ‘Good (or bad) decisions may have good or bad 
outcomes by virtue of chance, at the level of individual consequences…. post hoc 
assessments, based on the outcomes of decisions, are unsafe measures of good 
decisions.’ [9] (p141-2). Delayed assessment also permits regret to enter into any 
evaluation at ‘downstream’ follow-up. Experienced regret - indeed all hindsight - is a 
valuable input into a future decision, but only if it is not allowed to affect the 
evaluation of  a previous one, in which one has had the opportunity to input anticipated 
regret, in foresight. Dissonance reduction is another post hoc influence on evaluations 
of decision quality widely regarded as undesirable. 
Incorporation of an objective knowledge test is a further example of how a 
different construct of decision quality is created. Decision makers in some contexts 
may prefer a measure reflecting responses from ‘objectively informed persons’. Others 
will reject this: ‘… knowledge as a necessary component of a good decision - both as 
an evaluation of the effectiveness of deliberation and as an evaluation of the 
determined decision - may be difficult to operationalize and, at a deeper level, may 
reflect an untested assumption - that a standardized, pre-specified level of knowledge is 
necessary in order to achieve a high level of deliberation.’ [9] (p144). 
5. Conclusion 
Since the latent construct of decision quality is formative, each of these instruments 
measures the construct it measures. An instrument should be chosen for use in an 
evaluation if its characteristics are preferred and it is context-relevant, as deemed by 
the decision maker. Ambitions to produce a standardised, preference- and context-free 
decision quality assessment instrument should be resisted, with the different products 
accepted as a menu from which a preference- and context-sensitive selection can be 
made. We note that it is claimed that the definition of decision quality in DQIs has 
been validated by the International Patient Decision Aid Standards group [4,10]. While 
this establishes its serious credentials as a construction of decision quality, as with any 
formative construct these rest on the intersubjective agreement about its contents (items 
and weightings), reflecting the beliefs and preferences of the producing group. MDQ 
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does not seek to answer the philosophical question of what constitutes a ‘good 
decision’ [11], merely to provide a measure of ‘decision quality’ with its particular set 
of characteristics. Decision quality should be regarded as the fundamental outcome of a 
decision making process, despite the challenges its formative character presents. 
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Abstract. The Problem Oriented Medical Record (POMR) is considered a key 
charting method to support clinical care. Although not uniformly represented 
amongst digital health systems, this paper presents a clinical model to represent 
multiple clinical perspectives from a single problem list. The contextual problem list 
model is defined according to primary diagnosis, comorbidities and problems 
arising from the primary condition. It is represented within the patient record as a 
single composition according to the prescribed context. The model pattern could 
help alleviate the traditional criticisms of paper and digitally based problem records. 
Keywords. Contextual problem list, problem oriented medical record, problem list, 
clinical models, digital health, electronic health records. 
1. Introduction 
Health records are traditionally ordered into individual data silos such as pathology, 
medications or radiology. One such silo, the problem list is represented within the digital 
domain with variable degree of functionality[1] despite the rules of the concept being 
well understood[2]. Medical care pathways are traditionally arranged to support the 
management of multiple problems in the primary care setting through to secondary care 
via a range of diagnostic procedures[3]. This iterative process achieves a more granular 
focus with increasingly detailed problems for specific conditions such as diabetes. 
The Welsh Information Solution for Diabetes Management (WISDM) is being 
developed as part of a national digital platform. It is by definition a problem oriented 
medical record (POMR). Its specification describes functions to support the curation of 
a problem list according whether an entry is a complication of the primary disease, or 
other important comorbidity that may affect ongoing treatment. This paper describes a 
clinical model for a contextual problem list (CPL) as a persistent composition within the 
electronic health record (EHR) to support this requirement. 
2. Background 
As suggested by Dr Lawrence Weed, there is a need to align the patient record according 
to the problem[4]. Since the first computerised systems began to appear there has been 
great variability in how the problem list manifests in the (EHR). Merely replicating 
paper-based processes and transposing them to the digital domain are not sufficient. 
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Manual curation of a list is inherently burdensome and data quality impacts how likely 
it is to be used and updated[5]. The rules on what should or should not be included in the 
problem list are less clear[6]. As a result, the problem list as a component of the wider 
digital record has been shown to not always be available or necessarily complete[7,8]. 
Disadvantages of the POMR include emphasis of when problems manifest opposed 
to their priority, and the repetitious nature of their structure[9]. The effect of 
“compartmentalisation” in inhibiting the “synthesis” of multiple problems and the 
additional risk of substantiating a differential or incorrect diagnosis as the clinical truth 
is also cited[10]. POMR can be seen as a barrier to the patient narrative through the 
propagation of increasingly granular but clinically similar problems[1]. This is further 
complicated by the need for different views depending on clinical perspective or role and 
the nature of problems being recurrent[11]. Despite this, the problem list is a persistent 
function within many modern EHR systems. 
Weed[4] originally envisaged his chart as a flat list of entries marked as active or 
inactive with nested variants where appropriate. This juxtaposed the common pattern 
found within secondary care reporting or outpatient letters of primary problem/ diagnosis 
with comorbidities. The latter focused on a single problem or care pathway while the 
Weed POMR takes a more holistic approach.   
Grouping individual entries as a diagnosis or comorbidity is key for billing and the 
attribution of expended resource. However, it might be postulated that it provides direct 
clinical value in prioritising and focussing a set of complex clinical issues around the 
presented problem (and perhaps more so than a POMR styled list). We therefore present 
the pattern defined within this paper for the CPL as a hybrid of both approaches. 
3. Definitions 
Within the context of this research, a “problem” may be a presenting complaint or 
confirmed diagnosis. The nature of the CPL means that the following definitions are 
inherently flexible and individual records may exist within any given category depending 
on the clinical perspective and may change over time. As a result, the underlying model 
needs to support the ability to refute, dispute and replace individual entries and for those 
changes to be clear and visible within the patient record. Utilising coded entries derived 
from a terminology service is preferred although this represents a point of note for 
implementers to observe and is not mandatory. 
Primary diagnosis represents the condition for which the patient is receiving care 
and frames the clinical context of the CPL. While the primary diagnosis may be a 
variation of a range of entries, these should be limited to a specific care pathway (in this 
case diabetes). It is possible to initiate a CPL without a primary diagnosis being present 
as the context itself is categorised within the associated metadata of the composition.  
Co-morbidity is a coded diagnosis that does not require management or direct 
acknowledgment by clinicians within a specified disease domain. However, it is of 
clinical importance to the ongoing care of the specific disease context. It can be assumed 
that comorbidity entries will be actively managed through alternate care pathways, but 
they are compatible with the underlying information model for primary diagnosis. 
Problems and complication records represent a diverse range of entries. They may 
contain a clinical problem that has arisen from the primary diagnosis, is being 
investigated as a result of the problem or is a keynote for the clinician to consider such 
as a recent bereavement or learning disability. Disease complications will require active 
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management by the clinician and maybe the result of referrals from other care settings. 
Entries within this section may reside from clinical findings (e.g. a presenting complaint 
of pedal oedema) or disease related disorders (e.g. diabetic retinopathy).  
The final category concerns entries that may derive from a variety of findings or 
disorders, but are not of direct concern or relate to the context instantiated with the CPL. 
However, these records cannot be ignored as they may become important in future. 
Consideration must be given by the clinician to reconcile entries from a variety of sources. 
The approach defined here means that a diabetologist may be treating a patient with 
some form of diabetes and record a primary diagnosis of Type I diabetes mellitus with 
peripheral angiopathy. Conversely, a renal physician could be treating a patient with a 
primary diagnosis of chronic kidney disease. Both primary diagnoses are dependent on 
the clinical context, and in some cases may be linked if one disorder is predicated by the 
other (e.g. chronic kidney disease due to type 2 diabetes mellitus). Both entries are also 
suitable for inclusion under the comorbidity heading of their respective CPL. 
 
 
Figure 1. Shared problem records within three contextual problem lists. 
A diagnosis of “diabetic nephropathy” may be considered a complication of the 
patient’s primary diagnosis of Type I Diabetes i.e. this condition would not have occurred 
had the patient not had this primary diagnosis. However, this could also be considered 
the primary diagnosis for a nephrologist (Figure 1).  
3.1. Model Development 
The CPL was modelled with openEHR Archetype Designer[12]. Figure 2 describes the 
applied model pattern. Each context category is embedded within the relevant section 
with additional attributes from problem/diagnostic qualifier to support, barring the 
“Other problem”. This is to ensure that the pattern cannot be disrupted through incorrect 
attribution of problem categories within the “Other Problem” section.  
Additional data elements have been included to support the wider provenance of the 
CPL including an absence statement that describes why the list may be empty. For 
example, a patient early on the diagnostic pathway may be considered to have a finding 
of pre-diabetes. It may not be appropriate to record this as a primary diagnosis although 
it is still a condition of note. A recorded entry that there are “no known problems” or “no 
primary diagnosis” is a potentially valuable statement of fact for a patient at this stage.  
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Figure 2. Information model for the contextual problem list template. Each category is optional. 
4. Discussion 
While the criticisms of POMR are legitimate when concerned with paper, digital 
functionality can support or eliminate many of them. Duplication of data, a concern in 
the paper domain[2], is mediated where a digital repository is able to act as a single 
source of truth. Orientation of the record around the problem, as Weed suggested, is key 
to facilitating benefits such as more thorough and increasingly relevant medical charts 
with faster information retrieval[1]. By utilising the CPL as a digital composition, it is 
possible to view a problem list with a specific clinical perspective such as diabetes as 
well as a master list of all other problem records. This master list is considered a core 
component of the EHR[13]. 
The design of the CPL outlined here seeks to simplify the wider requirement for a 
single instance of the POMR by creating individual compositions that relate to specific 
problems or conditions. This is analogous to the “index concept” approach[14]. The level 
of granularity is focussed upon a primary condition and the many subproblems that may 
be present with complex cases.  
Where accuracy of the problem list is high, clinical errors can be reduced and patient 
safety increased [15]. This pattern facilitates multiple actors in the clinical pathway to 
create, review and update problems using data that is recorded once but shared widely. 
Data quality is of specific concern if we are to rely on the digital record. There is evidence 
that completeness of data is encouraged when alerting functions are presented to the 
user[16]. It has been suggested that there are benefits for sharing the POMR in cases of 
chronic disease management spanning multiple care domains[17]. In addition, this 
defines a basis from where algorithm-based care can be provided via well defined, 
standards-based data models.  
5. Conclusion 
The proposed method for representing the CPL can support multiple care domains from 
within a single data repository. It represents a hybrid of the traditional POMR and context 
specific records. While not a definitive list of all patient problems, it presents the key 
issues that are of concern for the management of the patient’s condition at a point in time. 
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Individual entries within a CPL may be recorded by other clinicians and considered of 
interest by other clinical specialties for inclusion in their own contextual problem lists. 
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Digital Follow-Up Application for Cancer 
Patients – Value Mechanisms Regarding 
Health Professionals’ Work 
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Abstract. This study examined the value mechanisms of a digital cancer follow-up 
application (CFUA). Value is defined as the health outcomes achieved per 
resources used. The focus was on how the digital health intervention (DHI) affects 
the professionals’ work. The research was conducted through interviews of 
healthcare professionals in the empirical context of gynecological cancer clinic at a 
university hospital in Finland. The identified key mechanisms were improved 
coordination and optimized care level. The CFUA improves coordination through 
reducing time restrictions of work, as the professionals have more chances to time 
their contacts and plan their work. The CFUA helps in optimizing care level, as the 
application can effectively filter patients to either nurses or physicians according to 
symptoms. Coordination mechanism is closely connected to other healthcare value 
mechanisms, such as reducing waste and supply management. This study increases 
understanding of DHI value potential recognition, and how value can be actualized. 
Keywords. Telemedicine, Cancer Care, Value-Based Healthcare 
1. Introduction 
Introducing new digital health interventions (DHIs) requires that their cost-
effectiveness, their value, is proven. Implementing DHIs with demonstrated value 
improves the economic sustainability of the healthcare system and benefits all parties, 
including patients, payers, providers and suppliers [1]. Porter defines value as the 
patient health outcomes relative to the costs of care for the patient [1]. 
Cancer care DHIs have been a subject for academic research. It has been found 
that digital interventions can through certain mechanisms help cancer patients to cope 
better with the disease and symptoms [2]. Patient-reported-outcome follow-up has been 
shown to improve cancer patients’ survival and quality of life [3,4]. According to [5], 
telemedicine in cancer care can reduce the travel costs for patients and thus improve 
total value. Web-based outcome surveillance was found to be a cost-efficient way of 
monitoring and can reduce the follow-up costs for the insurance-provider [6]. It has 
been stated that also the staff viewpoint should be considered in digital services in 
cancer care [7]. Thus, when analyzing an intervention’s potential for improving value-
based healthcare, it is important to examine the personnel perspective, where a 
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significant part of the costs are incurred. Therefore, this research took intervention’s 
impact on healthcare professionals’ work as the focus and aimed to find the 
mechanisms that cause changes in their behavior and affect costs. 
The studied DHI is a modular digital cancer follow-up application (CFUA) called 
Kaiku Health. This study focuses on the use of CFUA for gynecological cancer 
patients. The context of the CFUA case is the gynecology unit of a tertiary hospital in 
Finland. In the unit, all types of gynecological cancers are treated. CFUA is used both 
during treatments and in monitoring after treatments. The people using CFUA include 
patients, specialist physicians and nurses, some of which work with patients during 
cancer treatments, and some with patients in monitoring after treatments. All specialist 
physicians are specialized in gynaeoncology, and their tasks include diagnosis and 
treatment of gynecological cancer patients. Most of the patients are over 65 years old. 
The patients use CFUA to report their health status and symptoms by filling symptoms 
and quality of life questionnaires and can contact healthcare personnel through CFUA 
with chat messages. The message feature also allows sharing files, such as medical 
certificates. When a member of the personnel logs in, CFUA shows the patient cases 
that have new information that should be handled. Healthcare professionals react to the 
contacts either through CFUA or in acute situations by phone (Figure 1). 
Figure 1. Typical data flows in the use of CFUA. 
The application works with mobile devices and desktop devices. CFUA is offered 
as a separate installation for every customer clinic [7]. In WHO’s (2018) classification 
of digital health interventions, CFUA can be described as a telemedicine intervention 
including e.g. consultations between remote client and healthcare provider, and remote 
health monitoring [8]. CFUA also possesses features of personal health tracking 
interventions, as it allows self-monitoring of health in form of symptom data.  
The objective of this study was to identify and analyze the mechanisms through 
which CFUA creates value in cancer care from the healthcare professionals’ 
perspective in the context of tertiary gynecological cancer clinic. The research problem 
was approached using the CIMO logic, describing the context, intervention and 
outcomes to analyze the mechanisms [9,10]. CFUA’s CIMO-configuration and the 
changes were examined. We posed the following research question: How does a digital 
follow-up application change the work of healthcare professionals and which value 
mechanisms are activated through these changes? 
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2. Data and Methods 
This research was conducted as a single case study. The unit of analysis was the work 
of a healthcare professional, which comprises tasks, actions and work processes, as 
processes can be complemented with other units of analysis, especially when they are 
not always clearly manifested [11]. The data was collected through semi-structured 
interviews with eight members of the clinic’s healthcare professionals (N=8). Four 
informants were specialist physicians and four informants were registered nurses. 
Three of the nurses worked with patients during the cancer treatments and one nurse 
worked with patients after the treatments (Table 1). The interview data was transcribed 
verbatim, and sorted into categories. 
Table 1. List of informants. 
ID Role in Organization and Cancer Treatments 
Nurse 1 Works with patients in active treatment 
Nurse 2 Works with patients in diagnostics and monitoring 
Nurse 3 Works with patients in active treatment 
Nurse 4 Works with patients in active treatment 
Physician 1 Specialist, diagnostics and treatment of gynaecological cancers 
Physician 2 Specialist, diagnostics and treatment of gynaecological cancers 
Physician 3 Specialist, diagnostics and treatment of gynaecological cancers 
Physician 4 Specialist, diagnostics and treatment of gynaecological cancers 
The data collected from the interviews was analyzed qualitatively, using the 
Grounded Theory methodology. From the data, core categories were formed that 
described the relevant themes summarizing the data set [12]. 
3. Results 
The identified value mechanisms were improved coordination, right care delivery level 
and timing, reduction of waste, demand/supply-management, control information and 
health co-creation through symptom-based care (Table 2). Especially the mechanism of 
coordination comprises sub-mechanisms, such as reduced variation and is connected to 
other mechanisms. 
Having more accurate and exact data about the patient enables optimizing the care 
level. CFUA provides data about the patients’ symptoms, which is used to decide 
whether a physician or nurse should handle the case. Nurses first read the non-urgent 
CFUA contacts, and only forward them to the physicians if necessary. This allows a 
more efficient care level, as doctors only handle more challenging cases fitting their 
skills. 
Variation in tasks hinders productivity, as mental preparation and adaptation are 
needed when changing between tasks. The health professionals argued that they are 
able to follow their schedules better with CFUA, as the unpredictable phone calls do 
not interrupt and interfere with their current work. CFUA allows scheduling the day 
into sub-parts where the focus stays on a certain type of task for a longer period of time. 
Reduced time dependency allows the professionals to perform tasks with more efficient 
scheduling. The coordination mechanism of CFUA is primarily connected to 
organizing patient care and delivery of services in a timely manner. Instead of 
facilitating the organization of cancer care in a system level between teams and 
providers, CFUA is a tool for coordinating cancer care between the patient and specific 
nurses and physicians assigned to the patient. 
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Table 2. Value mechanisms of the CFUA. 
Mechanism Summary 
Coordination CFUA allows individual professionals to work more flexibly and plan their work 
better, reducing interruptions and improving productivity. 
Right timing (for 
personnel) 
With CFUA, the professionals have a time-window that allows them to choose a 
suitable time to handle a contact. 
Care delivery level CFUA allows optimizing care delivery to the lowest level by directing only the 
most challenging contacts to physicians.  
Reduction in waste As CFUA reduces interruptions in professionals’ work, they need to spend less 
time.  
Control 
information 
CFUA provides more complete information, such as time series of symptoms, to 
professionals. This information helps professionals to decide what they should 
do next, thus improving coordination of care. 
Demand/supply 
management 
By relieving the time restriction of communication, CFUA allows scheduling the 
supply, the answers to contacts, more flexibly.  
Symptom-based 
care 
Patients contribute to their care by actively monitoring and reporting their health 
status. With reduced routine appointments, the professionals focus more on 
providing care for patients who report symptoms. 
Improved control information can lead to a more optimal processing as the right 
decision can be made. The professionals using CFUA stated that the time-series of the 
patients’ earlier symptoms help in comparing the situation with previous weeks, and 
thus evaluating if further actions are needed. Reducing waste “Muda” happens when 
improved coordination of work reduces non-value adding tasks. In addition to 
providing more data about patients, the CFUA can also provide more structure to 
monitoring processes. With CFUA, the processes can potentially be more standardized, 
if the contacts are more predictable. On the other hand, any lack of clarity in the 
procedures of CFUA use can cause waste.  
In addition to the CFUA, the demand in the clinic is actualized through two 
channels: phone calls (scheduled and non-scheduled) and clinic visits. Although the 
timing of demand remains roughly the same, the channel of demand is connected to the 
timing of supply. In phone calls, the professionals must answer when a patient calls, 
whereas for CFUA contacts they have up to two days’ time to answer. Supply can be 
planned in a more flexible way, while still retaining sufficient patient experience, as the 
patients are instructed not to use CFUA for urgent matters. The mechanism of 
demand/supply-management is related to the coordination mechanism. The ability to 
time supply with a larger degree of freedom allows better coordination of work, both in 
individual professional and organization levels. Similar to coordination, this 
mechanism is enabled by removing or reducing the time-restrictions of professionals’ 
work. 
Routine clinic visits can be economically inefficient when the personnel spends 
time examining patients that do not have any symptoms. With CFUA, the professionals 
mostly contact patients that have reported significant symptoms. Symptom-based care 
is connected to the co-creation of health. In co-creation of health, the patient 
contributes to maintaining or improving their state of health. The co-creation of health 
mechanism functions also through managing demand. 
4. Discussion and Conclusions 
This study identified several mechanisms through which CFUA increases value. The 
mechanisms were analyzed from the healthcare professionals’ perspective, and most of 
the identified mechanisms create value by improving the productivity of the 
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professionals. The mechanisms affecting efficiency and productivity include both 
mechanisms improving individual professionals’ efficiency in tasks, as well as 
mechanisms that allow more efficient allocation of tasks between professionals. The 
implementation and organizational practices seem to have a strong effect on the value 
creation of digital follow-up applications. The digital application should be an integral 
part of the professionals’ work, with clear roles and procedures for using it. The 
primary source of value of digital application is the data output that creates or improves 
information. Incomplete movement of information in an organization deteriorates the 
value created. Key challenges that digital interventions could solve in healthcare are 
coordination and integration of fragmented knowledge. In the studied empirical context, 
CFUA has the potential to improve coordination in multiple ways. 
The findings of this study contribute to the development of value-based healthcare 
and to the evaluation of digital health interventions. The study also has certain 
limitations. We did not interview the patients. Therefore, the value creation was 
analyzed focusing on costs rather than health outcomes. However, changes in 
professionals’ work have effects on health outcomes, if the patient work changes. 
Patient outcomes also affect costs, as quick recovery incurs less costs than prolonged 
treatment. Furthermore, the actualization of the mechanisms as outcomes or costs was 
not measured. Nevertheless, this research has identified intermediate outcomes that 
could be used as measures for the value of digital interventions and for confirming the 
mechanisms in future research. 
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Digital Technology Trends Supporting 
Assisted Independent Living of Ageing Population
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Abstract. The paper provides a narrative overview of trends in digital technology 
related innovations for supporting ageing subjects to live independently with 
assistance, synthesized from selected scoping reviews and informed by subsequent 
analysis of peer reviewed literature appearing in the past 10 years. Four categories 
of trends are identified: assistive and supportive technologies; monitoring devices 
and systems; communications and connection technologies; and intelligent health 
information systems. For each of these categories, a synthesis commentary and 
illustrative examples are provided, concluding with a summary discussion on future 
directions.  
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Introduction
Technology for supporting ageing well and care provision for ageing subjects has 
traditionally been seen as providing additional capabilities to those supplied by human carers 
[1].  Their potential can be realized through consideration of appropriate alignments between 
technologies, users and care settings [2]. Three major categories of health purpose for this 
type of technology-based independent living assistance can be distinguished: enabling 
personal and social interactions; help with daily living activities; and as a means for delivering 
clinical services [3].  Recently, use of specific digitally-driven technologies to support ageing 
subjects in various supported situations has become increasingly adopted [4]. Examples of 
well-established digital technology for ageing subjects include devices to supplement body 
functions (e.g. hearing, heart function, diabetes medication), systems for monitoring health 
conditions (e.g. vital signs, physical activities, mental and sleep states), and services for 
enabling health and wellbeing interactions (e.g. videoconferencing, online health portals, self-
care management apps).  
The concept of using technology as a channel for implementing new models of care in 
ageing has been predominantly based on the notion that it is desirable that the care be provided 
in non-traditional delivery settings, such as the subject’s home [5].  This view leads quite 
naturally to the interpretation of the role of digital technologies in new models of care in 
ageing as enabling care delivery to be performed remotely (in location and timing), and with 
the augmentation of remotely collected information and remote interaction and 
communication mechanisms [6].  For example, it is recognised that remote patient monitoring 
offers a sound approach for management of chronic diseases [7], and that remote clinician-
patient interactions are suitable for a range of specific clinical tasks [8].  It is also 
acknowledged that various implementation challenges [9] and adoption barriers [10] exist for 
these approaches.
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1. General Model 
There is no apparent standardized nor widely accepted categorization of ageing health-related 
digital technology areas which can be followed in discussions of associated innovations. 
Recent literature reviews in the field have tended to aggregate many different application 
areas rather than conform to a defined structure (e.g. [11], [12]). Attempts to define a 
universal framework or taxonomy are frustrated by the huge volume and numerous variations 
in technology types, many having been developed as engineering exercises in non-clinical 
settings. A recent categorization based on contemporary technology development activities 
[13] suggested seven clusters: Robotics, General ITC, Sensor technology, Telemedicine, 
Medication dispenser and Video games. These are somewhat imbalanced for broad scoping 
purposes, as they vary between highly generic and highly specific topics.   
     Instead we will align our discussion with four areas of technology usage which are 
associated with broad types of care purpose, from the perspective of subjects-of-care, and so 
are distinctive in their orientations of access to or provision of care within the Ageing care 
ecosystem.  These four areas were synthesized initially from a collection of widely-cited 
scoping reviews and categorization discussions such as those abovementioned.  These sources 
were identified by expert consensus, as an initial step in a more extensive ethnographic 
analysis of references extracted by structured searching of peer reviewed literature appearing 
in the past 10 years as reported in detail in [14]. We did not include use of digital technology 
for business management and non-healthcare operations delivery (e.g. roster scheduling), nor 
technology used routinely for clinical process support (e.g. patient record systems).  
     For each of these four areas, we briefly summarize some apparent trends in the recent work 
related to major use cases, indicative of the overall directions that the field is following.  These 
use cases were chosen due to their high prevalence in literature on ageing and technology and 
are not necessarily exhaustive, but may be regarded as dominant. We contend that these areas 
are major “promising directions” in digital technology trends supporting assisted independent 
living of the ageing population, and can be expected to have a strong impact on the successful 
implementation of new models of care and health in ageing. The four identified areas are: 
-Assistive and supportive technologies which provide physical or cognitive aids to 
activities undertaken by a subject-of-care as an adjunct component of the activity. 
-Monitoring devices and systems which measure and analyze personal health 
characteristics of a subject.  
-Communications/connection technologies allowing a subject-of-care to interact with 
health carers remotely. 
-Intelligent health information systems which empower subjects-of-care to access 
information and exercise informed control on their health circumstances. 
2. Emerging Trends 
We next provide commentary on the trends observed for these above four areas, as discerned 
in our literature survey, including some illustrative examples. 
 
2.1. Assistive and Supportive Technologies 
  
A common need for the elderly is assistance in mobility to overcome ambulatory limitations 
(e.g. wheelchairs). Digital technologies incorporated in mobility devices may be simple such 
as instrumented canes or frames or may incorporate more sophisticated mechanisms such as 
motion surfaces, limb supplementation and balance enhancement, depending on the mobility 
purpose and needs.  An important related area is the detection and prevention of falling, which 
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is often a consequence of compromised mobility and potentially tractable through 
measurement and prediction.  The use of Smartphones for mobility information collection 
and analysis could offer an easier pathway to delivery. The possibility that routine home care 
activities could be conducted by an autonomous device such as a robotic assistant has become 
a popular view, suggesting an appropriate form of generic technology to assist ageing in place.   
Decline of auditory and visual sensory functions which enable interaction with 
surroundings cause limitations for older adults, typically addressed through external solutions 
such as hearing aids. The alternative of internally fitted smart devices such as the cochlear 
implant is now also established. Progress on augmenting or replicating loss of vision by more 
sophisticated technology solutions has been slower due to highly challenging neurological 
mechanisms at the three main sites of intervention: retina, optic nerve and visual cortex. 
Cognitive decline including loss of memory, balance, location and situational awareness, 
logical reasoning or understanding of context, through to pathological brain ageing or mental 
diseases, has been a popular target for technology-based approaches A range of technology 
options have been identified, from computer-based sensor-controlled living environments to 
communication systems enabling involvement of carers in times of need. This approach is 
sensitive to the specific nature of the cognitive impairment and associated behaviours.  
 
2.2. Monitoring Devices and Systems  
 
Healthy ageing support through digital technology applies measurement and feedback on 
aspects of healthy lifestyle habits, physiological status, and preventive practices to assist 
subjects to manage and maintain their condition.  This is generally achieved through use of 
wearable monitoring devices which collect data on variables appropriate to the subject’s 
health circumstances.  Other devices can be used to measure physiological quantities or 
signals which in conjunction with movement information, can allow prediction or detection 
of adverse circumstances e.g. falling, or cardiac events. A more comprehensive use can be 
the tracking of performance of conventional daily living activities or the remote observation 
of individuals by health service providers. Beyond activity tracking, numerous wearable 
devices for vital signs are also available. It is recognised that there is widespread potential for 
activity tracking for aged subjects in particular. Future devices may adopt IoT technology 
enabling greater chance of compatibility and redeployment.  
Management of health conditions of individuals (such as chronic diseases) can be 
conducted outside of clinical environments, using measurement devices located on the subject 
or in their living spaces which communicate data to a remote clinical decision support system 
or a clinician. Devices to conduct this telemonitoring function include single and multiple 
vital signs loggers, heart and brain signal capture, and patient contributed inputs such as alarm 
buttons. They can also be incorporated into standalone integrated platforms or workstations, 
which aggregate data locally and provide some limited feedback and analysis to the subject, 
while communicating and remaining under control of a central clinical agency.  The 
workstation may be used according to a fixed regime (e.g. daily) or when the subject feels it 
necessary (e.g. if experiencing symptoms).  Alternatively multiple devices can be combined 
in a single portable or wearable system with inbuilt data communication and collection 
capability, often implemented as body area networks. Incorporation of mobile technologies 
in this setting offers an easier alternative to integration but is reliant on telecommunications 
infrastructure.  There is argument for a more integrated approach to the future design of such 
systems to allow for their easier repurposing or extension, for different health conditions.  
Ambient Assisted Living (AAL) environments are sensor-equipped and computer-
managed living spaces which automatically observe and respond via messages and alerts to 
health status indicators of their aged and potentially frail or disabled occupants: this concept 
is also styled as “Health Smart Homes”.  Target areas for wider application in aged living 
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include health and environmental monitoring, and providing companionship, social 
communication and recreation/entertainment. Concerns on ethics of AAL for observing 
individuals closely and continuously raise issues on privacy and trust, and more generally for 
user acceptance in health IoT settings. A practical open issue is how large volumes of data 
generated by such uses can be efficiently and reliably processed by “big data” methodologies.   
 
2.3. Communications/Connection Technologies  
 
In a service environment where person-centred ageing care approaches are becoming more 
widespread, telehealth in various forms offers a natural technology-based mechanism for 
enabling new model of care solutions.  For example, an appraisal of potential expanded usage 
of telehealth services in UK based on the “Whole Systems Demonstrator” project has 
suggested that this is a favourable environment for achieving integrated care. Allowing 
delivery of care by remote clinicians through teleconsultations and teleprocedures is a major 
component of this area.  Another area which has benefited from embracing this approach has 
been chronic condition management. It has been noted that adoption and acceptance of home 
telehealth depends on the sensitivity with which the service is delivered, especially regarding 
the level of support given to subjects and their active involvement. These models also depend 
on dedicated service elements such as concierge in shared living facilities, or callcentres for 
broader scale community aged care, and on other appropriate technology solutions which are 
designed to support users sympathetically with their needs and abilities.  
The ability of a computer to substitute for the role of a human is a compelling approach 
when health tasks are sufficiently simple that human delivery is a waste of resource. A 
conversational agent is a computer program which interacts conversationally (by text or 
speech) with a subject and is able to satisfy the expectations of the user and the service being 
delivered: chatbots and avatars are common examples.  These have begun to see use in health 
applications which entail routine human verbal interaction such as self-report observations or 
medication reminders, with potential in mental health and dementia.  Agents for use in 
satisfying health needs for ageing subjects require particular conversational structures to be 
effective, and may need to be tuned or adaptive to cater for differences between user 
preferences and capabilities to ensure effectiveness and acceptability.  
 
2.4. Intelligent Health Information Systems  
 
The trend for individuals seeking information about their health condition to make use of 
Internet sources has accelerated and in general has become an expectation in primary health 
care where patient-centred activities are preferred.  Recently there has been a move to provide 
websites where information on particular areas of health need (e.g. cancer, diabetes, end-of-
life) is aggregated and a compendium of background explanations, guide to clinical; evidence, 
resources for self-help or group support, and links to external resources are provided. There 
is a view that the practice by subjects of extending and embedding their knowledge of their 
health conditions and health histories provides a lifelong mechanism for better engagement, 
with an implication that ageing individuals who have already developed familiarity with such 
an approach can benefit from it in their years of declining health.  Online sources of 
information on health conditions can be enhanced with material to support management of 
conditions and activate patient involvement in their care, and so improve patient outcomes.  
Use of technology can provide value in supporting care delivered in non-clinical settings 
which are served by a variety of carers (implied by the last three areas above) in care 
coordination, telehealth services, and data-driven quality of care monitoring.  These aspects 
of service delivery must be considered in the context of the need for services and the 
ecosystem which influences their delivery. It has been recognised that using technology to 
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move the focus of control to the subject can be effective: for example, cooperation by the 
individual in remote monitoring of chronic disease and behavior change, or in making use of 
mobile apps to take responsibility for their day to day health care needs.  
3. Concluding Discussion
Across the four identified categories there is much commonality in many of the technology 
components. The use of sensors and wearable devices, and the associated use of smartphones 
and networked/IoT environments, is a repeated theme.  A need exists therefore to ensure that 
these components can be easily integrated and interconnected, requiring progress in the area 
of standardization of protocols and data management. Much of the commentary on evolution 
of new digital technology solutions raises issues related to adoption and compliance, with 
associated ethical or social imperatives. Development of digital technology solutions in 
harmony with user expectations and preferences, taking into account limitations on digital 
literacy and usability for ageing subjects, is essential for creating successful products. While 
much progress has been made in conventional areas of health informatics such as electronic 
health record systems, addressing the needs of ageing citizens has generally been less popular. 
This has been due in part to design challenges across diverse stakeholder groups, and due to 
adoption reluctance by health services strongly reliant on human-based delivery mechanisms. 
If digital technology is seen as a means to enable new models of care and improve quality 
and equity of access, there is potential to accelerate new solution developments in this sector.
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Abstract. This paper describes how an Electronic Health Records (EHR) allowed 
for the implementation of a strategy to reduce maternal and child morbidity and 
mortality in outpatient settings of hospitals in the public healthcare system of 
Buenos Aires City. 
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1. Introduction 
Every day around 830 women die from preventable or treatable causes related to 
pregnancy or childbirth [1]. In 2016, dealing with unacceptably high maternal mortality 
indicators, the World Health Organization (WHO) published new recommendations to 
improve the quality of prenatal care in order to reduce the risk of prenatal deaths and 
pregnancy complications and increase the probability of a positive outcome for both  
mother and child. The new model changed maternal and fetal evaluations from four to 
eight to increase the detection and prevention of complications during pregnancy, 
childbirth, or puerperium. The identification of biological and psychosocial risk factors 
allows to provide guidance to pregnant patients on her and her child’s health care. This 
also promotes healthy habits and behaviors by decreasing the probability of prenatal 
deaths [2]. 
While in high-income countries the majority of women receive the recommended 
number of medical visits, 60% of women face the opposite scenario in low-income 
countries, registering more than half of the world’s maternal mortality in sub-Saharan 
Africa and almost one third in South Asia [1]. Other research warn of the disadvantages 
of pregnant patients in rural areas in terms of prenatal care and the increased risk of 
maternal mortality, with their identification to remove barriers to access health systems 
and guarantee continuity of care being a major challenge [3-5]. 
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In Buenos Aires City, 27% of registered pregnancies do not access enough prenatal 
care appointments and 5% have not had contact with the system until delivery [6]. To 
improve the number of prenatal care appointments in pregnant patients, the Ministry of 
Health designed a program called “Camino Verde de la Embarazada”. This was based 
on the improvement of access to comprehensive care of pregnant patients for an early 
identification of those conditions or determinants that may endanger the life of the 
pregnant patients, the fetus, or the newborn. This line of care consists of the 
recruitment of pregnant patients and in the active search by the primary healthcare 
(PHC) teams of those patients who are absent on scheduled prenatal care appointments 
to ensure the performance of the recommended prenatal care.  
The program was initially implemented gradually in PHC centers with paper 
records. It was possible because they work with PHC teams alongside the community. 
This fact facilitated the early recruitment and monitoring of pregnant patients in its 
population. Subsequently, the implementation of the program scaled up to the 
outpatient setting of hospitals. The greatest issue with the implementation in these 
institutions were the huge amount of patients in comparison to PHC centers, the lack of 
a process that confirms consultations, and the complications registering them on paper 
implies. It was difficult to achieve the program, which could only be completed in a 
hospital, due to the allocation of human resources destined exclusively for this task. 
The objective of this article is to describe how an EHR allowed a strategy that reduced 
maternal and child morbi-mortality in outpatient settings of hospitals in the public 
healthcare system of Buenos Aires City.  
2. Methods 
2.1.  Setting 
The public healthcare system of Buenos Aires City is made up of an Ministry of 
Health, hospitals, and PHC centers structured in program areas in charge of a geo-
referenced population. The main objective is to create an integrated network of care, 
strengthening PHC and more than 200 healthcare teams that provide to the community 
outside the centers and guarantee  access to the system. Since June 2016, an EHR is 
being gradually implemented in the outpatient setting and as of September 2019, 78 
healthcare centers are using EHR with a total of 4,984,680 health records across the 
health system [7]. 
2.2.  Study Design 
This is a descriptive study of how an EHR allowed for the implementation of a strategy 
to reduce maternal and child morbi-mortality in hospitals of Buenos Aires City. To 
accomplish this, the project leaders of the Office of Health Information Systems 
measured pregnant patients’ health care processes, flow and registration of information, 
use of EHR, absenteeism registration in the outpatient offices of four hospitals, by 
conducting observations and field interviews. With the analysis of the data collected, 
various alternatives were designed for the registration and output of absenteeism data 
of pregnant patients on scheduled visits in obstetric outpatient clinics in hospitals, as 
well as their implementation strategy. 
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3. Results 
The implementation of the “Camino Verde de la Embarazada” program in hospitals 
included the following aspects: 
3.1.  Basic agreement between parties of interest 
Before starting the implementation, a meeting was organized with all those involved: 
the Ministry of Health team, project leaders of the Office of Information Systems, the 
heads of external offices, obstetrics office, program areas and PHC centers 
corresponding to the area as well as the local coordinator of the EHR implementation. 
The objective was to communicate the guidelines of the program and to agree upon the 
strategy of its implementation. Then, the schedules related to maternal and child care 
consultations were obtained, which involved a manual reviewing process in each of the 
health centers. 
3.2. General Guidelines 
The healthcare network of pregnant patients is organized according to the complexity 
of each case, with PHC centers being responsible for low-risk prenatal care and 
directing the attention of high-risk pregnancies to hospitals. The record of patients’ 
absenteeism is carried out by health professionals, using a functionality of the EHR 
where they can view the list of patients with consultations scheduled and, if necessary, 
register missed appointments. It also allows them to register gestational age. 
3.3. Automated Report 
An algorithm in the programming language R [8] was developed for the identification 
of patients who were absent from arranged consultations in the obstetric schedules. 
Seeking to improve the filter and increase the identification of absent patients, the free 
text field associated with consultations based on regular expressions was used in 
addition to the absenteeism functionality, which also recover gestational age. Out of the 
absent patients identified, the algorithm consumed the Master Patient Index to obtain 
their basic and contact information. From this, each patient was associated with their 
corresponding health center under their geographic area, using georeferencing tools.  
The report is automatically produced on a weekly basis on a cloud platform 
mounted on an internal Buenos Aires City government server, which can only be 
accessed through an authentication process. This protects the confidentiality of 
sensitive data included in the report. It is composed of the following data: hospital, 
date, id number, name and surname, date of birth, telephone number, email, address, 
appointments schedules, gestational age, and corresponding PHC center. 
3.4. Articulation of different levels of attention 
The Ministry of Health team visualizes absenteeism reports from all hospitals. They are 
responsible for sharing the list of patients and their contact information with program 
areas. Then, each program area transmits this information to their respective PHC 
centers. If the patient's address corresponds to other jurisdictions, the team connects the 
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coordinators of the PHC centers to that corresponding jurisdiction. Once PHC teams 
receive the information, they will attempt to contact the patient after using gestational 
age to rank cases, where they can reschedule a consultation in a PHC center or in a 
hospital according to the complexity of the case. 
3.5. Implementation strategy 
A pilot test was conducted in the hospital where the program was already working. The 
solution implemented coexisted with its usual circuit based on paper records, to 
contrast with the operation of the data output. Once it was found that there was an 
overlap between both reports, the paper circuit was abandoned and the implementation 
of the new circuit in other hospitals began gradually (Figure 1). 
 
 
Figure 1. Evolution of the number of daily absent patients identified including nine hospitals of the public 
healthcare network of Buenos Aires City. The orange dotted line indicates when the new data circuit was 
implemented in all the hospitals. 
4. Discussion 
Childhood maternal morbi-mortality rates integrate key indicators of a population’s 
healthcare level and are widely used as measures to represent the effectiveness of a 
country's health care system. They are constantly used to analyze and monitor the 
etiologies that accompany, reinforce, reorient, and plan public policies aimed at 
improving care for mothers and children. It was important to scale the “Camino verde 
de la embarazada” program to the outpatient setting in hospitals while also conducting 
low and high risk prenatal care. The main obstacle was to obtain absent patients’ data 
to then carry out an active search. 
The EHR played a fundamental role in facilitating the necessary data so that 
pregnant patients can attend the largest number of prenatal care appointments. 
Nevertheless, there were several challenges including bringing a standard work 
procedure to health organizations accustomed to working in a heterogeneous and 
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independent settings. Another challenge was to bridge different levels of care 
(outpatient offices in hospitals and PHC teams) with various work modalities. 
All this entailed carrying out consensus among multiple parties of interest, making 
it vital to establish general guidelines and organize initial meetings with everyone 
involved. In this way it was possible to implement this strategy of active search for 
pregnant patients in nine hospitals, which is not usual in urban areas. At the same time,  
an automated report on a weekly basis has the advantage of accessing information 
faster than before, providing the opportunity for a quick intervention. 
The projection this proposal contemplates is that each PHC center can access the 
report of their corresponding population in real time and a new report with the results 
of the active search in order to carry out an evaluation of the program. In addition, it 
would be of interest to investigate the lack of adherence to prenatal care of pregnant 
patients in Buenos Aires City. 
5. Conclusion 
The implementation of the EHR was a fundamental tool in achieving an active search 
strategy for pregnant patients in the hospital outpatient setting with the intention of 
completing the pre and postnatal care recommended by the WHO in order to reduce 
maternal and child morbi-mortality. This also allowed the opportunity to manage 
public policy in nearby jurisdictions, as well as pursue more proactive strategies and 
not have to wait for patients to appear in the health center as the traditional paradigm 
had previously defined.  
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Abstract. Introduction: There are factors inherent in Health Information Systems 
that, when are used improperly, can degrade the quality of the information, which 
may imply, among other things, the lack of integrity, inconsistency or inaccuracy 
of the information. Objective: The aim of this study is to describe the quality of 
electronic clinical notes using the PDQI-9 score (Spanish version). Methods: We 
evaluated the judgment on the quality of two medical auditors trained in the use of 
PDQI-9 tool. The unit of analysis was the 3 types of clinical notes: admission 
notes, progress notes and discharge summaries of adult patients admitted to 
general wards. Sampling type: random. Statistical analysis: continuous variables 
were summarized with median and interquartile range. Medians between 2 
reviewers were compared using Mann Whitney hypothesis test. Results: 120 
Electronic Health Record (EHR) were selected, the median of the overall quality 
of the admission notes were 33 (31-34) and 32 (32-37) for each reviewer 
respectively, without any statistically significant differences (p=0.729). The 
overall quality of progress notes and discharge summaries were 28 (27-33) vs 27 
(27-32), p = 0.175 and 33 (32-34) vs 33 (31-34), p = 0.243, respectively. 
Conclusions: The quality of the clinical documents evaluated by the trained 
reviewers using the PDQI-9 score was good. The application of this type of tool is 
valuable for making a diagnosis in terms of quality that allows improving clinical 
documentation, as well as peer communication when reading the Electronic Health 
Record. 
Keywords. Electronic Health Record; Documentation; Clinical Note; Quality; 
Instrument 
1. Introduction 
The implementation of the Electronic Health Record (EHR), provides benefits  
regarding the accessibility, availability, and communication of clinical information, 
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impacting positively on the quality of patient care [1]. However, there are factors 
inherent in Health Information Systems that, when are used improperly, can degrade  
the quality of the information [2], which may imply, among other things, the lack of 
integrity, inconsistency or inaccuracy of the information [3]. An example of this 
problem is the inappropriate use of copy and paste, as well as the vast amounts of low-
quality information automatically inserted in the clinical notes[2]. 
In this sense, it is essential to audit the quality of clinical records made by health 
professionals [4], the main role of medical auditors. In our country, we have a validated 
tool to evaluate the quality of clinical notes in the electronic medical record, but its use 
is not standardized. This tool, called Physician Documentation Quality Instrument 
(PDQI-9), evaluates three clinical notes (admission notes, progress notes and discharge 
summaries), through 9 items using a Likert scale. Using this tool, a higher score 
indicates a higher quality of the clinical notes[5][6]. The PDQI-9 was adapted and 
cross-culturally validated in Buenos Aires Italian Hospital so that it can be used in our 
healthcare context by Internal Medicine specialists [7]. For expanding the use of this 
tool the aim of this study was to train clinical audits to use this tool in order to evaluate 
quality of clinical notes. 
2. Methods 
A cross sectional study was performed from March to May 2018. The Italian Hospital 
is a center of high complexity located in the City of Buenos Aires, Argentina. It's a 
school hospital who covers surgical and medical specializations. The informatic 
development from each one has been made by its own initiative. Since 1998, the 
Institution designs and builds its own Health Informatic System [8]. EHRs from non-
surgical adult inpatients from general wards were reviewed and admission notes, 
progress notes and discharge summaries were the units of analysis. They were selected 
by the following criteria: 
Inclusion criteria: 
• Adult Patients (18 years or more) hospitalized in non surgical general wards 
with at least 3 days and no more than 15 days from March to May of 2018. 
Exclusion criteria: 
• No record of admission notes, progress notes and discharge summaries. 
• First or last progress note 
PDQI-9 consists of 9 items scored using a 5-point Likert scale (1 -not at all- to 5 
-extremely-).   Responses   are   summed   to   create a total score, with higher scores 
indicating greater quality. The items included are up-to-date, accurate, thorough, 
useful, organized, comprehensible, succinct, synthesized, and internally consistent. 
In our case, considering that 9 is the minimum value that a document can reach 
and 45 is the maximum, taking into account that these values are the results of a Likert 
scale, to confer better interpretability and to be able to obtain results as an opportunity 
for improvement , the team of researchers chose to interpret the results in 5 categories: 
9-17 Poor quality, 18-26 Regular quality, 27-35 Good quality, 36-44 Very good quality 
and 45 Excellent quality. 
Two medical auditors received an one-hour training from the research team, once a 
week for three months. During the training, clinical notes of inpatients were assessed 
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and then excluded to participate in the analysis of this work. Auditors evaluated the 
clinical notes applying the PDQI9 SV tool and shared their views about the quality of 
them. Every instance was moderated by a member of the research team previously in 
charge of the tool validation process. 
Each reviewer individually assessed every clinical note, the corresponding EHR, 
and filled a Redcap form to complete the assessment. 
For statistical analysis, continuous variables were summarized with median and 
interquartile range. Medians between 2 reviewers were compared using Mann Whitney 
hypothesis test. The analysis was performed using STATA 15. 
The research project was approved by the institutional review board (CEPI #4092). 
The study was performed in full agreement with current national and international 
ethical regulations. The researchers declare no conflicts of interest. 
3. Results 
120 Electronic Health Record (EHR) were selected and reviewed. The median of the 
overall quality of the admission notes was 33 (31-34) and 32 (32-37)  for  each  
reviewer respectively, without any statistically significant differences (p=0.729). The 
overall quality of progress notes and discharge summaries were 28 (27-33) vs 27 (27-
32), p = 0.175 and 33 (32-34) vs 33 (31-34), p = 0.243, respectively. (Table 1) 
Table 1. Variation between reviewers about the Global Quality per clinical note (n = 240). HIBA, 2019. 
 
 Reviewer 1 Reviewer 2 p value 
Admission notes* 33 (31-34) 32 (32-37) 0,729 
Progress notes* 28 (27-33) 27 (27-32) 0,175 
Discharge summaries* 33 (32-34) 33 (31-34) 0,243 
 
*Median (IIQ25-75%) 
Regarding the quality by the domain (Table 2), most of them were around the 
value 3. Overall, "Organized" was the domain with the lowest value (admission notes, 
3.2; progress notes, 2.9; discharge summaries, 3.2). On the other hand, the best-rated 
domains were "Synthesized" (admission notes and discharge summaries, 3.8), 
"Internally consistent" (progress notes, 3.3; discharge summaries, 3.8) and "Up-to-
date" (discharge summaries, 3.8).  
Table 2. Quality by ítem per clinical note (n = 240). HIBA, 2019. 
 Admission notes Progress notes Discharge summaries 
Up-to-date* 3.7 (0.50) 3.1 (0.80) 3.8 (0.43) 
Accurate* 3.3 (0.54) 3.1 (0.70) 3.4 (0.51) 
Thorough* 3.6 (0.60) 2.9 (0.67) 3.7 (0.50) 
Useful* 3.7 (0.50) 3.1 (0.80) 3.7 (0.50) 
Organized* 3.2 (0.50) 2.9 (0.64) 3.2 (0.50) 
Comprehensible* 3.6 (0.60) 3.1 (0.72) 3.6 (0.50) 
Succinct* 3.3 (0.52) 3.0 (0.71) 3.3 (0.50) 
Synthesized* 3.8 (0.50) 3.1 (0.82) 3.8 (0.44) 
Internally consistent* 3.7 (0.60) 3.3 (0.81) 3.8 (0.50) 
*Media (DS)    
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4. Discussion 
The aim of this study was to train medical auditors to use the PDQI-9 Spanish version 
in order to evaluate quality of clinical notes. Admission notes, progress notes, and 
discharge summaries from 120 EHRs were reviewed. Most of the time, the items 
analyzed were around the value 3. When analyzing domains, admission notes and 
discharge summaries were better scored than progress notes, especially in organization 
and completeness. This could be explained by the fact that the first two have text entry 
in structured fields, while progress notes is recorded in free text format. Comparing  
with other experiences the quality obtained in this study was satisfactory. In results 
reported by Hahn [9], the highest-rated note attributes were “comprehensible” (4.7) and 
“accurate” (4.5) and the lowest-rated attributes were “synthesized” (4.2)  and  
“succinct” (4.2). This difference can be due to the training provided to residents in their 
education program. In this sense, there is evidence that this score is useful as  a  
measure of performance of training programs to improve the  quality  of  clinical  
record. As an example, in the study carried out at the  Children's  Hospital  of  
Wisconsin [10] the impact of a training for  residents  were  measured  with  the  PDQI-
9 tool. In addition, Miller et al [11], in 2017 published how from a training program 
they were able to improve the score of the quality above 40 points after training. The 
objective of the mentioned studies were  not only to measure the quality  of the records, 
but also to use the PDQI-9 results as a quality indicator, because a standard score is 
useful for tracing training strategies to improve the  quality  of  records. Future studies 
in our setting are necessary to examine the implementation of education programs 
centered in improve clinical note's quality. 
5. Conclusions 
The quality of electronic clinical notes evaluated by trained medical auditors using the 
PDQI-9 SV tool was appropriate. This adapted tool has the potential to improve the 
documentation using the record quality level as an indicator. 
Acknowledgement: We thank to Veronica Peuchot and Sofia Zanetti for their support 
in this project. 
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Abstract. We evaluated three repositories implementing the emerging healthcare 
data standard openEHR for their standard compliance, completeness and vendor 
lock-in. We found the basic functionality to work consistently across all tested 
repositories. At the same time, no vendor supports the entire API yet. Some 
functions like template listing differ slightly in their behavior. Some vendors offer 
additional custom APIs that are easier to use but lead to vendor lock-in. The 
openEHR standard itself is designed inconsistently regarding data formats and is 
missing some basic functionality, for example deletion of templates. With openEHR 
being a young standard, these issues may be resolved in future releases. 
 
Keywords. Health Information Interoperability, openEHR, Software Validation 
 
 
1. Introduction  
Automated exchange of clinical data between hospitals for improved care and research 
remains an ongoing challenge. Progress in this area is expected to save billions of dollars 
via reduced redundancy [1] as well as lead to new medical discoveries e.g. through 
extensive analysis of the resulting big data sets [2]. 
The Federal Ministry of Education and Research2 in Germany set up the Medical 
Informatics Initiative3 in 2017 to facilitate data exchange between university hospitals. 
It consists of several consortia, each of which tries to reach interoperability in a different 
way. The University of Münster is part of the HiGHmed4 [3] consortium that decided to 
use the openEHR5 standard to address this challenge. 
OpenEHR is a standard for clinical data storage, retrieval and exchange. It separates 
clinical modelling for clinicians from IT implementation. Interoperability is achieved by 
creating common data models. Hospitals that use the same data structures can then 
directly exchange data without the need for further conversion layers. The countries with 
the broadest deployments of openEHR are Australia, Slovenia and Norway6. Countries 
pursuing a nationwide eHealth strategy and setting standards for interoperability like 
Norway seem particularly well suited for the openEHR approach [4]. 
International cooperation is possible via the “Clinical Knowledge Manager”7 
(CKM) by Ocean Informatics. HiGHmed uses a governance model designed around a 
local CKM with clear roles and responsibilities [5] that feeds back parts of its work into  
1 Corresponding Author, Maximilian Fechner, Institute of Medical Informatics, University of Münster, 
Albert-Schweitzer-Campus 1, 48149 Münster, Germany; E-mail: max.fechner@uni-muenster.de. 
2 http://bmbf.de 
3 https://www.medizininformatik-initiative.de/ 
4 https://highmed.org/ 
5 https://www.openehr.org/ 
6 https://www.openehr.org/openehr_in_use/deployed_solutions/ 
7 https://openehr.org/ckm/ 
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the international CKM. Other countries like Sweden and Australia also use local CKMs 
[6]. 
Several vendors implement the openEHR standard and can in theory be used 
interchangeably, thus avoiding a vendor lock-in. We evaluated three different openEHR 
repositories for their standard compliance. 
 
 
2. Methods 
 
Multiple vendors offer patient repositories based on the openEHR standard in varying 
degrees of completeness. We selected only systems with support for the openEHR query 
language AQL, since querying records is crucial for our use-case in HiGHmed: Marand’s 
“ThinkEHR” (now “Better Platform”)8 (version 2.4.6), Ocean’s “LinkedEHR”9 (version: 
0.9 beta) and DIPS’s “EHR-Store”10 (version: 6.1.0.3166). For the sake of simplicity, 
these will be referred to by their vendor names, i.e. Marand, Ocean and DIPS. 
In an openEHR setting, the following terms are being used. An EHR is an Electronic 
Health Record that acts as a container for a single patient. An EHR contains no patient- 
data directly, only meta information like a UUID. A composition contains a single data 
record of a patient, e.g. the blood pressure or a microbiology report that is then attached 
to an EHR. A template is the structure definition of a composition. It is the equivalent of 
a schema definition in other languages, e.g. XSD for XML. Templates are substructured 
with reusable components called archetypes that can be queried independently of the 
template instances they belong to. To save any given data record into an openEHR 
repository it is necessary to have an existing EHR-container to attach it to, an existing 
template definition to validate against, and the data itself in the form of a composition. 
We used the official openEHR REST API 1.0.111 to compare the aforementioned 
solutions regarding completeness, standard compliance and proprietary functions. The 
openEHR Repository from DIPS was installed on a local machine. Demo installations of 
the repositories from Marand and Ocean were offered remotely on the vendor’s premises. 
The following methods of the official openEHR REST API 1.0.1 were tested on all three 
vendors’ repositories in both XML and JSON variants: 
 Template: Upload, List, Retrieval 
 EHR: Creation with custom ID, Creation with assigned ID, Retrieval 
 Composition: Upload, Retrieval, Removal 
 Queries: Upload, List, Execution 
 
3. Results 
 
The results of the tests of the different API calls are summarized in Table 1. Green values 
signify standard compliance. Orange values stand for a non-standard compliant solution. 
Red means that the function is not implemented yet. Grey values mark functions that are 
not included in the current version of the openEHR standard. 
 
 
8 https://platform.better.care/ 
9 http://www.oceanhealthsystems.com/products/linkedehr 
10 https://www.dips.com 
11 https://specifications.openehr.org/releases/ITS-REST/latest/index.html 
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 Marand Ocean DIPS 
Template Upload JSON XML JSON XML JSON XML 
Template List JSON XML JSON XML JSON XML 
Template Retrieval JSON XML JSON XML JSON XML 
    
EHR Creation JSON XML JSON XML JSON XML 
EHR Creation with ID JSON XML JSON XML JSON XML 
EHR Retrieval JSON XML JSON XML JSON XML 
    
Composition Creation JSON XML JSON XML JSON XML 
Composition Retrieval JSON XML JSON XML JSON XML 
Composition Removal Yes Yes Custom API 
    
Ad-hoc Query Execution JSON XML JSON XML JSON XML 
Stored Query Execution No Yes Custom API 
Stored Query Upload No Yes Custom API 
Stored Query List No Yes Custom API 
Table 1: Results of the openEHR REST API 1.0.1 evaluation 
 
3.1. Templates 
 
Template upload works across vendors in the standard Operational Template (OPT) 
format (Ocean accepts only archetype_id version > 0). Retrieval of templates is 
implemented within Marand using the XML representation and DIPS additionally 
supports the JSON format. Ocean has not yet implemented the template retrieval 
functionality. The listing of currently available templates works similarly within 
Marand and Ocean. The returned list contains the latest valid version for each uploaded 
template and is only available in the JSON format. In contrast, template listing in DIPS 
returns all versions of all templates including outdated versions. Therefore, the returned 
list from DIPS has to be filtered manually for currently valid templates to achieve the 
same result as in Marand and Ocean. The return values differ, too: Ocean returns only 
“concept” and “template_id”. Marand returns an additional “archetype_id” and 
“created_timestamp”. DIPS adds a further “id”, “filename”, “type” and “version”. 
 
3.2. Electronic Health Records 
 
EHR creation with automatically assigned ID in JSON format works consistently across 
all tested vendors. A possible variant using XML format is not documented in the current 
version of the openEHR standard. EHR creation with custom IDs only works with 
Marand’s repository. All three vendors support EHR retrieval in JSON format. Marand 
and DIPS additionally provide retrieval in XML format. 
 
3.3. Compositions 
 
All tested repositories support the creation and retrieval of compositions in JSON format. 
Besides, Marand and Ocean support XML retrieval. Composition removal in DIPS is 
only possible using the custom API, whereas Marand and Ocean provide a standard 
compliant solution. 
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3.4. Queries 
 
The results of ad-hoc queries show differences in the naming of columns (#0, #1, #2 in 
Marand versus path names in DIPS and Ocean), but can be performed on all repositories. 
Standard-compliant stored queries are only possible with Ocean, but DIPS offers a 
custom solution. Ocean returns only IDs for EHR-queries via AQL, metadata like 
systemID and creationTime are not supported. The only supported data format for 
queries in the tested repositories is JSON. 
 
 
4. Discussion 
 
We successfully evaluated three different openEHR repositories regarding standard 
compliance and proprietary functions. The examined repositories show differences in 
their implementation of the official REST API in every evaluated segment (templates, 
EHRs, compositions, queries). The most important parts of the official openEHR REST 
API (template upload, EHR creation, composition creation, basic querying) work 
consistently across vendors. Thus, repositories can be filled with data and data can be 
queried with the official API calls. At the same time, every tested repository misses some 
functionality of the official API. At present, Marand does not support stored queries. 
Ocean cannot create custom EHRs. DIPS cannot remove compositions. Some functions 
differ slightly in their behavior, such as template listing in DIPS and AQL EHR queries 
in Ocean. Since openEHR is a comparatively young standard, these issues may be 
resolved in future software versions. 
Additionally, Marand and DIPS both have extensive custom APIs in parallel to the 
official openEHR API. These custom APIs are in many ways easier to use than the 
official version, especially regarding compositions. Both vendors offer a custom “flat” 
composition format. Adoption of this API means that the “load” part of an ETL-process 
(Extract-Transform-Load) would have to be redesigned upon a change of the underlying 
repository. Furthermore, DIPS decided to implement some functions exclusively via 
custom API, like stored queries and composition removal. This approach is not in line 
with the general openEHR idea of interoperability and may lead to vendor lock-in. 
The standard’s API design itself leaves some areas for improvement, too. At present, 
there are some inconsistencies regarding data formats. Template upload and download 
are designed around the XML based OPT (Operational Template) format, while template 
listing returns JSON. Interestingly, DIPS does not even accept its own template JSON 
output as a valid input. It remains unclear why this design of alternating data formats was 
chosen. It might derive from merging of different pre-existing APIs. 
Template definition also requires a variety of formats. The XML based OET-format 
(OpenEHR Template) is used for the templates themselves and the custom ADL- 
format12,13 (Archetype Definition Language) describes archetypes. OETs and ADLs can 
then be combined into the aforementioned OPT, which can then be uploaded into the 
repositories. The benefits of the creation of the custom ADL format in addition to the 
mix of JSON and XML that is already in use remain elusive. 
 
 
 
12 https://specifications.openehr.org/releases/AM/latest/ADL1.4.html#_structure 
13 https://specifications.openehr.org/releases/LANG/latest/odin.html 
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In summary, working with openEHR requires the use of at least three different data 
formats (XML, JSON, ADL). Harmonization of the used data formats in future versions 
of openEHR would be beneficial. 
Another point regarding API design is the omission of some basic functions. The 
deletion of EHRs or templates is currently not supported; therefore, unused records and 
templates can pile up in the systems and might affect maintainability over time. 
 
 
5. Conclusion 
 
In their current version, the three tested repositories are standard-compliant regarding the 
essential parts of the openEHR REST API. None of the tested solutions shows complete 
support of all official API functions. 
Marand and DIPS both have extensive custom APIs in parallel to the official API. 
These custom APIs are in many ways far easier to use than the official version. 
Furthermore, DIPS decided to implement some functions exclusively via custom API. 
These proprietary functions might lead to vendor lock-in. In addition, functions to delete 
templates or EHRs are missing. 
Finally, the official API design itself is inconsistent in its use of data formats. At 
least three different formats (XML, JSON, ADL) are required to work with openEHR in 
its current form. Since standards like openEHR are in a continuous improvement process, 
this might change in future releases. 
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Abstract. Enabling interoperability is a challenging task in medical data exchange
and is often addressed by the use of versatile communication standards like HL7
FHIR. Although daily routine and scientific experiences show its suitability, the
use comes with major risks regarding safety and security of data. To overcome
these problems, we present an approach to enable a formal verification of medical
communication use cases. We identified the Neonatal Screening as a practical ex-
ample in which two process participants (physician and screening laboratory) are
involved. We analyzed the FHIR specification as well as identified necessary re-
sources in that context and formally modeled them as algebraic specifications. By
that, we were able to represent the participants’ behavior and data flow with help
of Algebraic Petri Nets. This strategy allows to formally verify the correctness of a
system by specified requirements regarding data safety and data security.
Keywords. Data Safety, Data Security, FHIR, Algebraic Petri Nets, Neonatal
Screening
1. Introduction
Integrated health care depends on both interdisciplinary collaboration of health care
providers and communication between their IT systems. Providing the required data in-
teroperability is a crucial task and subject of current research [1].
As an example for a medical process we focus on the screening for Phenylketonuria
(PKU), a disorder that is a target of the German Neonatal Screening program [2]. This
screening allows the early detection and treatment of congenital metabolic disorders, en-
docrinopathies and immunodeficiencies in all newborns (given the parents’ consent) [3].
For the diagnosis of PKU, a secure and reliable communication between the physician
and the screening laboratory is needed. In particular this means, it is necessary to en-
sure that exchanged data is send, received and interpreted correctly as well as it is only
accessible by authorized participants.
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HL7 FHIR (High Level 7 - Fast Healthcare Interoperability Resources) is a trend-
ing important communication standard in health care [4]. It theoretically allows for in-
tegrating legal specifications by providing a Contract Resource [5], which can include
information regarding consent and access restrictions [6].
As these contracts change, IT systems must be manually adjusted. This changes are
often tested with the help of simulation methods. However, these methods are usually
incomplete, which leads to safety and security problems. This can be countered by formal
specifications, which enable the analysis during the concept phase and the possibility to
ensure adherence to legal and medical regulations. One possibility to formally specify
data exchange processes is to use Algebraic Petri Nets [7] (APNs). APNs simultaneously
model control and data flow while being highly comprehensible. It has already been
shown that reliable data communication between medical devices can be realized if the
devices’ internal behavior and data flow are modeled as APNs [8]. We investigate, if it
is possible to formally model the participant’s behavior and their data exchange for a
medical process.
2. Methods
Based on the PKU screening process we proceeded a three step approach.
1. Modeling of Petri Nets (PN): The steps of the Neonatal Screening were inferred
from the standardized description of the process [3,2] and abstracted for a process
model. The participants (physician and screening laboratory) were modeled as
Open PN [9].
2. FHIR Based Data Modeling: Based on the standardized guideline mentioned
above FHIR resources that are necessary for the communication were identified,
analyzed and mapped into the structure of algebraic specifications [10].
3. Modelling of APNs: The Open PN were enriched with the FHIR-based medical
data to model the APNs.
3. Results
3.1. PN Model for Neonatal Screening
The modeling of the Neonatal Screening process, performed by the physician and the
screening laboratory, in an Open PN corresponds to the process shown in Figure 4. The
physician, who was responsible for the child’s birth, has to inform the parents about the
Neonatal Screening (p0, t0, p1). The parents can refuse (t2, p2) or agree (t3, p3). Given
consent, the test can be carried out (t4, p4). Therefore a sample of blood is transferred to
a test card which is sent to the screening laboratory (t5, p5). The physician is waiting for
the results (p6). The laboratory physician performs a tandem mass spectrometry (p11, p12,
t11) and documents the laboratory experiment at the test card (p13, t12, p15). The result of
the examination (p14) can be suspicious (t14, p17) or within normal range (t13, p16). The
physician will be informed about every suspicious result immediately by telephone (t15,
p18, p19). In both cases, the laboratory physician creates a record of the result (t17, t16,
p20) and returns it to the physician responsible (t18, p21, t19, p22, p23). When the physician
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is informed of the suspicious findings (p7, t6), further diagnostic measures are initiated
(p8) to confirm or refute the suspicion. If the findings are inconspicuous, the physician
will only be informed in writing (t10, p10) and no further action is required.
3.2. FHIR Based Data for Neonatal Screening
To enable the communication between physicians and the screening laboratory, the fol-
lowing FHIR resources must be considered: (1) The Patient Resource includes name and
birthdate of the newborn. The Neonatal Screening process also requires communicating
the newborns time of birth. As it is not included in the Patient Resource, we used the
extension birthTime. (2) The ServiceRequest Resource is needed to inform the laboratory
to start the diagnostics. (3) The DiagnosticReport Resource includes information about
the laboratory results and their interpretation. (4) The Contract Resource can include
information about access restrictions and consent acceptance.
These resources are connected to further resources; e.g. DiagnosticReport might
include information about the performer of the diagnostics which can be an organization
(Organization Resource) or health care provider (Practitioner Resource). We abstrain
from listing all of them in detail for clarity reasons. However, an overview is given in
Figure 1.
Figure 1. Necessary resources and their connection
By analyzing these FHIR resources, we found a basic structure that can be repre-
sented as algebraic specifications, which are shown in Figure 2.
Figure 2. Basic Structure of FHIR resources as algebraic specification
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3.3. APN Model for Neonatal Screening
The process of the APN is represented by Figure 4 and the corresponding algebraic
specification is described in Figure 3. The algebraic specification is used to formally
define data types (e.g. sorts: Resource), operations and constants on these data types (e.g.
opns:C→ Resource), variables (e.g. vars: resourceName: PrimitiveType) and equations
(e.g. eqns: resourceNameC = ”Contract”). The elements that are defined in the algebraic
specification are represented within the PN model, e.g. arc (p1, t3) is labeled with tupel
(E,C), which means that an Encounter Resource and a Contract Resource are passed.
Figure 3. Algebraic Specification of the Neonatal Screening Process
(a) Physician (b) Laboratory
Figure 4. APN for the Physician and Screening Laboratory at the Neonatal Screening
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4. Discussion and Conclusion
Based on the Neonatal Screening process for PKU we have shown that a formal modeling
of the participants’ behavior and their data exchange using APN is possible. By defining
a general mapping for FHIR Resources into algebraic specifications a formal data treat-
ment within the concept phase of a system that communicates with FHIR-conform mes-
sages becomes possible. The use of the Contract Resource enables the inclusion of safety
and security requirements into the initial specification. This forms the base to ensure a
safe, secure and reliable communication.
The example of PKU screening we described is somewhat limited: It focuses on
in-patient births with the test taking place within the first 36-72 hours after birth and
we did not include other disorders (e.g. atypical forms of PKU) [3]. Also the modeling
process itself leads to an abstraction of single steps. We performed these abstractions in
agreement with medical experts.
Albeit these limitations, our approach is a necessary step to formally treat data and
its exchange. This will allow formal verification of health care systems. There are cur-
rently no approaches but one on data formalization within the composition of communi-
cating systems [8]. To further improve our approach, we aim to include possibilities for
representing and verifying time constraints and allow for a real-time adaption process to
handle atypical courses of a disease. This could make it possible to test if the prerequi-
sites of a clinical guideline can be met (e.g. process participants, time limits, technology).
Also the effects of changes in the guidelines can be theoretically verified and therefore
adjustments can be made (e.g. other process participants, changed process steps). These
validated guidelines could not only improve the efficiency of health care systems but also
patient safety.
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Abstract An assessment of the quality of the information system was conducted in 
the 14 hospitals of Burkina Faso in 2017 using the HMN tool (Health Metrics 
Network). This evaluation was part of the process of developing a master plan for 
implementing a HIS for the hospitals in the country, and was aimed at analyzing 
the sub-components of the existing information system. The results are presented 
as scores, one per component, evaluated in % and converted into quartiles, ranging 
from the 1st quartile "Not adequate at all" to the 4th quartile "Highly adequate". 
The scores are as follows: Resources = Q1 (29%); indicator = Q2 (46%); data 
sources = Q1 (28%); information production = Q1 (21%); data management = Q2 
(47%); dissemination and use = Q3 (55%). In conclusion, overall the system is not 
adequate (mean score 39%), particularly at the level of information production 
(score 21%). 
Keywords: HMN Tool, Information System Quality, Hospitals, Burkina Faso 
1. Introduction 
In the health sector, it is critical to have high-quality data on performance available 
routinely [1-3]. Improving the performance of a country's national health information 
system depends on the quality of its healthcare information system. To address this 
challenge, the Ministry of Health of Burkina Faso recommended that each Hospital 
Center develops a Master Plan for implementing their Hospital Information System 
(MPHIS) [4,5]. It is within this framework that we conducted a study to evaluate the 
quality of the information system in terms of data collection and management in the 
fourteen (14) hospitals the country counts. The aim of this study was to analyze the 
current data collection and management processes to have a baseline evaluation, and 
then to follow its progression. In order to measure the performance of the system's 
components and ensure the comparability of the results between countries, the World 
Health Organization (WHO) and its partners have created an evaluation tool called 
"HMN" (Health Metrics Network). It has two parts, the normative portion (components 
and standards) and an implementation portion (a roadmap) [5]. The purpose of this tool 
is to create a harmonized framework for the development of a national health 
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information system that meets specific standards. The HMN methodology provides a 
comprehensive assessment of the system's environment and organization, the 
responsibilities, roles and relationships between actors as well as the technical and 
technological aspects related to data collection and analysis. The organizational, 
functional and technical components are the elements that we evaluated. 
2. Methods 
The evaluation focused on the following six sub-components: (i) background and 
resources: policy, regulatory and financing aspects as well as the available 
infrastructure and resources; (ii) indicators: basic indicators of disease management and 
health promotion; (iii) data sources: population census, vital statistics, population 
surveys, patient records and registers, care units reports; (iv) data management: data 
collection, sharing, and storage; (v) information production: quality of the data, 
especially aspects of transparency, disaggregation, representativeness, consistency, 
periodicity, timeliness, completeness and collection method; (vi) dissemination and 
use: information dissemination flow, use for decision-making, including policy 
development, advocacy, planning, implementation of interventions as well as follow-up 
and evaluation. Regarding data collection of the relevant information, different forms 
have been designed. The data collection was carried out by groups of people assessing 
a specific component of the tool in each hospital. The number of assessors varied from 
3 to 5 depending on the importance of the component. People in each group were asked 
to assign a score between 0 and 3 to each item of the component they were assessing 
and then to compute the average score per item. Collected data were recorded in the 
electronic version of the tool programmed to provide the results of the evaluation 
automatically. The results were converted into four groups or "quartiles" defined on an 
ordinal scale and reflecting the evaluation of the performance of the system by the 
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quartile; group 2, between 26% and 50% "Present but not adequate", corresponds to the 
second quartile; group 3 "Adequate", score between 51% and 75% representing the 
third quartile; and group 4 "Highly adequate", score between 76% and 100%, 
corresponding to the fourth quartile. The main difficulties encountered in our study 
were the unavailability of respondents, access to information and documentary 
evidence. The results of the evaluations are presented as bar charts and tables. 
3. Results 
The results of the evaluation showed some achievements, but also many shortcomings. 
For better consistency, the results of some components have been combined to make it 
easier to understand. 
3.1. Components resources, indicators and data sources 
The evaluation showed that both resources (32%) and indicators (46%) were not 
adequate with a very low score for implemented policies (16%), Table 1. 
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Overall, the data sources are not adequate (38%), Table 2. The sources that are 
adequate are those for which activities are systematically performed. These are the 
inventory of resources (55%). Civil status is the least adequate source (10%).  
Table 1: Resources and indicators component   Table 2: data source component scores 
Categories 
Max
i 
Score % 
  
Data source 
% 
Policy and Planning 30 4,9 16   Census 32 
HIS institutions, human  
resources and financing 
15 8,8 59 
  
Vital statistics 
10 
HIS Infrastructure 12 4,4 37   Population-based surveys 41 
Total 57 18,1 32   Health and disease records 37 
      Health service records 50 
Indicators 15 6,9 46   Resource records 55 
      Total 38 
3.2. Dissemination and use of data component 
Overall, use and dissemination are adequate (55%), Table 3. This result is mainly 
attributable to the use of information for action and advocacy (64%) as well as to the 
use of data analysis tools (61%). Use of information for resource allocation as well as 
use of information for action is low (44% and 45%). These unsatisfactory results may 
be explained by the fact that decision makers require complete, timely, accurate, useful 
and validated information, which is not always the case in hospitals. The integrated 
HIS analytical reports are produced and cover most of the main health indicators. 
Table 3: Presentation of the dissemination and use of information data component 
Categories Maxi Score % 
Analysis and use of information 12 7,3 61 
Information use for policy and advocacy 3 1,9 64 
Information use for planning and priority setting 6 3,5 59 
Information use for resource allocation 6 2,7 45 
Information use for implementation and action 12 5,2 44 
TOTAL 39       20,7     55 
3.3. Information products component (quality of information) 
The mean score of this component is 21%.This score, by the tool standards is 
considered as "Not adequate". Only "periodicity", "representativeness" and "data-
collection methods" criteria fall in the adequate zone. The other criteria are not 
adequate and are in the second quartile. These are: promptness, completeness, and 
method of estimating quartile information. 
3.4. Evaluation summary 
The evaluation summary results presented in Figure 1 shows that the quality of the 
information system is not adequate. The overall mean score is in the 2nd quartile (39%), 
so "Not adequate". The best score of the system is related to dissemination and use of 
information. The worse score is related to information production (21%). 
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 Figure 1. Overall information system indicators scores 
4. Discussion 
The National Health Information System of Burkina Faso is not efficient, particularly 
regarding its hospital sub-system. This was the rationale for this evaluation, which 
allowed to identify its strengths and weaknesses. The strengths of the hospital 
information system are a good organization of the services, a legislation related to 
mandatory reportable diseases, tools for collecting information, databases built with 
DHIS2 [4,5], procedures for implementing the principles of official statistics, effective 
means for cross consultation at all levels. There are also weaknesses, for example not 
including some parameters such as civil status. Social insurance is very limited. 
Moreover, there is no systematic evaluation of the hospital information system contrary 
to what is done in the peripheral health structures. Indicators of health status (maternal 
and infant mortality) are not adequate at all (21%). This is partly due to the lack of 
performance of the civil registration process and the lack of a good certification system 
of the causes of death [6]. In addition, administrative statistics do not always guarantee 
the quality of certain indicators such as deliveries attended by qualified personnel. 
There are indicators discrepancies revealed during the surveys [7]. It should also be 
noted that the results evidenced the existence of a true coordination problem in the 
management of information as reported in Botswana in 2015 [8] and in the study by 
Lippeveld T et al. [9]. There are also problems due to the lack of equipment, financial 
resources and qualified personnel as reported by Verberk et al in 2004 [10]. Of the 14 
hospitals, Bogodogo District Hospital and Tengandogo District Hospital have the 
highest scores with 62% and 69% respectively. We must mention that these two 
hospitals are recent institutions that benefitted from the support of certain partners such 
as the Chinese cooperation. The indicators of data dissemination and use got the 
highest score in our evaluation (58%). However, these scores remain low by current 
standards and show an underutilization of information in the hospitals of Burkina [11]. 
The results of the evaluation show the total score of the components is 39%. A similar 
score was found in an evaluation carried out at the University Hospital Center of Oran 
in Algeria (37%) [12].  
0% 25% 50% 75% 100%
Ressources
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Dissemination & use
Quality
Total
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5. Conclusion 
The evaluation of the hospital information system using the HMN tool has identified 
indicators measuring the performance of the information management system against 
current standards and practices. The analysis of the existing system made it possible to 
identify its strengths and weaknesses to extrapolate the needs for the design of the 
future system. It also evidenced the achievements and efforts that remain to be made in 
order to have an efficient and effective information system. The evaluation showed the 
weakness of the activity coordination, the poor quality of certain indicators, the 
insufficient exploitation of the databases and the low level of data production and 
dissemination of information. These are all the reasons that justify the development and 
implementation of a Master Plan for a Hospital Information System (MPHIS). This will 
have the advantage of unifying the efforts, coordinating the actions and harmonizing 
the information management at the national level. The implementation of the MPHIS 
also has the advantage of harmonizing the population numbers (reference population), 
to strength the quality of the subsystems and to improve dissemination of information. 
Health data sciences and mobile health (mhealth), will be an important contribution to 
the management of massive data produced in hospitals [10,11,13]. 
References 
[1] [WHO, Data Quality Review, September 2017. 
[2] J. Alipour and M. Ahmadi, Dimensions and assessment methods of data quality in health information 
systems, Acta Medica Mediterr 33 (2017), 313–320. 
[3] J. Lungo & F. Igira, Development of health information system in Zanzibar: practical implications. 
Journal of Health Informatics in Developing Countries, 2 (2008). 
[4] Direction générale des études et des statistiques sectorielles, Annuaire statistique 2017 du Burkina Faso, 
Ministère de la santé, 2018. 
[5] Burkina_Faso_National_Health_Strategy_2011-2020_French.pdf 
[6] S. G. Barro, J. C. Dufour, M. Somda, S. Malo & P. Staccini, Cause-of-death certification in Africa: 
analysis of a model implemented at the teaching hospital of Souro Sanou of Bobo-Dioulasso (Burkina 
Faso), Stud. Health Technol. Inform 205 (2014), 1110-1114. 
[7] Enquêtes et récensements. http://www.insd.bf/n/index.php/publications?id=83. 
[8] O. Seitio-Kgokgwe, R. D. C. Gauld, P. C. Hill & P. Barnett, Development of the National Health 
Information Systems in Botswana: Pitfalls, prospects and lessons, Online J. Public Health Inform 7 
(2015), e210. 
[9] T. Lippeveld, R. Sauerborn, C. Bodart, Design and implementation of health information systems 
http://apps.who.int/iris/handle/10665/42289. 
[10] F. Verbeke, P. Shamashanga, C. Amisi, G. Karara, Developing a national e-health strategy for DR 
Congo: a preliminary analysis of business needs, existing information systems and solutions, Journal of 
Health Informatics in Africa 2 (2014). 
[11] G. S. Barro, Certification des causes de décès en Afrique: Analyse de modèle au CHU Souro Sanou de 
Bobo Dioulasso, Burkina Faso, Aix-Marseille, 2014. 
[12] S. Chougrani, S. Ouhadj & F. Agag, Évaluation du système d’information hospitalier de 
l’Établissement hospitalier universitaire d’Oran, Sante Publique (Bucur.) 25 (2013), ! 
[13] D. Blumenthal, Stimulating the adoption of health information technology, N. Engl. J. Med 360 (2009), 
1477-1479. 
S.G. Barro et al. / Health Metrics Network (HMN-WHO)606
Implementation and Analysis of Two 
Knowledge Base Approaches for the 
Treatment of Chronic Wounds 
Stefan VOGELa,1, Jendrik RICHTERa, Stefanie WACHEa, Kerstin PISCHEK-KOCHa, 
Simon AUCHTERb, Sebastian ZEBBITIESb, Karen GÜTTLERb, Ursula HÜBNERc, 
Mareike PRYZSUCHAc, Jens HÜSERSc, Björn SELLEMANNd 
a
 Department of Medical Informatics, Univ. Medical Center Göttingen, Germany 
b
 Atacama blooms GmbH & Co. KG, Germany 
c Health Informatics Research Group, University AS Osnabrück, Germany 
d Münster School of Health, Univ. of Appl. Sciences Münster, Germany 
Abstract. The access to data in healthcare is an enabler for the implementation of 
clinical decision support systems (CDSS) in practice. The usage of CDSS aims to 
be of efficient assistance to healthcare providers. The aim of the BMBF project 
“PosiThera”, is to support the involved professions in the treatment process of 
chronic wounds. In this study we implemented the formalized knowledge of chronic 
wound diagnosis into two different knowledge base approaches, the HL7 Arden 
Syntax and a Petri net approach. The motivating factor behind our study was to use 
both approaches for the implementation of the projects knowledge base and to 
compare the results. We implemented the formalized knowledge successfully in 
both approaches. The results of our comparison showed similarities and differences 
of the Arden Syntax and the Petri net approach, which might support the evolution 
of both approaches in the future. 
Keywords. Clinical Decision Support, Arden Syntax, Petri net, Chronic Wound 
1. Introduction 
IT infrastructures have become increasingly important factors in the healthcare system 
especially for information exchange. The changing paradigm from the paper-based 
health record to the electronic health record promotes the rising of clinical decision 
support systems in practice, as the access to data is a crucial requirement for the 
processing of decision support algorithms. Key components of clinical decision support 
systems are the knowledge base and the inference engine. Both are required to implement 
and process knowledge for a CDS System. [1, 2, 3] 
The BMBF project “PosiThera aims to develop a CDS System for the diagnosis and 
treatment of chronic wounds [4]. The research aim of this study was to develop and 
compare two different implementations of the project’s knowledge base and inference 
engine by using HL7 Arden Syntax and a Petri net approach. 
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2. Methods 
The development process of our system was based on the knowledge engineering process 
recommended by Waterman [5] and Durkin [6], which is structured into the steps: (1) 
Problem assessment, (2) Data and knowledge acquisition, (3) Development of a 
prototype system, (4) Development of a complete system, (5) Evaluation and revision of 
the system, (6) Integration and maintenance of the system. 
This study gives some results for step 3 for the use case diagnosis of chronic wounds 
identified in step 1 [7]. The knowledge implemented in the prototype was obtained by 
analyzing S3 guidelines (3), publications (5), and literature (3) in the context of chronic 
wound treatment to extract and formalize the knowledge with the focus on our use cases 
(Step 2). In the formalization process we developed 60 production rules and 3 decision 
trees.  
To implement the formalized knowledge we tested two approaches and compared 
their performance based on a list of project specific criteria, which are as follows: 
Binding of Data Ressources, Logical Operators, Medical Logic Organization, Human 
Interpretable, Knowledge Base Scalability, Maintainability, FHIR Connection, Forward 
Chaining Algorithm implementable, Backward Chaining Algorithm implementable, and 
Uncertainty (Fuzzy Logic). 
HL7 Arden Syntax was selected, because it is an established and standardized 
approach to implement machine executable medical knowledge [8, 9]. The Petri net 
approach was chosen, because it is already implemented in a software product of 
Atacama Software GmbH in the context of nursing.  
2.1. Approach HL7 Arden Syntax 
Arden Syntax is a HL7 standard for computerized knowledge representation and 
processing [8, 9]. It can be used to create knowledge bases for CDS systems and enables 
the execution of machine-readable medical logic modules (MLM). The main 
components of every MLM are Maintenance, Library, Knowledge, and Resources. 
“Maintenance” contains metadata about the MLM, like version identifier, first 
implementation, and update. “Library” contains information about the MLM’s context. 
Crucial for example is in which use case the MLM should be used. This requires 
knowledge sources and institution specific source linkages used to implement them. The 
“Knowledge” section represents the processing logic of the MLM, which is expressed as 
production rules. “Resources” allow to define different language specific messages.  
Within this study we concentrate our efforts on the knowledge section.  
2.2. Approach Petri net 
Within the work of a Bachelor thesis at the University of Bremen in cooperation with the 
company Atacama Software GmbH [10], an implementation of an extended Petri net and 
a programming language have been developed, which are now also used within the 
product apenio by Atacama Software GmbH. The extended Petri net enables defining 
and processing logical rules modelled after most knowledge bases. Each net is defined 
by: Places, Arcs (flow relations) and Transitions. 
Any place is being mapped with a logical entity of the defined logical structure and 
can be marked with one or more tokens. A token represents a unique object of a place 
and can have varying attributes. Arcs are directed flow relations between a transition and 
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a place. They can contain Boolean expressions, which are executed on the tokens of their 
place. The place with an arc aiming on a transition is called input, otherwise output place. 
If the conditions of a transition are fulfilled, then it is called activated. An activated 
transition can fire. Firing means that tokens of the input places get consumed and a token 
in the output place will be generated. Based on a starting state of a Petri net with multiple 
tokens in some places (called marking) there is the possibility, that one or more 
transitions in the net can be fired and a new marking can be reached as a result. An 
example for the firing process of the petri net is illustrated in figure 1. 
 
Figure 1. Firing Process of the Petri net approach 
3. Results 
We were able to implement the knowledge base on the use cases diagnosis and 
therapy of chronic wounds successfully in both approaches. Based on our criteria list we 
compared the Petri net approach of Atacma Software GmbH and HL7 Arden Syntax. 
The results of the comparison are summarized in table 1. 
3.1. Similarities 
In our study we could identify a variety of similarities between the Petri net and Arden 
Syntax approach. Medical Logic Modules build up the core to implement medical 
knowledge in the Arden Syntax. These logic modules are highly standardized (see 
chapter 2.1). In our use cases it was necessary to organize the modules in file archives 
which are related by usage context. For example, an archive would consist of causal 
diseases of an Ulcus Cruris Arteriosum or Ulcus Cruris Venosum. In comparison the 
Petri net approach is not as highly standardized as the Arden Sytnax, but the logic 
modules can be organized as well in an archive hierarchy. This organization in both 
approaches enables a sufficient maintainability and scalability. Both approaches use a 
versioning of Logic Modules to support the developer in cases of maintaining the 
knowledge base.  
The Arden Syntax as well as the Petri net approach operationalize the logic modules 
by production rule algorithms. These can be implemented as forward and backward 
chaining procedures, which make both approaches quite flexible to solve complex 
decision problems. 
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  One benefit of the Arden Syntax is the high performance in human interpretability. 
The Petri net approach can be supported by easy to read excel lists which contain the 
medical logic. This approach is different in comparison to the Arden Syntax, but also 
enables non-informatical professions to understand and discuss about the module 
contents. 
For our implemented use cases both toolboxes of logical operators were sufficiently 
fitting.   
3.2. Differences 
While there are a lot of similarities, there are as well differences of the approaches. 
We could identify, that the binding of data resources is handled differently by both 
approaches. The Arden Syntax binds data resources separately in every medical logic 
module by a curly braces statement, which refers to a data source. The Petri net of 
Atacama Software GmbH uses a central data binding module. The benefit of a central 
data binding module is to avoid redundancies and could lead to higher transparency in 
more complex knowledge bases. 
Decision scenarios under uncertainty can be solved through the Arden Syntax since 
version 2.9 by the implementation of fuzzy logic. The Petri net solution does not 
implement fuzzy logic but can be extended by a Bayes net to deal with decisions under 
uncertainty. 
The usage of the HL7 standard FHIR is implemented in at least one commercial 
work suite solution of the Arden Syntax as a FHIR connector. The implementation of 
communication standards in context of scalable data-exchange is beneficial in cases of 
clinical decision support applications, for example by connecting the CDS System to a 
hospital information system (which can provide a FHIR interface). 
The Petri net approach does not provide a FHIR interface, but a REST interface. 
       
Table 1. Comparison Table of the Approaches Petri Net and Arden Syntax 
 
In conclusion, we could identify that the Petri net as well as the Arden Syntax 
approach are quite similar in their functionality. The main differences we were able to 
find in the areas FHIR Connection, Binding of Data Resources and Uncertainty.  
Criteria Petri net Arden-Syntax
Binding of Data Ressources Central Data Binding Module Curly Braces in every MLM
Logical Operators Fitting for the use cases Fitting for the use cases
Medical Logic Organization Blocked Production Rules, Archive Medical Logic Modules, Archive
Human Interpretable Yes Yes
Knowledge Scalability Yes, but increasing conflict management of rules
Yes, but increasing conflict 
management of rules
Maintainability  Logic Modules Versioning  MLM Versioning
FHIR Connection Customizable FHIR Connector in commercial product, 
Forward Chaining Algorithm 
implementable 
Yes Yes
Backward Chaining Algorithm 
implementable
Yes Yes
Uncertainty (Fuzzy Logic) Customizable Yes
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4. Discussion 
In the context of our project PosiThera the study was quite helpful for the future 
work relating to the evolution of our system with focus on extending the knowledge base. 
The results show gaps of both approaches as well as benefits and desired functional 
objectives, which may become relevant for further improvement in the future. Especially 
the Arden Syntax as established standard could benefit from the results of our study. 
Suggestions to evolve the Arden Syntax could be to provide a standardized FHIR 
interface and develop a more fitting solution for the binding of data resources. A second 
suggestion might also be a good start to overthink and advance the semantic 
interoperability issue of the Arden Syntax, known as “curly braces problem” [11]. 
5. Conclusion 
In this study we were able to show similarities and differences of the approaches HL7 
Arden Syntax and the Petri net approach of Atacama Software GmbH. Both were used 
to implement our projects use cases. For the ongoing project we decided to use the Petri 
net approach to benefit from existing interfaces like the connection to a terminology 
server. What we discern from our study is, that the knowledge modules could be easily 
transferred from the Petri net approach to the Arden Syntax as well as the opposite 
direction, which might be of benefit for our future work.  
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Abstract. Emergency medical situations are characterized by high physical, 
cognitive and mental demands on the paramedics on the ground. Studies suggest 
that crucial information such as treatments administered to patients is often 
documented retrospectively, during patient transport or once a patient is handed 
over to an emergency department. Information access may also be surprisingly 
difficult (e.g. patient medical history). In this paper, we focus on supporting in situ 
information capturing and report on a realistic laboratory-based study involving 
experienced paramedics that we used to explore the specific requirements and 
constraints of supporting in situ information capturing. Specifically, we focused on 
ways to use audio and visual data capture methods and how they need to be designed 
to better support paramedics without interfering with their work. We then use the 
resulting information centric perspective to argue for a roadmap towards smart 
emergency medical services. 
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1. Introduction 
 
Emergency medical service (EMS) providers play a crucial role in identifying, treating 
and transporting patients suffering from time-critical emergency medical conditions. In 
particular when following the Franco-German model of EMS delivery, patients are 
treated on site which requires complex clinical judgements [1]. In this context, EMS 
providers perform urgent actions such as the initial assessment of patients in need and 
treatment as required (vital signs, intravenous fluids, cardiac monitoring, and 
stabilization). The decision making leading to interventions requires comprehensive 
medical knowledge of the physiology and pathology of the human body as well as any 
pharmacological knowledge of drugs to be administered. Appropriate documentation is 
required, including documenting the patient’s initial condition, the care provided by first 
responders and EMS providers, the status of the patient during the ambulance transport 
and responses to any treatment [1,2]. A number of studies [3-5] identified a range of 
problems that are likely to occur over the course of this complex and time-sensitive 
process and that may impact on the quality and completeness of the information 
collected. Common mistakes include insufficiently communicated details of the medical 
intervention on-site [3-5] or an undocumented initial condition of the patient [6]. 
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Elements such as prehospital hypotension, Glasgow Coma Scale score, and other 
prehospital vital signs [4] or key elements of the history (witnesses, predisposing factors, 
and post-event symptoms) and physical examination [5] are not recorded consistently. 
Some of these problems can be attributed to the fact that EMS personnel may have to 
remember key information in the above-mentioned stressful setting and only gets to 
document information once a mission is completed or even towards the end of their shifts 
[7]. To address these issues, digital protocols become increasingly available in EMS, for 
example the Medical-Pad provided by Tech2Go (https://www.tech2go.de). Some of 
these systems allow for automatic data capturing from medical devices such as ECG. 
Speech recognition technology [8] and the use of body worn cameras [9] have been 
explored, but research in this field is still in its infancy. 
In this paper, we report on a realistic laboratory-based study involving experienced 
paramedics that we used to explore the specific requirements and constraints of 
supporting in situ information capturing. We present our study design and discuss our 
findings. We also use the resulting information centric perspective to argue for the need 
for a roadmap towards smart emergency medical services, and conclusions regarding 
possible concerns to be addressed. 
 
 
2. Exploring Options for Real-Time Data Capturing during EMS Delivery 
 
The Medical Informatics Living Lab at the Bern University of Applied Sciences in Biel, 
Switzerland brings together expertise in a range of relevant IT (information systems, 
process design, human centred design), clinical experiences as well as substantial, 
hands-on EMS experience. We collaborated with local EMS providers to set up a 
laboratory based study that helps us to probe the suitability of different in situ data 
capture methods (audio, visual) and how they could be designed in such a way that they 
fit paramedics’ ways of working without interfering too much with their work practices. 
 
2.1. Experimental Setup 
 
The study was designed around medical emergencies using SimMan, an advanced 
patient model that can be programmed to simulate medical cases of varying complexity. 
Two conditions requiring interventions were designed, anaphylactic shock (scenario 1) 
and a low-back injury (scenario 2). Visible injuries and pain zones were marked on the 
SimMan by images or text. A skilled research assistant was present on site and adapted 
the vital signs of SimMan during the study as to simulate the patient's responses to 
treatments administered. A mission was considered to be completed once the "patient" 
was stabilized and considered ready for transport by the paramedic team. Each of the 
teams of paramedics had to handle both cases in the same order with a 10 minutes break 
in between. We implemented the Wizard-of-Oz method [10], a method used for 
evaluating technology, interaction methods, and technology acceptance without the need 
to put the actual technology in place. In this particular study, the Wizard-of-Oz method 
enabled paramedics to document a situation or a particular aspect thereof (e.g. the visual 
impression of a wound) by using voice commands to "activate" in situ data capturing. 
The corresponding audio or visual recording was then administered by the research 
assistant standing in for the actual technology. Once the teams completed each of the two 
EMS deliveries, paramedics and researchers met to review and discuss the video 
recordings of the earlier EMS missions. In these reviews, participants were encouraged 
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to discuss their use of the "live" documentation feature and also whether they would have 
preferred different types of recordings (different angle, duration, close-up, wide-angle) 
or even different media (e.g. a voice recording instead of video recording or video 
recording where a photograph was taken). 
 
2.2. Data Collection 
 
We recruited as participants four experienced, active, male paramedics between 32 
and 41 years old (average 36.5 years) from EMS providers based in the Swiss Canton of 
Bern. Their work experience ranged between 4 and 12 years (average 8.25 years). 
Following the Franco-German model of EMS delivery they were to form teams of two. 
Participants were made aware that the experimental setup was realistic in the sense that 
be provided standard EMS equipment and that fully engaging in the EMS delivery would 
likely lead to physical exertion and physical stressors. Participants wear body worn 
GoPro cameras attached at chest level that documented the EMS delivery roughly from 
their point of view. As explained earlier, participants could also, at any point in time, 
"activate" documenting by picture/video/audio recording. This feature did not use the 
body worn cameras but would allow "free form" data capturing as per participants' 
specifications. Data collected included number of audio/video/photo recordings 
requested during the course of the live experiment, the number of audio/video/photo 
recordings requested while watching the footage, reasons for requesting media as 
recalled by participants, additional data needed (e.g. data transfer from medical devices 
such as ECG). Data regarding live recordings was then compared to data recording 
requests as they emerged during the review. 
 
 
3. Data analysis and interpretation 
 
In terms of duration it took the two teams between 6.85 and 8.50 minutes to have 
"patients" suffering from anaphylactic shock and a low-back injury stabilized and ready 
for transport which is in line with what our own EMS experienced personnel who 
designed the scenarios expected. The following data requests were made during the 
course of the experiments (see Figure 1): Audio recordings were requested most (n=13), 
followed by taking a picture (n=8). Some video recordings were taken during the mission 
(n=3) to document the overall situation. Participants asked only rarely (n=1) for 
transmitting data via external interfaces (e.g. vital parameters from monitoring systems 
to the documentation record). When reviewing the footage captured during the live 
events the paramedics would have preferred to use different data capturing methods: In 
general, more audio recordings were requested (m=22) when reviewing the recording 
than were requested during EMS delivery. Some video recordings were replaced by other 
media during the review (m=2). While watching the recording they asked more for data 
collection via external interfaces (m=8). The scatterplot (see Figure 2) shows that audio 
recordings were mainly used for documenting the medical history and administered 
medications during the mission and afterwards. Pictures were largely requested for 
documenting wounds and for medical documentation (for example, the documentation 
dossier of the nursing service). The video recordings were exclusively requested for 
recording the overall situation. 
We looked into reasons why there were these differences between Wizard-of-Oz 
enabled data capturing during the course of the live event and changes to the way 
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recordings were made during the retrospective review. One reason is that participants 
realized that audio recordings would not only help them remember certain aspects but 
that audio recordings could also be used to transfer data directly to an electronic version 
of the emergency protocol, via speech-to-text processing, therefore replacing the need 
for manual data entry. Paramedic participants explained that sometimes, it is difficult to 
verbalize an emergency situation in a way that all parties can understand the overall 
situation and surroundings. A video recording could help and was requested in the live 
event. However, during discussions, participants changed their opinion and preferred 
taking pictures of the overall situation instead of the initially requested video recording. 
A reason given for this is that pictures might be more meaningful and, more importantly, 
provide relevant information at a glance without having to watch a video. During the 
course of the live event, vital values were documented using audio (paramedics reading 
the values aloud) or photos (taken of medical devices). During the review paramedics 
would have preferred to have used audio only if this allowed them to have the data 
directly entered into an electronic version of the emergency protocol, via speech-to-text 
processing. 
 
Figure 1. Comparison of requests during and after the 
scenarios Figure 2. Scatterplot of requests 
during and after scenario correlated 
with documentation activities. 
 
4. Discussion and future work 
 
In this paper, we described a study to probe usefulness of different data recording 
approaches during EMS missions. There is some evidence that incident documentation 
in EMS could be supported by speech-to-text technology that would allow to enter data 
directly into the electronic emergency protocol which is needed for documentation 
purposes and for hand-over to emergency department staff. It is believed that this could 
help ease the problem of gaps or errors in documentation which are often due to 
retrospectively collected data. We would expect this to improve both timeliness and 
correctness of documentation. Ho et al. argue that body worn cameras could help 
increasing documentation accuracy [9]. While our research supports this observation, we 
also observed that user acceptance is a critical issue in this context. Participants 
recognized the benefits of a video recording including increasing their personal security 
during a mission. However, they were also keenly aware of potential legal ramifications. 
They know just too well that in emergency situations, decisions regarding treatments 
may need to be made in a split second and they may include non-standard treatment 
methods. A potential solution against the fear of after-mission misinterpretations of 
recordings might be that the recordings are only made available afterwards if paramedics 
explicitly agree or can add explanations to avoid misunderstandings by not involved 
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persons. We conclude, there are use cases for video recording in EMS settings, but 
research is still necessary to find solutions that are accepted by the paramedics and do 
not hamper the working process. 
Given the results of the study, we envision an intelligent rescue environment that 
supports real-time documentation, direct data capturing from devices, and electronic data 
transfer to the hospital information system. Further, paramedics have to be equipped with 
intelligent devices that automatically scan the environment for upcoming risks (like 
dropping material, changing environment due to weather changes) and provide 
intelligent decision support as needed, possibly involving services like a telemedicine 
approach via video guidance [11]. We are currently developing and evaluating a novel 
system that allows to capture data in a digital EMS protocol using speech recognition 
technology specifically designed for Swiss EMS and look into its integration with 
medical devices to enter vital signs into the protocol automatically and to implement data 
transfer using the CDA-CH RESP standard. In future, we will include methods for 
ontology mapping (e.g. mapping to a medical ontology [12]) and natural language 
understanding to make our voice user interface more powerful. Relying upon 
communication standards and medical ontologies will help in ensuring semantic 
interoperability. Our research clearly shows the need for acceptance (see also [11]) and 
that we keep in mind that we don't fall into the trap of designing interfaces that are more 
suitable for patient, logical, rational humans than for EMS staff who get tired, irritated, 
or distracted [13]. 
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Abstract. Pharmacogenetic testing can prevent adverse drug events but has rarely 
found its way into clinical routine. One reason is the lack of tools for smooth and 
automatable integration of pharmacogenetic knowledge into existing processes. 
Especially, electronic medical records (EMR) represent a suitable environment for 
such tools. We developed a modular service-oriented prototype of a 
pharmacogenetic decision support system within an EMR system of the Bern 
University Hospital. Here, we present the component architecture of our system and 
discuss issues required for generalizing our results. 
Keywords. Pharmacogenomics, pharmacogenetics, decision support, adverse drug 
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1. Introduction 
Pharmacogenetics is the study of genetic effects on the metabolic pathways of drugs. 
About 95% of individuals carry one or more known genetic variants that are important 
for drug dosing recommendations [1]. Ignoring genetic variation while prescribing a 
drug can cause adverse drug reactions (ADR) or insufficient drug effects [2–4]. 
Approximately 20 genes affecting about 80 agents have been identified as actionable in 
the clinic [5], and the Clinical Pharmacogenetics Implementation Consortium (CPIC) 
updates continuously related guidelines with dosing instructions for relevant gene-drug 
combinations [6]. Nevertheless, the actual implementation of pharmacogenetic testing in 
clinical patient treatment is progressing slowly. 
Relling and Evans summarized some general barriers for pharmacogenetic testing in 
clinical practice: lack of incentives to prevent adverse events; costs and complexity of 
computational approaches to identify and prioritize genetic variants that influence 
prescribing decision; disagreement among professional or guideline generating groups; 
and a lack of awareness of clinicians concerning pharmacogenetic effects. Further, they 
concluded that the costs associated with pharmacogenetics are shifting from the 
laboratory testing to the costs for generating evidence-based decisions from the genetic 
data [5]. 
Related to existing implementations, Hinderer et al. reviewed 20 pharmacogenetic 
decision support systems. Sixteen had prototype status and are often built for one 
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institution. Only one of the productive systems (TreatGx) was integrated with the local 
EMR [7]. The same lack of EMR-integration is corroborated by the Ubiquitous 
Pharmacogenomics project (U-PGx), where only one out of the seven involved European 
countries implemented an active clinical decision support for pharmacogenetics [8]. 
Having not found any suitable and EMR-related solution, we developed a prototype 
implementation for assessing gene-drug-combinations in clinical oncology at the 
Department of Clinical Chemistry of the Bern University Hospital Switzerland (INSEL). 
Our goal was to derive a component-based approach to support the integration of 
pharmacogenetic clinical decision support into a broader range of clinical information 
systems (CIS). 
2. Methods 
Initially, we identified the main components required for our prototype: inference engine, 
knowledge base, and data dictionary (see also [9]). Next, we iteratively defined the 
architecture according to a typical workflow of pharmacogenetic analysis as described 
by clinicians at the INSEL. We chose the open source tool PharmCAT as the inference 
engine [10]. It generates pharmacogenetic reports in JSON and HTML from genetic data 
in the Variant Call Format (VCF) and comes with a set of CPIC guidelines (the clinical 
knowledge base) in a proprietary JSON format, which we adapted to our needs. To map 
information about described drugs we used the Swiss medication catalog “hospIndex” 
[11] which is incorporated in the INSEL EMR system. The link to the EMR user 
interface was implemented using the HAPI API, an open-source object-oriented HL7 2.x 
parser for Java [12]. The CDSS user interfaces were created with the proprietary 
parametrization language of the CIS within the medication module of the INSEL EMR 
system. In order to verify our prototype, a synthetic data generator for producing VCF 
data was implemented using the proprietary parametrization language of the INSEL 
EMR system. 
3. Results 
The underlying generic system architecture of our solution (Figure 1) considers two 
different workflows. The first workflow is triggered by the entry of new patient related 
genetic data and generates a report comprising the relevant pharmacogenetic findings 
(PGx Report Generator in Figure 1). It uses following components: 
 The genetic data repository to store the raw genetic data. 
 The knowledgebase with rules to annotate the genetic data. 
 The data dictionary to encode the resulting report. 
 The genetic annotation engine to generate the pharmacogenetic report. 
 The pharmacogenetic report repository to store the report. 
When a new genetic record is added to the Genetic Data Repository, the record is 
pushed to the Genetic Annotation Engine. This engine is supplied with the relevant 
pharmacogenetic rules from the knowledgebase and with the code mapping (e.g. 
translating phenotype “Poor Metabolizer” into a LOINC code) from the data dictionary 
(Knowledge Resources in Figure 1). Finally, the annotated report is added to the shared 
PGx report repository.  
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Once a PGx patient report is available (PGx Decision Support System in Figure 1), 
the second workflow can be triggered by a drug prescription event, which returns the 
case specific information from the corresponding CPIC guideline. It comprises the 
following components: 
 The CIS, which sends the prescription and receives the decision support result. 
 The pharmacogenetic report repository to read the patients report. 
 The knowledgebase containing the decision support rules to evaluate the report 
for the given drugs. 
 The data dictionary to encode the results. 
 The CDSS-Engine to deduce the correct decision support message. 
Upon a new drug prescription, the CIS sends a prescription event with the encoded 
prescription data to the CDSS-Engine. The CDSS-Engine looks up the encoded drug in 
the Data Dictionary and loads the corresponding guideline rules from the knowledgebase. 
If guideline rules are found, the CDSS-Engine tries to find an existing pharmacogenetic 
report of the patient. If none exists, a warning is sent to the CIS, since a potential 
pharmacogenetic adverse event cannot be excluded, and a genetic examination might be 
advisable. If a pharmacogenetic report of the patient exists, the CDSS-Engine applies the 
guideline rules on the report and returns applicable dosing instructions to the CIS. 
Finally, the CIS displays the received message to the prescribing physician. 
 
 
In our implementation, the PGx Report Generator uses a system folder with VCF 
files for the Genetic Data Repository. A modified version of PharmCAT acts as the 
Genetic Annotation Engine. The modifications enable PharmCAT to: 
 Accept HL7v2 observation request messages as a trigger to read data from the 
Genetic Data Repository.  
 Read the Data Dictionary in form of a configuration file containing the mapping 
between the genotypes/phenotypes/substances and their encoding. 
 Encode genotypes, phenotypes and substances with codes from the Dictionary. 
Figure 1. Generic model of a pharmacogenetic decision support system. A Genetic Data Repository acts as
the fact database for the Genetic Annotation Engine and provides access (1.1) to the genetic data of the
patients. The Genetic Annotation Engine creates a report with the relevant pharmacogenomic findings using
the parameters from the shared Knowledge Resources (1.2). The report is stored (1.3) in a PGx Report
Repository, which acts as the fact database for a second inference module (CDSS-Engine). Once the rules
from the Knowledge Resources have been applied to the patients PGx report, the engine uses the drug
prescription from the CIS (2.1) and returns a warning (2.4). 
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 Turn the pharmacogenetic report into a HL7v2 observation result. 
The drug selection event in the CIS oncology drug prescription form triggers the 
PGx Decision Support System. The CDSS and the PGx Report Repository have been 
implemented directly within the CIS. The reports from the PGx Report Generator are 
stored in the database of the CIS acting as the PGx Report Repository for the CDSS-
Engine. We implemented the knowledgebase and the data dictionary as internal CIS 
tables. 
For generating synthetic data, we developed a Laboratory Data Simulator (Figure 2). 
It generates custom VCF data with user defined genetic variants and allows to validate 
our solution. The following validation workflow was realized in order to compare the 
issued message with the expected one: 
 The validator selects variants to be tested within the laboratory data simulator. 
The selected variants are added to an existing VCF file template. 
 The VCF file is added to the Genetic Data Repository and a HL7v2 observation 
request message triggers the PGx Report Generator to generate a report. 
 The resulting report is returned as HL7v2 observation result to the 
Pharmacogenetic Report Repository of the CIS and the PGx CDSS is triggered. 
Figure 2. Our prototype integrated with the Laboratory Data Simulator (LDS). In the Clinical Information 
System (CIS), the user can invoke the LDS and generate a genetic data set for one of the test patients. When 
finished, the LDS triggers the PGx Report Generator with a HL7v2 ORM message (1). The PGx Report 
Generator reads the genetic data of the patient and creates a PGx report in the HL7 ORU format, which is then 
sent to the CIS (2). The user can now either switch to the medication prescription user interface and test the 
actual workflow integration or test the PGx Decision Support System output directly in the LDS. The system 
supports pre-test and post-test alerts.  
4. Discussion 
We presented a component-based architecture for genetic decision support during 
medication prescription. We could identify six generic components, namely a Genetic 
Data Repository, a Genetic Annotation Engine, a PGx Report Repository, a CDSS-
Engine, a Knowledgebase for PGx rules and a Data Dictionary (see Figure 1). 
Due to the following reasons, we consider an architecture with two different 
workflows (writing genetic reports and providing decision support) as mandatory: First, 
discussions with physicians revealed that access to the pharmacogenetic report is 
required to assess the content of the CDSS warnings. Second, the processing of large 
genetic data records would lead to increased response times without a report in which the 
drug related phenotypes are available. This makes our approach suitable for such large 
genetic data contexts. 
The modularity of the system enables, a hospital to select components from the 
system architecture according to its requirements and plugging them together. Our 
prototype implementation does not completely match the proposed architecture. While 
the PGx Report Generator is indeed loosely coupled with the CIS using the HL7v2 
K. Tippenhauer et al. / Integrating Pharmacogenetic Decision Support 621
standard, the PGx CDSS itself depends not only on the CIS in use, but also on its 
configuration within the hospital. In addition, we have not implemented shared 
knowledge resources. Instead, the PGx report generator and the PGx decision support 
system have each their own copy of the knowledge resources, which need to be updated 
simultaneously to ensure the correctness of the results. Such a solution is vulnerable to 
inconsistencies. To avoid this risk, the knowledge resources should be shared as depicted 
in Figure 1. 
Using proprietary data formats, as we did to access the knowledge resources reduces 
the systems adoptability. However, the goal should be to provide a plug and play 
experience for the whole pharmacogenetic decision support system, as proposed, e.g. by 
the SMART Health IT movement [13]. Hence, a standardized data exchange model such 
as HL7 FHIR with the modules “Terminology” and “Clinical Reasoning” should be used 
for interfacing with the knowledge resources. 
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Abstract. Background: C3-Cloud is an integrated care ICT infrastructure offering 
seamless patient-centered approach to managing multimorbidity, deployed in three 
European pilot sites. Challenge: The digital delivery of best practice guidelines 
unified for multimorbidity, customized to local practice, offering the capability to 
improve patient personalization and benefit. Method: C3-Cloud has adopted a co-
production approach to developing unified multimorbidity guidelines, by collating 
and reconciling best practice guidelines for each condition. Clinical and technical 
teams at pilot sites and the C3-Cloud consortium worked in tandem to create the 
specification and technical implementation. Results: C3-Cloud offers CDSS for 
diabetes, renal failure, depression and congenital heart failure, with over 300 rules 
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and checks that deliver four best practice guidelines in parallel, customized for each 
pilot site. Conclusions: The process provided a traceable, maintainable and audited 
digitally delivered collated and reconciled guidelines. 
Keywords. multimorbidity, integrated care, clinical interpretable guidelines, co-
production, clinical decision support 
1. Introduction 
There is an increasing need to organize care around the patient and not on conditions [1], 
taking into account his or her multiple physical and psychosocial conditions [2]. An 
integrated, patient-centered care and cure delivery architecture needs to be developed 
considering the realities of multi-morbidity and poly-pharmacy. This needs to take into 
account the medical, technological, organizational and socio-economic challenges of 
creating a collaboration environment for all of the stakeholders involved in the holistic 
continuum of care. Clinical guidelines re-factor the best available published evidence on 
clinical effectiveness, into decision trees and care pathways. They are increasingly multi-
professional, and work across care providers. However, they usually focus on treating a 
single disease. Clinical guidelines may clash (e.g., due to incompatible treatment and 
monitoring regimes). Following more than one clinical guideline, can result in 
inefficiencies for the patient and for the health system, due to duplicating and 
inconveniently scheduled investigations and clinic visits, and more importantly, 
treatments that may exacerbate another condition [3]. 
C3-Cloud is ICT infrastructure enabling a collaborative care and cure cloud for 
continuous coordination of patient-centered care activities; by a Multidisciplinary care 
Team (MDT), and patients/informal caregivers. It implements integrated care pathways 
for chronic heart failure, renal failure, depression and diabetes, based on best practice 
guidelines [4]. The C3-Cloud approach to integrated care is demonstrated in varying 
clinical, technological and organizational settings by piloting in three European regions 
(South Warwickshire, Basque Country, and Region Jämtland Härjedalen) with 
considerably different health and social care systems, and ICT landscapes. 
The paper presents the co-production, and implementation approach adopted in C3-
Cloud, which delivers an infrastructure able to offer multiple personalize-able best 
practice guidelines for multimorbidity. C3-Cloud also incorporates localization, 
necessary to be deployed in the heterogeneous pilot site environments. 
2. The Collaborative Care and Cure (C3-Cloud) Solution to Multimorbidity  
C3-Cloud achieves its objectives using the concept of the personalized care plan. The 
care plan consolidates and reconciles data, goals, treatment, and medications, 
personalized for each patient, addressing their collective multimorbidity needs, and 
encapsulating clinical practice guidelines. The care plan can be thought of as an 
integrated care visualization and management tool. Figure 1 presents the high-level 
architecture of C3-Cloud and its constituent components, which offer the care plan. The 
Coordinated Care & Cure Delivery Platform (C3DP) is an innovative online means for 
multidisciplinary care team members (MDT) to collaboratively manage (execute, 
monitor, update) the integrated personalized care plans for patients with multi-morbid 
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conditions. Clinical Decision Support Services (CDSS) support personalized care plan 
development and execution by clinical guideline reconciliation, risk stratification, poly-
pharmacy management, and goal setting and monitoring. A Patient Empowerment 
Platform (PEP) ensures active participation of patients and their informal caregivers to 
the management of their multi-morbid chronic conditions, thus alleviating the non-
adherence problem. Interoperability middleware  addresses technical (TIS), semantic 
(SIS), and privacy/security (SPS) interoperability challenges to seamlessly integrate with 
the existing health care, social care, and home/community care information systems. 
This will allow interfacing the information exchanges, but also the clinical terminology 
systems between the local systems and C3-Cloud. 
 
Figure 1: Overview of the C3-Cloud Architectural Components 
 
Finally, all data are stored in a database as HL7 Fast Healthcare Interoperability 
Resources (FHIR) (https://www.hl7.org/fhir/), annotated with the codes of the 
terminology systems, C3-Cloud uses. FHIR, along with other standards used internally 
in C3-Cloud, result in an easily maintainable and upgradeable architecture.  
3. From Medical Knowledge to Localization and Personalization  
One of the main objectives of C3-Cloud is to deliver integrated care, based on best 
practice guidelines. In order to achieve this, C3-Cloud had to overcome a number of 
challenges: a) unify and reconcile guidelines to offer the patient a single multimorbidity 
management plan rather than a digitization of multiple separate guidelines; b) deliver an 
infrastructure suitable to customize the vision of an enhanced service for all pilot sites; 
and c) increase patient benefit by offering further personalization options based on what 
the clinical team of each pilot site identified as important. Figure 2 illustrates a process 
that enabled co-production of the consolidated and reconciled multimorbidity guidelines 
delivered by C3-Cloud. Local practice for each pilot site was identified by the clinical 
teams of each pilot site. Then, pilot sites recorded their vision of an enhanced service, 
and performed a gap analysis with the current service to identify core functional 
requirements for C3-Cloud. This includes personalization rules that need to be applied in 
multimorbidity, which are then translated into service processes. For example, online 
messaging to adjust goals of a patient, and online patient reported outcomes triggering 
automated clinical recommendations. 
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Figure 2: C3-Cloud Consolidated Multimorbidity Guidelines Process 
An organizational analysis was then performed to identify how the newly 
defined capability would be integrated to each pilot site, including allocation of roles, 
and specification of local procedures. Figure 3 illustrates a comparison of how the C3-
Cloud enabled service would fare against existing practice, as evaluated by clinical 
teams in each pilot site. The evaluation dimensions were identified by the C3-Cloud 
consortium based on current literature on integrated care. This process was informed by 
the UK National Institute of Care Excellence (NICE) evidence-based guidelines, which 
provided a skeleton gold standard that all pilot sites used as reference. NICE guidelines 
balance best available evidence with cost benefit, ultimately resulting in a gold standard 
for care. Nevertheless, even the NICE guidelines, offer limited supported to 
multimorbidity. 
   
Figure 3: Before and after pilot site internal clinical evaluation of the service 
 
Multimorbidity options, rules and actions, were developed by the C3-Cloud 
Clinical Reference Group (CRG), consisting of clinicians from each pilot site. The CRG 
also had overall oversight of the resultant clinical practice. Throughout this process, 
functional and technical requirements for C3-Cloud were also identified by using a 
Model-Driven Engineering approach, which resulted in the specification of the software 
architecture, as well as the system specification document.  
4. Implementation of Guidelines in C3-Cloud  
The specification of the C3-Cloud guidelines was followed by their implementation, and 
deployment as part of the system. The guidelines development process resulted in a 
number of technical requirements for C3-Cloud. They provided requirements such as: 
data that needed to be stored in the FHIR database; the user interface that users (MDTs 
and patients) would experience, capturing all aspects of multimorbidity management 
identified in the guidelines; and automated rules implemented by the clinical decision 
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support modules. Figure 4 presents the steps followed for implementation of the CDSS 
logic, and integration with the local sites.  
 
Figure 4: Guidelines Implementation and Deployment in C3-Cloud 
 
In order to meet the interoperability requirements, each step of the C3-Cloud 
guidelines was annotated with terminologies by the CRG. This allows for unambiguous 
retrieval of the relevant information from the FHIR repository, as well as an automated 
interface, which mapped the C3-Cloud terms to the terms used in each pilot site. 
Furthermore, the guidelines were annotated with the FHIR resources with which they 
needed to interact. For example, when patients enter data, the system will create an 
[Observation] FHIR resource, and when the CDSS identifies suitable conditions for 
certain medications (e.g. beta blockers for high blood pressure), the system will propose 
to a physician new medication, by creating a [MedicationRequest] resource that they will 
need to review before approving. This resulted in an annotated logic of the guidelines, 
that was then implemented using the GDL2 openEMR standard [5]. The GDL2 
implementation is deployed as an executable CDSS module, in each pilot site.  
5. Conclusions  
C3-Cloud had deployed collated and reconciled guidelines on multimorbidity in three 
European pilot sites. Achieving this required a co-production process involving the pilot 
site clinical teams, the C3-Cloud clinical reference group, the pilot site technical teams, 
and the C3-Cloud technical team. The process resulted in over 60 clinical scenarios, 300 
CDS rules and over 380 design requirements.  
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Abstract. Clinical practice guidelines (CPGs) often include ambiguous criteria 
making their translation as computer-interpretable guidelines a difficult task. In 
breast cancer management, whether to perform a breast conservative surgery 
(BCS) or not is one example. Most international CPGs recommend to perform a 
BCS when the tumour volume / breast volume ratio allows for good cosmetic 
results, which cannot be directly translated into a computable format. We propose 
to compute an estimate of the ratio using the maximum size of the tumour to 
compute the tumour volume and the bra size to compute the breast volume. In 
addition, we take into account the location of the tumour according to quadrants 
and unions of quadrants. The model has been tested on a retrospective sample of 
34 clinical decisions of a breast cancer unit in a Parisian university hospital 
(France). Concordance was found in 91.2% of the cases, with good sensibility and 
specificity. This finding could set a new pathway to advance on the development 
of actionable decision criteria to be used in a future clinical decision support 
system for breast cancer management. 
Keywords. Clinical decision support systems, Breast cancer surgery, Tumour 
burden, Clinical practice guidelines, Computer interpretable guidelines 
1. Introduction 
Although breast cancer happens to be one of the most advanced research fields in 
oncology, each step achieved implies an increase on management complexity. 
Professional organisations and expert groups regularly publish clinical practice 
guidelines (CPGs) in an effort to bring state-of-the-art knowledge to the medical 
community. Despite literature clearly reports that CPG compliance leads to a 
significant improvement in overall survival and disease-free survival [1], adherence to 
CPG recommendations is lower than expected [2]. The development of 
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multidisciplinary breast cancer units (BCUs) has proven to improve guideline 
compliance [3,4], but daily practice is hampered by the increasing number of complex 
patients and data available.  
Clinical decision support systems (CDSSs) have been suggested as possible tools 
to promote the implementation of guideline recommendations. In fact, embedding 
CPGs in those systems has shown some improvement on overall guideline compliance 
[5]. In the breast cancer domain, several CDSSs have been developed such as MATE 
[6], OncoCure [7], OncoDoc [8], or DESIREE [9], but their development remains a 
challenge. Most CPGs are developed as narrative documents which makes them 
difficult to be translated into a computer-interpretable format. Clear examples, among 
others, is the presence of subjective notions, very difficult to be formally modelled, and 
the reference to decisional criteria which are not routinely collected. 
In breast cancer management, the indication of conservative surgery (BCS) against 
radical surgery is one of the concepts harder to translate. Normally, the goal of surgery 
is to ensure both local control and breast preservation with an optimal cosmetic 
outcome. The current standard of care is BCS followed by adjuvant treatment which is 
equivalent, in terms of overall survival, to a mastectomy. CPGs propose several criteria 
contraindicating BCS, some of them being objective such as inflammatory breast 
cancer, contraindications to radiotherapy, or the patient’s choice. Apart from these 
well-defined situations, CPGs recommend to perform BCS if “optimal surgery is 
feasible, maintaining good cosmetic results”. Then, for most cases the decision whether 
to perform a BCS is subjective, making it difficult to formalize this criterion in order to 
use it in a CDSS. The Erasmus MC Cancer Institute research group published a series 
of works dealing extensively with this issue. After determining the three independent 
predictors of superior cosmetic result after BCS, tumour volume (TV), breast volume 
(BV), and tumour location, they published a prediction model based on the TV/BV 
ratio [10,11]. Unfortunately, the direct application of this model remains complicated 
since neither TV nor TB is part of the routine workup for breast cancer. 
In this paper, we propose an adaptation of this prediction model to make it more 
easily usable, especially for automated CDSSs. Considering that the tumour location is 
available in patient records, the aim is to compute the TV/BV ratio from an assessment 
of both tumour size and patient bra size and to translate the notion automating the 
recommendation of either BCS or mastectomy. In order to evaluate if this approach is 
concordant with current clinical practice, the model has been tested on a retrospective 
sample of cases. 
2. Material and methods 
2.1. Tumour volume 
Measurement of a breast tumour volume normally implies complex techniques such as 
MRI or 3D ultrasounds. These costly techniques are not systematically used in an 
ordinary breast cancer extension workup. We considered to estimate the tumour 
volume assuming the tumour to be a sphere. Since the maximum tumour size is 
essential information in any breast cancer record, we used it as the diameter of the 
sphere, thus overestimating the tumour volume. 
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2.2. Breast volume 
Even though breast volume can be assessed by MRI and some complex formulas from 
mammography measurements, still it is not a standard practice yet. Thus, we proposed 
to extrapolate the breast volume from the bra size of the patient. Bra size is not 
systematically described in the medical records, but is it is quite commonly used to 
describe breast size in BCUs. The relation between bra size and breast volume in cm3 
was obtained from a technical pattern and sewing association [12], which is used as a 
manufacturer design standard in France/Spain/Belgium and is reported in Table 1. 
 
Table 1. Approximate bra size-volume equivalents 
Volume (cm3) Contour and cup 
200-250 80A 
250-300 80B 85A 
350-400 80C 85B 90A 
450-500 80D 85C 90B 95A 
550-600 80E 85D 90C 95B 100A 
650-700 85E 90D 95C 100B 105A 
750-800 90E 95D 100C 105B 
850-900 95E 100D 105C 
950-1000 100E 105D 
1050-1100 105E 
2.3. Cutting points and tumour location 
According to the Lagendijk et al. model [11], cutting points below which BCS is 
expected to achieve a satisfactory cosmetic result are when the TV/BV ratio are below 
21.6 in case the tumour is located in the upper lateral quadrant, 4.1 in the lower lateral 
quadrant, 15.1 in the upper medial quadrant, 3.2 the in lower medial quadrant, and 15.7 
in the central position. 
Again, a limitation was encountered, since in a substantial number of cases, the 
location of the tumour is described in the union of quadrants. Thus, we extended the 
model and assumed that the cutting points in those junctions of quadrants could be 
estimated by the arithmetic mean value of the cutting points of adjacent quadrants, 
resulting as it follows: 18.35 for the upper quadrants junction, 3.65 for the lower 
quadrants junction, 12.85 for the lateral quadrants junction, and 9.15 for the medial 
quadrants junction. 
2.4. Assessment of the method 
We performed a retrospective analysis to assess the method on a sample of clinical 
cases. The study population consisted of female breast cancer patients submitted to 
BCU meetings between August 2019 and October 2019 at Hôpital Tenon, a university 
hospital part of Assistance Publique–Hôpitaux de Paris (AP-HP), in France. All 
patients had given their informed consent to the re-use of their pseudonymised data for 
research purpose at hospital admission. Cases where collected in October 2019 when 
the following inclusion criteria were met: (1) Pre-malign or malign breast tumour 
confirmed by histological evaluation, (2) Radiologic extension study available, (3) Bra 
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size specified, (4) Decision regarding surgical management made. Patients were 
excluded in case of bilateral disease, separated bifocal tumours, prior neoadjuvant 
therapy, or surgical treatment affected by patient’s preferences. 
3. Results 
Among nine BCU meetings, 174 clinical cases were analysed. From 34 to 93 year-
old, the average age was 55.9. Both unifocal and close bifocal tumours were taken into 
account with an average size of the whole tumour mass of 12.8 mm. Eighty-seven 
medical records specified the bra size (missing data in 50% of the cases). When the bra 
size was available, the mean breast volume was 556 cm3, which corresponds to a 
majority of 90C and 95B. After careful review, 34 cases met the inclusion criteria. 
BCU physicians chose mastectomy (radical surgery) in 26.5% of the cases, whereas the 
73.5% of cases left where oriented towards a lumpectomy (BCS).  
For each case, TV/BV ratio was calculated and, according to the tumour location, 
was classified to determine the surgical procedure recommended by our extended 
version of the Lagendijk et al. model. Then, each recommendation was confronted with 
the actual decision made by BCU physicians. Concordance reached 91.2%. Model 
sensibility and specificity were 88% and 100%, respectively; positive and negative 
predictive values were 100% and 75% respectively. 
4. Discussion 
Breast volume is not routinely computed pre-operatively because as yet there is no 
accepted technique to assess its value. Bra size represents an accessible information 
since most women know it or it can be assessed by simple anatomic measurements. 
However, there is not much published in medical literature about the relation between 
breast volume and bra size. On the other side, this relation has been studied in other 
domains such as sewing and patronage or even plastic surgery prothesis manufacturers. 
We have found interesting to exploit those sources of knowledge in profit of science.  
According to our results, bra-size is recorded by clinicians in 50% of the cases 
discussed during BCU meetings. Whether this size is obtained by clinical history or by 
anatomic measurements could not be assessed. Of course, bra size does not characterize 
breast shape or ptosis, and it has been suggested that more than half of woman 
population could be wearing a wrong size of bra [13]. Nevertheless, our results showed 
that it can be feasible to estimate the breast volume to be used in the computation of the 
TV/BV ratio. Our recommendation is to get the bra size during physical examination, 
measuring chest and bust. Regarding the tumour volume, assuming the tumour shape as 
a sphere has no evidence-based studies to rely on, but this approximation has been done 
by other research groups [14]. In any case, the documentation of the maximal tumour 
size along with the tumour localisation is mandatory for staging breast cancer.  
Given the good results for sensibility and specificity, our extended version of 
Lagendijk et al. predictive model appears to be secure and could be used in CDSSs as 
an orientation tool to decide between BCS or radical treatment. The 8.8% non-
concordant decisions were cases for which the model suggested mastectomy whereas 
BCS was decided. These decisions concerned low malignancy tumours, which could 
explain the choice of BCU physicians for a less aggressive treatment. Accuracy of the 
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volume measurements (TV and BV) were not addressed in this study. The goal was not 
to develop a new clinical predictive model, which would require a much more 
developed methodological strategy and a higher number of cases. Hopefully this issue 
is already being addressed by important and experienced research groups.  
The actual lack of more explicit definitions regarding the surgical choice for breast 
cancer patients makes it mandatory to invent creative solutions. We believe this finding 
could alleviate the frustration in creating a more precise computer-based CDSS to 
assist with the management of breast cancer from evidence-based guidelines.  
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Abstract. Wound networks, as a voluntary structure formed by interdisciplinary 
health professionals, have the capacity to improve the continuity of care. Health IT 
systems (HIT) might be able to support these networks ensuring the information 
continuity in this process but electronic networking usually fails. The aim of this 
qualitative study is to examine the barriers why the networks do not take this step and 
possible approaches on how to overcome them. Based on interviews with 11 managers 
of wound networks 13 barriers could be detected which can be assigned to the main 
categories personal, financial, technical and legal barriers. It becomes clear that 
networks as voluntary bottom-up movements cannot increase the information 
continuity and hence also not the continuity of care on their own. This requires an 
overall concept. However, according to health experts, this must be drawn up, 
financed and above all coordinated by policy makers. In addition, these experts 
postulate structural guidelines for a cooperation in networks as well as nationally 
binding processes and standards in wound care. These guidelines and processes should 
then be mapped in a mandatory central HIT. 
Keywords. Continuity of care, health information technology, integrated care, 
qualitative research 
1. Introduction 
A vertical or horizontal networking of health professionals (HP) along a care pathway can 
build an integrative structure to improve the continuity of care (CoC) and the quality of 
care (QoC) [1-3]. The need for integration is especially given for the increasing number 
of elderly multi-morbid patients with chronic diseases [4]. The chronic wound is also one 
of these diseases. In Germany alone, studies demonstrate that more than 890,000 
predominantly elderly people suffer from chronic wounds, almost 85% of them suffering 
multi-morbidity [5]. To better coordinate wound care for the benefit of the patient and to 
increase the CoC, many HP voluntarily form so-called interprofessional wound networks 
(IPWN) [2]. According to our research over 90 such IPWNs exist in Germany. However, 
the number fluctuates due to persistent new foundations and dissolutions. 
To ensure the information continuity as part of the CoC [6], the implementation of 
health IT systems (HIT) in a network is seen as a key enabling factor, which also has 
directly or indirectly an effect on QoC [1,4,7]. Networks of HP with existing social 
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relationships represent a solid basis for the implementation and use of a shared HIT [8]. A 
first analysis of the wound networks reveals that an IPWN alone is not sufficient for 
establishing an electronic network for the benefit of the wound patients. To this end, freely 
accessible online data material on 37 of these IPWNs was compiled and searched for key 
terms such as electronic, digital or IT using MAXQDA. Only nine networks had 
information on the topic of electronic networking, which does not mean that a shared HIT 
is actually employed. 
For this reason, this study aims to examine the barriers why these IPWN do not take 
the next step by trying to increase the information continuity through a shared HIT and 
possible approaches how to overcome these barriers. 
2. Methods 
Numerous studies deal with barriers to IT use in the health sector. However, these are 
usually limited to individual medical specializations or institutions. Furthermore, these 
studies are suitable as a starting point but do not allow for differentiated insights into 
IPWN. For this reason, we chose a qualitative approach applying guideline-based expert 
interviews, prompting network managers to report on their experiences with HIT in IPWN. 
As these interviews were carried out in the context of an overarching project, we also 
asked questions on other network-specific topics that are not part of this study. 
Selected main contacts (e.g. named as managers, coordinators, speakers, chairmen) 
of IPWN were written to, contacted by telephone or addressed at wound congresses. All 
together 11 experts (two physicians, three nurses/wound manager, two medical 
supplier/pharmacist, three managing directors of a management company with a medical 
background and one other HP) could thus be recruited. These experts are managing 13 
wound networks that are under closer examination. The interviews were conducted face- 
to-face between April and September 2018 and lasted from 74 to 130 minutes each (Ø 104 
minutes). 
Nine of the networks are a non-profit association. Four networks do not have their 
own legal form, of which two are publicly funded project networks. In addition, one 
network is organized as an ICW2 working group. All networks are multiprofessional. With 
the exception of one network, the connectivity is intersectoral. Only two of the networks 
label themselves as supraregionally active networks. 
All interviews were recorded and transcribed. The evaluation was framed by a ded- 
uctive-inductive content analysis. For this purpose, we created a deductive category 
system. This system was inductively expanded throughout the course of the analysis [9]. 
3. Results 
According to the experts, only one network never raised the issue of a HIT application. In 
the other 12 IPWNs this was at least discussed, and in five networks an electronic patient 
record (EPR) was finally introduced. In two IPWNs the HIT application was discontinued 
after the test phase. In another IPWN HIT was not used at all, and in the other two IPWN 
                                                     
2 The Initiative Chronische Wunden e.V. [Initiative Chronic Wounds] was launched in 1995 by physicians, 
nurses and other activists in order to improve the prevention and treatment of people with chronic wounds. 
URL: https://www.icwunden.de/da/about-us.html 
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the EPR is currently used by at least one network member, even while use falls short of 
expectations. The experts agree that HIT can support networking in various ways. A 
number of network activities that go beyond general personal information exchange or 
joint training activities are only made possible by this. However, what are the reasons for 
either not implementing a HIT or for a limited use? In the course of the content analysis, 
we initially defined four main topics inductively as possible categories of barriers: A) 
personal, B) financial, C) technical and D) legal [10]. The subcodes, as displayed in Table 
1, were defined inductively. 
 
Table 1. Barriers of a HIT application: list of defined codes and subcodes 
 
 
Category A: Personal barriers are mentioned by all experts without exception. The 
heterogeneity of the actors requires different needs, demands and objectives in 
relationship to HIT. In addition, the HP have doubts about the advantages of an EPR. “The 
system itself, the communication platform itself, does neither unite the network nor does 
it result in higher quality. If I have not defined quality beforehand, it will not be complied 
with. It can only be a means to an end and will be accepted wherever I really see it. I have 
been logging it with a lot of effort so far, and now I press a button and it is easier.” 
(Managing director 2) Many HP prefer to hold on to the tried and tested because a new 
HIT always means a change in individual working methods and routines. Older network 
members, in particular, are generally skeptical about new digital applications. A feared 
restriction of the autonomy to act and the fear of control by other members “[can] be so 
negative that people always have the feeling that we are always looking into their cards. 
And that everyone would rather do their own thing” (Nurse 1). In addition, a lack of trust 
in the data of other HP may prevent the introduction of a HIT. A lack of technical affinity 
and competence also means that for many nurses and physicians the topic is “a book with 
seven seals” (Managing Director 1). Hence, it receives little attention in voluntary wound 
networks. 
Category B: Financial barriers are among the most frequently mentioned barriers 
in the literature [10]. The experts allude investments in necessary hardware and software. 
Moreover, a new HIT can also result in running costs, for instance, for support. A possible 
interface to existing IT systems in order to establish interoperability and avoid double 
documentation is also described as very costly. HP fear financial losses due to additional 
time, if the new system must be used in parallel with existing systems. Fears of financial 
losses due to the elimination of medical examinations due to electronic exchange are also 
mentioned. Eventually, double examinations represent a source of income for HP. 
Code Subcode 
A Personal Heterogeneity of the actors (requirements, demands, goals) 
Doubts about the advantages 
Holding on to the tried and tested 
Fear of control of other network members/restriction of autonomy to act 
Lack of trust in data of other network members 
Lack of technical affinity and competence 
B Financial Investments in hardware and software 
Financial losses due to additional time expenditure 
Financial losses due to the discontinuation of medical examinations 
C Technical Missing interfaces / interoperability 
Missing network coverage 
Missing hardware equipment 
Lack of technical support 
D Legal --- 
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Category C: Technical barriers result from a lack of interfaces or interoperability. 
“To dare the next step: I hook up there, just pick up something and can even write 
something in there. That does not work! The office-based physician asks: how can that 
enter my practice management software system? Not at all! The hospital doctor in the 
ambulance asks: how do I recognize it? Neither, because these are all structures that do 
not belong together, and do not belong together intentionally.” (Managing director 2) 
Inadequate reception quality - for example in areas with a low network coverage - and 
poor or missing hardware equipment on the part of the members make IT networking 
impossible. A lack of technical support, e.g. by a software company, can also delineate a 
potential usage barrier. 
Category D: Legal issues. Data protection is a sensitive issue, especially in the 
healthcare sector. Doubts as to whether highly sensitive patient-related data are secure 
with other users and are not misused are a potential barrier. 
4. Discussion 
The exploratory research demonstrates that interconnectedness of HP alone does not pave 
the way for the implementation and use of health IT. Similarly, none of the networks 
considered can be highlighted as the best case. 
According to the experts, an attempt to overcome the barriers described in the 
categories A-D separately would be insufficient. This is due to the interconnectedness of 
the barriers and the difficulty to gain direct impact on them [10]. This can be illustrated 
by several examples: some of the experts complain about the lacking financial support for 
a HIT, which impairs the funding of such a project. However, the costs alone cannot 
determine the lack of software introduction and application. For example, the HIT in one 
of the IPWN was financed by public project funds, and the use was free of charge for the 
actors involved. Nevertheless, it was hardly used or completely rejected. Four other 
experts report a similar situation, where the software and some of the hardware were 
offered to network members free of charge or for only a small fee. However, in the end 
the expected success failed to emerge. In the case of all these networks, the HIT was even 
developed internally or selected together with the members for the sake of diversity of the 
actors. Despite initial euphoria, training courses to harmonize wound care and increase 
technical competence did not result in the desired use. 
Overcoming the barriers is a complex process and requires a holistic concept and 
support from various actors. Voluntarily formed networks themselves cannot guarantee 
information continuity. “After all, a network is also a bottom-up movement, if you like. It 
is professionally triggered, it is largely care-triggered but does not solve the system 
problem in this way”. (Managing director 2) 
The establishment of a network and the topic of HIT depend too much on the 
commitment of individual HPs. Once the networking and implementation of HIT succeed, 
then only isolated solutions are created. The experts see a particular duty on politicians, 
who should not only provide the financial means for individual pilot projects. They must 
also accompany and coordinate networking at a regional level in terms of its content. 
According to the experts, this includes creating discussion platforms and structural 
guidelines for cooperation and communication in networks and, above all, defining 
nationally binding processes and standards in wound care that are mapped in a mandatory 
and central HIT. Instead of an individual obligation to provide evidence, it might also help 
Ö. Teckert / More Information Continuity Through Health Networks?636
to enable an integrative consideration of services. This study is limited due to the small 
sample size. In addition, the findings are confined to wound networks and cannot be 
readily generalized to other health networks. Evaluating the impact of the structure and 
the quality of the networks on HIT usage is subject for future work [11]. 
5. Conclusion 
The study demonstrates that networks of HP cannot guarantee information continuity. The 
experiences of 11 managers reveal that, despite the voluntary structures created, there are 
numerous barriers to a HIT implementation and use. The overcoming of these barriers 
should not be left to the commitment and voluntariness of individual HPs but should be 
actively controlled by policymakers. In this way, QoC can be improved by HIT used across 
institutions [3]. 
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Abstract Hospitalization expenses account for a high proportion of national medical 
care expenditure in Japan. In 2015, the total national medical care expenditure in 
Japan was 42.4 trillion yen, and hospitalization expenses were 15.6 trillion yen 
(36.8%). Therefore, it is necessary to reduce hospitalization expenses. The labor cost 
of physicians and nurses accounted for about 1/3rd of all expenditure of general 
hospitals in 2015. Moreover, the personnel cost of nurses accounted for about 1/5th 
of all expenditure, indicating that it has a marked impact on hospital management. 
Nurses spend a lot of time completing descriptive records; however, the quality of 
such records is poor. It is necessary to improve nurse’s records to make them highly 
accessible and reduce the amount of time nurses spend producing records. The 
objective of this study was to improve the processes underlying record-keeping by 
nurses in order to harmonize structured clinical knowledge among doctors and 
nurses. We created 778 Patient Condition Adaptive Path System (PCAPS) items, 
covering all of the clinical departments that were registered for the PCAPS content 
master. The resultant masters will be standardized by sharing them with hospitals 
that adopt the “Team Compass” application. We were able to summarize all of the 
information in clinical progress sheets because we could link the information 
described in electronic medical records with that described in Team Compass. 
Therefore, it became easy to collect information by linking information about 
clinical orders. The system also made it possible for foundational nursing plans to 
be created in collaboration with doctors instead of being developed by nurses alone 
because it allowed information regarding patients’ problems, the clinical process, 
and observation selection to be shared smoothly with doctors. We implemented 
Team Compass in May 2019. On the first day, PCAPS-based care pathways were 
used to treat 580 of 623 inpatients. Approximately 4,000 patients were treated using 
this system from May to August 2019. No major problems have arisen since the 
implementation of Team Compass.  
Keywords: digitalization, quality management, healthcare, structured clinical 
knowledge 
1. Introduction
Hospitalization expenses account for a high proportion of national medical care 
expenditure in Japan. In 2015, the total national medical care expenditure in Japan was 
42.4 trillion yen, and hospitalization expenses were 15.6 trillion yen (36.8%). Therefore, 
it is necessary to take measures to reduce hospitalization expenses. The total labor cost 
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of physicians and nurses accounted for about 1/3rd of all expenditure of general hospitals 
in 2015 [1–3]. Moreover, the personnel cost of nurses accounted for about 1/5th of all 
expenditure, indicating that it has a marked impact on hospital management.  
Nurses spend a lot of time producing records. Specifically, nurses produce 
descriptive records; however, the quality of such records is poor. Therefore, it is 
necessary to improve record-keeping systems to make nurse’s records easily accessible 
and reduce the time nurses spend producing records. In a survey evaluating the quality 
of nursing records, Tsuru et al. suggested that <50% of the patient observations required 
to deal with individual patients were recorded by nurses. In addition, failures in planning, 
implementation, and recording have been identified in nursing care in Japan [4–6]. 
Moreover, it was clarified that data production and input depend on individual nurses, 
and many observations are recorded in descriptive electronic records, which can be 
difficult for other staff members to interpret. 
To solve planning failures, the preparation and utilization of many high-quality 
models of treatment and nursing care plans is useful. Thus, we have developed a 
structured clinical knowledgebase by incorporating the Navigator for Thinking Processes 
in Nursing (NursingNAVI™) into the Patient Condition Adaptive Path System™ 
(PCAPS) [7–9].  
During this process, structured nursing care plans were developed using the 
Standard Terminology for Nursing Observation and Action (Ministry of Health, Labour 
Standards since 2016) for electronic medical records (EMR). Then, an application for 
supporting the recording of structured nursing care plans was designed and implemented 
at a large-scale acute-care hospital with 1,000 beds. As a result, the proportion of nurses 
who took ≥30 minutes to identify the conditions of patients in their charge decreased 
from 45.4% to 5% within 3 months. It was suggested that the utilization of high-quality 
structured nursing care plans based on clinical nursing knowledge supports the thinking 
processes of nurses and reduces the time they require to complete their work. After 3 
years, the amount of overtime being performed in the hospital had markedly decreased, 
and almost no overtime was being used to complete records [9]. 
In Japan, to improve the efficiency of medical care services, the development of an 
information system to support medical fee payment was initiated in the 1980s, and the 
development and introduction of a hospital information system (an EMR system) that 
could record instructions and the execution of tests and treatments was initiated in 2000. 
Since then, the use of EMR systems has increased, and they have become essential for 
medical fee payment. In hospitals that use a comprehensive payment system termed DPC, 
the system records data about any medical care provided, leading to an era of big data in 
medical care. However, there is a problem with the quality of the data included in EMR, 
and a survey performed by Yahagi et al. suggested that such records are a long way from 
being useful for clinical evaluations. It was considered that the development of a new 
EMR system is necessary to allow analyses of the relationship between hospital 
management and clinical quality.  
Thus, we decided to develop an operational support system that could be used 
to manage a larger amount of structured clinical knowledge and support routine work.  
Since medical care is provided by many departments, 24 hours a day, 365 days 
a year, it was decided that the system would have to possess the following functions: (1) 
It should not change existing tests or treatment work and (2) should improve the quality, 
recording, and execution efficiency of nursing plans. 
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2. Implementation method
2.1. Development of the ‘Team Compass’ application 
We developed ‘Team Compass’ as an application for PCAPS [7–9]. Team Compass has 
many functions that support the work processes of nurses and doctors. We implemented 
the first system, which we developed at an acute care hospital with 300 beds, at a 
university hospital with 900 beds. We listened to the demands of nurses with regard to 
the functions they wanted and pushed forward with developing these functions. We 
adopted the following rule to ensure patient safety: Patients’ data should be recorded in 
both their EMR and the Team Compass system. Therefore, we decided on the following 
procedure: First, a nurse should enter a patient’s data into their EMR. Then, they should 
transfer the data to Team Compass. 
 Figure 1.  Functions and rules used to ensure patient safety during the use of EMR and 
Team Compass  
2.2. Development of care pathways using PCAPS™ and NursingNAVI™ 
We interviewed doctors from each clinical department and classified structured 
treatments into four categories: surgery, internal medicine, short admissions, and one 
unit. In addition, we linked problems described in the medical task order sheet and Team 
Compass to share information with doctors, and we constructed a system in which 
nursing plans are created automatically without checking orders from doctors. We 
created nursing plans using masters related to surgery and other treatments, which were 
collaboratively created by doctors and nurses. We used the PCAPS content master 
developed by the University of Tokyo as the basis for these masters. Also, nursing care 
and observations completely followed the nursing practice standard masters of the 
Ministry of Health, Labour and Welfare.  
Add ‘PCAPS’ button
Terminal of EMR
P
1. A medical doctor orders PCAPS items for each patient from their.
2. A nurse opens the EMR system and selects the patient.
3. When the nurse clicks the ‘PCAPS’ button, the PCAPS items for the patient are.
4. The nurse is able to understand the patient’s condition, and starts their work.
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We created 778 PCAPS items, which covered all of the clinical departments 
that were registered for the PCAPS content master. These masters will be standardized 
by sharing them with hospitals that adopt Team Compass. We were able to summarize 
all of the information in patients’ clinical progress sheets because we linked the 
information described in the patients’ EMR with that in Team Compass. Therefore, it 
became easy to collect information by linking information about clinical orders. 
The system also made it possible for foundational nursing plans to be created in 
collaboration with doctors instead of being developed by nurses alone because it allowed 
information regarding patients’ problems, the clinical process, and the selection of 
observations to be shared smoothly with doctors. In the future, we aim to develop a more 
sophisticated system that manages the support of patients and reduces the burden of 
nursing tasks. 
Figure 2.  Structured clinical knowledge relating to National Standard Terms for 
Nursing Practice, NursingNAVI, and PCAPS 
3. Results
We implemented Team Compass in May 2019. On the first day, PCAPS-based care was 
provided to 580 of 623 inpatients. Approximately 4,000 patients were treated using 
PCAPS from May to August 2019. There were no major problems after the 
implementation of the system.  
The description record of the nurse decreases sharply and, as a structured 
record, can see it with a progress table. The way of working of the nurse changed. 
First, they take charge and grasp the summary of the patient from process chart. 
Secondary, they obtain detailed information with a progress table. The structured 
record of the nursing is stored within EMR as a PDF file every day in AM at 5:00.  
The change of the patient state is detected by a unit shift in the process chart 
and event occurrence information. The change is shared with a doctor in nurses. The 
team care between doctor and nurses became in this way smoother. 
National 
Standard 
Terms
?observations
?care actions
NursingNAVI
items of each disease or 
therapy
set of observations
set of care actions
PCAPS
items of each disease or therapy
?Clinical Process Chart
?Unit sheet
examinations
therapy
observations
care actions
management work
assessments/judgments
PCAPS application
Team Compass
Get from EMR
Send PDF file to 
EMR as nursing 
document
Team Compass was used in combination with EMR at three hospitals 
from 2018. Four hospitals are currently preparing to use the system
778 Items relating to
373 Items relating to
Items developed at a 
university hospital with 
900 beds
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Nurses handling duties effectively can realize real-time input, and over hours 
decreases. However, the nurse whom over hours cannot yet shorten exists. We analyze 
the causes. 
4. Discussion
Our system successfully harmonized structured clinical knowledge among medical 
doctors and nurses. The improvement of record-keeping by nurses at our 
university hospital has started. We are developing an evaluation system for quality 
improvement. In the near future, we will implement the evaluation system and advance 
quality improvement at our hospital. 
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Physicians’ Experiences of Patient-Initiated 
Online Consultations in Primary Care 
Using Direct-To-Consumer Technology 
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Abstract. Both private and public primary healthcare providers increasingly offer 
their patients online consultation services on request. However, the actual use of 
these services from a physician’s perspective as well as the educational 
competencies required by the physicians are insufficiently studied. The aim of this 
study is therefore to explore how general practitioners (GPs) experience video 
consultations with patients compared to physical consultations in primary care in 
Sweden. We performed a web-based survey amongst 32 GPs. Despite the 
advantage of being perceived as time saving, more than half of the physicians did 
not agree that video consultations are more effective than physical consultations. 
Most physicians had a positive attitude towards the use of video consultations in 
their work but reliability of the technical platform was considered to be essential, 
younger physicians should have worked with physical consultations prior to 
working with online consultations and the use of (semi-) automatic triage systems 
was wanted when patients themselves can book appointments for online 
consultations. 
Keywords. Digital visit, online consultation, video consultation, primary care 
1. Introduction 
Recently the use of mobile technologies related to healthcare delivery has experienced 
a rapid growth. Direct communication between a healthcare professional and a patient 
at home or work, so called Direct-to-Consumer (DTC) telemedicine gives patients 
quick and convenient access to a healthcare professional [1].  
In primary care the feasibility and acceptance of utilization of healthcare-initiated 
telemedicine is supported by many studies and is often more acceptable to patients than 
healthcare professionals [2]. There are however limited studies about how physicians 
perceive patient-initiated video consultations. Most studies [3-5] focused on the 
patients´ experience and their satisfaction with using video consultation. Some studies 
on video consultation investigated physicians´ perceptions showing that participants 
were positive to the use of video consultations in general [6] and elicited potential 
benefits to use video consultation in primary care [7]. However, at the same time 
participants felt it should not be used as a substitute for physical consultation and some 
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GPs were concerned about the possibility that video consultations would prevent 
younger physicians from getting clinical experience [7].  
In Sweden both public and private care providers have delivered a variety of 
digital care services and the number of patient-initiated digital visits to physicians is 
increasing rapidly. Physicians in Sweden have raised concerns regarding their work 
environment, patient safety and healthcare priorities which have been partly analysed at 
a smaller scale [8]. Nevertheless, studies of video consultation from a physician’s 
perspective are limited and there is a lack of knowledge about how video consultations 
are adopted by GPs compared to physical consultations. 
Therefore this study aims to explore how general practitioners (GPs) experience 
video consultations with patients compared to physical consultations in primary care in 
Sweden. 
2. Methods 
Data was collected through a web-based survey targeting general practitioners (n=32) 
in Sweden using exploratory and snowball sampling. The questionnaire consisted of 28 
statements to be rated by the GPs on a five-point Likert scale [do not agree at 
all…completely agree]. The statements were structured according to eight categories; 1. 
Background, 2. Accessibility, 3. Consultation, 4. Communication, 5. Competence, 
Education, 6. Care delivery structure, 7. Technology and 8. Open-ended questions 
regarding the advantages and challenges of video consultation and the competencies 
needed for physicians in video consultation.  
A link to the questionnaire was sent by e-mail to representatives of organizations 
that offer online video consultations to their patients and to the Swedish Medical 
Association. 
Respondents signed an informed consent when contributing to the study, the data 
was treated anonymously and was used for research purposes only. 
Microsoft Excel and R were used to analyze and visualize quantitative data from 
the questionnaire. Microsoft Excel and KH Coder were used to analyze and visualize 
free text/qualitative data. 
3. Results 
The total number of respondents was 32 with an average age of 42.8 years and the ratio 
of males to females was 56% and 44%. The average years of experience as GP was 9.6 
years.19 respondents had less than 10 years of experience and 2 respondents had more 
than 20 years of the experience. The average of years of experience doing video 
consultation was 1.3 years. The ratio of private, public and both private and public 
organizations where GPs worked with video consultation was 16%, 78% and 6% 
respectively. The respondents belonged to 10 different organizations. 
28 respondents had access to the patient’s health record during video consultations 
in the same way that they had during physical consultations, four respondents did not. 
Two third of the respondents (n=22) received education about how to communicate 
with the patient during video consultations, one third (n=10) did not. The average 
length of video consultation´s time (9.3minutes) was shorter than physical 
consultation´s time (20.8 minutes). Only 1 respondent stated the same length for both 
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video and physical consultations. All respondents worked with both physical and video 
consultations, on average 14% of fulltime work was devoted to video consultations. 
3.1. Comparison of physical versus video consultations 
There was a strong agreement among the respondents that video consultations give 
patients faster access to healthcare [AVG: 4.4; SD: 1.26]2, provide high flexibility to 
patients [AVG: 4.3; SD: 0.84], decrease travel time and costs for patients [AVG: 4.3; 
SD: 1.26] and increase accessibility for persons with functional disabilities [AVG: 4.1; 
SD: 1.14]. The respondents were indecisive whether video consultations increase 
accessibility for patients with chronic diseases [AVG: 2.8; SD: 1.70]. 
The respondents considered information for decision making during video 
consultations to be limited compared to physical consultations [AVG: 4.1; SD: 0.78] 
but a majority agreed that video consultations however influence their working 
environment in a positive way [AVG: 3.9; SD: 1.27], e.g. through higher flexibility. 
They were indecisive, however, if video consultations reduce their workload [AVG: 
3.1; SD: 1.45] and most respondents did not think that video consultations are more 
effective than physical consultations [AVG: 2.2; SD: 1.01]. Also, a slight majority did 
not feel comfortable referring patients from a video consultation directly to secondary 
care [AVG: 2.8; SD: 1.35]. 
The respondents were indecisive whether communication with the patient works as 
good during a video consultation as during a physical consultation [AVG: 3.4; SD: 
1.27] and whether GPs need to get extra education about communication and need 
extra skills when doing video consultations [AVG: 3.3; SD: 1.13]. The respondents 
however strongly agreed that younger physicians need to get clinical experience from 
physical consultations prior to working with video consultations [AVG: 4.6; SD: 0.86]. 
In general, few respondents were concerned about patients recording the video 
consultations [AVG: 1.7; SD: 0.85]. There was not much agreement among the 
respondents if they lose the personal contact with the patient during a video 
consultation [AVG: 2.8; SD: 1.45]. 
The respondents further strongly agreed that a (semi)-automatic triage system 
needs to be in place that would guide patients to the right level of care [AVG: 3.9; SD: 
1.29] and respodents tended to agree that it is possible to predict which patient is 
appropriate for video consultation by analyzing the medical history [AVG: 3.2; SD: 
0.96]There was also a strong agreement among the respondents that the technology for 
video consultations is easy to use [AVG: 4.2; SD: 0.85] and its quality (sound, image, 
reliability of the connection) is good enough [AVG: 3.9; SD: 0.98]. 
3.2. Advantages of video consultations 
Time efficiency, flexibility regarding working hours and working from home as well as 
improved working conditions and opportunities for clinical consulting were mentioned 
as advantages of video consultations.  
                                                          
2 Text in this section resembles the statements from the questionnaire that were 
rated on a five-point Likert scale [do not agree at all…completely agree]. This 
example: Video consultations give patients faster access to healthcare (= Statement); 
AVG = average Likert value; SD = standard deviation 
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Time efficiency was supported in the free-text analyses by quotes such as “I get 
time to meet more patients”, “I meet many patients and can help them urgently” or 
“Digital visits give a better structure for how the consultation time is used in an 
efficient way”. 
Respondents also pointed out the flexibility of the work specifically by expressing 
opinions such as “Video consultations give more flexibility for me as physician”, 
“Flexibility to work from home” and “Flexibility regarding working time”. 
They further mentioned advantages regarding their work environment such as 
“New experience that you would need in case of a general digitalization that you 
cannot avoid”, “Stimulating and challenging to work in a different way”, “It is very 
good to be able to follow your own patients”, “Reach patients who are unable to get to 
the clinic themselves”, and “That patients who are not very sick do not take time slots 
on the clinics”. 
Respondents also discussed video consultations vs  phone consultations in their 
free-text answers exemplifying additional benefits such as  “Visual contact is a 
complement to contact over the phone”, “For example, when dealing with psychiatric 
disease or skin disease, it is better to have video contact with the patient compared to 
using phone” and “Gives somewhat more information than a phone call”. 
3.3. Challenges of video consultations 
The respondents considered it to be challenging to guide the right patients to video 
consultations, i.e. they should not require a physical examination. This was clearly 
articulated in free-text answers such as “Need to find the right way in which patients 
and conditions can best be managed” and “To deselect patients who do not need 
medical assessment in order to save on healthcare resources”. Further, other forms of 
digital communication were proposed in some cases - “A lot of consultations can be 
made with chat not requiring video consultation”. Automatic triage systems were seen 
as a possible solution to guide patients to the right level of care - “Faster and safer 
consultations with AI-triage in place”. 
Respondents also reported about high expectations and a poor understanding by 
patients of what can be handled during a video consultation. This is supported by 
statements such as “Wrong patients are looking for video meetings and they are not 
those with disabilities but those who are in a hurry in everyday life”, “Some patients 
have a poor understanding of what can be handled digitally” and “Without triage 
patients are to a large extent looking for things that are obviously not suitable for video 
visits”. 
Further challenges mentioned by the respondents include the lack of a continuous 
relationship between physician and patient, the lack of an automatic system for patient 
triage, the lack of accessibility to integrate with physical care, and the necessity to 
adapt the current reimbursement model.  
4. Discussion and conclusion 
The respondents of this study were in general very positive to video consultations. The 
main advantages mentioned were GPs’ flexibility regarding time and working place, 
increased accessibility for patients and time efficiency for both physicians and patients 
which is in line with other studies [7-10]. 59% of the respondents were were of the 
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opinion that the lack of a physical examination makes the assessment of the patient 
insecure during video consultations. This is comparable with the results by Randhawa 
et al [7] who found that many GPs thought the lack of physical examination was a 
drawback in video consultations and the assessment of the patient became somewhat 
incomplete.  
The main challenges of video consultations were to find a way to guide the 
patients to the appropriate consultation that matched with their conditions and the 
limited information for decision making in video consultations compared to physical 
consultations. It was considered necessary to introduce a (semi)-automatic triage 
system before video consultations. 
The respondents were indecisive regarding the need to get extra education and 
need extra skills when doing video consultations. Nevertheless, skills related to digital 
technology certainly need to be introduced into physicians’ educational programs 
which is also confirmed by a study by Jiwa and Meng [6] who considered video 
consultation techniques to be required to be learned by medical students in 
undergraduate education. 
In conclusion, most physicians had a positive attitude towards the use of video 
consultations in their work but reliability of the technical platform was considered to be 
essential, younger physicians should have worked with physical consultations prior to 
working with online consultations and the use of (semi-) automatic triage systems was 
wanted when patients themselves can book appointments for online consultations. 
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Abstract. Polypharmacy therapies, quite frequent in older populations, pose 
significant health risks for patients due to a high possibility of their cumulative 
adverse drug reactions. We present Personalized Medicine Therapy Optimization 
Method (PM-TOM) for the discovery of polypharmacy therapies with minimal 
drug- drug interactions, drug-gene interactions, and drug-condition interactions. 
The inputs of the PM-TOM heuristic algorithm are the patient’s conditions, 
genome, and the drug products and therapy considered by a clinician. Its output is 
a comprehensive report that explains details of the optimal therapies for considered 
drug products and all drugs that treat the patient’s conditions. PM-TOM was 
developed by using the Electronic Medical Records repository of the Personal 
Genome Project (PGP), and the public repositories: DrugBank and Comprehensive 
Toxicogenomics Database (CTD). Testing of PM-TOM showed potential for 
significant reduction of the cumulative adverse drug interactions in personalized 
polypharmacy therapies. In the group of patients with 8 to 17 conditions, PM-
TOM reduced the average cumulative drug interactions from 22 to 5.83, and the 
group with 6 to 7 conditions from 11.17 to 3. These results encourage further 
research and development of clinical decision support tools like PM-TOM. 
Keywords. Personalized Medicine, Electronic Medical Records, Polypharmacy 
Therapies, Clinical Decision Support, Adverse Drug Reactions, Drug-Drug 
Interactions, Drug-Gene Interactions, Drug-Condition Interactions. 
1. Introduction 
Multiple studies show that polypharmacy therapies can lead to dangerous adverse drug 
reactions (ADR) and high healthcare costs due to their cumulative drug-drug 
interactions (DDI), drug-gene interactions (DGI), and contraindicated drug-condition 
interactions (DCI). Paper [1] reports that the average patient in the examined cohort 
was prescribed with 12 medications; significant DGIs were found in 73% of tested 
patients and DDIs in 87% of patients. In the study explained in paper [2], DDIs 
accounted for 66.1% of the total interactions, and the remaining 33.9% were DGIs. In 
Canada, among patients aged 65 years and older with polypharmacy (>5 drugs) 
admitted to hospital, the prevalence of potential drug interactions is 80% [3]. The study 
described in the paper [4] states that in 1994 some 2,216,000 hospitalized patients had 
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severe ADRs with 106,000 fatal outcomes, making these reactions between the fourth 
and sixth leading cause of death in the US that year. 
Our research is motivated by the urgency of finding solutions to these troubling 
facts. In this paper, we present the Personalized Medicine Therapy Optimization Method 
(PM- TOM) for the discovery of polypharmacy therapies with minimal DDIs, DGIs, 
and DCIs (referred to in the paper as cumulative adverse interactions - CADIs). In 
Section 2, we explain the inputs, outputs, and the database of the PM-TOM method, 
and in Section 3, its heuristic algorithm. In the development, testing, and validation of 
PM-TOM, we used the public data repositories of the Personal Genome Project (PGP) 
[5], DrugBank [6], and Comparative Toxicogenomics Database (CTD) [7]. Results, 
presented in Section 4, show that PM-TOM has the potential to aid in the significant 
reduction of the cumulative drug interactions in polypharmacy therapies. 
2. PM-TOM Database, Inputs and Outputs 
The components of the PM-TOM database are (i) Electronic Medical Records (EMR) 
repository (denoted as EMR), (ii) Drug Repository (DRG), and (iii) Gene-Drug Repository 
(GDR). The current version of PM-TOM requires from EMR only the patient conditions, 
drug product prescriptions, and genome (gene variations that could be pathogenic or 
affect drug behavior, i.e., found to be pharmacogenetic). Other EMR elements, such as 
the patient’s gender, race, blood type, drug dosages, etc., will be used in the future PM- 
TOM versions. Formally, EMR  PID ×  (C) ×  (G) ×  (P), where PID is a set of patient 
IDs, C the set of all conditions, G the set of all genes and their variants, P set of all 
commercial drug products, and  powerset symbol. 
The drug repository (DRG) includes data about the active drug ingredients (referred 
to as “drugs” in this paper), commercial drug products (referred to as “drug products”), 
drug-drug interactions, and drug-condition contraindications. The database keeps drug 
interactions by referencing active drug ingredients (drugs) rather than drug products. If 
D denotes the set of all drugs, then the set of drug products P can be defined as P D × 
N (N is the set of product names). Set DC describes the drug indications, DC D × C. Set 
DDI  D × D × DDS defines the drug-drug interactions, where set DDS = {1, 2...} quantifies 
their relative severities. Similarly, set DCI D × C × DCS describes the drug 
contraindications, where set DCS quantifies their severities. Gene-Drug Repository 
(GDR) keeps data about drug-gene interactions and their severities, denoted as set DGI 
D × G × DGS (DGS is a set of their severities). 
PM-TOM inputs include a patient’s (i) conditions, (ii) considered drug products, 
(iii) genome, and (iv) the initial therapy, which is composed of a single drug product 
for each condition. Formally, the input PM-TOM record is ri = (pidi, Ci, Gi, Pi, ti), where 
pidi PID; Ci is the set of the patient’s conditions, Ci C; Gi is the patient’s genome, Gi  
G; Pi is the set of considered drug products, Pi  P; and ti is the initial therapy, ti  C i× Pi. 
PM-TOM outputs are (i) optimal therapy for considered drug products, tc, (ii) 
optimal therapy for all drugs, to, which PM-TOM creates after examining all drugs 
from EMR applicable to the patient’s conditions, and (iii) a detailed personalized therapy 
report. The report elaborates both optimal therapies, indicating their CADIs, and 
explaining their drug-drug, drug-gene, and drug-condition interactions. It also includes 
the list of all available drug products for each drug suggested in to. 
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3. PM-TOM Algorithm 
In Step 1, PM-TOM collects the patient’s record. An example is a PGP record with 
patient’s ID =’huC29627’; conditions Ci= {Anxiety, ADHD, Depression}; genome Gi = 
{CBS, TGM1, MBL2, C3, BRCA2, COL41A, TP53, ITPA, KCNH2, DRD2, MBL2, CACNA1C}; 
considered drug products Pi= {Venlafaxine, Xanax, Zoloft, Escitalopram, Adderall, Ritalin, 
Celexa, Wellbutrin, Viibryd}; and the initial therapy ti = {(Anxiety, Zoloft), (ADHD, 
Adderall), (Depression, Celexa)}. 
PM-TOM identifies, in Step 2, the corresponding drug (drug ingredient) of each 
considered drug product. For example, the active drug ingredient of Xanax is Alprazolam. 
Next, as Step 3, PM-TOM prepares the set of pairs of conditions and considered drug 
products, called CDi. In the above example, CDi= {(Anxiety, Venlafaxine), (Anxiety, 
Xanax), (Anxiety, Escitalopram), (Anxiety, Zoloft)*, (ADHD, Adderall)*, (ADHD, Ritalin), 
(Depression, Celexa)*, (Depression, Viibryd), (Depression, Wellbutrin)}. The pairs 
marked with * indicate the initial therapy (ti). 
In Step 4, PM-TOM uses set CDi to identify candidate therapies, tk, for considered 
drug products. It forms candidate therapies by replacing only one drug in the initial 
therapy with another drug from set CDi applicable to the same condition. An example of 
a candidate therapy is {(Anxiety, Xanax), (ADHD, Adderall) *, (Depression, Celexa) *}, i.e., 
for Anxiety, Xanax replaced Zoloft. Note that PM-TOM does not evaluate all 
combinations of considered drug products so that it could miss the most effective 
therapy. However, the testing results show that this approach can lead to significant 
improvements in the initial treatments. If d is the average number of candidate drugs 
for n conditions, then the complexity of an algorithm that evaluates all drug 
combinations will be proportional to dn. PM-TOM examines only n*d candidate 
therapies. 
In Step 5, PM-TOM calculates CADI indicator (w) of each candidate therapy tk after 
examining  the following  sets: (i)  drug-drug  interactions  DDIk  =  {ddik  =  (d1,  d2, dds): 
(c1,d1) tk, (c2, d2) tk, ddik  DDI}, (ii) drug-gene interactions DGIk = {dgik= (d, g, dgs): 
(c,d) tk, g  Gi , dgik  DGI}, and (iii) drug-condition contraindications DCIk = {dcik = (d, c, 
dcs): (c1, d) tk, (c, d1) tk,  (c1, d1) tk, dcik  DCI}. w (tk) is calculated as 
w(tk) = DDIP *  ddik [dds] + DGIP *  dgik [dgs] + DCIP *  dcik [dcs]. (1) 
ddik  DDIk dgik  DGIk dcik  DCIk 
DDIP, DGIP, and DDIP are the PM-TOM parameters that define relative weights of 
DDIs, DGIs, and DCIs (set to 1 by default). ddik [dds], dgik [dgs], and dcik [dcs] indicate 
severities of these interactions. As an example, the CADI indicator of the above initial 
therapy is w(ti) = 6. 
Next, in Step 6, the algorithm iterates through all conditions, and for each condition, 
finds candidate therapy with minimal CADI. In Step 7, PM-TOM uses the drugs for each 
condition that form these candidate therapies to create the optimal therapy for considered 
drug products. In the above case, the optimal therapy is tc= {(Anxiety, Venlafaxine) #, 
(ADHD, Ritalin) #, (Depression, Celexa)#}, with w(tc) = 4. 
As mentioned above, PM-TOM is an iterative method. It repeats the above steps, 
taking the optimal therapy found above as the initial therapy for the next iteration. If the 
new candidate optimal therapy shows no better w(tc), the algorithm will stop (Step 8). 
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In the next phase, PM-TOM repeats Steps 3-8 to find the optimal therapy for all 
drugs (to) after (i) collecting all drugs from the EMR used to treat the patient’s 
conditions and (ii) taking already found therapy tc as the starting point, instead of 
therapy ti. In the above example, EMR returned 33 applicable drugs. to was found as 
{(Anxiety, Butabarbital)#, (ADHD, Dexmethylphenidate HCL) #, (Depression, SAM-E) #}, 
with w (to)=1. The report for this EMR can be found at https://www.abs-info-
age.com/project-1. 
4. PM-TOM Validation and Testing 
In the development, testing, and validation of PM-TOM, we used the EMRs of PGP, 
which include the patient conditions, genome, and administered drug products. 
DrugBank provided the drug product, drug-condition, and drug-drug interaction data, 
and CTD the drug-gene interaction data. We tested 286 EMRs. Table 1 lists in column 
(A) various categories of tested EMRs, which have the same number of conditions. 
Column (B) shows the count of cases and (C) the average number of genes in each 
category. Columns (D) and (E) display the average number of considered drug products 
and all drugs applicable to the patient’s conditions. 
 
Table 1. Average CADI of the optimal therapies for the considered drugs and all applicable drugs. 
 
(A) 
Conditions 
(B) 
Cases 
(C) 
Genes 
(D) 
Consid. 
drugs 
(E) 
All 
drugs 
(F) 
CADI - 
Consid. drugs 
(G) 
CADI – 
All drugs 
1 77 13.58 1.31 6.12 0.6 0.09 
2 119 5.74 2.34 10.6 1.05 0.22 
3 49 3.43 3.51 16.71 2.1 0.33 
4 16 4.31 4.38 20.88 3.38 0.56 
5 13 4.46 5.92 26 4.92 2.08 
6..7 6 2.33 7.33 34 11.17 3 
8- 6 10 12.83 42 22 5.83 
 
Columns (F) and (G) display the average CADIs of the optimal therapies for 
considered drug products and all applicable drugs, which indicate a significant 
reduction of the average CADI between these two therapies (approximately three to six 
times, depending on the category). The algorithm required two iterations (Figure 1). 
 
Figure 1. Average CADI for optimal therapies 
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5. Discussion 
In paper [8], the author underlines the need for highly personalized drug selection by 
expert systems. To the best of our knowledge, PM-TOM is an original approach to do 
so. The testing results presented in Section 4 show that the method can identify 
possible treatments with significantly decreased CADIs. We also tested EMRs for some 
recurrent multi-diseases, like {Hypertension, Diabetes Mellitus, Hyperlipidemia}, and 
their CADI reduction was approximately five times. A data mining algorithm for 
finding frequent multi-diseases, and their possible monogenic causes, is explained in 
paper [9]. 
Why do prescribed therapies typically have a high number of drug interactions? We 
speculate that the reasons are the lack of the patient’s genetic data, which would enable 
finding highly personalized therapies, and the limitations of used tools, which are 
typically focused on DDI alerts. Also, according to the investigation in the US, reported 
in paper [10], these alerts are overridden for various reasons in about 90% of cases. 
PM-TOM is an efficient iterative heuristic algorithm. Its testing confirmed that 
very few iterations lead to finding therapies with significantly decreased CADIs. The 
algorithm complexity is rather low as it evaluates a small subset of candidate therapies. 
For example, for seven candidate drugs for 12 conditions, PM-TOM will examine only 
84 candidate therapies per iteration of possible 14 billion ones. Due to that feature, PM- 
TOM has room for extension with other features relevant for polypharmacy therapies, 
such as (i) rule-based medical guidelines, (ii) lab test results, (iii) drug dosages, (iv) 
patient’s demographic data (age, race, gender, environment), (v) drug-drug-gene 
interactions (DDGIs), (vi) drug-food interactions, (vii) drug-microbiome interactions, 
and others. 
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Abstract. New forms of care for complex chronic diseases require substantial 
efforts in the collection, storage, and analysis of privacy sensible medical data. 
Additionally, providing practical support for those who coordinate the actual care 
management process within a diversified network of regional service providers is 
beneficial. In this paper, we present a follow-up with the current status, lessons 
learned, and preliminary results of the IT infrastructure in project STROKE OWL. 
The project aims at a comprehensive implementation of cross-sector care 
management for stroke patients. Patients are accompanied in their recovery by 
stroke pilots, who use a specially designed tablet app for the piloting. It is shown 
how the tablet app uses receiver-oriented encryption to support the piloting process 
while ensuring privacy. 
Keywords. STROKE OWL, Data Management, Privacy by Design, ROE 
1. Introduction
The project STROKE OWL [1] (located in the pilot region Ostwestfalen-Lippe,
Germany) aims at a comprehensive implementation of cross-sector care management for 
patients after a stroke. The actual care management process is carried out by so-called 
stroke pilots, who accompany patients in coordinating their lives after the stroke incident 
like case managers. In a population-oriented approach, the complete care path is 
integrated, i.e. the formation and coordination of a network of regional service providers 
consisting of stroke units, rehabilitation partners, and ambulatory actors, as well as health 
insurance funds. The primary goal of the project is to measure the change of recurrence 
rates due to this new care management process. 
The mere number and diversity of individual actors (stroke pilots, health insurance 
funds, study nurses etc.) place high demands on the underlying IT infrastructure of such 
projects about the collection, provision, and evaluation of data, especially concerning 
security and privacy. Due to the overall demand for Privacy by Design [2], we proposed 
a model of comprehensive receiver-oriented encryption (ROE) [3], which we are using 
in STROKE OWL. In this paper, we show how ROE is practically implemented in the 
accompanying LotsenApp, a tablet application that supports the stroke pilots in their 
work with the patients, and how ROE is used in the central data structure. We also present 
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a follow-up with an update about the current status, lessons learned with ROE and its 
implementation in STROKE OWL. 
In the following Section 2, we give a brief overview of ROE. Section 3 describes 
the implementation details of the LotsenApp tablet app and our system architecture 
motivated by ROE. In Section 4, we give a small overview about some lessons learned 
during this development. Finally, we conclude with a small status update of STROKE 
OWL with over 1000 patients and 1 year of app usage. 
2.Receiver-oriented encryption (ROE) in STROKE OWL
ROE [3] aims to restrict the access of data recipients using encryption so that only they 
can access their data and only their data. Especially for medical data it is essential that 
their accessibility is as limited as possible. To enforce this ROE combines and adapts 
two existing methods: asymmetric cryptography [4] and pseudonymization.
In STROKE OWL, we realized ROE as follows [3]: stroke pilots gather needed 
primary data of their accompanied patients. Primary data is a combination of personal 
data (name, address, etc.), domain-specific data (e.g., cross-sectoral medical data from 
doctors), and case management data for the stroke pilots (e.g., case schedules, 
assessments, contact network management). The collected primary data is then encrypted 
with the specific recipient key and stored at the central servers (as data packets). Due to 
asymmetric encryption, the server infrastructure operators are not able to decrypt them. 
Since each recipient get their encrypted data, it was necessary to create individual 
private-public-key pairs for asymmetric encryption. 
The following recipients have warranted demands on these packets: two study 
nurses (to send paper-based questionnaires to the patients), seven health insurance funds 
(to provide additional secondary data), and the University of Bielefeld (UBF) (which 
gets secondary data, parts of primary data, and questionnaires answers to finally evaluate 
STROKE OWL). Each of these recipients gets their own data packets. 
In ROE, the server-application sends the data packets to their respective recipients 
for decryption (only they have the needed individual private keys). To avoid the 
possibility to merge the decrypted packages again (e.g., to re-identify a patient), we 
proposed in ROE to send a different pseudonym (PSN) for each recipient (so-called 
recipient-oriented PSNs, ROPSN). The server-application uses a central PSN for each 
patient to (1) store the encrypted data packages in a consistent way and (2) for identity 
management - to translate between different ROPSN when needed. 
3.Development and system architecture
With the early focus on Privacy by Design, our system design process was heavily 
driven by data security and safety. Especially the first implementation and later updates 
for ROE forced us to document and evaluate every single design decision. This lead us 
to two important documents: (1) a detailed description of needed data attributes, 
formats, transfer protocols, roles and role interaction processes (data format and 
transmission concept) and (2) a data security and privacy concept, which describes 
measures to secure this data in the context of STROKE OWL. After all project 
partners agreed to these 
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documents and concepts, we designed and implemented our IT system architecture 
accordingly with ROE in mind (see Figure 2). 
Our current architecture is divided into three parts: (1) client application, (2) server 
application and (3) recipient application(s). The client application LotsenApp is used by 
each stroke pilot (see an example screenshot in Figure 1). It is a graphical user interface 
which helps the pilots to input primary data fast and easy. We defined well-formed 
selection lists, added simple plausibility checks, and developed a documentation 
structure to manage the huge number of different fields needed to fill for each patient. 
Additionally, the LotsenApp contains tools to manage the contact networks of patients, 
doctors etc. easily.  
The LotsenApp is the only application which has a reason to access, edit, and delete 
all primary data. It encrypts (parts of) this data asymmetrically with the individual public 
keys of all recipients. If the client application has access to the internet, encrypted data 
packets are sent to the server application. 
The LotsenTablet is a mobile tablet the LotsenApp is running on and allows stroke 
pilots to access the data at the patients side everywhere (in hospitals, at patients, etc.). 
The realization of the server-application is called DAVE (Data Vault Environment). 
DAVE (1) manages and distributes public keys for data encryption, (2) stores encrypted 
data packages for each recipient, and (3) contains the identity management for translating 
and transmitting PSNs and ROPSNs.  
Since the collected primary data in STROKE OWL is essential for the success of 
this project, we also implemented a three-layered backup system to minimize the 
possibility of data loss or unintended changes. This procedure is independent to ROE. In 
the first layer, the LotsenApp stores primary data always locally at first (in so called save 
states). Every save state creates a new local file (up to 200 files). With this, stroke pilots 
can “jump back” to older save states to recover from errors or data loss. If a connection 
to DAVE is available, the LotsenApp transmits a backup copy to DAVE (second layer 
to avoid data loss due to hardware failures). Finally, in the third layer, DAVE creates 
backups of all its databases.  
To maintain data privacy, all backup copies are symmetrically encrypted with a data 
password, chosen and only known by the specific stroke pilot. Data passwords are also 
Figure 1: Example screenshot of the LotsenApp (with generated example primary data) 
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independent from our authentication mechanisms. Therefore, each stroke pilot has two 
passwords: one for authentication and one for their primary data.  
Instead of using one central server application for implementing DAVE, we decided 
to move towards a modular design with multiple, smaller, and independent server 
applications (connected with REST-APIs and HTTPS). Some of them are the following: 
primary data backup, authentication and authorization management, identity 
management (ROE), secondary data management, recipient data package storage (ROE), 
and data import/export. There is also a mirrored (but separate) server of DAVE (called 
staging server), which allows us to test data loss, connection problems, new 
developments, changes, and corrections in more realistic environments (integration and 
system tests). This avoids problems of losing a tablet or a hacking attempt stated in [5]. 
The recipient applications proposed in ROE are represented by multiple smaller 
applications in STROKE OWL. In each recipient application, the user (study nurse, UBF 
and health insurance funds) provides his private key to decrypt the data packages, which 
were sent from DAVE beforehand. The StudyNurseApp, the recipient application for 
study nurses in STROKE OWL, additionally helps in coordinating the paper-based 
questionnaires (marks, which questionnaires were sent, received, etc.).  
4.Lessons learned
Defining and communicating the data format and transmission concept aswellas the 
data security and privacy concept played a key role in implementing very important 
security features like asymmetric encryption and ROE. Both documents helped us to 
communicate with our project partners in technical, organizational, and computational 
concerns. Especially health insurance funds, who will provide secondary data, needed 
these descriptions. In similar (health-specific) projects, we strongly encourage to define 
Figure 2: Overview of the IT system architecture in STROKE OWL
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these documents beforehand to avoid security-related problems and misunderstandings 
between different sectors, persons and stakeholders. 
Additionally, the three-layered backup system to avoid data loss is beneficial.
Despite the fact that backups are necessary measures for data safety, three backup layers 
also offer a remedy against user-induced, non-grave data loss. Therefore, not every data 
loss leads to a complete recovery of the entire IT-infrastructure saving time and money. 
The generation of receiver-specific key-pairs was more time-consuming and 
organisationally complicated as expected. For similar projects with many different 
recipient, we need to dedicate more time for this crucial step. In STROKE OWL, we 
compensated the time-loss with a developed simple application which creates key pairs 
automatically. Every recipient created a pair in one minute. For decryption, we provide 
another application. With this, recipients can use their primary keys to decrypt their 
encrypted data. 
5.Current state and conclusion
We outlined the practical implementation of receiver-oriented encryption on the 
basis of the STROKE OWL project. Privacy by Design is a complex but important 
design paradigm especially in health-care. In STROKE OWL, this resulted in our 
proposed ROE. ROE can be used in similar projects with high data security demands 
and many data recipients with focus on very strict asymmetric encryption rules. 
However, due to its organisational complexity with that many project partners, a long 
planning phase must be considered to avoid later problems. The success of STROKE 
OWL shows us that this drawback is worth to take: As of January 2020, currently 17 
stroke pilots are using the LotsenApp successfully. More than 1200 patients are 
participating in this project. Two study nurses using the StudyNurseApp. Up to 3200 
paper-based questionnaires were sent and filled successfully. The reports from pilots and 
other users showed high satisfaction and productivity with the applications. We are 
content with this development and continuously refine and update our applications 
and components. 
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Abstract. The purpose of this study was to investigate the effect of a
telerehabilitation system on the quality of sleep in patients with multiple sclerosis
(PwMS). Fifteen females and two males (60.1 ± 11.4 years) who used the system 
for three months completed the Pittsburg Sleep Quality Index (PSQI) at the 
baseline and end of follow-up. Total System Usage (TSU) and Total Exercise 
Time (TET) were elucidated from the system web logs for each PwMS. A
significant association (p<0.05) was found between PSQI sleep efficiency (SE) 
and TSU (0.76) and between SE and TET (0.81). The association between PSQI 
total score (TS) and TSU and between TS and TET were -0.507 and -0.702 
respectively (p<0.05). Our results uncovered an association between amount of 
exercise time spent by PwMS and positive effects on both the efficiency and 
quality of sleep. Thus, further development of approaches promoting continuous 
participation of PwMS in telerehabilitation is warranted.
Keywords. Telerehabilitation, exercise duration, multiple sclerosis
1. Introduction
Sleep disturbances in people with multiple sclerosis (PwMS) are associated with 
fatigue, depression, and reduced quality of life [1]. Over 60% of PwMS report impaired 
sleep quality [2]. In middle-aged and older adults with sleep problems, an exercise 
program improved the quality of sleep [3]. Current evidence indicates that patients with 
multiple sclerosis can gain health benefits similar to those from healthy populations 
through regular exercise [4, 5]. Home-based telerehabilitation has been shown to be 
well accepted by PwMS [6, 7]. The Home Automated Telemanagement (HAT) system 
supporting regular multimodal exercise was described previously as promising means 
to improve mobility and improve quality of life in PwMS [8]. The sustainable impact 
of remote disease management depends on patient adherence to the program [9]. In 
addition, high levels of participation, which include proper exercise engagement,
facilitate improvements in patients' quality of life, curb the negative effects of fatigue, 
and improve the quality of sleep. However, the association between extent of 
1 Corresponding Author, Joseph FINKELSTEIN, MD, PhD, Department of Population Health 
Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; E-mail: 
joseph.finkelstein@mssm.edu.
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200242
658
participation in home-based exercise promulgated by a telerehabilitation system and 
changes in sleep quality has not been systematically evaluated. The main purpose of 
this study was to investigate the effects of a telerehabilitation system usage patterns on 
the quality of sleep in PwMS. 
2. Methods 
2.1. Systems 
The HAT system supporting individualized home-based telerehabilitation in PwMS 
was used in this study [6]. Following the chronic care model, the HAT system guides 
PwMS in executing their individualized exercise plans at home, facilitates patient-
provider communication and multidisciplinary care coordination as previously 
described [8]. Tailored motivational messages are provided to enhance adherence [6-8]. 
2.2. Study design 
After being consented as a study participant, PwMS were prescribed an individualized 
exercise plan based on a comprehensive physical therapy examination by a licensed 
physical therapist. All patients were trained how to perform exercise at home by the 
physical therapist and received the necessary exercise equipment. The study 
participants were asked to use the home-based telerehabilitation system on a daily basis. 
The system guided them in following their exercise prescription, logged their exercise 
performance, and communicated exercise logs to their physical therapist who followed 
up with the patients on as needed basis based on patient performance.  
The Pittsburg Sleep Quality Index (PSQI) [10] was used to evaluate self-reported 
quality of sleep at baseline (BL) and 3-month follow-up (3M). Sleep quality was 
characterized by four PSQI factors: sleep efficiency, sleep disturbances, daytime 
dysfunctions, and total score.  
The patterns of telerehabilitation system usage including extent of regular exercise 
completion over the 3-month period were elucidated based on daily web-based logs. 
The web logs were automatically generated by the HAT system which included time 
stamps for each web page visited by the telerehabilitation system users. Based on these 
logs, the following telerehabilitation usage indicators were calculated:  
 Total system usage time: total system usage time over 3-month period from 
BL to 3M 
 Daily usage time: average time spent with the system on the days when a user 
logged in (users could log in multiple times during a single day) 
 Visit usage time: average time spent with the system for each separate log-in 
instance 
 Average percent of sets completed: average percent of exercise sets completed 
out of all sets prescribed for a daily exercise program 
 Total exercise time: total time spent in an exercise mode in the 
telerehabilitation during the 3-month period from BL to 3M 
The system usage indicators provided insights on how different patients used the 
telerehabilitation system and how much time they devoted to the prescribed exercise 
I.c. Jeong et al. / Relationship Between Exercise Duration in Multimodal Telerehabilitation 659
program. Associations between the PSQI scores and system usage indicators were 
analyzed using IBM SPSS Statistics 26 for Windows. Association between study 
variables (r) was assessed using Pearson correlation coefficient. 
3. Results  
3.1. Socio-demographic characteristics of patients  
Overall, 3-month telerehabilitation data from seventeen PwMS were analyzed (15 
females and 2 males). The average patient age was 60.1 ± 11.4 ranging from 39 to 76 
years old; 70.6% of the participants were Whites and 11.8% were Hispanics; average 
duration of education was 15.5 ± 2.7 years. The time since multiple sclerosis diagnosis 
varied between 2.5 and 50.8 years and the average of education was. Self-assessed 
disease severity was reported as severe by 11.2% of participants; 29.4% reported that 
their disease is progressing (Table 1). 
Table 1. Socio-demographic Characteristics of Patients 
Characteristics (yrs.) Minimum Maximum Mean SD 
Age  39 76 60.1 11.4 
How long have MS 2.5 50.8 26.0 13.5 
School 10 20 15.5 2.7 
Characteristics Gender Race Hispanic 
No. (%)  
(N=17) 
female 15(88.2) 
AA 3(17.6) 
yes 2(11.8) 
Asian 2(11.8) 
Male 2(11.8) no 15(88.2) 
white 12(70.6) 
Characteristics MS severity Disease 
No. (%)  
(N=17) 
Mild 5(29.4) progressing 5(29.4) 
moderate 10(59.8) stable 11(94.1) 
severe 2(11.2) improving 1(5.9) 
yrs.: years, MS: multiple sclerosis, SD: standard deviation, AA: African American 
3.2. PSQI and system usage patterns 
Average changes between BL and 3M for PSQI sleep efficiency, PSQI sleep 
disturbances, PSQI daytime disturbances, and PSQI total score were -0.1, 0.9, 0.5 and 
0.2 respectively (Table 2). 
The total time that PwMS spent using the HAT system over the 3-month follow-up 
period ranged between 6 and 68 hours with average time of 30.7 ± 19.8 hours. The 
mean total time patients spent with a system on a day when they logged-in was 26.5 
minutes, and the average total time patient spent at each single sign-in visit was 22.0 
minutes. The patients' average percentage of completed exercise sets and prescribed 
number of exercise repetitions were 46.5% and 72.6% respectively, and the average 
total time spent in the exercise mode was 13.5 hours (Table 2). 
3.3. Bivariate correlations 
Pair wise associations between nine sleep quality and system usage parameters were 
investigated including 4 PSQI scores and 5 usage pattern indicators. The association 
between PSQI sleep efficiency and Total system usage time and between PSQI sleep 
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efficiency and Total exercise time were 0.757 and 0.814 respectively. The association 
between PSQI total and Total system usage time and between PSQI total and Total 
exercise time were -0.507 and -0.702 respectively. Correlation between Daily usage 
time and Visit usage time was 0.910 and r between Total system usage time and Total 
exercise time was 0.886. The r between PSQI sleep efficiency and PSQI total was 
0.722. 
Table 2. PSQI scores, PSQI changes in 3 months, and system usage indicators 
Parameter name Minimum Maximum Mean SD 
PSQI sleep efficiency (BL) 57 100 84.7 12.6 
PSQI sleep efficiency (3M) 56 120 84.5 16.2 
PSQI sleep efficiency (3M-BL) -23.3 38.3 -0.1 15.9 
PSQI sleep disturbances (BL) 1 11 6.4 3.3 
PSQI sleep disturbances (3M) 3 18 7.3 4.1 
PSQI sleep disturbances (3M-BL) -6 8 0.9 4.6 
PSQI daytime dysfunctions (BL) 0 3 1.0 1.0 
PSQI daytime dysfunctions (3M) 0 4 1.5 1.4 
PSQI daytime dysfunctions (3M-BL) -1 3 0.5 1.1 
PSQI total (BL) 1 11 6.7 2.8 
PSQI total (3M) 2 14 6.9 3.4 
PSQI total (3M-BL) -6 3 0.2 2.3 
Total system usage time (sec) 21,494 244,042 110,569.9 71,212.8 
Daily usage time (sec) 311.5 4,258.3 1,588.2 947.9 
Visit usage time (sec) 307.1 2,248.8 1,324.8 601.0 
Average percent set completed (%) 69.4 142.0 97.8 17.7 
Total exercise time (sec) 7,489 157,502 48,457.2 45,499.8 
SD: standard deviation, BL: data acquired at the baseline, 3M: data acquired at the 3-month follow-up, 
3M-BL: difference in PSQI score between 3M and BL 
Table 3. Correlation matrix between PSQI score changes and system usage indicators 
   Parameter name         
A. PSQI sleep efficiency (3M-BL) A        
B. PSQI sleep disturbances (3M-BL) -0.041 B       
C. PSQI daytime dysfunctions (3M-BL) 0.562 0.362 C      
D. PSQI total (3M-BL) -0.722 0.248 -0.105 D     
E. Total system usage time (sec) 0.757 0.085 0.400 -0.507 E    
F. Daily usage time (sec) 0.536 -0.109 0.490 -0.240 0.588 F   
G. Visit usage time (sec) 0.532 -0.153 0.306 -0.302 0.596 0.910 G  
H. Average percent set completed (%) 0.102 -0.255 -0.047 0.166 -0.098 0.135 0.278 H 
I. Total exercise time (sec) 0.814 0.127 0.321 -0.702 0.886 0.369 0.436 -0.114 
All values represent the Pearson correlation coefficient (r), light gray cells have p value<0.05 and dark gray 
cells have p-value<0.01, BL: data acquired at baseline, 3M: data acquired at the 3-month follow-up, 
3M-BL: score difference between 3M and BL 
       
Figure 1. Comparisons between the enhanced group and the degenerated group 
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Table 4. Comparison between sleep improvement and deterioration groups (mean ± standard deviation)
Group TSU TET ʌSE ʌTS
Sleep Improvement 38.6±20.9 19.7±14.5 12.7±12.7 -1.4±2.0
Sleep Deterioration 22.0±15.2 6.4±4.1 -11.6±7.3 2.0±0.8
TSU: total system usage in 3 month (hours), TET: total exercise time in 3 month (hours),
ʌSE: change in PSQI sleep efficiency score, ʌTS: change in PSQI total score
4. Discussion
In this study, we used the a telerehabilitation system supporting an individualized 
multimodal exercise prescription to investigate how system usage patterns are 
associated with sleep quality. Our results indicate the accumulation of the system usage 
time has a positive effect on both the efficiency and quality of sleep. In particular, the 
accumulation of exercise time had a greater impact on PSQI scores (Table 4). We 
found that there was a significant difference in the total exercise time between the 
PwMS with improved or unchanged sleep efficiency and those whose sleep efficiency 
deteriorated (F=8.570, p=0.010). Similarly, there was a significant difference in the 
total exercise time between the group of patients with improved or unchanged total 
quality of sleep (PSQI total) and the group of patients whose total sleep quality score 
deteriorated over 3-month follow-up period (F=6.247, p=0.024) as depicted in Figure 1.
Based on the results from 3-month telerehabilitation, improvements in sleep 
quality were associated with approximately 9.3 hours of total exercise time which is an 
equivalent of at least 20 minutes of exercise twice a week. Our data strongly support 
positive impact of telerehabilitation on PwMS who might otherwise have difficulty 
traveling to an outpatient program. Further work to enhance PwMS participation in 
telerehabilitation is warranted. 
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Abstract. Digital pathology is the computer technology that allows the management 
of the information generated by the whole-slide scanners from a microscopic slide, 
encompassing the virtual microscopy. This paper proposes and describes the 
architecture of a secure collaborative platform that integrates a web pathology 
viewer with role-based access control. The proposed architecture is ensured by a 
shared medical repository that serves web pathology viewer with the medical 
images, using the DICOM standard. The system offers collaborative work session 
management tools as the managing of users, sessions, access control to sessions, and 
many others. Furthermore, the use cases related to telepathology and e-learning are 
presented. 
 
Keywords. WSI, collaborative, digital pathology, PACS, DICOM, access control 
1. Introduction 
Digital pathology has gained popularity in the most recent years as a consequence of the 
proliferation of the Whole-slide Imaging (WSI) [1,2], replacing the traditional 
microscopes [3]. The digital era in the pathology field brought new features in the review 
process: the samples can be easily accessed from anywhere and anytime and at the same 
time as other users and then remotely reviewed and annotated. The improvements lie  in 
the diagnostic accuracy and efficiency of the support systems. The handling of the 
samples becomes more secure as there is no deterioration in the image quality [4]. 
Digital pathology made available new methods to teach histology and pathology that 
was impossible until the digital revolution [5]. The digital replaces the old and expensive 
microscopes and simplifies the process in a way that all that is required is a device with 
internet access and a web browser for concurrent access to the same sample, either for 
teachers or students. Still, the regulation nowadays forces to protect the patient’s data 
[6]. Therefore, the handling of these samples over the network requires strong access 
control and security protocols. 
Digital pathology made available new methods to teach histology and pathology that 
was impossible until the digital revolution [5]. The digital replaces the old and expensive 
microscopes and simplifies the process in a way that all that is required is a device with 
internet access and a web browser for concurrent access to the same sample, either for 
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 teachers or students. Still, the regulation nowadays forces to protect the patient’s data 
[6]. Therefore, the handling of these samples over the network requires strong access 
control and security protocols. 
This paper proposes and implements a secure architecture for the management of 
digital pathology remote working sessions2. The management platform provides means 
for a session creator to restrict and personalize permissions for the access and handling 
of medical images. The framework also integrates a pure web pathology viewer fully 
compliant with Digital Imaging and Communications and Medicine (DICOM) standard, 
the Dicoogle open-source project to support the WSI storage, and a web platform for the 
management of all the working sessions and their associated users. Furthermore, the 
introduction of a security layer [7] enables to control access policies in a non-secure 
environment, deploying an innovator multi-repository concept. The data management is 
assured by this accounting mechanism specially designed for medical imaging archives 
which creates the concept of virtual archives for each user. 
2. Background 
2.1. DICOM-PACS Universe 
The evolution of the radiology regarding the digital paradigm let to the implementation 
of Picture Archiving and Communication Systems (PACS). PACS is an aggregation of 
hardware and software services that orchestrate acquisition, storage, and display of 
medical imaging data. All of the previous steps are integrated into digital networks 
supported by DICOM standard. PACS rely on DICOM, which is one of the most popular 
standards in the medical imaging field [8]. 
In 2010, microscopy was introduced in the DICOM, as a result of the rapid spread 
and adoption of the standard. The publication of the supplement 145 boosted the 
development of the automated whole-slide scanners [4]. However, the technology 
maturity level and initial vendor-lock positioning of scanners industry does not promote 
a fast adoption of DICOM-WSI in the first years. 
Whole-Slide Images are specimen-centric, unlike the traditional DICOM 
information model, that are considered patient-centric where the specimen is not the 
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Figure 1. Screenshot of the platform during a work session. 
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 most relevant subject [9]. The most recent DICOM standard supplement dedicated to 
WSI specify the workflows regarding the preparation, acquisition, and storage of this 
kind of imaging objects [9]. 
 
2.2. Dicoogle 
Dicoogle3 is an open-source PACS [10]. Its applicability encompasses different contexts 
as clinical, research and academic. Dicoogle’s architecture follows a modular approach, 
allowing the development of new features over time. 
The Dicoogle Software Development Kit (SDK) allows the addition of new features 
by third parties without the need to change the software core. The Dicoogle SDK pro- 
vides interfaces that the developers need to implement to build a plugin4. Dicoogle, 
during the startup, automatically loads the modules contained in this directory and all the 
operations related to storage, querying and indexation become immediately available via 
its API. 
3. Architecture Overview 
Figure 2 shows the general architecture of the proposed system. Four main components 
can be identified: the PACS archive, the management platform (MP), the web viewer 
and the access control module. 
 
HTTP HTTP 
  
Management Platform 
WADO-RS WebSocket 
 
Web Viewer 
 
 
Figure 2. Collaborative platform general architecture. 
In this context, a working session is a live persistent document, that maintains 
synchronization between all users. The MP is where all the data, regarding sessions, 
users and their permissions, is stored. This component is independent of the viewer, so 
with little effort, other viewers can be attached to the management platform to support 
the working sessions. 
The purpose of the MP is to give the user the necessary tools to manage his sessions, 
with the possibility to create user groups (that speed up the process of inviting users), 
define user permissions in the working sessions, define access control configurations to 
each session, insert new case studies and create new sessions. The MP handles the access 
to the working sessions at two different levels: controlling the access to the working 
sessions through user-defined parameters, such as access dates, invited users and their 
permissions; controlling the access to the case studies that the sessions are based on. 
The users can be invited via two ways: email, where a personal invitation link to the 
session is delivered, with preemptively defined permissions; or through a public share- 
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 able link, up to a defined limit, which will be given no permissions to edit the session. 
These permissions can be changed live in the session. 
The permissions on the session define which actions the user can perform 
concerning the image and the study, such as moving around the image or create 
annotations, and regarding the collaborative tools, such as inviting or kicking users from 
the session. 
The MP controls the users in the session, registering who and how many users are 
connected, preventing the simultaneous usage of the same invitation link and limiting the 
number of users connected through a public link. 
Given that the platform works over medical repositories, including personal archives 
that constitute sensitive information and therefore need to be compliant with the General 
Data Protection Regulation (GDPR), the access to the case studies needs to be con- 
trolled. In this case, access to the case studies is role-based and controlled by an existing 
accounting mechanism developed by Lebre et al. [7]. This mechanism is role-based, pre- 
venting users from accessing archives they should not have access to. The permissions 
can be extended to third-party entities allowing to create multiple virtual archives and 
share them amongst other users and institutions. 
Upon logging in into the MP, a role is given to the user, defining which case studies 
he/she has access to. The user can upload to the platform his cases or the system 
administrator can grant this user access to existing archives. 
Within a working session, the viewer, using the web link, determines the 
visualization mode to be used, retrieving the user’s permissions and session’s details 
from the MP and the specific medical case from the PACS archive. It has three 
visualization modes, all sharing the same basic visualization tools: live mode, the 
representation of the working session; replay mode, allowing to review all the actions on 
the working session; archive mode, the study case can be viewed without any of the 
collaborative features. 
4. Use Cases 
A collaborative paradigm in pathology enables the interaction and discussion by several 
users simultaneously, each in their own device. The collaborative system was designed 
to satisfy two usage scenarios, clinical and educational. 
In the clinical field, the leader of the study can create a group of users from his peers 
to an easier attribution of permissions. Alternatively, the leader may specify or change 
the permissions of each member when establishing the working session. The replay 
mode will allow the peers to review actions performed and be able to keep up with the 
research. In the educational field, the groups could be formed with students or can be 
given the public link, allowing these users to follow along with the class. By changing 
the permissions of one of the attendees, the educator can, for instance, evaluate the 
ability of a specific student to detect critical regions in the study. Moreover, tasks for 
students can be defined. For instance, annotation of a working case that will be saved as 
a session than can be reviewed later by the evaluator. 
On both cases, the framework virtualizes the concept of PACS archive. I.e., the 
management platform creates virtual sessions where the users only have access to the 
DI- COM objects that the creator of the session has previously defined. However, all of 
the DICOM objects are stored in the same archive. The framework provides then, the 
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 capacity to share studies and instances among users belonging to distinct healthcare 
organizations or departments. 
 
5. Conclusion 
In the medical field, the imaging field represents a crucial tool in the quality of 
diagnosis. Sharing patient data between entities boosts the accuracy of decision making. 
In this line, collaborative work is a breaking-change in clinical decision-making. The 
collaborative paradigm addresses also educational purposes, allowing collaboration 
among professors and students. 
This paper presents the architecture and use cases of a DICOM web digital 
pathology viewer with access control mechanisms integrated. The proposed framework 
creates the concept of collaborative sessions. However, the existence of such a 
framework requires a permission management system which led to the deployment of a 
management framework that promotes the resource sharing among users or institutions. 
The working sessions are virtual web viewers where an administrator can define which 
users can have access to which resources. These features turn the system institution-free 
and enhance telemedicine and remote diagnosis. Moreover, using pure web technologies, 
the system can be used anywhere, anytime, regardless of the operating system and 
without any prior installation. 
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Safer Surgery Checklist: Barriers in the 
Adoption of Tablets in Operating Room 
Giuliana COLUSSI1a,, Gabriela GARCIA a, Maria GRANDEa, Daniel LUNAa  
a Health Informatics Department, Hospital Italiano de Buenos Aires, Argentina 
Abstract. It is crucial that registering the checklist needs to be done synchronously 
and according to the care tasks within the operating room. Therefore, we aim to 
find out what are the difficulties that the surgical technicians have when checking 
the list and exploring potential barriers to implementing the use of tablets. 
Qualitative research was conducted based on focus groups, in-depth interviews and 
on-site observations until a full coverage of the topics was achieved. We detected 
that this problem includes technical aspects (connectivity, hardware and software 
issues), those related to workflow and logistics, those related with registration 
process, and those related to organization culture and power structure. Based on 
results, we developed a plan to solve problems detected. 
Keywords. Checklist; Operative Surgical Procedure; Patient Safety; Qualitative 
Research 
1. Introduction 
In order to standardize care processes in the operating room, the World Health 
Organization designed a checklist with the advice of surgeons, anesthetists, nurses, and 
patient-safety experts from around the world [1]. It aims to reinforce established safety 
practices and promote communication and teamwork across multiple clinical 
disciplines. 
Checklist´s implementation during the surgical procedure is intended to work as a 
tool to improve patient safety, human factors, reduce the incidence of adverse events, 
morbidity and mortality [2] [3] [4]. 
However, evidence shows that there are some factors that prevent this procedure 
from being done on time and correctly [5], despite being a requirement of the Joint 
Commission International [6]. The barriers to the correct implementation of the  
surgical checklist are multifactorial and cover both cultural and structural aspects, 
including communication gaps, the benefit perceived by the user, lack of understanding 
of the procedures, the perceived ambiguity of the process and negative perceptions 
regarding operational efficiency, and others [7] [8]. 
In 2014 the Italian Hospital of Buenos Aires (HIBA), computerized the checklist 
to be used during the surgical process, and in 2015 the use of tablets was implemented 
so that the surgical technicians team can complete it from a mobile device, and thus 
be able to do it next to the patient. However, the use of the tablets was not maintained 
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over time, and gradually ceased to be used for the checklist registration. 
It is crucial that registering the checklist needs to be done synchronously and 
according to the care tasks within the operating room. Therefore, we aim to find out 
what are the difficulties that the surgical technicians have when checking the list and 
exploring potential barriers to implementing the use of tablets, in order to formulate 
solutions that guarantee the correct realization of it. 
2. Methods 
The HIBA is a center of high complexity located in the City of Buenos Aires. Every 
year performs 52,000 surgical procedures in its 41 operating rooms. 
Qualitative research was conducted based on focus groups, in-depth interviews and 
on-site observations until a full coverage of the topics was achieved. Both the 
interviews and the focus groups were audio recorded for further analysis, protecting the 
identity of the participants who voluntarily participated through an informed oral 
consent. The research project was approved by the institutional ethics committee (CEPI 
# 5001). The study was performed in full agreement with current national and 
international ethical regulations. 
Between November and December of 2018, 2 focus groups were held, one with 
the morning shift group and the other one with the afternoon shift group. A total of 41 
surgical technicians participated. A tool from the Lean Change Management was used 
as a triggering material for the investigation. This tool consists in expressing which is 
the summoning problematic [9]. Then each member, individually, writes in a piece of 
paper the reasons why they think this is happening. Next step, the reasons are collected, 
grouped by categories and the different issues that arise begin to be discussed among 
all the participants. This way, participant’s feedback is shared, eliminating biases and 
generating perceptions of greater value, where possible solutions arise from the group 
itself. 
A group interview was carried out with 2 key participants: the surgical technicians 
coordinator and the management and update coordinator of the surgery department. 
Three surgical processes were observed on different days, schedules and operating 
rooms. Also electronic devices, access to networks and the software involved during 
the surgical processes were reviewed. The observations were carried out in the central 
operating room, covering all the tasks performed by surgical technicians, especially 
focusing on the checklist registration process. The information was systematized in 
field newspapers, elaborating a dense description [10] through interviews and focus 
groups. 
The analysis process was carried out simultaneously with the information 
collection process, through the coding and categorization of information, based on a 
constant comparison process. The categories were built taking into account the central 
research questions such as the findings that emerged from the same focus groups, 
interviews and observations, building a descriptive framework that helps contextualize 
the collected data [11].  
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Emerging categories according to the checklist completion arise from the combination 
of three employed techniques, that allowed greater wealth in the understanding of the 
phenomenon. We found three main dimensions. These dimensions account for 
technical aspects expressed in problems ranging from device´s hardware, software, and 
problems with Wifi signal. We also found workflow related problems, manifested as 
logistic and organization issues, as well as problems related to the process at registering 
the checklist, to the organizational culture and about power structure. 
3.1Technical aspects 
We evidenced difficulties or barriers in the inquiry that were related to technical 
aspects associated with checklist registration, which includes connectivity, software 
and hardware problems. 
Connectivity: We detected connectivity problems as unstable range of Wifi inside 
each operating room, that causes logged out, browsing slow, or lose information 
loaded. This could make the registration process problematic and longer times. 
“often the wifi is wrong and that's it, if you don't have Wi-Fi ... it doesn't work” 
Software problems: In order to access checklist interface, surgical technicians must 
enter to the Electronic Health Record (EHR) from the tablet. In this sense the screen 
does not adapt to the resolution of used device, making zooming and scrolling 
necessary. This creates which creates possibilities of error when accidentally touching 
buttons and when they need to click many times to enter the surgical episode of each 
patient. 
“It is cumbersome to have to enlarge and shrink the image to check option“ 
“I had to be enlarging the screen, you went to the next step and you had to enlarge it...if 
there was an application in a standard size, that’s it, the size would not be a problem” 
Hardware problems: Tablets were slow and usually freeze, and users have difficulty 
writing on them: 
“The tablet´s size creates difficulties for writing” “The icons looked very small” 
3.2Workflow 
Within this dimension we find three barriers, one is related to dynamics inside the 
operating room, another refers to operational logistics of tablets and the last one refers 
to registration itself. Dynamics inside the operating room: in the record of the 
observations, we noted that operating rooms have 2 desktop computers, one is 
exclusively used by anesthesia team, expressed explicitly, and the other one, although it 
was not expressly announced, was constantly used by surgeons. This makes difficult to 
synchronize the checklist because surgical technicians must wait until computer was 
available.  
“getting to the computer is very difficult and the computer is far from patient”,  
“in order be able to register something that is done at a certain moment you need to get away 
from the patient, turn their backs at them. It is 
 very careless and when they register the data, the computer is busy” 
Tablets operational logistics: responsibility generated by using a device that is not their 
3. Results 
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own but belongs to the institution is explained. In order to use them, a process to ensure 
safety and cleanliness of tablets had to be respected. Circuit becomes disruptive in 
routine surgical technicians tasks, since they have to go to storage and complete a form 
when borrowing the devices, taking responsibility for them, which consumed too much 
time and made them uncomfortable to continue with another tasks. In addition, tablets 
were not always available because they were stored without enough battery, and 
chargers were missing. 
“you were going to ask for tablet, you opened it, it had no battery, you had to go back to ask 
for a charger, and there were no chargers”, “They (surgeons) asked for charger to another use 
(phone charge), I don't know if they would take it home, or leave it there. Doctors have their 
radio, they never have battery and they have the same charger plug as tablets”, “A lot of liability 
for possible losses between surgeries while we have to prepare material” 
Check List Registration: problematic of synchronous register of checklist is given 
by a set of topics related to assistancialist aspect of surgical technicians work. On one 
hand, presence of a mobile device such as tablets could hinder dynamics their work, 
since they need to have both hands free to specify their care tasks with patient, since 
interrogation until ensuring availability of necessary supplies on operating table. 
“At patient's admission we have many things to do, we cannot have it (tablets) in our 
hands”, “One difficulty is having to have it during surgeries” 
On the other hand, check list is generic and unique for different services and types 
of surgeries, which implies that all fields present in it do not always apply, or some are 
missing, or order items may not correspond to a specific workflow. 
3.3Organizational culture and power structures in operating room 
Transversally to addressed problems, an underlying category refers to organization 
culture and power structures in operating room. We observed that power structures 
within operating room set out priorities on devices use of such as computers and tablet 
chargers. Sometimes surgical technicians relegate tasks to comply with requests from 
surgeons in the ward, for example bringing their cell phone, taking a picture of surgical 
marking on patient. Likewise, although correct application of check list is a 
responsibility of the entire operating room team, surgical technicians adopt this task as 
their own. 
4. Discussion and Conclusion 
We explored difficulties of surgical technicians that arise checklist procedure. We 
detected that this problem includes technical aspects (connectivity, hardware and 
software issues), those related to workflow and logistics, those related with registration 
process, and those related to organization culture and power structure. 
Based on preliminary results, we solved connectivity issues, we installed more Wi-
Fi access points in operating rooms, and we developed a plan to replace obsolete 
devices. Regarding the software, we plan to develop a new mobile application that 
responds to specific registration needs of surgical technicians team. However, solving 
technical aspects would not solve all difficulties detected. Despite our plan with 
informatics issues, additionally, it will be convenient to attend organizational and 
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cultural factors, concordant with literature [8]. 
Workflow problems could be solved by installing a bedside post next to patient to 
hold tablets and allowed hands free. This would ensure that surgical technicians have a 
device exclusively for them, and able to prevent wasting time in withdrawal and return. 
Finally, we consider that could be convenient to redesign checklist according to 
specific context in which it will be used, as Raman recommends [12]. According to 
organization culture and power structure, it would be desirable to work with the entire 
Department of Surgery to raise awareness among all members of operating room about 
the importance of correct completion of checklist on patient safety, following the 
importance of the team's commitment is highlighted [13], as a collective responsibility. 
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Abstract. In hospitals, patient attendants are often necessary in order to closely 
monitor patients with high risk of self-endangering actions and reactions. However, 
such additional monitoring of patients is associated with high costs. In this paper, 
we describe a technical infrastructure for monitoring the patient’s activities, which 
helps to assess whether an attendant should be requested. It was central to for us to 
use non-invasive sensors and to exploit a variety of patient data such as heart rate, 
micro-activity and oxygen saturation. 
Keywords. clinical decision support; sensors; micro-activity; patient sitters 
1. Introduction 
Monitoring inpatients in hospitals is an ever-increasing challenge, as the amount of 
multimorbidity rises with aging population. Especially in acute care settings, many 
adverse events, such as delirium or a psychotic episode, are not related to the actual 
reason for being hospitalized. Patients who develop a delirium are disoriented, 
confused and/or unable to understand their current situation. In the elderly patients, a 
delirium can be superimposed on dementia. As a result, such patients might suddenly 
remove medical devices (such as venous access devices, tubes, catheters, electrodes, 
cables, etc.), they show stress reactions and/or attempt to stand up. Currently, in 
nursing practice, it is often difficult to predict whether and when a patient will develop 
such states that require close monitoring [1, 2]. There are certain known risk factors 
(such as age, drugs used, etc.), but often health professionals can only rely on their 
experience for taking any precautions or initiating any measures [3]. 
Attendants can be nursing trainees, medical students and non-health care 
professionals [4, 5]. Hospitals usually have a pool of such staff. Their job is to 
permanently watch the patient at risk and to intervene if required. On a normal ward, 
the options for interventions are limited to, e.g., calming down the patient by talking or 
calling additional nursing staff for help. Such additional monitoring of patients is 
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associated with high costs. According to internal information from a Swiss university 
hospital (approximate bed size 900) yearly costs for patient attendants can sum up to 60 
full-time nurse equivalents.  
As the request for an attendant must be made several hours in advance, a positive 
decision can result in attendants sitting beside a sleeping patient, thus wasting resources. 
A case study at a hospital in Ohio reported that using a risk-based digital assessment 
tool for regularly allocating attendants can reduce the working hours without increasing 
the adverse events, indicating that there is potential in reducing costs [6]. 
Our goal was to provide and examine a sensor-based technical infrastructure 
monitoring the patient’s activities, which might be helpful to assess whether an 
attendant should be requested. It was central for us to use non-invasive sensors and to 
exploit a variety of patient data such as heart rate, micro-activity and oxygen saturation.  
2. Methods 
2.1 Review of the literature  
We conducted a literature research in Cinahl, PubMed, Web of Science and Google 
Scholar with a focus on the work of patient attendants, the decision process of 
employing them, sensors for detecting and preventing adverse events, and clinical 
decision support systems for allocating patient attendants. Keywords were identified in 
particular through preliminary discussions with stakeholders. These were then entered 
in various combinations: 
 "sitter" or "attendants" 
  ("sitters" OR "attendants") AND "risks" 
 "constant observers" 
 "constant observers" AND "risks" 
 "inpatient" AND "fall detection"  
 "patient monitoring" AND "fall detection" 
 "mattress sensor care" 
 "health data sensor" 
 "patient monitoring sensor"  
 "vital data sensor" 
2.2 Approaches considered 
In order to get insights into the actual work of patient attendants, a semi-structured 
questionnaire for interviews with attendants was prepared and eight interviews were 
conducted. The questions were related to the preparation and training for the job, 
contents of the tasks tackled, subjective assessments of the job, and opinions to the use 
of sensors in the context of the job. Inclusion criteria for the interview were: working at 
least half a year as patient attendant within the last two years, speaking German or 
English, working in a Swiss hospital, being of age.  
To derive the requirements of a sensor-based monitoring system we developed 
several use-cases. In addition, we composed scribbles inspired from the Design-
Thinking approach to visualize the processes itself and potential problems from the 
perspective of a patient attendant [7]. Based on that input, we implemented a web 
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application to integrate the sensor data using the agile Scrum approach [8] in ten one-
week sprints. We applied the JavaScript framework vue.js and loopback for the 
frontend and the backend, respectively.  
3. Results 
The results of our literature research showed a variety of definitions of the concept 
“patient attendant” [9,10]. Many different settings have been reported that require 
different forms of monitoring and interventions. This was corroborated by the eight 
interviews we have conducted. Some attendants just observed, others had to intervene, 
others used a lot of communication with the patient. In most cases, there were no 
trainings beforehand. Attendants had to deal with different medical conditions such as 
delirium, dementia, schizophrenia, suicidality, alcohol problems, etc. Interventions 
comprised calming down the patient, preventing the patient from standing up or make 
sure that a member of clinical staff is available swiftly. Approximately half of the 
deployments were futile because no interventions were required. The study participants 
indicated that sensors monitoring patient mobility and/or attempts to leave the bed 
might be beneficial.  
We developed an evaluation matrix for sensors currently available on the market. 
Main criteria were measured parameters, running time, interfaces, how data is gathered 
(extend of invasiveness), costs, and certification as a medical device. Based on these 
attributes, we decided to use two complementary and nearly non-invasive sensors. One 
sensor is the Mobility Monitor TM (momo) of Compliant Concept, which monitors 
micro-movements of the patients in their bed by placing a sensor under the mattress. 
The system can detect accurately agitation and bed-leaving events. The other sensor 
(Everion TM) from Biovotion is placed on the patients arm and measures pulse, skin 
temperature, oxygen saturation, respiratory rate, and some more parameters. For the 
momo sensor a REST API is available, for Everion a JAVA SDK has to be used in 
order to read the data. 
The overall architecture of our prototype, called SensorLink, is given in Figure 1. 
Both sensors are queried every 10 seconds using the corresponding API. We combined 
the data of both sensors with clinical parameters into one single backend and provide 
interactive graphical outputs in order to assess whether a patient needs more 
monitoring. An example output of the front end is given in Figure 2. Interactivity in the 
graphical outputs is achieved by using the ApexCharts.js library for vizualiations.  
 
Figure 1. Overview on the prototypical sensor network system with two sensors (Everion and the Momo 
sensor) that provide data via different interfaces to the backend for display on a web interface.  
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Figure 2. The graphical user interface of the SensorLink system. Here, the pulse trajectory of one night is 
shown in the main panel. The peak pulse value is at 110 and the average value throughout the night was 64. 
 
 
The data in Figure 2 was collected by installing the sensors and the system at the 
medical informatics laboratory in Bienne/Switzerland with the aim to validate our 
solution. The co-authors SG and PK slept two days each in the laboratory. Central 
events, such as leaving the bed, are given at the left panel of the graphical interface. In 
the right panel, different criteria can be selected, e.g., measurement period, micro-
activity, pulse, heart frequency variability, etc. The results for this selection are 
provided in the main panel. The graphics are interactive and aligned with each other 
based on the time stamps, which allows to monitor several parameters at desired time 
points.  
4. Discussion 
Currently, various sensor-based wearables, external sensors and even mobile video 
monitoring are available [11,12]. However, such solutions are frequently not apt for 
either reducing the amount of complications or for improving the decision efficiency 
regarding patient attendants’ placements [13]. Especially, inappropriate decision and 
bad user experience associated with such additional systems pose serious problems [14]. 
To tackle these problems, non-invasive sensors data should be used together with rule-
based reasoning and machine learning [15]. We have provided a first step in that 
direction.  
The experiences in our project showed that it is rather cumbersome to individually 
integrate the diverse sensors. A decision-making system that uses many different 
sensors should use a comprehensive gateway solution that enables plug and play of 
those sensors. One commercial solution (https://www.leitwert.ch) provides an IoT 
middleware for managing and configuring such a gateway. It allows to collect data on a 
local server, which paves the way to use wearable medical devices in health care 
settings. Clocking of the different sensors is also a relevant issue, as the clock pulse can 
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vary between sensors. Further, it should be taken account that the amount of data 
generated by many sensors in short time intervals indicate that cloud-based solutions 
should be taken into consideration for scalability reasons.  
We have gained first insights into the possible advantages of increased information 
on patients and suitable graphical summaries for the decision concerning placement of 
patient attendants. It is crucial, however,  to prove the benefits of such a decision 
support tool for those who decide in practice. This requires a proper implementation 
study to evaluate the impact in a real-world setting. Central outcomes are acceptability, 
adoption, appropriateness, costs, feasibility, and sustainability [16]. Our goal is to 
conduct an implementation study with an extended version of our prototype, using a 
sensor gateway and machine learning components that do not just condense 
information but deliver advice whether a request of a patient attend is adequate or not. 
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Smart Ageing: Digital Solutions for Future 
Care 
Anthony MAEDERa,1 and Gary MORGANa 
aCollege of Nursing & Health Sciences, Flinders University, Adelaide, Australia 
Abstract. We propose a framework for discourse on digital solutions to support 
consumers and carers in delivery of health care and services for aged persons, based 
on a major needs analysis conducted across 56 diverse business entities in Australia. 
The resulting framework was based on two major identified domains: ”Ageing in 
Place” for independent living situations, and ”Ageing with Care” for managed aged 
care facilities. The paper describes the process used and the intermediate outcomes 
which enabled the framework to be synthesized. It is anticipated that the framework 
could be used to inform future scoping studies and to enable collaborative design, 
implementation and delivery of appropriate smart ageing digital solutions. 
Keywords. Ageing, health services delivery, models of care 
1. Introduction 
It is well established that the age profile of world population is shifting rapidly towards a 
significantly higher proportion of aged persons than previously. The World Economic 
Forum has estimated that by 2050 more than 20% of world population will be aged 60 
years and older [1]. In Australia (typical of developed countries) the proportion is even 
higher: it has been estimated that by 2046, 22% of the population will be aged 65 years 
and older, and that average life expectancy will be 85 years with 19% of older people 
(i.e. over 4% of population) being aged 85 years or older [2]. 
This change in the essential nature of our population will have profound impact, 
stimulating transformational changes underlying health care mechanisms. Today’s older 
citizens wish to remain living in their own homes and to pursue an active lifestyle as 
long as possible, with appropriate support where necessary [3]. Those who require 
assisted living and clinical management through the health care system, expect that 
services reforms which will ensure optimal quality of life can be enjoyed in those 
circumstances [4]. We need to develop a variety of approaches to deal with this 
transformation, some of which will undoubtedly incorporate digital technologies. 
Prior work has provided landscape commentary on opportunities for technology- 
delivered health care support for ageing citizens by appropriate technologies [5] and 
from clinical perspectives [6]. A common emphasis in these domains is the maintenance 
of independence and quality of life for subjects of care [7]. The consequential impact of 
these trends on health technology markets has also been characterized [8]. 
The research study summarised here was intended to provide a qualitatively 
validated clarification of major health services delivery needs for individuals of a future 
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ageing society which can be potentially addressed by digital solutions. These major 
needs may be identified by the subjects-of-care themselves, or may be known to the 
providers of care services who deal directly with individuals: both groups constitute a 
body of end-users for the needs-derived solutions. 
Before developing such solutions as these, it is important to understand their scope 
and to leverage common elements of them to derive the best outcomes. This could be 
expediently achieved by using a high level framework for considering approaches to 
developing digital solutions such as these: the major end-user needs identified here 
provide a basis for describing such a framework. We do not claim uniqueness for the 
framework but we believe that if similar exercises were undertaken, there would likely 
be a degree of commonality due to the diversity of the stakeholder sectors represented. 
2. Methods 
During February to October 2017 structured interviews were conducted with 56 
Australian business entities representing a wide cross section of organisations involved 
with services for ageing. These included companies and not-for-profits engaged in 
community and aged care, hospital and acute care, primary care, nursing and allied 
health, finance, insurance, technology, software, built environment and urban design. 
Further consultations involved local and state government departments and peak 
professional bodies operating in the ageing sector, as well as ageing consumers directly. 
Interviews were commenced with a short description of the context and purpose of 
the study. Interactive interviews followed, with a conversational approach adopted to 
enable free ranging inputs to be collected. Interview durations ranged from 30 mins to  2 
hrs, and in most cases were conducted 1-to-1 between one of the authors and an 
informed senior executive representing the participating organisation. In some cases a 
second interviewee was present but in all cases the vast majority of responses were 
obtained from the primary participant. 
A pro forma interviewing instrument based on prior work was developed to elicit 
problem statements and responses. The instrument contained the following discussion 
prompts: 
• alignment of organisation with Ageing population sectors and situations; 
• perceived major business problem statement and significance to organisation; 
• actions currently being considered or already taken to address the problem; 
• success criteria and need for collaboration and resources to progress solution; 
• potential adoption and deployment settings within the organisation portfolio; 
• strategic perspective on business impact of solving problem (2-5-10 years). 
Conversational responses were captured verbatim from participants in written 
format. These were subsequently independently summarised using a simplifying 
terminology derived by a commonly used wordcloud formulation method, which 
extracted essential and repeated content from the conversational records. These 
condensed responses were subjected to topic clustering using concept-distance measures 
associated with the terminology, to extract common themes. 
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3. Results 
From the topic clustering process, three distinctive end-user sectors were identified, 
which constitute domains of mutual interests spanning the overall ecosystem for a future 
ageing society: 
Individual consumers and their personal circle of other persons, who are self- 
managing their ageing with support from both informal (e.g. family or friends) and 
professional (e.g. allied health workers) carers and the wider community within 
which they are situated (e.g. religious or social groups). 
Community and aged care provider organisations and numerous associated service 
delivery agencies who are addressing and managing the needs of ageing clients, 
through services delivered in the home (e.g. cleaning, excersise), or through 
services delivered in residential managed care settings for those clients unable to 
care for themselves (e.g. feeding, medication). 
Corporate or Government organisations, including clinical professionals, suppliers 
of health systems and technology solutions, developers and funders/payers 
responsible for business and infrastructure design and planning, and policy 
makers/influencers (e.g, bureaucracies, consultancies). 
Two major thematic areas cutting across all three domains were discerned for 
development of digital technology solutions, from categorisation of the problem 
statements and significant recurring content descriptions from the interviews: 
Ageing in Place, where consumers wish to continue living independently, in their 
own accommodation setting and maintaining responsibility for their own health 
status by accessing external sources of support. This will contribute to extending the 
years of healthy ageing and quality of life, as well as retaining longer engagement of 
ageing persons generally in economic and societal activities. 
Ageing with Care, where it is necessary for consumers to live in conditions of 
clinical management, within specialised ageing facilities having associated inhouse 
health care professional support. This will provide platform systems for 
enhancement of key business processes and capabilities, improving consumer 
orientation of the current community and aged care business landscape, and aligning 
with needs to operate in a digitally informed knowledge environment. 
For Ageing in Place, the dominant needs for solutions were identified as follows: 
• Personal Wellness, with information gathered from about daily health related 
lifestyle habits of an individual, as well as summary data from digital 
monitoring sources and records of health check events. 
• Community Connections, with a social networking online environment to 
enable individuals to establish and maintain a personalised set of community 
based group interactions and event participations. 
• Adverse Event Reduction, using a “Health Smart Home” platform system for 
continuous surveillance of occupants, with multimodal sensing and pattern 
analysis to prompt alerts if anomalous situations are detected. 
For Ageing with Care, the dominant needs for solutions were identified as follows: 
• Personal Health Trajectories, representing and modelling of an individual’s 
‘health trajectory’ based on health records and contributed data, mapping their 
advance through the ageing life course. 
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• Consumer Care Portal, a software system integrating information across service 
providers aligned with health data derived client profiles, and sharing health 
history and choices with clients/carers. Chronic Disease Management, via a 
generic software system including data collection and management, analysis of 
trends and recommendations on actions related to health condition self-care. 
These findings are summarised in Table 1 below. While there could have been 
further less prominent topic areas extracted, to perhaps constitute a secondary layer of 
minor elements in the framework, the strength of consensus achieved by those identified 
here was sufficient to confirm them as dominant. 
Table 1. Ageing digital technology solutions framework 
 
Domain Ageing in Place Ageing with Care 
Individual / Patient Personal Wellness Personal Health Trajectory 
Community / Carers Community Connections Consumer Care Portal 
Corporate / Clinicians Adverse Event Reduction Chronic Disease Management 
4. Discussion 
The focus of this work was an approach to enable us to identify and describe the needs 
and issues of older people and care providers, and which allows us to work 
collaboratively to design, implement and deliver solutions to those who need to apply 
them or use them. Through the coordination of research and development activities 
addressing these needs across diverse disciplines, organisations and sectors, innovative 
solutions can be developed which will create impact at scale. 
This framework approach provides a set of channeled elements through which can 
be addressed the challenge of selecting and developing appropriate digital technology 
solutions to achieve the following high value benefits which participants indicated: 
• Optimise the health and support the independence of older people, and thereby 
reduce the cost burden of care, by designing integrated solutions that focus on 
the person and their individual health circumstances. 
• Empower older citizens to self-manage their health while ageing, to the greatest 
extent possible, with improved wellness and enablement while living 
independently and in communities, and provide for their eventual care in health 
facilities by equipping the clinical sector with integrated and comprehensive 
toolsets for appropriate and timely care. 
• Address the business transformation needs of aged care and services providers, 
using living laboratory co-design models, to ensure solutions are appropriate, 
usable by customers and the workforce, and able to be integrated into wider 
systems, and validate their effectiveness at population scale such that they can 
be deployed widely. 
• Develop transformational ‘ageing well’ approaches across the continuum of 
wellbeing, health and care services, which will improve the quality of life for 
ageing individuals and more generally enrich communities through the 
increased engagement of a previously excluded sector in the ageing population. 
Feedback from interviewees included some broader aspirational elements as well as 
the specific needs analysis, which could not be categorized as precisely. These included 
adopting holistic viewpoints on health, living meaningful and purposeful lives, balancing 
increasing consumer expectations against diminishing services and choice, difficult to 
navigate the health system, complexity of integrating technologies. 
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5. Conclusions 
The abovementioned benefits are consequential on the provision of appropriate 
technology solutions in the particular care setting. In the case of Ageing in Place, the 
wide range of potential technologies [9] must be tempered by their careful selection and 
application, to ensure success in their adoption and achievement of utility for purpose 
[10]. Further consideration will be necessary to address the challenges of data 
management and systems architecture [11] in this type of setting, as these are still far 
from being standardised. In the case of Ageing with Care, the overarching issue of 
integration and interoperability of component sub-systems and data flows [12] must be 
solved, harmonizing new solutions and current systems to enable care collaboration [13]. 
The Australian focus of this research may be seen as a limitation, but should nevertheless 
be comparable with the situations of many other high-income countries. Constructing a 
framework distilled from many lengthy and detailed interviews was seen as a beneficial 
way to provide scaffolding to support repetition of the process elsewhere. This approach 
should be of strong interest to the community and aged care sector to enable high level 
strategic planning and prompt social and economic flow-on impacts to its supporting 
sectors, to the health care system broadly, and finally to society at large. 
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Abstract. Clinical decision support systems (CDSS) fail to prevent adverse drug 
events (ADE), notably due to over-alerting and alert-fatigue. Many methods have 
been proposed in the literature to reduce over-alerting of CDSS: enhancing post-
alert medical management, taking into account user-related context, patient-related 
context and temporal aspects, improving medical relevance of alerts, filtering or 
tiering alerts on the basis of their strength of evidence, their severity, their override 
rate, or the probability of outcome. This paper analyzes the different options, and 
proposes the setup of SPC-CDSS (statistically prioritized and contextualized 
CDSS). The principle is that, when a SPC-CDSS is implemented in a medical unit, 
it first reuses actual clinical data, and searches for traceable outcomes. Then, for 
each rule trying to prevent this outcome, the SPC-CDSS automatically estimates 
the conditional probability of outcome knowing that the conditions of the rule are 
met, by retrospective secondary use of data. The alert can be turned off below a 
chosen probability threshold. This probability computation can be performed in 
each medical unit, in order to take into account its sensitivity to context. 
Keywords. Adverse drug events, Clinical decision support systems, data reuse. 
1. Introduction 
Adverse drug events (ADEs) are the most common type of iatrogenic injury. It is 
commonly admitted that coupling a clinical decision support system (CDSS) with a 
computerized order entry system (CPOE) may prevent ADEs [1]. But for current CDSS, 
over-alerting is an important issue: too numerous and inappropriate alerts may interrupt 
the clinicians’ workflow and induce alert-fatigue [2,3], anger or annoyance [4]. This 
may prevent CDSS from improving patient safety [3,5]. As a consequence, up to 96% 
of alerts are overridden by prescribers [2,6–10], mainly because of poor 
appropriateness [11,12]. Unfortunately, appropriate alerts may be perceived as useless 
[2] and then overridden, but followed by actual ADEs [13–16]. The objective of this 
work is to propose a new approach to improve the ability of CDSS to prevent ADEs. 
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2. Material and methods 
We first performed a narrative review of the tracks that have been proposed in the 
scientific literature, to reduce the over-alerting and alert-fatigue of CDSS, by searching 
for scientific papers in the Medline database, without time limit (keywords: CDSS, 
alert-fatigue, over-alerting). We also performed a recursive search including papers 
cited by those papers, and additional keywords. We then classified and discussed the 
tracks exposed in those papers. We finally proposed a new approach named SPC-CDSS 
(see below), in accordance with the results. 
3. Results 
3.1. Narrative review 
In order to decrease over-alerting and alert-fatigue, it has been proposed to improve the 
way the CDSS interacts with the prescriber, and notably to improve the way the alerts 
are displayed [4], to provide the users with relevant instructions for post-alert medical 
management [3,17–19], and to involve non-medical healthcare professionals [6]. Some 
works also proposed to take into account the context of the drug prescription: user-
related context (task, workflow, knowledge, preferences, medical unit) [2,20–22] and 
patient-related context (demographic data, risk factors) [3,17,20,21]. The temporal 
aspects have been identified as an important aspect: half of the prescribing errors occur 
on the first day of stay [14], the repetition of alerts has to be handled [9,20,21,23], as 
well as the kinetic of laboratory parameters [24]. 
It has also been proposed to improve the medical relevance of rules. One important 
track is to filter or tier the alerts by taking into account the strength of evidence 
[3,20,21]. It has been also proposed to ask medical experts to tier the alerts function of 
the severity of the potential outcome [3,5,6,20,21,25–27]: this approach seems to bring 
good results [5,25,27], but the experts hardly agree on the way to classify the rules 
[5,28]. Another option is to turn off rules that have the highest override rates 
[5,20,21,29]: this is efficient and mechanically decreases the override rate [29], but 
other studies demonstrated that most alert overrides were inappropriate [13–16]. 
Finally, given an ADE prevention rule, the conditional probability of ADE 
knowing that the conditions of the rule are met could be used to turn a rule on or off. 
This feature is largely asked by the physicians [3,20,21]. However, those approaches 
are still not implemented, although the reuse of electronic health records could enable 
to automatically estimate the conditional empirical probabilities of ADEs [30–33]. 
3.2. Proposal of SPC-CDSS 
We propose to implement SPC-CDSS, which stands for “Statistically prioritized and 
contextualized clinical decision support systems”. The main idea is that, when a SPC-
CDSS is implemented in a medical unit, it first reuses actual clinical data, and 
automatically searches for traceable outcomes (e.g. “INR>5”). Then, for each rule 
trying to prevent this outcome (e.g. “vitamin K antagonist & quinolone  risk of 
increased INR”), the SPC-CDSS automatically estimates the conditional probability of 
outcome, knowing that the conditions of the rule are met. In case of low probability 
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(the threshold can be customized), the corresponding alerts are automatically turned off 
(“statistically prioritized”). Moreover, this computation is performed in each medical 
unit, in order to take into account its sensitivity to context (“statistically 
contextualized”). This notion of context is a statistical proxy for latent undocumented 
variables, such as patients’ characteristics (e.g. some conditions, admission ground), 
organizational characteristics (e.g. monitoring policies), and physicians’ characteristics 
(e.g. knowledge about drugs, specialty, risk aversion) [30]. 
4. Discussion 
Being able to compute the empirical probability of outcome for each ADE prevention 
rule may allow for two main benefits, that have been tested [30,33,34]. The first benefit 
could be to turn off some rules which empirical probability is below a chosen threshold 
(“A” arrow on Figure 1). Many CDSS rules are inappropriate [11,12], but experts 
hardly agree on which rule should be turned off [5,28]. The second benefit could be to 
show empirical evidence to the physicians to improve their adherence to the remaining 
alerts (“B” arrow on Figure 1). Indeed, too many appropriate rules are overridden by 
users [13–16]. Moreover, such information is requested by many physicians [3,20,21]. 
 
Figure 1. Expected benefits of SPC-CDSS: (A) turning some rules off, and (B) making rules more acceptable 
 
Figure 2. Left: current paradigm for ADE prevention. Right: proposed paradigm for ADE prevention. 
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The current paradigm for ADE prevention relies on the idea that CDSS should be 
calibrated based on the current academic knowledge (left part of Figure 2). But the 
physicians have also been initially trained on the basis of this knowledge. Consequently, 
the CDSS alerts are redundant with their own knowledge, and are useless. We propose 
to consider that the empirical morbidity and mortality are a residual risk, i.e. the 
maximal theoretical risk minus the benefits of the physicians’ training. We then 
propose (right part of Figure 2) to use those empirical probabilities to calibrate the 
SPC-CDSS. Then, the SPC-CDSS alerts would be able to handle situations that have 
not been properly prevented by the initial training of the physicians. In terms of ADE 
risk, these considerations are summarized at the bottom of Figure 2. 
The present proposal should be tested and evaluated using actual clinical data. It 
also rises new issues, such as the threshold to choose, the variability between 
physicians, and the medical staff turnover. Finally, other solutions may be proposed to 
consider the final user’s point of view. 
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Tackling Polypharmacy: A Multi-Source 
Decision Support System  
Guilherme REDEKERa1 and Juliana BOWLESa  
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Abstract. Managing the use of multiple medicines, also known as polypharmacy, 
is a challenge for physicians, pharmacists and patients alike, and is a particular 
concern for patients with multiple chronic conditions (aka multimorbidity). 
Patients with multimorbidity are often required to take a considerable number of 
medications for their different ongoing conditions, and managing/revising these 
medications effectively is a challenge. There is a need to periodically rearrange 
drugs taking into account patient's preferences and avoiding adverse drug reactions. 
We present an incremental, constraint solver based framework for a clinical 
decision support system that makes it possible to check drug prescriptions using 
information from multiple sources, including a constraint database and patient 
records. We illustrate how it can be used to manage clinical conditions while 
reducing polypharmacy problems and undesired side effects in a patient-centric 
approach.  
Keywords. Polypharmacy, multimorbidity, constraint solvers, clinical decision 
support systems 
1. Introduction 
Polypharmacy can be defined as the concomitant use of multiple medications by a 
patient [1] [2], and is commonly linked to the treatment of multiple chronic diseases, 
also known as multimorbidity, which occurs with the highest prevalence in the elderly 
[3]. In addition, the use of many drugs simultaneously to treat different diseases is not 
always clear and may not match patient expectations and preferences [3] [4]. It is 
important that the use of various medications is safe and effective [5], and this may 
become questionable when the risks of medication combinations outweigh the benefits. 
Studies have indicated that there are risks associated with the use of multiple 
medications, which include drug interactions and adverse drug reactions [6] [7].  Drug 
interactions have a negative outcome when the reaction between drugs has, for 
instance, a toxic effect or decreases the effect of one drug [6]. An adverse drug reaction 
is defined as any undesirable medical occurrence caused by a pharmaceutical product 
but not necessarily related to treatment [8] and may occur for different reasons, such as 
the wrong dose, drug or route [9].  Studies have shown that over half of the hospital 
admissions and between 25% to 50% of outpatient care arise from adverse drug 
reactions which could have been mitigated [10].  
The complexity of taking decisions when treating patients can be a significant 
challenge, especially in the presence of polypharmacy which invariably combine many 
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factors/variables. Additionally, treatments should be personalised and the patient's 
individual preferences included in the decision process. The position we take is that, 
specially in the case of complex decision making, automated tool support is essential. 
Our approach combines medical knowledge with formal methods techniques to search 
for and compute optimal solutions for managing the treatment of patients with complex 
needs. This paper is structured as follows: we describe the proposed framework in 
Section 2 and illustrate how our approach works in Section 3. We conclude the paper 
with some overall comments and future work in Section 4. 
2. Proposed Framework 
To support physicians in making appropriate decisions, we propose a clinical decision 
system framework to check and manage constraints between drugs, exams, and 
diseases and take into account patient preferences.  The solution consists of five parts: 
the Electronic Medical Record (EMR) interface, the Knowledge interface, the 
Knowledge database, the Inference engine and the Decision maker 
 
Figure 1. Multi-Source Decision Support System Framework. 
The framework shown in Figure 1 takes constraint data from the knowledge 
sources and patient data from the EMR which are processed independently. The 
information from both sources is used in the Inference engine, which is responsible for 
merging both patient and constraint data.  The Inference engine checks in the 
knowledge database if there are constraints that need to be solved according to the 
patient information then automatically searches for alternative solutions without 
constraints and displays them for the doctor to decide the appropriate prescription. 
2.1.  Knowledge interface and database 
There are different sources of constraints in knowledge sources which can be used in 
the Inference engine. To standardize the link between the Inference engine and its 
sources, we propose a generic knowledge interface. This interface enables the retrieval 
of data about different constraint types such as drug interactions, side effects, 
alternative drugs, exam and vital sign reference values. Developing a generic interface 
will allow users to connect new and different types of constraint sources.  
The knowledge interface operates in three steps: receive, process/convert and 
deliver. The data can be received from different channels. Each channel is for a specific 
type of constraint (e.g., for drug interaction data) and has a custom layout. The data 
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received by the hub is converted into a formal model illustrated in Figure 1 on the 
assert  text between the knowledge interface and database, which is compatible with 
the Z3 [11] solver. Delivery is divided into checking (searching the knowledge database 
to see if a specific constraint is already recorded) and inserting. If a constraint is 
already recorded it is discarded, otherwise the system inserts it in the knowledge 
database to be used by the Inference engine.  
2.2. EMR interface 
The EMR interface deals with different types of patient data to link the information 
between the EMR database and Inference engine. Initially, the EMR interface was 
developed to receive all available information from the patient such as Computerized 
Physician Order Entry (CPOE) which includes drug prescriptions, laboratory results 
from the Laboratory Information System (LIS), Vital Signs and Patient Records. The 
EMR interface also has a channel to receive information on patient preferences. For 
example, there are medications with side effects such as headache, dizziness or 
drowsiness, that patients may want to avoid. In these situations, physicians should 
select drugs which avoid particular side effects. 
Similar to the knowledge interface, after receiving information from the EMR, the 
EMR interface processes the data in three steps: identify, process/convert and deliver. 
In the first step, the hub identifies the type of data (e.g., exam results, drug 
prescriptions, vital signs or patient records). In the next step, the hub converts the data 
into a formal showed in Figure model to be compatible with the Z3 [11] solver, showed 
in Figure 1 between the EMR database and interface. Finally, the information is 
delivered to the Inference engine. 
2.3. Inference engine and decision maker 
The Inference engine was proposed to create links between the knowledge database and 
patient data, so that it is possible for example to search for drugs that do not have 
undesired side effects. The compiler receives patients’ clinical information and selects 
the related constraints on the knowledge database to define solutions using the 
constraint solver Z3 [11]. 
Firstly, the compiler receives the data from the EMR interface and checks if there 
are constraints that need to be solved. Secondly, after receiving patient data, a query is 
executed in the knowledge database based on the received data (e.g., Acetaminophen 
and Leflunomide drug prescription), to find the linked constraint (in this example, the 
drug-drug interaction, drug-adverse reaction, drug-disease interaction and drug-food 
interaction). Finally, if constraints are found for the patient data, the compiler is 
executed to solve or manage them. As a result, the compiler returns advice to 
physicians, the decision maker, which takes into account a number of important 
variables and allows the physician to choose the most appropriate treatment plan to be 
adopted for a given patient.  
3. Practical example 
To illustrate how our approach works, we present an extended hypothetical example 
taken from [5] about a 69 years old man. The patient arrives in hospital after a fainting 
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and seizures episode and complaining about arm pain and dizziness. The physician 
checks the patient’s previous data on the EMR as shown on the first row of Table 1. 
Thereafter the physician requests a blood glucose test, verifies the blood pressure and 
prescribes Dextrose 10% and Electrolyte 500 ml and Codeine phosphate (7,5 mg) + 
Acetaminophen (300 mg) as shown in the second row of Table 1.  
During the consultation, the patient data (previous and new records) is sent from 
the EMR to the EMR interface and sent to the Inference engine. 
 
Table 1. Patient data 
Current medical history Result exams Drugs Patient’ preferences 
(Previous) 
Frequent falls 
Dementia – mixed 
Alzheimer’s disease 
/alcohol abuse 
(Previous) 
BP 120/74 
mmHg 
Blood glucose 
test 90 mg/dL 
(Continuous use) 
Trazodone 150 mg 
Thiamine 50 mg 
Bendroflumethiazide 2.5 mg  
(Previous) 
Patient reports: 
feeling tired and short 
of breath 
(New records) 
Fainting episode, seizures 
(New records) 
BP 132/74 
mmHg 
Blood glucose 
test 125 mg/dL 
(New records) 
Codeine phosphate (7,5 mg) 
+ Acetaminophen (300 mg) 
Dextrose 10% and Electrolyte 
500 ml 
(New records) 
Patient reports:  
Feeling arm pain and 
dizziness 
Given the drug interactions and medical recommendations from the knowledge 
source, the Inference engine checks the constraints from the knowledge database 
against the patient data and highlights the relevant constraints as in the three tables 
below. 
 
Table 2. Constraint drug interaction data 
Drug Drug Interaction Severity 
Trazodone Codeine 
phosphate 
risk of a rare but serious condition called the serotonin 
syndrome, which may include symptoms such as 
confusion, hallucinations, seizures, blurred vision 
Moderate 
Trazodone Bendroflumethiazide lowering blood pressure Moderate 
 
Table 3. Medical recommendations 
Drug Condition Recommendation 
Dextrose 10%  blood glucose test 125 mg/dL May cause hyperglycemia 
 
Table 4. Side effects 
Drug Side effects Used for the following conditions (associated conditions) 
Trazodone 10%  dizziness Alcohol Dependence, Alzheimer's Disease (AD), Dementias 
Bendroflumethiazide dizziness High Blood Pressure 
Codeine dizziness Pain, Acute, Severe Pain, Moderate Pain 
 
Thereafter, the physician interactively manages these constraints with the 
Inference engine. To solve the first interaction in Table 2 between Trazodone and 
Codeine phosphate, the system shows to the physician the drug interaction and lists 
alternative drugs to manage the problem. The alternative drugs are selected from the 
knowledge database according to the associated conditions shown in Table 4. For all 
listed drugs, the system shows all the possible constraints, for example, interactions 
with other drugs or side effects that should be avoided according to patient preferences. 
The alternative drugs are sorted from the best to the more intricate options, that is, from 
the smallest to the biggest number of related constraints. The physician can also decide 
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to exclude a drug from the prescription or prescribe a drug that is not listed, for 
example, to minimise a side effect. 
Moreover, if the physician decides to change/include/exclude a drug, the system 
reloads in real-time the constraints based on this decision. Otherwise, the system keeps 
the existing constraints and flags the chosen drugs in order to avoid repeated alerts in 
case of reloading. The same process is repeated to solve the medical recommendations 
in Table 3 and the side effects in Table 4. The process ends when there are no 
constraints to be solved, which does not mean that all restrictions have been solved, but 
that all decisions regarding the constraints have been made. 
4. Conclusion 
In this paper, we presented the vision of a framework to support physicians to make the 
appropriate decisions considering different types of drug constraints and interactions, 
and respecting patient preferences. The framework is enabled to receive multiple data 
sources combining patient and constraint records. As a clinical decision support 
system, our proposed automated solution only offers advice and the final decision 
remains with the physician. We demonstrated how the system can give advice to 
manage drug conflicts for a realistic but hypothetical example, highlighting the 
importance of gathering medical evidence and knowledge in decision making. In future 
work, we intend to fully develop, implement and evaluate the proposed solution. 
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Abstract. Patients with diabetes are often worried about having low blood glucose 
because of the unpleasant feeling and possible dangerous situations this can lead to. 
This can make patients consume more carbohydrates than necessary. Ad-hoc 
carbohydrate estimation and dosing by the patients can be unreliable and may 
produce unwanted periods of high blood glucose. In this paper we present a system 
that automatically estimates and dispenses the amount of juice (or similar) according 
to the current patients’ blood glucose values. The system is remotely accessible and 
customizable from a chatbot, exploits sensors and actuators to dispense the 
necessary amount of liquid carbohydrates. It relies on a cloud solution (Nightscout) 
to acquire the patient’s blood glucose values, which are constantly updated thanks 
to a commercial wearable continuous glucose monitor (CGM). 
Keywords. Diabetes, Hypoglycemia, Carbohydrates, Cyber-Physical Systems, 
Internet of Things 
1.Introduction
Measuring and managing blood glucose concentration is a key element in 
diabetes care, especially in type 1 diabetes. Since the first real time continuous glucose 
monitor (CGM) was provided for patients in 2001 [1],  its relevance in both ambulatory 
diabetes care and clinical research has increased over the years [2]. Decreasing 
size, weight, complexity and cost of CGM sensors/devices have increased 
usage and dissemination [3]. CGMs have helped patients to improve their 
quality of life, by increasing their confidence in self-management of their disease. 
In diseases such as diabetes, due to the availability of low cost technologies, well-
educated patients, or engaged relatives, it has become possible to formulate, develop and 
distribute solutions that aim to answer specific needs in managing the disease, based on 
the patients individual situation [4]. 
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In this study we show how it is possible to integrate patient-initiated solutions such 
as Nightscout [5], different sensors, mobile technologies and actuators, as concrete tools 
in patients’ daily life. The system referred to as “The House of Carbs”, was developed 
in collaboration with patients, to help them in one of the daily challenges in insulin-
treated diabetes, namely low blood glucose episodes (hypoglycemia). The goal was to 
design a solution that can automatically dose an estimated amount of juice (or similar) 
from a reservoir to a glass, when required. The motivation is to avoid serious 
hypoglycemia situations and in preventing subsequent high levels of blood glucose 
(hyperglycemia) due to intake of more carbohydrates than necessary. We aim in 
stabilizing the blood glucose and avoid the “Roller coaster effect”, when the blood 
glucose is fluctuating between levels outside the normal range. 
This paper is organized as follows: first we describe the methods used, and then we 
present the designed prototype and data from 2 months of use by two patients. The paper 
concludes with limitations and challenges for integrating sensors and actuators in a 
cyber-physical system for people with type 1 diabetes. 
2.Methods
A literature review was conducted for mapping the available systems for managing 
hypoglycemia. The outcomes of this review and a patient-involvement approach were 
then used to define the system functionalities and requirements. Patients’ needs and 
expectations were also used to improve the software during the prototype testing phase. 
Figure 1 shows the conceptual overview of the system, and how it interacts with 
external hardware and software components. 
	
 House of Carbs – a conceptual overview 
Nightscout provides the real time data necessary to detect the hypoglycemic 
episodes and to evaluate the result achieved by the liquid carbohydrates delivery. 
The patient must be an active part of the system, (s)he will have to insert the silicon 
tube inside the juice container and glass. Furthermore, the patient needs to provide the 
information about the juice’s content of carbohydrates and the web address of the 
Nightscout platform. In addition, (s)he is responsible for proper maintenance and use of 
the system, e.g. if the glass is removed from the system, the consequent assumption is 
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that the patient has drunk its content, and it needs to be replaced with a new glass before 
the next delivery. 
3.Results
3.1. The prototype “House of carbs” 
We built a fully functioning prototype using a Raspberry Pi 3 and an add-on board to 
control two high-power DC motors. The “House of carbs” includes an additional 
chatbot application to remotely control the hardware (e.g., clear the pump, remotely turn 
off the machine), define system parameters (e.g., carbohydrate content and amount of 
juice present, Nightscout address, units), and send notifications (e.g., “dose ready to be 
picked up”, “glass removed”), see Figure 2. 

 The prototype “House of Carbs”, based on communication with Dexcom G4 CGM 
and the Nightscout platform. 
The system reports its status and the blood glucose values through a LCD display. 
The detection of the glass represents a critical issue in this system, and this is done by IR 
sensor. In case the glass is not detected, the system will block any juice distribution and 
users will receive a notification about the missing glass via the chatbot. 
3.2. Treatment of hypoglycemia and prevention 
A common approach to treat hypoglycemia is the 15/15 rule [6] (eat 15 grams of 
carbohydrate and wait 15 minutes), especially effective when using liquid 
carbohydrate sources [7]. This rule suggests checking the blood glucose value after 15 
minutes and repeating the procedure if the glucose value is still under 3.9 mmol/L (70 
mg/dL). The proposed system was designed together with real users, revealing the 
importance of automatically detect hypoglycemic episodes and deliver carbohydrates. 
The amount of carbohydrates was made personalizable, and the users can choose 
the amount of delivered carbohydrates (e.g. 20g instead of 15g). According to 
their suggestion, the system allows patient to request carbohydrates when expecting 
hypoglycemia, especially 
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relevant before an intense activity (e.g., physical activity) [8] or for safety reason before 
activities that may be risky (e.g. driving a car) [1].  
3.3. Testing 
The trial ran for two months involving two persons with type 1 diabetes. During this 
period the system logged 3116 different CGM readings and distributed 52 doses of 
carbohydrates. The system delivered either 15 or 20 grams of carbohydrates each time, 
based on the patient’s preferences. Table 1 presents the summary of these distributions. 
	
Successful juice distribution divided by patient and dose type (hypoglycemic or request) 
Patient no 
Carbs 
(g) 
Total 
doses 
Description Value 
1 
15  9 
Average hypoglycemic glucose value 
detected before the dose (mean ± SD) 
3.48 ± 0.51 
mmol/L 
Average glucose value after approx. 15 
minutes (mean ± SD) 
4.17 ± 0.79 
mmol/L 
20  20 
Average hypoglycemic glucose value 
detected before the dose (mean ± SD) 
3.56 ± 0.43 
mmol/L 
Average glucose value after approx. 15 
minutes (mean ± SD) 
4.13 ± 1.08 
mmol/L 
2 20 2 
Average hypoglycemic glucose value 
detected before the dose (mean ± SD) 
3.9 ± 0 mmol/L 
Average glucose value detected after the 
dose (mean ± SD) 
4.7 ± 0 mmol/L 
1 
15 6 
Average glucose value detected before dose 
request (mean ± SD) 
4.75± 0.59 
mmol/L 
Average glucose value after approx. 20 
minutes (mean ± SD) 
4.17 ± 1.38 
mmol/L 
20 15 
Average glucose value detected before dose 
request (mean ± SD) 
4.85 ± 0.62 
mmol/L 
Average glucose value after approx. 19 
minutes (mean ± SD) 
4.77 ± 0.83 
mmol/L 
4.Discussion
Health systems involving sensors and actuators need to be robust and adaptable to 
unexpected conditions and subsystem failures [9]. However, no component is 
perfectly reliable, and the physical environment will produce unexpected conditions.  
The presented system integrates the open source diabetes-monitoring tool 
Nightscout, that has an informational and educational purposes only. Thus, the CGM 
data from Nightscout were the unique source of information in this system – which only 
was made to present future possibilities. All the designed functionalities are dependent 
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of this data, and when no data are received from Nightscout, the system is not able to 
provide these functionalities. Additionally, to maximize the accuracy of the system, the 
sensors connected to Nighscout must be calibrated according to the device producer’s 
instructions. It is important to make it clear that the test period was short, the number of 
subjects were limited, and the patient participants have more than 20 years of diabetes 
experience and involved in different diabetes research projects. 
4.1. Practical limitations 
Designing such a system requires several assumptions. For example, that the source of 
carbohydrates is a safe and efficient liquid, the target glass has a capacity that can hold 
the maximum delivered dose, and both the source and target containers need to be 
clean due to hygienic reasons. Also, the entered settings need to be accurate for the 
system to deliver the right doses. If the user enters incorrect information (e.g., the 
carbohydrates content of the juice), the system may not help the user to achieve a 
healthy blood glucose level. Furthermore, the chatbot component of the system can 
potentially be accessed by anyone and therefore additional security solutions is needed 
to avoid abuse or misuse. 
5.Conclusion
The main contribution of this research is demonstrating the design of a practical 
system able to monitor and prevent hypo- and hyperglycemia. The system has 
been designed using a patient driven approach, and integrates some already 
existing components. 
The absorption of glucose into the bloodstream was shown to be effective for 
the two test-persons, after one or more delivered doses, in average after 15-20 minutes. 
They were satisfied with the use of the system and even surprised how it was able to 
stabilize the blood glucose. No hyperglycemia episodes or “Roller coaster effect” were 
caused by the system.  
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P. Randine et al. / The House of Carbs: Personalized Carbohydrate Dispenser 697
Update on the DMP,  
the French Nationally Shared Medical 
Record: Did We Make It?  
Brigitte SÉROUSSIa,b1 and Jacques BOUAUD c,a 
a
 Sorbonne Université, INSERM, Université Paris 13, Sorbonne Paris Cité, UMR_S 
1142, LIMICS, Paris, France  
b
 AP-HP, Tenon Hospital, Paris, France 
c
 AP-HP, DRCI, Paris, France 
Abstract. Different countries have solved the problem of care coordination by 
implementing a nationwide centralized framework of clinical information sharing 
with “new” secure online care records stored in specifically created platforms. The 
French DMP initially launched in 2006, relaunched in 2010, and re-relaunched in 
2016 follows this model. After a difficult start and some governmental actions to 
promote its adoption, the DMP has been nationally deployed in November 2018. 
New features have been developed (creation of DMPs for children, management of 
minors’ rights, addition of living wills, notification of the first access of any 
healthcare professional), and financial incentive measures have been implemented. 
In September 2019, over seven million people had a DMP in France. In 18 months, 
we observed a significant increase of GPs feeding (from 0.7% to 20.9%) and 
consulting (from 1.6% to 44.8%) DMPs.  
Keywords. Personal Health Records, Electronic Health Records/utilization, 
Patient Access to Records, Patient Participation, Mobile application  
1. Introduction 
Patients suffering of chronic diseases and related morbidities are currently managed in 
multiple settings by numerous healthcare professionals. Care is thus currently strongly 
fragmented and care coordination among the different healthcare professionals is 
complex. As a result, care management may be not effective and sometimes harmful to 
the patient [1]. The potential of electronic health records (EHRs) and other health 
information technology (HIT) tools to facilitate information flow at care transitions has 
been described [2]. In particular, these tools allow the different care providers to share 
the same information about a patient’s condition which allows to access crucial 
information in emergency room and optimizes the quality of care, reduce adverse drug 
reactions considered as the leading causes of morbidity and mortality in health care, 
and decreases health care costs by improving care relevance and not duplicating 
diagnostic tests. However, while EHRs are necessary, they are not sufficient to 
guarantee care coordination because non-interoperable EHRs and vendors' expensive 
custom interfaces are hindering health information exchanges [3].  
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Different countries have implemented a nationwide centralized framework of 
clinical information sharing to solve the problem of care coordination relying on the 
development of “new” secure online care records stored in specifically created 
platforms [4]. Adoption of these medical records has historically been poor and 
governmental actions were taken to promote their uptake. For instance, the DMP or 
“Dossier Médical Personnel”, currently “Dossier Médical Partagé”, has been 
relaunched in France in 2010 after a first start in 2006 and a first stop six months later 
due to security concerns [5]. It has also been re-relaunched in 2016 because of the poor 
uptake after the first relaunching (only 520,000 DMPs and about a coverage of 1.5% of 
the target population). At this time, the DMP program governance was transferred to 
the French national health insurance or CNAM (instead of the national technical 
agency in charge of HIT systems interoperability or ASIP Santé) and acted by the 2016 
French Health Act. 
Since 2016, new functionalities have been developed to improve the uptake of the 
“new” DMP, including the creation of DMPs by patients themselves, the automatic 
post of health data derived from insurance claims at the creation of DMPs (giving some 
medical contents to DMPs), the publication of a mobile app, and the organization of 
large public communication campaigns to inform patients and more widely involve 
citizens. These new features have been tested between December 2016 and August 
2018 in nine pilot French departments with a good success [6]. This paper describes the 
evolution of the DMP program since August 2018, and specifically after the DMP 
official national deployment in November 2018 by both the French Ministry of Health 
and the French national health insurance’s director.  
2. Methods 
Originally, the DMP project was designed to support care coordination. All care 
providers may populate their patients’ DMP (discharge summaries, lab results, 
radiology reports, etc.). However, only care providers authorized by a DMP’ owner 
may access and read his/her DMP contents. To promote the national deployment of the 
DMP program, new functionalities have been developed to improve the quality of 
services provided by DMPs, along with the implementation of financial incentive 
measures varying with the different types of healthcare providers. 
First, a huge work has been done by the French national health insurance with 
EHR vendors and care professionals to resolve remaining technical issues and promote 
the smooth interoperability of the DMP and EHR systems (almost all private 
physicians and hospitals have been accompanied by French national health insurance 
technical agents to help them upgrading their EHR systems). In addition, new features 
have been implemented such as the creation of DMPs for children, the management of 
minors’ rights (although under the responsibility of their legal representatives who are 
in charge of managing their DMP, minors may hide information to their parents with 
the support of an adult and in relationship with their general practitioner, GP), and the 
creation of a DMP chapter to collect advance directives (living wills). Besides, since 
DMPs are technically open to all healthcare professionals (except to those that have 
been explicitly excluded by the patient) to allow emergency accesses by any healthcare 
professional if necessary, the patient owner of a DMP is now notified of the first access 
of any healthcare professional to his/her DMP, in addition of this access being tracked 
in the DMP journal of accesses (only accessible to the patient and his/her GP). Finally, 
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a second version of the DMP app has been developed to improve interface ergonomics 
and usability. 
Financial incentives have been implemented to accompany the deployment of the 
DMP program. Because pharmacists were very good to create the patient 
pharmacological record (DP), the French national health insurance offered them one 
euro per DMP created (nurses are the next on the list to get this incentive). DMP 
compatibility with EHRs used by private practitioners is now a prerequisite to get the 
ROSP (“Rémunération sur Objectifs de Santé Publique) that accounts to a maximum of 
3500 euros per year. Biologists are also encouraged to use DMP-compatible HIT tools 
and they may receive from 5,500 to 10,000 euros per year (according to their levels of 
activity) when pushing biological reports / lab results in DMPs. Hospitals and private 
clinics may consider entering the nationwide HOP’EN program (HOP'EN builds on 
healthcare institutions digital transformation and modernization, the aim being that by 
2022, whatever their status, size, and activity, they could bring their HIS to the 
maturity level necessary to address the new challenges of the health system 
defragmentation) and get revenues when they post discharge summaries in their 
patients’ DMP. Finally, nursing homes are also supported to use a DMP-compatible 
information system and to push post emergency liaison records in DMPs (they can 
receive up to 2,500 euros). 
3. Results 
Whereas there were 580,000 DMPs in June 2016, and 930,000 DMPs by the end of 
October 2017, there were seven million DMPs on September 15th, 2019. Currently, 
10,000 DMPs are created every week. Figure 1 displays the evolution of DMP creation 
over the time. The acceleration of DMP creation after the national deployment of the 
program is visible. DMPs are mostly created in French national health insurance offices 
(45%), pharmacies (35%), and by patients using the DMP website on Internet.  
Figure 1. Evolution of DMP creation visualizing the acceleration of the process after the national 
deployment of the DMP program. 
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DMP contents essentially come from private clinics and hospitals inputs. Currently, 
400 out of the 3000 French care structures are pushing discharge summaries in DMPs 
(24 university hospitals out of a total of 32 nationwide). Besides, there is a significant 
increase of DMP feeding by GPs (from 0.7% to 20.9% in 18 months), and a significant 
increase of DMP consultation by doctors (from 1.6% to 44.8% for GPs, and from 0.1% 
to 7.3% for other medical specialists). The case of pharmacists is also noticeable with 
an increase of DMP consultation from 0.0% to 11.3%. Currently, and for political 
reasons (there is still no consensus between the French national health insurance and 
biologist unions on how, when, and which levels of incentives should be provided), 
biologists remain less involved in DMP creation, population, and consultation. Table 1 
displays the evolution of DMP population and consultation according to the type of 
care practitioners.  
 
Table 1. Evolution of DMP population and consultation according to practitioners types in 18 months. 
 
 
A new DMP mobile app has been developed to improve the display of all the 
documents contained in the DMP. A totally updated interface has been implemented, 
starting with a home page displaying the last documents added as well as the identity of 
the last care provider that accessed to the DMP. New features have been developed 
such as the access to images, and a button to help the patient hide some information of 
his/her DMP. Some screen shots of the new DMP mobile app are given in Figure 2.  
4. Discussion and conclusion 
After a difficult starting period, the French DMP looks to be successfully adopted by 
both patients and care providers. However, although the pace of DMP creation is 
impressive, DMP feeding is substantially increasing, and DMP consultation is 
beginning to happen, the DMP remains unnatural for many care providers that consider 
it as an extra tool on top of their usual EHR. Thus, new features are currently under 
development to make DMPs attractive, such as a chapter to represent the vaccination 
record, and the connection with mobile devices to collect relevant medical data, but it is 
not clear whether this will be enough and patients who are active supporters of the 
DMP program have to ask their care providers to populate and consult their DMP. 
The next step will be the switch from the opt-in to the opt-out model where DMPs 
will be automatically created unless the patient opposed to it. This has been written in 
the last French Health Law (2019) and should be performed by the beginning of 2022. 
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This is similar to what happened in Australia with “My Health Record” and it is when 
the program started to encounter serious difficulties [7] because of public distrust over 
data privacy. We hope the transition to be smoother in France and expect about 60 
million DMPs by 2022 (to account for the usual 10% of opt out rate). At this time, we 
would know if we really made it. 
 
 
Figure 2. Screen shots from the new DMP mobile app. 
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Abstract. Electronic health records (EHRs) are becoming the norm in healthcare. 
Typically, these EHRs are large-scale suite systems. The up-front presence of ready- 
for-use EHR suites changes the role of user requirements and the conditions for 
deciding which requirements to include in the final contract. In this paper, we 
investigate how user requirements are negotiated in the ongoing preparations for the 
implementation of Epic throughout the region of Central Norway. User requirements 
shape vendor selection but they are also shaped by the vendors’ existing EHRs and 
by the requirements of the selected vendor’s other customers. 
Keywords. Electronic health record, Epic, implementation, user requirements 
1. Introduction 
Electronic health records (EHRs) are becoming the norm in modern healthcare. 
Typically, these EHRs are large-scale suite systems with many modules and extensive 
configuration facilities [1]. Examples include Cerner, Epic, and InterSystems. In the 
initial procurement phase healthcare organizations choose among vendors that already 
have EHR suites ready for deployment. Subsequently, healthcare organizations negotiate 
configurations, extensions, and revisions with selected vendors. The initial presence of 
ready-for-use EHR suites changes the role of user requirements and the conditions for 
deciding which requirements to include in the final contract [2]. We investigate how user 
requirements are negotiated in the ongoing preparations for the implementation of Epic 
throughout the region of Central Norway. The new EHR in Central Norway is not 
restricted to its hospitals but will also cover its municipal healthcare services, that is, 
general practitioners (GPs), home care, and nursing homes. Due to the heterogeneity of 
these healthcare providers, the user requirements are many and diverse. It is essential to 
convey these requirements to the vendors. After a single vendor has been selected it is 
especially important that this vendor comes to understand the requirements. At the same 
time the requirements – and the implementation preparations in general – will be 
strongly shaped by the EHR suite already available from the vendor. The outcome of this 
process is still open [3]. 
We ask: How are user requirements negotiated and shaped in the meeting with 
large-scale EHR suites? Empirically, we ask this research question in relation to the 
Epic implementation in Norway, but the process is not specific to the Norwegian case. 
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2. Method 
The study takes an interpretive research approach [4,5]. The data consist of interviews 
and publicly available documents. We conducted six interviews with top management in 
the Health Platform program, which is responsible for the Epic implementation in 
Central Norway. The director of the program was interviewed twice. The interviews 
were audio-recorded and transcribed for analysis. Media coverage and informal 
discussions with project members provided supplementary input. The data were 
collected in the autumn of 2018, about half a year before the contract with Epic was 
signed. 
3. Case 
The Health Platform is a regional program owned by the Central Norway Regional 
Health Authority and Trondheim municipality. It aims to acquire and implement an EHR 
for the whole region, including all the hospitals, GPs, nursing homes, and home-care 
services. By including the municipalities, the health authorities want to make the Health 
Platform a pilot for the long-term national goal of establishing a nationwide EHR 
functionality, "one citizen - one record" [6]. 
The Central Norway region includes 44,000 healthcare professionals and an 
approximate population of 720,000 citizens. There are 3 hospitals whereof the largest is 
the university hospital, St Olav’s Hospital, located in Trondheim. St Olav’s Hospital is 
already at a high level of digitization. In contrast, the level of digitization varies 
substantially across the GPs, nursing homes, and home-care services, where particularly 
the GPs already have well-working systems at their disposal. The Health Platform has 
identified 80 current information systems that will be replaced by the new EHR. In 
addition, 160 integrations between the EHR and other systems must be developed. 
Trondheim municipality will be in the first wave of implementation, while the rest of the 
84 municipalities in Central Norway have the option to opt in after that. 
3.1 The bid for tender 
The invitation to tender was announced in August 2016 with an upper limit for the 
contract of NOK 2.7 billion (EUR 270 million), including licenses, the vendor’s 
services, and 10 years of maintenance [7]. The time schedule for the main activities was 
as follows: vendor prequalification in 2016, dialog phase with selected vendors in 
2017/2018, contract with a specific vendor signed in 2019, and implementation and go- 
live in 2021. 
From early on, extensive user participation was identified as crucial to the success of 
the program. When the acquisition process started, 400 clinicians from municipalities 
and hospitals across the Central Norway region became involved. These clinicians 
participated in 101 workshops in which they described what they valued about their 
current information systems, what challenges they currently experienced, and what was 
missing. The outcome of these workshops became the basis for the requirements 
specification, which amounted to 4000 user requirements. 
A total of 11 EHR vendors applied for prequalification in 2016. In February 2017, 
the Health Platform sent out the final information for the procurement of the future HER 
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to the five prequalified EHR vendors: Cerner, CSC Scandihealth (later renamed to DXC 
Technology), Epic, InterSystems, and Tieto. The tender was based on the user 
requirements and a dialogue with the vendors about how they planned to meet these 
requirements. The bids submitted by the vendors were evaluated by project members and 
by people from the line organization. In May 2017 four EHR vendors submitted revised 
bids, and in January 2018 the number of vendors was reduced to two, namely Cerner and 
Epic. However, Cerner decided to withdraw, because they could not see a business case 
for making a bid that met all requirements in the functionality for the municipalities. The 
contract between the Health Platform and Epic was signed in March 2019. 
3.2 Negotiating the development of functionality 
In spite of the substantial functionality and configurability of Epic, some new software 
development was needed, particularly to extend Epic with additional functionality for the 
municipalities. The Health Platform requested that Epic developed a pregnancy record, a 
medication module for home care, and support for patient-related administrative 
procedures such as which benefits the patient shall receive. Although Epic initially 
responded positively to these requests, things became more complicated closer to the 
deadline for signing the contract. The Health Platform had to work hard to convey 
Norwegian routines to Epic, particularly in relation to the administrative procedures. 
A lot of functionality is dependent on integrations between Epic and other systems. 
In the municipalities, the systems that need to be integrated with Epic include Transmed 
at the security centers, employee administrative systems, economy systems, and the 
roster module in the administrative resource management system. The need for 
integration invoked questions about the location of certain data and functions. For 
example, the GPs’ current EHR stores their economy data. As a result, all claims against, 
for example, the Norwegian Labor and Welfare Administration are handled in their 
EHR. In addition, the GPs have billing systems where patients pay for their GP visit. The 
vendors of the billing systems handle debt collection from patients who have not paid 
what they owe according to the data in the GPs’ EHR. Epic was not familiar with such a 
setup, but with one in which the billing system handled all economy data. It requires 
considerable work to develop the integration between Epic and the billing systems. 
To ensure the continued evolution of the EHR after its implementation, the Health 
Platform management envisions to increase its collaboration with other European Epic 
customers. This is in line with the Epic strategy for development. As a means to 
establish common requirements, Epic encourages its customers to collaborate on 
requirements for new functionality. For example, there is currently a collaboration 
between Epic customers in Switzerland and Denmark about the development of 
functionality for medication management. These collaborations mean that new 
Norwegian user requirements will have to be brought into alignment with those of other 
customers as well as to be negotiated with Epic. A new version of the entire Epic system 
is rolled out to all customers four times a year; the philosophy is that all new 
developments are available to all customers. 
3.3 Configuring the system 
Overall, the Health Platform management was satisfied with the configuration facilities 
in the system. The Health Platform was, for example, pleasantly surprised when they 
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learned that Partogram (graphical maternal and fetal data) functionality could be 
configured and, thus, did not have to be developed from scratch by Epic. However, Epic 
promoted configuration proactively, and sometimes at the expense of development. An 
illustrative example is the Health Platform’s request for offline EHR functionality in the 
ambulances. When ambulance personnel lose online contact with the EHR, they should 
still be able to read and update the EHR in an offline mode, and these updates should 
then be synchronized with the online version later. Epic argued that the development of 
offline functionality would delay the project. As an alternative, they suggested that they 
could configure the existing user interface of the ambulance module in a way that would 
partially cover the requested functionality. After conferring with the relevant clinical 
disciplines, the Health Platform decided to let go of offline functionality and settle for 
the solution that Epic offered. 
Configuring the Epic system in the start-up phase involves lots of decisions about 
how the system should function. While Epic can be configured differently for different 
settings (e.g., GPs, home-care services, hospitals, and nursing homes), a great deal of 
standardization of work processes is necessary to achieve the goal of an all-compassing 
EHR that can support inter-organizational information exchange and workflows. 
Standardization can also be a means of getting rid of unwanted variation in treatment and 
care. For a given patient condition and a given step in, say, an outpatient work process, 
the system could for example enforce the prescription of certain drugs or tests, and in a 
specific order. The Health Platform has established an extensive formal decision 
structure to decide on such standardizations, but some decisions will also require top- 
level approval because the standardization has far-reaching organizational consequences. 
For example, the Health Platform is considering to enforce a fully electronic medication 
management process (ordering, dispatching, distribution, dispensing, and 
administration), which currently is only supported by paper-based routines. 
The formal decision structure will be pertinent to a successful implementation. 
During the preparations for going live in 2021, it is estimated that Epic will raise 
something like 8000-12000 questions about the details of how the system should be 
configured. The customer must respond within a 10-day deadline, otherwise Epic will 
choose the default configuration for the area in question. 
After Epic has been implemented, key users (and not the vendor) will be responsible 
for the continued configuration of the system. In Epic terminology, these clinicians are 
called “physician builders”. They will become responsible for configuring the layout of 
the system, its information flows, and its support of workflows. During the configuration 
of the initial Epic setup the physician builders will work together with Epic personnel. In 
a subsequent regional organization, the physician builders will continue to work on 
optimizing and streamlining work processes. To prepare for this task, the physician 
builders will attend a training course of up to six weeks and will subsequently work full- 
time as physician builders in Central Norway. This policy is intended to ensure 
flexibility for the users and to reduce dependence on the vendor. 
4. Concluding discussion 
In the initial procurement phase of EHR suites, the customer has the option of choosing 
between different vendors based on a detailed requirement specification. The vendors 
present what functionality they offer, and the development of new functionality is 
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negotiated. In this phase, the vendors must be able to respond satisfactorily to the 
customer’s demands. However, after the vendor selection the preparations for 
implementing the system are strongly shaped by the product already available from the 
vendor, including its configuration possibilities. During these preparations the 
customer’s (and future users’) involvement consists to a large extent of responding to 
opportunities provided by the vendor, such as to queries about configuration choices. In 
this process the requirements specification may face considerable competition and initial 
requirements may be revised on the basis of descriptions and demonstrations of the 
vendor’s suite system [8]. We are not claiming that requirements specification is no 
longer important but that its main role is in vendor selection. 
After go-live the vendor will most likely be less available, both for system 
development and for configuration. New functionality that requires development must be 
aligned with other Epic customers along the lines of the current collaboration between 
Switzerland and Denmark. By encouraging such collaborations, the vendor shifts it onto 
its customers to reach agreement about how the system should evolve [9]. This way 
alliances and shared – or conflicting – interests among the customers will shape the user 
requirements that the Health Platform can present to Epic. Requirements specific to 
single customers will likely receive low priority from Epic or be considered topics for 
configuration (by the individual customer) rather than development (by Epic). 
Regarding future configuration, it is expected that the physician builders do this. 
However, given that many decisions about configuration will have to be made before go- 
live, it is an open question to what extent it will be practically possible for the physician 
builders to make larger configurations later. After all, some of these decisions must be 
made in a complex decision structure, sometimes requiring top-level organizational 
approval. For larger configurations to happen, a continued organizational commitment to 
the same extent as in the implementation phase will probably be necessary. Without such 
a continued commitment, the extensive configuration possibilities will remain a dull 
instrument for meeting emergent user requirements. 
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Abstract. The purpose of this study was to investigate the value mechanisms in 
implementing a digital health intervention (DHI) in different contexts and 
countries. We utilized realist evaluation and the CIMO logic (Context, 
Intervention, Mechanism, Outcome) to analyze the mechanisms explaining the 
value capture of Klinik Pro, an Intelligent Patient Flow Management system 
(IPFM), which is a DHI for seeking of treatment and triage purposes. The study 
was conducted as a multiple case study using semi-structured interviews to 
research four market expansions in three countries. In total, seven healthcare 
mechanisms were discovered: co-creation, proper competence level, coordination, 
evidence-based medicine, integration, proper timing, demand management. The 
first four mechanisms were the same in all cases. CIMO framework proved to be 
useful in the value formulation of the IPFM. 
Keywords. Digital Health Intervention, Value-Based Healthcare, CIMO 
1. Introduction 
There are increasing investments into digital health interventions (DHIs), but the value 
capture of these solutions is difficult to measure due to the complexity of the 
interventions and their implementation areas [1-2]. In particular, the mechanisms 
through which the outcomes of the DHI are achieved are often elusive, because there is 
insufficient understanding of the dynamics between the implementation context and the 
activated value mechanisms in healthcare. Thus, this study focuses on expanding 
knowledge on how to discover the mechanisms that explain the value formulation of 
DHIs. The approach used for this is the CIMO logic, which stands for Context, 
Intervention, Mechanism, and Outcome [3]. As an approach emerging from design 
science, CIMO can be used to structure the logic of outcomes and dynamics of an 
intervention when implemented in a given context [4]. Value in healthcare in this study 
is understood as the health outcomes achieved per resources used, i.e. a relation [5]. 
The studied DHI in this research was an Artificial Intelligence based intervention 
by a Finnish health technology company, Klinik Healthcare Solutions Oy. Their DHI, 
                                                          
1  Corresponding Author: Henni Tenhunen, Aalto University, Espoo, Finland; E-mail: 
henni.tenhunen@aalto.fi 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200252
708
called Klinik Pro, is an Intelligent Patient Flow Management system (IPFM) that 
supports efficient seeking of treatment and triage. Patients report their symptoms online 
to the IPFM, which then utilizes AI to analyze the level of urgency and suggesting an 
initial differential of diagnoses. This information is then directed to healthcare 
professionals to perform further actions (Figure 1). 
Figure 1. An example of a setup and functionalities of Klinik Pro (the IPFM) 
The real-time empirical setting of this study was formed when in 2019 the 
company was simultaneously expanding its operations in four instances enabling 
international comparisons: one in Mexico, one in Portugal and two in Finland. These 
four contexts were analyzed using the CIMO logic and following [6]. By collecting 
data regarding the intervention, contextual environments, and expected outcomes of the 
IPFM, our aim was to deduce which value mechanisms are activated in the 
implementation of the IPFM. The main research question was: RQ1: How to discover 
the mechanisms through which digital health intervention accomplishes value? As a 
sub question we asked: RQ1.1: How does the implementation context modify the 
activation of the mechanisms? 
2. Data and Methods 
The research design followed the principles of design science and service engineering. 
Due to utilizing the CIMO logic in our empirical cases, the study also followed the 
principles of theory elaboration model [7] as well as grounded theory [8]. The study 
was performed as a multiple case study with one unit of analysis: the seeking of 
treatment and triage process within the primary care unit in each case (Table 1). 
Table 1. Case descriptions. 
Context Targeted healthcare 
system 
Main example of IPFM’s 
expected outcomes 
Market phase 
Large city in Finland Public primary care Reduce nurses’ stress levels In Production 
National association in 
Finland 
Public primary care
More efficient handling of 
patient flows 
Piloting / Pre-
production 
Large city in Mexico 
Public and private 
primary care 
Create a system to manage 
electronic health records 
Pre-market 
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Medium large city in 
Portugal 
Public primary care Create a digital triage system 
Piloting 
 
We gathered data by conducting ten semi-structured interviews following the 
structure of the CIMO-configuration. The interviews took place during spring 2019 and 
were targeted on a diverse group of stakeholders within each market expansion 
including healthcare professionals, investors, managers, and IT experts (Table 2). 
Table 2. List of informants. 
Organization type Description of the organization Informant role 
Health technology company Klinik Healthcare Solutions Chief Medical Officer 
Primary care unit Finnish medical center Chief Physician 
Primary care unit Finnish medical center Assistant Head Nurse 
Primary care unit Portuguese medical center Managing Physician 
Primary care unit Portuguese medical center Physician Intern 
Primary care unit Finnish medical center Manager of Health Services 
Primary care unit Finnish medical center ICT Service Coordinator 
Venture capital Healthcare VC company  CEO 
Primary care unit National healthcare association CIO 
Primary care unit Mexican medical center MD, CEO 
3. Results 
The activation of healthcare mechanisms relies not only on the dynamics of the 
intervention and its implementation, but also on the prerequisites of purposeful action. 
In all cases the informants considered the IPFM to improve the precision of 
information, break time and location boundaries, and enable inexpensive data 
collection from patients. However, there were differences in implementations as in 
Mexico the existing IT infrastructure could hinder proper use of the IPFM, whereas in 
Portugal the informants considered the decentralization of patient information to cause 
challenges. Considering the prerequisites for purposeful action, all informants 
considered the IPFM to provide improvements in the control information among 
healthcare professionals to make decisions that are more justified. Furthermore, the 
motivation to use the IPFM was perceived to be good in all cases. Finally, a few 
informants considered the IPFM to create new capabilities such as inventing new ways 
to plan clinical pathways utilizing the analysis performed by the IPFM’s AI.  
Four healthcare mechanisms were discovered in all cases. First, co-creation is a 
mechanism that is inherently active in the IPFM due to engaging both patients and 
healthcare professionals in using the IPFM. Second, all informants perceived the IPFM 
to activate the proper competence level mechanism that allows the utilization of the 
lowest sufficient resource in each operation leading ultimately to cost savings. Third, 
the IPFM was considered to activate the coordination mechanism due to improved 
control information. Finally, as the IPFM’s AI performs the conditional analysis of the 
patients based on the most relevant scientific findings, the evidence-based medicine 
was the fourth mechanism active in all cases. 
Besides the aforementioned four healthcare mechanisms, the Finnish informants 
considered the IPFM to support integration mechanism that results in more coherent 
and consistent knowledge of patients’ conditions. This was not considered active by the 
informants in the case of Mexico due to issues in the pre-existing IT infrastructure. 
Moreover, integration was also not considered to be activated in Portugal due to 
decentralized implementation. Besides integration, proper timing, a mechanism to 
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route and schedule patients effectively, was considered to be active in the Finnish 
cases. However, it was not seen activated in Mexico or Portugal due to same reasons as 
with integration. Finally, the seventh healthcare mechanism considered to be somewhat 
present in all cases was demand management. As the IPFM acts as an additional 
channel to seek treatment, all informants considered the possibility of the IPFM 
supporting efficient contacting of patients. However, in all cases it was also elaborated 
that this additional channel might result in overcapacity problems as patients might 
utilize multiple channels while seeking treatment. Thereby, the demand management 
mechanism was considered less relevant for all cases. 
Generally, the mechanisms in each case were perceived to be very similar despite 
the contextual differences. In spite of the similarities, the varying intentions and 
priorities to utilize the IPFM among the stakeholders result in diverse outcomes 
responding to the actual problems the IPFM aims to solve. Thus, the same DHI can be 
used for very different purposes. 
4. Discussion and Conclusions 
By analyzing and comparing the cases, it is possible to discover patterns in the IPFM’s 
functionality to understand its value formulation on a more general level. In short, the 
IPFM’s ability to function correctly relies on the co-creation mechanisms to engage 
patients to report their symptoms to a digital system. Consequently, the practices 
regarding triage (e.g., whether it even exists) and the existing IT-infrastructure are the 
critical factors. Any issues with these factors result in uncertain activation of any 
healthcare mechanisms. 
Depending on the willingness of actors, the IPFM produces a more precise 
understanding of the patient’s condition, which forms a foundation for a better access, 
planning, and implementation of treatment. IPFM improves not only the knowledge of 
the patient and healthcare professionals but also enables optimization of resources, thus 
potentially leading to costs savings, enhanced productivity, and improved quality of 
care. Consequently, more effort can be allocated to actual patient care tasks. This is the 
kind of value that decision-makers appear to be looking for. Additionally, IPFM could 
even provide new competences for its users. However, a critical factor in realizing all 
the mechanisms rely on the users’ adaptability and willingness to use the IPFM in the 
first place. Figure 2 illustrates this value formulation process of Klinik Pro (IPFM) on a 
general level. The purple color indicates patient while the red color refers to healthcare 
professionals. The IPFM and its activity is described with gray. Healthcare mechanisms 
are illustrated with blue while the outcomes are highlighted with green. The arrows 
indicate the interdependent relationships between the factors. 
There are certain limitations in this research that need to be taken into account. 
First, this study concentrates merely on DHIs directed to triage and seeking of 
treatment, i.e. IPFM solutions. Second, the patients, the most important stakeholder 
group, were not studied, thus making patient perspective vital to study in future studies. 
Third, although being a multiple case study, the number of interviews in total was 
limited. 
Despite these limitations, this study provides new insights into discovering the 
mechanisms of DHI value by examining the interdependent relationships between the 
intervention, its context, and its expected outcomes. Furthermore, this study supports 
the customers of the health technology companies (e.g. medical centers) to understand 
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the value formulation of similar DHIs as the IPFM, improving managerial decision-
making. With this information, it is possible to concentrate on activities to maximize 
value capture while also detecting unnecessary activities. 
 
Figure 2. Value Formulation of Klinik Pro (the IPFM) 
References 
[1] C. Sorenson, M. Drummond, B. Khan, Medical technology as a key driver of rising health expenditure: 
disentangling the relationship, Clinicoecon Outcomes Res 30 (2013),;223–234. 
[2] E. Murray, E. Hekler, G. Andersson, L. Collins, A. Doherty, C. Hollis et al., Evaluating Digital Health 
Interventions: Key Questions and Approaches, American Journal of Preventive Medicine 51 (2016), 
843–851. 
[3] D. Denyer, D. Tranfield, J. Van Aken, Developing design propositions through research synthesis, 
Organization Studies 29 (2008), 393–413. 
[4] J. Holmström, T. Tuunanen, J. Kauremaa, Logic for design science research theory accumulation, 
Proceedings of the Annual Hawaii International Conference on System Sciences (2014), 3697–3706. 
[5] M. Porter, What is Value in Health Care?, The New England Journal of Medicine 363 (2010), 1–3. 
[6] A. Väljä, H. Tenhunen, H. Harno, L. Mäkitie, T. Tanila, P. Lillrank, From Tertiary to Primary Care – 
Understanding Context in the Transfer of Digital Headache Service Pathway, Studies in Health 
Technology and Informatics 262 (2019), 304–307. 
[7] M. Ketokivi, T. Choi, Renaissance of case research as a scientific method, Journal of Operations 
Management 32 (2014), 232–240. 
[8] B. Glaser, A. Strauss, The Discovery of Grounded Theory: Strategies for Qualitative Research, Aldine 
de Gruyter, New York, 1967. 
T. Tanila et al. / Value Mechanisms in the Implementation of IPFM System712
  
Virtual Reality Therapy for Social Phobia: 
A Scoping Review 
Elham SALEHIa,1 Mahdi MEHRABIa Farhad FATEHI b,c Asiyeh SALEHI d  
a Islamic Azad University, Shiraz, Iran  
b
 Centre for Online Health, The University of Queensland, QLD, Australia 
c Tehran University of Medical Sciences, Iran  
d
 School of Health and Human Sciences, Southern Cross University, QLD, Australia 
Abstract. Virtual reality (VR) has become an interesting alternative for the 
treatment of social phobia. This scoping review explored the impact of VR 
technologies in the treatment of social phobia (25 papers were included). Treatment 
approaches to social phobia included virtual reality exposure therapy, cognitive 
behaviour therapy, exposure group therapy, in vivo exposure therapy, and waiting 
list. VR was identified as the most successful approach, not only in improving social 
phobia, but also resulting in real life changes such as improvement in occupational 
success. VR Head Mounted Displays were used in most of studies (76%), followed 
by VR-based Specific Systems (24%). Although VR techniques indicated positive 
impact on patients to reduce their anxiety, it is paramount to consider variables such 
as the way therapists control the environment as well as individuals' characteristics 
for achieving the best outcome. 
Keywords. Social phobia, Social fear, Social anxiety, Virtual reality 
1. Introduction 
Anxiety disorders are characterized by apprehension, tension, nervousness, or worry. 
Social phobia, as the most common anxiety disorder, is the unreasonable fear of social 
situations and the interaction with other people that can bring on feelings of self-
consciousness, judgment, evaluation, and inferiority, and can result in social isolation 
[1]. Diagnosis and treatment of anxiety disorders are difficult as there are no objective 
biomarkers, however, phobia therapy is the first-line treatment for anxiety disorders, 
modifying the result of fear of in-memory structures [2, 3]. The treatment approaches 
include Cognitive Behavioural Therapy (CBT) and Exposure Therapy (ET). CBT 
includes exposure to fear-triggering stimuli (e. g. speaking in front of a group), social 
skills training and relaxation training to change cognition and behaviours [4]. In 
Exposure Group Therapy (EGT), patients are exposed to the feared object or context 
without any danger to overcome their fears. If the patient is exposed to the real situation, 
it is called In Vivo Exposure Therapy (iVET) [5].  
Virtual Reality (VR) is a human-computer interaction that allows a person to step 
into an unseen environment to face their fears which participants could react in the virtual 
world with their observation through images on a computer screen [6, 7, 8, 9]. VR is an 
effective method for the treatment of a variety of phobias such as social phobia, post-
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traumatic stress disorder, claustrophobia, arachnophobia and fear of heights [10, 11,12]. 
This review aimed to investigate the efficacy of VR in improving social phobia. 
2. Methodology and design  
This scoping review systematically searched four databases (PubMed, PsycINFO, IEEE 
Explore, and Science Direct) from 2000 to 2018. Keywords were: ("virtual reality" OR 
"virtual environment" OR "cyberspace") AND ("social phobia" OR "social isolation" OR 
"social fear" OR "anxiety"). Peer-reviewed papers written in English that used VR for 
improving any case of social phobia, social fear, and social speaking fear were included. 
A total number of 726 records were initially considered for the review, and a final set of 
25 papers were deemed eligible and included in this scoping review. Constant 
comparative analysis was used to explore and categorize the themes across the studies. 
Synthesis of the information was performed based on different approaches of VR for 
treating social phobia, and comparing VR with conventional treatments. 
3. Results 
3.1 Study characteristics 
Participants’ age range was 18-70. Sample size varied from 2-97, with a relatively equal 
distribution of both genders. Treatment included Virtual Reality Exposure Therapy 
(VRET) with the highest percentage (65%), cognitive behaviour therapy (CBT), 
exposure group therapy (EGT), in-vivo exposure therapy (iVET) and waiting list (WL). 
This review identified three main themes.  
3.2 Virtual reality in the treatment of social phobia - trends and applications 
By comparing different therapeutic approaches, VR approaches and CBT showed the 
most remarkable improvements in the treatment of social phobia [1, 5-6, 13-18]. There 
were no significant differences between VR and CBT and they indicated relatively equal 
outcomes [1, 6]. However, VR was highly recommended and there has been an 
increasing number of studies during the last 19 years. VR is affordable and provides 
equal or even more satisfactory results in comparison to other non-VR approaches such 
as CBT. VR has a paramount impact on not only the treatment of social phobia but also 
different aspects of personal life and wellbeing. Some examples are: more improvement 
in well-being and quality of life; fewer sessions for accomplishing the therapy; 
confidence [14], positive self-statement [5], improvement in emotion and 
communication, real life changes such as occupational success [7, 17], decreased fear, 
anxiety, avoidance of the social situation, improvement in physiological measures on 
public speaking anxiety, patient's attention focus, and changing behaviour [10, 14, 15].  
The number of treatment sessions in VR interventions varied from 1-12 sessions and 
the duration ranged from 5-90 minutes. There were also variations in the follow-up 
period, from a few weeks to one year. Among VR approaches, iVET group was more 
realistic than VR conversation, and participants commented that the VR conversation 
would be more realistic if they did not meet the actor and if they were not in the same 
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room as the other participants [1, 6, 16, 19]. In addition, fear rating was higher during 
VR conversation than in iVET conversation [1, 6, 16, 19]. 
3.3. Virtual reality tools for social phobia treatment  
The VR equipment can be categorized into two groups: Virtual Reality Head Mounted 
Displays (HMD), and Virtual Reality based Specific Systems (VRBSS). The majority of 
the research experiments (76%) used HMD, while, the other 24% of the studies used 
VRBSS, mainly different 3D display/sound equipment and motion trackers. 
For HMD usage, there is a Distributed Interactive Virtual Environment, which 
consists of a computer, HMD, display screens for each eye, stereo ear-phones, Silicon 
Graphics, main memory, avatar face and model and a head-tracking system. In a virtual 
environment (VE), the conversation is managed through a virtual avatar interaction with 
participants, the virtual social situations such as shopping; attending a job interview 
include semi-scripted dialogues consists of modification templates based around the 
video game. The participants interact via HMD and wear headphones and a microphone 
headset to interact. Therefore, avatars mouth movements during the dialogue seem 
natural [19, 22, 23]. The tracker allows patients to see the virtual world with head 
movement in the real world, and software package that provides the scenes of speech 
among the audience [5, 16]. The patient's head movements change the environment, and 
the therapist can control the audience's reactions and communicate with them via a 
microphone. During the talk, their heart rate is monitored and the content of the 
presentation is recorded [10, 12, 14,  15, 20, 21]. Due to the limitation of VR hardware 
and software, and the associated expenses, off-the-shelf applications for different issues, 
such as public speaking practice during different scenarios have been developed and are 
available on mobile app stores [24, 25, 26]. 
VRBSS consists of the Delft Remote VR system with the capacity to display 3D 
video, 3D images and 3D glasses and ear headphones for sound immersion. The program 
displays images and then commands given by the therapist through a wireless USB 
keyboard for activation of the interaction and changing the scene [17, 23]. The laboratory 
for VRBSS comprises of two rooms that are separated by a mirror while the therapist 
can see the patient but the patient cannot see the therapist, they have a face-to-face 
contact during exposure and communicate via intercom [27].  
3.4 Measurement tools in social phobia  
Two types of measurements were used during the course of treatment: 1) self-report 
measure - individual's own report of their symptoms, behaviours, beliefs, or attitudes. 
This was conducted via pre-treatment and post-treatment assessments. 2) physiological 
measure - measuring bodily variation such as: heart rate, dry mouth, and blood pressure. 
An overall of 30 psychological instruments were used as outcome scales across studies 
[11]: APQ (answer psychology questions), ATQ30 (automatic thought questionnaire), 
ATPS (attitudes towards public speaking questionnaire), BDI (Beck depression 
inventory), BCSS (brief core schema scales), BAT(behavioural assessment task), CGI 
(clinical global improvement scale), DAS (dysfunctional attitude scale), DASS 
(depression anxiety stress scale), DSM-IV (diagnostic and statistical manual of mental 
disorder), EUROHISQOL (Eurohis quality of life scale), ERQ (emotion regulation 
questionnaire) , FNE-B (fear of negative evaluation-brief Form), GPTS (green paranoid 
thought scales), HAD (hospital anxiety and depression), HADS (hospital anxiety and 
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depression scale),  IPQ (I group presence questionnaire), LSAS (Liebowitz social anxiety 
scale), LSAS-SR (Liebowitz social anxiety scale-self report), PRCA (personal report of 
communication apprehension), PDBQ (personality disorder belief questionnaire), PRCS 
(personal report of confidence of speaker), PDBQ (personality disorder belief 
questionnaire), SUS (slater-Usoh-steed questionnaire), SCID (structured clinical 
interview for the DSM-IV), SSPS (positive and negative self-statement during public 
speaking), SCIA (social contexts inducing anxiety), SIAS (social interaction anxiety 
scale), SAS (social adjustment scale), SF -36 (the medical outcome 36-item short-form 
health survey), SSQ (simulator sickness questionnaire), SPAI (social phobia and anxiety 
inventory), STAI (state-trait anxiety inventory), and SUD (subjective unit of discomfort) 
[1-30]. Key methodological features and findings of the reviewed studies are available 
online (DOI: 10.13140/RG.2.2.12587.39209/1). 
4. Discussion and recommendations 
VR treatment has a great impact on the communication and seems to be more effective 
and efficient than conventional therapies for social phobia. However, there have not been 
any specific comparison between different VR tools, and few mobile-base tools were 
considered. In addition, from a technological aspect, although HMD and VRBSS are the 
key effective VR tools, there has not been any specific comparison between them to 
examine the outcome and performance clearly. 
Although the diverse variety of VR tools indicated some type of positive impact in 
reducing the anxiety, it is still paramount to consider confounding variables, such as the 
individuals' characteristics and the way therapists control the environment. Some of the 
participants felt anxious during VRET, due to the presence and the monitoring of the 
therapist during the session. In addition, therapists should try to maximize a patient's 
presence because attentional focus leads to better treatment. A powerful sense of 
presence and immersion is needed to make the experience real, and to enhance the 
effectiveness of the interventions [6, 21]. Further studies (with larger sample size) are 
required to clarify the differences between different VR tools in regards to their 
effectiveness and efficiency. There have been also limited studies around mobile-based 
VR and their potentials [24, 29, 30]. Future studies may also explore different 
behavioural patterns in regards to gender for using VR and the treatment outcomes. 
There were issues related to the interventions that need to be considered to facilitate 
future studies. These include: difficulties in producing and editing movies as they are 
time-consuming [30]; different behavioural patterns due to gender; lack of control for 
audience interactions with each other for the virtual reality-based specific system; lack 
of sense of presence/immersion to overcome cognitive barriers [29]; and patients’ 
anxiety due to therapist presence/monitoring [22], small sample size, and limiting the 
generalizability of the results of the studies [14]. 
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Abstract. Electronic Medical Record (EMR) systems are complex systems with 
interdependent features. Redesigning one feature of the system can create a 
cascade effect affecting the other features. By calculating the cascade effect, the 
designers can understand how each individual feature could be affected. This 
understanding allows them to maximize the positive effects and avoid negative 
consequences of their redesign activities. To understand the cascade effect, the 
designers can look at their computations’ results; a task that becomes more 
difficult when the number of features grows. To reduce their task load, we propose 
a tool for visualizing the cascade effect of redesigning features in an EMR system. 
Our preliminary evaluation with six graduate students shows that visualizing the 
cascade effect reduces the task load and slightly improves their performance when 
analyzing the cascade effect. Ways for improving the tool include (i) showing the 
computation results within the visualization, and (ii) allowing the designers to 
compare the cascade effect generated by redesigning different features. 
Keywords. Design, EMR System, Visualization 
1. Introduction 
The designers of Electronic Medical Record (EMR) systems need to continuously 
redesign the systems to fulfill the emerging needs of their users [1,2]. It is common for 
the designers to be faced with multiple EMR features to redesign. Each EMR feature 
represents a distinctive aspect or attribute of the EMR system. For example, one EMR 
feature could be its usability, while another EMR feature could be its integration with 
the used medical devices. Since the designers have limited resources, they need to 
choose which feature to redesign. This choice is difficult because EMR systems are 
complex socio-technical systems where the systems’ features are interdependent i.e., 
redesigning one feature will affect the other features of the system. For example, 
integrating the EMR system with the used medical devices would increase its usability. 
As another example, automatically generating EMR summaries from the EMR notes 
would facilitate the exchange of EMRs between healthcare providers which would 
consequently reduce the preparation time for the consultations [3].  
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Previous work showed that considering the interdependency of the features is 
needed to know which features are the most important to (re)design [3]. By calculating 
the cascade effect generated by (re)designing each feature, the designers can assess the 
overall effect that redesigning each feature will have on the system as a whole. 
Accordingly, the designers can optimize their design strategies by choosing to work on 
the features that generate the largest positive effect on the system.  
To understand the cascade effect of redesigning each feature, the designers need to 
understand how each individual feature in the system is affected. To do so, the 
designers can check the details of the computations. However, when multiple features 
are considered, looking at the computations’ outputs requires a high mental demand 
and could result in an incomplete understanding. In this case, visualizing the cascade 
effect can reduce the required mental workload by offloading work to the perceptual 
system [4].  
The aim of this work is to support EMR designers in understanding the cascade 
effect of their redesign activities. To this end, we propose a tool for visualizing the 
cascade effect generated by redesigning features in an EMR system. 
2. Methods 
Previous work described a method for calculating the cascade effect of redesigning 
features in an EMR system [3]. First, the designers have to analyze the relationships 
between the features and then compute the overall effect of modifying each feature. 
2.1.  Analyzing the Relationships between the EMR Features 
First, the designers have to analyze and quantify the influence that each feature has on 
all the other features. For every two features fi and fj, the designers have to answer the 
following question: “If we redesign feature fi, how will that influence feature fj?”  
To answer this question, the designers assume that feature fi has a positive influence 
on feature fj when an improvement of fi leads to an improvement of fj. Similarly, feature 
fi has a negative influence on feature fj when an improvement of fi leads to a 
deterioration of fj. To quantify the influence, the designers can employ a linear scale 
ranging from “-0.9: very strong negative influence” to “0.9: very strong positive 
influence” with the middle point being “0: no influence”.  
Once the relationships between the features are quantified, the designers can create 
the feature dependency matrix D = [dij] where all principal diagonal elements are equal 
to zero and dij represents the degree to which feature fi has an influence on feature fj . 
2.2. Computing the Cascade Effect 
A = [aij] is the direct effect matrix where aij represents the direct effect of modifying 
feature fi on feature fj. Matrix A is an identity matrix. The cascade effect of modifying 
each EMR feature is computed using the following equation: 
 
C = A×D + A×D2 + ... + A×Dh,  
 
C = [cij] where cij is the cascade effect that modifying feature fi has on feature fj. 
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2.3. Visualizing the Cascade Effect
The purpose of the visualization tool was to support the designers in understanding the 
effects of redesigning a feature. Therefore, for every feature, we needed to visualize the 
cascade effect that redesigning this feature will induce on all the other individual 
features. To build a prototype of the visualization tool, we worked with a case study of 
redesigning an antenatal care EMR system. We used the list of features and the 
dependency map presented in that study [3]. To compute the cascade effect of 
redesigning each feature, we used python and followed the calculation steps described 
in section 2.2.  
We built the prototype of the visualization tool using HTML, CSS, and JavaScript. 
The prototype’s interface is shown in Figure 1. The green bars represent the baseline, 
i.e., the initial state of the EMR system before any redesign activity. By pressing on a 
“Redesign” button, the users can see the direct effect in blue and the indirect effects in 
yellow. The figure shows, as an example, the cascade effect of redesigning the EMR 
system to automatically generate summaries from the EMR notes. The working 
prototype is accessible via: casceffect.netlify.com. 
Figure 1. The interface of the visualization tool. 
2.4. Evaluating the Prototype of the Visualization Tool 
We conducted a preliminary evaluation of the visualization tool with six graduate 
students. We indicated to the participants the three features that have the largest overall 
effect on the system. Then, we asked them to conclude why these three features had the 
largest overall effect by using the results of the computations shown in Figure 2, and by 
using the visualization tool. Half the participants used the results of the computations 
first and the other half used the visualization tool first. After using each method, the 
participants answered a NASA-TLX questionnaire. NASA-TLX is a multi-dimensional 
scale used to measure the workload estimates of a task [5]. 
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Figure 2. The computations results.
3. Results 
The results of the evaluation are shown in Figure 3. Each bar represents the distribution 
of the scores given by the six participants. By considering the mean and the median of 
the reported scores, we conclude that using the visualization tool tends to require less 
mental demand, temporal demand, and effort. Moreover, using the visualization tool 
may reduce the designers’ frustration and slightly increase their perceived performance. 
However, the tool requires more physical demand due to its interactive nature. 
Figure 3. Using the computations’ results versus using the visualization tool. 
4. Discussion 
All the participants agreed that using the visualization tool required less mental and 
temporal demand than the computations’ results. However, two participants reported 
that the visualization tool was more physically demanding. One of these two 
participants further reported that using the tool required more effort and caused them 
more frustration. The effort required by the tool was attributed to the difficulty of 
S. Helou et al. / Visualizing the Cascade Effect of Redesigning Features in an EMR System 721
comparing the cascade effect of different features. The current prototype only allows 
the designers to visualize the cascade effect of one feature at a time. One way to 
address this issue is to allow the designers to choose multiple features and visually 
compare their cascade effects.  
The participants also reported that they could not accurately quantify the cascade 
effect when they used the tool. Instead, they had to qualitatively and approximately 
assess it. This issue could be addressed by adding the quantitative data from the 
computations’ results to the visualization. Moreover, in order to fully understand the 
cascade effect, it is important to know how the effect is propagating across the features’ 
network. In other terms, the designers need to know the source of the effect on each 
feature. To this end, an animation tool showing how the cascade effect propagates 
along the system’s features might prove fitter as these tools are usually used to 
represent dynamic systems [6].  
Finally, it is important to note that the effect generated by a design change 
depends on the way the features are implemented and on the context in which the EMR 
system is used. Moreover, the calculated cascade effect depends on the subjective 
interpretations of the designers. Therefore, the prediction of the cascade effect may not 
accurately reflect the real world. The method’s current merit lies in its ability to support 
the designers in finding a way of calculating, approximately, where a good course of 
redesign lies. Further research is needed to evaluate the method in work place settings. 
5. Conclusion 
Understanding the cascade effect of redesigning features in an EMR system allows 
designers to optimize their redesign strategies. To support the designers in their 
analysis, we proposed a tool to visualize the cascade effect of redesigning features of 
an EMR system. Our preliminary evaluation with six participants showed that the 
visualization tool could reduce the designers’ mental and temporal demand and 
improve their performance when analyzing the cascade effect of redesigning the 
system’s features. Further work is needed to reduce the physical demand required by 
the visualization tool and to allow designers to easily compare the cascade effect of 
redesigning different features. 
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Abstract. The paper presents a web application integrated in a platform containing 
hardware and software components for optimizing the activities of home care 
providers (HCPs) and their services. The integrated platform is called CDMS, an 
acronym for the Romanian translation of Dispatching and Management Center for 
optimizing the Services offered by HCPs. The presented web application is at the 
center of the platform, offering functionalities for optimizing the activities of an 
HCP, the activities of the nursing staff and other functionalities that will be 
presented in the paper. 
Keywords. home care provider, web application for home care, home nursing 
1. Introduction 
Population aging can be defined as an increase in the proportion of older persons that 
changes the age composition of a population [1] and it is already well known that there 
is an ongoing process of aging for the population of the entire globe. Europe has the 
oldest population (21% of its population aged over 60).  
Aging usually implies some level of decrease in physical and mental capacity and 
a growing risk of disease [3]. Common health problems for elders include mobility 
problems associated with pain and frailty, hearing/ visual acuity reduction, diabetes, 
depression, Alzheimer, dementia [3]. These implications are the reason that most elders 
benefit from continuous/ periodic care: health care and assistance in performing certain 
tasks.  
The best motivation in developing solutions for health and social care for elders 
arises from studying the need (the aging population) and is driven by the altruist 
purpose of taking care of our elders: our older relatives. Other motivation is the fact 
that healthy and more independent elders can lower the burden felt on public and 
private health sectors and they can also contribute to the economy and the society that 
integrates them (by working as mentors, caregivers, innovators, entrepreneurs or other 
members of the workforce [3]). The less altruist reason to develop solutions for elders 
is the fact that a market dynamics analysis shows that older adults are projected to 
spend $15 trillion annually by 2020 and they will generate more than a third of global 
consumption growth [4]. [4] recognizes the caregiving market as a market that offers 
great opportunities, as it is expected to reach $72 billion by 2020. 
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The paper presents a web application integrated in a platform containing hardware 
and software components for optimizing the activities of home care providers (HCPs) 
and their services. The integrated platform is called CDMS, an acronym for the 
Romanian translation of Dispatching and Management Center for optimizing the 
Services offered by HCPs. The CDMS platform is an integrated platform containing 
software components: web applications acting as access portals for different types of 
users (a web application for users at the CDMS level and a web application for the 
users of HCPs: employees with different roles and permissions and patients/ informal 
caregivers), scripting applications for technical system administration, mobile apps for 
point of care documentation and supply management, APIs for integrating 
teleassistance/ telemonitoring devices and hardware components that allow running all 
the above mentioned software components. The designed functionalities for the 
software components are presented in [5]. The current paper focuses on the web 
application developed for the HCPs. The presented web application is at the center of 
the platform, offering functionalities for optimizing the activities of an HCP, the 
activities of the nursing staff and other functionalities that will be presented in the 
following sections. It is designed to be accessed as a Plaform as a Service, so that an 
HCP subscribes to a CDMS and gets access to all the functionalities it needs to run. 
2. Technologies used for development 
Container technologies have been used to allow for a clear delimitation between data 
and processing and for a clear delimitation between the components dedicated to each 
subscribed HCPAs a security measure, the database and the web application are 
deployed on separate containers, to allow for better access control on the data. Another 
reason for using containers is for obtaining separate modules that may easily be 
replicated. This way, accommodating a new HCP consists, mainly, in replicating two 
containers: the data and the processing containers. An in-house container orchestration 
solution has been developed to allow the management of containers and the necessary 
services for each of them. 
The chosen main programming language is PHP, a well-known and used 
programming language for web portals, for managing dynamic content, managing 
database connections, keeping track of opened sessions and so on. Laravel [6] is an 
open source development framework for PHP and it was chosen for this project. It uses 
the Model-View-Controller design pattern [7], it allows modular development, easy 
code reutilization, features that aid the testing activities, routing between the 
components of the web application, configuration management, template utilization, 
implementation of predefined security features and many other features. The database 
is created using MySQL, one of the most popular open source database management 
systems.  
3. Implemented features 
The web application for HCPs has been developed keeping in mind the need for 
integration in the whole CDMS platform.  
The first step in developing the web platform consisted in analysis of the existing 
framework of HCPs. This stage contained documentation based on available literature 
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(legislation, normatives, case-studies) but also on field visits, interviews and open 
discussions with employees of HCPs. The specification design document summarized 
requests directly from the end-users. 
The web application offers the following main features: management of the HCP’s 
presentation web page; management of the HCP’s service offer; employees 
management; clients management; inventory management; management of medical 
data; management of nursing visits; management of authorized devices: mobile devices 
for point-of-care documentation and devices for teleassistance/ telemonitoring. The 
web application contains predefined lists of procedures and services together with 
default supplies needed for each of the physiological parameters to be monitored, but it 
also allows for customization of these lists by allowing the input of new types of 
procedures and alterations on their characteristic data. A short description of the 
designed features is available in [5]. Table 1 presents most of the functionalities offered 
through the main navigation menu of the web application. 
Table 1. Navigation menu (partial) of the web application for HCPs 
Company configuration  
HCP profile 
general information: legal name, address, logo, main contact 
information and other info 
presentation web site 
for each HCP a presentation website is generated in a predefined 
format: main page/ about page/ contact page/ terms and conditions for 
using the application  
bank accounts 
 
working addresses  
configuration of bank accounts used for issuing bills and other 
financial aspects 
configuration of working addresses  
Employees’ management  
manage employees list create, view, edit employees’ accounts; activate/ deactivate accounts 
Patients management  
manage patients list and their 
electronic health records 
view/ add/ edit/ deactivate patient account 
for each of the patients, manage:  
- personal data, medical record, physiological measurements, 
uploaded files, medical prescriptions, requested services 
(subscriptions), appointments 
Devices management  
manage list of authorized devices view/ add/ edit/ remove authorized devices that may access the 
platform (mobile devices for point of care documentation and 
telemonitoring/ teleassistance devices) 
Supplies management  
manage list of supplies view/ add/ edit/ remove supply item 
view/ add/ edit/ remove supplier 
view/ add/ edit/ remove producer of supplies 
manage current inventory 
inventory logs 
Medical services management  
manage list of offered medical 
services 
view/ add/ edit/ remove offered procedures  
view/ add/ edit/ remove managed health problems 
view/ add/ edit/ remove allergy types 
view/ add/ edit/ remove physiological parameters 
view/ add/ edit/ remove type of documents that may be added to a 
patient’s electronic health record (medical report, test results, 
treatment plants, consent forms and others, medical prescriptions) 
Subscriptions management  
manage subscriptions and offers  manage subscription types and packages of services 
manage offered services (other than medical) 
Financial management  
manage financial documents manage billing information/ invoices/ pricing 
Calendar management  
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schedule management appointments management 
employees working schedule 
Reports management  
generate reports employee’s activity 
patient’s services  
supplies reports 
performance reports 
financial reports 
Notifications management  
manage notifications for: unpaid bills 
appointments: requested/ missed appointments 
support notifications: tickets generated by employees or patients 
vital parameters notifications: parameters with abnormal values 
supplies alerts: out of stock items or items below a predefined 
threshold 
subscriptions: expired or expiring subscriptions 
 
These features are designed to be accessed by the following user categories: a) 
administrative personnel; b) nursing staff; c) clients/ patients of an HCP and their 
informal caregivers. These three large categories of users are identified in the activity 
of any HCP. In order to create an efficient (secure) access mechanism to the resources 
and functionalities of the web application, a role and permission based access control 
list has been implemented. The following roles/ activities have been identified and 
implemented in the platform: IT/ technical administrator; general administrator; 
financial manager; human resources manager; medical manager; medic; nurse; 
telemonitoring/ teleassistance manager. As observed from the field activities performed 
during the specification design phase and continued during development, different 
HCPs have different organizational charts, so these roles may be differently 
implemented in each HCP: for example an HCP may only have a small number of 
administrative employees, so the same person may perform multiple roles, or a larger 
HCP may have multiple employees for financial management so each of them must 
perform only a subset of the tasks involved in this specific activity. In order to 
accommodate that, a more specific list of permissions has been created, mainly a 
permission for each of the main functionality of the platform (management of the 
presentation web site, of the bank accounts, employees, billing and taxes, supplies, 
general medical data management, patients, appointments and so on). With this level of 
customization, a user’s access to the application’s data and functionalities may be 
accurately controlled. 
4. Results 
The web application has been deployed together with the other components of the 
CDMS platform at a center for managing HCPs in Alba County, Romania. The center 
is acting both as a CDMS and as an HCP. As seen in practice, the administrative 
personnel reported that the platform is easy-to-use, has an intuitive interface and this 
has been shown through the fact that it was a matter of a few months for the 
administrative personnel to integrate the usage of the platform in their activities. At the 
moment, the experimental deployment of the web application is used for keeping track 
of the inventory of the HCP, the employees list and test patients. Testing activities are 
still currently being run for each of the functionalities presented in the paper leading to 
functionalities improvements and minor bug fixes. 
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5. Conclusions and future work 
The paper presents a web application for optimizing the activity of HCPs and the 
services they offer. The relevance of the proposed solution is increased in the context 
of an aging population with complex care needs that would benefit from home care 
services. Also, the market created for elders is expected to be the fastest growing 
market in the following years.  
The application represents a single point of access for managing all the 
administrative activities of an HCP, including managing the nursing activities. There is 
no installation required from the point of view of an HCP. The CDMS offers the web 
application and the complex hardware requirements for storage and processing (in the 
situation of a complex HCP). The HCP only needs any kind of Internet enabled 
terminal to access the web application. The most important difference between the 
proposed solution and readily available solutions on the market, is the integration in the 
whole CDMS platform that offers additional components and functionalities, the most 
important of them include a mobile application for point-of-care documentation, a 
mobile app for supplies management and software components for technical 
management. Another important aspect of the proposed solution is the integration of an 
API that allows the platform to gather health data from devices provided by different 
vendors already on the market. 
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A Model for Early Identification of Chronic 
Obstructive Pulmonary Disease  
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Abstract. Chronic obstructive pulmonary disease (COPD) is highly underdiagnosed. 
Early diagnosis is, therefore, essential to reduce costs and exacerbations and prevent 
disease progression. This calls for the development of a COPD case-finding tool. 
The present study aimed to develop a model for early identification of COPD with 
an eye to optimizing COPD case finding. The study was based on data from the US 
National Health and Nutrition Examination Survey (NHANES) dataset (2007-2012). 
For the analysis, 772 participants with spirometry defined COPD were included. 
Potential predictors for COPD (n=42) were extracted. The model was based on 
logistic regression, and the predictors were included using a stepwise forward 
selection. A five-fold cross-validation was used to train and validate the model. The 
predictors included age, gender, and pack-years of smoking. The model obtained an 
AUC of 0.71. In conclusion, such a model can be useful for identifying individuals 
that should perform post-bronchodilator spirometry to aid early identification of 
COPD. 
Keywords. Airflow obstruction, COPD, prediction, diagnosis 
1. Introduction 
Spirometry remains the decisive marker in the diagnosis of chronic obstructive 
pulmonary disease (COPD). According to the Global Initiative for Chronic Lung Disease 
(GOLD), a post-bronchodilator forced expiratory volume (FEV1) / forced vital capacity 
(FVC) of <0.7 confirms the presence of COPD [1]. The diagnosis of COPD should also 
be based on an assessment of symptoms, comorbidities, and risk of exacerbation [1].  
However, COPD remains highly underdiagnosed and misdiagnosed [2–4]. Globally, 
approximately 70% of subjects with COPD are undiagnosed [5].  
Early identification of patients with COPD is warranted. Early diagnosis may reduce 
healthcare costs [6], reduce exacerbations, and prevent disease progression. [2,6,7]. 
However, no direct evidence supports that a broad spirometry-based screening of 
potential COPD patients will improve longitudinal health parameters [8]. Inline herewith, 
GOLD does not recommend spirometry screening, and advocates for active COPD case 
finding as an alternative [2].  
Several studies have explored the characteristics of subjects with COPD who remain 
undiagnosed [9–13]. One may assume that a focused model based on potential 
characteristics of undiagnosed COPD have the potential to improve early identification 
of subjects with COPD. A previous study used 34 variables based on demographic, 
clinical, and health care resource utilization characteristics to identify subjects with 
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undiagnosed COPD [14]. However, such a model is considered too complicated for 
implementation. Therefore, a simple and accurate case-finding tool is yet to be developed. 
Thus, the present study aimed to develop a simple model for early identification of COPD.    
2. Methods 
Data were extracted from the US National Health and Nutrition Examination Survey 
(NHANES) dataset (2007-2012). NHANES data are publicly available, and they include 
a variety of medical, nutritional, behavioural, and demographic data. The data is 
collected through examinations and interviews and are representative of the US 
population [15,16].  
Data from a total of 23,433 participants were extracted from the NHANES database. 
A subsample of 1,564 participants whose FEV1/FVC ratio was below the lower limit of 
normal or below 0.  	
   	   -adrenergic 
bronchodilator medication to open up their airways. Participants below the age of 40 
were also removed as COPD predominantly develops hereafter, and thus 772 participants 
remained for further analysis.  
2.1. Stratification and feature extraction     
The participants were stratified into participants with COPD (n = 460) and without 
COPD (n = 312) based on a post-bronchodilator FEV1/FVC<0.7. A total of 42 potential 
predictors for COPD were extracted involving questionnaires related to age, anxiety, 
BMI, chest pain, colds recently, cough, days lost to wheezing, days of recreational 
activity, depression, difficulty walking up ten steps, difficulty walking a quarter-mile, 
dyspnea, education, emphysema, exposure to exhaust fumes, mineral dust, organic dust, 
and other fumes, fatigue, gender, general health condition, hay fever, height, 
hypertension, income, lung cancer, marital status, pack-years of smoking, phlegm, race, 
respiratory illnesses, shortness of breath, smoked 100 cigarettes, smoking currently, 
smoking in household, smoking amount in household, social difficulties, trouble sleeping, 
vigorous work, vigorous work amount, and waist circumference. 
2.2. Model training and validation 
The model was based on logistic regression, and the predictors were included using a 
stepwise forward selection. In each step, a predictor was included if it significantly 
improved the model compared to the previous step (p < 0.001).  
A five-fold cross-validation was used to train and validate the model based on the 
included predictors. A concatenation of the model-estimated probability of COPD for 
each participant was then used to form a receiver operating characteristics (ROC) curve. 
A ROC curve displays the true positive rate against the false-positive rate at different 
thresholds. The area under this curve (AUC) is used for quantifying the general 
performance of the model, where the AUC ranges from 0 (no correctly classified targets) 
to 1 (perfect classification with no false positives).   
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3. Results 
Table 1. Predictors included based on stepwise forward selection (p < 0.001) 
 
Step Predictor p-value AUC 
1 Age 1.21e-11 0.62 
2 Gender 5.39e-8 0.65 
3 Pack years of smoking 2.39e-4 0.71
 
The included predictors involved age, gender, and pack-years of smoking, which were 
then used to train and validate a logistic regression model. Figure 1 presents the ROC 
curve based on the model’s ability to differentiate between the 722 participants with and 
without COPD. The model obtained an AUC of 0.71. 
 
 
 
Figure 1. Receiver operating characteristics curve. 
4. Discussion 
The present study aimed to develop and validate a simple model to identify subjects with 
COPD. The model performance is considered acceptable as the model did not include 
any pulmonary function indicators. The model can, therefore, be used to identify subjects 
that should be considered for pulmonary function testing for early diagnosis of COPD.   
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The previous study by Moretz et al. [14] presented a stepwise logistic regression 
based on 34 variables, closely related to COPD, involving respiratory conditions, 
cardiovascular conditions, comorbidities, medications, hospitalizations, and patient 
characteristics. The model obtained an AUC of 0.75 with a sensitivity of 0.60 and 
specificity of 0.78. The present study presented a simple model based on age, gender, 
and pack-years, which is considered more likely to be successfully implemented. This 
model obtained an AUC of 0.71 and a sensitivity of 0.50 at a specificity of 0.78.  
The present study was limited by basing COPD diagnosis solely on spirometry and 
not assessing symptoms, comorbidities, and risk of exacerbation.  
5. Conclusion 
A model approach, as described in the present study, can be used to identify individuals 
that should perform post-bronchodilator spirometry to aid early identification of COPD.  
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Abstract. Although early diagnosis of developmental delay is important, there are 
challenges in identifying cognitive status in developing countries because of limited 
human and financial resources to perform diagnostic tests. Moreover, diagnosis 
stability of developmental delay in children using neuropsychological tests (NPTs) 
can remain unsettled. The aim of this study is (1) to verify the effectiveness of a 
serious game (DoBrain), (2) to identify existing inconsistencies between NPTs, and 
(3) to explore the potential of the serious game as a complement to diagnostic tools. 
Eligible children who had completed results of NPTs were selected (n=119/235; 
116/235; case, control). With these children’s scores, we performed the Mann- 
Whitney U test to investigate the effectiveness of the serious game by comparing 
the improvement of scores in both groups. Among the participants, we additionally 
selected a case group to identify the potential of the serious game for detecting mild 
developmental delay. Using the results of the CGI-S as a baseline, we defined the 
participants whose scores indicated more than mild illness (>=2 points) in at least 
one area as the suspected group. The score improvement related to memory in case 
group was greater than that of the control group (p<0.05). Furthermore, four of the 
NPTs were not inconsistent, and the sensitivity/specificity of DDST-II was the 
highest score considering CGI-S results as the ground truth (0.43; 0.96). 
Additionally, games measuring discrimination, velocity, memory, and spatial 
perception showed statistical significance (p<0.05). This study verifies that the 
serious game can help specific cognitive areas and suggests that the serious game 
could be used as a low-cost and unconstrained spatiotemporal alternative to NPTs. 
Keywords. Digital therapeutics, digital phenotyping, serious games, inter-observer 
variability 
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1. Introduction 
Developmental delay in early childhood tends to deteriorate or spread into other 
psychological disorders gradually. For this reason, early detection of developmental 
delay  
at an early age is important [1]. However, conventional neuropsychological tests 
(NPTs) for developmental delay have two issues: the inter-observer and intra-observer 
variability [2] and lack of accessibility to the diagnosis of developmental delay due to 
cost or time demands [3]. This problem is more apparent in developing countries where 
access to health service is relatively difficult [4]. The purpose of this study is (1) to verify 
the effectiveness of a serious game, (2) to investigate the discordance of NPTs and (3) to 
identify the possibility of mild developmental delay in Cambodia by using a serious 
game. 
2. Method 
2.1. DoBrain and Population recruitment 
This study was based on a multi-centre, two-arm, cluster-randomized controlled trial 
with the first endpoint to identify the effectiveness of serious mobile game (DoBrain) for 
cognitive development of children in Cambodia. DoBrain is a serious game based on an 
animated cartoon and is a smart device-based application certified for child suitability. 
We chose this game as an intervention tool because this app showed a high retention rate 
(42.5%) for 30 days compared to an 8% retention rate of general health apps [5]. 
In a clinical trial, we recruited a total of 403 children from Xavier School (Sisophon) 
and Mirero School (Phnom Penh). The participants were males and females between 
three and nine years old. By choosing each four classes randomly to assign into case 
and control group, we conducted a case-control study with a case group of 204 
participants and a control group of 199 participants, which lasted from March 11 to 
July 31 in 2019. We assessed each group with pre-NPTs to appraise the children’s 
overall cognitive function, executive function, memory, and attention. These included 
the following: (1) the clinical global impression – severity scale (CGI-S), (2) the 
Denver developmental screening test, second edition (DDST II), (3) the Cambridge 
neuropsychological test automated battery (CANTAB), and (4) the behaviour rating 
inventory of executive function, second edition (BRIEF-II). We guided study 
participants through the process of downloading, starting, and using DoBrain. 
Participants used provided software 2 days a week for 20 weeks. Finally, we again 
assessed each group using the same NPTs to measure the participants’ overall cognitive 
function. Ethical clearance was obtained from the Ministry of Health National Ethics 
Committee for Health Research in Cambodia (Number: 212) before participants were 
recruited. 
2.2. Selection of eligible users and analytic methods 
Of the total 403 participants, we included those who completely underwent the four 
NPTs as eligible users (n=236). Further, we excluded the participants who did not have 
two pre- or post-tests (BRIEF-II, CANTAB) to evaluate the effectiveness of the serious 
game (n=1). With these participants (n=235), we figured out the effectiveness of this 
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app (Table 1) and identified the inconsistencies between NPTs (Figure 1). Furthermore, 
only the case group were selected to identify the potential of the serious game for 
detecting mild developmental delay because they had experience with DoBrain (n=119) 
(Table 2). 
Because the line between normal and abnormal in NPTs is ambiguous, we defined 
suspect results of tests for developmental delay, as follows, in order to identify 
inconsistency between NPTs for developmental delay: (1) CGI-S: cases where a clinician 
with a PhD in pediatric psychology gave severity scores ranging from mild to severe 
(two or more points) in at least one cognitive subfield; (2) DDST-II: cases that received 
a caution or delay score in at least one area in each cognitive subfield; (3) CATNAB: 
cases with scores less than 3% on at least one sub-test; and (4) BRIEF-II: cases with at 
least one area with a score more than 65 converted to a t-score considered clinically 
significant. At this cutoff, we established a percentage to classify children as low 
growth, that is, less than 3% of the growth curve of normal child development. In 
addition, we considered the CGI-S results as a foundation for comparing the consistency 
of other NPTs because CGI-S is a clinician-determined measure that takes into account 
all available information about patients. 
Finally, we conducted the Mann-Whitney U test to investigate the effectiveness of 
the serious game by comparing the improvement of scores in both groups (Table 1). For 
each test, the suspect results were visualized by binary coding: 1 for suspect and 0 for 
normal (Figure 1). Further, to identify the potential to classify the CGI-S results by game 
scores, we examined the difference of game scores in each group by performing a t-test 
from 1 chapter to 63 chapters (Table 2). 
3. Results 
Case and control groups did not show a significant difference in age and proportion of 
sex (their mean age is 7.0, 6.9 years, respectively; p=0.620; 0.613, ratio of male is 69/116 
(59.5%), 71/119(59.6%)). After intervention, PRMPCI and SWMBE486 scores related 
to memory area were significantly improved in both groups (p<0.05). Furthermore, the 
score improvement in the case group was greater than that of the control group (p<0.05) 
(Table 1). MOTML related to attention, and psychomotor speed showed no significant 
difference between before and after intervention in case group (p=0.556). 
 
Table 1. Comparison with pre and post-test of Case and Control group in BIREF-II test and CANTAB test
Outcomes Case (n=119) Control (n=116) Median 
difference 
between 
groups† 
p-value 
Pre test Post test Pre test Post test 
BRIEF (Median, IQR) 
Emotional control 
 
56.0 (27.0) 
 
52.0 (13.5) 
 
66.0 (20.5) 
 
59.0 (21.3) 
 
-6.0 
 
0.025 
Inhibit 55.0 (19.0) 52.0 (13.0) 57.0 (16.3) 53.0 (13.0) -4.0 0.002 
Initiate 53.0 (18.0) 53.0 (9.0) 56.0 (9.0) 53.0 (11.0) -7.0 <.001 
Organization of material 49.0 (16.0) 52.0 (13.5) 52.0 (16.8) 49.0 (16.0) 0.0 0.120 
Plan/Organization 51.0 (18.0) 49.0 (12.0) 56.5 (15.0) 49.0 (13.0) -8.0 <.001 
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Task monitor 51.0 (19.0) 50.0 (15.0) 54.0 (17.0) 49.0 (10.0) -3.5 <.001 
Working memory 53.0 (24.5) 52.0 (14.5) 57.0 (14.0) 52.0 (14.0) -3.0 0.016 
CANTAB (Median, (IQR))       
MOTML (latency time) 777.6(231.8) 799.1(235.2) 867.8(340.4) 791.0(273.5) -69.2 0.022 
PRMPCI (correct patterns) 66.7(33.3) 91.7(33.3) 75.0(33.3) 83.3(27.1) -21.1 0.002 
PRIFMDR (reaction time) 515.0(135.0) 530.0(111.5) 514.0(104.4) 510.8(88.1) -13.7 0.122 
PRFMDMT (movement time) 270.0(102.5) 267.5(72.6) 303.5(95.8) 305.0(70.6) -3.2 0.379 
SSPFSL (correct sequences) 4.0(2.0) 4.0(2.0) 3.0(1.0) 4.0(2.0) 0.4 0.200 
SWMBE468 (error times) 25.0(8.5) 22.0(8.0) 24.0(6.3) 24.0(6.0) 2.5 0.010 
†Estimated between-group difference (intervention –control) after the intervention (post-test), for pre-test values 
 
The CGI-S result showed that 200 participants were classified into the normal 
group, and 35 participants were classified into the suspect group (85.1% and 14.9%, 
respectively). With these participants, inconsistencies were seen between the results of 
the four NPTs (Figure 1). In addition, using the results of CGI-S as a baseline, there were 
variabilities in the sensitivity and specificity of DDST-II, CANTAB, and BRIEF-II 
(sensitivity, specificity: 0.43, 0.96; 0.34, 0.67; 0.89, 0.49; respectively). 
 
 
Figure 1. Inconsistency between four neuropsychological tests ([A] heatmap and [B] Venn diagram) 
 
In the case group, chapters of DoBrain 4, 5, 22, 23 and 24, showed statistically 
significant differences in average game scores of the normal and the developmental delay 
group. In particular, the average of game scores for measuring discrimination, spatial 
perception and inference, organizing, memory and velocity perception areas in chapters 
4, 5, 22, 23, and 24 were significantly higher than suspected group (p<0.05). 
 
Table 2. Chapters in DoBrain showed statistically significant differences based on CGI-S results 
 
 Normal Group 
(n=105) 
Suspected group of 
developmental delay 
(n=14) 
p- value 
Chapter 4: Discrimination, (median (IQR)) 10.5 (0.6) 9.2 (1.1) 0.048 
Chapter 5: Spatial perception, (median (IQR)) 7.9 (3.3) 6.9 (2.2) 0.011 
Chapter 22: Inference (median,(IQR)) 8.9 (2.2) 8.1 (1.3) 0.037 
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 Chapter 23: Organizing, (median (IQR)) 8.2 (1.4) 7.3 (1.3) 0.008 
Chapter 24: Memory, (media, (IQR)) 10.2 (1.6) 9.6 (1.4) 0.017 
Chapter 24: Velocity perception, (media, (IQR)) 8.2 (1.4) 7.1 (1.1) 0.006 
* The number of children who played each game is slightly different for each game chapter  
4. Discussion 
The first major finding of this study is that this serious game can improve the memory 
area of children in Cambodia. To identify the effectiveness of this intervention, we 
adjusted the effect of the natural development process by comparing differences in 
scores between the case and the control group. The scores of BRIEF-2 did not change; 
however, BRIEF-2 is based on the scores reported by teachers, so we considered it to be 
the result of observer-variability in the BRIEF-II test. 
Second, the conventional tests were not consistent and varied in criteria for 
suspected mild developmental delay, even in the same child. Although the purposes of 
these tests are to screen for developmental delay in children or to measure cognitive 
level, this inconsistency may result from measurements of heterogeneous areas. For 
example, BRIEF-II can measure eight cognitive areas in detail; however, DDST-II can 
measure only four areas. 
Lastly, we found games where the average of game scores differed between the 
two groups related to CGI-S results. In particular, the discrimination, inference, 
velocity, memory and spatial perception categories within the game showed high 
relevance. 
This study has a limitation that cognitive levels of children were over or 
underestimated because some children were suspected of having mild developmental 
delay by comparing their score to that of other children (under 3%). To make our 
findings more robust, further research with clear diagnosis data is needed. 
In conclusion, this study verified that a serious game could help in the improvement 
of specific cognitive areas and showed that inconsistencies exist among four 
conventional NPTs. It also identified the potential for serious games to be used as a 
low-cost, unconstrained spatiotemporal NPT in low- and middle-income countries. 
References 
[1] D.L. Robins, D. Fein, M.L. Barton, J.A. Green, The Modified Checklist for Autism in Toddlers: an 
initial study investigating the early detection of autism and pervasive developmental disorders, Journal 
of autism and developmental disorders 31(2) (2001), 131-44. 
[2] S.M. Gore, Assessing clinical trials--between-observer variation, British medical journal (Clinical 
research ed.) 283(6283) (2001), 40. 
[3] D.L. Morelli, et al., Challenges to implementation of developmental screening in urban primary care: a 
mixed methods study, BMC pediatrics 14(1) (2014), 16. 
[4] S. Saxena, et al., Resources for mental health: scarcity, inequity, and inefficiency, The Lancet 
370(9590) (2007), 878-89. 
[5] G.H. Tison, et al., Achieving High Retention in Mobile Health Research Using Design Principles 
Adopted from Widely Popular Consumer Mobile Apps, Circulation 136(suppl_1) (2017), A21029-A. 
H.H. Kim et al. / A Study of the Possibility of Detecting Pediatric Mild Developmental Delay740
Current Use of Sensor-Based 
Measurements for Paraplegics: A Literature 
Review 
Nils-Hendrik BENNINGa,1, Niclas HAGENa and Petra KNAUPa 
 a Institute of Medical Biometry and Informatics, Heidelberg University, Germany 
Abstract. Sensors are used in many fields to measure physical phenomena, often on 
mobile persons. Paraplegia is a disease with a massive impact on the ability to move, 
so patients show changes in walking behaviour or are even wheelchair users. It is 
unclear how sensors can be used with paraplegics to generate valid data for research. 
In the ParaReg project, such data shall be integrated with a medical register. In this 
paper, we elaborate current approaches for sensor measurements that might serve as 
an additional data source for ParaReg with the help of a literature review. We 
queried IEEE Xplore and MEDLINE to find publications that describe the current 
use of sensors for patients with paraplegia. The retrieved publications were screened 
for eligibility by two reviewers independently. To ensure reproducibility, we 
conducted an initial alignment. All publications were assessed based on their 
abstract. Inclusions were analysed for their major topic, and we proposed categories, 
which were statistically described afterwards. We retrieved 685 publications in total 
and included 287 publications in our analysis. The categories we found are: 
“diagnostic sensor tools for clinical environments”, “seating position analysis”, 
“functional electrical stimulation (FES) / neuroprosthesis control”, “seating 
position analysis”, “control systems for devices” and “assessment of physical 
activity”. “FES / neuroprosthesis control” shows most publications and the highest 
publication rate in history, followed by “assessment of physical activity”. 
Keywords. Sensor, paraplegia, spinal cord injury, literature review. 
1. Introduction 
The use of sensors to measure physical functions is an evolving field. Such 
measurements can be used to observe various physical phenomena or even to control 
technical systems [1]. One example of an observational measurement is the assessment 
of patient postures. Typical methods and solutions in this field are suited for healthy or 
mobile persons. But paraplegia is a disease which limits the physical functions of 
patients significantly [2]. So, these methods might not be appropriate for paraplegics 
because they show unwanted different walking patterns [3] or even use a wheelchair. 
In the ParaReg project, we want to find out how sensor data can contribute to the 
database of medical registers, to enrich the medical information value. With this 
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literature review, we want to elaborate on current approaches for sensor measurements 
in care and research that might be used in ParaReg. 
2. Methods 
We systematically reviewed original works in IEEE Xplore and MEDLINE databases. 
Our research question for this review is: for which purpose were sensors used for 
patients with paraplegia. We accepted reports on experiments or other kinds of 
presentations, like developed prototypes or concepts. For our study, we considered 
articles from all years in English and German language. The search was performed on 
the 1st June 2019 and updated on 1st July 2019 using the following search strategy, 
exemplarily presented based on the PubMed query. 
The query consisted of two main parts, linked by an AND condition. The first part 
queried for sensors. The keyword “sensor” was extended by common sensor forms, 
which might be used instead of the general term “sensor”. They were added with OR 
conditions, so the query became broader and not narrower. The second part of the query 
was specific for the disease. Because of the ambiguous use of language, we included 
both paraplegia and spinal cord injuries. 
The search strategy was transferred to the IEEE syntax in order to query the second 
database in the same manner. Besides these queries, we did not use any filters or limits. 
The retrieved articles were merged into a single reference list, and then duplicates 
were eliminated. The screening started based on abstracts, which was done by two 
reviewers independently. Eligibility of an abstract was assessed on the fact if it was 
assignable to a type of sensor-based measurement for paraplegics. Furthermore, we used 
the following exclusion criteria: 
E1 – Studies not published in English or German 
E2 – Publications not related to patients with paraplegia or spinal cord injury 
E3 – Reported exclusively on animals 
E4 – Not presenting original work in the field 
E5 – Presentation of work in the field of Biochemistry 
("sensor"[Title/Abstract] 
OR "sensors"[Title/Abstract] 
OR "gyroscope"[Title/Abstract] OR "gyroscopes"[Title/Abstract] 
OR "accelerometer"[Title/Abstract] OR 
"accelerometers"[Title/Abstract] OR "IMU"[Title/Abstract] 
OR "inertial measurement unit"[Title/Abstract] 
OR "inertial measurement units"[Title/Abstract] 
OR "inertial sensor"[Title/Abstract] OR "inertial 
sensors"[Title/Abstract] OR "GPS"[Title/Abstract] OR "Global Positioning 
System"[Title/Abstract] OR "Fitness Trackers"[Mesh] 
OR "Fitness Tracker"[Title/Abstract] OR "Fitness 
Trackers"[Title/Abstract] OR "Activity Tracker"[Title/Abstract] OR "Activity 
Trackers"[Title/Abstract] OR "Activity Monitoring"[Title/Abstract]) 
AND 
("Spinal Cord Injuries"[MeSH Terms] OR "SCI"[Title/Abstract] 
OR "Spinal Cord Injury"[Title/Abstract] 
OR "Spinal Cord Injuries"[Title/Abstract] 
OR "paraplegia"[MeSH Terms] OR "Paraplegia"[Title/Abstract]) 
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We conducted an abstract-based initial alignment with both reviewers. We measured 
the agreement of the decision for either “include, relevant publication” or one of the 
exclusion reasons (E1-E5). Afterwards, the agreement of the reviewers was assessed 
with Cohen Kappa; values above 0.75 were accepted [4]. Disagreement during the 
initial assessment was solved by an intensive discussion of the article’s abstract and on 
content. After the initial assessment,  all remaining publications were split and each 
of them assigned to one reviewer. For the included publications, the reviewers began 
to develop categories, describing the kind of sensor-measurement in the use case. This 
development was done cooperatively and inductively. Each inclusion was assigned 
to the best fitting category. In cases where there was no appropriate category 
defined, the reviewers discussed different approaches before introducing a new one. 
The included and categorized articles were exported to a separate table and 
analysed statistically. 
3. Results 
 
Figure 1 - Flow Chart of the screening process (adopted from [5]) 
In total, we retrieved 685 publications. There were 621 distinct ones without 
duplicates. During the initial assessment, we achieved a Cohen Kappa of ~0.85, which 
was accepted due to the given threshold of 0.75. We excluded 334 publications during 
the screening. So, in total, we included and thus classified 287 publications, which can 
be found in the published dataset [6]. 
The analysis of the abstracts resulted in five categories. These categories have 
been assigned to the included publications. The categories and the share of publications 
in them are: 
C1 (9,1 %) – Diagnostic sensor-based tools, which are suited only to clinical 
environments or study centres (non-mobile) 
C2 (9,1 %) – Seating position or pressure distribution analysing in wheelchairs 
C3 (50,9 %) – Control systems for FES devices (functional electrical stimulation) 
or other neuroprostheses 
C4 (11,5 %) – Human control interfaces for devices (e.g. personal computers) 
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C5 (19,5 %) – Focus on the assessment of physical activity
 
  
                                              
 
 
 
 
 
 
 
 
To analyze if the found publications are also an evolving topic, with recent 
publications and ongoing activity, we analyzed the publication history. Figure 2 shows 
the cumulative publication activities. C3: “FES / neuroprosthesis control” (Figure 2) 
only has very few periods where no new publications appeared, and it increased rather 
steadily. In contrast, “assessment of physical activity” (C5) did not have new 
publications for 14 years in a row (see Figure 2). “Diagnostic sensors for clinical 
environments” (C1), “seating position/pressure analysis” (C2), “control systems for 
devices” (C4) and especially “assessment of physical activity” (C5) have a stronger 
increase in 2018. “FES / Neuroprosthesis control” (C3) shows a comparable increase in 
2016/2017. 
Table 1 - Total number of publications in the given topics 
4. Discussion 
All included publications could be assigned to one of the five categories. “FES / 
neuroprosthesis control” (C3) seems to be the field of research with the longest history 
and richest experience. Younger categories are “control systems for devices (such as 
personal computers)” (C4), “diagnostic sensors for clinical environments” (C1) and 
“seating position/pressure analysis” (C2). 
First publications appeared remarkably close to each other in the categories 
“diagnostic sensors for clinical environments” (C1), “seating position/pressure 
analysis” (C2) and “control systems for devices” (C4) (years 1998-2002). Improved 
availability for sensor technology could explain this. The first publications in “FES / 
Measure C1 C2 C3 C4 C5 
Sum 26 26 146 33 56 
Share 9.1 % 9.1 % 50.9 % 11.5 % 19.5 % 
C1 C2 C3 
C4 C5 
Figure 2 illustrates grafically the cumulative publication activity for the
five categories. 
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neuroprosthesis control” (C3) appeared a decade earlier and continuously increased, 
which suggests a higher maturity of C3 compared to the other fields. First publications 
on “assessment of physical activity” (C5) appeared in 1978; however, there was a long 
stagnation of the publication counts until 2005. 
The insights of this systematic review have to be interpreted with care. Even 
though the search strategy was very generic, the used keywords might always lead to 
selection bias, and thus the results cannot claim to be exhaustive. However, by using 
one medical database and one technically focussed database, combined with a generic 
search strategy, we could identify a reasonable number of relevant articles and 
corresponding categories. 
5. Conclusions 
The use of sensors for paraplegics is not new (first publications from 1978), but it is 
still a highly relevant topic, as publications rates are even increasing within five 
categories during the last years. This encourages sensor-based data generation in one of 
the categories found for integration into the ParaReg register, to support medical 
research with a more extensive database. 
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Detection of Psychomotor Agitation Pattern 
from Motion Sensor Data in a Living 
Environment of a Patient with Dementia 
Corinna MIELKEa,1, Rasmus ANTONSa and Reinhold HAUX a 
a Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and 
Hannover Medical School, Braunschweig, GERMANY 
Abstract. Agitation is a symptom of many mental illnesses such as dementia. The 
aim of this work is to detect psychomotor agitation pattern in the living 
environment of a patient with dementia. To reach this goal, we built a smart home 
environment to collect the motion data of our patient. These data can be used to 
show the single movements of a person between different rooms in this apartment. 
The interpretation of these movements allows us to conclude if movements are 
normal or look like psychomotor agitation, in particular wandering around. This 
information might be useful for further analysis and interpretation. Additionally, it 
might be possible that the movement can give an indication of possible mood and 
behavioural changes in the patient. So it should be possible to create a long-term 
living environment that enables residents to live a long and independent life in 
their own home. 
Keywords. Mental illnesses, dementia, behaviour monitoring and interpretation, 
ambient assisted living, health-enabling and ambient assisted technologies, home 
automation technology, smart home 
1. Introduction 
Agitation describes a neuropsychiatric symptom which is characterized by 
pathologically increased, unproductive motor activities and the feeling of being driven 
and agitated. [1] According to this definition, agitation manifests itself through 
excessive motor activities such as nesting, reaching around, constant undressing, 
trembling or pointless wandering. The basic characteristic of agitation is that the 
hyperactive movements are carried out hastily, erratically and aimlessly. In particular, 
this symptom can be found in mental illnesses such as dementia or depression. [1] 
The review by Khan et al. [2] gives a brief overview of the existing studies that use 
sensors to detect agitation in patients with dementia. They conclude, “that actigraphy 
shows some evidence of correlation with of agitation and […] multi-modal sensing has 
not been fully evaluated for this purpose” [2]. Therefore, the research question of this 
paper is, if it is possible to detect incidences behaviours such as aimless wandering in 
the home with home automation technologies and health-enabling and ambient 
assistive technologies (HEAAT). This question is based on the work of Haux et al. and 
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their conclusion that “HEAAT remain an important field for future health care and for 
interdisciplinary research” [3]. In addition, Mielke et al. describe in [4] the first 
example of an apartment as a diagnostic and therapeutic area. Following this example, 
it is possible to build up several modern apartments equipped with information and 
communication technology for medical care. They used home automation technologies 
and HEAAT to build this apartment, and as a result, they presented data from various 
types of sensors. Therefore, our goal is to build a Smart Home for medical care with 
the function to detect the psychomotor agitation pattern from motion sensor data in a 
living environment of a patient with dementia. 
2. Method 
In cooperation with Baugenossenschaft Wiederaufbau eG we equipped a housing unit 
in a building complex of assisted living with a home automation system, which can 
record and analyze selected data of the resident. Our first step to build this system was 
to develop a technical concept and a design on how to equip the apartment with sensors 
and smart home technologies. We decided to use the home automation system 
“provedo” with flat cables to minimize expenditure and cost for retrofitting. This home 
automation system was built by former company PROVEDO GmbH, and retrofitting 
was done by Baugenossenschaft Wiederaufbau eG. We equipped the apartment with a 
mini-computer and the necessary software to collect and analyze home automation data. 
In the following, we describe some details of this home automation system, the 
algorithm and the graphical user interface we developed for the detection of movement 
agitation patterns from motion sensor data in a living environment. 
2.1. Details of the home automation system – sensors, data, resident 
The apartment was equipped with different sensors. The installation includes motion 
sensors for activity detection, power sensors to collect the energy consumption, 
temperature and humidity sensors for automatic control of the heating system as well as 
contact sensors to detect the opening and closing of windows and doors. Therefore, the 
resident can experience several comfort functions like an automatic heating system, a 
chip-controlled door lock for keyless opening, a floor lighting as a night light, a stove 
and window control display and a stove monitoring. Additional to these comfort 
functions, the data collection runs autonomous and without any intervention of the 
resident. The sensors we used in the system are not intrusive and inconspicuous. 
PROVEDO offered a house bus system (see figure 1), which could easily be installed 
in existing apartments. Flat ribbon cables were used which could be placed under the 
wallpaper. The sensors and actuators are small devices that were mounted on the wall 
or ceiling like a light switch or smoke detector and thus could be integrated 
inconspicuously into the entire electrical installation of the home. Figure 1 shows the 
positions of the sensors in the apartment. The data recorded by the sensors are 
movement data within the apartment, the power consumption of the apartment, power 
consumption of the stove, room temperature and humidity, window status 
(open/closed) and access control. For the detection of psychomotor agitation, we used 
data recorded in the retrofitted apartment by a male subject aged 85+ and diagnosed 
with dementia between October 2016 and October 2018. The subject’s guardian was 
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informed about the project details and a signed consent form for the collection and use 
of data is available. 
 
Figure 1. Schematic for the installation of sensors in the apartment with designation of individual 
components. 
2.2. Algorithms for detection of movement agitation pattern 
A relevant evaluation related to the behaviour of a person is the detection of inner 
restlessness and agitation. This evaluation is possible with the help of the analysis of all 
movement events over a certain period. In doing so, coherent movement sequences are 
identified, documented and evaluated. Connected motion sequences result from 
observation of individual motion events between rooms and their temporal distances. 
These movement sequences can be observed, recorded and evaluated by monitoring 
movements through individual rooms of the subject’s home. In particular, the duration 
of an agitation phase and the frequency of room changes are of interest. 
Motion sensors on the ceiling of each room are the basis for movement detection. 
They generate an event every time they detect motion, which is stored as the number of 
events per second. We only attempt to detect movements when one person is present in 
the apartment. The first step is to create a list of the resident’s location for every time of 
day. Because the detection radius of sensors in neighbouring rooms overlap, it is 
possible to detect one person as being present in two rooms simultaneously. When no 
sensor detects motion, the resident has either left the residence or is rather motionless 
in the current room. We assume the resident has left the apartment if no motion is 
detected for 30 minutes, and the last room was the corridor. The following list with the 
current timestamp and the corresponding room in the residence can be derived from the 
data. 
 
[  [1498953600000, ["bathroom"]], 
  [1498953955000, ["bathroom", "corridor"]], 
  [1498954003000, ["corridor"]], 
  [1498954037000, ["living room"]], 
  [1498954044000, ["living room", "bedroom"]], 
  [1498954091000, ["bedroom"]], 
  ...] 
The list of all movement sequences is composed of individual movements, which 
are aggregated to a complete sequence if on the last individual movement the occupant 
stays at the same place for at least three minutes. A sequence of movements is marked 
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as critical if it lasts more than three seconds and contains the same room more than 
three times none consecutively. It is also marked critical if it contains impossible room 
changes, i.e. a direct change between two non-neighbouring rooms because this could 
indicate that more than one person is present. 
3. Results 
The data analysis results in a list of movement sequences. Due to its type and quantity 
of information contained, this list is now the basis for assessment and evaluation of 
individual movement sequences with regard to inner restlessness and agitation. For the 
research apartment, figure 2 shows the general overview of the evaluation for the 
movement data. The schematic floor plan with the possible movement points for 
orientation and better visual comprehensibility of movement sequences in the 
apartment is shown. The selected period is also displayed as well as the general 
summary for all found motion sequences and the motion sequences that were marked 
as critical through the evaluation for inner restlessness. In addition, this illustration also 
shows a normal motion sequence from September 26, 2017, with a defined start and 
end of the motion and the list with single movement sequences detected in the selected 
period. The motion sequences of this list that are marked as critical in the sense of inner 
restlessness are shown in red. Figure 2 shows a passage to the bathroom with a duration 
of 1 minute and 16 seconds. 
 
 
Figure 2. Controlled and targeted movement - a normal motion sequence with a defined start and end 
(Example from September 26, 2017, blue dots - motion points for single and neighbouring rooms, a motion is 
marked with an arrow in the floor plan and the same colour dot in the list of motions). 
In contrast, figure 3 shows an accumulation of movement on the same day that has 
been evaluated as critical or conspicuous. This motion sequence is characterized as 
critical because each stay per room has lasted less than three minutes and contains the 
same room more than three times none consecutively. 
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Figure 3. Agitation movement – movement sequence with many room changes about a duration of 8 minutes 
(Example from September 26, 2017, blue dots - motion points for single and neighbouring rooms, a motion is 
marked with an arrow in the floor plan and the same colour dot in the list of motions). 
4. Discussion 
The movement sequences marked as conspicuous or critical can give an indication of 
possible changes. The accumulation or temporal shift of such movement sequences 
could be indicators of a changing state of health in patients with dementia. 
With the knowledge gained from this, we can develop systems that detect changes 
in lifestyle at an early stage. This enables relatives, caregivers or -providers, and 
doctors to intervene in a supportive manner in time. Thus, it should be possible to 
create a long-term living environment that enables residents to live a long and 
independent life in their own homes. In future work, we want to refine the algorithm, 
so that it is possible to improve the statements regarding agitations. Furthermore, we 
consider how a suitable study plan could look like in order to investigate to what extent 
agitation episodes can possibly be reduced with the help of the developed algorithm. 
References 
[1] M. Garriga, I. Pacchiarotti, S. Kasper, et al., assessment and management of agitation in psychiatry: 
Expert consensus, World J Biol Psychiatry 17(2) (2016), 86-128. 
[2] S.S. Khan, B. Ye, B. Taati, A. Mihailidis, Detecting agitation and aggression in people with dementia 
using sensors-A systematic review,  Alzheimers Dement. 14(6) 2018, 824-832. 
[3] R. Haux, S. Koch, N.H. Lovell, et al., Health-Enabling and Ambient Assistive Technologies: Past, 
Present, Future, Yearb Med Inform 25 (2016), S76-S91. 
[4] C. Mielke, T. Voss, R. Haux, Residence as a Diagnostic and Therapeutic Area-A Smart Home Approach, 
Studies in health technology and informatics 238 (2017), 92-95. 
C. Mielke et al. / Detection of Psychomotor Agitation Pattern from Motion Sensor Data750
ECG-Quality ssessment of ry-Electrode
ooperative ensors
Michael Ra, Josias W	
a, Damien F
a, Etienne H
a,
Stephan D
a, and Olivier C
a,1
a CSEM SA, Neuchâtel, Switzerland 
Abstract. Classical approaches for measuring high-quality ECG require the use of 
gel electrodes and individually shielded cables, which limit patient comfort, 
especially in long-term use. We recently introduced a novel sensing architecture—
so-called cooperative sensors—that allow the use of active dry electrodes connected 
by two unshielded wires. The aim of this work is to qualitatively evaluate an ECG 
recorded with a dry-electrode cooperative-sensor system. To that end, preliminary 
observations were made on three healthy subjects. The ECGs were concurrently 
recorded with cooperative sensors and a gold-standard 12-lead ECG device during 
a stress test on a stationary bicycle. First experimental measurements demonstrated 
the reliability of the approach for a wearable 12-lead ECG monitoring system tested
in real settings.
Keywords. Wearable sensors, dry electrodes, electrocardiography (ECG), multi-
lead, active electrodes, cooperative sensors, long term monitoring.
1. Introduction
For many years the electrical activity of the heart has been measured with adhesive gel 
electrodes connected with shielded cables to a centralized electronic device used to 
record the electrocardiogram (ECG) signals [1]. One of the limitations that blocked the 
market entry of alternative wearable solutions—such as textile electrodes—was their 
signal quality that was not demonstrated as sufficient for medical use [2]. In order to 
solve this issue, we developed and patented active dry electrodes called “cooperative 
sensors” [3]. Cooperative sensors rely on voltage-sensing analog frontends which are 
directly placed onto the skin, allowing to maximize the input impedance and to reduce 
the sensitivity of the system to electromagnetic disturbances [4]. In addition to replacing 
glued gel electrodes with more comfortable, glue-free dry electrodes, cooperative sensors 
do not need shielded cables but work with a non-shielded two-wire bus which makes 
their integration in a garment simpler and further increases the wearing comfort of the 
system.
Since cooperative sensors use a different transducer (dry instead of gel electrodes) 
and a different way of application (pressure from a tight-fitting vest instead of an 
adhesive), tests cannot be limited to compliance to medical standards (e.g., IEC60601-
2-47 or IEC60601-2-25), but require a qualitative assessment in a real setting. This work
presents such an assessment.
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2. Methods 
The prototype depicted in Fig. 1 uses ten cooperative sensors embedded in a vest to 
measure 12 ECG leads [5]. The cabling, connecting the sensors together, consists of a 
bus of two non-shielded wires integrated into the textile of the vest. Sensors are located 
according to the Mason-Likar placement [6]. They are attached to the vest and connected 
to the two-wire bus with snap buttons. All sensors have a stainless-steel dry electrode. 
The diameter of each electrode in contact with the skin is 28 mm. To start a recording, 
the vest is simply put on naked skin (neither skin preparation, nor shaving) and closed 
with the zipper. The sensors automatically start to measure the ECG leads when they get 
in contact with the skin. One of the sensors (the master sensor) collects the ECG signals 
and sends them via Bluetooth to an external unit (e.g., a computer or a tablet), where the 
data is displayed and recorded for further analysis. As shown in Fig 1, ECG lead II is 
also displayed as a continuous wave below the 12-lead complexes. 
Figure 1. 12-lead ECG system under test made of ten dry-electrode cooperative sensors embedded in a tight-
fitting vest [5]. 
The ECG-quality assessment was performed on three healthy male subjects. The 
clinical standard 12-lead ECG System Cardiovit CS-200 (Schiller, Baar, Switzerland) 
was used as a reference. The gel electrodes of the reference system were glued onto the 
skin at locations as close as possible to those of cooperative sensors (see measurement 
setup shown in Fig. 2). The subjects underwent the following three-steps protocol: 1) a 
few minutes resting in supine position; 2) exercise stress test on a stationary bicycle 
(starting at 50 W, increasing the intensity in 25 W-steps, each one 2 min long, and up to 
the subject’s capability); 3) recovery in supine position. 
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 Figure 2. Test setup with reference system (left) and subject performing the ECG stress test (right). 
3. Results 
Fig. 3 shows excerpts of signals recorded on subject 1 with the reference system (black 
curves) and with the dry-electrode cooperative sensors (red curves) before (left) and 
during (right) the stress test. The ECG curves in Fig. 3 exemplify the general qualitative 
observation that the signals acquired from the two systems are very similar. As shown in 
the right graph in Fig. 3, similar noise appears simultaneously on both signals, which 
means that the electrical artefact is already present on the body. Differences in the shape 
of the signals (see for example Fig. 4, which shows a ventricular ectopic beat in the 
lead II and lead V2) are best explained with the position of the electrodes that cannot be 
exactly the same for the reference system and cooperative sensors. 
Figure 3. Typical ECG measured on the first subject with the reference system (black) and dry-electrode 
cooperative sensors (red): (left) supine position at rest before stress test and (right) during the stress test. 
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Fig. 5 shows that the baseline wandering is similar for both systems. However, the 
baseline of the data acquired with the Cardiovit CS–200 may be improved via signal 
processing with their baseline stabilizer that reduces baseline fluctuations. However, the 
purpose of this evaluation is not to compare the signal quality after post-processing but 
to qualitatively compare the ECG acquires with both systems that have an equivalent 
bandwidth. 
Qualitative observation on Fig. 6 shows that ECG signals acquired from both 
systems on the second (left) and third (right) subjects during the exercise stress test are 
very similar. We can also notice that similar noise appears simultaneously on signals 
from both systems. 
Figure 4. Typical ECG measured on the first subject with the reference system (black) and dry-electrode 
cooperative sensors (red): (left) ventricular ectopic beat seen from lead II and (right) same ventricular ectopic 
beat seen from lead V2. 
Figure 5. Comparison of baseline wandering during motion (160 s measurement on the first subject). 
Cooperative sensors (red) behave slightly better (no other filter than the basic 0.05 Hz to 150 Hz first-order 
band-pass filter) than the reference system (black). 
 
M. Rapin et al. / ECG-Quality Assessment of Dry-Electrode Cooperative Sensors754
Figure 6. Typical ECG measured with the reference system (black) and dry-electrode cooperative sensors 
(red) on the second (left) and third (right) subjects during the exercise stress test.
4. Conclusion
This paper demonstrates the feasibility of measuring a 12-lead ECG with dry-electrode
cooperative sensors in a real-life setting. The observations performed on three healthy 
subjects qualitatively shows that the dry-electrode cooperative-sensor technology 
provides signals—at rest and during exercise stress tests—of quality equivalent to 
conventional 12-lead ECG systems. Further studies must be carried out in order to 
formally validate these promising preliminary observations.
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Abstract. This paper presents a convolutional neural network-based classification 
of the hand flexion and extension gestures used in wrist recovery after injury. The 
hand gesture recognition device used in our study is the Leap Motion controller. 
The Leap Motion device's inability to accurately differentiate the left hand from 
the right hand when performing hand rotation gestures was eliminated by 
introducing hand and thumb direction vectors into the database used to train the
neural network. A 3D environment was created for the introduction of the data 
describing the gesture into the database. A classification accuracy of 95% was 
achieved for the hand flexion and extension gesture divided into three levels for 
each hand. The populated database may also be used to classify other gestures 
involving hand rotation.
Keywords. Gesture, neural network, leap motion, hand recovery
1. Introduction
As substantiated by the literature, several sensors are used to detect hand gestures. A 
Flexible Epidermal Tactile Sensor is used to detect five gestures: finger flexion and 
extension, hand flexion and extension, and the non-state gesture (a gesture that 
expresses no particular state of the hand) [1]. To classify such gestures, a neural 
network consisting of 10 input layers was built for each gesture and an arbitrary 
number of hidden nodes was chosen. A set of 450 data was used to train the neural 
network, and 50 data entries were used for testing. A gesture classification accuracy of 
88% [1] was obtained for the neural network. Image processing is also used to 
recognize hand gestures.  In [2] a neural network is used to detect gestures representing 
letters, numbers or punctuation marks. Three thousand nine hundred (3,900) images 
were used to train the neural network. A gesture classification accuracy of 90% was 
achieved. Numbers and letters of the alphabet expressed by dynamic gestures may also 
be recognized by using the Microsoft Kinect device.  The use of a radial basis function 
(RBF)-based neural network to classify gestures representing numbers or letters is 
described in [3].  The experimental results led to an accuracy of 97.25% for the 
gestures representing the English language alphabet, respectively of 92.63% for the 
gestures representing the Arabic numerals. The Microsoft Kinect device may be used in 
hand recovery – hand deviation exercise [4] as well as to monitor the users' correct 
sitting posture at a computer [5].
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Judging by the degree of involvement of the limbs and by how recovery is 
performed, the devices used in recovery may be classified into four categories: passive, 
active, haptic and coaching devices [6]. Coaching devices are the cutting-edge 
technology in recovery. They are based on the use of cutting-edge technologies such as 
virtual reality, augmented reality or mixed reality to train patients on how to perform 
the recovery exercise. Moreover, they provide feedback to the users on the accuracy of 
the exercise being performed. The Leap Motion device may also be assigned to this 
category. It may be used in hand recovery inasmuch as it recognizes hand gestures, but 
also in monitoring or classifying the evolution of a disease [7] (e.g. classification of 
Parkinson disease). New recognizable gestures may be implemented for it [8]. The 
software of this device has four predefined gestures: Screen_Tap, Key_Tap, Swipe and 
Circle. One downside to it is that when using gestures that involve hand rotation, it 
confuses the left and the right hand. One immediate solution for this issue is the use of 
2 Leap Motion devices [9]. The 2 devices are placed on a stand so as to be 
perpendicular to one another (the first is placed horizontally and the second vertically). 
The classification of the gestures implemented for the Leap Motion device may be 
performed with the aid of neural networks [10]. 
The objective of this paper is to achieve a specific classification for the hand 
flexion and extension gesture detected by means of a neural network. The Leap Motion 
device's main issue of recognizing the left hand from the right hand will be eliminated 
by entering the data corresponding to the hand and thumb rotation direction in the 
database. The neural network will classify the recovery level 1, 2 or 3 for each hand. 
The major advantage of the implemented neural network is that it is able to accurately 
identify the hand being used. Another benefit lies in building the database, which may 
also be used in training other neural networks for the classification of other types of 
gestures involving hand rotation.     
2. Method
The accuracy of the neural network depends on: the selection of the relevant data 
describing the flexion and extension gesture and the number thereof, the computation 
of the number of neurons for the hidden layers of the neural network as well as on the 
division of the gesture into levels so as to make it usable/functional/useful in recovery. 
We explain below how the neural network was parameterized in order to achieve the 
best possible classification accuracy. 
2.1. Neural Network
For the clusterization of the hand flexion and extension gesture by levels, we used an 
open-source machine learning platform (Tensorflow), which was parameterized. The 
neural network consists of 13 input layers and six output layers (Figure 1). A variant on 
two levels including each 17 neurons was chosen for the hidden layers. The number of 
neurons for the hidden layers was determined by the following formula:
?? ?
??
????????
(1)
where: Nh – number of hidden neurons;
Ns – number of data in the database (1737);
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Ni – number of inputs (13) 
No – number of outputs (6)
α – an arbitrarily chosen number, taken from the 2-10 range, in our case α is 3
(selected by former experience).
Training and testing the network required the use of the parameterized open-source 
Tensorflow library. A hand flexion and extension gesture detection accuracy (level 
classification) of 95% was achieved. A set of 1737 data was used to train the neural 
network and 786 data entries were used to test it. 
Figure 1. The Neural Network
2.2. Database and 3D environment
To devise gestures in the 3D Unity Editor for the Leap Motion device we integrated the 
Leap Motion version 2.3 Software Development Kit (SDK) into the editor. A 3D game 
was created in the Unity Editor, based on the hand flexion and extension movement, 
C# and PHP (Hypertext Preprocessor) scripts were written for functionality, and 
Python scripts to train the neural network. To have the device work as correctly as 
possible it was calibrated to a performance of 110 frames per second. 
A MySQL database containing 13 types of data describing the hand flexion and 
extension gesture was created. The data types contained in the database are the 
following: – left or right hand, hand rotation, hand pitch, and hand yaw, palm position 
on all the three axes, hand direction and thumb direction. The last six input data, which 
refer to direction, provide higher precision in hand detection – left or right hand. In 
terms of data describing the gesture, a choice was made to use the hand and thumb 
direction because it was noticed that in some cases the Leap Motion software confuses 
the right hand and the left hand. Thus, such confusion was eliminated and when a hand
is detected upon examination of the gesture all the elements of the other hand are 
deleted by the C# Destroy(object) method. To calculate the hand direction or the thumb 
direction we used the following formula: 
?? ?
??
?
(2)
where: Di – hand/thumb direction and i refers to the x, y or z axis
pi – hand/thumb position and i – refers to the x, y or z axis
β – angle calculated based on the following formula: β = ??? ? ?? ? ??
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To enter the gesture description data a 3D environment (Figure 2) was created with 
the aid of the Unity Editor, where the users have to control an aeroplane so that it 
passes through a series of obstacles. The 3D object is controlled by performing left- or 
right- hand flexion or extension movements. 2 virtual 3D hands from the Leap Motion 
software package that copy the movement of the real hand were used to allow the users 
to constantly observe how they move their hand.  The Unity Editor and the database 
were connected via a C# script which refers to another PHP script (Hypertext 
Preprocessor).  
 
Figure 2. The 3D environment  
Certain hand rotation angle ranges were selected, as shown in Table 1 to filter the 
data based on levels for each hand. The name assigned to each level was given in the 
following form: Level_n_H, where n represents level 1, 2 or 3 and H represents the left 
hand – L or the right hand – R.   
Table 1. Ranges for each level of the flexion and extension gesture 
Level Range 
Level_1_R [-180; -60) 
Level_2_R [-60; 60) 
Level_3_R 
Level_1_L 
Level_2_L 
Level_3_L 
[180; 60] 
[180; 60) 
[60; -60) 
[-60; -180] 
 
A division of the hand flexion and extension gesture into several levels was made 
because in hand and wrist recovery patients are initially unable to perform a full hand 
flexion and extension movement. Thus, recovery progress may be observed when 
moving from one level to the next.  
The C# RiggedHand script was rewritten to achieve best possible results in the 
classification of the hand flexion and extension gesture, eliminating, therefore, the 
possibility for the virtual hands which copy the movement of the real hands to take any 
virtual position within the 3D space. Such operation was made because as far as the 
hand rotation gestures are concerned, the data related to distances and positions of the 
fingers are not important. It may be said that the virtual hands are mobile, but they have 
a single rotation point. 
3. Results and discussion 
Table 2 shows the results obtained for each level of each hand. The following metrics 
were computed: precision, recall, f1-score. It can be noticed that the relation between 
the training data number is directly proportional to precision. The maximum F1-score 
is of 0.98 for 675 training data for level 2 of the left hand, while the minimum F1-score 
is of 0.47 for level 3 of the right hand. Thus, the larger the training data set, the better 
the F1-score.   
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Table 2. Precision, recall, f1-score and number of training and test data
Hand Level precision recall f1-score No. of training data No. of test data
Level 1 – right 0.94 0.99 0.96 148 152
Level 2 – right 0.99 0.92 0.95 473 146
Level 3 – right 0.31 0.92 0.47 201 12
Level 1 – left 0.83 0.58 0.68 127 52
Level 2 – left 0.99 0.98 0.98 675 368
Level 3 – left 0.92 0.96 0.94 113 56
This paper focused on the creation of a neural network for the classification of the 
hand flexion and extension gesture recognized by the Leap Motion device. A gesture 
classification accuracy of 95% was achieved. Emphasis was placed on the correct 
detection of the hand being used to perform the gesture, eliminating the confusion 
between the right and the left hand. The database created to train the neural network 
allows the users to also train other neural networks in order to classify other types of 
hand rotation gestures (e.g. pronation and supination). The gesture was divided into 
several levels so as to enable using the gesture in patients' hand and wrist recovery. Our 
next objective is to use machine learning techniques to detect multiple gestures 
performed with both hands for the Leap Motion device. 
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Abstract. Heart Failure is a severe chronic disease of the heart. Telehealth 
networks implement closed-loop healthcare paradigms for optimal treatment of the 
patients. For comprehensive documentation of medication treatment, health 
professionals create free text collaboration notes in addition to structured 
information. To make this valuable source of information available for adherence 
analyses, we developed classifiers for automated categorization of notes based on 
natural language processing, which allows filtering of relevant entries to spare data 
analysts from tedious manual screening. Furthermore, we identified potential 
improvements of the queries for structured treatment documentation. For 3,952 
notes, the majority of the manually annotated category tags was medication-related. 
The highest F1-measure of our developed classifiers was 0.90. We conclude that 
our approach is a valuable tool to support adherence research based on datasets 
containing free-text entries. 
Keywords. Adherence, heart failure, telemedicine, text mining, machine learning. 
1.Introduction 
Heart Failure (HF) is a severe chronic disease of the heart. For affected patients, an 
active change of lifestyle regarding nutrition and physical activity as well as 
individually tailored medication is recommended in the Treatment Guidelines 
published by the European Society of Cardiology [1]. Telehealth networks like the HF 
disease management program HerzMobil Tirol support patients and all stakeholders 
involved in their treatment by implementing a closed-loop healthcare paradigm [2]. In a 
recent publication, Köhler et al. provided evidence that such a telehealth system can 
improve the outcome of HF treatment [3]. 
The main aims of HF telehealth solutions typically relate to a) outcomes and b) 
economics-related targets. These targets can be achieved by early detection of acute HF 
events. Besides vital sign monitoring, documentation of patients’ medication and their 
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adherence to it are major features to achieve this goal. Medication management is a 
crucial part of each HF telehealth system. However, medication regimes are often 
complex, as they are subject to drug-drug-interactions, and should be tailored to vital 
parameters, individual circumstances, co-morbidities, etc.  
Telehealth data may comprise structured data (e.g. vital signs) as well as 
unstructured, textual entries (e.g. free text notes). For efficient monitoring of drug 
adherence, data on medication need to be available in a structured fashion. Therefore, 
HerzMobil Tirol is linked to the Austrian drug database (SISIX – Spezialitäten-
Informations-System, Apotheker-Verlag) and regimes of drug intake can be specified 
by the physician. Patients, on the other hand, are requested to document the correct 
intake of drugs. However, a relevant part of the information regarding medication and 
adherence is gathered via phone calls by involved nurses, who subsequently create free 
text notes within the HerzMobil Tirol database, mostly, because of difficulties to 
provide complex information from the patients’ side on drug compatibility and 
adherence as well as from the stakeholders’ side on possible changes in the procedure 
and medication within the structured variables as provided by the telehealth systems. 
Screening of free-text entries can be used to identify missing input fields, which should 
be added to the queries for structured treatment documentation. To avoid tedious 
manual screening of numerous free texts, natural language processing and machine 
learning can be applied. 
In a recent systematic review, Sheikhalishahi et al. give an overview of natural 
language processing of clinical notes on chronic diseases [4]. The biggest fraction of 
papers resulting from their literature search was related to diseases of the circulatory 
system. In the context of HF, various objectives were addressed through natural 
language processing. Garvin et al. [5] measured the quality of HF inpatient care based 
on various document types. Watson et al. [6] used electronic health record data to 
identify psychosocial risk factors related to a higher hospital readmission risk. While 
those papers deal predominately with in-clinic data, studies have been performed in our 
group, which focus on the specific requirements in HF treatment via telehealth. Modre-
Osprian et al. [7] analysed collaboration notes of stakeholders in their HF treatment 
network and identified medical and organisational issues. Gruber et al. [8] designed a 
pipeline to classify free-text notes into task and status categories. 
In this study, we analysed the content of all free-text notes found in a given dataset 
of HerzMobil Tirol with respect to medication and adherence information. We tagged 
the notes with pre-defined categories to potentially reveal missing input fields of the 
queries for structured treatment documentation. Furthermore, based on the first level of 
tagging, we developed a classification algorithm, which can be used in subsequent 
studies to automatically filter numerous free texts to a smaller subset of relevant entries. 
2.Methods 
2.1.Dataset 
De-identified (as described in [8]) data from phases I-IV of the Austrian HF disease 
management network HerzMobil Tirol were used. HerzMobil Tirol connects several 
stakeholders who are involved in the treatment of patients (see Figure 1).  
The HerzMobil Tirol disease management network started in 2012 with project 
phase I (feasibility), followed by phase II (proof-of-concept), III (specification of 
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Figure 1. The HerzMobil Tirol heart failure 
disease management network involves several 
stakeholders. Clockwise: coordinator, 
clinician, nurse, general practitioner, relatives, 
helpdesk. [9] 
routine care), IV (preparation of translatio tine 
care) and V (translation to routine care). Curr
HerzMobil Tirol is part of routine care for
patients in Tyrol. 
Within HerzMobil Tirol, patients record 
vital data (blood pressure, heart rate, body 
weight), subjective wellbeing and medication on 
a daily basis, using a specific smartphone App. 
Data are transmitted to a backend service, where 
authorized health professionals can access the 
data. Various roles (patient, coordinator, 
clinician, nurse, general practitioner, relatives, helpdesk) can communicate with each 
other via collaboration notes. Details concerning HerzMobil Tirol can be found in [10]. 
Our dataset comprised 3,952 notes, which were created during the treatment of 106 
patients, who participated in the initial four project phases (2012 – 2016) of HerzMobil 
Tirol (see Table 1). 
 
Table 1. Patient statistics for the initial four project phases of the HerzMobil Tirol disease management 
network. *One patient of project phase II participated also in project phase IV. 
Project phase Monitoring time Patients Age (M ± SD) Male / female Notes 
- months - years - - 
I 12 10 72.8 ±   8.7 2/8 142 
II 6 40 75.4 ± 13.0 15/25 1,746 
III 3 15 70.7 ± 10.0 7/8 494 
IV 3 42 66.9 ± 11.3 8/34 1,570 
Total - 106* 71.1 ± 12.1 32/74* 3,952 
2.2.Note classification via manual annotation and natural language processing 
For note annotation, seven categories were defined: absence of the patient, adaptation 
of the thresholds for vital parameters, death, medication, period of in-clinic stay, 
technical problems and therapeutic advice. Due to the high number of medication-
related tags and since the focus of our study was on medication adherence, category 
medication was divided into five sub-categories: dose adaptation, drug added to 
prescription, drug removed from prescription, intake-related information and reason 
for prescription change. For each category, the notes were manually screened for 
relevant information and tagged correspondingly. The annotation was done with a web 
application called Twister, which has been developed with the Python-based web 
framework Django [11] and is a part of our Predictive Analytics Toolset for Healthcare 
(PATH) [12].  
Automated classification was done based on the machine-learning framework 
scikit-learn [13]. A bag-of-word model was used for classification. Stop words were 
removed and numbers, medication and references to time and units were abstracted. 
Tokenization was done with spaCy (ExplosionAI GmbH, Berlin, Germany) based on a 
pre-trained German corpus. Classification was done based on linear classifiers using 
stochastic gradient descent learning. For each category, a binary classifier was trained.  
,
ourn to
ently  
 HF 
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3.Results 
Table 2 shows the number of tags for each category as well as the performance 
measures of the classifiers developed using a total sample size of 2,049 notes (= subset 
of notes with at least one tag) that were split to training (80%) and test (20%) set for 
evaluation. While death-related notes were very rare, there were many notes on a 
period of in-clinic stay. The majority of tags, however, were in the medication category. 
The classifier of the adaptation of the thresholds for vital parameters category showed 
the highest F1-measure, followed by the classifiers of the period of in-clinic stay and 
medication categories. For the death category, too few samples were available for 
classifier training. 
Table 3 shows the results of the manual sub-categorization of 956 medication-
related notes. While dose adaptations were the most frequent sub-category, the 
smallest number of tags was in the drug removed from prescription sub-category. 
An example of a medication-related note by a general practitioner is: “I adapted 
the medication regime because of asymptomatic hypotension.”, which was further 
tagged with the dose adaptation and reason of prescription change categories. 
 
Table 2. Category tags and performance measures of the trained classifiers. 
Category Tags Precision Recall F1-Measure 
Adaptation of the thresholds for vital parameters 146 0.99 0.82 0.90 
Period of in-clinic stay 640 0.97 0.77 0.86 
Medication 956 0.91 0.80 0.85 
Technical problems 354 0.93 0.75 0.83 
Absence of the patient 178 0.90 0.58 0.71 
Therapeutic advice 180 0.75 0.44 0.55 
Death 11 - - - 
 
Table 3. Results of the manual sub-categorization of the medication category. 
Sub-category Tags 
Dose adaptation 287 
Intake-related information 253 
Reason of prescription change 204 
Drug added to prescription 124 
Drug removed from prescription 91 
4.Discussion 
Annotation of the free-text notes revealed that information is mainly provided 
regarding the medication, period of in-clinic stay and technical problems categories. 
Therefore, free text notes are a valuable source of additional information for the 
evaluation of medication adherence in a telehealth HF disease management network. 
However, manual analysis of every single note is a time-consuming task. Our 
automated classifiers achieved F1-measures of up to 0.90 with F1 > 0.80 for four out of 
7 categories. Therefore, our classifiers could be used as an accurate filter of subsets 
containing only relevant notes, thus sparing researches from tedious screening work. 
In the medication category, many notes contained intake-related information and 
revealed the reason for a prescription change. Although it is possible to document 
addition or removal of a drug or to change the medication dose in a structured way in 
the system, we found that additional information is often documented in free-text notes, 
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such as the reason for prescription, or complicated dosage regimes (every second day, 
dosage depending on patient status, etc.). Hence, a suggestion to further improve the 
queries for structured treatment documentation would be to add respective input fields.  
Collaboration notes were manually tagged with categories by only one of the 
authors. To obtain a more reliable gold standard for the machine learning tasks, the 
notes need to be re-tagged by multiple persons independently for subsequent analyses. 
In future studies, text mining algorithms should be further developed towards 
fully-automated information extraction from free texts, like identifying events, dates 
and values to automatically add them to structured data. Moreover, it needs to be 
investigated if doing annotation and classification on a sentence level will result in 
better performance.  
In conclusion, our approach for automatic notes categorization is a valuable tool to 
support adherence research based on datasets containing free text entries, as it allows 
data scientists to filter a subset of relevant entries. 
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Patient-Generated Health Data in the Clinic 
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Abstract. Physician appraisal of Patient-Generated Health Data (PGHD) is unclear. 
It is not known how willing they are to consider self-registered measurements prior to 
treatment. In this research, a semi-structured interview was designed and 
administered to 10 physicians in Denmark. The study found that physicians are 
willing to work with unsolicited PGHD and integrate it as a part of the treatment if 
evidence proved the data to be valid and reliable. They request documented 
evidence for the use of each PGHD device and mobile application. 
Keywords. Patient-generated health data, eHealth, Medical wearables 
1. Introduction 
The health care system is awaiting a revolutionizing paradigm shift, where it becomes 
more personalized and enable citizens to take more responsibility for their health and 
well-being. Digitalization in the health sector is increasing all of Europe as personalized 
medicine, digital innovations, the Internet of things, and artificial intelligence gains 
momentum [1]. This shift transfers the control of health care from hospitals and 
physicians into the hands of patients; more specifically, into their homes and mobile 
devices [2]. It is estimated that the global market for medical wearables will reach $19.5 
billion in 2021 [3]. Patients are becoming more self-reliant in using digital opportunities 
to maintain their health [4]. Patient-Generated Health Data (PGHD) can be obtained 
digitally using various devices and mHealth applications. PGHD are health-related data 
created, recorded, or gathered by or from patients [5]. PGHD is often confused with 
patient-reported data (PRO-data). In Denmark, PRO-data is described as data about the 
patient's health, including physical and mental health, symptoms, health-related quality 
of life, level of functioning, as reported directly by the patient. The collection and 
reporting of data are requested by the health practitioners. In contrast, PGHD is initiated 
and driven by individuals, hence a patient-driven data collection modality [6]. 
It is assumed that PGHD can be instrumental in changing the health care system to 
focus on health care rather than sick care and to assist patients in being able to prevent 
many health problems before they become manifest [7]. Despite the growth in the use of 
PGHD, a literature search indicated a knowledge gap and a lack of evidence-based 
literature examining physicians' appraisal of PGHD in Denmark. However, the use of 
PGHD is more common in other countries, mostly in the US, where several health care 
professionals have worked with PGHD for clinical usage [8]. By accepting and utilizing 
PGHD, it is possible for physicians to gain greater insight into patientsoverall health, 
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from which the physicians can make more informed decisions [9]. Examples of PGHD 
can be physical activity, sleep, temperature, heart rate, electrocardiogram (ECG), blood 
pressure, blood glucose, and oxygen saturation. In addition to data captured by sensors, 
PGHD can be supplemented by patient entered information such as mood [10]. More 
active patients will result in an increasing number of appointments with self-recorded 
measurements [7]. The benefits of PGHD can be limited for patients if their physicians 
do not agree to utilize the collected data, and physicians’ appraisal of PGHD is still 
unclear in many countries. It is not known how willing they will be to consider these 
measurements prior to treatment, hence the aim of this study is to examine physician’s 
appraisals of unsolicited PGHD and investigate how these data can be applied in the 
clinic in collaboration with patients. 
2. Methods and material 
Since the aim of this research is to describe and understand clinicians’ subjective 
appraisal of practical PGHD use, qualitative interviews were chosen as the method. An 
interview invitation was sent to 17 possible participants from the author's professional 
network in Denmark. Attention was paid to variation in age and field of specialization. 
In qualitative studies, it is not possible to determine the minimum sample size, but it was 
assumed that data saturation could be reached within the 17 respondents. An interview 
guide reflecting the research questions was developed for the semi-structured interviews. 
In order to test the set of interview questions, two pilot interviews were performed. 
Explanations for key terms for PGHD, PRO-data, mHealth, pHealth, and patient 
empowerment were prepared and used for unanimously describing the terms during the 
interviews. The need for this description indicates how known these terms were. 
10 of the 17 invited agreed to participate, and interviews were conducted in the 
period from 21-03-2019 to 10-04-2019. The physicians decided the date and place for the 
interviews. All participants provided consent to the interview and audio recording. The 
interviews ranged in length from 7 to 36 minutes. The interviews were transcribed 
verbatim for later analysis. 
A deductive analysis approach was applied to derive information on categories from 
the interview guide, priori concepts, and pre-existing knowledge. The themes and coding 
categories were: 1) current knowledge of PGHD, 2) Physicians´ perspective of PGHD, 
3) Future use of PGHD. 
To guide the questions and have a specific focus for the interviews, the ECG 
measurement facility on the Apple Watch, series 4, was demonstrated and used for 
reference during the interviews. Additionally, pictures of the ECG reading were shown, 
in the health application and in a PDF file. 
3. Results 
Generally, the physicians were open-minded about PGHD and the increasing use of 
mHealth and growing patient empowerment. Some of the perceived benefits mentioned 
are patients being more liberal, active in maintaining their health, can result in less 
overload for the physician and also be an assisting tool for the physician. One of the 
physicians mentions the following: I actually think there are some things that might be 
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really great if the patients could monitor themselves because then they do not have to 
show up here to find out things and I also believe in that way it is the relevant patients 
which come to you, it is not just everyone that comes in, and then you think I am sorry, 
but I cannot really help you... Whereas you can be some kind of gatekeeper from the 
start and then the relevant patients come in, now I have this, you can see this is what I 
have, I want to come in and talk to you.  
The results of the analysis of the interviews are presented in Table 1. Some of the 
concerns expressed were that it could create unnecessary worrying among patients and 
over-observations, concerns about an increase in the inequality in health and about the 
Table 1. The different aspects investigated in the study 
Item Aspect/construct Responses (n=10) 
1 Not familiar with PGHD % 70 
2 Confused PGHD with PRO % 30 
3 Familiar with the existence of PGHD % 10 
4 Experiences of patients seeking out to them with health-related data 
generated by themselves without prior being solicited from the physicians 
% 40 
5 Experienced the increasing use of mHealth and patient empowerment % 70 
6 Worried about patients over-diagnosing themselves and creating unnecessary % 70 
7 Worried about increase/creating an inequality in health % 40 
8 Feels it is a good idea that patients can register own data when symptoms 
occur 
% 20 
9 Concerned about data credibility and needs validation of data % 80 
10 Willing to work with PGHD in the future as a part of patient treatment if they 
find data 
% 80 
data validity. The majority of the physicians do not trust data validity for the Apple 
Watch´s ECG application and indicated that they would perform their ECG 
measurements. 
The physicians have different opinions about the future use of PGHD. Most of them 
are willing to use it but have different criteria and necessities. Additionally, physicians 
reported different ideas for future use where PGHD is included as part of treatment, as 
well as perspectives on how the data should be integrated as a part of the  EHR. 
4. Discussion 
Overall the physicians were not familiar with the term PGHD. Those who said they were 
actually confused it with PRO-data, which some of them were familiar with to a certain 
extent. Although some of the physicians were not familiar with PGHD and the use of it, 
they already had experienced patients bringing their self-registered data without it being 
solicited by their physician. Most of the physicians had experienced increasing patient 
empowerment, except for two of them who work with elderly and mentally ill patients. 
Most of the physicians were familiar and experienced with the patients´ use of mobile 
health applications and patients looking up their symptoms and diagnosis on Google. 
Generally, the physicians are open-minded about PGHD. Some of the benefits and 
concerns expressed in the interviews replicate results reported in the literature [6, 8], 
[11–13]. Benefits can be gained not only for the physicians but also for the patients, by 
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being more active and involved in the decision making for their treatment, thereby 
becoming more patient-centred. This can likewise help physicians to be diagnostic 
efficient and effective. The data validity and verification were one of the main concerns 
mentioned by the majority of the physicians, and it was decisive for their willingness to 
use PGHD. Concerns about over-diagnosing, patients becoming excessively worried, 
and making themselves feel more ill than they were, in reality were mentioned repeatedly. 
Even though the physicians felt that patients became more concerned from generating 
their data, some of the physicians still had an understanding of why they did so. 
Another major concern was an increase of inequality in health among patients. The 
increasing inequality and deepening of the gap between the “haves” and “have-nots” are 
also one of the main apprehensions mentioned by Eysenbach as a considerable threat 
[14]. The concern of the availability of PGHD among low-income and elderly 
populations and those who often needed it the most was also shared among physicians’ 
opinions found in the literature [11]. A cardiologist at University of California San 
Francisco states that the individuals who purchase Apple watches often are those who 
are already health-conscious and probably quite healthy, whereas those who would have 
the most benefit from the atrial fibrillation screening tend to be the elderly, who might be 
less tech-savvy and less concerned about their health [15]. In addition to worried 
patients, this situation can also induce a greater workload for the physicians. 
Many of the physicians emphasize the importance of not only looking at 
measurements but also at the patients’ symptoms. They would consider forwarding the 
patient to a cardiac specialist if the symptoms were significant and the ECG still showed 
a sinus rhythm. Generally, in this research, it was discovered that most of the physicians 
did not fully trust the ECG application on Apple Watch. Most of them were open to 
looking at the ECG reading brought by the patients but would then use their own 
verified device, e.g. a Holter. However, according to Cardiologist John P. Higgins, the 
updated capabilities of the Apple Watch Series 4 can broaden the monitoring capabilities 
of existing technologies. He states that it is less invasive than Holter monitor, has great 
battery life and can be with the person 24/7 [16]. 
American physicians share the concerns of their Danish colleagues about the lack of 
evidence to justify the Apple Watch ECG against the risk of false positives. The latter 
would cause healthy/wealthy people to take up the time resources of both physicians and 
hospitals since there is no evidence that the benefits outweigh the harm. At the same 
time, another American physician states that for people with heart conditions or 
symptoms, the Apple Watch could serve as a good tool for detecting when something is 
wrong and when a visit at the physician is necessary [15]. This research shows that the 
physicians are willing to use PGHD as a part of treatment, as long as their individual 
criteria and needs are met. Some of the needs reported in the literature [13], such as 
making time to review PGHD, uncertainty of data quality and the need to distinguish 
between data measured by patients and by health care professionals. 
Most physicians agreed with integrating PGHD into the EHR, as was already done 
according to [17]. Many of their future ideas for the use of PGHD is likewise based on 
importing the data into the EHR. However, it was important for physicians to be able to 
distinguish between the data collected by themselves and by the patients. 
Despite the different opinions about PGHG and the benefits that can be gained by 
using it, and likewise the increased workload and burden for the physicians, it is clear 
that the first priority among the physicians is the safety of the patients. They do not wish 
to place all responsibility on the patients. They want to make sure that the devices and 
mobile applications can be trusted while avoiding unnecessary patients worry. 
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5. Conclusion 
This qualitative study showed that Danish physicians sampled have an overall positive 
appraisal of PGHD for clinical usage. Despite the many clinical benefits to be gained, 
the physicians prioritize data from validated, and reliability checked sources before 
taking it into consideration for clinical decisions. The physicians appreciate increasing 
patient empowerment and are willing to use PGHD as a part of the treatment for those 
who have the resources and desire to do so. Additionally, the physicians welcome 
importing PGHD into the EHR, as long as they are clearly marked. The physicians 
request more studies and documented evidence for the use of each PGHD device and 
mobile application; therefore, further research is needed to achieve a general appraisal. 
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Register-Based Research of Adverse Events 
Revealing Incomplete Records Threatening 
Patient Safety 
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Abstract. Inadequate, missing or incorrect patient information is usually related to 
poor documentation. It has several negative effects on patient care processes, and, 
thus to quality of care, care continuity, and patient safety. It is one of the causes of 
patient claims. The aim of this study was to analyze patient safety reports and to find 
out which documentation hazards are damaging to patient safety. Data consisted of 
the patient incident reports (n=82 353) from seven health and social care areas from 
2007–2016 in Finland. A descriptive analysis was conducted to explore the type of 
service provider and incidents reporting risks in patient data management and 
documentation. Adverse events due to patient data management and documentation 
were unusual; however, 18 cases were documented where patients suffered serious 
harm. Nearly half of the reports resulted from inadequate, missing or incorrect 
information. Uniform structures, documentation, and service processes need to be 
developed.  
Keywords: Documentation, safety management, patient harm. 
1. Introduction 
The transition from paper-based patient documentation systems to electronic systems has 
been widespread during the past years both internationally [1] and in Finland [2]. Some 
existing evidence shows that computerized patient data management systems [3-4] and 
electronic documentation systems [5] affect positively patient safety and quality of care. 
In addition, structuring electronic health records can have an impact, e.g., on decreasing 
medication errors, increasing documentation quality, and on care process efficiency, care 
guidelines conformation and decreasing of prescription errors [6]. However, in some 
cases, despite classifications [7] or electronic systems [8] in use, the quality of 
documentation is weak [3,4]. Thus, poor or missing documentation is among the most 
common causes for patient claims. Poor documentation hinders the visibility and 
evidence of health care professionals’ competencies, compliance of standardized care 
procedure and clinical guidelines, quality of care, the assessment of the health care 
provider, and the defence against claims [9].  
One of the aims of the Finnish Patient and Client Safety Strategy 2017–2021 
published by the Ministry of Social Affairs and Health [10] is that by 2021, all electronic 
health service processes and procedures will be safe, and patients and clients protected 
from harmful incidents. This also includes patient data management and documentation 
where all the essential processes in information flow and documentation must be 
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actualized using the same formats and structures in every health and social care 
organization, and in information exchange between the organizations. In addition, 
professionals in health and social care will have access to information systems and 
patient or client information that support their work and their processes [11]. A large 
number of incidents related to information management consist of documentation errors. 
Inadequate, missing or incorrect information, e.g. wrong name or birthday, might stand 
for some specific information loss. This might have a very important role, e.g., in the 
continuity of care and more, in patient safety [12].  
Common data structures and structured patient data benefit broadly and in various 
ways, both the patient, professionals, and organizations [6, 13]. The Finnish patient 
safety incident reporting system, HaiPro, [14] is widely used in national health and social 
care. The online reporting system allows reporting of incidents for professionals, but also 
patients and their families. The aim of this study is to analyze incident reports and 
especially concentrate on finding out which documentation hazards are most damaging 
to patient safety. 
2. Methods 
Data consisted of the incident reports (n=82 353) from seven health and social care areas 
from the years 2007–2016: three hospital districts, health and social care of two large 
cities, and two social and health care districts. Reports were retrieved from the Finnish 
Society for Patient Safety database, which collects reports from about 200 health and 
social care facilities. Reports include both structured and free-text descriptions of safety 
events. 
A descriptive analysis was conducted to explore the type of service provider 
(primary, health and social care) and incidents reporting risks in category Information 
flow and information management related. HaiPro [14] system has 13 incident categories 
(Table 1). In addition, the reporter describes the incident by narrative text clarifying the 
type, context, and circumstances of the incident. The consequences for patients or service 
providers are also assessed. Reporting incidents is confidential, voluntary, and 
anonymous, highlighting learning from mistakes and blame-free actions. HaiPro system 
implementation began in hospitals in 2007, and the social service began implementing 
the HaiPro system just recently. Reports of inadequate, missing or incorrect information 
were by inpatient wards and outpatient departments. 
 
Table 1. Categories of HaiPro system 
Categories 
1 Medication or iv fluid care, blood transfusion, 
or contrast agent related 
8 Devices or their use related 
2 Information flow and information 
management related 
9 Hygiene related/protection against 
infections 
3 Diagnoses related 10 Injury 
4 Surgical procedures related 11 Paramedical services related 
5 Invasive procedures related 12 Violence 
6 Other care related 13 Deviation in radiotherapy 
7 Laboratory, imaging-related     
 
The analyzed adverse events consisted of reports of primary healthcare, special 
healthcare (hospitals) and social care (i.e., elderly service). Approval of the University 
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of Eastern Finland Committee on Research Ethics was required. SPSS 23 software was 
utilized for analyzing the structured data (Armonk, NY, IBM). 
3. Results 
Adverse events during Information flow and information management (n=12 294) 
comprised 41.2 % (n=5070) of incident reports concerning Patient data management 
and documentation (Table 2). Of those, more detailed description of the incident reports 
of Patient data management and documentation included 40.8 % (n=2066) were the 
reports of inadequate, missing or incorrect information. Analyses showed that the 
relative proportion of adverse events was similar in primary healthcare as well as 
secondary and tertiary healthcare. In both sections, half of the adverse events were 
reports from inpatient wards. Of all data obtained, most of the reports (63,2 %) came 
from registered nurses and physicians 4,2 percentage. 
 
Table 2. Information flow and documentation related adverse events 
Information flow and information management related    adverse 
events (n = 12 294) n % 
Patient data management and documentation 5070 41,2 
Care coordination 4686 38,1 
Verbal communication 2538 20,7 
Patient data management and documentation related adverse 
events (n = 5 070) n % 
Inadequate, missing or incorrect patient information 2066 40,8 
Error in personal data or contact information 576 11,4 
Patient information not retrieved or printed from patient records 413 8,1 
Wrong or outdated information in patient records 376 7,4 
Missing referral or inadequate, missing or incorrect information in 
referral 
329 6,5 
Information input or retrieval of patient records hindered 306 6 
Referral of test result documentation for wrong patient 215 4,2 
Patient information documented in wrong place 201 4 
Other or unknown 588 11,6 
 
When reporting, the nurse or physician picks the incident category and the 
applicable harm that he or she thinks has occurred to the patient.  In most cases (59,2 %, 
n = 1948), as a consequence, no harm was done to patients due to adverse events of 
Patient data management and documentation. Patients suffered from moderate harm in 
178 (5,4 %) cases and serious harm in 18 (0,5 %) cases. Five of those serious cases were 
related to inadequate, missing or incorrect information. Not knowing the degree of harm 
were 10.8 % of the cases (n=166) which related to inadequate, missing or incorrect 
information. 
4. Discussion 
Uniform, accurate, and standardized data structures and documentation are a prerequisite 
to safe and good-quality care [6]. Inadequate, missing or incorrect information can be 
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very important information. It may be essential for patient care which has an explicit 
connection to patient safety [3-5,12].  There are a lot of differences in the structures of 
patient care documentation [13]. Over one-third of the incident reports of Information 
flow and information, management were related to Patient data management and 
documentation. Of those reports, nearly half were of inadequate, missing or incorrect 
information. This information deficiency can be, e.g. missing information about patient’s 
medicine or allergy, which cannot be seen in the electronic documentation system. It can 
also be inadequate documentation of medicine administration, a missing patient 
identifier in a laboratory test, or wrong electrocardiogram for a physician to interpret. 
Adverse events related to patient data management and documentation included a 
total of 18 cases where the patient suffered serious harm. Most of these incidents were 
because of inadequate, missing or incorrect information. Lack of and deficiencies in 
documentation likely refers to poor-quality care and missing standardized care processes 
[7]. Adverse events related to Patient data management and documentation can refer to 
inoperative work and operational practices, which means that professionals need to be 
trained simultaneously when implementing a new system [10-11]. 
Documentation deficiencies can also be an outcome of inoperative and unclear 
documentation systems [7] or lack of rules and requirements for documentation [8]. 
These need to be taken into account in the early stages of the electronic documentation 
system’s acquisition and when defining the common documentation guidelines for both 
organizational and national levels [6, 11]. Advances, such as improved data quality and 
patient’s legal protection, decreased misinterpretations, better possibilities for data re-
use and data retrieval, and possibilities for decision support connection to patient records 
and its use have been presented. This also applies to the use of standardized health and 
social care languages [6, 13]. 
The purpose of HaiPro system is highlighting learning from mistakes [9, 14]. 
Accurate documentation is evidenced to affect patient safety, and the main criteria for 
high-quality healthcare are considered to be well-trained staff and treatment that works 
[3-5].  Incidents of Patient data management and documentation occurred both in 
primary and special healthcare. Our data illustrated that the handling process requires 
confirmation.  
5. Limitations 
Data for this study represent seven health and social care districts. However, our data 
included safety incidents reported by the largest hospital district in Finland, which 
accounts for approximately one-third of the population. Due to the voluntary nature of 
the HaiPro incident reporting system, not all incidents are reported. In the future, more 
emphasis should be put on how the systems can be made more comprehensive and more 
effective. 
6. Conclusion 
Good quality and accurate documentation are known to affect patient safety positively. 
Organizations need to plan and implement standardized documentation platforms and 
care processes. Additionally, we need more accurate information on adverse events and 
understanding of the problem for improving health and social care processes. Even 
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though the amount of serious harm to the patient because of inadequate, missing or 
incorrect information was not big in this data, this example shows the value of incident 
reporting systems. Patient safety must never be harmed because of poor documentation. 
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Abstract. Non-urgent consultations to an Emergency Department (ED) contribute 
to overcrowding. Telecommunications represent a potential strategy to reduce 
some face-to-face consultations. Objectives: To describe characteristics of patients 
who used the Teletriage Program during the pilot study, to explore safety and to 
report user acceptance and satisfaction. Methods: Cross-sectional study, including
all adult patients affiliated to our health insurance attended to via this telemedicine 
service between January 18th and May 31st, 2019 (during pilot-study). Patients 
were followed-up for seven days to assess re-consultation to ED or unscheduled 
hospitalization. Results: 276 effective consultations occurred, corresponding to
241 patients, with a mean of age of 50 years, 68% (189) were women. Chief 
complaints were related to clinical issues (70%) and remaining (30%) were 
administrative problems. Only four patients were suggested a referral or face-to-
face assessment. Rate of re-consultation to the ED was 18% (51) at seven days of 
follow-up, and the rate of unscheduled hospitalization was <1% (2), both with 
good clinical evolution. Patient satisfaction was 72.73%, and regarding
acceptability, 66.12% stated that without this channel they would have attended to 
a face-to-face consultation and 64.02% that they would do so if their needs 
remained unmet. Conclusions: Implementing this new communication channel 
could be a useful and safe strategy to reduce unnecessary non-urgent consultations 
to the ED.
Keywords. eHealth, mHealth, teletriage, telehealth, telemedicine
1. Introduction
Non-urgent consultations to the Emergency Department (ED) contribute to a 
phenomenon known as overcrowding [1]. Evidence suggests that telemedicine plays an 
important role in evaluating patients that would otherwise attend to the ED. On the one 
hand, support by remote pre-hospital electrocardiogram for patients with suspected 
acute cardiovascular disease proved to avoid unnecessary hospitalizations and to 
confirm correct diagnoses, by-passing delays in the ED and therefore lowering 
mortality and costs [2–4]. Furthermore, the use of a telemedicine consultation program 
significantly decreased neuro-emergent stroke patient transfers from rural hospitals to 
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urban settings, while increasing stroke specialist reading of patient imaging studies 
within 3 hours of the onset of stroke symptoms [5]. This experiences, as well as 
previous evidence on the use of telecommunications as a strategy to reduce non-urgent 
consultations to the ED [6], have reported reducing costs through a safe intervention 
[7], with elevated acceptance by users [8].
Our institution implemented a virtual program for low complexity respiratory 
teleconsultations during the epidemiological outbreak of Influenza in 2018, which 
proved to be a safe and effective strategy [9]. In that project, we perceived unmet 
clinical and administrative needs, which prompted us to implement a broader program 
for mild symptoms and non-urgent clinical consultations for adult patients.
The objective of this article is to describe the characteristics of patients who used 
this service during the pilot study, as well as to explore patient acceptance and 
satisfaction with the use of this tool.
2. Methods
Observational, descriptive, cross-sectional study at Hospital Italiano de Buenos Aires, a 
high-complexity hospital located in Buenos Aires, Argentina, that has its health 
insurance called Plan de Salud (PS) with over 150,000 affiliates. Our average daily rate 
of consultations to the ED is 500, 50% of which are attended to at a low complexity 
walk-in area with an admission rate below 1%.
Teletriage program was implemented and made available during the pilot period,  
on business days between 4 P.M., and 8 P.M. Consultations were initiated by patients 
through their Personal Health Records (PHR) via desktop or mobile devices, and 
attended to and registered by physicians in the EHR, with a structured form designed 
ad hoc. Variables in this form were used as secondary databases for the retrospective 
data collection.
We included all adult patients affiliated to PS who performed a teleconsultation 
between January 18th and May 31st, 2019. We excluded all teleconsultations with 
failure to communicate (initiated but not answered), non-effective consultations (failure 
with video, audio or chat, or with interruptions to the communication that could not be 
by-passed through an effective phone-call) or those with no complete structured form 
in the HER. Patients were followed-up for seven days from the date of teleconsultation 
to assess re-consultations to the ED and hospitalization.
Additionally, we evaluated waiting times (measured as the difference between the 
moment that the patient checks in and the moment in which the physician initiates the 
communication), patients’ acceptance of the tool (through two mandatory questions to 
users before teleconsultation) and patients’ satisfaction (measured through Telehealth 
Usability Questionnaire -TUQ- adapted from English [10]). 
Mandatory questions with multiple-choice options were: (1) If this communication 
channel did not exist, what would you do? (A- Attend to a face-to-face consultation: 
walk-in clinic, ED; B- I would not carry out any consultation; C- Solicit an 
appointment with a physician; D- Use another Telemedicine system) and (2) If you 
could not solve your chief complaint through this teleconsultation system, what would 
you do to solve it? (A- Attend to a walk-in-clinic or ED, B- I would not carry out any 
consultations, C- Solicit an appointment with a physician).
Quantitative variables are presented according to distribution as means and 
standard deviation (SD), or median and interquartile range (IQR) or 25-75 percentiles. 
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Categorical variables are presented as absolute frequency and relative frequency 
(percentage). Rates are presented as prevalence, with its 95% confidence interval. 
This research project was approved by the institutional review board. 
Confidentiality was guaranteed. There were no potential risks for patients. 
3. Results 
There were 476 virtual consultations registered. After applying exclusion criteria, we 
had a total of 276 effective consultations with a complete structured form, pertaining to 
241 patients (see Figure 1). 
 
Figure 1– Flow chart of included patients 
 
Service was offered for 90 days during the study period. Patients had a mean age 
of 50.46 years (SD 19.45), including patients from 18 to 97 years old, and 68.47% 
(189) were women. Data of care process was registered in EHR.  Majority of chief 
complaints were clinical issues (detailed in Table 1) and solved through this channel. 
Administrative cases were related to drugs prescriptions or information, appointments, 
vaccines prescription, test results and medical information. 
 
Table 1. Consultations and patient attention process  
Chief complaint n: 276 
Administrative 
Clinical 
         
Respiratory 
Infectious 
Pain 
Gastrointestinal 
Gynaecological 
29.34% (81) 
70.66% (194) 
 
18.11% (50) 
17.75% (49) 
13.76% (38) 
13.40% (37) 
3.98% (11) 
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Cardiological
Mental Health
2.89% (8)
0.77% (2)
Referral (ED, walk-in centre, doctor home 
visit)
1.44% (4)
The physician suggested a referral for a face-to-face assessment for only four 
patients (1.44%). At the seventh day of follow-up, the rate of re-consultation to ED was 
18.47% (51), and the rate of unscheduled hospitalization was 0.72% (2), due to an 
asthmatic crisis and dehydration respectively. One patient had been referred to the ED
while the other was already on her way to ED (during teleconsultation was carried out). 
Both had good clinical evolution.
In terms of waiting times, we found a median of 4 minutes (RIQ 9) and a mean of 
7 minutes (SD 7.16).
As to patients’ acceptance of this communication channel, 667 patients answered 
the mandatory questions (some never effectively checked in for a teleconsultation, and 
others experienced technical difficulties). 66.12% stated that without this channel, they 
would have attended to a face-to-face consultation and 64.02% that they would do so if 
their needs were not met with Telemedicine.
Regarding satisfaction assessment, 110 patients answered the TUQ (response rate 
of 23.45%). The percentage of patients that agreed 7/7 with the statements of the 
questionnaire were as follows: ‘I am satisfied with the use of the system’ (72.73%), ‘I 
would use it again’ (76.36%), ‘Telemedicine is an acceptable way of receiving 
provision of healthcare’ (73.64%), ‘Teleconsultations are equivalent to face-to-face 
consultations’ (28.18%), ‘I am comfortable communicating with the physician via the 
Telemedicine system’ (74.54%), ‘I could see the physician as if I saw him in person’ 
(52.73%), ‘I could hear the physician when using the system’ (57.27%) and ‘I would 
recommend the Telemedicine system of HIBA to other people’ (74.55%).
4. Discussion
This pilot study shows that implementation of an unscheduled teleconsultation program 
was a useful and safe strategy to meet patients’ needs, representing an innovative and 
feasible experience for our institution, in compliance with recent suggestions by our 
Health Ministry for the development of Telemedicine in Argentina.
Additionally, based on emerging legal and moral consensus on hospitals’ 
obligations towards its surrounding communities, Emergency Departments should not 
be treated as mere sources of admissions [11]. Therefore, management strategies such 
as this one are needed in order to improve the functioning of a collapsed system.
In consistence with our previous work, many chief complaints were administrative 
[9], which could be due to delays in patient attention in the outpatient setting. Our pilot 
also showed a high rate of satisfaction and acceptability. The lower percentages in 
patient satisfaction regarding how users saw and heard physicians were in line with the 
technical difficulties some patients experienced. This is mainly due to poor home 
Internet connections, which are highly prevalent in our country. 
Lessons learned throughout this project will fuel improvements needed before 
implementing it at a larger scale. In consistency with evidence in the literature, we 
detected most usability issues in the initial phase of implementation of the telemedicine 
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system [12]. These issues prompted us to carry out a redesign of the tool and the 
process at the end of the pilot, with results that will be reported in the near future.   
There are certain limitations to our study that need to be addressed. Real re-
consultation rates can be underestimated since we did not take into account 
consultations to peripheral walk-in clinics that are part of our institution because we 
were unable to collect such information retrospectively. The analysis was also affected 
by effective teleconsultations not registered in the structured form in the EHR, due to 
the elevated number of physicians assigned to this project (higher possibility of errors 
in the process). The TUQ response rate was 23.45%, which could suggest a potential 
information or response bias, a denominator of self-selection or volunteer effect that 
has been reported in the literature [13], and it was adapted from English but not 
validated [14]. 
In accordance with the literature [15], we believe that part of our success was due 
to the existence of a local framework and the involvement of an interdisciplinary team, 
the activity of institutional communication channels, and the support provided by the 
Health Informatics Department, which allowed us to prioritize the caregiving process, 
maintaining efficacy of the workflow and improving providers’ trust on the project. 
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Abstract. Chronic kidney disease (CKD) is a Public Health problem affecting a 
considerable number of patients worldwide. CKD treatment is complex and 
requires patients’ education. Based on this we have created technological tools, 
including an application for smartphones and a profile on Instagram (Renal 
Health) aiming to educate patients to self-monitor and cope with their disease, to 
increase adherence to treatment. In this study, we have analyzed the spontaneous 
feedbacks patients, and other people have posted on the Renal Health Instagram 
(comments) to investigate which information was needed the most by which types 
of patients. During the first 15 months since the release of this profile, there were 
3380 followers, a total of 449 posts, with 36,079 “likes”. Most of the followers 
were patients and parents, they gave spontaneous testimonials of their experiences 
with having kidney disease, and were thankful for the information provided and 
for the response we gave to their questions. From the analysis of the comments, we 
found that information on nutrition, physical activities and kidney transplant were 
the most discussed and valued. Our results also showed that the main use of this 
medium for dialysis and transplant patients was to share their experience. The 
Renal Health Instagram was considered a good digital platform of trusted 
information for both patients and the general population and also a space for 
sharing experiences in the context of kidney disease epidemics. 
Keywords. Kidney disease, patient empowerment, internet, Instagram, education 
1. Introduction 
Since 1980 debates regarding health promotion are advancing in Brazil, with focus on 
the multi causality of diseases and the right to health, culminating in the creation of the 
Brazilian Unified Health System (SUS), which is now one of the largest Public Health 
Systems in the world, with free universal coverage [1]. Since the creation of the SUS, 
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health education is valued, and patients are considered as crucial in the process of 
healthcare and the management of their care, to have an active role for achieving a 
good health condition [2]. 
This protagonism of patients in healthcare is crucial in the context of chronic 
disease, as in the case of chronic kidney disease (CKD). CKD is currently a worrisome 
Public Health problem, which affects approximately 11-13% of the general population. 
This reality is not different than in Brazil, where these rates have grown, having a 27% 
increase of patients on hemodialysis from 2012 to 2017, and in 2018 there were more 
than 130,000 people receiving dialysis [3]. The main causes of CKD are hypertension 
and diabetes, which are controllable, require patients’ education and collaboration to 
change their habits. Therefore, educational measures are crucial, and technology can 
help. 
Recent data shows that more than 70% of internet users claim to have searched for 
health information in the past year [4]. In Brazil, recent data from the Ministry of 
Planning, Development and Management showed that 74.9% of households have 
internet access, and 97% of the population has a smartphone [5]. Although there are 
many sources of information on the internet, many are neither trusted nor valid. 
Therefore, there is a need to create educational material, with a multidisciplinary team, 
which can be frequently updated [2, 6]. In this way, patients and people who connect 
with our social networks and other technological tools that we create can have easy 
access to qualified professionals, who cannot be so easily accessed in regions where 
access to health is limited, such as in poor and developing countries. In addition, one 
size does not fit all. Therefore, the aim of our study was two-fold: first, we aimed to 
analyze the effects of a recently created social network for patients with kidney disease 
(the Renal Health Instagram) through their spontaneous comments, using the internet 
and smartphones as a way of getting information for health education. 
2. Methods 
The Renal Health project started in 2015, aiming to develop technological tools for 
patients, and the public in general, to get information about kidney disease in Fortaleza, 
Brazil, including an application to help CKD patients in their treatment [6]. Although 
the fifth largest city in Brazil, Fortaleza, still faces several problems, including poverty, 
lack of sanitation, unemployment, and difficulties with access to health care, we have 
the possibility to offer technological tools to help people cope with chronic diseases, 
and they have easy access to the internet. All this makes health education essential to 
achieve better results in terms of decreasing the burden of chronic diseases. In the most 
recent official document about the mortality causes in Brazil, CKD appeared as the 10th 
most common cause of death in this region [5]. We created an Instagram profile and a 
YouTube channel to educate people, using not only text but also movies. We posted 
information about nutrition, medication use, physical exercises, and several other 
aspects of kidney diseases, prevention and treatment, on a weekly basis. The profile can 
be accessed through this link: https://www.instagram.com/renal_health/. We analyzed 
the spontaneous feedback people who follow the Renal Health Instagram profile have 
given from 1st June 2018 to 8th September 2019. Aside from analyzing all the feedback 
given in this period, including a quantification of the “likes”, we specifically analyzed 
the posts that were most commented on, and what type of information was required the 
most by which type of kidney disease patients. An analysis of the testimonials and 
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acknowledgements was also done, in order to identify which groups of patients and 
people were most “reached” by the information provided by the Renal Health Profile so 
that in the future posts we could offer more tailored information based on these 
patients’ needs. We have analyzed all the posts of the profile (“Renal Health” 
Instagram), as well as each comment and feedback, and made a classification based on 
the subject. It consisted of a content analysis. Subsequently, we have made a 
characterization of the socio-demographical profile of the followers. 
3. Results 
Since the first publication in the Renal Health Instagram profile on June 1st, 2018, we 
have gathered a total of 3380 followers. In total there were 449 posts: 14 (3%) about 
medication, 63 (14%) about nutrition, 9 (2%) about excesses, 123 (17,39%) about 
kidney disease and comorbidities, 70 (15,59%) about treatment stimuli, 55 (12,2%) 
about kidney transplants and organ donations, and 35,78 % others. Virtually all posts 
received “likes” and comments. A total of 36,079 likes have been observed, and the 
post that has received the highest amount of “likes” (n=837) was one regarding organs’ 
donation.  
Of a total of 1381 comments, these comments were performed by 469 profiles, of 
these are 80 (17%) men, 350 (74.6%) women and 39 (8.3%) profiles without gender, 
noting the prevalence of women among the comments made. One hundred eighty-five 
(185) comments were posted regarding congratulations and acknowledgements on the 
profile (Figure 1). People were thankful for the fact that our profile is interactive, and 
all questions are answered. We have identified 95 patients with kidney disease, mainly 
CKD. Of these, 73/95 (63.1%) spontaneously reported their illnesses in their 
comments, being on 60.2% dialysis, 21.9% transplanted patients, 6.8% 
glomerulonephritis, 5.4% kidney stones and 5.4% renal cysts. In total, 95 patients had 
posted spontaneous testimonials about their diseases and experiences with having 
CKD, and the difficulties they had faced. Also, 28 acquaintances of patients with 
kidney diseases had posted comments on our publications, most regarding questions to 
help them cope with the care of their children. 
 
Table 1. Types of themes posted in the Renal Health Instagram, June – September 2019. 
Posts category    Number of posts 
Medication          14 
Nutrition            63 
Excesses            
Kidney disease and comorbidities 
Treatment stimuli 
Kidney transplants and organ donations 
Others                     
 
9 
123 
70 
55 
115 
449 
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Figure 1. Testimonials of patients following the Renal Health Instagram, showing the impact on their habits 
and lifestyle. On the right side, a testimonial showing a patient’s lifestyle change, and on the left, a tattoo 
with our project’s logo in a patient’s arm in a sign of gratitude and comprehension of the aims of the project. 
 The most commented posts were: 32 posts with comments on nutrition, followed 
by kidney transplants (with 29 comments), totalling 61 comments. From 90 comments 
that were posted in the groups of 45 patients on dialysis, there were 14 comments 
covering the questions on this topic, 68 comments of personal experiences on the 
subject, and finally eight comments on the importance of this information. In the group 
of 12 patients having kidney transplantation, 11 comments demonstrated their 
happiness after the transplant and their experiences, followed by one comment covering 
a question about their happiness after the transplant and their experiences. We have 
also identified other health professionals interacting with the profile, declaring that it 
was useful to help them to give advice to patients. And finally, this platform had 
crossed the borders, since we have also identified comments by people from other parts 
of the world, such as other South American countries, the Middle East and Europe. 
 
Table 2. Types of comments from 45 dialysis patients posted in the Renal Health Instagram, June – 
September 2019. 
Types of comments from dialysis patients     Number of posts 
Questions on the topic 14 
Personal experiences on the subject 68 
About importance of this information 8 
4. Discussion 
The Renal Health Instagram showed to be a valuable digital platform for patients with 
kidney disease and surpassed the initial objective of the researchers, which was to 
provide information to patients and caregivers. Our results showed that methods of 
dialysis and treatment of chronic kidney disease were the most important information 
for the patients with dialysis and transplantation, followed by nutrition. Our results also 
showed that the main use of this media for dialysis and transplant patients was to share 
their experience.  
Currently, Medicine and healthcare, in general, cannot be practised without 
technology and connecting with patients. According to Meskó (2017), there are very 
interesting new terms in Medicine, for example, the “e-patient”, which can be defined 
as the patient who is “empowered, engaged, equipped, enabled, equal, or expert”, and 
“Participatory Medicine”, which is “a model of cooperative health care that seeks to 
achieve active involvement by patients, professionals, caregivers, and others across the 
continuum of care… to increase patient satisfaction and improve the cost of care” [7]. 
The use of social networks, such as the Renal Health Instagram, by patients and 
the general population, as a way of getting trusted information for health education is 
benefic, and a real way of connecting patients and the healthcare team in a trusted 
relationship. Using these platforms, a broader audience can be reached, cross the 
borders, as the internet can be easily accessed from any part of the world. As 
technological tools may empower patients with information and abilities to cope with 
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chronic diseases, medical recommendations might be better followed and therapeutic 
goals achieved. It is expected that treatment’s adherence increases, and therefore 
complications might decrease, and outcomes might improve. Clinical trials are needed 
to test this hypothesis. 
There are few studies analyzing the impact of the use of Instagram on patients’ 
health education. In a study regarding the use of this social media in the area of 
Orthopedics, posts on Instagram were predominantly from patients, and fewer were 
made from doctors [8]. These posts had in the majority of cases positive comments [8]. 
Another study evaluated the experience of patients using social networks regarding 
Twitter and Instagram to discuss their experience about a specific surgery (Gamma 
Knife stereotactic radiosurgery), and the authors evidenced that the main use of these 
media was to share patients’ experience [9], which is accordance with our findings for 
transplant and dialysis patients. To the best of our knowledge, this is the first study to 
extract information need for specific types of CKD patients using comments of the 
provided general information for CKD patients in an internet social network. Future 
studies are needed to analyze bigger dataset to identify the specific information needs 
of CKD patients.  
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Abstract. Over the last few years, the use of social media mobile applications or 
apps (SMAs) has increased exponentially. The potential advantages of using these 
technologies by health professionals in clinical settings have been discussed many 
times. Considering that the nursing profession is the largest segment of the 
healthcare workforce in the majority of countries in the world, the impact of using 
these apps by these professionals is very relevant. The objectives of this study 
were, firstly, to determine if nurses were using SMAs professionally and the most 
frequent SMAs used and secondly, to find out if, among nurses, there is a need for 
training in the use of these mobile applications for professional purposes. The 
study is a descriptive cross-sectional study based on an Internet survey of 1,293 
nurses in Catalonia (Spain). The average age of the respondents who had these 
apps installed on their mobile phones or tablets, was 43.12 (SD ± 11.32) years old. 
WhatsApp was the most frequent SMAs used by nurses for professional purposes, 
and 79.2 % of nurses mentioned they used it several times a day. WhatsApp was 
the preferred SMAs for communicating with colleagues (31.2% of nurses) 
followed by Facebook (18.4%) and Twitter (11.3%). In contrast, the use of the 
SMAs was much less frequent as a means of communication with patients (7.2% 
in the case of WhatsApp). Nurses expressed their need for specific training in the 
use of these apps for professional purposes, indicating the interest and potential 
impact of the introduction of these technologies in clinical environments. The use 
of SMAs is quite common among nurses at the moment of the survey, and 
WhatsApp was the most popular one to support their professional activity. Based 
on the results of the survey, the Nursing Association of Barcelona (COIB) will 
consider the design of specific training activities in the use of SMAs in clinical 
settings. 
Keywords. Social media, nurse role, survey, mobile health 
1. Introduction 
Over the last few years, the use of social media platforms and mobile health 
applications (apps) has increased exponentially. The potential advantages of using 
these tools by professionals in clinical environments have been discussed in several 
forums  [1-3]. Currently, there are a lot of social media apps (SMAs), and Facebook,  
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YouTube, Twitter, WhatsApp, LinkedIn, Pinterest, Tumblr or Instagram are among the 
most frequent ones[4-6], which are available to assist health professionals with many 
different tasks. Some of these tasks allow us to work in collaboration, to communicate 
with patients and other professionals, to perform patient management and monitoring, 
health education, training and research [7,8]. Nevertheless, it is not clear enough how to 
use these technologies in clinical settings considering the different aspects mostly 
related to ethical and legal aspects such as privacy of personal data and security [9]. 
Considering that the nursing profession is the largest segment of the healthcare 
workforce in the majority of countries in the world, including Spain [10, 11], the impact 
of the use of mobile applications by nurses, is highly relevant in the future of modern 
healthcare. 
The objectives of this study were, firstly, to determine if nurses were using SMAs 
professionally and the most frequent SMAs used, and secondly, to find out if, among 
nurses, there is a need for training in the use of these mobile applications for professional 
purposes. The survey included questions about the use of SMAs and also health apps 
for professional purposes. In this paper, we present the results of the study related to 
the use of SMAs. 
2. Methods 
The study is a descriptive cross-sectional study based on an Internet survey of 1,293 
nurses in Spain. LimeSurvey [12], an open-source platform, was used to gather the 
information of the survey online. In March 2018, an e-mail, including a link to the 
website with the survey, was automatically sent to the 26,907 registered nurses who had 
a contact e-mail in the Nursing Council of Barcelona (COIB) of Catalonia [13]. COIB is 
the second-largest Nursing Council in Spain with 34,327 registered nurses. The e-mail 
also included information about the purpose of the survey and that the information 
gathered would be analysed anonymously. After the first e-mail, two more e-mails 
were automatically sent as reminders within the following 30 days. 
The survey consisted of 34 questions organised in three parts: (1) questions related 
to sociodemographic and professional information such as age, gender, workplace and 
professional activity or speciality, (2) questions about the use of social media and 
health apps for professional purposes and finally, (3) questions asking for the training 
needs for using SMAs for professional purposes. This paper is focused on describing 
the characteristics of the respondents and the use of SMAs for professional purposes. 
The description of the use of health apps for professional purposes was published in 
another journal [14]. Descriptive statistics were applied for all the items in the survey 
using the R programming language version 3.4.2 importing a .csv file with all the data. 
The governing board approved the study of the Nursing Association of Barcelona. 
3. Results 
The percentage of respondents to the survey who used SMAs for professional purposes 
installed on their smartphones or tablets was 46.4% (600/1,293). The remaining 693 
respondents said that they did not use apps for professional purposes and were not 
included in the analysis. The average age of the respondents was 43.12 (SD ± 11.32) 
years old, and there were no significant differences between the age of men and women 
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(t=-1.5078, P = .1336). The distribution of age was: 16% baby boomers (> 56 years old), 
58% generation X (between 35-56 years old) and 26% millennials (< 35 years old). 
Concerning the professional area, most nurses worked in hospitals (48%) and primary 
care (24%). The remaining respondents worked in social healthcare (7%), management 
(5%), pre-hospital care (4%) and teaching/research (3%). Regarding the specialisation, 
the most frequent groups were general nursing (53%), medical-surgical (14%), 
paediatrics (8%) and family and community (7%). 
Regarding the frequency of use of SMAs for professional purposes, WhatsApp was 
the most frequent SMAs used for professional purposes. 79.2 % of nurses reported using 
WhatsApp several times a day, followed by Facebook (28.7% several times a day), 
without significant differences comparing hospital and primary care use (p=0.220). 
Instagram, Twitter and Skype were not so frequently used for professional purposes. 
Overall, nurses preferred smartphones (91.2%) instead of tablets (8.8%) for managing 
SMAs professionally. Figure 1 shows the frequency of use of the seven most common 
SMAs as a means of communication, according to the respondents of the survey. 
WhatsApp was used preferably as a means of communication with colleagues (31.2% of 
nurses) as well as Facebook (18.4%) and Twitter (11.3%). Nevertheless, the use of these 
SMAs was much less frequent as a means of communication with patients (e.g. 7.2% in 
the case of WhatsApp). Most of them (81.8%) considered that it was necessary to receive 
specific training in the use of SMAs in professional environments, without significant 
differences among age groups and gend2=3.40; P=.347). 
Figure 1. Use of social media apps by nurses for professional purposes 
Most devices were less than two years old (77.0%), and 42.7% of the devices were 
less than one year old. As for the operating system, 51.1% had Android, and 45.7% had 
iOS. Table 1 shows the proportion of nurses that were using different SMAs as a means 
of communication with patients and professionals. WhatsApp and Facebook are the 
most frequently used SMAs as a means of communication with other professionals. 
Table 1. The proportion of nurses that were using different social media apps as a means of communication 
with patients and professionals. 
Social Media Apps With patients (%) With professionals (%) 
Facebook 5.0 18.4 
Twitter 2.2 11.3 
LinkedIn 1.5 9.4 
Instagram 1.2 4.5 
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WhatsApp 7.5 31.2 
Skype 2.2 6.84 
Youtube 1.8 3.0 
4. Discussion 
Over the last few years, the evolution of smartphones and other devices, as well as the 
applications developed, have evolved at an unprecedented rate. Our study shows that the 
use of SMAs is common among nurses (46.4%), being WhatsApp and Facebook the most 
frequently used apps to communicate with other professionals, as is the case of other 
health professionals such as medical doctors [6,15]. In contrast, the use of these apps is 
not frequent to communicate with patients. It could be of interest to know the content of 
these communications and the reasons why nurses use SMAs instead of other means of 
communication, considering that it is necessary to take into account different ethical and 
legal aspects when using these apps for professional purposes. Most likely, the ease of 
use and immediacy are the main reasons to use these SMAs. 
The majority of nurses expressed their interest in receiving training in the use of 
mobile applications, indicating the potential impact of the introduction of these 
applications in clinical settings. It is essential to promote the training of nurses, and 
health professionals in general, who must be trained in the use of mobile applications, 
wearables or telemedicine applications. Currently, there is a need to analyse the specific 
advantages and drawbacks as well as consider all the aspects related to the use of these 
technologies among clinicians and it is necessary to analyse the ethical, legal, technical 
and security aspects to introduce SMAs in healthcare services [16-18]. In addition, the 
interoperability and the integration of SMAs in electronic health records should be 
evaluated very carefully to guarantee the quality, correctness and the compliance of all 
the legal and ethical requirements of each healthcare system. More experience is needed 
to determine the actual use and clinical usefulness of these technologies [19,20]. 
This study has some limitations, on the one hand, the number of participants in the 
survey was low compared with the number of nurses who potentially received the 
survey, and for this reason, the results could overestimate or underestimate the real use 
and interest of nurses in social media tools introducing a selection bias. On the other 
hand, the survey did not include all the types of SMAs available on the Internet that 
may be used by nurses. As far as we know, there are no other studies of the same 
characteristics in Spain or other countries that are focused only on nurses [1,6,15]. 
5. Conclusions 
The use of SMAs is quite common among nurses at the moment of the survey. The most 
popular SMAs used by nurses to support their professional activity is WhatsApp, which 
was mostly used as a means of communication with other colleagues. Nevertheless, the 
use of SMAs is not as frequent as a means of communication with patients in clinical 
settings. Nurses expressed their need for specific training in the use and applications of 
SMAs for professional purposes, indicating the potential impact of the introduction of 
these technologies in clinical environments. Based on the results of the survey, the COIB 
will consider the design of specific training activities for nurses in the use of SMAs for 
professional purposes in clinical environments. 
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Abstract. In traditional West African medicine, most practitioners are illiterate for 
official languages. 1127 local languages exist in this region. The transmission of 
knowledge in this traditional medicine is notoriously oral. In order to enable 
practitioners to communicate and preserve this knowledge, we are building 
SysMEDTRAD, a traditional medicine management system, based on a formal 
ontology of traditional medicine called ontoMEDTRAD. To overcome the language 
and illiteracy barriers, we propose to combine realistic photographs of plants with 
formal iconic descriptions of plants and recipes. This paper presents the formal and 
automatized representation of traditional African medicine recipes. 
 
Keywords. Ontology, Traditional medicine, ontoMEDTRAD, West  Africa, Iconic  
composition, Non-verbal communication. 
1. Introduction 
Traditional medicine (TM), despite the progress of modern medicine (MM), still exists. 
Without seeking to replace or to copy the MM, and even less to be obliterated by it, the 
TM practiced in Africa and especially in its western part, persists and knows a renewed 
interest at the dawn of the 21st century. This resurgence is partly justified by the fact 
that the populations health care needs are insufficiently covered by the MM. In 
addition, health care costs in MM are often expensive and prohibitive for the 
disadvantaged social groups [1]. Without any discrimination, almost all social classes, 
for their health and medical needs, even if they use MM, continue to refer to TM. 
About 80% of the population commonly uses TM [15].  In West Africa, and 
particularly in rural areas, every inhabitant knows and uses the therapeutic properties of 
a number of plants. We are therefore talking about popular medicine. In this part of 
Africa, we count 15 countries and 1127 local languages [13]. Thus, TMP (Traditional 
medicine practitioners) face a huge language barrier. Moreover, the majority of them 
do not know how to read nor to write  the official languages. They speak them with 
difficulty or not at all. Knowledge of TM is widely transmitted orally, when it is not 
kept secret. Academic and research institutions related TM  are almost non-existent in 
these countries. Most of these TMP are illiterate (the illiteracy rate varies from 65% to 
80% [8]) and belong to a wide linguistic and cultural diversity. Consequently, a visual 
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approach can be more appropriated for supporting the collaboration between TMP and 
also the preservation of TM knowledge. 
 SysMEDTRAD [2] aims at addressing this problem. It includes ontoMEDTRAD, 
an ontology of West African TM associated with a visual approach. ontoMEDTRAD is 
divided in two modules: a terminological module ontoCONCEPT-Term, and an iconic 
ontoICONE. In a previous work [2], we proposed a formal method for representing 
medicinal plants with icons. Here, we extend this representation with realistic 
photographs and we propose iconic recipes of plant-based medicines, automatically 
generated from the ontology. We focused on malaria [8], one of the most morbid and 
deadly diseases in Africa. 
2. Background 
Concerning TM, Ayimdji A. [5] made some tools in Cameroon, but without a visual 
approach. An ontology for African TM [4] from G. Atemezing, has its object focused 
on the validation of knowledge managed by a system of agents. It does not address the 
fact that the TMP are mostly not literate. In Côte d’Ivoire, VetoMed [6] of K. Brou  
explores some visual aspects, but does not contain an ontology.  
Regarding MM, LAMY J.B. et al. proposed an iconic language named VCM 
(Visualization of Concepts in Medicine) for representing symptoms, disorders, 
treatments and follow-up surveillances [12]. VCM is equipped with formal semantics 
defined in an ontology [11]. VCM aims at facilitating and speeding up the access to 
medical data and knowledge, rather than crossing the language barrier. 
3. Materials and methods 
We carried out field visits to TMP accompanied by translators, in Côte d'Ivoire and 
Senegal. We collected TM documents from NPTMP, the National Program of TM 
Promotion (Côte d'Ivoire) and some NGOs such as PROMETRA (Sénégal). Given the 
highly implicit and hidden nature of TM, we have conducted sensitization activities 
with 50 Ivorian TMP to increase their openness and their commitment to the project. 
The Abidjan-based NPTMP manager played a facilitating role in these activities 
alongside the TMP. We also visited 59 Senegalese TMP, mainly in the Saint-Louis 
region. From published works [1, 10, 3, 9, 8, 16], we extracted 31 traditional medicines 
for treating malaria with 28 recipes made of 22 distinct medicinal plants. We extracted 
realistic photographs of these plants from Wikipedia.  
We followed an incremental and progressive general approach. First, we considered 
three use cases for our system: identifying the plants for a given recipe, preparing the 
medicine, and administrating it to the patient. We structured the pieces of information 
describing the medicines and the recipes in a formal ontology of TM. This ontology 
was manually modelled using the Protégé editor. We also collected various concepts 
from existing top ontologies (e.g. open biological ontologies (OBO), general formal 
ontology (GFO) and descriptive ontology in linguistics and cognitive engineering 
(DOLCE)) and domain ontologies (e.g. plant ontology (PO) [14]). 
Second, for describing and identifying plants, we combined two approaches: 
realistic photographs showing the leaves and the fruits, and icons showing the main 
botanic criteria permitting the identification of the plant. Candidate criteria were 
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 extracted from botanic sources [3], and then selected according to their discriminant 
capacity, as determined by the Weka Ranker and JRIP modules, as described in our 
previous works [2]. The resulting criteria were integrated into the ontology. 
Third, plant icons are obtained by combining various iconems (i.e. small 
pictograms or colors), each corresponding to a specific value for a given criterion. 
Three strategies were used for visual representation, inspired by Peirce: analogy i.e. 
visual similarity, index i.e. semantic association and symbol i.e. arbitrary conventions 
[7]. Iconic recipes are obtained by the juxtaposition of one or several ingredients. Each 
ingredient is a part of a plant, and is represented graphically by the photographs and the 
icons of the plants, and a small icon representing the part of the plant used (e.g. leaves 
or roots). Iconic recipes are then enriched with icons representing the preparation and 
administration modes. 
Finally, pictograms were drawn using the Inkscape vectoral drawing software. The 
icons and iconic recipes are generated as Scalable Vector Graphic (SVG) image files, 
automatically from the knowledge in the ontology, using Python scripts and ontology-
oriented programming with the OwlReady module [11]. These scripts combine the 
pictograms and colorize them as needed excepted leaf for which green color is retained. 
4. Results 
 
 
 
 
 
 
 
The resulting ontology, previously described in [2], uses the ALCHOIQ Description 
Logic. Figure 1 shows the UML model of the plant-based medicine and recipe in 
ontoMEDTRAD. A medicine is characterized by a recipe and one or more 
administration modes (e.g. oral route, nasal route with fumigation, topic application 
during bath, …). The recipe includes one or several plant-based ingredients and a 
preparation mode (e.g. decoction, infusion,…). Each ingredient is described by a plant 
and a part of a plant, using functional object properties. This ensures the uniqueness of 
ingredients. 
The criteria retained for describing plant icons are given in Figure 2, with an 
example of icon for the plant azadirachta indica A. Juss.  
Figure 1: UML model of TM recipes and medicines. 
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 Figure 3 gives an example of iconic recipe and its decomposition in icons. This recipe 
has two ingredients : leaves of Azadirachta indica A. Juss. and leaves of Senna 
occidentalis L. It is prepared as a decoction and the resulting medicine can be 
administered orally or in a bath. We included a total of 28 herbal recipes and 31 herbal 
antimalarial medicines in the current ontoMEDTRAD ontology. 
5. Discussion and conclusion 
In this paper, we proposed a formal method for the visual and iconic presentation of 
plant-based recipes in traditional West African medicine. This approach relies on a 
formal ontology of TM, namely ontoMEDTRAD. 
Many ontologies exist for MM. However, it stands important differences in the 
way the patient is managed. In TM, diseases are detected by signs and symptoms that 
are clues and not necessarily by clinical examinations of MM. While remedies of TM 
are used in their almost natural state, MM often uses a synthetic product chain bound to 
a chemical industry. Unlike MM practioners, the TMP is at the same time a 
"physician", a "pharmacist" and a "nurse. Hospitalization and surgery are very rare in 
TM. Consequently, we did not reuse existing MM ontologies. 
A few ontologies were proposed for TM [5, 4]. However, they are embryonic and 
they lack of medical validation. They also miss the information required for the visual 
presentation of plants as icons, e.g. they do not include the color of flowers and fruits. 
Therefore, we preferred to design our own ontology. 
In addition to plant icons, we have included realistic photographs of the plants. 
 
Figure 2:  Example of compositional plant icon for Azadirachta indica A. Juss., with the various botanic 
criteria (Numbers between parentheses indicate the number of distinct possible values for each criterion). 
 
 
Figure 3: Example of iconic recipe (on the left) and examples of pictograms (on the right) 
(Numbers between parentheses indicate the number of distinct possible values for each criterion). 
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Both icons and photographs are visual presentation and description of the plant. They 
are highly complementary : the photographs allow an immediate recognition of the 
typical plant individuals, while the icons permit recognizing plant individuals that are 
significantly different from the photographs, e.g. due to the variability of the same 
plant species according to the various ecosystems, thanks to the botanic criteria that 
characterize the species. Pictograms were drawn by ourselves, however, they could be 
improved by a professional graphic designer without modifying the semantics and 
semiotics of our work. Both icons and photographs allow overcoming the linguistic 
barriers for TMP. A short training is probably needed before TMP fully understand our 
iconic language. 
This work is part of a larger project aimed at the modernization and the 
valorization of West African TM. The main perspectives of the present work are : (1) 
the extension of the iconic and photographic presentation to other concepts such as 
symptoms, disorders, or mineral and animal medicinal resources; (2) the validation of 
the proposed visual presentation with TMP; (3) the integration of the visual 
presentation in a semantic wiki, allowing TMP to collaborate and to write and read 
medicinal recipes online. 
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Abstract. Background and objective: The number of publications on the use of 
chatbots for health is recently increasing, however to our knowledge, there are no 
publications summarizing what is known about using chatbots for public health yet.
The objective of this work is to provide an overview of the existing scientific 
literature on the use of chatbots for public health, for which purpose have chatbots 
been used, and whether health-related outcomes have been reported. Methods: We 
carried out a literature review on this topic across 5 databases: Pubmed, EMBASE, 
PsychINFO, SCOPUS, and IEEE Xplore. Identified papers were classified 
according to their underlying technology, application area, and study design.
Results: A total of 15 relevant papers were identified: eight of these papers were 
developmental studies that tested the feasibility or usability of a chatbot, and seven 
were interventional studies. All the interventional studies reported positive health-
related outcomes associated with the chatbot use. Discussion: The first studies 
testing chatbots for public health seem very promising; however, there are various 
aspects that should be improved, including the chatbots' designs, studies' methods, 
and analysis and reporting of results. More high-quality studies and improved
reporting of chatbots' use are needed.
Keywords. Chatbot, public health, mHealth, public health informatics
1. Introduction
Public health is defined as the branch of medicine concerned with the prevention and 
control of disease and disability, and the promotion of physical and mental health of the 
population on the international, national, state, or municipal level. One of the main 
concerns of public health is the growing burden of chronic diseases, which highlights 
the urgent need to create and make available interventions that can reach large 
populations at a low cost [1].
Fully automated self-help interventions based on chatbots could serve as highly 
cost-effective health promotion interventions for large groups of people. Chatbots are 
computer software programs based on statistical learning, statistical analysis and 
educational theories aiming at simulating a human conversation by text or voice 
message, that are easy to use and do not require familiarity with a specific user 
interface. Although the number of publications on the use of chatbots for public health 
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is increasing, this is still a small and emerging field [2-4], and to our knowledge, there 
are no publications summarizing what is known about using chatbots for public health 
yet. 
The objective of this work is to provide an overview of the existing literature on 
the use of chatbots for public health, what kind of underlying technologies have been 
used, for which purpose have chatbots been used, and which health-related outcomes 
have been reported.  
2. Methods 
In order to get an overview of how chatbots have been used for public health purposes, 
we carried out a literature review in July 2019. We searched for research articles 
involving the use or testing of a chatbot for public health purposes, reporting results 
that were published from 2015 until July 2019. The search strategy covered 5 databases 
(Pubmed, EMBASE, PsychINFO, SCOPUS, and IEEE Xplore) and comprised the 
following keywords: "chatbot" or "conversational agent" or "relational agent" or 
"dialogue system" or "Siri" or "Alexa" or "Cortana" or "Google Home" or "Google 
Assistant" in combination with "public health"; "health promotion"; or "health 
education". Relevant identified papers were then classified according to technology, 
application area, and study design. 
3. Results 
A total of 140 publications were identified in the initial literature review. After 
removing duplicates, and excluding publications for being out of scope, or not 
reporting any clinical outcome, we ended up with 15 publications.  
Among the 15 included studies, 14 were based on an own developed chatbot, and 
only one study used a commercially available chatbot [5]. Four studies focused on 
voice-only chatbots [6-9], and 11 studies used a text-based or hybrid chatbot [5, 8-17]. 
Voice-only chatbots for public health purposes were tested only in feasibility or 
usability studies and were developed to provide counselling. Only four of the chatbots 
were connected or integrated with different social media or website, i.e. LINE, 
Wikipedia, WhatsApp, and WeChat [11, 12, 17, 18], and four more referred to chatbots 
connected to sensors or other Apps [10, 14, 15, 19]. 
Regarding the study design, eight of the papers showed results related to the 
development of a chatbot, including usability or feasibility studies [6-12, 14]. The 
chatbots from these eight developmental studies focused on motivating users to control 
or reduce their weight [11, 14], and to provide different kind of health information, 
such as HPV vaccination [6], medication [7], breastfeeding [10], diabetes [12], atrial 
fibrillation [8], and spinal cord injury [9]. Participants involved in these eight papers 
described the chatbots as easy to use [6, 8], engaging [11], and were positive towards 
using chatbots or were satisfied with them [7-10, 12, 14]. 
Seven of the included papers were interventional studies where health-related 
outcomes linked to chatbots' use were reported [5, 13, 15-19]. All of these 
interventional studies used a text-based or hybrid chatbot, and the bot was used to 
motivate and to provide counselling on healthy lifestyles and wellness [18, 19], to 
improve mental health [5, 16], to reduce reproductive health preconceptions [13], to 
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encourage loss of weight [15], and to motivate smoking cessation [17]. Table 1 
summarizes the reported health-related outcomes in these interventional studies. 
 
Table 1. Health-related outcomes reported by the 7 interventional studies 
Reference Health domain Reported results (intervention duration) 
Gardiner [19] 
 
 
 
Souza [18] 
 
 
Ly [16] 
 
 
 
 
Inkster [5] 
 
 
 
Jack [13] 
 
 
L'Allemand 
[15] 
 
 
Wang [17]  
Healthy lifestyle/wellness 
 
 
 
Healthy lifestyle/wellness 
 
 
Mental health 
 
 
 
 
Mental health 
 
 
 
Reproductive health 
 
 
Weight control/obesity 
 
 
 
Smoking cessation 
Chatbot group: significantly decreased alcohol 
consumption, and increased daily fruit consumption (1 
month) 
 
100% of participants loved the experience of receiving 
incentives from the chatbot (1 week) 
 
Chatbot group: participants who adhered to the 
intervention showed significant positive effects on 
psychological wellbeing and perceived stress (2 weeks) 
 
Significantly improvement in symptoms of major 
depression and a higher proportion of positive experiences 
among high chatbot users (3 months) 
 
Chatbot use was significantly associated with a higher 
proportion of preconception risks being resolved (6 
months) 
 
70% of participants had >4 interactions per day with the 
chatbot, and 37% of the daily challenges were completed 
successfully (4 months) 
 
Chatbot groups: much higher quit rates (2 months) 
4. Discussion 
Fifteen relevant papers on the use of chatbots for public health were identified in a 
literature review. Eight of them were developmental studies that only tested the 
feasibility or usability of a chatbot, while seven were interventional studies. All the 
interventional studies used a text-based or hybrid chatbot and reported benefits linked 
to its use, including significant increase in fruit consumption and wellbeing, 
improvement in depression symptoms, higher proportion of preconception risks solved, 
and higher smoking quit rates; as well as significant decrease in alcohol consumption, 
and positive experiences with interacting with the chatbot. 
Nowadays, the role of chatbots in the public health system is still limited. 
Nonetheless, chatbots could provide auxiliary care through providing counselling and 
encouraging self-management of illness [3], adherence to treatment [20] or 
administrative services such as scheduling appointments [21], among others. With the 
continuous advancement in technology and behavioural sciences research, the 
competency and trustworthiness of chatbots are expected to be increased and promote 
its use in more complex and significant tasks in the health organizations [3]. First 
studies testing chatbots for public health seem very promising; however, there are 
various aspects that should be improved, including the chatbot design, study methods, 
and analysis and reporting of results.  
Regarding the chatbot design, although there is evidence showing higher 
effectiveness of digital interventions when they are linked, integrated or delivered 
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through social media [22-24], only a few studies connected or integrated the chatbot to 
social media or other apps. The connection of chatbots to social media and integration 
of information from various apps and sensors would make chatbots more tailored to 
each individual, substantially enhancing the usefulness and motivation for the users to 
relate to chatbots – thus better possibilities to improve health parameters.   
On the study methods, very few studies carried out an intervention, and many of 
these papers were of very short duration (down to 1 week), and consequently, 
increasing the likeliness that the positive effects were caused by the "Hawthorn effect" 
[25]– not the chatbot. More randomized trials should be done on this topic, and future 
research should increase the duration of the interventions to prove its sustained effect 
over time. 
Better analysis and reporting of results are also needed. It is important to take into 
account that two of the papers that reported benefits, both of them testing the chatbot in 
the field of mental health, reported that the positive effect was only present in 
participants who adhered to the intervention, or that had higher use of it [5, 16]. 
Adherence to digital interventions is correlated with the characteristics of the 
innovation, and also with participants' interest towards it [26]. Therefore, and in order 
to move this field forward, it is relevant that researchers report, analyze and discuss 
usage metrics and determinants of attrition linked to the chatbots use in health 
interventions [26]. Security issues related to the chatbot are also a relevant issue that 
was unconsidered or unreported in the included papers, even though security is crucial 
in the health domain, and especially relevant for systems that are collecting or 
processing data from a user. Another security risk that needs further consideration is 
the possibility of chatbots to motivate the user to do actions that could be dangerous for 
the individual (e.g. obese person with type 1 diabetes who wants to lose weight, not 
eating due to encouragement from a chatbot – ending up in hypoglycemia – 
hospitalized or even dying). Who assumes responsibilities for these risks and the 
possible dangers, and therefore must be addressed by researchers? 
Our literature review has covered five databases; however, we might have missed 
additional relevant publications on the use of chatbots for public health. Future reviews 
should expand the scope of the search and incorporate research projects that are being 
carried out currently, in order to have a better overview of the potential different uses 
and benefits that chatbots could have for public health in the near future.  
Although there are promising results, there is not enough evidence supporting the 
use of chatbots for public health yet. More high-quality studies and improved reporting 
of chatbots' use are needed. 
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Abstract. After the national introduction of the ePrescription in Belgium to the 
broader public in 2014, community pharmacists are still not satisfied completely. 
Reasons are (1) low acceptance of the implementation due to slow systems, (2) high 
reported downtimes, and (3) alert fatigue due to technical and incomprehensible error 
messages. Therefore, we investigated which technical errors occur in the flow of 
handling an ePrescription and how these errors can be avoided. A cross-sectional 
design was used to capture interactions of all national community pharmacists 
connected to the national eHealth platform on a randomly chosen working day. Per 
interaction, the number of errors made was observed. In total, 567,883 interactions 
were registered and analyzed, of which the getPrescription interaction, to download 
the ePrescription from the national server, was most prevalent (n = 196,433; 37.21%). 
A difference of 14,961 interaction calls was observed without reaching a final state 
(delivered or undelivered). Reasons for these differences are repetitive calls for 
obtaining the ePrescription or by trying to obtain the prescription again when this 
should no longer be possible (e.g., when an ePrescription is already delivered or 
archived). When looking at the markAsDelivered, markAsUndelivered or 
markAsArchived interactions, most of the technical handling errors are due to 
attempts that generate not allowed state transitions. Most of these incorrect state 
transitions could have been avoided by maintaining the state diagram in the 
pharmacist’s system to enforce legal transitions and by training the community 
pharmacists to handle ePrescriptions appropriately. 
Keywords. Electronic prescribing, community pharmacy services, eHealth 
1. Introduction
The Belgian electronic prescription (ePrescription) system consists of the typical 3Ps 
model between prescriber, patient and pharmacist [1]. The electronic prescriptions are 
securely transferred from the prescriber to the pharmacist, selected by the patient. 
Typically, from the back-office of the pharmacist, this flow is extended to a price-fixing 
service that is responsible for the billing to the patients’ health care insurances in the name 
of the pharmacies, since a third-party payment system applies in the Belgian healthcare 
system [2]. 
In Belgium, the ePrescription works in a decentralized way where the ePrescription 
is stored on a central database server, in an encrypted manner. The prescribers send their 
prescriptions in XML-coded format to this national server, whereafter the patient may visit 
his pharmacist of choice to get his prescription delivered. Currently, the patient still 
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receives a paper proof of the electronic version, which possibly will vanish after the 
dematerialization phase where the government wants to avoid unnecessary paper use. 
Currently, the paper-based proof of electronic prescription serves as an access token and 
feedback mechanism for both the prescriber and the patient so that they can verify what 
was prescribed. On top of this paper proof, a unique Recip-e ID (RID) barcode is printed, 
identifying the electronic prescription in the Recip-e database so that the pharmacist can 
easily retrieve the ePrescription from the national database, by scanning the barcode. 
However, even after five years of successful deployment, enabling ambulatory care 
providers prescribing and delivering of ePrescriptions, care providers are still unsatisfied 
with this system in place. Closed fora for pharmacists in Belgium[4] report about (1) low 
acceptance of the implementation due to slow systems, (2) high reported downtimes of the 
eHealth services, and (3) a raised alert fatigue due to error messages that are written in a 
technical language that are uneasy to understand for the pharmacist.  
The Belgian ePrescription follows the state diagram represented in Figure 1. It 
corresponds to the “normal workflow” related to handling medical prescriptions in a 
community pharmacy. Initially, when the prescriber submits an ePrescription, this 
prescription is in the state undelivered. When the community pharmacist retrieves the 
ePrescription of the national server via the getPrescription interaction, the state changes 
into inProcess. When the pharmacist does not have the product in stock, the pharmacist 
should trigger a markAsUndelivered interaction so that the patient can get his drug delivery 
at another pharmacist. The status is then returned to undelivered. When the state of the 
ePrescription is inProcess, the community pharmacist might decide to revoke the 
prescription, when he, for example, thinks the prescribed medication can be harmful or 
irrelevant for the patient, by the revokePrescription interaction that sets the state of the 
prescription at revoked. The ePrescription will now no longer be available for other 
pharmacists. When the pharmacist decides to fill the prescription, he can trigger a 
markAsDelivered interaction, putting the state at delivered. Eventually, the ePrescription 
will be sent from the pharmacy that made the delivery to a price-fixing service, thereby 
informing Recip-e using the markAsArchived or markAsArchivedBis interaction, putting 
the prescription in the end state archived. All of these interactions use a RID argument to 
indicate on what ePrescription they want to perform their action. 
The low perceived acceptance, high perceived downtimes and growing alert fatigue 
raised the question of investigating the reason for this. Therefore, we investigated which 
technical errors in the flow of handling ePrescriptions happen by searching errors in the 
audit trail of the interactions performed on ePrescriptions and how these errors can be 
avoided. 
2. Methods 
In this study, we used a cross-sectional study design where all ePrescriptions’ interactions 
were taken under the loop to observe the audit trail of interactions taking place at the 
pharmacy. We, therefore, chose to observe a random day in the delivery process, i.e. 
Friday, September 6th, 2019. Experiences of the Recip-e organization show that we have 
to multiply this number by about 25 times to obtain an estimate of the monthly reported 
number of interactions that take place. The reason for not multiplying 
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Figure 1. State diagram of Belgian ePrescription when received by the community pharmacist 
this amount by 30 is that during weekends, Belgian citizens require fewer medications to 
be prescribed or filled than during weekdays. 
The types of errors that occurred were identified and quantified by reporting the 
number and percentage of occurrences within the collected sample. The technical errors 
occurring were categorized as errors to be avoided by a good software implementation or 
as errors to be avoided by the community pharmacist user (by memorizing the state 
diagram presented in Figure 1 and actions taken). 
3. Results 
In the collection of the sample of September 6th 2019, a total number of 527,880 digital 
interactions of the community pharmacist were observed (see Table 1). Of this total 
number of interactions, 196,433 (37.21%) were getPrescription interactions, where the 
pharmacist tried to retrieve an ePrescription. When observing the number of interactions 
bringing the ePrescription from the initial undelivered state to the revoked state or the 
delivered state, we observed respectively 11,632 markAsUndelivered (2.21%), 39 
revokePrescription (< 0.01%) and 169,801 markAsDelivered interactions (32.17%). The 
sum of these interactions adds up to 181,472 interactions or 92.38% of the total number 
of getPrescription interactions. So, we found a difference of 14,961 ePrescription calls that 
requested the download of an ePrescription without being handled in a final form. A 
possible explanation lies in a total of 2,553 repetitive getPrescription calls where the 
ePrescription was already in a state no longer allowing to be fetched again (states archived, 
delivered, inProcess). The other differences (n = 12,408) are to be explained by the further 
manual processing of the prescription like they used to do when a paper-based prescription 
was used.  
3.1. Incorrect getPrescription interactions 
When observing the reason for these 2,533 repetitive getPrescription interactions, we 
observed that the highest number of repetitive calls occur when the ePrescription is already 
archived (n = 1,547; 60.60%). This type of error can be explained by the fact that a 
community pharmacist archives his prescriptions digitally towards a price-fixing  
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Table 1. Interactions performed on one day, and the number of errors made per type 
Interaction Total nr of 
interactions 
Total nr of 
pharmacies 
Nr of errors Percentage of 
errors (%) 
getPrescription 196,433 4,688 2,553 1.30 
markAsDelivered 169,801 4,667 1,419 0.84 
markAsUndelivered 11,632 3,645 534 4.59 
markAsArchived 147,901 4,211 1,302 0.88 
markAsArchivedBis 2,074 890 - - 
revokePrescription 39 26 - - 
TOTAL 567,883 4,859 5,808 1.02 
 
service and tries to retrieve the digital content a second time. However, since the content 
has already been archived, its retrieval is no longer possible. Also, copies of the paper 
proof of prescription that were already delivered and archived at a different pharmacist 
will result in this incorrect state transition. This type of transition was observed in a total 
of 367 community pharmacists, of which 279 community pharmacists took care of the 
archiving of ePrescriptions themselves. It is expected that the user could avoid errors 
emanating from the user’s pharmacy as the user’s system should keep track of the handling 
of electronic prescriptions processed at this pharmacy. 
3.2. Incorrect markAsDelivered, markAsUndelivered or markAsArchived interactions 
The remainder of the incorrect calls deal with the markAsDelivered (n = 1,419), 
markAsUndelivered (n = 534) and markAsArchived (n = 1,302) interactions. Comparing 
this number of incorrect calls to the total number of interactions made of that type, we 
respectively obtained 0.84%, 4.59% and 0.88% of incorrect calls (see Table 1). 
The main reason for all of these incorrect interactions is again the triggering of an 
incorrect action coupled to a not allowed state transition: (1) 1,005 of the 1,419 incorrect 
markAsDelivered interactions (70.82%); (2) 518 of the 534 incorrect markAsUndelivered 
interactions (97.00%); and (3) 1,302 of the 1,302 incorrect markAsArchived interactions 
(100.00%). All these incorrect state transition attempts were rejected but could have been 
avoided by the user when the state diagram, presented in Figure 1, would be memorized 
by the pharmacist and would be correctly enforced by the pharmacy system.  
Other incorrect calls that were made could have been avoided by generating a correct 
call, i.e., at least giving a RID code as argument when a markAsDelivered call was 
generated (414 out of 1,419 calls; 29.18%) or using a correct RID code when a 
markAsUndelivered interaction was called (16 out of 534 calls; 3.00%). A good software 
implementation could additionally help verify these checks. 
4. Discussion and conclusion 
In this research, we showed that on an average working Friday, the Belgian community 
pharmacists jointly make 527,880 interaction calls with the national database in order to 
retrieve, (un)deliver, or revoke the ePrescription. This total amount does not include other 
calls being made by the prescriber to generate and store the ePrescription in a secure way 
to the server via the national eHealth platform. Five years after national deployment was 
initiated, still lots of problems related to slow responses, high downtimes and alert fatigue 
due to technical and incomprehensible error messages are perceived by the community 
pharmacist. This cross-sectional research tried to find reasons, by looking at the digital 
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interactions and errors made during interaction that takes place at a community pharmacy 
with the ePrescriptions on a randomly chosen working day.  
About 1.10% of the interactions of pharmacists resulted in attempting to make a 
technically invalid interaction with the national database. Community pharmacists then 
typically get a quite technical message of their software stating something about the 
current status of an ePrescription. However, most of the community pharmacists do not 
understand these error messages, that in the end trigger their alert fatigue. An example of 
such a message is “Retrieval of ePrescription failed - [ERR100028] ePrescription 
BEP1PDT1F5SP is archived”. Here an incorrect state transition was requested. 
Most of these error messages are easy to avoid, keeping the allowed state transitions 
in mind. This status follow-up should be tracked as well by the pharmacy software, but 
often this is not the case. However, when a patient presents the Belgian proof of 
ePrescription to a pharmacist, who does not know of earlier interactions in a different 
community pharmacy, these errors may seem odd and not appropriate. All too often, the 
pharmacist still tries to execute this prescription, possibly in its paper-based form [2].  
Clearer alerts could help in the prevention of this type of errors. Also, clear 
instructions for the community pharmacist of what state transitions are allowed could help 
to this. In Belgium, future pharmacists are trained to work with digitalized systems by 
doing internships in different pharmacies. However, when this state diagram is not present 
in the mindset of tutoring community pharmacists, the tutor during the internship will not 
be able to guide the intern correctly. 
An additional verifyStatus interaction might help to limit certain incorrect interactions 
of the community pharmacist by disabling them in the interface. However, a multiplication 
of the number of interactions is not desirable, since nowadays we are confronted with a 
high amount of downtimes due to technical issues at the level of our national eHealth 
platform. The finding of these high unavailability rates, due to downtime of the national 
services, was first reported by Suykerbuyk et al. [5] when reporting about the perceptions 
of the patient about the national ePrescription. 
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Abstract. Ballistocardiography (BCG) has gained more attention due to the 
fundamental goal of medical intervention in diagnostics and follow-up. BCG is 
particularly suitable for the study of heart failure, which a recent study has shown. 
The results of this working group shall be validated and reproduced with another 
study trial. Therefore, acceleration sensor prototypes will be placed on various parts 
of the patient’s body and be connected to a computer unit, which allows a high data 
quality and high signal resolution. A temporal shift of only 20 ns ensures real-time 
measurement of BCG parameters. The reference measurement will be done with a 
12-channel ECG. The study will include patients with heart failure. All conducted 
tests take place as part of the diagnostic-therapeutic routine. The only change in the 
procedure concerns the additional equipment with the measuring sensors. The 
results will be the validation of the data from the other working group, as well as the 
information about the choice of sensors and clock frequency, the measuring points 
and the needed features for early detection of heart failure in BCG signals. 
Keywords. Ballistocardiography, Seismocardiography, Heart Failure 
1.Introduction 
In recent years, the ballistocardiography has gained more attention [1–10], with the 
fundamental goal of medical intervention, for example, the diagnosis or follow-up. 
However, ballistocardiography or seismocardiography [4,5] is particularly suitable 
for the study of heart failure (HF), as new studies confirm [10]. 
With the prospective study described here, the previous explorative results of the 
scientific society are to be reproduced, and this validates their validity. 
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The determination of the course of development of heart disease or long-term 
measurements of cardiac parameters are currently still difficult to implement and can 
only be determined with the help of medical visits or measurements of only 24 hours. 
However, there are diseases that have a much slower course or can appear at irregular 
intervals and are therefore unnoticed or measured within 24 hours. 
Ballistocardiography should be a simple and inexpensive solution, but at the same 
time efficient and highly specialized [4,5,9,11,12]. Thus, it is possible to determine the 
blood pressure with the aid of the measured pulse transit time (time difference of the 
same signal between various measurement points on the subject’s body), without the 
patient being awakened by inflating a cuff around the arm at night or interfering with his 
activities during the day, thereby distorting the result [13]. Since such a system is very 
small and has a battery with several days of running time, measurements of more than 
24 hours (as a single measurement) can be made to reduce the disease deterioration of 
e.g. Cardiac insufficiency or high blood pressure (even over a longer period, for example, 
over months) [4,5]. 
At present, there are only a few ballistocardiographic measurements performed in 
everyday life or with cardiac patients. Data on the signal morphology of cardiac 
insufficiency have only been collected in an exploratory fashion [1]. With this 
prospective study planned, we then want to validate these exploratory results. 
Furthermore, in literature found setups raise further questions, so the technical 
measurement setup from the point of view of the working group is not optimal (choice 
of sensor, choice of clock frequency, choice of measurement position). 
The overall objective of this prospective study is the validation of the results from the 
published results [10] for the measurement of ballistocardiographic or rather 
seismocardiographic signals in cardiac patients and their usability for heart failure 
diagnostics and/or course analysis, through the use of a highly specialized sensor 
measurement system consisting of body-worn acceleration sensor. 
Secondary goal is to find out what features are needed for early detection of heart disease 
(e.g., Graph Similarity Score or other correlation) and what the signals of such diseases 
look like in a ballistocardiographic record. 
2.Methods 
The BCG sensor system is intended for the measurement. Components include the core 
unit, the FPGA processor board, and seven suitable triaxial acceleration sensors 
(Accelerometer). For the reference measurement, a 12-channel ECG is read out via the 
analog output parallel to the acceleration signals. This is a common method to be able to 
compare the two signals to each other and to provide information when in the BCG signal 
the characteristic features should appear. 
The measuring system allows a high data quality (low signal-to-noise behavior) 
and a high signal resolution (2g scaling at 16 bit). In addition, an isochronous readout 
of the 3x7 acceleration sensor channels at a suitable sample frequency can be realized. 
The sensor positions are 1x sternum, 2x cardiac apex – medio-clavicular (5. ICR), 1x 
torso, lateral le., 1x spine (7.-8. th), 1x A. temporalis le., and 1x A. radialis left-hand 
side. The aim of the used two-digit kilohertz range including oversampling is to ensure 
data robustness. A temporal shift of only 20 ns ensures real-time measurement of 
ballistocardiographic parameters. 
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The measurements are carried out simultaneously with the recordings of the general 
patient assessment. Participation in the study will not give subjects any further 
inconvenience with regards to additional assessment procedures (e.g., 6-minute-
walking- test) or separate visits to the measurement environment. All conducted tests 
take place as part of the diagnostic-therapeutic routine. The only change in the 
procedure concerns the additional equipment with the measuring sensors. 
The subject is initially in a stationary position during the measurement (for about 
one minute). Further, a six minutes gait phase, as is commonly done within the general 
clinical routine assessment, will follow. After this physical stress on the subjects, there 
is a five-minute recovery period. Conversations should be avoided during the 
measurement. 
 
Figure 1. Model of the measure points. 
 
The additional BCG sensor on the apex of the heart serves as a supplement to the 
first sensor since the electrode of the ECG is also attached to this position. This ensures 
a good recording of the acceleration at this. 
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Based on the hypothesis that there will be no subjects within the study population 
whose BCG/SCG signals differ fundamentally from the known morphology and the 
assumption that a homogeneous group exists under the given conditions more than 60 
percent of the subjects have comparable features in the BCG or SCG signal, a rather 
small panel of subjects provides sufficient security for verification. In order to test the 
results of the difference between compensated and decompensated cardiac insufficiency 
subjects found in the literature see [10], 52 probands are needed with an effect size of 
0.35. These subjects should be distributed as equally as possible to the four NYHA 
classes. In addition, the number of compensated and decompensated subjects should also 
be equally distributed. 
3.Prospective Results 
The main results of this study will be the validation of the data and results from the 
exploratory study with heart failure patients [10]. Hopefully, we are at least able to 
reproduce these results and give an overview of the performance of ballistocardiographic 
sensors in the diagnostics of cardiac patients. Moreover, we are confident to collect BCG 
or SCG signal data in the best quality state, so we can provide them to the scientific 
community soon as open data like it is requested by FAIR-principle. Those results will 
provide highly synchronous signal data with the best sample frequency we can reach 
(about 17 kHz) and the optimal entropy about the heart’s movements and functions. 
Another result of the performed measurements will be a deeper knowledge of the 
usability of specific digital triaxle acceleration sensors and other system specifics, like 
the clock frequency, to gain an optimal measurement result and furthermore, more 
knowledge about the measurement positions on a patient’s body. 
In the end, the ideal setup for those measurements is going to be presented. Moreover, 
the needed features for early detection of heart failure and the characteristics of the 
disease in BCG data will be shown and also the usability of this type of diagnostic for 
cardiac patients. 
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Abstract. The Text REtrieval Conference (TREC), co-sponsored by the National 
Institute of Standards and Technology (NIST) in the US and US Department of 
Defense, was started in 1992. TREC’s purpose is to support research within the 
information retrieval community by providing the infrastructure necessary for large-
scale evaluation of text retrieval methodologies. In 2017, the TREC Precision 
Medicine (Roberts et al., 2017) track grew from the Clinical Decision Support track 
and focused on a narrower problem domain of precision oncology. After three years 
of computer runs being evaluated for relevance by physician readers, we provide a 
unique perspective of how to evaluate computer-generated articles and clinical trials 
pulled from PubMed and Clinicaltrials.gov to find relevant information on medical 
cases.   
Keywords. Precision medicine, information retrieval  
1. Introduction 
Starting in 2017, the Text REtrieval Conference (TREC), co-sponsored by the US 
National Institute of Standards and Technology (NIST) and the US Department of 
Defense, produces as part of its large information retrieval research program a project 
devoted to information retrieval focused on precision medicine.  The 2017 “Overview of 
the TREC 2017 Precision Medicine Track” reported on search challenges with “precision 
medicine.” Many more treatment options become available with information tailored to 
the individual patient.  The abundance of clinical information can easily overwhelm 
clinicians attempting to stay up to date with the latest findings and can easily inhibit a 
clinician’s attempts to determine the best possible treatment for a particular patient. As 
a forerunner to the Precision Medicine Track, three consecutive years of the TREC 
Clinical Decision Support (CDS) track sought to evaluate information retrieval (IR) 
systems that provide medical evidence to the point-of-care. The CDS track then focused 
on the needs of precision medicine so IR systems can focus on this important issue [1]. 
The years 2017, 2018, and 2019 Precision Medicine Tracks focused on a single field, 
oncology, for a specific use case: genetic mutations of cancer. The main idea behind 
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precision medicine is to use detailed patient information (largely genetic information in 
most current research) to identify the most effective treatments. Improving patient care 
in precision oncology then requires both (a) a mechanism to locate the latest research 
relevant to a patient, and (b) a fallback mechanism to locate the most relevant clinical 
trials when the latest techniques prove ineffective for a patient. In the first part, the track 
continues the previous Clinical Decision Support track [2], while in the second part the 
study expands the task to cover a new type of data (clinical trial descriptions). All of the 
TREC Precision Medicine tracks have used synthetic data to create topics of clinical 
cases for the computer search.  All topics were created synthetically because it was 
difficult to obtain actual patient data for the project [3]. 
Detailed results from the TREC Precision Medicine Tracks are available in the 
overviews published on the TREC website. This paper focuses on the process of 
recruiting physicians to read the output from the computer runs, analyze the relevancy 
of the article or clinical trial for information about the topic, and help researchers provide 
information about the accuracy of the computer to find useful information for the 
physician. 
2. Methods   
A pooling strategy was used to determine the set of articles and trials to be judged. 
Slightly different pooling strategies were used for each year for each type of result, but 
the most common method is as follows. All articles and trials that were within the top 10 
results for any research participant (i.e., the research groups searching for the article and 
clinical trial documents) were included in the pool. Additionally, a 10% sample of the 
results in position 11 to 100 were added to the pool. The pooled articles and clinical trials 
for each topic were judged by physicians who, in most cases, were graduates of the 
Oregon Health & Science University (OHSU) biomedical informatics graduate program. 
In the case of the clinical support track where physicians evaluated whether a clinical 
visit was relevant to the case, the challenges included terminology differences, negation, 
and time aspects having the most impact on retrieval inaccuracy. Edinger et al. describe 
in detail that these challenges also arise during cohort identification in medical text [4]. 
The cohort of graduates from OHSU ideally needed to have the following 
characteristics to become readers for the project: a certificate or master’s degree in 
biomedical informatics, a medical or doctor of osteopathic medicine degree to evaluate 
relevancy appropriate in a clinical situation, and an ability to quickly review many 
documents from a website created for the project.  The number of topics (topic examples 
are in Table 1), documents found (total number of abstracts from PubMed and clinical 
trials from ClinicalTrials.gov), and readers for each year in the precision medicine track 
are outlined in Table 2.  
 
Table 1. Example topics (3) 
Disease Variant Demographic 
melanoma BRAF (V600E) 64-year-old male 
melanoma high serum LDH levels 69-year-old female 
medullary thyroid cancer RET 45-year-old female 
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Table 2. Number of topics, documents and readers 
 2017 2018 2019 
Number of Topics 30 50 40 
Total Number of Documents 36081 36617 32162 
Number of Physician Readers 18 26 19 
2.1. Recruitment 
Over three years of reader recruitment for the Precision Medicine track, we had to 
slightly change where we got readers for the project.  In all three years, the chair of the 
OHSU Department of Medical Informatics and Clinical Epidemiology (DMICE) would 
send a letter to DMICE alumni roughly three months before the October 1 deadline. As 
the numbers in Table 2 indicate, we had many more topics in 2018 and so also sent the 
letter to chair people in other departments of biomedical informatics for their suggestions 
of clinical informatics fellows and doctorate students who might be interested in being 
readers for the project. 
The incentives for readers to work on the project were to learn more about 
information retrieval and receive payment for reading. Noted in our recruitment letter for 
the work, we paid a set amount per hour. We paid for quantity of articles judged, not by 
time, but experience has shown that almost everyone can average one minute or less per 
article. 
3. Results and discussion 
The primary purpose for the physician readers in this project was to determine if each 
article and clinical trial found for a particular topic was 1) human medicine, 2) disease is 
relevant, partially relevant, or not relevant, 3) whether gene variants were discussed, and 
4) whether the demographics (age and sex) matched (see figure 1 for screenshot of 
OHSU website for viewing articles and trials the computer selected).  Details on the 
relevancy statistics for TREC Precision Medicine Tracks are in (1) and (2) and are 
forthcoming in 2019. The input of the physician readers has helped the project in many 
ways outlined in the following three years. 
 
Figure 1. Example of OHSU website for reading articles captured in the computer runs. 
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3.1. 2017 
The recruitment for readers began on August 17, 2017, and 18 readers finished 18 topics 
in 30 days. The remaining 12 topics were finished by October 8.  In 2017, there were 
roughly 9% judged definitely relevant out of 22,642 literature articles, and 3% judged 
definitely relevant out of 13,441 clinical trials. We had and continue to have an 
international contingent of physician readers with many throughout the US and some in 
South America, Taiwan, and the Middle East.  Readers mentioned that it was particularly 
difficult to find genes mentioned in the articles and usually would need to search in the 
full text of the article (the web interface we use shows article abstracts only). In terms of 
the web interface to read the abstracts and clinical trials, readers had, in some cases 
skipped articles and trials and had difficulty finding the particular missing article or trial 
in the web interface.  Some of the time involved to get topics finished was due to skipped 
articles.  By 2019, the website had been refined so that missing articles while working 
on the web interface was not a problem. 
 
3.2. 2018 
The second year of the Precision Medicine track included almost 50 topics, and it was 
necessary to recruit outside of the OHSU graduate program and in particular we found 
doctorate candidates in National Library of Medicine programs across the United States. 
The recruitment for readers began on August 22, 2018, and on average, 26 readers 
finished 25 topics in 21 days. The remaining 25 topics were finished by October 1.  In 
2018, there were roughly 15% judged definitely relevant out of 22,429 literature articles, 
and 6% judged definitely relevant out of 14,188 clinical trials. Readers from the doctorate 
programs would, in some cases, complete ranking topics faster than the physician readers 
and in other cases had the most questions and took more time.  While we felt it was 
important to include informatics doctorate students without medical degrees, the 
physician readers had more skill in identifying articles and trials that would help for a 
particular topic. 
 
3.3. 2019 
At the time of this writing, the Precision Medicine Track reader analysis is still in 
operation (results due October 1, 2019). The recruitment for readers began on August 
12, 2018, and on average 19 readers finished 19 topics in 16 days. The website took 
longer this year to produce, and there were more questions about how to match what the 
computer found as a genetic variant in articles and clinical trials. 
The challenge with working with physician readers is that most have full-time 
clinical responsibilities (one reader was on call for forest fire duty in California in 
addition to clinical duties), but all readers were able to finish on time and in the case of 
two readers, one reading up to 1212 combined abstracts and trials for one topic in 10 
days and another did four topics in 2 weeks.  15 readers in 2019 have made all of the 
previous Precision Medicine Tracks and look forward to working with us again.  Many 
of the readers provide us with questions to help make the search for precision medicine 
topics better: e.g., the computer runs were sometimes not bringing in any relevant articles 
and how do the research groups change the algorithm to bring in more relevant articles 
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and trials.  Some readers tried to do the reading and analysis on mobile devices. That is 
not possible now but could be considered in the future to enable more readers to work 
with the TREC website from OHSU DMICE.    
It is possible that duplicate judging might improve the process as readers thought 
that in some cases, they were not as familiar with the case and suggested that another 
expert review their cases. We used to do duplicate judging (in the CDS Track) with kappa 
analysis, but the results always seemed to be about the same (good but not great 
consistency). While readers noted that there seemed to them poor relevancy of the 
articles and clinical trials chosen by computer, there appear to be improvements from 
2017 to 2018, and there were fewer comments by readers about how few relevant articles 
there were in 2019 (only one reader and he was new). 
The TREC assessment exercise can improve how we look for cases that closely 
resemble a clinical problem in precision medicine. The data from the physician readers 
has allowed more work on computer analysis of medical cases and eventually help with 
better searching for clinical cases in electronic health records.  
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Abstract. Digital Health is one of the three pillars for the effective implementation 
of Universal Health Coverage in Argentina. The Ministry of Health published the 
National Digital Health Strategy 2018-2024 in order to establish the conceptual 
guidelines for the design and development of interoperable health information 
systems as a state policy. The World Health Organization "National eHealth 
Strategy Toolkit", "Global Strategy on Digital Health" and other international and 
local evidence and expert recommendations were taken into account. The path to 
better healthcare involves adopting systems at the point of care, allowing for the 
primary recording of information and enabling information exchange through real 
interoperability. In that way, people, technology and processes will synergize to 
enhance integrated health service networks. In this paper, we describe the plan and 
the first two years of implementation of the strategy. 
Keywords. eHealth, electronic health records, health information exchange, national 
health programs, health level seven, SNOMED. 
1. Introduction 
The United Nations have set universal healthcare coverage (UHC) as a target for 
sustainable development goal 3.8, to be achieved by 2030[1]. 
Only the appropriate use of digital technologies can enable the development of 
sustainable health systems that promote universal access to care. To deliver this 
potential, digital health initiatives must be guided by a robust strategy that integrates 
financial, organizational, human and technological resources [2]. History shows that ill-
coordinated initiatives lead to vertical or stand-alone ICT solutions, that although well 
intended, often result in information fragmentation, and consequently poor delivery of 
care. Additionally, developing countries face specific challenges such as poor 
economics, political uncertainty, and the lack of cutting-edge infrastructure, that 
hampered the quality of healthcare [3].  
Argentina has a complex federal healthcare system, where the national government, 
24 jurisdictions and three subsystems interact: Public care, social security and private 
insurances. Many of its shortcomings come from its segmented and highly fragmented 
system, which also translates into the generation of information siloes. In many health 
centres in the country, health records are still kept in manual registries and logbooks. In 
a preliminary survey, at least 80% of the public healthcare facilities do not have 
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computers or Internet connection. This often results in duplication, over-reporting and 
underreporting for public health. To undertake this situation, in 2018 the Ministry of 
Health (MoH) promoted a National Digital Health Strategy, rising capacity building, 
engaging multiple stakeholders and promoting the development and interconnection of 
interoperable information systems, based on standards. This paper reflects the 
foundations and steps taken during the last two years to advance this mid and long term 
strategy. 
2. Materials and Methods 
2.1.  Setting 
Argentina is a Federal Republic subdivided into 24 jurisdictions, with an area of more 
than 1 million square miles and located in the southern half of South America. Its 
population is around 45 million people, unevenly distributed mainly in urban and 
suburban areas. Beyond the recurrent economic crises, it is an upper-middle-income 
country and has a developed healthcare system. However, health outcomes lag behind 
the country’s potential, considering spending per capita of nearly 10 % of its gross 
domestic product. We have a mixed healthcare system with three components: public 
care, social security and private insurances. The social security subsystem is based on 
job taxes and covers 60% of the population, including active/retired workers and their 
families. Almost 2 million people (4%) pays for private insurance, leaving 36% (16 
million people) with exclusive public care coverage based on jurisdictional states 
resources. There are significative gaps in morbidity and mortality outcomes between 
regions and subsystems. Since 2018, the National MoH has embraced an action plan to 
implement public health reform. Overall, the ultimate goal was to provide actual UHC 
by strengthening provincial health systems [4]. 
The existing fragmentation and segmentation of the healthcare system hamper the 
aggregation of patient data. Even though there is a need for digitalization, the creation of 
a single national health database is not possible given the political and health model. The 
incipient and progressive individual computerization of each system does not 
spontaneously solve this difficulty. Therefore, a distributed but interconnected health 
information ecosystem was selected as a feasible approach. 
2.2. Methods 
Our National Digital Health Strategy was built, taking into account international 
recommendations, like the World Health Organization toolkit for National eHealth 
Strategies, and their recent global strategy on digital health. We also participated in 
working groups such as HL7 International, SNOMED International and the Global 
Digital Health Partnership (GDHP). We capitalized regional initiatives like Information 
Systems for Health (IS4H) and RELACSIS from the Pan American Health Organization 
(PAHO)[5], and Inter American Development Bank sponsored RACSEL. We interacted 
with Latin American leaders in charge of other national digital transformation 
experiences like Uruguayan SALUD.UY. Our approach is also grounded in the 
Principles for Digital Development and the subsequent Principles of Donor Alignment 
for Digital Health. These principles highlight the importance of supporting strong 
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national digital health strategies for sustainable country ownership, avoiding project 
overlap and fostering coordination and alignment of implementation activities [6]. 
However, it was essential to uphold the local existing resources and capacities, 
based on public, private and non-government organizations stakeholders who have been 
using Information Technologies for health services improvement for many years [7]. 
Moreover, the OECD has highlighted the ambitious general digital agenda and the 
efforts taking place in Argentina to digitalize and improve data governance in its public 
sector and build the foundations for a digital government [8].  
3. Results 
Through Resolution 189/2018, the highest health authority in Argentina settled the way 
forward to build, in collaboration with provincial governments and referents of the three 
subsystems, a network of information systems focused both on the population and 
individual health of each patient. The MoH created a National Directorate of Health 
Information System to coordinate such a strategy. It was essential to work on 
governance, making agreements with each province within the UHC framework plan. 
The investments that each jurisdiction makes in its digitization projects are 
reinforced with national and international funds. Multilateral funding organizations (such 
as the World Bank and Inter American Development Bank) support projects like so-
called SUMAR, which strengthen public health coverage to protect the most vulnerable 
populations [9]. Recently, they have included the Digital Health Strategy goals and will 
give economic incentives to the provinces that accomplish them for the next four years. 
As a result, every digital health transformation project should be aligned with the 
National Strategy. Additionally, the MoH got the funding for a National Connectivity 
Plan for public healthcare facilities. It will reach 2,000 remote primary care centres in 
the next two years, using satellite connections and optic fibre. 
The Digital Health Strategy has two consecutive phases. Phase 1: Consensus, 
Infrastructure and Scalable Projects (2018-2019), which define the technical, regulatory 
and political foundations, with the participation of the community of experts and 
jurisdictions. Phase 2: Deepening, scaling up, and maturation (2020-2024) focuses on the 
adoption extension of the Digital Health tools and the functional enhancement of 
Information Systems. The priorities for the first stage were to: 
Define interoperability standards: SNOMED, FHIR, ICD, etc. 
Make the Central Infrastructure available: the enterprise service bus (EBS). 
Identify and integrate the information needs: governance on the data flow. 
Enhance local information systems: licensed, homegrown, or open-sourced. 
Define the architecture to share clinical records, with HL7-FHIR. 
Inform and empower the patient through a Citizen Health Portal (Mi Argentina). 
Advance in the legal framework for digital health transformation. 
Grow capacity building: train human resources in health information systems. 
Argentina joined the SNOMED International Consortium in 2018. The National 
Release Centre has published three local extensions during the last 18 months, including 
medication codes to allow interoperable ePrescriptions. The MoH stated SNOMED as 
the clinical terminology standard for electronic health record (EHR) systems, leaving 
ICD for statistical and other administrative tasks. In addition, FHIR (Fast Healthcare 
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Interoperability Resources) [10] a next-generation standards framework created by HL7, 
was chosen as the standard for health care data exchange. 
The National Digital Health Network was launched in April 2019, using an 
enterprise service bus technological infrastructure to connect different domains (EHR 
systems) across the country, as shown in Figure 1. We defined the required 
interoperability standards based on international recommendations and extensive local 
expertise in the field. By involving multiple stakeholders, we understood their views and 
gained their collaboration, support and endorsement of the strategy. A joint team 
including MoH, HL7 Argentina and Hospital Italiano (HIBA) experts developed the 
HL7-FHIR Enterprise Service Bus. The network enables the communication between 
domains but does not change the current processes of storage of health information. The 
data remains in each information system repository, and is only communicated to other 
domains when necessary (i.e. when the patient visit another clinic). 
 
Figure 1. Simplified ESB architecture of the National Digital Health Network. 
The MoH acquired RedHat OpenShift® licenses and services to support such 
infrastructure, hosted at the main Government Datacenter (ARSAT). The MoH team has 
been adopting this open-source container application platform based on the Kubernetes 
container orchestrator for enterprise application development and deployment, to 
guarantee the Health Network required availability and performance level.
After two years, every province (24) has defined its Digital Agenda for Health. 
Regarding their information systems, they have freely decided whether to acquire 
commercial EHR licenses, develop locally or adopt open-source software. There are 
advanced Projects in 16 of 24 states, where they selected pilot areas to carry out the 
digital transformation. Human resources, technology and processes were aligned to fulfil 
the project goals. Adopting a change management strategy was crucial for EHR 
implementations. The national MoH helped local teams to implement standards like 
SNOMED and FHIR in their systems. Vendors are progressively adopting standards to 
comply with National recommendations. Up to date, there are more than 2 million 
patients registered in the Network: it means that they have received care in an institution 
with interoperable EHR, and if they attend to another clinic, it would be possible to ask 
individually for such records through the network. 
In collaboration with the Ministry of Modernisation, we launched a Citizen Health 
Portal. As of October 2019, more than 2 million users had been registered on the digital 
public service delivery platform Mi Argentina. It gives personal information like the 
Digital Vaccination Card, but also works as a patient privacy manager, to configure the 
opt-out consent for the information exchange trough the EBS health network. 
We developed and implemented a National Telehealth Platform to perform 
eReferrals and eConsultations nationwide. It allows every clinician to interact with other 
healthcare professionals (specialists) using a personal computer or a mobile device in a 
secure environment, even if they do not have an EHR in place. As the Telehealth 
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Platform is connected to the National Enterprise Service Bus, different EHR can 
interoperate with it. 
Besides the existing legal framework that rules Health IT implementations (Digital 
Signature, Personal Data Protection, EHR, etc.), the MoH dictated several resolutions to 
promote digitization while caring for privacy, confidentiality and security. In addition, 
there is a Digital Health Law project to be discussed at the Congress. Every jurisdiction 
can dictate their legal regulations, or endorse national laws. 
 We promoted several initiatives to enhance capacity building. In 2018 the MoH, 
PAHO and HIBA launched the “100 Leaders” Training Plan, using an online AMIA 
10x10 course. There is also a monthly open course on standards and Conectathon, both 
onsite and online. We developed a basic online course on EHR fundamentals for more 
than 1,500 healthcare staff. The next big step is introducing these topics in healthcare 
professionals’ undergraduate curricula. 
4. Conclusion 
The Digital Health Strategy is not an end in itself but has the vision of reducing quality 
gaps in health care, implementing information systems that identify the characteristics 
and needs of the population, allowing longitudinal and comprehensive monitoring of 
people throughout the entire health system and providing innovative tools to health 
professionals and patients.  
This paper underlines the role of the MoH in setting a National Digital Health 
Strategy for Argentina. Even though it has been a short period, since 2018, there have 
been several achievements that should be sustained. Besides its mid and long term 
planning, the strategy itself has to prove that it can succeed the time challenge of 
political transitions. Using international benchmarks and strategies like IS4H could be 
useful to support this initiative. 
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Assessing Opioid Use Patient 
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Abstract. Precision medicine, diagnosis, treatment, and prevention that accounts for 
natural human variability, can be beneficial for complex populations.  The opioid 
user population is heterogeneous, characterized by many disorders, medications, and 
procedures.  Using Electronic Health Record data, we create a patient representation, 
finding similarities between structured data, and then cluster the patients into patient 
subtypes.  These subtypes can then be used for subsequent analysis. 
Keywords. electronic health records, precision medicine, deep learning 
1. Introduction 
Health professionals are required to make analytic decisions influenced jointly by 
evidence-based medicine, prior practice knowledge, and specific patient attributes.  
Precision medicine aims to find appropriate treatments and diagnoses based on an 
individual patient since no method is ideal for every patient.  Opioid-related adverse 
events and addiction are the main public health concern in the United States.  Since 1999, 
more than 700,000 people have died from a drug overdose [8].  Partially due to over-
prescribing and increased availability of potent synthetic opioids such as fentanyl, the 
opioid crisis has brought to light the need for finding better treatment options that are 
tailored to the patient for pain and addiction [7, 13].    
Previous literature has demonstrated that high opioid dosage, concurrent use of 
sedative-hypnotics, substance abuse, and mental health comorbidities are associated with 
an increased risk of overdose [9].  Very few models have assessed the entire patient 
clinical picture and those that do focus mainly on medication data, require reliance on 
some sort of manual feature creation, and specifically are tasked to predict overdose [1; 
5].  Therefore, characterizing an opioid prescribed population for specific pain treatment 
candidates, adverse opioid drug-drug interactions, and unknown risk factors for opioid 
overdose could be beneficial.   
As a step toward precision medicine for an opioid prescribed population, using 
electronic health record data (EHR) provides the benefit of a large source of longitudinal 
data that encompasses the clinical picture with diagnoses, medications, and procedures.  
Retrospective observational data is especially useful for discovering unknown 
associations and can give a basis for finding similar patients [11].  However, EHR data 
suffers from an abundant amount of sparse attributes in the form of structured 
terminologically codified data and unstructured clinical text [10]. 
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Deep learning advances have made it possible to incorporate high-dimensional data 
as input, as opposed to a select set of manually engineered features, by learning low 
dimensional dense embeddings [2, 6, 12].  Patient representations can be learned from 
neural networks that encode meaning and relationships into the dimensions.  These 
patient vectors have been shown to increase predictive performance, assess patient 
similarity, and create patient subtypes [3, 14].   
Using a paragraph vector model, we learn low dimensional dense patient 
representations from codified diagnoses, procedures, and medications for an opioid 
prescription population.  To analyze these representations, we look at how well the 
vectors cluster patients into opioid user subtypes and known opioid misuse risk factors.  
2. Methods 
Two retrospective EHR databases, an outpatient practice and a hospital, were collected 
from January 2013 to December 2017 for patients who received an opioid prescription 
within the time frame. The data was approved as exempt research by the University at 
Buffalo IRB.  Merger and de-identification of the data with assigned unique research 
identifiers were done with patient matching on social security number, date of birth, last 
name, and first three letters of the first name.  Encounters for patients with a cancer 
diagnosis or those in palliative care were removed from the analysis. In order to assess 
the effects of opioid usage, patients were retained if they had at least two visits.  
Due to the large volume of terminological codes and version differences across the 
time window, clinical classification software (CCS) was used to classify ICD-9 and 
ICD-10 diagnoses and current procedural terminology (CPT) codes to upper-level 
classes.  Medications were mapped from national drug codes and local facility drug 
codes to the drug classes opioids, muscle relaxants, benzodiazepines, zolpidem, and 
Schedule II stimulants within the 2018 IBM® MarketScan® RED BOOK Database 
(www.ibm.com/Watson-Health/Marketscan).  Finally, additional demographic variables, 
age at first opioid prescription, gender, race, ethnicity, and marital status were included.  
Race and ethnicity were standardized according to the Agency for Healthcare Research 
and Quality (AHRQ).  Codes for drug overdose and adverse events, defined by ICD and 
manual review of clinical text, were removed from the patient representation for 
downstream prediction tasks. 
To build the distributed representations of patients and their specific medical codes, 
we implemented the distributed bag of words algorithm (PV-DBOW) with 200-
dimensional feature vectors and negative sampling [4].  Codes that were used less than 
two times in the analysis were removed. A patient vector consisted of all codes in 
temporal order by encounter date with randomization of medication, diagnosis, and 
procedure codes within an encounter.  A temporal embedding was not considered due to 
the small patient sample in relation to deep learning methods.  We trained the model for 
500 epochs.  To visualize our patient representations, we used t-distributed stochastic 
neighbour (t-SNE) embedding to collapse the representations into two dimensions. 
Cosine similarity, a simple mean of the projection weight vectors, is used to assess 
similar codes. Finally, we used k-means with Euclidean distance to create patient 
subtypes from the patient representations and assessed the distribution of features within 
those groupings. 
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3. Results 
After removal of patients with cancer and palliative care diagnoses, the patient 
representation was trained on 3,986 patients. The features consisted of 129 distinct 
procedural CCS codes, 44 distinct medication codes, 256 distinct diagnostic CCS codes, 
and four demographic variables.  For diagnostic codes, ‘residual codes; unclassified,’ 
‘medical examination/evaluation,’ and ‘administrative/social admission’ were removed.  
13% of patients had a diagnostic code for opioid dependence, with 11.4% on 
buprenorphine treatment and 4.1% on methadone treatment.  Opioid-related adverse 
events and overdoses made up only 3.6% of cases.  Mental health-related diagnoses were 
recorded in 60% of the population, and non-opioid substance abuse was recorded in 
8.1% of the population. Analysing the demographic features of the cohort, 64% were 
female, 58.8% were White, 40.14% were Black, and 3.7% were Hispanic. On average, 
there were 29 codes per patient. 
Cosine similarity was assessed between the codes in the embedding (Table 1).  
Opioid medication codes, psychological and mood disorder codes, and procedures 
relating to pain were similar, implying the associations of previously reported risk 
factors in an opioid-related population are being learned by the distributed representation.  
 
Table 1. Validation examples of patient representation code embeddings measured by cosine similarity. (p) 
indicates CCS procedure code as opposed to diagnosis code. 
Code 1st Similar (cosine 
similarity) 
2nd Similar (cosine 
similarity) 
3rd Similar 
(cosine 
similarity) 
4th Similar 
(cosine 
similarity) 
Methadone CCS 211: Other 
connective tissue 
disease (0.59) 
Morphine Long-
Acting (0.57) 
CCS 204: Other 
non-traumatic 
joint disorders 
(0.56) 
Hydromorpho
ne Short-
Acting (0.53) 
CCS 651: 
Anxiety 
disorders 
CCS 661: Substance-
related disorders (0.67) 
CCS 663: History of 
mental health and 
substance abuse codes 
(0.65) 
CCS 652: Malaise 
and fatigue (0.62) 
CCS 657: 
Mood 
Disorders 
(0.61) 
CCS(p) 
155: 
Arthrocent
esis 
CCS(p) 173: Diagnostic 
procedures on skin and 
subcutaneous tissue 
(0.40) 
CCS(p) 38: Diagnostic 
procedures on lung 
and bronchus (0.34) 
Tramadol Long-
Acting (0.27) 
Orphenadrine 
(0.25) 
 
Visualizing our patient representations, we see that opioid abuse, misuse, and 
poisoning, opioid dependence, mental illnesses, and other drug abuse are not well 
represented in two dimensions of the embeddings (Figure 1).   
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Figure 1. T-SNE patient representations of opioid-related outcomes misuse and dependence and other risk 
factors, drug abuse and mental health. 
 
Using the elbow method and distortion, 8 clusters were found to be optimal for k-
means clustering. Compressing the data into two dimensions using t-SNE, the clusters 
were plotted for visual inspection (Figure 2).  The clusters have well-distinguished 
groupings.  Cluster 6 is characterized by opioid dependence (58%) and opioid 
poisonings and misuse (44%).  Cluster 0 has a high proportion of hydrocodone, fentanyl, 
and nutritional disorders.  Cluster 1 has a high proportion of buprenorphine users, 
benzodiazepines, and mental health disorders, particularly substance-related disorders, 
anxiety, and mood disorders.  Cluster 2 has a high proportion of opioid users related to 
bone and tissue diseases and spine and back pain.  Cluster 3 is characterized by joint and 
nervous system disorders, muscle relaxers, and hydrocodone or buprenorphine use.  
Cluster 4 is also characterized by connective tissue and joint disorders, but patients are 
primarily on tramadol or hydrocodone.  Cluster 5 is characterized by urinary infections 
and disorders and arthrocentesis. Cluster 7 is characterized by hypertension, diabetes, 
and gastrointestinal disorders. 
 
 
Figure 2. K-means clusters using t-SNE dimensions for opioid prescribed patient population.
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4. Discussion and Conclusion 
Patient subtyping, seeking similar groups of people in an opioid patient population with 
different diagnostic, medication, and procedural patterns, is important to address the 
heterogeneity in patients and to find potential new treatments or treatment plans.  By 
learning a patient representation of EHR codes as opposed to primarily manually 
featured engineered features, we can learn new risk factors for predicting multiple tasks, 
including opioid misuse, in a general and overly complex cohort of opioid users. 
Shown in the k-means clusters, patient representations can be grouped into subtypes 
that can be beneficial to individual treatment plans and policymakers for complex patient 
populations.   
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Automated Engineering for Health Smart
Homes: Find a Way in the Jungle of
Assistance Systems
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Abstract. Health Smart Homes are a promising part of digital personalized health
care. However, engineering of the underlying residential assistance systems is a
complex process that needs to be supported by computer-based design tools. This
paper presents a formal definition for the engineering task and proposes a method-
ology for model-driven design process automation, that is implemented in a web-
based pilot application. Using this approach for design support, the challenge to
efficiently compose personalized assistance systems for patients can be coped with
in the future, which reduces a major barrier for smart home assistance applications.
Keywords. Ambient Assisted Living, Health Smart Home, Digital Personalized
Health, Interoperability, Telemedicine, Telehealth
1. Introduction
As a promising part of digital personalized health care, Health Smart Homes (HSH) [1,2]
combine concepts from Smart Home, Ambient Assisted Living (AAL), and Telemedicine
[3], aiming to improve the quality of health care delivery [4, 5]. Yet, a significant prolif-
eration of HSH technology into real-world applications is still missing [6,7], largely due
to ineffectiveness of system design [8]. The range of available assistance components is
overwhelming and these components are not always compatible with each other [4, 9].
Even professional planners are not able to chart the area of assistance solutions com-
prehensively, as they can only be familiar with a small number of components. Thus,
engineers, patients and health care providers are tangled up in navigating the confus-
ing “jungle” of assistance solutions. They require support for component selection and
composition in order to tailor assistance systems to patient needs.
We envision an automated design approach that takes patient requirements and needs
into account and identifies several suggestions that each fulfill the patient’s individual
demand for technical support [9]. As a prerequisite for this vision, this paper presents a
formal definition for the engineering task and proposes a methodology for model-driven
design process automation.
1Corresponding author, e-mail: bastian.wollschlaeger@tu-dresden.de.
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The remainder of the paper is structured as follows: The next section infers require-
ments for a design methodology and discusses related work for HSH engineering. The
proposed new methodology is presented in Section 3, after introducing a formal problem
definition for the engineering task. Section 4 discusses the methodology based on a pilot
application. Finally, Section 5 summarizes the paper and provides further research areas.
2. Related Work
A design methodology needs to meet the following requirements: Req. A) Efficiency and
Sustainability allows the methodology to incorporate the re-use of existing components.
Req. B) Allowing for individual Customizability states that fine-grained customization
capabilities are required [1, 10]. Since manually exploring the design space is not feasi-
ble due to a large number of potential solutions, Req. C) Capability of Automation de-
mands the automation of key processing steps of the design methodology. Considering
the variety of possible solutions, determining the most suitable solution will involve mul-
tiple criteria (such as costs, installation and maintenance effort). Thus, Req. D) Multiple
Solutions states that a design methodology needs to be able to offer a "design space"
containing possible alternative designs [11].
Nowadays, HSH systems are often developed from scratch as monolithic systems
(one-off approach) [6, 12], applying generic high-level methodologies such as model-
driven approaches (MDA). While this allows for a precise customization, these ap-
proaches become inefficient [11] as they incur an high effort for system design. Alter-
natively, HSH are sometimes designed based on coarse-grain bundles of existing modu-
lar components (bundle approach) [10], in an attempt to achieve a rudimentary level of
customization with lower design effort. However, given the diversity of assistance solu-
tions [9], the bundle approach does not allow a sufficiently fine-grained customization.
Integration-focused approaches rely on standardization of data exchange, integration
frameworks or plug-and-play mechanisms when composing systems from components-
off-the-shelf [6]. Yet, while this reduces interoperability issues [1], selection of compo-
nents and communication planning still needs to be done manually.
As a consequence, there is a need for a new methodology that is capable of fulfilling
Req. A) to D), especially providing individual customization capabilities in combination
with an efficient design approach.
3. Automated Engineering of Health Smart Homes
3.1. Formal Task Definition
The task in HSH engineering is to design a suitable assistance system by selecting and
composing assistance components to Candidate Solutions HSHcand in order to meet the
set of requirements posed by the HSH occupant (Condition Portfolio HSHreq ). The de-
sign process builds upon a Knowledge Base HSHKB containing the vocabularies of user
requirements, assistance functions and assistance components [13] as well as their inter-
dependencies. This task description can be formalized as follows:
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Definition 1 Knowledge Base: Let be: (i) Rˆ the universal set of user requirements; (ii) Fˆ
the universal set of assistance functionality; (iii) Cˆ the universal set of assistance com-
ponents; (iv) Tˆ the universal set of semantic types of the information exchangeable by
assistance components; (v) Rf ⊆ Rˆ the set of user requirements satisfied by each assis-
tance functionality f ∈ Fˆ; (vi) Fc ⊆ Fˆ one set of realized assistance functions for each
assistance component c ∈ Cˆ; (vii) then the knowledge base for HSH design is defined as
HSHKB = (Rˆ, Fˆ, Cˆ, Tˆ,
⋃
Rf ,
⋃
Fc)2.
Definition 2 Condition Portfolio: The patient’s condition portfolio is defined as a subset
R of user requirements s. t. HSHreq = R⊆ Rˆ.
Definition 3 Candidate Solution: Let be: (i) C the multi set of selected assistance com-
ponents, with ∀c ∈ C : c ∈ Cˆ; (ii) B the multi set of bindings (i. e. communication re-
lations) modeling the information exchange between assistance components, with each
binding b = (co,ci,T) ∈ B defined by the tuple of the information output and input com-
ponents co and ci, and the set T ⊆ Tˆ of information types of the exchanged data; (iii) then
a candidate solution of a HSH is defined as HSHcand = (C,B).
Definition 4 HSH Engineering Task: Given the input of: (i) HSHKB a knowledge base
for HSH engineering and (ii) HSHreq a specific patient condition portfolio, the goal
of the HSH engineering task is to find the set C of valid candidate solutions HSHcand
with validity of a candidate solution HSHcand = (C,B) ∈ C meaning that all patient
requirements are met by the candidate solution: R⊆⋃c∈C
⋃
f∈Fc Rf .
3.2. Engineering Methodology for Health Smart Homes
Following the MDA paradigm to abstract from technology-specific information, we pro-
pose to add an additional technology-independent intermediate layer. As can be seen
from the equation in Def. 4, when determining the validity of the candidate solutions,
an intermediate step is taken to relate assistance components C to the requirements R. In
accordance to this observation, a suitable intermediate model layer consists of an infor-
mation flow graph containing technology-independent assistance functions F:
Definition 5 HSH System Specification: Let be: (i) F the multi set of required assistance
functionality, with ∀f ∈ F : f ∈ Fˆ; (ii) L the multi set of links modeling the information
exchange between assistance functions, with each link l = (fo, fi,T) ∈ L defined by the
tuple of the information output and input functions fo and fi, and the set T ⊆ Tˆ of abstract
information types of the exchanged information; (iii) then a system specification for HSH
is defined as HSHspec = (F,L).
With the introduction of the intermediate model layer HSHspec , the design task can
be split into Step 1) Computation of HSH system specification, which yields technology-
and vendor-neutral formalized specifications for the HSH, and Step 2) Materializing the
specification with assistance components, which in turn yields several design suggestions
(Figure 1). The different design alternatives may now be inspected in order to determine
the most promising design proposition. As this depends on planner’s experience and
2For readability we do not write the index for unions/sums that are unambiguous, i. e.
⋃
Fc =
⋃
c∈Cˆ Fc.
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Figure 1. HSH engineering task and methodology of Automated Design for HSH
involves assessing additional criteria (e. g. costs) not modeled here and the decision may
be rooted in the planner’s experience, making the final decision is out of scope of this
methodology and needs to be made in close collaboration with the patient.
4. Prototype and Discussion
To show the feasibility of the methodology, a pilot application has been implemented as
a web-based suggestion system for AAL counselors, intended to facilitate the design and
tailoring process of HSH solutions during patient consultation. After an interview-style
analysis of user requirements, appropriate assistance functionality is determined. Finally,
suitable assistance components are suggested to the AAL counselor and patient.
By composing existing assistance components based on their functionality, the pre-
sented methodology is able to efficiently provide several system proposals without the
need for labor-intensively developing assistance systems from scratch. It therefore meets
Req. A) Efficiency and Sustainability. Since the methodology is based on formal sets of
user requirements, assistance functions and assistance component functionality, it can
be supported by computer-based tools, fulfilling Req. C) Capability of Automation. The
application of computer-based tools furthermore allows for an efficient exploration of
the design space. The methodology is thus able to meet Req. D) Multiple Solutions. Fi-
nally, the input for the proposed design process is not confined to a fixed set of coarse
patient types, but rather features a detailed vocabulary Rˆ of possible user requirements
and patient conditions, which in the pilot application have been identified according to
personas and insights of health care providers. Thus, a fine-grained customization of the
assistance systems is possible, fulfilling Req. B) Allowing for individual Customizability.
Compared to the engineering methods one-off and bundle approach discussed in Sec-
tion 2, the proposed methodology allows for an efficient exploration of the design space,
thus lowering the overall costs of HSH engineering. Subsequently, integration-focused
approaches can be applied for realization of the selected system design.
5. Conclusion
One major barrier for the proliferation of assistance systems in the context of smart
homes is the tedious and ineffective design process. This paper proposed a model-based
methodology for the automated engineering of HSH, enabling re-use of existing assis-
tance components as well as fine-grained customization of the resulting assistance sys-
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tems. By splitting the design task introducing a technology-neutral intermediate layer
for system specification, the overall engineering task becomes more manageable and an
abstraction from technology-specific information can be achieved.
Next steps include a further investigation into functional component models to en-
sure that the broad variety of real-world assistance functionality can be adequately mod-
eled. Similarly, refining the universal set Rˆ as well as optimizing the algorithm for design
candidate identification are important tasks. Finally, tool-support for the actual process
of functional component modeling shall reduce the impediments for component manu-
facturers to provide high-quality functional component models.
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Abstract. We measured the first time the number of prescriptions in Finland by 
using a centralized national shared repository of e-prescriptions and their dispensing 
data. This was made possible by introducing two policy interventions that were 
effective since 1 January 2017: mandatory e-prescribing and extension of a 
prescription’s valid period from 12 months to two years. The trend in recording e-
prescriptions started decreasing since the ‘big bang’, but pharmacy dispensations 
were not affected, as followed up to September 2019. It is possible to monitor the 
effects of health policy interventions by utilizing national e-health data systems, 
especially at the occurrence of a natural experiment. 
Keywords. Electronic prescribing, large-scale interventions, health policy analysis, 
national data repositories, eHealth, Kanta services, Finland 
1. Introduction 
Successful nationwide e-health services, such as electronic prescription service, across 
different health systems in various countries or regions, can provide valuable 
information for authorities that have yet to launch these services [1,2].  
In Finland, implementation and adoption of the national Kanta services have been 
carried out in phases step-by-step since May 2010 [3]. Electronic prescriptions (e-
prescriptions) are part of the national data system services for healthcare, pharmacies, 
citizens and social welfare service providers. A fully operational and nationwide shared 
Prescription Centre has been mandated by law to be implemented in all community 
pharmacies (2012), in public healthcare (2013), and private healthcare (2015). Finnish 
community pharmacies started to dispense e-prescriptions in 2012. A web service for 
physicians and dentists for the issuing of e-prescriptions (Kelain) was launched in 
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September 2016. First, in Europe, Finnish citizens could use their e-prescriptions to 
purchase medication that is dispensed in Estonia (since January 2019) and Croatia (since 
June 2019). 
In the 2007 e-health roadmap [4], Finland chose to ensure the availability of 
information for patients undergoing treatment, regardless of time and place, in both 
public and private healthcare. Second, Finland chose to enable the participation of 
citizens and patients and to ensure that citizens have access to more information, 
including high-quality health information. These strategic choices are also reflected in 
the decisions to introduce the national e-prescription system, Prescription Centre, and 
citizens’ access to their health data and e-prescriptions in May 2010. 
Finland is a sparsely populated country of 5.5 million inhabitants. In the eastern and 
northern parts of the country, the population density is especially low, and distances are 
long. A large number of small municipalities have big responsibilities that include 
providing both healthcare and social welfare services, which is a unique characteristic of 
the Finnish healthcare and social welfare system [5,6]. The Finnish health system is 
highly decentralized and performs rather well, with users expressing comparatively high 
levels of satisfaction with the quality of services. 
Patients are offered access to their health data on a national level only in few 
countries, such as Australia, Canada, Denmark, Estonia, Finland, France, Iceland, New 
Zealand, Norway, Scotland, Singapore and Sweden [7]. In Finland, community 
pharmacy customers are familiar and very satisfied with the national e-health service for 
viewing their e-prescriptions [8,9]. General practitioners in Finland report that e-
prescribing has improved their patient medication management [10,11]. By introducing a 
nationwide e-prescription and a centralized shared Prescription Centre, Finnish citizens 
are provided with direct online access to their complete prescription data. 
The introduction of a mandatory e-prescribing did not come as a surprise to 
healthcare actors in Finland. It was discussed lively during Parliament committee 
hearings in early spring 2014 when Parliament accepted a two-stage introduction of the 
mandatory e-prescription for the private sector. Since 2017, all public and most private 
healthcare providers have subscribed and use the Prescription Centre’s services. At the 
same time, the valid period of a prescription was extended to two years. 
The administrative nationwide ‘big bang’ change of 1 January 2017 was essentially 
constructed on top of a ‘blueprint’ plan. These large-scale healthcare changes provided 
us with the first opportunity to measure prescription volume in Finland, and how 
healthcare professionals (physicians and dentists) learn to use new ways to issue e-
prescriptions in their care and cure processes. 
2. Material and Method 
The Prescription Centre is a national centralized and shared repository of e-prescriptions 
and their dispensing data. Since January 2017, community pharmacies record paper or 
telephone prescriptions into the repository (100% coverage). 
We extracted prospective monthly indicator data in aggregate form from May 2010 
to September 2019. Based on numbers of medication dispensations at community 
pharmacies in the Finnish Statistics on Medicines, it is estimated that Prescription Centre 
data was 90% complete in 2015, 95% complete in 2016 and 100% complete after that. 
Variation in monthly numbers of e-prescriptions and their dispensing events was 
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smoothed by using a 3-month moving average. In annual calculations of number of 
persons, one personal identification code was included only once. 
3. Results 
Totally 162.90 million (M) e-prescriptions and 297.15M dispensations were recorded 
into the Prescription Centre from May 2010 to December 2018. Altogether 4.34M 
persons received an e-prescription in 2017 and 4.38M in 2018. 
3.1. Medication dispensations in 2015–2019 
Numbers of dispensations from e-prescriptions were 49.03M in 2015 (90% coverage; 
estimate corrected as 54.48M), 55.12M in 2016 (95% coverage; estimate corrected as 
58.12M), 61.39M in 2017 and 64.42M in 2018. An estimated corresponding figure in 
2019 would be 65.82M. Monthly numbers of dispensations in community pharmacies in 
Finland, smoothed by using a 3-month moving average, are presented in Figure 1. The 
trend curve shows an overall increasing time series, and some signs according to which 
monthly dispensation number vary on average 5.5M dispensations per month. 
 
 
Figure 1. Monthly time series of dispensing events and e-prescriptions from the national Prescription Centre 
service launch in May 2010 to September 2019 in Finland. 
3.2. E-Prescriptions in 2015–2019 
Numbers of e-prescriptions were 27.93M in 2015 (if 90% coverage, corrected as 
31.03M), 29.61M in 2016 (if 95% coverage, corrected as 32.90M), 31.91M in 2017 and 
28.29M in 2018. An estimated corresponding figure in 2019 would be 29.13 M. Annual 
numbers of recorded e-prescriptions present an increasing trend in 2015–2016, given 
estimates for 2015–2016 were correct, and a decreasing trend in 2017–2019, given that 
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the estimate for 2019 was correct. Monthly numbers of recorded e-prescriptions into the 
national Prescription Centre trend curve shows an overall increasing time series for 
2015–2016 and an overall decreasing time series for 2017 onwards (Figure 1). The trend 
curve also describes an annual decrease of e-prescription recordings in June–July, 
common summer holiday months in Finland. 
3.3. Paper and telephone e-prescriptions in 2017–2018 
Numbers of paper and telephone prescriptions recorded at the community pharmacies 
were 0.404M in 2017 (1.26% of all prescriptions) and 0.384M in 2018 (1.23%). The 
numbers were highest (on average 37,000 per month) in the first quarter of 2017 but 
decreased towards end-2018 being on average 31,000 per month during the last quarter 
in 2018. During 2017–2018, a third of the prescriptions recorded at pharmacies were 
issued via telephone and two-thirds were paper prescriptions. If one issues a paper or 
telephone prescription, the reason for action must be recorded. Legal categories include a 
technical system failure (80% of the reasons) and an emergent need for medication 
(12.5% on average). The other reasons’ proportion decreased from 10% in 2017 to 5% in 
2018. 
3.4. E-Prescriptions via Kelain web service in 2016–2019 
The Kelain web service was launched in September 2016. Using Kelain, the number of 
e-prescriptions issued was 0.020M in 2016, whereas 0.322M in 2017 and 0.301M in 
2018. Monthly numbers rose rapidly to 25,000–30,000 but have since decreased to 
current 20,000–25,000 level. Comparing numbers of paper prescriptions recorded at 
pharmacies to those of Kelain web service, it seems that Kelain has taken volumes from 
paper prescriptions in general. The number of registered Kelain users rose rapidly from 
10,000 in early-2017 to current 18,600 in September 2019. The latest number is 
approximately 50% of the physicians and dentists in Finland. 
4. Discussion and Conclusions 
We measured the first time number of prescriptions in Finland in 2017 by using national 
e-health data systems (e.g., Prescription Centre). We were also able to monitor the 
effects of two simultaneously introduced policy interventions, mandatory use of e-
prescribing and extension of a prescription’s valid period for up to two years. The trend 
in recording e-prescriptions decreased since the ‘big bang’, but pharmacy dispensations 
were not affected, and this followed up to September 2019. 
From a clinician’s point of view, e-prescription has brought several welcomed 
changes. The extended 2-year valid period has reduced amounts of prescription renewals, 
especially among patients reviewed to be in a stable state, such as steady hypertension. 
In general, e-prescription is seen as a valuable asset among clinician peers. Physicians 
can check all the patient’s prescriptions through Kanta, and several electronic patient 
record (EPR) systems are also able to search for and inform the physician on drug 
interactions otherwise overlooked. The most common complaint heard among peers is 
that sometimes renewing prescriptions is a labour-intensive process. However, this 
process varies between EPRs’ process designs. Citizens’ access to their e-prescriptions 
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via national My Kanta Pages has also brought possibility for patients to send prescription 
renewal requests straight to physicians with no accessory contact to their respective 
healthcare site. With known patients, this reduces the amount of work for a physician. 
As a downside, this also allows patients to request renewals of prescriptions that are 
meant for short-term use or prescriptions that require contact to a physician, such as 
antibiotics, corticosteroids or central nervous system medication. Prescription renewal 
requests are usually directed to public primary healthcare which may require additional 
work to be done there. 
Large-scale changes (such as described in this paper) allow, at least in theory, for 
dealing with interrelated elements of a policy. However, such reforms are rare [12]. The 
outcomes of policy reforms depend on the integration of scale and pace, the intersection 
of which yields basically four possibilities: rapid enactment of large-scale change (‘a big 
bang’), step-wise enactment of large-scale change (‘a blueprint’), rapid enactment of 
multiple small-scale changes (‘a mosaic’) or piecemeal enactment of small-scale changes 
over time (incrementalism). In our case, we first introduced a step-wise enactment of a 
large-scale change by introducing e-prescription and national Prescription Centre 
services. In the second stage, based on the results of the implementation, adoption and 
large-scale use of the Prescription Centre, we were able to change healthcare system and 
professionals to start using e-prescriptions all over Finland since one date (1 January 
2017). 
In conclusion, it is possible to introduce large-scale, national, centralized, integrated 
and shared e-prescription service that is implemented and widely in sustainable use in a 
country. Full e-prescription coverage (100%) can be used to monitor and evaluate 
various medication interventions or administrative changes in real-time. 
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Abstract. Despite recommendations for the routine HIV testing of all sexually 
active individuals, a significant percentage of HIV-positive adults are unaware of 
their HIV status. Therefore, a number of strategies have been implemented to 
expand HIV testing, which in turn makes it necessary to develop tools for identifying 
patients with unknown HIV status. This study presents the results of an external 
validation of an electronic phenotyping algorithm for identifying HIV status and its 
application on a retrospective cohort in order to explore temporal trends of HIV 
knowledge status and associated factors. 
Keywords. HIV, universal HIV testing, electronic phenotyping algorithm, external 
validation 
1. Introduction  
The early detection and treatment of human immunodeficiency virus (HIV) infection in 
its early stages has been shown to have a number of benefits at the both the individual 
and social level, not only because it decreases the risk of progression to acquired 
immunodeficiency syndrome (AIDS), but also because it diminishes the risk of sexual 
and perinatal transmission[1]. Based on these findings, the U.S Preventive Service Task 
and Force (USPSTF) recommends that clinicians test patients aged 15 to 65 years for 
HIV infection, as well as all pregnant women regardless of age, whether or not 
behavioural risk factors have been reported[6]. Nonetheless, a significant percentage of 
HIV-positive adults are unaware of their HIV status (18% internationally and 30% within 
Argentina) [3]. Thus, a number of methods have been developed to detect patients with 
unknown HIV status. Although self-report has been widely used, the validity of this 
method has been called into question given that patients may not recall whether or not 
they have previously been tested[5]. Therefore, alternative methods based on information 
available in clinical records have been designed. Nonetheless, although electronic 
medical records (EMRs) facilitate the search for HIV-positive patients, who tend to be 
easily identifiable through laboratory data, the identification of patients with unknown 
HIV status is more complex since there is currently no reliable method for assigning a 
patient to that category. Accordingly, unknown HIV status should be inferred from the 
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absence of information identifying a patient as HIV-positive or HIV-negative. Based on 
this assumption, Felsen et al. [4] developed a rule-based algorithm for electronic 
phenotyping based on electronic medical records in order to classify patients by their 
HIV status. The algorithm’s accuracy for identifying patients with unknown HIV status 
was assessed by comparing the results to a manual review. Its sensitivity and specificity 
were 99.4% (95% CI: 96.5-100%) and 95.2% (95% CI: 83.8-99.4%) respectively. 
Despite the fact that the development of EMR-based algorithms has become popular in 
recent years, their external validation – that is, their application to populations other than 
those they were initially developed for – is far less common [7]. Thus, we decided to 
externally validate the algorithm developed by Felsen et al. using data obtained from the 
EMR at Hospital Italiano de Buenos Aires (HIBA) and apply it to a cohort of patients to 
explore the temporal trends of HIV status knowledge change and associated factors. The 
two main aims of our study are 1) To locally validate the EMR-based phenotyping 
algorithm for identifying HIV status developed by Felsen et al. and 2) To describe the 
trends over time in the percentage of individuals who know their HIV status among 
patients enrolled in the health insurance plan at HIBA and explore the relationship 
between HIV knowledge status change, sex, age and year of enrollment. 
2. Methods 
For the validation of the phenotyping algorithm, two types of variables were included: 
1) standardized codes linked to HIV/AIDS (used at inpatient, outpatient, and emergency 
department facilities); and 2) laboratory data such as anti-HIV antibodies, western blot, 
viral load, and CD4 cell count. No free-text data was used. The algorithm is shown in 
figure 1. 
 
 
Figure 1. HIV status classification algorithm. VL: Viral load; WB: Western Blot; UD: undetectable; Ab: 
ELISA antibody test. 
Manual chart review was defined as the reference standard. Two family physicians 
analyzed all of the data available in the EMR of each patient. The criteria for classifying 
patients according to their HIV status were as follows: HIV-positive: presence of a 
positive WB, detectable VL, documented HIV infection by a provider, prescription of 
antiretroviral therapy, or mention of infection in narrative text notes; HIV-negative: does 
not meet criteria for HIV-positive, and the presence of a negative western blot or ELISA 
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test for anti-HIV antibodies; Unknown HIV status: does not meet criteria for HIV-
positive or HIV-negative. Assuming that our algorithm would have a sensibility of 99% 
and a specificity of 95.2% – as in Felsen et al. (2014) – a sample size of 300 observations 
was estimated in order to obtain a margin of error of ±0.75% on a 95% confidence 
interval in our test set. 
For the assessment of HIV status temporal trends, we applied the algorithm to all 
the patients enrolled in the insurance plan at the HIBA for at least 12 months aged 15 to 
65 between 1/1/2008 and 31/12/2015, every year at the last day of the year. We measured 
the percentage of HIV status knowledge both per year and cumulative. We also assessed 
the percentage of patients that changed their status over time.  Lastly, using a three year 
follow up sub-cohort of yearly newly enrolled patients (assuming their status before 
enrolment was ‘unknown’), we assessed the time until status change using a cox 
proportional hazards model which allowed us to explore its association with sex, age and 
cohort entry year. All statistical analyses were computed using R. 
3. Results 
When applied to our test set, the algorithm showed similar metrics to those reports by 
the authors [sensitivity 97.25% (92.16 - 99,42); specificity 100% (98.08 - 100), positive 
predictive value 100% (97 - 100) and negative predictive value 98.45% (96 - 100)]. 
regarding HIV knowledge status trends, as it is shown in table 2, ‘known’ HIV status 
(positive + negative results) percentage has been increasing since 2008, mostly due to an 
increasing percentage of negative tests, at a mean increase of 0.6% per year. HIV 
knowledge status change (from ‘unknown’ to ‘known’) appears to be in an upward trend 
since 2013, which coincides with the initial USPSTF recommendation (figure 2). This 
trend seems to be led by young adults (20 – 40 years old). Upon visual inspection of the 
trends between sexes, a higher percentage of women have changed their status to 
‘known’, although men show a steeper curve since 2013. 
Table 2. Patients’ description and HIV knowledge status. 
Year n 
Sex - 
Female 
(%) 
Age 
(median [IQR]) 
Known 
status – 
Negative 
(%) 
Known 
status –
Positive 
(%) 
Unknown 
status 
(%) 
At least one 
HIV test 
since 2008 
(%) 
Newly 
enrolled 
(%) 
2008 89481 
49340 
(55.1) 
40.00 
[29.00, 54.00] 
6164 
(6.9) 
234 
(0.3) 
83083 
(92.8) 
19082 
(21.3) 
11352 
(12.7) 
2009 90621 
49977 
(55.1) 
40.00 
[29.00, 54.00] 
6393 
( 7.1) 
240 
(0.3) 
83988 
(92.7) 
20892 
(23.1) 
9703 
(10.7) 
2010 91812 
50656 
(55.2) 
40.00 
[30.00, 54.00] 
6633 
(7.2) 
115 
(0.1) 
85064 
(92.7) 
22732 
(24.8) 
9346 
(10.2) 
2011 86416 
48793 
(56.5) 
42.00 
[31.00, 55.00] 
6912 
(8.0) 
126 
(0.1) 
79378 
(91.9) 
23601 
(27.3) 
9655 
(11.2) 
2012 89089 
50167 
(56.3) 
41.00 
[31.00, 55.00] 
7228 
(8.1) 
160 
(0.2) 
81701 
(91.7) 
25591 
(28.7) 
9966 
(11.2) 
2013 89540 
50291 
(56.2) 
42.00 
[31.00, 55.00] 
7761 
(8.7) 
161 
(0.2) 
81618 
(91.2) 
27498 
(30.7) 
8028 
(9.0) 
2014 89080 
49773 
(55.9) 
42.00 
[31.00, 55.00] 
8726 
(9.8) 
150 
(0.2) 
80204 
(90.0) 
29591 
(33.2) 
7139 
(8.0) 
2015 89072 
49527 
(55.6) 
42.00 
[31.00, 54.00] 
9981 
(11.2) 
155 
(0.2) 
78936 
(88.6) 
32321 
(36.3) 
7257 
(8.1) 
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Figure 2. HIV knowledge status change. 
 Figure 3 and 4 show a clear and independent association between sex, age, cohort 
entry year and time until status change. Cohort entry year shows to be strongly associated 
with a higher proportion of patients who changed their status from ‘unknown’ to ‘known’ 
after the three years of follow up. This association seems stronger for every year 
compared with 2008, as is shown by the increasing hazard ratios. 
 
 
Figure 3. Unadjusted survival curves for time until HIV knowledge status change in the 3-year follow up sub-
cohort of newly enrolled patients. 
 
 Figure 4. Hazard ratios from Cox proportional hazards model exploring the association between time until 
HIV knowledge status change, age, sex and cohort entry year in the 3-year follow up sub-cohort of newly 
enrolled patients. 
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4. Discussion 
When applied to our population, the performance characteristics of the original algorithm 
were similar to those initially reported by the authors. EMRs combined with validated 
algorithms provide a useful source of information for monitoring temporal trends. 
In our results, patients between 20 and 40 years of age, showed to be consistently 
more likely to have at least one HIV test and thus change their HIV knowledge status 
from ‘unknown’ to ‘known’. This, combined with the overall upward trend of status 
change over the years that we found, is promising for the future given the clear benefits 
of early diagnosis that have been demonstrated over the last decade[1]. Nevertheless, the 
lower proportion of older adults that have had access to an HIV test in our study 
population is of concern given the higher comorbidity and mortality associated to older 
adults with delayed HIV diagnosis[2]. 
5. Conclusion 
We were able to validate the algorithm developed by Felsen et al. in our population, 
which showed to have similar performance metrics as the ones reported the authors. 
When applied to our cohort, we found that HIV status knowledge change has been 
increasing, particularly since 2013 and that it seems to be independently associated with 
sex, age and cohort entry year. 
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Abstract. Global public health surveillance relies on reporting structures and trans- 
mission of trustworthy health reports. But in practice, these processes may not al- 
ways be fast enough, or are hindered by procedural, technical, or political barriers. 
GPHIN, the Global Public Health Intelligence Network, was designed in the late 
1990s to scour mainstream news for health events, as that travels faster and more 
freely. This paper outlines the next generation of GPHIN, which went live in 2017, 
and reports on design decisions underpinning its new functions and innovations. 
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1. Introduction 
Global public health surveillance relies on reporting structures and transmission of trust- 
worthy health reports. But in practice, these processes may not always be fast enough, or 
are hindered by procedural, technical, or political barriers. At the same time, the news 
travels much faster and more freely, certainly in this day and age. Recognizing that, 
Public Health Agency of Canada has been operating the Global Public Health 
Intelligence Network (GPHIN) since 1997, designed around capturing mainstream media 
stories from around the world, analyzing them, and then disseminating the insights 
globally, through WHO, for rapid responses such as initiating treatment and vaccination 
efforts, and slowing spread through travel advisories and port-of-entry screening. 
This paper describes the efforts and results from the GPHIN rejuvenation project.1 It 
provides an overview of the (added) functionalities, design decisions, and high-level 
implementation details. It also aims to inspire readers that are looking to extend these 
ideas to other types of real-time, broad scope surveillance efforts in life sciences. 
2. Background 
For a detailed overview of disease surveillance principles and systems, we refer to review 
papers on this topic. Abat et al. in their 2016 review paper [1] put multiple syndromic 
surveillance efforts in perspective, citing multiple data sources from the environment 
(including weather and animal data), population behaviours (including drug sales and 
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inter- net use), health care (clinics and hospitals), and demographics. We note that 
mainstream media was not considered in this review. Barboza et al. [2] analyzed several 
earlier bio- surveillance systems and concluded that they are indeed generally effective at 
publishing information about infectious diseases using news media compared to a 
goldstandard. 
In addition to human disease surveillance, there are monitoring systems for live- 
stock health that can inspire us. Lower privacy concerns surrounding animals have con- 
tributed to quicker advancements of such systems. Additionally, problems with livestock 
health can lead to human health concerns downstream, as animals can function as hu- 
man disease vectors, and livestock epidemics can affect the human food supply chain 
[9]. EpidVis [7] is one such initiative that combines news collection with compelling 
visualizations for animal epidemiology. 
GeoSentinel is a syndromic surveillance network that collects and disseminates re- 
ports on sicknesses in travellers. The information can inform pre-travel preparation, as 
well as guide post-travel differential diagnosis when a recent traveller has fallen ill [8]. 
The first version of GPHIN was conceived in the late 1990s, and soon proved its 
worth by enabling early detection of the 2003 SARS outbreak [6]. While the premise of 
the system remained relevant, advancements in software technology and data processing 
methods warranted a ground-up rejuvenation effort, which this paper reports on. 
3. Methods and Results 
The base architecture of GPHIN involves data intake, data processing, information 
storage, and interactive user tools [3]. In many cases, third-party or off-the-shelf 
components are used. Data originates from multiple sources, the majority of articles 
arriving through a large media aggregation service, others through curated RSS feeds – 
news sites, public health organizations, product recalls, and some high-relevance 
epidemiological (micro)blogs. Processed and tagged data are then stored in a relational 
database and also in an off-the-shelf full-text search tool, for analysts to search, retrieve, 
and digest. 
A number of innovations were implemented. We highlight several of these in the 
following paragraphs, starting with its multilingual capabilities, including translation. 
Multiple languages: GPHIN is a global effort, and as it uses local-level mainstream 
media signals, it must be able to process multiple languages. GPHIN processes data in ten 
languages: English, French, Spanish, Portuguese, Russian, Arabic, Farsi, Simplified and 
Traditional Chinese, and Indonesian – covering logograph, abjad and alphabet scripts and 
covering both left-to-right and right-to-left languages. Text analytics takes place partly in 
the language of origin (keyphrase extraction from restricted phrase lists), partly based on 
English machine-translations of the source document. Pragmatically, the Microsoft 
Azure Translate API was selected to detect the language of source material and translate 
it to English. These translations are somewhat noisy, and are never used as full substitutes 
to the source text, but even lossy translation can inform human analysts as well as various 
machine analytics components such as classifiers. Occasionally, downstream problems 
such as ambiguity can be averted by using modern context-sensitive machine translation 
algorithms: for example, the Chinese character can mean twenty-first, the family name 
Ma, or horse, and only one meaning is relevant when tracking equine diseases. 
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Relevance scoring is a function that discriminates first-line reports from background 
stories, retrospectives, opinions, policy documents, or any story that was accidentally 
caught by the aggregator service (e.g., “Bieber fever”). The technique is implemented as 
a binary classifier but with a confidence estimate that allows for ranking and flexible 
threshold setting. The classifier [5] is built around a machine learning classifier (SVM) 
using a set of approximately 1400 documents represented as unrestricted word and 
character n-grams. Articles with a high relevance score are published immediately, while 
low-scoring articles are automatically suppressed; only the remaining medium-relevance 
articles are triaged by analysts. 
Information extraction: Medical terms in text are detected and mapped to UMLS by 
MetaMap Lite. The tool is restricted to a set of semantic types that is generally relevant 
to the public health community – largely syndromes and disease vectors. Subsequently, a 
hand-curated blacklist of common false positive terms is applied. The resulting 
annotations inform downstream components such as clinical reasoning, and links to 
UMLS definitions and ontology elements are provided next to articles. General named 
entities, such as person and organization names, are tagged using Stanford CoreNLP’s 
named entity recognizer. Heuristics were created to infer people’s job titles when 
mentioned, as well as to consolidate organizations’ full names and acronyms. 
Geographic entity resolution: One part of situational awareness is knowing precisely 
where things are happening. We use Stanford CoreNLP’s named entity recognition plus 
heuristics to resolve mentions of geographic entities (countries, states/provinces, 
cities/towns, some lakes, some regions) to latitude-longitude coordinates and to 
canonical forms in the Geonames ontology so that they can be counted and mapped, 
collecting synonymous mentions of places and inferring parent-child relationships. When 
large outlets report on Tokyo or New York, local news sites may specify the sub-city 
(Yokohama or Shinjuku; Queens or Tribeca). A search in GPHIN for Tokyo will include 
all sub-cities, which makes it easier to synthesize very local media from a global 
perspective. This function also reconciles synonyms and language differences, 
coalescing multiple spellings/forms into a single known entity. Non-unique place names 
(e.g. London, UK versus London, Ontario, Canada) are resolved through heuristics that 
take into ac- count where an article was published. Geo-tagging allows users to quickly 
drill into de- tails about the geography of a document, checking population sizes, median 
age, poverty rates, and human development index measurements, for example. 
Deduplication: Near-duplicate reports on the same incident are unavoidable when 
many media outlets republish newswire articles verbatim. To avoid duplicate stories hi- 
jacking trend detection algorithms, a duplicate detection algorithm was devised. The 
technique is built on two main principles: text edit distance, where a certain percentage 
of the word triplets in the article must be the same; and shingling, an observation that if 
all possible three- or four-word phrases are randomly assigned a number, sorting and 
sampling the set of such unique numbers for the phrases in two documents produces a 
substantially similar sample for documents that are similar but not necessarily identical. 
This solves the challenges like editors lightly rewording newswire articles for space 
constraints and adding/removing extra paragraphs of context at the end of an article. 
Duplicates are not removed but clustered / flagged as such, and the initial version among 
candidate duplicates is used as the exemplar. Minor but critical differences, such as an 
updated death count, are extracted using StructPred and tracked separately. 
Narrative discovery and change point detection: On a daily basis, it looks for 
statistically unusual pairs of non-generic ontology keywords plus locations, and 
publishes these in a list of new “narratives”. As new articles come in to the system that 
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match each such pair of keyword plus location, it aggregates the content and tracks the 
narrative. While GPHIN may ingest as many as 10 000 new articles in a given day, the 
number of new narratives tends to be between 20 to 50 daily, which is small enough for 
an analyst to digest. For narratives that span at least several days, GPHIN applies topic 
modelling technology [10] to estimate when the language of the narrative is changing – 
when the language of an infectious disease pandemic is changing from uncertain to 
certain, or from investigation to response to rehabilitation, and so on. While GPHIN was 
designed around data streams that carry more noise than permissible for highly sensitive 
aberration detection algorithms, this combination of narrative discovery plus change point 
detection accomplishes a similar goal of trend detection and tracking. 
User interface: The dynamic and faceted nature of the task is supported by a range of 
user interface modes. Figure 1 illustrates some of these. The basic interaction model in 
GPHIN is a set of filtering criteria coordinated with a colour-coded map, a configurable 
bar graph (showing activity over time or top keywords/locations/categories), and a list of 
documents. If a user has a hypothesis to test, a user might compose a search for a tagged 
syndrome in a geographic area, and then drill down by clicking on red hot spots on the 
interactive map or drill down into increasingly specific keywords or combinations thereof 
(Figure 1, left). If the event is a serious outbreak or a mass gathering, there are integrated 
report generation tools to support daily surveillance workflows outside the tool – users 
can tag and collate documents into topical reports, and GPHIN analysts can highlight 
portions of text within documents. Analysts can disseminate their findings via e-mail and 
RSS, while recipients can specify their own alert filters. 
 
Figure 1. Coordinated search, map, and graph tool (left); knowledge graph for a measles outbreak (right) 
GPHIN also supports workflows where the user has no specific hypothesis. The 
recently discovered narratives are listed with recent activity time series graphs, extractive 
summaries [11], and any detected inflection points. A further tool that GPHIN provides to 
try to illustrate surprising correlations is a basic knowledge graph (Figure 1, right), 
placing top keywords, locations, people and medical entities in bubbles. Location bubbles 
are linked when they are geographically adjacent. GPHIN is used primarily for 
monitoring current events in recent news, but also supports retrospective research, 
whether for psychoactive substances [12] or for analysing how media reporting changed 
the behaviour of the general public in the midst of past pandemics [4]. 
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4. Discussion 
GPHIN currently has more than one thousand registered user accounts in 56 countries, 
representing public health, governments at various levels, military, research, education, 
diplomatic, and travel organizations, from global to municipal. Aside from day-to-day 
syndromic surveillance activities, GPHIN was used for specific mass gatherings and 
summits (Olympics, G7), as these tend to come with exceptional volumes and directions 
of human (and therefore disease) travel. Surrounding the 2016 summer Olympic Games 
in Rio de Janeiro, WHO epidemiologists were not just concerned about Zika, but also 
that an ongoing MERS outbreak in the Middle East might migrate to Rio. 
As domain knowledge was kept separate from the software code, we have since 
expanded the platform to support food safety surveillance (food, animal, and plant 
hazards, for example) and natural disasters in the context of public safety. 
5. Conclusion 
We presented an overview of added functionality to a global syndromic surveillance tool 
that leverages local mainstream media articles, in a range of different languages, to 
provide a rapid and global view to public health officials. 
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Abstract. Online digital tools are considered an innovative method to promote HIV, 
hepatitis and STIs prevention, testing and treatment services, overcoming individual 
and social barriers, especially for younger people and other, possibly hard-to-reach, 
target population groups. In this paper, we introduce INTEGRATE RiskRadar, a 
web and mobile application developed in the scope of the EU-supported 
INTEGRATE Joint Action (JA), that aims to enhance the integration of combination 
prevention, testing and linkage to care for HIV, hepatitis, STIs and tuberculosis by 
providing integrated information and digital tools regarding all four diseases to 
population groups at increased risk, aiming to eliminate the individual and social 
barriers to effective adoption of prevention practices, testing and linkage to care, 
and thus reduce the incidence and burden of these diseases in the European Region. 
Keywords. Human immunodeficiency viruses (HIV), hepatitis, sexually 
transmitted infections (STIs), tuberculosis (TB), integrated approach, prevention, 
combination prevention, testing, linkage to care, eHealth, mHealth. 
1. Introduction 
Despite the fact that the global HIV response has resulted in impressive achievements, 
HIV epidemics continue to have a profound impact on the health and lives of millions of 
people worldwide [1]. At present, the coverage of the HIV services is still inadequate, 
and the rate of their expansion has to be accelerated to meet the 2020 target as well as 
the 2030 sustainable development goals (SDGs). Equally important, one of the key 
challenges is the burden of HIV coinfections, namely sexually transmitted infections 
(STIs), viral hepatitis and tuberculosis (TB), and the impact they have on HIV prevention, 
treatment and the related increasing morbidity and mortality [1]. This calls for the 
implementation of several prevention strategies that, if combined, may have additive and 
synergistic effects on reducing new HIV transmission incidences. Combination 
prevention is the strategic and coordinated use of biomedical, behavioural and 
social/structural activities operating on various levels (individual, community, societal) 
to reinforce the sustained impact of HIV prevention. The World Health Organization 
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(WHO) emphasises that the existing momentum of the HIV response should be bolstered 
by new evidence- and rights-based combination prevention tools that are tailored to the 
needs of specific people and communities, especially those of vulnerable population 
groups that are disproportionately affected by HIV [1]. 
In this context, digital tools are considered an innovative method to promote HIV, 
hepatitis and STIs prevention, testing and treatment and overcome individual and social 
barriers, especially for young people and hard-to-reach target population groups [2], 
given the rapid uptake and ubiquity of smartphones and Internet access in Europe. 
Although notable progress has been achieved recently in the fields of eHealth and 
mHealth, the main focus has been on the management of non-communicable diseases 
(NCDs), rather than infectious ones. While a growing pool of HIV/hepatitis/STIs-related 
apps and online tools exists [3], they mostly target medication adherence and specific 
groups [4]. Several gaps remain in the implementation agenda, e.g. the inclusion of more 
key populations and other points along the care continuum besides treatment [4] [5]. 
In this paper we introduce INTEGRATE RiskRadar, a web-based and mobile application 
developed in the scope of the INTEGRATE joint action (JA), that aims to enhance the 
effectiveness of combination prevention for HIV, hepatitis, STIs and TB. By providing 
integrated information and digital tools regarding all four diseases to the public 
regardless of gender, age, sexual orientation or insurance status, we aim to eliminate the 
individual and social barriers to effective adoption of prevention practices, testing and 
linkage to care, and to thus reduce the incidence and burden of these diseases in EU 
member states. 
 
Figure 1. Overall RiskRadar development process and landing page for Web tool and mobile app. 
2. Methodology 
Our design and development approach focused on the assessment of available relevant 
digital tools to identify promising and innovative features and their consequent 
adaptation to address all four disease areas. The design of this new integrated ICT 
(information and communication technology) toolkit accommodates the distinctive 
needs of various vulnerable groups, i.e., Young adults and men who have sex with men 
(MSM) who adopt new partner-seeking and sexual behaviours [6], might engage in illicit 
drug use [7], report an enhanced need for privacy and anonymity, especially in some 
countries and demand an attractive and modern user interface (UI) [8]. For persons who 
inject drugs (PWID) risk reduction advice is needed, while migrants require a toolkit 
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with mobility and ubiquity to help them acquire an understanding of additional risk 
factors. Finally, prisoners and homeless persons would benefit from an easily accessible, 
fast and simple web interface available at clinics and NGO sites, focusing on risk 
reduction. The RiskRadar development methodology involved three phases (Figure 1). 
2.1. Mapping Exercise 
First, a mapping exercise was conducted, aiming to identify existing ICT resources 
addressing combination prevention strategies worldwide with additional focus on tools 
implemented on a national level in the European region. A "mapping matrix" was 
introduced to align the data collection process, where a specific structure was proposed, 
featuring fields describing the tool, the target audience, the disease(s) addressed and its 
availability. INTEGRATE partners were invited to contribute to this phase by submitting 
any relevant tool they were aware of. The outcomes of the review were harmonised, 
resulting in the complete mapping matrix of ICT tools, consisting of 115 candidates. 
2.2. Evaluation of Existing Tools  
To evaluate the collected tools, we determined the appropriate criteria by analysing the 
matrix and excluding any non-ICT tools such as online guides, manuals or training 
modules. These were flagged for further consideration during the JA's capacity building 
activities. The final list of tools for consideration was reduced to 53 and divided into two 
groups, according to their respective uses in the care continuum, i.e., Group A-
Prevention, containing 29 tools related to prevention, harm reduction and PrEP (pre-
exposure prophylaxis); and Group B-Testing, containing 24 tools related to testing, 
partner notification and linkage to care. A two-fold, more thorough review of these tools 
followed based on the following criteria: (a) perceived relevance and adaptability to the 
JA purposes, and (b) adaptability, reproducibility, and data relevance from a technical 
standpoint, since the vast majority of the tools addressed a single disease. 
The review process identified seven tools that scored high in all criteria, then the 
results were discussed with respect to their strengths, weaknesses and shortcomings with 
the JA steering committee members. An initial proposal for the RiskRadar structure was 
formulated according to the toolkit's intended use, target audiences, and overall scope. 
2.3. RiskRadar Components 
The proposed toolkit features modular components that could be enabled according to 
the capacity and intended target audience. The following components were defined: (a) 
a Factsheets component offering basic information regarding the different diseases; (b) 
a Risk Calculator (RC) tool that allows users to assess if they have been exposed to the 
diseases based on underlying risk assessment algorithms, tailored to each key group's 
needs; (c) a PrEP component to inform the user of this novel prevention tool; (d) a Test 
Finder featuring filtering capabilities per disease, type of point-of-care, and country; (e) 
a Reminders component to help users stay on track with their respective testing 
schedule; (f) a Partner Notification (PN) tool based on the combination of existing 
services, and (g) a TB component offering information and highlighting the differences 
with the other three disease areas in terms of transmission, prevention, and care. 
RiskRadar will be piloted in Croatia, Italy and Lithuania; thus appropriate translations of 
its components have been prepared to accommodate language barriers. 
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Figure 2. (a) Question of the RC component in the web app (upper left part) and question from the RC 
component in the mobile app (lower left part); (b) the result of the RC (right part). 
2.4. Design and Development Considerations 
The main challenge concerned the RC component, since (to the authors' knowledge) a 
comprehensive tool for calculating the inextricable nature of the combined risks for all 
four disease areas tailored to the high-risk key populations consisting RiskRadar's end 
users is missing. A consolidation of all available guidelines by WHO and ECDC 
reinforced the algorithms derived by the previous analysis of the partial risk assessment 
tools for each disease. The RC decision tree resulted from an extensive iterative process 
of obtaining input from all partners, while its final release was approved for official 
translation in the piloting countries' languages. As regards the information components, 
contacts with central information sources were established, such as NAM for the Test 
Finder, "PrEP in Europe" for the PrEP component and ECDC for the factsheets. 
Overall, the design approach relied on (a) effective communication strategies 
outlined by WHO and ECDC, and (b) informed UI design based on the literature findings 
of relevant websites and mobile apps [9]. Emphasis was placed on offering adequate 
information to the user to make informed decisions and possibly adjust risky behaviours 
while keeping users with low health/eHealth literacy engaged with the app. 
3. Results 
RiskRadar is available as a web application and as native Android and iOS mobile apps, 
integrating the various components presented in section 2.3. Overall, our development 
approach was based on the following pillars: (a) easy to update content and (b) adaptable 
content to fit diverse target groups, via a modular design for the RC answers which can 
be independently modified according to the target audience (Figure 2); (c) easy to use, 
intuitive and interactive UI; (d) use of acceptable, non-judgmental, non-threatening and 
non-fear-inducing language and imagery, through an iterative process of consulting with 
various public health institutions and relevant NGOs; (e) patient empowerment by 
providing direct PN services as well as a self-evaluation risk calculator tool, and (f) 
ensure that the user feels safe and also that their trust, privacy, and confidentiality are 
clearly perceived while using the app. The latter is achieved by establishing privacy and 
cookie policies that explicitly state the anonymisation and encryption mechanisms 
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employed, featuring them prominently in the application; namely the use of anonymous, 
unique random codes to access the PN component, the encryption and enhanced security 
during data transfer and the absence of any identifiable information in the RC component. 
Each pilot country targeted different populations. Currently, the pilot sites are 
testing RiskRadar before its release to the public. The outcomes of the pilots will be used 
to evaluate RiskRadar's effectiveness and usability. A short questionnaire was added to 
support pilot exercise, given that it is difficult to evaluate the effectiveness of ICT tools' 
in the prevention of the four diseases. This is because measures such as the number of 
web accesses or downloads do not give a precise measure of the usefulness of ICT tools. 
Nonetheless, RiskRadar has the potential to be an appealing source of information for 
the prevention and testing of these diseases. Especially for people who encounter barriers 
to care, RiskRadar could facilitate entry to and retention in the healthcare system. 
4. Conclusion 
In this paper, we presented the overall approach regarding the design and development 
of an integrated toolkit accessible over the web or a dedicated mobile application, in line 
with the current public health authorities' guidelines. The development of RiskRadar 
exploits the expertise and various insights from INTEGRATE's inter-disciplinary 
consortium, thus enabling the synergy of biomedical and behavioural prevention and 
offers a new level of privacy, confidentiality and security as well as the opportunity to 
satisfy the diverse needs of various target groups at the same time (scalability). 
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Abstract. Administrative claim data is believed as one of the promising data set to 
augment the mandatory surveillance system which suffered from under-reporting 
and delay in reporting. Therefore, this study aims to examine whether the Indonesian 
National Health Insurance (INHI) sample data could complement dengue case-based 
surveillance system in a more practical way. Afterwards, this analysis also identified 
several future opportunities and challenges in improving the dengue surveillance 
system. We utilized the referral care table linked with capitation and non-capitation-
based primary care service table from 2015-2016. Data cleaning, query and 
visualization were performed using Tableau Public and Microsoft Power BI. Result 
shows that dengue referral pattern is indicating the opportunity to detect dengue 
cases in an earlier stage and high utilization of referral care disclose the patient 
behaviour. Therefore, anonymous INHI sample data set potentially to complement 
dengue traditional surveillance system. A huge number of health facilities as data 
providers, bridging and interoperability chance and opportunity of early detection 
are identified as future opportunities. However, we also determine challenges 
involving how to provide the mechanism for the quick and interoperable reporting 
system, how to construct supportive regulation and anticipatory approach regarding 
the change in dengue diagnosis criteria as the implementation of ICD 11 code. Thus, 
practical approaches should be prepared to support the utilization of INHI sample 
data. 
Keywords. Dengue, public health surveillance, claim data, Indonesia 
1. Introduction 
Dengue was identified as the most rapidly spreading vector-borne disease including in 
Indonesia with national incidence rate count for 24.73 per 100,000 population [1, 2]. And 
even has been circulated over 50 years, dengue viruses remain to persist in 440 districts 
or 85.60% of total area and resulting in an immerse burden [2]. Therefore, an adequate 
dengue surveillance system might be a key to tackle the dengue occurrence. 
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But unfortunately, most contributor countries for global dengue infections are suffering 
from poor reporting systems [1] that result in a huge under-reporting issue. Research 
from Bandung, Indonesia, reveals that the adequacy of case reporting was only 45.7% 
[3]. Another problem that encounters with dengue surveillance system in Indonesia is 
the delay in reporting that takes days to month even though dengue cases should be 
reported within 24 hours after confirmed diagnosis [3, 4]. However, adequacy and 
timeliness are important aspects in order to provide a near-real-time response within the 
dengue incubation period. 
Under-reporting and delay in reporting might come because of the absence of the 
integrated reporting system. Dengue reports from hospitals are reported to the district 
health offices with diverse formats through email, online messaging, or paper-based 
reporting system. Then, data from districts are submitted monthly to the province and 
national level with various structures of the report and in aggregate forms. This condition 
may cause dengue control, and prevention programs act too late. Thus, strengthening 
the dengue surveillance system requires a massive effort, including initiatives to 
identify potential data sources that sought the traditional surveillance system. 
Given the widespread implementation of Universal Health Coverage (UHC), many 
studies reveal the novel uses of health claim data to augment the mandatory reporting 
system and provide disease-specific information [5-9]. This approach is potential to be 
examined in Indonesia since UHC has been implemented in 2014, along with the 
implementation of online claim reporting system which covers 221.203.615 members 
and 27.315 health facilities including the private sectors [10, 11]. 
Recently, as part of the open data implementation, the Indonesian Health Insurance 
Agency (IHIA) launched the sample data that record transactional data either in primary 
or secondary health care [12]. These data sets derived from 1.7 million members that 
explained in four relational tables, including membership, capitation, non-capitation- 
based primary health care and referral care table [13]. And even only derived from 1% 
of the total membership in 2015 using stratified random sampling [12], this data set 
contains a relatively short range of data records [14]; still, this data set could be the only 
nationally representative administration data set that is currently available and potentially 
updated yearly. 
Accordingly, this study aims to examine whether INHI sample data could 
complement dengue case-based surveillance system in a more practical way. Previous 
studies defined the usefulness of health claim data using similarity standards with routine 
surveillance systems [5-7]. Nevertheless, assessing whether health insurance claim data 
could provide disease-specific information could be more useful for decision making. 
Hence, this study evaluated the utilization of INHI sample data through assessment of 
dengue specific information related to referral patterns. Afterwards, this analysis also 
identified several future opportunities and challenges in improving the dengue 
surveillance system using INHI sample data. 
2. Method 
This study uses anonymous INHI sample data (2015-2016). In order to provide dengue 
specific information related to referral patterns, we utilized the referral care table linked 
with capitation and non-capitation-based primary care service table. Dengue cases 
included in this analysis were in-patient cases, A91 ICD-10 code and primary visit. The 
patient IDs of dengue cases then were traced in capitation and non-capitation-based 
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primary care service table within seven days before patients were hospitalized. Severity 
level and health outcome then retrieved from referral care table. Data cleaning, query 
and visualization were performed using Tableau Public and Microsoft Power BI to 
illustrate dengue referral patterns. And as a future depiction, we also identified 
opportunities and challenges regarding the utilization of INHI sample data by 
comparing it with current policies on dengue surveillance system applied in Indonesia. 
3. Results 
Five thousand eight hundred ninety-one (5,891) dengue cases from the referral care 
table were obtained during 2015-2016. Within seven days, 1,131 cases (19%) were 
recorded in primary health care both in capitation and non-capitation-based primary 
care service. 13% of those cases then were registered in referral care (outpatient) along 
with 6% of dengue cases that treated immediately in outpatient care. But, most dengue 
cases (75%) were identified as having no interaction with the gatekeeper before 
hospitalized. 
Figure 1. Referral patterns of dengue cases (2015-2016) 
Furthermore, the Sankey diagram illustrated the dengue referral pattern, as shown 
in Figure 1. This graph showed dengue treatment stream linked with severity level and 
health outcome. Sankey diagram showed that most of the dengue cases were identified 
as having no interaction with the gatekeeper before hospitalized even 82% of cases 
were classified as level 1 severity. 
Hereinafter, future opportunities and challenges regarding the utilization of INHI 
sample data are identified and listed in Table.1 
Table 1. Future opportunities and challenges regarding the utilization of INHI sample data 
Num Opportunities Challenges 
1. An increasing number of hospitals are potentially 
providing dengue data as their contribution to the 
UHC system 
How to develop a mechanism for the quick 
and interoperable reporting system 
2. 19% of dengue cases have been detected in primary 
health care, promising the early detection before 
hospitalization 
How to construct regulation involving 
primary health care into the dengue 
surveillance system 
3. IHIA has providing bridging facility between the 
IHIA reporting system (PCare and INA CBGs) 
and health centre information system (Simpus) or 
hospital information system. Therefore, dengue 
cases recorded in gatekeeper and referral care can 
How to anticipate change in dengue 
diagnosis criteria as the implementation 
of ICD 11 code  
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be easily managed cross-platform for surveillance 
purposes 
4. Discussion 
Based on the Sankey diagram provided as a result, this study successfully demonstrated 
that anonymous INHI sample data could provide disease-specific information related to 
dengue referral patterns. Thus, INHI sample data potentially complemented dengue case-
based surveillance systems in a more practical way. Provided information could be used 
for decision making. 
Observed dengue referral patterns indicate two important findings. The first one is 
the opportunity to detect dengue cases earlier before hospitalization as 19% of dengue 
cases have been detected in primary health care. This chance is supported by the bridging 
facility between IHIA reporting system (Primary care or PCare) and public health centre 
information system (Simpus). Therefore, dengue cases recorded in primary health care 
can easily manage cross-platform for surveillance purposes. However, the challenge is 
how to construct regulation that counts primary health care into the dengue reporting 
system. 
Current regulation [15] involves gatekeeper in the system, required them to send 
weekly and monthly dengue cases to district health offices. But decision makings 
related to dengue control and prevention are taken using dengue reports provided by 
referral health care facilities. In fact, involving gatekeeper into the dengue surveillance 
system is not a big through. Since previous regulation has initiated an integrated 
dengue surveillance system that put gatekeeper and referral care as the same level data 
source [16]. Thus, strengthening policies are needed. 
Another significant finding is the massive utilization of referral care discloses the 
patients’ behaviours that tend to access the hospital. It may be caused by the rise of 
literacy level [17] as the knowledge of dengue symptoms, and risk perception play an 
important reason for visiting a doctor [18]. However, it might also an opportunity since 
dengue cases recorded in the IHIA reporting system (Indonesia case-based groups or 
INA CBGs) in hospitals also could be linked with the hospital information systems. 
Hence, dengue cases could be directly imported to the dengue surveillance system 
through data linkage. This approach would potentially shorten the dengue tiered 
reporting system. And as the increasing number of hospitals that contribute to the UHC 
system, it might be a good opportunity since UHC in Indonesia target the national 
coverage in 2023. Consequently, developing a mechanism for quick and interoperable 
reporting systems is required. 
Successful implementation of a simple dengue reporting system has been recorded 
in Taiwan [19], which might be a good example. Minimal reporting steps lead to high 
adherence (99%) to report cases within 24 hours. Thus, dengue surveillance system 
utilizing claim data should be designed simply and facilitated with interoperability 
features between PCare, INA CBGs, Simpus, hospital information system, local, 
provincial and national health offices. 
The latter action is also necessary to help anticipate change in dengue diagnosis 
criteria. Although ICD 11 code was released on June 2018, the INHI sample data still 
makes use of the former ICD 10 code. In the new ICD 11 code, dengue is divided into 
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four different diagnoses [20] which is completely different from the previous 
classification. 
In conclusion, INHI sample data could provide disease-specific information related 
to dengue referral patterns. Therefore, this sample data set potential to complement the 
dengue traditional surveillance system. A huge number of health facilities as data 
providers, bridging and interoperability chance and opportunity of early detection are 
identified as future opportunities. However, we also determine several challenges 
involving how to provide the mechanism for the quick and interoperable reporting 
system, how to construct supportive regulation and anticipatory approach regarding 
change in dengue diagnosis criteria as the implementation of ICD 11 code. Thus, 
practical approaches should be prepared to support the utilization of INHI sample data. 
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Intelligent Tools for Precision Public Health 
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Abstract.  The idea of “precision public health” (PPH) was proposed as an alternative 
to a one-size-fits-all approach to improving population health, which is not always 
effective. PPH aims to develop and apply interventions in a customized way, taking 
into account the detailed information about the target group. To enable the 
implementation of PPH in practice, we are developing an ontology-driven software 
platform that provides: a) access to detailed up-to-date information about population 
health, b) a structured machine-readable repository of evidence about public health 
interventions, and c) a set of intelligent tools to facilitate the assessment of evidence 
transferability, i.e. to determine how well certain interventions fit a given population. 
Keywords. Evidence-informed decision-making, ontology 
1. Introduction 
Public health organizations tend to develop general policies and programs using a one-
size-fits-all approach to improving the health of populations, which is not always effective 
in achieving the desired outcomes. Recently, the idea of “precision public health” (PPH) 
was proposed, where a variety of traits of subpopulations or even communities are 
detected and tracked to enable the development and targeted application of interventions 
that are best suited to that group [1]. This concept of ‘precision’ is borrowed from the more 
familiar context of ‘precision medicine’, which refers to targeting therapy (particularly for 
cancer) using detailed data about individual genomic and other traits on one hand, and 
available evidence on the effectiveness of treatment options in different patients under 
different conditions, on the other hand. At a population scale, PPH similarly aims to use 
the detailed information about a defined population and evidence about the effectiveness 
of available interventions in different populations under different conditions, to precisely 
match an intervention to a population for best results. 
Despite the general appeal of this vision, the computational tools to support the 
implementation of PPH in practice are still lacking. Most PPH frameworks agree on 
prioritizing the development efforts in the three areas: 1) access to detailed population 
health information, 2) access to evidence on health interventions, and 3) tools for 
combining population information and evidence. Artificial intelligence methods, 
including semantic technologies, have the potential to address the challenges in all three 
priority areas of PPH. Using software ontologies to organize both population health 
information and intervention evidence can facilitate access to these resources and support 
the development of intelligent decision-support tools. In the rest of the paper, we first 
introduce our initial work in enhancing access to population health information through 
the Population Health Record (PopHR) project, we then describe the Interventions 
Knowledgebase, which extends PopHR to provide access to evidence about public health 
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interventions, and finally, we discuss future work towards the development of intelligent 
tools for transferability assessment. 
2. Population Health Record 
Just like personalizing therapy in precision medicine, developing targeted public health 
interventions requires the capacity to integrate, analyze, and interpret a growing volume 
of heterogeneous population health data. Decision-makers must have access to timely and 
accurate indicators of population health, including health information about diseases and 
risk factors and information about available resources. Regrettably, state-of-the-art health 
information systems tend to suffer from certain weaknesses in their design and operation, 
including out-of-date static indicators, insufficient spatio-temporal resolution, and limited 
transparency of computational algorithms and data sources. As a result, they do not 
provide sufficient precision in describing populations that could be targets for 
interventions. The PopHR is an ontology-driven web-based software platform that was 
designed to address the shortcomings of the existing systems and provides access to 
comprehensive, timely and detailed information about population health [2].  
In order to collect, align, integrate, and transform data from multiple sources, the 
PopHR relies on a suite of ontologies that encode an explicit semantic framework for 
population health. This framework includes taxonomies of population characteristics, 
diseases, determinants of health, a multiaxial classification of health indicators, spatio-
temporal relations, etc. In addition, it incorporates epidemiological causal knowledge, 
identifying upstream and downstream relationships for different health conditions. The 
PopHR uses this framework to organize and present health indicators in a meaningful way. 
The current version of the PopHR focuses on chronic diseases and their risk factors. With 
partners from the Institut National de Santé Publique du Québec (INSPQ) and funding 
from the Public Health Agency of Canada (PHAC), we are in the process of deploying the 
PopHR in the province of Quebec for routine use by public health professionals. 
By providing access to the detailed population health information, PopHR supports 
one of the PPH priority areas, and serves as a foundation for the development of intelligent 
tools in the other two areas. Extending the PopHR to support integrated access to evidence 
about interventions and decision-support tools that would suggest to the user the 
interventions that are likely to be the most effective in a given population (something that 
requires juxtaposition of evidence about an intervention with information about a 
population in a target region) is the focus of our current research. As far as we know, no 
existing system currently supports such functionality. 
3. Interventions knowledgebase 
Biomedical literature has accumulated an enormous amount of evidence documenting the 
effectiveness of health interventions in many populations and settings. This evidence, 
however, is neither readily accessible, nor encoded consistently, and therefore not easy to 
use for the purpose of PPH. The field of knowledge translation (KT) has made 
considerable progress to address this problem [3], including the development of searchable 
online repositories of evidence [4]. To date, however, these repositories rely heavily on 
manual curation, with the associated high costs of building and maintaining them. Keeping 
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up with the exponentially growing body of biomedical evidence comes at a cost of reduced 
precision of these repositories: most of them limit their focus to systematic reviews and 
exclude the original studies, and annotate the evidence coarsely with only a small set of 
intervention and study design characteristics, insufficient for precise matching of the 
evidence to target populations. 
To enable the encoding of evidence with a precision sufficient for assessing its 
transferability to a defined population in the context of PPH, one needs a sufficiently 
expressive vocabulary. While all existing web repositories for health evidence use some 
sort of an underlying conceptual model to describe interventions and their effects, the 
model is often shallow and informal, which limits precision and presents a barrier for the 
use of automated tools to process such evidence. In contrast, a formal intervention 
evidence framework in the form of an ontology will provide the necessary level of 
expressivity, enable logical reasoning over existing evidence, and provide a foundation 
for automated retrieval and annotation of new evidence. 
The most popular standard framework for describing health evidence, PICO, has been 
formalized as an ontology by the Cochrane group [5] and it identifies the essential 
components of evidence (population, intervention, comparison, outcome) and the 
relationships among them. The high-level PICO framework can be supplemented by more 
detailed vocabularies to further classify instances within each component. However, while 
extensive terminologies exist to systematize clinical interventions, and behavior change 
techniques, little work has been done to develop a standard vocabulary for describing 
public health interventions. To address this gap, we have developed an Ontology of Public 
Health Interventions (OPHI), which can be used to formally encode evidence about 
intervention effectiveness in a standard, machine-readable format. 
3.1. Ontology of Public Health Interventions (OPHI) 
To ensure that our ontology reflects a consensus among public health professionals 
regarding intervention classes and properties, we conducted a scoping review of literature 
to identify existing conceptual frameworks and classifications of public health activities. 
The search extended over articles in public databases (PubMed, Scopus, Google Scholar 
and Cochrane Library) as well as the grey literature: documents from PHAC, INSPQ, 
Public Health Europe, WHO, and the National Public Health Partnership. Two 
independent researchers examined the titles and abstracts of nearly 1000 articles for 
relevance, leaving around 200 articles for full-text review, yielding a total of fourteen 
sources to be synthesized. These sources included several formal ontologies and 
classification systems, as well as informally described conceptual frameworks and 
diagrams. 
We extracted concepts from each of the 14 proposed frameworks along with their 
definitions. Some of the sources did not formally define any concepts that were used. As 
a result, many of the concept definitions had to be inferred based on the provided examples 
of usage and lists of child concepts or property values. We also identified a number of 
concepts that were used synonymously across different frameworks, as well as ambiguous 
terms that had different meanings in different frameworks. After the required 
disambiguation and merging of synonymous terms, we developed a synthetic conceptual 
model and formalized it using Web Ontology Language (OWL). 
The resulting Ontology of Public Health Interventions (OPHI) builds on the basic 
structure introduced by the PICO ontology to capture health evidence, augments it with 
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the concepts and relationships from the synthesized frameworks, and provides a multiaxial 
classification of interventions based on settings, recipients, purpose and methods. As part 
of the PopHR ontology suite, OPHI is directly linked to other ontologies we developed 
previously for this platform, notably, the ontology of public health (PHOnt), which 
encodes a broader range of concepts relevant to public health practice (e.g. public health 
resources), and includes causal knowledge about health conditions and health 
determinants. This linkage is essential when it comes to assessing the applicability and 
feasibility of implementing interventions in new contexts and predicting their effects in 
target populations. Although OPHI specifically focuses on public health interventions, the 
underlying knowledge model is compatible with and suitable for encoding clinical 
interventions as well. This is important since evidence from clinical trials is more abundant 
compared to studies evaluating the effects of public health programs. 
3.2. Sample knowledgebase of influenza interventions 
To demonstrate how OPHI can be used within the PopHR infrastructure to support PPH 
practice, and to verify its suitability for annotating studies of interventions, we have 
created a small sample knowledgebase of interventions, focusing on influenza control2. 
As much of the evidence related to influenza control focuses on vaccination, we have 
extended OPHI with a well-established Vaccine Ontology [6] to increase the annotation 
precision in this area. We selected four systematic reviews that focused on diverse aspects 
of influenza control measures (vaccine safety, effectiveness, vaccine uptake, non-
vaccination prophylactic measures) and retrieved fifty-six associated studies. We 
manually extracted from this corpus the essential findings about the effectiveness of 
interventions and annotated all relevant terms and features of the interventions and study 
populations. We were able to align the relevant properties of study design, categories of 
interventions, characteristics of study population and types of outcome with the existing 
OPHI terms. Figure 1 presents a fragment of the encoding. 
 
Figure 1. Sample encoding of influenza intervention evidence using OPHI (fragment) 
In our pilot work building a sample knowledgebase of influenza control interventions, we 
demonstrated that OPHI provides a suitable semantic framework for describing and 
classifying existing evidence about public health interventions. While we believe that our 
ontology can be applied successfully to other subject areas, our experience encoding 
                                                          
2 Subject area has been chosen because of the high burden associated with influenza, and because it has been 
extensively studied within clinical trials, and public health programs, and large amounts of evidence is available. 
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influenza vaccination studies reveal the potential need to incorporate additional 
vocabularies to achieve the necessary level of precision. Combined with the causal 
knowledge already captured in PopHR ontologies, the OPHI-based interventions 
knowledgebase would support searches for interventions with specific properties and with 
demonstrated effectiveness in specific populations and settings and will provide a 
foundation for the development of the intelligent tools for evidence transferability 
assessment. Another direction of our future work is exploring the potential of employing 
statistical natural language processing (NLP) techniques to automatically populate the 
knowledgebase with instances of interventions and evaluation findings from published 
literature and databases. Such automation has been previously demonstrated as feasible in 
the context of clinical trials [7]. The influenza interventions knowledgebase will provide 
a set of annotations that can be used for training the machine learning algorithms. 
4. Future work 
The third PPH priority area has seen the least amount of progress. In the context of PPH, 
to make an evidence-informed decision, one must have not only detailed information about 
target population and evidence of interventions’ effectiveness but also the cognitive 
capacity to assess the ‘fit’ of the evidence to the target population. Systematic reviews, 
which constitute the standard of evidence for public health decision makers, estimate an 
intervention’s impact over a range of settings and provide limited detail on the populations 
and conditions of included studies. This means that extensive additional information 
gathering from individual studies is usually needed to assess the potential effects in a local 
population setting. Given the complexity of this task, decision-support tools have the 
potential to facilitate this process significantly. To date, however, there has been little 
research on the development of tools and software to help practitioners effectively 
combine evidence about health interventions with population information.  
The OPHI-based interventions knowledgebase will make characteristics of the study 
population used to generate evidence readily available for access by automated tools, 
while corresponding characteristics of the target population can be retrieved from PopHR 
data. With a set of conversion rules that account for various measures of the same 
characteristic, it will be possible to compare the two populations using measures of 
statistical and semantic similarity [8], and assess how well an intervention “fits” a given 
population and possibly estimate the expected effect of that intervention. 
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Abstract. Introduction: Prevalence of overweight and obesity are increas-
ing in the last decades, and with them, diseases and health conditions
such as diabetes, hypertension or cardiovascular diseases. However, hos-
pital databases usually do not record such conditions in adults, neither
anthropomorfic measures that facilitate their identification.
Methods: We implemented a machine learning method based on PU
(Positive and Unlabelled) Learning to identify obese patients without a
diagnose code of obesity in the health records.
Results: The algorithm presented a high sensitivity (98%) and predicted
that around 18% of the patients without a diagnosis were obese. This
result is consistent with the report of the WHO.
Keywords. Obesity, Overweight, Identification, Machine Learning, PU
Learning
1. Introduction
Overweight and obesity epidemic prevalence has increased since the 1970s in most
of the countries, affecting children and adults alike [1,2]. According to the World
Health Organization (WHO) in Europe, more than 50% of the population is
overweight, and 20% is obese (WHO Data and statistics, 2019). In Spain, obesity
already affects 17.4% of the adult population, whereas considering obesity and
overweight together, more than half (54.5%) of adults are overweight.
The most challenging feature of this situation is the increasing trend of people
with obesity and overweight in our society. This trend is especially worrying due
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to conditions and diseases that are associated with an excessive weight such as
diabetes, hypertension or cardiovascular disease [3].
However, this increase in obesity and overweight among the population has
not been reflected in hospital practice, which usually attends the problems derived
from obesity but not the underlying condition [4]. For example, at the Hospital
Universitario La Fe, in Valencia (Spain), the percentage of patients in the elec-
tronic health records with a diagnosis of obesity (278.00 and 278.01 ICD9 codes)
is 2.4%. Also, the lack of anthropometric measures in the databases (only around
3%) makes it difficult to extract useful indicators for identification, such as the
Body Mass Index (BMI).
Public policies and hospital interventions based on that data may lack cor-
rectness, producing biases in the conclusions extracted from it. Under this situa-
tion, other methods to know the real condition of patients are required. Among
others to cross-reference with primary care data, active questionnaires to patients
or data imputation are actions to mitigate this limitation.
To solve this identification issue, several restrictions should be considered 1)
No specific information is compiled about obesity and overweight in the adult
population; 2) Majority of samples are not labelled as obesity, overweight or no
obesity, neither BMI is collected 3) real classes are unbalanced given the statistics
about WHO.
With this scenario, we propose to develop a machine-learning model based
on positive-unlabelled (PU) learning for obesity identification trained by positive
and unlabelled electronic health records as a public health tool to estimate hidden
positive patients with obesity before studying comorbidities at patient aggregation
level. The authors developed this work in the context of the H2020 European
project CrowdHealth (https://crowdhealth.eu/) to provide helpful tools for
public policies’ developers.
2. Materials and Methods
In this study, we analysed data from a total of 49805 anonymised patients repre-
sented by their basic demographics and information coming from the Electronic
Health Records of HULAFE such as external specialist consultations, emergency
room registries, hospital admissions, laboratory results and home hospitalization
(UHD) registries. Ethical approval was obtained for this study from the Ethical
Committee of Hospital Universitario La Fe (Ethical Code: 2016/0350).
We searched for conditions associated with obesity and overweight in the
scientific literature [2,3,5] and created a list of concepts to query against the data,
extracting a final set of predictive variables. These variables were mostly related
to the frequency of diagnoses, frequency of visits to specialist and laboratory
results about cholesterol. A total of 32 variables (see Table 1) composed the final
version of the dataset. From the 49805 patients that formed our sample, 7033
(∼ 14.12%) were labelled as positive for obesity, having an ICD9 code for obesity
present, and 42772 (∼ 85.88%) were unlabelled.
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Table 1. Variables obtained from the dataset
Variables
Stroke Angiologists consults Circulatory diags
Hypertension diags LDL analyses HDL analyses
Triglycerides analyses Endocrine diags Insuline Tests
Insuline-related emergencies Cardiologist consults Infarction diags
Cardiology diags Coronary-related admission Gastric issues
Gallbladder-related emergencies Gallbladder-related admissions Rheumatology consults
Musculoskeletal diags Sleep issues Sleep breathing problems
UHD onco Radio or Quimio events Oncologist visits
Protein analysis Psiquiatric diags Pain diags
LDL mean HDL mean Triglycerides mean
Diabetes diags Age
As mentioned before, the number of identified obesity patients in the Elec-
tronic Health Records (EHRs) are meagre. The authors hypothesise that among
unlabelled patients there is a significant amount of obese patients (∼ 17% of the
population) according to the statistics by the WHO. This problem belongs to the
class imbalance type, which is characterised for having a majoritarian class where
most of the samples belong [6].
Therefore a classic machine learning classification algorithm is not appropri-
ate for this task. As a consequence, a correct approach under machine-learning
discipline for dealing with our problem is PU Learning. Liu et al. in [7] define PU
Learning as a semi-supervised technique for building a binary classifier based on
positive and unlabelled examples. In PU Learning, two sets of samples are avail-
able for training: the P set of positive instances, and a U set, assumed to contain
a mixture of both positive and negative examples but unlabeled at training time.
This technique is particularly useful when the level of contamination, positive
samples among negatives, in U is low (around 15%).
In concrete, we have used an implementation of the algorithm ”Bagging In-
ductive PU Learning” (see algorithm 1) proposed by Mordelet et al. [8]. In this
version, an ensemble of T classifiers is trained using the P set and a randoms
sub-sampling of U set with size |P | for each classifier. We implemented Mordelet’s
algorithm in Python 3 [9], using instances of the Random Forest (RF) [10] from
the scikit-learn library [11] as classifiers in the ensemble.
To demonstrate the validity of PU Learning in the obesity identification prob-
lem we developed an experiment where we split the data randomly, but keep-
ing the class proportion, in two sets: train (80%) and test (20%). After that we
trained an ensemble of 11 models using Mordelet’s algorithm and evaluated the
sensitivity and the amount of negatives in U . This last metric is calculated as the
specificity but taking into consideration that does not exist a real ground truth for
unlabelled/negatives. We repeated 100 times the same random experiment to get
different partitions of train and test and reported the mean and 95% confidence
interval of the metrics.
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Algorithm 1 Mordelet’s Inductive bagging PU learning
INPUT: P ; U ; K = size of bootstrap samples, T = number of bootstraps
OUTPUT a function f : χ → R
1: for t = 1 to T do
2: Draw a subsample Ut of size K from U .
3: Train a classifier ft to discriminate P against Ut.
4: end for
5: return
1
T
T∑
t=1
ft
3. Results
The results of the experiment are summarised in Table 2. The algorithm can
identify almost every patient with obesity, obtaining a sensitivity of 98%. Also, it
estimates that the U contains around 18% of persons with an obesity condition,
which is similar to the estimations reported by the WHO.
Table 2. Experimental results over 100 iterations using PU Learning
Metric Mean Confidence Interval 95%
Sensitivity 0.981 0.981, 0.982
Estimated negatives in U 0.822 0.820, 0.823
Estimated positives in U 0.178 0.177, 0.180
4. Discussion
As seen in the previous section, almost every obesity case presented to the al-
gorithm is recognised correctly, presenting a 98.1% of sensitivity. The amount of
negatives in U identified by the algorithm is around 82%, which means that the
18% of the patients in U are obese. These numbers are coherent with the statis-
tics reported by the WHO. The results are relevant because, aside from being
promising, no negative samples are required to train the model and the result was
obtained with a relatively large N (49805).
The main contribution of this work consists in the application of one known
machine learning algorithm to the identification of patients with obesity using a
small fraction of labelled data. This solution could be useful to identify obesity at
the patient level and mitigate the under-representation of this condition among
the EHR [4]. This algorithm could be used to implement an automatic tool used
in workflow mining, comorbidities statistics and screening, providing hospitals
with a rapid method for detecting patients target for a program or intervention
related to obesity.
The main weakness of this method is its bias to ignore obese patients that
have made little use of the hospital resources. This effect is due to the variables
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used to make the models, which are based mostly on the frequency of visits to
specialist and diagnosis.
As future work, the most straightforward way of profiting this model is its
implementation as part of a web-based platform, allowing users to send their
data to get the predictions from the model and some statistics at the end of the
interaction.
5. Conclusion
The implementation of the PU Learning methodology in the obesity identifica-
tion produced satisfactory results, providing high sensitivity and identifying a
similar number of patients with obesity to the WHO data. This model can be
used to identify patients with obesity among the hospital’s population to prepare
interventions or public policies.
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Medical Informatics in the Digital 
Personalized Health and Medicine Era: A 
SWOT Analysis and Actionable Strategies 
Rada HUSSEINa,1 
a Ludwig Boltzmann Institute for Digital Health and Prevention, Austria 
Abstract. With the rapid proliferation of digital health technologies, the role of 
medical informatics in advancing personalized healthcare and wellbeing is 
emphasized. To examine the readiness of medical informatics for fostering digital 
health moving forward, a Strengths, Weaknesses, Opportunities, and Threats 
(SWOT) analysis was performed. As a result, actionable strategies have been 
identified to maximize the benefits of medical informatics and overcoming the faced 
challenges in the digital health era. 
Keywords. Digital health, medical informatics, strategic planning, SWOT 
1. Introduction 
The movement from "eHealth" to "Digital Health" emphasizes on providing people-
centred and integrated health services utilizing the technological advances, such as 
mobile health (mHealth), Internet of Things (IoTs), Artificial Intelligence (AI), big data 
analytics, cloud computing, blockchain, etc. [1]. 
Medical Informatics or Biomedical and Health Informatics (BMHI) has become an 
established scientific-multidisciplinary discipline involving computer, cognitive and 
social sciences [2]. BMHI utilizes health information technologies to provide the optimal 
use of information for improving individual health, healthcare, public health and 
biomedical research. 
The goal of this paper is to analyze the strengths, weaknesses, opportunities and 
threats (SWOT) of the current status of the BMHI field. Consequently, actionable 
strategies are identified to leverage the anticipated potential of BMHI for the Digital 
Health (DH) era. 
2. SWOT analysis and actionable strategies 
SWOT analysis is one of the world's most widely used methods for strategic planning 
[3]. This paper uses this instrument to match the strengths and weaknesses of the BMHI 
field with opportunities and threats of DH. The SWOT analysis has been performed 
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based on the review of literature, industry reports and initiatives of the global health 
agencies. 
To identify the potential 
tactical strategies for 
maximizing the benefits of 
BMHI for the DH era, an 
extended "variant" version of 
the SWOT-named the 
Threats, Opportunities, 
Weaknesses and Strengths 
(TOWS) analysis was 
conducted [3]. Figure 1 
depicts how to develop 
actionable strategies through 
the TOWS analysis. 
3. Medical informatics strengths and limitations 
The BMHI domain has a broad scope with the full range of knowledge (research) and 
practice (applications) [4] covering several sub-disciplines, mainly: bioinformatics, 
imaging informatics, clinical informatics and public health informatics. Additionally, 
there are two rapidly growing domains within the BMHI field, namely: 1) Consumer 
Health Informatics (CHI) that addresses consumers' articulated needs with managing 
their health concerns [4,5], and 2) Global Health Informatics (GHI) that focuses on 
empowering people to use appropriate technology, aligning with a global perspective of 
healthcare provision to all [6]. 
The main limitations of scaling up the eHealth initiatives and reaching the desired 
impact are [6]: 1) limited interoperability with legacy systems at national scale, 2) lack 
of evidence regarding the eHealth impact on health system performance and individual 
health, 3) lack of regulatory framework concerning data privacy and security, and 4) the 
insufficient use of large sets of data, i.e., converting data into health intelligence. On the 
other hand, the main barrier that hinders CHI [4,5] is the misalignment between the 
used technology and the users' socio-technical environment. This can significantly 
impact the technology utilization, endorsement by healthcare providers and users' 
empowerment. 
4. Digital personalized health and medicine opportunities and challenges 
The DH domain is considered as a key enabler of the personalized, preventive, 
predictive, participative, and precision (5P) medicine through leveraging the vision of 
providing equitable and person-centred care [5]. Consequently, DH has been 
attracting great interest of all stakeholders, including academic researchers, consumers, 
global health agencies, healthcare industry, policymakers and others. Recent studies 
covered different aspects of the DH domain, for example, industry and academic 
reviews of the DH technical trends [1], the World Health Organization (WHO) 's 
practical guide for monitoring and evaluating digital health interventions as well as the 
draft version of the global strategy on digital health 2020-2024 [7], Stanford medicine's 
Figure 1 TOWS analysis and actionable strategies 
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report on the democratization of healthcare [8], Johns Hopkins' roadmap for digital 
health validation [9], and a framework for assessing the impact of connected health 
services [10]. At the regulatory level, the Integrating Healthcare Enterprise (IHE)-
Europe published its perspective in understanding and adopting the General Data 
Protection Regulations (GDPR) [11]. Additionally, a vision of how the GDPR supports 
healthcare transformation is described in [12]. 
Nevertheless, the main challenge facing the DH market [5,13] is that it is like "wild 
west" because most of the applications are neither based on the evidence of effectiveness 
nor adopting existing technical standards. Furthermore, most of the DH applications are 
mainly technology-driven as "one-size fits all" that may lead to harmful use. At the 
integration level [5,13], there is a lack of interoperability between user-generated data 
and health records in addition to an inadequate or fragmented legal frameworks, 
especially in the area of privacy and data security. Moreover, there is a mandate to 
address the DH from the socio-technical and organizational perspectives [1] in the 
context of change management, user engagement, information governance, workforce 
capacity, citizen empowerment, regulations, business models, etc. 
5. Medical Informatics and digital health TOWS analysis 
Table 1 summarizes the results of the SWOT analysis and their translation into TOWS 
analysis and actionable strategies. 
6. Medical Informatics and digital health actionable strategies 
As listed in Table 1, the actionable strategies can be categorized as follows: 
The SO actionable strategies aim to shape the BMHI research and education for the 
DH era utilizing the advances in science and technology. This also matches with 
the proposed research agenda described in [2]. 
The WO actionable strategies aim to build interdisciplinary partnerships and 
collaborations to tackle the pressing challenges in aligning the BMHI field with 
future trends in medicine and DH technologies. 
The ST actionable strategies aim to leverage the role of the BMHI associations in 
building the ecosystem for DH connected health with all involved stakeholders, 
including researchers, consumers, global health agencies, DH industry, standard 
development organizations, policymakers and others. 
The WT actionable strategies aim to roadmap an integrated future for BMHI and DH 
at technical, environmental and organizational levels. This requires 
interdisciplinary teamwork of healthcare providers, informaticians, data scientists, 
systems developers, consumers, and experts in behavioural science, law, human-
computer interaction, business modelling, and change management. 
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Table 1. BMHI and DH TOWS analysis and corresponding actionable strategies 
 BMHI Strengths (S) 
S1 Breadth and diversity of BMHI 
subcategories 
S2 Wide scale of BMHI methods, 
tools and applications S3 Consumer 
Health Informatics articulates the 
user-centric approach 
S4 Global Health Informatics focuses 
on improving healthcare systems and 
outcomes 
BMHI Weaknesses (W)  
W1 Too many overlapping standards 
hinder interoperability  
W2 misalignment between the used 
technology and the "real world" 
socio-technical environment 
W3 Limited large-scale evidence 
W4 Limited convergence of data into 
health intelligence at national and 
global scales 
DH Opportunities (O) 
O1 Wide scale of technological 
innovation in big data analytics, 
cloud computing, AI, wearable 
devices, IoT, blockchain, etc.  
O2 Future trends in medicine: 
personalized, pervasive, 
predictive, preventive, 
participatory, precise, 
preemptive, and patient- 
centralized (8P medicine) 
O3 The WHO global health 
initiatives for digital health, 
universal health coverage, 
democratization of data, 
evidence for all, sustainable 
development goals, etc. 
O4 Great interest of the BMHI 
community (academia, industry 
and associations) worldwide in 
digital healthcare 
transformation 
SO actionable strategies:  
SO1 Strengthen the BMHI discipline 
with new trends in medicine and 
technology (S1, O1, O2) 
SO2 Establish strong partnerships for 
international collaborative research 
programs and initiatives (S1-S4, O1-
O4)  
SO3 Align the BMHI education and 
research programs with the WHO 
global health initiatives (S3, S4, O3) 
SO4 Leverage the strengths of the 
BMHI national and international 
associations in developing and 
updating the BMHI competencies 
frameworks (in regular basis)- that are 
intended for curriculum development, 
accreditation and workforce 
certification (S1, O4) 
WO actionable strategies:  
WO1 Take the initiative (by the 
international standards organizations) 
to coordinate their efforts in 
improving the existing BMHI 
standards and resolving the 
interoperability gaps (W1, O1, O2, 
O4) 
WO2 Adopt socio-technical systems 
theory to support a better 
understanding of end-user 
performance (W2, O1, O2, O4) 
WO3 Adopt the WHO guidelines on 
DH interventions and corresponding 
frameworks for DH monitoring and 
evaluation (W3, O1-O4) 
WO4 Establish international scale 
research programs (that adopt new 
methodological or technical 
approaches) to advance 
interdisciplinary understanding (W4, 
O1-O4) 
DH Threats (T): 
T1 Rapid pace of technology-
driven applications (as one size 
fits all) 
T2 Lack of international 
regulatory frameworks for DH 
testing, validation, safety, and 
data privacy and security 
T3 Lack of interoperability 
standards for user-generated 
data T4 Low acceptance and 
adoption of DH 
ST actionable strategies:  
Leverage the role of the BMHI 
associations to: 
ST1 Engage all stakeholders in 
designing national DH connected 
health services and the corresponding 
consumers' empowerment programs 
(S1, S2, T1, T4) 
ST2 Establish multidisciplinary 
taskforce to validate the current 
initiatives of DH regulatory 
frameworks in addition to technical 
working-groups to resolve the 
interoperability gaps with standards 
development organizations (S1-S4, 
T2, T3) 
ST3 Develop a specialized 
competencies framework for 
implementing and monitoring the DH 
regulatory framework (S1,T2) 
ST4 Develop a collaborative online 
platform for sharing best practices and 
lessons learned in overcoming the DH 
challenges across the associations' 
members (S1-S4, T2, T3, T4) 
WT actionable strategies:  
Overcome weaknesses by making 
them strengths (move toward SO 
strategy) 
Leverage the role of the BMHI 
associations to: 
WT1 Develop a specialized 
competencies framework for DH 
open data and science (W1, W3, W4, 
T1, T3) 
WT2 Build a multidimensional 
collaborative team to develop a 
roadmap for interdisciplinary 
understanding of the DH socio-
technical and organizational 
environment (W2, T2, T4) 
WT3 Develop a collaborative online 
platform for open innovation to 
tackle the DH challenges (W3, W4, 
T1, T4)  
WT4 Utilize change management 
concepts to 1) tackle the unpredict-
table and complex interactions be-
tween the people and DH technology, 
2) strengthen user engagement (W2, 
T2, T4) 
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7. Conclusion 
Medical informatics is expected to play a pivotal role in the transformation of digital 
"personalized" healthcare and medicine. To achieve this goal, the described actionable 
strategies support paving the way of the BMHI field towards the DH era, through 1) 
enriching the BMHI research and education agenda with emerging DH technologies, 
WHO initiatives and medicine trends, 2) strengthening the role of the BMHI associations 
in building the ecosystem of digitally connected health, and 3) road-mapping an 
integrated interdisciplinary future of BMHI and DH at socio-technical and 
organizational levels. Thus, realizing the BMHI aim in advancing science and 
improving healthcare outcomes. 
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Abstract. HUMIRA, a biologic therapy, has been approved to treat autoimmune 
diseases and been marketed in many countries worldwide. Much like other 
medications, it demonstrates many effects on the human body. It is important to 
understand its effects from the information generated by its users, and social media 
is one of the venues its users share their experience with the medication. To 
understand what HUMIRA effects were reported on Twitter, we utilized a relational 
similarity-based approach to infer HUMIRA effects based upon known medication- 
effect relations of other medications. With a corpus of 3.6 million preprocessed, 
“clean” tweets, a total of 55 effects were identified, and among them, 46 were 
previously observed, and nine were potentially unreported after verification with 
six reliable sources. The results not only indicate that many HUMIRA effects shared 
by the Twitter users are consistent with those previously reported, but also 
demonstrate the power and utility of our method, making it applicable to studying 
effects of other medications shared by Twitter users. 
Keywords. HUMIRA, medication effects, mining social media, relational 
similarity, relation extraction 
1. Introduction 
As a blockbuster medication of AbbVie Inc., HUMIRA (adalimumab), a biologic therapy 
administered via subcutaneous injection, has been approved to treat autoimmune 
diseases in North America and the European Union as well as being approved in Japan 
for the treatment of intestinal Behcet’s disease. It has been sold in many countries 
worldwide, including Japan, China, Brazil and Australia [1]. Like other prescription 
medications, HUMIRA demonstrates various effects to those who took it, and its adverse 
effects such as serious infections and a rare type of cancer have been observed and 
reported [2]. With its broad use, it is important to understand how consumers share their 
experience of taking HUMIRA to help gain more insights into its effects directly from 
users of HUMIRA. Studies have shown that information shared by patients can be 
different from what was documented by healthcare professionals: a better 
understanding of adverse experience, better explanation of the nature, significance and 
consequences, and more detailed information [3]. 
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One potential source of obtaining user experience with medications is social 
media, including general-purpose platforms such as Twitter. A great number of efforts 
have been made in using social media as an alternative source of information for 
pharmacovigilance. As reported by Golder and colleagues in early 2015, more than 3000 
published citations were found in their searches of research articles containing “social 
media” and “adverse events” [4]. Many published works focus on identifying 
expressions of medication and adverse effect concepts in the social media data, and little 
effort has been made in understanding the relations between mediation and effect, 
yielding probably incorrect, false-positive or irrelevant results. 
A number of semantic relations exist in the medical domain. The U.S. National 
Library of Medicine (NLM) compiled a collection of normalized semantic relations for 
biomedical literature2, and many of them pertain to medication-effect relations such as 
treats, causes, occurs_in, exhibits, and produces. The SemRep software developed by 
NLM [5] extracts predicates from subject-predicate-object triples found in biomedical 
citations and maps them to the semantic relations. However, biomedical citations are 
written with closely followed grammatical and spelling rules, which is not the case for 
social media posts, in particular Twitter where these rules are not followed by its users 
to place needed text within the space limitation. 
Identifying semantic relations between medication and effect from social media is a 
challenging task in natural language processing (NLP). Methods developed for formal 
writing do not perform satisfactorily with social media posts not following grammatical 
and spelling rules. Mikolov and colleagues reported that using relational similarity in the 
vector space model of neural embedding of text achieved state-of-art performance in 
many NLP tasks such as identifying syntactic and semantic relations [6]. To address the 
limitation, we devised a method of identifying semantic relations by finding the relations 
most similar to any known semantic relations. In other words, any pair of semantic 
relations share sufficient similarity is considered semantically similar, indicating that 
they have similar meanings. In the identified semantic relations between medication and 
effect, the effects associated with the relations are identified effects. 
2. Method 
Our relational similarity-based approach infers any potential relations of a study 
medication based upon their similarity to the known relations of other medications. For 
example, our method infers a relation of Depakote: bad dreams from the known relation 
of Toprol XL: chest pain for that there exists a similarity between the two medication- 
effect relations. Using this approach, we were able to infer the effects of HUMIRA. 
Described below are the steps of our pipeline of gathering, processing, analyzing data 
and validating the results. 
2.1. Inference with Relational Similarity 
Mikolov and colleagues suggested that in the vector space model, the relational similarity 
can be derived by computing the cosine value between the two relation vectors each of  
which is an offset vector of two-term vectors [6]. In our study, to compute the 
relational similarity, a vector space model was first learned from a corpus of unlabeled 
2 https://www.nlm.nih.gov/research/umls/META3_current_semantic_types.html 
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tweets with the help of word2vec software3, and each term, including medication and 
effect in the text corpus was represented as a real number vector. A medication-effect 
relation was represented as the offset of the medication vector and effect vector, and 
the similarity between the two offsets (relation) vectors was computed by the cosine 
value between the two vectors. Mathematically, we have medbase : effectbase :: HUMIRA: 
effectpotential to represent the similar relations between two pairs of medication and 
effect. In implementation, effectpotential is derived by finding the most similar effect 
vector to the result of vector(effectbase) - vector(medbase) + vector(HUMIRA), where 
medbase and effectbase are known and for all the medications except HUMIRA – that is, 
multiple known relations may be used to infer a single relation. A collection of 
HUMIRA effects was gathered by inferring all possible effects based upon all the 
known medication-effect relations of other medications. 
2.2. Data 
A corpus of 53 million unlabeled tweets related to a list of medication names including 
HUMIRA was collected by a self-made crawler for twitter.com. The tweets were posted 
in a time span from March 2006 to summer 2017. The collected tweets were preprocessed 
to remove any non-English and duplicate tweets. The preprocessed tweets were further 
filtered by a list of effect terms found in the SIDER database to ensure that each tweet 
contains HUMIRA and at least an effect expression so that both will appear within the 
window of the context, facilitating the inference. The resultant 3.6 million “clean” tweets 
were used to learn the Word2vec vector space model. 
SIDER is an online resource of side effect information from marketed 
pharmaceutical products, and hosted and maintained by EMBL [7]. Its data of all known 
effects were utilized to filter preprocessed tweets. The SIDER’s effect data of each 
medication were used to come up with a collection of known medication- effect 
relations. SIDER has two distinct types of effects: side effects (SEs) and indications 
(INDs). One major advantage of the SIDER data is that each effect is associated with a 
UMLS Concept Unique Identifier (CUI), facilitating the expansion of effect concepts to 
include corresponding Consumer Health Vocabulary (CHV) terms. 
2.3. Annotation 
Inferred HUMIRA effects are the results of vector algebraic arithmetic, and the vector 
manipulations do not appear to be straightforward to comprehend in the semantic 
sense. Annotating related tweets can help us confirm that inferred effects (or relations) 
were actually mentioned in the Twitter posts. After effects were inferred, we expanded 
each effect concept by adding its corresponding CHV terms, and tweets containing 
both HUMIRA and the CHV-expanded effects were extracted from the corpus of 
“clean” tweets. The extracted tweets were annotated by one of the co-authors to label 
them as SE or IND based upon the semantics of the tweet text. 
2.4. Verification 
To uncover if any inferred effects were known or potentially unreported, we, in early 
2018, checked the inferred CHV-expanded effects against six reliable sources: SIDER, 
3 https://code.google.com/archive/p/word2vec/ 
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FDA Dailymed, Fdable.com, MedlinePlus, PubMed, and Google Scholar. SIDER 
contained both side effects and indications of many marketed products, but it did not 
contain either for HUMIRA. FDA dailymed contains both side effects and indications. 
Fdable.com is a Web-search engine of FDA Adverse Event Reporting System (FAERS) 
data, containing adverse event data. MedlinePlus provides curated consumer health 
information and prescription and over-the-counter medication information. Both 
PubMed and Google Scholar helped us to verify if any HUMIRA were mentioned in 
any scientific publications. Any inferred effects found in any of the six sources were 
considered known, and those not found were considered potentially unreported. 
3. Results and Discussions 
Table 1. Statistics of inferred effects. 
Count of Effects Count of SE Effects Count of IND Effects 
Inferred 87 70 17 
Annotated 55 44 11 
Accuracy 0.632 0.629 0.647 
As shown in Table 1, our relational similarity-based method generated 87 inferred 
effects, among which 70 were SE effects and 17 IND effects. After annotation, 55 
effects were confirmed to have relevant tweets, among which 44 were SE effects and 
11 IND effects, yielding an overall accuracy of 0.632. 
Table 2. Statistics of inferred effects after annotation and verification. 
Effects Count of Inferred Count of Known Count of Unreported 
SE 44 36 8 
IND 11 10 1 
 
After verification against six reliable sources, 46 out of 55 annotated effects were 
found to be previously reported, showing the consistency on these effects, and 9 of them 
were found to be potentially unreported, as shown in Table 2. It demonstrates the ability 
of our method to (1) correctly infer HUMIRA effects which had been previously 
observed and reported, and (2) infer effects potentially unreported previously. Being able 
to infer the known effects correctly indicates that our relational similarity-based 
method can discover existing effects similar to the known base relations. Capable of 
inferring potentially unreported effects are of special importance for pharmacovigilance 
in which the safety or suspected effects of pharmaceutical products are being 
continuously monitored and assessed. It was noticed that there is no entry of HUMIRA 
or adalimumab in the SIDER database, and this does not affect the inference of HUMIRA 
effects. Instead, it shows a unique power of our method: effects of any medications can 
be inferred whether their data exist in SIDER as long as the data for the study medications 
can be incorporated into the model. 
Table 3. Example tweets of potentially unreported HUMIRA effects 
Effect CUI Tweets 
Ache C0234238 had an overall ache after my humira shot...Thursday my Cellulitis 
infection came back. 
Panic attacks C0086769 Day 2 panic attacks and chest pain. Think new drug is freaking out my 
immune system. #IBD #Humira 
Swellings C0013604 Again humira day and got huge swelling around injection site anyone 
 else get this ????  
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Table 3 lists a few example tweets relevant to the HUMIRA effects inferred by our 
method. Not only do they mention both HUMIRA (the medication) and effects, but they 
do show the semantic relations between both. Any potentially unreported effects of 
HUMIRA discovered by our method warrant further assessment or clinical 
investigation. They may serve as the foundation of developing a hypothesis of 
suspected effects to help advance pharmaceutical knowledge, medical science, and 
clinical practice. It is known that misspellings of medication names and side effect 
concepts are common in Twitter posts [8, 9]. Covering broad linguistic variations of 
tweet text is one area of improvement for this project, and it may help discover more 
HUMIRA effects 
from Twitter posts. 
4. Conclusion 
In this work, we investigated mining HUMIRA effects mentioned in Twitter posts using 
our relational similarity-based method, and we were able to identify effects previously 
known and potentially unreported, demonstrating the power and effectiveness of our 
relational similarity approach. We believe that our pipeline of gathering, processing, 
and analyzing data is applicable to identifying the effects of many other medications 
mentioned in Twitter posts, to gather user-generated information on medication effects. 
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Abstract. Financial losses in Medicaid, from Fraud, Waste and Abuse (FWA), in the 
United States are estimated to be in the tens of billions of dollars each year. This 
results in escalating costs as well as limiting the funding available to worthy 
recipients of healthcare. The Centers for Medicare & Medicaid Services mandate 
thorough auditing, in which policy investigators manually research and interpret the 
policy to validate the integrity of claims submitted by providers for reimbursement, a 
very time-consuming process. We propose a system that aims to interpret 
unstructured policy text to semi-automatically audit provider claims. Guided by a 
domain ontology, our system extracts entities and relations to build benefit rules that 
can be executed on top of claims to identify improper payments, and often in turn 
payment policy or claims adjudication system vulnerabilities. We validate the 
automatic knowledge extraction from policies based on ground truth created by 
domain experts. Lastly, we discuss how the system can co-reason with human 
investigators in order to increase thoroughness and consistency in the review of 
claims and policy, to identify providers that systematically violate policies and to 
help in prioritising investigations. 
Keywords. Healthcare fraud, ontology-based information extraction, claims 
auditing 
1. Introduction 
Improper payments for Medicaid in fiscal year 2018 were estimated at 9.8% of Medicaid 
spending ($36.2 billion) [1]. Examples of improper payments include billing for services 
exceeding permitted unit limitations, billing separately for services already included in a 
global fee (unbundling) and billing for medically unnecessary services. Regulations 
around compliance and accurate billing are described in federal and state policies. 
Armed with a deep understanding of these policies, FWA investigation units aim at 
identifying violations in claims submitted for reimbursement by medical providers. 
However, the sheer volume of claims, benefits, and policy to review,  combined with  the 
limited investigation resources and varying skill sets of  
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 investigators, lead to poor coverage and understanding of the opportunity landscape. 
The Centers for Medicare & Medicaid Services have developed a fraud detection 
system that analyses claims to identify providers with suspicious billing patterns [2]. 
This and similar approaches rely on a combination of applying data analytics techniques 
to patterns in structured claims data [3, 4] and hand-crafting rules that flag sets of 
claims for additional investigation. The system presented in this paper focuses on 
fusing policy and claims together to identify improper payments. It achieves this by 
semi-automatically converting policy text into benefit rules, which are applied directly to 
claims. This approach is novel to the best of our knowledge and presents a number of 
research challenges, including: 
 
a) Domain modelling & knowledge extraction: Key to our system is building an 
ontology that is flexible enough to capture the diversity and complexity of the 
policy benefit rules as well as expressive enough to represent the knowledge in a 
simple, unambiguous and human-readable way to support policy comprehension 
and human oversight. The ontology is used to integrate relevant terminology and 
heterogeneous domain sources (e.g., state programs, eligible places of service, 
coding systems, such as the International Classification of Diseases ICD-9/10 and 
corresponding updates), as well as to guide the information extraction. 
b) Linking of policy information to the claims data: Some elements of the benefit 
rules can be easily mapped to claims data columns (e.g., a minimum age 
constraint will be linked to the birth date of the patient), while others require a 
more complicated process (e.g., aggregated units of service for a given patient 
over a given period). The system also needs to map services described in policy to 
their representation form used in claims, such as the Healthcare Common 
Procedure Coding System (HCPCS). 
c) Rules polarity: In policy documents, benefit rules usually express what will be 
reimbursed (a positive rule), e.g. "Adults at high risk for caries may have up to 2 
units of dental prophylaxis per year". Sometimes, they express what will not be 
reimbursed (a negative rule), e.g. "Dental prophylaxis is not a covered benefit for 
children aged 0-4". This provides a challenge for automated identification of 
improper claims because while the negative rules are generally unambiguous and 
directly identify violations, the positive rules are often ambiguous and incomplete. 
In the example, we must infer that more than two units are not allowed for a high-
risk adult and that there may be an implied rule for non-high-risk adults and 
separate rules for children and high-risk children. 
d) Validation of the approach: Validating the feasibility and impact of our system 
when used as part of the investigators' workflow requires constructing a set of 
ground truth rules to evaluate its performance and measuring its generalizability 
across different policy areas as well as geographic regions. 
2. Method 
Below we present the components that comprise our system. Fig. 1 runs an example 
through the end-to-end pipeline.  
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Policy Ingestion: This component converts the PDF policy document into an HTML 
document 3, and further enriches the HTML with information identifying sentences,  
and their hierarchical arrangement (e.g., grouping sentences under a common header or 
identifying a paragraph introducing a list).  
 
Figure 1. Proposed system's pipeline overview with benefit rule extraction and claims validation example. 
Rules Extraction: This component is an ontology-based information extraction system 
based on the enriched HTML policy. Two extractors are implemented on top of two 
different NLP technologies: Watson X [5] and SystemT [6]. For each textual fragment, 
the extraction involves the annotation of medical concepts and relations guided by UMLS 
and the domain ontology. We construct a machine-processable representation of a benefit 
rule by reasoning over the ontology and translating textual patterns into ontological 
entities and corresponding relations. Each extracted rule is represented in a knowledge 
graph (KG). The rule extraction process may generate multiple KGs from the same textual 
fragment(s), which can be consolidated based on different strategies. Human oversight of 
this extracted knowledge is essential to correct any errors and establish trust. To that end, 
we transform each KG into a user-friendly representation, that contains conditions and 
corresponding values (e.g., applicable service with value topical fluoride or maximum 
age with value 20). This empowers the investigators to interact with, adapt and use the 
extracted knowledge. Rules in policies follow different templates that we captured in the 
ontology working together with FWA investigators. A detailed discussion of the ontology 
creation is presented in [7]. The extracted benefit rules are then normalised, i.e., properties 
values are standardised, so that rules execution can unambiguously identify them in 
claims. The normalisation steps include linking extracted services to specific procedure 
codes, e.g., topical fluoride treatments maps to codes D1206 and D1208, and representing 
dates in a standard format, e.g., representing fiscal year as the appropriate dates range 
depending on the geographic area. 
Mapping to claims: The conditions of each benefit rule must be mapped to claims 
columns in order for the rule to be executed. We assume a claims schema against which 
the mapping is performed. Examples of mappings are: direct - e.g., a minimum age 
property in the rule maps directly to an age column that can be calculated from the birth 
date of the patient and the date of service, aggregations - e.g., a rule that places an upper 
limit on the number of claims over a period of time. To map this to claims, we need to 
(i) filter claims, e.g. by service, (ii) group claims, e.g., by patient or date and (iii) 
compute the aggregation, e.g. an incremental count of claims, value-dependent - e.g., a 
rule may have a 'requirement' element with values such as 'prior authorisation', 'medical 
necessity', etc. Each of these values may map to distinct columns in the claim data. 
3IBM Compare and Comply: www.ibm.com/watson/developercloud/compare-and-comply/ 
 
“Topical fluoride is a covered 
benefit for child members through age 
20 and topical fluoride treatments are 
allowed twice (2) per  year for child 
members.” 
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This component applies the benefit rules to claims and outputs a status for each 
claim: improper, correct or unknown, with the latter representing claims that are not 
represented by any rule. Claims that appear to be improper are linked automatically to 
both the executed benefit rule and the relevant policy documentation. 
3. Results and Discussion 
We designed a prototype investigation workbench (Fig. 2) that highlights the impact of 
bringing policy and claims data together into a unified workflow. Using this 
workbench, investigators can contrast what providers are authorised to do with what 
they actually do. This starts by selecting a policy area (e.g., topical fluoride) and the 
policy sections (rules) to be investigated (Fig. 2: #1, #2). An Investigator can then 
immediately visualise, inspect and prioritise claims that appear to be out-of-sync with 
that policy (Fig. 2: #3, #4). 
This helps in addressing significant problems in investigation planning and 
execution: (1) investigators can size potential recovery opportunities before deciding 
where to allocate scarce resources; (2) maintaining a direct connection between policy 
and related claims helps build a water-tight case for recovery; (3) automatically showing 
the relevant claims (and claim fields) for a policy area under investigation saves time by 
reducing dependencies on other departments for pre-defined data extracts/spreadsheets; 
and (4) it enables investigators to review and correct the automatically-extracted 
benefit rules (Fig. 2: #2), thereby building up a shared store of high-quality, executable 
policy knowledge. 
We validate the rules extraction performance via precision and recall. To create 
Ground Truth (GT) for these measurements, we used a set of documents for Physical 
Therapy policy from one U.S. state, plus Dental policy from two U.S. states. For each 
one, a team of three FWA Investigators manually translated the associated benefit rules 
into a computable form, based on our ontology (GT rules). Automatically extracted 
rules were then compared to these, yielding the evaluation results presented in Table 1. 
Table 1. We pair a GT rule R with the set of extracted rules from the same text, and we compute a pairing score 
that takes into account the number of common conditions and values. If the pairing score is always zero, then R 
is a false negative. Otherwise, the true positive corresponding to R is the extracted rule having the maximum 
pairing score. Details on the pairing score calculation can be found in [7]. The last column of the table shows 
the average maximum pairing score across all rules. 
Policy num. GT rules num. extracted rules precision recall avg. pairing score 
Physical Therapy 25 38 0.58 0.88 0.61 
Dental (State 1) 50 46 0.65 0.60 0.69 
Dental (State 2) 34 42 0.64 0.79 0.56 
 
The ontology used in the experiments comprises of 35 classes, 1151 individuals, 29 
properties and 4214 lexicalisations (i.e., ontology entity labels used to annotate textual 
entities). We are currently extending our work to improve the breadth and coverage of the 
models and the extraction, in particular across paragraphs, headings and in cases where 
there are conflicting extracted information. Most of the effort required to generalise across 
domains and geographical areas is on identifying external (instance) area-specific data to 
be incorporated into the ontology, such as programs and grouping of codes that are not 
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Figure 2. Workflow: The investigators receive a phone tip about a suspicious dental provider Dr. Smiley and 
decide to look for violations related to topical fluoride. Next, they 1) search for related policies, 2) select one or 
more extracted rules from these policies and modify/correct the automatically extracted rule(s), if necessary, 
3) define the scope (e.g., provider and date range), and apply the set of rules to the related claims, seeing the 
impact of the violations in terms of number of improper claims and potentially recoverable amount of money, 4) 
carefully inspect each improper claim and the corresponding policy it appears to violate. 
 
part of a global (e.g., federal) code set. Without these groupings, for example, 
considering the Dental (State 2) policy, recall started at around 0.59. When clinical 
vocabularies such as UMLS are used to find services, treatments and diagnoses, recall 
increases to 0.76 (with a precision of 0.68). Furthermore, when 135 different groupings 
of codes were added by a coding expert, recall improved to 0.79, with a small drop in 
precision to 0.64 (Table 1). 
4. References 
[1] U.S. Government Accountability Office, https://www.gao.gov/key_ 
issues/medicaid_financing_access_integrity, 2018. 
[2] U.S. Government Accountability Office, https:// www. gao. gov/ assets/690/686849.pdf , 2017.  
[3] H. Joudaki, et al., Using data mining to detect health care fraud and abuse: a review of literature, Glob. 
J. Health Sci. 7(1) (2015), 194. 
[4] D. Thornton, et al., Predicting healthcare fraud in medicaid: a multidimensional data model and 
analysis techniques for fraud detection, Proc. Technol. 9 (2013), 1252–1264. 
[5] A. Kalyanpur, et al., Structured data and inference in DeepQA, IBM J. Res. Dev. 56.3.4 (2012), 10–1. 
[6] L. Chiticariu, et al., SystemT: Declarative text understanding for enterprise, NACCL-HLT. 3 (2018), 
76–83. 
[7] V. Lopez, et al., Benefit graph extraction from healthcare policies, ISWC, 2019. 
T.S. Brisimi et al. / Ontology-Guided Policy Information Extraction 883
Text-Mining Services of the Swiss Variant 
Interpretation Platform for Oncology 
Déborah CAUCHETEURa,b,*,
1
, Julien GOBEILLa,b,*, Anaïs MOTTAZa,b,*, Emilie 
PASCHEa,b,*, Pierre-André MICHELa,b, Luc MOTTINa,b , 
Daniel J. STEKHOVENb,c, Valérie BARBIÉb  and Patrick RUCHa,b  
a HES-SO / HEG Geneva, Information Sciences, Geneva, Switzerland 
b SIB Swiss Institute of Bioinformatics, Geneva, Switzerland 
cNEXUS Personalized Health Technologies, ETHZ, Zürich, Switzerland 
Abstract. The Swiss Variant Interpretation Platform for Oncology is a centralized, 
joint and curated database for clinical somatic variants piloted by a board of Swiss 
healthcare institutions and operated by the SIB Swiss Institute of Bioinformatics. To 
support this effort, SIB Text Mining designed a set of text analytics services. This 
report focuses on three of those services. First, the automatic annotations of the 
literature with a set of terminologies have been performed, resulting in a large 
annotated version of MEDLINE and PMC. Second, a generator of variant synonyms 
for single nucleotide variants has been developed using publicly available data 
resources, as well as patterns of non-standard formats, often found in the literature. 
Third, a literature ranking service enables to retrieve a ranked set of MEDLINE 
abstracts given a variant and optionally a diagnosis. The annotation of MEDLINE 
and PMC resulted in a total of respectively 785,181,199 and 1,156,060,212 
annotations, which means an average of 26 and 425 annotations per abstract and 
full-text article. The generator of variant synonyms enables to retrieve up to 42 
synonyms for a variant. The literature ranking service reaches a precision (P10) of 
63%, which means that almost two-thirds of the top-10 returned abstracts are judged 
relevant. Further services will be implemented to complete this set of services, such 
as a service to retrieve relevant clinical trials for a patient and a literature ranking 
service for full-text articles. 
Keywords. Precision medicine, literature, variant, terminology, text-mining 
1. Introduction 
After several years of collaboration to improve and harmonize the NGS (next-generation 
sequencing) practices in somatic mutation calling, a number of Swiss hospitals, 
pathology institutes and the Swiss Institute of Bioinformatics members have pointed to 
a set of shortcomings, most prominently the lack of a central repository for clinically 
verified variant annotations in cancer. To support the harmonization of variant annotation 
in diagnosis, to provide a centralized curated database of somatic variants coming from 
Swiss hospitals, and to enable a seamless interaction between participating institutes and 
global initiatives, the Swiss Variant Interpretation Platform for Oncology (SVIP-O) was 
developed [1]. 
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The curation of variants is a labour-intensive process. First, NGS analyzes result in 
a huge amount of variants in the patient sample. Second, for each variant, many 
sources must be consulted, including the scientific literature. While for some already 
well-studied variants (e.g. BRAF V600E), identifying a set of relevant scientific 
literature is not an issue, for variants of uncertain significance (VUS), the task can be 
more difficult. Indeed, the curator must comprehensively gather the relevant literature 
to assign a standardized tier level (ASCO/AMP/CAP guidelines), in which the variant, 
the gene or the diagnosis could have been labelled in different ways [2]. Thus, the 
curator must author multiple queries to avoid missing out on an important paper. 
Moreover, when large sets of literature are available, triage of the literature (i.e. 
selection of relevant papers as well as rejection of irrelevant papers) can be a very 
time-consuming task [3]. 
Therefore, we developed a set of text analytics services intended to facilitate and 
improve the comprehensive collection of literature to support further processing steps, 
which will include the capture of textual evidence by Swiss-Prot curators and clinical 
validation by medical specialists for final storage in the SVIP-O knowledgebase. First, 
we developed a service to annotate the clinically relevant information contained in the 
scientific literature. This service enables not only to accelerate searches (i.e. queries are 
performed using unique identifiers in a standardized field) but also to increase the recall 
(i.e. the annotation step conflates synonyms and string variants). However, the 
annotation of variants faces a serious limitation: no universal terminology is available. 
In order to offset this issue, variants can be searched in literature using synonym 
expansion. Thus, as a second task, we propose a service to expand a variant name with a 
set of expressions, including Human Genome Variation Society (HGVS) standard 
descriptions for the protein, transcript and genomic DNA levels, but also non-standard 
formats found in the literature (e.g. V-600-E or BRAFV600E) [4]. Finally, a service 
collecting and prioritizing literature is available: it combines heterogeneous information 
retrieval results for an optimal article triage, which altogether can reduce the triage effort 
by a factor of 3 [5]. 
2. Methods 
Our MEDLINE and PMC collections consisted of respectively 30,415,832 and 2,632,396 
documents (in January, 7th 2020), daily updated and loaded into a MongoDB document 
database and then into an ElasticSearch index. 
2.1.Recognition of terminological entities in the literature 
The collection was annotated with codes from various terminologies and ontologies, such 
as neXtProt [6] for genes, Drugbank [7] and WHO-ATC [8] for drugs, NCI Thesaurus 
[9] and ICD-O-3 [10] for diseases, and HPO (Human Phenotype Ontology) for 
phenotypes. Querying MEDLINE through annotations is not only faster because the 
indexes are pre-computed but also it results in a better recall as each occurrence of a 
concept receives one unique ID for all its synonyms. We also applied string pre- 
processing methods. For instance, if dashes are present, they are treated to form a “new” 
word (e.g. “AB-C” becomes “AB”, “C” and “ABC”). Papers which contain only the 
word without dash will thus be retrieved. 
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2.2.Generation of synonyms for variants 
While many databases of polymorphisms and variants exist, such as ClinVar, COSMIC 
or dbSNP, using those resources as terminologies is fairly challenging. They describe 
variants using a standard nomenclature recommended by the HGVS [11]. These 
standards require a precise syntax and a reference sequence on which the variation is 
described to avoid uncertainty about the position of the change. Both of them are rarely 
observed in publications. Depending on the database, variants entries are also centered 
on different levels: genomic, transcript or protein, which are not true synonyms. 
Therefore, we developed our own synonym generation tool that enables us in 
addition to annotate variants not necessarily present in those databases. Our efforts 
focused until now on SNPs. Our tool generates synonyms given a gene and a variant. It 
includes a validation step, where we check whether the given base or amino acid exists 
at the given position. Then, we compute the description of the variant at the other levels, 
using the Mutalyzer tool [12]. We finally generate synonyms with many syntactic 
variations as encountered in the literature [4]. We also extend the search to all possible 
mutations in the case the replacing amino acid is not defined. 
2.3.Prioritization of literature 
The report focuses on the literature triage tasks, i.e. the ability to rank MEDLINE 
abstracts - as opposed to full-text articles - to support further curation steps. Triage is 
usually performed on abstracts, whose content is sufficient to help a domain expert to 
decide whether a particular report needs in-depth reading or not. 
Our literature prioritization system is based on two steps: collecting a complete set 
of abstracts and reranking the MEDLINE set. A most complete set of abstracts related to 
a particular triplet (i.e. a variant in a gene for a specific diagnosis) is built by the 
intersection of several queries’ output: normalized entities (i.e. gene and diagnosis) are 
searched with unique identifiers within the MEDLINE annotations, while a keyword 
search expanded with synonyms is performed within free texts from MEDLINE for not 
normalized entities (i.e. variant). Moreover, a set of queries, with decreasing levels of 
specificity (e.g. abstracts not mentioning diagnosis) is also performed. Results are 
linearly combined with previous abstracts set. Then, we apply different strategies to re- 
rank the MEDLINE set: 1) based on the number of occurrences of some annotated 
entities (e.g. abstracts mentioning drugs); 2) based on demographic information; 3) based 
on a set of keywords that should (e.g. treat) or should not (e.g. marker) be present in 
the abstracts and 4) based on the breadth of treatments returned in the top articles. The 
last re-ranking strategy aims at avoiding that all top returned articles are related to the 
same treatment, but rather favoring abstracts that are discussing different treatment 
options. 
The system is evaluated following standard TREC procedures using TREC PM 2019 
benchmarks [13], comprising 40 synthetic patient cases, each consisting of a disease, a 
variant, a gene and some demographic information. 
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3. Results 
3.1.Recognition of terminological entities in the literature 
Thanks to our annotations, we are able to retrieve more papers than classical queries on 
PubMed. The query BRAF retrieves 14,099 papers on PubMed versus 14,952 papers on 
our index with his corresponding code NX_P15056. Another example, query non-small 
cell lung cancer retrieves 51,858 papers on PubMed versus 70,972 (code C2926) with 
our index. These results are explained by expansions provided with annotations: 
synonyms (BRAF1 or RAFB1; NSCLC) and processing of hyphens (B-RAF becomes 
BRAF, thus a paper containing B-RAF will be retrieved). Table 1 represents an overview 
of annotations which are available for our collections for some of the terminologies. 
Table 1. Extract of statistics about annotations on MEDLINE/PMC collections obtained in January 2020. 
Type  Terminologies  No of entities annotated in 
 MEDLINE PMC 
Drugs DrugBank 80,100,2684 86,769,820 
Drugs ATC 46,173,559 30,404,688 
Diseases NCIt 131,577,959 108,049,190 
Diseases ICD-O-3 4,837,713 2,955,200 
Genes neXtProt 36,320,459 91,930,787 
Total annotations  785,181,199 1,156,060,212 
Average per document  26 425 
3.2.Generation of synonyms for variants 
Our tool generates 42 synonyms for a given valid variant when successfully mapped to 
all levels, with 16 synonyms for protein variant, 13 for transcript variant including 
COSMIC id and 13 for genomic variant including dbSNP id. It increases the retrieval 
between a few percent and several times the number of publications depending on the 
variant frequency, with smaller effect for very popular variants. For instance, 708 
additional abstracts, over 1715, are retrieved for the variant V617F in JAK2. 
3.3.Prioritization of literature 
Precision at rank 10 (P10) has been used to evaluate our system. This metric reflects the 
proportion of relevant documents retrieved in the top ten results. Our system resulted in 
a P10 of 63%, which means that almost two thirds of the top-10 returned abstracts are 
judged relevant. This service is publicly available: http://candy.hesge.ch/Variomes/. 
4. Discussion 
We have thus developed a set of services that can be used to facilitate the process of 
variant curation and validation by physicians, and in particular molecular pathologists, 
oncologists and hematologists, as well as rare disease experts. The literature triage 
service, boosted by the variant expansion service and the MEDLINE annotations service, 
is able to reduce the search burden by simplifying the paper triage. Indeed, the system’s 
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evaluation demonstrated that in the top-10 abstracts proposed by our system, more than 
six are relevant for the clinical decision-support task. In addition, such services can 
increase the possibility of finding a relevant paper. Although this aspect might be 
marginal for common variants, it is key for rare (or poorly studied) variants for which 
each publication matters. As an example, the search for the TP53 V143A variant in 
PubMed results in only seven abstracts, while our system is able to return 34 abstracts. 
Indeed, while PubMed strictly searches for V143A, our system is also able to search for 
Val143Ala or 428T>C. 
Additional services will be implemented to complete this set of services, such as a 
literature ranking service for full-text articles. Indeed, scientific abstracts reporting on 
treatments do not always mention all the information regarding diagnosis, gene and 
variant, so that full-text articles are needed, as well as supplementary data when 
available. A service to retrieve relevant clinical trials for a given patient is also under 
development, enabling to connect patients with experimental treatments. 
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Abstract. Consumer wearables can provide objective monitoring of movement 
disorders and may identify new phenotypical biomarkers. We present a novel 
smartwatch-based prototype, which is implemented as a prospective study in 
neurology. A full-stack Machine Learning pipeline utilizing Artificial Neural 
Networks (ANN), Random Forests and Support Vector Machines (SVM) was 
established and optimized to train for two clinically relevant classification tasks: 
First, to distinguish neurodegenerative movement disorders such as Parkinson's 
Disease (PD) or Essential Tremor from healthy subjects. Second, to distinguish 
specifically PD from other movement disorders or healthy subjects. The system was 
trained by 318 samples, including 192 PD, 75 other movement disorders and 51 
healthy participants. All models were trained and tested with hyperparameter 
optimization and nested cross-validation. Regarding the more general first task, the 
ANN succeeded best with precision of 0.94 (SD 0.03) and recall of 0.92 (SD 0.04). 
Concerning the more specific second task, the SVM performed best with precision 
of 0.81 (SD 0.01) and recall of 0.89 (SD 0.04). These preliminary results are 
promising as compared to the literature-reported diagnostic accuracy of neurologists. 
In addition, a new data foundation with highly structured and clinically annotated 
acceleration data was established, which enables future biomarker analyses utilizing 
consumer devices in movement disorders. 
Keywords. Mobile applications, artificial intelligence, machine learning, 
movement disorders 
1. Introduction 
Movement Disorders as Parkinson's Disease (PD) are primarily diagnosed via clinical 
examination. A meta-analysis by Rizzo et al. 2016 indicated that the pooled diagnostic 
accuracy is at 73.8% for general neurologists, geriatricians, or general practitioners (95% 
Credible Interval (CRI):  67.8%-79.6%) and 79.6% (95% CrI 46%-95.1%) for movement 
disorder experts regarding initial assessment and 83.9% (95% CrI 69.7%-92.6%) 
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regarding refined diagnosis after follow-up [1]. It ascertains that the overall validity of 
clinical diagnosis did not improve in the last 25 years and new biomarkers are needed, 
ideally with high availability. We present a novel mobile prototype, called the smart 
device system (SDS), which has been implemented and approved for a two-year 
prospective study [2]. The system is the first one, which captures two-side synchronous 
acceleration data from smartwatches with the integration of electronic questionnaires to 
account for early symptoms, medication, medical and family history. Health 
informaticians and movement disorder specialists designed the system, including a 
smartphone app to guide the examination step by step. Previously, we have demonstrated 
the accuracy of raw measurement data and tremor frequency detection as proof of 
concept to visualize and detect subtle movement characteristics, which are imperceptible 
to human vision [3].   
As a clinical use case, we trained a diagnosis classification model. To our knowledge, 
most of the related models (summarized in [4]) for PD deal with limited sample sizes 
(n<<100) and are overly restricted to classify PD vs healthy. However, in clinical 
practice, the neurologist does not only face people being exclusively a PD case or healthy 
case. Instead, there are many differential diagnoses with PD-similar symptoms. In these 
cases, the models mentioned above would not be applicable or would perform 
significantly poorer. To address this issue, an important disease category is part of the 
patient recruitment: movement disorders other than PD as essential tremor, atypical 
parkinsonism, secondary causes of parkinsonism, dystonia, which will be summarized 
as DD in the following. Our system is trained for two clinically relevant classification 
tasks. First, to distinguish between movement disorders (PD+DD) and healthy subjects. 
Such a system could potentially be used at home-based settings or at general practices, 
e.g. to indicate whether certain abnormal movement characteristics (e.g. hand tremor) is 
pathologic or still normal (e.g. physiological tremor). Second, to distinguish PD from the 
rest (DD + healthy), which addresses a setting in specialized practices.  
2. Methods 
Details of the study design, examination steps and feature extraction have been published 
previously [2]. Study participant's assessment starts with smartphone-based data entry 
on medication, current diagnosis, family history and early symptoms. The smartwatch-
based examination consists of ten different coordination tasks, including serials seven to 
provoke and monitor different movement characteristics while seated in an armchair. 
Altogether, the examination takes 15 minutes. The system is composed of two 
smartwatches (Apple Watch Series 4) for two-hand acceleration measurement and two 
smartphones (Apple iPhone version 7) for electronic questionnaires, examination 
guidance, watch-pairing and data transfer. These devices are connected via one central 
iOS app on the master smartphone. Sampling rate of acceleration data in all three axes is 
100 Hz. Each sample is pseudonymized and ready for real-time visualization and further 
data processing [3].  Table 1 summarizes the three aforementioned relevant study 
participants categories PD, DD and Healthy. The full list with demographic details and 
years of disease onset is provided for each sample in the supplement. It also includes 
diagnosis details of the DD cluster [5]. All diagnoses were confirmed by neurologists 
and finally reviewed by one senior movement disorder expert. The current stack of the 
data analytics pipeline is implemented in Python, illustrated in Figure 1 and includes 
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Artificial Neural Networks (ANN), Random Forests and Support Vector Machines 
(SVM) as the three main classifiers.  
 
Figure 1. Data Analytics pipeline. ANN = Artificial Neural Networks, SVM= Support Vector Machine.
  
Table 1. Class population.  
Class Sample Size Average Age 
(SD) 
PD 192 65.71 (9.61) 
DD 75 60.88 (15.58) 
Healthy 51 60.45 (14.22) 
 
TSFresh 0.12.0 is used to extract a series of general-purpose time-series 
characteristics [5]. Moreover, acceleration data is processed with Fast Fourier Transform 
to extract tremor frequencies. Amplitude-Histogram analyses are applied and checked 
for dominances on the left or right-hand side. A complete list of all extracted features 
and descriptions is given in the supplement [6]. The set of features is trained with nested 
cross-validation using five inner and five outer folds. During one inner fold, we applied 
the random undersampler from Scikit Learn 0.21.3 [7] in order to remove the bias 
towards the majority class by randomly removing samples of that set. The standard scaler 
from Scikit Learn subtracts the mean and scales to the unit variance for every feature. 
The principal component analysis (PCA) reduces the dimensionality without assuming 
independence. The Scikit Learn-based 'Select Percentile' step randomly selects a subset 
of features, which are then used for training the classifier.  While the standard Scikit 
Learn library implements SVM and Random Forests, the ANN is implemented with 
dense multi-layered perceptron networks using the KERAS 2.2.4 package and Google's 
Tensorflow 1.3.1, which provides full GPU support [8].  The whole process of model 
training and testing is wrapped by Photon-AI, a hyperparameter optimization toolbox [9]. 
During an inner fold, we optimize the hyperparameters for the PCA, the Select Percentile 
and the classifiers. We used the Scikit Learn's grid-search optimizer as our optimizer. A 
list of the full hyperparameter space is provided in our supplement [6]. 
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3. Results 
Tables 2 and 3 list the best performing models for each of the three classifiers after nested 
cross-validation. While the ANN performed best for the first task regarding average 
accuracy of 0.89 and precision of 0.94, the SVM – using radial basis function (RBF) as 
kernel – performed best in the second task with accuracy of 0.79 and precision of 0.81. 
None of the different classifiers outperformed the others when taking the overlap of their 
corresponding standard deviations into account. Details on all optimized hyperparameter 
values and best performing features are provided in the supplement [6]. Further 
classifiers, including deep neural networks, are being evaluated and discussed in the next 
section. 
Table 2. Average Performances for general classification task: Parkinson's and related movement disorders vs 
Healthy. SD= standard deviation. Rbf= Radial Basis function.  
Estimator Accuracy (SD) Precision (SD) Recall (SD) F1 (SD) 
ANN  0.89 (0.00) 0.94 (0.03) 0.92 (0.04) 0.93 (0.00) 
Random Forest 0.88 (0.04) 0.91 (0.04) 0.95 (0.04) 0.93 (0.02) 
SVM - rbf 0.89 (0.03) 0.92 (0.03) 0.95 (0.04) 0.93 (0.02) 
 
Table 3. Average Performances for specific classification task:  PD vs. Other related movement disorders and 
Healthy.  
Estimator Accuracy (SD) Precision (SD) Recall (SD) F1 (SD) 
ANN  0.77 (0.04) 0.78 (0.04) 0.90 (0.06) 0.83 (0.03) 
Random Forest 0.75 (0.03)  0.75 (0.03) 0.91 (0.04) 0.823 (0.02) 
SVM - rbf 0.79 (0.01) 0.81 (0.01) 0.89 (0.04)  0.85 (0.01) 
4. Discussion 
The more general task was evaluated with precision and recall above 90% for all 
classifiers, which highlights potential applicability in non-specialized settings as home-
based assessment or general practices. Regarding the more specific task, the average 
diagnostic accuracy (79%) of the best performing model is higher than pooled reported 
accuracy of general practitioners and comparable to movement disorder experts 
regarding initial assessment [1]. A number of machine-learning approaches share a major 
disadvantage as they are trained by retrospective data sources, with high data quality, 
which however might be illusory at real-time or point of care. A major strength of our 
mobile system is that it only requires the self-generated data from the 15 minutes 
examination being not dependent on any further patient data or external information 
systems. Thus, we are confident that our results are reproducible in prospective 
scenarios. The reported results still need to be taken with caution as our setting comes 
with general limitations: The study is conducted at a single site, and thus we cannot rule 
out bias due to specific site population, examination setting or target diagnoses. We 
recruit from a large tertiary care centre and include all types and stages of Parkinson's 
disease and other movement disorders, and therefore, we believe the training data 
provides a suitable data foundation to start from. However, as a matter of our recruitment 
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setting, only a minority of samples are Parkinson's cases with early disease stage, which 
would be the ideal population to train from. After study completion, a multi-centric study 
design is planned for 2021, which would include different outpatient clinics and home-
based assessments. At the current state, the system is to be used for scientific purpose 
only as it is not cleared as a medical device.  
We have tested several approaches towards Deep Learning with recurrent networks 
as Long-Short-Term Memories. Their performances were remarkably poorer, being not 
significantly higher than random guessing. Our sample size may not be sufficient (e.g. > 
10,000) to train a deep network that requires substantially more model parameters. As 
our data-preprocessing steps evolve and the sample size grows, we are monitoring 
different types of Neural Networks and further traditional statistical models. Apart from 
the machine-learning framework, the highly interactive research platform enables 
researchers to visualize objective movement characteristics and to have a deeper look at 
subtle characteristics within a hundredth of a second. In a previous study, we could 
visualize tremor characteristics imperceptible to non-sensor-based human vision [3]. 
This could unveil further morphological features in the future, which are not yet utilized.  
To conclude, we have generated a sensor-based data foundation to study movement 
characteristics in a broad area of different movement disorders. Machine Learning 
classifiers show high accuracy for distinguishing relevant diagnoses classes compared to 
expert-based performances. Further research is underway to show generalizability of the 
system. 
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Abstract. The rapid improvement in mobile health technologies revolutionized what 
and how people can self-record and manage data. This massive amount of 
information accumulated by these technologies has potentially many applications 
beyond personal need, i.e. for public health. A challenge with collecting this data is 
to motivate people to share this data for the benefit of all. The purpose of this study 
is to survey and examine factors that may motivate sharing this data. We asked 447 
participants four questions related to health data sharing and motivation. Participants 
with a chronic disease were concerned about data sharing but also willing to share 
health data if personalized feedback is provided. Functionality, ease of use, and 
privacy are regarded as crucial features of health apps. 
Keywords. Public health, mHealth, motivation, health surveys, health data sharing. 
1. Introduction 
The ubiquitous nature of smartphones, wearables, and sensors have revolutionized the 
way people collect health-related data. An increasing number of people collects large 
amounts of data for disease-management, fitness, and self-surveillance. In a recent study, 
more than 60% of American participants tracked various health parameters, including 
diet, weight, and physical exercise, where 21% relied on fitness tracker technology [1]. 
People with chronic diseases use different technologies, e.g. mHealth apps and 
continuous glucose monitors for diabetes management, collecting and processing health 
data for their self-management. This data can potentially be used as a secondary source 
of information for public health, including tracking of disease trends, behavioural patterns 
over time, chronic diseases status, research, and policy work [2, 3, 4, 5]. The impact of 
these self-collected data highly depends on people's willingness to share their data for 
the intended purpose. Considering the potential of these data to inform about individual 
and population health, understanding the users' expectations and willingness towards 
mass data sharing is an important area of research. Various factors could affect people's 
motivations to engage in mass data sharing, e.g. lack of trust, which is mainly  
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subject to data security, privacy, and confidentiality issues [6]. When sharing such data, 
expectation and willingness often differ in different patient groups, as well as in healthy 
people [7, 8], e.g. people with type 1 diabetes have a high need to record health data 
several times per day. Here, we examine factors related to people's knowledge and 
expectations toward raising motivation for sharing of health-related data and comparing 
these factors across different groups. 
2. Method 
We created an online survey with questions related to motivational factors around 
mHealth apps and data sharing. Questions were derived from 16 in-person interviews [6]. 
The survey was conducted among English-speaking internet users in a Swiss cohort of 
healthy people and also in English and Norwegian online diabetes groups. We collected 
data between 11/2018 and 08/2019. The questions related to data sharing are: 1) How 
concerned are participants about sharing health data, 2) what do participants expect in 
return when sharing health data, 3) which data types are participants willing to share 
anonymously for research, and 4) how important are different criteria in order to agree 
to install an application that collects and shares data from their wearable device. Options 
were on a 4-point Likert scale from "not important at all" to "very important" (including 
"I don't know"), or multiple-choice. We stratified responses into three groups: 1) People 
with diabetes (PWD), 2) people with other chronic disease and 3) people without a 
chronic disease. Details about the questionnaire are available at DataverseNO [9]. We 
report descriptive statistics on age, gender, experience using wearable devices and 
mobile health apps and wearables for sharing health or activity data. 
3. Results 
Four hundred forty-seven (447) participants finished the survey, of which eight did not 
answer whether they have a disease, and nine selected "Do not want to answer". 
Further analyses are based on the remaining N=430. Sixty-one (61) participants had 
diabetes, 82 participants had another chronic disease, and 285 had no chronic disease. 
The majority of participants came from Switzerland (187), Norway (59), 
US/UK/Australia/Canada (77), France (26), and Germany (13). Remaining 46 came 
from 35 countries covering all continents. Table 1 gives their demographics, familiarity 
with mHealth apps, and sharing experience. There was no age (p=.083) or gender 
(p=.133) difference between the groups. However, 97% in the diabetes group use a 
wearable device for collecting activity or other health data, compared to only 51% in 
the "no disease" group, and 55% in the "other chronic disease" 	


p=.001. Many PWD has experience in sharing data, less so people without a chronic 
	
19.6, p < .001. 
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Table 1. Demographics and familiarity with mHealth apps. Na= no answer. 
 With diabetes With other chronic diseases Without chronic disease 
Age: <30 y; 30-50y; >50y 15; 17; 27 (Na: 2) 9; 32; 40 (Na: 1) 34; 96; 146 (Na: 6) 
Gender: female; male; other 35; 25; 1 59; 20; 3 177; 99; 3 
Wearable device: yes; no 59; 2 44; 36 143; 137 
Sharing experience: yes; no 24; 27 (Na: 10) 22; 45 (Na: 14) 47; 160; (Na: 11) 
3.1. Technologies use for health tracking 
87% of those with diabetes use a health-specific device, in addition to often using a 
Physical Activity (PA) tracker. 3% use no sensor or wearable device. Among those 
with other- or no chronic diseases, the use of sensors integrated in the smartphone and 
PA trackers are most common. 25-30% use mobile health apps. Generally, participants 
preferred to discuss health issues with health providers. PWD would discuss it with 
others PWD (17%), but rarely with their family (6%). This is in contrast to persons with 
other- or no chronic disease, where 19% and 20%, respectively, would discuss health 
issues with their family and friends, see Figure 2b. This difference with whom to share 
was statistically significant, 2=34.67, p<.001. 
3.2. Concerns about data sharing 
Regarding what people are most concerned about sharing health data, persons with no 
chronic disease are in general least concerned, and all three groups rate storage as least 
and transparency as most concerning. Figure 1a shows how each group rate concerns 
about confidence and trust, data ownership, storage location/availability, and 
transparency of third party usage. Figure 1b shows how important certain features are 
for each group in order to agree to install an application that collects and share health 
data from their wearable device. 
 
Figure 1. a: Concerns about different aspects of data sharing. b: Importance of features, answer option 1 to 4. 
3.3. Participants expectations for sharing health data 
Regarding what participants expected in return for sharing their health data, personalized 
feedback was chosen by 60% of participants, integrated view (i.e. aggregated results), 
was chosen by 53%, decision support by 36%, and least chosen (16%) was comparing 
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status with others. There was no difference between the groups in their expectations, 
smallest p > .74, but comparing with others was rated as least important (Figure 2a). 
Figure 2. a: Expectations for sharing data. b: Group distribution of health tracking technology. 
3.4. Willingness to anonymously share given data types in a research project 
Groups do not differ in sharing lifestyle/dietary information, signs of infection, daily 
mood, geographical location, sleep duration, social environment (corrected for multiple 
comparisons). Participants are least willing to share their geographical location. Persons 
with chronic disease are more willing to share medication intake, physiological 
indicators and their weight. An overview is given in Table 2.  
Table 2. Overview of willingness to share specific health data by group. Chr. = chronic. 
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N 213 219 195 202 193 248 87 240 221 173 89 
Diabetes 53 41 31 46 29 43 20 43 43 30 5 
Other chr. 44 45 45 40 46 54 16 50 49 35 16 
No chr. 116 133 119 116 118 151 51 147 129 108 68 
2 43.48 9.05 5.22 24.39 5.73 8.93 6.92 8.29 15.48 2.87 7.59 
p-value <.001 .011 .074 <.001 .057 .012 .031 .016 <.001 .238 .023 
3.5. Features' importance in mHealth app 
Regarding which features of a health-app is important to participants (1=not important 
to 4=very important), non-disturbed tracking and automatic setup is rated by most as 
important, i.e. the main effect of feature, F(3.2= .011. All 
features were more important to people with a chronic disease, F(2, 304)=12.09, p<.001, 
2=.074. PWD rate automatic data collection as most important, yielding a significant 
interaction effect, F(7.66, 1163.75)=2.104, p=.035, 2=.014. 
4. Discussion 
Mass sharing of health data could provide vital information for individual health 
management and public health. Continuous collection of quality health-related data and 
willingness to share these are limited by the user's motivation and expectations. The rate 
of acceptance of health tracking devices among clinicians is increasing [10], but 
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retention is decreasing [11]. Compared to PWD who use wearable sensors, participants 
with no- and other chronic disease reported higher adoption of sensors integrated in the 
smartphone and PA trackers. Automatic data collection, easier interface, e.g. voice 
command, tailored and personalized feedback is likely to increase usage and long-term 
engagement in such devices. 
Concern about health data sharing is dependent on the type of data, and related 
concerns on issues such as privacy, security, confidentiality, transparency, and 
ownership. Participants with no chronic disease are less concerned compared to people 
with a chronic disease. Indeed, potential consequences of data leakage like repeated low 
blood glucose level (hypoglycemia) might result in the suspension of one's driving 
license or disqualification of health insurance enrollment in some countries. Some 
privacy and security shall be kept, i.e. many participants do not want to share their 
geographical location. 
This study on how to motivate health data sharing is a collaboration between several 
projects where different systems for health data collection are under development. 
Results from the present study, and upcoming publications on related topics, will be used 
to direct the implementations of these systems for maximum acceptance. Future works 
include data collection, data quality and accuracy analysis, and detecting health patterns 
at the population level and in people with specific chronic diseases. Fulfilment of 
participant's expectations and resolving individual concerns could motivate sharing 
health-related data. Results indicate that participants expect some kind of immediate 
benefits from sharing their data, including tailored and personalized data analysis, 
integrated view, feedback and others. Comparison of status among peers was found to 
be less relevant. 
References 
[1] J. Vitak, Y. Liao, P. Kumar, M. Zimmer, K. Kritikos (eds.), Privacy Attitudes and Data Valuation Among 
Fitness Tracker Users, Cham: Springer International Publishing, 2018. 
[2] J. Chen, A. Bauman, M. Allman-Farinelli, A Study to Determine the Most Popular Lifestyle 
Smartphone Applications and Willingness of the Public to Share Their Personal Data for Health 
Research, Telemed J E Health 22(8) (2016), 655-65. 
[3] K.T. Pickard, M. Swan, Big Desire to Share Big Health Data: A Shift in Consumer Attitudes toward 
Personal Health Information, 2014 AAAI Spring Symposium Series, 2014. 
[4] K. Ostherr, S. Borodina, R.C. Bracken, C. Lotterman, E. Storer, B. Williams, Trust and privacy in the 
context of user-generated health data, Big Data & Society 4(1) (2017). 
[5] A. Seifert, M. Christen, M. Martin, Willingness of Older Adults to Share Mobile Health Data with 
Researchers, GeroPsych 31(1) (2018), 41-9. 
[6] AZ. Woldaregay, D.Z. Issom, A. Henriksen, H. Marttila, M. Mikalsen, et al., Motivational Factors for 
User Engagement with mHealth Apps, Studies in health technology and informatics 249 (2018), 151-7. 
[7] K.K. Kim, J.G. Joseph, L. Ohno-Machado, Comparison of consumers' views on electronic data sharing 
for healthcare and research, J Am Med Inform Assoc. 22(4) (2015), 821-30. 
[8] D.J. Willison, V. Steeves, C. Charles, L. Schwartz, J. Ranford, et al., Consent for use of personal 
information for health research: do people with potentially stigmatizing health conditions and the general 
public differ in their opinions?, BMC Med Ethics 10 (2009), 10. 
[9] A. Henriksen, A.Z. Wolderegay, D-Z. Issom, G. Pfuhl, A. Richard, et al., Questionnaire for motivation 
in mobile health, DataverseNO V1, 2019. https://doi.org/10.18710/28SRMJ 
[10] M. Bradway, L. Ribu, G. Hartvigsen, Årsand E, The evolution of clinicians' preparedness for mHealth 
use (2013-2017) and current barriers, Proceedings from the 16th Scandinavian Conference on Health 
Informatics 2018, Linköping University Electronic Press, Denmark, 2018.  
[11] C. Attig, T. Franke, Abandonment of personal quantification: A review and empirical study 
investigating reasons for wearable activity tracking attrition, Computers in Human Behavior 102 
(2020), 223-37. 
A.Z. Woldaregay et al. / User Expectations and Willingness to Share Self-Collected Health Data898
Section 5 
Human Factors and Citizen Centered Digital 
Health 
This page intentionally left blank
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Abstract. In Argentina, since 2012 the Gender Identity Law guarantees that people 
who identify as transgender must be called by their chosen name, among other 
things. Transgender patients are usually not represented in information systems, 
whether electronic or not. This can place them in situations of vulnerability and 
discrimination. With that in mind, an interdisciplinary team was formed to take 
address the problems of this population regarding to the information systems of 
Hospital Italiano de Buenos Aires. The aim of this study is to spread the 
experience of the transdisciplinary team on the Electronic Health Record’s 
modification and other associated applications to achieve include the self-
perceived gender identity and the chosen name of those people who modified their 
gender. 
Keywords. Transgender, Electronic Health Record, User-centered design, 
prototype 
1. Introduction 
In health systems it is common that people who identify with a different gender or 
name than the one that was assigned to their birth, suffer discrimination [1] by both 
administrative and healthcare staff. According to a survey conducted by INDEC and 
INADI in 2012 [2], three out of ten transgender or transvestite women present stories  
of abandonment of medical treatment due to discrimination in health institutions. For 
the same reason, five out of ten, stopped going to hospitals. The same study also 
indicates that a significant barrier to access the health system is the lack of coverage. It 
is estimated that 80% of this population does not have access to health insurance or 
prepaid medicine [3]. 
Gender identity is understood as “the internal and individual experience of gender 
as each person feels it, which may or may not correspond to the sex assigned at the time 
of birth, including the personal experience of the body. This may involve the change of 
the appearance or body function through pharmacological, surgery or other methods, 
when it is freely chosen. It also includes other gender expressions, such as dress, speech 
and manners” [4] 
According to a study carried out by Fundación Huésped in 2011 [5] about the 
perceptions and experiences of stigma and discrimination in populations of trans 
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women, men who have sex with men and drug users, it was found that trans women 
were the most systematically excluded group from an early age and that their social 
welfare was below expectations due to stigma and its consequences, such as the legal 
non-recognition of their identity. 
In 2012, Law 26743 of “Gender Identity” [4] is sanctioned in Argentina, which 
defines in its Article n°1 that every person has the right: 
To the recognition of their gender identity; 
To the free development of his person according to his gender identity; 
To be treated accordingly to their gender identity and, in particular, to be identified 
in this way in the instruments that prove their identity regarding to the name, image and 
sex with which it is registered there. 
The Ministry of Health of the Argentinian Republic, issued a "Guide for health 
teams" on comprehensive health care for transgender people [6]. This guide mentions 
that people must be respected in their name and gender of choice within the health 
system, both with respect to the physical place of hospitalization and in the registration 
instruments (medical history, certificates, records, etc.). 
There’s plenty bibliography about the inclusion of sex, gender and chosen name in 
in electronic health records [7][8][9][10][11][12][13][14]. Reviewing all of these 
papers, we could agree that there is a general consensus that these changes can 
positively affect this population's quality of care and medical attention. 
1.1. Situation in Hospital Italiano de Buenos Aires 
The Hospital Italiano de Buenos Aires (HIBA) it is a private hospital, of high 
complexity that has 780 beds, 40,000 hospitalizations per year and more than 2 million 
outpatient consultations. Within its structure is the Department of Health Informatics 
that develops the information systems within the institution. Since 1995, the Hospital 
has an electronic information system that covers both the assistance and administrative 
and management areas. The department is responsible both for the design of the tools 
and also for the storage’s optimization and information retrieval with the aim of 
increasing patient safety, reducing error and increasing quality of care. 
The HIBA has an application for the registration of patients. In 2017, with the 
objective to apply Law 26743 to the Master Patient Index (MPI), it was decided to 
develop a modification in it [15] with the aim of include the different identities that 
coexist in the Argentine territory as well as the use of the chosen name for people 
identification. 
Analyzing the current bibliography and the sanctioned Argentine law, the 
possibility of registering the following items within the MPI was added: 
 Chosen name 
 Self-perceived gender identity (with structured fields: Man, 
Woman, Trans - man, Trans - woman, Intergender, Other) 
After the implementation of the change in the registration system, the work team 
raised the need to include this information into the Electronic Health Record (EHR) so 
that the self-perceived gender identity and the chosen name are available to all 
healthcare professionals. 
Because of that, the Department of Health Informatics is currently working on the 
visualization of this new information in the differents availables applications: from the 
patient caller system located in the waiting rooms, to Electronic Health Record, where 
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health professionals will have a comprehensive record that will allow them to provide 
holistic healthcare. 
The aim of this study is to spread the experience of the transdisciplinary team on 
the EHR’s modification and other associated applications to achieve the inclusion of 
self-perceived gender identity and the chosen name of those people who modified their 
gender. 
2. Methods 
In the meetings held with the healthcare team that take care of the trans population, the 
following needs were detected: 
 View the name chosen as well as the name that appears on 
the National Identity Document (DNI). 
 Known the person's biological sex and self-perceived gender. 
 Identify which organs related to biological sex the person has [16]. 
 Identify what surgeries or hormonal treatments the person received 
[17]. 
 
The Health Informatics work team decided to divide these needs into two work 
stages; 
First stage: within this first stage, we worked on the visualization of the people’s 
identification information (chosen name, DNI name, biological sex and self-perceived 
gender) in the different applications. 
Second stage: it was defined to focus the second stage of work on the needs 
related to clinical care: organs, surgeries and hormonal treatments of patients. 
In this study we will focus mainly on the description of the work done during the 
first stage of the project. 
Based on the need detected in the healthcare staff to be able to visualize the 
identification information of the people, it was decided to carry out the card sorting 
technique in a random way to different people from the HIBA (nurses, physicians, 
administrative staff). This technique is used to investigate how users think that 
information on digital products should be organized and / or categorized. Because the 
HIBA’s EHR has iconography to represent the gender of the patients, for this work, the 
“card sorting” technique was used to identify the knowledge that the staff had about the 
icons that represent trans and intergender identity. After this process, we proceeded to 
choose the icon that represents the transgender population of Argentina to be included 
in the EHR. 
Then, different prototypes of the EHR that contemplate the person's chosen name, 
the surname corresponding to the DNI and the initials of the DNI name in parentheses, 
were designed. 
 
Structure: [First name + last name + (initials first name + initials last name)] 
(Figure 1) 
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Figure 1. Representation in the EHR 
 
These designs were prototyped and tested with end users who were unaware of this 
project. This process will be published in another research paper. 
As part of the inquiries and while the design was being made for the EHR, a 
meeting was held with representatives of the Health Secretariat of the Argentine LGBT 
Federation (FALGBT) in order to showing them the prototype created for the EHR and 
the election of iconography for gender representation. 
During this meeting the FALGBT provided advice on the visualization of 
information, privacy/confidentiality of data and information regard to trans and 
intergender identities. They considered that the presented prototype was adequate to 
represent transgender identities. Also, they suggested continuing with the second stage 
(detailed above) in order to integrate this information with the patient's clinical 
information. 
3. Conclusions & Discussion 
Throughout this process, we re-discovered the importance of teamwork and the added 
value that interdisciplinarity gives. Having user-centered design specialists and health 
professionals with informatics orientation within the team, allowed a holistic vision 
when devising the solution for the correct identification within the EHR. 
Besides it was very important the opportunity to have meetings with health 
professionals at the time of making the inquiries, validating the information and being 
able to detect their needs to continue the path towards inclusion. 
Our next step is to incorporate a list of surgeries, hormonal treatments and other 
clinical data relevant to the care of this population. 
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Abstract. Clinical decision support systems (CDSSs) provides vital information for 
managing patients by advising clinicians through an alert or reminders about adverse 
events and medication errors. Clinicians receive a high number of alerts, resulting 
in alert override and workflow disruptions. A systematic review was carried out to 
identify factors affecting CDSS alert appropriateness in supporting clinical 
workflows using a recently introduced framework. The review findings identified 
several influencing factors of CDSS alert appropriateness including: technology 
(usability, alert presentation, workload and data entry), human (training, knowledge 
and skills, attitude and behavior), organization (rules and regulation, privacy and 
security) and process (waste, delay, tuning and optimization). The findings can be 
used to guide the design of CDSS alert and minimise potential safety hazards 
associated with CDSS use.  
Keywords. CDSS, Alert fatigue, Alert override, Framework, Appropriateness, 
Clinical workflow  
1. Introduction 
Clinical decision support systems (CDSS) has widely been implemented to improve care 
quality, patient safety, reduce costs and enhance healthcare outcomes [1]. CDSS 
encompasses various tools such as automated alerts and reminders that provide its users 
with information that can enhance clinical decision making [2] through evidence-based 
recommendations to clinicians at the point of care [3]. Despite the wide adoption of 
CDSS, clinicians receive numerous alerts, leading to a phenomenon known as ‘alert 
fatigue’ [4]. These alerts are meant to avoid possible safety risks, such as drug-drug 
interactions (DDI) and allergies.  
However, clinicians override relevant and irrelevant alerts, which may lead to 
adverse events or unintended patient harm. A significant reason for alert override is 
disruption in clinician’s workflow [5]. Therefore, evaluating the appropriateness of 
CDSS alerts and its effect on workflow enables us to understand how alerts can be 
triggered effectively to support clinical workflow. This paper presents a systematic 
review on factors affecting CDSS alert appropriateness in supporting clinical workflow. 
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2. Theoretical background  
The new framework for evaluating CDSS alert appropriateness in clinical workflow is 
proposed based on critical review and adaptation from previous health information 
technology framework including Human-Organization-Technology-fit (HOT-fit) [6,7], 
Human Automation and Interaction (HAI), [8], business process management (BPM) life 
cycle [9], and Systems Engineering Initiative for Patient Safety (SEIPS) [10] (Figure 1).  
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Figure 1. CDSS appropriateness framework 
3. Methodology  
This review seeks to answer “what are the factors affecting CDSS alert appropriateness 
in supporting clinical workflow?”. The review followed the guidelines of Preferred 
Reporting Items for Systematic Reviews (PRISMA). Bibliographic databases namely 
PubMed, Scopus, ACM, Science Direct, IEEE, Ovid Medline, and Ebscohost, were 
searched for relevant literature from 1997 to 2018. The search was conducted on October 
11, 2018 to February 28, 2019. The following keywords such as clinical decision support 
system (CDSS), alert fatigue, alert override, electronic health record (EHR), electronic 
medical record (EMR), health information system (HIS), were used to search the 
databases. We included studies on features and functions pertinent to CDSS alert 
appropriateness and alert and workflow related problems in healthcare settings. Studies 
on medical devices with alarms and beeps, such as physiological monitors, ventilators, 
and pumps, were excluded. A quality assessment tool known as Critical Skill Appraisal 
Program (CASP) for qualitative, quantitative and retrospective study was used to 
evaluate the quality of the selected articles.  
The bibliographic databases returned 9769 publications. Then, 8899 titles and 
abstracts were initially screened, and 7796 were excluded. In summary, 76 papers were 
obtained (64 main papers and 12 additional papers from citation chaining). Deductive 
data analysis was conducted based on the proposed evaluation framework dimensions 
and measures, whereas inductive analysis enabled us to identify new themes and sub-
themes such as knowledge base, alert flexibility, alert content and workload which are 
categorized under system design and implementation dimensions.  
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4. Results 
Table 1 highlights key factors affecting CDSS alert appropriateness in supporting clinical 
workflow.  
 
Table 1. Factors affecting CDSS alert appropriateness in supporting clinical workflow 
  
Technology Human Organization  Process 
System design 
Alert content (N = 14) 
specificity/ sensitivity (N = 
7) 
Usability (N = 7) 
Alert presentation (N = 7) 
Alert flexibility (N = 7) 
Knowledge base (N = 5) 
System implementation 
Workload (N = 8) 
Hardware and software (N 
= 7) 
Documentation (N = 6) 
Communication (N = 6) 
Information acquisition 
Knowledge and skills (N 
= 5) 
Training (N = 5) 
Information analysis 
Perception (N = 7) 
Behavior (N = 6) 
Attitude (N = 3) 
 
Policy and procedure 
Privacy and security (N 
= 5) 
Rules and regulations (N 
= 3) 
 
Process analysis 
Waste (delay (N = 6); others 
 N = 6)) 
Process redesign 
Modification (N = 7) 
Process mapping (N = 1) 
Process implementation 
Automation (N = 9) 
Process monitoring/ 
improvement 
Bottleneck (N = 7) 
Tuning and optimization (N = 
4) 
 
  
Technology. Usability problems such as illegible screens, excessive mouse clicks and 
poorly designed drop-down menus that are counter-intuitively arranged, disrupts 
clinician’s workflow [11,12]. Moreover, alert fatigue and override persists because alerts 
do not indicate severity levels (i.e., mild, moderate and severe) [12]. Alerts should 
contain reliable and clear text messages that can inform or enhance clinician’s decision 
making. Studies reports that knowledgebase problems such as poorly categorized codes 
and wrongly configured default settings contributes to adverse events and medication 
errors [13,14]. Therefore, CDSS rules, codes, and default settings must be properly 
modified to present accurate and up-to-date information to users during patient care [14]. 
Poorly implemented CDSS has created additional problems for busy clinicians such as 
workload, data entry burden, system downtimes, hardware and software breakdown 
[1,14]. For instance, system is down when the hardware and software cannot handle 
transaction loads [1]. Software malfunctions such as outdated versions of operating 
systems and system lockout hindered clinicians from entering and verifying orders 
[14,15]. Successful implementation of CDSS requires a proper understanding of clinician 
workflow to ensure the fit between them.     
  
Human. Inadequate knowledge and skills hindered clinicians from using CDSS with its 
alert function effectively [1,16]. For example, incompetent clinicians cannot create, view, 
and adjust reminders (e.g., removing inapplicable reminders). Clinicians without any 
formal training or education on how to use CDSS might engage in self-learning, which 
leads to alerts misinterpretation [1,15]. However, most clinicians agree that hands-on 
training will improve their skills in handling CDSS [14,16]. Clinician’s attitude towards 
alerts depends on how alerts are displayed (i.e. intrusive or interruptive) during workflow 
[17]. CDSS alert that provides irrelevant information can subconsciously change 
prescriber’s behavior during prescription [5].   
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Organization. Flawed organizational policies and procedures can contribute to CDSS 
failure and workflow disruption. Hospital rules and regulations resulted in rigid task 
execution such as inability to adjust alert settings [17], tedious process of overriding 
password and justifying alert override prior ordering [18]; inability to access most 
CDSS features due to the security measures [19]; conflicting alerts; [20]; and silenced 
low-level alerts for drug-drug interactions (DDI) [21].  
 
Process. Delays caused by system downtime impedes patient flow and disrupts 
clinician’s workflow [22]. Examples include a lockout system feature that hindered 
clinician from ordering medication, resulting delays in prescribing medication; switching 
between screens and overriding alert caused non-value added activities (i.e. waste); [23]. 
Monitoring recurring errors and identifying bottlenecks such as alert fatigue, alert 
overload during the clinical process will minimize workflow disruption [13]. In addition, 
tuning and optimization strategies such as the use of alert evaluation dashboard to 
monitor alert override rates or physician response to alerts will prevent recurring errors 
and subsequently enhance clinician’s workflow [23].  
 
5.  Discussion and conclusions  
 
This review evaluated CDSS alert appropriateness that was mostly contributed by 
technology factors, particularly system design that is related to alert content, accuracy, 
and usability. Process factors are the second highly influencing factors where waste, 
including delay, and bottleneck from the use of CDSS alert required process modification 
and redesign to improve workflow efficiency. Human factors reported negative user 
perception and behavior towards CDSS alerts that are highly influenced by poor system 
design, followed by inadequate skills and training. Disruptive CDSS alerts that affect 
clinical processes were highly reported. Therefore, CDSS must be well designed to 
support clinical tasks, workflow, and cognitive activities and aligned with the socio-
technical aspects. Organizational policies and procedures should be flexibly adapted to 
accommodate CDSS implementation. Continuous process improvement methods such 
as BPM and Lean can be implemented to identify and eliminate inefficient clinical 
processes impeding the fit between technology, human, organization. Our findings 
indicate the usefulness of the proposed evaluation framework in addressing alerts and 
workflow problems in clinical settings. Future studies should address cognitive work 
challenges or activities that impede the use of CDSS alerts. 
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Analysing Sentiment and Topics Related to 
Multiple Sclerosis on Twitter 
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Abstract. Background and objective: Social media could be valuable tools to 
support people with multiple sclerosis (MS). There is little evidence on the MS-
related topics that are discussed on social media, and the sentiment linked to these 
topics. The objective of this work is to identify the MS-related main topics 
discussed on Twitter, and the sentiment linked to them. Methods: Tweets dealing 
with MS in the English language were extracted. Latent-Dirilecht Allocation 
(LDA) was used to identify the main topics discussed in these tweets. Iterative 
inductive process was used to group the tweets into recurrent topics. The sentiment 
analysis of these tweets was performed using SentiStrength. Results: LDA’ 
identified topics were grouped into 4 categories, tweets dealing with: related 
chronic conditions; condition burden; disease-modifying drugs; and awareness-
raising. Tweets on condition burden and related chronic conditions were the most 
negative (p<0.001). A significant lower positive sentiment was found for both 
tweets dealing with disease-modifying drugs, condition burden, and related 
chronic conditions (p<0.001). Only tweets on awareness-raising were most 
positive than the average (p<0.001). Discussion: The use of both tools to identify 
the main discussed topics on social media and to analyse the sentiment of these 
topics, increases the knowledge of the themes that could represent the bigger 
burden for persons affected with MS. This knowledge can help to improve support 
and therapeutic approaches addressed to them. 
Keywords. Multiple sclerosis, Twitter, natural language processing, sentiment 
analysis, topic modelling 
1. Introduction 
Multiple Sclerosis (MS) is the leading cause of non-traumatic neurological disability in 
young adults [1]. In order to successfully self-manage such a chronic condition, 
patients require to learn about and manage their symptoms and problems [2-4]. 
Moreover, they also need social support that enhances the awareness that they are cared 
for. 
Social support is known to be an important aspect for persons with MS (pwMS) 
[5-7]. However, problems in societal participation, such as reduced interactions with 
family or friends, are common among people affected by this condition due to physical 
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disabilities and MS fatigue [8]. In this sense, the ubiquity of social media and their 
great potential to engage and communicate with others could make these channels 
valuable tools to support pwMS [9-10]. PwMS using social media could benefit from 
communities that share content linked to positive sentiment, as positive emotion 
motivates cooperation [11]. However, there is not much evidence on what are the 
topics being discussed on social media related to MS, and if these topics are linked to 
positive sentiment, and therefore could provide the needed social support. 
The objective of this work is to identify the main topics related to multiple 
sclerosis that are discussed on Twitter, and to analyse the sentiment polarity linked to 
these topics. 
2. Methods 
We collected tweets from Twitter using the Twitter API matching the query: #ms OR 
#multiplesclerosis OR "multiple sclerosis” that were posted between February 9th 2019 
and June 26th 2019, and were in English language.  
In order to identify the topics discussed in these tweets, we utilized Latent-
Dirilecht Allocation (LDA) [12]. LDA is a generative statistical model that assigns to 
each document (e.g., a single tweet) a probability to belong to each topic of a list of 
topics which number is fixed and usually small[13]. We pre-processed each tweet with 
the following steps: 1) All URLs were removed using the following regular expression: 
https?://[[:alnum:][:punct:]]*; 2) All tweets were tokenized2; 3) All tokens were 
lemmatized using the R packages textstem3 and lexicon4; and 4) Tokens were filtered to 
remove stop words using stopword lists from R packages lexicon and tm [14] (English 
stopwords). 
We built a document-term matrix from the lemmatized and filtered tokens of all 
tweets collected. Then we trained an LDA model using the 47,852 original English 
tweets posted between February 9th and May 2nd 2019 and 20 topics. We fine-tuned 
LDA hyper-parameters using a differential evolution algorithm [15] with R package 
DEoptim [16] with 200 iterations and a population size of 30. For each population 
member (a pair of values for hyperparameters) considered, an LDA model was 
generated using a random sample of 80% of the training data. The model was then 
evaluated computing the perplexity of the other 20% of the training data. At the end, 
we obtained hyperparameter values 0.292217 and 0.026492 that were used for the final 
model.  
The sentiment analysis of the tweets was performed on the whole dataset (74,076 
tweets) using SentiStrength[17]. This software is specially designed to analyse the 
sentiment in short texts by assigning two scores: the intensity of the positive sentiment 
(1 to 5) and the intensity of the negative sentiment (-1 to -5). To apply SentiStrength, 
all tweets were allocated in plain text file, which means that unicode special characters 
were removed from the original text. As a result of the analysis every tweet was 
assigned a positive and negative sentiment score. 
                                                        
2 https://cran.r-project.org/web/packages/text2vec/index.html 
3 https://cran.r-project.org/web/packages/textstem/index.html 
4 https://cran.r-project.org/web/packages/lexicon/index.html 
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The treatment of personal information for this study was approved by the data-
protection officer at the University Hospital of North Norway (Ref:02275). 
3. Results 
The API extracted a total of 74,076 original tweets (i.e., not retweeted) on MS written 
in English. The sentiment analysis showed an average positive strength of 1.6 
(SD=0.8); and a negative strength of -1.78 (SD=1.0) on the extracted MS tweets. 
The 20 topics identified with LDA were analysed and recurring themes were 
identified and grouped into 4 main topics through an iterative inductive process. These 
4 topics dealt with: Related chronic conditions; Condition burden; Disease modifying 
drugs; and Awareness raising. Table 1 summarizes the main keywords identified with 
LDA and included in each of the topics. 
Table 1. Recurring MS’ topics identified with LDA and grouped through iterative 
inductive process 
Topic Keywords included 
Related chronic 
conditions 
Autoimmune; autoimmune_disease; parkinsons; alzheimers; rheumatoid; 
rheumatoid_arthritis; chronic_illness; crwriter; neurodegenerative; mental; 
Gofundme; injury; nervous; nervous_system; spinal; central; spinal_cord; 
central_nervous; cord; brain_injury 
 
Condition burden Sign; ms_symptom; symptom_ms; quality_life; quality; warn_sign; sign_ms; 
sign_symptom; early_warn; risk_multiple; Cbd; cancer; marijuana; pain; dying; 
chronic_pain; bill; spasm; plea; cancer_multiple; Diagnose_multiple; diagnose; 
letsbeatms; intezaarnakaro_letsbeatms; inzaarnakaro; visit_intezaarnakaro; 
suffer_multiple; income; disability_progression 
 
Disease modifying 
drugs 
Cell; immune; sclerosis_patient; therapy; stem; trial; stem_cell; immune_system; 
disease_modify; phase; Drug; relapse; fda; approve; fda_approve; remit; 
treat_multiple; relapse_remit; oral; novartis 
 
Awareness raising Goal; goal_multiple; blog; count_donation; sclerosis_count; donation_donation; 
raise_goal; donation; count; energy; Month; awareness_month; march; 
ms_awareness; sclerosis_awareness; awareness; awareness_week; hob; ov; 
march_multiple 
When comparing the sentiment polarity of tweets, we find that those with a lower 
sentiment polarity are the ones with a probability >0.6 to belong to the topics “disease 
modifying drugs” and “condition burden” (1.40 and 1.44 respectively, vs 1.60 for all 
other tweets, t-test p<0.01). Only tweets on awareness raising had a higher positive 
strength than the average (1.80 vs 1.60, t-test p<0.01). On the other hand, the tweets 
with a more negative strength were the ones dealing with condition burden and related 
chronic conditions (-2.53 and -2.14 respectively, vs -1.78, t-test p<0.001). Only tweets 
on awareness raising and disease modifying drugs had lower negative strength than the 
average (-1.23 and -1.61, vs -1.78, t-test p<0.05). Table 2 shows the average sentiment 
positive and negative sentiment values of the tweets with a probability >0.60 to belong 
to one of the 4 identified LDA topics, (t-tests compare the sentiment of these tweets 
with the tweets within the same topic with a probability <0.60).  
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Table 2. Average sentiment of tweets with a probability >0.60 to belong to each topic 
LDA topic Number 
of tweets 
Positive 
Mean (SD) 
Negative 
Mean (SD) 
Related chronic conditions 1106 1.58 (0.6)* -2.14 (1.3)* 
Condition burden 2256 1.44 (0.6)* -2.53 (1.3)* 
Disease modifying drugs 1749 1.40 (0.6)* -1.61 (0.7)* 
Awareness raising 1171 1.80 (0.7)* -1.23 (0.6)* 
ALL TWEETS 74076 1.60 (0.8) -1.78 (1.0) 
* Students t-test, p<0.01 
4. Discussion 
The MS topics discussed on Twitter that were identified with LDA, and that we 
grouped into four main categories, are consistent with the topics discussed in a recent 
publication on MS Facebook groups [18]. The importance of information and 
awareness, treatment related issues, and other MS-related symptoms was also key in 
that study [18]. 
It is well-known that people affected with chronic conditions, such as MS, carry 
painful emotions in need of sharing [19], and that expressing these emotions is linked 
to feelings of relief and alleviation [20]. In our study we found that Tweets dealing 
with disease-modifying drugs, condition burden, and related chronic conditions had a 
significant lower positive sentiment than the average of Tweets on MS; tweets on 
condition burden and related chronic conditions were the most negative ones. These 
could represent the topics with more emotional burden for those affected with MS, and 
therefore the topics for which they should receive greater social support. This is in line 
with other literature on reported feelings of pwMS[5]. 
Strengths and limitations: Our study has several limitations. We extracted tweets 
using the standard Twitter API, that did not index all tweets published in the considered 
dates, and therefore, the data extraction might not be representative, and should be 
considered as a random sample of tweets on MS. Relevant content may not have been 
included due to our search strategy. Additional research could consider including other 
keywords related to MS, expand the search by including other languages, include other 
social media channels, analyse emojis and metadata such as users’ profiles. We used 
SentiStrength software to conduct the sentiment analysis of the collected tweets on MS. 
This software has not yet been validated for use in the health domain. However, it was 
developed using posts on Myspace and shows a good performance with informal text, 
such the ones that can be found on Twitter. 
Conclusions: The use of tools to identify main discussed topics on social media, 
and to analyse the sentiment of these topics increases the knowledge of the themes that 
could be representing the bigger burden for people with MS. This knowledge can help 
to improve support and therapeutic approaches addressed to people with multiple 
sclerosis. 
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Automatic Interpretation of Laboratory 
Tests and Its Influence on Follow-up  
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Abstract. Failing to follow up on the abnormal test results can cause serious health 
problems to patients. We conducted a retrospective medical record review of 3200 
randomly selected patients aged 18 to 76 in 14 state clinics and two private laboratory 
services querying the common regional patient registry. One patient could be 
included (1 clinical case) in the study only once. We invited patients to take part in 
the interviews to gain a deeper understanding of the motives to follow up or not after 
receiving a recommendation and explanation of the role of the automatically 
generated interpretation in this decision. A qualitative study of the patients’ 
motivation was performed with a group of 689 patients. All the patients who received 
their interpretations showed a much higher follow-up rate (68% average) than the 
patients who did not receive interpretations (49 % average).  The results of our 
research demonstrated that there is a significant impact on the patients’ decision to 
follow up on the tests. Patients consider time factor as an important advantage of the 
computer interpretations and are willing to get automatic interpretations if they can 
receive it faster than the ones from their doctor (question 4: median =3 out of 7).  
Discussing the reasons behind the decision to follow up, the patients do trust the 
computerized clinical decision support systems (question 5: median = 5 out of 7), 
however, they prefer to receive interpretations and recommendations from doctors 
(question 3: median = 7). 
Keywords. laboratory test, interpretations, decision support systems, follow-up 
1. Introduction 
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traction in helping patients in various clinical situations [9; 19]. Such systems can produce 
patient-specific reminders, interpretations, and recommendations motivating a more 
appropriate delivery of care [10; 14]. For example, such systems are used to interpret 
laboratory test results [16], alert about vital signs being outside of a reference interval [1], 
support in dietary questions [5; 20], and many other critical issues. The effect of CDSSs 
on laboratory test ordering was assessed in several systematic reviews [6; 13; 15]. These 
reviews determined that, when integrated into clinical workflow, CCDSs have a positive 
influence on the process of test ordering by the doctors. However, when the decision to 
run a diagnostic test or to follow up on a test is switched from a doctor to a patient, the 
effect of a CDSS can be very strong. Direct access of patients to the test results can lead 
to the patients becoming better-informed [4], more engaged [8], and able to manage their 
care more efficiently [21]. Another potential benefit is improving patient safety. Casalino 
et al. discovered that 8–26% of abnormal test results are not followed up in a timely way 
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[3]. Pillemer et al. demonstrated that access to test results is appreciated by patients and 
increases adherence. However, it may cause patient nervousness and increase the number 
of visits [12]. Direct access to the test findings may let patients pursue a proper follow-
up rate. A major concern expressed in [18] is that direct access can cause excessive patient 
nervousness because they can face difficulties interpreting the results. Interpretations 
given by a CDSS can support patients as they proved to deliver correct interpretations, 
provide great user experience, and are generally accepted by the patients [16]. A good 
and timely provided interpretation of the laboratory tests results given to patients by a 
CDSS, especially in the situation when a patient does not visit a doctor after the test is 
done can help to decide how to proceed with the diagnosis without support from a 
healthcare professional. The objective of the research is to study how patients perceive 
the interpretations of the laboratory tests automatically generated by a clinical decision 
support system in comparison with the interpretations given by doctors and how this 
affects the follow-up rate. 
2. Methods 
A clinical decision support system provides interpretation of laboratory test results for 
patients [11]. The common regional patient registry with obligatory registration of all 
laboratory tests helps to identify all testing events for every patient, including a list of 
tests that the patient ordered. We conducted a retrospective medical record review of 3200 
randomly selected patients aged 18 to 76 querying the common regional patient registry. 
One patient could be included (1 clinical case) in the study only once. We studied 4 groups 
of patients: 
1. The patients from the first group received their test interpretations automatically 
generated by a clinical decision support system with a clear indication that the 
interpretation was done automatically by a clinical decision support system. 
2. The patients from the second group received their interpretations personally from a 
doctor with a clear indication that the interpretation was done automatically by a 
clinical decision support system. 
3. The patients from the third group received their interpretations from a doctor with 
no indication of their automated generation. 
4. The patients who did not receive any recommendations, only the test results.  
We selected six laboratory tests commonly done by the patients (86.4% of all 
laboratory tests ordered in 2018), for which a decision support system could generate 
interpretations. Interpretation of each test with abnormal results included a 
recommendation to run another specific laboratory test or to repeat the same test again 
depending on the conditions of the patient. Participants were randomly selected for each 
group, using Random Sampling method, that ensured comparability to Russian 
demographic distributions. The reference intervals for the patients were taken from the 
recommendations of the Ministry of Health of the Russian Federation. We considered test 
results to be abnormal only if they were at least 20% outside of the reference range 
because it indicated a danger or potential risk for the patient's well-being over time. 
A follow-up rate was calculated as a ratio of the number of patients who referred to 
a laboratory service for a follow-up investigation after receiving a recommendation within 
two weeks after the first test with abnormal test results had been completed and the 
interpretation was delivered to the patient. We calculated only the follow-up rate for the 
patients that had a recommendation to run additional laboratory tests. We invited patients 
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from groups 1 and 2 to take part in interviews to gain a deeper understanding of the 
motives to follow up or not after receiving a recommendation and the role of the 
automatically generated interpretation in this decision. The patients were invited by email 
and personal telephone calls. Patients were eligible for the study if they were 18 years 
and older and received a laboratory test interpretation during the previous months. We 
invited all the patients (1600) from groups 1 and 2 to participate in the interviews, 836 of 
them accepted the invitations: 421 from group 1 and 415 from group 2. From the patients 
who agreed, we formed a study group to represent the initial study population in terms of 
gender and age. Based on these constraints, we formed a group of 689 patients to run the 
study. The study was performed using one-on-one structured interviews. We asked the 
patients to rate questions 2–5 based on a Likert scale from 1 (not at all) to 7 (very much) 
[7]. For question 1, there were two possible answers: “yes” and “no”. The interviews were 
done by one researcher by phone or in person. The interview agenda was developed by 
the project team and reviewed and accepted by the ethics committee of the regional 
Department of Health. Before the interview, the patients were informed about the goals 
of the research and received a printed declaration of anonymity and confidentiality. Every 
patient had signed a consent form before the interviews began. Interview agenda for the 
patients consisted of the following questions: 
1. Q1: Did you notice that the recommendation was generated automatically? 
2. Q2: Do you think the fact that the interpretations are done automatically affect your 
decision to follow up? 
3. Q3: Do you think doctors will give a more precise and valid interpretation? 
4. Q4: Would you wait to get a recommendation from a doctor rather than get an 
immediate interpretation from a CDSS? 
5. Q4: Do you trust the interpretation given be a clinical decision support system? 
3. Results 
The demographic data of the patients were recorded from the regional patient registry and 
presented in Table 1. 
Table 1. Demographic characteristics of the patients  
Gender Group 1 Group 2 Group 3 Group 4 Age Total 
Age >=60 
19.4% 
<60 
80.6% 
>=60 
19.4% 
<60 
80.6% 
>=60 
19.4% 
<60 
80.6% 
>=60 
19.4% 
>60 
80.6% 
  
Males 47.0% 46.75% 47.38% 46.38% 38.8 46.87% 
74 302 70 304 76 303 72 299 
1500 
 
Females 53.0% 53.25% 53.62% 53.62% 39.4 55.13% 
97 327 95 331 97 324 99 330 
1700 
 
Total 171 629 165 635 173 627 171 629  3200 
The follow-up rates for every group of patients are shown in Table 2. 
Table 2. Laboratory test follow-up rate for every group 
Gender Group 1 Group 2 Group 3 Group 4 
                             Age >60 <60 >60 <60 >60 <60  >60 <60 
Males 59%  60% 73% 74% 75% 79% 48% 42% 
Females 61% 61% 72% 75% 73% 80% 55% 49% 
Total, age-dependent 55% 61% 72% 75% 74% 80% 49.7% 46% 
Total 58% 74% 78% 49% 
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Average follow-up 
with interpretations 
68%  
 
Patients’ attitude to the automatic test interpretations is presented in the table 3. 
 
Table 3. Patients’ attitude to the automatic test interpretations 
Question Group 1 Group 2 Total 
Mean Median Mean Median Mean Median 
Q1 3.4 4 
 
3.1 3 
 
3.3 3 
Q2 6.8 7 6.1 7 6.2 7 
Q3 3.1 4 3.4 3 3.3 3 
Q4 5.9 5 5.7 5 6.8 5 
 
4. Discussion and conclusion 
Patients are generally willing to have access to their test results [16], so the automatically 
generated interpretation, especially in the case when a patient is not visiting a doctor, can 
enhance their experience and increase follow-up rates. 
Callen et al. in their systematic review revealed that 6.8–62% of laboratory tests were not 
followed up by patients [2; 17]. Utilization of clinical decision support systems for test 
interpretations can assist in overcoming the problem of failures to inform patients of 
abnormal outpatient findings, which is a common case now according to Casalino et al. 
with up to 26.2% of abnormal results not delivered to patients [3]. Automatic delivery of 
test result interpretations can potentially decrease the number of uninformed patients. 
The results of our research demonstrate that there is a significant impact on the patients’ 
decision to follow up on the tests. Promotion of laboratory test result notifications with 
detailed interpretations still demands communication effort and improvement of the 
algorithms to increase the reliability and trust to the patient-facing clinical decision 
support systems. 
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Abstract. People use language to express their thoughts and feelings, unveiling 
important aspects of their psychological traits and social interactions. Although 
there are several studies describing methodologies to create a collection of words in 
English related to depression and other conditions, in most of them the selection of 
words is not clinical or expert based. The objective of this study is twofold: firstly, 
to introduce a comprehensive collection of Spanish words commonly used by 
patients suffering from depression, which will be available as a free open source for 
research purposes (GitHub), and secondly, to study the usefulness of this collection 
of words in identifying social media posts that could be indicative of patients 
suffering from depression. The level of agreement among medical doctors to 
determine the best words that should be used to select tweets related to depression 
was low. This finding may be due to the complexity of depression and the 
extraordinary diversity in the way people express themselves when describing their 
illness. It is critical to perform a thorough analysis of the specific language used in 
each condition, before deciding the best words to be used for filtering the tweets in 
each disease. As our study shows, the words supposedly more linked to depression 
are very common words used in other contexts, and consequently less specific for 
detecting depressive users. In addition, grammatical gender forms should be 
considered when analysing some languages such as Spanish. 
Keywords. Depression, social media, surveys and questionnaires, terminology 
1. Introduction 
People use words to reflect their thoughts and feelings, revealing a huge amount of 
information about their personality and social interactions, as well as different 
psychological traits [1]. Language is the medium by which mental health professionals 
attempt to understand human beings and mental disorders. Several studies have found 
that linguistic styles are indicative of depressed mood [2]. Another interesting point is 
that people’s language is stable over time and consistent across subjects or context; 
consequently, it can be used as a tool to measure differences among individuals [3]. 
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Several studies used social media platforms such as Twitter to analyze psychiatric 
symptoms and diseases, including depression [4,5]. Although these studies describe 
different methodologies to create a collection of words in English related to depression 
and other mental disorders, in the majority of them the selection of words were not 
extensive or clinical and expert-based [6,7]. In addition, Spanish speaking countries, 
such as Spain and Mexico, are among the ten countries with most Twitter users 
worldwide, with more than 6 million and 7 million users, respectively [8]. As far as we 
know, there are no studies focused on the creation of a list of words of depression in 
Spanish. The selection of the best terminology and keywords in any information system, 
including electronic health records, bibliographic databases or social media platforms, is 
critical for their usefulness in management and scientific research. 
The objective of this study is twofold: first, to create a comprehensive collection of 
Spanish words commonly used by patients suffering from depression, which will be used 
for streaming Twitter and that is available as a free open source for research purposes in 
GitHub. Second, we determine the usefulness of the different words in identifying social 
media posts potentially related to depression. 
2. Methods 
The methodological approach consisted of three phases. The first phase consisted of the 
review of the most common tests and rating scales for assessing depression (using their 
Spanish version) in order to extract terms related to the expression of the depression 
symptoms. The different tests and rating scales analyzed are shown in table 1. The review 
was carried out by a psychologist and a family physician with experience in the clinical 
characteristics of depression, who reached an agreement on the words representative of 
the language used by depressive patients. The Diagnostic and Statistical Manual of 
Mental Disorders, fifth edition (DSM-5) [9] was reviewed to complete the list. In this 
way, a list of 255 words was created. 
Table 1. Tests and rating scales used for selecting words related to the expression of depression by patients 
(the Spanish versions were used) 
Name of the tests and rating scales 
Beck Depression Inventory (BDI)  
Brief Symptom Inventory (BSI)  
Carroll Rating Scale for Depression 
Center for Epidemiologic Studies Depression Scale (CESD-R)  
Clinically Useful Depression Outcome Scale (CUDOS) 
Goldberg Depression and Anxiety scales (GADS)  
Hamilton Rating Scale for Depression (HRSD) 
Hospital Anxiety and Depression de Zigmond and Snaith (HAD)  
Montgomery-Asberg depression rating scales (MADRS) 
The Patient Health Questionnaire (PHQ-9) 
Zung Self-Rating Depression Scale (SDS) 
In the second phase, a questionnaire was created including the aforementioned list 
of words. The questionnaire was sent in December 2017 via email to 50 psychiatrists 
from the Institute of Neuropsychiatry and Addiction (INAD) of Parc Salut Mar in 
Barcelona and 5 family physicians from the Spanish National Health Service. The email 
included the purpose of the questionnaire, the guidelines for its completion and an Excel 
file with the words selected. A second email was sent as a reminder in February 2018. 
The objective of this questionnaire was to obtain a score that represented how well these 
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words are related to depression, as described by patients explaining their symptoms in 
clinical settings. The score of a word was obtained by adding the scores provided by each 
rater using a Likert scale (1. never, 2. rarely, 3. occasionally, 4. frequently and 5. very 
frequently). Since 20 raters participated in the scoring process, the maximum value of 
the score was 100 points. The list of 255 words and their scores are available at GitHub 
for research purposes: https://github.com/angelaleism/WordsDepression. 
Finally, the third phase involved streaming of tweets that included at least one of 
the 375 words (the list of 255 words plus their different plural and gender forms), which 
was carried using the Twitter Application Programming Interface (API) [10]. The 
streaming was set up between June and September 2018 obtaining 8,832,256 tweets. In 
order to compare the usefulness of the words to detect tweets with signs of depression, 
two sets of 500 tweets were randomly selected after retweets removal. One of the sets 
was created by including five subsets of 100 tweets, each one composed by tweets that 
included one of the five most highly scored words, and the second 500-tweet set included 
low scored words. The 1,000 tweets were manually reviewed by two experts to determine 
whether they were potentially indicative of depression or not. The R programming 
language was used for the statistical analyses. 
3. Results 
The questionnaire was answered by 30% of psychiatrists (15/50) and all the family 
physicians (5/5; 100%). The respondents were 13 women and 7 men. All the respondents 
rated the complete list of 255 words. The mean and SD of the scores of all the participants 
are shown in figure 1. 
Figure 1. Distribution of the means and standard deviations (SD) of the 20 participants’ scores 
In order to assess the reliability of agreement among the raters, we calculated the 
intraclass correlation coefficients (ICCs) and the agreement among all the raters was 
0.47, for the psychiatrists was 0.53 and for the family physicians was 0.37. 
Based on the health professionals’ scores, the 10 words in Spanish most frequently 
expressed by depressive patients were (the translation in English is in parenthesis): 
deprimido/a (depressed), triste (sad), tristeza (sadness), desanimado/a (downhearted), 
depression (depression), depresivo/a (depressive), ansiedad (anxiety), cansado/a (tired), 
lloro (crying), insomnio (insomnia). The 10 less frequent words were: autocrítico (self- 
criticism), ingrato/a (ungrateful), mísero/a (vile), languidez (languid), mutilado/a 
(disabled), apetencia (hunger), sombrío/a (gloomy), achacoso/a (sickly), desdeñado/a 
(disdained), lasitud (weariness). It is necessary to take into account that in the translation 
A. Leis et al. / Clinical-Based and Expert Selection of Terms Related to Depression 923
of these words into English there are some nuances that may be missing. There are some 
words that are more frequent in its feminine form on Twitter such as anxious, distrustful, 
distressed, insecure or shy and more frequent in masculine such as loser, solitary, 
incompetent or defeated. 
Regarding the analysis of the tweets, table 2 shows the number of tweets that 
included the studied words, as well as the scores assigned to these words by the health 
professionals and the ranking of the words on the basis of the scores. In addition, the 
table shows the proportion of tweets for each word that were potentially indicative of 
depression when manually reviewed by an expert. 
Table 2. Frequencies of words in the 8,832,256 tweets analysed, scores and proportion of depressive tweets 
Word Number of tweets Score (Rank) % depressive tweets 
Deprimido/a 63,019 97 (1) 12% 
Triste 56,776 97 (2) 5% 
Tristeza 54,789 96 (3) 10% 
Desanimado/a 24,079 94 (4) 23% 
Depresión 51,408 92 (5) 12% 
Infelicidad 12,116 63 (110) 4% 
Suicida 42,615 57 (127) 1% 
Vencido/a 43,020 52 (162) 3% 
Melancolía 22,896 43 (194) 9% 
Desdichado/a 4,663 41 (203) 9% 
4. Discussion and conclusions 
The diagnosis of depression is a complex process because of the heterogeneous nature 
of this disease, the lack of biological markers, the different symptoms among individuals 
and the diverse ways in which patients express those symptoms. 
In relation with the scores assigned by the health professionals that participated in 
the survey, there was more agreement among the psychiatrists than among the family 
physicians. These results may be consistent with the fact that the psychiatrists deal with 
more patients with depressive disorders, and therefore, they are more familiar with the 
language used by patients with depression. As a result, the agreement between 
psychiatrists and family doctors is low. This finding may be due to the extraordinary 
diversity in the way people express themselves when describing their illness, the 
complexity of depression [9], how health professionals interpret these words for making 
a diagnosis and their clinical experience. For this reason, it is critical to perform a 
thorough analysis of the specific language used in each condition, before deciding the 
most suitable words to be used for filtering the tweets in each disease [2]. As our study 
shows, the words supposedly more linked to depression are very common words used in 
other contexts on Twitter, and consequently less specific for detecting depressive people 
(e.g. triste/sad). On the other hand, words less frequently mentioned on Twitter can have 
more weight to link them to depression or suicide tendency (e.g. desanimado/ 
downhearted). The gender of words should be always considered when analyzing some 
languages that have grammatical gender forms such as Spanish. 
Nevertheless, the analysis of words related to depression also require us to consider 
other aspects such as the linguistic features (i.e. the different use of personal pronouns, 
the number of negative words and the expressions associated to the basic emotions) and 
the behavioral patterns (i.e. the distribution of tweets over time and the number of 
characters or hashtags per tweet) [5]. However, the extensive list of words provided in 
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this study can be used as a basis for developing new studies and strategies for the analysis 
of depression on Twitter in Spanish. Patients can be monitored, introducing new 
opportunities for studying depression and providing additional health services. 
This study presents some limitations. On the one hand, the tweets can be considered 
an indirect and inaccurate way of detecting users suffering from depressive disorders and 
it is not possible to verify whether the diagnosis is genuine or not. On the other hand, 
although the list of words was carefully developed, there may be more expressions or 
words not included in the list. 
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Abstract. It is important but difficult for citizens to gain a proper overview of their 
health-related information. The CAPABLE project aims to create a digital tool that 
enable citizens to actively utilize their clinical and personal health information to 
manage medication, improve nutrition, and facilitate health services coordination. 
57 participants have participated in various user-centered co-creation activities. A 
key finding of citizen’s needs and expectations is that citizens are positive about 
such a tool provided it is easy to use and requires minimal work. Especially, 
opportunities to collect and utilize already existing digital health information, 
having access to personalized and relevant checklists and personalized resources, 
and be able to share health information with health personnel and others according 
to their own trust and privacy preferences. Involving other stakeholders to ensure 
integration with other systems is of principal importance to fulfil citizens’ 
expectations of integration and automatization. 
Keywords. User-centered design, inclusive design, mHealth, automatization, 
personalization, privacy, medication management, interoperability 
1. Introduction 
Today, citizens can access subsets of their health information through dedicated, secure 
patient portals [1], but content can be fragmented and access unequal [2], or requiring 
users to manually enter information into the apps of their choice [3]. Apps are usually 
targeting one specific condition, e.g., diabetes [4], heart failure [5] or cystic fibrosis [6] 
to mention a few. Over time, most people experience many health issues leading to health 
encounters, many of which produce information and knowledge that may be of relevance 
and importance for self-management and the best possible follow-up of treatments. The 
result is that citizens ends up managing a mix of paper documents, digital snippets of 
information exchanges or data in incompatible formats, supplemented with ad-hoc 
strategies for interpretation and management. The extent of health information exchange 
varies considerably, and is only partly achieved in some countries [7]. For citizens, there 
is currently no simple way to collect, curate or complement nor control health 
information from multiple institutions, services and systems, making it quite challenging 
to retain a good overview and understanding of its implications. 
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We anticipate that easy access to and overview of all health-related information will 
contribute to increased empowerment and improved digital health literacy, which in turn 
can contribute positively to health status [6]. In our ongoing project, CAPABLE, we aim 
to support citizens’ ability to manage their health and participate in health-related 
decisions. We are creating a mobile tool to enable citizens to actively utilize their clinical 
and personal health information to manage medication, improve nutrition, and facilitate 
health services coordination. To counteract current inequality in health services 
provision [8], we emphasize and pay special attention to the needs of vulnerable groups, 
people with disabilities, complex and or chronic conditions, and those with low health 
literacy. The research focus for the user-centered design process we report from was: 
what are the citizens’ needs, values and the social context for developing the 
CAPABLE tool? What are the expectations of citizens for such a tool? 
2. Method 
The development of the CAPABLE tool is based on an inclusive user-centered design 
approach [9], emphasizing user involvement from the very beginning and throughout the 
full development and deployment cycle. Involving users in the design process contributes 
to increased applicability, accessibility, acceptance and adoption of the designed 
solution. It is considered especially efficient and influential in the early stages of the 
development process since the costs of making changes increases as the development 
continues [10]. We follow an interpretive research approach and utilize different user-
centered methods. The variety and flexibility of methods allowed us to further 
investigate certain issues and questions, helping to clarify and identify recurring themes 
and topics. 57 citizens have participated in two focus groups (n=13), five personas 
workshops (n=15), a design workshop with five groups (n=24), a pluralistic usability 
walkthrough (n=4), and a paper prototype user testing (n=1). Municipalities affiliated 
with the project (n=3) recruited participants through existing municipal councils 
(elderly, disability, youth), and non- governmental disability and health organizations 
(n=3) recruited via their members. Participants represent citizens, from adolescence to 
elderly, with and without disabilities, with varying degrees of health problems, digital 
health literacy, and in different stages of life: pupils, workers, next of kin and retirees. 
We conducted a thematic analysis based on detailed field notes from all the activities. 
3. Results 
The analysis showed a wide range of expectations toward the CAPABLE tool – both 
affirming and contradictory to each other, ranging in level of detail and developmental 
implications. An overall, very common expectation was for the CAPABLE tool to 
require only small amounts of work to utilize it since many citizens experienced that 
creating an overview of their health information could be labor-intensive. 
Providing citizens with a tool that requires them to register all their health 
information comes with little value, according to the participants in our research. They 
expected to be able to utilize the information that they are aware of already exists 
digitally. Presupposing imported digital health information, citizens expressed a 
willingness and eagerness to log additional, relevant health parameters related to their 
health challenges to gain knowledge and overview. In general, citizens are well aware 
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of the national summary care record “Kjernejournal“ containing information from the 
last 3 years [1]. When they see themselves as healthy or have few or straightforward 
health issues, they find information about themselves in “Kjernejournal” as sufficient, 
but if conditions are more complex, they told that information could be incomplete or 
missing, requiring them to recall incidents from years or decades ago when asked. 
Citizens anticipated that the CAPABLE tool could help them to manage experiences, 
questions and information before and after consultations with health personnel. To 
keep documentation to a minimum, citizens anticipate that checklists relevant to 
diagnosis, conditions or medicines could be useful. They pointed to examples of 
resources and information from the public health authorities or NGOs. However, 
CAPABLE tool should facilitate modifications in the resources it to their specific 
needs, according to their experiences and knowledge. 
To support their memory in relevant situations, our participants would like to store 
health information in a secure place, where they can access it when they need to. At the 
same time, participating citizens were conscious of how their personal health data needs 
to be accessible for them, but not for their community. If functionality exists, they want 
to share their information with people of their own choice. The attractiveness of sharing 
relevant information, and decide how much information to share, for which treatment 
purposes and period, was high and seen as a feature for personal control. 
4. Discussion 
Citizens’ expect to utilize their health information with as much automation as possible 
comes with three main implications for design, discussed in the following. 
4.1. Collecting Already Existing Digital Information 
Our findings confirm previous research, which consistently find that ease of use, 
usability, accessibility and readability are key factors for successful adoption and use of 
eHealth systems [3,11-13]. Our participants go even further by emphasizing the need for 
and attractiveness of integration and utilization of existing digital health information. To 
collect existing digital health data, as we propose for the CAPABLE tool, the citizen 
could ask for access to personal health information from electronic sources, and save a 
copy of their health information for personal use, annotation, complementation, or even 
sharing personal health data at the person’s discretion. This approach complements 
established communication lines and should maintain data integrity in the source. 
CAPABLE build extensively on HL7 FHIR® resources to foster interoperability, the 
international leading interoperability standard, also recommended by the Norwegian 
Directorate for eHealth [14]. Above all, the CAPABLE tool will give the citizens an 
opportunity to maintain personal health information in one system, which was also a 
principle finding in Floch et al. [6]. 
4.2. Curating Personal Health Information 
Personalization can contribute to making the application relevant and reduce the amount 
of work for each user. Kwon & Kim [15] differentiate between two types of 
personalization: implicit, based on previously collected consumer data, or explicit where 
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the consumer proactively specifies elements. In the CAPABLE tool, using an implicit 
approach could be possible as a starting, focal point of reference. Assumptions of health 
conditions can be delineated from a medication classification system, e.g. if a citizen take 
Carbamazepine, epilepsy is quite likely. However, the citizen might use the same drug 
for neuropathic pain or bipolar disorder. Moreover, the citizen may need information for 
conditions that cannot be deduced from the medication list. Therefore, explicit 
personalization would be a better strategy. As discussed by Li [16], incorrect information 
makes people more likely to interpret content as non-personalized, meaning that efforts 
to make content personalized in the CAPABLE tool can be futile. To balance these trade- 
offs, we propose a procedure where the citizens explicitly are asked to confirm 
deductions about health conditions. Further, we propose functionality where the citizens 
can select between predefined checklists and texts, and then add text alternatives that 
they miss to curate or adjust information to be meaningful for them. 
4.3. Controlling Health Information 
“Privacy by design” is important to comply with a legal perspective, but also 
paramount to the citizens’ maintained trust and willingness to use the CAPABLE tool. 
Recent research has found that many mHealth apps run the risk of jeopardizing the 
privacy of its users [17] because they do not conform to the General Data Protection 
Regulation (GDPR). CAPABLE needs to provide citizens with an easy and flexible 
way to control and share their information, while at the same time avoid unintended 
and unforeseen incidents. For sharing information from CAPABLE with health 
personnel, we plan to use SMART on FHIR to integrate CAPABLE with other health 
information systems if the citizen chooses to do so. This is well-aligned with The 
Norwegian Directorate of eHealth advice for our setting – that SMART on FHIR based 
on HL7 profiles is the most promising framework for application integration in EHR’s 
[14]. 
4.4. Limitations 
Although this research has involved a relatively large number of participants, the current 
emphasis has been on the users of health services and their representatives. There is a 
need for further work to integrate this with the needs and expectations of other types of 
stakeholders. In addition, the views reported here reflect those who were willing to take 
part in this research project. People who were not interested or not able to participate 
may potentially have different viewpoints. A strength of the study is the combination of 
methods and the involvement of a wide diversity of citizens. 
5. Conclusion 
User involvement from citizen stakeholder assessment shows that it is of paramount 
importance to create and offer novel functionality going beyond “yet another registration 
tool”. Providing novel opportunities to collect and actively use digital personal health 
information to minimize text entry, be able to curate and annotate to meet personal needs 
and relevance, and ensure interoperability in privacy preserving manners could foster 
innovation that really empower the citizen. This user centered design approach has 
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informed the first step in designing the CAPABLE prototype. Based on the experiences, 
we will create a first prototype, piloting with approximately 50 additional users. Finally, 
we will carry out a large-scale feasibility trial with a proof of concept version of 
CAPABLE. The main challenge ahead is involving other stakeholders to meet the needs 
and expectations articulated from citizens. 
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Designing a Patient-Centered Notification 
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Abstract. Personal health records could help patients overcome the anxiety related 
to gaps on health related information. The objective of this research was to explore 
what type of information was perceived by patients as useful to receive as a 
notification on their PHR as a framework for the design of a patient-centered 
notification system. We applied a qualitative approach followed by usability tests. 
From interviews to patients, we obtained main categories of notifications to 
include according to its perceived usefulness while, from iterative usability tests, 
we obtained a final version of prototypes developed according to patient-interface 
interaction experiences. This research helped us to understand patients needs and 
behavior to design an efficient notification system and also represents the first step 
for the development of clinical decision support systems for patients into the PHR 
with the potential to improve clinical outcomes and healthcare delivery. 
Keywords. Personal Health Records, Software Design, Patient preferences 
1. Introduction 
At present, patients are increasingly demanding information and effective 
communication in order to understand the background in which healthcare is taking 
place [1, 2]. In this context, personal health records (PHR) are tools developed to meet 
these needs [1,3], helping patients to overcome the anxiety related to gaps on health 
information [4]. Besides, PHR contributes to the interaction of patients and families 
with healthcare systems, facilitating a shared decision-making process and 
empowerment [5, 6]. 
As highlighted by Johnson et. al. [7], patients usually appreciate receiving test 
results notifications at the appropriate time, the availability of a direct communication 
channel with providers, and any tool that could facilitate healthcare management. 
Delays related to these needs might lead to increased anxiety generated by lack of 
information. 
The objective of this research is to explore what type of information is perceived 
by patients as useful to receive as a notification or reminder on their PHR. The latter, as 
a framework for the design of a notification system applying user-centered design 
techniques, to ensure information availability at the appropriate time. 
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 2. Methods 
Hospital Italiano de Buenos Aires (HIBA) is an academic non-profit tertiary level 
organization that covers all health specialities at different levels of the care system. 
Since 1998, HIBA has his own health information system (in-house) [8]. An integrated 
PHR is available since 2007. Its main functionalities include: appointment scheduling, 
test results visualization, patient-physician secure messaging, management of 
prescribed medication, and different modalities of teleconsultation. At present, our 
PHR has approximately 400,000 registered users [9]. 
We conducted a mixed-methods research divided into 2 stages. On the first stage, 
we performed semi-structured individual interviews with patients to explore what type 
of information they found useful to receive as a notification or reminder into their PHR, 
as well as the preferred means to receive it. Once the data had been collected, we 
defined notifications categories determining the system functionalities that would 
support them and finally, we designed prototypes of the different interfaces. 
At the second stage we applied a user-centered interaction approach to adjust 
prototypes design and usability. This approach gave as a clear input on how patients 
used the system. The interaction of users with prototypes was suitable to detect 
usability problems. Test participants were asked to read aloud 4 tasks related to 
notification functionalities and tried to solve them. At the same time, they were 
requested to describe the actions they were performing, expressing their thoughts as 
regards the interaction with interfaces. These tests included 3 participants: the user, the 
facilitator, and the observer. 
Both, interviews and usability tests, were performed on a convenience sample of 
adult outpatients on different hospital waiting areas and dates. Both were recorded 
previous oral informed consent. The data was kept anonymous, protecting 
confidentiality of participants. In what concerns to data-analysis, we proceeded to 
analyze the previously recorded audios and categorize the information in domains 
according to the main findings. Data collection and data analysis were initiated 
simultaneously. The analytic process was performed through codification and 
categorization of the information, based on a process of constant comparison. The 
categories were defined taking into account both the research main questions and the 
findings that emerged from the interviews [10]. 
To analyze usability tests, we classified users’ problems to fulfill the given tasks 
using a severity 3 point scale (critical, serious and minor), and we complemented this 
information with participants’ suggestions. 
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3. Results 
15 interviews were conducted on patients (table 1). 80% were female and age range 
was from 31 to 78 years old. 100% of participants were PHR users. 
 
Table 1 - Patients characteristics  
n: 15 
Female 12 (80%) 
Age  
31-50 4 (26,7%) 
51-70 9 (60%) 
+70 2 (13,3%) 
PHR users 15 (100%) 
 
When participants were asked about those subjects/information they considered as 
useful to be notified of, 5 main categories emerged: 
3.1Appointment scheduling management 
Patients explained that they found suitable to be notified about their closest medical 
appointments and any changes on them in advance. They considered this remainder 
will facilitate their own time management according to health visits. 
3.2 Medication management 
Interviewees considered as valuable to receive notifications whenever they need to 
request their physician for a prescription update before it expires. Besides they 
expressed the need of a tracking system, with notifications, for home delivery of 
medication. 
3.3Test results management 
Participants mentioned as useful to receive notifications whenever test results were 
informed and available to read into the PHR. Also, they highlighted as an advantage,  
to be notified when a complementary study order was close to expire. 
3.4 Administrative processes 
Users expressed they would appreciate being notified on different administrative 
procedures needed to receive medical care, such as bill payment information and help 
desk answers upon their requests for support, among others. 
3.5 Hospital Information 
Hospital news and activities were other topic in which a notification process was found 
useful. Another type of information included institutional changes or system 
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downtimes. As regards the mean by which they preferred to be notified, we didn't find 
consensus in favor of a unique mean of notification. Some participants chose the email, 
while others preferred push notifications on their mobile PHR. Besides, they suggested 
that the mean of notification could vary according to the type of notification. 
With the information collected from patients inquiries we defined notification 
categories. For the notification system design, we opted for a fully customizable 
feature, meaning each user can configure what notification to turn on or off, upon their 
preferences along with the preferred mean to receive them (email, push notification or 
mobile PHR). 
Departing from designed prototypes, we conducted 3 iterations of usability tests 
with final users of different ages and technological literacy levels. Each iteration cycle 
resulted in prototypes modifications to overcome usability problems detected until 
reaching a final proposal. Each testing cycle was carried out with different users. 6 
patients participated in the first set of usability tests and, its results, evidenced the 
presence of 3 degrees of usability problems: critical, serious and minors. After some 
adjustments that emerged from the analysis of these results, we performed a second 
iteration with the participation of 8 final users. Analysis of results showed that minor 
problems were still present. With this in mind, we completed another set of prototype 
adjustments that were tested, in a third iteration, with 8 patients. After this cycle no 
usability problems were detected and thus, we arrived to a final version of prototypes. 
4. Discussion 
Results obtained from this research allowed us to design a patient-centered notification 
system into our PHR. From interviews with patients, we obtained 5 main categories of 
notifications to include in the system according to its perceived usefulness. Besides, 
performing iterations of usability tests to patients, we obtained a final version of 
prototypes developed according to patient-interface interaction experiences. 
Usability evaluation and user experience are key points for design and 
development of PHR functionalities [11,12,13]. In line with this fact, the results of our 
research, contributed to a better PHR user experience. Final versions represent an 
efficient design adjusted to user’ needs. 
The development of this functionality for the PHR, might enhance patient 
empowerment by displaying suitable information in time, optimizing the management 
of health-related aspects and decision making. A notification system gives patients the 
option to choose what to receive and when, acting according to the delivered 
information. PHRs could send notifications and reminders and contribute to a better 
healthcare without generating alerts fatigue [14]. In concordance with our findings as 
regards preferred functionalities to be notified, the implementation of a notification 
system for test results avoids important results to be overlooked [15]. 
We also arrived to similar conclusions concerning means of notification, that is, 
the preferred mean depends on the type of notification [15]. Furthermore, evidence 
suggests that message or notification systems to patients can improve outcomes such as 
infant vaccination coverage by sending reminders  to patients [16] and increase 
smoking cessation rates [17]. This research also represents the first step for future 
research for the development of clinical decision support systems for patients into the 
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PHR. These tools might contribute to the shared-decision model with the potential to 
improve clinical outcomes and healthcare delivery. 
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Abstract. Routinely collecting and using electronic patient-reported outcome 
(ePRO) data in clinical practice can improve patients’ experience and outcomes,
but implementing this at scale has proved challenging. As part of the Optimising 
routine collection of electronic patient-reported outcomes (OPT-ePRO) study, we 
therefore developed an intervention that aimed to facilitate the implementation of 
ePROs. We are conducting OPT-ePRO in the context of secondary care for people 
with chronic kidney disease in the UK, with three renal units participating as our 
study sites. Intervention design was guided by Normalisation Process Theory, and 
informed by published literature and qualitative research. The intervention 
consisted of a national infrastructure to securely collect, transfer and display ePRO 
data, complemented with materials and procedures to support kidney patients and 
renal unit staff with embedding ePROs in usual care pathways. The next step will 
be to bring the OPT-ePRO intervention into practice and iteratively refine it. 
Keywords. eHealth; Patient-generated health data; Symptom assessment 
1. Introduction
Electronic patient-reported outcome (ePRO) data is digitally collected information that 
reflects the personal impact of illness and treatment as assessed by patients, such as 
information on symptom burden or quality of life. Studies have shown that routinely 
collecting and using ePRO data as part of clinical care can improve patients’ 
experiences and outcomes [1], while also informing audits and commissioning of 
services. The challenge now is to implement ePROs more widely in order to harness 
these potential benefits.
Despite extensive knowledge on how to successfully implement ePROs [2,3],
national initiatives have struggled with low response rates [4,5]. One issue is that 
patient and staff engagement in the implementation varies widely between groups and 
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facilities, and is often limited [4,5]. This may be explained by insufficient support for 
embedding collection and use of ePROs into usual care pathways. Therefore, we 
developed an intervention aimed at facilitating implementation of ePROs into clinical 
practice, with UK renal services as the exemplar context. This formed the first phase of 
the Optimising engagement of routine collection of electronic patient-reported 
outcomes (OPT-ePRO). 
2. Methods
2.1. Theoretical framework 
We used Normalisation Process Theory (NPT) as the theoretical framework to guide 
development of the OPT-ePRO intervention [6]. NPT has been widely used to plan 
implementations of eHealth interventions in clinical practice [7] and consists of four 
constructs: coherence (e.g. do users have a shared view of the intervention’s purpose); 
cognitive participation (e.g. do users understand and agree on who will deliver the 
intervention); collective action (e.g. do existing resources and systems allow the 
intervention to ‘fit’); and reflexive monitoring (e.g. how do users appraise the 
intervention’s value).
2.2. Study setting 
Secondary care for people with chronic kidney disease in the UK is provided by over 
70 main renal units; three of these acted as our study sites. We selected renal units as 
our study setting because they are more digitally mature than many other parts of the 
National Health Service. All renal units have an electronic patient record (EPR) system 
connected to a national infrastructure. Currently, this infrastructure –commissioned by 
the Renal Association—enables digital clinical data from renal units’ EPRs to flow into 
a national repository to facilitate: audit by the UK Renal Registry; research; and 
patients’ self-management via a patient portal (https://www.patientview.org/) (see 
Figure 1). As part of the OPT-ePRO intervention, we aimed to make this infrastructure 
bidirectional:  with ePRO data –in our case: symptom burden and EQ-5D (i.e. quality 
of life) scores—flowing from the portal through the repository into renal units’ EPRs. 
2.3. Approach to intervention development 
To develop the intervention, we used literature reviews [2,3] and frameworks [8,9] on 
implementing ePROs in general, complemented with context-specific qualitative data 
and stakeholder codesign (see below). We recruited participants from our study sites: 
 Non-participant observations of workflows: we observed three 4-hour
outpatient clinics (total: 12 hours) and eight in-centre haemodialysis sessions
of nearly five hours each (total: 39 hours) to gain insight into existing routines
and to identify opportunities for collecting and discussing ePROs. We used a
data collection template to gather field notes on e.g. patient time and
activities; staff presence and activities; and on how patient data was recorded,
reviewed and discussed;
 Observations of clinic consultations: to understand if and how symptoms and
quality of life were discussed, we audiorecorded and transcribed 11 routine
clinic visits (177 minutes in total) in haemodialysis and outpatient settings;
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 Participatory co-design workshops; we conducted three workshops with
patients and caregivers (total n=25) and two with staff (n=13) to review
designs and prototypes of intervention elements; identify potential
implementation barriers; and to co-create solutions to overcome these through
collaborative synthesis. Each workshop took approximately three hours.
Guided by our theoretical framework, we thematically analysed field notes, 
consultation transcripts and workshop materials. Using the constant comparative 
method [10] we synthesised results across sites, settings and data sources. We 
described intervention elements in line with relevant reporting guidance [11], while 
mapping them to NPT constructs. To deliver the IT-related intervention elements, we 
worked closely with study sites’ IT departments and the patient portal supplier. We 
provided them with technical and functional requirements (developed with input from 
end users and the Renal Association), as well as an end-to-end test plan and data.  
The UK Health Research Authority’s Research Ethics Service, North West - 
Greater Manchester West Research Ethics Committee approved the study (ID 245870). 
3. Results
The extended national infrastructure as outlined in Figure 1 encompassed all IT 
elements of our OPT-ePRO intervention. It enabled patients to enter ePRO data at 
home or in clinic via the existing patient portal, which they could access on any PC or 
mobile device. Many patients already had access to the portal, but only some were 
actively using it. Before each clinic consultation, staff would invite a patient to enter 
their ePRO data. Within 2-3 minutes, results were sent to the national data repository,
and then pushed into the renal unit’s EPR system for clinical staff to review and discuss 
with the patient. An overview screen in the EPR displayed current and previous ePRO 
results in tabular format, with colour coding linked to symptom severity. When 
discussing results with patients, clinicians could generate pop-up screens to graphically 
display scores for individual ePRO items. There was a review functionality in the 
portal for patients to access their own ePRO results. 
We identified relevant intervention components relating to values and roles, 
presented in Table 1 under the NPT constructs of coherence and cognitive participation.
Components relating to service organisation and delivery are presented under collective 
action. We will explore reflexive monitoring –the process by which users adapt to and 
collectively assess the impact of the intervention—in future work evaluating the 
intervention in practice. Materials and procedures for each element left room for 
individual sites to organise the ePRO implementation in a way that fitted their local 
Figure 1 National infrastructure for capturing, storing, transferring and displaying ePRO data for people 
with kidney disease in the UK. HSCN refers to the NHS’ secure Health and Social Care Network
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context. All staff materials were combined into a handbook that contained information 
on how different aspects of the ePRO implementation would work. Patient materials 
were mostly delivered as flyers with concise messages, handed out in clinic or included 
in patient letters. Local champions were involved in delivering several parts of the 
intervention, and were usually a nurse manager and a consultant nephrologist. 
Table 1. Overview and description of OPT-ePRO intervention elements, organised by NPT construct 
Element name Materials and procedures (what) Delivery (how, by whom, where)
COHERENCE & COGNITIVE PARTICIPATION
Implementation 
initiation and 
engagement
 Initiating the implementation process and
driving it until the local champion and other 
staff were ready to take this over
 Building relationships with and across all 
those involved, including patients, clinical 
staff, IT staff, management, volunteers, etc.
F2F, email and phone conversations by 
study facilitator
Patient 
outreach
 Explaining the implementation to patients;
present potential benefits of ePROs;
demonstrate ePRO module in patient portal 
F2F conversations with individual patients 
in clinic by staff and volunteers
 Flyer announcing the implementation and
listing potential benefits of ePROs
Handed out in clinic or included in 
outpatient letters by staff
Staff outreach
 Planning implementation with local champion Study facilitator
 Explaining the implementation to staff;
present potential benefits of ePROs
F2F during team meetings by local 
champions and study facilitator
 Overview of the implementation process and
of potential benefits of ePROs
Included in the handbook (on paper at 
nursing station and in electronic format) 
Assigning key 
staff roles
 Identifying staff members or volunteers for 
key roles in collecting and discussing ePROs
F2F conversations with individuals
candidates by local champions
 Checklist of implementation responsibilities,
and the capabilities required to fulfill them
Included in the handbook (on paper at 
nursing station and in electronic format)
COLLECTIVE ACTION
ePRO data 
entry &
transfer
 Providing patients access to the patient portal,
i.e. registering new users and resetting 
passwords of non-active users
F2F conversations with individual patients 
in clinic by staff or volunteers; information
included in outpatient letters by staff
 ePRO data entry & transfer functionality for 
patients
Screen accessible online by patients via the 
portal in clinic or from home; data transfer 
via the national infrastructure (Fig 1)
 Patient materials, such as patient portal user 
guidance, password reminder cards, and a list
of frequently asked questions regarding ePRO 
data collection and use
Mostly on paper, handed out by staff in 
clinic; the list of frequently asked questions
was accessible online by patients via the 
portal
Review of 
ePRO results
 ePRO review functionality for patients Screen accessible online by patients via the 
portal in clinic or from home
 ePRO review functionality for staff Screens accessible by staff via the renal 
unit EPR system in clinic
 Discussing ePRO results with patients F2F consultations with individual patients 
by staff in clinic
Staff training 
and support
 Instructing key staff on how to fulfill their role 
in the ePRO implementation, including how to 
access and interpret ePRO results
F2F sessions with individual staff members 
in clinic by study facilitator and local 
champions
 Training materials that outline the information 
provided during the F2F instruction sessions
Included in the handbook (on paper at 
nursing station and in electronic format)
Abbreviations: EPR, electronic patient record; ePROs, electronic patient-reported outcomes; F2F, face-to-face
4. Discussion and conclusion
We developed a theory-informed and co-designed intervention to facilitate 
implementation of ePROs into UK renal services by supporting patients and staff with 
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embedding collection and use of this data into usual care pathways. Previous studies 
explored the feasibility of using tablets in renal settings to support ePRO collection 
locally [12,13], but our study is the first to deliver an infrastructure that is nationally 
scalable. In addition, we proposed a strategy to optimise use of ePROs in these settings, 
thereby addressing an acknowledged gap in the literature [14]. 
In the next phase of the OPT-ePRO study, we will evaluate the intervention in 
practice. When sites deploy the intervention, we will monitor for low ePRO response 
rates and conduct qualitative research to identify implementation barriers and to 
explore ways to address them. The qualitative research will also give us insight into 
how patients and staff understand and experience the intervention. This will inform 
iterative modifications of the intervention, mapped to the reflexive monitoring 
construct of our theoretical framework. Once all major barriers have been addressed, 
we expect the intervention to be suitable for deployment by other renal units, thereby 
enabling national implementation of ePROs in UK renal services and contributing to 
harnessing their potential benefits for patients and healthcare services. 
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Development of a ePRO- ased Palliative 
Care Intervention for Cancer Patients: A 
Participatory Design Approach 
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Abstract. This paper describes a qualitative study conducted in the context of 
developing a novel ePRO (electronic Patient Reported Outcome) based palliative 
care intervention for cancer patients. The aim of the study was to elicit end-users’ 
needs, judgements of the MyPal system and recommendations for improvement. A 
participatory design was chosen as the value of this approach has been well 
established in eHealth systems’ design as well as the development of novel 
healthcare services. Focus groups with Chronic Lymphocytic Leukemia (CLL) 
patients were conducted at the Centre for Research and Technology (CERTH) in 
Greece using specially designed vignettes and discussion guides. Findings 
revealed that patients saw MyPal offering increased, direct contact with the 
healthcare team, freedom of physical and psychological symptom reporting as well 
as valid and reliable information. However, they had concerns about the 
appropriate use of data collected by MyPal, the efficiency of data analysis and data 
security adopted for sensitive personal information. The participatory design 
approach used has been very useful in encouraging the genuine involvement of 
participants, a factor which over time can empower and promote participants’ 
long-term engagement. 
Keywords. Palliative care, cancer, electronic patient reported outcome (ePRO), 
Participatory design, Focus Groups, eHealth 
1. Introduction 
There is a growing body of research demonstrating the value of participatory design in 
the development of novel healthcare services. In the context of palliative care, namely 
supportive care aiming to improve the quality of life of patients facing life-threatening 
illness through the assessment and treatment of psychosocial, physical and spiritual 
problems [1], participatory design is especially relevant. Considering that the demand 
for palliative care is increasing, discrepancies between care needs and care 
arrangements must be noted and rectified [2]. Actively involving patients in the design 
or development of eHealth tools [3], resources [4,5] or systems [6] for palliative care 
can provide a unique perspective on user acceptability, system usability as well as 
insight into the feasibility of the overall effort [7]. 
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MyPal (https://mypal-project.eu/) is a collaborative H2020 research project, 
funded by the European Commission, aiming to use eHealth technologies, in order to 
support cancer patients and healthcare professionals (HCPs). The main goal of MyPal 
is to develop and clinically assess new ePRO-based interventions for the palliation of 
cancer patients, in order to improve their Quality of Life (QoL) [8]. One group of 
cancer patients targeted by MyPal includes adults suffering from specific chronic 
hematologic malignancies. MyPal has committed to both adopting a patient-centered 
approach and adapting technology in order to cater for fundamentally different profiles 
of patients of different age groups as well as levels of digital and health literacy. 
Therefore, during the MyPal intervention design and protocol development, it is 
imperative to take into account not only the context i.e. current clinical practice for 
cancer patients, their interaction with healthcare professionals, provision of palliative 
care etc., but also users’ personal needs as they identify and express them. To this end, 
use case scenarios were defined for the implicated stakeholders (patients and HCPs) to 
better illustrate the use of MyPal’s technological tools appropriately responding to user 
needs in realistic situations. The aim of the present study has been to elicit the needs of 
end-users’ representatives, their judgements with regards to different aspects (i.e. 
functionalities, characteristics) of the MyPal system, and finally their recommendations 
for system improvement. 
2. Method 
This was a cross-sectional study employing a qualitative methodology. Qualitative data 
were gathered via focus group discussions [9]. Ten focus groups (4-8 participants each) 
were conducted with: a) adult patients with a diagnosis of either Chronic Lymphocytic 
Leukemia (CLL) or Myelodysplastic Syndromes (MDS), and b) HCPs working in 
participating hospital units. Focus groups were conducted in partner sites in Greece 
n=5; Italy (n=1); Germany (n=2), and the Czech Republic (n=2). This paper presents 
our overall methodology and the findings from the two focus groups conducted with 
CLL patients at CERTH, Greece. 
With respect to materials used, two versions of vignettes were prepared: one for 
HCPs and one for adult patients. The following vignette, prepared for CLL patients, 
introduces the main character, Mr. Leonard Jones and his journey of managing CLL. 
The scenario starts with the enrollment of a treatment naïve patient, into the study. On 
Day 0 he completes the entry questionnaires, signs an informed consent and receives 
the MyPal smartphone application as well as a smart wristband. On Day 7, Mr. Jones 
receives a motivational message aiming to keep him engaged to the MyPal system. 
Two weeks later, he receives a notification to fill in the 1st symptom questionnaire via 
which he reports some fatigue, also is also becoming evident through a reduction in his 
physical activity. On Day 18, Mr. Jones searches for information in the personalized 
medical information search. He finds out that symptoms like fatigue combined with 
swollen lymph nodes can signify CLL progression. On Day 22 he develops rash and 
reports it via the spontaneous reporting functionality of MyPal app. He uploads a 
photograph and marks all his symptoms including swollen lymph nodes on a list. As all 
indicators (spontaneous reporting, symptom questionnaires and wristband data) 
demonstrate that CLL has progressed, MyPal issues an indication to the treating 
physician, who contacts Mr. Jones and asks him to undergo blood tests. After 
verification, on Day 24, Drug D is prescribed to Mr. Jones. He checks for drug 
C. Karamanidou et al. / Development of a ePRO-Based Palliative Care Intervention942
interactions and inserts timing preferences for reminder notifications on the MyPal app. 
Mr. Jones continues to receive motivational messages and self-report questionnaires to 
complete on physical and psycho-emotional symptoms. Mr. Jones keeps experiencing 
diarrhea, so on Day 42 he reports it via the MyPal app and his clinician is notified. As 
the diarrhea persists, he develops distress, evident in his facial expressions and tone of 
voice. Due to the distress picked up by the smartphone sensors in conjunction with the 
spontaneous reporting by Mr. Jones, the clinician is alerted and calls to reassure him. A 
sample screenshot from the vignette under discussion is presented in Figure 1. 
The discussion guides reflected the episodes of the vignettes from enrollment up 
until the end of the storyline. An example follows: ‘Mr. Jones starts feeling fatigue and 
searches for info, since he thinks this might indicate disease progression. The 
information that he finds via MyPal is personalized, i.e. information relevant to him as 
a CLL patient. How do you judge this feature? How would you feel given the 
opportunity to access information tailored for you as a patient with CLL? How can it 
be improved?’. 
 
 
Figure 1. Sample screenshot from the patient vignette. 
 
Concerning data analysis, the framework method was employed [10] for 
performing thematic analysis. It is an established approach for managing and analyzing 
qualitative data in applied health research [11]. Ensuring uniformity of the focus group 
analysis in the different participating sites was a primary concern. The main reasons for 
choosing this method of analysis included: a) the multi-disciplinary research teams 
involved, b) the sample with clinical and patient representation, c) the complexity of 
the collected data pertaining to 4 different countries and languages, and d) the nature of 
the data consisting of expressed positive and negative judgements as well as concrete 
recommendations for MyPal system development. The collection of data in diverse 
cultural contexts and from multiple perspectives contributed to the richness and 
thickness of data. Codes were developed at a national level and these were grouped into 
categories at a European level. Researchers are satisfied that data saturation has been 
achieved per emerging category for both clinical and patient groups. 
User acceptance is not only a methodologically major challenge, but also one of 
significant ethical importance as it aims to enhance patients’ autonomy and is directed 
towards their beneficence [12]. MyPal is indeed tailoring the technological aspects of 
the intervention to the exact patient needs, rather than requiring patients to adapt 
themselves to the employed technology. During recruitment participants were informed 
about the study, gave their consent for participation, recording of the discussion and 
use of content for the needs of the MyPal program. The information collected did not 
include any personal data but rather information on the functionality of the system as 
well as recommendations for better use. It must be noted that in the clinical studies to 
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follow later in the course of this project, consent forms will be submitted with the 
actual protocol to the appropriate Research Ethics Committees for approval. 
3. Results 
Nine patients with CLL, aged 39-73, participated in the two focus groups held at 
CERTH, Greece. Five were males and four were females. Three participants were 
receiving treatment at the time of the focus group, four had received treatment in the 
past, while two were treatment-naïve. CLL patients expressed what they considered to 
be the most important advantages that the MyPal system has to offer (Table 1), but also 
voiced important concerns (Table 2). Participants have given recommendations which 
have led to amendments in the MyPal system design and MyPal intervention delivery. 
Indicative examples can be found in Table 3. 
 
Table 1. Patients’ positive judgements on aspects of the MyPal system. 
Themes Explanation 
Valued contact 
with the 
healthcare team 
MyPal promotes direct contact with the doctor, instantly updatingthe medical file and, 
thus, expediting medical decision-making and initiating  supportive treatment 
following the presentation of an issue the patient is concerned about. 
Freedom of 
reporting  
MyPal allows the communication of physical and psychological symptoms attributed 
to either the disease or its treatment through ePROS or other information difficult for 
patients to assess. Patients positively perceived MyPal’s capability to record on a 
scheduled or spontaneous basis, in a structured or unstructured way.  
Validity and 
reliability of 
information 
The MyPal database will relieve them from stress and put a stop to misinformation. It 
will be safer and much more specialized than most generic databases available on the 
web since many physicians will be contributing throughout the study. 
 
Table 2. Patients’ concerns regarding aspects of the MyPal system. 
Themes Explanation 
Reliability of 
collected data 
The data generated might not provide essential or reliable information (e.g. the data on 
the quality of sleep might be affected by the use of sleeping aids). 
Interpretation 
of collected 
data 
The data gathered might not be interpreted correctly(e.g. smartphone sensors might not 
be able to distinguish real distress from happiness and exertion). The need to combine 
different sources of information, so that data is interpreted in context was stressed.  
Privacy and 
digital safety 
of collected 
data 
Patients desired transparency over issues such as who will be viewing their personal 
files, who these data belong to, where data will be stored, etc. Finally, concerns were 
voiced about safeguarding privacy, e.g. whether the system will be recording 
information without patient consent and/or awareness (e.g.. smartphone sensors reading 
facial expressions and tone of voice). 
 
Table 3. Impact of participants’ recommendations on MyPal system design and intervention delivery. 
MyPal proposal Participants’ feedback Amendment Decisions  
MyPal will notify 
participants that a PRO 
assessment is due and 
accept submitted PRO 
reporting 
Patients stressed the need 
for feedback after 
submission 
The MyPal system will issue a notification to 
inform the participant that the information has 
been successfully submitted and that it will be 
seen by a HCP as soon as possible. 
The MyPal system was 
designed to record 
spontaneous symptom 
reporting and scheduled 
symptom reporting 
Patients expressed 
concerns that the 
physician will not see the 
information in real time or 
that he/she will not be 
Informed consent will state that MyPal is not an 
emergency service. During symptom reporting, 
patients will be informed that in case of 
emergency they should contact the hospital 
directly. Participating HCPs will check the system 
available or not respond for new information every 72 hours. 
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4. Lessons learnt 
The purpose of this study was to present the vision of the MyPal system to all 
implicated stakeholders. Findings from the focus groups conducted with CLL patients 
offered insights into patients’ requirements from an eHealth system like MyPal. It was 
evident that, in order to support patients and their caregivers in getting the most of 
MyPal, it is necessary to alleviate their concerns about the appropriate use of data and 
the efficiency of data analysis, while also providing reassurance with high standards of 
data security adopted for sensitive personal information. End users’ valuable 
contributions are already informing and shaping the MyPal design and the next cycle of 
iteration has already been planned for preliminary field testing. The employed 
participatory design approach has been very useful in that it has encouraged genuine 
involvement of participants, a factor which over time can empower and promote 
participants’ long-term engagement. 
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Abstract. Painful conditions are prevalent and substantially contribute to disability 
worldwide. Digital manikins are body-shaped drawings to facilitate self-reporting 
of pain. Some of them have been validated, but without allowing for recording of 
location-specific pain intensity and for use on a smartphone. This paper describes 
the initial development of a digital pain manikin to support self-reporting of pain 
location and location-specific intensity using people’s own mobile device. 
Subsequently, we conducted reliability and usability tests with eight researchers 
and seven patient representatives. Test-retest reliability depended on the manikin’s 
level of detail, but was generally high with most intraclass correlation coefficients 
≥0.70 and all similarity coefficients ≥0.50. Participants found the manikin easy to 
use, but suggested clearer orientation (front/back, certain body locations) and 
would value additional feedback and diary functions. We will address these issues 
in the next version of the manikin before conducting a validation study. 
Keywords. Pain measurement; Patient-generated health data;  mHealth 
1.Introduction 
Pain is one of the leading causes of disability worldwide [1]. It is a symptom of all 
musculoskeletal diseases, and prominent in many other conditions, such as cancer. Pain 
substantially affects people’s quality of life and imposes a significant burden on society 
due to treatment costs and absence from work [2]. To optimally manage pain and 
understand treatment response, we need insight into how it changes over time. This 
requires validated instruments to capture key aspects of pain, which often vary per 
location, such as pain intensity. 
Digital manikins are human-shaped drawings where people can shade areas to self- 
report the location of their pain on a computer. In contrast to their paper counterparts, 
digital manikins support automated (rather than manual) calculations of e.g. the extent 
of the affected area. Previous studies presented validated, digital pain manikins [3–5], 
but none of them facilitated the capture of location-specific pain intensity (i.e. different 
intensities for different locations within one pain report). They also required a 
dedicated device with a pre-defined screen size, limiting opportunities for people to use 
their personal devices, which in turn hampers deploying these manikins for large 
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 mHealth studies. Manikins incorporated in pain self-management apps that are 
currently available in app stores (e.g. https://www.catchmypain.com/) are unsuitable as 
research tools because they have not been validated as measurement instruments. We, 
therefore, developed a digital pain manikin to enable people to self-report the location 
and location-specific intensity of their pain using any (mobile) device. This paper 
reports its initial development and usability testing. 
2.Methods 
2.1.Initial development 
We developed a prototype, for Android IOS in the first instance, together with an 
industry partner (https://www.umotif.com/). The prototype design was guided by the 
manikin’s intended purpose, published digital pain manikin studies [3–5], and input 
from clinicians and researchers with pain measurement expertise. The manikin was two 
dimensional, black, and gender-neutral with anchors for chin/back of the head and 
groin/buttocks; users could select a zoomed-in view on the lower arm and hand. There 
was a slider to indicate pain intensity before shading an area; score and colour ranged 
from 1 (grey; no pain) to 10 (red; severe pain). Users could erase incorrectly shared 
areas by selecting an intensity of 1. There was a visible grid with squares overlaying 
the manikin; ‘active’ squares were those that had been shaded with intensity >1. A 
mechanism for exporting a table with the coordinates and intensity scores of all active 
squares facilitated a pain score calculation that was not influenced by screen size. 
2.2.Selecting the optimal grid 
As we expected the grid’s granularity to affect both user experience and the accuracy of 
pain drawings, we evaluated the usability and reliability of three grids with different 
granularities: coarse (40x80 squares); medium (80x160); and fine (100x200); we tested 
full body and zoomed-in arm manikins separately. We aimed to identify the grid that 
best balanced ease of use with drawing accuracy. 
We recruited eight researchers from our professional network; five had experience 
with measuring pain. A sample size of eight was sufficient to detect an intraclass 
correlation coefficient (ICC) of 0.70 or more [6], found by previous studies [3–5].  
After receiving verbal instructions and completing one practice drawing, participants 
completed a first test set of six drawings (i.e. one for each grid-manikin combination) 
on a Samsung S6 smartphone by copying an example manikin from paper (Figure 1); 
we randomised the order in which grids were tested. We then interviewed participants 
for 30 minutes to explore their views on the ease of use of each grid before asking them 
to complete a second set of the same six drawings (i.e. retest). 
For each grid-manikin combination we evaluated the test-retest reliability of pain 
extent by calculating (i) the size (i.e. mean of difference) and range (i.e. limit of 
agreement as ±1.96×standard deviation) of within-participant differences between test 
and retest [7] for the proportion of active squares within the manikin perimeter, and (ii) 
the ICC [8]. For the test-retest reliability of pain location we calculated the Jaccard 
similarity coefficient (per [3]), which is the number of squares that were active in both 
test and retest divided by the number of squares that were active in either test or retest; 
values range from 0 to 1 (no to complete overlap in pain location). We also calculated 
mean completion time during the retest and synthesised interview notes per grid. 
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Figure 1. Screenshots of the medium grid body manikin (left panel) and arm manikin (right 
panel), as completed on a Samsung S6 smartphone by one of the participants 
2.3.Exploring usability 
We explored the general usability of the digital pain manikin, including the manikin’s 
ease of use; its look and feel; and suggestions for additional functionalities to improve 
its usefulness for pain management more widely. We collected qualitative data through 
the researcher interviews (see 2.2), complemented with a 3-hour workshop with seven 
members of a patient and public involvement (PPI) panel with personal experience of 
chronic pain. The workshop included individual 30-minute sessions where participants 
were interviewed and performed a series of tasks with the manikin using the medium 
grid. They then shared their experiences in a group discussion. We imported written 
interview and workshop notes into NVivo and analysed them thematically. 
3.Results 
3.1.Grid selection 
Table 1 shows that for pain extent, the coarse grid had the lowest test-retest reliability 
for both manikins with the highest mean of difference and the lowest ICC. The medium 
grid performed best for the body manikin, with the lowest mean of difference and the 
highest ICC. The fine grid showed the best results for the arm manikin. For pain 
location, the test-retest overlap was comparable between grids for the body manikin. 
For the arm manikin, the coarse grid showed most overlap, but also the highest 
proportion of active squares in test and retest. Within grids, completion time varied 
widely between participants but generally increased with granularity. 
Compared to the fine and medium grids, participants found the coarse grid easier 
to use but also felt it produced the least accurate pain drawings. Others reported a 
higher risk of unintentionally activating squares, and having to dab (rather than draw) 
to shade areas. In contrast, they considered the fine grid the most time-consuming, but 
also the most accurate method that felt most like drawing. Some participants 
questioned whether real pain reports would require such a fine level of detail. For the 
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 medium grid, most participants reported similar experiences as for the fine grid, 
although some explicitly stated that the medium grid better balanced ease of use with 
drawing accuracy. 
Table 1. Test-retest reliability of pain extent and location, and completion time per grid-manikin type 
combination 
 
     Coarse grid (40x80) Medium grid (80x160) Fine grid (100x200) 
Manikin type → Body Arm Body Arm Body Arm 
Extent     
Number of available squaresa) 1,866 133 6,922 483 10,519 734 
Mean (SD) proportion of active squaresb) 
Test 0.17 (0.09) 0.39 (0.09) 0.16 (0.07) 0.34 (0.06) 0.14 (0.08) 0.34 (0.10) 
   Retest 0.16 (0.06) 0.44 (0.07) 0.13 (0.06) 0.36 (0.05) 0.14 (0.05) 0.37 (0.07) 
Mean (1.96×SD) of differencec) 4.39 (5.13) 5.83 (12.62) 2.31 (3.90) 4.48 (6.92) 2.60 (6.72) 3.90 (7.98) 
ICC (95% CI) 0.77 
(0.27 – 0.95) 
0.48 
(-0.23 – 0.87) 
0.90 
(0.63 – 0.98) 
0.51 
(-0.20 – 0.87) 
0.81 
(0.36 – 0.96) 
0.80 
(0.33 – 0.96) 
Location     
Mean (SD) Jaccard coefficient 0.50 (0.15) 0.71 (0.12) 0.51 (0.16) 0.59 (0.12) 0.54 (0.15) 0.59 (0.13) 
Completion time (retest)     
Mean (SD) number of seconds 64.0 (57.4) 47.5 (21.7) 72.0 (52.2) 68.2 (40.7) 82.1 (33.7) 70.1 (42.2) 
Abbreviations: CI, confidence interval; ICC, intraclass correlation coefficient; SD, standard deviation 
a) Total number of squares in the grid that fall within the manikin perimeter 
b) Proportion of available squares shaded with pain intensity >1 
c) Difference and limit of agreement between test—retest [7] in the proportion of active squares 
3.2.Usability of the manikin 
All participants found completing a manikin report easy and expected basic user 
instructions and some practice to be sufficient for most people to use it unsupervised. 
Some participants made sweeping movements to activate squares, while others dabbed, 
especially PPI members. Dabbing was more time consuming, which may explain why 
some PPI members would prefer a coarser grid. Many participants ‘pinched’ in an 
attempt to zoom in on certain body locations, but were equally happy to use the 
predefined zoomed-in views. Some participants struggled to activate squares as 
intended, especially on the border of the manikin perimeter. The method for 
deactivating squares was considered acceptable, although some suggested an eraser or 
‘undo’ function. 
Most participants saw the manikin as male, and PPI members additionally 
characterised it as “elongated” and “a frog man”. Additionally, many had trouble 
distinguishing front from back and therefore suggested adding labels (front/back, 
left/right), as well as more and clearer anchors (e.g. chest, lower back). They generally 
liked the grid being visible, and most considered the colour scheme for pain intensity 
appropriate. However, some found green colours for scores of 4-5 counterintuitive and 
many would prefer an intensity score of ‘0’ (rather than ‘1’) to reflect ‘no pain’. No one 
expressed concerns with the manikin being black. 
Participants suggested several additional functionalities for improving the 
manikin’s usefulness for pain management, including: option to record additional pain 
aspects (e.g. location-specific pain type (throbbing, stabbing, etc.)), pain interference 
with daily life); feedback of pain reports over time (e.g. heat maps); diary to record free 
text information alongside a manikin report (e.g. description of the pain experience); 
and an option to share manikin reports with your doctor to inform (tele)consultations. 
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 4.Discussion and conclusion 
We developed and tested a digital pain manikin that facilitates measuring self-reported 
pain location and location-specific intensity on any device. Study participants found the 
manikin easy to use, and it generally showed moderate to very high reliability. 
A limitation of our study is that we asked participants to copy a detailed manikin 
example, which might be more complex than reporting a personal pain experience. 
They also had to do this 2×6 times instead of the usual 2×1. The increased task 
complexity and repetitiveness may explain why our ICCs for pain extent did not exceed 
the 0.90 reported by other studies [3–5]. The reliability of pain location seemed less 
affected by this, with Jaccard similarity coefficients in some other studies not 
exceeding 0.50 [3,5]. 
Overall, the fine grid came out as most reliable across manikins, but the usability 
tests suggested that it might be too difficult and time consuming to use. The next 
version of the manikin will, therefore, use the medium grid, as well as addressing most 
of the issues and suggestions this study identified, such as: providing written user 
instructions; improving the look and feel of the manikin; facilitating the capture of 
additional pain aspects, and including diary and feedback functions. Through continued 
collaborations with patients, clinicians, researchers and industry, we will use the new 
manikin version to collect digital pain reports in a range of painful conditions to (i) 
reassess the manikin’s reliability for capturing people’s personal pain experience, and 
(ii) develop and validate algorithms for calculating quantitative manikin scores that 
combine pain location, extent and intensity. Ultimately, we expect this contribute to our 
digital pain manikin becoming a new standard for digital pain reports in large mHealth 
studies, while also being suitable for supporting clinical care and self-management. 
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Abstract. In this paper we present a study on the needs and requirements in a digital 
tool to support self-management in children and adolescents (0-18 years) with type 
1 diabetes. The study was formally initiated by the Steno Diabetes Center North 
Jutland (SDCN), which wanted to develop a virtual universe that could support 
children and young people in coping with their disease. Through this study we 
interviewed the project manager from SDCN and the head of the family group in 
North Jutland. Furthermore, we observed a workshop involving health care 
professionals and learning specialists who were working with ideas for the virtual 
universe. We conducted two focus group interviews, one for children with type 1 
diabetes and one for parents with diabetic children. The analysis of the data revealed 
very different ideas about what digital support is important for the self-management 
of this target group. Health care professionals focused on developing various 
learning materials using virtual reality or augmented reality, while the parents 
desired security and control and requested materials that could inform and educate 
people in their locale, such as school teachers, parents of their children’s friends, 
etc. The children emphasized the importance of not being singled out and requested 
simple tools that could be used from their smartphones. They especially asked for 
tools that could help them manage their diabetes by themselves in a fast and effective 
way, e.g., making it easier to count carbohydrates and calculate their insulin intake. 
Based on the analysis, we developed suggestions for a design. The main lesson 
learned from this study was the importance of focusing on the actual users and their 
everyday lives in developing new tools, and not on technological possibilities.  
Keywords. diabetes; app design; user research; 
1. Introduction 
In 2017, approximately 425 million adults (20-79 years) and more than 1,106,500 
children lived with the chronic disease diabetes [1]. The most well-known types of 
diabetes are type 1 and type 2. Type 1 diabetes occurs when people cannot produce 
insulin themselves and type 2 diabetes occurs when people cannot use insulin to turn 
glucose into energy [1]. The study presented in this paper focuses on children diagnosed 
with type 1 diabetes [2]. 
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Diabetics have an increased risk of serious health issues and complications, 
including cardiovascular disease, blindness, kidney failure, and lower limb amputation 
[3]. It is therefore important that children and young adults learn to self-manage and take 
responsibility for their disease even at a young age. To help children and young adults 
manage their diabetes, the Steno Diabetes Center North Jutland (SDCN) wished to 
develop a digital concept that supports diabetic children and their families in their 
everyday life. When we began our cooperation with SDCN, the vision for the project 
was still in a very early state, but SDCN knew they wanted “something digital” and were 
interested in the idea of a virtual universe for the children. It was important that the digital 
device would support self-management and empowerment, that is, to maximize the self-
care knowledge, skills, self-awareness, and sense of personal autonomy of patients and 
to enable them to take charge of their own care [4].  
To understand the context of diabetes-related technology, we explored existing ICT 
apps and tools for diabetes on the market. We found several diabetes-related apps, but 
almost all the apps were made for monitoring diabetes. We found only one app, provided 
by the Danish Diabetes Association, that was developed to help children master and 
manage diabetes. Monitoring and mastering/managing are different types of help: 
monitoring focuses on keeping track of your numbers (insulin, blood glucose levels, etc.) 
while self-mastering also focuses on having the knowledge and competences to handle 
and manage the disease. The collaboration with SDCN led to a study on the needs and 
requirements for digital support to aid self-mastery for diabetic children, aged 10-18 
years, in order to develop suggestions for a design.  
2. Methods 
For this study, we applied a user-centered approach [5] to understand the aims and needs 
of the stakeholders: the children, the parents, and the health care professionals. 
We conducted an unstructured interview with the project manager from SDCN with 
the aim of understanding the thoughts and wishes regarding a virtual platform for 
children and teenagers and why this project was initiated. A few days after this interview, 
we participated in a SDCN workshop to inspire innovation in digital health for children 
and teenagers with type 1 diabetes. Doctors and nurses from Aalborg University Hospital 
worked with two digital learning specialists from a company called CadPeople and the 
project manager from SDCN. While observing this workshop, we conducted an 
unstructured non-participatory observation and took fieldnotes. After collecting data 
from health personnel and experts, we wanted to obtain the users’ perspective. Therefore, 
we had a conversation with the chairman of the Danish Diabetes Association of Northern 
Jutland. Through our contact with the chairman, we arranged two separate focus-groups, 
one with 8 children, aged 9-13 years, and another with 7 parents. We prepared an 
interview guide for the children with questions that allowed us to focus on their 
experiences and feelings about being diagnosed with diabetes and dealing with the 
disease. We asked the parents questions about parenting a child with diabetes. As 
expected, the parents were able to reflect upon the questions, whereas the children needed 
help. Therefore, we chose to include the generative techniques inspired by Sanders and 
Stappers [6]. We used pictures in the form of different social activities to provoke 
reflection and help the participants to recall memories, make interpretations, explain 
feelings, and imagine future experiences. 
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Data from the interviews, observations, and focus groups were transcribed in order 
to for us code it and draw out the relevant knowledge from the study. The coding process 
was approached with an open mind; as a framework we followed Braun and Clark’s six-
step thematic coding [7]. This led to the identification of important themes that are 
presented in the findings below. 
3. Findings 
The identified themes represent the different issues and challenges that the children and 
their parents encounter on a daily basis, including “Practical challenges with diabetes,” 
“Challenges when educating the network,” “Lack of knowledge about the illness,” “The 
balance between independence and childhood,” and “Overprotective parents”. We 
condensed the themes further and ended up with three main concerns that should be 
addressed in a digital tool that could support self-management. The first one is easy 
access to carbohydrate calculation, the next is easy access to relevant guides and 
information, and the third one is what to do in an emergency.  
Besides these findings, it was also clear from our interview with the children that 
they wanted a solution that they could carry with them all the time. The children already 
have access to an app that counts carbohydrates, provided by the Danish Diabetes 
Association. But this app does not provide its users with sufficient options or a large 
enough database to support self-management. Inspired by this app, our aim was to come 
up with a digital solution that improves all aspects and functionalities, based on the 
identified themes and concerns from our analysis.  
The current app is not easy or fast to use in counting carbohydrates. For example, 
the application should provide the users with a larger database of food and beverages that 
must be easy to navigate and the users must be able to select specific kinds of food and 
beverage as “favorites” (see Picture 1).  
 
 
Picture 1. Show product and save as a “favorite” 
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Furthermore, the application had to inform and provide advice about type 1 diabetes, 
not only to enlighten its users (the children with diabetes), but also to provide the network 
with an easy and accessible way to learn about the disease. Thus, it was a main concern 
for the parents that e.g. school teachers, sports association leaders and others did not have 
the necessary knowledge about diabetes to take care of their child. Therefore, the child 
could not participate in social events like summer camps and sleepover parties. An 
important part of this issue is also a specific guide on how to handle a hypoglycemic 
incident 
Another result of the data analysis showed that there is a need for a function that 
could help the children and their parents to feel more confident that they will get help 
quickly if needed, especially when the children are away from home. Therefore, we 
decided to incorporate an alarm. To do so, we had to include and activate the phone’s 
GPS, which caused several ethical questions whether the purpose of the application is to 
support the children’s self-management—not for the parents to be able to track them. 
Instead of activating the GPS all the time, we developed the ALARM function so the 
users (children with diabetes) could include three different emergency contacts. If the 
alarm is triggered, these contacts receive a message with the child’s location (see Picture 
2). 
 
 
Picture 2. ALARM 
 
In summary, the design proposals point to a relatively simple solution that 
particularly addresses the demands of children for easy access to carbohydrate 
calculations and the parents’ requirements for security and access to relevant information 
for networks and friends. 
4. Discussion 
The analysis of the data from the health professionals, parents, and children revealed 
very different foci about what is important in digital support for children and adolescents 
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with type 1 diabetes. The workshop with health care professionals resulted in three 
design suggestions: a digital diabetes diary, an interactive understanding of diabetes, and 
the implementation of virtual reality to build bridges between parents and children. The 
parents’ concerns were connected to the security of their children; for example, “how 
much responsibility should be given to a 7-year-old?” and “are the teachers aware of how 
to help and support my child?” Also, the parents assumed that the children would like to 
participate in an online community. The children, however, were not interested in digital 
diaries, augmented reality, or online communities. They wanted an optimization of a 
carbohydrate app that could help them manage their diabetes, provide security when on 
their own, and offer information when needed. As stated above, our study shows the 
importance of putting the end-users and their daily life situation at the center when 
designing new applications.  
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Abstract. Patient involvement can be supported in many ways, some of these 
through health IT (HIT). Health care practice is changing with digitalization and 
technologies that patients can use to generate data outside the formal health facilities 
are growing. Inequality affect citizens ability to participate. There is a need to be 
mindful of the perceptions and the willingness of citizens and the health care pro-
fessionals to meet this change.  Selected data from two Danish surveys, highlight 
the citizens and health care professional’s perspective on health IT. From the anal-
ysis emerge central considerations on what to be aware of in the future development 
of HIT. 
Keywords. eHealth, Survey, Citizens, Clinicians, Equality.  
1.Introduction 
1.1.Strategy and practice 
In line with the WHO global strategy on people-centered and integrated health service 
[1] the latest Danish Digital Health Strategy 2018-2022 emphasize that: “Patients should 
be more involved in their own treatment, so that the health system interacts with the 
patients on his/her own terms” [2] (p.21). Throughout the strategy we can read an in-
creased focus on the involvement of the patients and an interest to increase the support 
to them and their relatives “… in taking greater ownership of their own illness in their 
daily lives …” [2] (p.18).  
There is a general international interest in the use of what is termed patient generated 
health data (PGHD), in the healthcare sector [3]. The availability of technological solu-
tions makes it possible for citizens and patients to collect data themselves. This is one of 
the ways of framing patient involvement through HIT. However, equality and inequality 
aspects of HIT is not predominant. 
The strategy recognizes that in the formal health care system there are relatively few 
experiences using data collected by the patient’s own equipment but also “that the areas 
where apps, medical devises and medication converge are currently shifting” [2] (p.24). 
Hence there is a need to develop a shared framework that allow patients to start using 
devices and apps and share their data with the health care system. A central notion is to 
combine the potential of HIT and PGHD to improve service and reduce costs. However, 
in Denmark and in most other countries little is known about what type of technologies 
citizens use, and which social groups use the technologies as well as how clinicians and 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200303
956
citizens recognize and use digital health care [4]. Here we explore the different perspec-
tives on the use of patient generated health data from selected questions in two different 
surveys. 
Present-day, we see small devices sensing a range of vital measures among average 
consumers allowing them to track their own health data. It is no longer exclusive toys 
for more well-off first movers [3]. Although the potential in PGHD and health apps for 
mobile devices is immense a German study shows that a substantial proportion of the 
population is not engaged [5]. They conclude that although there are many health app 
users a substantial proportion of the population are not engaged. They suggest that soci-
oeconomic-related and literacy-related disparities as well as motivation to change should 
be considered by app developers and researchers. A Study from US show that Collage 
education has a significant positive impact on eHealth behaviors [9]. Nonetheless, as 
stated in the Danish digital health strategy, it still remains to work out how best to inte-
grate these data into contemporary clinical work, and as emphasized by [5], to make sure 
those in most needs also are those being encouraged to collect own health data and thus 
benefitting from the use of the health data. 
To direct the future development of citizens centered health apps it is necessary to 
have more knowledge on who the actual users of health apps are, and knowledge on the 
health providers attitudes towards citizens using these tools and services. 
2.Methods 
Selected questions from two different studies were used to analyze the citizens’ experi-
ences with accessing and using health information systems, and health providers attitudes 
to opportunities for patients’ use of information systems and the impact of these systems 
on patients’ engagement in personal health. 
2.1.Citizen survey 
The 2017 citizen survey reported from in this paper is the third in a bi-annual series of 
National surveys on Danish citizens’ expectations and perspectives on eHealth. A ques-
tionnaire was developed by the authors and a Danish market research agency (Megafon), 
was commissioned to administer the surveys, on a population sample of n=1059. The 
survey is combinational using both email and telephone. The selected respondents are 
part of a citizens’ panel reflecting the Danish adult population with respect to age, edu-
cation and geographic distribution. The questionnaire consists of 10 demographic back-
ground questions (Age, gender, education, state of health, etc.) and 39 questions about 
their relations and attitudes towards their use of e-health technologies (hardware, service 
used, etc.). Data from three questions are reported in this paper. 
2.2.Clinician survey 
The 2017 study of clinicians use of health information systems has been conducted for 9 
consecutive years. Questionnaires was distributed to medical doctors, nurses and medical 
secretaries with the help from their respective professional associations. Random sam-
ples (in average 10.000) from their member files received a link to a web-based ques-
tionnaire. An average response rate of 23% was achieved over the 9 years of study. The 
questionnaire consists of 7 background questions (Age, gender, education, seniority, 
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medical specialty etc.) and 48 questions about their use of specific systems, their user 
experience (Ux) and attitude towards e-health in general. Data from one question is re-
ported in this paper. 
3.Results 
3.1.What is the educational background of the citizens using e-health? 
There is a clear majority of citizens with a master level university education that are 
using e-health services to monitor their health or seek health advice (Figure 1). 48% were 
familiar with one or more of these services compared to 29 % of those with elementary 
public-school education. 
Figure 1. Number of citizens who indicate they have used e-health services to manage their health (e.g. 
sleep monitoring, smoking cessation, nutrition or exercise). 
There are 59% to 64% of citizens who expect that the use of health-IT will improve 
the quality of the healthcare services they get. Only 10% -12% are concerned that it might 
impair the quality of health care services. About every four indicate that they have not 
made up their mind. As shown in figure 2 the attitudes have been quite stable in the 
period where the studies have taken place. 
Figure 2. Citizens expectations to whether the use of health-IT will improve or impair the quality of the 
healthcare services they receive.  
In the question of clinicians’ attitude to citizens potential benefits of the national 
health-IT, almost one third indicate that they do not think the health-IT initiated by the 
national initiatives will improve the citizens engagement in their own health situation 
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(Figure 3). Of these just under 8% disagree strongly. On the other hand, more than 20% 
agree that health-IT can enhance the citizens engagement in health issues, of which only 
just over 1% strongly agree. More than half of the responding clinicians indicate a neutral 
attitude, or they don’t know.  
Figure 3. Clinicians attitude to the statement: The national health IT initiatives will strengthen the citizens 
engagement in their own health  
When clinicians are asked about their opinion on how patient can benefit from 
health-IT by having improved capabilities to master own diseases more than 30% 
strongly disagree or disagree (Figure 4). Half of the responding clinicians are neutral, or 
they don’t know. Only 18% indicate they strongly agree or agree. This question was not 
part of surveys before 2015. 
Figure 4. Clinicians response to the statement: I believe that the digital tools we provide to the patients 
give them better options to master own diseases. (2017, in %, n=1144) 
4.Discussion 
The objective of this paper was to provide insight into citizens and clinicians perspective 
on HIT. Despite a well-developed Danish health care service high inequality in health 
pertains [6].  Our data shows how the citizens with highest education have used e-health 
services more than twice as much as citizens with the lowest education (26% vs 10%). 
This, notwithstanding the fact that those citizens in most need of health care service are 
to be find among those with lowest education [7]. This result is very much in line with 
the data from the German study [5], that also find a socio-economic difference in the use 
of HIT, and call for strategic awareness among health care managers and e-health system 
developers on how to target those citizens in most need of health care when developing 
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HIT interventions? Awareness of how to beat inequality in use at an early stage when 
designing health IT is needed. Health inventions need to be context sensitive in its design 
and need to be supported by health care professionals, to have high impact [8]. We claim 
this should also be considered for development of HIT. The demographic development, 
comorbidity, increased expenses should work as enough incentives.  
Further, data show that citizens and clinicians have different opinions on the role 
that HIT can play to enhance citizens engagement and ability to master own disease. 
Citizens express a far more positive predictions than clinicians as to whether HIT initia-
tives will strengthen the citizens engagement in their own health or not. 
Clinicians also express a dis-satisfaction with the available HIT tools, as to whether 
they actually do give a better option for the patients to master their health. Whether this 
view is nourished by clinicians’ experience of patient’s difficulties in handling HIT tools 
available today, or from their own disbelieve in HIT tools, are not known but could be 
further investigated by qualitative research methods.  The HIT technology needs to be 
understood as a socio-technical intervention and therefore, designed and targeted with 
attention to the context of its use and its users. Finally, we like to draw attention to limi-
tation being the difficulties we have faced in getting a high respondence rate in the self-
selected clinician survey. However, this is not specific for our study but common for this 
type of studies. 
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Abstract. Directly extracting data from site electronic health records for updating 
clinical trial databases (eSource) can reduce site data collection times and errors. 
We conducted a study to determine clinical trial characteristics that make eSource 
vs. traditional data collection methods more and less economically attractive. The 
number of patients a site enrolls, the number of study data elements, study 
coordinator data collection times, and the percent of study data elements that can 
be extracted via eSource software all impact eSource economic attractiveness. 
However, these factors may not impact all clinical trial designs in the same way.  
Keywords. economic analysis, clinical trial, data collection, eSource, HL7 FHIR 
1. Introduction
The complexity of clinical trial protocols continues to increase and is associated with 
higher clinical trial total and per patient costs [1]. Site-related costs account for 70% of 
late phase clinical trial total costs [2]. While remote monitoring has been shown to 
reduce site management costs by reducing the number of on-site monitoring visits [3], 
there has been less success in reducing costs associated with site personnel workload. 
Directly extracting data from site electronic health records (EHRs) for updating clinical 
trial databases (eSource software) has been shown to reduce site data collection time 
and errors [4,5]. However, previous studies did not consider the costs of the informatics 
infrastructure needed for sites participating in eSource-enabled clinical trials. 
Decision analytic methods are used to simulate complex decisions by combining 
disparate data sources [6,7]. These tools are particularly useful where there is 
uncertainty regarding key decision parameters. We conducted a study to determine 
which clinical trial characteristics make eSource-enabled versus traditional data 
collection methods more and less economically attractive for clinical trial sites. 
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2. Methods 
Model Design: We developed a decision analytic model to compare per patient total 
data collection costs for eSource-enabled vs. traditional data collection methods at 
clinical trial sites. Our base case model uses characteristics of the TRANSFORM-HF 
clinical trial [8]. Briefly, TRANSFORM-HF is a 6000 patient, 50-site pragmatic 
clinical trial to evaluate the use of two loop diuretic medications in patients 
hospitalized for new or worsening heart failure. Sites in this trial are responsible for 
collecting information related to the patient’s enrolling hospitalization and a centralized 
call center conducts follow-up patient interviews. 
Decision Model Structure: The decision analytic model used here was constructed 
to evaluate two data collection strategies: eSource-enabled and traditional (i.e., manual 
data abstraction from medical records by humans). During the patient’s enrolling 
hospitalization, three types of data collection occur: (1) a study coordinator collects and 
enters hospitalization data, (2) the study coordinator resolves queries regarding those 
data, and (3) an on-site monitor verifies selected cases against the source data. Queries 
are divided into those that can be resolved while the study coordinator is still in the 
patient’s EHR and those subsequent queries that require the study coordinator to 
reopen the patient’s record in the EHR. The study’s model includes four types of 
measurement data: (1) clinical trial site characteristics, (2) study personnel costs and 
productivity, (3) eSource costs and productivity, and (4) study outcomes.  
Clinical Trial Characteristics: Our model includes six clinical trial site 
characteristics: (1) number of patients enrolled, (2) number of data elements collected 
for the study database, (3) percent of study data elements that are FHIR accessible (can 
be accessed via eSource software using the HL7 Fast Healthcare Interoperability 
Resources (FHIR) standard) [9], (4) number of queries generated, (5) number of onsite 
monitoring visits and (6) number of cases reviewed per monitoring visit (Table 1). The 
TRANSFORM-HF study design assumes that each site will randomize 120 patients on 
average during a 24-month enrollment period.  
Garza et al. identified 155 unique TRANSFORM-HF data elements of which 82 
(52.9%) could be mapped to the US Common Core and would be accessible using HL7 
FHIR [9]. In a review of 14 protocols for which study data were managed by our 
institution, queries were generated for 1.5% of study data elements. Based upon 
operational experience with multicenter studies coordinated by our institution, 
approximately, 67% of these queries would be resolved during initial data entry while 
the site coordinator was in the patient’s medical record and 33% would be resolved 
after initial data entry was completed, requiring the patient’s medical record to be 
reopened and reexamined. We assumed a risk-based monitoring strategy where each 
site would have one monitoring visit, 30% of sites would have a second visit and 10% 
of sites would have a third visit (average 1.4 visits per site). We also assumed monitors 
would verify source documents for 5 patients per visit (average of 7 cases for all visits). 
 
  Table 1. TRANSFORM-HF Clinical Trial Characteristics 
Variable Estimate Range Tested (+/- 50%) Data Source 
Patients randomized 120 60 to 180 Protocol (Ref 8) 
Study data elements 155 78 to 232 Garza (Ref 9) 
FHIR accessible rate (%) 52.9% 27% to 79% Garza (Ref 9) 
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Study Personnel Costs and Productivity: We used keystroke level modeling to 
estimate the number of data elements a study coordinator would collect and enter per 
hour for (1) initial data entry, (2) query resolution during initial data entry while in the 
patient’s medical record and (3) query resolution after initial data entry requiring the 
medical record to be reopened and reexamined (Table 2). Keystroke level modeling 
estimates the length of time an expert will take to accomplish an interactive computer 
system task without errors [10,11]. We then estimated the number of data elements site 
personnel would map and confirm to FHIR resources per hour as well as the hourly 
costs for study site and monitoring personnel. Although site monitors typically are paid 
by study sponsors (and are not included in site personnel costs), we included 
monitoring costs to obtain estimates of all data collection costs incurred at clinical trial 
sites. Hourly costs were estimated by inflating annual salary costs by a 35% fringe 
benefit rate and 50% indirect costs. Based upon our experience, we assumed personnel 
could allocate a maximum of 30 hours per week to specific projects. 
 
Table 2. Personnel Characteristics 
Variable Estimate Source 
TRANSFORM-HF   
Site coordinator data collection rate 134 data elements per hour Keystroke level model 
Number of queries resolved   
  While in patient’s medical record 134 data elements per hour Keystroke level model 
  No longer in patient’s medical record 106 data elements per hour Keystroke level model 
FHIR Mapping   
  Data element mapping 10 data elements per hour Observation 
  Data element mapping time 15.5 hours Computation 
  Data element confirmation 30 data elements per hour Estimation 
  Data element confirmation time 5.2 hours Computation 
   
Personnel Costs Annual Hourly  
  Site principal investigator $200,000 $260 UAMS 
  Site study coordinator $80,000 $104 UAMS 
  Information technologist $65,000 $84 UAMS 
  Information security officer $100,000 $130 UAMS 
  Site monitor $80,000 $104 UAMS 
*UAMS is the University of Arkansas for Medical Sciences 
 
eSource Costs and Productivity: eSource software implementation costs have fixed 
and variable components. The fixed costs are incurred to set-up a trial and the variable 
costs are incurred per study data element. Fixed costs include (1) study materials 
presented to site team members and (2) site eSource security review/approval, setting 
up the EHR research record, connectivity testing and eSource user training. Variable 
costs include the time to map study data elements to site EHR FHIR resources and to 
confirm those mappings. For study material presentation and review, we estimated the 
site principal investigator, site study coordinator, an information technologist and the 
site security officer each would require 5 hours (20 total hours, $2890 cost). For 
eSource security, we estimated the site coordinator would require 7 hours, the 
information technologist 4 hours, and the security officer 4 hours (15 total hours, 
$1584). Lastly, we estimated the site coordinator and information technologist would 
require 15.5 hours each to map the TRANSFORM-HF data elements (n=155) to EHR 
FHIR resources, and the site coordinator would require an additional 5.2 hours to 
confirm these mappings (36.2 total hours, $4474 cost) (Table 2). 
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Study Outcomes and Analyses: The primary study outcome is total per patient data 
collection costs for each strategy (eSource-enabled and traditional). Secondary 
outcomes include the major components of total costs and study coordinator costs. The 
study’s model estimates primary and secondary outcomes and sensitivity analyses. For 
each data collection strategy, we consider the lower cost strategy to be preferred. 
Sensitivity analyses investigated the impact of 50% increases and decreases in clinical 
trial characteristics upon per patient data collection costs. These analyses also identified 
threshold values for clinical trial characteristics that make eSource-enabled the 
preferred data collection strategy vs. traditional data collection. 
3. Results 
Cost Outcomes: The study’s model estimated TRANSFORM-HF per patient total data 
collection cost was $10 lower for eSource-enabled versus traditional methods ($119 vs. 
$129) (Table 3). Coordinator costs were $68 lower ($61 vs. $129) while the per-patient 
cost for eSource software implementation was $58 higher.  Thus, for a site that could 
enroll 120 patients over the 24-month accrual period, investing in eSource 
infrastructure would be marginally economically attractive. Coordinator cost savings 
included $64 for initial data collection, $1 query resolution, and $4 onsite monitoring. 
 
  Table 3. TRANSFORM-HF Cost Outcomes 
 Data Collection Method  
Cost Outcome eSource-Enabled Traditional Difference 
Total Costs $119 $129 ($10) 
  Coordinator component $61 $129 ($68) 
  eSource component $58 $0 $58 
    
Coordinator Costs    
  Initial data collection $57 $120 ($64) 
  Query resolution $1 $2 ($1) 
  Site monitoring $3 $7 ($4) 
 
Sensitivity Analyses: The benefit of eSource-enabled vs. traditional data collection 
in TRANSFORM-HF clearly was influenced by clinical trial characteristics (Table 4). 
With a small number of patients, a small study database (number of data elements), a 
lower FHIR accessible rate (percent study data elements accessible via eSource 
software), and a higher site coordinator data entry rate, the use of eSource vs. 
traditional data collection would not be cost saving. However, at higher values for these 
parameters, the use of eSource software becomes much more economically attractive.   
 
 Table 4. TRANSFORM-HF Sensitivity Analysis 
Variable Less 
50% 
Strategy 
Cost 
Difference 
Plus 
50% 
Strategy 
Cost 
Difference 
Break 
Even 
Value 
Total 
Strategy 
Cost 
Number of patients 60 $45 180 ($28) 102 $130 
Study data elements 78 $14 232 ($33) 123 $102 
FHIR accessible rate 27% $35 79% ($55) 47% $130 
Data elements / hour 67 ($74) 201 $12 158 $111 
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4. Discussion and Conclusion 
Our results demonstrate that eSource-enabled vs. traditional data collection methods 
can be cost saving for the typical TRANSFORM-HF clinical trial site. Our decision 
analytic model estimated a $68 per patient reduction in site coordinator data collection 
costs and a $58 per patient increase in eSource-related costs. However, these results 
vary greatly depending upon the number of patients a site enrolls, the number of study 
data elements and the percent of those data elements that are accessible via HL7 FHIR.  
Our study was confined to the economics of sites contemplating the use of eSource 
software. This work contrasts with the EHR4CR cost-benefit analysis that took the 
pharmaceutical company perspective [12]. We believe the site perspective is both 
important and under-investigated. If the use of eSource is not economically attractive 
for sites, adoption of this technology is unlikely unless clinical trial sponsors include 
additional study start-up compensation.  
If eSource-enabled clinical trials are to become a reality, clinical trial coordinating 
centers and sites will need to have personnel with the requisite skill sets to implement 
and manage eSource software. Our model omitted potential eSource benefits such as 
greater data quality and shorter clinical trial durations. Nonetheless, we believe we 
have started an important dialogue that could lead to greater recognition of the value of 
eSource-enabled data collection as we learn more about the ways in which clinical trial 
design factors drive the economics of eSource-enhanced data collection. 
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Abstract. Online symptom checkers and assessment services are used by patients 
seeking guidance on health problems. In this study, the goal was to identify health 
professionals’ experiences of the benefits and challenges of new symptom checkers 
providing triage advice. Data was collected through an online survey of 61 health 
professionals who were target users of the online symptom checkers implemented 
in six public health organizations and one private occupational health clinic. Most 
of the health professionals supported the use of online symptom checkers and found 
services useful to patients because they provided patients quick contact with health 
professionals and referral to care or self-management instructions regardless of time 
and place. Health professionals were less confident that most of the patients were 
capable and willing to use the symptom checkers. Health professionals were 
satisfied with symptom checkers providing them with more useful information 
before meeting patients. By contrast, symptom checkers were seen as disrupting 
clinical work and time-consuming. The results imply that the clinical work processes 
should be redesigned to guide patients in an efficient manner, avoid work overlap, 
and provide work motivation for professionals. 
Keywords. Online symptom checkers, triage advice, health professionals 
1.Introduction 
Online symptom checkers and assessment services are used by patients seeking guidance 
on health problems [1]. Using computerized algorithms, symptom checkers ask patients 
questions about their symptoms, provide them with a potential diagnosis, suggest self-
care, and direct them to the appropriate care setting [2]. The goal is often to supplement 
or replace resource-intensive telephone triage lines. The online symptom checkers also 
have the potential to support self-care and decrease the number of unnecessary visits. 
Based on Chambers’ et al. [1] recent literature review, the evidence of the diagnostic 
accuracy and impacts of online symptom checkers remains weak. Triage advice provided 
by symptom checker algorithms tended to be more risk-averse than that given by health 
professionals. Thus, symptom checkers may encourage patients to seek care in cases 
where self-care would be more justified [2]. In addition, younger and more highly-
educated people are more likely to use online symptom checkers, whereas older and less 
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educated patients are more likely to prefer telephone or face-to-face contact [1]. Thus, 
health professionals through their endorsement play an important role in supporting 
patients and increasing their trust in technical solutions [3]. If only younger and more 
highly educated patients use online symptom checkers, the cost-effectiveness goals of 
these services may not be reached, and health equity issues may arise. 
In Finland, a joint project of 14 of the largest cities and hospital districts have been 
developing a patient portal called Omaolo. The three main services include an online 
symptom checker called Oirearvio, a patient self-assessment and well-being coaching, 
and a health care plan. In spring 2017, health professionals’ pre-implementation 
expectations relating to the patient portal were studied through an online survey [4]. Most 
of the 2,943 respondents (74%) expected benefits for patients; however, many expressed 
concerns that patients were unwilling or unable to use the new service. As symptom 
checkers are a new kind of health technology and the personnel appear to have concerns, 
it is important to follow-up on their implementation. Follow-up activities were also found 
to be generally important to support personnel during change, avoid resistance, and 
remove barriers [5]. 
In 2018, healthcare organizations started to use online symptom checkers, which 
were the first finalized functionality of the patient portal. The symptom checkers do not 
provide diagnosis, but they are used to direct the patient to obtain appropriate care or 
provide self-care instructions. The symptom checkers were designed for specific 
conditions: low back pain, urinary tract infection, and upper respiratory tract infection. 
The goal of this survey study was to identify health professionals’ first experiences of 
using symptom checkers. Findings provide a better understanding of the role of symptom 
checkers in clinical work and the views of health professionals’ relating to the benefits 
and challenges of the system. 
2.Methods 
An online questionnaire was developed to identify the experiences of health 
professionals, including nurses, physiotherapists, and physicians. The questionnaire was 
a new version of the previous expectation questionnaire including both multiple-choice 
and open-ended questions [4]. Health professionals were asked to evaluate their current 
experiences (instead of expectations as in the previous questionnaire), and the wording 
was changed from future to present tense. 
The questionnaire included existing validated survey items for measuring 
professionals’ support for the symptom checkers [6], their usability [7], and their 
influence on professional autonomy [8]. In addition, the participants were asked to rate 
whether the symptom checkers had brought the planned benefits to their work and 
patients and whether good implementation practices were used in their organization. The 
scales ranged from 1 (fully disagree) to 5 (fully agree) and included a sixth option, 6 (I 
do not know), which was removed from the analysis. Two open-ended questions were 
related to the benefits and challenges of the symptom checkers. In the background 
questions, participants were also asked how often they had used the symptom checkers. 
The quantitative data were with using descriptive statistics, and the responses to open-
ended questions were content-analyzed. 
The data was gathered from December 2018 to March 2019. The survey invitation 
with the link to the questionnaire was sent to health professionals identified by the local 
project managers as potential users of the symptom checkers. The respondents 
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represented six public health organizations and one private occupational health clinic 
that was located in the largest cities of Finland. The seven organizations were selected 
for the study as they were the first ones to adopt the symptom checkers. Although 
participation was anonymous, respondents could submit their email address at the end of 
the survey to participate in a draw for 10 movie tickets. 
3.Results 
A total of 61 health professionals answered the questionnaire; the response rate was 
15.2% in six of the organizations (unfortunately, we were unable to identify a response 
rate for one organization). The mean age of the respondents was 43.8 years (SD = 10.4), 
and 87% were female. Most of the respondents (77%) were nurses, 15% were 
physiotherapists, and 7% physicians. The use of the symptom checkers was not yet very 
established: Most of the respondents (41%) had used them one to two times per month, 
39% weekly or daily. Furthermore, 18% had only tried, and one respondent (1.6%) had 
not used them at all. A few of the respondents also commented that the symptom checkers 
were not yet widely used among patients. 
Most of the health professionals (88.5%) agreed that they supported the use of online 
health checkers. The majority of them also agreed that the symptom checkers resulted in 
planned patient benefits (Table 1). In particular, respondents believed that the symptom 
checkers improved the availability of the services. However, the respondents were 
clearly less confident that most of the patients were capable and willing to use the 
symptom checkers. 
Table 1. Percentage of health professionals agreeing with the statements related to the patient benefits of the 
symptom checkers. 
 
Patient benefit Professionals 
agree (%) 
The symptom checker improves the availability of the services. 79 
By using the symptom checker, patients have the same criteria to receive care. 68 
The symptom checker supports individual care. 62 
I believe that over half of the patients are capable of using the symptom checker. 50 
I believe that over half of patients are willing to use the symptom checker. 42 
 
Table 2. Percentage of health professionals agreeing with the statements related to the benefits of the symptom 
checkers for their work. 
Benefit for professionals’ work Professionals 
agree (%) 
Using the symptom checker provides me with more useful information before 
meeting a patient. 
67 
The symptom checker leaves more time for meeting with patients. 45 
The symptom checker reduces the amount of routine work in my tasks. 38 
The symptom checker reduces my work. 33 
The symptom checker decreases my control over the patient process. 16 
The symptom checker decreases my control over professional decisions. 12 
 
Most health professionals also agreed that the symptom checkers were useful for 
their work because it provided more useful information about patients before meeting 
them (Table 2). However, less than half of them believed that the symptom checkers 
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would be efficient in their work. A minority also believed that symptom checkers 
decreased their control over the patient portal and professional decisions. 
In open-question responses, the most often mentioned benefits included the 
following: a) patients will be guided to the right professional (a nurse, physiotherapist or 
doctor), b) patients get quick help and standardized self-management instructions, c) 
there will be less unnecessary visits, fewer phone calls, and less queuing. The most often 
mentioned challenges were related to the changes that the new symptom checkers 
brought to work, responsibilities, and common work processes. The symptom checkers 
were seen as added work, as they created one more channel to handle, and some 
respondents mentioned that patients started to unnecessarily use several contact methods. 
Many were also concerned that not all patients were able to use computers or the 
symptom checkers and believed that the care instructions should be made easier so 
patients could understand. For example, one respondent mentioned that the symptom 
checkers required more work than a phone call because patients did not know how to use 
them. Furthermore, the symptom checkers were seen as needing development, as they 
did not notify nurses when a patient made contact, and they also required extra work as 
nurses needed to transfer patient health information to a separate system. 
4. Conclusions 
The majority of the health professionals had a positive view of the new online symptom 
checkers. Most of them accepted the use of online symptom checkers, and they found 
that the services were useful to patients because they provided patients with a method of 
quick contact with health professionals and referral to care or self-management 
instructions, regardless of time and place. Health professionals valued the fact that the 
symptom checkers provided them with more patient information before meeting patients. 
Some of the professionals also saw opportunities to save resources as patients were 
immediately guided to see the right professional and, in some cases, patients could 
manage the health issues by themselves. 
On the other hand, the symptom checkers clearly challenged existing work practices 
and the roles of health professionals. Health professionals believed that symptom 
checkers created extra work for them, considering that the services offered patients a new 
channel to contact health professionals. Some of the health professionals believed that 
the symptom checkers were a threat to their professional autonomy as they reduced their 
control over the patient process and professional decision making. Previously, this 
perceived threat was found to have a significant negative influence on health 
professionals’ acceptance of new technology [4,8]. Furthermore, in our studied 
organizations, a minority of the health professionals resisted the new symptom checkers. 
Thus, there is a risk that teams would not work optimally and some professionals would 
not recommend the symptom checkers to patients. 
The results imply that the implementation of symptom checkers, new work 
processes, and division of work require special attention in health organizations. Health 
professionals need support and training for this novel situation, and work processes 
should be redesigned to guide patients efficiently, avoid work overlap, and ensure work 
motivation among health professionals. The technical solutions should support health 
professionals’ work in a holistic manner, so that they are not separated from other 
systems used and that incoming messages notify the responsible person. 
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Successful implementation of symptom checkers also requires patients to be 
engaged and motivated to use them. The variety of patients and their skills makes this 
challenging. Respondents indicated that patients lacked skills to use computers and 
symptom checkers. Although the content of the symptom checkers was built on scientific 
evidence, it is possible that they could lead to wrong conclusions if patients misinterpret 
the questions used. Furthermore, one respondent commented that the symptom checkers 
appeared to create concerns and lack of support among patients. Thus, it is important that 
symptom checkers are easy to understand and use. In addition, patients’ experiences 
should be studied to identify their support needs and barriers of use. 
The sample size of this survey study was relatively small as the online symptom 
checkers were used less than one year in a few organizations. This study focused on 
health professionals’ subjective experiences in the early phase of the adoption process. 
As health professionals and patients will gain more experience in using the online 
symptom checkers, usage may become more routinized and smoother. However, 
providing a better understanding of the health professionals’ views of symptom checkers, 
and their benefits and challenges will help developers in designing technical solutions 
and health organizations in supporting the adoption of the new services. 
Acknowledgements 
The authors are grateful to the participating health organizations and project managers. 
This work was supported by the Strategic Research Council at the Academy of Finland, 
decision numbers 303606, 327145 and 327147. 
References 
[1] D. Chambers, A.J. Cantrell, M. Johnson, L. Preston, S.K. Baxter, A. Booth, J. Turner, Digital and online 
symptom checkers and health assessment/triage services for urgent health problems: systematic review, 
BMJ Open. 9 (2019) e027743. doi:10.1136/bmjopen-2018-027743. 
[2] H.L. Semigran, J.A. Linder, C. Gidengil, A. Mehrotra, Evaluation of symptom checkers for self diagnosis 
and triage: audit study, BMJ. (2015) h3480. doi:10.1136/bmj.h3480. 
[3] S. O’Connor, P. Hanlon, C.A. O’Donnell, S. Garcia, J. Glanville, F.S. Mair, Understanding factors 
affecting patient and public engagement and recruitment to digital health interventions: a systematic 
review of qualitative studies, BMC Med Inform Decis Mak. 16 (2016) 120. doi:10.1186/s12911-016- 
0359-3. 
[4] S. Kujala, I. Hörhammer, J. Kaipio, T. Heponiemi, Health professionals’ expectations of a national 
patient portal for self-management, International Journal of Medical Informatics. 117 (2018) 82–87. 
doi:10.1016/j.ijmedinf.2018.06.005. 
[5] T. Ingebrigtsen, A. Georgiou, R. Clay-Williams, F. Magrabi, A. Hordern, M. Prgomet, J. Li, J. Westbrook, 
[6] J. Braithwaite, The impact of clinical leadership on health information technology adoption: Systematic 
review, International Journal of Medical Informatics. 83 (2014) 393–405. 
doi:10.1016/j.ijmedinf.2014.02.005. 
[7] R.L. Wakefield, D. Whitten, Mobile computing: a user study on hedonic/utilitarian mobile device usage, 
European Journal of Information Systems. 15 (2006) 292–300. doi:10.1057/palgrave.ejis.3000619. 
[8] K. Finstad, The usability metric for user experience, Interacting with Computers. 22 (2010) 323–327. 
[9] Z. Walter, M.S. Lopez, Physician acceptance of information technologies: Role of perceived threat to 
professional autonomy, Decision Support Systems. 46 (2008) 206–215. doi:10.1016/j.dss.2008.06.004. 
S. Kujala et al. / Health Professionals’ Experiences of the Benefits and Challenges970
How Come Nothing Changed? Reflections 
on the Fasting-Time Project 
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Abstract. Many healthcare interventions fail to produce the intended effect. In this 
paper we look back at the fasting-time project, which aimed to shorten patients’ 
preoperative fasting times. However, the project failed to achieve this effect, even 
though it had been identified and prioritized by the clinicians at the studied 
hospital. A set of mutually reinforcing factors collectively explain why the project 
failed to produce change. The four main factors are: lack of urgency, risk aversion, 
day-to-day busyness, and lack of managerial commitment at the department level. 
The simultaneous presence of these factors complicates efforts to counter them. 
Keywords. effects realization, implementation, change management, fasting time 
1.Introduction 
It is nontrivial to improve hospital practices by introducing new information systems 
and new ways of working. Diffusion-of-innovations theory states that for an innovation 
to be adopted it must, among other things, be compatible, avoid complexity, provide 
relative advantage, and be actively championed by people such as opinion leaders [1]. 
Technology-acceptance research finds that for systems to be adopted and used they 
must be perceived as useful, easy to use, and even enjoyable [2]. Reviews of the 
implementation of electronic health records confirm many of these factors and add 
factors such as adaptability, data migration, implementation climate, management, 
organizational readiness, planning, staff training, and external policy and incentives 
[3][4]. In this study, we look back at a project that failed to produce the intended effect, 
even though the clinicians had themselves identified and prioritized this effect. 
The project [5] concerned the reduction of patients’ preoperative fasting times. To 
reduce the risk of pulmonary aspiration due to vomiting during anesthesia, patients 
must fast for six hours prior to surgical operations. Fasting times in excess of six hours 
should, if possible, be avoided to reduce postoperative complications and patient 
discomfort. But avoiding fasting times in excess of six hours presupposes efficient 
coordination among the involved clinicians. Organizationally, the fasting-time project 
was to introduce new procedures for recording fasting times and acting on long fasting 
times. Technologically, the project was to utilize a network of electronic whiteboards 
for recording, and visualizing, how long the individual patient had fasted. In the 
following, we first summarize the method and results of the project, then we reflect on 
why the project failed to produce shorter preoperative fasting times. 
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2.Method 
The effort to improve the coordination of operations, and thereby reduce fasting times, 
was a participatory-design project conducted by the authors and a group of staff from a 
hospital in Denmark. The project followed an effects-driven approach [6]. That is, the 
project consisted of specifying the purpose of the project in terms of an effect, realizing 
this effect through technical and organizational changes, assessing the extent to which 
the specified effect had been achieved, and iterating to achieve a fuller realization of 
the effect. Table 1 gives the timeline of our empirical activities. 
We started with four workshops (a total of 10 hours) during which clinicians from 
different departments and staff groups at the hospital specified and prioritized the 
effects to be achieved in the project. The effect of reducing preoperative fasting times 
received top priority. After these workshops, a small group was established. It 
consisted of the authors, three staff members (a nurse from the operating ward and a 
secretary from each of the two surgical departments), and a research assistant. This 
group met for 16 participatory-design meetings (35 hours) to realize and assess the 
fasting-time effect. In between the meetings the three staff members worked to 
implement the group’s decisions in their departments. The group meetings were 
supplemented with observation (70 hours) of how the operations were coordinated at 
the hospital. During the effects assessment, fasting times were recorded and visualized 
for three months. 
Table 1. Timeline of the empirical activities, which spanned the period September 2014 – December 2015 
Date Activity 
Phase 1: effects specification 
Sep 18 Workshop with 5 clinicians and a hospital IT project manager to specify effects 
Sep 26 Workshop with 10 clinicians and a hospital IT project manager to specify effects 
Nov 7 Workshop with 7 clinicians to specify effects 
Dec 12 Workshop with 9 clinicians to prioritize and elaborate effects 
Phase 2: effects realization 
Feb 17 Group meeting to kick off the realization of the fasting-time effect 
Feb 20 Group meeting to plan the project activities and begin defining fasting time in detail 
Feb 26 Observation at surgical departments to get a sense of the coordination of operations 
Feb 27 Observation at operating ward to get a sense of the coordination of operations 
Mar 6 Group meeting to define fasting time (and how to record it) in detail 
Mar 17 Workshop with whiteboard vendor to configure the fasting-time fields 
Mar 27 Group meeting to devise a standard procedure for the recording of fasting times 
Apr 10 Group meeting to ensure the adoption of the whiteboard fields and standard procedure 
Apr 24 Group meeting to promote the project and align it with the current use of the whiteboard 
May 8 Group meeting to finalize the setup of the effects assessment: the fasting-time recordings 
May 22 Group meeting to organize and schedule the follow-up on the fasting-time recordings 
Phase 3: effects assessment 
Jun 4 Group meeting to prepare the next phases and the analysis of the fasting-time recordings 
May 11 - Aug 14 Fasting times recorded and visualized on the whiteboard 
May 18 - Jun 30 Observation at the surgical departments of how fasting times were recorded and used 
Aug 21 Group meeting to validate the fasting-time recordings and brainstorm new interventions 
Sep 4 Group meeting to discuss the fasting-time recordings with department management 
Phase 4: effects realization 
Sep 13 - Oct 4 Observation of whiteboard meetings at the operating ward (four Sundays) 
Sep 18 Group meeting to analyze project progress and identify barriers that curbed progress  
Oct 2 Group meeting to prepare a project presentation and discuss the whiteboard meetings  
Oct 23 Group meeting to analyze project progress and identify barriers that curbed progress 
Nov 5 Group meeting to devise a renewed intervention: daily whiteboard meetings 
Nov 16 - Dec 15 Observation of whiteboard meetings at the operating ward (daily for a month) 
Dec 11 Group meeting to discuss lessons learned by the project group and the hospital at large 
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3.Results 
In brief, the changes made to reduce the patients’ fasting times consisted of (a) defining 
fasting time in meticulous detail, (b) extending the hospital-wide network of electronic 
whiteboards with fields showing each patient’s fasting time, (c) devising a standard 
procedure for the recording of the fasting time on the whiteboard, (d) instituting this 
procedure among the clinicians, (e) bringing fasting times to the attention of staff and 
management, (f) adjusting the instructions given to patients about when to eat for the 
last time before arriving for elective operations, and (g) introducing daily whiteboard 
meetings at the operating ward. During the daily whiteboard meetings, the surgeons 
reviewed the patients scheduled for operation, fine-tuned the schedule to accommodate 
acute operations and reduce fasting times, and had the possibility to order a meal for 
patients who would not be operated within the following six hours. For more detail 
about the changes made to reduce the fasting times, see Simonsen et al. [5]. 
In the period May 11 – August 14, 2015, the fasting time was recorded for 416 
(32%) of the patients who were operated upon during this period of time. The average 
fasting time was 12.8 hours, more than twice the required 6 hours. The top 10% of the 
fasting times were 18-23 hours for acute patients and 16-20 hours for elective patients. 
In assessing the fasting times, a chief physician expressed surprise that they were so 
long, especially for the acute patients. Another chief physician agreed that the fasting 
times were long and likely to cause postoperative complications, such as prolonged 
wound healing. He also asked the pertinent question: “Who assumes responsibility for 
this?” His own tentative answer was that on a daily basis no one really cared about 
long fasting times. Our observations of the daily whiteboard meetings, introduced to 
heighten awareness of fasting times, confirmed this answer: Many clinicians did not 
attend these meetings, and on no occasion did we observe that a meal was ordered for a 
patient who would not be operated within the following six hours. The fasting-time 
project was discontinued in February 2016 without obtaining shorter fasting times. 
4.Discussion 
Looking back at the project we contend that no single factor explains the failure to 
shorten the patients’ preoperative fasting times. Rather, multiple factors interact and 
reinforce each other. The review by Ross et al. [4] makes a similar point, while that by 
Priestman et al. [3] merely catalogs single factors. The simultaneous presence of 
interacting factors complicates any attempt to counter the factors and make change 
happen. In retrospect, we identify four primary and several supplementary factors that 
collectively explain the outcome of the fasting-time project. 
First, the physicians did not experience an urgent need. During the effects 
specification the fasting-time effect was championed by one emergency department 
(ED) physician in particular. This ED physician saw shortened fasting times as an 
indicator of improved preoperative coordination. Furthermore, this physician knew the 
whiteboard technology, which had been in use in the ED for three years prior to its 
introduction throughout the hospital. In the ED the whiteboard had spawned multiple 
process innovations. However, the ED physician did not become a member of the 
fasting-time project group, which throughout the effects realization and assessment 
struggled to obtain buy-in from the physicians. Shortened fasting times never became 
an urgent issue for the physicians for two reasons. First, it did not in itself present a 
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problem they perceived as a threat to their competent performance of their work. In 
spite of clinical evidence that prolonged fasting times cause postoperative 
complications, fasting times remained a matter of discomfort to the patients. Second, 
shortened fasting times did not tie in with a performance indicator the physicians were 
keen to achieve (see below). Improved preoperative coordination was not recognized as 
an important goal, but rather seen as a means. Using the improved coordination as a 
means to attract more patients (who would value waiting less) was discussed favorably 
by hospital management, but was not a goal that motivated the individual physicians. 
While lack of urgency is a recognized barrier to change [7], it is not easily dismantled. 
Second, the surgical department was not prepared to risk idle operation slots. An 
idle operation slot is the situation where an operating room is ready and staffed with a 
surgical team but there is no patient to operate upon. One of the key performance 
indicators at the surgical department was to avoid idle operation slots. To achieve this 
goal, the operations were scheduled so that there would always be two patients ready 
for operation. If it turned out that the first patient could for some reason not be operated 
anyway, then the second could be operated instead. While this practice virtually 
prevented idle operation slots, it prolonged fasting times: In most cases, the first patient 
could be operated upon; the second was not operated until later and faced prolonged 
fasting as a consequence. The practice of always having two patients ready for 
operation was one of the up-front reasons for believing that changes in how operations 
were scheduled could realistically lead to shorter fasting times. However, alternative 
practices that shortened the fasting times increased the risk of occasionally not having 
any surgical patient who had fasted for the required six hours. Although this risk was 
small it was influential because it involved a key performance indicator. The aversion 
of this specific risk may be a conscious priority – filled operation slots over shortened 
fasting times. However, a more general risk aversion stifles any change [8] because 
change, by definition, upsets the status quo and thereby incurs uncertainty and risk. 
Third, the clinicians’ daily schedules left few resources for change efforts. The 
clinicians were busy seeing patients, ordering tests, looking up procedures, keeping 
records, interpreting test results, consulting colleagues, obtaining equipment, and so 
forth. As a somewhat extreme example, one of the surgical chief physicians routinely 
had parallel calendar appointments. These parallel appointments partly indicated his 
stressful work situation and partly increased the stress on his colleagues, who could 
never know which appointments he would attend. A large surplus of time for change 
efforts would have been inappropriate because it would have meant that the hospital 
was not run in a cost-effective manner. But the current state of affairs was also 
reproachable. The constant resource and workflow optimizations in Danish healthcare 
had resulted in the near absence of slack resources at the hospital. The clinicians tended 
to feel that all their resources were tied up in their performance of their day-to-day 
activities. Few had the resources necessary to engage in change efforts, such as the new 
practices intended to shorten fasting times. To the hospital, this meant that it was at risk 
of going solid [9], that is, of becoming more or less incapable of change. 
Fourth, managerial commitment was lacking at the department level. The fasting-
time project was supported by hospital top management, which advocated the project 
and its use of the whiteboard. Top management also met with management at the 
department level to obtain their commitment to the project and negotiate the terms of 
their participation. However, the departments enjoyed a high degree of discretion, 
which is common in hospitals [8]. In practice, top management could not order the 
departments to participate in the project, but merely ask them to do so. While the 
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department managers accepted the project, they remained uncommitted to it, partly due 
to its reliance on the whiteboards. The decision to use the network of whiteboards for 
recording, and visualizing, fasting time was based on the successful use of the 
whiteboard for such purposes in the ED. In the other departments, the whiteboard had 
not been similarly successful. For these departments committing to the fasting-time 
project would also mean committing to turning the whiteboard into a technology that 
was in regular use by the staff, who was already skeptical toward the whiteboard [10]. 
While hospital top management liked the prospect of increasing the adoption of the 
whiteboard through the fasting-time project, it eventually had to accept that the 
department managers were not going to put their weight behind the project. 
In addition to the main factors discussed above, several supplementary factors also 
contributed to the outcome of the project. These included (a) competing priorities such 
as the preparations for the upcoming introduction of a new electronic health record 
across the hospital, (b) difficulty establishing an occasion in the planning of the 
operations where information about fasting times could influence decisions, (c) the 
limited interest in information technology among many of the clinicians, (d) the 
interdepartmental character of the project, which increased its organizational 
complexity compared to the successful use of the whiteboard within the ED, and (e) the 
ripple effect of incomplete fasting-time recordings on the subsequent use of these 
recordings in scheduling the operations, for example at the daily whiteboard meetings. 
5.Conclusion 
In spite of top management support, considerable participatory-design work, and good 
intentions, no one really assumed responsibility for shortening patients’ preoperative 
fasting times. The identified set of mutually reinforcing factors collectively explain 
why nothing changed. The four main reasons are lack of urgency, risk aversion, day-to-
day busyness, and lack of managerial commitment at the department level. 
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Abstract. Application of conversational user interfaces (CUI) or chatbots to 
healthcare is gaining interest fueled by the rising power of artificial intelligence, 
increasing popularity of mobile health applications and the desire for engagement 
and usability. While their use is mainly justified by increasing adherence to mobile 
health applications and facilitating interactions with the system, the question arises: 
How can such systems be evaluated in a reliable manner? This paper introduces an 
evaluation framework for health systems whose core interaction principle is a CUI. 
We derive quality dimensions and attributes by collecting relevant evaluation 
aspects from applications that have been developed in previous work and from 
literature on health chatbots. The collected aspects are aggregated into six thematic 
categories for chatbot quality, including user experience, linguistic, task-oriented 
and artificial intelligence perspectives, but also healthcare quality and system 
quality perspectives. The framework is intended to support developers and 
researchers in the domain of chatbots in healthcare in selecting relevant quality 
attributes to be assessed before their systems are distributed to patients. 
Keywords. Evaluation, Health application, Chatbot, Conversational user interface, 
Chatbot evaluation, Natural language understanding 
1. Introduction 
Mobile health applications are increasingly used by patients to collect health data, and in 
this way to continuously monitor personal health and to get support from a virtual 
personal health coach throughout the day. To realize virtual health coaches or to provide 
mobile health interventions, conversational user interfaces (CUI) have been gaining in 
interest with mobile health application developers in recent years [1]. A CUI-based 
system is a computer program that interacts with users using natural language (written 
or spoken). The aim of such a system is to simulate a human conversation. To reduce 
system complexity, the user input is often restricted to selecting specific predefined items 
(e.g. choosing options as replies). A minority of CUI-based systems allow unconstrained 
natural language input. Some systems use embodied avatars, while others reduce the 
conversation to an exchange of text messages. Among healthcare chatbots, we can 
recognize different application areas or scopes of use. Therapeutic or counselling 
chatbots provide some specific therapy such as cognitive behavior therapy (CBT) [2]. 
Disease or medication management chatbots support the user in managing medications, 
provide knowledge on medication or a disease, remind on intake, explain interactions or 
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Figure 1  Evaluation framework. Quality
attributes fall into six thematic categories 
 
 
contraindications etc. (e.g. eMMA [3]). Educational applications can be stand-alone or 
integrated in an application with additional scope of use (e.g. psychoeducation is 
integrated in a CBT chatbot). Other chatbots are used for screening or collecting the 
medical history (e.g. Ana [4]). Several applications exist that collect symptoms from a 
user to make a triage. Finally, chatbots could help in retrieving information such as 
enabling physicians in getting the relevant information from the electronic health record 
of a specific patient. Depending on the scope of use of a chatbot, different quality 
attributes gain in importance when judging the quality. While thousands of health 
chatbots can be downloaded from app stores, evaluation results are reported only rarely 
[1]. If at all, only selected aspects are evaluated with results often not comparable due to 
different methodologies, evaluation aspects and metrics used [1]. In this paper, we 
address the question: What are the relevant aspects for evaluating healthcare chatbots? 
The main objective of this work is to provide guidance on relevant dimensions for 
evaluating health chatbots. 
2. Methodology 
We are focusing on mobile health applications for patients with CUI that allow 
unrestricted natural language user input. In previous work, we developed four such 
applications: eMMA – a medication management assistant [3], CLAIRE – a mobile 
application with virtual reality and voice user interface to educate patients [5], Ana – a 
system that collects the music biography as a starting point for music therapy [4] and 
SERMO – a mental health chatbot that helps in regulating emotions. In previous work, 
these chatbots have been evaluated using different methods and from various 
perspectives. However, their clinical effectiveness has not yet been studied. From those 
works, we collect evaluation aspects. Additionally, we reviewed articles on healthcare 
chatbots retrieved by a PubMed search with keywords "chatbot, conversational user 
interface, chatbot, CUI". According to a snowball approach, we added additional works 
starting from the retrieved results. To develop the framework, we grouped the attributes 
reported on healthcare chatbots and derived evaluation dimensions. 
3. Results 
Six perspectives emerge as important for our 
framework, including user experience, 
linguistic, task-oriented and artificial 
intelligence perspectives, as well as healthcare 
quality and system quality perspectives (Fig. 1). 
 
3.1. Task-oriented perspective 
The task-oriented perspective of a chatbot 
evaluation assesses the capabilities of a chatbot 
K. Denecke and J. Warren / How to Evaluate Health Applications? 977
to perform a specific task such as retrieving information, collecting specific 
information from a patient or predicting a diagnosis etc. It considers the degree of task 
completion or task success and the result quality. For example, a chatbot that is supposed 
to make a triage based on the symptoms described by a user should be assessed with 
respect to 1) the completeness of collected data relevant for triage and 2) the quality of 
the classification based on the symptoms. As such, the underlying algorithm should 
minimize triage classification errors and an appropriate statistic should be selected and 
measured (e.g. as accuracy, if the triage classes are relatively equal in frequency and in 
harm associated with confusion of one class for another). As a further requirement to 
avoid patient harm, the underlying knowledge base of a healthcare chatbot has to be 
evidence-based and relevant. This issue is included in the framework by the aspect data 
provenance within the task-oriented perspective. An underlying knowledge base also has 
to be complete with respect to the task that a chatbot is supposed to do. 
3.2. Artificial intelligence (AI) perspective 
The AI perspective studies to what extent the chatbot is capable of acting like a human 
being, e.g. in terms of problem solving or influencing a user as well as the dialogue 
efficiency (Note obviously, this isn’t the full scope of AI, but we use ‘AI perspective’ 
as a convenient label for this focus on achieving human-like/anthropomor- phic 
behavior). In principle, human-likeness can be studied with the Turing test. Since the 
Turing test cannot measure emotional engagement with users, the metric conversation 
turns per session has been introduced for success of social chatbots [6]. However, in 
healthcare applications, it is important that users are not deceived into over- reliance on 
a chatbot and led to failure in recognizing its limitations due to its human- like dialog. 
To address this issue, it could be assessed whether the chatbot implements mechanisms 
to determine its own intellectual limits, so that it can forward a patient to a human 
healthcare provider to avoid patient harm. Error handling is another aspect of relevance 
for healthcare chatbots within the AI perspective. It concerns the capability of a bot to 
react on unexpected user input or even missing data points. 
3.3. System quality perspective 
System quality in healthcare chatbots should consider data security and performance 
(e.g. answering time). Unlike patient-doctor encounters, where patient privacy and 
confidentiality are protected, healthcare chatbots often do not yet consider these 
aspects. Some of these systems even run on social media platforms such as Facebook 
messenger where the use of collected data is unknown to the user or captured in data 
policies that are long and difficult to understand and to assess. This means the data 
could be sold, traded or marketed by the distributor of a chatbot. To address this issue, 
we included data security into the framework. In existing evaluations, aspects related to 
system quality have not yet been reported. They include among other things that 
privacy policy must be provided that is application-specific and easily accessible, 
ideally within the application; and the treatment of confidential data of the chatbot user 
must be described in detail. Some of the relevant aspects can be assessed using a checklist 
such as to which third parties data are transmitted, and where data are stored. Further, 
health chatbots must comply with existing regulations such as the General Data 
Protection Regulation and Medical Device Regulation. 
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3.4. Linguistic perspective 
Evaluation of a chatbot from the linguistic perspective concerns the effectiveness of a 
conversation. Relevant aspects include response relevance [7], context-awareness or 
overall dialogue quality given divergent user input. The latter addresses the fact that the 
language of bot responses should be suitable for the target user group, i.e. a chatbot 
designed for interacting with children must use different language than one for adults. 
Patient-doctor encounters are ideally characterized by empathy, particularly for 
counseling applications. Thus, a health chatbot should express empathy in its dialog, and 
this is an aspect that should be evaluated for example by adopting the interpersonal 
communication competence scale [8]. 
3.5. UX Perspective 
The UX perspective evaluates an application from a human factors or usability point of 
view, i.e. the feasibility of a chatbot solving specific tasks. It is mainly reflecting 
usability issues, for example adherence, user friendliness, ease of use, appropriateness 
[4], user engagement [2], user satisfaction, enjoyment. The indicator acceptance is a new 
aspect that has been added to our framework and could not be found in existing 
healthcare chatbot evaluations. For example, acceptance could be assessed in terms of a 
classic technology acceptance model (TAM) [9] which combines a user's perception of 
ease of use along with their perception of usefulness of the technology. 
3.6. Healthcare quality perspective 
The healthcare quality perspective addresses patient safety, appropriateness, and 
efficacy or health outcome. Patient safety concerns evaluations studying whether the use 
of the chatbot might create patient harm or risks for patients. For example, a medication 
assistant chatbot should provide the correct dosage of the medication to be taken. 
Appropriateness of using a healthcare chatbot assesses whether it is appropriate to 
deliver a certain healthcare service by means of a chatbot, e.g. whether it is appropriate 
to deliver cognitive behavior therapy using a chatbot for a particular patient. Finally, 
health outcome or efficacy has to be assessed aligned with practice of Evidence-Based 
Medicine (EBM). Then the ideal is 'Level 1' evidence as produced by randomized 
controlled trials (RCTs). To conduct an RCT requires measurement of a relevant 
validated health outcome as the dependent variable, and random assignment of subjects 
from the target population to the health chatbot or an appropriate 'control'. How to 
quantify the health outcome of a mobile application depends on the medical condition 
and treatment it is supposed to support (e.g. quantify efficacy of a diabetes 
management app by comparing the HbA1c value, or scoring systems such as Patient 
health questionnaire PHQ-9). 
4. Discussion 
This paper introduced an evaluation framework for health systems whose core 
interaction principle is a CUI. Jadeja et al. [10] distinguished four perspectives for 
evaluating general domain chatbots: Information retrieval (IR) perspective, UX 
perspective, linguistic perspective, and AI perspective. We adapted this categorization 
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by broadening the scope of the IR perspective to a task-oriented perspective. 
Furthermore, we included two dimensions that have not yet been reported explicitly for 
chatbot evaluation: the system quality perspective and the healthcare quality 
perspective. Low quality healthcare chatbots could readily harm their users in myriad 
ways - such as divulging confidential data, delaying available treatment, or 
recommending ineffective or directly contraindicated treatment - which must be 
avoided. Our framework suggests attributes to be assessed for a health chatbot. We still 
have to assess whether relevant evaluation aspects are included related to the Medical 
Devices Act that have to be considered for chatbots that makes recommendations for 
drug administration. What is still missing are experiences on the judgement, i.e. when 
can we consider a health chatbot to be good or appropriate to deliver health support for 
real patients? Depending on the scope of use of a chatbot, some of the quality attributes 
suggested in the framework might become irrelevant while others gain in importance. 
As a next step, we start a scoping review to fortify our framework. Afterwards, a 
Delphi study will be conducted to collect input on how to weight the different criteria. 
The ultimate goal of these efforts is to provide means that help in evaluating healthcare 
chatbots and to ensure that only validated, evidence-based, evaluated applications will 
be adopted by app stores or distributed by trustworthy distributors of health 
applications. Experiences with implementing the framework for chatbot evaluation has 
to be gained. For enabling comparison among healthcare chatbots with respect to 
quality, agreement upon standardized metrics for the single dimensions would be 
helpful. 
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Abstract. Access to electronic medical record systems is limited in many medical 
informatics education programs. The objective of this study was to inventory 
open-source patient record systems with decision support capabilities, implement a 
system for educational use, and test the effect of the system on students' learning. 
We sought systems that were under active development, with source code 
available, having an SQL-queryable database, and having decision support 
capabilities. We identified 20 candidate electronic health record systems, of which 
6 mentioned decision support capabilities in their documentation. Of these, the 
OpenMRS system appeared to meet all of the requirements for use in our course; 
however, decision support capabilities needed to be added by use of a custom 
module implementing Arden2Bytecode, an Arden Syntax interpreter. Students 
who used this system showed an improvement in their knowledge of decision 
support systems and their capabilities. We conclude that there are a number of 
promising open-source electronic patient record systems currently under active 
development, but decision support capabilities are still immature. We anticipate 
further developments in this area in the coming years. 
Keywords. Free and Open Source Software; electronic health record; decision 
support systems, clinical; medical informatics education 
1. Introduction 
Hospitals are moving from using a collection of small systems toward adoption of 
hospital-wide information systems. One of the major benefits expected from the use of 
electronic patient records is the ability to re-use data, for uses such as research and 
improving patient safety through clinical decision support systems (CDSS).  
In an environment of many small medical software applications, Medical 
Informatics Master's students could readily build small tools which solved real 
information problems and gave them an active learning experience with systems 
similar to those that they will encounter in their career.  Hands-on experience with an 
electronic patient record has been shown to be beneficial in health informatics 
education [1]. However, because most systems are closed-source, medical informatics 
students have no way to see how such systems are designed. This situation is further 
complicated by non-disclosure clauses, inhibiting the sharing of screen layouts and 
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interactions. Future medical informaticians will be expected to build decision support 
that is integrated with electronic health records; however, currently students can only 
get hands-on experience with stand-alone systems. With no patient record to use, 
students can only be educated in terms of knowledge and tested in terms of recall.  
As a solution to the above problems, we propose creating a "virtual hospital" using 
one of the currently-available Free and Open Source electronic patient record systems. 
"Free and Open Source" (FOSS) means that not only is the software freely available, 
but the computer code which is used to make the software is also available, and is 
licensed so that anyone is free to make changes to the software. A number of such 
systems are available, including some that are in clinical use, particularly in middle-to-
low-income countries [2]. However, it is not currently known if any such systems are 
suitable for use in medical informatics education, and particularly for teaching students 
about data re-use and building decision support applications. 
The objective of this study was to choose a suitable FOSS patient record system 
with decision support capabilities, implement that system for use in Medical 
Informatics Master's education, and test the effect of the system on students' learning. 
2. Methods 
The first step was to select an electronic patient record for use. We searched for 
systems using an Internet search engine (duckduckgo.com) using synonyms for "open 
source" and "electronic patient record". This search was conducted on 1 June 2018. 
This was augmented by searching for lists of systems, using the names found in the 
first search. This process was repeated iteratively until no new systems were found. We 
then evaluated the documentation for these systems to assess for suitability for use in 
our educational program. The requirements were: 
 The system should have source code available in a publicly-accessible 
repository. 
 The repository should show current, active development (assessed by the 
number of contributors and commits in the last year). 
 The system should be a hospital system, not a general practice system 
(systems which accommodate both would be accepted). 
 The system should run on the Linux operating system. 
 The system should have a database that is queryable in the Standard Query 
Language (SQL). 
 Clinical decision support functionality should allow the creation of simple 
rule-based reminders. 
The search and evaluation was carried out by one researcher (SM) with the results 
checked by a second researcher (RC). 
Systems that appeared to meet the criteria were installed and assessed empirically 
to confirm that it met our needs. Once a system was selected, it was implemented on 
virtual machines and populated with synthetic patients. The data were generated to 
emulate the data quality problems found in actual patient record data: thus, the data set 
had missing data, data entry errors, misuse of coding systems, etc. Each group of 
students was made the "administrator" of a patient record system on a virtual machine. 
The 3-week assignment was to implement the recommendations for anticoagulant 
management from the ESC 2010 Guidelines for Atrial Fibrillation [3], assess the 
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accuracy of the advice generated by their system, and make a recommendation as to 
whether decision support should be implemented for the rest of the guideline. 
Achievement of the learning goals was assessed through a voluntary pre- and post-
test, which gave scenarios that CDSS implementers might encounter and asked the 
students to choose a course of action (Analyzing/Evaluating levels of Bloom's 
taxonomy). Students assigned to a different project served as non-randomized controls 
for students who completed this assignment. Statistical testing was not performed, due 
to the small number of students in the course. 
3. Results 
We identified 20 systems, of which 2 (OpenMRS and Bahmni) were judged to be 
suitable for use in our educational program. Bahmni is an extension of OpenMRS, thus 
we chose the core OpenMRS system for further investigation. Of the 20 systems 
identified in our search, 13 appeared to no longer be actively maintained (last commit > 
1 year prior to the assessment). These systems were: FreeMed, OSCAR EMR, and 
openMAXIMS (last commit in 2017); ClearHealth, TolvenEMR, and UltimateEMR 
(last commit in 2016); Care2x (last commit 2015); WorldVisa and the Astronaut VistA 
installer (last commit 2014); OpenVista, LiUEEE (last commit in 2013); and 
OneTouchEMR and Solismed (no source code found). The other 7 systems, and the 
results of the assessment, are given in Table 1.  
 
Table 1. Open-source electronic patient record systems identified by our search, and the results of 
assessment for suitability for decision-support education based on available documentation. 
system sourcecode 
repository 
active development hospital or 
GP 
SQL variant CDSS 
functionality 
OpenMRS github 303 contributors hospital MySQL yes 
Bahmni (based on 
OpenMRS) 
github 78 contributors hospital MySQL yes 
OSEHRA VistA github 3 contributors, 300 
commits, 
hospital requires M-to-
SQL  
yes 
OpenEMR github 100 contributors ambulatory MySQL yes 
GnuHealth gnu.org 2 contributors, 179 
commits 
hospital PostgreSQL maybe in an 
add-on 
module 
OpenClinic GA sourceforge 1 contributor,  22 
commits 
hospital MySQL unclear 
Open Hospital sourceforge 2 contributors, 80 
commits 
hospital MySQL unclear 
All systems were cross-platform and thus met the criteria of being able to run on 
Linux virtual machines. Most systems were SQL-queryable, although derivatives of the 
Veteran's Administration's VistA system are written in the M programming language 
which incorporates a "no-SQL"-like database, and thus are not SQL queryable. Only a 
few systems had decision support functionality; the VistA-based systems, OpenEMR, 
OpenMRS, and Bahmni (which is based on OpenMRS). At the time, the decision 
support capabilities of OpenEMR were very simple, and it was designed for 
ambulatory rather than inpatient use.  
Although the documentation for OpenMRS discussed support for Arden Syntax 
Medical Logic Modules (MLMs), an HL7-standard domain-specific language for 
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decision support, empirical evaluation showed no decision support capabilities in the 
current version. However, OpenMRS had good plugin support and used a standard 
interface (JDBC) to connect to its database. Therefore we were able to create a new 
OpenMRS addon module which supported the integration of Arden MLMs  (see 
https://github.com/RSSchermer/openmrs-module-ardenreminders) using  
Arden2Bytecode, an existing FOSS Arden Syntax interpreter [4]. The system was 
hosted by a local service provider (Slash24 B.V.). 
In the learning goals assessment, all 40 students completed the pre-test and 31 
completed the post-test. Students who would later do the CDSS project (CDSS group, 
n=14) had a median pre-test score of 29% (IQR 15%-43%), while students doing other 
projects (non-CDSS, n=26) had a median pre-test score of 46% (IQR 34%-57%). On 
the post-test, the CDSS group showed a median absolute improvement of 10% (n=10, 
IQR 1-16%) while the non-CDSS group showed a median absolute improvement of 4% 
(n=21, IQR -4%-12%).  
4. Discussion 
We successfully incorporated an open-source patient record system with decision 
support in our Medical Informatics Master's program. The search for candidate systems 
identified 20 open-source patient record systems, of which 2 were suitable for use in 
our curriculum. Only 6 of the 20 systems had decision support capabilities; all of these 
were based on one of three core systems: OpenEMR, the Veteran's Administration 
VistA system, or OpenMRS. We were able to build a decision support module and 
implement it in OpenMRS. Assessment of students' mastery of the learning goals 
suggested that use of the system did aid in understanding the learning goals, although 
the number of students is too small to draw firm conclusions. 
The strengths of our approach include a systematic assessment of the available 
candidate systems. However, the landscape of open-source systems is changing 
rapidly; this assessment should be considered a snapshot of the current state of the field. 
The main limitation is the small number of students in each group. Furthermore, in this 
year's class, we had 20 foreign exchange students, most with computer science 
backgrounds, participating in our class. By chance, a majority of the students in the 
CDSS group were foreign exchange students. This meant that only two regular Master's 
students completed both the pre- and post-test (with pre-test scores of 42% and 66%, 
and post-test absolute improvement of 12% and 15%). Although improvement for these 
two students was similar to that of the foreign exchange students, improvement in the 
CDSS group may still be attributable to the fact that the majority of these students had 
more room for improvement. However, it is encouraging that post-test scores on the 
learning goals assessment were acceptable even for students who started with little to 
no medical informatics background. We plan to continue to use the system and monitor 
its effect on learning goals, including the use of other methods for assessing learning 
goals.  
A recent study assessed the capabilities of FOSS electronic health records, 
including their decision support capabilities [5]. The authors found 12 of the 20 
systems that we found, plus an additional 5 systems not identified in this review (all of 
which appear not to be under current development or do not have source code 
available). They also found that OpenEMR and VistA were the systems that offered 
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decision support [5]. An earlier review of FOSS electronic health record systems did 
not assess decision support capabilities [6]. 
For our course, we used a custom-built decision support module integrated with 
OpenMRS. Previous efforts included the integration of an Arden Service, used by the 
Child Health Improvement through Computer Automation (CHICA) project [7]. 
Currently, OpenMRS does not have native decision support capabilities, but there are a 
number of promising efforts to add this functionality. For example, Kabukye et al. are 
working to develop a care pathway (including decision support) for oncology patients 
in low-resource settings [8]. Partners in Health is working to implement support for the 
triage of patients using the South African Triage System [9]. We intend to contribute to 
the development of other CDSS options, including integration of CDS Hooks and/or 
HL7 FHIR-based decision support, and we hope that future projects will include 
contributions from our own students to the OpenMRS code base 
On the basis of this work, we conclude that there are a number of FOSS patient 
record systems under active development. However, the decision support capabilities 
of these systems are, at this time, limited. We successfully implemented an open-source 
patient record for teaching purposes: OpenMRS with a custom Arden Syntax module. 
Use of this system seemed to help students achieve the learning goals of the course. We 
look forward to future developments in decision support in open-source software. 
 
The authors would like to thank the project funder, the Netherlands Initiative for 
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Abstract. Rare conditions can make it difficult for physicians and healthcare
providers to find the right answers and treatment for patients suffering rare dis-
eases. The number of experts specializing in rare diseases in Europe is low. In order
to ensure qualified diagnosis, treatment and care for these patients, the European
Commission has founded the European Reference Networks (ERNs), which are
virtual networks that include healthcare providers across Europe aiming to provide
better care for patients across Europe. The European Reference Network LUNG
(ERN-LUNG) has been established for patients with rare respiratory diseases seek-
ing care and advice on all aspects of rare respiratory diseases. In the context of
ERN-LUNG, the Expert Advisory Board (EXABO) was implemented. EXABO is
a pan-European internet platform based on a question-answering system to sup-
port answering questions regarding all areas of rare respiratory diseases. This paper
gives a brief overview of the first steps taken regarding the implementation of the
EXABO platform, the challenges faced and the lessons that have been learned.
Keywords. Rare Diseases, rare respiratory diseases, ERN-LUNG, Expert Advisory
Board
1. Introduction and Motivation
At present, the awareness of rare diseases is increasing. Diseases that affect less than 5 in
10,000 people are considered rare [1]. Between 6,000 and 8,000 rare diseases have been
identified worldwide so far and affect 6% to 8% of the European population [1]. As a re-
sult, it becomes challenging for patients and their families to receive a confirmed diagno-
sis and adequate treatment for their condition, as the clinicians and healthcare providers
often lack extensive experience in the majority of these rare conditions. Obtaining appro-
priate expert advice on a disease can be highly beneficial for patients as well as the clin-
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icians attempting to provide a targeted therapy. Launched in March 2017, the European
Commission established the 24 European Reference Networks (ERNs) that work on a
range of thematic issues [2]. Their main objective is to ensure and promote excellence
in care and research for the benefit of patients affected by rare diseases. The European
Reference Network for rare respiratory diseases (ERN-LUNG) addresses nine rare and
complex pulmonary disease groups, including Interstitial Lung Disease (ILD), Cystic Fi-
brosis (CF), Primary Ciliary Dyskinesis (PCD), Pulmonary Hypertension (PH), nonCF-
Bronchiectasis (nCF-BE), α1-Antitrypsin Deficiency (AATD), Mesothelioma (MSTO),
Chronic Lung Allograft Dysfunction (CLAD) and Other Rare Lung Diseases (ORLD),
which are represented in nine Core Networks [3]. ERN-LUNG has 72 collaborating
healthcare providers from 17 different European countries. Due to the lack of experts in
the field of rare diseases, patients should benefit directly from expert knowledge, if they
have a specific question regarding a rare respiratory disease. To provide the opportunity
to address questions from patients and clinicians Europe-wide relating to any rare dis-
ease of the respiratory system to ERN-LUNG experts, the internet platform for an Expert
Advisory Board (EXABO) was developed.
2. Methods
The concept of EXABO is based on the knowledge and experience with the former EU
pilot project ECORN-CF2, which is an online expert advisory board for Cystic Fibro-
sis. The key aspects of ECORN-CF were further developed and integrated into EXABO.
While one area of rare respiratory diseases is covered in ECORN-CF, EXABO should
be extended to all areas within ERN-LUNG. The experts must therefore be categorized
based on their area of expertise and country. In each participating country, there is one
expert group for each area of rare respiratory diseases. Each of these expert groups is
organized by a moderator. The “superordinate moderator” takes on the task of organiz-
ing an area of rare diseases throughout Europe. In EXABO, the questions asked are dis-
tributed to the experts by moderators and the responses are monitored under quality as-
pects. Should an expert team not have the appropriate answer to a question, the superor-
dinate moderator can reassign the question to the pool of Europe-wide experts [4].
Based on the stakeholder analysis and the concept, a prototype of EXABO was im-
plemented. For the development of EXABO the waterfall model has been chosen. A two-
staged testing process was used for testing. The results are significant for further devel-
opment. In addition to the design and the technical realization of the Internet platform,
the question-and-answer process, the internal communication between moderators and
experts as well as the administration of the questions and users were of particular impor-
tance in the implementation of the prototype and the advancement to the present state. In
the following the test phase is described and the improvements of the key features based
on the evaluation of the test phase are highlighted.
2.1. Testing
The subject group, consisting of patients, relatives, physicians and programmers, was
split up into the user roles questioner, moderator, superordinate moderator and adminis-
trator, so that a simultaneous interaction between them was possible.
2ecorn-cf.eu
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In the quantitative test procedure, the subjects had to answer 30 questions regarding
user friendliness, accessibility and navigation operating system based on a bipolar rating
method using the four categories “do not agree”, “rather not agree”, “more likely agree”
and “fully agree”. The neutral response option was excluded due to the fact that the test
group for the EXABO prototype consisted of a very small number of persons.
The second stage was a qualitative test procedure, in which the subjects answered
ten interview questions addressing improvement and weakness aspects.
2.2. Question-and-answer process
During the test phase, the question-and-answer process was tested for functionality and
usability. The first step in the question-process in the prototype is selecting one of the
eight rare and complex pulmonary conditions covered by ERN-LUNG: (1) ILD, (2) CF,
(3) PCD, (4) PH, (5) nCF-BE, (6) AATD, (7) MSTO, (8) CLAD. In a next step, the
questioner selects his desired language zone and inserts the question. The platform does
not contain an automatic zone recognition, as it should be optional for the person using
the EXABO platform to choose the language zone during travels. In the last step, per-
sonal data such as e-mail address, age, gender and country of residence are to be entered,
whereby age and gender are not mandatory fields. For security reasons e-mail addresses
are hidden even for logged-in users. The country of residence is essential for the assign-
ment of questions as some languages are registered as official language in several coun-
tries. In consequence, a question that is asked in French will be sent either to a French or
a Belgium group of experts, depending on the name of residency of the questioner.
The test phase has shown that a question cannot always be clearly assigned to a field
of rare respiratory diseases in the beginning of the question-answering process. Above
that, some questions may be so complex that it requires a different group of experts in
the field of rare respiratory diseases. For this reason, the ninth Core Network “Other rare
Lung Diseases” (ORLD) was set up. Furthermore, questions asked by a physician can be
answered more specifically than those asked by laypersons, i.e. patients or their relatives.
Figure 1. EXABO question entry mask.
After the questioning process, each question entered is automatically forwarded to
the responsible moderator, who is the leader of his disease specific expert group and
initiates the response process. The moderator assigns each incoming question to one of
the ERN-LUNG experts in his group to either give the answer to the question or start
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a discussion with other experts before publishing the response. However, questions can
be returned by the expert if they are not fully answered. Returned questions are then
translated to English and forwarded to the superordinate moderator, who will forward
the question to the rare respiratory disease specific panel group across Europe, where the
question can be discussed and the answer sent back to the respective moderator. When
the answer is translated back in the source language, it can be published and archived on
the internet platform.
During the test phase, it became apparent that a discussion with several experts is
not only beneficial in the level of the superordinate moderator, but can also be initiated
by the moderators in each expert group. Additionally, experts as well as moderators can
comment on questions and answers and discuss the questions in a panel group of rare
lung disease experts. In this context, the system provides date time for chat messages
as well as a chat history, which enables the involved ERN-LUNG experts to retrieve
their communication history. If the communication between an expert and the moderator
involves additional experts and experts across Europe, the moderator may censor parts of
the communication, i.e. if an expert has not fully answered a question and hence, returns
it to the moderator. The reason for not having answered the question and other aspects
can be set invisible by the moderator. However, the expert’s commentary may already
contain further approaches which are of advantage for other experts or discussion groups.
In this case, the related moderator has the opportunity to censor the commentary instead
of hiding the whole commentary.
Figure 2. Moderator’s welcome page with his jobs.
2.3. Administration of EXABO
An administrator manages the Internet platform and the user and role management. In
the prototype implementation, the user interface of Keycloak [5] was used for the role
and user management. The role distribution of EXABO is complex. In addition to ex-
perts, moderators and superordinate moderators, a user must also be assigned to a group
of experts in a country with a specific field of expertise. Additionally, a user can be both
an expert and a moderator, even for different fields of expertise or several countries. For
example, a user can be an expert for cystic fibrosis and for primary ciliary dyskinesis,
but is only the moderator for one of these fields. Accordingly, the responsible adminis-
trator who manages the user administration must work exactly to not forget or mix up a
dependent role. If all roles are only listed without any structure, as is the case with the
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prototype interface used, it will make it more difficult for the administrator to do his job
correctly.
As an aid to the administrator, a completely new user interface with dependencies
was programmed for the beta version. First, the actual role of expert, moderator, super-
ordinate moderator and administrator is chosen, in the second step, the field of expertise
is selected, whereby it is possible to make a multiple choice.
2.4. Technical realization
EXABO was implemented as a Spring Boot Java application and build with Maven. The
front-end was realized with FreeMarker and Bootstrap [6]. The open-source single sign-
on tool Keycloak [5] was used for the user and role management. The roles “experts”,
“moderators” and “superordinate moderators” were included.
For the prototype a Web Application Resource (WAR) was used, so that an addi-
tional Tomcat server had to be installed on the server, in order to run the application. Af-
ter the test phase and further development, it turned out that packaging with JAR and an
integrated Tomcat server is the better choice for this application. The JAR is immediately
executable.
3. Conclusion and Outlook
The generic aspect played a substantial role in the implementation of the EXABO In-
ternet platform. As a result, new roles can easily be added in just a few steps and the
platform can be enlarged for the implementation of other European Reference Networks.
The menu items are arranged in a logical manner, which makes the system user
friendly and easy to use for laypersons as well as professionals. Translation into further
European languages would allow a large number of other European citizens to enter their
questions regarding rare lung diseases into the system and find more answers to their
conditions. The internet platform is currently available in German and English in the beta
version since March 2019 and is used by patients and care team members seeking ad-
vice on all aspects of rare respiratory diseases. The release of the full version is planned
shortly. Special emphasis has been placed on a user-friendly interface/system/entry-
points and an easy navigation operating system.
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Abstract. Both patients and physicians of the University Hospital of Erlangen 
would welcome means of digital data exchange between patients and the hospital. 
This work presents a system’s architecture, FHIR based data model, security 
measures, and application flow based on patient’s smartphones and a public cloud 
infrastructure to obtain patient reported outcome measures and merge that 
information with clinical routine data. 
Keywords. Patient Reported Outcome Measures, FHIR, Mobile Applications 
1. Introduction 
Recent research revealed that both patients and physicians of the University Hospital 
Erlangen (UKER) would welcome means of digital data exchange between patients and 
the hospital [1]. Driven by the German eHealth law passed in 2015 [2] and encouraged 
by the growing research interest in patient reported outcome measures (PROM) [3-5], 
we developed the strategy for a digital patient connection into existing hospital IT 
infrastructures. For patients, the system relies on smartphone devices as a way of 
interacting with the hospital and their physicians. Information provided by the patient is 
pseudonymized, encrypted and stored in a public cloud infrastructure. From there it can 
be captured by a local application within the hospital’s network, de-pseudonymized 
and then transmitted via FHIR interface to the hospital´s electronic health record 
system (EHR). 
Currently the system's purpose is to collect patient reported outcome measures, but 
it can easily be extended e.g. to allow patients to send other self-collected data (e.g. from 
wearable devices) to their physicians, or to enable physicians to send information to their 
patients while not being hospitalized. The hospital may specify definitions of care plans 
that describe at what point of time a patient is required to provide answers to a given 
questionnaire. Results are transmitted into the hospital's network and viewed by 
physicians. 
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The objective of this paper is to describe the system´s generic data model, to 
illustrate the complete system architecture, including all security measures and to depict 
its use within a clinical scenario. 
2. Methods 
To enable a straightforward integration into existing systems, it was decided to use HL7’s 
Fast Healthcare Interoperability Resources (FHIR, [6]) as a data persistence and 
exchange format. First, the required subset of FHIR resources had to be identified and 
the corresponding data model had to be created. The smartphone application relies on 
this data model to its full extent. Participating hospitals may require a transformation into 
their proprietary data model when accessing patient data in the FHIR format provided by 
API interfaces. 
Then, an architecture was created meeting the strong requirements of the German 
health care system regarding the exchange of patient-related data as well as granting 
access to any number of private smartphones without endangering the protected IT 
infrastructure of participating hospitals. This included the decisions on the location of 
the patient data storage, security measures to protect patient data against unauthorized 
access, mitigating the risk of leaked data, and providing access to participating hospitals 
in compliance with data protection regulations. 
3. Results 
.1. The data model 
Figure 1. The system’s FHIR based data model 
To facilitate interoperability, a subset of the standardized HL7 FHIR data model is used 
to store and exchange patient data. The seven FHIR resources utilized for this patient 
reported outcome application are linked together according to the data model illustrated 
in Figure 1. 
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Each participating department is represented by an "Organization" resource. Inner- 
hospital hierarchies can be mapped using the reflective relationship "PartOf". Each 
organization may publish one or more “PlanDefinition” resources which are used to 
define at what point of time a patient is requested to answer a questionnaire. Each patient 
is represented by a "Patient" resource with a unique Identifier (“Id”, referred to as "Cloud 
ID"). A patient’s pseudonym is stored in the “Patient” resource’s “Identifier” collection. 
When an organization needs to collect data from a patient, a "CarePlan" resource is 
created that implements the specification of a particular "PlanDefinition" for that 
"Patient" and references all results. A "CarePlan" consists of multiple "Tasks", whereby 
a "Task" specifies at which point of time that patient needs to answer a given 
questionnaire. A “Questionnaire” resource consists of a list of questions to ask a patient 
and may serve as input to a “Task”. A patient’s answers to a given questionnaire are 
stored in a "QuestionnaireResponse" resource (abbreviated to "Q-Response" in Fig. 1) 
and subjected to the corresponding "Patient". 
3. . System Architecture 
The entire system comprises of eleven components spread across four logical and three 
physical sites (see figure 2): The hospital's on-premise network infrastructure (A), a 
public cloud (B and C) and the patient's private smartphone (D). 
Figure 2. Integrating the patient app, the hospital´s EHR and public cloud storage 
Inside the hospital's secure network infrastructure (A) the system relies on the 
established workstations (A1) as user interfaces. Authenticated physicians may interact 
with the system to enroll patients into care plans and view patient reported results. 
Workstations connect to the system using a web server appliance (A2) hosted inside the 
hospital's network providing the patient's ID of the Hospital Information System. A local 
store (A3) is used for generating and managing unique pseudonyms for each patient. 
When communicating with the public cloud components (B and C) the local server only 
uses that pseudonym, the patient's ID of the Hospital Information System is never 
transmitted outside the hospital. 
No public endpoint into the hospital's network is exposed. The Local Server 
regularly polls the Relay Endpoint (B1) inside the public cloud for patients’ responses to 
questionnaires. 
2
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In order to provide access to both, the hospital and its patients, a public cloud 
infrastructure is used. That infrastructure is located on German soil and run by a German 
provider subjected to the General Data Protection Regulation (GDPR)[7]. 
Common artifacts are services used by both, the Local Server (A2) hosted inside the 
hospital's network infrastructure and the patient's smartphone (D). 
A common API (C1) provides functionality like creating a new patient record by the 
smartphone application (D), or requesting a one-time code for patient enrollment to be 
presented at the hospital's workstation by the Local Server (A2). Patient data is stored 
inside a FHIR database (C3) on an encrypted storage. A FHIR API (C2) provides secure 
access to the patients’ data. A scheduled Worker Service (C4) regularly checks for 
updates in care plans and requests patients to answer questionnaires or transmits 
responses to the Relay Endpoint (B1). A cloud User Store (C5) and authentication service 
is used to secure communication between components and limit access to patients’ data. 
Patients may interact with the system using their private smartphone device. A 
platform specific application is available in the usual app stores. The use of the respecting 
application does not require the patient to disclose identifying features such as name, 
email, or telephone number. It is also refrained from using device specific identifiers like 
IMEI, SSAID, MAC addresses/EUI, or Advertising-IDs. Instead, a random installation 
ID is created and used to create a new user in the User Store (C5) and a new patient 
resource in the FHIR Database (C3) after downloading the app. 
3. . Security 
The following measures are taken to protect data and secure communication with and 
within the system: 
i. Data minimization: Patients using the smartphone application are not forced to disclose 
identifying information. 
ii. Pseudonymization: Information exchange between the components hosted inside the 
hospital's network relies on randomized pseudonyms preventing local identifier and cloud 
ID from being disclosed. 
iii. Short-term access codes: In order to enroll in a care plan, the patient enters a code 
displayed at the physician's workstation into the smartphone application. This code is 
valid for only a single enrollment within a short period of time. 
iv. Secure communication: For all communication between components, Transport Layer 
Security (TLS/SSL) is enforced. 
v. OAuth 2.0 for access: Access to a patient's data is restricted to their smartphone and to 
confidential clients (i.e. cloud components). 
vi. Encryption-at-rest: When saved to the FHIR Database, all data is encrypted so that even 
with theft of the data media no access is possible. All other cloud components hold 
decrypted data only in transient memory and never persist in health information. 
vii. Relay into hospital network: To deliver information into the on-premise hospital 
infrastructure, no public endpoint into the hospital's network is exposed. Using a polling 
mechanism, the local server reads data from the relay endpoint containing information 
to be transferred into the hospital.  
3. . Exemplary usage 
The patient downloads and installs the application on his smartphone. After download, 
a random installation ID is created on that patient’s smartphone. In the public cloud, a 
new “Patient” resource with a new Cloud ID is created and stored in the FHIR 
Database that may only be accessed by that patient’s smartphone. The physician opens 
3
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the patient’s health record in the EHR system and requests enrollment to a care plan. The 
EHR then requests a one-time code for enrollment from the Local Server providing the 
patient’s ID. The Local Server either retrieves that patient’s pseudonym from the Local 
Store or creates a new one. The Local Server then requests the one-time code from the 
Common API providing the pseudonym and an identifier for the care plan and passes the 
one-time code to the workstation for display. 
The patient enters that one-time code into the smartphone application and chooses 
to enroll in this care plan. The smartphone application requests enrollment at the 
Common API, which creates the necessary resources in the FHIR database. Invoked by 
a schedule, the Worker Service determines, that this patient is required to answer a 
questionnaire and sends a push notification to the patient's smartphone. The patient then 
may provide answers in a given period of time. The results are stored in the FHIR 
Database. Invoked by a schedule, the Worker Service determines that the patient 
provided answers to a questionnaire. Using the Patient's pseudonym, the Worker Service 
posts a corresponding message to the hospital's Relay Endpoint. The Local Server polls 
the message from the Relay Endpoint, resolves the patient's ID in the Hospital 
Information System, stores the patient’s answers and may notify the physician. 
4. Conclusions 
In this paper, we described a system relying on patients' smartphones and a public 
cloud infrastructure to create a digital connection into existing hospital IT 
infrastructures. An assessment by the data protection officer and the IT security officer 
at the University Hospital Erlangen already granted permission to use the system in 
studies using real patient data. We are currently planning initial research projects with 
departments at the University Hospital Erlangen in which the system is to be used and 
evaluated. 
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Interaction with Medical Venues in
Megacities
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Abstract. With the vast amounts of data that is being generated today, come new
possibilities of understanding patient mobility. In this study, of urban mobility in
ten mega cities worldwide, we try to understand the relationship between patients’
environment and behaviour with regards to venues that provide some kind of med-
ical care. We analyze longitudinal mobility data set from ten of the world’s megac-
ities and investigate urban dynamics and travel patterns in terms of interaction with
medical centers. Our goal is to investigate universal patterns and gain an under-
standing of where people are coming from when they visit such venues and where
they go afterwards as well how travel patterns progress throughout the day.
Keywords. Mobility, Health Data Science, Location Based Social Networks,
Patient Behaviour
1. Introduction
Due to the global environmental changes and increased focus on sustainable living, there
is a growing interest in understanding the movement patterns of people [1]. In line with
that, the research on travel medicine and epidemiology has benefited from the increase
of technologies such as location based social networks (LBSN) that enable geotagging
as a new way of understanding mobility patterns and urban behaviour. The research on
LBSN has been focused on understanding different aspects of mobility and user behav-
ior [2,3,4]. Within that interest is mobility and user behaviour in relation to health pur-
poses. Research has e.g. focused on geographic variation in well-being in Tweets [5] and
exploring Twitter for medicine and health-related terms to find geographical patterns in
symptoms control [6]. Furthermore, Foursquare data has been analysed to gain an un-
derstanding of the spatial distribution of ambulance incidents [7]. There is however still
a gap in the literature regarding the understanding of how people interact with medical
venues. In this paper we explore what people do before and after they visit a medical
center, when their visits take place, and whether the mobility patterns are universal.
We analyze a longitudinal mobility data set from the location based social network
service Foursquare, which has over 50 million active users monthly. We explore the
movements of people between venues in the cities Chicago (CI), Istanbul (IS), Jakarta
(JA), London (LO), Los Angeles (LA), New York (NY), Paris (PA), Seoul (SE), Sin-
gapore (SI) and Tokyo (TO). The mobility data set originates from Foursquare and was
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Figure 1. Relative frequency of categories of the origin of movements when destination is Medical Center
Figure 2. Relative frequency of categories of the destination of movements when origin is Medical Center
provided for the participants of the Future Cities data challenge 2 and spans two years. A
movement is created in the data set each time a user checks-in at one of the city’s venues
and consists of two end points, the origin, where the user was last time they checked
in and the destination where the user is currently checking in, as well as the part-of-
day indicating the time of arrival at the destination, defined as morning (06-10), midday
(10-15), afternoon (15-19), night (19-24) and overnight (00-06).
2See https://www.futurecitieschallenge.com/
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Foursquare?uses?a?hierarchical?category?set?to?categorise?the?venues?on?the?platform.?
There?are?ten?categories,?as?shown?on?the?legend?in?Figure?1.?Each?category?is?separated?
into?subcategories?which?are? furthermore?divided? into?subsubcategories.?Medical?Cen-
ters?are?for?instance?a?subcategory?within?the?category?Professional?&?Other?Places,?and?
can?be?separated?into?subsubcategories?such?as?Hospitals,?Dentist’s?Offices?and?Physical?
Therapists.?In?total?there?are?923?categories?3?on?different?levels?where?we,?in?this?paper,?
focus?on?venues?that?belong?to?the?subcategory?Medical?Centers.
2.? Analysis?of?Movements
For?our?analyses,?we? inspect? the?data?from? two?perspectives,?namely?where?people?are?
coming?from?when?they?visit?medical?venues?and?where?they?go?to?after?their?visits,?by?
extracting?all?movements?that?end?and?start?in?a?venue?in?the?Medical?Center?subcategory,?
respectively.?We?look?at?the?distribution?of?origin?and?destination?venues?on?two?levels?of?
granularity,?that?is,?category?and?subcategory.
Figure?1? shows? the?distribution?of? categories?of? the?movement?origins? in? the? ten?
cities.?In?each?subplot,?there?are?six?bars?showing?the?distribution?during?various?parts?of?
the?day.?The?first?bar?in?each?subplot?shows?the?overall?distribution,?that?is,?irrespective?
of?the?time?of?day,?where?as?the?remaining?five?columns?show,?from?left?to?right,?the?dis-
tribution?in?the?morning,?at?midday,?in?the?afternoon,?at?night?and?overnight.?Evidently,?
this?distribution?varies?from?city?to?city,?for?example,?venues?in?the?category?Outdoors?&?
Recreation?are?more?frequently?visited?in?Istanbul?than?in?Jakarta,?and?Travel?&?Transport?
venues?are?used?more?in?Tokyo?than?in?Chicago?and?Los?Angeles.?There?is?also?a?differ-
ence?in?patterns?throughout?the?day.?In?London,?for?example,?Travel?&?Transport?venues?
have?a?higher? frequency? in? the?morning?and? in?many?cities? the? frequency?of?Nightlife?
Spots? is? the?highest? in? the?overnight?period.?The?variation? in?venue?categories? is?more?
prominent?in?Figure?2?which?shows?the?distribution?of?to?movements.?Here,?we?can?see?
that?in?many?of?the?cities,?Professional?&?Other?Places?are?much?more?often?travelled?to?
from?Medical?Centers? in? the?morning? than?overall,?Food?venues?are? less?frequented? in?
the?morning?and?more?at?night.
Next?we?look?at?the?venues?travelled?from?and?to?at?the?more?granular?subcategory?
level.?Based?on?Figures?1?and?2?we?select?the?cities?New?York?and?Tokyo,?because?they?
show?variety?in?their?distribution?of?movements?and?they?represent?cites?in?different?parts?
of?the?world.?As?there?are?over?four?hundred?subcategories,?we?only?look?at?the?most?fre-
quented?ones.?Tables?1?and?3?show?the?highest?ranked?subcategories?of?venues?of?move-
ment?origins?in?New?York?and?Tokyo?at?different?parts?of?the?day,?respectively.?Tables?2?
and?4?show?the?same?for?the?destination?of?movements.?The?first?entry?in?each?column?is?
the?most?frequent?subcategory?during?the?respective?part-of-day,?and?so?on.?The?numbers?
in?brackets? show? the? ranking?of? the? subcategory? in? the?overall?data? set,? that? is,? taking?
into?account?all?movements.?This?gives?an?indication?of?the?general?frequency?of?the?sub-
categories?in?the?data?set.?These?tables?gives?some?interesting?insights?into?how?people?
interact?with?Medical?Centers?within?and?between? the? two?cities.?First?of?all,?Medical?
Centers?appear?very?high?in?all?the?tables.?This?means?that?movements?where?both?end?
points?belong?to?Medical?Centers?are?very?common.?This?is?probably?due?to?people?who?
are?employed?at?these?venues?and?therefore?go?there?regularly?and?frequently?check-in.
3See https://developer.foursquare.com/docs/resources/categories for a complete list
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Table 1. The highest ranked subcategories of venues visited before a Medical Center in New York.
Morning Midday Afternoon Night Overnight
1 Medical Centers Medical Centers Medical Centers Medical Centers Medical Centers
2 Metro Stations (1) Metro Stations (1) Metro Stations (1) Metro Stations (1) Metro Stations (1)
3 Food & Drink Shops (3) Parks (2) Food & Drink Shops (4) Food & Drink Shops (5) Parks (6)
4 Parks (4) Food & Drink Shops (4) Parks (2) Parks (4) Bars (1)
5 Train Stations (2) Coffee Shops (3) Coffee Shops (3) Bars(2) Food & Drink Shops (7)
6 Coffee Shops (6) Athletics & Sports (5) Athletics & Sports (6) Athletics & Sports (6) Athletics & Sports (9)
7 Athletics & Sports (5) Pharmacies Asian Restaurants (8) Asian Restaurants (3) Asian Restaurants(5)
8 Pharmacies Asian Restaurants (7) Bars (5) Coffee Shops (7) Train Stations (8)
9 Bars (8) Train Stations (8) Pharmacies Pharmacies Pharmacies
10 Asian Restaurants Bars (6) Train Stations (7) Fast Food Restaurants Residential Buildings
Table 2. The highest ranked subcategories of venues visited after a Medical Center in New York.
Morning Midday Afternoon Night Overnight
1 Medical Centers Medical Centers Metro Stations (1) Medical Centers Medical Centers
2 Metro Stations (1) Metro Stations(1) Medical Centers Metro Stations(1) Metro Stations(1)
3 Parks (6) Food & Drink Shops (4) Food & Drink Shops (2) Food & Drink Shops (4) Parks (5)
4 Coffee Shops (2) Parks (3) Parks (3) Bars (2) Bars (2)
5 Athletics & Sports (3) Coffee Shops (2) Athletics & Sports (7) Asian Restaurants (3) Athletics & Sports (6)
6 Food & Drink Shops (8) Athletics & Sports (5) Coffee Shops(6) Parks (5) Airports (3)
7 Train Stations (4) Asian Restaurants (6) Pharmacies Athletics & Sports (7) Bridges
8 Offices (5) Pharmacies Bars (4) Pharmacies Fast Food Restaurants
9 Donut Shops Offices (7) Train Stations (5) Train Stations (8) Food & Drink Shops (9)
10 Bridges Fast Food Restaurants Asian Restaurants (8) Coffee Shops (10) Train Stations (7)
Table 3. The highest ranked subcategories of venues visited before a Medical Center in Tokyo.
Morning Midday Afternoon Night Overnight
1 Train Stations (1) Train Stations (1) Train Stations (1) Train Stations (1) Train Stations (1)
2 Asian Restaurants (3) Asian Restaurants (2) Asian Restaurants (2) Asian Restaurants (2) Medical Centers
3 Metro Stations(2) Metro Stations (3) Medical Centers Metro Stations (3) Asian Restaurants (2)
4 Medical Centers Medical Centers Metro Stations (3) Medical Centers Convenience Stores (5)
5 Convenience Stores (4) Convenience Stores(4) Convenience Stores (4) Convenience Stores (5) Metro Stations (3)
6 Food & Drink Shops (5) Food & Drink Shops (6) Food & Drink Shops (7) Food & Drink Shops (8) Bars (4)
7 Coffee Shops (6) Coffee Shops (5) Coffee Shops (6) Coffee Shops (6) Parks
8 Intersections (8) Parks Shopping Malls (5) Intersections Food & Drink Shops (6)
9 Parks Intersections (10) Parks Bars (4) Intersections (7)
10 Bridges (7) Shopping Malls (7) Intersections Shopping Malls (7) Coffee Shops (8)
Table 4. The highest ranked subcategories of venues visited after a Medical Center in Tokyo.
Morning Midday Afternoon Night Overnight
1 Train Stations (1) Train Stations (1) Train Stations (1) Train Stations (1) Train Stations (1)
2 Medical Centers Asian Restaurants (2) Asian Restaurants (2) Asian Restaurants (2) Medical Centers
3 Metro Stations (2) Medical Centers Metro Stations(3) Metro Stations (3) Convenience Stores (3)
4 Coffee Shops (5) Metro Stations (3) Medical Centers Convenience Stores (5) Asian Restaurants (2)
5 Convenience Stores (3) Convenience Stores (4) Food & Drink Shops (4) Food & Drink Shops(6) Metro Stations (4)
6 Asian Restaurants (4) Coffee Shops (5) Convenience Stores (6) Medical Centers Food & Drink Shops (8)
7 Schools Food & Drink Shops (7) Coffee Shops (7) Bars (4) Parks (10)
8 Intersections (8) Intersections (10) Shopping Malls(5) Intersections(9) Intersections (7)
9 Parks Shopping Malls (6) Intersections Coffee Shops (8) Hotels (6)
10 Bridges (6) Parks (9) Cafés (9) Shopping Malls (7) Steakhouses
Secondly, Train and Metro Stations also appear very frequently. We already know that
Travel & Transport venues are common in these two cities, and as with other venues,
people use public transport when commuting to and from Medical Centers. Places for
eating and buying food are also dominant in combination with Medical Centers. When
comparing the two cities, we can highlight a few aspects. In New York, Pharmacies have
a high ranking both before and after visiting a Medical Center. This is not the case in
the other cities. We also see that venues that offer food and are not ranked high in gen-
eral, appear in the list after visiting a Medical Center in New York, such as Fast Food
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Restaurants?and?Donut?Shops.?In?Tokyo,?there?is?high?correspondence?between?general?
travel?patterns?and?those?related?to?Medical?Centers,?as?seen?by?the?numbers?in?the?brack-
ets.?Only?Parks?seem?to?be?out?of?place?here,?as?they?are?highly?ranked?before?visiting?a?
Medical?Center.
3.? Conclusion
Data?from?LBSN?have?the?potential?of?revealing?different?patterns?in?human?mobility.?In?
this?paper?we?draw?from?a?study?where?we?explore?mobility?patterns?on?what?people?do?
before?and?after?their?visit?to?a?medical?center,?based?on?data?from?the?LBSN?Foursquare.?
We?compared?data?from?ten?megacities?and?examined?two?megacities?in?more?detail.
As?the?data?set?is?from?ten?megacities,?it?should?make?the?users?rather?homogeneous?
in?the?different?cities.?However,?the?different?cities?exhibit?heterogeneous?travel?patterns?
where?different?categories?of?venues?are?dominant?for?each?city.?For? instance,? the?sub-
category?of?athletics?and?sports? is?absent? in? the?Tokyo?data?but? is? frequent? in? the?New?
York?data.?Another? interesting?finding? is? the? lack?of?pharmacies.?The?New?York?data?
shows?that?pharmacies?are?visited?both?before?and?after?visits?to?a?medical?center,?which?
is?not?he?case?in?the?other?cities.?The?different?user?behaviour?can?also?be?shown?through?
apparent?interaction?with?bridges?and?intersections?in?the?Tokyo?data?set?in?general?and?
with?parks?in?relation?to?a?visit?to?a?medical?center?in?particular.?As?the?data?comes?from?
the?same?period?of? time,?Foursquare?as?a?LBSN? looked?and?performed? the?same?at?all?
locations.?However,?the?popularity?in?the?different?places?and?the?stream?of?tourists?that?
either?use,?or?do?not?use?LBSN,?can?vary?in?the?ten?megacities.?Future?work?could?both?
include?understanding?what?the?data?represents?in?terms?of?the?users?of?the?LBSN,?and?to?
understand?the?patient?patterns.?Furthermore?we?want?to?examine?the?distance?between?
the?venues?that?show?up?in?the?data?and?explore?the?different?ways?geotagging?is?used?in?
the?ten?megacities?in?relation?to?visits?to?medical?centers?and?develop?a?measurement?of?
the?similarities?between?the?geotagging?of?medical?centers?and?overall?categories.
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Abstract. The development of artificial intelligence (AI) systems to support 
diagnostic decision-making is rapidly expanding in health care. However, 
important challenges remain in executing algorithmic systems at the frontlines of 
clinical practice. Hence, most often, these systems have not been trained with local 
data nor do they fit with context-specific patterns of care. This research examines 
the implementation of an AI-based decision support system (DSS) in the 
emergency department of a large Academic Health Center (AHC) in Canada, 
focusing specifically on the question of end-user adoption. Based in an 
interpretative perspective, the study analyzes the perceptions of healthcare 
managers, AI developers, physicians and nurses on the DSS, so as to make sense 
of the main barriers to its adoption by emergency physicians. The study points to 
the importance of considering interconnections between technical, human and 
organizational factors to better grasp the unique challenges raised by AI systems in 
health care. It further emphasizes the need to investigate actors’ perceptions of AI 
in order to develop strategies to adequately test and adapt AI systems, and ensure 
that they meet the needs of health professionals and patients. This research is 
particularly relevant at a time when considerable investments are being made to 
develop and deploy AI-based systems in health care. Empirically probing the 
conditions under which AI-based systems can effectively be integrated into 
processes and workflow is essential for maximizing the benefits these investments 
can bring to the organization and delivery of care. 
Keywords. artificial intelligence, decision support system, emergency care, 
adoption 
1. Introduction 
The development of artificial intelligence (AI)-based systems to support clinical 
decision-making in health care is currently undergoing rapid expansion. AI, broadly 
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defined as the imitation of human cognition by a machine [1], is expected to enable 
better surveillance, detection and diagnosis of illnesses, as well as uncover novel 
treatments to spur precision medicine [2-4]. AI systems have already proven more 
effective than dermatologists at diagnosing skin cancer [5], and experts believe they 
will outperform medical specialists in surgery by 2050 [6]. As a result, health care is 
often presented as one of the most propitious domains in the upcoming "AI revolution" 
[7][8]. Yet, despite the enthusiasm around AI's capacity to increase the quality, safety 
and efficiency of care, important challenges remain in executing algorithmic systems at 
the frontlines of clinical practice. Hence, most often, these systems have not been 
trained with local data, nor do they fit with context-specific patterns of care [1][9][10]. 
The present research aims to explore some of these challenges by analyzing the 
implementation process of an AI-based decision support system (DSS) in the 
emergency department of a large Academic Health Center (AHC) in Canada. Research 
to date has identified several hurdles facing the deployment of AI systems in health 
care. These relate mainly to technical issues (e.g. lack of quality data sets to train 
algorithms; non-interoperable information platforms) and ethical/legal considerations 
(e.g. concerns about data privacy, algorithm opacity and patient safety; lack of ethical 
and legal frameworks to provide safeguards against inappropriate use) [11-14]. 
Research gaps remain in understanding how these barriers interrelate with human and 
organizational factors to drive and influence implementation.  
This article adopts an interpretative perspective [15] to analyze the implementation 
of an AI-based DSS in an emergency department (ED), focusing on actors’ 
representations of the system. We explore how health managers, AI developers, 
physicians and nurses perceive the AI-based DSS and interpret the interrelated 
technical, human and organizational barriers that lead to its ineffective adoption in the 
AHC.  
2. Methodology 
2.1. Study site and AI system 
The study site is one of the largest AHCs in Canada, located in the province of Québec. 
In November 2018, an AI-based DSS was tested for implementation as a pilot project 
in the AHC's ED. The DSS is a diagnostic technology based on a deep-learning 
algorithm using clinical data and evidence-based results from the scientific literature. 
For patients visiting the ED, the DSS presents as a questionnaire that is answered on a 
mobile tablet. First, the patient is asked about the purpose of their visit to the ED. A 
Natural Language Processing engine then analyzes the text written by the patient to 
identify the chief complaint (e.g. skin rash, abdominal pain, etc.).  
The patient is then asked a series of questions based on the chief complaint, with 
each question adapted to the previous response. The main objective is to identify red 
flags and signs of serious conditions. At the end, the DSS outputs a medical history that 
is printed by nurses or clerks and presented to the physician prior to their encounter 
with the patient. According to the DSS developers, who are also emergency physicians 
at the AHC, the medical history is meant to optimize patient questioning and diagnostic 
decision-making by providing physicians with information about the history of the 
presenting complaint, pertinent positives and negatives, past medical/surgical/family 
history, and social history. 
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2.2. Data collection and analysis strategies 
An in-depth case study was performed at the ED, triangulating data collection methods 
and sources in an ethnographic approach to make sense of actors' perceptions of the 
DSS implementation process. A snowball technique was used to recruit participants 
and 20 semi-structured interviews were conducted: first with the DSS developers (5) 
and AHC managers (5), and then with emergency physicians (7) and nurses (3). 
Complementing the interviews (which were recorded and transcribed), informal 
conversations with nurses and clerks took place, as well as non-participant observations 
of meetings with managers, designers, physicians and nurses (10 in total), and of DSS 
utilization in context (15 hours). Field notes allowed observed situations to be 
contextualized, and preliminary elements of analysis to be identified. Finally, multiple 
secondary documents were gathered to better grasp actors’ interpretations and trace the 
DSS implementation history; these included emails sent to physicians, documents 
prepared by AHC managers and developers, as well as different versions of the DSS-
generated medical history. For data analysis, a description of the implementation 
process was first completed using a narrative strategy [16] that highlighted key 
timelines and activities. Then, using all collected data, thematic content analysis was 
performed with NVivo 12 software (QSR International) to identify, categorize and 
refine the main barriers to physician adoption of the DSS. [17] 
3. Findings 
Our analysis of the implementation process revealed several barriers identified by 
research participants that limited the DSS integration into clinical processes and 
workflow, and eventually drove several physicians towards non-adoption. These 
barriers related to three types of issue.  
3.1. Availability  
First, trials were conducted with patients to test whether they could complete the DSS 
questionnaire. Following adjustments to improve the intelligibility of the questionnaire, 
AHC managers and DSS developers jointly decided that only a subsection of patients 
would be asked to complete the questionnaire: English- or French-speaking outpatients 
who did not present any mental deficiency, visual handicap or alcohol/drug 
intoxication symptoms. This considerably limited the number of medical histories 
generated by the DSS. 
Moreover, the lack of interoperability between the DSS and the AHC clinical 
information systems (Electronic Patient Record and Emergency Information System) 
meant that medical histories had to be printed and handed to physicians in paper form. 
These tasks were assigned to nurses and clerks who were already overworked with 
their regular obligations. As a result, medical histories were often not printed and thus 
were not provided to physicians. According to the DSS developers, this was the main 
factor limiting physician adoption of the medical history. Developers argued that 
physicians did not have enough opportunities to read medical histories and learn how to 
integrate them into their clinical practice. However, according to nurses, this did not 
really explain why physicians were not becoming "early AI adopters": 
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Every time it doesn't work, they say it's because nurses didn't print the history, or didn't 
direct them [patients] to the tablet, or because... "Wait a minute, you, [developers], what 
have you done to change our processes? What have you done to improve the medical 
history? What have you done to innovate?"[...] Since, it's something to help physicians, they 
need to play their part. (Nurse 2) 
3.2. Usability  
Some nurses were convinced that physicians were not using the medical histories 
because they had difficulty understanding patient information reported by the DSS. 
This was, in fact, a major barrier reported by several physicians. The physicians 
interviewed considered that the AI-based system was good at reporting simple 
complaints (a localized pain, a broken leg, etc.) but very poor at making sense of multi-
complaint conditions (pain throughout the body, pain related to severe pre-existing 
conditions, etc.). This was a major concern, as most patients coming to the ED 
presented with the latter profile: 
 
The history shows a multitude of symptoms to which the patient responded 'Yes, I have this'.   
But is it relevant? Is it active? Is it related to the current complaint? Afterwards, you need to 
disentangle all this. (Physician 4) 
 
This type of feedback was directly reported to the DSS developers during focus 
groups. In response, adjustments were made to the design of the medical history to 
better classify patient information and simulate the clinical reasoning of physicians 
(presentation of pre-existing conditions, chief complaint, etc.). However, adoption rates 
did not increase significantly. Implementation data collected by the DSS developers 
showed that the proportion of annotated medical histories remained almost the same 
(around 30%) before and after these adjustments. 
3.3. Perceived usefulness 
At the start of implementation, several physicians were positively disposed toward 
using an AI-based DSS to enhance their diagnostic practice. However, some reported 
having discovered "errors" in the medical histories. In particular, two physicians 
reported that reading the medical history led them down the wrong diagnostic path. 
Had they not questioned the patient again, they would have made a serious clinical 
error:  
 
But, you know, there are times when it completely took me down the wrong path... Not 
often... But it happened and it should not happen. It’s like, me... I have zero tolerance. It’s a 
tool that's supposed to help us... not at the price of losing a patient... But to miss something, 
something huge, you know... So that's... It didn’t happen often. But it happened, so it cooled 
my enthusiasm. (Physician 6)  
 
Perceptions of DSS-induced errors were shared among physicians, and this led 
some to develop a persistently sceptical attitude towards the usefulness of the DSS. The 
AI system was thus viewed as introducing a real risk into clinical practice that was 
capable of causing harm to patients. This is a perception that tends to increase clinician 
resistance to health information systems. 
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4. Discussion and implications 
This in-depth case study shows how the combination of availability, usability and 
perceived usefulness can contribute to physician distrust of an AI-based DSS. The 
study further points to the importance of empirically probing the interconnections 
between technical, human and organizational factors to make sense of barriers that 
limit the implementation of AI-based systems in health care. However, these 
interconnections are rarely taken into account by researchers working on the 
deployment of AI-based technologies in clinical environments [4][9].  
Moreover, the research emphasizes the need to consider the unique challenges 
raised by AI integration into clinical processes and workflow [10]. As shown in this 
study, actors’ perceptions of a technology influence their actions towards it, be they 
related to adoption or resistance. For this reason, it is essential that managers 
responsible for implementation deal with specific assumptions and expectations 
regarding AI systems. Since these can generate negative perceptions (e.g. distrust in the 
effectiveness of automated decision making), that can hinder testing and adaptation, it 
is necessary to develop systematic learning processes based on user feedback to ensure 
that AI systems are implemented effectively. 
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Abstract. The health outcomes of high-need patients can be substantially influ-
enced by the degree of patient engagement in their own care. The role of care man-
agers (CMs) includes enrolling patients and keeping them sufficiently engaged in
care programs, so that patients complete assigned goals leading to improvement
in their health outcomes. Here, we present a data-driven behavioral engagement
scoring (BES) pipeline that can compute the patients’ engagement level with re-
gards to their interest in: (1) enrolling into a relevant care program, and (2) com-
pleting program goals. This score is leveraged to predict a patient’s propensity to
respond to CMs’ actions. Using real-world care management data, we show that the
BES pipeline successfully predicts patient engagement and provides interpretable
insights to CMs, using prototypical patient cases as a point of reference, without
sacrificing prediction performance.
Keywords. Care management, personalization, metric learning, interpretability
1. Introduction
Care management is a patient-centered approach to population health that is “designed
to assist patients and their support systems in managing medical conditions more effec-
tively.” The Agency for Healthcare Research and Quality (AHRQ) recommends [1] that
researchers should investigate (a) the benefit of care management services to different pa-
tient segments and (b) the parameters that affect modifiable risks. This can be especially
important for those with chronic conditions and those who are transitioning to home care
after being discharged from hospital [2].
While machine learning (ML) models may be helpful for patient segmentation and
risk analysis, there is a desire for such models to be more explainable, or interpretable,
so that they are more likely to be acted upon by human decision makers [3]. Recent re-
views [4] have shown that a majority of studies in model interpretability are tied to the
optimization of certain model properties for extracting explainable insights. While prior
studies have attempted to identify risk stratification and disease progression parameters
that affect modifiable clinical risks [5], to our knowledge, this is the first study that has
proposed to learn engagement strategies directly from data, based on the quantifiable dif-
ference of patient engagement levels and segment-differentiating parameters that affect
modifiable risk factors beyond those related to clinical risks.
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Table 1. Goal attainment records of patients distributed across focus areas & intervention categories.
Focus Areas Coaching Coordination Education Referral Screening Tracking Other Total Status Met
Educational 138 18 277 100 65 0 23 621 81.62%
Implementation 3 192 4 7 0 0 0 206 98.54%
Medications 7 96 30 7 90 0 10 240 84.91%
Reducing Risks 0 1 0 545 53 0 1 600 97.00%
Self-care 130 0 189 12 116 0 49 496 78.69%
Other 29 0 2561 14 29 12 19 2644 99.19%
Total 307 307 3061 685 353 12 102 4827
This paper focuses on using ML methods to identify patient segments who are most
likely to engage in care management, and on care manager (CM) decision support for
explaining why they may or may not engage. While a few prior studies have measured
patient engagement via quantitative surveys [6], no prior studies have successfully shown
to measure patient engagement from real-world data. Its success will be critical for in-
forming individual-level intervention decisions for care management [7].
2. Data
Care Management Records: The care management data, based on which we developed
our method, are phone conversation logs of a private, not-for-profit network of commu-
nity and specialty hospitals. It includes 4,504 transition of care and 440 chronic care
related interactions of 3693 unique patients over a 22-month period (Dec-2015 to Oct-
2017). From each patient’s anonymized (by Mongo Patient ID) engagement interaction
history, we extracted 53 features that includes: (a) basic demographic information (e.g.,
age, gender); (b) patient’s care program context (e.g., program experience, whether the
patient is enrolled, number of days in the program etc); and, (c) interactional context
between CMs and patients (e.g., the day of the week when the recorded call occurred).
Using this data, we aim to introduce a data-driven approach to achieve two crucial tasks
for decision support: program enrollment (“ENROLL”) and goal attainment (“GOAL”).
The ENROLL dataset captures the enrollment status for the two assigned care programs:
“Transition” include those transitioning from hospital to home after being discharged,
and “Involve” include those involving with chronic disease (diabetes etc.) management.
The GOAL dataset, composed of 28 different goals, is classified into six focus ar-
eas based on their similarity: Educational (e.g., demonstrate understanding of post dis-
charge, diabetes education), Implementation (e.g., adequate functional, transportation,
support for healthy coping), Medications (e.g., adhere with medication regimen), Re-
ducing Risks (e.g., resolve care gaps), Self Care (e.g., understand the benefits of being
physically active & healthy diet needs), and Other (e.g., effective care transition). Ta-
ble 1 summarizes the goal attainment rate for each goal focus area, i.e., the ratio of the
number of goals recorded as ‘met’ to the total number of goals in each focus area. The
interventions of each goal area are grouped into seven categories: Referral (e.g., refer to
a nutritionist for diabetes nutrition education), Education (e.g., educate patients on the
importance of physical activity), Coordination (e.g., follow up with providers on refills),
Screening (e.g., assess breathing symptoms), Coaching (e.g., provide a log for side effect
recording), and Other (e.g., follow up with provider treatment).
3. Methods: Behavioral Engagement Scoring Pipeline
To further incorporate the data-driven approach for indicating patient engagement level
and producing interpretable insights, in this paper, we introduce the Behavioral Engage-
ment Scoring (BES) pipeline, which is composed of three components:
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3.a)?Engagement?Outcome-driven?Distance?Learning:?This?component?aims?to?learn?
an? engagement? outcome-driven? distance?metric? so? as? to? project? patient? feature-based?
vectors?onto?a?subspace?wherein?patients?with?similar?outcomes?are?closer?to?each?other.?
Such?metrics?would?be?essential? to?ensure? those?with?opposite?outcomes?are? far?away?
from?each?other.?Here,?we?adapt?Locally?Supervised?Metric?Learner?(LSML)?[8],?which?
helps?estimate?the?outcome-adjusted?distances?among?patients?in?the?newly?transformed?
vector?subspace.?The?patient? features?are? represented?as?X?∈?Ω,?where?Ω? is? the?vector?
space,?and?the?class?labels?as?Y?∈?{0,1}.?For?program?enrollment,?y?=?1,?if?the?status?is?
”Enrolled”?or?”Completed”,?and,?y?=?0,?if?the?status?is?“DidNotEnroll”?or?“Disenrolled”.?
Similarly,?for?goal?attainment,?y?=?1,?if?the?status?is?“Met”,?and,?y?=?0,?otherwise.
We?minimize? the? generalized?Mahalanobis? distance? across? all? CM? records? seg-
mented?into?homogeneous?(records?with?same?outcome)?and?heterogeneous?(records?with?
opposite?outcomes)?neighborhoods.?The? feature? transformation?matrix? that?minimizes?
this?generalized?Mahalanobis?distance,? renders? the?data? into? the?desired? space,?where?
records?with?similar?outcomes?are?compact?and? those?with?opposite?outcomes?are?dis-
tant.?Refer?to?[8]?for?the?complete?LSML?algorithm?that?derives?this?feature?transforma-
tion?matrix.?We?employ? this?matrix? to?obtain? the?projected? feature? set.?For? the? rest?of?
the?pipeline,?we?leverage?these?outcome-adjusted?projected?features?and?the?correspond-
ing?Mahalanobis?distance?between?patient-based?vectors?to?learn?patient?segments?and?to?
estimate?each?patient’s?propensity?to?engage?with?CMs.
3.b)?Learning?Patient?Segment-based?Behavioral?Profiles:?This?component?aims? to?
capture?patient? segments?wherein?patients?and?CMs? interact?with?a? similar?behavioral?
profile.?However,?the?optimal?number?of?patient?segments?is?not?known?“a?priori”.?With?
that?objective?and?constraint?in?mind,?hierarchical?clustering?[9]?is?employed?to?identify?
patient?segments?based?on? the?outcome-adjusted?distances? in? the?newly?projected?vec-
tor?subspace?and? to? learn? the?key? factors? that?drive?differential?engagement?outcomes.?
We?choose?Complete?Linkage?method?(as?it?has?highest?outcome-differentiation?power,?
measured?by?ANOVA?scores)?to?compute?inter-segment?similarity?of?the?furthest?pairs.
To?compute? the?optimal?number?of?segments,?Elbow?method?(an?automatic? tuning?
algorithm)?tracks?the?acceleration?of?distance?growth?among?segments?and?thresholds?the?
agglomeration?at?the?point?where?the?acceleration?is?the?highest.?Hence,?our?population?
is?clustered?into?k?segments,?each?capturing?distinctive?patterns?that?drive?differential?pa-
tient?responses?in?engagement.?We?further?identify?prototypical?patient?cases?in?each?seg-
ment?to?serve?as?examples?to?showcase?the?distinctive?patterns?in?their?behavioral?profile?
and?to?add?interpretability?to?the?engagement?scores?produced?by?the?BES?pipeline.?The?
prototypical?patient?cases?are?those?with?positive?engagement?outcome,?i.e.,?y?=?1,?while?
being?closest?to?the?centroid?of?each?patient?segment?in?the?transformed?feature?space.?
3.c)?Estimating?propensity?to?respond:?In?this?component,?we?train?a?Generalized?Lin-
ear?Model?(GLM)?to?compute?the?engagement?score?for?patients?who?have?been?assigned?
a?program?to?enroll?or?a?goal?to?attain,?using?the?behavioral?segment?information?found?
in?3.b.?The?GLM?feature?weights?for?each?segment?k?are?computed?by?minimizing? the?
least?squared?errors?over?all?the?data?points?from?that?segment?k.?This?trained?GLM?with?
optimized?feature?weights?is?used?to?compute?the?scores?for?new?patients,?which?repre-
sents?their?propensity?to?respond?to?CM’s?engagement?calls?or?intervention?assignments?
for?goal?completion.?The? last?stage?of?our?pipeline?contains?a?Support?Vector?Machine?
(SVM)?to?classify?the?potential?engagement?outcome?of?each?patient?using?their?BES.
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Fig. 1. Feature weights indicating patient response driver across 5 behavioral segments for goal attainment.
4. Results & Discussion
The BES pipeline, introduced in this paper, segments patients based on not only the
patterns exhibited during patient-CM interactions, but also their engagement outcomes.
Although each feature contains only weak signals to differentiate overall engagement
outcomes, when considered collectively in a segment, the combined feature sets can
explain rich engagement behaviors for care planning.
Performance evaluation on engagement outcome prediction: The predicted engage-
ment outcome of each patient task is compared with what actually happened as indicated
in the CM transaction records. The results across all patient tasks are aggregated to eval-
uate the overall performance of the BES pipeline on engagement outcome prediction in
terms of precision, recall, accuracy and F1-score. In particular, the evaluation aims to
compare the following three versions. The first “Population-based (Baseline)” directly
trains a SVM classifier in the BES pipeline using all the population data without differ-
entiating patient segments. The second “Behavioral Profile-Driven” trains BES for each
of the patient segments using data belonging to patients in that segment. The third “Pro-
totypical User-Driven” trains BES using only prototypical patient cases in each segment.
Table 2 shows the performance evaluated with 5-fold cross validation, indicating that the
BES pipeline helps predict patient responses (“whether to engage”) for each type of en-
gagement tasks with high precision (> 90%). This implies a high percentage of success-
ful engagements if BES-based recommendations are followed for task prioritization.
Drivers of Differential Patient Response: We analyze feature weights of the model
trained for each of the five patient segments in order to pinpoint drivers that contribute the
most to its engagement outcome prediction. The results are used to provide support for
CMs to understand the rationale of the predictions. Fig 1 demonstrates that feature rank-
ings are significantly different when the population-level feature rankings are compared
with the segment-based ones (Spearman’s coefficient ρ; p < 0.01). In some segments,
Table 2. Performance with 5-fold cross-validation.
Method Performance Metrics Program Enrollment: Involve Program Enrollment: Involve Goal Attainment
Population
Based
(BASELINE)
Accuracy 0.96 0.96 0.89
Precision 0.95 0.94 0.93
Recall 0.99 1 0.95
F1 0.97 0.97 0.94
Behavior
Profile-
Driven
Accuracy 0.93 0.74 0.79
Precision 0.95 0.94 0.92
Recall 0.96 0.65 0.83
F1 0.95 0.76 0.87
Prototypical
User-Driven
Accuracy 0.93 0.74 0.95
Precision 0.95 0.93 0.99
Recall 0.96 0.65 0.96
F1 0.95 0.76 0.97
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Fig. 2. Interpretable engagement insights for Care Managers for shared decision making.
we observe strong indicators of CM influence (e.g., how long a CM has been trying to
help the target patient obtain his/her goal, how many calls have been attempted before
the goal attainment status is determined). In other patient segments, we observe certain
goals as more likely to yield positive engagement responses.
Interface and API for Shared Decision Making: We developed a web-based user inter-
face that provides the CMs access to explainable insights about the gauged engagement
level, the predicted response and the prototypical patient cases. Fig 2 shows the interac-
tive tooling based on a demo API customized for CMs to make their decisions before the
call regarding which patients to call first for program enrollment and for goal attainment,
and what are the reasons that they might or might not be engaged.
5. Conclusion
The main contributions are: (1) developing a quantitative and personalized approach for
identifying patients who are more likely to engage in care management; (2) demonstrat-
ing empirically, using real-world data, that our approach provides more accurate engage-
ment outcome predictions compared to a “one-size-fits-all” population-based approach;
(3) generating explainable insights on each patient’s behavioral profile from the proto-
typical patient cases within his/her segment. Performance evaluation results show that,
in our case, explainability does not come at the expense of model performance.
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Abstract. The Ministry of Health (MoH) stated the National Digital Health 
Strategy 2018-2024 in order to establish the conceptual guidelines for the design 
and development of interoperable health information systems. It included the 
creation of a National Digital Health Network, and a Citizen Health Portal to 
inform and empower patients about their rights. For instance, the Digital 
Vaccination Card is already available and has equal legal validity as its paper 
version. The platform also works as a personal privacy manager, to configure the 
consent for Health Information Exchange through the network, or to check the 
access logs. This paper outlines the implementation experience of this powerful 
tool at a national level. 
Keywords. eHealth, Personal Health Records, Health Information Exchange, 
Privacy. 
1. Introduction 
The development of sustainable Health Systems that promote universal access to care 
can only be enabled by the appropriate use of digital technologies[1]. According to the 
Argentine legislation, the medical record can be paper or magnetic supported, and 
should always be subjected to the principles of integrity, uniqueness, inviolability and 
confidentiality. There is a legal obligation for the health institutions "...upon request of 
the patient, owner of the medical record, an authenticated copy must be provided, 
within a period of forty-eight hours from request...". 
Argentina has a complex federal, segmented and highly fragmented healthcare 
system, which also translates into the generation of information silos. In many health 
centres around the country, health records are still kept in manual registries and 
logbooks. In a preliminary survey for the public sector, at least 80% of the healthcare 
facilities had no computers or internet connection. Therefore, patient’s right to access 
their own information is frequently hard to accomplish. 
During the previous 15 years several management systems were implemented at 
the Ministry of Health (MoH) for the Essential Public Health Functions. Most of them 
T
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were independent collecting tools that required paper form fulfilment for later 
electronic transcription, fuelling the administrative burden. Nevertheless, these systems 
empowered the MoH with important information for decision making: Surveillance, 
Immunization, Vital Statistics, Disease Registries, Public Health Insurances, among 
others. Most of this information is not available to general practitioners or patients 
themselves. 
The Argentinian National Digital Health Strategy 2018-2024[2] has the vision of 
reducing quality gaps in health care, implementing information systems that identify 
the characteristics and needs of the population, allowing longitudinal and 
comprehensive monitoring of people throughout the entire health system and providing 
innovative tools to health professionals and patients. It encourages every healthcare 
institution in the country to progressively adopt any interoperable electronic health 
record (EHR) system. The National Digital Health Network was launched in April 
2019, using an enterprise service bus technological infrastructure to connect different 
systems across the country. The data remains in each information system repository, 
and is only communicated to other domains if necessary (e.g. when the patient visit 
another clinic), and the citizen has given his consent for Health Information Exchange. 
A Personal Health Record (PHR) has been defined as a set of computer-based tools 
that allow people to access and coordinate their lifelong health information and make 
appropriate parts of it available to those who need it. They usually consist of provider-
tethered applications that allow patients to electronically access health information 
documented and managed by a healthcare institution. Although patient portals are 
already being implemented, it is still unclear in which ways these technologies can 
influence patient care[3]. In digitally advanced countries like Estonia, every person has 
a personal account in a patient portal, where they can review all their healthcare data 
and insurance expenses[4]. My Health Record is Australia's electronic PHR system, 
which from 2012 to 2017 got 21% of registered population. There were low levels of 
awareness and concerns about sharing records and equity of access for all 
Australians[5]. The government changed patient enrolment from opt in to opt out, 
reaching 90% of the population by 2019. There are not many international examples of 
Vaccination eCards, despite it seems there would be many benefits with its 
implementation[6]. 
In 2017 the Argentinian Ministry of Modernisation (MoM) jointly with the MoH 
launched a Citizen Digital Health Portal (Mi Argentina / Mi Salud) for personal access, 
empowering the people and recognizing their pivotal role in their own health. This 
paper describes the implementation of the Citizen Health Portal in Argentina. 
2. Materials and Methods 
2.1. Setting 
Argentina is a large country of more than 1 million square miles located in the southern 
half of South America. Its population is around 45 million people. The sovereign state 
is a Federal Republic subdivided into twenty-three provinces and one autonomous city. 
Beyond the recurrent economic crises, it is an upper middle-income country, and has a 
developed healthcare system. It has a quite complex organisation, with 3 subsystems: 
Public Care, Social Security and Private Insurances. Many of its shortcomings come 
from its segmented and highly fragmented nature. Since 2018, the MoH has embraced 
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an action plan to implement a public health reform to provide actual Universal Health 
Coverage (UHC) by strengthening provincial health systems[7]. 
Digital Health is one of the three pillars for the effective implementation of UHC. 
Through Resolution 189/2018, the highest health authority in Argentina settled the way 
forward to build, in collaboration with provincial governments and referents of the 3 
subsystems, a network of information systems focused both on the population and 
individual health of each patient. 
2.2. Methods 
The Citizen Digital Health Portal was designed and developed following the user 
centered design and accessibility rules promoted by the MoM[8]. People should be able 
to access their health data in an easy and comprehensive way[9]. Usability was tested, 
but it is not in the scope of this paper. The different modules of Mi Argentina -the 
Citizen Digital Platform- are described, including Mi Salud, the health section. We 
assessed its utilisation with quantitative aggregated and de-identified measurements of 
different services provided by this tool. 
3. Results 
The Citizen Digital Health Portal Mi Salud is the health section of Mi Argentina[10], 
the digital public service delivery platform developed by the MoM. In 2017 the 
Argentinean Government unified the official landing website in the Argentina.gob.ar 
domain. These two platforms are crucial milestones in terms of digital service delivery 
in the country. Important work has been undertaken, following the example of the 
United Kingdom (gov.uk), and other OECD members and partner countries in the 
region like Mexico (gob.mx) and Peru (gob.pe)[11]. As a result, the government-citizen 
relationship builds on the use of Argentina.gob.ar website and Mi Argentina platform. 
Both were designed and implemented by the Service Delivery Team within the MoM. 
Unique personal identification, privacy and security were undertaken by different 
modalities of accreditation, the highest one requiring biometric validation. Since its 
deployment in 2017, the number of users has been constantly growing. As of October 
2019, more than 2.3 million users had registered on Mi Argentina. A line chart with the 
number of active accounts can be seen in Figure 1. 
 
Figure 1. Line chart showing the number of Mi Argentina accounts during the last 2 years. 
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To gain full access to Mi Argentina, each citizen must create an account and 
validate her digital identity through biometric technology. Although this strategy 
potentially reaches the entire population, it was initially available for citizens over 13 
years old who could individually open an account in Mi Argentina. Children will be 
included soon, with special permission from their parents or tutors. 
Mi Argentina provides appointment booking (Turnos) for government services like 
immunization and online certifications from the National Administration of Social 
Services (ANSES) and other offices. There is a Wallet (Mi Billetera) where users can 
access their national identity eCard, driving licences, car documents and insurances, 
and other digital certificates in one place. Mi Argentina can be accessed both web and 
through mobile application. Screenshots of the App can be seen in Figure 2. 
 
 
Figure 2. Screenshots of Mi Argentina App and Mi Salud, the Citizen Digital Health Portal. 
The Health Section (Mi Salud) includes different services for citizens: a map with 
the location of healthcare centres, institutions that perform free HIV test, online consent 
for organ donation will, online access to health formalities like getting the unique 
disability certificate, and information about the current healthcare coverage. One of the 
most important milestones was the Health Information Exchange (HIE) consent. The 
portal itself is a domain of the Digital Health Network. It works as a personal privacy 
manager, to set the consent for information exchange through the network. Patients can 
also check the EHR access logs. Up to December 2019, there have been almost 41,000 
citizens (73% male) who have set their consents, with 94% of affirmative responses, as 
seen in Table 1. Even though it could be seen as a low enrolment rate, HIE is based on 
an opt-out modality. 
Table 1. Data regarding patient utilization of the Digital Health Network and the Citizen Portal. 
Number of Citizens (2019) 44,938,712 
with an EHR linked to the Digital Health Network 2,068,448 
with an active Mi Argentina account 2,375,949 
with a validated Mi Argentina account (biometric) 922,480 
with active consents for Health Information Exchange 40,940 (94% affirmative) 
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Recently, we implemented in Mi Argentina the Unified Digital Vaccination eCard. 
It is digitally signed and has a QR validation code that gives the same legal validity as 
the usual cardboard immunization card issued by health institutions. Through the 
citizen digital platform Mi Argentina people can individually see their registered 
vaccines. There are almost 30,000 daily accesses to the eCard. Patients can report if 
there is missing data in the digital card. This eCard is built using the data from the 
Federal Registry of Nominalized Vaccination (NOMIVAC)[12]. NOMIVAC is a 
module of the Argentinian Public Health Information Management System (SISA) that 
collects the vaccination data of every citizen in the country. There are more than 52 
million registered doses. This module allows any vaccinator to register the applied 
doses in real time, through the web or a mobile application that even works offline. It 
also gets data from local systems through interoperable web services, mainly from 
public centres but progressively also from social security and private healthcare 
institutions. 
4. Conclusion 
Even though single institution PHR might not change the traditional passive patient 
role, we strongly believe that our National Digital Health Portal has the potential of 
empowering citizens. It allows patients to access their information and change their 
HIE consent for the National Digital Health Network. The progressive addition of new 
tools within Mi Argentina (Vaccination eCard and soon International Patient Summary, 
Lab results, ePrescriptions) would enhance such vision. Further analysis of the platform 
utilisation is needed. Improved promotion and support might lead to higher citizen 
engagement with Mi Salud, especially for populations at risk of digital exclusion. 
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Abstract. Collecting accurate food consumption data is challenging for nutrition 
practitioners. Mobile devices are interesting alternatives to traditional ways of 
collecting assessments by reducing burden of use. Our objective was to develop 
and evaluate a mobile application for food intake documentation, targeting 
particularly the parents of pediatric patients. NutriKids is an application designed 
to guide users step by step in their assessment by asking relevant questions and 
taking advantage of the camera function. The quality of nutritional assessment 
using NutriKids was evaluated through the analysis of food diaries completed 
during two days under real-life conditions (home use). NutriKids demonstrated to 
provide satisfying degree of quality in 84% of the reported items. A detailed 
analysis of quality components highlighted that NutriKids interface could be 
improved for quantitative estimation and for specific information on added fat or 
sugar. Besides, a feedback survey highlighted the high acceptability of the 
application by the participants. These findings demonstrate the potential of this 
guided approach application. With further development of NutriKids and 
controlled based assessment with larger populations, we hypothesize that our 
results would reach statistical significance in all aspects of nutritional assessment 
quality.
  
 
Keywords. mHeatlh, mobile applications, nutrition assessment, diet records, child 
1. Introduction 
In the pediatric setting, dietary assessments are required in a wide range of medical 
conditions, such as children with weight problems, gastrointestinal disorders, metabolic 
or endocrine disorders, etc. Collecting accurate food and beverage consumption data 
from patients is challenging for nutrition practitioners. Thus far, three methods have 
mainly been used: Food Frequency Questionnaires (FFQ), 24H Dietary Recalls (24HR) 
and Food Records [1]. These methods usually require parents to write down precisely 
everything eaten and drunk during a few days, using different means such as 
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questionnaires or paper journals in the form of a blank table. This task requires 
personal investment and time. Moreover, traditional paper tools are hampered by 
practical limitations, which generate burden for the user and thus challenges the 
cooperation between user and practitioner.  
With digitalization, new dietary assessment methods are developing rapidly. 
Comparative studies have already demonstrated the positive impact of digital 
technologies over traditional paper-based methods by increasing participation rates and 
reducing the burden of use [2]. However, evidence validating their efficiency is still 
lacking and the accuracy of collected data, namely precise description and quantitative 
estimation of the reported food, remains a critical point.  
Digital tools to quantify food servings have greatly evolved over time. Early 
versions help users by displaying different serving sizes pictures. Studies have 
demonstrated that these tools were associated with lower precision compared to 
weighing [3], although they increased accuracy of intake estimation when no scale is 
available [4]. Other techniques rely on photographs taken by the user which are then 
analyzed by dieticians. However, in studies evaluating dieticians’ proficiency to 
estimate dietary intake based on digital food images (pictures of meals), it appears that 
the quantification accuracy is quite low without specific training for this task [5,6]. 
More recently, new approaches relying on artificial intelligence, featuring automatic 
food identification and portion size estimation are under development (e.g. NutriNet, 
Snap-n-Eat). Regarding the precision of food description, studies have shown that long 
exhaustive lists of food items based on food databases don’t improve quality. Overall, 
existing tools still suffer from suboptimal reliability, and tools based on guided 
approach may represent a promising improvement.  
1.1. NutriKids 
We developed a new mobile application, NutriKids, in partnership with a group of 
experts in paediatric dietetics at the Geneva Children’s Hospital. NutriKids is meant to 
offer a smartphone alternative to actual paper journals (food record method). The 
creation process started by analyzing recent nutritional assessments to identify which 
information should be collected. It highlighted the importance of three elements for 
assessing valuable dietary intake, namely description, quantity and information on 
added fat/sugar. From there, we designed our application. The aim was to guide parents 
in the assessment process in order to minimize the omission of key information 
previously identified. For example, no food item can be registered if its quantity hasn’t 
been indicated. More specifically, for every food item potentially cooked or seasoned 
with fat, the application automatically asks the user about the amount of added fat (see 
fig. 1). A camera function is also provided to capture food labels or product 
specificities, reducing the burden of writing down descriptions. Besides, we set up a 
system of « typical meals »: when the users select the main food item they wish to 
report, other items, expected to be associated with the main one, are automatically 
proposed (see fig. 1). We decided to avoid long exhaustive lists of food items that users 
can select. Instead, we preferred short lists containing frequently selected items and 
added the possibility for the user to write down his own description or to take pictures 
of the product. These particularities differentiate NutriKids from the numerous existing 
applications that we have tested on the market (e.g. Gluci-Check, MealLogger, SHYE, 
Food(lg), FatSecret, iEatWell), which are already very useful for some functions but 
lack the guiding aspect in data collection.  
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After the implementation of the first version, we performed an expert evaluation 
using the Nielsen criteria [7] and modified few elements to enhance the application’s 
coherence and efficiency of use.   
A usability test, performed by a distinct group of 10 users with the application’s 
final version, confirmed that users don’t encounter major difficulties using the 
application. 
Figure 1. Screenshots of NutriKids’ interface displaying the “typical meal” structure as well as 
the automatic recall for fat/sugar quantity  
 
Following the creation of the application, we evaluated NutriKids during a two-
day assessment period in a pediatric setting. This period of time was set to be very 
close to the current conditions of dietary assessment at the hospital (3 days), to avoid 
bias of motivation. 
2. Method 
2.1. Evaluation 
We performed a critical evaluation of the quality of the data reported by a group of 12 
participants during a dietary assessment. Participants included parents from pediatric 
patients requiring a nutritional assessment or having completed such an assessment in 
the past two years, as well as volunteering parents from the local community.  
Participants were requested to report all food and beverage intake within a period 
of two days using NutriKids. Once collected and anonymized by the investigator, data 
were then analyzed by hospital dieticians according to the criteria identified as being 
essential for a valuable dietary assessment:  
 Information about added fat and/or sugar (if relevant)  
 Detailed description of ingredients and/or picture of food brand 
 Precise weight (given in gr., ml., tsp. or Tbsp.) or picture of the portion??
For every food or drink item reported during the two-day evaluation period, each 
criterion was evaluated by a dietician as « sufficient » or « insufficient », depending on 
whether additional information was required or not in order to evaluate properly the 
nutritional content of the meal. Thus, on the two-day period, we calculated for each 
criterion (description, quantity and added fat/sugar) the percentage of items reported 
correctly: 0% being no reporting deemed sufficient at all and 100% being perfect 
reporting for all items. Each criterion had identical ponderation for the evaluation of the 
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global quality (primary outcome), which was calculated as the mean of the three 
criteria. 
We calculated the group results as the mean of participants’ individual score.  
To limit assessment biases, a second evaluator independently controlled 10% of the 
data and found no significant discordance (kappa analysis > 0.8).  
At the end of the evaluation period, participants also had to complete a survey 
containing Likert based questions, as well as open questions providing a more 
qualitative evaluation of the application. 
3. Results 
3.1. Evaluation of NutriKids  
All 12 participants were women, mostly aged between 35 and 45 years and from higher 
educational levels. 88% of them were familiar with smartphone use. 55% had medical 
reasons to participate, 44% volunteered.  
The total number of food and drink items reported for all 12 participants was 193, 
among which 69 needed information about added fat or sugar. As shown in table 1, 
mean global reporting quality was rated as 83.80%. Quality was specifically considered 
as “sufficient” for descriptions in 95.52%, for quantitative estimation in 88.20% and for 
added fat/sugar information in 67.68%.  
 
Table 1. Mean quality of the assessment for each criterion 
 n Mean (%) ± SD 
Global quality  83.80 ± 15.66 
Food description 185 (N=193) 95.52 ± 6.86 
Quantitative estimation 
Added fat/sugar information 
173 (N=193) 
  50 (N=69) 
88.20 ± 14.62 
67.68% ± 33.95 
3.2. Feedback evaluation form 
Participants rated the general ease of use of NutriKids 7.4/10 and its intuitiveness 
8.9/10. The major difficulties reported were about finding desired food items in the lists 
and informing about food’s quantity, especially when done without using a scale or 
when the meal was complex. The majority of the participants used the camera function 
and reported it to be very useful.  
Interesting improvement suggestions concerned the possibility to add notes with 
recipes, or the possibility to create a personal list of specific items to reuse, avoiding 
the burden of copying all information again if often consumed.  
4. Conclusion 
The evaluation of NutriKids confirms previous findings that mobile applications may 
represent a valid alternative to traditional paper-based methods. The quality of intake 
assessment was globally good, and participants were mostly satisfied with NutriKids. 
Separate analysis of each quality criterion underscores which aspects cause 
difficulties to participants and could benefit from further improvement. Precise 
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description of food does not appear to be a problem given that more than 90% of the 
items are evaluated as sufficiently well described. Difficulties were mostly encountered 
for quantitative estimation, especially when no scale is at hand. Possible improvements 
include image-assisted tools such as a food atlas (ranges of food photographs 
displaying different serving sizes with associated quantities) or machine learning (real-
time analysis for automatic food recognition and weight estimation). However, even 
though machine learning has demonstrated its potential in improving quantitative 
estimation and reducing underreported food [8,9], it may require a certain time before 
being used out of the lab and may not solve the problem of complex meals with mixed 
ingredients.  
Concerning information on added fat or sugar, our fairly good results for this 
specific aspect of food reporting strengthen our hypothesis that a guided approach 
represents a valuable tool to improve the quality of nutritional assessments. To our 
knowledge, no other study has addressed the issue of a guided approach up to now. 
4.1. Improvements, Perspective 
NutriKids’ interface could be improved to guide even more the food collecting process. 
Users could, for instance, be constrained to inform about added fat or more clearly 
invited to provide pictures. Additional research should be undertaken to find the best 
solution for quantitative estimation when no scale is available. No clear solution has 
yet been found to achieve this error prone task, but a combination of different image-
assisted methods could be sufficient for daily practice. With those few adjustments, we 
hope to provide a valid alternative to the traditional paper journal. 
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Abstract. The work environment for nurses is challenging, and even though new 
technology has major advantages, it has often also caused new stressors and prob- 
lems for nurses. When Patient Accessible Electronic Health Records (PAEHR) was 
introduced in Sweden, research showed that nurses were worried about possible 
negative effects for patients as well as on their work. However, to this date there are 
very few follow up studies on the more long term effects of PAEHR, despite 
research pointing to the fact that reactions after long term use might differ from 
initial experiences. In this paper we present an interview study to fill this research 
gap. An analysis based on interviews with physicians and nurses in Oncology care 
reveals three areas where nurses’ work is experienced to have been affected: 1) 
nurses receive more questions from patients after PAEHR has been introduced, 2) 
nurses have changed their documentation practices and 3) the log list functionality 
has made nurses feel questioned. Finally, these results are discussed in relation to 
nurses’ work environment from a sociotechnical and gender perspective. 
Keywords. eHealth, patient accessible electronic health records, work environment, 
nurse, interview 
1. Introduction 
The work environment in health care is indeed challenging and even though computer 
systems have managed to improve some areas and make them more efficient, they have 
also brought new problems and challenges into nurses’ work. Nurses are currently faced 
with increasing workloads due to patients with co-morbidities, staff shortages and 
increased administrative work [1] [2] on top of new technology being implemented on a 
regular basis that has unwanted negative side effects for nurses [3]. 
When Patient Accessible Electronic Health Records (PAEHR) were launched in 
Sweden in 2012 nurses were skeptical to the system, which has been shown in a large 
survey study [4] and a small interview study in primary care [5]. Areas of worry related 
to the risk of PAEHR creating added work through changed work practises, changes in 
documentation practices, increased stress and worsened work environment. Other studies 
also pointed to nurses in psychiatry care worrying about PAEHR contributing to an in- 
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 creased number of threats and violence due to patients knowing names of nurses, through 
the access log list, and being able to contact them [6] [7]. 
A sociotechnical system, such as nursing and PAEHR, cannot be properly 
understood without taking gender into account. Physicians and nurses do gender [8], i.e. 
perform what is expected from them as women and men in relation to other people, and 
in relation to technology. Studies on gender and technology reveal that communication 
patterns in nursing are influenced by gender and gender power, and that nursing is 
traditionally seen as a nurturing and emotional work [9]. However, too little is known 
about how the nursing profession is affected by technology. 
Moreover, there are still very few studies looking into the experienced effect on work 
as PAEHR has reached a more mature use - most earlier studies in the area have been 
carried out within a year after launch. Initial experiences with and reactions towards new 
technical solutions, like the PAEHR in this case, are often different from experiences and 
reactions after more long-term use [10]. Given the current work environment problems in 
health care, this is a crucial area to look into from a societal perspective, and from a 
research perspective, more research is needed on the connection between digitalisation 
and the work environment. Additionally, most studies to date on the effect of PAEHR on 
the work environment of healthcare professionals have focused on effects for physicians 
[11] [12] [13] [14]. Hence, this paper looks into the experienced more long term effects 
of PAEHR on the work environment of nurses - an area which is under-investigated and 
in need of a qualitative research approach. More specifically the paper looks into the 
experienced effects on the work of nurses including general effects on workload and 
documentation and a specific technical part - the access log list. 
 
2. Method 
 
This paper reports on preliminary results from an interview study at Uppsala University 
Hospital. The study was ethically approved by the Regional Review Board in Uppsala 
(EPN 2017/045). 
The results presented here are based on a content analysis of semi-structured 
interviews with 15 physicians and five nurses at the Oncology department. The 
interviewees were recruited through the head of department as well as the department’s 
business developer. The interviews were held in rooms chosen by the interviewees, most 
often in empty examination rooms or private offices. Each interview took around 45 
minutes and covered several topics, such as attitudes towards PAEHR, effects on work 
and effects on various aspects of communication with patients. The interviews were 
recorded and transcribed in verbatim prior to the analysis. 
This paper focuses on results related to the effects on the work of nurses, including 
general effects on workload and documentation, and a specific technical part - the access 
log list - is treated in depth since it was shown to affect nurses in particular. 
 
3. Results 
 
The results describe in what ways PAEHR is experienced to have a clear impact on the 
Oncology nurses’ work. 
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 3.1. Nurses Receive More Questions as They Are the First Line of Support for Patients 
According to the majority of the interviewed physicians, nurses in oncology care - and 
so-called contact nurses in particular - act as the first line of contact with patients. 
Consequently, patients ask nurses more often about health care conditions, test results 
and procedures. Accordingly, when patients call the hospital to ask for example about 
the information they have found in the PAEHR, they reach one of the nurses. According to 
several physicians, this has resulted in nurses receiving a lot of questions that they cannot 
answer questions that are then forwarded to a physician. An increase in questions from 
patients and questions that nurses cannot answer in particular - after the launch of the 
PAEHR is also confirmed in the interviews conducted with nurses in oncology care. 
3.2. Nurses Have Changed Documentation Practices 
According to some of the interviewed physicians, many nurses are more restrictive 
regarding what to write in the medical record now when the patients can access their 
health records online. This could, in some cases, lead to important information being left 
out of the medical record. A few of the interviewed physicians presented short incidents 
related to patients or relatives that became very upset when nurses had added a short 
note about the patient’s mental health status - information that was important for the 
current treatment. In two cases, strong reactions on information found in the PAEHR 
had led to nurses deleting relevant information from the medical record. 
3.3. The Log List Functionality Makes Nurses Being Questioned 
In Region Uppsala, patients who log in to their PAEHR can use a function called log list 
to see which clinicians who have accessed their record and when access has been made. 
This particular function was brought up during some of the interviews as being 
problematic especially for nurses. 
One of the issues brought up stems from the fact that patients often know the name 
of their primary physician, but not necessarily the name of the nurses connected to the 
care team around the patient. Nurses often access patients’ medical records by request of 
a physician and they also often do routine checks of blood work or similar. In all these 
cases there is a chance that the patient will find unfamiliar names in the log list online. 
Some physicians reported that nurses were worried about this and they also reported on 
some cases when patients had asked a physician about unfamiliar names found in the log 
list. In all cases reported during the interviews, however, these kinds of questions from 
patients could be easily handled. 
Another issue brought up in two of the interviews, related to documentation, is that 
some nurses often leave small snippets of information in the medical record to explain 
why access was made. These snippets do not add anything that could be seen as medically 
relevant, and hence these physicians were annoyed by them. The occurrence of these 
snippets was attributed to the existence of the online log list and interestingly enough the 
issue was brought up spontaneously by these two physicians before the log list had been 
brought up by the interviewer. 
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 4. Discussion 
The results presented in this paper highlight some effects of PAEHR on the work situation 
of nurses in oncology care. This is one of the few papers to date that reports on effects 
of PAEHR for nurses in any discipline and also one of the very first that covers effects 
several years after the launch of Journalen in Sweden. It is important to note that the 
number of interviewed nurses is relatively small. Even though clear problem areas have 
been identified, more research is needed that include a larger sample as well as 
interviewees from different medical disciplines. 
It is clear from the results of the recent interview study that there are some clearly 
identifiable effects related to patient contact, documentation practices and the access log 
list functionality. 
When it comes to effects of PAEHR on the contact with patients, both nurses and 
physicians experience that PAEHR has resulted in nurses receiving more questions from 
patients. The increased workload that is described could among other things be explained 
by the gendered norms related to the nursing profession. Nursing is traditionally coded 
as a female profession quite low in the hospital hierarchy, and the traditional terms that 
define nursing are emotional and nurturing work [9]. The contact between nurses and 
patients is also more often continuous and close, and the expectations for nurses are 
quite different from that on physicians when it comes to communication [15]. Physicians’ 
meetings with patients, on the other hand, are more often fragmented, and short term. 
These differences among professions, the lack of research on effects of PAEHRs for 
nurses, as well as the pronounced effects for nurses shown in this study, highlights the 
importance of including nurses in these kinds of studies. 
However, one should note that this increased workload for nurses when it comes to 
questions from patients might not be only negative in nature, as other studies have shown 
that person-centeredness in care has correlations with nurses’ improved satisfaction with 
care and work [16]. More research is needed when it comes to the correlation between 
job satisfaction and the launch of PAEHR. 
The perceived effects on documentation practices could also be a result of different 
gendered expected behaviours between the professions, looking at nursing as a 
traditionally female coded profession. Changed documentation practices might be 
understood in the light of women’s more relational way of thinking. This indicates that 
women, more than men, notice and respond to other people’s needs and expectations 
[17] [18]. In this case, nurses change and respond to the patient’s need and expectations 
to understand PAEHR to a larger extent than physicians do as one way of doing gender 
[8]. This result could have implications for future nursing education especially when it 
comes to balancing the need to keep a complete and accurate record and the need to 
satisfy patients. 
The log list function has been discussed in earlier research when it comes to effects 
of PAEHR on work, and especially perceived risks of threats and violence towards 
medical staff [6]. The results from the present interview study do not give any indication 
that nurses perceive any risk of threats or violence, but the existence of the online log list 
still has an impact on actions taken by nurses. The very nature of the nurse profession - 
in this case being a part of a team who may work with many doctors, and often not 
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 being known by his/her name by the patient - is at the core of the problem. There is a 
clearly described insecurity here in relation to documentation, and an obvious need to 
explain one’s presence in the electronic health system. More research is needed into the 
gendered explanations of this in the sociotechnical system. 
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Abstract. Many people take prescription medications and need information about 
the risks and benefits associated with taking them. Citizens are increasingly 
turning to the internet for health information and medication information is no 
exception. There are a variety of websites that offer Online Medication 
Information for Citizens (OMIC). This study compared six such websites using the 
Health Literacy Online (HLO) Checklist as a framework. Additionally, we 
conducted a detailed analysis of the individual content in each OMIC for three 
different medications. We identified several strengths and weaknesses of the 
different websites in terms of how they were designed and written and their 
appropriateness for users with limited eHealth literacy.  
Keywords. Consumer health informatics, medication information, health literacy, 
eHealth literacy 
1. Introduction 
Worldwide spending on pharmaceuticals (i.e., prescription medications) reached 1.2 
trillion in 2018 and is projected to continue increase in the coming years [1]. Many 
North Americans use short-term and/or long-term prescription medications and use 
invariably increases with age [2, 3]. Given the prevalence of prescription medication 
use and the risks and benefits of taking medications, people need information about 
them. The most commonly used resources for medications are patient information 
leaflets, doctors, and pharmacists [4]. However, the internet gaining popularity as a 
resource for medication information, especially younger people [4].  
This study assessed how well Online Medication Information for Citizens 
(OMIC) was designed for users with limited health or eHealth literacy in terms of both 
its content and design. Specifically, three prescription medications from six online 
resources were examined to determine their relative strengths and weaknesses using the 
Health Literacy Online (HLO) Checklist [5] as a framework with a complementary in-
depth examination of each OMIC’s individual content [6]. HLO is provides evidence-
based guidance to assist in the development of “user-friendly health websites and 
digital health tools” [6]. 
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2. Methods 
We assessed OMIC from six different Websites for three different medications: 
Asmanex (mometasone inhalation), Crestor (rosuvastatin) and Humalog (insulin lispro) 
(see Table 1). 
Table 1. Websites Examined Offering Online Medication Information for Citizens.  
Website Type of Resource Medication Information Data Source 
Rexall.ca Canadian pharmacy MediResource Inc. 
Walgreens.com American pharmacy Clinical Drug Information LLC 
Min.Medicin.dk National Danish medication 
information resource 
Danish Medicines Information A / S 
WebMD.com Health information resource First Databank, Inc. 
MayoClinic.org Not-for-profit health information 
resource 
IBM Watson Micromedex 
Drugs.com Independent medication 
information resource 
IBM Watson Micromedex, Cerner 
Multum™, Wolters Kluwer™ and others 
 
We compared each website against the four applicable categories of the Health 
Literacy Online Strategies (HLO) Checklist: Write Actionable Content, Display 
Content Clearly on the Page, Organize Content and Simplify Navigation, and Engage 
Users [5]. The category Test Your Site with Users with Limited Literacy Skills was 
excluded because this was an inspection study.  
We used word count and Simple Measure of Goobledygook (SMOG) scores [7] 
as indices of HLO Checklist’s guidance to write in plain language in the Write 
Actionable Content Category. SMOG [7] scores are derived using a calculation of the 
number polysyllabic words in a sample sentences to estimate of how many years of 
education are required to understand the text. To this end, Danish OMIC from 
min.medicin.dk, was translated to English using Google Chrome and each OMIC was 
converted to a simple text document (either through print functionality or copying and 
pasting). We then determined each OMIC’s SMOG score using an online readability 
calculator [8]. Notably, we excluded the information on the “professional” tab of 
Drugs.com, as it was not for the target audience of citizens. We calculated the average 
number of words and average SMOG scores for each website. 
Additionally, to assess the content in greater detail, we used a previously 
developed set of criteria for content utility which outlines 11 helpful topics for 
medication information: benefits, contraindications, directions, precautions, adverse 
effects, storage, missed dose, allergic reaction, drug interaction, overdose, and general 
information [6]. We averaged the number of content criteria satisfied amongst the three 
OMIC per website. Further, we examined each OMIC’s reported side effects to 
determine whether there was conflicting medication information [9].  
3. Results 
3.1. Write Actionable Content  
Min.medicin.dk (1,296 words) and Walgreens (1,501 words) used the fewest words on 
average for their OMIC. Drugs.com was the lengthiest, with an average of 4,507 
words. Walgreens had the most readable content, with the lowest average SMOG score 
of 8.47. The remaining five websites’ average SMOG scores ranged from 11.69 for 
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WebMD to 14.51 for Drugs.com. As alluded to in the methods, Drugs.com also 
contained information for professionals in the form of a tab and as additional content in 
its side effects tabs. This has the potential to create confusion for users and 
unnecessarily overwhelm them. In contrast, Min.medicin.dk offers an alternative site 
specifically for professionals (pro.medicin.dk). Drugs.com and Rexall had many bullets 
and lists, whereas others had fewer (e.g., WebMD, MayoClinic) or almost none (i.e., 
Walgreens).  
3.1.1. Content Utility and Comparison of Potential Side Effects  
Min.medicin.dk satisfied the fewest content criteria (73%), followed by Rexall (82%), 
Walgreens (88%), Drugs.com (88%), and the MayoClinic (91%). WebMD (97%) 
satisfied the most content criteria.   
There was considerable variation between which possible side effects were 
reported, how many in total, as well as how they categorized the potential side effects. 
Specifically, Min.medicin.dk reported the fewest possible side effects amongst all of 
the websites, whereas the MayoClinic and Drugs.com reported the most. There were 
also discrepancies with the language used to describe or categorize possible side 
effects: some websites focused on frequency of occurrence (e.g., more common, less 
common, rare, may occur, unlikely) and others focused on severity (e.g., very bad, 
serious) or both frequency and severity. Arguably, Min.medicin.dk utilized the clearest 
approach to describe the frequency of side effects by using numbers. For example, they 
reported maximums of “10 out of 100 people get the side effect” (common), or “1 out 
of 1 people” (uncommon) and “1 out of 1,000 people (rare) as well as unknown 
frequencies of possible side effects. In terms of text presentation, Walgreens was the 
least structured and most difficult to read and extract information due to its format. 
Specifically, the information was all presented in in big blocks of text with capitalized 
letters to attract attention or serve as headings. Additionally, Drugs.com listed 
additional possible side effects and frequencies for health care professionals that were 
categories by medical specialty (e.g., gastrointestinal, nervous system, respiratory) and 
labelled more common (10% or more), common (1% to 10%) or uncommon (0.1% to 
1%). Some sites listed side effects that do not require medical attention, but which may 
still cause consumer concern. 
There was no consensus on which possible side effects were reported or how they 
were reported. For an illustrated example, to compare whether or not a possible side 
effect was reported by each site and how it was labeled is provided in Table 2.  
Table 2. A Comparison Sample of Possible Side Effects for Reported by Each Website for Asmanex 
Website Fever Cough Nausea Headache 
Rexall.ca *    
Walgreens.com     
Min.Medicin.dk     
WebMD.com *    
MayoClinic.org     
Drugs.com     
Legend:  = Possible side effect reported. * = Reported as a sign of infection, not as a possible side effect. 
3.2. Display Content Clearly on the Page  
Some sites displayed their content more clearly than others. Specifically, Walgreens 
and Min.medicin.dk were both spacious and visually appealing. They achieved this by 
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using collapsible categories. The selected categories varied greatly amongst sites. 
Walgreens listed just five selection options (Instructions, Side effects, Patient reviews, 
Pricing, and PDF download). At the other end of the spectrum, min.medicin.dk lists 16 
selection options such as active compounds, packaging, precautions related to breast 
feeding, pregnancy, and donating blood. Drugs.com contained several advertisements 
which not only gave it a busier appearance but could potentially distract users from the 
main content. Similarly, WebMD had many links, which could encourage users to 
navigate away from the page before reading its entirety. Further, on almost every tab on 
WebMD, users had to click the “read more” button to reveal the remaining content. 
WebMD also had an excessive amount of links and not enough bullets or short lists. 
With the exception of Rexall, nearly all of the websites provided some helpful images 
of pictures of the medications. However, Min.medicin.dk leveraged multimedia further 
for medication instructions. MayoClinic and Min.medicin.dk provided buttons and 
printer friendly versions of the OMIC. Walgreens allows users to download PDFs of 
the OMIC and Rexall can be printed using the browser. However, WebMD and 
Drugs.com did not offer printer friendly options.   
3.3. Organize Content and Simplify Navigation 
Search functionality varied amongst the six resources. Min.medicin.dk, Drugs.com, 
Walgreens and WebMD demonstrated strong search functionality by supporting users 
with auto-complete and offering suggestions for misspellings. However, Rexall and 
WebMD returned no results for misspelt medications. Moreover, Drugs.com and 
WebMD search results were displayed below advertisements and therefore disobeyed 
the HLO Checklist [5] guidance to display search results clearly. Despite having 
autocomplete functionality, the medications were not suggested by the MayoClinic. 
Further, the MayoClinic’s search results only named the generic name of the 
medication and not the brand name, which could lead users to falsely conclude their 
search was unsuccessful. We tested the responsiveness of all six websites and found to 
be present using the developer functions of Google Chrome. 
3.4. Engage Users  
Only Rexall and Drugs.com demonstrated strong sharing capabilities by providing 
options on each OMIC page to share the information on social media (e.g., Facebook, 
Twitter). Min.medicin.dk did not support sharing to social media, but it did provide an 
option to email the link, as did Drugs.com. Walgreens (sourced from PatientsLikeMe) 
and Drugs.com also included patient reviews of the medications on their sites. 
4. Discussion and Conclusion 
There were several strengths and weaknesses of the six websites in this investigation. 
Overall, the strongest site in terms of placing the fewest demands on users (i.e., abided 
by the guidance of the HLO Checklist) was Walgreens and its content was the most 
readable and easy to navigate. However, despite performing well on the metrics, the 
information itself poorly formatted. Specifically, Walgreens content was frequently 
dense walls of text. Thus, it is important to note that despite satisfying many criteria, 
there is still substantial room for improvement of its content (e.g., use bullets and short 
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lists). Moreover, are some HLO Checklist criteria more important (i.e., impact users 
more) than others? Should they be weighted? 
Alarmingly, there were discrepancies between how the websites reported possible 
side effects. Specifically, some reported possible side effects, while other websites did 
not report the same ones (see Table 2). Conflicting medication information has been 
shown to negatively impact adherence [9] and therefore there are likely consequences 
to these OMIC side effect discrepancies. Further, how websites categorized varied by 
emphasizing frequency of occurrence or severity of experiencing the side effects, 
concepts often confused by citizens [10]. Moreover, how frequency of occurrence 
using either a vague label (e.g., common) or specific value (e.g., 1 in 100 people) could 
have an effect on citizens’ interpretation and might also impact adherence.  
 There were some limitations to this study. We only examined three medications 
from the six websites. Further, we excluded pharmaceutical manufacturer information. 
The Danish OMIC was translated using Google Chrome which is an imperfect proxy. 
Additionally, websites that did not provide a print option (i.e., Drugs.com, WebMD) 
were copied and pasted and excluded the redundant content that around the tab areas. 
Finally, we neither tested the accessibility nor the mobile versions of the websites. 
There are a variety of OMIC options available to citizens and each website in this 
study had its strengths and weaknesses. Based on the current evaluation, we 
recommend that these websites make an effort to improve the consistency of 
information they are providing to citizens, to limit conflicting medication information. 
Further, findings from this study could be incorporated to improve the OMIC and its 
adherence to the HLO guidelines for simplicity of navigation and content itself and also 
its structure are warranted. Future research opportunities including comparing the 
influence of health care system structure, culture, and prescription practices 
internationally (e.g., North America vs. Europe), as how citizens select amongst OMIC 
alternatives, and finally how these resources might be designed to address the needs of 
people with varying eHealth literacy skills.  
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Abstract. Patient portals are used as a means to facilitate communication, 
performing administrative tasks, or accessing one’s health record. A qualitative 
study was therefore performed to understand how people with hearing loss 
experience using the Swedish national patient portal 1177.se and the patient 
accessible electronic health record Journalen. Data was collected through focus 
groups and individual interviews. Ten persons with varying degree of hearing loss, 
age and years of using a hearing aid participated. The data was analyzed through 
thematic content analysis and three themes emerged; access to written information, 
patient-created information and personalized communication. Although the study is 
limited in size, we believe that important lessons can be learned regarding the needs 
for personalized communication, including access to written information.  
Keywords. Patient portals, Electronic health records, Hearing loss 
1. Introduction 
Patient portals are used to facilitate communication between patients and healthcare 
professionals, as well as for performing administrative tasks, such as appointment 
bookings and prescription renewals. Patients are also increasingly provided with access 
to their electronic health records (EHRs), sometimes referred to as patient accessible 
EHRs (PAEHRs) [1][2] or OpenNotes [3], through portals. Most of these systems are 
designed to meet the needs of the general population, and few studies are available on 
how patients with special needs experience the use of such systems. In Sweden, a 
national patient portal is used that connects to all EHR systems used in the different 
regions [2], through a national health information exchange platform [4]. By logging in 
using a national e-ID one can access a number of administrative services as well as the 
PAEHR Journalen. In July 2019, 61% (6.3 million/10.3 million) of the Swedish 
population had logged in to the portal, and 29% (3 million/10.3 million) have used the 
PAEHR Journalen at least once [5]. Several studies have been performed exploring 
patients’ and healthcare professionals’ views on Journalen [6][7], but to our knowledge, 
no studies have focused on how persons with hearing loss use and experience the patient 
portal 1177.se and Journalen. Since this group of users have additional needs regarding 
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communication and access to information, we aim to explore their experiences of using 
the Swedish national patient portal 1177.se and the PAEHR Journalen, as well as their 
suggestions for future improvements.  
2. Methods 
Hearing aid users who had used 1177.se and Journalen were recruited through online 
advertisements spread through social media and patient organizations. The participants 
(n=10) were recruited from different parts of Sweden, and given the option to join a focus 
group interview or to participate in an individual interview, in person or over the phone. 
Two focus groups were conducted; in Uppsala and Stockholm. Each focus group lasted 
90 minutes. Three individual interviews were conducted by telephone and lasted 
approximately 40 minutes. A validating workshop was conducted using raw data from 
focus groups and interview, confirming the results that emerged and is therefore not 
reported separately. The participants represented a variation of age, gender, severity of 
hearing loss and years of using hearing aids (Table 1).  
Table 1. Demographics of the participants (n=10). U = Uppsala FG, S = Stockholm FG, I = Interview, V = 
Validating workshop  
Participant ID Gender Age Years using hearing aids 
U1 Male 47 10 
U2 Male 76 5 
S1 Male 51 44 
S2 Female 40 12 
S3 Female 47 42 
I1 Male 69 6 
I2 Male 82 16 
I3 Female 75 20 
V1 Female 75 15 
V2 Female 74 1 
Data were analyzed using a thematic content analysis approach, providing a rich and 
thorough, interpretation of the data [9]. The analysis was done manually and in iterative 
dialogue between the authors. The Swedish Ethical Review Authority granted ethical 
approval for the project PACESS (Dnr: 2017/1028-31).  
3. Results 
Both current experiences of using 1177.se/Journalen and participants’ suggestions for 
future improvements were discussed. Three themes were identified; access to written 
information, patient created information and personalized communication.  
3.1. Access to written information  
Having access to written information in general and the notes from the electronic health 
record, in particular, was described as very important by the participants. Depending on 
the gravity of the participants hearing loss, it required a lot of energy and focus to listen 
to what clinicians said during an appointment. Some of the participants described that 
they focused so hard on hearing what the person said that they couldn’t process and 
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remember much of the information. Being able to go back and review notes then became 
even more important. 
Access to the record as a safety tool. A few of the participants described that having 
access to record notes was also a patient safety issue, as they could see when the 
information was missing or wrong.  
“When I saw that things were missing in my health record I contacted the clinic and 
asked why.” (I1) 
Improved understanding with access to record notes. Reading the health record 
online gives the patient a summary of what was said during the meeting. Having the 
option to read their health record online was described as a means to improve 
communication with healthcare. 
“I get a summary of what we have been talking about during the care visit. Things 
that I have misunderstood during the actual meeting, I can go in and read about in 
my health record to understand what the healthcare professional meant.” (U1) 
Specific information for hearing aid users. Several participants reasoned that they 
would like the hearing clinic to post more specific information for hearing aid users on 
1177.se, e.g. related to specific services that hearing aid users may benefit from. 
“New hearing aid users are extremely dependent on their audiologist and the 
information provided by the audiologist. More information about this should be 
available at 1177.se.” (S1, S2, S3)  
A few of the participants would also like self-management films on 1177.se on e.g. how 
to care for the hearing aid.  
Diagnostic examination results. All the participants had ideas for what kind of 
diagnostic examination results they would like to see on 1177.se; audiograms, X-rays 
and ECG (this type of information is currently not available). Some of the participants 
received paper copies of their audiogram when they visited the audiologist others 
received the audiogram as a pdf file to their email. Several participants would rather have 
it accessible through 1177.se 
“I received my audiogram on paper, and after the visit, I took a picture of it with my 
phone, so I could have I accessible, but I would rather have it on 1177.se.” (S 2) 
3.2.  Patient created information 
The participants did not only want access to more and better information, they also 
wanted to contribute with their own information to healthcare through 1177.se. Three 
different types of patient created information was suggested.  
Add attachments to messages. In one of the focus groups, the participants wanted to 
send attachments with messages through 1177.se, for example, sending medical 
certificates in attachments. 
“I had contact with my counselor through e-mail and she asked if we could take the 
errand through 1177.se instead but that was a problem because I was not able to 
send attachments with my medical certificate through 1177.se” (U1) 
Add information about hearing and medical aids. A list or a profile where patients 
could add information about what hearing and medical aids they use was also suggested. 
Having a list or a profile makes it easier for other healthcare providers or other 
audiologists to know what the patient already use. 
“I would be good if there were some kind of list on 1177.se of what hearing aids and 
medicals I use so that I could go in and add things and perhaps write instructions 
how my different aids work and how they are set.” (U1, U2) 
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Commenting/adding to their own health record. At the moment, the only functionality 
for most users of 1177.se/Journalen is the ability to read their health records. In the 
Uppsala Region, it is, however, possible for patients to make comments in the record that 
healthcare professionals can read. A few of the participants thought that this function 
would help them reflect and remember things about their health and that it could also 
save time during the actual health meeting.  
“When I read my health record entries, I get ideas and remember things about my 
health from several years ago and this I would want to add to my health record. It 
would also save time for both myself and the healthcare provider. /…/ it would also 
help me bring this up in the next meeting” (U1) 
3.3. Personalized Communication  
Communication with healthcare and the importance of the national patient portal for 
users with hearing loss in this communication was an important topic. 
Impact of hearing loss on communication with healthcare. Several participants 
reasoned about how their lack of hearing affected their communication with healthcare. 
Many did not use the telephone when contacting healthcare since their hearing loss 
increases the risk for misunderstandings, and where happy that 1177.se provides means 
for written communication instead.  
“I never use the telephone when contacting healthcare because I have a really hard 
time hearing what they say, I use 1177.se so I don’t miss important things.” (S2) 
Yet, several of the participants expressed frustration that despite their hearing loss, 
healthcare would insist on using the telephone when initiating contact.  
“For me, it doesn’t work at all. My health record from the hearing aid clinic states 
that I am deaf and cannot receive phone calls. SMS or messages via my 1177.se 
works but despite this, I get calls from healthcare professionals.“(U1)  
Participants with less severe hearing loss used the telephone to communicate with 
healthcare, and it was clear that different individuals had very different needs. 
Lack of dialogue through 1177.se. Users of the patient portal 1117.se can send 
messages to their healthcare providers. Several of the participants reasoned that sending 
and receiving messages worked well through 1177.se but after receiving an answer the 
dialogue ended, and they could not send anything back.  
“I think it’s good that you get answers, but there is no dialogue or feedback. It’s 
difficult to have a discussion if there’s something you want to explain or bounce 
ideas. It works when you want to book lab tests or renew prescriptions.” (S2) 
Communication and equality. Participants described different ways of communicating 
with their audiologist/hearing clinic. Some had direct email contact with their audiologist 
and appreciated this but were aware that this was a special case.  
“The audiologist does not give out their e-mail address to whoever. /…/ But I have 
contact with my audiologist via e-mail.” (S2) 
Alternative online communication methods. Participants wanted to be able to send 
messages directly to the audiologist through 1177.se, but they also proposed a chat 
function with receptionist/nurse or using a videophone.  
“Videophone, sign language chat should be offered.” (S1, S2, S3) 
Handling appointments. Currently, patients receive appointments from many 
healthcare professionals in a variety of formats (oral, paper and in some cases electronic). 
Many of the participants would prefer booking appointments online. 
“Appointment booking to my audiologist would be better if it was digital.” (I3) 
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Others reasoned that there should be an easier booking system in 1177.se and that 
healthcare professionals should be able to send appointment bookings digitally.  
“Easier appointment booking system on 1177.se like a guide that would help you if 
you not sure how to book an appointment.” (S1, S2, S3) 
Ensure awareness of a person’s hearing loss among healthcare professionals. Many 
of the participants were concerned that healthcare professionals did not always know that 
they had a hearing loss. Information should be clearly visible in the patient’s health 
record and healthcare professionals’ portal interface, perhaps in the format of a patient 
profile, to both reduce the risk for communication problems and save time during visits, 
for now, hearing-related health issues.  
“Other healthcare professionals should know I have hearing loss.” (S1, S2, S3) 
4. Discussion and conclusion 
Although a fairly small group of people participated, the in-depth interviews provided a 
rich material that clearly indicates some of the challenges experienced by people with 
hearing loss in their communication with healthcare, and highlights benefits that digital 
tools can and do provide for these users. Further flexibility and adaption to individuals’ 
needs and preferences are still needed to fully support people with hearing loss. Improved 
tools for written communication and access to clinical documentation can provide such 
support, and would likely be beneficial to other users.  
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Abstract. Health information systems (HIS) and clinical workflows generate 
medication errors that affect the quality of patient care. The rigorous evaluation of 
the medication process’s error risk, control, and impact on clinical practice enable 
the understanding of latent and active factors that contribute to HIS-induced errors. 
This paper reports the preliminary findings of an evaluation case study of a 1000-
bed Japanese secondary care teaching hospital using observation, interview, and 
document analysis methods. Findings were analysed from a process perspective by 
adopting a recently introduced framework known as Human, Organisation, Process, 
and Technology-fit. Process factors influencing risk in medication errors include 
template- and calendar-based systems, intuitive design, barcode check, ease of use, 
alert, policy, systematic task organisation, and safety culture Approaches for 
managing medication errors also exert an important role on error reduction and 
clinical workflow. 
Keywords. Medication error, health information systems, evaluation, workflow, 
lean, case study 
1. Introduction 
Despite the potential of health information systems (HIS) in reducing medication errors, 
HIS have been associated with new types of medication errors [1]. This paradox is 
primarily attributed to HIS misfit with the work patterns and settings of health care, 
resulting in the inefficient use and unintended impact of HIS in error reduction. The 
prevalence of HIS adoption and safe application remains at its infancy due to technical 
and organisational challenges [2, 3]. Further research is required on work organisation 
problems, cooperative work problem [2] and identifying safe practices for managing 
information technology (IT) transition. A close look at clinical process management can 
demonstrate the overall process, its specific steps in identifying the control mechanism 
and error risk and its impact pertinent to HIS-induced errors. This paper reports the 
preliminary findings of a case study on the management of HIS-induced medication 
errors from a process perspective in clinical practice. 
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2. Theoretical background 
The proposed Human, Organisation, Process and Technology-fit (HOPT-fit) evaluation 
framework was developed after critically appraising the literature [4]. Previous error 
models were also used to categorise evaluation factors, dimensions and measures. As an 
organisational element, process is featured as one of the factors and is represented as the 
dashed line that links process and organisation in Figure 1. Process plays a central role 
in error failure and management because errors are commonly triggered during the 
execution of a process. The developed framework proposed three dimensions of process: 
the clinical stages, business process management (BPM) life cycle and lean methods. 
This study focused on medication errors; thus, it examined the stages of medication and 
its compliance with the five rights: right drug, dose, route, time and patient (5R). Process 
management can be assessed in accordance with various stages of BPM. Meanwhile, 
process quality and safety can be examined using various lean tools and methods. 
 
Figure 1. HOPT-fit framework (adapted from [4]). 
3. Method 
A summative case study evaluation was conducted in actual clinical settings to explore 
the context and nature of the event to be investigated. Data were gathered using 
interview, observation and document/artefact analysis. We studied a number of HIS in a 
1000-bed Japanese secondary care teaching hospital (SCTH). Face-to-face and written 
interviews were audio- and manually recorded and then transcribed in English and 
Japanese by translators. Using a purposeful snowball sampling method, 13 informants 
among clinicians and management committee were interviewed. Four techniques were 
used to analyse the results: coding, analytic memos, contextual analysis and narrative 
analysis. To understand medication error management holistically, data were analysed 
using process approaches [5, 6]: 1) Major medication processes in an end-to-end clinical 
process were identified and structured into five sub processes, from prescribing to 
monitoring. 2) A process step table was constructed; it includes process information 
flows and owners. 3) Process error risks were summarised, and their sources (input, 
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process or output flaws) and subsequent impact were identified. 4) Activities that serve 
as preventive, detective or corrective controls were determined. 
4. Results 
Medication use (MU) for the SCTH’s inpatients was documented using a process step 
table that featured the medication process, control, flaw, and impact. MU steps were 
identified based on the MU process for hospital and long-term cases [7]. The SCTH 
additional processes is nearly double the number of those of MU. The selected steps, 
error control, flaw and impact are provided in Table 1. The medication process for the 
STCH inpatients involved several HIS, and a safety measure is implemented on every 
possible point of care. The doctor prescribes medicine in the consultation room using a 
computerised provider order entry (CPOE). The medication order is sent to the pharmacy 
department for drug preparation. The doctor gives order instructions to the nurse through 
a calendar, template-based instruction system (InstS). The nurse receives the instruction. 
The doctor checks whether the nurse has seen the instruction (indicated by a changed 
coloured display). The nurse sees the new doctor’s instructions that are highlighted in 
different colour. When the nurse checks it, he/she can post questions to the doctor or 
clicks the ‘received button’ to confirm the receipt of the doctor’s instruction.  The 
pharmacist checks the order data on Pharmacy IS (PhIS), downloads the data to PhIS, 
prepares the drug envelope and sends the envelope and drug to the nurse station for 
dispensing the medication to the address entered in a mechanical cart. The nurse delivers 
the envelope to the ward for administration. STCH policy requires the preparation of a 
one-dose package to avoid confusion.  
Changes in the doctor’s order are designed with error control but are still prone to 
errors. Error risk may occur when the doctor changes the order but the nurses are unaware 
of it because they do not always check the system. Therefore, the system should ensure 
that nurses are informed about changes. If the doctor changes instructions before a drug 
is mixed, then the nurse will print the mixing sheet with a new bar code. Otherwise, if 
the nurses check the old mixing sheet bar code against the new bar code update in the 
system, then an error alert is prompted due to bar code mismatch. Similarly, if a change 
is made after an order is sent to the pharmacy, then the pharmacy does not know about 
the change. The drug may already be delivered but administration should be stopped. 
The instruction system is updated with the change and the medicine should be returned 
to the pharmacy. The new mixing sheet is printed out. The information in the pharmacy 
system is only updated if drug quantity increases.  
5. Discussion 
The current study adopted the core processes and adapted them to MU processes that are 
unique to the SCTH setting. The process model is beneficial for modelling the overall 
process, ensuring the inclusion of basic processes and arranging them in a structured and 
systematic manner. Breaking down the process to the simplest task unit enabled the 
discovery of process variance, barrier, error risk, and fit with HIS that are otherwise 
overlooked in the SOP. The process of determining step breakdown and classifying it as 
either a step or control, a single or a sub step is challenging. Optional activities are 
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explicitly modelled due to their intuitive manner and positive influence on  ‘the structural 
complexity and the understanding of the process flow’ [8].  
 
Table 1. Selected medication process, control, risks and impact 
 
Process steps [resource(s)] Control and impact Error risk  and impact 
Prescribing   
P1.1 Make clinical decisions  Calendar-based interface, graphical 
symbol and colour - AL 
Overlapping medication - VACT 
P1.2 Select drug   
P1.3 Determine drug regimen Automated dosing and calculation – 
ACT; Alert - A 
Alert override - ART 
Excessive alert - R 
P1.6 Stamp prescription  Identity authentication - V  
P1.7 Submit order  Daily-based drug - AT  
P1.8 [O] Change order 
 
Must cancel previous order - A Incomplete changes - VAT 
P1.9[O] Submit order change   
Instructing   
I2.1 Send instruction Template, calendar-based interface-
L; Timing-based drug - LT 
 
I2.7 Check if order is received Automated colour-coded change - 
LAT 
 
12.8 [O] Send change order 
instruction 
Prevent instruction overlap – VAT; 
Change message – ALT;  
View nurse check - AT 
Highlights in MD interface - LT 
Nurse does not check changes – 
VACT; Nurse forgets to exclude 
stopped medication or include 
added medication - VACT 
I2.8 [O] Check seen changes Disappeared highlights  
Transcribing   
T3.1 Check order data Correctness check: IF before Ph. 
check  THEN OK; IF after Ph. 
check  THEN error - VAT 
Automated colour-code change - L 
Change is made after order is sent 
to PhIS and drug is prepared - 
VACT 
 
T3.2 Download data to PhIS   
Dispensing SOP - VACT  
D4.1 Enter and screen data   
D4.2 Prepare drug envelope  Completeness of patient and drug 
information - VACT 
 
D4.3 Prepare, mix and 
compound drug 
5R, patient-drug bar code match:   
IF before drug mix  THEN OK 
IF after drug mix  THEN error 
message – VACT 
Prepare one-dose package - AT 
Two independent nurse checks - VA 
Error can occur if the system is 
not checked before injection drug 
mixing - AT 
D4.4 Dispense to nurse station Dispensing and cart machine - AT  
D4.5 Dispense to ward   
Administering   
A5.3 Nurse verifies order 5R, patient-drug barcode match:  
IF match, THEN OK; IF mismatch, 
THEN prompts error alert-  VACT 
Nurse does not check the system 
or use the barcode before 
administering - VACT 
A5.4 Administer drug Colour code for taken, delivered and 
undelivered drugs -VACT  
Nurse forgets to take out stopped 
drug or add new drug - VACT 
Notes: Italicised step = unique to SCTH Ph. = pharmacy; 5R = 5 rights; Data quality measures: validity (V), 
accuracy (A), timeliness (T), completeness (C), relevancy (R), legibility (L) 
 
STCH has established various controls to ensure patient safety including intuitive 
design using template, calendar, and automated functions. However, several controls are 
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also error-prone. Subsequent flaws that penetrate through the aligned control 
mechanisms from all four HOPT factors will result in an error incident. By contrast, 
several error risks have no control mechanism. Continuous monitoring and evaluation 
through lessons learned can improve HIS development and use, fitting it with the clinical 
process to prevent recurring errors. In addition, safety culture and Japanese Kaizen 
approach, which focuses on continuous incremental improvement, has been proven to 
yield significant results over time in STCH.  
Although the study was conducted at specific, clinical settings of one hospital over 
a short duration, the data were collected rigorously and systematically, yielding to in-
depth findings that are also applicable to other clinical contexts. Additional feedback was 
obtained from the participants to clarify and gain more information. 
6. Conclusions 
Every process step is prone to errors, but several steps have a control mechanism to 
prevent or minimize error. Human intervention is still required in tandem with system 
intervention to avoid errors. The case study findings also demonstrate the feasibility of 
the process approach to address process as one of the essential components of IS, and the 
fit between the HOPT factors. This evaluation approach is potentially useful to 
researchers and practitioners for conducting rigorous evaluation studies. Lessons can be 
learned from this study’s findings and recommendations for improving HIS development 
and process management can be identified to guide the future development of HIS, 
increasing its effectiveness and improving patient safety.   
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Abstract. Psycho-social factors are often addressed in behavioral health studies. 
While the purpose of many mHealth interventions is to facilitate behavior change, the 
focus is more prominently on the functionality and usability of the technology and 
less on the psycho-social factors that contribute to behavior change. Here we aim to 
identify the extent to which mHealth interventions for patient self- management 
address psychological factors. By understanding users' motivations, facilitators, and 
mindsets, we can better tailor mHealth interventions to promote behavior change. 
Keywords. Self-management, apps, behavior change, psycho-social factors 
1. Introduction 
Mobile health (mHealth) technologies (e.g., smartphone apps or wearables), affect 
patients’ self-management (SM), clinical care, and health research. Especially for 
those with chronic health conditions like diabetes, mHealth enables patients to gather 
relevant data such as information about blood glucose, diet, and physical activity to 
better understand their health and make decisions about diabetes SM. With this 
knowledge at their fingertips, patients are now encouraged to participate in their care 
by sharing mHealth data with their healthcare providers (HCPs). As patients do this, 
HCPs will need to adjust their approach to patient care and guidance, and health 
researchers need to understand how mHealth technologies impact the ways patients 
and providers work together.  
The purpose of most health and mHealth interventions for lifestyle-related health issues, 
e.g. diabetes, is to facilitate health management and, if necessary, behavior change. Research on 
mHealth interventions has focused on user experiences, with some pre-post measures of health 
behavior change, e.g. frequency of blood glucose measurements. However, less attention is 
placed on users’ environments, motivations, or interactions with others [1]. Both internal (e.g., 
self-efficacy, sense of control, mindsets about health) and external factors (e.g., social 
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 connection, communication, and the patient-provider relationship) influence the process of 
health behavior change. If we do not address these factors within mHealth intervention studies, 
we will not be able to understand the comprehensive impact of such technologies. 
 We propose that it is critical to design research questions that capture psycho-social factors 
in behavior change. Therefore, we have assessed the prevalence of questions related to these 
concepts in mHealth intervention studies, thereby revealing current gaps and future directions. 
2. Methods 
We aimed to identify articles that were published after the release of the 2015 
Guidance for Industry and Food and Drug Administration Staff regarding how to 
address mHealth technologies [2]. These articles would thereby reflect the most 
updated efforts to assess new mHealth technologies, including those that address these 
new guidelines. We reviewed studies published in English between Jan. 1, 2015 and 
Jan. 18, 2019, describing mHealth interventions for patient self-management of 
WHO’s listed major chronic non- communicable diseases (NCD) [3], as well as 
chronic mental illnesses. We searched Medline, PubMed, Google Scholar, and 
ProQuest Research Library for combinations of “mobile application” or wearable, and 
self-management or self-efficacy, and patient. We focused on qualitative questions 
asked in the following methods: study-specific questionnaires, interviews, and focus 
groups. Methods that described the purpose of the inquiry, e.g. satisfaction, without 
listing the questions themselves, were also included. Questions asked to both patients 
and HCPs were then grouped under emergent themes and then overarching categories: 
user experiences and four major psycho-social theories of behavior change: behavior 
change intentions, facilitators/barriers, measures of behavior change. 
3. Results 
The search resulted in 31 articles. Twenty-four articles included qualitative questions 
(Figure 1). 
 
Emergent categories (n=18) were identified, and then grouped under broader 
categories (n=4).
Figure 1 PRISMA diagram describing the selection of articles 
for data synthesis. 
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 We identified 204 questions and six articles that did not list their questions but, instead, 
described the topic of their inquiries. User experience was the most represented category 
(n=103 questions in n=13 articles, and n=5 articles addressing this category). Other inquiries 
focused on motivation, goals, and control [22], daily or SM habits [23, 24], confidence in future 
use [25] and focus on intention of use [26]. It is important to note that articles cited under a 
category may contain few questions that address that category, e.g. Fortuna et al. only included 
one question that addressed the category Facilitators and barriers [4]. Two of the seven 
articles that used interviews included questions that expanded upon previous feedback, e.g. 
“Anything else?”, “What makes you say that?”. While it was most common that patients were 
the target of inquiries (n=192 questions addressed to patients), three studies queried HCPs on 
satisfaction, experiences, and expectations (n=13 questions, n=1 interview). 
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 4. Discussion 
The number of questions related to Behavior change intentions and Facilitators or 
barriers to behavior change (n=72), compared to those about User experience and 
Measures of change (n=132), demonstrates the weight of inquiry in research toward 
the latter. While psycho-social factors influence the use of mHealth, this review shows 
that there are relatively few assessments of these forces in mHealth studies. For 
example, by inquiring about motivation as well as intention and external support, 
studies could provide a greater understanding of not just how much something has 
changed after a study, but also why. We need to understand the context, i.e. 
motivations, facilitators and mindsets, to which we are introducing mHealth 
interventions to understand what makes mHealth-use relevant and sustainable. 
Inherent factors within patients and HCPs, such as perceived roles and responsibility 
within chronic health care, influence how these users choose to –or not to- use an 
mHealth intervention. By including questions that address psycho-social factors, in 
addition to those that measure objective or quantitative pre-post factors, we can begin 
to explain when, how and why users choose to engage with mHealth in such ways that 
do –or do not- lead to sustainable health behavior change. 
5. Conclusion 
This review has demonstrated that while the qualitative questions asked in mHealth 
intervention studies do cover essential information, e.g. usability, there is a gap in our 
understanding of how and why users’ choose to use mHealth interventions. By 
leveraging underutilized psycho-social factors, we can better understand the reasons 
for mHealth-use and study outcomes. Future studies could then tailor interventions to 
address end-user needs and more effectively optimize these technologies to facilitate 
health behavior change. 
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Business Models 
Somaya Ben ALLOUCHa, and Lex van VELSEN b 
aAmsterdam University of Applied Sciences, Amsterdam, The Netherlands 
bRoessingh Research and Development, Enschede, The Netherlands 
Abstract. This paper discusses a study that aimed to elicit promising 
application areas and potential business models for social robotics in healthcare. 
For this goal, we conducted focus groups with care professionals and the 
management of elderly care organizations in the Netherlands and Germany. Three 
use cases were mentioned as the most promising: the robot as a ubiquitous aid, the 
robot as a helper in the room, and the robot as a guide. Finally, we discuss the 
implications of the medical device and privacy legislation for these three use 
cases. 
Keywords. Social robots, healthcare, use cases, elderly care, business models, 
GDPR, legislation 
1. Introduction 
It is well known that large parts of Europe, including the Netherlands, must address 
growing challenges in the current health system. The number of elderly people is 
increasing, as is their demand for care, and Europe is struggling with a shortage of 
professionals in the care sector to cope with the increasing demand. To keep healthcare 
costs under control, it is important for older people to live independently at home for as 
long as possible and, where possible, to support professionals in their daily work 
activities to reduce the high workload. Social robots, which can be defined as robots that 
aim to foster “close and effective interaction with a human user for the purpose of giving 
assistance and achieving measurable progress in convalescence, rehabilitation, learning, 
etc.” [1, 2], can be of value here. For example, they can monitor the health of elderly 
adults and help improve or maintain elderly adults’ physical and cognitive health (e.g., 
by offering personalized training programmes) [3]. In addition, social robots can also be 
used by professionals for tasks and activities that they feel are less urgent. In this way, 
they can focus on the clients who need care at that moment. 
The use of social robots for healthcare purposes is far from commonplace in 
Europe due to various issues, such as the current reimbursement system for the use of 
robotics in healthcare, a lack of familiarity with the possibilities of social robotics 
among healthcare professionals, and a lack of clarity among companies as to how they 
can and may use robots in healthcare institutions. This reluctance among companies is 
fuelled by uncertainty about privacy legislation and medical device regulations 
regarding robotics. To gain better insight into the role that social robotics can play in 
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elderly care, we created an inventory of promising use cases, potential business models 
and relevant regulations. To this end, we conducted a range of focus groups among 
care professionals and care management in the Netherlands and Germany. 
2. Methods 
To identify promising use cases for social robots in elderly care, we conducted three 
focus groups with care professionals. Two focus groups took place in the Netherlands 
(with six and seven participants) at care organizations that focus on elderly care in the 
broadest sense of the word (home care, nursing, rehabilitation, etc.). A German focus 
group included five participants and was held at a rehabilitation centre that treats many 
elderly people. The focus groups consisted of the following parts: 
 Introduction of participants and the goal of the focus group; 
 Moments of frustration during a workday. Here, we inventoried problematic 
situations about working in elderly care; 
 Improvement for work activities. Here, we inventoried which solutions the 
participants saw for improving the problematic situations; 
 Introduction of social robots. At this point, we introduced social robots and 
explained to the participants what they are and can generally do; 
 Potential roles for social robots. Participants were asked to indicate for what 
type of activity (consultation, diagnosis, monitoring, training, social, lifting 
and carrying people or things) they thought social robots were most useful; 
 Promising use cases. Together, participants looked at the problematic 
situations and linked these with the potential roles for social robots to identify 
the most promising use cases. 
To uncover potential business models for the use cases we identified in the first 
round of focus groups and to discuss relevant legislation. We conducted focus groups 
with the management of elderly care organizations. Two focus groups were held with a 
Dutch (n=6 in both focus groups) institution and one with a German (n= 4) healthcare 
institution. The employees who participated in this focus group consisted of Information 
and Communication (ICT) managers, policy-makers, training managers, innovation 
and care policy-makers, purchasing managers and members of the management team. 
During these focus groups, we presented the results of the sessions with care 
professionals, repeated the introduction of social robots and the inventory of potential 
roles, and added discussions on potential business models, implementation strategies, 
and applicable legislation. 
3. Results 
3.1. Care Professionals 
During the focus groups, the participant ranked the six potential roles for social robots. 
They are as follows (from high to low): 1) social interaction; 2) monitoring; 3) training; 
4) lifting and moving; 5) consultation; and 6) diagnosis. The professionals indicated 
that they would like to use the robots so that the client has “someone” to talk to 
because they felt that they did not always have enough time for this activity due to tight 
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work schedules. They also indicated that they wanted to use the robots so that they 
could monitor and reassure clients. A third point was that the robots could help to train 
the clients. A robot could perform the right exercises more often and help motivate 
people to perform permanent exercises so that their health could improve. It was also 
mentioned that robots could be used for lifting and moving clients. Finally, it was 
mentioned that robots could make diagnoses, but the general tendency was that people 
can still do this better than robots and that healthcare professionals found this function 
the least attractive. 
An exploration of possible application areas led to three scenarios that were widely 
supported by the various healthcare professionals and that can already be realized with 
the current technology: 
The robot as a ubiquitous aid. This robot records questions from clients/patients 
(e.g., questions about daily activities, requests for help with nausea), prioritizes the 
importance of these questions and only forwards a question to a professional in case of 
high urgency (as healthcare professionals indicate that they are overwhelmed by all the 
care questions they receive). The robot can also pick up objects from the ground (such 
as cutlery). In this way, the robot can reduce the workload of healthcare professionals 
and remove uncertainty from clients/patients. This use case was particularly helpful in 
helping clients in the common room of a care facility. 
The robot as a helper in the room. This robot can look into the home of a client when 
an alarm goes off to determine whether an alarm is false or not. The privacy of a client 
is unnecessarily harmed if a professional must enter the home/room of a client at night 
for no reason; such a situation can be avoided by using a social robot. The robot can also 
set up a speech connection between the client and the healthcare professional to discuss 
whether help is needed. Finally, the robot can provide spoken memories (for taking 
medication, help with a regular daily routine). This reduces the workload of the 
professional, reduces unnecessary help and improves the daily rhythm of the client. 
The robot as a guide. This robot reminds patients who are staying in a healthcare 
facility about an upcoming appointment (e.g., with a physiotherapist) and guides them 
to the location of this appointment (currently, patients often get lost, which is detrimental 
to the care provider's timetable and efficiency). In addition, the robot can guide visitors 
to their destination within a healthcare institution. 
3.2. Management 
The most important result of these focus groups was that with regard to a sustainable 
business case of social robots in healthcare, the majority of the participants stated that 
social robots should, above all, have added value for clients rather than for care 
professionals. The great potential that the participants saw to use social robots for 
patients and employees was partly reduced by many unresolved questions about the use 
of social robots. These questions relate to data security and liability, reliability during 
use by patients, quality management and integration into existing structures in the 
healthcare system, as well as their financing. 
Interestingly, themes such as the replacement of personnel by social robots and the 
possible lack of human contact did not play a major role. The participants saw the 
possibility of relieving staff both physically and organizationally (e.g., taking over 
logistic tasks by a robot, completing customer surveys) and giving them more time to 
stay in touch with the patients. 
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An important barrier mentioned by participants was that they encounter problems 
with the implementation and use of social robotics in relation to relevant legislation 
and regulations, such as those that have been established for medical devices. The three 
user scenarios that emerged from the focus group with professionals were then used to 
map out relevant legislation and regulations with regard to social robots and current 
legislation and privacy. 
3.3. Medical Device and Privacy Legislation 
In the discussion with management, two main sets of legislation were discussed: the 
Medical Device Regulation (MDR) and the General Data Protection Regulation (GDPR). 
The MDR states that a device should be considered a medical device when it is used for 
one or more of the following purposes (limited to those that are applicable to the case of 
social robotics): the diagnosis, prevention, monitoring, prediction, prognosis, treatment 
or alleviation of disease; and/or the diagnosis of, monitoring of, treatment of, 
alleviation of, or compensation for an injury or disability. Key in this definition is the so-
called ‘intended use’, which is stated by the manufacturer. For medical devices, the use 
of the device for purposes other than the intended use is prohibited, since the CE 
certificate is not valid when the device is not used for the intended purposes. Only in 
specific cases, e.g., during clinical investigations, may a device be used for purposes 
other than those intended, but only when this is allowed by the manufacturer. 
Research into these regulations shows that robots in use cases 2 and 3 are not 
regarded as medical devices. After all, the robot is a means of communication (use case 
2) or does not have a medical purpose (use case 3). The robot in use case 1 is regarded 
as a medical device, class IIa, but depending on the monitoring purposes for which the 
robot is used, it can also be classified as class IIb or III. 
The General Data Protection Regulation (GDPR) has been in force in Europe since 
25 May 2018 [4, 5]. A user of the robot (or its representative) will have to give permission 
for the storage and use of personal data. In addition, the supplier must provide 
information about the reasons for storage, how the user can influence this, and how data 
are exchanged. Since users will also be profiled in use case 1, the supplier will have to 
explain why this is done and in what way and will have to give the user the option not to 
use these profiling services. For use cases 2 and 3, the same rules apply (although the 
rules on profiling will probably not apply). 
 
 
4. Discussion 
In this study, we have identified the most promising use case for using social robots in 
elderly care and have explored potential business models. These use cases are the robot 
as an ever-present helper, the robot as an aid in the room, and the robot as a guide. Next, 
we mapped potential business cases with elderly care management and discussed related 
legislation. This study is one of the first to take such an approach towards social robots 
in elderly care or even healthcare. However, insights such as these are instrumental for 
developing social robotics applications, implementation plans, and exploitation plans 
and, as a result, are a prerequisite for successful and durable implementation. 
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As in any study, ours has some limitations. First, the identified use cases and 
insights regarding potential business models are highly influenced by the Dutch and 
German context and care systems. Therefore, caution should be exercised when 
generalizing these results beyond these two countries. Finally, elderly care has an 
extremely wide range of functions, involved professionals, and care protocols. To 
cover all of them in a study such as this one is impossible. It is possible that we missed 
a potential use case. However, we feel that we have generally identified the most 
important use cases. 
The use of social robotics can be of tremendous added value for healthcare 
practice. However, we will have to experiment, deploy and collaborate more frequently 
and in an increasingly informed way, especially with professionals and clients, to 
determine the contexts in which the use of social robots in the healthcare sector will be 
most sustainable. 
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Abstract. This paper elucidates how the functionality of Patient-Reported Outcome 
(PRO) has evolved due to its digital transformation. Hence, PROs traditional use 
within healthcare is described and compared to the application of electronic PROs 
(ePROs); leading to a discussion regarding PROs functionality. The literature 
included in this paper stems from a systematic scoping review. The digitalization 
supplements former functionalities of PRO by enabling timely, accessible, 
systematical and progression oriented data; however, further improvements are 
necessary to enhance PROs application in current healthcare.      
Keywords. Patient-reported outcome, PRO, digital mediation, ePRO and PROs 
functionality 
1. Introduction
Patient-reported outcomes (PROs) are increasingly used in current healthcare due totheir 
multidimensional functionality, among other things, made possible by the 
digitalization of PRO. An alteration in the use and mediation of PROs, which have shown 
to be feasible [2], also as part of clinical practice [1].  
A commonly used definition of PRO was coined by the American Food and Drug 
Administration (FDA) in 2009, stating that PRO is: “Any report of the status of patient’s 
health condition that comes directly from the patient, without interpretation of the 
patient’s response by a clinician or anyone else” [3].  
Traditionally, PRO-questionnaires was used to test the effect of new drugs on 
patients, and as aggregated data targeted research purposes [5]. However, more extensive 
use of PRO in clinical practice is currently gaining ground within healthcare. Thus, data 
is no longer preserved clinicians and scientist, since PRO-data now is expected to inform, 
include and actively engage patients in managing their own disease [6]. Therefore, PROs 
integration into clinical practice has altered its current purpose and functionality [7]. 
Hence, this paper provides an overview of PROs functionality pre and post its 
digitalization and discuss ongoing challenges. 
2. Method
The literature included in this article stems from a systematic scoping review
regarding the link between PRO and patient participation. A comprehensive review, 
1 Corresponding Author: je@plan.aau.dk. 
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which therefore also provides an overview of PROs functionalities and digital 
transformation.  Hence, the articles in this paper are a selective extraction, included if 
they pertain to PROs functionality pre or post its digital mediation.  
The publications were identified using the following databases: PubMed, Embase, 
CINAHL and Scopus. The objective was to identify associations between patient 
participation and PRO. When conducting the search, the word ‘patient-reported outcome’ 
was included every time, and then combined with search words covering either: ‘patient 
recognition’, ‘patient participation’ or ‘patient empowerment’. Exclusion criteria 
pertained to studies regarding primary care, traditional research studies where PRO was 
used as a secondary endpoint and studies where children were the subject field. Inclusion 
criteria consisted of articles covering, e.g. PROs used at hospitals or outpatient clinics, 
articles examining PROs effects, directly as well as indirectly. This strategy resulted in 
6.895 articles; decreasing to 4.343 after duplicates had been removed. After reading and 
sorting the abstracts 256 articles were fully read and assessed for eligibility [8]; hereof, 
27 articles are included in this article.  
3.Applications of PRO
3.1. PROs functionality 
Originally, PRO was used for group-level research and medical research, as 
supplement data/secondary outcome measures in clinical trials, e.g. in randomized 
controlled trials (RCT) studies, testing new drugs and evaluating the comparative 
effectiveness of healthcare interventions. Thus, the collection of PRO-data established a 
systematic approach when eliciting patients perspective on what mattered to them 
regarding their health status, their experiences pertaining to adverse effects, side-effects, 
comorbidity, and the burden of illness or treatment [5][9].  
Therefore, the integration of PRO means that the evaluation of treatment no longer 
merely is based on objective criteria and physicians assessments, but on patients’ 
perceptions and experiences as well [4]. A shift of focus in healthcare interventions, 
emphasizing the importance of patients health-related quality of life (HRQoL) to 
complement more traditional survival measures [10].  
3.2. ePROs functionality 
Furthermore, the digital transformation of PRO may enable new functionalities. 
Firstly, when PRO is digitally mediated it allows real-time monitoring of patients 
and timely-data becomes available during patient-clinician consultations; potentially, 
leading to tailored patient management, improved decision making, more accurate 
diagnosing and better treatment [11].  
Secondly, accessibility of PRO-data changes when digitalized as it enables patients 
to access data from at home; allowing them to follow their disease progression 
systematically over time. Therefore, the completion of ePRO-questionnaires potentially 
initiates a learning process as patients are confronted with issues pertaining to their 
condition; thus, PRO-data might empower and engage patients [12]. This feature, 
coupled with patients opportunity to track their disease progression over time and, e.g. 
set disease-related goals, are focal reasons why PRO-data is perceived as a self-
management tool [13]. Thus, ePROs increased accessibility potentially improves patient 
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participation and self-monitoring as part of patients everyday life [13][14]. Moreover, 
ePROs might also affect patients’ ability to engage more actively in conversations with 
healthcare professionals;  potentially, enhancing shared-decision making in clinical 
practice [11]. 
Furthermore, improved accessibility also means that PRO can be used as a 
coordination tool as it supports organizational information flows on both a vertical and 
horizontal level. In other words, the digitalization of PRO potentially enables healthcare 
teams and providers on different organizational levels to share data. As a result, 
stakeholders are able to base decisions on timely data, while patients’ avoid having to 
complete similar questionnaires over and over again, as they progress through the 
healthcare system [7]. However, this feature of PRO-data arguably relies heavily on 
adequate digital infrastructures [15] and regulations like, e.g. GDPR. 
Thirdly, the systematic digital collection of PRO-data offers stakeholders an 
opportunity to plan and execute healthcare based on population data; exemplified by the 
value-based healthcare (VBHC) approach, where the reduction of health care costs and 
efficient use of resources are central aspects [16]. Thus, VBHC, via the use of digital 
PRO-data, might enable benchmarking, reimbursement and accountability of healthcare 
providers based on values pertaining to patient preferences and economic efficiency [14]. 
Moreover, this application of PRO-data might be used to improve systematic knowledge 
sharing among healthcare providers [14].  
Lastly, PRO, as part of a triage system, is an example of a more recent application. 
The system is based on algorithms, which sorts patients into different categories (green, 
yellow and red) according to their health status; subsequently, determining who needs to 
show up for a patient-clinician consultation. Hence, some patients are able to skip 
unnecessary routine consultations, which ensures that those patients who are in need of 
medical attention, are prioritized [17]. 
Table 1. PROs functionality on an individual and population level pre and post its digitalization. 
Stakeholders2 Functionality Pre 
digitalization 
(PRO) 
Post 
digitalization 
(ePRO) 
C Decision-making and treatment [11]  x x 
C Diagnosing [18] x x 
CP Patient perspective [4][6] x x 
CP Shared-decision making (SDM) [6] x x 
CI Drug testing [19] x x 
CI Research [14] x x 
CPM Patient-centred healthcare [14][20] x x 
CP Communication/dialogue [13][20] x x 
C Screening [11][20] x x 
CPM Patient satisfaction [6] x x 
P Patient participation [6] x 
P Self-management [6][13][14][17] x 
M Health policy development [21] x 
CPM Quality of care [1][14][20] x 
CM Best practice [14] x 
CP Adherence [6][15] x 
M Reduce health care costs/efficient use of resources 
[22] 
x 
CM Triage system based on algorithms [17] x 
2 Stakeholder terminology: C – clinicians, P – patients, M – managers/politicians, I -industry 
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P Patients goals [15] x 
M Monitor population health/preventive tool [7] x 
C Monitoring and patient management [22] x 
M Value-based healthcare (VBHC)/ 
Benchmarking/Reimbursement/ 
Accountability [16] 
x 
CM Coordination tool/ 
Interdisciplinary/multidisciplinary communication 
[20] 
x 
P Patient Empowerment [23] x 
P Self-monitoring [24] x 
Table 1. Demonstrates how the digitalization of PROs has altered its functionality. 
Thus, PRO has changed from mainly being a tool used by clinicians and industry for 
research and drug testing, to now also being a tool used by patients, healthcare managers 
and politicians, e.g. facilitating systematic patient participation, patient management and 
VBHC.   
4. Discussion
The paper elucidates how the digitalization of PROs has changed their functionalityand 
purpose. However, even though the digitalization has improved and innovated PROs 
functionality, certain issues pertaining to the application and implementation of PROs 
still persist.  
Therefore, even when ePROs, in some cases, might increase data accessibility, the 
use of PROs in healthcare can also exclude particular groups of patients. Thus, low 
health/eHealth literacy [25][26] and lack of technological access [19][22][27], are factors 
which potentially exclude patients; subsequently, creating a barrier towards patient 
participation. Hence, clinicians and managers need to be aware of the patient burden 
PROs might entail [22][27], to make sure that the use of PROs enables patient 
empowerment and not turns into patient work [28]. 
Furthermore, it is essential to make sure that PRO-data is actionable [6] and actually 
used in clinical practice since this is not always the case [29]. Therefore, to secure the 
use of PRO-data in clinical practice PRO measures need to be clinically relevant [22][29], 
and clinicians should be trained regarding the application and interpretation of PRO-data 
[29][30]. Whereas, on an organizational level, attention to how workflows are affected 
[27]and whether sufficient time is allocated for meaningful use of PROs [30] is needed.
Hence, even after PROs digital transformation, there is still a lot of work to be done
to make sure that PRO fulfil its potential, which is why further research within this area 
is recommended. However, as the overview in table 1. Demonstrates, ePROs have the 
potential to further a more personalized and actively engaging approach in healthcare.      
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Abstract.During recent years, patient accessible electronic health records (PAEHRs)
have been implemented nationally in Sweden, as well as internationally, as a means
of supporting patient engagement and shared decision making. Few studies have,
however, investigated the long-term effects of PAEHRs on communicaiton with
care professionals and involvement in care. The national survey study presented
here, answered by 2587 patients in Sweden, focuses on these aspects specifically.
The results show that the Swedish PAEHR system Journalen has had a positive
impact on communication with care overall (84% agree or strongly agree with that
communication with medical staff has improved), but only 31% agree or strongly
agree with that the content of the PAEHR is discussed with care professionals.
Journalen also seems to have a positive impact on involvement in care, but the
results are mixed when it comes to effects on shared decision making.
Keywords. eHealth, patient accessible electronic health records, communication,
patient involvement, national survey
1. Introduction
The communication between clinicians and their patients is a fundamental component of
clinical practice and is essential for achieving quality healthcare [1][2]. In recent years,
a growing emphasis on patient autonomy, patient-centered care and patient participation
has further exemplified the importance of effective doctor-patient communication [1].
Prior research on patient complaints has shown that poor attitudes and poor quality of
information provided are the most commonly identified communication errors made by
doctors [1]. In Sweden, a new legislation - the Patient Act or Patientlagen - was approved
in 2015 with the aim to strengthen the patient’s position and rights in healthcare. The pa-
tient act covers areas such as accessibility, patient participation, information provided by
healthcare professionals and consent. However, studies have reported that the act has had
limited impact on healthcare [3]. Patients are still feeling poorly informed regarding their
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test?results,?treatment?options?and?management?and?less?involved?in?their?own?healthcare?
[3].?These?results?are?worrying?as?there?is?a?growing?recognition?that?patients?can?partic-
ipate?more?actively? in?decisions?regarding? their?own?care?when? they?are?provided?with?
information?[4]?[5].?Moreover,?the?WHO?in?their?policy?framework?for?Health?2020?[6]?
and?the?Swedish?government?[7],?like?other?governments?worldwide?e.g.?England?[8],?ad-
vocate?and?endorse?the?need?for?healthcare?organizations?to?support?patients?being?active?
participants?in?their?own?care.?Therefore,?a?lot?of?effort?has?been?put?into?the?development?
of?new?technologies?for?health?(eHealth)?with?tremendous?potential?for?promoting?patient?
participation,?enhancing? information-sharing?and?communication?between?patients?and?
healthcare?professionals?and? improving?health?outcomes? [9].?An?example?of? this? type?
of?a?service?is?to?provide?patients?with?easy?access?to?their?electronic?healthcare?record?
(EHR),?so?called?patient?accessible?EHR?(PAEHR),?through?secure?eHealth?services.?The?
overall? goal? of?PAEHR? is? to? improve? communication? between? healthcare? profession-
als?and?patients,?ultimately?increasing?patients’?participation?in?care?and?improving?the?
shared?decision-making?process?[10].?Two?of?the?most?well-known?examples?of?PAEHR?
are?OpenNotes? in?USA?[5]?[11]?and?MyUHN?Patient?Portal? in?Canada?[12].?A?similar?
service?was? launched? in?2012? in?Sweden,?when?Region?Uppsala?gave?all?citizens?over?
18?years?of?age?online?access?to?their?EHR?through?the?eHealth?service?Journalen.?This?
service?was?eventually? launched?as?a?national?system? in?Sweden,?accessible? through?a?
national?patient?portal.?However,?PAEHR?are?still?accompanied?by?major?concerns?from?
healthcare?professionals,?who?stress?that?online?access?might?lead?to?an?increased?work-
load,?privacy?risks?and?cause?patients?to?worry?[13]?[14].?Studying?and?understanding?if?
and?how?PAEHR?affects?communication?between?healthcare?professionals?and?patients?
is?important?as?communication?is?essential?for?the?quality?of?healthcare.?Moreover,?pa-
tients?use?of?and?attitudes? toward?PAEHRs?has?up?until? today?mostly? focused?on?gen-
eral?attitudes?to?the?prospective?introduction?of?such?eHealth?services.?Hence?the?aim?of?
this?paper? is? to? investigate? the?effects?of?Journalen?on?communication?with?healthcare?
professionals?and?the?patients’?involvement?in?their?own?care.
2.?Method
A?national?patient? survey?was?made?available? through?a? link?on? the? login?page?of? the?
Swedish?PAEHR?system?Journalen.?The?survey?was?ethically?approved?by?the?Regional?
Ethical?Review?Board?in?Uppsala?(EPN?2016/129).?The?survey,?which?was?open?for?all?
patients?accessing?Journalen?during?the?five?months?period?June-October?2016,?included?
questions?on?several? topics?such?as?attitudes?and? reactions,?access? to?and?use?of? infor-
mation,?personal?health,?usage?behavior,? information? literacy?and? information?security.?
The?questionnaire?included?questions?with?various?response?options?(5-point?Likert?scale,?
multiple?choice,?and?free?text?form).?In?total,?2587?patients?responded?to?the?survey,?giv-
ing?a?response?rate?of?0.61%?(2587/423141).?Moll?et?al.?[15]?presents?the?study?design?
in?more?depth?and?some?overview?results?from?the?survey.?Even?though?the?results?from?
two?of? the?questions? in? this? study? (a?and?d)?are?also?presented? in? the?overview?article?
(Moll?et?al.?[15]),?the?contexts?in?which?those?results?are?presented?are?different?-?while?
this?paper?focuses?on?communication?and? involvement? the?overview?article?focuses?on?
general?usage?behaviours?and?usage?patterns.?Only?completed?questionnaires?have?been?
analyzed,?as?the?answers?were?stored?in?the?database?only?when?the?respondent?chose?to
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submit?on?the?last?page.?This?paper?covers?two?important?themes?from?the?survey,?and?the?
debate?about?eHealth?systems? in?general?–?namely? (1)?communication?with?healthcare?
professionals?and?(2)?involvement?in?care.?SPSS?25?was?used?for?all?analyses.
3.? Results
When? it? comes? to?gender?distribution? among? respondents,? the?majority? (1629/2587?=?
63%)?of?the?respondents?were?women,?which?corresponds?well?with?official?data?on?us-
age?of?the?system.?The?majority?of?the?respondents?(61?%)?also?had?an?educational?back-
ground?of?at?least?three?years?in?higher?education.
3.1.? Communication?with?clinicians
Results? related? to? questions? on? communication? are? presented? in? Table? 1.? The? ques-
tions/statements?are:?(a)?The?PAEHR?improves?communication?between?medical?staff?and?
me;?(b)?To?take?part?of?the?patient?information?via?Journalen?has?affected?the?relationship?
with?health?care?system?positively;?and?(c)?I?discuss?the?content?of?Journalen?with?medical?
staff.?As?can?be?seen?from?the?table,?the?majority?of?the?respondents?believe?that?access?
to?Journalen?has? improved? the?communication?with?medical?staff?and? the? relationship?
with?healthcare?overall.?On?the?other?hand,?the?content?of?Journalen?does?not?seem?to?be?
discussed?with?medical?staff?to?any?large?extent.
Table?1.? Results?regarding?PAEHR?in?relation?to?communication.?The?highest?value?for?each?question?
is? indicated?with?bold? face.
Question Strongly agree Agree Neutral Disagree Strongly disagree
a 1418 (56%) 705 (28%) 280 (11%) 67 (3%) 55 (2%)
b 865 (34%) 781 (31%) 656 (26%) 95 (4%) 118 (5%)
c 255 (10%) 511 (21%) 448 (18%) 329 (13%) 945 (38%)
3.2. Involvement in care
Results related to questions on involvement in care are presented in table 2. The ques-
tions/statements are: (d) I use Journalen to become more involved in my care; (e) Infor-
mation in Journalen had a positive impact on the ability to work together with medical
staff making decisions about care and treatment; (f) Information in Journalen had a pos-
itive impact on the ability to follow the prescription of treatment; and (g) Information
in Journalen had a positive impact on the ability to take own steps to improve health.
As can be seen in the table the majority of the respondents strongly agree or agree with
all statements, even though there is a rather high portion of neutral respondents when it
comes to shared decision making and self-care.
4. Discussion and Conclusions
The results presented in this paper show how patients experience that their communi-
cation with healthcare professionals and their involvement in the care process has been
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Table? 2.? Results? regarding? PAEHR? in? relation? to? involvement? in? care.?The? highest? value? for? each?
question? is? indicated?with?bold? face.
Question Strongly agree Agree Neutral Disagree Strongly disagree
d 1372 (56%) 651 (26%) 283 (12%) 57 (2%) 107 (4%)
e 571 (24%) 645 (27%) 785 (32%) 186 (8%) 215 (9%)
f 848 (35%) 712 (29%) 575 (24%) 117 (5%) 170 (7%)
g 652 (27%) 681 (28%) 725 (30%) 139 (6%) 207 (9%)
affected by PAEHR. The results are important for our understanding of the effects of
PAEHR for patients, since they are based on the first large follow-up study conducted
several years after launch of Journalen in Sweden. Earlier studies, like the interview
study with cancer patients conducted by Rexhepi et al. [16] one year after launch, rather
reflects short-term effects. It is clear that the majority of the respondents believe that ac-
cess to information from PAEHR allows them to communicate more effectively in con-
versations with healthcare professionals regarding their own care. One explanation for
these results may be that access to test results and information about care plan, treat-
ments etc from PAEHR can, as reported in studies such as [17] and [18], improve the
patients’ understanding of their medical condition. Hence, it is possible that the patients’
understanding of their illness affect their ability to engage in meaningful conversations
with the physician. Moreover, as a result of accessing information from the PAEHR, the
majority of the patients also report an improved communication and relationship with
healthcare professionals.
Furthermore, a significant amount of patients reported that they use Journalen to
become involved in their own care. However, when it comes to involvement in terms of
increased ability to engage in self-care and shared decision making, the results are not
as positive. The reasons are difficult to find in a survey, however engaging in e.g., shared
decision making is a two-way-process where a clinician and patient jointly participate
in making a medical decision [19]. If patients do feel that their opinions are not valued,
they may be less inclined to engage in the meaningful conversations needed for effective
shared decision making. Hence, provision of information alone from PAEHR will not
automatically result in patients engaging in shared decision making. Instead, healthcare
professionals must incorporate patients into the decision-making process. Future studies
will be needed to look more closely at the association between note reading and shared
decision making. Furthermore, despite ethical principles and legal requirements to en-
gage patients in their own care, some patients may not want to be active participants. It
is however vital that clinicians assess and understand the role each patient wishes to play
in his or her care. Moreover, the majority of the respondents also strongly agree with that
Journalen makes it easier for them to follow prescriptions, which is in line with earlier
studies in the area [20]. The results also show that the contents of the PAEHR is not
discussed to any large extent during the patient meeting. This is not surprising consider-
ing the resistance shown by the healthcare professionals, especially physicians and their
trade union, in Sweden [14]. However, given that patients, over all, perceive PAEHR as
positive and important it is of high relevance to study why the contents of PAEHR are
not discussed with patients and how they can be integrated into the patient meeting.
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Abstract. PROMISE (Personal Medical Safe) was a German research project 
which aimed to provide the responsibility of genomic data to the patient via a 
mobile app. The patient should accept or decline study requests to use his/her 
genomic data via the app. In the evaluation of the app the experiences with mobile 
health as well as the opinion on being the genomic data manager were measured. 
Furthermore, the test patients were asked about their opinion and their concerns on 
the PROMISE app. Most of the 19 test patients were aware of the high sensibility 
of genomic data and thought that the PROMISE app was a suitable solution. The 
largest part found it good that they were the responsible data owner. However, 
several participants also found it important to have a permanent contact person 
when it comes to questions on inquiries or the app. 
Keywords. Personalized medicine, genomic sequencing, patient empowerment, 
technology acceptance 
1. Introduction 
In today’s healthcare there is a shift to empower the patient from being a mere recipient 
of medical treatments to being an active partner in the own healthcare process [1]. It 
has been shown that patients that are willing to actively participate potentially can 
achieve better health outcomes than more passive patients [2-4]. In Germany statutory 
health insurances are obligated to provide electronic health records for their patients 
starting in the year 2021; and consumer-based health apps can be prescribed by 
physicians to their patients in the future [6]. 
A big trend in current healthcare is the so-called personalized medicine which 
takes individual factors into account and offers therapeutic measures individually 
tailored for each specific patient [7]. This includes the use of genomic data to develop 
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 the best therapy options. Different institutions also access and use anonymized  
genomic patient data for research purposes. Until now patients however mostly have no 
or very limited access to their genomic data which have been collected in the clinical 
setting. In the German BMBF funded (German Federal Ministry of Education and 
Research) research project PROMISE DS (Personal Medical Safe) the patient should  
be an active partner in this genomic medicine assuming that he or she is indeed able 
and willing to. Studies have shown that patients in general want to be involved in new 
health technologies [8, 9] but that it is necessary to assess the patients’ preferences 
towards engagement strategies beforehand [10]. 
PROMISE DS developed and provided an infrastructure and patient app, which 
allows encrypted storage of genomic data in the background and patient management 
of access to this data in the foreground. The objective of our companion study was to 
evaluate patients´ attitude towards and acceptance of this innovative technology. We 
wanted to gain insights into the potential genomic data managers’ point of view and 
thus learn for the further development and deployment of such a new and innovative 
technology. The main research questions were: 
1. How much experiences have the patients with apps and health apps? 
2. What is the knowledge of the patient regarding genomic testing and what are 
the patients’ concerns? 
 What do patients think of the PROMISE app?
4. What is the patients’ general opinion on being the genetic data manager? 
2. Methods 
We selected test patients to use the PROMISE app over four months. All the test 
patients were cardiomyopathy patients recruited at Heidelberg university hospital. 
Cardiomyopathy is a disease known for its genetic predisposition. The genomes of all 
patients in our study have been sequenced before. 
We included patients with a minimum age of 18 years with a medical indication 
for genetic testing and regular access to an Android-based smartphone. Patients who 
fulfilled the inclusion criteria were given an information sheet about the study and had 
to give their informed consent. The treating physician helped them to install the 
PROMISE app on their personal smartphone. It was made clear that the app would not 
offer medical advantages for the patient but the focus of the project was to learn about 
possible ways of designing an app with the patient as genomic data manager. Over the 
course of four months the patients received 12 simulated queries through the mobile 
application. There were no real customers; the requests have been developed by project 
members. The inquiries were designed to look as if they originated from hospital 
researchers, university researchers and commercial companies. The patient had the 
options 1) to accept, 2) to decline or 3) to ignore the request. Before and after the use of 
the PROMISE app the patients each fulfilled a questionnaire consisting out of closed 
questions in a pen-and-paper-approach. The questionnaires were designed on the basis 
of self-developed questions and already existing tools such as the questionnaire on 
patients’ perspective on pharmacogenetics testing by Rogausch et al [11]. 
Supplementary to the paper-based questionnaires interviews were performed at the 
second time point to further assess the opinion toward genetic testing. The evaluation 
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 was performed with 19 patients at both time points – the interviews with 11 
participants. 
3. Results 
3.1 App Using Experience and Knowledge on Genomic Testing 
We asked the participants about their current use of apps and health apps. 
The largest part said that they used apps on a daily basis (14 of 19). Nevertheless, 
ten of 19 participants stated that they never use specific health apps, five used health 
apps very rarely and only each two persons stated to use health apps on a daily or 
weekly basis. 
The test patients were asked to self-assess their knowledge regarding technical 
terms such as “gene”, “genetics”, “genome” or “pharmacogenomics”. Whereas the 
knowledge on the terms “gene” and “genetics” was rather good, the patients assessed 
their knowledge on “pharmacogenomics” very low. 15 out of 19 test patients said after 
the test use of the PROMISE app that they are aware or very aware that genetic data are 
particularly sensitive; before they used the app also 13 patients agreed or fully agreed 
on that. In the interviews data security was as well revealed as a major concern 
regarding genetic testing. 
Also the major part of the participants agreed or fully agreed that genetic 
information should only be stored when high safety precautions are met (15 
agreed/fully agreed before the test use; 18 agreed/fully agreed after the test use). Most 
participants (14 before the test use, 18 after the test use) stated that they thought that 
the safety concept of PROMISE protected their privacy well or very well. 
3.2 Opinion on the PROMISE App 
After the test use of PROMISE most participants said that they found the (simulated) 
study inquiries very interesting or interesting (79%), 21% were unsure about it. None 
of them did find the inquiries disruptive in their daily life. 
Also after testing PROMISE, 10 persons were afraid to falsely accept inquiries due 
to misunderstanding them, only three to falsely decline inquiries. In the interviews 
nearly every participant stated that the PROMISE app was a good idea. Several 
participants also mentioned that it was very important to have a permanent contact 
person to ask when it comes to difficulties or uncertainties when using the PROMISE 
app. 
3.3 Opinion on Being the Data Manager 
Most of the test persons found it good or very good (15 before and 18 after the test use) 
to own a safely stored copy of their own genetic data. Before the test use four persons 
were unsure, after the test use only one person was unsure about this question. Also in 
both time points most participants stated that they were satisfied or highly satisfied 
with being in control over the use of the genetic sequence data (13 before, 17 after). 
Nevertheless, 5 resp. 4 persons said that they were afraid of being the responsible 
person for the genetic sequence data. 
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 4. Discussion 
Even though the participants stated that they used apps in general very frequently, 
almost no one used health apps frequently. The general self-assessed knowledge on 
genomics and related terms was relatively low. Most test persons saw genetic data as 
especially sensitive and in need of high protection but also found the security concept 
of PROMISE convincing. Most participants were interested in the simulated inquiries 
and found them non-disruptive. They were more afraid to falsely accept study inquires 
than to falsely decline study inquiries. 
Owning a personal copy of the genomic data was found good or even very good by 
most of the participants. Also, most persons were satisfied with being in control over 
the use of the data. Besides the fact that the largest part of participants was not afraid of 
it, it has to be taken into account that several persons indeed were afraid of being the 
only data owner. 
5. Conclusion 
In our small study setting it got clear that data security plays an important role for the 
data-managing users. Further we might conclude that the layperson users would need 
support when it comes to the usage of technical/medical terms and scientific concepts 
in study inquiries, e.g. by a permanent contact person such as their treating physician. 
Also the test users were not familiar with the use of health apps. In general one might 
say that the users should not feel overtaxed by their responsibilities. 
Although the findings of our study are not representative due to the small number 
of participants they nevertheless show that medical laypersons are indeed interested  
and willing to be the data manager of personal genetic data but that electronic services 
supporting them should be designed very thoroughly regarding their comprehensibility 
and data security and that a “real” contact person would be important. 
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Towards a Highly Usable, Mobile 
Electronic Platform for Patient Recruitment 
and Consent Management  
Daniel ROBINSa1, Rachel BRODYa, In Cheol JEONG a, Irena PARVANOVAa, 
Jiazhen LIUa, and Joseph FINKELSTEINa 
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Abstract. This study seeks to assess usability and acceptance of E-Consent on 
mobile devices such as tablet computers for collecting universal biobank consents. 
Usability inspection occurred via cognitive walkthroughs and heuristics evaluations, 
supplemented by surveys to capture health literacy, patient engagement, and other 
metrics. 17 patients of varied ages, backgrounds, and occupations participated in the 
study. The System Usability Scale (SUS) provided a standardized reference for 
usability and satisfaction, and the mean result of 84.4 placed this mobile iteration in 
the top 10th percentile. A semi-structured qualitative interview provided copious 
actionable feedback, which will inform the next iteration of this project. Overall, 
this implementation of the E-Consent framework on mobile devices was considered 
easy-to-use, satisfying, and engaging, allowing users to progress through the consent 
materials at their own pace. The platform has once again demonstrated high usability 
and high levels of user acceptance, this time in a novel setting. 
Keywords. electronic consent, usability inspection, patient engagement, mobile app 
1. Introduction 
The E-Consent platform has matured through multiple iterations to capture patient 
consents for research studies in a highly usable way. Its central premise is to deliver 
interactive multimedia content that enhances patient engagement and education relevant 
to a study. Essentially, research staff just upload an approved informed consent and 
multimedia into the system, which then reorganizes the materials and presents it to end-
users in a simple and easy-to-understand fashion. The key component of this approach, 
however, is the interface: the interface must be intuitive for the target audience and 
exceptionally easy-to-use for optimal engagement. By utilizing an iterative development 
approach and collecting feedback from key stakeholders and subject matter experts, our 
team refined the user interface over numerous cycles. The overarching goal of this multi-
faceted project is to prospectively assess usability, patient engagement, and acceptance 
of the system across a multitude of settings. 
Previously we demonstrated its highly usable interface and acceptance when 
implemented at a workstation-like setting [1]. This study represents the continued 
usability inspection performed on the most recent iteration of the system, while also 
extending the platform to mobile devices such as tablets with touchscreens. 
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2.  Methods  
2.1.  System Design 
As described in our previous studies, system 
design has been guided by the Cognitive 
Theory of Multimedia Learning; information is 
structured on learning principles accounting 
for working memory and cognitive load [2]. 
The user interface was informed by our 
multiple previous works to deploy tools aimed 
at improving health literacy and patient 
engagement [3][4], while also accommodating 
limited literacy or numeracy [5]. Lessons 
learned from these studies have led to a Table-
of-Contents design for the main menu of the 
application. Complex information is organized 
into a series of smaller ‘chapters’. Each chapter 
is structured similarly, beginning with a video 
explanation (Figure 1) of a person who 
explains the section in plain language. 
Subsequent pages in the chapter feature a few 
sentences of text that reiterate and expand on 
the relevant content. One-question quizzes 
appear periodically, to reinforce specific 
concepts. The full consent form is available at 
all times and on all pages of the system via the 
‘Consent Now’ link. In any event, the user is 
automatically presented with the full consent 
form and the option to digitally sign it (Figure 
2) upon completing all chapters. 
For this study, content was entirely in 
American English. 
2.2. Study Design 
The study was designed to evaluate the usability of the system on mobile devices by 
eliciting quantitative and qualitative feedback. 
 
Participants were all patients at the Mount Sinai Hospital in New York, coming from 
clinics including primary care, specialty care, and employee health. Upon sitting down 
with a tablet computer, participants were given a packet of surveys, followed by 
instructions to complete 3 tasks, then an additional package of evaluations and surveys 
to record their feedback. The tablet computer included a touchscreen, a stylus, and a 
keyboard with trackpad, and it was preconfigured to display the Electronic Consent 
system on screen. 
 
Surveys began with a sociodemographics form and the Rapid Estimate of Adult Literacy 
in Medicine (REALM). Participants then performed three tasks as part of the cognitive 
Figure 2. Signature Page 
Figure 1. Video introduction to a chapter 
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walkthrough. Afterwards, 
participants provided feedback 
on post-task questionnaires, a 
heuristics evaluation form, and 
the Process and Quality of 
Informed Consent for Clinical 
Research (P-QIC) form. A semi-
structured qualitative exit 
interview completed the session. 
The three tasks for the 
cognitive walkthrough could be 
completed with or without 
assistance from the research 
associate; if a participant needed 
help, this request was recorded. 
Task 1 instructed the user to 
complete all chapters of the 
educational module. Task 2 
required users to complete the 
consent module and electronically sign the consent form. Task 3 asked users to complete 
an electronic version of the System Usability Scale (SUS).  
After completing tasks 1 and 2, the participant was asked to grade each task on a scale 
of 1 (very difficult) to 5 (very easy) using a survey that included the following questions: 
1) How difficult or easy was it to review the content and finish the sections? 2) How 
difficult or easy was it to answer the questions? 3) How satisfied are you with using this 
system to complete this task? 4) How would you rate the amount of time it took to 
complete this task?  5) Is the system visually appealing? 6) Is the system easy to 
navigate? There were also two open-ended questions that ask the participant to share any 
other feedback and to describe problems they might have encountered. Since Task 3 was 
simply an electronic version of the System Usability Scale, its post-task evaluation 
omitted questions that were not relevant to this section. 
3. Results 
Overall, 17 healthy adults at our clinics participated in this study at the end of Q3 2019. 
Average age of the participants was 33 years old ranging from 22 to 84 years; 12 
participants identified as female, 4 identified as male, and one did not provide a response 
for this question. Participants reported a range of familiarity with informed research 
consent, from completely naïve users to experienced research coordinators. The average 
REALM score indicated a ‘High School’ level of health literacy. 
Task self-assessment results are presented in Table 1 as average scores, with a score 
of 5 indicating highest satisfaction. For tasks 1 and 2, content difficulty ranged between 
4.4 and 4.7, while question difficulty ranged from 4.7 to 4.8; task satisfaction varied from 
4.2 to 4.3; ease-of-navigation ranged from 4.6 to 4.7. One participant required help to 
complete each of the tasks.  
The heuristic evaluation’s highest mean scores were 4.7 for Visibility and 4.8 for 
Matching between the system and real world, whereas the lowest mean scores of 4.1 and 
4.2 were associated with Help Documentation and Controls, respectively. 
Table 1. Task Self-Assessment Mean (SD) 
Task 1: Complete Education Module 
    Content Difficulty 
    Questions Difficulty 
    Satisfaction 
    Amount of Time 
    Visually Appealing 
    Easy to Navigate 
 
 
4.7 (0.7) 
4.8 (0.7) 
4.2 (1.0) 
4.1 (1.2) 
4.1 (1.0) 
4.6 (0.8) 
Task 2: Complete Consent Module 
    Content Difficulty 
    Questions Difficulty 
    Satisfaction 
    Amount of Time 
    Visually Appealing 
    Easy to Navigate 
 
 
4.4 (0.9) 
4.7 (0.8) 
4.3 (1.1) 
3.9 (1.3) 
4.4 (1.1) 
4.7 (0.5) 
Task 3: Complete E-Questionnaire 
    Satisfaction 
    Amount of Time 
    Visually Appealing 
    Easy to Navigate 
 
 
4.8 (0.6) 
4.2 (1.2) 
4.6 (0.7) 
4.9 (0.3) 
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System Usability Scores (SUS) were normalized in the usual fashion; SUS mean 
was 84.4, which corresponds with an ‘above average’ usability rating and places this 
system at greater than the 90th percentile.  
The semi-structured qualitative interview captured feedback that described 
electronic consent on this platform as easy-to-use, engaging, and faster than paper. 
 
4. Discussion 
 
This mobile implementation of the E-Consent platform was well-received by users. The 
results of the cognitive walkthroughs are largely consistent with our previous work on 
this platform as well. Indeed, cognitive walkthroughs are well-suited for these 
evaluations as they effectively focus on how well a naïve / first-time user can perform a 
task without formal training [6]. 
The semi-structured qualitative interview yielded numerous actionable points and 
areas for improvement (Table 2). 
The majority of participants reported that the interactive nature of the system 
improved their attentiveness to the content: “The interactivity helped me pay more 
attention to it”. Multimedia was also cited as a preferred feature. In the words of one 
participant, “I really like the videos, I prefer someone speaking to me rather than reading.” 
And another participant commented “Much better than reading it on paper. Definitely 
better to have this faster process. More concise is better.”  
Although there was wide consensus that this interactive platform is preferable to 
paper, there was also agreement that human interaction should be maintained in some 
way: “Humans can build rapport”, “Human interaction is better”.  
Regardless, users felt generally comfortable using the system on their own. One 
participant described an advantage of the interactive platform is that users “...can take 
their time...” Another described the milieu as “Very comfortable, simple, my parents who 
are not native English speakers could use it”.  
Table 2. Semi-Structured Qualitative Interview, Summarized 
Barriers Advantages Suggestions 
Controls not visible enough 
Content too long 
Too wordy 
Videos too long 
Videos not descriptive enough 
Need more human interaction 
Need paper supplement 
Poor sound effect quality 
Font size too small 
Images too small 
Simple to understand 
Easy to use 
Interactive 
Engaging 
Move at own pace 
Faster than paper 
Less waste 
Option to email 
Concise 
Easy to navigate 
Instructional video at start 
Progress bar 
Additional navigation buttons 
Subtitles for videos 
Pop-up explanation over words 
Controls to adjust font size, color 
Streamline, reduce amount of content 
Audiobook feature / read-aloud text 
Emphasize compensation of study 
Emphasize risks of study 
Option to mute audio 
‘Save and continue' feature 
Real-time chat with human 
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Some participants were concerned about the intuitiveness of the interface for older 
patients. “Someone older or not familiar with tablets would have problems understanding 
and using it”. These concerns are 
reflected in the heuristics evaluations, 
which demonstrated lowest scores for 
‘Help and Documentation’ and 
‘Controls’. These scores may be due 
partly to the smaller display sizes on 
mobile devices; users may need to 
scroll the pages to find the buttons to 
navigate. This also indicates the need 
for a more obvious ‘help’ feature with 
instructions that describe this scenario. 
Limitations of this study include 
the brisk sample size (17 patients) and the relatively high English literacy of those 
patients as evaluated by the REALM assessment. The mean REALM score was at the 
‘High School’ level of literacy, which corresponds with participants’ English 
Proficiency; all users described their English proficiency as either ‘Excellent’ or ‘Good’. 
This limitation can be mitigated by broadening the patient base and expanding the study 
to more locations.  
Next steps should be twofold: 1) further refine the interface for mobile devices based 
on feedback from this study, and 2) expand usability analysis and testing to include more 
diverse locations with a larger sample size. Electronic consent systems can conceivably 
reach into patient homes, and so the home setting is another logical next step for 
evaluation.  
 
5. Conclusion 
 
Formal usability inspection methods continue to generate actionable feedback, which has 
shaped the E-Consent platform into a highly usable framework for capturing electronic 
consents and engaging patients. The mobile iteration of this platform has now 
demonstrated a high usability rating with excellent levels of user-reported satisfaction. 
To enhance user-friendly design and engage as many patients as possible, future 
iterations of the product should account for mobile devices. 
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Table 3. Heuristics Evaluation Means 
Heuristic Average Score (SD) 
Visibility 4.7 (0.6) 
Match (system to real world) 4.8 (0.3) 
Control 4.2 (1.3) 
Consistency 4.6 (0.6) 
Error Prevention 4.6 (0.6) 
Recognition 4.6 (1.0) 
Flexibility 4.5 (0.7) 
Aesthetics 4.6 (0.9) 
Error Recovery 4.6 (0.6) 
Help & Documentation 4.1 (1.0) 
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Abstract. Hospital quality improvement initiatives that focus on the patient 
experience are increasingly gaining attention. One of the known improvement 
methodologies is patient journey mapping. Central to this methodology is the 
mapping process, resulting in a patient journey map: a visual presentation of the 
complete route a patient follows during all stages of a care trajectory and the patients 
emotional experience during this journey: the patient journey map. Currently, there 
is no standard approach on how to perform the steps in the mapping process and 
evidence is lacking on the most effective and efficient way. As a result, the adoption 
of the methodology by healthcare professionals is hindered, more time than 
necessary is spent on the mapping and a lot of significant variation exists in the 
quality of the resulting patient journey maps. The Lean methodology has a proven 
track of record to optimize and standardize processes. Hence, by performing a Lean 
analysis onto the patient journey mapping process, opportunities to optimize and 
standardize the process may be identified. This study aimed to assess the value of 
Lean methodology to optimize patient journey mapping in a hospital setting. 
Observations and interviews were performed to identify the process for patient 
journey mapping in a Dutch academic hospital. Lean was used to visualize the 
process and identify inefficiencies. An expert panel reviewed the improvement 
suggestions. We conclude that Lean can provide value for aligning different views 
on the process, for structuring the process steps and phases and for identifying 
optimization actions in the mapping process.  
Keywords. Lean, patient journey, quality improvement, patient experience 
1. Introduction 
Understanding and improving how patients experience their care is increasingly 
recognized as one of the key components to successfully delivering high quality 
healthcare. Patient journey mapping is a relatively new and upcoming methodology used 
in hospital quality of care improvement initiatives to identify actions which could 
improve patient experience with the healthcare system [1]. In mapping a patient journey 
the experiences with and interaction between the patient and the healthcare providers in 
all stages of a care trajectory is explored. One of the foundations of this methodology is 
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 that patient experience is not limited to a visit to a specific healthcare provider. It includes 
the period before and after the visit, such as a visit to a GP, making an appointment for a 
hospital visit, waiting for the appointment to take place or looking up information in an 
(online) patient folder. How patients experience their care, is likely to change during this 
journey. Another central idea therefore is that patient experience is more than the rating 
that a patient gives to a healthcare provider, it also includes the feelings a patient 
experiences, like anxiety or uncertainty. The final result of the patient journey mapping 
is a visual representation of the patient journey: a map showing a timeline indicating all 
relevant interactions between the patient(group) and its healthcare providers (including 
interaction with their Electronic Systems) in combination with the different aspects of 
the patients’ experience. The review of the patient journey by healthcare professionals 
subsequently leads to new insights on how healthcare services can better fulfill patient 
needs. This results in the identification of improvement actions [1,2]. 
Central to the methodology of patient journey mapping is the mapping process. 
Mapping a patient journey is a highly complex and time-intensive process that consists 
of multiple stages with interrelated activities to complete [2]. Currently, there is no 
standard approach on how to perform the steps in the mapping process and evidence is 
lacking on the most effective and efficient way. As a result, the adoption of the 
methodology by healthcare professionals is hindered, more time than necessary is spent 
on the mapping and a lot of significant variation exists in the quality of the resulting 
patient journey maps [3].  
The Lean methodology has a proven track of record to optimize and standardize 
processes. Hence, by performing a Lean analysis onto the patient journey mapping 
process, opportunities to optimize and standardize the process may be identified. Because 
of the shortage in healthcare staff and financial limitations, it is important to work as 
efficiently and effectively as possible [4,5]. The objective of this study was to assess the 
value of lean in optimizing and standardizing the patient journey mapping process in an 
academic hospital setting. 
2. Methods 
First, the patient journey mapping process was observed and described in a Dutch 
academic hospital setting. This hospital was selected because of the availability of 
resources to participate in this research and its recent efforts to define a hospital-wide 
approach for mapping a patient journey. The scope of this study encompassed all 
activities from the moment a hospital department initiated a patient journey project till 
the delivery and review of a patient journey map. The observation was done by an 
independent Medical Informatician. A Lean tool for visualizing a process, a Swimlane 
diagram, was used to describe the mapping process. A Swimlane diagram documents 
process flows with different tasks per role and to provides insight into the order in which 
tasks are performed [6,7]. 
In the second step an expert panel consisting of a representative from the 
Communications department (who developed the approach and toolkit), an Operational 
Lead, a Medical Lead, a Lean expert (Master Black Belt) and a Medical Informatics 
junior researcher redesigned the mapping process based on the documented process in 
step one. In this step a Lean waste analysis was performed by a Lean expert. A Lean 
waste analysis is a tool which identifies suboptimal activities aiming at streamlining a 
process [8]. This step resulted in a proposal to optimize the process for mapping the 
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 patient journey based on the applied Lean analyses. The value of applying Lean was then 
determined by the expert panel review on basis of accepted optimizations and insights 
gained the process. A Lean improvement was accepted by the expert panel if they 
considered it feasibility for implementation and if it fit the hospital’s vision on patient 
journey mapping. 
3. Results 
The observations and interviews provided insight in the process for patient journey 
mapping in the academic hospital. The communications department took ownership on 
the mapping process and educated the departments that were supposed to apply it. In this 
paper this department is referred to as the Quality Improvement (QI) team. There was no 
top leadership pressure to create patient journey maps. The mapping process consisted of 
2 workshops (a kickoff and a follow up workshop), actions to be taken by either the 
medical lead or operational lead and a toolkit to support the activities to follow. Tasks 
between the medical lead and operational lead were different depending on the way the 
specialty was organized. Use of the Swimlane diagram resulted in the identification of 
three phases with interrelated activities: the initiation, the data collection and the mapping 
phase.  
Overall the Lean waste analysis provided sight on 11 improvements. The expert 
panel review accepted eight improvements and rejected three. Figure 1 shows the 
resulting Swimlane diagram. The rectangular boxes in Figure 1 represent activities. Each 
activity has detailed work instructions.  
  
Figure 1. Swimlane diagram showing Lean improvements for patient journey mapping. Stars indicate 
improvement suggestions, QI Team = Quality Improvement Team 
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 The numbered stars highlight the accepted Lean optimizations. Below each 
optimization is described in detail. 
• Star 1- Align team upfront 
Prevent wasting time and effort on discussion and confusion about who is 
supposed to be involved in which actions by agreeing up front on the roles and 
responsibilities between QI Team, Medical Lead and Operational Lead. 
• Star 2 – Faster determination of persona, scope and goals  
Reduce time and effort spent by healthcare professionals on determination of 
persona, scope and goals by providing guidance on how to do this.  
• Star 3 – Use available resources to determine contact points with patient 
Prevent having to change the patient journey later on by using available system 
data to determine contact points with patients.  
• Star 4 – Collect high quality input on patient experience 
Increase quality of data on patient experience by providing guidance on the 
selection of patients and by standardizing questionnaires for collecting data about 
patient experience. 
• Star 5 - Only start a workshop when all input is available 
Make sure all required data which is needed in a workshop is available, so that 
the workshop can deliver expected outputs without wasting time and energy of 
attendees.  
• Star 6 - Reduce amount of workshops  
Do not organize workshops if the goal can be realized by using other means of 
communication so that timelines are reduced. 
• Star 7 - Review patient journey map with patient 
Increase quality of the patient journey map by reviewing the map by a patient (or 
representative) before finalizing it. This prevents rework later on and prevents 
healthcare professionals from spending time on analysing incorrect or incomplete 
patient journeys. 
• Star 8 - Periodic update 
In a changing world a patient journey map needs regular updates to stay up to 
date. Otherwise time is waste on analyzing incomplete or incorrect patient 
journeys and opportunities to improve patient experiences are missed out. 
 
Rejected improvements included: the creation of online instruction materials to 
reduce time needed to attend a workshop, the creation of online instruction materials, to 
replace focus groups and questionnaires for collecting patient input by phone calls and 
drawing the patient journey map once instead of twice (during workshop on paper/ board 
and after workshop in electronic format). 
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 4. Discussion 
In this study we assessed the value of Lean for improving the patient journey mapping 
process in an academic hospital setting. First, the Swimlane diagram helped with aligning 
different views on the current mapping process and with structuring the process activities. 
Secondly, an expert panel reviewed eight out of 11 Lean suggestions based upon Lean 
waste analysis as valuable and  fitting their hospital vision on patient journey mapping.  
Other studies also confirmed the value of Lean for optimizing and standardizing 
processes in healthcare settings, resulting in quality improvement. The systematic review 
performed by Glasgow in 2010 showed ample examples of successful quality 
improvement initiatives based on Lean, varying from improving laboratory tests to 
radiology processes [9]. A strength of our study is to base the Lean analysis upon 
observation of an actual patient mapping process from initiation till finalization by an 
independent researcher. Other strength include the execution of the Lean analysis by a 
Lean expert and the involvement of an expert panel in reviewing the Lean improvements. 
A limitation of the setting of this study is that all healthcare professionals involved 
were mostly unexperienced with patient journey mapping which is reflected in the 
process. For example there is a higher need for clear instructions and examples, teams 
had to get aligned at the startup of a new patient journey process execution, etc. The 
improvement findings might therefore differ from a setting where an experienced team 
is executing the process.  
On the basis of this work, we conclude that Lean can provide value for aligning 
different views on the process, for structuring the process activities and phases and for 
identifying optimization actions in a patient journey mapping process. The mapping 
process described by us is a first step in optimizing the process for patient journey 
mapping. Further validation and adjustments are needed to come to an optimal process.  
We look forward to further develop the process for patient journey mapping and intend 
to validate the proposed model in the near future. 
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Abstract. User experience (UX) theories, models, and frameworks (TMFs) help 
scope user-centered design activities, aid in the selection of constructs and 
measures, and contextualize findings within a larger knowledge base.  However, 
the fragmentation of literature across disciplines and the inconsistent use of TMFs 
makes integrating concepts and selecting UX tools challenging.  Therefore, we 
conducted a focused review of the healthcare literature to identify a succinct list of 
UX-specific TMFs for academic UX researchers and industry practitioners alike. 
Keywords and MeSH terms. Human-Computer Interface, Theoretical Models, 
Ergonomics, human factors, usability, frameworks, user experience. 
1.  Introduction and Problem Statement 
User experience (UX) encompasses user perceptions and responses resulting from the use or 
the anticipated use of a product, system, or service [1]. Because UX research in healthcare is 
a high-stakes endeavor, questions arise concerning methods and instrumentation.  For 
example, “what methods best suit the context?” and “how will we know if a technology is 
effective”?  Practitioners can use theories, models, and frameworks (TMFs) to answer these 
questions.  Using Nielsen’s definitions, we define “theory” as a set of statements that explain 
observable phenomena, “model” as a descriptive simplification of those phenomena, and 
framework as the lexicon to organize constructs [2].   
Collectively, TMFs scaffold UX work by organizing concepts, aiding in method 
selection, and contextualizing results [3].  Because it can be challenging to stay abreast of the 
literature, we offer a focused review of relevant TMFs reported in healthcare.  Our goals 
were to (1) provide a succinct list of UX TMFs used to study health information technology 
(HIT); (2) describe several general models that can meet a wide array of UX research needs; 
and (3) identify theory-research and theory-practice gaps and opportunities. 
2. Methods 
We completed a PubMed search from 1946 through to 2019 using the following 
medical subject headings (MeSH) terms and keywords: “Human-Computer Interface 
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 OR Ergonomics OR human factors OR usability OR technology acceptance OR user 
experience” AND “Models, Theoretical OR Models, Psychological OR Information 
Theory or Systems Theory OR frameworks”. We restricted the results to manuscripts 
applying a theory, model, or framework to healthcare and limited output to “human 
subjects” and “English language”.  We excluded articles of methods without TMFs. 
3. Results 
We identified 4369 article titles, selected 307 for abstract review based upon relevance 
(i.e., if they described technology development or implementation), and 104 for full 
text review.  We identified 101 unique articles speaking to UX and related disciplines 
including implementation science, software development, and cognitive psychology2.  
Of those articles retrieved, 36 TMFs expressly addressed user experience, interface 
design, or interface usability.    
Table 1 User experience theories, models, and frameworks in healthcare (n=36)2.   
 Theory, model, framework Brief description Reference 
Human-computer interfaces and design 
1 Health Human Computer 
Interactions Framework 
Identifies the major components of human-
computer interaction and disambiguates user roles. 
Staggers et al., 
2001 
2 Ecological Interface Design 
Framework 
General approach to interface design to simplify 
information processing and improve cognition. 
Effken, 2002 
3 Human Centered 
Distributed Information 
Design Model 
Analysis of human computer interaction at four 
levels of abstraction. 
Zhang et al., 
2002 
4 Benefits Evaluation 
Framework 
A framework of three quality, two system 
usability, and three net benefits dimensions. 
Lau et al., 
2007 
5 Formative Evaluation in 
Instructional Design 
A decision-making template for developing 
formative evaluation strategy. 
Street et al., 
2007 
6 Elements of User 
Experience 
Stratifies dimensions of usability according to the 
product timeline or information abstraction. 
Crutzen et al., 
2009 
7 Usability Analysis 
Framework for Healthcare 
Information Technology 
A usability analysis framework designed for 
inspection of health information technology that 
identifies and prioritizes potential errors. 
Sarnikar et al., 
2009 
8 Cognitive-sociotechnical 
Framework 
Organizes usability and work into levels of user 
interaction from individual to group interactions. 
Borycki et al., 
2010 
9 User Centered Design 
Development Lifecycle 
Organization of UX activities according to 
software development lifecycle. 
Yen et al., 
2011 
10 Technology User 
Representativeness 
Functions framework 
(TURF) 
A comprehensive framework that can support a 
multi-dimensional usability evaluation of HIT to 
predict safety and impact. 
Zhang et al., 
2011 
11 Usa-Design Model© A model consisting of four phases in the software 
design lifecycle. 
Merino et al., 
2012 
12 Health IT Usability 
Evaluation Model (Health-
ITUEM) 
A usability evaluation model designed specifically 
for evaluating the usability of mobile health 
technologies. 
Brown et al., 
2013 
                                                          
2 For search method and a complete bibliography please contact the corresponding author. 
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  Theory, model, framework Brief description Reference 
13 Senior Technology 
Acceptance Model (STAM) 
Adaptation of the TAM to elderly target users. Chen et al., 
2014 
14 Use of Technology for 
Adaptation by Older Adults 
and Those with Limited 
Literacy (USABILITY) 
A model based upon the Technology Acceptance 
Model and the Theory of Planned Behavior to 
predict technology adoption by elderly patients. 
Caboral-
Stevens et al., 
2015 
15 Health Information 
Technology Frustration 
Incidence Model 
A holistic approach to understanding users’ 
frustration with healthcare interfaces, recognizing 
that safety and patient outcomes are at stake. 
 
Opoku, 2015 
16 Organization for the Review 
of Care and Health 
Applications Framework 
(ORCHA-24) 
A framework for evaluating the quality and risk of 
health applications based upon observed indicators 
of information security, clinical efficacy, user 
engagement, and user experience. 
Leigh et al., 
2017 
17 Factors Affecting Safety 
and Performance in Human-
machine Interactions 
A framework of activity system components used 
to inventory and predict factors influencing safety 
and performance of human-computer interactions. 
Stowers et al., 
2017 
18 Model for consumer use of 
medical devices 
A model that describes four dimensions of a device 
and a user that promote safe use practices. 
Reyes et al., 
2018 
19 MOLD-US Usability 
Framework for Elders 
Aging barriers framework for usability problems 
encountered by older users. 
Wildenbos et 
al., 2018 
Technology implementation and acceptance 
20 Technology Acceptance 
Model (TAM) 
A model that characterizes usability determinants 
predicting attitudes towards technology adoption. 
Davis, 1989 
21 Technology Acceptance 
Model 2 (TAM2) 
An added variables TAM that identifies the system 
variables mediating technology adoption. 
Venkatesh et 
al., 2000 
22 Diffusion of Innovation 
Theory 
A theory intended to explain how, why and at what 
rate innovations spread. 
Rogers, 2003 
23 Human, Organization, and 
Technology-Fit framework 
(HOT-Fit) 
A model that evaluates how individuals, 
organizations, and technologies interact to 
influence HIT adoption. 
Yusof et al., 
2006 
24 Contextual Implementation 
Model 
Human-computer interaction model looking at 
three levels of interaction: user, unit, and system. 
Callen et al., 
2008 
25 Combined Technology 
Assessment Model and 
Theory of Planned Behavior  
Combines TAM and TBP to produce a complete 
set of determinants influencing technology use. 
Duyck et al., 
2008 
26 Normalization Process 
Theory 
Identifies, characterizes, and explains mechanisms 
that promote or inhibit implementation. 
May et al, 
2009 
27 Framework for testing 
electronic adherence 
monitoring devices 
A conceptual human factors framework that 
incorporates objective and subjective dimensions 
of electronic adherence monitoring technology. 
DeBleser et 
al., 2011 
28 Capability, opportunity, 
motivation – behavior 
system (COM-B) 
A behavioral-change framework that sits at the 
‘hub’ of a behavior change wheel and that seeks to 
overcome limitations of prior frameworks. 
Michie et al., 
2011 
29 Effective Technology Use 
(ETU) model 
An actionable model of technology adoption that 
identifies five determinants of use behavior. 
Holahan et al., 
2015 
30 Consumer Health 
Information System 
Adoption Model 
Predicts the influence of user characteristics and 
perceptions of an innovation on informatics 
adoption. 
Monkman et 
al., 2015 
31 Unified Theory of 
Acceptance and Use of 
Technology (UTAUT) 
Explains the internal and external factors including 
users’ intention to use an information system. 
Venkatesh et 
al., 2016 
Computer science and software engineering 
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  Theory, model, framework Brief description Reference 
32 Model of PC Utilization Identifies factors influencing computer utilization 
including complexity and user affect. 
Duyck, 2008 
33 Information System Success 
Model 
Identifies the processes and attributes of 
represented information mediating system success. 
Golob et al., 
2008 
Systems engineering 
34 Fit Between Individuals, 
Task, and Technology 
(FITT) 
A framework looking at the interaction between 
system variables and human-computer interactions 
to optimize technology implementation. 
Ammenwerth 
et al., 2006 
35 Systems Engineering 
Initiative for Patient Safety 
(SEIPS) 
An extension of the Structure-Process-Outcome 
framework for understanding the interactions 
between people and systems. 
Carayon et al, 
2006 
36 Sociotechnical Model for 
Health Technology 
An eight-dimensional model addressing challenges 
in design and implementation. 
Sittig et al., 
2011 
4. Discussion 
Principle Findings and Three Key Models 
We identified 36 unique TMFs describing UX studies of HIT.  Many articles used TMFs 
from related fields or pragmatically borrowed constructs without articulating a link to UX 
theory. We purposefully selected three examples of UX models for further discussion: the 
User Centered Design Development Lifecycle, the Cognitive Socio-technical Framework, 
and the Task, Users, Representations, and Functions framework [3-5]. These are “general 
purpose” models (i.e., provide a range of constructs and explanatory interactions) developed 
expressly to facilitate UX work at any stage of development.  Other models may be better 
tailored to a particular task or context such as app development or designing for the elderly. 
The User Centered Design Development Lifecycle, described by Nielsen, is a 
cycle of activities fusing iterative design-thinking with the software development 
lifecycle [6-8].  Yen adapted this model to healthcare by tracing development stages to 
evaluation methods and healthcare goals [3]. The model describes three phases.  The 
pre-design phase calls for UX instrument preparation during project planning.  The 
design phase includes four steps: (1) specifying user needs; (2) defining requirements; 
(3) designing components and; (4) combining components.  The post-design phase 
includes two steps: (1) system integration; and (2) routine use (i.e., UX to optimize 
regular use) [4, 5, 7].  
Borycki and Kushniruk’s Cognitive Socio-technical Framework (CSF) integrates 
two complementary characterizations of user interactions: (1) cognitive models 
describing how humans process information and; (2) sociotechnical models describing 
how technology affects work [4].  The framework suggests UX evaluation methods 
throughout the technology lifecycle.  Initially, researchers should study the interaction 
between technology and individual. Later, researchers can examine work processes 
among groups in context.   
The Task, Users, Representations, and Functions (TURF) framework developed by 
Jiajie Zhang is a four-step sociotechnical model that emphasizes the interactions 
between users, tasks, and functions [5].  The first step requires identification of all 
system users.  In the second step, researchers gain an understanding of the work by 
developing an ontology of activities, interactions, and knowledge.  Then, teams can 
look at software through multiple lenses to identify unmet needs.  The third step is a 
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 task analysis wherein researchers catalog tasks associated with complex activities to 
measure complexity and time on task.  Finally, the team can study how effectively data 
displays represent concepts.  
Limitations and Opportunities for Future Research 
We only searched PubMed using MeSH terms and keywords; we did not search other 
bibliographic databases.  A future systematic review should include other bibliographic 
databases (e.g., Scopus, Embase), trade publications, and grey literature. 
Future research needs to focus on: (1) schematizing the dimensions of usability; 
(2) predicting the effect of constructs upon outcomes; and (3) publishing practical 
guides linking TMFs to use-cases, technology phases, and study methods [9, 10].   
5. Conclusions 
Application of UX TMFs can help scope projects, address usability issues, and improve 
overall system performance.  However, the state of the literature makes it difficult to 
integrate concepts and apply to practical problems.  Although we provided a list of 
generalizable models, we have identified opportunities to close the theory-practice gap.      
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Abstract. A well-designed social platform has the potential to reduce senior
isolation and promote active ageing. However, to design tools that respond to the 
user need it is important to understand what types of seniors will use it and what are 
their needs. Through a user-oriented approach at several design stage: focus group, 
co-creation and usability test we were able to identify the different roles related to 
the use of the platform, which allowed us to classify them by type, each type having 
very specific needs. Among the types of users identified, “Active users” are looking 
for an efficient platform. “Socialiser users” are more passive and mainly interested 
to participate in activities and are sensitive to trust. “Low skilled users” have limited 
digital skills and must be accompanied to start with the platform. Finally, “Sporadic
users” lack of time to actively use the platform but would use a platform involving 
a large number of stakeholders. It is important to include all these different types of 
users in the design phase to ensure the future success of the social platform.
Keywords. Aged, social participation, social media, needs assessment, user-
computer interface
1. Introduction
While good quality of life among seniors is correlated with an active social life [1],
loneliness is strongly associated with depression, thus decreasing well-being of elderly
[2]. Unfortunately, prevalence of loneliness in Europe is still high since it has been 
measured at 9.6% in older adults [3]. One way to fight isolation is to strengthen the social 
link between communities. Researches showed that participation in social activities can 
be motivated by online social support platforms [4,5]. While some researches have 
studied seniors’ requirements to use social media [6-9], only few studies have focused 
on the different type of seniors’ users and their heterogeneous needs. PaletteV2 is a 
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European project aiming to develop Palette, an online social support platform for seniors 
to encourage them to an active and social life. The aim is to provide to seniors a user-
friendly online platform that gives them access to likeminded people and activities, 
aligned with their interests. They can create different types of events such as recreational 
or volunteer events and search for their activities according to their interests and by type 
of event. They can also easily discuss with the creator of the activities.  
It is known that ageing influences how people feel comfortable using technologies 
and how they learn to use new technologies [10]. To ensure the success of any product 
and its adoption by users, it is essential to understand end-users needs and to design and 
evaluate it with a range of potential end-users at each stage [11]. An iterative user-
centered design process took place in which the interface was iteratively ideated, 
designed and evaluated with end-users at each stage of the project. In this article, our 
goal is to present the different users types of such platform and their requirements. 
2. Methods 
The development of the social platform named “Palette” was conducted as an iterative 
process involving targeted users at each stage. First, focus-groups allowed us to identify 
user’s difficulties and needs [12]. This stage highlighted their desire of seniors to engage 
in meaningful and social activities. Then, co-creation sessions were organized to 
understand how an online platform could support this goal and to ideate the platform 
functionalities with end-users [9]. Finally, prototypes and final platform were iteratively 
tested with end-users to assess and improve the usability [13].  
During this whole process we collected a large amount of information about our user 
group and aimed to classify them into categories regarding their intended and actual use 
of the platform. Then we associated these categories with their main need and barrier 
regarding the platform  
Although there is no strong consensus on a single taxonomy, there are several attempts 
to classify social network users in particular categories depending on their behavior. To 
classify our users, we were guided by the research of Brandtzaeg & Heim (2011) [14], 
which define  five roles of users on  social networks: sporadics (new comers  and users 
who use the  platform  irregularly),  lurkers (people  using  media  for  lurking  or  time-
killing), socialiser (early majority, intermittent contributors ), debaters (early adopters, 
intermittent contributors), active (users who actively participate on social networks).  
3. Results 
3.1.  Participants 
In total, 165 end-users participated in the participatory design process of the platform. 
Focus groups were held in 3 countries, Switzerland, the Netherlands and Romania from 
August to December 2016. The first session was organized in the Netherlands and 
Switzerland and included 4 participants each time (average age = 75 years) and the focus 
groups that followed included 2-3 sessions each with 4-6 participants aged 50 to 80 years 
(average age = 64 years). This represents a total of 41 participants.  Co-creations sessions 
took place in March 2017 in the same countries with a total of 47 participants (mean age 
= 67 years). Concerning usability testing of the platform, it involved 5-10 participants 
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ages between 50-80 years old (mean age = 68 years) in each country with a total of 77 
participants.
3.2. Types of users and their requirements
During the different design phases, we were able to classify our participants into 4
categories guided by the Brandtzaeg & Heim model (2011). However, we had to create
a new category to consider users who do not have the necessary skills to use the platform 
despite their willingness to use it.
Some participants did not have the necessary skills to get involved, others wanted to 
get involved minimally, others wanted to be actively involved and finally participants 
did not have the time to get involved. Based on these 4 types of users we associated their 
need and barrier from the data collected at the different design stages,
Table 1. Type of users, needs and barriers
Type of user Needs Barrier
Low skilled user Improving digital skills Independence
Socialiser user Platform offering a wide 
range of activities and a wide 
variety of offers
Trust
Active user Easy-to-use platform with 
feedback and quickly and 
easily publish and evaluate 
events
Poor platform ergonomics
Sporadic user Have all the activities 
organized in the municipality
not a lot of time (socially 
active) and very busy
Low skilled user - seniors with poor digital skills
Due to their poor digital skills, some of these seniors do not have an email address. They 
also have difficulty using a keyboard or a mouse. People with such profile needs to be 
helped in order to use the platform. This category of seniors considers that the use of the
platform could be a good way to improve their digital skills. To use the platform by their 
own, they would need a support functionality. Organizing meetings to teach them the 
basics of computer use in addition to test the platform could be beneficial to them and 
could allow this category to benefit from this service. This is a category that is not found 
in the Brandtzaeg & Heim (2011) model because their model does not take into account 
people who do not have enough skills to use social networks but would like to use them.
Socialiser user - seniors who just want to participate in activities
This category can be considered as poorly qualified regarding their digital skills. They 
sometimes have doubts about Internet security. Some of them don't feel safe trying things 
on the Internet and they are afraid of making mistakes. They are interested in the concept 
of the platform and want to use it to meet people and find activities but they don't want 
to organize events themselves. For these seniors, it’s necessary to offer a platform 
offering a wide range of activities and a wide variety of offers, including support 
services. They would like to have a system that shows all the offers grouped by 
municipality or region. This category of users’ needs to know that the platform is 
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trustworthy. One way to do this is to use a moderator to moderate the content. Ideally, it 
should be a local person who can be contacted by phone or email. 
 
Active user - seniors who are active and want to offer events 
This profile of seniors is active and wants to help others, invite others to join activities 
in which they have already participated or to propose activities they organize themselves. 
They are often more comfortable with digital than the others. They are often effective in 
explaining to other seniors how the platform works. The platform must be easy to use 
with system feedbacks. For example, that tells them that they have correctly created their 
events and to make sure that other users have access to them. For people who offer 
several activities it’s important to quickly and easily publish and evaluate events. In 
particular, it should be possible to create an event without a specific start and end date. 
 
Sporadic user - seniors who are socially active and too busy 
This category of senior are very socially active with a busy schedule, they don’t feel the 
need to use such platform. They don't really have something to offer and they don't need 
to use it to have social contacts and participate in activities. Although this category of 
seniors is not the most concerned by the platform, it can be useful for them to have a 
platform where all activities of municipalities and organizations are centralized and 
displayed. The platform could be used by some as an online agenda and replace the 
activities posted on the different websites. 
4. Discussion 
Seniors attitudes’ and uses’ of digital tools in known to be heterogeneous [15]. The 
user-centered approach used throughout the project allowed us to identify four types of 
users to consider when creating an online social platform for seniors. Each type have 
specific needs and thus a different use of an online social platform. 
Among the types of users identified, the “Active users” want to participate actively 
to the platform by providing a lot of activities. For them, the most important is to have 
an efficient platform to avoid losing time in using the platform. To satisfy this need, it is 
important to be able to filter by categories the different events proposed. It is also 
important to be able to sort according to the user's interests, otherwise the platform 
becomes complicated to use when it offers many events. “Socialiser users” are more 
passive and mainly interested to participate in activities. They are looking for various 
content and are sensitive to the trust in the platform. To address trust issue, a moderator 
role is important to moderate the content and strengthen users' trust in the platform. “Low 
skilled users” have limited digital skills, highlighting the importance of offline training 
sessions to help to get started with the platform. It is also necessary to ensure that the 
various functionalities are easy to access and use. Online tutorials should also be offered 
to these users. Finally, “Sporadic users” are already socially active and lack of time to 
actively use the platform, they would still use it as an event reference if the municipality's 
activities were listed on it. This requires involving stakeholders like municipalities as 
event provider in platform if we want to attract this type of senior.  
When developing such platform, it is important to include all types of end-users into 
a user-centered process to make sure the tool meet the needs of all users. 
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Abstract. The paper introduces a structured approach to transforming healthcare 
towards personalized, preventive, predictive, participative precision (P5) medicine 
and the related organizational, methodological and technological requirements. 
Thereby, the deployment of autonomous systems and artificial intelligence is 
inevitably. The paper discusses opportunities and challenges of those technologies 
from a humanistic and ethical perspective. It shortly introduces the essential 
concepts and principles, and critically discusses some relevant projects. Finally, it 
offers ways for correctly representing, specifying, implementing and deploying 
autonomous and intelligent systems under an ethical perspective.  
Keywords. pHealth, P5 medicine, autonomous systems, artificial intelligence, 
ethical principles 
1. Introduction 
In many countries, specific initiatives and strategic programs are established and 
continuously updated, aiming at improving care quality, patient safety, and care 
process efficiency and efficacy, thereby moving from volume to value based care to 
respond to the challenges health systems face. Those challenges are, e.g., ongoing 
demographic changes towards aging, multi-diseased societies, the related development 
of human resources, a health and social services consumerism, medical and biomedical 
progress, and exploding costs for health-related R&D as well as health services 
delivery. Organizational, but especially by disruptive methodological and technological 
paradigm changes enable this move. The paper shortly introduces in those paradigm 
changes and the accompanying organizational and ethical challenges and proposes 
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principles and methodologies for mitigating them, thereby critically discussing some 
ongoing solutions and projects. 
2. Methodological, Technological and Organizational Paradigm Changes 
Methodologically, phenomenological and evidence-based medicine, both relying on 
population-based diagnostic models based on retrospective data sets, slowly evolve 
towards personalized, preventive, predictive and participative precision (5P) medicine. 
It considers individual health state, conditions and social, environmental, occupational 
and further contexts at bedside in relation to the community, fully understanding the 
specific pathology of the health problem [1]. This requires the multidisciplinary 
approach of systems medicine, deploying the explicit and enhanced knowledge of all 
stakeholders from the different domains to be involved including the subject of care in 
the center, replacing the observational and analytical medicine approach [1]. 
Christensen et al. described healthcare transformation as move from intuitive through 
empirical to precision medicine [2]. Involved disciplines/domains include medicine and 
public health, natural sciences, engineering, administration, but also social and legal 
sciences and the entire systems sciences world (systems medicine, systems biology, 
systems pathology, etc.). Organizationally, health systems transform from an 
organization-centric through a cross-organizational, pre-defined and process-controlled 
to a context-sensitive, individually tailored, highly dynamic, fully distributed 
personalized care paradigm. The latter is sometimes also called ubiquitous care or care 
anywhere at any time. With a stronger focus on the information and communication 
technology (ICT) support, thereby referring to pervasive computing technology, 
another term frequently used is pervasive care. Both described paradigm changes are 
supported, impacted or even enabled by related technological paradigm changes. Here 
have to be mentioned: Mobile, nano-, bio- and molecular technologies; artificial 
intelligence (AI); robotics; bioinformatics; big data and prescriptive (based on current 
data) as well as predictive (includes future outcome) analytics; natural language 
processing (NLP) and understanding (NLU); cloud computing; cognitive computing 
and social business; but also the Internet of Things (IoT) [3]. A more detailed 
description of health systems transformation is provided in [1]. 
We cannot place health and care specialists, educators, lawyers, etc., next to every 
person to be comprehensively served. Ubiquitous 5P medicine requires the deployment 
of robotics and artificial intelligence, or more generally autonomous and intelligent 
systems (AIS), aiming at [3, 4, 5, 6]: 
a) capability and engagement augmentation for care provider and subject of care 
including education, access to information and services, thereby advancing 
accuracy, precision, location independency [7]; 
b) enabling cooperation; 
c) improved staff and patient experience; 
d) process improvement including clinical workflow and scheduling, but also 
business efficiency, productivity and cost containment as well as risk analysis; 
e) facilitating faster and more precise decision at administration, direct and 
indirect caregiver, and patient level including prognosis; 
f) collaborative business intelligence as self-service. 
More details on types of artificial intelligence, services and related challenges 
especially in the health and social care context are provided, e.g., in [8]. 
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Any action and relationship in enlightened democratic societies, but especially the 
health, care and welfare system have to accommodate legal, moral and ethical 
principles. In the next chapters, we will consider the different levels of AIS, reference 
moral and ethical principles, discuss initiatives and projects tackling the ethical 
challenges, and finally propose a sound approach for addressing this problem. 
3. The Ethical Challenge of AIS  
Social contracts and law define and enforce behavior for maintaining social order, 
peace, and justice in society. Ethics provides code and conduct guiding to decide what 
is good or wrong, and how to act and behave properly, thereby establishing as well as 
defending rules of morality and frequently going beyond the law [9]. With the 
evolution of societies including sciences and technologies, different approaches to, or 
theories on, ethics have been developed in the framework of meta-ethics, normative 
ethics and applied ethics. Here, Aristotle’s and Plato’s virtue ethics, Kant’s 
deontological ethics, Mill’s utilitarian ethics, and Rawls’ justice as fairness ethics have 
to be mentioned [9]. Ethical values are strongly impacted by culture, social norms and 
geographic locations. Having the evolutionary characteristics of ethics and the terrific 
social and technological developments in mind, there is no chance for one global 
comprehensive standard of ethics. Instead, basic social ethical principles such as 
dignity, freedom, autonomy, privacy equality and solidarity, or the more technological 
categories like fairness, robustness, explainability, and lineage have been established. 
For bridging the gaps (at least partially), trust through transparency is discussed as 
solution [10]. Societal and policy guidelines help to remain human-centric by 
supporting humanity’s values and those ethical principles [11]. There are many 
organizations and initiatives proposing ethical frameworks and design methodologies 
for AIS, such as the EU Council of Europe with its “Guidelines on Artificial 
Intelligence and Data Protection”, the Future of Life Institute with the “Asilomar AI 
Principles”, IEEE with “The IEEE Global Initiative on Autonomous Systems”, the U.S. 
Congress Resolution “Supporting the Development of Guidelines for the Ethical 
Development of Artificial Intelligence”, the OECD “Principles for AI Research and 
Development” proposed by the Conference Toward AI Network Society, April 2015, in 
Japan, The World Economic Forum “Top Ethical Issues in Artificial Intelligence”, and 
many others. An overview about those initiatives, some content details and references 
are provided in [8]. Table 1 summarizes the common principles of some of them. 
Table 1. Common ethical principles proposed by different organizations 
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4. Representing/Modeling Ethical, Moral and Legal Concepts 
Ethics and morality are complex humanistic domains with social, legal, religious and 
philosophical impact. Their concepts, relations and constraints on them can be 
represented but not be defined and justified in ICT viewpoints due to the context-free, 
highly expressive and formal languages deployed, resulting in inconsistent, indefinite 
and incomplete models. Instead, the concepts, relations and constraints of the domains 
contributing to the real-world business system must be formally represented and 
interrelated/harmonized using the ISO 23903 Interoperability and Integration Reference 
Architecture approach [12]. Its system-oriented, ontology-driven, policy-controlled 
formal representation of real-world business systems and the related software 
development process extends ISO/IEC 10746 Open Distributed Processing – Reference 
Model and turns it into a multi-domain model [13]. Figure 1a presents the AIS use case 
to be automatically transformed into corresponding ICT solutions. 
 
  
  a     b 
Figure 1. AIS representation, design and implementation enabling advanced interoperability and integration 
acc. to ISO 23903 
Despite the aforementioned limitations regarding the ICT modeling of complex 
systems, overcome by profiling specifications and remaining at quite generic level, 
projects have been established to specify implementable components representing 
ethical and context-related behavior. Here, efforts in modelling morality with 
prospective logic [14], but also the IEEE P70xx project series [15] have to be named. 
As they just focus on the ICT representation, they must be integrated and correctly 
interrelated using the ISO 23903 framework as shown in Figure 1b. 
5. Discussion and Conclusions 
It is crucial to define objectives, constraints and limits for AIS as well as inevitable 
principles and not acceptable behavior, auditing their entire lifecycle. In that context, 
AIS can never be used as means relinquishing or displacing humans’ responsibility 
[10]. The complexity of AIS and the multiplicity of interaction levels for ethical 
behavior require the consideration of all aspects of human value instead of defining and 
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implementing a sub-set of legal and ethical principles. Modelling such AIS and their 
components must be performed following Good Modelling Practices [16, 17], starting 
with the multi-disciplinary knowledge space, its formalization and harmonization. 
Many of the ongoing ethics-related projects are limited to ICT perspectives, ontologies 
[18], and representation styles. The IEEE P7007 project “Ontological Standard for 
Ethically Driven Robotics and Automation Systems" for example starts with 
representing some ethical principles and scenarios as UML diagrams, whose elements 
are then axiomatized using the free and IEEE owned Suggested Upper Merged 
Ontology (SUMO), developed as foundation ontology for a variety of computer 
information processing systems. For integration with other specifications, the 
deployment of the ethical domain ontology represented in the domain’s language [19] 
is inevitable. The current ISO 23903 project provides an appropriate framework also 
for developing ICT solutions under legal and ethical concerns. A recent formulation of 
those concerns is provided in [20].  
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Big Data, Information Technology and 
Information Professionals: Some 
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Abstract. It is generally accepted that the global evolution of health information 
technology, both in design and usage, raises ethical issues that should be addressed. 
However, the terms in which this concern is expressed are shrouded in ambiguity. 
Even what constitutes an ethical issue itself is never clearly defined. The present 
discussion attempts to clarify the landscape and suggests how the concern should 
be addressed. 
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1. Introduction 
It is generally accepted that the global evolution of health information technology, both 
in design and usage, raises ethical issues which should be addressed. Big Data, digital 
ethics and information technology, as well as the behavior of health informatics 
professionals and institutions stand at the center of concern. However, as so often 
happens, the problematic itself as it is usually stated is essentially unclear. For example, 
what counts as Big Data? What is covered by the phrase “Information Technology?” 
Who is an information professional? What is meant by “Digital Ethics?” More 
importantly still, why would anyone think that ethical considerations are worth looking 
at in this connection? Why not let pragmatic and legal considerations carry the day? 
2. Some Clarification 
Perhaps the best way to answer these questions is to start with the phrase “Digital 
Ethics.” It is of course a phrase of art. It refers to the ethical parameters that play a role 
in the design and use of digital technology. It assumes that there are special ethical 
considerations that are relevant whenever digital technology is designed or used in 
informatic contexts in health care.  
 Like all assumptions, this assumption should be justified. However, doing 
that assumes that the phrase “ethics” itself is clear and unambiguous—and 
unfortunately, that is not the case. What people call ethics often has nothing to do with 
ethics but instead refers to custom, ethos and even to law. Ethics deals with the moral 
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principles that govern a person’s behavior or conduct. This immediately distinguishes 
ethics from law. While legal considerations may overlap with ethical considerations, 
and while one may hope that laws, legal traditions, protocols or codes of conduct are 
grounded in ethical principles, this is not necessarily the case. The reason is that laws, 
protocols and codes of conduct are rules that are created by a duly constituted authority 
to regulate the behavior of members of society or of associations. They may be 
grounded in ethical principles, but that is not necessarily the case. Ultimately they are 
dependent on the decisions of those who promulgate them. Ethical principles are not 
thus decision-dependent. They are grounded in what it is to be a person. Therefore they 
hold irrespective of whether they are recognized in law, tradition or ethos, and 
independently of whether they are enshrined in legal stipulations, quasi-legal codes or 
protocols.  
There have been various attempts to show how these principles should be 
reflected in ethical guidelines or codes of practice by providing lists of so-called 
fundamental values such as privacy [1], justice [2], autonomy [3] etc. There have even 
been attempts to systematize and collect these values into a matrix applicable to 
information technology in general and Big Data in particular [4]. However, values are 
what people consider important. Therefore, they are ultimately psychological in nature. 
Hence they may differ from individual to individual and from society to society. To 
have truly objective validity, ethical guidelines and codes should ultimately be 
grounded in the principles that are enshrined in Universal Declaration of Human Rights. 
When these latter principles are particularized to the informatic context, they 
emerge as Principles of Information Ethics [5]: the Principle of Privacy and Disposition 
(All persons and group of persons have a fundamental right to privacy, and hence to 
control over the collection, storage, access, use, communication, manipulation, linkage 
and disposition of data about themselves.); the Principle of Openness (The collection, 
storage, access, use, communication, manipulation, linkage and disposition of personal 
data must be disclosed in an appropriate and timely fashion to the subject or subjects of 
those data.); the  Principle of Security (Data that have been legitimately collected about 
a person should be protected by all reasonable and appropriate measures against loss, 
degradation, unauthorized destruction, access, use, manipulation, linkage, modification 
or communication.); the Principle of Access (The subjects of health records have the 
right of access to those records and the right to correct them with respect to their 
accurateness, completeness and relevance.); the Principle of Legitimate Infringement 
(The fundamental right of privacy and of control over the collection, storage, access, 
use, manipulation, linkage, communication and disposition of personal data is 
conditioned only by the legitimate, appropriate and relevant data-needs of a free, 
responsible and democratic society, and by the equal and competing rights of others.); 
the Principle of the Least Intrusive Alternative (Any infringement of the privacy rights 
of individuals, and of their right of control over these data, may only occur in the least 
intrusive fashion and with a minimum of interference with the rights of the affected 
parties.); and the Principle of Accountability (Any infringement of the privacy rights of 
a person, and of the right to control over data about them, must be justified to the latter 
in good time and in an appropriate fashion.). These Principles govern—more correctly, 
perhaps, should govern—the development and use of any information technology and 
the conduct of those involved with it in a professional or institutional capacity. 
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3. Digital Ethics, Big Data and Electronic Health Records (EHRs) 
Which brings the discussion to digital ethics, Big Data and electronic health records 
(EHRs). Digital ethics is merely information ethics applied to digital data, and Big Data 
is nothing more than the collection and manipulation of vast amounts of data. 
Here it is important to remember something that is often ignored. Technology 
itself is ethically neutral. It is just that: technology. It is its use that has ethical 
implications. When it is used in an ethical manner this not only serves a useful purpose 
but also advances otherwise legitimate aims. For instance, the scientifically valid and 
ethically appropriate collection, storage, use and manipulation of data can advance the 
delivery and effectiveness of health care. Likewise, without this modern medical 
research would essentially be impossible. What is ethically indefensible is collecting 
and using data sets inappropriately, surreptitiously or without consent—as was done by 
Cambridge Analytica. 
As to why digital ethics takes a special turn in health informatic contexts, the 
reason lies in the nature of EHRs. Viewed materially, they are merely electronic 
entities with certain characteristics; viewed informatically, they are the totality of data 
that have been generated about a given patient: As such, they are patient analogues in 
data-space; and because of their relationship to their subjects, they are subject to ethical 
considerations [6]. 
And this also has practical implications. Because if it had no practical 
implications, then digital ethics would be a nice conceptual exercise—the sort of thing 
one would consider in a theoretical university seminar—but it would be pointless to 
worry about it in real life. 
Legal and policy requirements of course also have practical implications. 
However, they are only as good as their last version, and as the example of the GDPR 
shows [7] they may be altered over time; and as changes in informatic laws of various 
countries show, these may even overturned [8-12]. Therefore institutions and 
professionals who only follow legal or quasi-legal provisions may find themselves in 
an uncomfortable position when these are changed or amended. And there is also the 
fact that statutes and similar provisions are meaningless in practical terms until they are 
interpreted. To be sure, they set relevant frameworks, but what they mean in real terms 
is a function of how they are interpreted in actual cases. Therefore, as the old saying 
goes, “To rely on law is to be only as safe as the last case that interpreted the relevant 
statute.” 
This, then, is where ethics is different and where ethics “bakes bread.” An 
institution that follows the fundamental principles of information ethics in its protocols 
and provisions will reap three practically important advantages: (1) It will not have to 
make fundamental changes in its protocols and operational guidelines as time 
progresses and statutes or quasi-legal provisions change. (2) It will be able to use its 
protocols in inter-jurisdictional settings because they are not law-based but ethics-
based. (3) They may hold themselves out as providing ethically impeccable services—
which can be advertised to tremendous commercial advantage. Therefore, again, “Good 
ethics is good business.” As for professionals, ethically sophisticated professionals 
make good employees; and it is very difficult to accuse someone—or to find them 
guilty—of inappropriate conduct when they have acted in an ethically appropriate 
manner. 
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4. Conclusion 
However, having an ethically valid framework for digital ethics and supplying 
informatics professionals, institutions and other users with ethical protocols and 
guidelines is one thing; ensuring that the stipulations that govern the framework are 
understood and that the guidelines are actually followed is another. That can be 
achieved only by putting in place an independent and objective body that provides such 
guidelines and that monitors how all of they functions in actual practice. There 
currently is no such body. Therefore ethics-in-application essentially remains a 
haphazard and spotty affair. 
However, even if such a body existed, that would only be part of that story. 
What also is missing is some means of ensuring that professionals and institutions are 
qualified to follow ethical guidelines and protocols in the first place, and are actually 
able to operationalize ethically its tenets when using the digital technology as it 
currently exists or as it changes with the advent new technology and with changes in 
the structure of health care deliver itself. 
Fortunately, some of these considerations have already struck a responsive 
chord at the global level. The need of providing an overall ethics framework was 
addressed by the International Medical Informatics Association (IMIA) when it 
promulgated its Code of Ethics [13], latter which constitutes the overarching 
framework of the ethics codes of its member associations. As for the need to ensure 
that professionals and institutions are actually qualified to operationalize this ethical 
framework, this is what underlies the ethics-certification project that is currently being 
worked on by a subgroup of IMIA. It is expected that this work will have the 
endorsement of WHO and associated agencies. Clearly, if and when this it comes to 
fruition it will have practical implications for Big Data, information technology, 
information professionals and digital ethics on a global scale. However, whether it 
comes to fruition only time will tell.  
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Abstract. Understanding motivation and resistance factors affecting citizen 
participation in health and scientific research allows to find solutions to improve 
citizen engagement and interest in science. Through a survey, we identified the 
main factors influencing citizens’ participation in scientific research, and their 
wishes to be more informed. Results show that the respondents’ reasons to 
participate in research were altruistic motivations, in line with other studies carried 
out in developed countries. The main factor influencing the non-participation is the 
lack of opportunity, highlighting the importance to better inform citizens about 
ongoing studies. 
Keywords. Community participation, motivation, attitude, research, clinical trial, 
ethics, global health 
1. Introduction 
Reasons why citizens participate or not in scientific research have been studied in the 
fields of sociology and psychology. While research has been conducted on 
motivational engagement in research in Europe [1-3], Brazil [4] and USA [5], no 
studies have yet investigated the context of Switzerland. 
Switzerland is a country with a specific legal context. As not being part of the 
European Union, it does not have to comply with the same legal framework. However, 
following the General Data Protection Regulation (GDPR) in Europe [6], a Swiss 
Federal Act on Data Protection has been created. The relation of the Swiss citizens to 
their personal data might be country specific and it may have an impact on their 
willingness to participate in scientific studies. 
In this paper, we describe a survey that was developed to understand the 
motivation and resistance factors affecting citizen participation in health and scientific 
research but also their wish to be more informed. It aims at understanding the processes 
behind these decisions and to gain an insight on how to improve this situation. 
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2. Methods 
We developed a survey with questions related to motivational and resistance factors 
that may affect citizen participation in health and scientific research. Questions and 
multiple-choice answers were derived from a literature review to identify factors that 
motivate or dissuade people to participate in scientific studies and clinical trials. The 
survey was distributed in French to citizens during two general public events held 
between July and November 2018 in Geneva (Switzerland), aimed at raising citizens’ 
awareness about science. 
The survey was separated into three parts: 1) What are their motivations to 
participate in scientific studies (e.g. surveys, psychology's experiments) and/or clinical 
trials? These questions were multiple choices with several possible answers. 2) Why 
did they never participate in scientific studies and/or clinical trials? These questions 
were also multiple choices with several possible answers. 3) What do they want to be 
informed about? 
Concerning parts 1 and 2, since several answers were possible, the number of 
responses to each question was divided by the total number of responses to all the 
proposed answers. This allowed us to compare response frequencies out of a total of 
100%. 
3.  Results 
A total of 124 participants completed the survey. 52% were women (n=64), 46% were 
men (n=57) and 2% (n=3) did not answer to this question. The mean age was 43 years 
old. The majority of participants were Swiss (66%) and French (18%). Concerning the 
level of education, 1% of respondents (n=1) did compulsory school, 11% (n=14) went 
to high school, 72% (n=89) have a higher or university level, and 16% (n=20) did not 
answer. 
58% (n=72) of participants reported they had already participated in a scientific 
study (e.g. questionnaires, psychology’s experiment) while the remaining 42% (n=52) 
had never participated in a similar study. Among the participants who already 
participated in a scientific study, 60% (n=43) had participated in questionnaires, 63% 
(n=45) in an experiment and 19% (n=14) in another type of survey (e.g. interviews). 
Concerning clinical trials, 9% (n=11) of the respondents stated they had participated in 
a clinical trial. 
3.1.  Motivations to participate in scientific studies and clinical trials 
Scientific studies 
They were 72 responders to the question about the motivations to participate in 
scientific studies. Figure 1 shows that the motivational factors most often chosen were 
“to help the science” (30%), followed by “to help the organizer of the study” (25%) and 
“to help people concerned by purpose of the study” (21%). “Financial compensation” 
represented only 11% of the responses, followed by “to help relatives concerned by the 
purpose of the study” (5%), “I’m directly concerned by the purpose of the study” (4%) 
and others (4%). 
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Clinical trials 
They were 11 responders and figure 1 shows that the main motivational factors 
concerning the participation in clinical trials were “to help the science” (28%), 
followed by “to help people concerned by the purpose of the study” (24%) and “to help 
the organizer of the study” (24%). “Financial compensation” and “I’m directly 
concerned by the purpose of the study” represented only 10% of the responses, 
followed by “to help relatives concerned by the purpose of the study” (4%). 
 
  
Figure 1. Distribution of motivations to participate in scientific studies (left) and clinical trials (right) 
3.2. Resistance to participate in scientific studies and clinical trials 
Scientific studies 
The total number of respondents to this question were n=52. Figure 2 shows that the 
main resistance factor influencing the non-participation in scientific studies was the 
lack of opportunity (86%), followed by the lack of time (6%) and “the fear of what 
could happen to me” (4%). “The fear that confidentiality and anonymization of my data 
are not respected” and “the lack of interest for the subject” both represent only 2% of 
the responses. 
 
Clinical trials 
The total number of respondents to this question were n=111. Figure 2 shows that the 
main resistance factor influencing the non-participation in clinical trials was also the 
lack of opportunity (69%), followed by “the fear of what could happen to me” (19%). 
The lack of time represented 6% of the answer followed by “The fear that 
confidentiality and anonymization of my data are not respected” (5%). The lack of 
interest for clinical trials represented 1% of answers. 
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Figure 2. Resistance to participate in scientific studies (left) and clinical trials (right) 
3.3. Willingness to be informed about scientific and health research 
78% of the participants expressed their willingness to be informed about scientific 
studies going on in Switzerland. Concerning clinical trials, 70% of participants 
expressed their willingness to be more informed. Regarding the willingness to be 
informed about the results of scientific studies, results are quite similar with 77% of 
positive answers. Concerning results of clinical trials, 71% of respondents answered 
positively.Regarding more information about ethical committee, 58% of respondents 
answered positively. 61% of respondents expressed their willingness to be more 
informed about data privacy management. Finally, regarding more information about 
data anonymization management, 60% answered positively. 
4. Discussion and conclusion 
The most frequent motivational factors to participate in scientific studies and clinical 
trials could be defined as altruistic motivations (e.g. help the science, the people 
concerned by the purpose of the study and the organizer of the study). These findings 
are in line with other studies demonstrating that altruistic motivations are the most 
important motivational factors in developed countries [1, 2, 5].  
Individualistic motivations were rarely mentioned in our study both for scientific 
research and clinical trials, in contrary to other studies where financial compensation 
was the main motivational factor to participate in health research [7]. According to 
studies, low educational level and low socio-economic status and young age appear to 
have a positive link with financial incentives [7, 8]. Our finding can be explained by 
the high educational level (72%) of our respondents. The main factor influencing the 
non-engagement on scientific research or clinical trials was the lack of opportunity. 
This finding is in line with other researches [3, 9] and highlights the need to better 
inform citizens about ongoing studies. Moreover, the high percentage of respondents 
that would like to be more informed about ongoing studies, their results, data privacy 
management, data anonymization management and ethical committee, shows the poor 
communication between scientific community and citizens. The second factor 
influencing the choice not to participate in clinical trials was the fear of what could 
happen (19%), which was much higher than for scientific studies (4%). This result is in 
line with findings of other studies, underlining that the psychological or physical risks 
to enroll in clinical trials were one of the major reasons to decline participation [10-11]. 
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It is therefore important to clearly explain the risks and benefits to participants in an 
understandable language intended for lay people. 
Some limitations should be taken into account regarding the results’ interpretation. 
The high frequencies of altruistic motivations compared to individualistic motivations 
may be partly due to the social desirability bias driving respondents to be viewed 
favorably [12]. Moreover, respondents were recruited using convenience sampling 
method (by physical location) during events aimed at raising citizen’s awareness about 
science. This method may impede the generalizability of the results [13]. Also, the 
number of respondents who participated in clinical trials was low (n=11). Therefore, a 
broader study needs to be performed. 
In conclusion, these results show that to improve citizen participation in scientific 
studies, the focus should primarily be put on communication to reduce the lack of 
opportunity. Being able to explain research and science better to lay people as well as 
the implications of participating in a study is crucial. New initiatives around general 
and dynamic consent could help to move forward on this topic.  
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Abstract. Electronic systems for managing consent do exist but are generally only 
able to record consent from the research subject directly. Consent for research is 
also challenging to integrate into many electronic patient record systems. The Born 
In Bradford study is a large, from birth cohort study in the North of England which 
requires consent to be recorded by the pregnant mother of a child who will be 
included in the study from birth. This creates a complex challenge for consent 
management that has previously been achieved through paper-based processes. As 
the study begins a new phase with the objective of inviting all new parents within 
the Bradford region to participate in the study the solution also needs to work with 
existing maternity systems. This paper considers the specific challenges of 
converting the often grey rules around consent of children into an electronic 
system that is transparent and supports the trust of both the family and the clinical 
and care teams  recruiting research subjects into a large cohort study, and describes 
the user centred design and technical approach taken to resolve it. 
Keywords. Digital consent, User centred design, UCD, Electronic Patient Records 
1. Introduction 
The first Born In Bradford study began in 20101. Following its success, a second birth 
cohort study, Born In Bradford 20192 (BiB) began recruitment. BiB will give every 
mother in Bradford the opportunity to participate in a second cohort which will collect 
and link patient records from across NHS organisations for both mother and child, and 
also link to education and other data sources. The BiB team identified that continuing 
to use paper-based processes for collection and management of maternal consent would 
be impractical, but had not found a digital solution able to meet their requirements, 
such as easy integration with their electronic medical record (EMR) system and their 
existing research dataset. Most systems record consent either directly within the EMR 
(usually only for medical treatment) or within the study dataset, making it inflexible, 
hard to maintain and potentially lacking transparency. Consent by mothers for children, 
especially when planned over the lifetime of the child, is a relationship that must adapt 
to changes in the child’s life. Connected Health Cities3 (CHC) was established to test 
learning health systems at scale across the North of England, and has worked with BIB 
19 to develop a solution to address the complex consent management requirements of a 
birth cohort study.  
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2. Methodology 
We adopted a user-centred approach to the design and development of the consent 
system. User centred design (UCD) is a collection of methods emphasising end users of 
a system and their goals, over the technology, and provide mechanisms for the users to 
be deeply involved in the design, development and testing of a system.  A number of 
key principles inform this approach4: 
Early focus on users and tasks: it was important for us to work with users to understand 
their existing and to-be working practices, environment, tasks and goals.  
Empirical measurement: the testing and measurement of current performance, and 
throughput, e.g. numbers of births, recruitment rates, as well as testing of prototypes. 
Iterative design - following cycles of investigation - design - build - measure.  This 
approach fits well with Agile software development practices. 
Our starting point was a project charter jointly developed by the teams from BIB and 
CHC, which set out key functional and nonfunctional requirements, including 
legislative and regulatory constraints. The project charter was used to derive a 
programme of UCD work: interviews and workshops with users to explore and 
document existing working practices, and develop a shared understanding of the 
requirements implied by the project’s Standard Operating Procedures (SOPs.)  We co-
developed a series of artefacts: 
 user stories to understand stakeholders’ motivations, goals and context 
 process maps to document current and future workflows 
 system architecture diagrams, showing where different types of data would be 
stored 
 low fidelity prototypes of user interfaces 
These artefacts were used to support discussions with users, and iteratively updated to 
reflect our emerging joint understanding. 
3. Consent Requirements and Implementation 
Consent is a key component for people to be able to participate in research, as defined 
in the Declaration of Helsinki.5 BiB is a birth cohort study that does not involve a direct 
clinical intervention in the consented subject but consent for data access is still 
required. The guidance for consent of children from the MRC is that a legal guardian 
can provide consent for themselves and their children.6 
The process for recruiting subjects into the BIB 2019 study has been to train midwives 
to discuss the project with all women during pregnancy and, if they consent, to record 
this within the maternity EMR. Only the mother or a guardian is required to provide 
this initial consent, which allows for both the mother and child’s current and future 
medical records to be collected, de-identified and used in future research.  
Understanding how to codify and implement complex consent requirements is 
challenging: developers do not have the detailed domain knowledge necessary, whilst 
the study team are used to working with paper or simple spreadsheets. An iterative 
UCD approach allowed us to jointly explore and resolve these challenges. Through the 
design process with stakeholders different requirements were mapped, including: 
The data must be kept up to date and accurate. As far as possible the identity details, 
for example a person’s address, are checked against hospital systems connected to the 
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NHS spine at regular intervals and also when the consent for a specific individual is 
requested. 
The key for identity within the NHS is the NHS number. However, children are not 
given an NHS Number until they are born and so their consent and identity record 
needs to be directly linked to their mother and updated in the EMR, and then our 
consent store at the time of birth, once an NHS number is allocated. This is also linked 
to a birth order in the case of multiple births. 
Children could be born out of area. This means updating of the child’s identity record 
will not possible through the local hospital IT systems and must be manually 
investigated if the maternity record shows a pregnancy longer than 10 months 
(implying birth may have taken place out of area.) 
Consent is given by mother for both herself and the child. Alternatively, a young or 
vulnerable mother may have a guardian who can give consent for the mother and her 
child. This means that both consents need to be managed, and the relationship between 
the consent owner and the child recorded. When withdrawing consent a later 
requirement was added to ensure that the person requesting the change and their 
relationship to the data subject is also recorded. 
Mechanisms to request and integrate data from external agencies (e.g. education) must 
minimise the information shared externally.  
Two types of withdrawal of consent that are defined. Firstly, a subject can ask to stop 
future data collection, but agree that existing data will remain within the cohort dataset. 
Secondly consent can be completely withdrawn meaning the collection of data is halted 
and the records associated with that consent are deleted.  
 
Figure 1. Consent Process Technical Scope including existing NHS systems, BIB 19 consent management 
and pseudonymised research datastores. 
 
Other considerations include the death of a participating mother or child, and 
monitoring other changes in the child subject’s status, such as being taken into care. In 
this latter case the parents of the child may no longer have the right to give or withdraw 
consent. This responsibility is now that of the new guardian of the child. There is a 
further question as to when the child becomes responsible for consent and can be 
considered competent to manage consent for themselves. The age at which the child 
becomes solely responsible for their consent is defined as 16 although they do not need 
to be re-consented, in-line with other approaches and the Gillick test in the UK.7,8 
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Where a guardian previously gave consent for the mother and her unborn child, when 
the mother reaches the age of 16 she must be re-consented. 
The technical implementation of the consent model was based on two main data stores: 
Identity and consent in order to reflect the need to manage the relationships and consent 
through distinct mechanisms, as well as make it easier to logically separate identifiable 
data from the consent. Figure 1 describes how these data stores are managed and 
updated through a local administration web application, by the study team, and how it 
interfaces with numerous NHS systems to manage identity and provide core services 
for the pseudonymised research data set.  
Once consent has been collected this gives permission for data to be collected about 
both the mother and the child. The processes for this data collection are currently in 
place within Bradford Teaching Hospitals NHS Foundation Trust and cover a variety 
of sources, including hospital and primary care medical records. This data is stored 
separately, in a de-identified format using a key linking to the original consent. The 
record of consent is regularly checked via an API that was developed to match a 
subjects’ study id, and check any date constraints for consent. Standard Operating 
Procedures (SOPs) for managing consent have been developed and technical changes 
to the forms within the maternity EMR were agreed. The key requirement for the 
consent store is to enable the data management team to regularly check for changes in 
consent amongst the study cohort data in order to be able to update the research 
dataset.  
Finally, there is a web-based administration application which enables the study 
administrators to manage subjects’ details and consent preferences directly. 
4. Conclusions and Challenges 
The basic principles of consent are clear, but the numerous edge cases and changes to 
consent that can occur through a child’s life present challenges in the design of a 
computerised consent solution for birth cohort studies. Furthermore, the translation of 
soft, paper-based processes to computer-based algorithms requires upfront discussion. 
Interpretation of rules and regulations that are not well codified is challenging, 
especially for consent for children, which can also vary between different 
jurisdictions.9 There are related challenges to guardianship, divorce, and changes in 
legal status. Using a UCD approach allowed the project teams to negotiate a joint 
understanding of these complex requirements, and provided users and developers with 
a clearer understanding of the implications of the legal requirements and study 
procedures on the architecture and software implementation.  
Benefits include the ability to audit a complex area of consent more closely and 
simplified management of a large cohort. The solution integrates with the midwives’ 
existing workflow and EMR systems, simplifying subject recruitment. The solution has 
been designed to be flexible and meet a wide range of edge cases, including integration 
with different EPRs and research data systems using APIs, making it flexible for the 
future. The code is made available under open source licence10 and continues to be 
improved based on users’ feedback.  
Working closely with the software team using UCD ensured that the platform met the 
requirements of the study team while also consulting other stakeholders, such as 
information governance, to provide a new type of consent management tool necessary 
for the scale, self-management and linkage of family and consent given for multiple 
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individuals. In order for this, or similar consent stores, to be able to deliver even greater 
value for research there is a need to define consent processes more precisely, especially 
consent for children, within ethical guidelines and law in order to be able to better 
codify and audit consent against best practice. This will be increasingly important with 
regards to international co-operation and standards for use of EHR data in research. 
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Abstract. UN have recommended the adoption of Web Content Accessibility 
Guidelines (WCAG) version 2.0 from W3C to guarantee that web content is more 
accessible to everyone. This study aims to evaluate the effectiveness of WCAG 2.0 
implementation by comparing the country with and without WCAG2.0 policy 
adoption. The objective is to compare the impact of adopting the WCAG 2.0 
standard in health information provision by analyzing the differences between 
countries that adopted the WCAG 2.0 standard and those that did not, specifically 
for health information related to the elderly. To this end, searches were performed 
on the Google search engine for online health websites with the keyword 
“Alzheimer” and the specific country settings for Indonesia and UK, in the local 
language of each country. Website evaluations were performed for ten websites 
found with this search by using the WCAG 2.0 measurement tool Axe. Statistical 
analysis using descriptive and Mann-Whitney analysis to measure the impact of 
the WCAG 2.0 showed a predominance of low violation occurrences in the UK 
with 40% from selected websites compared to 80% medium violation occurrences 
and no low violation occurrences in Indonesia. Although the country with WCAG 
2.0 implementation had a lower frequency of violation, no significant differences 
were found between countries and the media type in WCAG 2.0 evaluation, 
implying the need to improve the effectiveness of policy implementation. 
Keywords. Web Accessibility, Alzheimer, Policy, Online, Information 
1. Introduction 
Seeking health information online has become the most popular Internet activity among 
patients [1] and mobile phone users [2]. Previous studies have shown that the majority 
of people used commercial websites (71.8%), followed by search engines (11.6%), 
while only 5.5% use government websites for health information [3]. In addition, users 
with serious health problems and/or disabilities were more enthusiastic about online 
health information regarding their own health condition [4][5]. Previous studies have 
suggested that older people use the Internet the least due to many determinants such as 
age, physical limitation, education, social economic situation and social situation [6]. 
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Proper accessibility of online information related to health is a necessity for individuals 
who seek out health-related information due to their physical conditions. 
Meanwhile, the World Wide Web Consortium (W3C) have designed the Web 
Content Accessibility Guidelines (WCAG) in collaboration with international figures 
and institutions to create international general standard of web accessibility that is 
suitable with any institutions, public and governments [7]. The guidelines have targeted 
web developers, web authoring tool developers, web accessibility evaluation tool 
developers, and others (individuals, decision makers, administrators, scholars. etc.) [7]. 
WCAG 2.0 has been approved as an ISO standard (ISO/IEC 40500:2012). WCAG2.0 
encompasses web pages, web applications, mobile device applications, phones and 
tablets, digital TVs, wearables, devices in car dashboards and airplane seatbacks, 
household equipment, and other Internet of Things (IoT) [7], [8]. WCAG 2.0 have four 
accessibility principles: perceivable, operable, understandable, and robust, which must 
be fulfilled to avoid violations [9]. These principles have their own success criteria that 
determine the type and number of violations. The perceivable principle has 22 success 
criteria, the operable principle has 20, the understandable principle has 17, and the 
robust principle has 2. The UN prioritized web accessibility in resolution 61/106, and 
the standards have been implemented in their system [10]. With the resolution, access 
to information and communication technology have become basic human rights [11]. 
WCAG2.0 of W3C  are the only internationally recognized standards [10]. Therefore 
some countries have ratified the standards following this UN recognition [12], [13]. 
This study aims to evaluate the effectiveness of the implementation of WCAG 2.0 
in country with and without policy implementation. The study compared country that 
adopt the WCAG 2.0 standard in health information provision with the one that do not 
adopt the WCAG 2.0 standard to study the particularly of policy implementation on 
Alzheimer Disease (AD). To reach the aim, the study addressed two research questions 
(1) What is the level of web accessibility of AD-related information online both in the 
UK and Indonesia? (2) What are the similarities or differences in the information 
available online for AD between the two countries, one with a policy of accessibility 
(UK) and one without (Indonesia)? 
2. Materials and Methods 
Two countries were chosen for this case study. The United Kingdom was chosen for 
being a country that has adopted the WCAG2.0 standard [13], [14], and Indonesia was 
selected as a country that has not adopted the WCAG 2.0 standard. The selected 
countries were chosen also based on the first author language capacity. In addition, the 
idea to measure the difference have become consideration to choose the countries that 
are very contrasting based on their economy level besides the policy adoption.  Web 
selection was based on the inclusion criteria of local language content: Bahasa 
Indonesia for Indonesia and English for the UK. It is important to note that the same 
word “Alzheimer” is used in both local languages to refer to AD [15]. The first ten 
websites from each country were picked based on their rank on the Google search 
engine list. The method for selecting the first ten websites has been previously used 
[16]. Google was first set up to the country-specific language, and a search was 
performed using the keyword “Alzheimer”, due to its high frequent used among 
individuals searching for information related to AD [9], and it is known that AD affects 
cognition and memory [17], as consequences better accessibility of online information 
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is required. Among the obtained results, the website should be in a webpage format, 
and information from the same source will be excluded. The websites should have 
content related to AD, and the websites should not be from a journal publisher, 
university, or scientific research institution with the reason they are usually for 
academic community. 
Website evaluations were performed for ten public online health information pages 
using the WCAG 2.0 evaluation tool recommended by W3C “Axe” [14]. In addition, 
Axe tool evaluate the website compliance to WCAG 2.0 with respect  to WAI-ARIA 
(Web Accessibility Initiative-Accessible Rich Internet Application) 1.0 that is for 
assistive technology such as screen reader [18].  Based on the number of violations 
found, the website was assigned to one of four levels: low (0–20 violations), medium 
(21–50 violations), high (51–100 violations), and very high (above 100 violations). The 
term of violation means the unfulfilled WCAG2.0 criteria for accessibility for all.  
Statistical analysis was carried out using SPSS version 25. Descriptive and Mann-
Whitney U tests were used to measure the differences between the two countries with 
and without WCAG 2.0. 
3. Results 
Entering the keyword “Alzheimer” for Indonesia and UK searches yielded 153,000,000 
and 232,000,000 results, respectively. Using Axe tool analysis on the 20 websites (10 
per country search), 17 types of violations were found. These were the violations 
found: (1) ARIA roles used must conform to valid values, (2) Elements must only use 
allowed ARIA attributes, (3) hidden ARIA element must not contain focusable 
elements, (4) Certain ARIA roles must contain particular children, (5) ARIA attributes 
must conform to valid values, (6) Buttons must have discernible text, (7) Element must 
have sufficient color contrast, (8) IDs used in ARIA and labels must unique, (9) ID 
attribute values must be unique, (10) Frames must have title attribute, (11) Html must 
have language attribute,(12) Image must have alternate text, (13) Form elements must 
have labels, (14) Links must have discernible text,(15) “ul” and “ol” must only directly 
contain li, script or template elements (16) Zooming and scaling must not be disabled, 
and (17) Timed refresh must not exist. Most website violations in the UK-specific 
search were under the low level category, whereas none of the violations in the 
Indonesia-specific search were of low level. Most of the tested websites in the 
Indonesia-specific search were found to have medium-level violations. 
In addition, the 20 selected websites could be categorized into four types: non-
government organization (NGO) websites (n = 5), medical related company websites (n 
= 4), newspaper-type websites (n = 10), and government agency websites (n = 1) 
(Figure 1 below). 
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Figure 1. Violation Occurrences Based on Website Type 
NGO and government websites in the UK showed good compliance. Newspaper-
type websites were the most common type of website for both countries. In the UK, 
two of the six newspaper-type websites with AD information showed good compliance 
with the standard and two showed a very high level of violation. On the other hand, all 
four online news websites in Indonesia showed medium-level violations. 
The Mann-Whitney test revealed no significant differences between countries with 
and without WCAG 2.0 standard implementation. In addition, the most dominant type 
of violations found for both countries was “element must have sufficient color contrast” 
and “links must have discernible text.” Furthermore, “ID attribute value must be unique” 
was the third most violated standard in UK webpages while “image must have alternate 
text” was the third most violated standard in Indonesian webpages. A similar result was 
found when comparing newspaper-type websites and other website types. 
4. Discussion 
Implementing web accessibility policy globally continues to be a challenge. Despite 
national regulations, for example the United States Section 508 regulations requires 
every government agency to comply with web accessibility, accessibility problems 
persist [19]. In addition, the WCAG 2.0 policy has no impact outside government 
agencies [20]. Even within the municipal government, there are many issues such as 
national support and close collaboration across local administrators and external parties, 
citizen and other rules [21]. For example, although in the UK better accessibility was 
on the health administration agencies, only NGOs have slightly implemented better 
accessibility. Meanwhile, online newspapers were found to be the worst online channel 
in terms of adopting the WCAG2.0 standard. 
The complexity in deploying WCAG 2.0 is elaborate, e.g., lack of law 
enforcement, no report or certification of WCAG 2.0 compliance, limited resources, 
policy content, lack of responsibility, and unclear guidelines from the department that 
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released the regulation [21], [19], [20]. The study revealed that the most common 
mistakes that should be easy to be understood, such as alternate text and color contrast 
in webpages still exist means whether web developers have reluctancy to comply or 
excessive working load with short time due to particular business characteristic. 
Another factor that might influence the evaluation is the richness of website 
content. It is known that the richer of the website content the more potential violation 
might exist. 
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Abstract. The IMIA History project book we are co-editing with colleagues from 
the IMIA History Working Group includes histories of early contributions to 
medical and healthcare informatics, as described by a sample of pioneers and experts, 
detailing how their own ideas developed from their work on various topics in the 
field at the beginnings of their contributions to the field.  Its contents serve as a 
preliminary guide for meta-analyses of how the different contributors state their 
personal interdisciplinary origins from today’s perspectives. In this short article we 
provide a brief preview of how an analysis of disciplinary characteristics from 
individual histories can begin to shed light on processes of interdisciplinary 
evolution of medical informatics in Europe. 
Keywords. Interdisciplinarity, History, Medical and Healthcare Informatics 
1. Introduction 
The history of science illustrates how the development of different disciplines and 
domains of study has almost invariably given rise to various “boundary sciences” or 
interdisciplinary fields in order to deal with problems through new approaches that draw 
from methods and threads of inquiry and experimentation from several existing 
disciplines. Such inter-weavings usually prove to be quite productive, yielding 
interesting new scientific discoveries or important technological and practical advances. 
A web of inter-relations between various domains frequently takes place, revealing 
sometimes-unforeseen links between apparently unrelated fields.  
Usually, the very name of a new interdisciplinary domain tells us about its origin, 
specifying the “parent domains” whose intersection or blending has created the new 
discipline, as in biochemistry, psychopharmacology, and bioinformatics, among many 
others. This is also the case with medical informatics, which results from the intersection 
and interweaving of two very large fields of practice and study – medicine (relying on 
the biomedical and life sciences applied to healthcare) and informatics (relying on 
computer and mathematical sciences applied to information technology). Its name 
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reflects its nature as an interdisciplinary field, or, as van Bemmel stated: “medical 
informatics is interdisciplinary avant-la lettre” [1].  
Studies on interdisciplinarity analyze various aspects of the links between concepts, 
knowledge and data structures or methods involved in the rise of a new domain. Such 
meta-analyses require a study and insight into the origins of the connections, which are 
not always presented clearly enough in the literature largely produced by authors from 
the existing disciplines. An incursion into a domain's history can cast some rays of light, 
revealing the roots of subsequent studies, which had strong follow-up and became 
substantive subfields of the new field.  
2. Materials and Methods 
We have recently carried out such a study, examining the roots of interdisciplinarity in 
medical informatics [3,4], based on 54 stories from European scientists who started their 
careers before 1980, or the early stage in medical informatics history, and which has been 
called its “pioneering period” [5]. The breakdown by length of experience in the field as 
measured from their year of university graduation consisted of 14 from 1960 and earlier, 
20 from the 1961-1970 period, and 20 from 1970 to 1980. By gender, 48 were male and 
6 were female. 
We were interested in analyzing this date to uncover relations between the first 
professional background discipline of a pioneering investigator, through their 
professional affiliation, type of occupation or professional milieu within which the early 
medical informatics topics were approached (academic/university, healthcare 
organization, industry, other institution) and the medical informatics topics or 
approaches, both initial and subsequently developed.  
3. Results 
3.1. Professional Origins 
Our study showed that 48 or about 81% of this sample of European pioneers in medical 
informatics had some kind of background involving technology or the exact sciences 
while 27 or 50% had backgrounds in medicine or the life sciences; with an overlap of 
30% representing those who had a double specialization. Among the scientific or 
technical backgrounds, the most common were mathematics/statistics (19 persons), 
physics (13 total, but 10 of whom also had mathematics/statistics backgrounds also) and 
engineering (14 of which 7 involved computer science) but also chemistry/biochemistry 
(4) and biophysics (4). The biomedical profiles were predominantly in traditional 
medical specialties (20), while other fields included nursing (2), public 
health/epidemiology (2), dentistry (1) and psychology (1). 
A obvious question that arises from this distribution of backgrounds is: “why is there 
such a high percentage of those coming from scientific and technical fields?” One might 
speculate that this might arise from an asymmetry that is observed in most 
interdisciplinary domains, including medical informatics, where one field  provides the 
object of study (in this case biomedicine), while the others provide methods of analysis 
and interpretation (informatics). It has often been observed that those working in 
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information technology as researchers and scientists were able to foresee the great 
potential of computing technologies for various applications before the application-
domain specialists come to fully realize and embrace it. The altruistic goals of medicine 
and nursing, and the desire to uncover the mysteries of life have led to a proliferation of 
several interdisciplinary fields, including medical informatics. Multidisciplinary teams 
have arisen, bringing together specialists from various fields trying to solve the complex 
problems that cross the boundaries between the more formal analytic disciplines, new 
technologies, and the field of medical and healthcare practices. But, to support effective 
collaboration and integration, specialization in a single domain is rarely enough. It is not 
a surprise that many researchers have felt the need for a double specialization. This has 
happened in  both directions –  medical and healthcare practitioners involving themselves 
in informatics and/or mathematics/statistics, while  mathematicians, statisticians, 
engineers and computer scientists have in turn focused on biomedicine.  
3.2. Occupational Backgrounds and Experiences 
Most early medical informatics practitioners in our European sample (over 75%) were 
mainly academics who started their work within various departments of universities, with 
over 20% of them being from university hospitals; while others came from industry, non-
academic hospitals or public health or research units.  
It is interesting to note that we have found a large number (over 25%) involved in 
governmental activities or pan-European organizations. Indeed, the potential of 
information technology to be part of the process of improving healthcare activities often 
appear to have drawn the attention of official or governmental institutions (ministries or 
other healthcare authorities) from the earliest days of medical informatics. 
The most frequent research activities involved coordinating or participating in 
various projects or acting as experts. Given the preponderance of academic affiliations, 
education and training was omnipresent, contributing significantly to the development 
of the field. 
3.3. Subfields and Topics 
One of the most interesting aspects of this first overview study drawing on histories of 
how experts developed their interests and contributions to the field has to do with the 
evolution of key problems addressed or topics defined: how the ideas evolved, what 
challenges presented themselves, and how they were overcome. Such inquiries are 
important since they better disclose the essence of those connections which motivate and 
build the effective interdependences and webs of interdisciplinarity. One can understand 
interdisciplinarity more fully as going beyond being just the passive application of 
methods from one field in a study to answer a direct question about some concept or 
object from another field. A simple statistical analysis of some clinical data can hardly 
be considered an interdisciplinary study. The substance of interdisciplinarity is a bilateral 
relationship between people from different disciplines who actively work together to ask 
new types of questions, with the goal of uncovering new features of a subject or object 
of study which can drive the development of new methods in order to reach a deeper 
understanding of the phenomenon being investigated. Such an approach was highlighted 
earlier by van Bemmel in his detailed personal story [6], tracing the evolution of ideas in 
medical informatics as they changed over the course of his career. 
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In the present overview we use the four research challenge subfields or areas in 
medical informatics proposed by Kuhn et al. [6]: bioinformatics and systems biology, 
biomedical engineering and informatics, health informatics and individual healthcare, 
and public health informatics. As expected, since studies on bioinformatics and systems 
biology had barely started during the pre-1980 pioneering period we are examining, they 
represented only 5% in our sample, while studies on health informatics and individual 
healthcare are most plentiful, representing almost 45% of the total during this period. 
Studies in biomedical engineering and those on public health informatics had almost 
equal shares of approximately 25%., representing the disciplines that existed before 
informatics came to be defined as a separate field in its own right. 
As discussed  by Altman and colleagues recently [8], these subfields or areas of 
medical informatics interconnect at several levels and it is sometimes difficult to place 
studies in one specific group vs. another; so we have developed a number of  criteria in 
order to do so, as discussed in more in detail in [3]. A better overall picture can be 
obtained by using a more granular, or refined breakdown of the areas or topics of study. 
The most frequently covered major topic out of a total of 65 was health information 
systems (28, or almost 20%), of which 14, or half, dealt with hospital information 
systems, with the others being clinical/laboratory or national information systems, The 
topic of data bases, most often associated with data processing or statistical analyses  
accounted for 15%, decision support systems including expert systems, AI and 
ontologies accounted for 10%, while electronic health records were the topic of another 
10%. Remaining topics involved  security and protection, standards and technological 
assessment, processing biological signals, medical imaging, modeling and simulation of 
pharmacological or biophysical phenomena, healthcare management and organizational 
impact, ethical issues and qualitative assessment studies, nursing informatics, clinical 
guidelines and telemedicine.  Each were covered by a relatively small percentage of the 
persons involved in this sample from the early period of medical informatics research in 
Europe. 
4. Discussion 
Our study is preliminary, yielding just initial quantitative results, which, nevertheless 
point to how we can proceed with further more detailed follow-up studies. An important 
consideration is that personal narratives in free style do not lend themselves to the 
extraction of very precise data. Secondly, the professional backgrounds considered are 
very general and based on academic degrees or specializations, which does not 
characterize the important group of self-taught people, especially those who were self-
instructed in the use of computers, which makes actual numbers of those with double 
specializations likely to be even higher than what is reported here. Since the boundaries 
between topics are not crisply defined; with some types of investigations distributed over 
several topics, the assignment of a study to a topic is not straightforward. Nevertheless, 
despite these limitations, the overall results are already quite suggestive about the 
patterns of backgrounds and interests of individuals, and their intertwinings, and 
correspond to the experiences of the authors in what they have observed over the years. 
Some topics have persisted over time, remaining most relevant, or “hot”, either due 
to their generality, complexity and potential impact (artificial intelligence applications, 
the digital patient) or strongly determined by “external factors” (large healthcare 
information systems, requiring socio-economic and political involvement), or both (EHR 
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systems). Some topics have faded – such as biological signal analysis, where research 
has mostly migrated to specialized biomedical disciplines, or, once mature, to 
industrial/commercial development. Beyond the period covered by this analysis, totally 
new topics have arisen – having mostly to do with the internet, social media, privacy and 
security, patient empowerment, big data and, most recently, data science. These, while 
building on earlier methodologies and studies of the social impact of computers and 
information, have to confront completely new challenges of scale, complexity, and 
density of interactions in the evolving human-machine ecologies of today. 
5. Conclusion 
We can see from the histories or essays submitted to the IMIA history book that they 
give the reader selected glimpses of individual professional studies, investigations, and 
practices,  which, taken together, allows us to begin to begin to discern a map for tracing 
the ideas and practices of medical informatics history. A thorough analysis of the stories 
specific to various periods in medical informatics history, which will require careful 
definition and study, would yield a dynamic map representing “medical informatics in 
evolution” – a necessary enterprise which looks forward to more complete investigations 
and the involvement of new generations of biomedical and health informatics 
professionals. 
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Abstract. General Data Protection Regulation came into effect across the European 
Union in May 2018 but its implications in healthcare are yet to be fully understood. 
The aim of this study was to identify the fronts and hot topics in research on GDPR 
in healthcare. We analyzed the relevant records in Scopus through bibliometric and 
scientometric approach and visualization techniques. A set of 155 records was 
obtained and processed for co-occurrence analysis of key terms and concept 
mapping. The number of published papers showed a steep rise in the past two years, 
mainly by European countries. Analysis of the abstract of the papers showed that 
data protection, privacy, and big data were the most frequently used terms. Three 
dominant research fronts of GDPR are 1) general implications of GDPR, 2) 
technology aspects of GDPR, and 3) GDPR in healthcare service. Blockchain and 
machine learning are among the remerging topics of GDPR research. 
Keywords. GDPR, General Data Protection Regulation, bibliometrics, 
scientometrics 
1. Introduction 
With the proliferation of invasive digital technologies and the emergence of data-
exploiting business practices, it is increasingly difficult for individuals to maintain 
control over their own personal data. Consequently, this issue of control over personal 
data has become a significant subject in European privacy law. Compared to earlier 
regulations, the General Data Protection Regulation (GDPR) explicitly addresses the 
rights of individuals concerning this issue [1]. This means that organizations are no 
longer able to use individuals’ personal data without their consent. GDPR dictates that 
entities collecting and processing data related to European Union (EU) residents adhere 
to GDPR articles regardless of where these entities are located, or where the data is stored. 
GDPR compliance support the protection of privacy at various levels. Healthcare data 
breaches not only can affect substantial adverse personal and social impacts on patients, 
but also suffer a huge cost [2]. Most notably for the healthcare community, GDPR 
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explicitly introduces regulations for “data concerning health”, “genetic data”, and 
“biometric data” [3]. 
In spite of the fact that GDPR is a recently developed legal instrument, there have 
been many research studies on GDPR since its adoption in 2016, such as [4; 5]. Thus, it 
is important to identify and monitor the research fronts and trends relating to GDPR for 
better understanding and integration of this regulation with other security, privacy, and 
technological policies. Research fronts refer to the most dynamic research areas in 
science and technology that attract the most scientific interest [6] and are the body of 
articles that researchers actively cite in a short time span [7]. One main characteristic of 
emerging research fronts is high citation in a short time interval. The objective of 
distinguishing hot topics within a research front is to identify significant insights that are 
likely to determine the future direction of research. This study aimed to establish a GDPR 
research agenda by identifying the current trends, emerging research fronts, and hot 
topics in research on GDPR in healthcare using a bibliometric analysis approach. 
2. Methods 
We conducted a bibliometric and scientometric analysis of the papers that have discussed 
GDPR in healthcare. The data were obtained through an electronic search of Scopus 
database in October 2019. No limit on year of publication or language was imposed. The 
results of the electronic search were exported and loaded into Bibliometrix package for 
R v.3.6.1 and VOSviewer v.1.6.13 for bibliometric and scientometric analyses and 
visualization. [8; 9]. Research fronts and hot topics were identified by concept mapping 
of the abstracts as well as co-occurrence analysis of the keywords of each record. We 
used co-occurrence analysis of keywords to extract the topics of research and find the 
links between these topics directly from the content of abstracts. Sankey diagram was 
used to visualize the main items of three fields (i.e. Country, Keywords, Year), and how 
they are related. 
3. Results 
The first paper on GDPR in healthcare has published in 2012 and the number of 
publications was less than 10 per year until 2017, when it shows a radical increase up to 
76 papers in 2018 (the year that GDPR was enacted). Germany has published the highest 
number of papers, followed by the UK and the Netherlands (Figure 1).  
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Figure 1. Countries with more than two papers based on the corresponding author’s 
address. (MCP:  Multiple-country publication; SCP: Single-country publication) 
 
A three-field Plot (Sankey diagram) of Country, Keyword, and Year of publication 
of the cited references was created to depict the proportion of research topics for each 
country and the recency of the papers that they cited. As shown in Figure 2, the main 
interests of GDPR researchers in France are big data and data protection. The dominant 
topic of research in the Netherlands is privacy. Most of the papers that discussed consent 
have published by Ireland, the Netherlands, and the UK. Research on GDPR and 
Blockchain, though are few in numbers, are mainly published by USA, Norway, UK, 
and Netherlands. 
 
 
Figure 2. A three-field Plot (Sankey diagram) of Country, Keyword, and Year of 
publication of the cited references for the ten most researched topics.  
 
The co-occurrence map of the most frequently used terms in the abstract of the 
papers was created to reveal the link between the terms and visualize the main clusters 
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of the terms (Figure 3). This map unearthed and visualized three main clusters, namely,
legal, technical, and health clusters. 
 
Figure 3. Co-occurrence map of the key terms in Discussion and Conclusions 
 
 
 
4. Discussion and conclusions 
The enforcement of the GDPR in organizations has dictated the need to comply with 
GDPR obligations and requirements. As evident in a recent case where a hospital in 
Portugal was fined €400,000 for non-compliance, healthcare organizations in particular 
have to be GDPR compliant in order to avoid sanctions, as supervisory authorities 
impose sanctions whenever non-compliance is detected [10]. In this study, we identified 
hot topics and emerging research fronts of GDPR in healthcare. We used keywords, titles, 
and abstracts of 155 papers that made up our research sample. Our analysis revealed the 
main topics, their relevant weight in the extant literature, as well as the dominant 
university affiliations of the authors studying each topic (Figures 1,2). 
Moreover, based on a co-occurrence analysis and its subsequent visualization and 
interpretation (Figure 3), we identified three clusters as emerging fronts in this stream of 
research, and the terms included in the clusters as hot topics. Table 1 summarizes these 
research fronts. 
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Table 1. Research fronts and hot topics in GDPR research  
Cluster  
(Color in Figure 3) Research Front Hot Topics 
Cluster 1: Legal  
(Red) 
General 
Implications of 
GDPR 
Personal Data, Legal Aspects, Data Protection, Data 
Subject, Data Subject Rights, Data Access, Genetic Data, 
and Context-Specific Applications 
Cluster 2: Technical 
(Green) 
Technology 
Aspects of GDPR 
Information Systems, Technology Solutions, Risks, 
Security, Controls, Timeliness of Data 
Cluster 3: Health 
(Blue) 
GDPR in 
Healthcare 
Practice 
Patient, Patient Consent, Hospital Implementation, Health 
Data, Data Quality, and Use of Data 
 
Prior evidence tells us that these dynamic research areas that create the greatest 
interest among the scientific community tend to be the most promising in terms of 
generating highly cited research, creating attitudinal change among researchers, 
challenging existing orthodoxies, anticipating possible paradigm shifts, attracting 
institutional funding, and enhancing the business value of the outcomes [4].  
Researchers interested in data protection in healthcare can use our findings to plan 
for studies on the identified hot topics by observing the research trends, as well as 
research gaps in this domain. Likewise, journal editorial boards can benchmark their 
respective journals against these findings and introduce policies for publishing research 
on the increasingly important topic of personal health data protection. We believe Figure 
2, in particular, reveals several opportunities for proposing special issues on important 
yet understudied topics, such as implications of GDPR for machine learning, Blockchain 
applications in healthcare, and ethics of collecting and processing personal health data. 
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Abstract. Improvements in artificial intelligence and machine learning combined 
with the availability and exponential growth in individual and population health 
data offer opportunities for innovative patient/citizen-centered eHealth solutions. 
However, this confluence of social, technical, and economic interests can result in 
the privatization of control of patient data and contribute to widening inequity in 
access to healthcare. This paper explores these issues and advocates for a more 
equitable approach to advances in health big data for patients and citizens. 
Keywords. Health disparities, big data, eHealth, health equity, digital divide, 
artificial intelligence, patient-centered 
1.Introduction 
Recent developments in artificial intelligence (AI) and machine learning (ML) have 
combined with the availability of and exponential growth in individual and population 
health data to offer opportunities for new and innovative patient-centered eHealth 
applications [1] eHealth has been defined as “the cost-effective and secure use of 
information technologies (ICT) in support of health and health related fields [2]” 
mHealth may be seen as the use of mobile devices for medical and public health 
purposes [3]. This convergence has many positives, including strengthening the 
patients’ voice by enabling them to share data both with one another and with health 
professionals, which enables being more active participants in their own care [4]. 
Simultaneously, the health information technology (HIT) industry views health big 
data and patient-generated health data (PGHD) as an opportunity to generate value 
through the commodification of personal and population to generate value through the 
commodification of personal and population data aggregation, mining and exploitation. 
Opportunities for HIT to benefit from smart sensors, applications, and services abound 
as AI automates “datafication of health” [5], problematizes individual de-identification 
[6], and contributes to erosion of trust in health data sharing [7]. 
The capacity of the private sector to exert ever greater control over this big fata 
aided by advances in AI and ML is little understood by individuals and policy-makers. 
It is evident that data commodification is occurring in ways that raise social, ethical, 
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and moral questions [8] and debate about value and benefit [9]. Failure to appreciate 
the implications of these technologies on health data hampers discussions about data 
privacy, data ownership, and consent for access and use of personal data. Given the 
pace of technological change, it is unsurprising that legal and policy frameworks, as 
well as mechanisms for their enforcement, remain inadequate. Technology-agnostic 
responses that meaningfully address data ownership, data protection, data retention and 
transmission, and data control processes are limited in scale and scope [10]. 
These socio-technical and economic developments may widen existing disparities 
in healthcare access between empowered and disempowered individuals and groups in 
healthcare access between empowered and disempowered individuals and groups [11]. 
Regardless of benefits that may arrue to some people, others are further marginalized. 
Many people lack the technical, health and genetic literacy to benefit from 
opportunities driven by big data and related patient-centered care models [12]. This 
paper explores these issues and advocates for a more equitable approach.  
2.Background 
Public and private health sector agencies are increasingly reliant on digital platforms 
for service delivery. These platforms are themselves become increasingly complex as 
AI, ML, and the Internet of Things (IoT) become embedded in HIT [13]. In 
combination, these developments mask the very real challenges that many individuals 
and groups face in accessing, using and benefiting from eHealth [14-16]. 
The General Data Protection Regulation (GDPR) provides for the protection of 
natural persons with respect to the processing of personal data and its free movement 
[17]. It applies to personal data relating to an identifiable person who can be identified 
in particular by reference to an identifier [18], such as those seeking health services.  
Many patients find it challenging to understand how data held on them within 
eHealth systems is being managed, controlled, and valued. While many citizens believe 
that they own their data, numerous health entities – providers, institutions, HIT vendors, 
and third parties – may also claim ownership [19]. Although many patients may not 
own their electronic health record (EHR) [3], they should have to consent to its use and 
have access to it, as the GDPR provides for same [17]. Even when patients perceive 
that ownership of a digital device may support their claim to data ownership, others 
still may control and monetize that data [20], such as via control of PGHD that is 
accessible by device manufacturers, app developers, and third-party trackers [21].  
In this context the eHealth inverse care law (the potential for meaningful use of 
appropriate eHealth is inversely proportional to the needs/capacities of the individual or 
population served) and equity gap become most evident [22]. Socially disadvantaged 
people are already known to be disproportionately affected by consent issues, and this 
is even more problematic in eHealth domain [23]. In the EU, however, such consent 
must be specific and informed, should cover all processing purposes [18] and requires a 
positive opt in [17]. Special category or certain sensitive data may be afforded more 
protection, e.g., in the healthcare context, genetics, biometrics, health, sex life, or 
sexual orientation [3], [17], [18]. Given that the GDPR is seen as more comprehensive 
than other such laws, including those addressing such issues in the United States, the 
GDPR provides for data protection in the context of international transfers where that is 
not deemed to be appropriate safeguards in those countries [17], [18]. Many digital 
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apps require high levels of technical and health literacy [24] , which widens disparities 
within the eHealth ecosystems [25].  
3. Data Sharing and Challenges for Patients and Citizens  
There are huge opportunities and benefits associated with deployment of AI and ML 
into eHealth. However, the health care system needs a better understanding of how new 
technologies are best deployed. Equity, not equality, should guide roll-out and use. 
Patient-focused eHealth technologies typically aim to obtain consent for data 
sharing in a “one-size fits all” approach that provides the same options to all users of 
the system. However, users have differing needs, experience, and skills, and few may 
experience equivalent risks when agreeing to secondary use of their data. Socially 
disadvantaged people are likely to be disadvantaged as users and sharers of personal 
health information, including PGHD. 
The asymmetry of costs and benefits regarding data sharing has multiple aspects 
and, potentially, numerous adverse effects on health outcomes and quality of life. 
People with lower socioeconomic status may be less able to reap the benefits of 
treatments and products developed using PGHD shared by themselves and others. They 
may be unable to pay for care or medications, or may lack transportation to clinical 
sites where advanced treatments are available, or have greater difficulty understanding 
consent forms and digital products’ “Terms of Service,” and thus be at a disadvantage 
in making informed decisions and in advocating for themselves. Such asymmetry also 
may result in skewed research results affecting populations. For example, those with 
more education report greater willingness to sign up for biobank research [26-27], that 
may result in development of inaccurate clinical guidelines and ineffective policy-
making that further extend eHealth inequities. The GDPR can provide some protections 
for covered individuals. 
People who have uncommon traits may be identifiable if certain other pieces of 
information (e.g., birthdate, postal code) are known or can be located using public 
databases [28]. Even without the intent to share data without consent, the recurrence of 
data breaches leaves individuals exposed [29].  
At the same time, individuals who have a high expectation of benefiting from 
research in which they participate will provide broad consent for use of their data in 
research without knowing exactly what that research will address [30]. Some expect 
min-health-specific benefits, such as improved patient-clinician communication [31], 
or view data sharing as a way to access better more personal information and care [32]. 
However, expectations of benefits cannot be guaranteed, and may contribute to the 
growing mistrust of healthcare organisations, clinicians, and the eHealth system. 
Although the GDPR provides some protections for secondary data use and the need for 
specific and informed consent, those who seek to benefit from such research may well 
interpret such protections broadly, such as contending that further processing of such 
data for specific scientific purposes is compatible with lawful processing operations.   
4.Improving Use of Health Big Data for All Patients 
Equity is about fairness. AI and ML have the potential to deliver precision medicine 
where “n equals you.” It is thus reasonable to require equity as a design principle for 
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new eHealth products and services so that patients and citizens can easily understand 
the benefits, value, and control of data manipulated by new tools and consented to their 
use when alone or in interaction with clinicians [33]. To reduce barriers, developers of 
mHealth apps, creators of health IT, policy-makers and researchers should consider 
citizens’ psycho-social and economic contexts when using eHealth and avoid design 
that could compound disadvantage, bias, and inability to access resources.  
5.Conclusion 
This paper has highlighted how advances in AI and ML in eHealth may contribute to 
the privatization of control over patient data in ways contributing to widening inequity 
in access to healthcare. The paper has advocated for a more equitable and informed 
approach to emerging advances in health big data for all citizens. 
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Abstract. Modern research projects in healthcare research and medical research are 
oftentimes multi-centered, multi-disciplinary, and conducted by a consortium of 
multiple collaborators. Increasingly, the resulting data emanating emerging from 
different primary and secondary sources is linked on a personal level. The General 
Data Protection Regulation regulates many fundamental processes in such research 
projects. Despite the regulatory framework given, it can happen that a collaborator 
does not handle data properly. We propose a systematic risk management for the 
handling of data as well as a systematic error management.  
Keywords. privacy, risk management, organization and administration, legislation 
and jurisprudence 
1. Introduction 
Benefiting from healthcare research, modern health information technologies can reduce 
human errors, improve safety, and thus refine the treatment provided to patients [1]. 
Aside from occurring during the delivery of care, human errors also ensue within 
healthcare research [2], inter alia when sensible data is processed in study projects. A 
common type of errors are data breaches when proprietary data is disclosed to an 
unauthorized viewer [3]. While this is not an immediate thread to most patients, the 
implications can be severe as well; sensible information mandates adequate handling [4]. 
Networked Healthcare research projects are conducted by a consortium of multiple 
collaborators. The data results from various primary and secondary sources and is linked 
on a personal level which opposes complete anonymization [5]. The handling of data 
relatable to a natural person is regulated by the General Data Protection Regulation 
(GDPR) [6]. The GDPR requires an effective risk management in the form of a Data 
Protection Impact Assessment (Article 34, GDPR [6]) and appropriate technical and 
organizational measures (Article 25 (1), GDPR [6]). 
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However, when working as a trusted third party in networked research projects, we 
frequently encounter situations in which proprietary data are not handled adequately. 
One collaborator sent Patient IDs to the wrong collaborator, another revealed a password 
in email conversations, and hospitals shared medical information together with 
identifying data. Many researchers seem to be insecure when handling data breaches that 
are caused by human errors. Contrary to breaches arising from cyber-attacks, theft, loss 
or data leaks, these are understood to be ultimately inescapable [1,7]. In the case that an 
error leads to a data breach, a systematic risk- and error management with appropriate 
counteractions is necessary. 
Despite the regulatory framework given by the GDPR, there is no easy-to-use risk 
and error management framework to systematically aid researchers in the event of a data-
breach.  We provide an abstract case example, from which we start to discuss methods 
and strategies that can be used to avoid, and if necessary, address risks or errors occurring 
in healthcare research projects.  
2. Method 
 
Figure 1: Data linkage process and data flow for the exemplary study design 
 
We suggest tools to handle and prevent data breaches in health research projects when 
applying the current legislation regarding the GDPR in Germany [8]. Based on a generic 
study design, we discuss human errors and the compulsory risk management.  
The exemplary research design is used to send two datasets collected by different 
collaborators via a trusted third party (TTP) to a third collaborator that evaluates the data. 
The TTP employs some method of data linkage to allow for the analysis of two medical 
datasets from two different sources (c.f. Fig.1). The datasets will be linked on patient-
level through the pseudonymization of a project-wide, unique ID. This unique identifier 
could, for instance, be a case number identifying individual patients across datasets. The 
data is locally preprocessed with a software that encrypts only the medical data, not the 
ID. All processed datasets are then send to the TTP, which exchanges the ID for a new 
random pseudonym using a software that locally stores related IDs and pseudonyms. All 
data is then delivered to a data analyst as a file that contains data in a table-based structure. 
After decryption, each row contains medical data under the given pseudonym for analysis.  
Human-induced data breaches in this context can happen during processing, data 
linkage, transmission or evaluation. One can discriminate three types of errors leading to 
a data breach event. Data can be (1) directly compromised (e. g. a screenshot of sensitive 
data in an email or data sent to an unauthorized person), (2) indirectly compromised (e. g. 
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not sufficiently pseudonymized) or (3) compromised due to misuse of technology (e. g. 
the wrong column in a dataset is pseudonymized). 
For the assessment and handling of data breaches in such networked research, there are 
various laws to be considered. Aside from the GDPR, the BDSG, defines specific 
regulation for Germany. Processing of medical data for the purpose of research in both 
regulatory frameworks (Article 5, Article 9,  GDPR [6]) and the BDSG(§22, §27,  BDSG 
[8]). The GDPR requires a data protection impact assessment for data that could cause 
high risk to freedoms or rights of a natural person, and offers a minimum structure for 
such (Article 35 (1), (7), GDPR [6]). It is mandatory to employ data protection by design 
and by default similar to the Privacy by Design concept suggested by Cavoukian et al. 
[9]. The data controller (Article 4 (7), GDPR [6]) has to implement appropriate technical 
and organizational measures (Article 25 (1), GDPR [6]). Thus, the compromization of 
critical data requires the data controller to notify the responsible supervisory authority 
and affected persons within a determined period of time (Article 33, Article 34, Recital 
85-88, GDPR [6]; §29, BDSG [8]).  
Considering the GDPR, human errors have to be addressed on three levels; it is 
necessary to (1) work with adequate technical and organizational measures, (2) employ 
a systematic risk management, and (3) use an effective error management strategy 
3. Results 
Technical and organizational measures should render errors as unlikely as possible. 
State-of-the-art encryption and transport-encryption of all data are an indispensable 
prerequisite. In the context of the given example study, data need to be integrated button-
up in the organizational design. Dataflow and software are usually designed with 
requirements engineering, so that it is –in theory– not possible to directly compromise 
data if software is used properly. Indirectly compromised data and the misuse of software 
have to also be addressed; the software in our example could check if the column 
containing the ID is not encrypted but the columns containing the medical data.  
Direct and indirect compromization need to be conceptually addressed on an 
organizational level. Checklists and standard operating procedures (SOP) are generic 
methods to support processes. Checklists specify a set of goals to be fulfilled giving the 
user a framework to handle a specific process. The design of a checklist is challenging; 
a checklist must take the needs of different stakeholders into consideration and requires 
a careful mixture of guidance and independence, as not to limit people in their 
opportunity to make reasonable decisions [10]. SOPs give a detailed list of 
proceduralsteps which must be fulfilled. SOPs can be used for fixed processes that are 
repeated multiple times. In the context of our examplary study, organizational measures 
would enhance and secure the project on working process level. SOPs would guide 
through the pseudonymization process, even when software is used. Another SOP would 
forbid workers revealing using the ID in email conversations. Checklists would offer the 
possibility to double check manually, whether the files have been processed according 
to the given framework conditions.  
 
For a systematic risk management we adopted the HIT risk management concept from 
the IMIA Working Group for Health Informatics for Patient Safety [11]. During Risk 
Assessment, the risk of data breaches is analyzed and evaluated, Risk Monitoring serves 
as the instrument to identify data breaches and Risk Control comprises all counter 
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measures to manage data breaches on an operational level. Hence, risk management for 
data breaches is an iterative process resulting in continuous enhancements (cf. Fig. 2). 
 
Figure 2: Systematic risk and error management of human-induced data breaches 
 
Each error leading to a data breach has to be analyzed and handled individually as part 
of an error management. On an operational level, we suggest to divide error management 
into three generic phases and a subset of generic subtasks. The process should start 
immediately after the breach was discovered (Recital 87, GDPR [6]). In a first step the 
circumstances of current data breach are identified. It is crucial to categorize the 
compromised data in order to evaluate the risk. The GPDR defines different types  of 
personal data into directly identifiable, pseudonymized, and anonymized [12]. In the 
second phase, the situation has to be evaluated in cooporation with the local data 
protection officer. The assessment of a risk for an affected person is the central process 
in handling data breaches. The target is to evaluate, if persons affected by the data breach 
will suffer a high risk in rights and freedom (Article 33 (1), GDPR [6]). If so, it induces 
a notification of the local authorities and the affected person. The notification should be 
made immediately and preferably within 72 hours (Article 33 (1), GDPR [6]). In the third 
phase, the actual data breach is handled by notifying authorities – if necessary – and 
isolating and deleting the compromised data. For the explicitprocedure, the local data 
protection directives need to be considered.  
What happens if the data analyst from our example received the full name of one 
participant and the respective ID when a data subject access request was handled? After 
identifying the data breach, she has to consult the local data protection officer to estimate 
the risk for the affected person. It is not mandatory to notify, when technical and 
organizational measures deny unauthorized persons access to the compromised data 
(Article 34 (3) (a), GDPR [6]). In our example this is the case, since the encryption denies 
the access to the medical data to any person except the data analyst; few people have 
access to the data and only the TTP can relate an ID to a natural person. Further, it is not 
obligatory to notify when the data leak will not result in a high risk to the rights and 
freedoms of data subjects (Article 34 (1), Article 34 (3) (a), GDPR [6]). If the data analyst 
analyzed the data breach, identified and isolated the compromised data, she can argue 
that the subsequent risk is low if the request containing name and ID is deleted (Article 
34 (3) (a), GDPR [6]). We recommend documenting the data breach precisely; a 
controller has to be able to demonstrate a minimum risk (Recital 85, GDPR [6]). The 
consequential systematical failure analysis will then lead to a revision of potential SOPs 
for the handling of data subject access requests. 
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4. Discussion and Conclusion 
Human-induced errors will always happen. We discovered the need for the development 
of adequate risk and error management in our everyday work. The framework of the 
GDPR gives room to interpretation and the legal space has yet to be embellished, which 
opposes easy handling of risks and errors. We developed a risk management concept and 
a protocol for error management giving guidance dealing with human induced errors and 
data breaches. Such a framework can prevent human-induced errors due to continuous 
learning and refined processes within distributed health care research projects. 
The premise of all measures taken to reduce the consequences of human error is 
maximum transparency. A culture which facilitates the reporting of data breaches, which 
is the ultimate prerequisite for effective risk and error management, has been 
consensually established in medicine within the past decade [13]. However, it has not 
been translated to healthcare research yet. Reliability, safety, quality, and human factors 
are well-established fields in applied medicine and healthcare but not been applied on 
the level of healthcare research. A reporting system like the Critical Incident Reporting 
System (CIRS) [14] could be used to anonymously collect data of incidents and almost 
occurred incidents in order to establish an error culture. This data would contribute to 
developing and enhancing tools for a systematic risk- and error management. 
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Abstract. In 2017, French institutions reformed their data access policy regarding 
the national insurance and administrative databases systems (French abbreviation: 
SNDS), including claims data from hospitalization discharge summaries for the 
entire population follow-up encompassing over 10 years. Our study aimed to 
quantitatively and qualitatively describe such authorization before and after the 
reform. We extracted data access demands for French National Health Data Institute 
(INDS) data before and after the reforms. We included only studies that needed data 
extracted from the SNDS database and authorization of the regulator. We inferred 
the number of projects accepted pre- and post-reform, and we describe the types of 
studies, their topics, and the types of data used. We included 802 data access 
demands between January 1st 2008 and September 21st 2019. The median of data 
access demands by year increased from 21.5 to 203. This increase was lower in the 
studies included insurance data (21.5 to 70). The evolution is driven by the activity 
of Private companies and contract-research organization. The number of studies on 
Hematology and oncology and internal medicine increased respectively by 1.7 and 
1.4 factors. Data access of claims data refers to the “accessible” dimension of the 
FAIR guiding principles. However, extrinsic factors influence the accessibility of 
claims data such as human factors (e.g. data scientist with experience in claims data) 
and economic factors (e.g. data infrastructure HIPAA and GDPR compliant). 
Keywords. Data Sharing, Policy, Administrative Claims 
1. Introduction 
Data sharing is a prerequisite for open innovation in health to produce reproducible 
research and to promote open science. Healthcare professionals and citizens need to be 
equipped to share data to facilitate scientific research and minimize the potential privacy 
threats[1].Since May 2018, data sharing, including that of European citizens’ personal 
data, as well as data processing in the European Union, has been subject to the General 
Data Protection Regulation (GDPR)[2]. The GDPR provides a legal framework for data 
reuse and offers a chance to standardize data protection practices in research, as well as 
opportunities for researchers in medical informatics to develop new models for 
information technology infrastructure[3]. In 2017, French institutions reformed their data 
access policy regarding the national insurance and administrative databases systems 
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(French abbreviation: SNDS), including claims data from hospitalization discharge 
summaries for the entire population follow-up encompassing over 10 years. Researchers 
with access to the SNDS are producing studies on various topics such as patient care 
pathways, pharmacoeconomics, and pharmacoepidemiology[4]. The French reform for 
data access to SNDS aimed to open insurance data to a wider research community, 
including public and private research labs. The research community hypothesized that 
enforcement of the GDPR has impacted this reform’s effects. However, to the best of 
our knowledge, no previous studies have described the 2017 reform’s impact on data 
access authorization with regard to the influence of the GDPR. Our study aimed to 
quantitatively and qualitatively describe such authorization before and after the reform. 
2. Method 
Data sources. We extracted data access demands for French National Health Data 
Institute (INDS) data before and after the reforms. The data used in this study are 
available at www.github.com/vlooten/datapolicy, while more recent data can be 
downloaded from the INDS website (www.indsante.fr). 
Inclusion criteria. We included only studies that needed data extracted from the 
SNDS database and authorization of the regulator. Projects that were resubmitted were 
counted only once (for the first submission). 
Data access policy. Before the reform, a national committee evaluated submitted 
projects, and an approval from the French Data Protection Authority (CNIL) was 
required (i.e., two authorizations were required). After the reform, all projects following 
the CNIL national guidelines required just one authorization from a national committee. 
This committee checked concordance between objectives and methods, and 
compatibility of the study objectives with the public interest. 
Outcomes and definitions. We inferred the number of projects accepted pre- (before 
August 1st 2018) and post-reform (after August 1st 2018), and we describe the type of 
investigator, the types of studies, their topics, and the types of data used. The type of 
investigators described were: (1) Government and agencies (2) Private companies and 
Contract-research organizations (3) Hospitals and care structures (4) Citizens and 
associations (5) Schools and research centers. The categories of the type of the studies 
were: (1) Descriptive and transversal studies (2) Longitudinal or prognosis studies (3) 
Pharmacoepidemiology, pharmacoeconomic studies (4) Economics studies (5) Other 
(included methodological and unclassified studies). The topics described were: (1) 
Cardiology and vascular medicine (2) Hematology and oncology (3) Internal medicine 
(4) Psychiatry and addictology (5) Public health and occupational medicine (6) Surgery 
(7) Primary cares and (8) Other (included unclassified and unknown studies). The types 
of data described were: National data with or without insurance data. 
Statistical analyses. Data were expressed as number (%). Chi2 tests (for categorical 
data) was used to compare groups. All tests involved use of R 3.6.1(R Foundation, 
Vienna, Austria). 
3. Results 
We reviewed 2031 data access demands between January 1st 2008 and September 21st 
2019. We included 802 data access demands according to the inclusion criteria. Reasons 
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of exclusions were: no pairing with national administrative data (N=1146) data access 
rejected or canceled studies (N=41), renew data access authorization (N=32) and missing 
data (N=10). Years of data access demands were: 2019 (N=203), 2018 (N=257), 2017 
(N=74), 2016 (N=73), 2015 (N=61), 2014 (N=51), 2013 (N=24), 2012 (N=17), 2011 
(N=19), 2010 (N=15), 2009(N=6) and 2008 (N=2). The median number of data access 
demands by year increase from 21.5 to 203. Table 1 presents the characteristics of the 
data access demands. We observed a difference between the two groups for the type of 
investigator. The number of access of private companies increases from 26 (8.87%) to 
227 (44.6%), and school and research centers decreased from 98 (33.4%) to 59 (11.6%). 
We observed a change in the type of the studies with a reduction of 
Pharmacoepidemiology, pharmacoeconomic studies (from 100 (34.1%) to 99 (19.4%). 
The structure of the topics also changes. In particular, the number of Hematology and 
oncology studies increased from 27 (9.22%) to 81 (15.9%). 
 
Table 1. Description of the studies before and after the reform 
 Before the reform 
(N=293) 
After the reform 
(N=509) 
p value 
Insurance data 293 343 <0.001 
Investigator: 293 (100%) 343 (67.4%) <0.001 
Government and 
Agencies 
12 (4.10%) 27 (5.30%)  
Private companies and 
CRO 
26 (8.87%) 227 (44.6%)  
Hospitals and care 
structures 
125 (42.7%) 170 (33.4%)  
Citizens and 
associations 
32 (10.9%) 26 (5.11%)  
Schools and research 
centers 
98 (33.4%) 59 (11.6%)  
Type of study:   <0.001 
Descriptive and transver
sal studies 
48 (16.4%) 
 
91 (17.9%) 
 
 
Economics studies 22 (7.51%) 
 
47 (9.23%) 
 
 
Longitudinal or 
prognosis studies 
116 (39.6%) 
 
254 (49.9%) 
 
 
Pharmacoepidemiology, 
pharmacoeconomic 
studies 
100 (34.1%) 
 
99 (19.4%) 
 
 
Unknown 7 (2.39%) 
 
18 (3.54%) 
 
 
Topics:   <0.001 
Cardiology and vascular 
medicine 
29 (9.90%) 
 
51 (10.0%) 
 
 
Hematology and 
oncology 
27 (9.22%) 
 
81 (15.9%) 
 
 
Internal medicine 69 (23.5%) 
 
164 (32.2%) 
 
 
Public health and 
occupational medicine 
66 (22.5%) 
 
102 (20.0%) 
 
 
Psychiatry and 
addictology 
36 (12.3%) 
 
50 (9.82%) 
 
 
Surgery    
Primary cares 5 (0.98%) 12 (4.10%)  
Other 11 (3.75%) 20 (3.93%)  
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 Over the 802 studies included, only 636 required insurance data. In this subgroup, the 
median of data access demands by year increased from 21.5 to 70. Table 2 presents the 
characteristics of the data access demands of this subgroup. The difference observed 
between the two groups are similar. 
Table 2. Description of the studies included insurance data before and after the reform. 
 Before the reform 
(N=293) 
After the reform 
(N=343) 
p value 
Investigator:   <0.001 
Government and Agencies 12 (4.10%) 
 
24 (7.00%) 
 
 
Private companies and CRO 26 (8.87%) 
 
129 (37.6%) 
 
 
Hospitals and care structures 125 (42.7%) 
 
124 (36.2%) 
 
 
Citizens and associations 32 (10.9%) 
 
17 (4.96%) 
 
 
Schools and research centers 98 (33.4%) 
 
49 (14.3%) 
 
 
Type of study:   0.003 
Descriptive and transversal st
udies 
48 (16.4%) 
 
50 (14.6%) 
 
 
Economics studies 22 (7.51%) 
 
38 (11.1%) 
 
 
Longitudinal or prognosis 
studies 
116 (39.6%) 
 
172 (50.1%) 
 
 
Pharmacoepidemiology, 
pharmacoeconomic studies 
100 (34.1%) 
 
73 (21.3%) 
 
 
Unknown 7 (2.39%) 10 (2.92%)  
Topics:   <0.001 
Cardiology and vascular 
medicine 
29 (9.90%) 
 
31 (9.04%) 
 
 
Hematology and oncology 27 (9.22%) 
 
56 (16.3%)  
Internal medicine 69 (23.5%) 122 (35.6%)  
Public health and 
occupational medicine 
66 (22.5%) 
 
61 (17.8%) 
 
 
Psychiatry and addictology 36 (12.3%) 34 (9.91%)  
Surgery 43 (14.7%) 25 (7.29%)  
Primary cares 12 (4.10%) 4 (1.17%)  
Other 11 (3.75%) 10 (2.92%)  
4. Discussion 
Main results. To the best of our knowledge, we are the first to describe the effect of the 
French reform on the data access demands. After the reform, the median of data access 
demands by year increased from 21.5 to 203. This increase was lower in the studies 
included insurance data (21.5 to 70). The evolution is driven by the activity of private 
companies and contract-research organization. The number of studies on Hematology 
and oncology and internal medicine increased respectively by 1.7 and 1.4 factors. 
Technical significance. According to the FAIR guiding principles[5] data must be 
Findable, Accessible, Interoperable and Reusable. Claims data have important intrinsic 
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characteristics in the FAIR perspective. Data access of claims data refers to the 
“accessible” dimension of the FAIR guiding principles. However, extrinsic factors 
influence the accessibility of claims data such as human factors (e.g. data scientist with 
experience in claims data) and economic factors (e.g. data infrastructure HIPAA and 
GDPR compliant). Two reasons could explain the most important demands of private 
operators: (1) the reform has reduced the time of treatment (only one committee 
compounded by specialists of data) (2) and the legal framework has been simplified 
ensuring a good visibility for elaborate business plans. However, the activity of the public 
sector has increased fewer; this could be explained by the absence of new data 
infrastructure and new funding strategy (extrinsic factors). In our perspective, the 
efficiency of a data access policy should be quantitatively and qualitatively monitored to 
understand the potential leverages of data reuse.  
Remaining challenges. Schmidt et al.[6] have described the natural history of the 
data reuse in the Danish National Patient Registry. However, in the French context, data 
access demands database is not linked to scientific publications. A perspective of our 
work is linking data access demands and publication to describe the natural history of 
the French administrative data reuse. Data reuse of claim database has a natural history 
and this history is influenced by the data access policy.  
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Abstract. The paper presents analysis of the legal and ethical issues surrounding 
establishment of the Latvian Healthcare Monitoring Datalink. The paper covers 
three interconnected issues in the context of the use of administrative health data 
for research purposes – anonymization of data, concept of ‘public interest’ and 
involvement of research ethics committees. The analysis has been put into broader 
context of interaction between General Data Protection Regulation (GDPR), 
national legislative measures and practical needs of researchers. Neither GDPR, 
nor Latvian legal framework regulate the particularities on the use of potentially 
identifiable health data in research. Also, the practical use of ‘public interest’ as a 
basis for lawful processing of personal data concerning health for research 
purposes is not clear. More extended involvement of research ethics committees 
might serve as useful tool for determination the ‘public interest’ and for the 
evaluation of proportionality when balancing the aims of the research and the 
personal data protection 
Keywords. Personal data, data concerning health, secondary use, anonymization, 
informed consent, public interest 
1. Introduction 
To perform their functions, several state institutions in Latvia (the National Health 
Service, the Centre for Disease Prevention and Control, the State Emergency Medical 
Service and the Health Inspectorate) are collecting personalized patient level data. The 
primary use of these data does not require that the personalized data stored in one 
institution is linked to the data of the same person in another institution. Linking these 
data sets through a unique identifier for each person may ensure that the data can be 
used more broadly, e.g. for monitoring the quality and effectiveness of health care and 
for research. Joint initiative of the University of Latvia and the Ministry of Health of 
Latvia has resulted in development of a unique Latvian Healthcare Monitoring Datalink 
(Datalink) of unidentifiable persons and identifiable service providers [1]. 
The Datalink is controlled by the Centre for Disease Prevention and Control, and it 
includes healthcare process-related and outcome-related data of the population. The 
currently available data (2014-2018) includes information (health care provider, dates 
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of provided services, manipulations, primary and secondary diagnoses, costs etc.) about 
more than 65 million ambulatory and 3,5 million stationary treatment episodes as well 
as over 250 million units of medicines dispensed at pharmacies (including formulation, 
strength, quantity, and price). The demographic file provides information on patient’s 
age, sex, place of residence. Additionally, the Datalink includes data from national 
Causes of Death Registry and from registries for particular diseases (e.g. diabetes, 
cancer) and conditions (e.g. trauma). The Datalink is updated once a year. To ensure 
protection of personal data, the direct identifiers of persons are irreversibly anonymized 
to exclude the possibility for either party to store and reuse the encryption key. Thus, to 
add data each year, the Datalink is re-created. 
While the use of the Datalink for the monitoring of healthcare system performance 
by governmental institutions is regulated by the Cabinet decree assigning this function 
to the Centre for Disease Prevention and Control, the use of the Datalink for research is 
not clearly regulated by the existing regulatory framework leading to several legal and 
ethical problems. The present article addresses three of these issues – anonymization of 
data, concept of ‘public interest’ and involvement of research ethics committees. 
2. Anonymized or potentially identifiable?  
The data stored in the Datalink provides opportunity for researchers to analyse highly 
valuable administrative health data. However, due to gaps in legal regulation and due to 
ethical considerations, the secondary use of such anonymized but still potentially 
identifiable data is complicated. Some uncertainties arise also from the fact that the 
data originally have been collected for administrative purposes therefore there is no 
informed consent obtained for secondary use of the data in research. 
The main scientific value of the Datalink is a possibility to track an anonymous 
patient’s journey through the healthcare system knowing basic information about 
his/her health status, healthcare interventions and outcomes. The value of research data 
in many cases depends on keeping details regarded also as possible indirect identifiers 
as patient age, sex, place of residence, service provider, diagnosis, dates and codes for 
interventions. At the same time, the anonymization after linking independent datasets 
ensure privacy and confidentiality of persons concerned only if an indirect 
identification is not possible. It leads to the trade-off between the public interest 
justifying procession of such data for research and the small, but still existing risk of 
identification of persons. 
Some, but not all aspects of this problem are regulated by the General Data 
Protection Regulation (GDPR) which does not apply to fully anonymized data 
concerning health but applies to pseudonymized and potentially identifiable data. 
Article 9 of the GDPR includes data concerning health into “special categories of 
personal data” for which there is a presumption that its processing is prohibited, at the 
same time, part 2 of the Article 9 provides a long list of exceptions on when the 
processing of special categories of personal data is permitted [2]. Mostly those 
exceptions are related to the consent of data subject or to the overriding public interest 
justifying procession of special categories of personal data. However, also in these 
exceptional cases, data processing must be legitimized by EU or national legislation 
and must be proportionate, including the duty of the data processor to take "suitable 
and specific measures to safeguard the rights and freedoms of the data subject" [2]. 
Article 9 (2) (j) of the GDPR includes a reference to the Article 89 explaining further 
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how to apply the above-mentioned conditions to processing special categories of 
personal data. Among other, Article 89 refers to the principle of data minimization 
explained in the Article 5, namely, that the data must be adequate, relevant and only 
include what is necessary for the purposes of the processing. The preamble of the 
GDPR also clarifies the processing of data concerning health for research purposes in 
several recitals. Recital 56 of the preamble refers to the main objective that justifies the 
processing of special categories of personal data, including data concerning health – it 
must be in the public interest. Recital 159 states that the processing of personal data for 
scientific research purposes should be interpreted in a broad manner including, for 
example, technological development and demonstration, fundamental research, applied 
research and privately funded research. While outlining the basic principles of data 
protection, the GDPR at various places points out to the responsibility of Member 
States to adopt further legislation, providing “an unusually wide margin of maneuver 
for Member States” [3]. 
In 2018 Latvia adopted the Personal Data Processing Law. Article 2 of this law 
puts forward the aim of the law “to create legal preconditions for the establishment of 
the system of protection of personal data at the national level” [4]. Regrettably, the 
new law is overly brief regarding regulation of scientific research. Although the law 
contains Article 31 on the processing of data for scientific or historical research 
purposes, in substance this article is just a blanket norm referring to the GDPR and 
copying Article 89 (2) of the GDPR.   
Neither GDPR, nor Latvian legal framework directly regulates the use of 
anonymous or potentially identifiable health data in research. However, both the 
conditions for processing fully anonymous data and data anonymized but still 
potentially identifiable applies to the research use of the Datalink data. 
3. Public interest as a basis for secondary use of administrative health data in 
research 
One of the possible solutions is to use public interest as a basis for secondary use of 
administrative health data in research. The Article 9(2) of GDPR in listing possible 
grounds for processing of personal data not only includes a point (j) with specific 
reference to the “scientific or historical research purposes”, but also more general 
point (g) that allows processing of personal data “for reasons of substantial public 
interest”. The interrelation between those two grounds in the general scheme of the 
GDPR is rather unclear, especially considering recital 159 which states that “scientific 
research purposes should also include studies conducted in the public interest in the 
area of public health”. Yet, in any case, it should be possible to use public interest as a 
basis for secondary use of administrative health data in research, if all the preconditions 
on the proportionality, mentioned in the Article 9(2)(g) of the GDPR are fulfilled. 
The problematical aspects of seeking the balance between public interest in 
research and privacy rights of individuals have already been analysed by several 
authors [5]. There are particular problems regarding application of proportionality test 
in cases when public interest serves as a basis for conducting the research, for example: 
how to define and assess public interest in the context of particular research protocol? 
Assessment of the social value of the research study before it has been started is 
one of the main requirements in international documents defining the principles of 
research ethics for biomedical research involving human subjects. Human subject 
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research as defined in these documents is not only research where a person is directly 
involved in a study (e.g. clinical studies of medicinal products), but also research 
studies on identifiable human biological material and personal data. 
Article 16 (iii) of the Council of Europe Convention on the Protection of Human 
Rights and Dignity in Biology and Medicine states that studies involving human 
subjects may be carried out only if “the research project has been approved by the 
competent body after independent examination of its scientific merit, including 
assessment of the importance of the aim of the research, and multidisciplinary review 
of its ethical acceptability” [6]. A detailed requirement to assess the social value of the 
study is included in the International Ethical Guidelines for Health-related Research 
Involving Humans issued by the Council for International Organizations of Medical 
Sciences (CIOMS) (2016).  It states that “[t]he ethical justification for undertaking 
health-related research involving humans is its scientific and social value: the prospect 
of generating the knowledge and the means necessary to protect and promote people’s 
health” [7]. In Latvia, the Law on the Rights of Patients (Section 9, paragraph 8) 
allows research use of patient data recorded in medical documents without informed 
consent if several requirements are met, including the requirement that “the study is 
carried out in the public interest” [8].  
At the same time, several questions arise in the context of these requirements, like: 
who and how should assess the social value of a research study? what exactly makes 
the study socially valuable? The practice shows that there is a need for criteria for 
assessing the social value of a study that could be used by research ethics committees 
and other bodies involved in the evaluation process. CIOMS guidelines state that “The 
scientific and social value of research can be difficult to quantify, but it is generally 
grounded in three factors: the quality of the information to be produced, its relevance 
to significant health problems, and its contribution to the creation or evaluation of 
interventions, policies, or practices that promote individual or public health" [7]. 
Ethicist Ezekiel Emanuel and colleagues have defined the social value of the study as 
the instrumental value of the new knowledge for improving human health. They clarify 
that the two main reasons for assessing the social value of a study by ethics committees 
are the prevention of harming study participants (including breaches of privacy) and the 
waste of limited research resources [9]. The accessibility and dissemination of the 
study results, including publication of negative results also is an essential pre-condition 
for ensuring the social value of the study. 
4. New role for research ethics committees? 
The GDPR in the Article 40 as well as in the Recital 98 encourages “the drawing up of 
codes of conduct intended to contribute to the proper application of this Regulation”. It 
leads to the role that research ethics committees might play in evaluation of public 
interest and protection of research participants. Currently in Latvia, the ethics approval 
for research protocols is clearly required by law only in few specific cases: clinical 
trials of medicinal products, clinical trials of medical devices and human genome 
research. For clinical trials and studies using data from medical documents mentioned 
in the Law on Patient Rights there is no legal requirement for ethics committee review. 
This demonstrates the need for re-definition of the role of ethics committees in 
Latvia. The scope of research requiring review by research ethics committee must be 
broadened, because the current approach does not meet the requirements of 
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international documents on research ethics, as well as it does not ensure assessing of 
public benefit and protection of research participants for all types of medical and health 
research. 
5. Conclusions 
There are several ambiguities and problems in the context of establishing and use of the 
Datalink for the research purposes, which are not fully addressed by the existing legal 
framework in Latvia. First, it is not completely clear how to define and evaluate the 
public interest in the context of health research. Second, the line between fully 
anonymized and potentially identifiable data, as well as evaluation of risk of 
identification needs further clarifications. Third, there is a need to increase a role and 
involvement of research ethics committees in the review of secondary use of data 
concerning health. 
The GDPR was one of the most important and most massive legal developments in 
the EU law of 21st century, ambiguities in the context of research in the field of data 
concerning health being only one small fraction of challenges that follows the GDPR. 
One can only hope that future case-law of the Court of Justice of the EU as well as 
additional national legislative measures will help to deal with those challenges. 
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Abstract. Finland is a world leader in the use of public electronic services. 
Continuous improvement to competencies is a prerequisite for the success of 
digitalisation in the service development sector. The increasing use of information 
technology in health and social care needs to be taken into account in the education 
of the health and social care sector work force. The mandate of the national 
SotePeda 24/7 project is to identify and define the informatics competencies 
required for multidisciplinary education of this sector in Finland. The project has 
adapted international recommendations for use in the national context. The national 
recommendation covers 12 areas of competency and related content. In addition to 
defining competencies, the project has produced a toolbox of materials for use by 
educators of these topics in universities that cover applied sciences and lifelong 
learning. The results of the project are expected to significantly improve the 
preparedness of graduating health and social care and related engineering and 
business sector students to make full use information technology, all of which 
benefits the national health and social welfare system. 
Keywords. competence, skill, informatics, information technology, health care, 
social care, education 
1. Introduction 
Finland has the highest percentage of eHealth service users in the European Union (EU), 
(i.e., representing almost 50% of users). Generally, only 18% of EU citizens use online 
health care and social welfare2 services [1]. A key objective of the National Finnish 
eHealth and eSocial Strategy [2] is to support the renewal of the healthcare and social 
welfare sectors. It emphasises the active role of citizens in maintaining their own well- 
being, which can be achieved by improving information management and increasing the 
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2 In Finland, ’social welfare’ is social services, social assistance, social allowance, social loans and related 
measures intended to promote and maintain social security and the functional capacity of individuals, family 
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Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200341
1143
provision of online services; in this regard, the role of healthcare and social welfare 
professionals is crucial. A primary goal is that, by 2020, professionals in health care and 
social welfare will have access to information systems that support their work and its 
operating processes. The measures extend to national responsibility, for example, of 
training professionals in information management, as well as data entry, data protection, 
information security and knowledge management. The eHealth strategy of the Finnish 
Nursing Association 2015–2020 incorporates these objectives, with the aim of imparting 
competencies to nursing students in the use of technology, information literacy, 
knowledge management and informatics processes. These competencies will also be 
updated with supplementary training [3]. 
The increasingly widespread use of information technology [4] to support healthcare 
and social welfare professionals has created a need to improve informatics competencies 
in Finland. The Ministry of Education and Culture in Finland financed a national project, 
the Multidisciplinary Competencies for Health Care and Social Welfare Services in 
Finland (SotePeda 24/7) [5], with the primary aim of defining necessary informatics 
competencies and producing educational material for multidisciplinary use at the 
bachelor level education in the fields of health and social care and related engineering 
and business sectors of universities of applied sciences (UAS) in Finland. A secondary 
aim of the project was to support education that prepares students for work in a 
multidisciplinary team with a view to promoting the health and well-being of customers 
with the help of information technology. This paper presents how the competence 
definition work was carried out and what its present result is. 
2. Method 
The knowledge base for the descriptions of the competencies was primarily founded on 
international definitions of health informatics competencies in the Health Information 
Technology Competencies (HITComp) database [6,7]. The second version of the 
HITComp database which we used, is a result of the EU-US eHealth Work Project, an 
EU-funded project [13]. It was designed for educators, workforce developers, current 
and future workforce members, students, eHealth managers, staffing authorities, and 
others in healthcare information technology or eHealth [7]. Our project team used 
HITComp to search for competencies in a variety of healthcare roles. Competencies (i.e., 
‘direct patient care’ and ‘administration’) were sorted into domains. The ‘basic’ and 
‘baseline’ level competencies of HITComp were included for further elaboration. A 
healthcare professional with good knowledge of Finnish and English translated the 
competencies into Finnish and a group of health informatics professionals checked the 
correctness of the translations. 
To adapt the list of competencies to the national context, the descriptions of the 
competencies also took into account the competence need findings of the latest studies in 
Finland based on a literature search. These included the Finnish Care Classification 
System [8], the eHealth Strategy of the Finnish Nurses Association 2015-2020 [3], the 
Nurses’ Competence Survey [9], national eHealth and eWelfare system (i.e., Kanta) 
documentation [10] and research into the competencies of healthcare professionals [11, 
12]. The project team of around ten people, consisting mainly of experts in nursing but 
also participants with social welfare, health informatics and biomedical engineering 
backgrounds discussed the composition of competencies until a consensus was reached. 
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The HITComp originated descriptions of the competencies were grouped in the same 
way as those for the EU-US eHealth Work Project [13]. Areas of competence were 
initially described using a mind map, which made them clearer and easier to read. 
Finally, the mind-map was converted to a tabular form which then became the version 
1.0. 
3. Results 
The produced list of informatics competencies required for healthcare and social welfare 
professional education in Finland can be seen in Table 1. HITComp terminology was 
used or adapted for the definitions. 
4. Discussion 
Although international recommendations for informatics competencies for health care 
professionals are available [6, 7, 14, 15], they are only applicable to a certain extent in 
Finland. A need remains to adapt the curricula to include components that support the 
national health care and social welfare environment and culture, as well as national 
strategic objectives [2, 3]. The competency definitions produced by the SotePeda 24/7 
project [5] cater to these needs. For example, the proposed recommendations include 
social welfare-related competencies that are frequently absent from international 
recommendations, in addition to knowledge relating to the national health and welfare 
information repository, Kanta [10]. These recommendations also align with the Finnish 
eHealth and eSocial Strategy [2], which recognises that work is performed in 
multidisciplinary teams and sometimes includes business or technology professionals. 
The SotePeda 24/7 project will reach completion at the end of 2020; until then, the 
work on definitions of informatics competencies continues. The 12 defined areas of 
competence will remain in the final version of competency recommendations. However, 
any additional feedback obtained from interactions with social welfare and health care 
authorities may necessitate minor improvements having to be made to the 
recommendations. 
The proposed descriptions of the informatics competencies were valid at the time of 
writing. Digitalisation, innovations in information technology and new system 
implementations [4] will, however, necessitate updates to the descriptions from time to 
time. Each country should have a process in which competent professionals update the 
competence definitions. Finnish educational authorities on healthcare and social welfare 
informatics produced the recommendations, and the results will be followed and 
commented by authorities working in key healthcare and social welfare service positions 
and research institutions. 
In addition to the competency definitions, the SotePeda 24/7 project is also 
responsible for the production of educational materials that support the educational 
approaches relating to these competencies. For example, one work package elaborates on 
educational materials about the ethical aspects of care digitalisation. Specifically, a 
toolbox has been developed for use by UAS educators (but potentially in other levels, 
too), who can select the materials and method of instruction of choice. The intention is 
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that the materials should support monological, dialogical and trialogical learning. The 
materials will be stored in a national repository of educational material. 
Table 1. Definitions of health care and social welfare informatics competencies. 
Area of competence Main content 
Basicinformation and  
communications technology 
(ICT) competencies 
Information management and its tools, information and 
communication technologies and information literacy skills. 
Introducing new operating models, anticipating service and training 
needs, anticipating future digital literacy skills and motivation. 
Online interactive competencies Online dialogue with persons, changes in the roles of professionals, 
electronic communication environments, online meetings and 
consultations and the use of social media and online services. 
Service competencies in digital 
health and the social care sector 
Health and social care service structures, the usefulness of electronic 
health services, different electronic service environments and tools, the 
roles of social and healthcare actors, electronic service pathways, e-
services and virtual reception. 
Person-centred guiding 
competencies in a digital 
environment 
Assessing customers’ IT skills, IT guidance for customers, directing 
customers in search of information, supporting self- care by clients, the 
preparation of electronic guidelines, the production of online material, 
electronic outpatient clinics and information services, ie. chat rooms. 
Competencies to monitor health 
and well- being in a digital 
environment 
Artificial intelligence, sensors, robotics, wearable technology, utilities, 
various monitoring tests and instruments, monitoring information 
literacy and assessing the reliability and adequacy 
of information. 
Health and social care 
informatics competencies 
The interoperability of electronic systems, the communication of 
information via electronic information systems, electronic logging, 
national patient and social welfare data repository Kanta.fi, electronic 
data storage and roles and responsibilities 
regarding the use of information and legislation. 
Multi-stakeholder service co-
development competencies 
Assessing the reliability of data sources, information management 
guidance and collaboration, privacy and security, 
co-operation and new operating models. 
Ethical competencies Ethical operating models and ethical competence in electronic services. 
Service design competencies User orientation, participation, innovativeness and new service 
pathways. 
Knowledge management 
competencies 
The use of monitoring and research data, customer- and patient-
specific information, availability, quality and 
effectiveness of services (e.g., considering changing needs). 
Research, development and 
innovation competencies 
Assessment and continuous improvement of one’s own skills, work 
community skills development, the development of electronic 
services, quality criteria for electronic services, the development of 
health and well-being technologies, exploitation of evidence-based 
information and an evaluation of effectiveness. 
Societal competencies Continuous consideration of information security in operations, the 
social impact of health technology on well- being and daily life, 
digital democracy and the promotion of social inclusion. 
5. Conclusion 
This project has significant national responsibility as it comprises recommendations on 
the healthcare and social welfare informatics educational material and curricula content 
of nursing students, other healthcare and social welfare professionals, as well as those in 
related fields (i.e., engineering and business) in UASs in Finland. As almost all UASs 
that offer this type of education in Finland are involved in the project, it is likely that the 
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recommendations will be followed at least to some extent. The educational material 
produced by the project will assist educators to introduce these topics to their students. 
The present version of the recommendations defines 12 areas of competence, the 
corresponding content of which is defined in detail. The recommendations are supported 
by a toolbox of educational materials to be used freely by educators in relevant fields in 
Finnish universities. It is expected that the recommendations and online educational 
materials will significantly improve basic healthcare- and social welfare informatics-
related education in Finland. 
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Abstract. Background According to the Swiss Law on Research in Humans, the 
reuse of routinely collected genetic and non-genetic data and samples from patients 
for research purposes requires the consent of patients. Unfortunately, the so far 
established paper-based processes are intrinsically linked to the hospital admission 
process, labour intensive and not yielding the targeted return rates. Therefore, the 
overall goal of the presented SPHN project is to increase patient reach by providing 
hospitals with a patient-centric, user-friendly and admission-independent electronic 
general consent pathway. As part of the project, feasibility of different digital 
pathways was evaluated in a usability testing.  
Methods Based on a nationwide harmonised template, a mobile centric 
progressive web application was developed by the Department of Clinical Research 
Basel. Usability of the application and according user journeys were evaluated at all 
partner hospitals. Two options of giving consent were explored using 1) patients` 
smartphones without any involvement of hospital personnel and 2) a hospital device 
(tablet) with explicit confirmation of patient identity by hospital personnel. 
Participant signatures were captured as a picture of a handwritten signature on paper 
taken with the camera of the smartphone or tablet. Usability issues and feedback of 
participants were documented directly after usability testing.  
Results In total, 122 users agreed to participate in the usability testing using a 
tablet or smartphone. The general consent request workflow on the smartphone or 
tablet was regarded as user friendly and easy to navigate by 96% of all participants. 
However, capturing a picture of a handwritten signature resulted in usability issues 
in multiple cases, i.e. due to missing pen or paper.  
Conclusion Usability testing of our prototype application showed a broad 
acceptance of participants regarding the use of mobile electronic devices to give 
general consent. Therefore, we believe that easy-to-use digital general consent 
processes provide effective means to increase the patient pool for health-related 
research. Further discussions with legislative bodies are required to find patient 
centric, feasible and legally acceptable solutions in the specific case of electronic 
general consent for the near future. 
Keywords. SPHN, personalized health, electronic general consent 
1. Introduction 
In Switzerland, use of routinely collected personal data (genetic and non-genetic) and 
biological material for research requires written consent of the affected person or the 
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respective legal representative according to the Human Research Act (HRA) in January 
2014 [1].  Today, all Swiss university hospitals have implemented rules and procedures 
to assure information of patients and documentation of consent in accordance with HRA 
requirements (so called «general consent process»).  
 
 
 
Figure 1. Consent data from 2018 at the outpatient and inpatient sector of the University Hospital Basel. 
 
 
Presenting paper-based consent forms to patients and collecting responses is labour 
intensive and comprises several individual process steps. Analysis of consent data from 
2018 at the University Hospital Basel revealed that 36.7 % of patients in the outpatient 
and inpatient sector (47’290 out of 128’883) returned a decision. Of those patients, 86.1 
% (40’718 out of 47’290) agreed to share their data and samples. As shown in Figure 1, 
63.3 % of patients at the hospital where either not reached or did not return the general 
consent form. An internal survey revealed, that the situation is similar at all five Swiss 
university hospitals. 
Predominant reasons for low return rates show the urgent need to develop additional, 
patient-centric and easy-to-use methods to inform patients and electronically collect 
general consent information. Furthermore, it is important to improve understandability 
of the general consent information employing visually appealing and interactive 
presentation that support patient understanding and satisfaction [2, 3].  
Thus, the goal of the presented project was to evaluate the feasibility of an electronic 
general consent pathway through usability testing of a mobile prototype application. 
2. Methods 
A mobile progressive web application was developed by the Department of Clinical 
Research Basel as usability prototype based on the content of the harmonised national 
general consent template [4]. The aim was to find unforeseen issues with the consent 
workflow and user interaction when using the application in a real-world setting.  
Two electronic general consent pathways were explored: 
a) Giving general consent using the personal smartphone without any 
involvement from hospital personnel. Identity of participants was verified by a 
token supplied through a mobile short message or email message for which 
participants provided the respective contact information themselves.  
b) Giving general consent using a hospital device (i.e. tablet) and manual 
confirmation of patient identity through hospital personnel. 
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 Usability testing was performed at different settings (inpatient/outpatient), clinics 
and different patient population/participants (children/adults/elderly, male/female). 
Patients attending the hospital were asked by specifically instructed recruiters to 
participate in the testing. Participants using their own smartphone were provided with a 
language specific brochure containing a QR-code that could be scanned to directly access 
the mobile application website. In the case of hospital devices, hospital personnel would 
open the general consent website from a pre-installed app icon and hand it over to the 
patient. Visual features of the application were intentionally designed in close 
resemblance with hospital corporate design to establish a trust basis for participants. The 
landing page was presented in the same language as the brochure, with the possibility to 
choose a different language on request (DE, FR, IT, EN).  
On a subsequent screen, the key points of the general consent content where 
summarized, followed by the full consent information as well as a hospital specific 
contact address for further information or questions. Participants would subsequently 
choose to agree or refuse the general consent and provide personal information (last 
name, first name and date of birth) with the option to specify a legal representative. In 
case of smartphone only use, identity was then confirmed via a token supplied by mobile 
short message or email for which participants provided the respective contact 
information. As a next step, participants would sign on the back of the brochure and 
capture the signature using the camera of the mobile device. Participants were then given 
the option to directly download a copy of the general consent or receive a copy via email. 
In case of verification through hospital personnel, participants would hand the device 
over to hospital personnel, to enter a secret division code, followed by manual 
confirmation of patient identity and manual electronic signature on the device. 
Evaluation was done on a pseudonymized dataset with anonymized participant 
comments. 
3. Results 
Usability testing was conducted from October 2019 until the end of 2019. All Swiss 
university hospitals and the University Children Hospital Basel agreed to participate in 
the usability testing at their institutions. A total of 146 participants were asked to 
participate. 122 participants (56 smartphone/66 tablet) completed the usability testing 
and subsequent questionnaire. The participant demographics were heterogeneous with a 
large age range from child to elderly. Reasons for non-participation varied from refusal 
and not feeling comfortable in participating to technical problems of not having a 
smartphone or missing internet connectivity. 
In general, the electronic solution was well perceived by participants. On average, 
completion of the general consent process and usability questionnaire required 
approximately five minutes. Most participants agreed that the interface and the 
navigation was user-friendly. However, there were some issues regarding the signature 
workflow, mainly because participants did not have a pen at hand or had difficulties 
when taking a picture with the mobile device. In addition, participants criticized the 
amount of information which was provided as full consent text, «Too much to read»2, 
 
2 «Beaucoup à lire» 
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«Too much text»3 or «For me very comprehensible, but a lot – for people, not reading so 
fast, probably too much to read and too much to scroll»4. 
Most usability testing participants were used to handle digital information on their 
smartphones or tablets. In addition, most participants did not have any concerns sharing 
personal information such as name, birthdate, phone number or email address as a mean 
to verify their personal identity. Perceived safety of the electronic consent process was 
high for both pathways (94%), but lower for smartphone users, where identification 
occurred via mobile short message / email verification only (89%). Respective concerns 
about data protection and the safety of an electronic signature in general were also raised 
explicitly by various participants, «Taking a picture of the signature does not appear to 
be safe»5, « I found the information that genetic analysis was being done somewhat 
frightening»6.   
4. Discussion 
Electronic general consent pathways build on the possibilities arising from digitalization, 
presenting information in more user-friendly and flexible ways. 
An average completion time of five minutes and our own observations show that 
most users skip reading the full general consent text. This behavior is already known for 
the acceptance of general terms and conditions, nowadays a common pre-requisite for 
many online services. Feedback associated with length of text, indicated, that summary 
information with links to additional in-depth content would be perceived as more user-
friendly and approachable. This could be even further improved by the use of interactive 
features such as dynamic infographics or video content, especially in the context of care 
for children and young adults. 
Current legal requirements in Switzerland mandate a written consent for the use of 
data for research purposes (HRA Art. 16). Due to a missing definition of «writing» in 
this context, there is an ongoing legal debate whether consent has to be given in the form 
of a handwritten wet-ink signature or whether other means of «written consent» would 
be applicable. Usage of electronic identities and qualified electronic signatures would 
provide a legally equivalent digital process to a wet-ink signature [5]. Unfortunately, the 
implementation of electronic identities in Switzerland is still in its infancy and not a 
feasible solution in the near future. 
The presented approach with a paper-signature and subsequent digitalization in the 
form of a photography is clearly not suited in terms of usability and legal aspects. 
However, general consent is used for the re-use of data and samples constituting a 
substantially lower risk compared to a study specific informed consent.  Consequently, 
a less rigorous form of written consent – i.e. a handwritten signature on a mobile device 
– could provide a viable solution for general consent, if coupled with a reliable form of 
patient identification, such as verification through hospital personnel or biometric 
identification measures. 
 
3 «zu viel Text» 
4 «Für mich sehr verständlich aber viel - für Leute, die nicht so schnell lesen wohl zu viel und auch zu 
viel zum Scrollen» 
5 «Das Fotografieren der Unterschrift erscheint mit nicht ganz so sicher» 
6 «Die Information, dass genetische Analysen gemacht werden fand ich etwas beängstigend» 
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5. Conclusion 
Further discussions with involved legislative parties are required to find legally 
acceptable, feasible, and easy-to-use solutions in the specific case of electronic general 
consent for the near future. Once the solutions are feasible at daily hospital business, we 
believe that a digital general consent process has the potential to further increase the pool 
of health-related routinely collected patient data and leftover samples available for 
further research projects.  
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Abstract. The Swiss Personalized Health Network (SPHN) is a national initiative 
designed to promote the development of personalized medicine and personalized 
health in Switzerland. SPHN contributes to the development, the implementation, 
and the validation of coordinated infrastructures in order to make health-relevant 
data interoperable and shareable for research in Switzerland. To this end, SPHN 
rallies all decision-makers from key clinical, research-, research support institutions 
and patient organizations around the same table. 
Keywords. SPHN, personalized health 
1.Introduction 
Given the tremendous amount of health data available, health care and medical decisions 
should no longer be solely based on population averages, but take into account individual 
patient characteristics, including the variability in genes, molecular biomarkers, 
environment and lifestyle. To leverage the immense potential of these data for better 
prevention, improved medical practice and the development of innovative treatments, 
transdisciplinary scientific research, as well as specific infrastructural efforts are 
necessary: Health data need to be interoperable and broadly accessible for research 
according to the FAIR principles [1]. Additionally, research involving sensitive human 
data demands potent IT infrastructures that permit the collection, storage and analysis of 
high quality data, adequately link to biobank samples and, at the same time, fulfill 
stringent data protection and information security requirements.Furthermore, patients 
and citizens have to be included, not only for consent to release their data or samples for 
use in research, but also as active partners supporting research and helping to advance 
medical knowledge. These issues raise unprecedented ethical and legal (e.g., data 
protection) questions that must be considered even more within an extended personalised 
health ecosystem [2]. 
 Although the public Swiss healthcare system is universal, healthcare is provided 
by a combination of public, subsidized private and totally private systems, and is 
organized largely on the level of individual cantons. To a large extent, this federalist 
principle until now prevented a nationwide coordination and/or harmonisation of 
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biobanks, electronic clinical information systems and clinical data management 
infrastructures and created a  heterogeneity of health data infrastructures which has 
retarded the development of a nationwide personalised health ecosystem as compared to 
countries with more homogenous national health systems. These deficiencies have been 
realised early- on and appropriate initiatives have been undertaken on local and regional 
levels. In order to expand the local initiatives to the whole of Switzerland and 
complement them  with nationwide efforts for making health data findable, accessible, 
interoperable and usable for research (FAIR) on a national scale, the Swiss Government 
launched the Swiss Personalized Health Network (SPHN) initiative in 2017. The mission 
of the initiative is to contribute to the development, the implementation, and the 
validation of nationally coordinated infrastructures which are required to make health-
related data interoperable and shareable for research in Switzerland. Given its high 
quality health care network and excellence in research and technologies, Switzerland has 
the potential to become one of the European leaders in health and medical science, 
although the regulatory aspects of the federated health system are a major challenge for 
big data research. The initiative shall thus help to push Switzerland to the international 
forefront of personalised health-related research and health care. 
2.Mandate and governance 
The Swiss Personalized Health Network (SPHN) is an initiative of the Swiss federal 
government, namely the State Secretariat for Education, Research and Innovation (SERI) 
and the Federal Office of Public Health (FOPH). SPHN is led by the Swiss Academy of 
Medical Sciences (SAMS) in collaboration with the Swiss Institute of Bioinformatics 
(SIB). A total of CHF 68 million was allocated to the initiative for the first funding period 
2017-2020. As defined in the corresponding mandate, the long-term goal of the SPHN 
initiative is to establish a Swiss network in personalized medicine, in which all relevant 
research institutions and hospitals in this field are involved. The development of a 
nationally coordinated data infrastructure including interoperability of local and regional 
information systems in order to optimize the use of primarily clinical but also other 
health-related data for research in the field of personalized medicine, is the central focus 
of the first funding phase. Rather than building a new centralized database, SPHN adopts 
a decentralized approach and aims to establish interoperability of health-related 
information by building a dynamic scalable network of data providers based on common 
standards for formats, semantics, governance, and exchange mechanisms. It is therefore 
our mission to lay the foundations needed to establish a nationwide exchange of health-
related data for better disease prevention, improved medical practice and ground-
breaking innovative treatments, transdisciplinary scientific research, as well as specific 
infrastructural efforts. 
The SPHN project organization involves partners at national level, at technical level, 
and at institutional level (Figure 1). SPHN rallies all decision makers from key clinical, 
research and research support institutions around the same table. The combined 
knowhow, experience and commitment of the numerous partners and experts of the 
SPHN Boards and Working Groups enable discussion, collaborations and progress.  
The National Steering Board (NSB) is the highest body of SPHN and is responsible 
for the overall strategy, for maintaining regular contacts to the superordinate political 
authorities and for external communications in coordination with the Swiss Academy of 
Medical Sciences (SAMS). The NSB includes representatives from key institutions in 
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Switzerland (e.g. University Hospitals, universities, ETH-Domain, swissuniversities, 
FOPH, SNSF, patient organisation). In addition to the NSB, SPHN is composed of the 
following Expert Advisory Groups/Bodies: 
• ELSI Advisory Group (ELSIag). 
• National Advisory Board (NAB, foreseen in 2020). 
• International Advisory Board (IAB). 
• Data Coordination Center (DCC) including several technical Working Groups 
(operated by the Personalized Health Informatics Group of SIB). 
SPHN is further supported by the expert knowledge of several mandated SPHN adhoc 
Working Groups, which are responsible for solving specific issues related to 
infrastructure development. SPHN has put very strong efforts into close collaboration 
with other stakeholders from the biomedical research landscape. This includes funders 
such as the Swiss National Science Foundation (SAKK) or the ETH Domain 
Personalized Health and Related Technologies Program (PHRT), and also research 
networks such as the Swiss Group for Clinical Cancer Research (SAKK), the Swiss 
Biobanking Platform (SBP), the Swiss Clinical Trial Organization (SCTO), as well as 
patient organizations (e.g. ProRaris, for rare disease). During the last years, these 
organizations managed to identify common issues and obstacles, which need to be 
addressed. Typically, the above-mentioned Working Groups are now highly coordinated 
within these stakeholder groups.  
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Figure 1. SPHN Governance. 
3.Implementation  
The SPHN initiative supports the development and implementation of coordinated infra- 
structures by means of a 3-pillar funding strategy: 
1. Top-down: funding of compatible data management systems in the University 
Hospitals through Collaboration Agreements, as well as the SPHN Data 
Coordination Center (DCC) and ELSI projects.  
2. Bottom-up: selection of projects through competitive Calls for Proposals to 
lead the development of infrastructures and test it with concrete research 
questions (Infrastructure Development Projects and Driver Projects). In 2017 
and 2018, two SPHN Calls for Proposals were organized in close coordination 
with the Strategic Focus Area 'Personalized Health and Related Technologies' 
(PHRT) of the ETH Domain. Selected from a total of 76 proposals requesting 
CHF 90.4 million, SPHN funded 24 projects (incl. 6 co-funded by PHRT) for a 
total amount of CHF 25.3 million during this funding period. 
3. IT infrastructure networks:, a secure and cutting-edge IT environment 
(BioMedIT, a project of SIB) is established to support computational, 
biomedical research and clinical bioinformatics, ensuring data privacy [3]. 
Further information on the projects is available on the SPHN website (www.sphn.ch). 
The SPHN Management Office (MO) together with the SIB Personalized Health 
Informatics Group (PHI) are responsible for successfully implementing the mandate of 
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SPHN. The MO manages the daily operations of the initiative, coordinates the funding 
and ensures a good governance. The PHI group is in charge of the Data Coordination 
Center and the BioMedIT project.  
To ensure nationwide interoperability of biomedical data, a variety of technical, 
ethical and legal issues have to be tackled. The ELSIag is responsible for the ethical and 
legal questions related to SPHN activities. The technical aspects related to the 
development of coordinated infrastructures, compatible data management systems, 
interoperability of data, and governance of guidelines, are tackled by the Working 
Groups of the Data Coordination Center in collaboration with the University Hospital IT 
teams.  
4. Conclusion and Outlook 
The SPHN funded projects involve 35 Swiss organizations and institutions which 
demonstrate the magnitude of this national endeavor. Over the past years, we have 
identified several key success factors for the development of a nationwide network such 
as i) the need for a common understanding of the vision and scope; ii) commitment of 
all players to share health data for the benefit of society (citizens, patients, hospitals, 
research institutes, etc.); iii) a transdisciplinary approach between clinicians, researchers, 
bioinformaticians, machine learning experts, etc.; iv) nationwide interoperability of 
health data and nationally coordinated data infrastructures; v) process innovation in 
research and health care; vi) dialogue with citizens and patient groups; and vii) 
transparent communication concepts to enhance public trust.   
 A review of the overall progress of the initiative and gap analysis was performed 
in 2019 based on the first project progress reports and an external international review 
by the SPHN International Advisory Board (IAB). As a result from this first evaluation, 
the biggest achievement of SPHN during the past years is probably the increasing 
awareness of the systemic gaps and problems related to the field. Though the initiative 
is overall on a good track and has made significant progress, the gap analysis revealed 
significant obstacles and hurdles. Most of them related to the federated health care 
system and the strong local awareness and particularities of data protection issues as well 
as ethical and legal priorities. In order to achieve interoperability, these issues, priorities 
and policies need to be coordinated on a national level. Here, the willingness of the 
stakeholders to agree and implement common strategies, standards and guidelines is a 
prerequisite. The political discussion needs to be initiated whether or not this should be 
enforced. 
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Abstract. MedCo is the first operational system that makes sensitive medical-data 
available for research in a simple, privacy-conscious and secure way. It enables a 
consortium of clinical sites to collectively protect their data and to securely share 
them with investigators, without single points of failure. In this short paper, we 
report on our ongoing effort for the operational deployment of MedCo within the 
context of the Swiss Personalized Health Network (SPHN) for the Swiss Molecular 
Tumor Board. 
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1.Introduction 
Although within Swiss Personalized Health Network much effort is currently being put 
into data interoperability and integration, data privacy and security represent important 
challenges that, if overlooked, can potentially hinder or even block the access and use of 
this data across the different hospitals. To tackle these issues, researchers from the Swiss 
Personalized Oncology project and the Data Protection for Personalized Health (DPPH 
https://dpph.ch) project have joined forces. The intention is to work together towards the 
development and the adoption of cutting-edge privacy-preserving solutions for data 
analytics that provide strong and long-lasting protection guarantees for patient data. 
2.The Swiss Molecular Tumor Board Use Case 
As a first step in this direction, the idea is to empower the Swiss Molecular Tumor Board 
(SMTB), which is meant to be a reference for the entire country for analysing complex 
cases and identifying the best personalized treatment, with MedCo, the first privacy-
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preserving tool issued by the DPPH project that is co-developed by EPFL and the 
Lausanne University Hospital (https://medco.epfl.ch). MedCo [1] is a data discovery 
system that enables a researcher or clinician to securely perform, through a user-friendly 
graphical interface, exploratory queries (SQL-like queries for simple statistics) on 
encrypted clinical and molecular data that are horizontally partitioned across different 
hospitals. By relying on state-of-the-art technologies for information security such as 
homomorphic encryption, secure multi-party computation and differential privacy, 
MedCo ensures (1) that patients’ individual-level data are protected against illegitimate 
access by unauthorized people, (2) that no single authority has to be trusted for the 
security of the data and (3) that the re-identification risk is minimized. 
 Our goal is to deploy MedCo at all the University Hospitals in order to enable 
the SMTB to make more informed treatment decisions (Figure 1). MedCo will offer 
experts of the SMTB the possibility of obtaining, in real time, simple statistics and 
aggregate information about treatment and outcome for patients with a similar clinical 
and molecular profile to the ones under evaluation (e.g. overall survival, overall response 
rate, progression-free survival). At the same time, the use of MedCo will ensure that the 
privacy of both the patients in the hospitals and the patient presented at the SMTB is 
preserved. To securely identify similar patients, MedCo will perform an encrypted search 
over all the oncology patients whose data is stored encrypted in the MedCo databases 
that are distributed across the five Swiss University Hospitals and then compute the 
requested aggregate information directly on the encrypted data of the identified patients. 
 
 
 
Figure 1. Envisioned use of MedCo in the Swiss Molecular Tumor Board. DCC: Data Coordination Center 
3.Conclusion
MedCo will be initially deployed in the University Hospitals of Bern, Geneva and 
Lausanne for testing purposes. Once the data loading process, the governance and the 
functionalities of MedCo will be validated by the SPHN Data Coordination Center, the 
deployment will be extended to the University Hospitals of Basel and Zurich and the 
other hospitals members of the Swiss Group for Clinical Cancer Research , eventually. 
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Abstract. Sepsis is a highly heterogenous syndrome with variable causes and outcomes. As part of the 
SPHN/PHRT funding program, we aim to build a highly interoperable, interconnected network for data 
collection, exchange and analysis of patients on intensive care units in order to predict sepsis onset and 
mortality earlier. All five University Hospitals, Universities, the Swiss Institute of Bioinformatics and ETH 
Zurich are involved in this multi-disciplinary project. With two prospective clinical observational studies, we 
test our infrastructure setup and improve the framework gradually and generate relevant data for research. 
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1.Introduction 
Sepsis is a highly complex, life-threatening syndrome that develops when the bodies’ 
immune response to an infection causes injury to its own tissues and organs. The course 
and outcome of sepsis is highly heterogeneous and depends on complex host-pathogen 
interactions, the pathogen, and timing of diagnosis and effective treatment [1, 2]. Patients 
at risk for sepsis may benefit from personalized diagnostic assessment and treatment 
strategies. Multiple attempts have failed to develop classical biomarkers from e.g. serum 
to diagnose sepsis – also due to the heterogeneity of presentation. Digital biomarkers in 
sepsis may offer a different approach, as the collection of very large datasets allows to 
integrate time-series data of directly measured physiological parameters [3]. Within an 
integrative approach, digital biomarkers may be combined with -omics biomarkers (e.g. 
metabolomics, metagenomic, whole genome sequencing of bacteria, immune 
phenotyping) and form hybrid biomarkers with higher sensitivity and specificity. The 
use of novel machine-learning based algorithms to explore such datasets may help to 
better understand the data and discover patterns within the data linked to particular 
clinical phenotypes [2]. These algorithms may potentially allow to guide tailored 
personalized treatment strategies in sepsis. We aim to build a network for data-driven 
and -omics technology-based research to (i) recognize sepsis at an earlier stage and (ii) 
predict risk of mortality. 
2.Methods 
In the driver project funded by the Swiss Personalized Health Network (SPHN) and 
Personalized Health Related Technologies (PHRT), each University Hospital (Basel, 
Bern, Geneva, Lausanne and Zurich) and University of Bern and Zurich will provide 
data from critically ill patients hospitalized in intensive care units (ICUs).  
The locally generated data is collected from various hospital information 
systems (IS) such as clinical and laboratory IS, devices such as ventilators and dialysis 
machines, ICU monitors, and treatment-related data, e.g. drug doses and transferred and 
stored in local clinical data warehouses (CDWH). In order to follow Sepsis 3.0 criteria 
[4], we regularly tag patient with suspected sepsis and collect information in the clinical 
IS. This will allow to compute Sepsis-3 criteria and compare data patterns to this 
international accepted definition of sepsis. The data is structured and interoperable 
between centres following SNOMED CT and LOINC ontologies. Data is then transferred 
in a resource description framework (RDF) format after encoding and encryption via the 
BioMedIT nodes to the ETH domain for further analysis. A shared data model will be 
used for machine-learning based analysis. The legal and governance framework is 
established using a Data Transfer and Use Agreement (DTUA) and Consortium 
Agreement (CA) [Figure 1]. 
The clinical outcomes of our study include: (i) prediction of sepsis with new 
markers in comparison to Sepsis-3 criteria and (ii) prediction of in-hospital mortality. 
There are two prospective observational trials conducted with these patients. 
Study A includes every patient admitted to an ICU. Following specific 
inclusion/exclusion criteria, we include sepsis (cases) and non-sepsis (controls) upon 
entry of the ICU. Of all patients with an ICU admission also available pre/post-ICU data 
will be integrated into the data analysis. We will compare data patterns between cases 
and controls in regards of the previously defined outcomes. 
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Study B includes a subgroup of the patients from Study A. In all five hospitals 
a total of 300 patients with severe community acquired pneumonia (cases) and 100 
patients with a severe systemic inflammation (controls) will be included. We will collect 
additional patient material such as serum, whole blood for DNA and RNA, respiratory 
and stool material, immune cells and bacterial isolates. These samples will be in-depth 
characterized using metabolomics, metagenomics, whole genome sequencing and 
immune phenotyping technologies. Digital and -omics data will then be merged and 
analysed to form hybrid biomarkers. Again, case and control patients will be compared 
in regards of the previously defined outcomes. 
3.Results 
For the digital biomarker project (Study A) we have obtained ethical approval to collect 
data from 15,000 ICU patients from participating centres over the next few years. In 
addition, a data transfer and use agreement as well as a consortium agreement have been 
generated. The legal process to allow data sharing was complex and involved a multiple 
round assessment and discussion of the legal framework with various stakeholders. 
 A list of clinical, physiological and laboratory variables, covering more than 
500 attributes of interest was generated and linked to ontologies such as time points, 
application route and dosage of specific drugs, etc. Collection of data has started at local 
levels with a total of already several hundred patients from the participating ICUs. Within 
the next 6 months, we expect data from 3,000 patients to be collected.  
 Data transfer and exchange protocols are currently tested with all CDWH, 
BioMedIT, and ETH domain teams and continuously improved.  
 The second -omics biomarker project (Study B) has not yet started. The ethical 
proposal has been submitted and decision is pending. Study preparation are progressing 
at all centers. In regards of the sample management different biobank information 
management software (BIMS) systems have been established in the various centers.  
4.Conclusions 
Ethical and legal frameworks are critical in a data-driven large consortium and this 
bottleneck should not be underestimated. The legal discussions show a different 
momentum, content and motivation compared to research questions. This should be 
anticipated in such a project. A lead legal institution may be a good concept to provide 
legal advice, besides the availability of the DTUA and CA. The legal situation of large 
healthcare project is complex and requires a professional support. There is a clear benefit 
of regular meetings with all stakeholders for in-depth discussions and finding solutions 
for challenges. Once fully functional, the current framework will allow to collect and 
store data for research purposes across all Swiss University Hospitals ICUs – beyond 
sepsis. 
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 Figure 1. SPHN/PHRT framework for the Sepsis driver project. All centers locally collect data from 
different primary sources in clinical data warehouses. The is high interoperable and standardized 
following ontologies. The exchanged follows secured routes of BioMedIT to the ETH Domain for quality 
control and analysis. [1] 
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Abstract. In Switzerland by 2045, we expect 2.7 Mio citizens aged 65+ of whom 
1.0 Mio. aged 80+. A priority and focus of personalized health research is therefore 
aging biology to extend healthy life expectancy. Novel molecular and imaging 
features will emerge as candidate targets for risk prediction and screening of chronic 
diseases. It is of utmost importance to test the clinical and public health utility of 
candidate biomarkers evolving from this research in citizen reference cohorts. We 
will build a Swiss Aging Citizen Reference (SACR), a testable and scalable 
reference cohort offering interoperable, searchable, and accessible data. 1000 
participants from existing Swiss citizen cohorts will be combined and analyzed for 
DNA methylation and MRI brain imaging. SACR will serve as a testbed for clinical 
and public health utility of candidate biomarkers. As for a proof-of-concept study, 
we will conduct an agnostic search for structural and functional brain features 
associated with epigenetic aging acceleration to examine the potential of epigenetic 
age acceleration as the intermediate aging biomarker and to better understand the 
aging mechanism in brain. 
Keywords. SPHN, personalized health, citizen reference, aging, DNA methylation, 
brain imaging 
1.Introduction 
The number of older citizens in Switzerland is growing. In 2045 pensioners aged 65+ are 
expected to account for over 2.7 million inhabitants, with over 1 million aged 80+. It is 
of strategic importance for the country from both, economic and public health 
perspectives, to maximize the healthy life expectancy of future elderly people.  
Molecular and imaging biomarkers evolving from personalized health research 
depend on a healthy reference for utility testing. Citizen cohorts with prospectively 
sampled biomaterial are essential for investigating the reference distribution of 
exposome, risk prediction and screening biomarkers and their independent value in 
predicting morbidities. Among many indices and markers of biological aging, DNA 
methylation in blood has been demonstrated as a robust aging biomarker, with potential 
to interrogate molecular mechanism behind aging. DNA methylation-derived epigenetic 
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age acceleration was cross-sectionally associated with poorer cognitive performance 
(fluid intelligence), lower grip strength, poorer lung function, and with frailty. 
Cognitive decline and neurological disorders are becoming one of the most 
significant socio-economic burdens of our aging society. One of the fundamental 
questions in human neuroscience is how molecular and cellular processes in the living 
brain drive cognitive changes over the lifespan. In recent decades the study of brain 
structure and function in health and disease has been greatly aided by the advent of 
magnetic resonance imaging (MRI) and started revealing how acute focal lesions and 
chronic neurodegeneration can lead to impaired cognition and disease states. 
In this SPHN driver project we will build a Swiss Aging Citizen Reference (SACR) 
as a public health pillar for personalized health in Switzerland, where we implement 
brain imaging biobank into existing Swiss citizen cohorts to test the clinical and public 
health utility of candidate biomarkers including epigenetic age acceleration. 
2.Methods 
We build a scalable SACR infrastructure to integrate existing Swiss citizen cohorts, 
SAPALDIA, SKIPOGH, and CoLaus|PsyCoLaus, offering interoperable, searchable, 
and accessible data for researchers. The SACR population will continue to grow by 
integrating additional citizen cohorts in the future. 
DNA methylome and MRI brain imaging data will be obtained for 1000 SACR 
citizens from the three cohorts. DNA methylome is already available in SAPALDIA and 
will be obtained for SKIPOGH and CoLaus|PsyCoLaus. MRI brain imaging has been 
conducted in CoLaus|PsyCoLaus and will be complemented for SAPALDIA and 
SKIPOGH. As for a proof-of-concept study, structural and functional features derived 
from quantitative  MRI indicative for brain’s myelin, iron and free tissue water content 
will be agnostically searched for association with epigenetic age acceleration. 
3.Expected results 
From the proof-of-concept study, we will identify brain microstructure features 
associated with epigenetic age acceleration, which is considered as an early biological 
aging marker, therefore we will provide evidence towards the validity of epigenetic age 
acceleration as intermediate aging biomarker. Further analyses on the brain imaging 
features towards aging phenotypes, e.g. cognitive function, will contribute to better 
understanding of brain aging, and potentially to its prediction at an early stage. 
4.Public health impacts 
As a result of this SPHN driver project, we will have a testable and scalable reference 
“SACR”. This will constitute the public health pillar for personalized health in 
Switzerland, offering interoperable, searchable, and accessible data for personalized 
health researchers. Archived biomaterial and data from SACR participants will be 
accessible for testing the clinical and public health utility of candidate biomarkers and 
exposome features in predicting biological age and age-related (multi-)morbidities. 
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Abstract. The BioMedIT project is funded by the Swiss government as an integral 
part of the Swiss Personalized Health Network (SPHN), aiming to provide 
researchers with access to a secure, powerful and versatile IT infrastructure for 
doing data-driven research on sensitive biomedical data while ensuring data privacy 
protection. The BioMedIT network gives researchers the ability to securely transfer, 
store, manage and process sensitive research data. The underlying BioMedIT nodes 
provide compute and storage capacity that can be used locally or through a federated 
environment. The network operates under a common Information Security Policy 
using state-of-the-art security techniques. It utilizes cloud computing, virtualization, 
compute accelerators (GPUs), big data storage as well as federation technologies to 
lower computational boundaries for researchers and to guarantee that sensitive data 
can be processed in a secure and lawful way. Building on existing expertise and 
research infrastructure at the partnering Swiss institutions, the BioMedIT network 
establishes a competitive Swiss private-cloud – a secure national infrastructure 
resource that can be used by researchers of Swiss universities, hospitals and other 
research institutions. 
Keywords. Personalized health, SPHN, research infrastructure, scientific IT 
services, federated computation, sensitive data, confidential data, data privacy, data 
security, health-related data, interoperability, private-cloud, service virtualization 
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 1.Introduction 
The advent of digital transformation in health care has produced an exponential increase 
in the amount of information available for each patient. The use of this information in 
data-driven biomedical research has the potential to drive important changes in medicine 
[1]. In order to be able to leverage the potential of health-related data through biomedical 
research, data science and related research fields, data needs to be interoperable and 
available to researchers in various disciplines. In addition, strong capabilities in clinical 
bioinformatics and computational service infrastructure are required in order to enable 
the integration and interpretation of large and rich data sets. Furthermore, big data 
analyses and machine learning require vast amounts of data and accordingly high-
performance IT infrastructures for computing and storage.  
Given the sensitive nature of health-related information, data-driven personalized 
health research requires special IT infrastructures and services, blending the concepts of 
(i) security and compliance to protect the confidentiality of the data and the privacy of 
the research study participants; (ii) scalability and performance to be able to adapt to 
changing needs of users; and (iii) flexibility and ease of use to foster cutting-edge 
biomedical research. Security measures for Information and Communications 
Technology (ICT) systems are necessary to protect confidential information from 
unauthorized use, modification, loss or release2. A few years ago, these requirements 
were not a major concern for academic computing facilities in Switzerland because those 
were predominantly tailored towards the handling of (insensitive) basic research data.   
Another important requirement concerning the architecture of IT infrastructures for 
researchers working in multidisciplinary networks on big data sets in the biomedical field, 
is the possibility for controlled access to data sets across research teams from different 
institutions, also cross borders. In addition, in the context of nation-wide collaborative 
research projects, technical interoperability between different IT infrastructures should 
be granted in order to enable reproducibility of data analysis workflows executed at 
distributed locations [3].  
To address the needs listed above, the BioMedIT project was funded by the Swiss 
federal government for the period of 2017-2020 within the framework of the Swiss 
Personalized Health Network Initiative (SPHN) [4] and in close collaboration with the 
strategic focus area Personalized Health and Related Technologies (PHRT) of the Swiss 
Federal Institutes of Technology (ETH) domain [5]. The aim of the project is to provide 
all researchers in Switzerland with access to a service infrastructure for collaborative 
analysis of confidential data without compromising data privacy. The intention is to 
create and maintain a national infrastructure resource that can jointly be used by all Swiss 
universities, research institutions, hospitals and other interested partners. 
2.The BioMedIT Network: a National Secure Infrastructure Resource for 
Switzerland 
The BioMedIT network builds on three scientific IT competence centers – the BioMedIT 
nodes – in different geographical locations: one in Basel (sciCORE, operated by the 
University of Basel), one in Lausanne (Core-IT, operated by the SIB Swiss Institute of 
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 Bioinformatics) and one in Zurich (SIS, operated by ETH Zurich). Over the past two 
years, all three nodes established secure compute and data platforms specialized on 
handling confidential research data that is are subject to legal and ethical constraints. The 
computational service infrastructure is available to Swiss universities, research institutes, 
hospitals, service providers and other interested partners (organizational clients, see 
Section 2.4) that are not part of the BioMedIT network, to securely store, manage and 
process confidential research data. In addition, and specifically within the framework of 
the two Swiss national initiatives SPHN and PHRT, the BioMedIT network can be used 
for mono- and multi-site, individual and collaborative research projects (project clients, 
see Section 2.3). In fact, several innovative biomedical research projects [6] are already 
using a first version of the BioMedIT infrastructure.  
2.1.Security Aspects of the BioMedIT Network 
A common Information Security Policy [7] that applies to the entire BioMedIT network, 
defines the necessary organizational and technical measures to allow researchers to 
process sensitive data in a secure way3. This policy controls the way the confidentiality, 
integrity, and availability of information is handled, preventing misuse and malicious 
damage. In conventional high performance or high throughput systems available in 
scientific environments, the physical hardware and the respective software services are 
shared between all users. For data privacy and security reasons, BioMedIT takes a 
different approach: researchers involved in one particular project work completely 
isolated from any other project, meaning that all the data, software and resources belong 
exclusively to that project and there is no possibility to access it in any other way or from 
any other path. To this end, virtualization technologies are applied to establish private-
cloud environments in which each scientific project is completely isolated from other 
projects with respect to data and compute resources. Access of authorized users to any 
project space requires two-factor authentication. Furthermore, users that are authorized 
to use the secure BioMedIT network can only access the infrastructure from within 
trusted IT environments (either from within Swiss university or university hospital 
networks or via VPN). Access to the Internet from the BioMedIT nodes is strictly 
controlled, limited to trusted and explicitly white-listed web resources. 
The three BioMedIT nodes share a common security architecture to transfer, store, 
manage, analyze and share biomedical data while following the latest technical and legal 
standards required by Swiss legislation4 as well as internal regulations of the associated 
institutions. For project-related data transfer, an end-to-end encryption process from the 
data source through the BioMedIT network to the project space is set up, based on public-
key cryptography. Special consideration is given to key management which is provided 
as a central service to users of the network. 
Furthermore, the network follows the SPHN Ethical Framework for Responsible 
Data Processing in Personalized Health Research [11]. Importantly, before using the 
secure BioMedIT network, users are requested to follow a data security awareness 
training. BioMedIT offers the “Data Privacy and IT Security Training” as on-line 
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Protection Regulation [10] 
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 training [12] or class-room course hosted regularly in different cities in Switzerland. 
Finally, users must pass a mandatory on-line exam.  
2.2.Technical Features of BioMedIT’s ICT environment  
The BioMedIT nodes provide a broad range of secure services to store, manage, process 
and share biomedical data. For example, multi-CPU (central processing unit) and multi-
GPU (graphics processing unit) compute nodes are connected by fast internal networks 
to large and fast parallel file systems and state-of-the-art data management services. To 
date, the BioMedIT infrastructure features data storage capacity approaching in total 5 
PB, support for data encryption, secure backup, private-cloud and high performance 
computing (HPC) leveraging more than 3000 CPU cores and 324 GPUs. State-of-the-art 
software for data science and specialized tools for data management are provisioned 
alongside with long-standing expertise in scientific IT support for research data 
management, bioinformatics, HPC and computational analysis. 
2.3.Lowering Computational Barriers for Researchers (Project Clients) 
The BioMedIT network provides a flexible ICT environment, and individual project 
spaces can be configured based on the researcher’s computational and storage needs. 
This includes storage and compute capacity, up-to-date data analysis and modeling 
software packages, as well as backup and archiving solutions. The nodes can provide 
secure work environments for basic exploratory data analysis but can also scale up to 
cover high performance and high throughput needs such as large-scale machine learning. 
The BioMedIT portal, a central service of the network operated by the SPHN Data 
Coordination Center of SIB’s Personalized Health Informatics Group, provides a single 
access point to the BioMedIT nodes and associated resources, simplifying access control 
for the researchers. Depending on the use-case, the BioMedIT network can be accessed 
by command-line or by web-based remote-desktop technology. 
Standardized ways for secure data transfer from partner institutions, such as the five 
Swiss University Hospitals, the PHRT data centers and other data providers are currently 
being established and will be available to all projects relying on data from any of these 
providers. 
The BioMedIT network aims to enable interoperable workflow execution, providing 
a way for researchers to work seamlessly across the nodes. Containerization of data 
workflows using Open Container Initiative (OCI) standards [13] are playing an important 
role for this and will at the same time improve reproducibility of results obtained by these 
workflows. The ultimate goal of BioMedIT is to provide a data-aware federated analysis 
platform where researchers can work with distributed data. This approach is especially 
valuable for confidential data or large data sets, which cannot easily be shared. 
2.4.Outsourcing Sensitive Research Data Operation to BioMedIT (Institutional 
Clients) 
While the focus of the BioMedIT network is to support national research projects in the 
SPHN and PHRT programs, the BioMedIT nodes are creating a unique data and 
computing environment that will be useful and potentially required for research activities 
outside of these programs. Clinical institutions scaling up their data processing in 
preparation of clinical research projects or clinical decision support strategies, 
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 consortium projects with public and private partners, or novel ways to run clinical trials, 
which create large amounts of trial data and require good clinical practice (GCP) 
compliant data management, are examples for it. The BioMedIT nodes are offering a 
safe environment for these types of activities and are working on enhancing their 
platforms for future needs. By linking to the BioMedIT network, Swiss research 
institutions and hospitals can hence benefit from a trusted research IT infrastructure 
without the need to (re)develop costly in-house infrastructures and know-how. 
3.Conclusion  
BioMedIT provides data resources and a network of secure data nodes for doing data-
driven research on sensitive (confidential) biomedical data. It lowers computational 
barriers by provisioning an efficient solution for cross-institutional analysis of sensitive 
data, and is therefore unique in Switzerland. The technical solution is comparable to 
related activities within ELIXIR in various European countries [14]. However, 
BioMedIT operates within a national network of health-care providers, infrastructure and 
research support groups, research projects as well as citizens, and therefore has a great 
potential to become a platform of reference for health data exchange and analysis. A first 
version of the BioMedIT network is established and already used by SPHN and PHRT 
projects and pilot collaborations with Swiss university hospitals. These projects help 
shaping new versions of the BioMedIT infrastructure to make it even more useful, 
efficient and secure for current and future biomedical research applications.  
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Abstract. The aim was to describe nurses’ and physicians’ perceptions of a digital 
service logistics information system from an operative management perspective in 
emergency departments (EDs). A total of 24 professionals were interviewed. 
Based on the results the information systems support operative management of 
EDs but the professionals desire more detailed information about patients and staff 
to support situational awareness in the operative management of these units. 
Keywords. Emergency Department, Information System, Care Coordination 
1. Introduction 
Although information management in health care today is widely digitalized and 
electronic health records have received attention, less is known about information 
systems developed for operational management. Timely access to important 
information is essential when managing the day-to-day operations of emergency 
departments (EDs) in hospitals as decisions typically must be made without delay [1]. 
This study focuses on a service logistics information system (Columna Clinical 
Care Logistics®) that displays information about patients, staff and care processes for 
the professionals. It is available in hospitals on screens, personal computers and mobile 
devices. The system aims to support easy access to important information for 
multiprofessional needs. The aim of this study was to describe nurses’ and physicians’ 
perceptions about this information system from an operative manager’s perspective in 
an ED. 
2. Methods 
The study had a cross-sectional design. Data were collected in three EDs, including two 
emergency departments and one emergency inpatient ward in two central hospitals in 
Finland. A total of 24 professionals, including 7 physicians and 17 nurses, who were in 
charge of coordinating care, participated in the study. Data were collected through 
interviews with two open ended questions: 1) What do you think is good about the 
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service logistics system? and 2) what could be improved regarding the service logistics 
system? Data were collected in the autumn of 2018 and spring of 2018. Data were 
analysed using thematic content analysis [2]. 
3. Results 
The mean age of the respondents was 42.4 years (SD 10.2) and their mean work 
experience was 17.2 years (SD 11.7). Three respondents worked only at office hours, 
three worked only beyond office hours and eighteen worked both during office hours 
and beyond. Issues regarding the information system were divided into three main 
themes. 
 Support for care coordination: The system provides multidisciplinary task 
management support and a quick overview of patients, staff and 
processes, but the complexity of care needs and staff skills was not shown 
in sufficient detail. 
 System implementation and usage: Personal traits and the information 
management culture influenced system usage, and professionals used the 
system to a different extent when measured at one year after 
implementation. 
 Information exchange: A lack of information exchange with other 
systems limited the possible benefits in communication between care 
providers.  
4. Discussion 
The digital service logistics information systems support operative management of EDs. 
However, professionals desire more detailed information about patients and staff for 
situational awareness. Artificial intelligence could be used to support this task. Further, 
it takes a long time to learn how to use such an information system as it changes the 
professionals’ work. Hence, the need of a long follow-up period needs to be considered 
when measuring the impact of such systems to ensure that all users use the system in 
the way expected. In conclusion, digital service logistics information systems can 
support professionals’ situational awareness in EDs, but they should be developed 
based on evidence of information needs. Reliable use requires that all users use the 
system to its full potential.  
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Abstract: Automation of organizing and analyzing NHANES data can provide 
easier access to data and potentially reducing risk of introducing bias. This study 
investigates the potential for developing a software for this purpose. MATLAB 
R2016b was used for transforming and analyzing data from the NHANES. The 
software was tested successful by analyzing the association between smoking and 
glucose metabolism in the general population. 
1. Introduction 
The National Health and Nutrition Examination Survey (NHANES) (1) is a large, 
stratified, multistage survey conducted by the Centers for Disease Control (CDC) which 
collects health data on the US population. Data are made publicly available in two-year 
cycles and the data are categorized into six main areas; dietary, demographics, 
examination, laboratory, questionnaire, and limited access data.  
However, there is an absence of reproducible software and methods that transforms the 
data from its published online format into an analytic dataset. Even though the NHANES 
data are publicly available, actually analyzing the data requires a non-trivial amount of 
background information, data processing and linking. This preprocessing is prone to 
introducing bias into the data and requires considerable time and resources. We sought 
to investigate the potential for developing a software for simplifying this process and as 
an example applying the tool for analyzing the association between smoking and glucose 
metabolism in the general population.  
2. Methods  
 
We developed in MATLAB R2016b a two-level tool. Based on the desired NHANES 
year-cycles and data variables of interest the first level of the tool will download the 
relevant data from the public repositories and organize the files locally. The data files 
are published as a .xpt (SAS XPORT) format, therefore the files are subsequently 
imported and converted to tables in MATLAB which are then linked based on year-cycle 
and type of variable.  Based on the merged data the second level of the tool is able to 
analyze data (using an chosen statistical method) and produce tables with patients’ 
characteristics and effect estimates of independent variables in an unadjusted or adjusted 
analysis. In our study of smoking and glucose metabolism, several years of NHANES 
(2005-2014) and data types were utilized. From demographics, gender and age data were 
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collected; from laboratory, fasting glucose and oral glucose tolerance test (OGTT) results 
were collected; from examination, blood pressure and body mass index (BMI) were 
collected; and from questionnaire, data on smoking and alcohol habits were collected. 
The effect of current smoking was assessed in an unadjusted and an adjusted analysis, 
taking the mentioned covariates into account (gender, age, alcohol usage, BMI). 
3. Results 
The MATLAB tool was successful in organizing and analyzing data from several year-
cycles of NHANES. A total of 12460 participants was identified as currently smoking 
(n=2575), ex-smokers (n=3032), and never smoking (n=6853). Currently smoking was 
in the unadjusted analysis associated with higher fasting glucose (effect 3.46 mg/dL, 
SE:0.72, p<0.001). In the adjusted analysis smoking was associated only with lower 
OGTT (effect -3.94 mg/dL, SE: 1.44, p=0.01) 
4. Discussion and conclusion 
Automation of organizing and analyzing NHANES data can provide easier access to data 
and potentially reducing risk of introducing bias. The tool was successfully applied on 
data from several year-cycles. The test results showed a surprisingly negative association 
between smoking and OGTT. This association needs to be investigated in more detail. 
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A Path to Inclusion: Design and Prototype 
of Transgender Identity in n Electronic 
Health Record 
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Abstract. With the purpose of reducing discrimination on gender, the Department 
of Health Informatics of the Hospital Italiano de Buenos Aires (HIBA) developed 
changes in its Patient Master Index to register chosen name and self-perceived 
gender identity. To improve the visualization of information related to the identity 
of each person to provide comprehensive quality care, it was decided to modify the 
impact of this information on the EHR. For this, prototypes were developed with 
changes in the patient identification module and then user-tests were carried out. 
Keywords. Transgender, Electronic Health Records, Identification, Gender. 
1. Introduction 
Gender identity is the internal and individual experience of gender as each person feels 
it, which may or may not correspond to the sex assigned at the time of birth.  This may 
involve the change of the appearance or body function through pharmacological agents, 
surgery or other, when it is freely chosen. It also includes other gender expressions, 
such as dress, speech and manners. 
Since 2018, the self-perceived gender of the patient and their chosen name are 
included in the registration system [2]. In order to improve the visualization of 
information related to the identity of each patient to provide comprehensive quality 
care, it was decided to incorporate this information on the EHR. For this, prototypes 
were developed with changes in the patient identification module and then user-tests 
were carried out. The aim of this study is to describe the user-centered design process, 
used to visualize the identification of transgender patients within the Electronic Health 
Record. 
2. Methods 
Inquiries and usability tests were carried out with HIBA health professionals. Sample 
selection was for convenience. Users had to present the following inclusion criteria: be 
a health professional (regardless of training level), have used the EHR for at least 6 
months in in- and outpatient settings, without knowledge of the Transgender project. 
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2.1Design 
Stage 1: Situational diagnostic: Includes reviewing the literature using PUBMED. The 
articles were manually reviewed and a selection was made of those that mentioned the 
identification of the different identities in the EHR. Then, the current legislation in our 
country was evaluated to include the regulatory framework. 
Stage 2: Design and evaluation: Prototype Design: From the bibliography found, the 
Gender Identity Law [1] and the iconography, different prototypes were designed to 
cover the different use cases. They consisted of a capture of the summary module of 
the Electronic Health Record. On the sidebar, where the affiliate data is found, the icon 
was linked with the chosen name, followed by the initials of the legal name. Likewise, 
the last name, the chosen name, the legal name, the gender, a hyperlink to the gender 
law and the biological sex were included in the “More data” menu. 
Stage 3: User tests: A test round was carried out with five different users. Interfaces of 
the EHR with the iconographic incorporation were evaluated. A clinical case about a 
transgender patient with a chosen name, but without a change of birth ID, was 
conducted. Users were shown a mock up with the visualization of the case data. They 
were asked to interpret the patient from data, describe what they saw, decide the gender 
of the patient . Each professional was asked about whether he detected any change in 
the display of the patient's identity information, what the selected icon meant and what 
he thought the letters in brackets were referring to. This test was carried out in the 
workspace of each professional. After each test, reports were made with the findings 
per user. 
3. Results 
Prototype testing: All focused their answers on the patient's clinical data, that is, about 
the diagnosis, the reason for consultation and medical history. The majority of the 
professionals who participated in the test interpreted without hesitation that the patient 
in the case was "male". Only two users doubted the gender because it presented 
interconsultation with gynecology. This was expressed in phrases such as "I doubt 
because in records it says that it consults for infection of the cervix, is he 
transgender?" and "I think it is male because his name is Mariano but here in records 
they put it that it has a cervix and also they made him an interconsultation with 
gynecology. Did they make a mistake?" 
All professionals agreed that they usually infer the patient's sex through their  
name. The majority could recognize, after careful observation, that the icon represented 
in the prototype corresponded to the “transgender” identity. In turn, all users agreed 
that the letters in parentheses were new information in the EHR, but could not infer 
their meaning. These users expressed "I don't know, but now that I see that it is 
transgender I think that maybe is related to its old name". In conclusion, we believe 
that it is essential to accompany the adapting process to the information system with 
instances of awareness, education and training of both administrative and health staff. 
In this sense,  it is vital that all employees of the institution understand the importance 
of respecting each person's perception of themselves and how they want to be 
identified. Respecting and enforcing each other's gender identity allows us to live in a 
society with less discrimination and more understanding of others. 
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Abstract. Aiming to better understand the genetic and environmental associations
of Alzheimer’s disease, many clinical trials and scientific studies have been con-
ducted. However, these studies are often based on a small number of participants.
To address this limitation, there is an increasing demand of multi-cohorts studies,
which can provide higher statistical power and clinical evidence. However, this data
integration implies dealing with the diversity of cohorts structures and the wide
variability of concepts. Moreover, discovering similar cohorts to extend a running
study is typically a demanding task. In this paper, we present a recommendation
system to allow finding similar cohorts based on profile interests. The method uses
collaborative filtering mixed with context-based retrieval techniques to find rele-
vant cohorts on scientific literature about Alzheimer’s diseases. The method was
validated in a set of 62 cohorts.
Keywords. Alzheimer cohorts, Cohort catalogue, Recommendation systems
1. Introduction
There is a need for discovering new biomarkers to diagnose Alzheimer’s disease in the
predementia stage to predict the rate of decline [1]. Therefore, several institutions in-
creased the efforts in collecting Alzheimer’s patients’ data, as well as to build a har-
monised structure to store these cohorts.
In the EMIF project1, we have developed a platform to collect and publish metadata
about EHR databases and disease specific cohorts [2]. The EMIF Catalogue includes sev-
eral communities, one of them dedicated to the study of Alzheimer’s disease. In this cen-
tralised platform, data sets are classified through a set of general characteristics, which
allow the identification of similar patterns across the collection. However, the manual
analysis of these similarities is time consuming and hard to perform.
In this paper, we propose a methodology that, based on previous knowledge gath-
ered from user’s preferences and user’s data sets, is able to suggest similar cohorts and
related scientific publications. The method uses collaborative filtering and context-based
retrieval techniques, taking as inputs the cohorts’ metadata in an predefined ontology, its
concepts and relationships.
1http://www.emif.eu
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2.?Methods?and?Materials
The?EMIF?Catalogue?is?a?web?platform?for?biomedical?data?sharing,?where?data?custo-
dians?can?publish?information?about?their?data?sets?[2].?This?information?is?mainly?sta-
tistical?information?and?aggregated?databases’?metadata.?In?the?platform,?researchers?can?
search?for?databases?of?interest?and?request?access?to?the?raw?data,?data?subsets,?or?ask?to?
perform?certain?research?questions.
Most?of? the?research?studies?do?not?follow?a?standard?structure?or?format,?because?
they?are?built?with?a?specific?purpose,?with?inclusion/exclusion?criteria.?To?allow?the?re-
producibility?of? research?questions? in?different?cohorts,?our? strategy?was? the?adoption?
of?a?taxonomy?implemented?using?an?ontology?with?the?recorded?variables?and?also?the?
values?(columns?and?rows).?This?method?allows?comparing?multiple?cohorts,?i.e.,?all?the?
variables?will?be?mapped?into?ontology?classes,?and?this?ontology?supports?relationships?
between?concepts,?following?a?hierarchical?tree?with?root?entities?that?represent?core?cate-
gories?that?are?being?followed?(i.e.?Patient?Demographic?Data,?Neuropsychiatry,?Labora-
tory?Results,?etc.).?Moreover,?it?is?also?possible?to?create?constraints?in?the?cohort?scope,?
and? it? is?flexible?enough?to?extend?or?create?new?variables.?The?ontology?management?
is?maintained?by?community?using?a?common?RDF?(Resource?Description?Framework)?
specification.
3.? Results?and?Conclusions
We?proposed?a?recommendation?system?that?combines?two?techniques.?The?collaborative?
filtering?can?detect?s imilar?users?and?provide?the?recommendation?based?on?the?analy-
sis?when?the?cohorts?structure?of?the?users?interest?are?too?disperse.?On?the?other?hand,?
the?context-based? retrieval?can?predict?suggestions?when? the?user? is?more?singular,?by?
relying?only?in?the?cohorts’?concepts.?We?applied?evaluation?metrics?to?each?individual?
approach?and? then?combining?both? strategies.?The?methodology?was? integrated? in? the?
EMIF?Catalogue?platform,?using?the?statistical?data?collected?from?the?Alzheimer’s?com-
munity.?This?group?gathered?metadata?information?from?62?cohorts,?representing?in?total?
661?concepts,?which?have?also?been? indexed? through?our?system.?This?community?has?
more?that?500?registered?users,?allowing?a?first?test-bed?to?apply?our?methodology.
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Abstract. The integration of heterogeneous healthcare data sources is a necessary 
process to enable the secondary use valuable information in clinical research. Data 
integration is time-consuming for data stewards. The transformation using 
predefined rules for data harmonization can reduce the time-consuming and error-
prone work and ease the data integration at various sites. In our study, we 
examined various script(ing) languages to find the most suitable candidate for 
definition of transformation rules and implement a smart editor which supports the 
data stewards in selecting rules reusing them. Thereby, it also provides an 
automatic and seamless documentation to strengthen the reliability of the defined 
transformation rules. 
Keywords. Health Information Interoperability, Data Warehousing, HL7 FHIR 
1.Introduction 
The increasing digitalization of the healthcare sector produces a variety of new data 
sources which should be integrated to exchange data and therefore enable secondary 
use in clinical research [1]. But often, the origin and prior processing steps are not well 
documented, impeding the ability to reliably determine the data origin and thus 
hampering reproducible research [2]. Therefore, the data origin must be reliable. Data 
integration and therefore data transformation needs suitable tools to transform 
information with seamless documentation. Data stewards need to examine both input 
and output formats and define conversion rules and confirm the performed 
transformation. A broad variety of open source integration tools is available to extract, 
load and transform [3]. However, they share the same lack of exchangeability: the 
transformations are encoded locally in a proprietary representation. Healthcare data 
provider and integration centres facing the same integration problem, could benefit  
from exchanging these transformation schemes [4]. 
2.Methods 
A standardized data format and a commonly  used  transformation  language  are  
needed to promote the exchange of transformation rules. HL7 FHIR is a suitable 
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communication standard, which defines 143 interoperable resources including three 
suitable for transformation: ConceptMap, StructureMap, and Provenance. JavaScript is 
one of the internet core technologies and due to the code execution in the browser on 
every common environment applicable. 
3.Results 
We took the requirements into account and implemented an editor service. The 
development focused a modular structure with standardized HL7 FHIR input and 
outputs formats, assistance for the data steward and reproducibility of the created 
mappings. The ConceptMap is uploaded manually or received from a FHIR server. The 
content is visualized with additional details about the source and target data element 
[5]. The editor provides syntax highlighting for various script languages and live 
checking to minimize errors. The data steward can define the transformation in 
JavaScript and use sample data to validate the mapping in real-time. A proposal 
function is based on previously stored transformation rules and locally-sensitive 
hashing function [6]. OpenID Connect was used to obtain the user information for the 
Provenance resource. The editor exports the resulted mapping as a FHIR bundle 
including a StructureMap, a Provenance and the corresponding steward in a 
Practitioner resource. The source code of the editor is available on 
https://github.com/itcr-uni-luebeck/. 
4.Discussion 
The editor focuses on standardized approach to exchange defines rules to minimize the 
time-consuming integration task. Our approach uses FHIR resources to promote this 
exchangeability and enables a plug and play for data integration to expedite the 
process. The choice of JavaScript as the transformation language ensures system-
independent use since every common browser is capable of executing the rules. 
Nevertheless, the editor is implemented modular and language-agnostic, e.g., the use of 
Python is possible. In conclusion; Our study aims at closing the documentation gap for 
metadata-driven data integration by providing a supportive editor for the better 
reproducibility. 
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Abstract. Yuzawa Town, located in the Niigata prefecture of Japan, is famous for 
its hot springs. A citizen-centered health promotion program, Yuzawa family health 
plan, was initiated in 2002. It has been held for seventeen years. We evaluated 
changes their accessible rates to health information on the internet between 2002 
and 2017 in elderlies. 431 and 435 questionnaires were corrected from elderly 
people at least 65 years old at 2002 and 2017. The accessible rates to health 
information on the internet in elderlies increased (p<0.001). Profiles of accessible 
elderlies to health information on the internet were shown. Son and daughter might 
give them health information. Elderlies having any health concern or anxiety might 
be afraid to take health information. Accessible elderlies to health information were 
able to resolve suffering and breach risks by oneself. 
Keywords. health promotion, health information, elderly 
1. Introduction 
Yuzawa Town, located in the Niigata prefecture of Japan, is famous for its hot springs. 
The number of citizens is about eight thousands. The population is decreasing, because 
Yuzawa town is one of fast aging towns in Japan. A citizen-centered health promotion 
program, Yuzawa family health plan, was initiated in 2002. It has been held for 
seventeen years. Questionnaires were collected every five years. We evaluated changes 
their accessible to health information on the internet between 2002 and 2017 in elderlies. 
We evaluated the profiles for accessible to health information on the internet at 2017. 
2. Methods 
431 questionnaires were corrected from elderly people at least 65 years old at 2002, and 
435 questionnaires were corrected at 2017. Chi-square test was used to compare the rate 
of accessible health information on the internet. Chi-square test was also used to 
evaluate related profiles with accessible to health information on the internet at 2017 in 
elderlies. 
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Evaluated profiles were living alone, living with marriage partner, living with son or 
daughter, living with grandchildren, living with brother or sister, health consciousness, 
attention to health, health concern, awakening in a morning, clockwork life, fitness 
habits, smoking, taking alcohol, anxiety, loneliness, consultation, resolve suffering, 
economic problem, handle stress, taking a rest, risk breaching, communication, life 
satisfaction, talking with family, job at home, intercommunion with friends, greeting 
with neighbors, relationship with neighbors, relationship with babies, relationship with 
elementary school children, relationship with junior high school students, relationship 
with high school students, relationship with young adults, relationship with middle aged 
adults, and relationship with elderlies. 
3. Results 
Accessible rates to health information on the internet in elderlies increased from 4.5% at 
2002 to 13.1% at 2017 (p<0.001).  
Living alone (p<0.01), living with marriage partner (p<0.01), taking alcohol (p<0.05), 
resolve suffering (p<0.05), risk breaching (p<0.05), talking with family (p<0.01), and 
relationship with middle aged adults (p<0.01) increased the accessible rate to health 
information on the internet at 2017. Living with son or daughter (p<0.01), health 
concern (p<0.05), anxiety (p<0.05), consultation (p<0.01), and relationships with 
neighbors (p<0.05) decreased it. 
4. Conclusion 
Accessible rates to health information on the internet in elderlies increased about three 
times between 2002 and 2017. Profiles of accessible elderlies to health information on 
the internet were shown. Though living alone or living with marriage partner increased 
accessible rates to health information, living with son or daughter decreased it. Son and 
daughter might give them health information. Elderlies having any health concern or 
anxiety might be afraid to take health information. Accessible elderlies to health 
information were able to resolve suffering and breach risks by oneself. 
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Addressing Ethics in the CrowdHEALTH 
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Abstract. CrowdHEALTH is a R&D project involving high volumes of health-
related data. Although partners have been complying with all regulatory and ethical 
issues according to their context in different EU countries, ethical aspects related to 
the adoption of the project results and possible impact on individuals and 
populations were not in the project agenda from the outset. Inspired by an 
increasing number of initiatives in the EU concerned with aspects related to ethics 
in research and innovation, future plans consider investigating the level of 
awareness of all stakeholders involved in the project about the potential 
implications of their actions in terms of ethical acceptance of project outcomes.  
Keywords. Ethics, Ethical Issues, Responsible Innovation, RRI 
1. Introduction 
CrowdHEALTH is an EU research project that intends to collect and aggregate high 
volumes health-related heterogeneous data from multiple sources with the aim of 
supporting policy making decisions. A Policy Development Tool proposes an interface 
that allows policy makers to interact with data and key performance indicators to create 
visual representations that support the elaboration or evaluation of Health policies. 
At project start, mainly ethical issues that may affect the research and the testing of 
developed results in real cases pilots were considered. In the context of CrowdHEALTH, 
ethical issues were principally centered on privacy and data protection and children and 
patients’ involvement.  
2. Method 
The project collected information related to ethical requirements from partners that 
had to run pilots in their organizations. A structured template with hints for its 
fulfillment was provided to gather consistent data from all use cases. Contributions were 
integrated, extracting general procedures that applied to all pilots and describing the 
procedures specific to each pilot.  
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3. Results 
The compiled document showed that all measures to ensure that the project 
complied with ethical principles and relevant national and EU legislation had been taken.  
4. Discussion 
However, considering CrowdHEATH’s intention is to facilitate the access and 
analysis of large amounts of data for policy – and maybe intervention in the future – that 
may have an impact on whole populations, potential ethical implications go beyond 
mere research ethics. The question arises whether the project is dealing with all ethical 
aspects in a proper way. The project faces ethical challenges related to subjecting 
individuals and populations to policies and interventions based on non-transparent data 
sources, processing and analyses. Although CrowdHEALTH is developing components 
to clean data and ensure quality and reliability, it is not fully clear who will be 
accountable for the quality of the data input, or the algorithms applied. 
Inspired on the one hand by recent concerns and interest in the challenges that 
ethical aspects present when using technologies related to Big Data and Artificial 
Intelligence, where transparency and accountability are treated as key issues and, on the 
other hand by the EU's Responsible Research and Innovation (RRI) approach, implying 
that research in Europe needs to understand, anticipate, and address ethical, legal and 
social aspects, the project started wondering if all experts involved in the project were 
aware and applying methods to ensure that the results of the project are desirable and 
anticipate risks. We therefore started to shift our attention towards what could be done 
to anticipate effects related to ethical issues that would impact the adoption of the 
project outcomes.  
5. Conclusive Remarks 
It becomes evident that the project needs to investigate more if there is awareness within 
the team and if an individual questioning of choices and actions would be enough to 
ensure that project consortium culture is aligned with the EU RRI approach.  
To obtain insight about all stakeholders involved in the project (researchers, 
designers, developers, etc.) awareness on ethical issues in their daily work, a survey is 
being launched, including a few demographic questions, to allow clustering per profile.  
The objective is to reach directly individual experts along the research and 
innovation value chain, and understand how familiar they are with ethical aspects, such 
as transparency, accountability, social values, etc. and if this may result as a better 
understanding of ethical implication of the project outcomes on society.  
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Abstract. Colorectal cancer (CRC) ranked third among most commonly diagnosed 
cancers worldwide. The onset of second primary cancer (SPC) is an important 
indicator in treating CRC. We tried to use the advanced machine learning method in 
order to find the factors of SPC. Patients with CRC from three medical centers were 
identified from cancer registries in Taiwan. The classifier of A Library for Support 
Vector Machines (LIBSVM) and Reduced Error Pruning Tree (REPTree) were 
applied to analyze the relationship of clinical features with category by constructing 
the optimized model of every classified issue. Machine learning can be used to rank 
the factor affecting the secondary primary malignancy. In the clinical practice, 
physician should be of aware the possibility of cancer recurrence and routine 
checkups for early second primary malignancy detection is recommended. The 
accuracy rate of the may need more big data. The machine learning method is 
feasible in detecting/predicting potential second primary cancer in the future. 
Keywords. Colorectal Cancer (CRC), Second Primary Cancer (SPC), Machine 
Learning method. 
1. Introduction 
Colorectal cancer (CRC) is the third most common cancer in the world and the fourth 
most common cause of death overall [1]. It is also the most common type of cancer in 
Taiwan, the incidence of CRC is approximately 16%. Early detection of second primary 
cancers is essential to improve health outcomes of cancer patients. Therefore, a valid 
and reliable method/tool to help detecting the SPC is necessary. 
 
2. Methods 
Our study identified data associated with three medical centers from the cancer registry 
database (Taiwan). We used the ICD number C18~C20 to select the CRC patients. The 
colorectal cancer was all diagnosed from 2004 to 2012 and the age was 18 years old and 
above. A total of 4299 patients with primary colorectal cancer were enrolled. Of those, 
541 samples had primary colorectal cancer plus second primary malignancies. In this 
study, we used the correlation analysis to examine the following 20 factors associated 
with colorectal cancer: patient age, primary site, histology, behavior code, 
differentiation, tumor size, pathologic stage, surgical margins, surgical procedure, 
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radiation therapy, pre-operative radiation therapy, regional body order, highest dose, 
maximum number of times, lowest dose, lower number of times, body mass index 
(BMI), smoking, areca and drink. We use LIBSVM (A Library for Support Vector 
Machines)[2] with the radial basis function (RBF) kernel to construct predictive models 
	
	

REPTree Reduced Error Pruning 
Tree (REPTree) uses the regression tree logic and creates multiple trees in different 
iterations. The predictive ability of each system was evaluated using accuracy (Acc), 
sensitivity (Sn), specificity (Sp), and the Matthews correlation coefficient (MCC). 
3. Results 
By LIBSVM implementation, the model building employed 8 features, which includes 
behavior code, differentiation, regional body order, patient age, areca, surgery, radiation 
therapy and lowest dose, could achieve the equivalent performance outcome with the 
model using all features in the analysis. Applying the REPTree algorithm, we found that 
the decision tree employed three features of patient age, differentiation and 
organizational patterns have better accuracy of MCC in 0.294 and Sn in 0.706 than 
original model by parameters optimization. From the decision tree architecture, we 
discovered the value of differentiation > 9.5 was classified as SPM, when value of 
differentiation < 9.5, the organizational patterns and patient age were as the leaf node to 
classify the SPM and NSPM. 
4. Discussion 
Our study has explored risk factors for predicting second primary malignancy and 
discovered the top four important features were pStage, surgical margins, smoking and 
drinking. In addition, we found that the REPTree algorithm used only the three features 
(patient age, organizational patterns and differentiation) to optimize the parameters of 
REPTree model to improve performance. With machine learning program, we have 
developed a feasible and a robust method to identify four important factors: pStage, 
surgical margin, smoking and drinking contributing to the second primary cancer and 
recurrence in colorectal cancer. Mechanical learning can be used as an effective medical 
decision-making tool to assist physicians to establish a prognosis and improve their 
diagnostic accuracy. We strongly recommend clinicians to consider using mechanical 
learning method in diagnosing and treating cancer patients to provide high quality care. 
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Agent-Based Modeling and Simulation of 
Care Delivery for Patients with Thrombotic 
and Bleeding Disorders 
Noemi GIORDANOa, Samanta ROSATI a, Federica VALERI b, Alessandra 
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Abstract. The quality of patients care delivery is thought to be strongly affected 
by the physicians’ workload. In this study we present an Agent-Based model of the 
processes during a typical working day. We simulated the current scenario and a 
possible scenario concerning the introduction of a second ambulatory as a potential 
improvement in the center organization. Our results validated the reliability of the 
model and showed that the introduction of a second ambulatory averagely reduces 
the daily physician’ workload. 
Keywords. ABM, simulation, process modelling, clinical process, NetLogo. 
1.Introduction 
It is nowadays well known that the delivery of high-quality healthcare services to 
patients and the resulting clinical outcomes are dependent on the workload of the 
clinical staff. Physician’s workload higher than normal and consequent stress were 
proven to negatively impact on clinical outcome and on the quality of care [1]. 
Computational modelling and simulation is a unique tool to get a deeper insight in 
complex systems’ behavior and to predict the effect of changes [2]. The diffusion of 
Agent-Based Modelling (ABM) strongly increased across the latest decades to face the 
growing complexity of the world [2]. The aim of this work is to present an ABM of the 
care processes for patients with thrombotic and bleeding disorders with different 
scenarios and their effects on the physician workload. The study was conducted at the 
“Malattie Trombotiche ed Emorragiche” center of a Turin hospital. 
2.Materials and methods 
In a previous work [3], we described the process involved and performed data 
collection. Two Process Modelling tools, namely Synopsis diagrams and Swim lane 
activity diagrams, were used to analyze all clinical processes carried out by the two 
 
1 Corresponding Author: Gabriella Balestra, E-mail: gabriella.balestra@polito.it. 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200358
1193
 
 
 
 
 
 
physicians of the center during a typical working day. The results were used to perform 
the ABM modeling and simulation. Among available ABM software and tools, we 
chose NetLogo 6.1.0 platform1 for its simplicity in use, high scalability and high 
computational modelling strength. 
In our model, we defined three types of agents: 1) “Physician”: specialists of the 
center; 2) “Ambulatory patient”: patients with scheduled ambulatory visit; 3) 
“Internal advice patient”: patients needing internal advice. Agents correspond to the 
actors previously identified as involved in clinical processes [3]. All agents moved and 
performed the activities in the simulation environment that was defined accordingly to 
the scaled map of real hospital. The model rules were defined by implementing the 
processes as previously modelled [3]. The simulation was based on several parameters 
statistically defined based on the collected data [3]. First, a simulation of an average 
typical day in the present situation was carried out to validate the reliability of the 
model. Then, since the ambulatory care absorbed the highest percentage of the 
workload, a new scenario was simulated to evaluate the effect of the availability of a 
second ambulatory room. Two different situations were modelled: (a) the second room 
was used only when ambulatory visits were performed both in the morning and in the 
afternoon; (b) the additional ambulatory was used in parallel with the first one. 
3.Results and Conclusions 
The results of the simulations are compared with the collected data. The overall 
physicians’ workload (expressed in minutes) was 557 ± 74 for the current scenario, 561 
± 76 for the new scenario (a), and 555 ± 58 for the new scenario (b). Comparing the 
collected data (566 ± 135 minutes) with those obtained from the simulation of current 
scenario it can be noticed that the results are consistent demonstrating the accuracy 
reliability of the developed model. Moreover, it can be observed that the introduction 
 
of a second ambulatory room reduces the physician workload. Process modeling and 
ABM proved to be suitable tools to simulate clinical processes and to provide insight 
on possible organizational changes. 
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An “in silico” Bench to Bedside Approach 
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Abstract. Sepsis results in various patient complications and is due to a heightened 
inflammatory response against infection. This condition requires further exploration 
of biomarkers. We employed an “in silico” method comprised of text-mining and 
additionally clinical validation through the Medical Information Mart for Intensive 
Care. We highlight that Factor VIII shows potential as a pertinent septic shock 
biomarker.. 
Keywords. Biomarkers, Bioinformatics, Sepsis, Natural language processing 
1. Introduction 
Biomedical research is producing new data and knowledge at an unprecedented pace 
and is through an increasingly vast array of databases and data repositories containing a 
large variety of data contents and formats. This is leading to new avenues of research 
where it is possible to construct new experimental designs without needing to generate 
new data instead using the already existing published biomedical data.  
Sepsis is a condition caused by an overwhelming widespread inflammatory 
response to infection resulting in massive deregulation of the immune response. 
Globally, sepsis occurs in approximately 10 per 1000 hospital patients, of which 30% of 
these patients develop multiple organ syndrome, 60-80% of progression to septic shock 
and mortality rates reaching 20% [1].   
In this work we propose an “in silico” bench to bedside approach to analyse free-
text data (also typically referred as “unstructured data”) extracted from publicly 
available resources which might facilitate the identification of sepsis biomarkers. The 
aims of this project are to identify molecular biomarkers using text mining approaches 
and then validating them in a clinical dataset combining different medical coding 
systems to gain deeper insights into this condition. 
2. Methods 
The initial stage of the project involved identifying relevant biomarkers for sepsis. For 
this purpose, we use an in-house developed methodology [2] that combines PubMed 
                                                          
1 Corresponding Author,; E-mail: g.lopezcampos@qub.ac.uk.  
to Investigating Sepsis Biomarkers 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200359
1195
queries and Pubtator annotations [3] using R. This approach enables us to retrieve 
chemical and other protein/gene biomarkers.  
For clinical validation and analysis of the identified chemical biomarkers (encoded 
as MeSH or ChEBI terms) we used data from MIMIC-III, the ‘Medical Information 
Mart for Intensive Care’ [4], an openly available dataset comprising of de-identified 
health data collected from 61,532 intensive care unit admissions (53,432 adult patients 
stays and 8,100 neonatal), spanning from June 2001 – October 2012. Data collected 
from all aspects of ICU patient care includes patient details, vital signs, laboratory tests 
using LOINC coding and ICD-9 codes.  
Relevant patients were selected using ICD-9 codes for sepsis, severe sepsis and 
septic shock and a set of non-septic controls involving different degree of inflammation 
from epilepsy (EPI) and ventilator associated pneumonia (VAP) diagnosis. 
3.  Results 
5,566 chemicals, including many antibiotics and proteins, were retrieved from the initial 
analyses of the literature abstracts. Nine out of the top 20 occurring (as frequency in 
abstracts) potential sepsis biomarkers could be mapped to related LOINC codes. Those 
9 codes were subsequently searched in MIMIC-III to check that they were present in the 
groups of patients of interest with sufficient sample sizes for statistical analysis. The 
LOINC code for Factor VIII fulfilled all the previous criteria and was chosen for 
analysis comparing sepsis samples and controls. We performed Mann-Whitney unpaired 
tests which yielded the following results “Sepsis vs EPI” p=0.5714; “Severe Sepsis vs 
EPI” p=0.3928; “Septic shock vs EPI” p=0. 04843 and “Septic shock vs VAP” 
p=0.04492. 
4. Conclusions 
These results show that Factor VIII could be a potential element of interest to 
distinguish septic shock from controls and would be coherent with the development of 
coagulopathy in sepsis. 
This still under development approach aims to integrate and automate an “in silico” 
bench-to-bedside platform for the analysis and eventually the validation of biomakers in 
sepsis. This approach could be extended to other areas of interest in intensive care. 
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An Online Prevention Tool for 
Ophthalmological Disorders 
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Abstract. The information of the general population regarding the prevention of eye 
diseases is crucial. This work presents the design and development of an online 
prevention tool for the information and education of the general population about 
ophthalmological diseases. A literature review was conducted for the collection of 
all necessary and up-to-date information regarding the diseases selected. The phases 
of requirement analysis, design, development and evaluation were followed. The 
online tool developed, proved to accomplish the aims of usability and usefulness in 
the prevention of eye diseases and their complications. 
Keywords. Ophthalmological Diseases, Prevention, Primary Healthcare 
1. Introduction 
The regular eye health monitoring plays a crucial role in the prevention and correct 
treatment of ophthalmological diseases [1]. Despite of the common belief that 
ophthalmological diseases are more frequent to elders, there are some diseases which 
appear to younger people and evolve over time [2]. Since an early diagnosis and 
treatment can prevent the loss of vision and other complications, it is necessary to educate 
the general population and raise its awareness of eye health [3,4]. The purpose of this 
work is to present the development of an online prevention tool which informs the 
general population about ophthalmological diseases. 
2. Methods 
The pilot online tool for the prevention of the ophthalmological diseases followed the 
phases of requirement analysis, design, development and evaluation. In the requirement 
analysis the functions of the tool were defined, and a literature review was conducted to 
collect all the necessary and up-to-date information regarding these diseases. 18 
publications were used to structure the content of the tool. The criteria for the selection 
of the eye diseases were that they are very common and serious, they could lead to 
blindness if remained untreated, and their prevention is necessary and relatively easy. 
Based on the requirement analysis, an educational and instructional online tool was 
designed in order to serve the principles of usability, user-friendliness and usefulness. 
The language used had to be simple for the general population. A site map was structured, 
                                                          
1Corresponding Author,; E-mail: mary_patte@hotmail.com. 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200360
1197
and the most appropriate modules were chosen, according to the potential users’ needs 
and the requested functions of the website. The Content Management System (CMS) 
technology was used in the development phase. Finally, an evaluation was conducted to 
assess the users’ opinion regarding the usability and usefulness of the tool through semi-
structured interviews. Three small focus groups were composed and the criteria of 
selecting the participants were their age, and their familiarity with technology or 
healthcare sector. 
3. Results and Discussion 
A pilot online prevention tool (for primary and blindness prevention) was developed in 
Greek language targeting the general population. The content includes informational and 
educational material concerning the anatomy of the eye, some of the most frequent eye 
diseases, specific eye exams, articles on various eye-related topics, as well as, advises 
and guidelines about eye diseases. Some examples of the eye diseases included are 
cataract, glaucoma, strabismus, age-related macular degeneration (AMD) and diabetic 
retinopathy. The users can perform a self-examination test for age-related macular 
degeneration. In addition, the user can request for more information or advice from 
experts through a form. A main menu in the site allows the navigation to all information 
and functions. The evaluation results concerning usability and usefulness were positive. 
All evaluators agreed that the website is easy to understand and navigate. They noted 
that the presentation of the information is simple, adequate, with no confusion, 
promoting education and prevention; they agreed that this tool promotes the awareness 
regarding the Ophthalmological Disorders. Healthcare professionals also mentioned that 
this tool can be useful for the clinical practice.  
4. Conclusions 
The described online tool targeting the general population contributes to the prevention 
of ophthalmological diseases in a simple and easy-to-use way. Compared to similar 
websites it includes related content. The inclusion of more ophthalmological diseases 
(e.g. refractive errors of the eye), audiovisual material, and “search” functionality for 
visiting ophthalmologists, are some of the limitations defined. Future work could include 
more content and interactivity with the user, as well as the usage of this tool on a larger 
scale. 
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Abstract. Objective: This job analysis was conducted to compare, assess   and 
refine the competencies of the clinical research data management profession.  
Materials and Methods: Two questionnaires were administered in 2015 and 2018 
to collect information from data managers on professional competencies, types of 
data managed, types of studies supported, and necessary foundational knowledge. 
Results: In 2018 survey, 67 professional competencies were identified. Job tasks 
differed between early- to mid-career and mid- to late-career practitioners. A large 
variation in the types of studies conducted and variation in the data managed by 
the participants was observed. 
Discussion: Clinical research data managers managed different types of data with 
variety of research settings, which indicated a need for training in methods and 
concepts that could be applied across therapeutic areas and types of data. 
Conclusion: The competency survey reported here serves as the foundation for the 
upcoming revision of the Certified Clinical Data Manager (CCDMTM) exam. 
Keywords. Professional competencies, clinical data management, SCDM 
1. Introduction 
The Society for Clinical Data Management (SCDM) is a non-profit organization for 
Clinical Data Management professionals. It published the first version of the Good 
Clinical Data Management Practices (GCDMP) in 2000 [1], and established the 
Certified Clinical Data Manager (CCDMTM) program in 2004. The job tasks of 
professional clinical data managers have periodically been surveyed to maintain the 
exam [2]. 
2. Methods 
This survey was administered at the SCDM meeting, 23-26 September 2018, in Seattle 
WA. The tasks were obtained from previous surveys and job analysis work through the 
SCDM [2, 3]. 
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3. Results 
The response rate for our survey was 58.8%. The majority of the respondents 77.6% 
worked in private or publicly traded company. Respondents indicated a variety of 
organization types, the most frequently reported being pharmaceutical companies 
38.7%. Eighty-two percent of the respondents indicated that they were practicing 
clinical data managers and 55% of the respondents indicated that they supervised 
clinical data managers. Respondents reported an average of 12.6 years working in 
clinical data management, and 16% of them reported being certified.  
Most respondents (90.8%) managed data for randomized controlled trials (RCTs), 
but respondents also managed data for other types of studies. Respondents reported 
clinical data management tasks performed in their organization across the spectrum of 
design, programming, data processing, testing, project management, and training and 
review task domains. Future tasks they expected to perform included, risk-based 
monitoring, centralized monitoring, data visualization, maintaining awareness of new 
technology, new technology adoption, process improvement, metadata management, 
and data warehousing. At 77% and 74%, the respondents indicated data from personal 
wearable devices and data from home monitoring devices as types of data they 
expected to manage in the future. 
4. Discussion 
Our survey updated the previous professional job analysis and helps to monitor 
changes in work done by professional Clinical Research Data Managers. Changes 
between the 2015 and 2018 data confirmed a trend toward growth of the profession in 
terms to managing data for varied types of studies and data. This stands in contrast to 
the historical norms of data managers serving mainly one type of research and a limited 
variety of data. New tasks are consistent with application of basic informatics methods 
in clinical research contexts. This diversification calls for curricula and formal degree 
programs to educate Data Managers in general principles and methods that can be 
applied to new research settings, studies across the continuum of clinical research and 
varied types and sources of data.  
5. Conclusion 
The results of this study serve as the foundation for the Certified Clinical Data 
ManagerTM exam and inform the scope of the practice standards for the profession, the 
GCDMP. 
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Abstract. Literature reviews are crucial in the choice of the best personalized 
material type and restauration type in restorative dentistry. We developed an IBM-
Watson based system to support literature search for restorative dentistry, and 
compared its results to a literature search performed by a trained professional. We 
found that our system could assist the researcher in performing a literature review, 
but the grounding semantic model needs to be refined in order to provide more 
extensive results.   
Keywords. Literature review, restorative dentistry, cognitive computing. 
1. Introduction 
Technology for restorative dentistry is becoming more and more advanced, and new 
techniques and materials have been introduced to obtain minimally invasive treatments 
and better outcomes[1]. When choosing the best solution for patients, clinicians should 
rely on the available growing evidence. In this scenario, a system supporting the 
process of literature review[2] will optimize the choice of materials for restorations, 
and, in turn, the patient’s quality of life. To this end, we tested the ability of IBM 
Watson cognitive computing services to provide the ground engine for a system 
supporting dental inlays literature search process. 
2. Methods 
PubMed API were used to run the literature search. A concept model was developed 
and trained in IBM Watson Knowledge Studio using 42 annotated documents (review 
papers on dental inlays). The service uses proprietary natural language processing 
methodologies. The precision of the system (percentage of true positives on the overall 
positives recognized by the model) and the recall (percentage of true positives on the 
overall true from the ground truth) were used as performance measures of the model. 
The model was then implemented in IBM Watson Discovery in order to process 
PubMed abstracts and to retrieve the concepts, relationships, and specifications 
according to the semantic model. A user interface developed using Node-Red[3] allows 
the clinician to visualize the sentences (and abstracts) more relevant to the research 
question related to the restauration type, the material type, and the characteristics. The 
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system was validated comparing the literature review automatically performed with the 
literature review performed by a trained clinician, in terms of number and relevance of 
papers retrieved.  
3. Results 
The semantic model included 15 main entities (among them, “restauration type”, 
“material type”, “character”, “comparator”, “value”) and 13 main relationships and 
achieved an overall precision of 93% and an overall recall of 80%. In Watson 
Discovery, a total of 165 documents (abstracts) were processed using the general 
PubMed query. The system was tested with the aim to identify the papers relevant to 
establish the longevity comparison between composite inlays and ceramic inlays. The 
first man-made search yielded a total of 24 unique papers, 8 of which were included. 
The first search made by IBM Watson yielded a total of 18 unique papers, 9 of which 
were included. The two searches obtained completely different results, with only 3 
papers found by both the human researcher and IBM Watson, but all of them 
potentially fit to be included in a literature review. 
4. Conclusions 
These preliminary results show that IBM Watson could be used to assist the 
researcher in performing a literature review, but the model on which Watson is trained 
needs to be refined in order to provide more extensive results. These findings will help 
to further refine IBM Watson's abilities and getting closer to obtaining a Cognitive 
Computing Platform able to answer clinical questions made by Dental professionals 
 
 
Figure 1. Text annotation in Watson Knowledge Studio with the defined semantic model. 
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The Impact of Information Quality on 
Retracted Bioinformatics Literature 
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Abstract. One of the biggest challenges facing biomedical research today is the 
lack of reproducibility in findings. In response, a growing body of literature has 
emerged to address this. However, much of this focuses on bias and methods, 
while little addresses the issue of information quality. The purpose of this poster is 
to determine the role of information quality for retracted bioinformatics literature. 
1. Introduction
Irreproducibility continues to be one of the more emerging issues in recent biomedical 
research. Much has been written about its negative impact on the progression of 
biomedical science and ultimately patients [1], with guidelines proposed [2,3]. Few of 
these, however, address the impact of low information quality (IQ). In this poster, the 
IQ issues found in retractions are discussed, and corresponding patterns analyzed. 
2. Method
The Retraction Watch database [4] was filtered by: Retraction or other Notices From 
Date value 1/1/2018, To value 12/31/2018, and Reason(s) for Retraction value 
“Concerns/Issues About Data” which resulted in 124 retractions with fields such as 
Subject, Journal, Publisher, Original Paper Date, Retraction date, and Country. Of 
these, 119 were classified for associated IQ dimension by 2 independent coders. After 
obtaining the Scimago Journal Rank of each record, statistical analysis was then done. 
3. Results
54% of retractions were due to the Believability dimension of IQ. China was the most 
prevalent country being involved in 32% of all records, followed by India 24%, and the 
U.S. 19%. SJR score comparisons indicate records involving the top 2 IQ reasons 
(Believability & Wrong data used) are associated with higher-ranking journals (p = 
0.05), as well as significant differences between regions (p = 0.02). Articles published 
in the U.S. & Canada through publishers other than Elsevier, PLoS & Springer were 
3.3 times less likely to be associated with Believability than all other articles (p = 0.05). 
Survival analysis indicates studies having Biochemistry as a subject have a half-life of 
33.8 months and remain in publication longer than those with other subjects. 
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Figure 1. the association of higher journal scores with the top 2 IQ issues. 
Table 1. Articles least associated with Believability 
Believability All other issues 
U.S. & Canada articles not 
published by Elsevier, PLoS & 
Springer 
4 10 
All other countries & publishers 60 45 
Figure 2. survival analysis showing how those with Biochemistry subject remain in publication longer. 
4. Discussion & Conclusion
Our aim was to investigate what role IQ plays for retracted bioinformatics studies. 
While Believability is the most prevalent, others are associated with countries, subjects, 
and longevity in months published. Future work could involve expanding to a wider 
date range, as our study design was limited to calendar year 2018. 
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Abstract. RNA-editing is an important post-transcriptional RNA sequence 
modification performed by two catalytic enzymes, "ADAR"(A>I) and 
"APOBEC"(C>U). Although APOBEC-mediated C>U editing has been associated 
with a number of human cancers, the extent of C>U editing in human disease 
remains unclear. Here, we performed an association study and found that at least 
1293 human disease variants occur at sites predicted by sequence motif analysis 
(RNASee protocol) to undergo APOBEC3A/G C>U editing. These variants were 
associated with a wide array of human disease conditions ranging from cancer, 
metabolic disorders, retinopathies, cardiomyopathies, neurodegenerative disorders 
and immunodeficiencies. These results indicate that APOBEC mediated C>U RNA 
editing may have widespread and previously unreported contributions to human 
disease conditions.. 
Keywords: RNA-editing, Protein diversity, Cytidine deaminase 
1. Introduction
RNA-editing is an important post-transcriptional RNA sequence modification performed
by two catalytic enzymes, "ADAR"(A>I) and "APOBEC"(C>U)1.  An emerging body
of research has implicated APOBECs playing important roles in human disease
processes such as cancer2,3, Alzheimer disease and primary pulmonary hypertension4.
Although A>I RNA editing has been widely studied, the extent of C>U editing in human
disease processes is still largely unclear, and no comprehensive database yet exists for
C>U editing events. Using the features of the experimentally verified RNA editing sites,
we have developed a program to predict editing sites and compared with existing gene-
disease-variant information to further assess the extent to which C>U editing may
contribute to human disease.
2. Methods
2.1 Predicting C>U RNAediting sites and data collection 
The RNASee platform (http://128.205.176.246/rnasee/) identifies tetra-loop sequences 
by scanning the mRNA sequence (12789 CDS fasta sequence collected using UniProt 
REST services) with a four nucleotide loop (0-3) sliding window in order to identify 
target sequences containing a CC at the 2-3 positions. The secondary structure of the 
sequence contatining putative  C>U  editing  site  for APOBEC3A and 3G is then 
predicted using ViennaRNA (https://www.tbi.univie.ac.at/RNA/) and the resulting 
energy is used to support the structural stability. We compared the RNAsee list to the 
humsavar human variant list from UniProtKB/Swiss-Prot. We found 30705 (39%), 
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40035 (51%), 8081 (10%) total variants are classified as human disease  variants,  non-
disease  associated  variants (polymorphism), and indeterminate variants respectively. 
We identified 1278 functional sites from UniProt-SwissProt database (from 206/734 
genes/proteins), consisting of 9% active sites, 19% binding sites, 54% glycosylation sites 
and 18% metal-ion binding sites. 
3. Results
3.1 Predicted RNA editing sites are associated with known human disease protein
variants and pathway analysis
RNAsee generated a list of TOP25 ranked probable C>U RNA edit sites, associated with
78852 human variants and 12789 genes.  A comparison of C>U RNA editing sites  with
known  human-variants found 1293 out of 30705 (4%) variants and 734 genes were
associated with known human disease processes, 1828 out of 40035 (5%) variants were
associated with polymorphisms and 191 out of 8081 (2%) variants were unclassified.
The top 5 most frequently diseases and genes associated with C>U variants are listed in
Table 1. Pathway analysis showed enrichment of angiogenic, hematologic and hypoxia-
induced processes, consistent with recent in-vitro studies5. In addition, we identified
functional sites of metabolically essential proteins, including FGFR1, GALNS, G6PC
and FTO, suggesting these editing events may have direct impact on protein function.
 
 
Disease (# associated genes) 
Pheochromocytoma (9) 
Dejerine-Sottas syndrome 
(6) 
Diabetes mellitus, permanent 
neonatal (6) 
Li-Fraumeni syndrome (6)
Sporadic cancers (6) 
4. Conclusions
In this study, we were able to predict a large number of previously unidentified APOBEC
mediated C>U editing sites across the human transcriptome and associate them with a
wide array of human disease conditions. Our results suggest that APOBEC-mediated
C>U editing may play a key role in hypoxia-induced remodeling during oncogenesis. In
future research will apply our analysis to the transcriptomes/proteomes of specific
disease conditions in order to further clarify the functional and predictive role of
APOBEC mediated C>U RNA editing in human disease.
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 Genes(# 
associated 
diseases) 
TP53 (6) 
VHL (6) 
CDKN2A (5) 
G6PC (5) 
FGFR1 (5)  Figure 1: List of pathways 
Table 1: Top 5 associated diseases and genes     
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1.Introduction 
Glioblastoma multiforme (GBM), the most common type of malignant brain cancer in 
adults, has n poor prognosis with a median survival of around 15 months despite 
aggressive treatment.[1] GBMs are very heterogeneous tumors that differ in 
morphological and genetic aspects. Due to the genetic diversity, subtypes are described 
in the literature, that differ in their prognosis (a classical, mesenchymal, proneural, and 
occasionally neural subtypes).[2] Modern machine-based methods have a large potential 
for the automated analysis of medical images and are successfully used in 
neuropathology. [3] This study investigates if a neural network can automatically 
measure the heterogeneity of GBMs and can support prognosis estimates in a clinical 
setting. 
2.Method 
57 tissue samples of glioblastoma (Isocitrate dehydrogenase (IDH)-wild-type) have 
been fixed in 10% formalin and embedded in paraffin. 2 µm thick slices were stained 
with hematoxylin and eosin. 35 samples from brains from autopsies without 
pathological abnormalities have been prepared as a reference. 
Slides were scanned using an Aperio AT2 scanner. Next, tumor tissue was 
digitally labeled and separated from the surrounding brain tissue. The first step will be 
to train a neural network for the delamination of GBM tissue from healthy tissue. As a 
next step, an additional neuronal network will be trained to identify the degree of  
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morphological heterogeneity of glioblastoma. This data will be backed up by 
immunohistochemistry and presented as a color-coded image. A Convolutional Neural 
Network (CNN) will be developed and trained because it has already been used 
successfully on classification tasks for image analysis.[4] 
3.Results 
92 images have been investigated, which have an average size of 6 GB and overall 552 
GB of data that needed to be processed. Input for the neuronal network is always a small 
area of the regarded image. The network shall classify this area. After every step, the 
area is shifted by a stride. The shifting enables us to keep the network smaller as we train 
on smaller data samples, and with this technique, we generate a vast amount of training 
data. For example, if we have an image with 70.000x40.000 pixels and the area we want 
to classify has the size of 200x200 pixels, and we shift the area by 100 pixels in each 
step, we have generated 278.901 training samples from one image. The output is a 
probability distribution over the possible classes. Firstly, these classes are GBM and non- 
GBM, and in the second step, the classes will be over the heterogeneity of the tumor. 
4.Discussion 
The authors suppose that a higher heterogeneity in the tumor tissue is related to worse 
survival chances of the individual. The application of neuronal networks for the 
neuropathology is still at its beginning. Nonetheless, automatic measures of the 
histological tumor heterogeneity could lead to more precise predictions and therefore, 
also to individual risk-adapted therapies over the long term. 
5.Conclusion 
We presented a new method for GBM detection and classification. This method 
enables a faster and automated tumor detection, as well as classification on the tumor to 
enhance individual prognoses. 
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Abstract. Analyses of nerve histology are core assays in basic and applied research 
and even in clinical setting. Detailed report on nerve morphology may unbiasedly 
indicate the current state of a peripheral nerve. Manual method requires trained 
technician and is a time-consuming procedure. Available plugins to well known 
image processors are limited in use and data outcomes. Thus, the aim of the study 
was to create a. tool for for fast and repeatable analysis of a nerve section image. As 
a results we get very high precision of analysis in shorter time. 
Keywords. Axon evaluation, Neural network 
1. Introduction
Preclinical research of neuroregeneration requires assessment of nerve fibers histology. 
The most reliable results contain histomorphometry parameters of axons and myelin 
sheaths. Manual methods are prone to human error and are time consuming. Computer-
based techniques may improve the above and deliver the accuracy comparable with a 
experienced researcher. The study aimed to prepare a neural-network MATLAB script, 
with a novel approach to contrast-based method used for whole nerve section analysis. 
2. Materials and methods
Semithin sections of a rat sciatic nerve stained with toluidine blue were  a input data. 
They were scanned at 40x magnifications. Firstly, the analysis includes grey-scale 
conversion and contrast improving modifications e.g. CLAHE. Unlike other described 
methods, which analyze objects after binarization, we worked with the grey-scale image. 
Objects found with regionprops function were then filtered. Our protocol offers manual 
verification and removal of false-positive objects. We also applied Neural Net Pattern 
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Recognition from Matlab for filtering results. Then, a rectangle enclosing each border of 
an object was defined. From the center to the edge of the acquired area line segment 
was lead and histogram on this length was set. The border of each axon was determined 
in the point of highest contrast between neighbour pixels. The borders of myelin sheaths 
were defined likewise. This operation was repeated 360 times, around the analyzed 
nerve cell (radial histogram scanning and thresholding). The method resembles manual 
analysis since  local contrast is used to mark the axon.  
Finally, the main morphometric parameters may be determined (radius, G ration, 
thickness, area etc.). Results were compared with manual measurements of 28 random 
nerve images, estimated by 3 researchers in ImageJ. Comparison to manual data was 
shown as ratios: script: manual. 
3. Results
After optimization of brightness and contrast parameters,  axon area overlay at level 
1,001 and 1,009 of the myelin sheaths was achieved. Paired T-test showed no 
significant differences between these two methods (p-value = 0,321). Use of Neural Net 
enables to reach 93,6% of accuracy of axons recognition vs 3 researchers. A run time of 
the script is about 12 times shorter than the manual method.   
4. Discussion
Other similar methods consist of binarization, which doesn’t allow to define borders of 
the nerves precisely. The script presented shows a new approach to this case. It is based 
on reconstructing the way of evaluation done by the scientist. The presented script 
shows a new approach to this case. Our idea is based on reconstructing the way of 
evaluation done by the scientist Owing to this innovative idea, the higher level of 
accuracy of computerized evaluation is possible. The most depending factor is 
optimalising the differentiation between correctly and uncorrectly marked borders. 
Further researches focus on increasing the efficiency of this protocol. In conclusion, the 
presented script performs an accurate analysis of nerve sections on a grey-scaled image. 
It overcomes bias of a binarization. The method decreases time of analysis and remains 
repeatable.  
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Automatic Detection of Vital Signs in 
Clinical Notes of the Outpatient Settings 
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Abstract. The determination of vital signs is a fundamental aspect of patient care. 
Electronic health records have a structured format for their registration. It is known 
that the frequency with which this data is recollected is not representative of reality. 
To complement the missing data we have created a tool that extract the information 
regarding blood pressure, heart rate, respiratory rate, height, weight and pain level 
recorded in free text in the clinical notes of outpatients. 
Keywords. Natural Language Processing, Vital Signs,  Electronic Health Records 
1. Introduction 
The determination of vital signs is a fundamental part of patient care in order to control, 
maintain or modify the therapeutic measures carried out. Most electronic health records 
have a structured format for the registration of this information, however, the frequency 
with which this data is recorded is not representative of reality [1]. Electronic health 
records capture data in two ways: in a structured format and in free text format. For the 
use of clinical data for secondary purposes the data must be structured. However, the 
exclusive approach of structured data for the entry of clinical data can result in the loss 
of significant information that is usually entered in free text format. [2,3] To complement 
the data of vital signs missing from the clinical notes we have created a tool that extracts 
this information regarding blood pressure, heart rate, respiratory rate, body temperature, 
height, weight and pain level recorded in free text of the clinical notes of outpatients. 
2. Methods 
The system extracts mentioned vital signs from the text of the clinical notes. These texts 
typically include ad hoc abbreviations, common words and spelling errors. In order to 
create the extraction system, a set of clinical notes was manually annotated by experts 
and analyzed to infer patterns. Such patterns were coded as regular expressions, each 
with a degree of specificity. The system attempts to detect vital signs by first applying 
more specific rules and then testing more generic rules along with additional validity 
checks to exclude false positives. The application of more sophisticated machine learning 
techniques was evaluated but rejected due to the requirement of both high precision and 
false positive detection in this specific problem. The results of these patterns and rules 
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in the clinical notes were evaluated by experts, who tried to find opposite examples and 
then refine them in an iterative way to increase accuracy and recall. The system was 
implemented within the UIMA (Unstructured Information Management 
Architecture)[4]. The analysis of each clinical note is comprised by several phases: first 
a phase where grammatical sentences are divided, followed by a tokenization phase 
which aims to detect running words and, finally, a vital signs detection phase. The 
detectors of each vital sign are implements as independent components that the tool calls 
during the start of the process, so the tool is scalable and should be able to access new 
future components when available. 
3. Results 
For the phase of manual registration of vital signs in the clinical records, 3960 
representative clinical notes of the different specialties that record information in search 
of the vital signs were evaluated. We identified in the free text: 2 records of pain level 
(PL), 101 heart rate (HR), 22 respiratory rate (RR), 35 body weight (BW), 225 blood 
pressure (BP), 7 of height (HT) and 53 of body temperature (BT). 
Different configurations of the extraction tool were tested until obtaining a specificity 
and sensitivity of 100% against the training set. 
The tool was implemented in such a way that it would be executed after 5 seconds of 
inactivity of the medical user in the outpatient electronic health record. The registration 
rate of structured vital signs data was measured one year prior to implementation and 
measured again after implementing the tool. The results were as follows: HR 448 
occurrences, RR 122, BW 6935, BP 4156, HT 2610, BT 82, PL 15 and HR 4444, RR 
1084, BW 8289, BP 9820, HT 3786, BT 1472, PL 1230 respectively. Increases were 
registered in the PL record 82 times more, BT 18 times more, HR 10 times more, RR 9 
times more, BP 2.5 times more, HT 1.5 times more and BW 1.2 times more. 
4. Conclusions 
Vital signs registration in clinical notes is presented in patterns which can be determined 
and, therefore, rules can be developed to achieve their extraction by using tools that help 
achieve greater completeness of the records. The use of these tools increases the 
structured registration of these data, enabling their subsequent secondary use in clinical 
decision making. 
5. References 
[1] Patterson OV, Jones M, Yao Y, Viernes B, Alba PR, Iwashyna TJ, DuVall SL. Extraction of Vital Signs 
from Clinical Notes. Medinfo 2015: 1035. 
[2] Barrows RC, Busuioc M, Friedman C. Limited parsing of notational text visit notes: Ad-hoc vs. NLP 
approaches. Proc AMIA Symp. 2000:51–5. 
[3] Hyun S, Bakken S, Friedman C, Johnson S. Natural language processing challenges in HIV/AIDS clinic 
notes. AMIA Annu Symp Proc. 2003:872. 
[4] http://uima.apache.org/. Accesed 11/20/2018 
 
M. Diaz Maffini et al. / Automatic Detection of Vital Signs in Clinical Notes1212
Best Practices for Designing Discrete 
Choice Experiments and the Use for Older 
Adults with Cognitive Impairment 
Thomas ENGELSMAa, b, 1 Monique W. M. JASPERSa, b, Anne M. TURNERc, d  
a Center for Human Factors Engineering of Health Information Technology, 
b Department of Medical Informatics, University of Amsterdam, Amsterdam, The 
Netherlands; 
c
 
Department of Health Services, School of Public Health, University of Washington, 
Seattle, WA; d Department of Biomedical Informatics and Medical Education, School of 
Medicine, University of Washington, Seattle, WA. 
Abstract. Objective: the aim of this scoping review is to 1) identify guidelines, 
frameworks, issues, and recommendations regarding the development of a discrete 
choice experiment (DCE), 2) look at potential design considerations regarding the 
development of a DCE for older adults with dementia, and 3) summarize 
knowledge about the current inclusion of and experiences with older adults with 
cognitive impairment in DCE studies. Methods: Two literature searches divided 
into two topics were performed in PubMed, CINAHL, and PsycINFO. Results: 
Topic 1 found 19 articles regarding frameworks, guidelines and design 
considerations for DCEs in healthcare. Topic 2 found eight articles regarding the 
effect of cognitive impairment on DCE results and/or discussing the inclusion of 
cognitive impaired older adults in these DCE studies. Conclusion: There is 
minimal literature available regarding the effect of cognitive impairment on DCE 
results. In future studies we will explore if DCEs can be used to involve older 
adults with dementia in decisions regarding transitions in care. 
Keywords. Discrete choice experiment, design, older adults, cognitive impairment 
1.Introduction 
There are a growing number of older adults worldwide. Older adults are at increased 
risk of developing cognitive problems and dementia. Management of dementia often 
requires making a variety of important care-related decisions. These decisions often 
occur without the input of the older adult suffering from dementia or another severe 
illness [1]. It has been shown that including older adults with dementia in decision-
making can lead to an improved well-being and reduce dementia-related symptoms [2]. 
This literature review was conducted as preliminary work to inform the development of 
a DCE-based tool for older adults with dementia to support their participation in the 
decision-making process. 
 
1 Corresponding Author email: t.engelsma@amsterdamumc.nl 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200368
1213
2.Methods 
We conducted two literature searches regarding DCEs. The first topic (Topic 1) 
focused on lessons learned from applications of DCEs in healthcare. The second topic 
(Topic 2) focused on DCE studies including older adults with cognitive impairments. 
PubMed, CINAHL, and PsycINFO were searched for both topics. Studies had to be 
published within 2009-2019 and written in English. For inclusion in Topic 1 articles 
had to discuss the design process of a healthcare-related DCE. For Topic 2, articles 
were included that 1) describe DCE studies targeting older adults (65 and over) and 2) 
discussed the effect of cognitive impairment on DCE results and/or mentioned 
cognitive impairment in their inclusion process. 
3.Results 
A variety of frameworks, guidelines, and design considerations were identified in 
Topic 1 that might be useful when developing DCEs for older adults with dementia, 
such as using visuals. Minor literature regarding the effect of cognitive impairment on 
the results of a DCE was found in Topic 2. The few studies involving the use of DCE in 
older adults with cognitive impairment, suggest that older adults with mild cognitive 
impairment are equally capable of giving meaningful responses compared to those who 
are cognitively intact. However, these studies had a small sample size. A small number 
of studies discussed how they went about including older adults with cognitive 
impairment in their DCE. Most of these studies involved individuals with only mild 
cognitive impairment based on a cognitive assessment, or based inclusion on the 
opinion of professionals or ability to provide informed consent. 
4.Discussion and Conclusion 
This scoping review summarized insights on DCEs in healthcare with the aim of 
informing the design of a DCE for older adults with dementia. We found that in health-
care related context a minority of researchers included older adults with cognitive 
impairments in their DCE. Older adults with more severe levels of cognitive 
impairment are either completely excluded from participation in DCEs, or proxies 
(usually caregivers) participate in the DCE. However, studies suggest that caregivers’ 
preferences regarding healthcare often differ from the recipient’s preferences [3]. 
Therefore, DCE data may not be reliable when using proxies. In future studies we will 
explore if DCEs can be used to involve older adults with dementia in decisions 
regarding transitions in care. The final aim is to develop a DCE- based digital decision-
making tool for older adults with dementia and their caregivers. 
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Abstract. Biostatistics is one of the transversal subjects that all future doctors must 
acquire and master. Nonetheless, it is a subject that has the reputation of being 
difficult, which has not been able to be corrected even with the application of new 
pedagogical methods such as blended learning. We address this problem with our 
acculturative and disruptive approach in the form of a serious game scenario in 
clinical research that integrates biostatistics with our R4Web adapted tools. Our 
approach was launched in 2008 for the second year of medical school. Here we 
describe this LOE scenario for serious game including the biostatistics disruptive 
acculturation task and present its new international version. 
Keywords. “Schools, Medical”, Bio-statistics, Serious games, “Education, Public 
Health Professional”, “Games, Experimental”, “Data Interpretation, Statistical”  
1. Introduction: Learning context 
Some subjects are part of these transversal competencies that all modern health 
professionals must master. Biostatistics is one of those competencies, that provides the 
necessary foundation for understanding and analysis in all health fields whether through 
the critical appraisal of articles (CAA). Major efforts have been made to integrate this 
transversal subject into the initial medical training in the form of a revised pedagogy 
using e-learning, blended learning, etc. [1,2].  
Thus, it behoves health educationalists to develop pedagogical strategies that 
overcome the barrier of disinterest and misunderstanding on the part of students, who 
often consider it too mathematical, useless for health and medical practice and do not 
realize its underlying and real importance for their professional lives. To overcome this 
challenge, in 2008 a serious game simulating a clinical research process has been 
developed in Grenoble. The serious game scenario is called “LOE” (Laboratorium Of 
Epidemiology) is hosted on the multilingual health Grenoble Serious Games platform: 
Professional Health Fantasy (https://prohf.org). 
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2. Materials: Serious game scenario description  
Provided by the platform, interaction activities of the scenario are integrated in the form 
of online forms, emails, integrated pseudo websites such as the Medical Information 
Department for the data request, or the International Conference for the final step. 
Collaborative activities for students, groups or tutors are also supported by the platform. 
This platform therefore centralizes all the information and the digital tools required to 
simulate clinical research in all these dimensions. 
This LOE serious game scenario immerses students in a public health physicians’ 
situation, since it involves investigating the incidence of a disease: venous 
thromboembolic disease (VTE) and that includes all the steps required to undertake a 
real clinical research program. The main objectives for students of this situation are to 
(i) design the protocol and implement an epidemiologic study, (ii) prepare and submit a 
scientific paper including the biostatistical analysis task (with the adapted R4Web tool: 
https://r4web.univ-grenoble-alpes.fr), to describe the protocol and epidemiological 
study, for presentation at a simulated conference; (iii) finally propose a decision-making 
tool to optimize the VTE diagnostic process.   
3. Practice Analysis: User experience 
By discovering the game, the learner will wander through the various virtual tours of the 
group's hospitals to discover the units, services, resources and tools at his disposal for 
the mission. The IT environment is designed to stage different interactions with scenario 
characters in the game, such as patients in the hospital, PPC experts, members of the 
conference scientific committee, etc. This in order to help students to take on different 
challenges and acquire skills related to the scenario, by engaging into the game. Over 
time of the game, the students are judged on the quality of their production: protocol, 
article and keynote. The role of the teachers as tutors is to only guide the learners during 
the classroom sessions. The success of this serious game depends on the need for 
involvement and commitment of both learners and tutors. The challenge is that learners 
and tutors must leave their comfort zone and must go beyond with their computer.  
Finally, informal feedback from our clinical colleagues is that the tools that utilise 
real research projects provide immediate and positive implications for the young doctors 
in-training. All the feedback reinforces the benefits of this new approach, so that 
biostatistics is no longer an unavoidable cliff but just a fun step as part of an overall 
clinical health research process. This active approach to problem-based learning is 
necessarily more "disruptive" for students and a challenge for tutors. 
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Abstract. Hospital Italiano de Buenos Aires (HIBA) is an academic tertiary care 
hospital highly specialized that has started the process of informatization of 
chemotherapy protocols. The objective is to describe the development of a 
computerized physician order entry (CPOE) oriented to the oncology adult patient 
and the members of the healthcare team that works with him (physicians, 
pharmacists, nurses and administrative staf ) to improve the process and prevent 
errors at a critical point in the patient's health care: during prescription, preparation 
and / or administration. The development of this system consisted of several stages: 
inquiries about the usual work and perception of needs of the potential users; user-
centered design; interoperability with the electronic health record (EHR) and 
development of a final prototype 
Keywords. CPOE, oncology, chemotherapy
1. Introduction
The oncological patient represents a healthcare challenge [1] Patient safety is of vital 
importance and this is where information systems can reduce the rate of errors and 
adverse events. [2] The prescription cycle in oncology turns out to be complex due to the 
coexistence of multiple structured schemes and the high toxicity of drugs.[3] The 
benefits of implementing a CPOE for indication of medications have been described, 
from the reduction of errors to integration of clinical decision support systems. [4] and 
some have shown their long-term benefit [3, 4] One of the challenges in oncology is to 
prevent errors that may occur during the different phases of the prescription cycle[5]
Some appears to be associated with more significant adverse outcomes, with 
approximately one third of all errors identified as serious or life-threatening [5]. Methods
A descriptive observational study was carried. The study is a mixed design, with a 
qualitative and quantitative approach.
2. Results
In October 2012 we started to develop and implement a CPOE integrated into the 
hospital’s EHR, planning to incorporate pediatric patients at a later stage [7] For the start 
a surveyed and meetings were held between the project team. In a first stage in the 
standardization of order sets we start working in spreadsheet format for a year. The team 
was made up of one health informatics specialist, one process analyst and two developers. 
Six people participated in the preparation committee of order sets: one clinical oncologist, 
one hematologist, one gynecologist, head of oncology pharmacy, and oncology nursing 
supervisors. This phase lasted 7 months. By July 2013, the 50 most used protocols in the 
institution were completed, agreed between the prescribing services, oncology pharmacy 
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and nursing. In October 2013 there were 100 standardized protocols. The second stage 
began with the development of the RCM to structure the order sets, add agendas in the
ADT for the sectors that treat cancer patients, connect the prescription module with the 
pharmacy administration system (PAS), incorporate the preparation processes of the 
oncology pharmacy into the PAS, and modify the EHR to allow the prescription of 
oncological protocols. Finally, the design was completed and it was implemented in 
November 2014.
3. Discussion
Protocols were added up until reaching almost all of those available for adults. The 
implementation was followed by a process of continuous improvements and system 
adjustments that allowed a superior user experience and avoid frequent errors that were 
detected. As a strength, the in-house development that allowed the system to adapt to the 
previous workflow and fully interoperate with the HER.
4. Conclusions
We have described the process of implementing a CPOE of chemotherapy in a high 
complexity hospital with its own development team and how it was arrived from a paper
model to another that interoperates with 4 simultaneous systems in a complex circuit in 
which physicians, pharmacists, nurses and administrators interact in different stages, 
which are often critical for the patient.
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Classification of Biceps Brachii Muscle 
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Abstract. In this, study, an attempt is made to differentiate muscle nonfatigue and 
fatigue condition using signal complexity metrics derived from phase space network 
features. A total of 55 healthy adult volunteers performed dynamic contraction of 
the biceps brachii muscle. The first and last curl are segmented and are considered 
as nonfatigue and fatigue condition respectively. A weighted phase space network 
is constructed and reduced to a binary network based on various radii. The mean 
and median degree centrality features are extracted from these networks and are used 
for classification. The results of the classification indicate that these features are 
capable of differentiating nonfatigue and fatigue condition with 91% accuracy. This 
method of analysis can be extended to applications such as diagnosis of 
neuromuscular disorder where fatigue is a symptom. 
Keywords. Muscle fatigue, Phase space networks, Multilayer perceptron 
1.Introduction 
Neuromuscular fatigue can be defined as a task-induced reduction of the force- 
generating capacity of a muscle. Surface Electromyography (sEMG) signal reflects the 
occurrence   and   progression   of   muscle    fatigue.    Conventional    signal 
processing techniques fail to quantify muscle fatigue. In this study, nonlinear features 
are extracted using phase space networks to explore the dynamics of the complex 
biological system. 
2. Methods 
The study involves subjects performing biceps curl exercise  with  a  six  kilogram  
force dumbbell until fatigue. During this period sEMG signals are recorded from the 
biceps brachii muscle in accordance  with  the  SENIAM  standards.  A  data  
acquisition  rate  of 10ksps and a gain of 1000 is used. These signals are preprocess  
with a 10-400 Hz band pass and a 50 Hz notch filter. The first and last curl are  
extracted based on the methodology mentioned in  [1].  The  phase  space  is  
constructed based  on  Takens embedding procedure with a dimension of 3 using false  
1 neighborhood procedure. 
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The weighted phase space network is constructed based on the following criterion [2]. 
                      (1) 
Where, Wij is the adjacency matriz, and, Xi and Xj correspond to the instance in the 
phase space and represent a node. The binary network is constructed by using the 
following condition: 
		 
                (2) 
Here, the threshold value r ranges from 0.05 to 0.5 in steps of 0.05 times the standard 
deviation of the signal. This binary network degree distribution is computed. The mean 
and median degree centrality measures are extracted. The classification is performed 
using a multilayer perceptron (MLP) algorithm and a 10 fold cross validation scheme.
3.Results and Discussion 
        (a)       (b) 
Figure 1. Representative adjacency matrix obtained with an r value of 0.25SD (a) 
nonfatigue and (b) fatigue 
In figure 1, the adjacency matrix  obtained  from  a  subject  in  nonfatigue  and  fatigue  
condition  is  shown.  It  is  seen  that  the  fatigue  condition  has   a greater  number  of 
connections.  The   centrality  features   indicate  the   presence   of  a greater number of 
recurrent (similar) patterns in fatigue. The classification performance of the extracted 
features are shown in table 1. It is seen that mean degree centrality and median degree 
centrality separately perform well with an average accuracy greater than 85%. When 
both these features are used in conjunction an accuracy of 91% is obtained. It is to  be 
noted that Median centrality feature alone  gives similar performance where in a single 
subject is misclassified in this case leading to the disparity in the performance. 
 Table 1 Classification performance of MLP for various features 
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Features Sensitivity Specificity 
Mean Centrality 85.7 85.7 85.7 
Median Centrality 89.3 87.9 90.7 
Both 91.0 89.7 92.6 
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Abstract. This work explores the design and implementation of an algorithm for the 
classification of magnetic resonance imaging data for computer-aided diagnosis of 
schizophrenia. Features for classification were first extracted using two 
morphometric methods: voxel-based morphometry (VBM) and deformation-based 
morphometry (DBM). These features were then transformed into a wavelet domain 
using the discrete wavelet transform with various numbers of decomposition levels. 
The number of features was then reduced by thresholding and subsequent selection 
by: Fisher’s Discrimination Ratio (FDR), Bhattacharyya Distance, and Variances 
(Var.). A Support Vector Machine with a linear kernel was used for classification. 
The evaluation strategy was based on leave-one-out cross-validation. 
Keywords. Machine learning, neuroimaging, schizophrenia, support vector 
machines 
1.Introduction and methods 
Machine learning offers promising methods for computer-aided diagnosis of 
neuropsychiatric disorders. The use of these computing methods is highly desirable, as 
they have the potential to create an objective process of early diagnosis and prognosis. 
This research explores the design of the classification algorithm and the application of 
wavelet transformation to image data. Our proposed algorithm follows the ideas in [1]. 
Compared to the original algorithm, the main advantage of our version lies in the 
ability to carry out more experiments with different decomposition levels by wavelet 
transform. 
The algorithm consists of five main steps: (i) Two types of preprocessing were used 
to extract features: VBM (gray matter densities) and DBM (local volume changes), (ii) 
images were decomposed by wavelet transformation into another domain. It was 
necessary to specify two parameters: decomposition levels and mother wavelet (sym5) 
[2], [3], (iii) the number of features was reduced by the experimentally determined 
thresholding of absolute values smaller than 0.05, (iv) the number of features was 
reduced by selection. Three different metrics were used for this: FDR, Bhattacharyya 
distance, and Var., (v) the classification into two groups (FES/NC) was carried out. The 
algorithm was tested on a dataset provided by The University Hospital Brno (104 T1- 
weighted MR images of subjects, of which 52 subjects were patients with first episode  
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of schizophrenia (FES) and 52 were healthy volunteers (HC)). Classification 
performance was evaluated using leave-one-out cross-validation. The best results of 
experiments with differently selected parameters are shown in Table 1. 
Table 1. Classification accuracy for distinguishing between FES and HC.  
 
2.Discussion and conclusion 
The strongest results were obtained using DBM, where the classifier achieved the best 
performance for five decomposition levels selected using FDR and Var for 5000 features. 
The first case achieved 72.12% accuracy, 67.31% sensitivity and 76.92% specificity, and 
the second case attained 71.15% accuracy, 67.31% sensitivity and 75.00% specificity. 
Using VBM with four decomposition levels for 1000 features and Var. and FDR metrics, 
73.08% accuracy, 71.15% sensitivity, and 75.00% specificity were achieved. 
The results from this analysis are comparable to those of similar works [4], [5], [6]. 
Despite the classification of FES and HC, the resulting accuracy is still too low to 
propose the algorithm be used in clinical practice as an objective method for the 
diagnosis of this devastating neuropsychiatric disorder. This work was supported by the 
project No. AZV 17-33136A (Ministry of Health, CZ). 
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Abstract. The automated analysis of digitized immunohistochemistry microscope 
slides is usually a challenging task, because markers should be analysed on the 
tumor area only. Tumor areas could be recognized on a different slide, stained with 
Haematoxylin-Eosin. The basic idea of the present poster is to evaluate how well 
deep learning methods perform on the single haematoxylin component of staining, 
with the prospective possibility of developing a classifier able to recognize tumor 
areas on IHC slides on their haematoxylin component only. In a preliminary 
experiment, single stain images obtained by H-E color deconvolution showed an 
accuracy of 0.808 and 0.812 for Hematoxilyn and Eosin components, respectively. 
Keywords. Deep Learning, Digital slides, cancer 
1.Introduction 
The automated analysis of digitized immunohistochemistry (IHC) microscope slides is 
an actual and challenging problem, because markers should be analysed on the tumor 
area only. The IHC samples are stained with diaminobenzidine (DAB) to reveal a 
specific biological marker, and counterstained with Haematoxylin (H) to identify the 
cellular context. Tumor areas could be recognized on a different slide, stained with 
Haematoxylin Eosin (H-E). This normally raises the complexity of an automated analysis, 
introducing new tasks such as the alignment of the differently counterstained samples. 
In the last years, however, notable results have been obtained in tumor and metastases 
detection on H-E stained digital slides using deep learning techniques [1,2]. 
The basic idea of the present poster is to evaluate how well deep learning methods 
perform on the single stainings, with the prospective possibility of developing a classifier 
able to recognize tumor areas on IHC slides on their H component only. A preliminary 
experiment has been made on H-E stained images coming from the Bach Challenge [2]. 
2.Methods 
The dataset for the classification tasks comes from the BACH Challenge [2], Part A. It 
consists of training (n=400) histologic images from breast cancer, acquired at 0.42µm 
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and labelled with 4 categories, imagewise (normal, benign, in-situ carcinoma, invasive 
carcinoma).  As a baseline, a model has been trained on the original, full color images, 
split into 1024x1024 tiles with a 128 pixels stride, using Fastai as programming 
framework [3]. Images were then transformed into their H and E components, using the 
Color Deconvolution plugin of ImageJ [4] with its standard H-E vectors.  
The same model has been trained separately on the two staining components, after 
RGB conversion to make them compatible with the model. Accuracy evaluation has been 
carried out with the Bach Challenge rules [2]. 
3.Results 
The baseline model was based on ResNet152, pretrained on Imagenet on 3 epochs on the 
last layer, plus 3 epochs for fine tuning on the whole network. The model achieved almost 
state-of-the-art accuracy (average of 0.845 on 4 runs, with a maximum of 0.88).  The 
Haematoxylin model reached an average accuracy of 0.8075 on 4 runs (maximum: 0.84), 
while the eosin model reached 0.812 (maximum: 0.83).  
4.Discussion 
The models trained on single staining images obtained an accuracy lower than the full 
image one, although, if compared with the challenge results, they could still rank among 
the best 10 [2].  This result has been obtained without any specific optimization for these 
images, as the model architecture and hyperparameters of the baseline model have been 
fully replicated. Furthermore, no custom deconvolution vectors could have been 
computed, and this could have lowered the classification performance. 
Further work includes running the experiment on images acquired in a controlled 
environment, to compute the deconvolution vectors. Furthermore, classification of 
deconvolved H-DAB images in their Haematoxylin component will be also considered 
to prove a cancer recognition method for IHC in alternative to image registration 
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Classification of Normal and Cardiomegaly 
Cardio-Mediastinal Features
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Abstract. In this study, an attempt has been made to differentiate normal and 
cardiomegaly using cardio-mediastinal ratiometric features and machine learning 
approaches. A total of 60 chest radiographs including normal and cardiomegaly 
subjects are considered from a public dataset. The images are preprocessed using 
edge aware contrast enhancement technique to improve the edge contrast of lung 
boundaries. The mediastinal, cardiac and thoracic widths and their ratiometric 
indices are computed to characterize the morphological variations. The features are 
fed to three different classifiers for the differentiation of normal and cardiomegaly. 
Results show that the Linear discriminant analysis classifier is found to perform 
better with average values of recall 88.7%, precision 88.8%, and area under the 
curve 91.9%. Hence, the proposed computer aided diagnostic approach appears to 
be clinically significant to distinguish normal and cardiomegaly especially in remote 
and resource - poor settings.
Keywords. Cardiomegaly, Cardio-Mediastinal features, Machine learning
1. Introduction
Cardiomegaly is a medical condition that affects the cardiovascular system, specifically 
involving the enlargement of heart. This signature results from hosts of other diseases 
and strongly associated with congestive heart failure. Mediastinum region in the chest is 
considered as one of the substantial anatomical regions for the gross diagnosis of 
cardiovascular abnormalities. Early detection with mass screening approaches are crucial
to prevent such condition, particularly in remote and resource-poor settings. Chest 
radiographs (CXRs) have been widely used for this purpose due to their non-
invasiveness, and portability. Conventional image processing methods applied on CXRs
fail to characterize the condition and differentiate them from normal subjects.
2. Methods
The frontal CXRs of 60 subjects (Normal- 30, Cardiomegaly-30) are obtained from 
Chest X-ray14 publicly available dataset. The images are in grayscale with a resolution 
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of 1024*1024. The images are subjected to edge aware contrast enhancement technique. 
It is used to enhance the contrast in smaller sub-regions of the image by retaining the 
edge information [1]. This method uses local Laplacian filtering based on Gaussian to 
distinguish edges from details. Sharpness measure is used to validate the edge contrast 
enhancement of lung boundaries.
Left mediastinal width and mediastinal width [2], cardiac width and thoracic width
features are extracted, and their corresponding ratiometric indices such as Mediastinal 
width ratio, Cardiothoracic ratio [3], Mediastinal cardiac ratio (Mcr) and Mediastinal 
thoracic ratio are derived for all the subjects. All the features are provided to Linear 
Discriminant Analysis (LDA), Naïve Bayes (NB) and Support Vector Machine (SVM)
classifiers. Ten-fold cross validation is performed and the performance measures are 
evaluated.
3. Results and Discussion
(a) (b) (c)
Figure 1. Representative images (a) normal and cardiomegaly (b) preprocessed (c) Mcr plot
From Figure 1, it is seen that the original images have poor edge contrast especially along 
lung boundaries at significant anatomical landmarks and the adopted preprocessing 
method is found to enhance the edge contrast locally. Significant distinction is observed
between normal (0.3-0.55) and cardiomegaly (0.28-0.42) using Mcr plot.
The performance comparison of classifiers is shown in table 1. It is found that LDA 
performs better than NB and SVM with average values greater than 88% for recall, 
precision and F-measure and AUC of 91.9%. Large number of input images would be 
considered for future work.
Table 1. Performance of classifiers using all the features
Classifiers Recall (%) Precision (%) F-measure (%) AUC (%)
LDA 88.7 88.8 88.7 91.9
NB 82.3 82.4 82.4 88.4
SVM 85.5 85.5 85.5 86.0
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Abstract.This poster presents a non-exhaustive study of machine learning 
classification algorithms on pharmacovigilance data. In this study, we have taken into 
account the patient's clinical data such as medical history, medications taken and their 
indications for prescriptions, and the observed side effects. From these elements we 
determine whether the patient case is considered serious or not. We show the 
performances of the different algorithms by their precision, recall and accuracy as well 
as their learning curves. 
Keywords: Classification, Machine Learning, Pharmacovigilance, Decision support tool. 
1. Introduction 
Since 2017 in France, citizens can report directly to health authorities any adverse event 
related to health products. The objective of the presented work is to study to which 
extend machine learning algorithms could predict the seriousness of the situation from 
the description of the situation by patients. We used structured data recorded by health 
professionals from the verbatim of the patient to train machine learning algorithms. The 
main perspective is to apply the resulting prediction system to social media for 
pharmacovigilance monitoring. Although, signal detection in pharmacovigilance is 
historically based on statistical methods, more and more machine learning can make 
predictions for the detection of side effects [1]. Andrew M Wilson in [2] concluded that 
machine learning will not replace traditional pharmacovigilance technics but could 
collaborate to detect uncommon drug-related effects or reducing adverse drugs effects 
identification time. 
2. Methods and Results 
To carry out the study we considered a database that includes all the cases reported by 
patients from 2010 to 2019 resulting in a base of 13026 patient cases described by 50 
variables from HEGP (European Hospital Georges Pompidou), Paris, France. Cases 
reported in this database are standardized by pharmacovigilant using MedDRA terms. 
8699 cases are annotated as serious by health professionals. The aim of the study is to 
search the most efficient supervised learning algorithm that will enable the 
pharmacovigilant to prioritize serious cases. In a first step, all values of a variable are 
considered as a bag of word and translated in terms of presence/absence ("one-hot-
encoding"). This operation allows to keep the inter-variable interaction for poly-medical 
or poly-pathological patients. 
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Before applying an algorithm, the dataset is divided in two, 75% of the database will 
serve as a training base and 25% will be used to test the learning performance. This 
process is repeated 5 times in order to have a general tendency of the performances of 
the different methods. Then we apply 9 different state-of-art clustering models to our 
dataset thanks to available libraries: Decision Tree, Bagging Tree, Boosting Tree 
(AdaBoost), Gradient Boosting Machine, K-Nearest Neighbours (K-NN), Logistic 
Regression, Neural Network, Random Forest, Support Vector Machine (SVM). The next 
figure left shows the results in terms of precision (proportion of good prediction if the 
case is severe) and recall (percentage of serious cases correctly identified). The model 
with the best performance in terms of accuracy and recall is the logistic regression (next 
figure right). It does not over-fit the data and is very accurate (cf. LR learning curves 
next figure right). 
3. Discussions and conclusion 
It is important to note that the performance of machine learning methods depends on the 
input data that is used for learning. The same method on a different data set will give 
different results. Similarly, as new several observations are saved to the database, the 
performance of the same method will change over time. During this first study, it was 
decided to work initially with the default values of the algorithms because we did not 
have a priori knowledge to force the value of certain parameters. One possible 
improvement will be to choose optimal settings for all models and re-compare their 
performances later. For that we could use a search grid where all the parameters would 
be stored and build the models that would test all the possible combinations to determine 
the best of all. 
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 Model Recall Precision  
 
 
 Decision tree 0.73 +/- 0.15 0.73 +/- 0.11 
 Bagging 0.75 +/- 0.17 0.77 +/- 0.11 
 AdaBoost 0.68 +/- 0.22 0.77 +/- 0.15 
 Gradient Boosting 0.67 +/- 0.25 0.79 +/- 0.16 
 K-NN 0.74 +/- 0.13 0.72 +/- 0.10 
 Logistic Regression 0.77 +/- 0.19 0.81 +/- 0.11 
 Neural Network 0.75 +/- 0.13 0.75 +/- 0.09 
 Random Forest 0.76 +/- 0.18 0.79 +/- 0.11 
 SVM 0.50 +/- 0.00 0.34 +/- 0.00 
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Coping with IT Downtime in Hospitals 
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Abstract. Downtime of information systems is a universal challenge faced by health 
care institutions. In this poster, we present the findings of a scoping review of how 
hospital organizations and their staff deal with downtime, and how coping can be 
grouped into three strategies; 1) Increasing communication, 2) Analog fallback, and 
3) Restricted redundant systems. Our findings point to the importance of 
customizing coping mechanisms for individual healthcare institutions, and 
designing systems that empower users to deal with downtime.  
Keywords. Health Information Systems, Downtime, Coping, Failure 
1. Introduction 
Anecdotal stories about system breakdowns and information technology (IT) 
downtime are frequent in health care. More rigorous investigations into the incidence of 
downtime has found that almost all healthcare institutions have experienced at least one 
unplanned downtime event, and that for the majority of these events the duration 
exceeded eight hours. Despite contingency planning and strategies for downtime 
handling, organizations still struggle to ensure that end-users of IT react sensibly during 
prolonged incidents. The aim of this work is to present an overview of coping 
mechanisms for handling unexpected downtime in hospitals. We focus on systems that 
can be fully, or partially, substituted with improvised solutions during the episodes.  
2. Method 
The study was conducted as a scoping review based on the search phrase 
‘("technology failure" OR downtime) AND ("electronic health record" OR EHR OR 
"Information system" OR "electronic medical record" OR "Patient administration 
system" OR Paperless OR "Emergency care information systems" OR "Hospital 
Information Systems"). We searched Pubmed, Engineering Village, and Cinahl. Included 
papers was thematically analyzed to identify general coping categories. 
3. Results 
A total of 51 studies were assessed in full text, resulting in the inclusion of 13 studies 
for the final analysis. From the thematic analysis we structured the coping mechanisms 
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into three categories: 1) Increased communication which sought to facilitate the lack of 
coordination offered by the IT system, 2) Analog fallback to capture the clinical 
information and knowledge needed for processing and treatment of patients in alternate 
ways, and 3) Restricted redundant fallback systems which still utilized IT but without 
access to the entire suite of functionality. The findings of our analysis are distilled into 
Table 1.  
Table 1. Overview of results 
Category Coping mechanism Affected system Cause 
Increased 
communication 
 
Phone , Alternative working 
procedures, Email, Command 
center, Mass communication, 
Designated mediators  
EHR, CPOE, LIS, 
HIS 
System upgrade System 
launch, Hardware failure, 
Cyber-attack  
Analog fallback 
 
Printed labels, White board, 
Supplementary Paper Forms, 
Notebooks, Emergency 
Toolkit, Printed Ad-hoc logs  
EHR, CPOE, CDSS, 
LIS, HIS  
System upgrade, System 
launch, Hardware failure, 
Cyber-attack Natural 
disaster  
Restricted 
redundant 
systems 
Use of offline computers,  
Read-only systems 
EHR, Medication 
administration  
Hardware failure  
 
The majority of downtime cases involve Electronic Health Records (EHR) or 
Hospital Information Systems (HIS), but also order entry systems (CPOE), clinical 
decision support (CDSS), and laboratory systems (LIS) were implicated. The coping 
mechanisms were coupled to the type of system affected. 
4. Discussion 
Given the steady improvement of hard- and software technology, one might expect 
that the risk of downtime would diminish over time, or even be an outdated issue. Yet, 
as illustrated by anecdotes as well as literature, this is not the case. During breakdowns, 
organizations either resolve to utilize broadcasting of information, or appointing 
designated carriers of information. Fallback systems are either improvised or designed 
in advance. In some cases, institutions were aware of the growing disparity between 
electronic or paper-based documentation and consequently prepared an entire emergency 
toolkit. From our initial navigation of the field, it is evident that grey literature of all 
kinds actually include a richer source of cases and experience. Given enough time and 
resources, there is most likely a lot of learning to be distilled from a systematic approach 
to collection and analysis of these stories. 
5. Conclusion 
The three coping strategies identified in this review, and the frequency by which they 
have been utilized, are indicative of the continued need for having fallback systems in 
place to handle lack of access to the IT systems. Although there are a number of research 
instruments available for gauging the impact of downtime, there is a need to harvest the 
experiences described in grey literature. 
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for Health Analytics 
in a Public Health Setting 
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Abstract. The implementation of an Electronic Medical Record (EMR) in the 
public healthcare system of Buenos Aires City began in June 2016. AGISE is a 
government department that assists in health decision-making processes by 
providing timely and quality data. In this study we designed a professional 
development program to improve organizational capacities for health analytics.  
Keywords. professional development, training program, health analytics. 
1. Introduction 
The implementation of an Electronic Medical Record (EMR) in the public healthcare 
system of Buenos Aires City began in June 2016 as a central component of a Health 
Information System. The management of the large amounts of data that it generates is a 
complex, interesting, and vital challenge for the sustainability and development of this 
system and organization. 
AGISE is a government department within the Health Ministry of the city of 
Buenos Aires, whose objective is to assist in health decision-making processes by 
providing timely and quality data to people of all decision levels. Through qualified 
professionals with heterogeneous profiles, AGISE aims to form a multidisciplinary 
work team within the public health sector. Current challenges in achieving this include 
finding new people who are able to adapt to desired profiles, identifying any gaps 
between the experience of the potential hires and the needs of the organization, and the 
difficulties in competing with the labor market due to less competitive salary usually 
offered by government institutions. The aim of this study is to describe the design and 
implementation of a comprehensive development program including a training 
curriculum for new members of the team and a continuous training program for the 
stable staff; to encourage a dynamic and collaborative analytical community in the 
public health sector in the context of new information and communication technologies 
(ICT). 
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2. Methods 
The design of a competency-based educational program began with a review of the 
literature to rely on the best practices in professional development programs[1][2]. 
Expected analytic profiles were defined, with roles and tasks to be assigned. Training 
needs were assessed through semi-structured interviews with team members. As a 
result and according to the organization's mission, general and individual training and 
developmental goals were defined following the SMART criteria (Specific, 
Measurable, Achievable, Realistic, Timely). Transferable experience, skills and 
available resources were identified and analyzed to find out what the team was lacking. 
An action plan and timeline were developed, and its execution began in June 2019. 
Evaluation tools were designed to assess our progress and revise accordingly. 
3. Results 
The chosen training methodology is focused on competencies, with distributed learning 
following the principles of participation, repetition, relevance, transfer and feedback 
[3][4]. We selected priority contents for the curriculum of new members and organized 
them in an intensive two-week self-administrable package. For the continuous training 
of the stable team, we selected contents and organized them into seven thematic units 
distributed in an annual schedule. Small group projects, talks with experts, hands on 
workshops, theoretical classes, book clubs, and virtual courses were some of the 
modalities applied. For each thematic unit the programmed activities were scheduled in 
a shared calendar, their materials and resources stored in an accessible and indexed 
repository, and a forum was created to share questions, doubts, and experiences. We 
developed tools for both, evaluation and monitoring, to make it possible to adapt and 
optimize the curriculum’s contents, as well as consider including new topics.  
4. Conclusion 
The implementation of a professional development plan that guides the initial training 
of new members and the continuous training of the team is a vital resource for the 
growth and development of organizations. Monitoring is necessary to assess progress 
and review accordingly.  
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Abstract. Objective: To perform a cross-mapping study between nursing 
documentation from a Electronic Health Record (EHR) of a Brazilian hospital and 
four nursing terminology systems. Method: Descriptive, quantitative and 
retrospective study. Results: The EHR presents a total of 247 anamnesis / physical 
examination terms, 75 nursing diagnoses, and 205 nursing interventions terms to 
nurses make their choice. Conclusion: Authors strongly recommend that attempts in 
building more usable and friendly EHRs for clínical care practice documentation 
consider classification systems structures in their development, to ensure complete, 
safe, evidence-based and comparable registries. 
Keywords. Nursing documentation. Nursing Informatics. Electronic Health 
Record. Terminologies. Cross-mapping. 
1. Introduction
The Nursing Process (NP) is composed of interrelated steps that provide quality to 
nurse’s clinical thinking and enable continuity of care in healthcare settings [1]. 
Anamnesis and physical examination data are gathered in its first stage and are essential 
to measure the resolution of care [2]. Nursing diagnosis (ND) is a clinical judgment about 
problems of an individual, family or community, over which nurses can intervene 
favoring their quality of life. This judgment is based on the nurse's assessment of the 
history, complaints, social and physiological data of the patient to whom nursing care is 
being delivered [3]. Nursing interventions (NI) are sets of actions that coordinate the 
“doing” of nursing care, and should be based on observation and evaluation of problems 
presented by the individual, family or community [1]. 
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In order to organize the specific language of nursing, classification systems have 
emerged, which allow the unification of concepts relevant to this area, considering their 
wide scope and performance in the fields of teaching, management, research and care 
[3]. 
2. Method
In order to cross-map anamnesis and physical examination, diagnoses and nursing 
interventions terms available in the hospital’s EHR with four nursing
standardized classification systems, a descriptive and retrospective study of quantitative 
approach was performed. 
This study is part of a project entitled ‘Artificial Intelligence and the management 
of sepsis patients: its influence on decision making, nursing interventions and outcomes’, 
approved by the Health Sciences Sector of the Federal University of Paraná (UFPR,
Brazil) Institutional Review Board (IRB) in May 2018, under registration number 
84602218.8.0000.0102 and approved by the the co-participating IRB under registration 
number 84602218.8.3001.0098. 
3. Results
From the EHR list of options, 247 terms referred to the description of anamnesis and 
physical examination, 75 to ND and 205 to NI. The match rates range from 58% to 100%, 
depending on the stage of the nursing process and the classification system mapped. 
4. Conclusions
Care documentation is a challenge in current healthcare practice - it is a major cause of 
burnout among clinicians and nurses, and it is also mandatory for the continuity of care, 
visibility of nursing profession contribution and for legal and billing matters. 
In this study a cross-mapping experiment is presented which reflects the importance 
of translational research in health and nursing informatics. Scientific knowledge, here 
presented by robust classification systems, provide the foundation for data, information, 
knowledge and wisdom structures that contribute to highlight clinical reasoning and 
evidence of healthcare practices. Authors strongly recommend that attempts in building 
more usable and friendly EHRs for clínical care practice documentation consider these 
structures in the development, to ensure complete, safe, evidence-based and comparable 
registries. 
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Abstract. The aim of this study was to examine existing methods for sharing 
results of stem cell research via online data repositories. To identify the relevant 
repositories, a PubMed search was conducted using standard MeSH terms which 
was followed by a web-based search of relevant databases. The search yielded 16 
databases created between 2010 and 2019. The review of databases identified 35 
major rubrics and their sub-rubrics organized in a five-module system. Data 
integration approaches were characterized by three domains (common data 
elements, data visualization and analysis tools, and ontology mapping) which 
varied widely across the databases. Current state of stem cell data integration lacks 
reproducibility and standardization. Standardization of data integration approaches 
for representing stem cell studies is necessary to facilitate data sharing.  
Keywords. Data integration, data sharing, stem cells, standardization  
1. Introduction  
An exponential expansion of  stem cell research results in voluminous data set 
aggregation [1]. However, effective approaches for intelligent integration and sharing 
of these resources have not been established. The aim of this study was to examine 
existing methods for sharing results of stem cell research via online data repositories. 
2. Methods  
Stem cell repositories were identified by using “Databases, Factual AND Stem Cells” 
MeSH terms in PubMed and web search for stem cells databases created between 2010 
and 2019. All identified databases were manually reviewed and characterized. 
3. Results  
Overall, we located 14 academic databases indexed in PubMed and two databases not 
reflected in peer-reviewed literature (Table 1). The databases varied widely in data 
elements, analysis tools, search functionality and update methodology. Their features 
were summarized in 35 rubrics including names, lineage, surface markers, transcription 
factors as well as types of detection assays and clinical trial information.  
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 Diverse rubrics were organized into a five module system based on Minimal 
Information About a Cellular Assay for Regenerative Medicine (MIACARM) [2] 
including Project, Assay, Source cell, Experimental technology, and Data.  
Table 1: Stem cell databases 
Database Tittle Link 
SyStemCell http://lifecenter.sgst.cn/SyStemCell/ 
CODEX http://codex.stemcells.cam.ac.uk/ 
ESTOOLS Data@Hand https://ruoho.uta.fi/wp/estools/ 
Stem Cell Discovery Engine http://discovery.hsci.harvard.edu/ 
StemFormatics https://www.stemformatics.org/ 
LINCS http://lincsportal.ccs.miami.edu/dcic-portal/ 
LifeMap Discovery https://discovery.lifemapsc.com/ 
StemMapper http://stemmapper.sysbiolab.eu/ 
ESCAPE http://www.maayanlab.net/ESCAPE/index.php 
SKiP Stemcell Knowledge and Information Portal https://skip.stemcellinformatics.org/en/ 
hPSCreg https://hpscreg.eu/ 
CellNet http://cahanlab.org/macellnet.html 
StemCellNet http://stemcellnet.sysbiolab.eu/ 
HSC-explorer http://mips.helmholtz-muenchen.de/HSC/ 
CORTECON http://cortecon.neuralsci.org/ 
ESCD https://biit.cs.ut.ee/escd/ 
4. Discussion 
Data integration approaches were characterized by three domains (common data 
elements, data visualization and analysis tools, and ontology mapping) which varied 
widely across the databases. Current state of stem cell data integration lacks 
reproducibility and standardization. Standardization of data integration approaches for 
representing stem cell studies is necessary to facilitate data sharing. Consensus on 
common data elements and data exchange standards will facilitate data integration 
approaches in stem cell-based research and promote research transparency and 
reproducibility.  
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Data Provenance Standards and 
Recommendations for FAIR Data 
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Abstract. This article reviews the main characteristics of five widely used data 
provenance models and recommendations. We suggest a set of six provenance 
properties that should be satisfied by any provenance model as a basis for further 
implementation of provenance mechanisms, supporting the findable, accessible, 
interoperable and reusable (FAIR) principles for both, research and health data. 
Keywords. Data provenance, FAIR data, Metadata, Research data, Health data 
1. Introduction 
In health research, data capture and data quality varies strongly. Therefore, information 
on data provenance is needed along the whole processing pipeline [1]. This includes the 
generation of persistent identifiers (PIDs) to make the data findable and accessible and 
is crucial to reuse data. Therefore, providing data provenance information is a mandatory 
step towards findable, accessible, interoperable and reusable (FAIR) data [2].  
2. Methods 
We consider five provenance standards identified within the FAIR4Health project [3]. A 
widely used provenance model is the W3C PROV-DM data model [4]: an acyclic 
directed graph, consisting of nodes “entity”, “activity”, and “agent”. Recommending 
specific provenance items, the DataCite International Consortium developed a metadata 
scheme in 2009 [5]. It stresses assignment of digital object identifiers (DOIs) and 
includes six domain-agnostic mandatory properties. In 2016, a domain-specific 
extension to the DataCite metadata schema for health was presented: the ECRIN Clinical 
Research Metadata Schema [6]. It includes information on the source study, associated 
consent and access details. The Research Data Alliance endorsed 14 recommendations 
of the Working Group Data Citation (WGDC) [7] targeting reproducibility of data used 
in experiments and studies. Therefore, persistent identifiers have to be generated in a 
query-based manner, so that data views can be cited and retrieved by re-executing the 
query. As a result of the Data Quality Collaborative (DQC), Kahn et al. [8] proposed 20 
data quality and provenance recommendations. They especially highlight that each 
transformation of the source data has to be documented, including data cleansing values. 
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3. Results  
We extracted the following list as minimal “fit for use” requirements for provenance 
model (Table 1). Check-marks indicate, which recommendation(s) support these items. 
 Table 1.  Comparison of the different provenance recommendation sets. 
Criteria DataCite ECRIN WGDC DQC 
Persistent identifier (PID): Each data object is assigned a 
unique, persistently stored identifier. Ideally, a DOI is assigned. 
✔ ✔  ✔ ✘ 
Data origin: The project or event that generated the data. ✔ ✔ ✘ ✔ 
Data creator: A person or institution to be credited for. ✔ ✔ ✘ ✔ 
Data timestamp: The time of dataset creation/modification. ✔ ✔ ✔ ✘ 
Data versioning: Each transformation result of the data object is 
stored. Earlier versions are retrievable. 
✔ ✔ ✔ ✔ 
Query PID: If (sub-)sets of data are generated or cited, the query 
is stored with a persistent ID for reproducibility.  
✘ ✘ ✔ ✔ 
4. Discussion  
The present work has identified six minimal criteria from the given provenance overview, 
implementable using the PROV-DM data model. The feasibility of these items will be 
investigated in the FAIR4Health project’s demonstrators.  
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Abstract. Information visualisation is transforming data into visual 
representations to convey information hidden within large datasets. Information 
visualisation in medicine is underdeveloped. In midwifery, the impact of different 
graphs on clinicians’ and patients’ understanding is not well understood. We 
investigate this gap and its potential consequences. 
Keywords. data visualisation, midwifery 
1.Introduction 
Data visualisation is transforming data, information and knowledge into visual 
representations that convey meaningful patterns and trends hidden within large datasets 
[1]. Ineffective data visualisation negatively impacts clinical care and patient safety [2]. 
Effective visualisation mitigates comprehension, interpretability and data navigation 
issues [3]. Data visualisation in clinical medicine is underdeveloped [4]. This is 
especially true for midwifery. Finding appropriate ways to visualise data is challenging 
[5], and depends on objectives, context and audience [5]. Studies confirm the 
effectiveness of data visualisation. This paper investigates how data visualisation could 
be better applied in midwifery. 
2.Method 
A multi-database search was conducted using the terms “data visualisation” and 
“midwifery”. Duplicates, irrelevant papers and those which spoke of data visualisation 
but failed to present any form data visualisation in were removed. This resulted in a 
collection of just 10 papers for use in this review. 
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3.Results 
Our review identified that midwifery uses extremely limited and primitive data 
visualisation methods. Bar charts [6] and line graphs [7] dominated, with only one work 
[8] using any graphical representation. No works addressed visualisation methods for 
midwifery. Midwives are not being exposed to approaches that could improve their 
understanding and assimilation of clinical data, and accordingly lack awareness of 
approaches to and benefits of data visualisation. 
4.Discussion 
Direct patient care will continue to be the driving concern, but how midwives engage 
with patient data and research must evolve in the era of big data [9, 10]. Many consider 
data science as the next evolution for midwifery, yet few midwives understand what data 
visualisation is and the impact it may have [9, 10]. Increasingly, effective information 
visualisation may hold the key to understanding complex data in electronic health record 
datasets. Midwives must embrace data visualisation and the knowledge it can convey. 
5.Conclusion 
We have investigated the use of data visualisation within the domain of midwifery. 
Research is needed to assist midwives who work with or present data to do so using 
appropriate data visualisation. Without this, midwives will continue to be constrained by 
the challenge of seeing what datasets hide. 
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Abstract: We developed a deep learning approach for accurate prediction of PCA 
patients one year earlier with minimal features from electronic health records. The 
area under the receiver operating curve for prediction of PCA was 0.94. Moreover, 
the sensitivity and specificity of CNN were 0.87 and 0.88, respectively. 
Keywords: Prostate cancer, deep learning, convolutional neural network, 
electronic health record. 
1.Introduction 
Prostate cancer (PCA) is the most commonly diagnosed cancer in men and the fifth 
leading cause of death globally [1]. Earlier stratification of patients at high risk of PCA 
offers an immense potential to decrease morbidity and mortality. Prostate-specific 
antigen (PSA), however, is a widely used and reliable test that is currently applied in 
screening the patients for correct identification of PCA patients. We, therefore, 
developed a novel prediction model using CNN algorithm with minimal features from 
HER that may help to stratify high-risk patients before a diagnosis of PCA. To our 
knowledge, it is the first study to develop a prediction model of identifying PCA 
patients one year earlier. 
2.Methods 
Two million population data between January 01, 1999 and December 31, 2013 was 
randomly selected to conduct this current study. All the patients who were ≥20 years 
old and diagnosed with prostate cancer retrieved from the database between January 
01, 1999 and December 31, 2013. PCA patients were confirmed by using ICD-9 codes 
and record in the Registry of Catastrophic Illness Patient (RCIP), a subpart of the NHI 
database. 
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Patient to be included in the RCIP database must have pathological confirmation and 
treatment history of PCA. We then checked the total number of prescription and length 
of prescription for those patients. Afterwards, 7-days clinical information of all patients 
was summed up continuously. A total of 157 grid was constituted of 1095-days 
patients’ information. We developed CNN model with a 5- fold cross-validation 
technique in this study. The area under the receiver operating curve, Sensitivity, 
specificity was used to measure the performance of our model. 
3.Results 
A total of 4,071 PCA and 16,284 controls were included in our current study. The mean 
age of case and control patients were 70.0, and 47.5 years, respectively. All the patients 
diagnosed with PCA were male. The average number of diagnosis in patients with PCA 
were higher than controls (44 vs 24) when we considered PCA and non-PCA patients 
one year before index date. However, over the three years, the average number of 
diagnosis in PCA and non-PCA patients was 41.23 and 22.66. The mean of AUC of the 
CNN model in the minimal electronic health record feature was 0.94, with sensitivity 
of 0.87 and specificity of 0.88 at the threshold value of 0.4. 
4.Discussion & Conclusion: 
In this current study, we focused on predicting PCA patients one year ahead from the 
minimal feature of electronic health records by the widely used CNN model. However, 
the CNN approach has shown high sensitivity and specificity for predicting PCA with 
the minimal feature of EHR. Based on these current findings, it is obvious that deep 
learning prediction model could provide physicians immense opportunity to improve 
patient outcomes through earlier PCA identification and subsequent follow-up high-
risk PCA patients. Having provided timely treatment to patients may help to improve 
survival rate, minimize treatment costs and reduce risk of mortality [2]. We developed 
a novel deep learning risk prediction model for the prediction of PCA with minimal 
features of EHR. Our model, which includes patient demographics, comorbidities, co- 
medications, can be used to identify patients at high risk of PCA one year earlier. 
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Abstract. This work aims to define a standardized information model for 
representation of multiple data sources in breast cancer. A set of data elements has 
been identified using ICHOM Breast Cancer as the minimum data set and adapting 
it to the needs of Hospital Universitario 12 de Octubre. With this, an information 
model has been defined according to ISO 13606 and SNOMED CT standards. 
Keywords, EHR, Information model, Standardization, Breast cancer, ISO 13606, 
SNOMED-CT, ICHOM. 
1. Introduction 
Advanced uses of health information require standard data that allows its representation 
without loss of meaning [1], essential in a multidisciplinary condition such as breast 
cancer. This work aims to define an information model for the standardized representation 
of data in breast cancer domain. 
2. Methods 
First, the set of data elements for breast cancer domain was identified using ICHOM 
Breast Cancer [2] as the minimum data set. Second, tis data set has been reviewed and 
adapted to the needs of Hospital Universitario 12 de Octubre [3]. Finally, based on this 
specification, an information model has been defined according to ISO 13606 [4] and 
SNOMED CT [5]. 
3. Results 
Table 1 shows the number of data elements that have been identified, comparing them 
with the number of elements defined by ICHOM Breast Cancer. 
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Table 1. Data elements identified by categories and compared with ICHOM Breast Cancer 
Data category ICHOM BC Data Element Set 
Clinical 47 71 
  Pathological Anatomy 17 84 
  PROM 104 104 
 Total 168 259 
 
Table 2 shows an example of standardized data element using the reference model of 
ISO 13606 and SNOMED CT. 
 
Table 2. Data element standardized according to ISO 13606 and SNOMED CT standards 
Component Data-type Cardinality SCT Code SCT Term 
Element Coded Value 1 371480007 Tumor site 
Value - - 181134008 Entire upper outer quadrant of breast 
Value - - 181136005 Entire lower outer quadrant of breast 
Value - - 181132007 Entire upper inner quadrant of breast 
Value - - 181135009 Entire lower inner quadrant of breast 
Value - - 205042000 Entire central portion of breast 
Value - - 265780004 Entire nipple 
4. Conclusions 
Data set proposed by ICHOM Breast Cancer has been used as the minimum data set. It 
has been necessary to increase the number of data elements from 168 to 259 to adapt it to 
the needs of the Hospital (see Table 1). 
The combined use of ISO 13606 and SNOMED CT has allowed the standardized 
definition, structure and meaning, of previously identified data elements. This will allow 
advanced uses of these data with full meaning. 
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Abstract. The number of people in need of long-term care is rising and person-
nel scarcity is already foreseeable. The shortage of caregivers is further increased
due to early retirement attributed to the major health burden when working at high
speed with heavy lifting. Since nursing staff in many cases work beyond their phys-
ical strain limits during routine activities at the bed and existing systems do not
counteract the current trend, we investigate with the present work whether the con-
cept of a collaborative robotic support system can contribute to the physical relief
of the nursing staff to make it possible to fall below the physical strain limits.
Keywords. robotics, human-robot collaboration, computer vision, camera calibration
1. Introduction
As the worldwide population is aging, the demand for caregiving personnel is increas-
ing. In addition to this shortage of qualified personnel, the problem of physical overload,
which results mainly from the high working speed and heavy lifting, prevails within the
health care system. This overload in turn leads to an inability to work or an early retire-
ment of the personnel [1], thus resulting in an even greater shortage of available staff.
The biomechanical overload during routine nursing activities has been previously mea-
sured and described in detail [2]. In that work, the compressive force on the lumbosacral
disc of the spine of caregivers during the execution of nine different types of nursing ac-
tivities (e.g. moving the patient to the bed’s head end) was estimated using a biomechan-
ical model. In most cases, the estimated lumbar load values are not within acceptable
limits. Consequently, technologies to reduce the physical load must be developed. While
conventional support systems, such as patient lifts, have the drawbacks of slow patient
transfer and limited usability, robotic solutions may have the potential to cooperatively
support the nurse during physically demanding activities. In this work, we focus on the
research of such a system in order to identify its limits.
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2. Method
In order to provide comprehensive support for the movement of patients, an actuated bed
is to be used. For the actual support at the bed, we chose the LBR iiwa 7 R800 model
from Kuka, which makes safe human-robot collaboration possible due to its sensitive
joint torque sensors [3]. To bring the components together, an intermediate construction
was manifactured for the actuated bed on which the robot can be mounted. For interaction
with the caregiver or the patient, additional sensors are required to detect the robot’s
environment. For this particular case, a visual system based on multiple 3D cameras is
used to detect any unwanted collision at an early stage.
3. Results & Discussion
The result of the conceptional design can be seen in Figure 1. We decided to test the
system’s limits by using it in a scenario where the patient (rescue dummy, 80 kg) is
turned to the side, then the caregiver places the hand on the patient’s thigh for the transfer
towards the head end of the bed. A marker on the nurse’s hand is detected by the vision
system and functions as the reference for the robot goal. At this predetermined position,
the robot applies additional pressure with a predefined force so that the nurse supported
and hence physically relieved during the process.
Figure 1. Final setup consisting of an actuated bed, mounted robotic manipulators and a Microsoft Kinect V2
vision system. The right side depicts a potential supporting scenario using the robot.
4. Conclusion
It was possible for us to realize a robotic assistance system mounted at an actuated bed
with a visual detection system, which is able to support physically during predefined
nursing activities. Next, we plan to record all regular physically demanding nursing ac-
tivities executed by two cooperating nurses in order to make meaningful derivations for
the operation of the robot on the basis of this visual data.
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Abstract. The goal of this research was to design a solution to detect non-reported
incidents, especially severe incidents. To achieve this goal, we proposed a method
to process electronic medical records and automatically extract clinical notes de-
scribing severe incidents. To evaluate the proposed method, we implemented a sys-
tem and used the system. The system successfully detected a non-reported incident
to the safety management department.
Keywords. Safety management, supervised machine learning, medical records 
1. Introduction
In order to prevent medical accidents at hospitals, it is important to grasp those events
at early stages that lead to severe medical accidents and then take appropriate actions
based on the events. These events, which are defined as incidents, are usually reported by
medical staff to the safety management department, that is responsible for the prevention
of medical accidents in hospitals. The reports are analyzed by the department in order to
decide which measures should be implemented by the clinical staffs. This mechanism is
called an incident reporting system [1].
One of the main issues related to incidents is a long delay or even lack of report-
ing [2,3]. It is especially important to detect those cases since they affect the safety man-
agement departments ability to respond properly.
The goal of this research is to design a solution to detect these non-reported inci-
dents, especially severe incidents. To achieve this goal, we develop methods to process
electronic medical records and automatically extract clinical notes describing severe in-
cidents. The extracted notes are treated as incident candidates which are shown to the
safety management department for further analysis.
1Corresponding Author: Kazuya Okamoto, Kyoto University Hospital, 54 Kawahara-cho, Shogoin, Sakyo-
ku, Kyoto, 606-8507, JAPAN; E-mail: kazuya@kuhp.kyoto-u.ac.jp.
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2. Methods
We develop methods to process electronic medical records and automatically extract
clinical notes describing incidents of injection by using the SVM based technique [4].
First, we manually label a training set of clinical notes into two categories based on
whether they include a severe incident report or not. Next, by morphological analysis, the
training set is separated into words and arranged in a vector space using single words as
the axes. Then, the SVM creates the machine learning models from the arranged training
set with labels.
Finally, based on the created machine learning models, the SVM extracts positive
clinical notes which are estimated as clinical notes with incident reports. The extracted
notes are treated as incident candidates which are shown to the safety management de-
partment for further analysis.
3. Experiments
Using the proposed method based on the linear kernel SVM, we implemented an inci-
dent candidate reporting system. To evaluate the system, we asked a staffs of the safety
management department to judge whether extracted incident candidates were incidents
or not.
4. Results
The system extracted 121 incident candidates from the 294,731 clinical notes. 34 of
them were judged to include severe incident reports by the staff of the medical safety
department, which means that the precision is 28.1%. 31 of them were related to sud-
den critical changes of patients’ conditions; other two were related to incidents during
surgeries; the other was related to a fall from a bed. Moreover, several sudden critical
changes among the detected incidents were not reported actually.
5. Conclusions
In this research, we aimed to establish a method to extract incident candidates from
clinical notes in order to detect non-reported severe incidents. In addit ion, we imple-
mented a reporting system that presents incident candidates extracted by using the pro-
posed method. The system successfully detected a non-reported incident to the safety
management department, thus our goal was achieved.
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Abstract. According to recent revisions to medical laws in Korea, changes to 
electronic medical records are to be documented. To do so, however, a transparent 
system with which to store original documents and changes thereto is needed. The 
transparency and immutability of blockchain records are the key characters of 
blockchain technology. Employing these characteristics, we developed an 
application with which to monitor changes of medical records using blockchain. 
1. Introduction 
Although medical records are personal to the individual patient, patients themselves 
often face difficulties with gaining access to their medical records, compared to medical 
staff. If a patient would like to determine whether their medical records have been 
changed, they must request all medical records at a hospital. Also, according to Korean 
medical law, accessing electronic medical records is to be documented.[1] An objective 
and transparent system with which to preserve the history of revisions to original 
medical data is needed. Accordingly, we developed a system that allows patients to 
monitor changes to their medical records using blockchain technology, which is known 
for its transparency and immutability.[2] 
2. Method 
To begin, we categorized information contained within medical documents into three 
risk levels: medically important and incapable of being modified; medically relevant, 
but capable of being modified; and medically unrelated. Unlike existing blockchain 
transactions, transactions used in private blockchains do not include the recipient's 
address, allowing for a separate variable in the blockchain to distinguish patients. The 
transaction structure of a blockchain block comprises four items: the Owner, Topic, 
Key, and Value. The Key and Value items hold four additional items: Hash, 
DocumentUri, PreviousHash, and Modified. The Hash item represents the unique ID of 
a medical record, and DocumentUri indicates the address where the medical record is 
stored. PreviousHash reflects the previous version of the current record of the Hash. 
When a medical record is entered for the first time, the PreviousHash value is entered as 
Null. Finally, the Modified item indicates how many changes have been made to the 
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medical record. This application was developed with Android Studio using Java version 
1.8 and utilizes the published blockchain API. 
3. Results 
This application monitors the creation of medical records, changes thereto, the risk of 
changes, and the creation and modification timestamps through the blockchain. The 
processes of the application through the blockchain are shown in Figure 1. 
Figure1. How the application works 
 
On the left side, the origin data and modified data are recorded in the blockchain in the 
same text format as the center. So you can see how many your medical records been 
changed or not in the application through the medibloc panacea-core API. 
 
 
4. Conclusion 
 
In this study, we established a monitoring system that allows patients to be awareof 
changes to their medical records using blockchain technology. Using the application, 
patients can be informed about the status of their medical record as soon as the record is 
created or changed. Adopting this system will allow for more transparent management 
of medical records and potentially more trust among patients in their doctors. There 
have been cases of building electronic medical records4 or personal health records5 
with blockchain. However, only the construction of a blockchain system that stores 
information hasbeen discussed, and most proposed systems have been established for 
only the storage and sharing of medical records. This study is the first to develop an 
application for monitoring changes to electronic medical records, and a prospective 
study on its usability is being planned. The blockchain itself is decentralized, but it's not 
a perfect DApp. Due to it gets its value from the database to access the app. In addition, 
there are still Smart contracts security issues. Therefore, DApp is discussion and 
limitation. 
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Abstract. This project followed waterfall model to develop a context tailored and 
user-friendly reminder system to support home based TB treatment. piloting was 
conducted on expert and patient levels. We developed a flexible and user-friendly 
web-based system that allows medication and refiling reminder. Participants 
agreed on its usefulness despite infrastructure and personal related challenges. 
Keywords. Phone reminder, medication, refilling, Ethiopia  
1. Introduction 
Non-adherence to TB treatment worsen during continuation phase [1]. Mobile phone 
messaging showed promising output in supporting home-based medication [2]. Most of 
mHealth Apps run with smart technology but smartphone ownership is low in Africa 
and usability remained challenging due to poor tailoring and engagement of end-users 
during development process [3]. This project aimed to develop and test a web-based 
reminder system for home-based TB medication using both basic and smart phones.  
2. Methods 
The project is part of an ongoing randomised controlled trial study in Northwest 
Ethiopia, registered in PACTR201901552202539. The project applied a waterfall 
model development process and piloted at expert and patient levels.  We used 
NetBeans, Glass Fish, Java Persistence API, java platform Enterprise Edition, 
JavaScript and MySQL for frontend and backend development, and Serreta modem to 
handle SIM cards. Piloting, involved 2 IT experts, 3 health information technicians and 
4 TB focal persons to evaluate interface and layouts. To assess usefulness and 
challenges, 23 adult patients on continuation phase enrolled and received medication 
and refilling reminder for 2 months.   
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3. Result 
We developed a flexible and user-friendly web-based reminder system. The main 
features include: registration, reminder scheduling for medication and refilling (Fig.1). 
About, 20(87%) of patients received all reminders. Of them, all replied the system was 
useful. A respondent replied: “Rural people like me are busy and forget pills. This 
system helped me lot.” (42Y/O, M). Participants reported: weak mobile network, power 
inconsistency, medication time variation (4(17%) patients follow suggested time).  
 
Figure 1. Patient registration and cell phones based text (Amharic) and graphic reminder for TB treatment 
4. Discussion  
The current project developed a context tailored, user-friendly and flexible web-based 
reminder system for home-based TB treatments. Globally, various generic mHealth 
systems developed, however, usability and sustainability often determined based on 
contexts [4]. In resource limited setting where no reliable ICT infrastructure, low 
digital literacy and low access to smartphone and needs to consider those factors during 
development [5]. The mobile cellular subscriptions shown fastest growth 74% in Sub-
Saharan Africa including 51% in Ethiopia [6]. Therefore, development of mHealth 
technologies need to assess local requirements and tailored to the context. As a 
limitation, this reminder system works only with text and simple graphic messages. 
5. Conclusion  
A context tailored reminder system could be usable for home-based TB treatment in 
low resource settings. The randomised controlled study could address its efficacy.  
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Abstract. Uncontrolled cancer-related symptoms severely affect the quality of life 
of cancer patients. This study leveraged symptom data written in the online health 
communities (OHCs) and developed a symptom knowledge database for cancer 
patients. Further study is needed to apply this pilot study to the larger OHCs data.  
Keywords. graph-based database, text mining, consumer health informatics 
1. Introduction 
Uncontrolled cancer- and treatment-related symptoms not only severely affect the 
quality of life, but also decrease the overall survival rate of cancer patients [1]. In the 
Internet era, many patients share their symptom experiences on online health 
communities (OHC) that is not attainable from clinical data [2]. However, it is difficult 
to utilize the information written in the OHCs without a standardized approach to 
discover and manage information. Thus, there is a need to develop a pipeline to utilize 
this wealth of information for cancer research and clinical practice in the future.  
The overarching goal of the study is to develop a symptom knowledge database for 
cancer patients. As a pilot study, we will focus on ovarian cancer (OvCa). OvCa is a 
strong example for understanding the complex challenges of managing symptoms 
because OvCa patients have a wide range of tumor types and many face a lifetime of 
ongoing active disease management due to high recurrence rates [3].  
2. Methods  
Data was collected from the OHC sponsored by the American Cancer Society: Cancer 
Survivors Network (http://csn.cancer.org/forum/132).  We extracted posts that were 
posted between January, 2006 and March, 2016 (n=50,626). As a pilot study, we 
randomly selected 100 postings that described “nausea” and manually annotated them 
in four concepts: symptoms, treatments, results and other medications. After annotation, 
each concept was entered as a node in the Neo4j (https://neo4j.com/), an open-source 
graph-based database, allowing us to visualize data in an easily understood manner.  
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3. Results  
Our current database includes data from 88 users either an OvCa patient or caregiver of 
OvCa patient and 266 nodes. We have identified 27 symptoms including “nausea”, 10 
cancer-related treatment (e.g. Taxol, cisplatin) and 4 different effect of treatments. We 
also identified 6 co-existing medical conditions and 31 non-cancer related medications 
such as Tylenol.  Current database includes 5 types of relationship between nodes: 
“diagnosed_with”, “has”, “resulted_in”, “takes”, and “underwent”. Figure 1 showed an 
example of graph-based database.  
 
Figure 1. Example of nodes and relationships described in Neo4j 
4. Discussion and Conclusion  
We found that OHCs can capture more symptom related information compared to the 
current symptom assessment checklists. Furthermore, it is crucial to understand 
relationship between symptoms in a symptom cluster since cancer symptoms exist as a 
cluster of symptoms rather than a single symptom. Further study will apply natural 
language processing to automate the annotation process for larger datasets and capture 
additional factors (e.g., age, caner stage, race, and author type) from the OHCs. 
Our pilot study showed the potential of OHCs in the nursing research and clinical 
practice to understand cancer symptoms from the patients’ perspectives that have not 
been captured in the clinical setting. We believe that this will guide clinicians and 
researchers about to consider when designing interventions for managing symptoms.  
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Abstract. Based on care need assessment of colorectal and bladder cancer (CBC) patients 
with newly created ostomies (stomas) and caregivers, and with the input of the Wound, 
Ostomy, and Continence Nurses (WOCNs), we have developed an mHealth complication 
and symptom monitoring and self-management program, titled PRISMS). 
Keywords. cancer, patient-reported outcome, symptom management 
1. Introduction
Ostomy creation is one of the major treatment options for colorectal and bladder
cancer (CBC), the third and fifth most common cancers in the U.S., respectively.1 Up 
to 80-90% of CBC patients with new ostomies experience dehydration, infection, and 
other symptoms and complications after being discharged from hospitals.2,3 The 
symptoms and complications are associated with reduced quality of life (QOL),4 
depression and anxiety,and increased ER visits, hospital readmission,3,5 and high costs 
of care.3 This study aimedto develop an mHealth intervention to enhance personalized 
supportive care and improve QOL for cancer patients and caregivers during care 
transition from ostomy creationprofessional care in the hospital to self-management 
at home.
2. Methods
We conducted mixed-method formative research to identify the care needs amongpost-
discharge CBC patients and their caregivers. Based on analysis of the data 
abstracted from Reddit (www.reddit.com/) (n=206 patients and caregivers) and from 
a large survey among caregivers through the Bladder Cancer Advocacy Network 
(BCAN) (N=559), and qualitative interview of WOCNs, we have developed a web-
based mHealth complication and symptom monitoring and self-management program, 
titled PRISMS. 
3. Results
3.1. Social media analysis. We found most of the posts were written by children 
of patients (n=62, 55%), followed by patients themselves (n=33, 29%). Patients looked 
for support from others who have had similar experiences (peer support) (n=33, 29%) 
and talked about their physical symptoms and psychological/emotional struggles (both 
n=29, 26%). Family members expressed psychological/emotional struggles (n=42, 
37%), asked 
1 Corresponding author: Lixin Song, PhD, RN, FAAN, University of North Carolina-Chapel Hill, 
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for advice on how to provide emotional and behavioral support to the patient (n=24, 
21%), and sought peer support (n=15, 13%). Other post-treatment supportive care 
information needs included future quality of life (n=19, 17%), treatment side effects 
(n=11, 10%), and medical/financial resources (n=10, 9%).  
3.2. BCAN survey. The majority of caregivers in this cross-sectional online survey were 
spouses or partners, female, and college-educated or higher.  Mean age of caregiver was 
61 years (21-85). Although caregivers needed support for physical well-being, more than 
two thirds needed emotional support. Web-based programs and peer support were most 
preferred intervention format 
3.3 PRISMS development. Based on these results, a literature review, and the input of 
WOCNs (N=3), we identified the following needs of CBC patients with ostomies and 
caregiver: continuous access to post-discharge supportive care at home, knowledge of 
symptom and complication monitoring and management, and support from peers and 
professionals. We developed PRISMS to address these needs, to reduce symptoms and 
complications, and ultimately, to improve the QOL for both patients and caregivers and 
reduce unnecessary ER use and readmission for patients. PRISMS’ features include:  
a) Supportive care needs for the most common post-surgical symptoms and
complications, e.g., fatigue, dehydration, skin care, sleep issues, and emotional distress; 
b) Scalable self-management program used in home settings that can provide self-
monitoring and self-care guidance, communication with peer patients and caregivers, 
and access to health care professionals if needed.  
c) Knowledge and skills training for symptom and complication management,
moderated online forum for peer and professional support, and other resources. 
d) Integration of PRO and objective data from wearable devices to provide
continuous monitoring of patients’ symptoms and complications. 
e) Use of plain language to accommodate health literacy needs for this population
that is mostly comprised of seniors: https://www.plainlanguage.gov/ 
3.4 We have completed user testing of the PRISMS prototype among 10 nurses and 
physicians, as well as 10 CBC cancer patients with ostomies and their caregivers who 
have been extremely enthusiastic about the features of PRISMS and also provided useful 
information for refining PRISMS. 
3.5 We will conduct a 3-arm pilot randomized trial for feasibility testing among 45 
CBC cancer patients and their caregivers in the next 12 months. 
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1. Introduction 
With the advent of technology in healthcare, healthcare providers (HCPs) are 
increasingly using telemedicine services that enable them to diagnose or treat patients 
by means of digital remote consultation of a specialist. Due to their shown cost-
effectiveness and proven quality of care, telemedicine services have now permeated a 
wide variety of fields such as cardiology, ophthalmology, and dermatology. HCPs’ 
satisfaction (i.e. needs, wishes and expectations) with these services in health practice 
is a primary factor in the usage, acceptance and sustainability while dissatisfaction with 
these services will reduce their willingness to use the system. However, a validated 
questionnaire focusing on HCPs’ satisfaction with the use of integrated telemedicine 
services is lacking. We aim to develop such a tool. This validated instrument will 
capture individual perspectives on telemedicine services independently and 
confidentially. This abstract describes the steps followed to develop a first version of 
the questionnaire.  
2. Method 
Dutch experts from a telemedicine healthcare organization (Ksyos) participated in this 
project. Ksyos works with 12,000 HCPs; medical specialists, paramedics and GPs. First, 
an explorative literature search was conducted to acquire existing validated 
questionnaires on job-, communication-, and telehealth service satisfaction in 
healthcare. Two validated questionnaires, the staff satisfaction questionnaire used in the 
Basque health service and the telehealth usability questionnaire (TUQ), were explored 
to develop a list of potentially relevant constructs as input for our questionnaire [1,2]. 
Second, an appreciative inquiry of all revealed constructs was performed with a Ksyos 
domain expert and a human factor expert. Third, the questions were forward translated 
to Dutch by two researchers. Then, a focus group with account managers and a 
customer service employee was held to discuss the resulting constructs that would form 
the basis for the first version of the questionnaire. We used their input because they 
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have frequent contact with HCPs who use telemedicine services. During the focus 
group meeting consensus was reached by rating all constructs on relevance. Question 
formulation and applicability to the construct were likewise discussed. Questions could 
be added if construct seemed missing or changed if in need of rephrasing. Fourth, a 
pre-testing of the questionnaire took place among HCPs in two rounds. Eighteen HCPs 
received a PDF-document with all the questions (e.g., “I believe [name telemedicine 
system] suffices in fulfilling my wishes and expectations for telemedicine”) and were 
also asked to review each question phrasing in the document and, for certain questions, 
the applicability to their context. In the end, the questionnaire was built in an online 
questionnaire tool (LimeSurvey) and an invitation link was sent to another 21 HCPs to 
check for technical problems with filling in the digital questionnaire and to measure the 
needed completion time.  
3. Results 
The two questionnaires from the literature resulted in a list of 20 potentially relevant 
constructs. After the appreciative inquiry, three construct themes were not applicable 
within the current research setting and deleted. The focus group led to textual and 
contextual changes to the phrasing of the questions. Nineteen of 58 questions were 
rated as ‘not relevant’, four questions were added and two questions were merged. 
Respectively 10/18 and 8/21 unique HCPs participated in two pre-testing rounds. 
Again, textual changes were made based on terminology, three questions were removed 
and four questions were added in this phase. Besides the background characteristics, 
the remaining 49 questions could be classified in seven themes: working conditions, 
training, pay, communication, organization and policy and strategy, interaction with the 
telemedicine system, usage of the telemedicine system. Average questionnaire 
completion time was 9 minutes (2nd round) and no technical problems occurred. 
4. Discussion and conclusion 
Positive contributions of telemedicine on quality and costs of care are essential and 
shown. Equally important is to understand if, why and what makes HCPs embrace 
these innovative care services. HCPs’ satisfaction with telemedicine from different 
perspectives is ideally measured by use of a questionnaire. Such a tool may also allow 
telemedicine service benchmarking on quality criteria from the HCP perspective in 
different care fields. Based on a structured pre-testing approach, we developed a first 
version of a telemedicine service questionnaire. One of our limitations is that our 
current version of the questionnaire was mainly based on the store-and-forward context 
of the Ksyos system and therefore did not focus on direct video consulting services.  
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1. Introduction 
By 2030, 8 out of the 10 leading causes of death will be linked to risk conditions of 
‘Lifestyle diseases’, irrespective of gender [WHO]. Obesity is one of the major lifestyle 
diseases that lead to other health conditions, such as cardiovascular disease, chronic 
obstructive pulmonary disease, cancer, diabetes type II, hypertension, and depression. 
e-Health monitoring has become increasingly popular providing ICT-based remote and 
timely care support to patients and healthcare providers. In our research, we are 
working on a smart e-Coach solution to perform regular monitoring of health and 
wellness parameters related to obesity. We are going to develop a smart e-Coach 
system utilizing ICT, IoT and AI technologies to provide individual behavioral 
recommendations aiming at a healthier lifestyle to prevent obesity. 
2. Method 
We have divided our project work into the following task groups based on the well-
established design-science-research methodology: (1.) Systematic literature review; (2.) 
Design and development (feasibility study, data collection, development of a 
recommendation engine, e-Coaching through interaction); (3.) Trial run; and (4.) 
Model evaluation with performance parameters (goal achievement). The feasibility 
study includes (a.) What to measure? [independent variables (e.g., demographics) and 
dependent variables (e.g., weight)]; (b.) How to measure? [spending time to explore 
and find the right instruments and methods]; (c.) Type of data to be collected [personal, 
physiological, contextual and behavioral] and determination of data collection process; 
(d.) Policy for the recruitment of the participants; (e.) Preparation of consent form; (f.) 
Ensuring data security and privacy; (g.) Use of a standard framework for eHealth 
intervention and determination of its efficacy. This research is deeply focusing on 
“What to coach" and “How to coach", including the design, development, testing 
and evaluation of observational evidence-based, context specific and individual obesity 
recommendations. We have targeted group size of participants to 50-99 in Norway 
within an age group of 18-40 (both male and female). Healthy participants will be 
recruited on voluntary basis following a physical condition check and a consent form 
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[approved by the Regional Komiteer for Medisinsk og Helsefaglig Forskingsetikk 
(REK, https://helseforskning.etikkom.no/)] handover process during recruitment. 
3.  Results 
The project is in an early design phase with the focus on the data collection part. We 
have designed a solution architecture to collect data from participants and store them 
securely. We are working on the ‘eHealth ontology design’ that is another important 
part in our study to support the structuring and to establish interoperability between 
different heterogeneous system components and networks. In this poster presentation, 
we will demonstrate charts and diagrams related to ‘Health and Wellness Data 
Collection Process’, ‘Type of Data to be Collected’, ‘Solution Approach’, and ‘eCoach 
Recommendation plan for Achieving Goal’.  
4. Discussion 
The analysis of the problem space has shown three research directions that we will 
follow in this research: (1.) Data acquisition and its security; (2.) Health risk prediction; 
(3.) Personalized e-Coaching. We have targeted three main problems to solve in this 
research project: (a.) Creation of a compact, intelligible abstraction from massive, 
unintuitive raw, unstructured observations for health and wellness data (e.g. sensors, 
user preferences, questionnaires.) using an eHealth ontology; (b.) Protection against 
illegitimate access to the system and EHR; (c.) Development of a digital e-Coach 
system to model meaningful, observational and empirical evidence-based, context 
specific, automatic, personalized recommendations to achieve health wellness goals, 
and to advise about physical activity, nutrition, medication, and other relevant factors 
for healthier lifestyle. The digital e-Coach system will capture physiological (blood 
pressure, heart rate, blood cholesterol, blood glucose, height, weight), contextual (time, 
location, environment, social), and behavioral (activity, nutrition, sleep) data over time 
from secure wearable sensors, customized questionnaires, interviewing, apps, feedback 
forms and minimal-invasive way. Time series analysis of collected data will help to 
determine day-by-day random variation in lifestyle, weekly variation, seasonal 
variation, variation in diet, meal pattern, true changes in diet over time, and behavior 
change. In the recommendation process, participants will be given personalized, 
evidence-based, contextual recommendations and motivation (related to activity, 
nutrition) for long-term goal evaluation to keep BMI in the range of 18.5 - <25.  
5. Conclusion 
We are working on the assumed hypothesis that an effective e-Coach mechanism can 
reduce the obesity risk with automatic generation of personalized recommendations. 
Integrating offline (human) coaching psychology to an e-Coach, selection of an 
effective recommendation plan and improving it further to reach the convergence 
criteria (overweight to normal weight) is a computationally hard problem that we have 
planned to solve in our research with eCoach behavioral (diet, activity) interventions.  
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Development of a Systematic Text 
Camila VOLIJa,1 and Santiago ESTEBANa 
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Abstract. The influence of social relationships on mortality is comparable with that 
of standard clinical factors. In order to extract this information via supervised NLP 
algorithms, clinical notes have to be annotated manually. At present we did not find 
any systematic annotation standards to extract social support. In this work, we 
developed a systematic text annotation standard to detect social support in couples 
from electronic medical records. 
Keywords. Social Support, Electronic Medical Record 
1. Introduction 
The influence of social relationships on mortality is comparable with that of standard 
clinical factors such as smoking, obesity and hypertension [1]. In the last few years, the 
National Academy of Medicine recommended that social support be documented in 
electronic medical records (EMRs) [2].  Social determinants of health, and particularly, 
social support is usually recorded in free text form within EMRs. In order to apply 
supervised natural language processing pipelines (NLP) to extract this information, texts 
have to be manually annotated. Nevertheless, we were unable to find any systematic 
annotation standards for social support comparable to other already existing standards 
(i.e. TimeML). Thus, in this work we aim to develop and test an annotation standard that 
allows to create supervised datasets in order to extract information on social support from 
life partners. 
2. Methodology 
First, based on Valtorta el al. [3] systematic review, we thoroughly reviewed 54 
questionnaires on social support. Subsequently, a research committee of EMR specialists 
and users from our institution, evaluated the various questions and selected those that 
were considered, a priori, that could be answered via the EMR. Finally, we developed an 
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annotation standard that allowed us to describe the social support provided by a life 
partner defining entities and exploring the relationships between them. 
3. Results 
After the literature search and the focus groups with professionals, we defined social 
support from life partners in two dimensions: structural and functional support. We 
operationalized structural support by means of five variables: 1) Is there a mention of a 
type of personal relationship status? (true/false); 2) Does the relationship status refer to 
the patient (true/false); 3) What type of relationship status is mentioned (married, 
widower, ‘in a relationship’, single, etc); 4) Is the patient currently in a stable 
relationship? (true/false); 5) is the patient currently living with whomever she is in a 
relationship with? (true/false). 
We operationalized functional support using four variables: 1) Is there a mention of 
active social support in the text (true/false); 2) Is the patient the recipient or the provider 
of social support?, 3) Is the mention of social support positive or negative?, 4) Type of 
social support (psychosocial, healthcare related, general care related). 
We tested our annotation standard on a random sample of 2000 clinical notes that 
were previously filtered using a keyword-based filter (the filter had a positive predictive 
value of 81% and negative predictive value of 99% for detecting texts with mentions 
regarding social support from a life partner in an unfiltered random sample of clinical 
notes). 96% of those 2000 clinical notes had mentions on the patient’s current 
relationship status. Of these, 75% described stable relationships and 8% of them, that the 
patient and their partner lived together. Regarding functional social support, 28% of the 
notes mentioned some type of social support. Of those notes 90% mentioned the patient 
being the recipient. Lastly, in 89% of these notes the support was positive. 
4. Discussion and Conclusion 
The systematics of text annotation presented in this work, although presented as an 
innovative and efficient way of detecting intra-social support, has as a limitation the 
construct itself being difficult to define and therefore to measure even with 
questionnaires well known. Defined variables and their categories may be used for the 
creation of systematic annotation of texts on family social support, intra-friends, within 
institutions, among others. 
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Dumisani NKHOM a Charles Jenya SOKOa, Pierre BOWRINb and Usman IQBALa,b,c, 
a Masters’ Program in Global Health & Development, College of Public Health, Taipei 
Medical University 
b PhD Programs in Global Health & Health Security Dept., College of Public Health, 
Taipei Medical University 
c International Center for Health Information Technology (ICHIT), Taipei Medical 
University 
Abstract. Introduction. Diabetes Mellitus is a major global concern. DSME 
(Diabetes Self-Management Education and Support) helps improve outcomes. 
Over the years, newer technologies have delivered DSME warranting an update of 
evidence. Objectives: Describe current digital health interventions employed in 
DSMES and their effectiveness in improving glycemic control and quality of life 
of Diabetes Mellitus (DM) patients compared to usual care. Methods: Systematic 
review design and meta-analysis. We will search data from 2010 to 2019. The 
review will only include randomized control trials (RCTs) with digital health 
interventions (mobile health, social media, e-health) as the main intervention to 
deliver DSMES. Expected Results: We expect digital health intervention-led 
DSMES to improve target outcomes compared to usual care. This study will 
aggregate information on usage and challenges for these tools. It will also suggest 
the direction of effect of such tools in different populations. 
Keywords. Diabetes Self-Management Education and Support, 
1. Introduction 
Diabetes Mellitus is a major global concern and a costly disease. Currently, Diabetes 
Mellitus is a top ten global killer of humans. One method to improve outcomes and 
reduce costs is Diabetes Self-Management Education and Support (DSMES). DSMES 
also helps in preventing occurrence of complications. Ideally, quality DSMES should 
be easily accessible, however, its availability varies with different health systems. 
Digital health interventions help to solve these challenges with varying success. In 
addition, continuous digital innovations warrant up-to-date evidence for digital health 
interventions in DSMES. Therefore, we aim to know: What digital health interventions 
are being used in DSMES to improve glycemic control, Diabetes knowledge and 
health-related quality of life (HrQoL) for people with T1DM and T2DM in the past 10 
years? & What is the effectiveness of digital health interventions for DSMES in 
improving glycemic control, Diabetes knowledge and HrQoL as compared to usual 
care for people with T1DM and T2DM in the past 10 years? 
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2.  Methods 
 
Design will be systematic review and meta-analysis. The study framework and 
reporting will be done in accordance to Preferred Reporting Instrument for Systematic 
Review and Meta-Analysis (PRISMA). We will search literature from the following 
databases: PubMed, EMBASE, Cochrane Library, Web of Science and Scopus. The 
review will only include randomized control trials (RCTs) published between 2010 and 
2019 comparing digital health interventions delivering DSMES to usual care focusing 
on glycemic control, HrQoL and Diabetes Knowledge. Studies targeting other 
populations apart from confirmed Type 1 and 2 DM patients will not be included. In 
this review, healthcare that does not include use of digital health interventions will be 
considered as usual care. Protocol is registered on PROSPERO CRD42019139884. 
Articles are going to collected into Endnote X9. Studies will be screened against the 
eligibility criteria when looking at the titles and abstracts. Full text review will be done 
by two reviewers with disputes resolved through consensus. 
Table 1: Proposed study variables that may help explain effect of digital health interventions on outcomes 
 
Population Interventions Study Outcomes 
Age, sex, sex ratio, 
ethnicity, sample size, 
country, education 
level, disease type, 
duration of disease 
Digital category 
Description Length 
Frequency Follow-up 
time 
Setting Design 
Theoretical framework 
Comparison 
Author Journal Year of 
publication 
HbA1c HrQoL Knowledge 
Instruments used Scales used 
We will adapt Cochrane Collaboration’s data extraction form. Missing information will 
be sought through emails. Differences will be resolved through consensus or consulting 
a third reviewer 
1.1Analysis 
Variables will be summarized using descriptive statistics. We will use Cochrane Risk 
of Bias (ROB)-2 tool for parallel and cluster randomized studies. Assessment will be 
done independently by two reviewers, reaching consensus on differences. Random 
effects meta-analysis will be performed according to Diabetes type, digital health 
intervention route at various time points using Comprehensive Meta-Analysis Software 
Version 3 (Biostat, USA). Outcomes will be collected in one measuring unit or be 
aggregated using standardized mean difference. Qualitative analysis will assess 
acceptability & feasibility of digital interventions. Findings from subgroup analysis and 
meta-regression will help explain interaction of study variables with outcome 
estimates. The above will considered of great clinical importance. Publication bias will 
assess across studies. 
2.Expected Results 
We expect digital health intervention-led DSMES to improve target outcomes as 
compared to usual care. This study is expected to aggregate information on common 
usage and challenges for these tools. It will also inform us the direction of effect of 
such tools in different populations and environments. This study will be an addition to 
literature in support of Sustainable Development Goal 3 in the fight against non- 
communicable diseases and in ensuring universal health coverage. 
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Abstract. The Introductory Course to the Electronic Medical Records (EMR) is 
part of the Digital Health Strategy of the Ministry of Health’s Universal Health 
Coverage (UHC). One of its principles is achieving interoperability between 
different electronic medical records systems. The healthcare workforce training in 
these subjects is essential. During 2018, six editions of the course were developed 
in the Moodle Virtual Health Platform with 850 approved participants. We 
analysed the previous experience to reformulate the learning materials and create 
new instances for pedagogical support. 
Keywords. eLearning, Electronic Health  Records, Change Management. 
1. Introduction 
According to the Ministry of Health (MoH) Resolution 189/2018, Digital Health is 
one of the three strategic principles to achieve Universal Health Coverage in 
Argentina. Interoperable EMR can store primary information during contact with the 
patient to build a national medical record with clinical, statistical and management 
utility. 
Evidence shows that the implementation of any EMR is a complex process that 
may have to overcome multiple barriers: financial, technical, time, psychological, 
social and resistance to change [1]. Negative beliefs of social and psychological nature 
play a significant role in resistance to adopt EMR [2]. The potential of eLearning for 
health professionals is widely researched and reported [3]. The EMR online 
educational course for health professionals develops arguments to tear down usual 
adoption barriers, and challenges every student to become a champion of change to 
transform his own work practices. We analysed our previous online courses 
experience to reformulate the learning materials and enhance the pedagogical support. 
2. Materials and Methods 
Argentina has a decentralized federal organization divided into 24 jurisdictions. In its 
territory there are about 30,000 health centers of all levels of complexity that provide 
care for 45 million people. Around 60% of the population has fixed Internet access 
and there are 30 million users with mobile connectivity. Health workers are 
heterogeneous in digital literacy, but most of them interact with technological tools. 
Taking into account the amount and distribution of potential students (3,000 for 
the first stage), the virtual self-administered course was planned to be available 
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periodically in the Moodle Virtual Health Platform of the MoH, at no charge. 
Flexibility is one of the features that makes virtual education particularly suitable for 
most citizens, mainly adults [4]. After 6 cohorts, 850 students passed their 
examinations. Quantitative and qualitative data was gathered from course enrollment, 
follow up, passing rates and feedback surveys. Following a technical review, the 
course was redesigned to ease usability and comprehension. New cohorts were also 
analyzed. 
3. Results 
The original course had 3 sections: 1) General aspects of EMR; 2) Privacy, 
Confidentiality and Security; 3) Interoperability. The new edition kept the same 
sections, with great didactic evolution in: Language (technicalities were avoided, 
explicit references to more complex concepts were included); Content (simplification 
of complex concepts focusing on the main idea); Applicability (examples were 
provided to enable correlation with professional practice); Audiovisual tools (short 
videos and animations with clear locution voice, infographics to synthesize theoretical 
notions); Interaction (an online forum to answer questions and promote student 
exchange); Exams (focus on global understanding of central ideas); Follow up 
(enrollment in an alumni forum to exchange local experiences). 
Table 1. Number of enrolled and approved students during the last 3 cohorts of the online course (2019). 
Number of students 7th edition 8th edition 9th edition 
Enrolled / Finished / Approved 397 / 182 / 163 561 / 242 / 220 388 / 179 / 157 
 
Online surveys showed a trend towards better student perceptions. Table 1 shows 
the outcomes of the new course. Even though there was more than 50% dropout, there 
was a higher passing rate. 
4. Conclusion 
This course redesign aims to exploit the potential of e-Learning by identifying the 
better approach to teach about EMR in our context. The flexibility in space and time 
of online tools combined with proper contents favor the achievement of the strategy 
objectives. Enabling the MoH Moodle Virtual Health Platform for mobile devices 
could increase the benefits of this modality, including higher enrollment and retention. 
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Abstract. The purpose of this study is to describe nurses’ views of what supports 
safe medication administration in the current electronic medication administration 
system. Data was collected at the turn of 2014–2015 and open-ended answers were 
inductively analyzed using content analysis. The system’s usefulness, good usability, 
and the feature that there is extra information available on medications and the 
patient-specific information needed in medication administration are elements that 
support safe medication administration. The study identifies wide support for the 
electronic medication administration system in safe medication administration.   
Keywords. Safety, medication administration, electronic medication administration 
system, nurse  
1. Introduction 
Prevention of medication errors and avoidable adverse events1,2 is an important part of 
patient safety1 and nurses’ work2. The use of electronic medication administration system 
has been found to reduce the rate of medication errors in medication administration 
recording and their potential future risk3. 
The purpose of this study is to describe nurses’ views of what supports safe 
medication administration in the current electronic medication administration system. 
2. Methods 
This study is part of wider electronic health record implementation research. Data was 
collected from special health care in one hospital district in Finland with one two-part 
open-ended section of the back-translated Medication Administration System - Nurses 
Assessment Scale (MAS-NAS) (N=855). In the open-ended section, nurses were asked 
to write down their comments about the current medication administration system and 
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the degree to which the components of the current system enables them to administer 
medication safely and professionally. In this study, we report answers that described 
support for electronic medication administration system (eMAS) in safe medication 
administration. The data was collected during one month at the turn of 2014–2015. At 
that time, the respondents used the eMAS partly, completely, or not at all. The eMAS 
included an electronic home medication chart, electronic ward medication chart, and 
electronic prescription. Open-ended answers were analyzed inductively using content 
analysis.  
3. Results 
A total of 123 nurses answered the open-ended section; 80 of them had used eMAS 
partially or completely. Twenty nurses described what supports safe medication 
administration in the current eMAS; 15 of them reported that they had used eMAS 
partially or completely. Twenty-eight simplifications were formed. The eMAS elements 
that support safe medication are the system’s usefulness to user, system’s good usability, 
and the feature that there is extra information available in the system of medications and 
the patient-specific information needed in medication administration. Usefulness of the 
system was described as clarity of information, automated warning alerts, and continuity 
of medication. Good usability of the system was described as good technical quality and 
ease of use. Extra information available in the system was described as seeing the 
information needed in medication administration, such as information on medication 
preparation. Availability of patient-specific information needed for medication 
administration was described as the opportunity to read the medication list and 
prescriptions being in the patient record.  
4. Discussion and conclusion 
Nurses identified elements in the eMAS that support safe medication. Elements that 
support safe medication were the system’s usefulness, usability, and availability of 
information needed for medication. Because one of the most important parts of nurses’ 
work is to administer medication safely2, nurses’ opinions of how the system supports 
safe medication administration should be taken into account. The study identifies that 
eMAS widely supports safe medication administration. Further development of the 
systems should ensure that the system is useful for nurses, its usability is good, and the 
information needed for medication administration is available for nurses.    
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Abstract. In this work, an attempt has been made to discriminate arousal and 
valence dimensions in Electrodermal Activity (EDA) signals using Spiking Deep 
Belief Network (SDBN). EDA signals having different arousal and valence 
dimensions are obtained from public online database. These signals are divided into 
equal parts and normalized using channel normalization. Later, signals are subjected 
to SDBN for event-related features and classification. A leave-one-out cross 
validation is used to investigate the classification performance. The result shows 
that the SDBN classifiers are able to discriminate the emotional states. The network 
yields better classification performance for emotional dimensions of arousal and 
valence. It appears that the proposed approach can be used to differentiate 
autonomic and pathological conditions. 
Keywords. Emotion, Electrodermal Activity, Spiking Deep Belief Network, 
1.Introduction
Emotions are the fundamental component of human social interactions. It is 
necessary for behavior, perceptions and decision making. Analysis and recording of 
Electrodermal Activity (EDA) signals are widely used for the classification of 
emotions. Deep learning architectures are used for the automated recognition of 
emotions using physiological signals [1].  
2. Methods
For this study, EDA signals are considered from publicly available DEAP database [2].
These signals are digitized at sampling rate of 128 Hz, each one minute in length and 
are obtained from 32 subjects. These signals are preprocessed and divided into 60 equal 
segments. The segments are applied to Spiking Deep Belief Network (SDBN) for 
training. A two-layer 50-50 neurons SDBN architecture is used for this study. Weights 
at individual nodes are updated using Leaky Integrate-and-Fire (LIF) neurons. The 
activation probabilities of LIF neurons is identified using an accurate rate-based 
approximation. The standard dynamics of the LIF neurons is given by [3]: 
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where mtau  is the membrane time constant, resE represents the resting potential, 
and rM depicts the membrane resistance, n represent the number of incoming 
synapses, im depicts the number of spikes arriving at that synapse,  ft is a Dirac-
delta function set as zero except for the firing times ijft of the 
thi input neuron. 
3. Results and Discussion
(a) (b)
Figure 1. (a) The fine-tuned DBN weights in the second layer, and (b) A typical EDA signal class signatures 
generated by SDBN for classification 
 The visualization of fine-tuned DBN weights at the second layer is shown in 
Fig. 1(a). The critical features obtained in the second layer are highlighted using solid 
triangles. It is observed that the critical features are sparse and represents the abstract 
charactertics of various emotional states. The signatures of arousal and valence class 
generated by the SDBN for the classification are shown in Fig. 1(b). It is seen that the 
class signatures of arousal states are distinct from each other. In comparison to arousal 
class, valence class are also found to have different signatures. The classification 
performance of the proposed network are shown in Table 1. It is seen that the 
proposed approach obtained an average accuracy of 72.08% and 68.90% for arousal 
and valence states, respectively. It is also observed that the proposed approach obtained 
a precision of 74.70% for arousal class. In case of valence class, the proposed approach 
obtained the higher recall rate of 61.06%.
Table 1: Classification performance of SDBN architecture 
Class Accuracy Precision Recall
Arousal 72.08 74.70 83.23
Valence 68.90 50.96 61.26
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Evaluating the Use of a CPOE for 
Gimenez, Ca, de Matos Lima, Sa, Luna, Da 
 
a Department of Biomedical Informatics, Hospital Italiano de Buenos Aires, Argentina.  
Abstract. Chemotherapy drugs are one of the most common causes of serious and 
fatal medication errors, especially during prescribing, where computerized 
physician order entry (CPOE) take on importance. This study proposes the 
description of the post-implementation status of a CPOE in a highly specialized 
hospital between January and June 2018, among patients older than 18 years. 
Results: a total of 8835 protocols were indicated using the specific CPOE (93% use 
rate over all protocols) 91% completed the administration, 1.2% were rejected by 
pharmacy, and 6.8% was canceled. The most frequent cause of rejection by 
pharmacy and cancellation by oncologist was an inadequate dose. Most of the 
protocols indicated using the CPOE implemented, with a reject by pharmacy rate of 
1.2%, indicates the utility of CPOE as an error prevention strategy. 
Keywords. Computerized provider order entry, oncology, chemotherapy 
1. Introduction 
Chemotherapy drugs are characterized by low therapeutic index and significant toxicities 
at clinically prescribed doses, which, added to the vulnerability of patients with cancer, 
raises serious problems of drug safety [1]. Medication errors can occur at any stage of 
the chemotherapy process, especially at the prescription stage [2]. The most common 
source of error was within the order phase and that, compared with non-chemotherapy 
medication errors, could rise up to 48% more likely to be serious in nature [3]. The safety 
of chemotherapy has been a long-standing issue, particularly because is a complex 
process, with multiple steps and health professionals involved in the prescription, 
dispensing and administration of these agents [4][5]. CPOE is associated with a 
significant reduction in preventable adverse drug events [6] and focusing on 
chemotherapy, most studies find beneficial when compared to paper prescription [7].  
2. Methods 
A descriptive cross-sectional study was carried out in order to study the amount of 
oncological prescriptions made from the specific CPOE. 
3. Results 
During the study period, a total of 10475 protocols were indicated, of which 1380 
were excluded from the San Justo center (other medical center in the network), 255 since 
they did not have an assigned sector and 5 protocols that were indicated in a pediatric 
area, giving a total of 8835 protocols.  Each of the protocols corresponds to a patient. 
The CPOE was used in 93% of the oncological prescriptions. The remaining 7% 
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corresponded to indications on paper, drugs not approved by the Committee of the Cycle 
of Medication and drugs of research protocols. There was a total of 195 protocols loaded 
in the management system, of which 146 were indicated. There was an average of 1472 
protocols per month. A total of 7602 (91%) protocols were finalized. Oncology 
pharmacy put in review 107 protocols (1.2%). The number of canceled protocols 602 
(6.8%) includes both those canceled by medical initiative and those placed on review by 
pharmacy. In 41% (249) of the cases the oncologist entered a justification in free text at 
the time of cancellation. The most frequent reason was the need to modify the dose (33% 
- 82/249). There was 5% (13/249) of justifications with illegible content. Within the 
justifications charged by oncological pharmacy to put a protocol in the status "In review" 
(1.2%), 47% was related to an inadequate dose. All the justifications were complete 
regarding the reason and the instructions for correction by the physician. 
4. Discussion 
Numerous studies worldwide report the advantages of having a computerized 
physician order entry for prescribing chemotherapy protocols, supported by the evidence 
of providing patient safety, comparing with paper prescription [1]. The percentage of use 
of the CPOE was 93%, which indicates that most of the prescribed protocols used this 
system. Similarly, a study conducted in Switzerland where only 7% of the total 
prescriptions were manual and also highlight that the average error rate decreased 22 
times [4].  
5. Conclusion 
Most of the protocols indicated used the CPOE for prescribing chemotherapy 
protocols implemented, with a rate of use greater than 90%. The rate of protocols 
intervened by the pharmacist of 1.2% indicates the utility of a CPOE as an error 
prevention strategy. 
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Evaluation of Mobile Phone Mortality Risk 
Score Applications Using Data from the
Electronic Medical Records
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Abstract. Various mobile phone apps in the form of medical calculators are 
available for different prognostic assessments, especially for patients in intensive 
care units. We performed a systematic review of mobile phone apps in online mobile 
phone stores to identify apps for mortality risk prediction in intensive care units. Out 
of 2737 potential mobile phone apps, we included 20 of them in the final content 
analysis. The most frequently used mortality risk model was Sequential Organ 
Failure Assessment also known as SOFA. The mobile phone apps were compared 
based on realistic electronic medical record data. The discrepancies were shown in 
patients with lower mortality rate. Our results show that this kind of mobile phone 
apps can be helpful to healthcare professionals and are appropriate for use in clinical 
practices in most cases.
Keywords. Critical care, mortality, prognostic models, m-health
1. Introduction
In intensive care unit (ICU), healthcare professionals frequently use different prognostic 
models (PMs) for the quantification of severe physiological derangements in patients. 
Many PMs are automatically calculated as part of the electronic medical record (EMR) 
and become a part of health care process. Other can be also used in various mobile phones 
as mobile phone applications (apps) [1]. In our study, we wanted to identify potentially 
suitable apps for illness severity prediction in clinical settings and to quantify the 
characteristics of these apps.
2. Methods
We performed a systematic review of apps in two mobile phone stores (Google Play 
Store and App Store (iOS)) based on PRISMA recommendations [2]. Using the 
predictive parameters from the most frequently used PM, we created two different 
fictional patients with different values using data obtained from the MIMIC III database 
[3]. 
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3. Results 
Out of 2737, we included 20 apps into detailed analysis among which we identified 38 
different PMs. The most commonly used PMs were SOFA and APACHE. The PMs 
required different types of values for the predictions, such as vital functions (i.e. arterial 
pressure), laboratory test results (i.e. creatinine) and demographics (i.e. age of the 
hospitalized patient). Values of both fictional patients were put into SOFA score apps 
where mortality scores in all apps were consistent, but deviations occurred in the 
interpretation of mortality, were not. 
4. Discussion  
Predicting the severity of illness of critically ill patients in the ICU is a comprehensive 
process that helps physicians anticipate the course of treatment. Based on the data 
obtained, we found that most apps provide the user with information on which PM was 
used, since all relevant apps contained information on the scientific research underlying 
their model. This indicates the quality of PMs, as the calculations in all PMs are uniform 
and accurate. Discrepancies have occurred in the interpretation of mortality itself, as 
individual apps interpret the obtained estimate differently. The difference is most 
obvious in patients with lower mortality rate.  
5. Conclusion 
In the future, apps for risk prediction will become an important part of healthcare, as they 
represent a faster and easier access to relevant health information and can be easily used 
with the patient, allowing us to make a more relevant assessment as the patient's 
condition can be monitored all the time.  
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EVENT :  oncept Developped to 
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Abstract. Context and purpose. The University Hospital of Lausanne has been 
deploying the patient's electronic record since 2010. In 2014, it was time to 
abandon the nursing paper documentation file. This represented a user base of 
4,000 people to train and accompany during the change process. 
Design/methodology/approach: We developed the concept of an event as a support 
for nursing documentation, an empirical process. This project explored a 
combination of different strategies to improve the quality of care. Research 
limitations. It is not a research, the concept was new and a theoretical framework 
was developed. Unfortunately, there was no evaluation undertaken to measure the 
impact on the users. Practical implications. Today the use of an event helps the 
nurses to document complex situations and to guarantee the continuity of 
information. For the future, the question or plan? is to expand the concept to 
Doctors and other caregivers 
Keywords. Business process management, Nursing informatics, Usability, 
standardized Language, Event, Process modelling 
1. Introduction 
This poster presents one aspect of the conceptual work whose goal was to describe the 
nursing activity and roles. The electronic tool acts like a dashboard for a car driver. The 
concept of EVENT as an episode in which people are involved during an undefined 
period. These situations might be as different as, daily clinical evaluation, hospital 
admission, an adverse event, dialysis, surgical intervention, nursing consultation, etc. 
To make a simple documentation system that makes the Nursing care complexity 
visible, prevents a nursing burden being as intuitive as possible 
2. Method: Concept of Event and his taxonomy 
To document every activity, care, intervention, etc, the work environment must be 
adapted. In an EHR, this ergonomic facilitation is made possible thanks to the order 
systems (functionality?) and the related care planning. 
The untreated cases are all the situations for which no order is required due to the 
absence of planning. For example, in the case of a patient admission, a coronary 
angiography different people are involved, different care and evaluations are made, over 
a period of time, etc. All these elements are parts of different events. 
A C
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The taxonomy is in continuous development. The first branch of the taxonomy: 
Activity contains all the concepts related to the hospital stay. The first domain contains 
all the movements, the second is dedicated to all types of nursing consultations, the third 
includes the process related to the management in the operating room, interventional 
imaging. The fourth is dedicated to administrative activities. The second and third 
branches integrate the JCAHO taxonomy[2]. These events are dedicated to support the 
prevention of incidents or the handling of incidents. 
We created a documentation model to go out of the focus charting and avoid the 
model proposed by the Soarian system based on an assessment, nursing diagnoses, 
interventions and outcomes. ESPOIR [7] for Event, Sign & symptoms, Phenomenon, 
“Objective” (goal), Intervention, Response. This approach is time line oriented. The 
main change for the nurses was to do bedside documentation in a continuous mode. 
3. Results and discussion 
The event feature is very effective. Its use has evolved since the beginning of the 
nursing deployment of the EHR. Today the events implemented are more sophisticated 
to support nurses in complex clinical situations. 
The quality of the documented data has improved beyond that of the old paper age. 
The different solutions adopted to create the electronic documentation system with the 
event helped us to face the weakness of the legacy product or paper system? For the 
future, the question is to expand the functionality to Doctors and other caregivers 
Research limitations. It is not a research, even the concept was new, a theoretical 
framework was developed. Unfortunately, we did not measure the impact on the users. 
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1. Introduction 
Dermatologists’ experience with teledermoscopy (TDsc) and accuracy of 
teleconsultations seem to be related [1]. If so, the diagnostic accuracy of TDsc could be 
increased by letting more experienced teledermatologists (TDs) assess the 
teleconsultations [1]. Expertise with assessing dermoscopic pictures is deemed to be 
more important than image quality in assessing those TDsc consultations accurately [2]. 
Our aim is to provide an overview on reported characteristics in literature of TDs’ 
expertise in TDsc. 
2. Methods 
A systematic literature search was conducted using PubMed (MEDLINE), EMBASE 
(OVID), and Cochrane Skin Review Group with publications until July 2018. Two 
reviewers (ET and FS) independently evaluated the eligibility of the full original papers 
focusing on the detection of skin cancer with TDsc using dermatoscopic images. The 
data was extracted according to a pre-defined data extraction sheet. Based on a 
grounded theory approach, two main themes were determined for further analysis.  
3. Results 
47 Articles met inclusion criteria, of which 29 articles reported on years of experience 
and expertise of the TDs assessing the TDsc consultations (Table 1). The grounded 
theory approach provided insight on expertise with dermoscopy and pigmented lesions, 
and experience with TDsc. In five of the 24 studies, TDsc consultations were not 
assessed by dermatologists, e.g. physicians. Six out of 29 studies mentioned that the 
TDs were board-certified dermatologists without specific characteristics mentioned of 
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the obtained certification. Eight out of sixteen studies expressed explicitly the number 
of years of experience with TDsc, ranging from two until fifteen years. Seven studies 
rated the experience by general statements, like ‘low level of experience’.  
 
Table 1. Results of the data extraction concerning the teledermatologists’ expertise and experience 
Reported: Expertise (%) Number of years of experience (%) 
Yes 24 (83%) 16 (55%) 
No 5 (17%) 13 (45%) 
Total 29 (100%) 29 (100%) 
4. Discussion 
Data was extracted on the experience and expertise of TDs in assessing TDsc 
consultations. For a majority of the studies, it is unknown what the expertise in 
dermoscopy and pigmented lesions is, nor the education in (tele)dermatology. 
Unclearness in assessor expertise indicate to ambiguity in who should assess the TDsc 
consultations in order to obtain accurate diagnostic outcomes. Future work should 
focus on guidelines providing insight into the needed experience to be considered an 
‘experienced’ TD. Kittler et al. [5] reported an improved diagnostic accuracy for 
melanoma for experienced TDs suggesting the need of experience and training to 
perform TDsc. Training for GPs in TDsc has been proposed [6]. Secondly, future work 
needs to define clear experience scales and develop training guidelines in TDsc, both in 
studies and in current clinical practices. We will continue this study by focusing on the 
relation of TDs’ expertise and experience in TDsc with diagnostic outcomes.  
5. Conclusion 
We conclude that a minority of studies reported on the TDs’ experience and expertise 
in diagnostic accuracy studies. It is likely that this will influence the diagnostic 
accuracy.  
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Experience Story: How Do We Re- 
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Abstract. Since 2017, the Hospital Italiano de Buenos Aires, has a “Workstation 
on Wheels” project were nurses can access to a mobile application in order to 
register the drug´s administration, vital signs and complete an early warning 
assessment scale of the hemodynamic state of the patient. Although the overall 
objective was to achieve at least 95% drug registration through this system, their 
use did not remain stable over time. Therefore, it was necessary to create an 
interdisciplinary team to make a diagnosis of the project situation and reasons for 
the low use rate. In this process, a re-implementation of the barcoding 
administration system was carried out, focusing on the nursing staff maintaining 
the use of the system over time. The aim of this paper is to describe the experience 
and lessons learned in the process of re-implementing the drug barcoding system at 
the patient’s bedside. 
Keywords. BCMA, implementation, nurses, Workstation on Wheels 
1.Introduction 
The Hospital Italiano de Buenos Aires (HIBA) is an institution accredited by the Joint 
Commission International. In 2015 the implementation of the  correct  drug 
identification system was carried out through the technique of “barcoding” or reading 
with a QR code scanner on desktop devices [1]. Then, in 2017, mobile devices (tablets) 
were incorporated into “Workstation on Wheels” (WOWs) structures with transferable 
tray [2]. The mobile application is developed with IONIC as source code. This 
implementation was carried out in various hospitalization sectors, both pediatric and 
adult, including intensive care and general sectors. Although the overall objective was 
to achieve at least 95% drug registration through this system,  usage  did  not  remain  
stable over time. Therefore, it was necessary to create an interdisciplinary team to make 
a situation diagnosis. In this process, a re-implementation of the barcoding 
administration system (BCMA) was carried out, focusing on the nursing staff 
maintaining high system use over time. The aim of this paper is to describe the 
experience and lessons learned in the process of re-implementing the drug barcoding 
system at the patient’s bedside. 
2.Methods 
At first, the different areas involved in the BCMA project  belonging  to  the  
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Department of Health Informatics (DIS) of the HIBA were convened. Forming a 
transdisciplinary team of 2 informatic nurses, an informatic physician, two computer 
technicians, a network technician, a programmer and a designer. Tours around the 
sectors were organized to inquiry nurses about the reasons behind low system usage. 
3.Results 
During this process, several strategies were used. On one hand, those oriented to 
organizational change management and training of professionals, and on the other, 
strategies related to the adaptation, support and operation of technological equipment. 
Regarding change management and training: Incorporation of nursing supervisors 
to dynamics work, group and individual training, tracking users, training material 
development, communication lines, help desk, communication and dissemination. 
Related to adaptation, support and operation of IT equipment: A technical team 
consisting of specialists in mobile devices and WiFi networks was put together. They 
reviewed each HIBA inpatient sector to detect failures. Changes were made to the 
network, to improve broadcast and connectivity. Software improvements were made 
together with the development team. Applications to restrict general use of the devices 
were used, allowing only the BCMA application to run. 
4.Conclusions 
The management of organizational change is the basis  for  a  large-scale  
implementation that can modify staff workflow [3]. Communication improvement 
between parties involved in the project showed great changes at the organizational 
level. It enabled exchange spaces, allowing them to work more fluently. Empowering 
both nurses and technicians to form a single work team. It generated a feeling of 
belonging on both sides. It was very important to generate a communication channel in 
order to provide users with a space to report failures or malfunctions. It was also 
important for this channel to allow the tracking of tickets, generating improvements in 
response times and more durable solutions. With active listening, opportunities for 
improvement can be detected, such as the potential incorporation of functionalities 
already implemented in the desktop EHR to the bedside workflow, such as risk 
assessment [4]. 
References 
[1] Maydana T, Giraldo L, González Z, Schachner B, Mayan J, Luna D, et al. BarCode Medication 
Administration in ICU: Learning from Our Nurses. Stud Health Technol Inform. 2017;245:1095–8. 
[2] Giraldo L, Schachner B, Luna D, Benítez S. Exploring Nurses’ Perceptions and Expectations Toward a 
BCMA Implementation Using a Mobile App and Workstations as a Change Management Strategy. 
Stud Health Technol Inform. 2018;250:134–8. 
[3] Slotnisky D. Transformación digital: cómo las empresas y los profesionales deben adaptarse a esta 
revolución. Digital House. Coding School.; 2016. 184 p. 
[4] Watzlawick P, Bavelas JB, Jackson DD. Teoría de la comunicación humana: interacciones, patologías y 
paradojas. Editorial y Librería Herder; 1993. 260 p. 
M. Cassarino et al. / Experience Story: How Do We Re-Implement What Has Been Implemented?1280
Experiences of National Documentation in 
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Abstract. The Finnish National Patient Data Repository requires all health care 
professionals to document patient data with a uniform structure. The aim of the 
study was to gather the experiences of Occupational Health nurses for the 
usefulness and the ease of use of national patient data structures in electronic 
health records. The study was carried out in summer 2017. 177 OHNs participated 
in the study. The respondents felt that the use of the national patient record 
structures improve the quality of work but doesn't enable to accomplish tasks more 
quickly. Without patient data and the fluent health information exchange, the 
patient treatment pathways do not operate properly. The development of patient 
data structures in EHRs have to be continued. 
Keywords. Documentation, Occupational Health Nursing, Occupational Health 
Care, Electronic Health Records 
1. Introduction 
The purpose of the eHealth and eSocial Strategy 2020 by the Finnish Ministry of Social 
Affairs and Health is to provide health care professionals with access to up-to-date 
patient data and information systems that support their work. In Finland, almost all 
health care professionals use electronic health records (EHRs). The legislation requires 
that health care providers save patient data from their own data systems to the national 
Patient Data Repository (PDR). This requires all health care professionals to document 
the patient data with a national uniform structure. [1-3] Also the fluent health 
information exchange among the health care professionals should be done through the 
national PDR. Thus, the documentation of the patient data has to be executed 
structurally and consistently. When the data is structured and uniform, its reuse in the 
annual surveys monitoring health among citizens, and comparison of patient data is 
also possible. [4, 5] The aim of the study was to gather the experiences of Occupational 
Health Nurses (OHNs) for the usefulness and the ease of use of national patient data 
structures in EHRs.  
2. Methods 
The study was carried out in summer 2017. We used an electronic questionnaire for the 
data collection. The survey questionnaire was sent to 760 OHNs who were working 
with pre-selected Occupational Health Services providers. We analyzed the data by 
using SPSS Statistics 24. The questionnaire consisted of multiple-choice questions 
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about usefulness and ease of use of patient record structures. The technology 
acceptance model (TAM) was used to explain the participants’ experiences of 
perceived usefulness and the ease of use. [6] According to the TAM model, before the 
use of technology, there is an intention that affects the perceived usefulness (how much 
the system would enhance job performance) and the perceived ease of use (how easy it 
is to use the system). The easier a system is to use, the more useful it is perceived to be. 
3. Results 
177 OHNs participated in the study. Most participants (73%) documented patient data 
in the patient record during the patient contact, and the rest (27%) after the patient 
contact. The respondents felt that the use of the national patient record structures 
improve the quality of work (67%) but doesn't enable to accomplish tasks more quickly 
(36%). They felt that learning to document with the national patient record structures is 
easy (81%). It is also easy to remember how to perform documentation tasks using 
these structures (65%). However, a quite many of the respondents (43%) felt that the 
documentation with the national patient record structures is rigid and inflexible. 
4. Discussion 
The patient data is important in health care. Without patient data and the fluent health 
information exchange, the patient treatment pathways do not operate properly. [4] 
OHNs play an important role as producers of patient data. In Finland, they make the 
major of the health check-ups and various health counselling visits. The perceived 
usefulness and ease of use of technology were identified by the OHNs as important 
characteristics of the national patient data structure. It is important that national data 
structures will reduce the burden of OHNs’ documentation, rather than increase it. The 
development of patient data structures in EHRs have to be continued. 
5. Conclusions 
This study produces new information about national documentation structure that can 
be used in the development of EHR systems in OHS, and to better serve information 
exchange among OHNs and the other healthcare professionals. It also enables work 
ability data to be exchanged in the correct format and in the correct place effectively 
and reliably. 
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Exploratory Analysis of Animal Bites Events 
in the City of Buenos Aires Using Data from 
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1.Introduction 
Rabies is a viral disease transmitted by rabid animal bites or injuries. It is usually 
preventable with proper wound care, post- exposure prophylaxis and animal zoonoses 
programs [1]. In order to face this issue, it is important for the health care system to 
track animal bites and other animal related injuries. Animal bite information is usually 
registered in free-text form, within the electronic health record implemented in the 
public health system of the city of Buenos Aires. Thus, we aimed to develop an NLP 
pipeline that allowed us to extract animal-bites related information from clinical notes 
and represent it in a dashboard. 
Rabies is estimated to cause 59 000 human deaths annually in over 150 countries. 
Due to widespread underreporting and uncertain estimates, it is likely that this number 
is a gross underestimate of the true burden of disease. 99% of rabies cases are dog- 
mediated and the burden of disease is disproportionally borne by rural poor 
populations, with approximately half of cases attributable to children under 15 [2]. 
2.Methods 
A regular expression natural language processing pipeline was developed in order to 
extract the type of animal that caused the injury, the type of lesion it caused, which 
body part was compromised, geographic location of the event and whether the patient 
received rabies vaccine treatment. This information was represented in a dashboard for 
monitoring and evaluation. 
3.Results 
From January 2017 until December 2019, a total of 18676 animal bite events were 
registered. Dogs were responsible for nearly 50% of the events. These injuries occurred 
mainly in the south of the city, mostly in areas characterized by precarious housing. On 
the other hand, bat bites occurred close to the city center, an area with higher density of 
apartment buildings. The number of events tends to be regular over the year but winter 
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months have the lowest number of cases. Overall, male and female are equally affected 
but the cases are concentrated in the 0 - 15 age group, involving mostly dog bites. 
4.Discussion 
Free-text encoding is a very important source of information and physicians prefer it 
mainly because it is flexible. The development of this pipeline made evident 
asymmetries not only in geographic case distribution but also in age ranges 
distribution. This could be useful to create new strategies or improve existing ones. 
 
Figure 1. Plots included in the dashboard 
5.Conclusion 
We described how we managed to extract clinical information stored in the electronic 
health records using NLP algorithms. As health information is crucial we believe this is 
a very useful tool to help the ministry and other areas to design public health strategies. 
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Exploratory Analysis of Consultation 
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Abstract. Depression is frequently underdiagnosed or the diagnosis occurs in late 
stages, mainly because it usually presents as a paucisymptmatic diseorder. 
Electronic health records (EHRs) are a very useful tool to capture the longitudinal 
medical history of the patient which may help in diagnosing these patients earlier. 
We aimed to understand how these patients’ consultation patterns are represented 
in the EHR up until depression diagnosis. 
Keywords.  Depression, Electronic health records, Depressive Symptoms 
1. Introduction 
Depression is the most frequent psychiatric medical disorder observed in primary care 
[1]. The main problem that depression presents is the fact that 50% of the cases are not 
diagnosed [2][3]. Underdiagnosis is very frequent due to the atypical and varied 
clinical presentation of depression[3]. Usually, looking at the patients’ history and 
consultation pattern facilitates arriving at a diagnosis. EHRs help to collect and review 
patient data longitudinally. The objective is to describe the consultation patterns of 
patients before they are diagnosed with depression at Hospital Italiano de Buenos Aires 
using data from EHRs.  
2. Methods 
We manually reviewed a random sample of 600 adult patients over 18 that had at least 
one depression related code registered in their EHR between 2010 and 2016.278 had a 
first diagnosis of depression. We obtained several variables related to healthcare system 
use. Finally, we explored patient clusters using non-supervised algorithms like k-means 
and hierarchical clustering. A six cluster solution was found to be the best fit. Clusters 
were then manually inspected and qualitatively described. 
                                                          
1 Corresponding author. E-mail: sofia.sciarreta@hospitalitaliano.org.ar 
 
Patterns Prior to the Diagnosis of Depression 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200404
1285
3. Results 
Table 1 shows the patients’ characteristics and describes each cluster. Although we 
statistically obtained a 6 cluster solution, we combined them into 4 according to their 
main characteristics (Cluster 1, clusters 2 + 3, cluster 4, clusters 5 + 6). Cluster 1: We 
believe these patients already had a diagnosis of depression, due to the fact that they 
presented a large number of consultations within a short time of affiliation. In clusters 
2+3, there were a large number of consultations to specialties, general medicine, 
emergency room visits and hospital admissions. They present a pattern of consultations 
compatible with patients who are underdiagnosed and thus keep seeking care. Cluster 4 
and 5+6 comprise most of the sample. Patients in these clusters had most of their visits 
with their general physician, with different follow up times. They most likely represent 
patients who take advantage of a primary care centered health system. 
Table 1.  Patients’ characteristics and description of clusters 
Cluster no. 1 2 + 3 4 5 + 6 
n 6 16 4 53 149 50 
Age at 
diagnosis 
(median 
[IQR]) 
72  
[58.75, 76.25] 
68.50 
 [62.2, 80] 
64.5  
[37, 87.5] 
65.00 
 [54, 72] 
67.00  
[51, 79] 
64.5 
 [46.5, 74] 
Women (%) 6 (100.0) 11 (68.8) 4 (100.0) 48 (90.6) 149 (100.0) 0 (0.0) 
Seniority  
0.30  
[0.26, 0.61] 
7.47  
[1.90, 14.10] 
7.95  
[4.90, 
10.34] 
1.57  
[0.75, 2.29] 
8.27  
[5.85, 12.51]
8.89 
 [6.50, 
14.90] 
Emergency 
room visits  
0.00  
[0.00, 0.00] 
0.89 
 [0.40, 1.30] 
1.50 
[0.90, 2.48] 
0.00 
 [0.00, 0.82] 
0.22  
[0.00, 0.60] 
0.60 
 [0.20, 0.98] 
Hospital 
admission 
0.00  
[0.00, 0.00] 
0.00  
[0.00, 0.39] 
0.50 [0.39, 
0.85] 
0.00  
[0.00, 0.00] 
0.00 
 [0.00, 0.20] 
0.00  
[0.00, 0.00] 
Follow-up 
years 
0.30 
 [0.26, 0.61] 
5.00 
 [1.90, 5.00] 
5.00 
[4.46, 5.00] 
1.57 
 [0.75, 2.29] 
5.00  
[5.00, 5.00] 
5.00 
 [5.00, 5.00] 
No. visits per 
year 
203.15 
 [145.7, 408.7] 
62.10 
 [47.8, 91.2] 
42 
 [37, 47.7] 
38.3 
 [24.3, 64.2] 
13.2  
[5.4, 22.4] 
6.9  
[3.5, 16.7] 
4. Conclusions  
Longitudinal data in the EHR was useful for differentiating clusters of patients with a 
recent diagnosis of depression. 
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Exploratory Analysis of Exercise Mentions 
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Abstract. Physical activity has been associated with many positive health 
outcomes. In this study we explored clinical notes to better understand how 
physicians record information on this topic. 
 
Keywords. physical activity, electronic health record 
 
1. Introduction 
Physical exercise is defined as any body movement that increases energy consumption 
above the baseline value [1]. It has been associated with a improvements in mood [2], 
quality of sleep, cognitive level, bone density, obesity and type 2 diabetes 
prevention[3]. Given this, it has become a first line treatment strategy in primary care 
for many chronic diseases, like cardiovascular disease. For this reason, we set out to 
analyze clinical notes at Hospital Italiano de Buenos Aires to assess mentions of 
physical activity recorded. 
2. Methods 
 
As a first step we developed a keyword based filter to detect different types of exercise 
mentions. We evaluated the filter’s performance on a random sample of 2047 clinical 
notes that we manually reviewed and annotated (presence or absence of physical 
activity mentions). Afterwards, we applied the filter and obtained a random sample of 
750 clinical notes which we manually reviewed to identify which types of exercise 
patients report doing, which ones physicians prescribe and why they prescribe them to 
their patients. 
3. Results 
After manual review, we detected that 157 out of 2047 clinical notes had physical 
activity mentions (7.7%, 95% Confidence interval (CI) 6.59 - 8.9%). The keyword 
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filter yielded a sensitivity of 0,977 (95% CI 0.910 - 0.996), positive predictive value of 
0.840 (95% CI 0.750 - 0.903) and F1 score of 0.903 (95% CI 0.857 - 0.942). 
After reviewing the 750 clinical notes we observed that physicians mostly (68%) 
prescribe physical activity in a very generic way (recommendations of ‘starting 
physical activity’ or ‘joining a gym’). Less frequently (32%), they specify a certain 
type of activity, usually walking (23%). In most cases there was not enough 
information as to why a particular type of physical activity had been prescribed. 
Regarding the reasons why physical activity is being prescribed, the main ones were 
cardiovascular prevention (includes the treatment of risk factors such as hypertension 
or diabetes, 42%), treating obesity (25%) and improving general body aches (11%). 
4. Discussion 
Our results indicate that physical activity is seldom registered in the clinical notes and 
when it is, there is a lack of information on what it is being prescribed for. We believe 
that non-pharmaceutical treatments should be registered as rigorously as 
pharmaceutical treatments, since they are part of many treatment plans. Not having this 
information available hinders the decision-making process in future consultations.  
Furthermore, we see that there is not much variety in the activities suggested by 
medical professionals. It would be interesting to analyze in the future if this can be 
related to limited knowledge about the different options available. 
5. Conclusion 
In our study, physical activity mentions were present in a small proportion of clinical 
notes in the outpatient setting. Furthermore, information regarding the cause for 
prescription was scarce. We emphasize the importance of recording non-
pharmaceutical treatments rigorously. 
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Abstract. In this paper, we propose feature extraction method for prediction model
for at the early stage of diabetic kidney disease (DKD) progression. DKD needs
continuous treatment; however, a hospital visit interval of a patient at the early stage
of DKD is normally from one month to three months, and this is not a short time
period. Therefore it makes difficult to apply sophisticated approaches such as using
convolutional neural networks because of the data limitation. The propose method
uses with hierarchical clustering that can estimate a suitable interval for grouping
inputted sequences. We evaluate the proposed method with a real-EMR dataset that
consists of 30,810 patient records and conclude that the proposed method outper-
forms the baseline methods derived from related work.
Keywords. disease risk prediction model, diabetic kidney disease
1. Introduction
We constructed a risk prediction model for diabetic kidney disease (DKD) that receives
the medical events of a patient in the past 180 days and predicts whether the patient will
stay at the 1st stage after 180 days. A patient at the early stage of DKD needs continuous
treatment; however, a hospital visit interval is from one month to three months, and this is
not a short period. We focused on this issue, and the proposed method derives time series
variation with hierarchical clustering that can estimate a suitable interval for grouping
inputted sequences.
The number of studies on risk prediction models has increased and most of the
studies applied logistic regression or cox regression to the latest medical events. Some
studies focuses on patients that frequently visit a hospital, so records with many medical
events in a certain period of time are available [1][2] and use CNN to distill a time series
variation of a given patient.
The proposed method transforms a value sequence into groups on the basis of the
result of the hierarchical clustering for a corresponding timestamp sequence. We use the
hierarchical clustering method that has the constraint not on the number of the clusters
but on the distances among the clusters. Then, we derive the time series variation from
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Table?1.? The?AUC?in?the?prediction?for?the?stage?of?DKD?of?the?patient?after?180?days.?“LR”?stands?for?the?
logistic?regression.
ID Model AUC ID Model AUC
1 LR without time series variation 0.625 4 CNN #1 (interval 30 days) 0.632
2 LR with time series variation 0.722 5 CNN #2 (interval 14 days) 0.660
3 CNN #1 (interval 14 days) 0.666 6 CNN #2 (interval 30 days) 0.635
the group. For example, we calculate the averaged value and the standard deviation from
the averaged cluster’s values. The key factor is the hierarchical clustering that can esti-
mate a suitable interval for grouping inputted sequences. We use logistic regression as a
statistical model for the prediction because logistic regression can provide interpretable
results. Interpretation is one of the important factors in the field of medical informatics.
2. Results and Discussion
We evaluate the proposed method with a real-EMR dataset from a Japanese hospital.
We collected the medical history of a patient at the 1st stage. The number of patients is
30,810, where half of the patients remain at the 1st stage after 180 days. We focus on 12
kinds of laboratory tests as feature sets on, for example, uric protein and eGFR.
We conducted a 5-fold cross-validation test in the experiment and measured the
AUC, which is the standard evaluation metric for a classification problem. And we used
the baselines, the first of which is a logistic regression that handles the latest values of
the feature sets and does not handle the time series variations that the proposed method
creates. The other baselines are two kinds of CNNs that consist of 5 layers and handle
feature matrices created in a previous work [1] [2]. We created two kinds of feature
matrices created with different the interval for CNNs, 14 days and 30 days.
Table 1 shows the experimental results. The best performance is 0.722, which was
achieved by the logistic regression with the time series variation that the proposed
method creates. The experimental results point to the following conclusion: (1) under-
standing the time series variation improves the prediction performance of the risk predic-
tion model of diabetic nephropathy and (2) the proposed method outperforms the base-
lines. The first conclusion is reached on the basis of the comparison between the ID 1 re-
sult and the others; the AUC of ID 1 is lowest and is derived from the logistic regression
without the time series variations. The second conclusion is reached on the basis of the
comparison between the ID 2 result and the others. The ineffectiveness of CNN for this
task is caused by the missing value in the feature matrix. A low frequency of hospital
visits causes the missing value in the feature matrix for CNN.
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Abstract. The number of people with diabetes is increasing in every European 
country and as with all chronic diseases, coping with diabetes is a long-term process. 
Self-Management and supporting behaviour change are aspects when dealing with 
diabetes. The POWER2DM 2  system combines treatment planning and self-
management activities by providing interventions to change a patient’s lifestyle 
towards a healthier, diabetes-appropriate life. FHIR3 allows for data exchange. 
Keywords. decision support systems, self-management, behaviour change  
1.Introduction 
In this paper, we introduce the Self-Management Support System (SMSS) for Type 1 
and Type 2 diabetes patients based on the Personal Data Store (PDS), a fully FHIR 
compliant data repository providing electronic health records. Empowering patients [1] 
by integrating them to a greater extent with their own healthcare process is the overall 
target. Disease management becomes an integrated part of their life. 
2.Method 
Self-Management Support is implemented as a guided iterative workflow cycle, typically 
on a weekly basis. Treatment plans are usually generic and span longer periods of time. 
Patients are requested to adopt the practitioner’s treatment plans into personal goals and 
to plan activities he or she wants to accomplish within a shorter period of time. Increasing 
the patient’s adherence to the personal action plan is achieved by providing interventions 
based on Behaviour Change Techniques [2]. Basically, the workflow consists of four 
main steps as shown in Figure 1. First the patient specifies self-management Goals and 
relates them to the practitioners’ treatment plan.  
Secondly, Actions like tasks and activities are planned with a Calendar. Again, tasks 
and activities are related to self-management and treatment goals. In the Monitoring 
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phase, blood glucose, blood pressure and body weight are recorded with devices. 
Activities such as medication intake, physical exercises, meals are recorded manually. It 
is also possible to keep a diary for problems, mood, sleep and stress. Finally, with the 
Periodic Review, the recorded data is evaluated and performance feedback is provided. 
For each of the review categories, positive reinforcement messages [3] or 
recommendations for the next action plan cycle are given. In [4], the intervention 
mechanisms are explained in detail.  
            
Figure 1. Patient Empowerment Workflow  
Data is maintained FHIR compliant with the PDS while ensuring interoperability. 
39 FHIR “Profiles” and FHIR “Extensions” customize basic FHIR resources and 
contribute SMSS specific data elements [5]. A detailed architecture of the POWER2DM 
system is given in [6]. The FHIR profiles are available at Simplifier.net4. 
3.Conclusion
The Self-Management Support System supporting behaviour change is currently 
evaluated in pilot applications in a production environment with 230 patients (115 type-
1, 115 type-2) in the Netherlands and in Spain. The trial evaluates the acceptance rate 
and effectiveness of the presented interventions. Results are expected by the end of the 
pilot applications. A test system is also available and adjustable to other chronic diseases. 
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1. Introduction 
In 2018, The European Union instituted the General Data Protection Regulation (GDPR), 
which regulates the collection, processing, and securing of personal data, including 
protected health information (PHI). As detailed by the European Union Blockchain 
Observatory and Forum [1], in principle, there are no contradictions between the goals 
of GDPR and Distributed Ledger Technologies (DLT). However, there seems to be at 
least three areas in which GDPR still does not offer enough clarity about how real-world 
DLT applications for the health sector should be developed. These areas include (1) 
accountability and roles (eg, how to identify a data controller in a public DLT), (2) 
anonymization of personal data (eg, what techniques are sufficient to anonymize 
personal data to the point where the resulting output can potentially be stored in a DLT), 
and (3) GDPR rights conflicts (eg, how to rectify or remove personal data that are 
recorded in a DLT that is immutable by nature, or who is responsible for requesting and 
managing the “freely, specific, informed, and unambiguous” consent from a data subject, 
especially if the data controller is not specified) [2]. With regards to anonymization of 
personal data, it is clear that GDPR does not apply to anonymized data and that this type 
of information can be stored on the DLT. However, what qualifies as anonymized is still 
not clear. The only indication today is that it must be irreversibly impossible to identify 
an individual through any of the means “reasonably likely to be used” [3]. The objective 
of this study is the dissect the various designs of DTL and look for GDPR compliance 
for the different components in established or proposed blockchain/DTL applications 
that deals with health data. 
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2. Method 
A comprehensive review over the current GDPR official documents and other reports 
that touch upon the subject, including the report developed by the EU blockchain 
Observatory and Forum [1]. Furthermore, a summary of peer-reviewed publications 
under the topic and retrieval of white papers for proposed applications in the health 
sector. Literature reviews of high quality that summarize the current state-of-art and 
state-of-knowledge should be explored. Summarize the key aspect of the reviewed 
literature and the key components of blockchain/DTL will be based on peer-reviewed 
summaries/literature reviews. 
3. Results  
Our preliminary results indicate that there are several areas were blockchain/DTL in the 
health sector may face challenges when it comes to GDPR. More specifically, a public 
blockchain that contains on-chain data related to an individual’s health, faces serious 
challenges when guaranteeing the anonymization of that data.  
4. Discussion 
There are clear indications that carefully considerations should be undertaken when 
designing a blockchain infrastructure that deals with health data, to comply with the 
current GDRP. As previous research shows, the developer of a blockchain system have 
several important design decisions to make that affect the privacy, access and 
accountability of the system. It is of high importance to consider the GDPR and 
especially the three areas mention in the introduction. 
5. Conclusion 
How blockchain and DTL comply with current regulations for health data have been 
suggested to be one main barrier for implementation of this technologies in the health 
sector. Our preliminary result shows that when certain design chooses are made, 
blockchains and DTL for the health sector may not only comply with the current GDPR 
but will contribute to reinforce the regulations. 
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Abstract. The University Hospital of Gießen and Marburg (UKGM), Gießen, 
Germany participates in a country wide nosocomial infections surveillance project 
on intensive care units (ICU) called KISS. KISS data must be gathered daily and is 
comprised of detailed clinical data like patient movements, ward utilization, 
presence of central venous and urinary catheters and types of artificial respiration. 
This happens for all of the 10 ICU’s at UKGM Gießen and proved to be very 
tedious and time consuming for the institute for hospital hygiene. The goal of this 
project was the automated generation of the KISS reports from routinely collected 
data in the patient data management system (PDMS). The results show that this is 
largely feasible without changing the documentation habits of physicians and 
nurses. 
Keywords. PDMS, hospital hygiene, nosocomial infections, infection surveillance 
1. Introduction 
The University Hospital of Gießen and Marburg (UKGM), Gießen, Germany 
participates in a country wide nosocomial infections surveillance project on intensive 
care units (ICU) called KISS [1]. All participants of the KISS study must provide a set 
of clinical data items on a daily basis. The items are comprised of counters for patient 
movements, ward utilization, presence of central venous and urinary catheters and 
types of artificial respiration. They are collected for all of the 10 ICU’s at UKGM 
Gießen. This is a very tedious and time-consuming process for the members of the 
institute for hospital hygiene. The goal of this project was to derive automatically all 
parameters of the KISS report from routinely collected data in the patient data 
management system (PDMS). This should happen without changing the established 
documentation habits on the wards. 
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2. Material and Methods 
The University Hospital of Gießen and Marburg (UKGM), Gießen, Germany operates 
a patient data management system (PDMS) on all intensive care units (ICU’s) and 
intermediate care units (IMC’s) since 1999 [2]. The documentation is based on a 
controlled vocabulary that covers all aspects of intensive care including application of 
intravenous and urinary catheters, applied drugs and presence and type of artificial 
respiration. A background application has been developed, that routinely checks the 
PDMS data for the presence of information regarding the KISS study parameters. This 
is accomplished by checking the presence of a set of device related concepts from the 
vocabulary. The analysis is done for the complete course of a patient stay to keep track 
of application and removal of the different types of catheters. All results are collected 
in a separate hygiene database. The content of the hygiene database is displayed with 
an ASP.NET Web-Application. The GUI layout resembles the layout of the KISS data 
entry form and therefore allows for seamless copy and paste of information. 
3. Results 
Development started in early 2018. Since October 2018 the system is used for cross 
checks of the manually collected data which acts as a gold standard. Quality checks and 
optimizations are currently applied separate for every clinical department. Data shows a 
sensitivity of 1.0 for detection of admissions and discharges, 0.95 for urinary catheters 
and 0.9 for central venous catheters and artificial respiration. Specificity for admissions 
and discharges is 0.8 and 0.9 for urinary catheters, central venous catheters and 
artificial respiration. Incomplete documentation of device application or removal has 
been detected as the main reason for failure of the automated process. Additional 
analysis of the clinical context e.g. balance data for urinary catheters, has proven to be 
a valuable source of information to cope with this documentation deficits. 
4. Discussion 
The developed application allows for a great amount of time saving for the members of 
the institute for hospital hygiene. It removes the need to manually extract data from 
clinical charts on a daily basis which proves to be an error prone and tedious process. 
In future the data extraction system will be enhanced to extract more data which 
could then be used to act as an early warning system for nosocomial infections. 
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Abstract. In order to assist parents in providing rapid first aid to children in case 
of emergency, a mobile emergency application was developed. The children’s 
emergency app works with intuitive graphics and checklists and combines several 
functions such as tips for preventing accidents, easy-to-understand instructions for 
first-aid actions and a search function for the next pediatrician or hospital. This 
app is not intended to be a substitute, but rather an addition to first aid courses. 
Keywords. Mobile apps, children`s health, first aid, prevention 
1. Introduction 
Accidents are one of the highest risks to children’s health. The German Federal 
Ministry of Health estimates that in Germany medical care is given to around 1.7 
million children who experience accidental injuries each year [1]. An emergency of 
one´s own child is one of the greatest worries for any parent. When health emergencies 
occur and seconds count, adults must take the right actions to save lives. They need to 
feel confident within the situation to be able to do so, but in fact many people are afraid 
to do something wrong in case of an emergency [2]. For this reason the St. Johns 
Ambulance Service Germany, the BARMER health insurance, the mobile application 
development company Opwoco and the University Hospital Muenster developed an 
mobile application, which is intended to help parents, tutors or teachers to initiate 
necessary steps in emergency situations until paramedics or doctors can intervene. 
2. Method 
The cornerstone for the app was placed within a project called MARIKA, which was 
funded by the European Union and the Federal Ministry of Health, Emancipation, Care 
and Aging of North-Rhine Westphalia. Within this project a survey on user interests 
and needs in the field of mobile health applications was conducted among 316 patients 
and accompanying persons at the University Hospital of Muenster [3]. On the basis of 
these findings and on the basis of the guidelines of the European and German 
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Resuscitation Councils as well as the experiences of the nationwide "First Aid for 
Children" courses of the St. Johns, the children’s emergency app was developed. 
As a database for the location-based search function for pediatric and surgical 
ambulances, the quality reports of the clinics were used. These are published annually 
by all clinics in Germany.  
3.  Results 
The children's emergency app meets all data protection requirements of the Federal 
Data Protection Act in Germany and can be used free of charge on Android and iOS. It 
works with intuitive graphics and checklists, so it is easy to understand and intuitive to 
use and combines several important functions:  
 search for the next pediatrician, hospital, etc. 
 setting up an emergency call 
 easy-to-understand instructions for first-aid actions 
 tips for preventing childhood accidents 
 individually fillable address book for important medical numbers 
4. Discussion 
The number of downloads (107.688 downloads within two years) and ratings on the 
download platforms indicate a high user acceptance. The app is refined continuously, 
so in the beginning of 2019 an updated version was provided, which was extended by 
the topic "childhood diseases". In addition, the app has been provided with a new 
feedback function. Since the app is only available in German so far, the translation into 
different languages will also be considered. 
5. Conclusion 
The children's emergency app is not a substitute, but a valuable addition to first aid 
courses on the child. Even with the newly integrated feedback function, the greatest 
challenge for the developers remains to keep the contact data for all hospitals, 
paediatricians and pharmacies up to date, as there is a lack of a central and current 
database for all health care providers in Germany. 
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Abstract.Even though Internet is an exciting technological tool, it requires 
innovative design to be accessible to everyone, including people with 
disabilities.The purpose of the present work is to evaluate the accessibility of the 
web sites of the hospitals which areunder the Greek Ministry of Health and 
belong in the first Health Regionusing afreeWCAG 2.0 and Section 508 Web 
Accessibility Checksoftware. An observation of the websitesalong with the 
software showed that no website meets the W3C criteria of accessibility. 
 
Keywords.Accessibility, website, disability 
1. Introduction 
Internet access equality is important because of the impact on peoples’ health and on 
society [3].At the social level, Internet accessibility and use is associated with increased 
citizens' trust, interpersonal trust and life satisfaction[4].People with disabilities seem 
to be facing a significant digital divide having access to different types of services [1], 
[9],[11].People with disability are usually not independent with health information 
retrieval [2].More precisely, people with vision impairment tend to use screen readers 
to browse the Web. For this purpose, web sites elements must be accessible and 
readable from screen readers[8].The Web Content Accessibility Guidelines 
(WCAG)[7] were developed by the World Wide Web Consortium (W3C) [5] and are 
widely accepted as standards for digital accessibility [10]. The purpose of this article is 
to evaluate the web accessibility of the public hospitals which are under the Ministry of 
Health [6] and belong in the first Health Region in Greece. 
2. Methods 
Twenty five hospitals that belong to the first Health Region were identified from the 
official website of the Ministry of Health and twenty one of them had website. The free 
WCAG 2.0 and Section 508 Web Accessibility Check tool [5] was used to 
automatically scan the websites and evaluate accessibility based on the WCAG 2.0 
criteria. Website accessibility issues were distributed in the following categories: Font, 
Images, Tables, Headings, Links, Colours, Labels, Pop ups, Tags, HTML element 
missing, Sitemap missing. Hospitals with one or more accessibility issues did not meet 
the W3C criteria and they were rated as non accessible. 
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3. Results 
Twenty one hospital websites were evaluated giving the following results: 29% of the 
hospital websites had Font size issues. 72% of the hospital websites had images related 
issues such as images with empty alternate text, images inside an anchor tag without 
alternate text, animated images and images without alternate text.48% of the hospital 
websites had issues Tables.38% of the hospital websites had issues with missing or 
empty Headings. All hospitals websites had issues with empty links or missing skip 
links and links with ambiguous link text. Moreover elements to be using an event 
handler such as on click to emulate a link were found. 33% of the hospital websites had 
issues with the colour background. More precisely, an element was found to not have a 
contrast ratio of at least 4.5:1 between the foreground and background colours and no 
buttons for background colour alteration and letter size alteration was found. 29% of 
the hospital websites had a form field found to be missing labels.76% of the hospital 
websites had issues with pop up windows. 38% of the hospital websites had issues with 
the tags. 48% of the hospital websites HTML element was missing. 38% of the hospital 
websites had no sitemap. No hospital website met all the WCAG 2.0 criteria. 
4. Conclusions 
The main issues found in the majority of hospitals websites were related to images, 
links and pop up windows. More specifically missing skip links, untitled tables, and 
images without alternate text were identified. The hospital websites included in this 
work do not meet the WCAG 2.0 specifications and therefore cannot be considered 
accessible. These hospital websites should be updated in order to comply with 
accessibility standards. 
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Abstract.  In low- and middle-income countries, private and public facilities tend 
to have highly variable characteristics, which might affect their performance in 
meeting reporting requirements mandated by ministries of health. There is 
conflicting evidence on which facility type performs better across various care 
dimensions, and only few studies exist to evaluate relative performance around 
nationally-mandated indicator reporting to Ministries of Health. In this study, we 
evaluated the relationship between facility ownership type and performance on HIV 
indicator data reporting, using the case of Kenya. We conducted Mann-Whitney U 
tests using HIV indicator data extracted from years 2011 to 2018 for all the counties 
in Kenya, from the District Health Information Software 2 (DHIS2). Results from 
the study reveal that public facilities have statistically significant better performance 
compared to private facilities, with an exception of year 2017 in reporting of 
counselling and testing, and prevention of mother-to-child transmission indicator 
categories. 
Keywords. HIV-indicator reporting, health facility, ownership, performance,  
1. Introduction 
In most LMICs, health facilities are required by the Ministries of Health (MoH) to report 
on various HIV indicators to aid in monitoring and evaluation of HIV programs, 
advocacy, policy and decision-making. In general, reported indicators are expected to be 
timely, accurate and complete. Few studies exist that rigorously evaluate differences in 
performance, and reviews of performance by facility-type have often led to conflicting 
conclusions[1]. Ownership of health facilities has the potential to affect the performance 
of health facilities at meeting these HIV reporting requirements, yet rigorous evaluations 
on relationship between facility type and HIV indicator reporting are limited. With 
increasing use of national-level centralized electronic HIV-indicator data aggregation 
and reporting systems such as the District Health Information Software 2 (DHIS2), data 
now exists in several LMICs for these evaluations. The aim of this study is to establish 
the relationship of health facility ownership type with ability to meet HIV indicator 
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reporting requirements, using the case study of Kenya. The reporting requirements 
assessed in this study are completeness and timeliness in facility reporting. 
2. Method 
A retrospective observational study was conducted in order to identify the relationship 
between facility type and performance on HIV indicator reporting in Kenya. Reporting 
data used was from years 2011-2018. From DHIS2, we extracted the following HIV 
indicator categories based on Kenya’s MoH7312 summary form: (i) HIV Counseling and 
Testing (CT), (ii) Prevention of Mother-to-child Transmission (PMTCT) of HIV, (iii) 
Care and Treatment (CRT), (iv) Voluntary Medical Male Circumcision (VMMC), (v) 
Post-Exposure Prophylaxis (PEP), and (vi) Blood Safety (BS). Mann-Whitney U tests 
were conducted in order to compare the two ownership types.  
3. Results 
There were no statistical significances in performance in reporting of VMMC and BS 
indicators, which are peripherally associated with the HIV programs. Statistically 
significant results in performance, and mean ranks for both private and public varied in 
the different indicators. Performance in completeness and timeliness also varied by year, 
with public institutions performing better across multiple indicators with the exception 
of year 2017 in reporting of HIV CT, PMTC indicators. 
4. Discussion 
Our study only looks at yearly dimensions, but further analyses could be done by county, 
facility level, and facility type. This work highlights the key potential of how aggregate 
reporting data can be used to inform decision-making. Qualitative studies can further 
help highlight factors promoting or hindering quality indicator reporting 
5. Conclusion 
In this study, we observed a general trend of public facilities in outperforming private 
facilities in timeliness and completeness of health facility reporting of nationally-
mandated HIV indicators. 
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Abstract. In the context of increasing interest in computer-assisted diagnosis for 
skin lesion images and mobile applications to be used in real life settings, we 
propose a combined desktop-smartphone solution for dermatological image 
classification. Hierarchical agglomerative and divisive clustering are both 
implemented as methods of cluster analysis, with the RGB color histogram as 
descriptor for a global image analysis. The cosine similarity is employed for 
classifying the query image in one of the available clusters, characterized by their 
centroids. The solution has been tested with a public database of dermoscopic 
images, with an overall accuracy of 0.73, 95%CI (0.58;0.85). 
Keywords. Decision support, skin cancer, melanoma, color histogram analysis, 
artificial intelligence 
1. Introduction 
Skin cancer is an increasingly worrying medical problem and artificial intelligence 
solutions have proved increasing performance in the recent approaches for cancer 
diagnosis: clustering in general or for dermatology in particular, support-vector 
machines, deep learning, or even combinations with successful human-machine 
partnerships [1,2]. We propose a combined approach of desktop-mobile applications, 
employing hierarchical clustering for image classification. This is an ongoing work we 
have tested with a research database of annotated dermoscopic images, PH2 [3].  
2. Methods and implementation 
Two types of hierarchical clustering methods were implemented: (a) agglomerative 
bottom-up approach, with three linkage criteria (minimum or single-linkage; maximum 
or complete-linkage; and average linkage); (b) divisive top-down approach. Two 
metrics to measure the dissimilarity between the sets of images were implemented: the 
Euclidean and the Manhattan distances. Figure 1 shows the structure of the application. 
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Figure 1. Implementation of the hierarchical clustering: the reference database and histogram file are 
generated by the desktop application, while the clustering and classification can be performed within the 
desktop (full options) or mobile (reduced options) application. 
3. Results, discussion, and conclusion 
The performance assessment was four-folded: (i) hierarchical agglomerative (HAC) vs. 
divisive clustering; (ii) Euclidean vs. Manhattan distance; (iii) no of clusters; (iv) HAC-
related three linkage criteria. The overall results were: sensitivity=0.8, 95%CI 
(0.61;0.92); specificity=0.6, 95%CI (0.33;0.83); accuracy=0.73, 95%CI (0.58;0.85).  
The combined approach we propose merges the advantages of desktop applications’ 
computational power and mobile implementations’ friendliness towards a large variety 
of potential users. The hierarchical clustering presented herewith only uses the global 
color properties of images, so the classification is generalizable to both dermoscopic 
and general dermatological images.  
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Abstract. This study describes an approach to support decisions on the acquisition 
of innovative nursing technologies. The approach focusses a participatory design 
that involves nursing staff from the beginning of the process and aims at achieving 
positive results regarding identification with the decision of implementation and use 
of technologies by nursing staff. 
Keywords. Nursing technology, participatory management, nursing informatics 
1. Introduction
Within the project center of implementing nursing care innovations (PPZ Hannover)2 
innovative technologies are being integrated into everyday nursing work life to support 
nursing staff and improve patient care on a trauma surgery ward of Hannover Medical 
School. In order to involve the nursing staff into the research project, a participatory 
introduction concept was designed and implemented. 
2. Methods
Next to an extensive baseline investigation in a mixed methods design [1], the 
participatory approach uses results from workshops with nursing staff to assess the 
current work situation on the ward and to derive the need for technical solutions [2]. 
These results again lead to workshops where innovative nursing technologies are 
presented and discussed with all nurses of the ward. In the reported workshop a 
mobilization system for prophylaxis of decubitus ulcer and a robotic companion for 
dementia care were presented. Instruments for data collection in this setting were 
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• guideline-based discussions on usefulness
• a modified questionnaire on the suitability for use [3].
The discussion was documented and analyzed following qualitative content analysis.
The results of the questionnaire were calculated for two categories and a total score on 
defined suitability scores. 
3. Results
Both nursing technologies are believed to reduce burdens on patients and nursing
staff, while concerns differed between technologies as stated by the nursing staff. 
Possible improvements for a better adaptation on local conditions were discussed as well. 
The results of the questionnaire on suitability state a clear tendency for both the products 
being rated “very suitable” for nursing work life (see table 1). Even though the robotic 
companion received some criticism in general and in specific aspects of suitability.  
Table 1. Summarized results of questionnaire on suitability for use  
General suitability Specific suitability 
Suitability for use / total score 
Categories functionality 
usability 
workflow 
compatibility 
product quality 
patient´s well-being 
power supply 
alarms (MS) 
screen (MS) 
mobility 
consumables (RC) 
processing 
Robotic 
Companion (RC) 
n = 15 
14 % (3) 
22 % (4) 
64 % (8) 
19 % (4) 
31 % (5) 
50 % (6) 
9 % (2) 
34 % (6) 
57 % (7) 
not suitable 
limited suitable 
very suitable 
Mobilization 
System (MS) 
n = 14 
0 % 
11 % (2) 
89 % (12) 
12 % (3) 
33 % (5) 
55 % (6) 
5 % (1) 
31 % (5) 
64 % (8) 
not suitable 
limited suitable 
very suitable 
4. Discussion
The mix of quantitative and qualitative instruments seem to be an appropriate and reliable 
method to assess suitability of use for nursing technologies. Results of the discussion are 
matching the results of the questionnaire. The presentation of these results to nursing 
staff is necessary to comply with the participatory process and might lead to greater 
identification with the decision of implementation and use of technologies. 
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Abstract. Big Data technologies can contribute to medical fraud detection. The aim 
of this paper is to present the methodological approach of the Hellenic National 
Organization for the Provision of Health Services (EOPYY) in data analysis to 
detect financial or medical fraud. To analyze the data for fraud detection, a selection 
of prescription data from the year 2018 were examined. The Local Correlation 
Integral algorithm was applied to detect any outliers on the dataset. The results 
revealed that 7 out of 879 cases could be characterized as outliers. These outliers 
must be further investigated to determine if they have been associated with fraud. 
According to the results of this study, this outliers’ detection approach can support 
and help the fraud detection process conducted by the auditing services in 
Healthcare sector. 
Keywords. Fraud Detection, Healthcare, Big Data, Outlier Detection 
1. Introduction 
Big Data Technologies have been applied in Healthcare sector providing significant 
advantages on both the quality of the healthcare services and the control of the cost [1]. 
According to the international literature, the ability to detect fraud in medical claims 
seems to be a major asset on the expenditure control [2]. Specific Big Data analytic 
techniques can lead to effective fraud detection in the health domain [3]. The aim of this 
paper is to present by an example the methodological approach of the Hellenic National 
Organization for the Provision of Health Services (EOPYY) in data analysis to detect 
financial or medical fraud in claims. 
2. The EOPYY Case Study 
EOPYY carries the healthcare provision and claims data of all the Greek citizens. 
Currently, the databases size is approximately 5 TB with a data increase rate of 140 GB 
per month, creating a valuable Big Data repository for medical claims. To analyze the 
data for fraud detection, the 2018 prescription data of the following product categories 
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were extracted (more than 4,000,000 entries) from the above databases: (i) Products and 
Supplies for Diabetes Management, (ii) Catheters, (iii) Medical Pads, and (iv) Special 
Nutrition Products and Supplements. For each of the above case, the date of the 
prescription, the prescriber, the specialty of the prescriber, the patient’s social security 
number, the product name, the category of the product, the product provider, and the 
location of the provider were selected. After data selection, appropriate anonymization 
techniques (SHA-1 algorithm for one–way data encryption) were applied to comply with 
GDPR requirements before the data analysis. The aforementioned raw data were 
transformed in a manner to describe new features for each product based on the number 
of the cases. Specifically, the following features were calculated: (i) the number of the 
prescriptions, (ii) the number of patients who received each product, (iii) the number of 
prescribers who prescribe each product, (iv) the number of prescription to the number of 
patients ratio, (v) the number of prescription to the number of prescribers ratio, (vi) the 
number of the maximum prescriptions per patient, and (vii) the number of the maximum 
prescriptions per prescriber. A dataset of 879 products with 7 characteristics for each 
product was constructed. According to the international literature the Local Correlation 
Integral (LOCI) algorithm [4] is one of the latest algorithms for outliers’ detection giving 
more accurate results on several fields of study [5] compared to other algorithms. Based 
on this, LOCI was applied to detect any outliers on the dataset, setting the user selected 
parameter to default values, i.e. =0.5, Nearest Neighbors=20, and Threshold=3, 
producing some fruitful results. The results revealed that 7 out of 879 products could be 
characterized as outliers on this seven dimensional space. All of them had different 
behavior and space distribution, being further away from the rest of the data representing 
the other products. The 7 outliers may be assumed that have been associated with fraud, 
since at least two of them have been already confirmed as such by the EOPYY’s Auditing 
Services and the rest are still under investigation. 
3. Conclusions 
According to the results of this study, the applied outlier detection approach can support 
and help the fraud detection process conducted by the auditing services in the Healthcare 
sector. Future work will include the application of multiple algorithms on the healthcare 
expenditures datasets to achieve more accurate results, while it will also be expanded to 
the detection of frauds on the prescribers’ level. 
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Abstract. In this work, an attempt has been made to assess the texture variations of 
brainstem occurring in the Early Mild Cognitive Impairment (EMCI) condition. Fractal 
dimension is calculated for the segmented brainstem volume using Higuchi’s and 
Detrending moving average (DMA) method. These measures are validated using 
Random forest classifier. DMA shows better performance when compared to Higuchi’s 
method in categorising EMCI stage. Thus, the proposed approach using brainstem 
image’s DMA fractal measures with random forest can be used in diagnosis of EMCI. 
Keywords. Early Mild Cognitive Impairment, Brainstem, Higuchi’s Fractal analysis, 
Detrended Moving Average, Random forest
1. Introduction
Early Mild Cognitive Impairment (EMCI) describes the clinically asymptomatic stage 
of Alzheimer’s disease (AD). Research on neuropsychiatric symptoms presented by AD 
patients suggests the early changes in brainstem image texture. Fractals are proven to be 
effective measures to describe the texture changes in brain tissue.  
2. Methodology
Raw T1-weighted age- and gender-matched MR images comprising of 232 EMCI, 200 
normal and 200 AD subjects are considered from ADNI database. The images are 
preprocessed and brainstem volume is segmented using fuzzy based connected 
component technique. Fractal dimension (FD) is evaluated using Higuchi’s method and 
Detrended Moving Average (DMA) technique. Higuchi’s method estimates FD using 
gray values of pixels and their neighbors. DMA is the advancement of Higuchi’s method 
where, the trend present in the image gray values are removed using root mean square 
function and the FD values are estimated on the detrended image volume. The extracted 
fractal measures are further validated using random forest in classifying EMCI stage. 
3. Results and Discussion
Representative raw and processed images are shown in Figure 1. The raw images in 
Figure 1(a) are spatially registered, skull stripped and contrast enhanced as shown in 
Figure 1(b) and Figure 1(c) respectively. Brainstem volume in Figure 1(f) is segmented 
from the white matter tissue shown in Figure 1(d). Figure 2(a) shows the linear fit of 
double log plot calculated using Higuchi’s algorithm. The variations in the fluctuation 
function for different scale obtained using DMA technique is shown in Figure 2(b). The 
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slope of double log plot is found to be different for normal, EMCI and AD condition, 
stating the variations in the fractal nature of brainstem structures. Figure 2(c) shows the 
box plot indicating mean and standard deviation of fractal values for EMCI, normal and 
AD subjects. It can be seen that the mean of fractal values calculated using DMA is well 
separated when compared to Higuchi’s method and shows significant differences in 
distinguishing EMCI condition. As the fractal values are indirect measure of texture 
heterogeneity, it can be seen that the brainstem images of EMCI patients are 
comparatively less heterogeneous than normal and AD subjects. This may be due to 
changes in the neuronal structure during the preclinical stages of the disease. The changes 
in FD values are further validated using random forest classifier where, an accuracy of 
89% is achieved using DMA in classifying the EMCI stage.
(a) (b) (c) (d) (e) (f)
Figure 1. Representative images of (a) raw (b) spatial normalized (c) skull stripped
(d) white matter tissue (e) segmented brainstem structure (f) 3D brainstem volume
(a) (b) (c)
Figure 2. Double logarithmic plot representing FD calculated using (a) Higuchi’s and 
(b) DMA method (c) Box plot representing FD changes among EMCI, normal and AD
4. Conclusion
FD is able to capture the subtle changes in the fractal nature of the brainstem images.
The variations in FD obtained using DMA for brainstem volume are found to be 
significant in differentiating EMCI condition. Brainstem image’s fractal measure is 
found to be distinct in defining the clinical pathology and classifying the EMCI stage, 
and hence can be used for preclinical diagnosis of AD. 
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Abstract. Competency-based learning involves identifying the knowledge, skills 
and attributes required for carrying out workplace roles. In 2018, the World Health 
Organization’s (WHO) Health Emergencies Programme (WHE) introduced a 
competency framework with competency-based assessment (CBA) methodology. 
The CBA focuses on behavioural indicators that participants demonstrate and 
training faculty observe during training events. This article introduces the CBA of 
WHE. It is essential to use the framework to design learning programmes and 
provide the basis to appraise and manage WHE personnel and team performance. 
Keywords. Competencies, competency assessment, competency-based learning, 
learning and development, capacity building, health emergencies 
1. Introduction 
WHO has set a target of 1 billion more people better protected from health emergencies. 
To achieve that, a health workforce of excellence is needed, supported by a learning 
strategy that provides a framework for all learning using a competency-based approach.  
Competency-based learning has been derived from Human Resources practices of 
identifying the knowledge, skills and attributes required for staff to complete the roles 
assigned to them and linking these roles to the goals of the organization [1]. Employers 
have made the distinction between core competencies that should be demonstrated by all 
employees and functional or technical competencies that are required for staff to perform 
specific roles [2]. In emergency work where staff and leaders face unique pressures, their 
ability to demonstrate the core competencies becomes particularly important [3]. WHE 
has followed this model in the roll-out of its competency framework.  
2. Method 
WHE core competencies are a subset of WHO competencies: Moving forward in a 
changing environment, applying technical expertise, communication, teamwork, 
building and promoting partnerships, and leadership. The competencies are 
demonstrated by 49 observable behaviours. WHE initiated CBA to determine how 
competencies are met by staff undergoing training and simulation exercises. Participants 
are assessed by observers and scored based on their demonstration of the behaviours. 
The scores are aggregated to indicate areas of strength and weakness for each participant 
and of the whole training cohort. Competency-based discussions are held between 
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participants and training faculty before and after a training event. These discussions are 
designed to help participants reflect on the behaviours they feel they readily demonstrate 
and those which they would like to develop through further learning.  
3. Results 
The CBA has been piloted in four training activities with approximately 100 participants. 
It was found that where participants were observed against all 49 behaviours throughout 
the entire training period, the assessment provided an indication of strengths and areas 
for development which were largely in line with the participants’ self-assessments. 
Where the number of behaviours observed was reduced, the assessment provided less 
indication and was less helpful in guiding out-brief conversations with participants. A 
greater number of facilitators conducting observations improved the assessment 
consistency. It was also found that it was necessary to conduct a face-to-face training and 
briefing for the competency observers. Scores for all participants of a training activity 
are also aggregated into a gross finding to give an indication of areas of strength and 
weakness for the entire cohort. These can be addressed in future learning programmes.   
4. Discussion  
The CBA has provided invaluable input in producing meaningful feedback for learners 
about their demonstration of core competencies. It is also critical for the training owners 
to mark how the learning objectives are met and the need for further learning. WHE 
currently has core competencies that are essential for anyone working for WHO in 
emergencies. Functional competencies are encouraged to be developed by technical 
teams in charge of functional areas.  
5. Conclusions  
Providing objective and constructive feedback on behaviours can help an individual 
identify and reflect on his/her strengths and areas for development, which is a key part 
of the learning process. Competencies must be understood by the staff and personnel 
supporting a learning programme; faculty should be trained in their use for designing, 
delivering and assessing learning and training activities.  
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Abstract. The aim of this paper is to propose an approach based on preference
learning for building a model that represents the closest possible experts reasoning
to provide recommendations. We apply this method to antibiotherapy in primary
care. The preference model was learned from the recommendations and from a
database describing the domain.
Keywords. Preferences learning, Experts reasoning, Clinical Practice Guidelines
1. Introduction
Clinical practice guidelines (CPGs) are textual documents written by a group of experts.
They contain recommendations and their justifications. In the domain of antibiotic pre-
scription, we analyzed these justifications and showed that experts used antibiotic prop-
erties to recommend antibiotics [1,2]. The preference model used by experts is based on
these properties, but still need to be explicited, before to be implemented in a clinical
decision support system (CDSS). Here, we propose a method for learning preferences
[3,4] of CPG experts from both recommendations and a database containing the antibi-
otics and their properties. We aim at building a model that represents the closest experts
reasoning to provide recommendations in the domain of antibiotherapy in primary care.
2. Methods
We used a database containing the antibiotics, their properties, and their rank of recom-
mendations as defined in CPGs. This database was validated by antibiotic experts accord-
ing to a Delphi process [1]. Let P be the set of properties of antibiotics of the database D.
For each property pi ∈ P, we denote the domaine of pi by dom(pi)={1=True, 0=False}.
Each instance d in D has a recommendation rank. Antibiotics having Rd=1 are preferred
to those having Rd=2 which are also preferred to those having Rd=3 which are also pre-
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ferred? to? those?having?Rd?=4.?Antibiotics?having?R0? are?not?preferred?since? that?are?not?
recommended.?The?aim? is? to? learn?preference? rules? from?antibiotics?properties,?which?
will?allow?to?associate?the?same?recommendation?ranks?that?those?defined?in?CPGs.?Let?
us?give?in?the?following?definitions.
Definition?1?(Item)?Each?element?that?is?built?on?the?connective?logic?∧?and?contains?at?
most?two?properties?pi∈?P?is?called?an?item.?The?set?of?items?is?denoted?by?I.?We?define?
Sat(d?∈?D,x?∈?X)?a?function?that?returns?True?if?instance?d?satisfies?item?x.
Definition?2?(Preference?rule)?A? preference? rule? r? is? a? partial? order? in? the? form? of?
x1x2x3x4?where?xi? is?an?item?defined?in?Definition?1.
The?aim?is?to?define?the?best?items.?Hence,?we?define?in?the?following?the?support?of?each?
item?regarding?each?recommendation?rank.
Definition?3?(Support)? The?support?of?an?item?x∈X? regarding?instances?d∈D?having?a?
recommendation?rank?Rd?=?r?is?defined?as:
Supp(x,r) =
|{d | Sat(d,x) and Rd = r}|
|{d | Rd = r}|
Computing the support of each item regarding each rank allows to determine which item
is best for that rank. The interest of an item increases with its support. Our method is
summarized as follows:
1. Generate the list of possible items I following Definition 1.
2. Compute the support of each one regarding each recommendation rank R.
3. Determine best items (BestRi) for each R. They are those having the support
superior than the fixed minimal support (thresholdSupp is in the ]0, 1]). Different
preference formulas can be generated.
3. Conclusion
The aim of this paper is to propose an approach based on preference learning for building
a model that represents the closest possible experts reasoning and strategies to provide
recommendations. In the future, we aim at validating our approach in other infectious
diseases, and then implementing the preferences rules in AntibioHelp R© a CDSS for an-
tibiotic prescription in primary care.
Funding: Agence Nationale de Sécurité du Médicament et des Produits de santé
(ANSM). [AAP 2016-RaMiPA Project - Reasoning for a better antibiotic prescription -
Dr Rosy TSOPRA]
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Abstract.   We aimed to identify relevant indicators for end-users in integration 
engines for healthcare systems. Methods: The study was performed in two steps, 
including interviews and the identification of additional indicators from the 
literature. Results: 10 interviews were performed and 90 indicators identified. 
Discussion: Several of the indicators are difficult to calculate, nevertheless, they 
have the potential to improve data quality and processes in healthcare institutions 
and should be further explored in future studies.  
Keywords. Integration, indicators, interoperability 
1. Introduction
Integration engines are critical in the transmission of clinical and demographic data, 
maintaining accessibility and integrity within healthcare institutions worldwide [1].  
Indicators to assess and monitor data integration engines are essential, contributing both 
to improve data quality and to facilitate systems management [2].  
This study aims to identify relevant performance indicators for end-users regarding the 
implementation of integration engines.   
2. Methods
Data were collected using a 2-step exploratory qualitative approach. The first step was 
an individual interview with expert professionals from health institutions/health 
companies that used health information systems daily/almost daily. They were asked to 
identify indicators within four pre-selected relevant classes of indicators (identified by 
the authors based on literature review and personal expertise): Information System 
integration, Data quality, Performance, and Safety and General Data Protection 
Regulation (GDPR). Two new categories were identified during the interviews: 
Integration Management and Hospital workflow process. The second step was the 
identification of additional indicators from the literature [3,4].  
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3. Results 
We performed 10 interviews and identified 63 indicators. Additional indicators (n=27) 
were identified in the reports. Table 1 presents a sample of the identified indicators by 
domain. A list of all indicators (n=90) is available at http://shorturl.at/sIV28. 
  
Table 1.  Indicators concerning integrated software systems per domain; only a sample is presented. 
Information System integration Absolute n of messages 
delivered / n sent 
Calculate n of alerts by period of 
time 
Data quality Data availability Total messaging problems 
Performance Delivery/receiving time N of SLA metrics for integration 
Safety and GDPR Access history checking Key expiration time 
Integration Management N of integration problems N of hours to set up/manage 
Hospital work process indicators Number of coding errors Process reengineering 
N – number; SLA – Service Level Agreement; GDPR – General Data Protection Regulation  
4. Discussion 
We believe that this study describes a relevant list of indicators that should be assessed 
and promoted within an integrated health system. Although several of the indicators are 
difficult to compute, they might contribute to improve data quality and processes in 
healthcare institutions, by promoting the identification and facilitating the correction of 
system inefficiencies or malfunctions, and should be further explored in future studies.  
5. Conclusion 
This study identified 90 indicators that can be analyzed by actors involved in the 
healthcare system and have the potential to contribute to data quality improvement.  
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Abstract. Seizure is a common complication in a neurological intensive care unit 
(NICU) and it requires continuous electroencephalograms (EEG) monitoring. 
Implementation of EEG for each bed in a NICU is very expensive and require 
labor work for interpretation of EEG. To provide an affordable device of EEG in 
NICU, we developed a low-cost wireless biosensor, which utilized the current 
standard of the internet of things technology (IoT). In this study, we implement a 
wireless biosensor for continuous EEG monitoring in NICU and discuss its 
feasibility. To provide a low-cost EEG device, we embraced Bluetooth and mobile 
phone technology, which is convenient for implementation. We build a two-
channel EEG biosensor, which utilizes Bluetooth to transmit the signal to mobile 
phones. Then, mobile phones use Wi-Fi technology to send data to the server. 
Additionally, we also developed a registry to organize the patient’s EEG data. In 
six months research period, we have 65.8% of patients collected successfully. 
Using 2 channel-biosensor in NCU is feasible. It also develops a neuromedical 
database by collecting and monitoring physiological signals to develop future 
neuromedical research. 
Keywords. Continuous EEG, two-channel biosensor, Neurointensive care unit, 
wearable device 
1. Introduction 
Seizure is a common complication in a neurological intensive care unit (NICU), which 
the incident rate ranges from 3%-45% [1] and it requires continuous 
electroencephalograms (EEG)[2] monitoring. Implementation of EEG for each bed in a 
NICU is very expensive and require labor work for interpretation of EEG. To provide 
an affordable device of EEG in NICU, we developed a low-cost wireless biosensor[3-
4], which utilized the current standard of the internet of things technology (IoT). In this 
study, we implement a wireless biosensor for continuous EEG monitoring in NICU and 
discuss its feasibility. 
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2. Method  
To provide a low-cost EEG device, we embraced Bluetooth and mobile phone 
technology, which is convenient for implementation. We build a two-channel EEG 
biosensor, which utilizes Bluetooth to transmit the signal to mobile phones. Then, 
mobile phones use Wi-Fi technology to send data to the server. Additionally, we also 
developed a registry to organize the patient’s EEG data. 
3. Result 
From April 1, 2019 to September 30, 2019, there were 369 patients and 42 patients 
excluded. After deducting repeat patients, the number of cases was 241. The age ranged 
from 16 to 96 years. The main diagnoses included intracranial hemorrhage (43.9%),?
infarction(24.1%), subdural hemorrhage (15.1%), subarachnoid hemorrhage (14.0%), 
brain tumor (9.2%), aneurysm (8.6%), seizure(6.2%) and epidural hemorrhage (4.3%). 
The male to female ratio was 58.3%:41.7%. We reviewed the EEG data in the database 
and then compared them with nursing records and found that they were consistent with 
the seizure attack time. 
4. Discussion:  
In six months research period, we collected 65.8% of NICU patients successfully. 
Those patients which cannot be collected were due to 1.Network connection (16.2%) 
2.Patient skin irritation (11.9%), 3.Irritable patients (8.1%), 4.Wireless signal(6.5%), 
5.Operation wound (3.2%), 6.Out of battery (1.2%). To improve the above issues, we 
need to design a better server program that can stably pass data. For the skin irritation, 
we try to use some field for skin protection. Irritable patients will be excluded until the 
condition is stable. To enhance the wireless signal, the Bluetooth connective firmware 
needs upgrades and the mobile phone can be closer to the biosensor. The operation 
wound some times would overlapping on where we stick the sensor lead. To prevent 
influenced the treatment and infection, we exclude these cases. The battery wears in 
NICU stronger another place because vapor inhalation treatment is often in NICU. 
During the study period, 7 of the 34 battery circuit boards became rusty. Therefore, the 
development of a waterproof function is an essential topic in the future. 
5. Conclusion 
We can use wireless biosensor to collect continuous EEG and there were 65.8% of 
NICU patients collected successfully. It also develops a database by collecting and 
monitoring physiological signals to develop future neuromedical research. 
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1. Introduction 
Clinical decision support systems (CDSSs) can provide personalized predictions for 
cancer patients, such as overall survival and risk of side-effects associated with different 
treatments. Combined with shared decision-making (SDM), CDSSs can guide treatment 
decisions by supporting data-driven decision-making in line with patient values. Prior 
findings have established the value of SDM and CDSSs in improving care, yet 
implementation remains a significant hurdle due to barriers such as lack of accessibility, 
lack of clarity about the tool’s purpose, time pressure, and poor design.   
The purpose of this study was to explore the potential for implementing a CDSS in 
combination with SDM in the lung cancer trajectory in the Netherlands from the 
perspective of lung cancer specialists.   
2. Methods 
We used a mixed methods design consisting of qualitative interviews with 9 Dutch lung 
cancer specialists (7 pulmonologists and 2 radiation oncologists) and a retrospective 
cohort study on MTB treatment decisions of 257 non-small cell lung cancer (NSCLC) 
stages I-III patients in our clinic. Interview themes included the treatment decision-
making process, clinician views on CDSS and their requirements.   
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In addition, we determined the percentage of lung cancer patients that deviate from 
MTB recommendations and their reasons for deviation. We also compared the treatment 
outcomes and quality of life of deviating patients with those of non-deviating patients 
with chi-square and t-tests respectively.  
3. Results 
The majority (78%) of the clinicians were receptive towards CDSSs overall but cited 
barriers such as lack of trust in current prediction models, lack of validation studies, and 
time pressure. They felt a CDSS would be most valuable during the MTB discussion 
between clinicians rather than in consultations with patients. Current MTB 
recommendations are based on clinician experience, clinical guidelines and patients’ 
WHO performance status, and our cohort study revealed that in 89% of cases these 
recommendations were followed by patients. Indeed, although the specialists were 
supportive of SDM initiatives, the majority felt that it is difficult to practice in lung 
cancer as there is often one ‘best’ treatment option. 
Of the patients who deviated from MTB recommendations, 82.1% did so in order 
to choose a less intensive treatment. We found no significant differences in overall 
survival and toxicity between the two patient groups and a minor increase in quality of 
life in the deviating group. 
4. Discussion 
Our findings have implications for developing and implementing CDSS and SDM in 
lung cancer treatment. First, MTBs are generally characterized by lack of time, failure to 
reach decisions, and failure to take patient preferences into account. Second, clinicians’ 
survival predictions are positively biased and radiation oncologists are limited in their 
ability to predict lung cancer treatment side effects. This contrasts strongly with our 
finding that clinician experience was the primary factor influencing MTB decisions, and 
underlines the need for data-driven CDSS. 
Furthermore, when clinicians are skeptical of CDSSs due to lack of validation 
studies, steps can be taken to involve them in a user-centered design process so that their 
inputs, requirements, and feedback guide CDSS development. Finally, integrating the 
CDSS into the existing workflow is crucial to minimize the additional time required for 
clinicians to fill in patient data. 
5. Conclusion 
There is scope for CDSSs to support decision-making in lung cancer treatment, however 
care must be taken to incorporate these CDSSs into the clinical workflow.  
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Incorporating Tacit Knowledge of Experts 
in the Assessment of Shelters nder 
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Abstract. During disasters, prompt assessment of evacuation centres and 
appropriate measures taken based on the assessment are important for protecting 
local residents’ lives and health. To clarify experts’ tacit knowledge for improving
the management of shelters under disaster, we conducted a questionnaire survey of 
specialists in disaster management to examine the assessment items to which they 
accorded top priority. Our results suggest that specialists give highest priority to the 
number of evacuees, followed by infrastructure and need for medical intervention. 
Identifying their common views on priorities can be the first step towards taking
standard appropriate measures in evacuation centres.
Keywords. disaster management, shelter, Great East Japan Earthquake
1. Introduction
The Great East Japan Earthquake (GEJE) and tsunami on March 11, 2011, caused an 
unprecedented disaster with 15,897 deaths and 2,534 missing persons as of December 
10, 2018 [1]. During the disaster, many people (around 400,000) were evacuated to 
temporary shelters, such as schools, gymnastic halls, and public halls in Northeast Japan. 
Several organized teams cooperating with disaster specialists, various medical 
institutions, and local government officials managed to improve the conditions of the 
shelters [2]. It is important to understand how disaster experts make a decision based on 
the status of a shelter, which would be useful for all potential managers in future disasters. 
Our study aimed to clarify the algorithm through a questionnaire survey.
2. Methods
We conducted a questionnaire survey on 11 disaster management experts who had 
experienced the GEJE in 2011 or the Kumamoto earthquake in 2016. The research
protocol was approved by the Tohoku University Graduate School of Medicine Research
1 Corresponding author: 1-1 Seiryo-machi, Aoba-Ku, Sendai, Miyagi 980-8574, Japan;
E-mail: nakayama@cardio.med.tohoku.ac.jp
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Ethics Committee. The questionnaire comprised two questions, to examine 1) which of 
the 30 assessment items is given top priority and 2) whether a facility accommodating 
100 people (a larger shelter) with medium urgency or a facility accommodating 10 people 
(a small shelter) with greater urgency should be given priority, for each assessment item. 
More respondents favoured the former. Opinions were divided on the importance of the 
number of diseased/injured people. 
3. Results
The number of evacuees received the highest priority, followed by drinking water supply, 
information about diseased or injured people, basic information, number of diseased or 
injured people, electricity, sanitation, and information about people who require 
assistance. Next, to examine whether the priority changes depending on the number of 
evacuees and severity, we asked respondents to consider which they would give priority 
to between a shelter accommodating 100 evacuees (a larger shelter) with medium 
urgency and a shelter accommodating 10 people (a small shelter) with greater urgency 
for each assessment item. Most of them felt that the larger shelter required priority even 
though the smaller shelter was in a more serious situation. Among the 30 items, 
electricity, waterworks, drinking water supply, and food supply were evaluated as 
relatively important.
4. Discussion
Our results suggest that specialists give highest priority to the number of evacuees, 
followed by infrastructure and need for medical intervention. Clarifying specialists’ 
common views on priorities is the first step in identifying standard appropriate measures 
in evacuation centres. The present study has several strengths. First, our results suggest 
that specialists give highest priority to infrastructure and need for medical intervention. 
The study presents the tacit knowledge of specialists who are considerably experienced 
in disaster management. Second, this study also revealed a slightly different priority
based on urgency. This implies that information to evaluate the urgency of shelters is 
crucial at the headquarters when an area is struck by disaster, resulting in shelters needing
support using limited resources of manpower, medicines, food, and water. As advance 
preparation to establish an initial response system and decision-making is critical for 
disaster response management, this study’s findings may be useful in doing so.
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Abstract. This paper presents experiences of integrating assistive robots in Japanese 
nursing care through semi-structured interviews and site observations at three 
nursing homes in Japan during the spring of 2019. The study looked at experiences 
with the robots Paro, Pepper, and Qoobo. The goal was to investigate and evaluate 
the current state of using robots in the nursing care context, firsthand experiences 
with intended and real use, as well as response from the elderly and nursing staff. 
The qualitative analysis results pointed out user satisfaction, adjusted purpose, 
therapeutic and entertaining effects. Potentials of robots to assist in elderly care is 
advantageous. Limitations currently relate to the lack of ways to fully utilized and 
integrate robots.  
Keywords. Assistive Robots, Nursing Care, Human-Robot Interaction (HRI), 
Therapy, Communication, Impact on Care.  
1. Introduction 
According to the United Nations (UN) demographic statistics, Japan’s population 
has decreased since 2009. Japan’s population today (2019) is about 126,800,000, but the 
forecast is that the number will fall to 108,800,000 by 2050 [1]. Moreover, Japan 
currently holds the world’s largest population of elderly per capita with about 27% of 
Japan’s population being 65 years or older. In order to cope with the changing 
demographic, possible solutions are to decrease the need for more human workers 
through innovation and to keep the elderly as independent as possible for longer. 
 
The Japanese government has presented six priority areas where robot technology is 
to be introduced in nursing care, one of them being monitoring and communication 
systems [2]. We visited three different Japanese nursing facilities in order to see how 
robots are being used, what impact they made on the nursing care, and what positive and 
negative experiences the elderly and staff could share. The interviews focused on 
communication robots, being one of the newest items introduced as the government’s 
priority areas whose development has been supported since 2017. 
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2. Methods 
The three nursing facilities were chosen as the study sites from a public list of nursing 
facilities using the robot Paro [3]. The interviews were not limited to Paro exclusively, 
but rather aimed at acquiring information on all interactive robots used at each facility 
(Paro was used at all 3 facilities, Pepper at two, and Qoobo at one). The interviews were 
primarily held with the facilities’ managers and nursing staff in addition to observations 
of patients interacting with robots. The interviews were analyzed using open coding. 
3. Results 
The interviews suggested that these kinds of robots all work with the mind and the mental 
wellbeing of the patients. Patients suffering with dementia often believe Paro to be a dog 
or even a human baby, treating and interacting with it accordingly. Patients often cared 
and worried for Paro, thus indicating an emotional relationship. Interacting with Paro 
evoked memories about their childhood dog or child nursing days. Paro was found 
effective on both male and female patients if they liked animals, but patients that are 
more cognitively capable might find Paro less interesting. The use of robots has also 
depended on the nursing staff attitude. Pepper is used for recreation, entertaining patients 
through games and karaoke. Still, some patients found it loud and annoying. Qoobo was 
mostly used by one patient not interested in people but happy with the robot. 
Discussion 
Robots can be superior to the use of dolls or animals as therapeutic aids should be safe 
and have demonstratable therapeutic effects. Robots like Paro can work as an alternative 
to pet/animal therapy without the risk of allergy, bites, scratches, unpredictability, 
infections or even stress for the animal itself. However, some people dislike certain 
animals which makes them skeptical to animal-type robots as well. Pepper is mostly used 
to entertain, in addition to Taiso, the daily Japanese stretching exercise. However, the 
need for human workers is not eliminated. Ultimately, these robots are used to assist and 
relieve the humans from work overload. Patients, that usually did not smile to the human 
staff, were seen smiling and talking to the robots. Additional positive effects were 
increased interest of groups and often grandchildren to visit the nursing homes.  
Conclusion 
Positive effects were patient satisfaction, joy, and mood changes. On the downside, 
robots are not fully independent and demand staff attention which limits their use. 
References 
[1] https://population.un.org/wpp/Graphs/DemographicProfiles/ 
[2] https://www.meti.go.jp/english/press/2017/1012_002.html 
[3] https://www.daiwahouse.co.jp/robot/paro/map.html 
M. Kolstad et al. / Integrating Socially Assistive Robots into Japanese Nursing Care1324
Introducing Clinical Informatics Course in 
from Medical Faculty University of 
Belgrade 
Jelena MILIN-LAZOVICa, Andja CIRKOVICa, Marko SAVICa, Ognjen 
MILICEVICa, Ljubica CAREVICc, Nikola ILICc, Dejana STANISAVLJEVICa and 
Natasa MILICa,b 
 
aInstitute for Medical Statistics and Informatics, Faculty of Medicine 
University of Belgrade 
bDivision of Nephrology & Hypertension, Mayo Clinic, Rochester, MN, USA 
cCenter for Information and Communication Technologies, Faculty of 
Medicine, University of Belgrade, Belgrade, Serbia, 
Abstract. The healthcare environment in Serbia has changed dramatically 
over a last two decades, pointing out the necessity of clinical informatics (CI) 
education for future MDs. Total of 77 students were enrolled and 72 (93.5%) have 
successfully finished this course during 4 academic years. Mean total score for all 
students was 83.4 ± 9.0 points, without difference between genders. We presented 
blended learning module as an effective way of gaining competences in CI and 
recommend this course to be required for future MDs. 
Keywords. clinical informatics, education, blended learning 
1. Introduction 
The healthcare environment in Serbia has changed dramatically over the last two 
decades, pointing out the necessity of clinical informatics (CI) education for future 
MDs [1]. Therefore, our main goal for development and implementation of clinical 
informatics course was to enable students to better understand the uncertainty of 
medical data, information and knowledge via blended learning mode as effective 
strategy in delivering education [2,3]. 
2. Method 
Clinical informatics was first introduced in 2015/16 as an elective course for 6th 
year medical students of Medical Faculty University of Belgrade. This elective course 
was among 20 proposed, and a minimal number of students had to preselect it in order 
to be enrolled. Curriculum was developed to enable students, future MDs, to 
understand the uncertainty of medical data, information and knowledge. Course 
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materials included four topics and two projects (Figure 1). The blended teaching 
approach combined on-site lectures and interactive multimedia didactic materials 
which were accessed through the Moodle Learning Management System (LMS). 
Course competences were evaluated through projects, quizzes and knowledge test with 
maximum total score of 100. 
 Figure 1. Structure of Clinical informatics Course 
3. Results 
During the past four academic years, 77 medical students chose Clinical informatics as 
an elective subject. Seventy-two (93.5%) successfully finished the course. 
Competences assessment, presented by mean total course score of 83.4 ± 9.0 (for all 
enrolled students), suggested that students adopted knowledge and skills necessary for 
medical decision making in conditions of uncertainty. There were no gender 
differences, as well as no significant changes in scores over a 4-year period.  
4. Conclusion 
Clinical informatics course is an effective way for medical students to gain 
competences needed to better understand the medical data uncertainty. In the era of an 
overwhelming presence of new technologies supporting both learning and health care 
delivery, clinical informatics should become an obligatory course in medical school 
curricula.  
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Abstract. Extracting patient phenotypes from routinely collected health data (such
as Electronic Health Records) requires translating clinically-sound phenotype def-
initions into queries/computations executable on the underlying data sources by
clinical researchers. This requires significant knowledge and skills to deal with het-
erogeneous and often imperfect data. Translations are time-consuming, error-prone
and, most importantly, hard to share and reproduce across different settings. This
paper proposes a knowledge driven framework that (1) decouples the specification
of phenotype semantics from underlying data sources; (2) can automatically popu-
late and conduct phenotype computations on heterogeneous data spaces. We report
preliminary results of deploying this framework on five Scottish health datasets.
Keywords. health data, phenotype computation, data integration, ontology
1. Introduction
Health data in the UK is stored in different local communities, meaning they are main-
tained locally and stored in inconsistent formats and languages. A key technical chal-
lenge haunting almost all clinical studies is to extract or compute accurate patients’ phe-
notypes (traits of symptoms, diseases, medications or biochemistry test results) from
such a fragmented data space. Specifying the computations of a phenotype requires (each
time) significant human effort to understand database details, good data science skills
to do the querying and data manipulating, and caution & patience to deal with data in-
completeness/inconsistencies. Such phenotype specifications can hardly be reused as the
consequence of the heterogeneous data models across jurisdictions. This significantly
impedes the reusability and reproducibility of clinical researches.
2. Method
The main aim of this study is to realise a clinical data science framework [1] that makes
the underlying data sources transparent to phenotype computations. The key is to decou-
ple the formalisation of phenotype semantics and the technical details of underlying data
sources. We propose an architecture to implement such a decoupling, which is composed
of the following two aspects.
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Phenotype?Formalisation?Framework? This?has? three?components:? (1)?A?database? in-
dependent?phenotype?formalisation?using?Semantic?Web?knowledge?representation?tech-
nologies? to?define?phenotype?semantics;?(2)?A?core?phenotype?ontology?serving?as? the?
base?vocabulary? linking? to?standard?clinical? terminologies?available?at?BioPortal? (e.g.,?
SNOMED?CT,?ICD10);?(3)?A?query?formatter?that?generates?ontology?queries?from?an?
user?interface.?The?formatter?can?automatically?translate?phenotype?definitions?between?
standard?terminologies?(e.g.,?READ?to?SNOMED?CT).
Ontology?Based?&?Rule?Driven?Data?Access? To?automatically?compute?the?above?for-
malised?phenotypes?on?actual?data,?we?adopt?ontology?based?data?access?(OBDA)?tech-
niques?[2]?but?with?a?novel?extension?to?support?rules.?Such?an?extension?is?necessary?be-
cause?the?semantics?of?most?phenotypes?are?not?fixed.?They?either?change?with?research?
focuses?or?different?researchers?might?have?different?opinions?about?certain?rules?related?
to?a?phenotype.?For? this?reason,? in?our?framework,?we?minimise? the?ontology.?Instead,?
a?rule?engine? is? implemented? to?allow?flexible?definitions?of?phenotypes.?The? engine?
can?automatically?convert?user? specified? rules? into?new?data?mappings,?which?will?be?
translated?on?the?fly?to?do?phenotype?computations?on?databases.
3.? Deployment?and?Evaluation
This?study?was?supported?by?Health?Data?Research?UK?(https://www.hdruk.ac.uk/
projects/graph-based-data-federation-for-healthcare-data-science/)?
and? the?Medical?Research?Council? [grant? number?MC?PC?18029]? as? an? exemplar? to?
create?a? federation?of?distributed?health?data? in?Scotland.?The?above?described? frame-
work? has? been? deployed? on? 5? synthetic? data? sets? generated? using? BadMedicine? [3],?
which? represents?data/schema? characteristics? learnt? from? real?data.?Due? to? space? lim-
itations,?we?put? the? full?benchmark? and? evaluation?details?on? a?Github?page:?https:?
//github.com/Honghan/KGPhenotyping/tree/master/evaluation.
4.? Conclusion
To?overcome?obscure?phenotype?computation,?which?makes?experiments?difficult?to?un-
derstand? and? reproduce,?we?developed? a?new? framework? to? allow? clinical? researchers?
to?formalise?phenotype?semantics?independently?to?the?data?and,?more?importantly,?in?a?
computer?understandable?way?so? that? its?computation?can?be?automated?on? the?under-
lying?data?sources.?We?implemented?a?knowledge-driven?(based?on?ontologies?and?rule?
languages)?approach?to?define?an?interlingua?in?which?practitioners?can?represent?the?phe-
notype?semantics?they?want?to?use?and?automatically?translates?this?to?computations?as?
database?queries?on?participating?data?sources.
References
[1] Knowledge Driven Phenotyping - an open source Github repository for computing phenotypes across
heterogeneous datasets: https://github.com/Honghan/KGPhenotyping.
[2] Xiao, G., Calvanese, D., Kontchakov, R., Lembo, D., Poggi, A., Rosati, R. and Zakharyaschev, M., 2018,
July. Ontology-based data access: A survey. IJCAI.
[3] BadMedicine - a synthetic Scottish health data generator: https://github.com/HicServices/BadMedicine
H. Wu et al. / Knowledge Driven Phenotyping1328
Limits and Variability in Drug Databases: 
Jean-Baptiste LAMYa,1, Hélène BERTHELOTa, Madeleine FAVREb,c,Rosy 
TSOPRAd,e 
a
 LIMICS, Université Paris 13, Inserm, Sorbonne Université, 93017 Bobigny, France 
b
 Dept. of primary care, Université Paris Descartes, Paris, France 
c
 Société de Formation Thérapeutique du Généraliste (SFTG), Paris, France 
dINSERM U1138 Team22 Information Science to Support Personalized Medicine,Paris 
eLTSI Université-Rennes 1 Team Health Big Data, Rennes 
Abstract. Several drug databases exist, but sometimes differ in their content. Here, 
we propose a taxonomy of the variability we observed, and we present a tool for 
investigating the variability through the visual comparison of the properties of a 
given drug as represented in several sources or databases. 
Keywords. Drug databases, Computer Graphics, Nonverbal Communication 
1. Introduction 
It is known that drug databases suffer from many discrepancies, both intra- and inter-
databases. In a recent project named VIIIP (Integrated Visualization of Information on 
Pharmaceutical Innovation) [2], we aimed at comparing new drugs to the older ones 
with the same indication, on the basis of their properties. We planned to extract these 
properties from drug databases. However, we encountered many problems related to 
the quality and the structure of these databases, which impaired the project. 
2. Methods 
We compared the 4 drug database available in France, a Natural Language Processing 
(NLP) tool [3], and a manual coding by an expert pharmacist (HB), for 10 drug. We 
used ICD10 and MedDRA terminologies. We analyzed the differences between sources 
and built a taxonomy of variability. We also used rainbow boxes, a set visualization 
technique [1] that was initially designed for comparing similar drugs [2]. We adapted it 
for comparing the properties of the same drug, described by 6 sources. 
3. Results and discussion 
We identified 3 main causes of variability in drug knowledge: 
1) Differences in the writing of SPCs: when two drugs share a common property, it 
might be described differently in their SPCs. It includes: 1a) Variability in the 
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presentation of the SPC, e.g. plain text and/or table; 1b) Variability in the file format, 
e.g. PDF vs HTML; 1c) Variability in the wording; 1d) Variability in the level of 
granularity (e.g. “liver injury” vs a list of 10 conditions that are the 10 most common 
liver injuries). 
2) Differences in the drug databases: each database has its own structure and 
editorial practice. It includes: 2a) Missing information (e.g. seriousness of adverse 
effects); 2b) Structural limitation, when the desired information is present but not 
structured or coded (e.g. information available in free text only); 2c) Poor information 
quality; 2d) Heterogeneous coding, when the same information is coded differently for 
various drugs. 
3) Each drug database employs several experts, having their own coding practice. 
Figure 1 shows the variability found at level #2. Sources are shown in columns and 
ordered by similarity. Rectangular boxes indicate the adverse effects. Boxes that span 
over several columns represent adverse effects present in several sources. Box colors 
indicate the frequency of the adverse effects, from rare (yellow) to frequent (orange). 
In conclusion, it appears that drug databases are designed for providing 
information on a single drug, but not for comparing two or more drugs. 
Funding: This work was partly supported by the French drug agency (ANSM) 
through the VIIIP project (AAP-2012-013). 
 
 
Figure 1. Rainbow boxes comparing the adverse effects of Cialis® from 6 sources. 
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Abstract. The growing amount of available public data repositories containing a 
plethora of rich chemical and biomedical information is enabling new in silico 
research avenues. In this project we aim to link human genome variations and the 
exposome applying in silico biomedical informatics approaches to analyse the 
potential effects of those variants in the interactions with different chemicals. 
Keywords. Translational bioinformatics, Protein modelling, exposome, single 
nucleotide variant, toxicogenomics. 
1. Introduction 
Nowadays, human societies are living in an environment where individuals are exposed 
to an increasing number of xenobiotic chemicals. The acknowledgment of the 
importance of these and other exposures led to the development of the concept of the 
exposome defined as the whole set of exposures of an individual (including, chemical, 
biological, physical or and social exposures) [1]. The exposome could affect the human 
phenotype along with the genome and therefore its understanding could be important in 
the development of precision medicine. 
Two decades ago, toxicogenomics was developed combining toxicology with 
genomics and post-genomics approaches to study the effects of the exposures to 
chemicals and chemical toxicants. Biomedical informatics has played a key role in this 
discipline, providing tools and methods to analyse, store and integrate the results from 
these “omics” techniques. More recently, the development of modelling and simulation 
tools and methods designed to predict the potential interactions of newly designed 
chemicals with biological targets (mostly hormone and other cellular receptors) has been 
another important area of development. Toxicogenomics can be considered as the 
toxicological relative of pharmacogenomics. An important area of research in the latter 
is the analysis of the effects of the genetic variants in the response to different drugs, and 
this has led to different applications and biomedical informatics resources. The analysis 
                                                          
 1 Corresponding Author, Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University 
Belfast, 97 Lisburn road, Belfast, BT9 7BL, United Kingdom; E-mail: g.lopezcampos@qub.ac.uk.  
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of individual genetic variation is an aspect that has not been explored in detail in the area 
of toxicogenomics. Therefore, in this work we propose the development of a 
computational analytical pipeline designed to integrate the increasing amounts of 
information related with human genetic variation and the chemical component of the 
exposome analyzing the effects of different coding variants in the interactions with 
chemical compounds. 
 
2. Methods and Results 
As a proof of concept for our approach we have chosen to analyse the effects of the 
different coding genetic variants in the human Estrogen Receptor 1 (ESR1) and how 
those would affect the interactions with bisphenol-A (BPA), a chemical compound 
known to link with ESR1 and a potential endocrine disruptor due to its actions as a xeno-
estrogen. 
For the analyses we selected the wild type (WT) sequence and five single nucleotide 
variants (SNV) (R269C, R269H, M315V, E330K and R477Q) in the ESR1 gene. These 
variants were chosen as they were condign variants, they were not known to be 
pathogenic, were not located in the catalytic/binding site of the protein and had some of 
the higher minor allele frequencies for the variants in this gene. 
We first used I-Tasser [2] to predict the ESR1 structure beyond the resolved region 
available and then we modelled our five variants using SCWRL [3].  Finally, we used 
those models to simulate the protein/ligand docking and calculate the binding affinities 
for BPA and estradiol for each of the five mutants and the wild type structures using 
CANDOCK [4]. As expected the results showed (table 1) that there was a higher affinity 
in this case for the natural ligand (estradiol) than for the xenobiotic (BPA) as well as that 
the effect in the reduction of the binding activity was more intense for the natural ligand 
than for BPA in all the analysed variants.  
Table 1. Table showing the binding affinities (Kcal) for the wild type and the five variants analysed.  
 Wild type R269C R269H M315V E330K R477Q 
Estradiol -64.2911 -48.8941 -48.8198 -46.3230 -50.8965 -47.6796 
BPA -47.4722 -36.5059 -39.6272 -41.1594 -39.5739 -41.2424 
With this approach we brought together genomics and exposomics applying in silico 
approaches. This strategy can be extended for the analyses of other targets and variants 
for the different chemicals to which individuals are exposed daily  
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Abstract. This is an exploratory study on different variables known to be associated 
with epidemiological outbreaks of lower respiratory tract infections in children 
under 2 years raised to identify patterns and potential predictors for making strategic 
decisions in terms of strengthening health teams in periods of greatest demand. 
Keywords. Electronic Health Record, lower respiratory tract infection, weather, 
Google search. 
1. Introduction 
Lower respiratory tract infections (LRTI) are one of the most frequent causes of 
medical consultation, hospital admission and mortality in children with a very marked 
seasonal incidence [1]. These characteristics determine healthcare systems to be 
overloaded at the times of the year with higher demand for this group of pathologies. 
This is an exploratory study on different variables known to be associated with 
epidemiological outbreaks of LRTI in children under 2 years [2], [3] raised to identify 
patterns and potential predictors for making strategic decisions in terms of strengthening 
health teams in periods of greatest demand. 
2. Methodology 
We analyzed the proportion of LRTI consultations and hospital admissions for all 
causes in patients under 2 years, climatological variables (air temperature, humidity and 
atmospheric pressure) and Google search trends on respiratory symptoms keywords. 
Data of consultations were extracted from the EHR of the public health system of the 
City of Buenos Aires. Consultations related to LRTI were detected using a rule-based 
algorithm validated using as gold standard the manual review of the medical records 
(precision 85.96%, recall 82.35%, F1 score 84.12%). Hospital admissions data were 
extracted from an administrative database of all the hospitals of the public health network 
of the City of Buenos Aires and we included admissions for all causes due to many 
missing data about the cause of admission (35.5% of missing data). The information 
related to Google searches included the terms "cough", "bronchiolitis" and "flu" in 
Spanish (pediatrician experts selected them as main terms used by parents as cause of 
consultation) and the average relative popularity of these terms was calculated. We 
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analyzed weekly averages or accumulated totals since 2017-01-01 to 09-30-2019 to 
assess seasonal trends and the relationships between them. 
3. Results 
We found a very strong relationship between air temperature (Spearman´s rank 
correlation coefficient -0.89, p<0,001) and Google search trends (ρ 0.89, p<0,001) with 
the proportion of medical consultations for LRTI (figure 1). It is interesting that the LRTI 
consultation curve rises rapidly in the first weeks in which the temperature begins to fall. 
Google searches do not seem to have a pattern that allows for predictive analysis. Weaker 
relationship was found with hospital admissions (ρ 0.44, p<0,001), atmospheric pressure 
(ρ 0.62, p<0,001) and humidity (ρ 0.40, p<0,001).  
 
Figure 1. Relationship between air temperature and Google search trends with the proportion of medical 
consultations for LRTI. 
4. Conclusions 
This is a novel study about climatological variables and clinical information using 
the EHR in the City of Buenos Aires. Further investigation should be made in order to 
make informed decisions regarding strategies to strengthen the health care systems in 
times of greatest demand. Air temperature seems to be the most important factor that 
could predict new outbreaks of LRTI. 
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Abstract. A lexical method was used to map ICD-11 to the terminologies included 
in the HeTOP server. About half of ICD-11 codes (47.76%) were mapped to at least 
one concept. The developed tool reached a global precision of 0.98 and a recall of 
0.66. Lexical methods are powerful methods to map health terminologies. 
Supervised and manual mapping is still necessary to complete the mapping. 
 
Keywords. Terminology mapping; Semantics; Terminology as topic; Unified 
Medical Language System; Vocabulary, controlled 
1. Introduction 
The International Classification of Diseases (ICD) version 111 is a major revision of 
the ICD-10 which is widely used to code diagnoses in healthcare systems. Furthermore, 
the purpose of the Unified Medical Language System® (UMLS) [1] is to facilitate the 
development of computer systems that behave as if they "understand" the meaning of 
the health language. The process of terminology mapping consists of identifying 
identical (or approximately identical) concepts or relationships between terminologies 
[2]. Since 2007, the Rouen University Hospital (RUH) Department of Biomedical 
Informatics (DBI) has developed the HeTOP cross-lingual health termino-ontology 
server [3], which includes 75 terminologies (or ontologies) in 32 languages2.  
The objective of this work is to propose a mapping of ICD-11 to the UMLS 
Metathesaurus and to French terminologies which are not (yet) included in the UMLS.  
2. Methods 
French natural language processing tools and mapping algorithms were developed by 
the RUH DBI team to map health terminologies in French. These tools were used in 
previous works [3][5] and extended to link terms in multiple French health 
terminologies. This approach allows from a given term, to find a HeTOP concept with 
French (or English) terms that are most lexically similar to it.  
                                                          
1WHO International Classification of Diseases, 11th Revision (ICD-11); 
https://www.who.int/classifications/icd/en/ (Accessed September 5, 2019). 
2 https://www.hetop.eu/ 
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3. Results 
The RUH DBI automatic mapping tool has generated 144,823 ICD-11 mappings to the 
75 terminologies integrated into HeTOP. Concerning mappings between ICD-11 and 
ICD-10, WHO has manually provided 12,767, whereas RUH DBI has provided 6,925. 
The intersection between WHO and RUH DBI is 3,492 mappings (respectively 27.35% 
and 50.43%). This French automatic mapping tool has provided at least one mapping 
for 28,521 ICD-11 distinct codes (using their preferred labels and its synonyms and 
acronyms) among 59,709 ICD-11 codes (47.76%). The Top 6 terminologies with the 
most mappings to ICD-11 are SNOMED CT, MeSH and NCIT, which is coherent with 
the size of these terminologies and their translations as well as their main objectives, 
respectively 326,927 (201,659 in French), 378,024 (including the MeSH concepts; 
105,933 in French) and 148,215 (79,409 in French). Among the 144,823 automatic 
mappings from ICD-11 to the 75 terminologies integrated into HeTOP, 2,371 were 
manually supervised by one expert (SJD), using six relations types: EM (exact match), 
BTNT (broader than), NTBT (narrower than), RT (related), unknown and false. The 
total number of distinct ICD-11 codes manually curated was 464 (mean mappings 
number of 5.1 per code). 82% of these automatic mappings were validated in exact 
match. 15% were evaluated as “close” mappings (i.e. BTNT, NTBT, RT). Only 46 
mappings (2%) were evaluated as false. Furthermore, among the 464 ICD-11 curated 
codes, 183 have no mappings to any HeTOP concept. On the other hand, the expert 
manually added new mappings to 26 distinct ICD-11 codes without any automatic 
mappings. Thus the false negative rate is estimated to 26/(183+26)=12.4%. 1,226 new 
mappings from transitive closure were also added whose 154 automatically validated as 
Exact Match. Those figures allow an estimation of the recall: 
2,371/(2,371+1,226)=65.92%.  
4. Discussion and conclusion 
To the best of our knowledge, this is the first study to map the entire ICD-11 
classification to terminologies in French. The quality of these mappings can be 
considered as very good, as 82% were evaluated as an “exact match”, and only 2% are 
false. However, the cover of such tool is relatively low (47.76% of all ICD-11 codes) 
as many labels are too precise or not based on a state-of-the-art terminological method. 
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Abstract. Correct patient identification is the cornerstone for the proper 
implementation of electronic health records. Up to 20% of the registered patients 
are duplicated in most systems. Strong identification policies and robust systems 
can minimize such errors. In this poster we share the Ministry of Health 
recommendations for the Master Patient Index improvement using search 
algorithms.  
Keywords. Master Patient Index, Electronic Health Records, Soundex, 
Levenshtein, Patient Search Identification Service 
1. Introduction 
One of the most serious problems for Master Patient Index (MPI) is duplication of 
data[1]. Conventional database systems generally use deterministic searches to find 
document numbers or patient names, leading to mistakes. When the person responsible 
for entering data in the MPI is unable to find the patient, she will reenter the 
information, thus creating a duplicate patient. Duplicated patients in the MPI poses the 
risk of the loss of data due to the fragmentation of information [4]. It is important to 
use Patient Search Identification Service (PSIS) to avoid these types of mistakes. By 
using algorithms for a probabilistic search with multiple data (name, surname, 
birthdate, id type and number, gender), it is possible to identify suitable candidate 
patients by a group of similar data[2]. PSIS allows us to identify potential similar 
candidates and provides significant advantages over conventional searches [3]  keeping 
the MPI clean.  
2. Materials and Methods 
For our Model of PSIS we use a minimum set of patient data composed of six data 
points that are: Surname (first and following), Name (first and middle), Gender, 
Document Type, Document Number and Birthdate. We apply two combined 
algorithms, the first being phonetic (Soundex), the other comparative (Levenshtein). 
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PSIS makes the first search for candidates by using Soundex and the second level by 
the distance of Levenshtein’s algorithm and that allows us to find the patients 
candidates files, see figure 1 
The variables that consider are the relative weight V, the distance of Levenshtein 
and the length of the text of the candidate L. The coefficient F is calculated with the 
formula F = (L-D) / L and finally, the value of each variable is obtained by multiplying 
the weight V by the coefficient F. The sum of the 6 variables gives us the probability 
that the candidate is the wanted one, in this case, 73.75%. See figure 2 
3. Results 
In order to prove the advantages of the PSIS we compared the Traditional Database 
Search (TDS) with PSIS. Results showed that the PSIS we built was a substantial help.  
PSIS allows us to detect 350 duplications in an MPI that had 50.000 patients, compared 
to TDS detecting only 50 duplications. 
4. Discussion 
The PSIS significantly improves the discovery of duplicates in an MPI compared to 
that of TDS. PSIS searches identify 88% more duplicate candidates than those found in 
TDS. 
5. Conclusion 
If we make a mistake in the document number by a single digit, using conventional 
searches (TDS), the patients cannot be found. Using the Levenshtein distance algorithm 
allows us to identify that the number is very similar to the one searched often indicating 
a simple human error in data entry. 
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Abstract. Near-real time feedback on data quality allows clinicians and data 
managers at general practices to collectively contribute to improving the reliability 
of observational data. We report features of an enhanced dashboard used for 
virological surveillance after the first season of utilisation. Time-series analysis 
performed on dashboard usage data from 68 general practices (denominator = 
722,409) indicated utilisation patterns that correlated to influenza vaccination in 
general practices.  Near real time feedback via a dashboard may improve data quality 
and possibly vaccine uptake. 
1. Introduction 
Influenza contributes significantly to the burden of disease morbidity and mortality 
worldwide[1]. Virological surveillance helps identify the predominant strain in 
circulation; it also provides an understanding of the pattern of disease transmission and 
planning towards pandemic preparedness. We report enhancements made to the Royal 
College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) 
virological surveillance dashboard and usage analysis after its first use in surveillance 
activities during a complete influenza season (2018/2019) [2].  
2. Methods 
We obtained data for the dashboard from the RCGP RSC database which includes 
pseudonymised health care records of individuals registered with general practice 
network in England (68 practices that participated in the virology swabbing scheme with 
an overall denominator of 722,409) [3].  These practices provided nasal and 
nasopharyngeal swabs for confirming influenza within a laboratory setting. We enhanced 
the dashboard for the 2018/2019 influenza season by adding comparative assessment 
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episode type recording customised for each given practice. We carried out time-series 
modelling on the dashboard data (from July 2018 to March 2019) using the R statistical 
package (version 3.6.1) and compared with seasonal influenza and flu vaccination trends.  
3. Results 
The participating general practices accessed the dashboard particularly between October 
2019 and March 2020 which is the peak of the flu season. General practices typically 
start conducting flu clinics at the beginning of October (in any given year) and are held 
weekly for about 8 weeks. We observed a peak in dashboard access following the initial 
flu vaccination campaign and a 2nd peak in dashboard access soon after the increase of 
Influenza-like (ILI) incidence at the beginning of January 2019. Results of the Granger 
causality test indicated that there is evidence that after controlling for the lagged effects 
of flu vaccination counts, lagged visits carry predictive power (p<0.001) for flu 
vaccinations. There is no evidence that the same applies between ILI counts and visits.  
 
4. Discussion 
Trend analysis may explain the periods when dashboard utilisation increases across the 
sentinel network.  The results indicate that dashboard use increases shortly after influenza 
vaccination campaigns with the peak seen during influenza circulation not being 
statistically associated.   
5. Conclusion 
Findings of this study together with feedback from user surveys helps the RCGP RSC to 
understand the peaks of dashboard use, and which areas of the dashboard have more user 
engagement that could benefit from further development. Dashboard feedback may have 
a role in improving data quality and prompting vaccine administration.  
 
References 
[1] L.C. Ramsay et al. , S.A. Buchan, R.G. Stirling, B.J. Cowling, S. Feng, J.C. Kwong, and B.F. 
Warshawsky, The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review 
and meta-analysis, BMC Med. 17 (2019) 9. 
[2] S. Pathirannehelage et al., Uptake of a Dashboard Designed to Give Realtime Feedback to a Sentinel 
Network About Key Data Required for Influenza Vaccine Effectiveness Studies, Stud Heal. Technol Inf. 
247 (2018) 161–165. 
[3] A. Correa et al., Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) 
sentinel network: a cohort profile, BMJ Open 6 (2016) e011092. 
 
H. Liyanage et al. / Near Real Time Feedback of Seasonal Influenza Vaccination1340
Neural Networks for Cause of 
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Abstract. Determining the cause of death of hospitalized patients with 
cardiovascular disease is of the utmost importance. This is usually recorded in free 
text form. In this study we aimed to develop a series of supervised natural language 
processing algorithms to extract cardiovascular causes of hospitalization and final 
causes of death. 
Keywords. Natural language processing, discharge summaries 
1. Introduction 
Determining the cause of death of hospitalized patients with cardiovascular disease is of 
the utmost importance in order to take measures and thus improve the quality of care of 
these patients and prevent preventable deaths. Even though hospitalization causes and 
final causes of death can be recorded in structured form within electronic medical records 
(EMR), they are usually entered in free text form inside discharge summaries[1]. In this 
study we aimed to develop a series of supervised natural language processing algorithms 
in order to extract cardiovascular causes of hospitalization and final causes of death. 
2. Methods 
We manually reviewed a random sample of 6161 discharge summaries of patients who 
died between January 1st, 2005 and December 31st, 2016 at Hospital Italiano de Buenos 
Aires, Argentina. All annotations were carried out by one family physician. Patients’ 
cause of hospitalization was initially classified as cardiovascular causes vs non-
cardiovascular. Cardiovascular causes were further classified into ICD-10 codes. These 
comprised 21.3% (n = 1316) of the total sample. We defined three classification tasks: 
two related to cause of hospitalization (cardiovascular vs non-cardiovascular; specific 
type of cardiovascular cause) and one related to final cause of death. Causes of 
hospitalization were annotated as cardiovascular vs non-cardiovascular and then as 
ischemic cardiac diseases, cerebrovascular diseases and other causes. Final causes of 
death were classified in six categories namely, cardiogenic/hypovolemic shock, septic 
shock, cerebrovascular diseases, renal failure, malignant neoplasms and other causes. 
The sample was randomly split into training (80%), validation (10%) and test sets (10%). 
We then trained three different algorithms for the three classification tasks and evaluated 
their performance on the test set. For the three algorithms different architectures were 
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tested (Support vector machines, logistic regression, k-nearest neighbors, XGBoost, 
Random Forests, C5.0, GBM and different neural network architectures. For the three 
cases, neural networks showed the best results in the validation set. The final architecture 
consisted of a bi-directional long-short-term-memory recurrent neural network with 
attention mechanism, with two stacked dense layers. Words were represented using 
FastText word vectors. 
3. Results 
For the first classification task (algorithm 1), the performance on the test set resulted in 
an accuracy of 0.9546 (95% CI 0.9351, 0.9696), Recall of 0.979, Precision of 0.9225 and 
F1-score of 0.895. Table 1 shows the individual metrics per category for the second and 
third algorithms. 
 
Table 1. Performance of the second and third algorithms on the test set. 
Algorithm 2 
 Ischemic cardiac 
diseases (I20-25) 
Cerebrovascular diseases 
(I60-I69) 
Other cardiovascular 
causes 
Recall 0.67 0.967 1 
Precision 1 1 0.9 
F1-score 0.815 0.96 0.95 
Algorithm 3 
 Cardiogenic 
hypovolemic 
shock  
(R57.0/R57.1) 
Septic 
shock 
(R57.2) 
Cerebrovascular 
diseases  
(I60 - I69) 
Renal 
failure 
(N17-
N19) 
Malignant 
neoplasms 
(C00-C97) 
Other 
causes 
Recall 0.94 0.47 0.76 0 - 0 
Precision 0.79 1 0.59 - - - 
F1-score 0.86 0.64 0.66 - - - 
4. Discussion 
Even in this low sample size scenario, neural networks outperformed classical machine 
learning algorithms for text classification. Nevertheless, performance dropped 
significantly as the sample size was reduce for algorithms 2 and 3 and also as the number 
of classification categories increased. 
5. Conclusions 
We developed three NLP algorithms for information extraction regarding cause of 
hospitalization and final cause of death from discharge summaries. 
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Numerical Analysis of Conventional Air 
Pollutants and PM10 Concentration Affected 
to Respiratory Disease Patients in Bangkok, 
Thailand 
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Abstract. Ambient air pollution is a major cause of death and disease globally. The 
linear regression between respiratory disease patients, PM10 and other criteria 
pollutants were used in this study. Among respiratory disease patients and CO was 
statistically significant with P-value of <0.01 (r=0.198, 95% CI=48.74 - 288.16). As 
for respiratory disease patients and NOx was statistically significant with P-value of 
<0.01 (r=0.190, 95% CI=1379.74 – 9241.43).     
Keywords. Air pollutants, PM10, Respiratory disease    
1. Introduction 
Air pollution kills an estimated 7 million people worldwide every year. Air pollution 
resulting from traffic is a major problem in many cities in Asia, including Bangkok, 
Thailand. This pollution originates mainly from incomplete fossil fuel combustion, 
transportation, and construction (Ruchirawat et al, 2007). The concept of this study is 
utilizing the data obtained from the current conventional air monitoring station in 
Bangkok to analyze conventional air pollutants and PM10 concentrations affected 
respiratory disease patients in this area. 
2. Data analysis and Method 
2?1??Data collection and Analysis 
The air monitoring data used in this study were from Jan 2013 to Dec 2018. Conventional 
air pollutants and PM10 were monitored at 3 monitoring sites in The Bangkok 
Metropolitan area. The data of respiratory disease patients in this study from Jan 2013 to 
Dec 2018. The respiratory disease was bronchitis, emphysema, chronic obstructive 
pulmonary disease, and asthma. This study was collected from 3 hospitals. The 
correlation coefficient and linear regression analysis were used to determine a potential 
correlation between conventional air pollutants and PM10 concentrations and number of 
respiratory diseases patients. Independent variables were conventional air pollutants and 
PM10 concentrations. The dependent variable was respiratory disease patients.? 
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3. Results and Discussions 
3.1. Diurnal variation of PM10 concentration and respiratory disease patients 
The concentration of  PM10 shows a similar type of variation as a decrease from May to 
Sep an increase from Oct to Dec and Jan to Apr of each year. This is probably because 
of  the  enhance  emission  from  traffic  and  seasonal  variation  (Aurangojeb  M.,  2011).
The  number of respiratory disease patient’s tendencies increase from  Jan 2013 to Dec 
2018.  The number of respiratory disease patient’s tendency decrease from Jan 2013 to 
Apr  2017  after  that  increase  to Dec  2018.  The concentration of  PM10 shows a similar 
type of variation as a decrease from May to Sep an increase from Oct to Dec and Jan to 
Apr of each year. The number of respiratory disease patients slightly varies from Jan 
2013 to Dec 2018. After the government of Thailand has taken various roles to mobilize 
its resources for haze management in the second stage from 2011 to 2019. ? 
3?2??The correlation coefficient and linear regression analysis 
The Pearson’s product moment correlation coefficient (r) was used to determine the 
strength of association between a pair of variables, to test the relationship between these 
variables and to test whether the association is greater than could be expected by chance 
(Rummasak T., 2019). Among respiratory disease patients and CO was statistically 
significant with P-value of <0.01 (r=0.198, 95% CI=48.74 - 288.16). As for respiratory 
disease patients and NOx was statistically significant with P-value of <0.01 (r=0.190, 
95% CI=1379.74 – 9241.43) presented in Table 1. 
Table 1??Linear regression analysis of respiratory disease patients, PM10 and other criteria pollutants 
 
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
 
 
t 
 
 
Sig? 
95?0??Confidence 
Interval for B 
 
B 
Std??
Error 
 
Beta 
Lower 
Bound 
Upper 
Bound 
2????Constant? 366?33 110?14  3?326 ?001 149?22 583?45 
CO 168?45 60?73 ?198 2?774 ?006 48?74 288?16 
NOx 5310?59 1994?17 ?190 2?663 ?008 1379?74 9241?43 
4. Conclusions 
The concentration of PM10 shows a decrease from May to Sep an increase from Oct to 
Dec and Jan to Apr of each year. The number of respiratory disease patient’s tendency 
decrease from Jan 2013 to Apr 2017 after that increase to Dec 2018. The linear regression 
between respiratory disease patients, PM10 and other criteria pollutants were used in this 
study. Among respiratory disease patients and CO, respiratory disease patients and NOx 
were statistically significant. 
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Abstract. By the implementation of the EMR in the Primary Care Centers 
of the City of Buenos Aires, it has been claimed that there is a need to obtain 
systematic and accurate information about   the assessment that patients have 
about such incorporation. A qualitative research has been carried out in order to 
answer this query. 
Keywords. Doctor-patient relationships; Electronic medical records; paper 
health record. 
Introduction
The Health Information Systems Office at the Buenos Aires City health ministry EMR
launched the implementation of the EMR in the First level of Health Care in 2016. This 
comprises 44 primary care health centers (PCHC). In this context, we have recognized 
the need to obtain systematized and accurate information about patients’ experience
during the transition from the paper health record (PHR) to the EMR.
Methods
We conducted a qualitative exploratory study. We used semi-structured interviews of a 
convenience sample of patients. The participants selected were men and women over 18 
years of age who at least once had been treated in a center where the EMR had been 
implemented. Three PCHC were selected as these were the first to implement the EMR.
Interviews were audio-recorded and transcribed verbatim. The dimensions were 
extracted into a database table and categories were created depending on similarity and 
repetition among relevant segments to approach the problem.
Main outcomes
We interviewed 29 patients. The sample was divided based on age: “Young” (18<30); 
“Adult” (30<60); “Older Adult” (60<). Most of the interviewees considered that the 
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EMR is the same or better than the PHR. In relation to EMR’s attributes, they 
highlighted: practicality, exhaustiveness, speed, and the possibility of being in the 
network. As to the effects of the EMR implementation on the medical visit, they 
considered that it represents a substantial help to the professional. It also avoids repetition 
of information and allows for focusing directly on the reason for the medical visit, 
providing an integral view of the patient. With respect to the PHR, interviewees 
considered that the process involved in the PHR was more tedious or slower. It can be 
observed that the EMR prevails over the PHR. Nevertheless, patients in the three age 
groups insisted on the importance of having an updated backup copy in paper. Patients 
had a positive opinion towards health professionals’ advanced use and skills of the EMR.
They believe that health professionals are satisfied with the EMR implementation and 
that the time required to register information into the EMR is reasonable. As for the 
young and the adult groups, it can be observed that there is an interest in sharing the 
screen with the professional in order to help register the information. Instead, the older 
adults’ group stated that they do not find it necessary to see the screen as they “trust” in 
the professional. As emerging topics, the interest of young people in the possibility of 
reprinting lost prescriptions or vaccination certificates appeared; at the same time, they 
showed interest in having access to the EMR at home.
Discussion
Most of the interviewees viewed that the EMR is the same as the PHR while others 
considered that the former is better. This result led us to infer that the EMR
implementation has not been experienced as an interruption or breakdown in the 
attention, but instead as a continuity of their health care. As can be seen from the results, 
patients consider that professionals have a positive assessment on the EMR and that they 
master this new system.  As other studies reveal, the professional’s positive attitude 
towards the use of the EMR can impact on the patient’s assessment and experience [1]. 
The sample was divided based on age because the team considered that 
differentiation could directly influence on the naturalization of digital devices to daily 
life. In effect, the results obtained in relation to the young people would lead to think in 
new user generations of the health system with an active position and willingness to gain 
more participation. Unlike that perspective, within older adults, it prevails the idea that 
the doctor represents a figure of power and authority that hinders the possibility of 
thinking in a method of cooperative and symmetric attention.
Conclusion
Patients generally express a positive or neutral perception of the EMR. There are not 
elements to infer a loss of continuity of care. 
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Abstract. Personal Health Record (PHR) is not just the collection of personal health 
data but also a personal healthcare and disease management tool for the individual 
patient as well as a communication tool with the medical staff. Moreover, recently 
PHR has been considered an indispensable tool for patient engagement in the area 
of non-communicable diseases (NCDs) and has gained importance. Like many other 
developing countries, the growth of NCDs is very high in Bangladesh. Portable 
Health Clinic (PHC) system has been developed there with a focus on NCDs and 
PHR is there from the beginning. This study for the standardization of PHR system 
of PHC with the reference of the PHR proposed by Japanese Clinical Societies could 
be a reference work for the national PHR system development in the country.  
Keywords. Personal Health Record, Portable Health Clinic, Standardization 
1. Introduction 
Personal Health Record (PHR) has been getting popular as an important supportive tool for 
providing better healthcare service by the medical professionals. These days there are many 
applications for smartphones that help to manage personal clinical data about NCDs 
generated in clinics and drugs dispensed by pharmacies. This is the simplest form of PHR. 
However, a standard PHR system is expected to manage information regarding an 
individual’s vital signs, physical exercise, behavior, and location at home or at the office 
using built-in sensors in the smartphone or using sensor networks based on internet of 
things (IoT) technology. Patient will have access to monitor this personal health/medical 
data and express personal opinion for the progress of the treatment. This helps the physician 
to be confident to change the policy and to intervene [1]. 
2. Portable Health Clinic 
Portable Health Clinic (PHC) system was designed in 2010 by Grameen Communications, 
Bangladesh in a joint collaboration with Kyushu University of Japan as a telemedicine 
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based healthcare system [Figure 1]. Later some new modules have been added to this 
modular system for satisfying patients demand for serving secondary level of treatments 
in Eye (ophthalmic) Care and Maternal & Child Healthcare (MCH) [2].  
PHR service has been there 
as a personal service to the 
patients from the beginning. The 
patients can access to their own 
data on smartphone, monitor and 
share their feedbacks to the 
physicians if they need to receive 
any consultancy. 
3. Standardization of PHR 
As the content of the PHR of PHC system was developed independently, there are always 
some issues for the use of this PHR data by medical professionals of other countries in 
terms of clinical data items and measurement units. The clinical data items in PHR varies 
country to country. Thus, the need of standardization of the PHR has always been felt 
for data portability and to pass interoperability. 
Recently six major Japanese clinical societies jointly proposed a set of 41 items as 
standard for PHR for NCDs in Japan after years of investigations [3]. There was 
unanimous consensus, then installed and expanded allover Japan. This PHR protocol is 
being used in various top PHR service provider (app company) in Japan.  
This research aimed to standardize PHC`s PHR system considering this Japanese 
PHR system as a standard and passed the interoperability for NCDs. In case of Eye Care, 
the ophthalmic image in JPEG format has been added in PHR for diseases prediction by 
AI based image analysis. In case of MCH, hemoglobin measurement and fetus beat per 
minute has been added as these are the major issues for mother and child respectively. 
4. Conclusion 
Development of PHR system and its standardization is very much desired for wider scope 
of quality healthcare services in Bangladesh from medical service point of view. This 
work of PHR standardization of PHC system is just a step forward in this direction. 
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Figure 1 Work Flow of PHC System  
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Persuasive eHealth to Support Home 
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Abstract. Home rehabilitation after a hip operation can be daunting for the elderly. 
Lack of motivation to exercise and being insecure in the recovery process are 
common barriers. Personalized eHealth can help to ensure that the patient exercise 
efficiently, filling the gap between treatment in the practice with the physical 
therapist and practice at home. 
Keywords. eHealth, home rehabilitation, elderly  
1. Introduction 
The elderly population is growing worldwide, and osteoarthritis amongst this group is 
common, often resulting in a joint prosthesis1. The stay in the hospital after such an 
operation is very short. Rehabilitation after discharge from the hospital takes place with 
a physical therapist. The usual after-care is about exercising to improve the mobility of 
the hip / knee. Instructions are usually given in the form of folders of videos. However, 
physical therapists see a gap between treatment in their practice and practice at home. 
Furthermore, patients are not always motivated enough to exercise at home and are 
unsecure in what they do. The use of eHealth to support the patient’s rehabilitation at 
home is limited. Sensor technologies for example are used to collect quantitative 
information about joint recovery2. The research reported here focuses on exploring the 
design of a persuasive eHealth solution, for effective rehabilitation at home. 
2. Method 
In order to design a persuasive eHealth solution, we use the methodology we developed 
based on the CeHRes framework and other models for persuasive design and behavioral 
change3.. This methodology begins with a contextual inquiry, resulting into prototyping 
and finally implementation. Persuasive features and triggers for motivational behavior 
are throughout the design process incorporated into the eHealth solution. Three groups 
of 3rd and 4th year bachelor students (4 to 5 students per group) worked for a period of 
20 weeks with the Medical Technology Research Group on this project. One group 
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consisted of informatics students from InHolland University of Applied Sciences and
two other groups consisted of a multidisciplinary team from Rotterdam University. 
Students used a fictive casus reflecting a real-life situation. We chose the approach of 
student’s participation and action research in order to explore various proofs of concept 
and to provide students the opportunity to experience a healthcare setting and to think 
out of the box with other disciplines.  
3. Results 
The designing of an eHealth solution focused mainly contextual inquiry, 
requirements and prototyping. Formative evaluation was carried out with the targeted 
groups. Each group provided a proof of concept developed in co-creation with the 
targeted group and physical therapists. Researchers from the Medical Group acted as 
eHealth experts. Figure 1 shows a paper prototyping from one group during contextual 
inquiry, and a developed solution to ensure that the exercises are done correctly from 
another group. Students used Fogg’s Behavior Grid to determine the kind of behavior 
change that was needed to optimize the rehabilitation process at home. In the design of 
their eHealth solutions they used the principles of persuasive design as described by 
Oinas Kukkonen to determine which persuasive elements should be used.  
  
Figure 1. Prototype examples  
4. Discussion and Conclusions 
Home rehabilitation after a hip or knee operation often remains a challenge for a growing 
number of elderly and limit participation and self-management. Exploring various 
eHealth proof of concepts based on persuasive features and behavioral change can help 
to tune to a more personalized solution. Students’ participation is an added-value for the 
healthcare setting and for providing input to further research in this area.  
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Department of Computer Science and Biomedical Informatics, 
University of Thessaly, Lamia, Greece 
Abstract. The e-Prescription systems are modern and efficient prescribing tools 
which can affect the quality of the healthcare services. The aim of this study is to 
evaluate the e-Prescription systems in Greece based the users’ opinions. The 
survey was conducted in 2019 among 157 randomly selected healthcare 
profesionals through an on-line survey tool. The 51.2% of the sample were 
pharmacists and 48.8% physicians. 80.7% believe that the e-Prescription systems 
are reliable. More than the half of the professionals has the view that the e-
Prescription systems are useful. Regarding to the ease of use, the e-Prescription 
systems, seem to can not fulfill sufficiently the participants’ requirements. 
Keywords. Electronic Prescription, Evaluation Study 
1. Introduction 
The electronic prescription systems could be assumed as modern and efficient 
prescribing tools for drugs and other medical product or services [1]. The usage of the 
e-Prescription systems has significantly reduced the errors during the prescription 
process as well as, led to a better control of the health costs [2]. The evaluation of these 
systems seems to be important as it can affect the system functionality and the users’ 
satisfaction [3,4]. Today, two e-prescription systems are in use in Greece. The IDIKA’s 
system is used for drug and diagnostic tests prescription and the EOPYY’s system for 
all the other prescribing items. The aim of this pilot study is to record the physicians’ 
and pharmacists’ opinions regarding the above e-Prescription systems in order to 
evaluate the systems’ reliability, usefulness and ease of use. 
2. Methods 
To achieve the aim of this study, a self-developed questionnaire was used. The 
questionnaire included questions about the participants’ age, profession, years of 
experience, their opinions regarding the mistakes during the prescription process due to 
the systems, the reliability, the usefulness and the ease of use of the e-prescription 
systems, and the participant’s cost of usage for the e-prescription services. The survey 
was conducted in Greece in 2019 among 157 randomly selected Physicians and 
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Pharmacists through an on-line survey tool. Descriptive statistics and corellations 
between the participants’ profession and their opinions were examined using SPSS. 
3. Results and Discussion 
After the statistical analysis, the 51.2% of the sample were pharmacists and 48.8% 
physicians. The mean of the age was 43.46 years old. About the professional 
experience, the 23.3% of them have more than 10 years. As 39% of all mistakes on the 
prescription process are due to the e-Prescription system malfunctions, the 79.1% of 
the participants believe that the last two years the number of errors, due to system 
malfunctions, was decreased. Meanwhile, the 80.7% think that the e-Prescription 
systems are reliable. For IDIKA’s system, the 86% of the participants assumes that the 
system is useful and 73.8% accepts that it is easy to use. On the other hand, for the 
EOPYY’s system, the 56.9% of the participants believe that the system is useful and 
only 22.7% thinks that it is easy to use. Additionally, the mean of the annual cost of 
usage for the e-prescription services is 554.78 euro. Comparing the participants’ 
profession with their opinions regarding the e-Prescription systems, all comparisons 
were not confirmed (p>0.05), except the comparison between the profession and the 
perceived ease of IDIKA’s system use (p<0.01). Finally, the pharmacists believe that 
the IDIKA’s prescription system is easy to use, way more than physicians. No other 
differences in opinions between physicians and pharmacists were found.  
4. Conclusions 
According to the aforementioned results, although the participants believe that a large 
percentage of the prescription errors are related to the e-Prescription systems, they trust 
the systems, and these systems are assumed reliable by the majority of the participants. 
The majority of the professionals have the view that the e-Prescription systems are 
useful. Regarding to the ease of use, the e-Prescription systems, does not fulfill 
sufficiently the participants’ requirements and on one of the system, pharmacists seem 
to be more familiar with the systems usage rather than the physicians. Future work may 
include a wider scale survey using structured and valid measuring tools in order to 
record more accurately the healthcare professionals’ opinions about the e-Prescription 
systems on international level. 
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Abstract. Since a French organization (2016) has defined “the territorial hospital 
groupings”, public hospitals must share medical-economic knowledge and 
decision-makers expect prospective analyses. PoleSat aims, quick hospital-
catchment area modellings, completed by population analyses. Modellings are 
based on “diagnostic and interventional vascular catheterizations” acts and 
Nouvelle-Aquitaine, and they are carried out 3 times, through the graphical user 
interface’s main-setting values, coupled with 3 activity-scenarios. Scenario results 
cannot confirm the NA02-Atlantique‘s H0. The experts have approved PoleSat’s 
method as a robust help-tool; therefore they project to repeat its usages. 
Keywords. Models, Gravitation, Geographic Mapping, Management Information 
Systems, Diagnosis-Related Groups (DRG), Decision Making, Computer-Assisted 
1. Introduction 
Since a French organization (2016) has defined “the territorial hospital groupings 
THGs” i.e. a new sanitary level for health management, public hospitals must share 
medical-economic information [1]; also, keeping up with this movement, health 
decision-makers need prospective activity/recruitment analyses; thus, to help decision-
makers, PoleSat tailored IT tool [2] aims quick-easy modelling of hospital catchment 
area (CA), completed by population analyses (per scenario). Two main hospital centers 
(CH) are targeted to predict the activity transfer impacts between Rochefort - and 
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Saintes – CH, and to accept/reject the NA02 – Atlantique 17 THG’s recruitment
hypothesis H0.  
2. Materials and methods 
PoleSat allows to upload its own health ready-input file, [2] and to ensure a general 
data protection regulation compliance. Other variables are added [3] to obtain 
localization & geographic limits. Modellings are applied on “diagnostic and 
interventional vascular catheterizations (DIVC)” activity from DRG-PMSI 2018 [1], 
and concern 2 Nouvelle-Aquitaine’s THGs.  
Initial, transfer, and removal activity-scenarios are considered to confirm/refute 
H0: “High positive activity gain of 100% is expected for Saintes, under a transfer of 
617 acts from Rochefort - to Saintes”. Modellings are carried out 3 times, through the 
graphical user interface’s main-settings (P1: 2, P2: 54, P5: 2, & P8: 15), coupled with 
PMSI-ready-input files tied to each activity-scenario. 
3. Results 
The 3 activity-scenario modellings are presented in Figure 1. 
 
 
 
 
 
 
 
Figure 1. a- “initial scenario”, Rochefort’s CA inside a purple-ellipse appears in light-green. b- 
“removal scenario”, Rochefort’s CA has disappeared & almost all its CA is eaten by La Rochelle’s CA. c-
“transfer scenario”, inside a red-circle Rochefort’s activity transfer to Saintes. Saintes’ CA has weakly 
increased in “c” in comparison with the similar area in “b” 
4. Discussion & Conclusion 
Each hospital activity around Rochefort increases proportionally to the covered-
population growth; also, the transfer does not lead to the expected decrease of DIVC in 
Rochefort’s area; thus, La Rochelle could attract 2 to 3 times more patients than 
Saintes; therefore, the outcomes cannot confirm H0. Reduce activity leak of Saintes 
appears evident for the experts, which have validated Polesat (distance & mass) as a 
robust help tool, and project to repeat its usage to other health planning cases. 
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Abstract. Automated coding and classification systems play a role in healthcare 
for quality of care. Our objective was to predict diagnosis code from medication 
list of electronic medical record (EMR) using convolutional neural network (CNN). 
We collected the clinical note from outpatient department (OPD) of Wanfang 
hospital, Taiwan of 2016 and used three physicians from three departments. The 
dataset was split into two parts, 90% for training and 10% for test cases. We used 
medication list as input and International Statistical Classification of Diseases 10 
(ICD 10) code as output. After data preprocess, we used word2vector CNN to 
predict ICD 10 code. This study shows all the three physicians from three 
departments achieved better performance. The best performance of model was a 
physician from cardiology department achieved precision 69%, recall 89% and F 
measure 78%. We need to include more component such as text data, lab report for 
evaluation. 
Keywords. Clinical note, International Statistical Classification of Diseases 10 
(ICD 10), medication, convolutional neural network 
1. Introduction 
Electronic medical record (EMR) is routinely collected heterogenous data. Each record 
should have complete information of problem list to establish diagnosis and abnormal 
findings [1]. However, it is hard to create accurate predictive model, because of 
heterogenous data, data quality and label availability [2]. Medical coder put 
International Statistical Classification of Diseases 10 (ICD 10) code manually in the 
EMR and it’s labor intensive and time consuming. A study used 17 conditions for 
identifying problem lists of patients based on medication and laboratory results [3]. 
Natural language processing (NLP) uses for different problem transformation 
approaches and employing suitable label calibration and ranking methods [4]. Pre-
trained word vectors use for sentence-	
	5]. Our aim was to 
explore whether we can automatically assist physician to predict diagnosis code from 
medication list of EMR using CNN. 
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2. Method 
Dataset: This study is a retrospective cohort of patients. We collected clinical notes of 
outpatient department (OPD) from the EMR of Wanfang Hospital, Taiwan of 2016, 
consists of SOAP, medication, diagnosis lists. The total medical records were 10,364 
where 9,583 (90%) for training and 781 (10%) for test set that include three Physicians.  
Experimental setup: We consider the task as multi-label classification problem, 
where the input is medication list and the output is the ICD-10 label of clinical note. 
We implemented word embedding word2vector (w2v) CNN for multi-label 
classification task using python, Keras. We used Sigmoid activation function at the end 
of CNN. We used ranking method for getting top 10, top 5 diagnosis using the dataset. 
This ranking can identify the best diagnosis chronologically. Initially it takes the 
tokenization, use w2v and then use CNN. CNN used with Keras and weight parameters 
are optimized using Adam method that is a variant of the stochastic gradient descent 
(sgd) algorithm.  
Evaluation: The evaluation was done by precision, recall and F measure.  
3. Result 
Our study shows the best performance of CNN model for a physician from cardiology 
department as precision, recall and F measure were 69%, 89% and 78% respectively. 
The predicted ICD 10 using probability that identify the ranking where E782 Mixed 
hyperlipidemia is the top (probability 0.9972247) of a diagnosis list. 
4. Conclusion 
We find better model performance as well as better ICD 10 prediction chronologically 
through probability. However, we need to explore the evaluation by all physicians and 
include text data, lab report in future tasks. 
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Abstract. Out-of-hospital cardiac arrest (OHCA) is an important public health 
problem, with very low survival rate. In treating OHCA patients, the return of 
spontaneous circulation (ROSC) represents the success of early resuscitation efforts. 
In this study, we developed a machine learning model to predict ROSC and 
compared it with the ROSC after cardiac arrest (RACA) score. Results demonstrated 
the usefulness of machine learning in deriving predictive models. 
Keywords. Out-of-hospital cardiac arrest, ROSC, machine learning, random forest 
1. Introduction 
The return of spontaneous circulation (ROSC) serves as an indicator of the success of 
early resuscitation in out-of-hospital cardiac arrest (OHCA) patients. Given the global 
burden of OHCA and disparity among healthcare systems, a simple tool is needed to 
enable comparison of different EMS systems worldwide. The ROSC after cardiac arrest 
(RACA) score [1] developed in Germany is one solution, which uses variables that are 
available after EMS arrival to assess the probability of ROSC through logistic regression. 
In this study, we aimed to create a machine learning model to predict ROSC. 
2. Method 
We used the data collected from Pan-Asian Resuscitation Outcomes Study (PAROS) [2]. 
The data consists of OHCA victims recruited between January 2009 and December 2012 
from Japan, South Korea, Malaysia, Singapore, Taiwan, Thailand, and United Arab 
Emirates (UAE). In this study, we excluded paediatric cases (<18 years old), non-EMS 
transported cases, and those with a “do not resuscitate” order. We used random forest 
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and following variables to build a prediction model: gender, age, cardiac arrest aetiology, 
witness, location, initial rhythm, bystander cardiopulmonary resuscitation (CPR), and 
EMS arrival time. We randomly selected 70% data for random forest model training and 
the remaining 30% data for testing the model and the RACA score. 
3. Results 
A total of 63,059 patients were used in our analysis, of which 5,190 (8.2%) patients had 
ROSC at scene or en route to ED. Figure 1 shows receiver operating characteristic (ROC) 
curves generated by the random forest model and the RACA score. Area under the ROC 
curves were 0.76 and 0.73 for random forest and RACA score, respectively. 
 
Figure 1. ROC curves of the random forest model and the RACA score. 
4. Discussion 
Our study showed that a machine learning model (random forest) outperformed RACA 
score in predicting ROSC among OHCA patients. The results demonstrated the power 
of machine learning in deriving predictive tools. Overall, the discriminatory abilities of 
both machine learning model and RACA score (0.76 and 0.73 AUC) were comparable 
to the original RACA score (0.73 AUC) on German registry patients. Our study proved 
the applicability of the RACA score in Pan-Asian countries and illustrated the possibility 
of applying machine learning algorithms in developing new predictive tools. 
5. Conclusion 
Machine learning is worthy of further investigation in developing powerful predictive 
tools for OHCA and other medical applications. 
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Abstract. The aim of this study was to identify predictors for hospital admissions 
in community-dwelling adults based on routinely collected community data. 
Univariate logistic regression analyses were performed to assess each variable’s 
ability to predict preventable and all cause hospital admissions. 
Keywords. Prediction, primary health care, elderly, home care, hospital admission 
1. Introduction 
Population ageing challenges the existing healthcare systems as the older population are 
at higher risk of chronic diseases that require long-term care (1), and more frequent 
hospital admissions (2). Consequently, avoiding unnecessary hospital admissions have 
become a priority, as both the primary- and secondary healthcare sector cannot keep up 
with the rising demand (3). The Triage Changing Table has been recommended by The 
Danish Health Authority for early detection of acute events and prevention of 
preventable hospital admissions based on home care providers’ everyday observations 
of clients’ health states (4,5). No studies have examined the association between data 
obtained from the Triage Changing Table Database and hospital admissions. The aim of 
the present study was to identify predictors for preventable and all cause hospital 
admissions in community-dwelling adults based on everyday health state observations. 
2. Methods 
First paragraph. Data was retrospectively collected from The Patient Administrative 
System used in the North Denmark Region, which includes information about hospital 
admissions, and The Triaged Changing Table Database. 4,410 subjects aged 65 or above 
residing in Aalborg Municipality, Denmark, were included in the study. The outcomes 
were preventable and all cause, acute hospital admissions defined as an unplanned 
overnight stay in hospital. Prior to each acute hospital admission, we defined a prevention, 
event, and control period with length of three, 14, and 14 days, respectively. A total of 
279 and 261 features were constructed from the Triage Changing Table variables for the 
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preventable and all cause hospital admission analyses, respectively. Univariate logistic 
regression analyses were performed to assess each variable’s ability to predict the 
outcome. Five-fold cross-validation was applied to reduce the risk of overfitting and 
increase generalizability to new data. 
3. Results 
A total of 68 control and event period pairs from 53 subjects was included in the all cause 
hospital admission analysis. 19 control and event period pairs from 18 subjects were 
included in the preventable hospital admission analysis. The most discriminative 
predictor variable for all cause hospital admissions was the difference in total sum of 
item codes between the first and last registration in each period (OR = 1.20; 95% CI = 
0.94, 1.55; p = .14; AUC±STD = .60 ± .12). For the preventable hospital admissions, the 
most discriminative predictor variable was the number of Triage Changing Table 
registrations (OR = 1.05; 95% CI = 0.92, 1.19; p = .48; AUC±STD = .65 ± .16). No 
predictors showed statistically significant associations with the outcome. 
4. Discussion 
This study used only routinely collected data extracted from administrative databases in 
a community care setting, which compared to self-reported data tends to have greater 
predictive performance (6). The reported AUCs indicate some discriminative potential, 
however, no variables had statistically significant association to the outcome, which may 
be due to the relatively low sample sizes. The current data segmentation strategy limited 
the number of subjects and control/event periods. A less restrictive segmentation 
approach will likely increase the number of event and control periods.  
In conclusion this study has demonstrated that data collected using the Triage 
Changing Table may be useful in predicting impending hospital admissions. However, 
further research is needed to evaluate the true predictive potential of this tool. 
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Abstract. Adherence to the complex set of recommended self-care practices 
among people with Sickle-Cell Disease (SCD) positively impacts health outcomes. 
However, few patients possess the required skills (i.e. disease-specific knowledge, 
adequate levels of self-efficacy). Consequently, adherence rates remain low and 
only 1% of patients are empowered enough to master the self-care practices. Health 
coaching and therapeutic patient education have emerged as new approaches to 
enhance patients’ self-management and support health behavior changes. This 
preliminary feasibility study examined patients’ perceived usefulness of the 
information provided by a chatbot we developed following patient-important 
requirements collected during our preliminary studies. Participants tested the 
chatbot and completed a post-test survey. A total of 19 patients were enrolled and 
2 withdrew. 15 respondents (15/17, 88%) gave a score of at least 3/4 to the question 
“The chatbot contains all the information I need”. Results suggest that mHealth 
coaching apps could be used to promote the knowledge acquisition of 
recommended health behaviors related to the prevention of SCD main symptoms. 
Keywords. Sickle-Cell Disease, Chatbots, mHealth, Patient Empowerment. 
1. Introduction 
Sickle-Cell Disease (SCD) is the most prevalent monogenic disorder worldwide [1,2]. 
The major clinical manifestations are hemolytic anemia and vaso-occlusive pain crises 
(VOC) [3]. Triggers of VOCs are numerous and include inadequate eating behaviors, 
stress, infections, dehydration, fatigue [4]. To prevent them, patients require high 
cognitive capabilities, good disease-specific knowledge and high self-efficacy levels [5]. 
Yet, literature suggests that only 1% of SCD patients are empowered enough to fully 
self-manage [6]. Mobile health (mHealth) apps, because of their relatively low cost and 
scalability, can offer a potential route to support SCD self-management. Studies have 
shown that Conversational Artificial Intelligence (AI) such as chatbots to encourage 
people with Diabetes’ behavior changes, had a high acceptability and high user 
engagement [7]. To our knowledge, no work has been done to design such tools for the 
specific needs of people with SCD. This preliminary study aims at evaluating patients’ 
perceived usefulness of the information provided by a fully automated coaching app 
designed to empower patients through the learning of recommended self-care practices. 
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2. Methods 
To be part of the study, applicants had to be diagnosed with SCD. Patients had to be at 
least 16 years old and be able to understand French. People who had been cured (e.g., 
bone marrow transplantation) were excluded. Finally participants had to possess a 
smartphone. Patients have been recruited through patient associations in Guadeloupe 
during the World Sickle-Cell Awareness Day. All participants gave informed consent 
before the evaluation and all responses were anonymous. The instrument has been 
developed following patient-important requirements collected during our previous work 
[8,9]. Participants tested the chatbot and completed a post-test, the 9-items usefulness 
scale for patient information material (USE) survey.  
3. Results 
19 patients participated to the test (9 females and 8 males). 17 completed the evaluation. 
2 females withdrew because of problems with their smartphones. Patients were aged 
between 19 and 59 years old. 15 respondents (15/17, 88%) gave a score of at least 3/4 to 
the question “The chatbot contains all the information I need” for a total score of 54/68. 
10 participants (10/17, 58%) gave a score of at least 3/4 to the question “The chatbot 
encouraged me to be more active in order to improve my condition”, for a total of 51/68. 
4. Discussion 
Results suggest that chatbots for health coaching can be used to promote the knowledge 
acquisition of recommended self-care practices related to the prevention of VOCs.  
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Abstract. Effective bed management is important for hospital management. Until 
now, bed allocation process is generally controlled by administrative staffs in 
centralized manner but it is not always effective. In the present study, we proposed 
and evaluated new method for bed allocation applying market mechanism via 
token. Evaluation was performed with newly-developed game-type simulation. 
Nurse managers as research participants played it and answered for survey. The 
result showed that the proposed method can be useful with appropriate operational 
design. 
Keywords. Hospital Management, Bed Occupancy, Resource Allocation 
1.Introduction 
Effective bed allocation is important for hospital management [1], as bed capacity is 
central part of hospital’s competency. Current bed allocations are generally executed 
by administrators with centralized manner, but such management tends to result in 
front- line staffs’ decreased job satisfaction and even invokes their resignation [2]. 
Considering that healthcare is labor-intensive industry, current state can be seen as 
ineffective and we need improvement. Conventional discussion in economics has 
argued that centralized decision making such as collectivist society cannot be efficient 
comparing to decentralized, market mechanism-based society. We here propose a novel 
bed allocation system based on market mechanism in which physicians who needs beds 
“select” and “buy” “price-tagged” impatient beds from nurse managers through 
transactions with token. We implemented preliminary game-like computer simulation 
and performed evaluation of the system through survey to nurse managers. 
2.Method 
We regarded bed allocation process as transactions of nursing services between 
physicians and nursing staffs. In particular, wards offer prices of their nursing services 
for physicians planning patient admission, and physicians buy them considering prices 
and their preferences. By doing so, we expected improved bed allocation from the 
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viewpoint of hospital management. To evaluate the system, we developed web-based 
simulation game in which three players were required to act as nurse managers of a 
hospital using aforementioned bed allocation system. Players were asked to set prices 
for patients as nurse managers followed by computer agent acting as physician selected 
the cheapest ward. The game was set to end when the tenth cycle ended. Next, we 
recruited three nurse managers from a single university affiliated hospital in Japan. 
They were asked to play simulation game described above, assuming that they are 
carrying out their responsibilities as managers in the in-game world. As evaluation, we 
recorded price fluctuation and bed allocation results. In addition, we asked participants 
to answer several questionnaires. 
3.Results 
Research participants were nurse managers in active duty and all of them were female. 
Their work experiences were 20-34 years as nurse and 5-14 years as nurse manager. 
The prices of beds fluctuated according to wards bed occupancy. Answers of 
questionnaires were summarized as follows; participant A was generally skeptical to 
the system, while participant C was favorable. Even though their answers were diverse, 
they evaluated “patient-centeredness” of the system negatively while “fast decision 
making” neutrally or positively. When they were asked about preferred reward for 
collected tokens, they answered as follows: bonus, additional human resource, job 
training allowance, welfare expenses. 
4.Discussion 
In the present study, we proposed a new method for bed allocation and evaluated it 
with game-like simulation system. Simulation system showed slight association 
between bed occupancy and price for diseases, indicating nurse managers’ strategies 
considering surrounding situations. Referring conventional theories in economics, such 
rationalities of each stakeholders are expected to result in overall optimization [3]. In 
addition, participants showed their concern that the system could not be good for 
patient care because it does not reflect caregivers’ specialty. In addition, appropriate 
rewards for the tokens is said to be the key factor for the effective implementation for 
token economy [4]. Our survey also showed two of three participants preferred 
additional human resources. This result indicated that hospital administrators will be 
able to manage the system via controlling human resource allocations. In conclusion, 
token-based bed allocation system based on market mechanism approach can be 
effective when it is used with appropriate operational design. 
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Abstract. Our study team developed the MyPEEPS Mobile App for improving HIV 
prevention behaviors in diverse young men. We conducted a randomized controlled 
trial and evaluated the preliminary outcomes in the first half (N=350) of our intended 
study sample. Higher self-efficacy for HIV prevention behaviors (p=0.0042) and 
more recent HIV tests in the past 3 months (p=0.0156) were reported by the 
intervention group compared to control. Numbers of condomless anal sex acts were 
lower among the intervention group for both insertive anal sex acts (p=0.0283) and 
receptive anal sex acts (p=0.0001). Preliminary results indicate that some sexual risk 
behaviors were reduced among the intervention group in the preliminary analytic 
sample. 
Keywords. mHealth, digital personalized health, young men, HIV prevention 
1. Introduction 
Increased HIV incidence continues among young men who have sex with men 
(YMSM), with rates especially disproportionate among racial and ethnic minority 
YMSM in the US. Yet, there remains a dearth of evidence-based HIV prevention 
interventions for YMSM – and few that address racially- and ethnically-diverse 
YMSM. We employed a community-engaged research approach to design the 
MyPEEPS Mobile App targeting ethnically-diverse YMSM. MyPEEPs delivers 
information through 21 activities comprised of: didactic content, graphical reports, 
videos, and true/false and multiple-choice quizzes. [1] This ongoing randomized 
controlled trial is testing the efficacy of MyPEEPS, an evidence-based intervention for  
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reducing reduce sexual risk behaviors (e.g., sex without condoms) and strengthen 
protective factors (e.g., increasing self-efficacy around safer sex) among racially and 
ethnically diverse YMSM across the US. 
2.Methods 
Young males (ages 13-18) who report same-sex attraction and have kissed another male 
or plan to have sexual activity with another male in the next year were recruited from 
across the US (Figure 1). Enrolled participants provide demographic, psychosocial, and 
sexual behavior data at baseline. The intervention group receives the MyPEEPS Mobile 
App at the baseline visit, with follow-
up assessments at 3-month, 6-month, 
and 9- month time points. The control 
(delayed intervention) group 
completes 3-month, 6-month, 9-
month, and 12-month assessments. 
Regression analyses assessed data 
collected from a sub-sample of 350 
baseline visits and 271 matched 3- 
month visits. 
    Figure 1. MyPEEPS Mobile social media recruitment banner. 
3.Results 
Higher self-efficacy for HIV prevention behaviors (p=0.0042) and more HIV testing in 
the past 3 months (p=0.0156) were reported by the intervention group compared to 
control. Numbers of condomless anal sex acts were lower among the intervention 
group than control for both insertive anal sex acts (p=0.0283) and receptive anal sex 
acts (p=0.0001). The intervention group reported fewer condomless insertive anal sex 
acts (p=0.0061) but more condomless receptive anal sex acts than the control group 
(p=0.0001) while under the influence of alcohol and drugs. There were no group 
differences in the other HIV prevention measures. 
4.Conclusions 
Preliminary results indicate that some sexual risk behaviors were reduced among the 
intervention group in the preliminary analytic sample. Further analysis after study 
completion will provide more conclusive results. 
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Abstract. We discuss the preliminary safety analysis of a smartphone-based 
intervention for early detection of psychotic relapse. We briefly describe how 
we identified patient safety hazards associated with the system and how 
measures were defined to mitigate these hazards.  
Keywords. Safety, wearables, smartphones apps, serious mental illness 
1. Introduction 
We focus on a smartphone-based intervention, called the Wearable Clinic, which 
assists in remote monitoring of patients with chronic conditions, including serious 
mental illness. A key function of the Wearable Clinic is to detect relapse early by 
identifying sudden changes in activity and behaviour, particularly for patients with 
schizophrenia. Relapses often result in unscheduled hospital admissions, with 
substantial suffering of affected individuals and their families as well as high costs for 
mental health services. Despite the potential benefits of the Wearable Clinic, it is a 
complex digital intervention in a complex clinical and social setting. This increases the 
risk of new unintended hazardous events that can compromise patient safety [1]. The 
aim of this paper is to show how the consideration of these safety concerns was 
incorporated into the early design of the Wearable Clinic by proactively conducting a 
hazard analysis in order to generate safety requirements for mitigation of the identified 
safety hazards.  
2. Methods 
We modelled the intended use of the Wearable Clinic for an early detection of 
psychotic relapse in an explicit use case, clearly representing the flow of activities, 
decisions and data. This activity has been conducted with a multidisciplinary team 
comprising data scientists, engineers, economists, clinicians and public contributors. 
This use case provided a basis for scoping and conducting a hazard and risk analysis, 
which is a mandatory requirement for safety standards. The safety analysis of the 
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Wearable Clinic, as scoped by our use case, was conducted using the Software Hazard 
Analysis and Resolution in Design (SHARD) technique [2]. SHARD is used in the 
safety-critical domain to assess the suitability of a proposed design of a data-intensive 
system and derive safety requirements for the detailed development of the design. 
SHARD is structured around data flows, considering inputs to the system, e.g. from 
sensors, and outputs, e.g. to alerting devices. SHARD uses a set of guide words 
(omission, commission, early, late and value) for identifying potential deviations from 
the intended behaviour of each data flow, prompting the analysts to determine plausible 
causes, hazardous effects and the safety requirements. 
3. Results 
SHARD was applied to all the data flows in the use case. Take the data flow between 
the decision ‘Is risk of relapse high?’ and the activity ‘Inform care team’, considering 
three key deviations (omission, commission and late). Here, the omission and late 
reporting of high risks of relapse represent two potential hazardous failures that have to 
be mitigated. For example, a potential omission cause is a common smartphone 
notification option that can centrally disable all notifications. This could limit the 
ability of the Wearable Clinic to collect user data and thus to proactively predict 
relapse. A mitigation measure comprises user training and greater control over central 
OS functions. These form explicit safety requirements for the subsequent detailed 
design, and the potential deployment, of the app.  
4. Discussion and Conclusions 
An important feature of the Wearable Clinic is that its functions are interweaved into 
the care pathway. With this benefit comes the challenge of identifying the safety 
considerations that have to be mitigated specifically by the Wearable Clinic designers. 
For example, is the scope of the system limited to (1) alerting the care team, (2) 
automatically initiating an intervention or/and (3) guiding the intervention? The greater 
the scope, the more safety-critical the system becomes, with more stringent regulatory 
constraints. Further, the confidence with which the safety requirements have to be 
satisfied should be proportionate to the risks posed by the technology. However, 
neither the safety standards nor clinical guidelines state what would be deemed as 
acceptable risk targets. Without these targets, it is a significant challenge for the 
engineers to make transparent decisions concerning the reliability of the different 
system components, e.g. choice of accelerometers or mobile phone platforms, in the 
absence of any qualitative or quantitative notion of risk acceptance.  
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Abstract: Although routine healthcare data are not collected for research, they are 
increasingly used in epidemiology and are key real-world evidence for improving 
healthcare. This study presents a method to identify prostate cancer cases from a 
large English primary care database. 19,619 (1.3%) men had a code for prostate 
cancer diagnosis. Codes for medium and high Gleason grading enabled 
identification of additional 94 (0.5%) cases. Many studies do not report codes used 
to identify patients, and if published, the lists of codes differ from study to study.  
This can lead to poor research reproducibility and hinder validation. This work 
demonstrates that carefully developed comprehensive lists of clinical codes can be 
used to identify prostate cancer; and that approaches that do not solely rely on 
clinical codes such as ontologies or data linkage should also be considered. 
Keywords. Prostate cancer, primary care, case identification, real-world evidence  
1. Introduction
Prostate cancer is a chronic condition, with good prognosis but long-term consequences.
Health services worldwide are stretched so it is important to understand the needs of the
growing population of people affected by cancer. The increasing use of electronic health 
records (EHRs) can facilitate epidemiological research. However, the usability of data is 
limited by the lack of standards and variability in the quality of recording of cancer 
diagnosis and treatment. In this study, we investigate the usability of clinical codes to 
identify and describe a cohort of prostate cancer patients from an English database.
2. Methods
A primary care-based, retrospective cohort study using a nationally representative, 
English database from the Royal College of General Practitioners (RCGP), Research and 
Surveillance Centre (RSC) was used [1]. A December 2016 data extract was analyzed 
comprising 164 practices and 1,529,922 EHRs for male patients. 
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Prostate cancer diagnosis was extracted using commonly reported diagnostic codes.
This included B46 (malignant neoplasm of prostate), B834 (carcinoma in situ of 
prostate) and HNG0200 (cancer of the prostate). We also included 4M01 and Xalmc 
(Gleason prostate grade 5-7 (medium)), and 4M02 and Xalmd (Gleason prostate grade 
8-10 (high)). Date and age at diagnosis was based on the first occurrence of the clinical
code. Ethnicity was extracted in five categories using an ontology-based algorithm [2].
3. Results
The average age at diagnosis was 70.8 (SD = 9.5) and the majority of men (11,586, 
94.1%) were white (Table 1). Men identified with prostate cancer were spread evenly 
across the country (Figure 1). The most commonly extracted treatment was hormone 
therapy, 9324 (47.5%) men received it. The mean age at death was 80.6 (SD = 9.1).  
Diagnosis was established for 19,619 (1.3%) men. The three codes: B46, B834 and 
HNG0200 were used for 18,356 (93.6%), 1,549 (7.9%) and 666 (3.4%) men respectively. 
Medium Gleason grading was recorded in 1535 EHRs and high in 562 EHRs. This 
enabled identification of 94 (0.5%) additional cases.  
4. Discussion and conclusion
Primary care-based epidemiological studies often identify cancer cases using diagnostic 
codes. In clinical practice, we found variations in the recording of cancer diagnosis. This 
work contributes to establishing standards for primary care cancer case ascertainment.
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Characteristic Mean (SD) n (%)
Age at diagnosis (years) 70.8 (9.5)
Ethnicity 
White 11586 (59.1)
Asian 195 (1.0)
Black 432 (2.2)
Mixed 67 (0.3)
Other 37 (0.2)
Missing 7302 (37.2)
Treatment 
Radiotherapy 634 (3.2)
Hormone therapy 9324 (47.5)
RT and HT 1970 (10.0)
None recorded 7691 (39.2)
Age at death (years) 80.6 (9.1)
Not recorded 18170 (92.6)
Table 1. Demographic and treatment characteristics Figure 1. Location of study participants.
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Abstract. Clinical and medical knowledge evolve and this causes changes in 
concepts and terms that describe them. The objective of this work is to formally 
present an ontology-based standard architecture that will be used in the scenario of 
neurodegeneration research to maintain terminologies and their relations updated 
and coherent over the time. The proposed structure is composed by three elements 
that will allow the user to do a list of operations on the terminology resources 
explicitly contemplated by the Common Terminology Service Release 2 (CTS2). 
Keywords. CTS2, ontologies harmonization. 
1. Introduction
As in all scientific domains, clinical and medical knowledge evolve over time. In a 
scenario of multiscale and multimodal data integration it is mandatory to use shared 
semantics because of the need to deal with heterogeneous datasets [1]. In order to 
correctly manage this type of semantic framework, it is important to consider that the 
medical knowledge evolution causes the change of concepts and of the terms used to 
define them. For this reason, it is necessary to manage historical evolution and 
versioning [2]. So, in the scenario of collaboration projects, it is essential to use both 
controlled vocabularies and standard infrastructures to guarantee both high-quality data 
collection and interoperability between partners. 
2. Methods
As defined in [3], ontologies have been originally developed from the need to represent 
and to communicate a domain’s knowledge unambiguously. As the project is linked to 
neurodegeneration research, a group of specific ontologies have been selected. This 
will not only guarantee the correct dialogue between homogeneous datasets, but it will 
also support the information extraction workflows for “cause-and-effect”-type 
relationships. Ontologies are not isolated; indeed, it is possible to define links between 
them in a process of ontologies harmonization. The four ways to reach this goal are: 
matching, mapping, alignment and merging. In the context of this work, it will be 
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necessary to guarantee the correct mapping between the ontologies. As detailed in [4], 
the objective of CTS2 is to provide technical and functional specifications for the 
development of service interfaces based on the Service Oriented Architecture (SOA) 
that allow the management, search and reading of terminological content defined both 
locally and internationally. The CTS2 standard provides a list of terminology resources 
and, for each of them, a list of functional profiles has been defined. 
3. Results
The proposed architecture is composed by three elements: a relational database, where 
all the ontologies and information about them will be stored (already developed and not 
part of this project); a CTS2 compliant Windows Communication Foundation (WCF) 
service whose interface exposes all the operation contracts expected by the CTS2 
standard (already developed and not part of this project); a CTS2 compliant web 
application, client of the WCF service. This web platform will give the user the 
possibility to easily use the functionalities of the CTS2 compliant Service, for example: 
create, update, delete a terminology resource; read a terminology resource in a specific 
context; search the terminology resources with specific features in a certain context and 
get the list of all the changes applied to a particular terminology resource. Moreover, 
the use of controlled vocabularies, defined in different countries, will help the data 
extraction and integration from different sources containing notes, reports and referrals 
written in the original languages of the countries involved in the present project. 
4. Discussion & Conclusions
The proposed architecture allows the correct management of mappings between 
different ontologies over the time and to monitor the evolution of a terminology 
resource through different versions. Future works will be the development of the web 
application cited above and the possibility of using a non-SQL database instead of a 
relational one. 
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Providing Personal Health Records ased 
on a Mobile Application for Emergencies  
Su Min KIMa , Suyoung YOOa, Won Chul CHAa,b, Tae Rim KIMa,b  
a
 Samsung Advanced Institute for Health Science & Technology (SAIHST), 
Sungkyunkwan University, Seoul 
b
 Samsung Medical Center, Seoul 
Abstract. We developed the service showing patient health record altogether 
which is managed by each hospital separately and recording the patient health 
information based on mobile application. We evaluated the effectiveness and 
satisfaction of the service. This study is aimed to reduce instances where patient's 
medical records are unknown to the medical staff in emergencies and allow 
patients to use and utilize their health information.  
Keywords. Personal medical information, personal health report, mobile 
application, emergency 
1. Introduction 
With the aging and increase of chronic diseases, the importance of continuous health 
care is increasing. In addition, there has been an increasing demand for patients to 
manage and use their own medical information previously held by medical institutions. 
However, there was a limit to developing an appropriate platform between information 
providers and consumers. The purpose of this study is to develop appropriate channels 
for returning sovereignty of medical information to patients. 
2. Method 
The three hospitals, including Samsung Medical Center, provided application-based 
services for emergency patients called Firster to 1,000 emergency patients or cares and 
12 medical staffs. Patients and carers are surveyed on the usability and satisfaction and 
the System Usability Test (SUS). Set a target of 69.5, which is slightly above the 68 
SUS score that 50% of people in the reference evaluate, a total sample size of 1,000 
was obtained based on one sample and t test.  
Afterwards, interviews to Patients, carers and medical staffs are conducted to 
further explore usability and satisfaction. 
3. Results 
This study was conducted from October to November 2019 and the data is analyzing, 
thus this paper included only a few results of the data analysis. A total of 1,000 patients 
or carers participated in the demonstration, and the average of system usability test 
(SUS) was 67.08 (SD=13.8), which was lower than the average of 68 as the reference. 
B
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Table 1 Comparison between two groups by SUS score under and over 68 
However, The lower the age, the higher the usability and satisfaction. 
As a result of dividing into two groups based on the average SUS score of 68, the 
age group under 56 showed a high rate in the group with over SUS 68. As a result of 
comparing the usability of the smartphone and the usability of the app, the group with 
over SUS 68 showed higher usability than the group with under SUS 68.  
 
 
 
 
 
 
 
  
4. Discussion and conclusion 
The average of SUS was 67.08 (SD=13.8), which was lower than the average of 68 as 
the reference. But the period for demonstration was just 2 months and it was conducted 
only three hospitals. Therefore, we cannot predict the service usability and satisfaction 
of this service because it is still in the process of proof. Through demonstration, the 
usability of the app service varies with age and smartphone using status; The older 
people tend to have lower usability than the younger people do. There should be efforts 
to improve the usability of the high-age population.  
It is expected that the personal health information utilization service will improve 
access to health information that has been managed separately by each medical 
institution and facilitate the utilization of health information, thereby reducing 
emergency difficulties and responding to the needs of patients for health information. 
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Qualitative Study to Design an Online 
Community for Patients with Psoriasis 
Giuliana COLUSSI1a, Janine SOMMER a, Mariana SIMÓNa, Lucila BRUCHANSKIa, 
Daniel LUNAa 
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Abstract. The aim of this research was to understand the needs of patients with 
psoriasis and the concerns of specialists in this pathology. Interviews with adults 
with psoriasis and dermatologists were conducted. We found 4 main dimensions: 
Frequently asked questions; Social stigma; Education to patients and Patient 
empowerment. The findings represent a first approach to understand the needs and 
perceptions of patients and dermatologists, for the design of a virtual community. 
Keywords. Self-Help Groups, personal health records, psoriasis 
1. Introduction 
A virtual community in healthcare refers to a  group  of  people  who  interact  with  
each other, performing activities related to healthcare and education [1]. Patients with a 
recent diagnosis in which doubts and fear may arise, could find in virtual communities 
psychological support [2] by contacting people who have gone through similar 
circumstances. Participation of patients with long-term health conditions as psoriasis, 
improves self-control of the disease, produces positive outcomes related to health [3], 
facilitates shared decision making [4] and can even reduce mortality [5]. The objective 
of this research was to understand the needs of patients with psoriasis and the concerns 
of specialists in this pathology; for the design of a virtual community of patients with 
psoriasis into our PHR, applying user-centered design techniques. 
2. Methods 
We conducted a qualitative study, based on in-depth, semi-structured individual 
interviews to both patients and physicians. Patient selection was based on  a  
convenience sample of adult patients diagnosed with psoriasis, whereas for physicians 
selection, we included dermatologists specialized in this disease. Each interview was 
audio-recorded, with the prior informed consent and protecting participants’ 
confidentiality. We proceeded to analyze and categorize the information in domains 
according to the main findings. The analysis was performed through codification and 
categorization of the information, based on a process of constant comparison [6]. 
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We conducted 15 interviews with patients and 9 with dermatologists. We found 4 main 
dimensions. 1) Frequently asked questions: Patients were frequently interested on 
finding out causes of their disease, types of treatments available and treatment options 
that have shown better results. 2) Social stigma: Beyond the typical physical signs of 
the disease, the major source of patient discomfort came from social stigma and 
discrimination. An informed patient, might be beneficial for the community by 
promoting the dissemination of information on the the non-contagious status of the 
disease and thus, helping to overcome barriers in terms of social stigma. 3) Patient 
Education: Most patients will have read information on the internet, by the time they 
arrived to the physician appointment. Dermatologists argued about the difficulties they 
face trying to change patients minds once they have already acquired false beliefs and 
knowledge. 4) Patient empowerment: Most participants mentioned that it would be 
interesting to include questionnaires about the longitudinal follow-up of this pathology. 
and it would be interesting for patients to self-report these questionnaires in order to 
have a complete follow-up. Besides, it could represent a benefit for doctor-patient 
relationship since the time they now-a-days expend completing these questionnaires 
during the office visit, could be used to address other important topics. 
4. Discussion 
The main findings obtained from the interviews were related to information and 
education needs along with recommendations regarding psoriasis management, as well 
as the physical, emotional and social impact generated on people and the approach  
from the patient and family perspective [7]. 
We detected the need of a technological tool capable to give patients access to 
reliable information sources, promote online information sharing with  the medical  
team or peers, and facilitate data management according to users experience [7]. The 
main findings will help us to develop a tool focused on user needs. Conclusively, this 
research represents the first step in the design of a virtual community by understanding 
the needs and perceptions of patients and dermatologists. 
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Results of the se of the Teleconsultation 
Platform After 2 Months of Implementation 
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Abstract. The Ministry of Health (MoH) set the National Digital Health Strategy 
2018-2024 as a state policy. It included a National TeleHealth Plan to enhance 
access and quality of healthcare in a wide territory like Argentina, leveraging more 
than 20 years of national telemedicine experiences and coordinating it with the 
territorial integrated health service networks proposed by the Universal Health 
Coverage strategy. In collaboration with the Ministry of Modernisation, the MoH 
developed and implemented a new TeleHealth Web Platform to perform eReferrals 
and eConsultations nationwide. This poster describes the first 2 months of usage. 
Keywords. Telehealth, eConsult, eHealth, Telemedicine. 
1. Introduction 
Digital Health is one of the three pillars for the effective implementation of Universal 
Health Coverage in Argentina. The Ministry of Health (MoH) created a National 
Directorate of Health Information System to coordinate the National Digital Health 
Strategy 2018-2024. It included a National TeleHealth Plan to promote the development 
of this technology.  
In collaboration with the Ministry of Modernisation, the MoH developed and 
implemented a new TeleHealth Web Platform to perform eReferrals and eConsultations 
nationwide. The teleconsultation platform allows primary care physicians located in 
remote areas to contact specialist for difficult patient cases[1], improving 
communication, and eventually avoiding physical referral. It was designed to close 
territorial specialist availability gaps[2]. In-advance training and education for leaders 
and end-users is one of the critical factors[3]. Governance and management aspects of 
Telemedicine are crucial, and have the potential of transformative challenge for the 
health system [4]. The platform was developed using international standards suggested 
by the MoH. The components were: the front end; a layer of data services; a back end 
that is responsible for persisting and retrieving information and a server to store the 
database. We used Fast Healthcare Interoperability Resources (FHIR), such as service 
request. This poster explains the first overview of its implementation. 
U
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2. Materials and Methods 
The analysis of the implementation was done using de-identified data exported from the 
system, regarding institutions, specialties, telemedicine programs and teleconsultations. 
3. Results 
The Platform implementation was rolled out in 2 phases: an initial pilot with 2 provinces 
and a big bang adoption in the whole country afterwards. Previously, main leaders took  
a telehealth course provided by Mina Gerais University. Final users were trained locally. 
Explanatory videos and manuals were available through the MoH website. Initial 
parameterization, helpdesk and support was in charge of MoH personnel. Telemedicine 
Programs were created based on specialties and health disorders coded with SNOMED. 
Each province created healthcare institution networks, called Subsystems, and set the 
rules for the teleconsultations workflow. Interestingly, 23 out of 24 (95.8%) provinces 
started using the teleconsultation platform. 
During the first 2 months, 18 telemedicine programs were created. The most used 
were Tele-Pediatrics (TPed) and Tele-Internal Medicine (TIM). The TPed program is 
well consolidated, based on a longstanding experience since 1987. Even though in 
August 2019 the consultations were 87.14% for TPed and 12.86% for TIM, in September 
the adult program usage increased 146%: 81.1% (TPed); 18.6% (TIM). 
Regarding the reason for teleconsultation, 31.8% were initiated to reach a diagnosis, 
20.4% were looking for treatment advice, 18% for physical referral request. Few 
consultations asked for an interventional procedure (11.3%), while 10.93% needed 
further lab or image studies. Finally, other categories were counter-reference (7.03%), 
prevention (0.35%) and rehabilitation (0.18%). 
4. Conclusion 
 
The TeleHealth Web Platform for eConsultations is a promising tool to close 
accessibility gaps and enhance territorial integrated health service networks. 
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Risk Factors for Chronic Diabetes Patients  
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Abstract. Specific predictive models for diabetes polyneuropathy based on 
screening methods, for example Nerve conduction studies (NCS), can reach up to 
AUC 65.8 – 84.7 % for the conditional diagnosis of DPN in primary care. Prediction 
methods that utilize data from personal health records deal with large non-specific 
datasets with different prediction methods. It was demonstrated that the machine 
learning methods allow to achieve up to 0.7982 precision, 0.8152 recall, 0.8064 f1-
score, 0.8261 accuracy, and 0.8988 AUC using the neural network classifier.   
1. Introduction 
Every third patient with diabetes suffers from diabetic polyneuropathy (DPN). This 
complication is a severe problem for a chronic patient because it can be accompanied by 
neuropathic pain and lead to a decrease in the quality of life. Neuropathic pain 
significantly disrupts sleep, negatively affects daily activity and life satisfaction. The 
earlier the diagnosis is found, the easier the disease can be managed. Several studies on 
the prediction of diabetes mellitus that utilize Linear regression (LR) developed 
predictive models based on records with up to 967 independent variables available from 
large electronic health record archives resulted in up to 0.80% Area Under The Curve 
Receiver Operating Characteristics (AUC-ROC) and enabling to formulate the most 
likely trajectory of comorbidities. Application of the ensemble models approach based 
on the naïve Bayes, Linear regression (LR), Instance-Based Learner, support vector 
machine (SVM), artificial neural networks (ANN), decision trees, and random forest 
(RF) help to increase the accuracy of diabetes prediction with the accuracy of up to 74%. 
The goal of this study is the implementation of machine learning methods for early risk 
identification of diabetes polyneuropathy based on structured electronic medical records. 
2. Methods 
The dataset contains a total number of 238590 laboratory records. Each record contains 
patient and episode identifiers, a timestamp, and a varying number of measured 
parameters, the total number of which is 31 (27 laboratory tests, retinopathy, 
nephropathy, age, and gender). The records include information 5846 diabetic patients. 
Diagnosis served as the source of information about the target class values. To identify 
subclasses within the class of patients with diabetes, the classification problem was 
solved. Each experiment ran in the setting of stratified 5-fold cross-validation (i.e., 
random 80% of patients were used for training and 20% for testing, target class ratios in 
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the folds were preserved). The AUC was calculated based on an average of 5 curves (one 
curve per fold in the setting of 5-fold cross-validation). 
3. Results 
There are two large clusters (#0 and #3) that are opposite to the percentage of patients 
with polyneuropathy, namely the smallest and the largest rate of polyneuropathy. Cluster 
# 0 has an increased rate of patients with polyneuropathy: 59 %. In cluster #3, on the 
contrary, the reduced number of patients with polyneuropathy is 22 %. However, these 
are both female clusters. In male clusters #1 and #2, the percentage is close to the average. 
Cluster #4 is slightly below average. In clusters 0, 1, and 2, patients are about the same 
age. The difference in cluster 1 is that there is an outlier on the left, and it is male in 
contrast to cluster 0. Cluster 3 patients are young men, younger than patients cluster 0, 
1, and 2, and also male. Cluster 4 are young male patients, which explains their low 
percentage of polyneuropathy. Cluster 5 patients of different ages with a small portion 
of polyneuropathy are mostly men. It is evident that the female gender and the age of 
more than 50 years is a risk factor for the development of polyneuropathy in patients 
with diabetes mellitus. However, there is a particular group of young men (cluster 4) 
with the probability of polyneuropathy. As a result of the cluster analysis, several groups 
of patients were identified: younger men and women (clusters 4 and 3, the share of 
polyneuropathy is significantly lower), older men and women (clusters 1 and 2: men, 0: 
women, the share of polyneuropathy is significantly higher). The most significant 
features were those of neutrophils and glucose level in the blood and the urine. The 
correlation matrix shows the high correlation of MPW, RBC, HGB, and polyneuropathy. 
If we discuss the main features (indicators) affecting the development of polyneuropathy 
in diabetes, the presence of a decrease in the relative number of segmented neutrophils, 
which supports the postulate of the main contribution of monocyte cells in the process 
of inflammation development [13], as well as signs of unsatisfactory glycemic control 
manifested in glucoseuria and hyperglycemia, become clinically important events.  
4. Discussion and conclusion 
Clustering shows differences within patients with diabetes mellitus. Decision trees 
demonstrate pathophysiological mechanisms. It was demonstrated that inclusion of just 
two features, namely “nephropathy” and “retinopathy”, allows to increase the 
performance even further, achieving up to 0.7982 precision, 0.8152 recall, 0.8064 f1-
score, 0.8261 accuracy, and 0.8988 AUC using the neural network classifier. 
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Rosacea Patients Are at Higher Risk for 
Obstructive Sleep Apnea: Automated 
Retrospective Research 
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Abstract. Using big data science we employ NLP and a novel interface the BMI 
Investigator to answer clinically meaninful questions.  The use case presented is the 
association between Rosacea and Obstructive Sleep Apnea.  
Keywords. Big data science, information Retreival, NLP, Rosacea, Obstructive Sleep 
Apnea 
1. Introduction 
Automated retrospective research is a goal of an EHR driven research program.  Here 
with this application we can go from clinical observation to science in ten minutes using a 
large cohort driven observational database linked to codified clinical notes using 
SNOMED CT.  In this study we show that patients with Rosacea are at significantly 
increased risk for Obstructive Sleep Apnea (OSA).   
Rosacea is a chronic skin condition that typically affects the face.[2][3] It results in 
redness, pimples, swelling, and small and superficial dilated blood vessels.[2] Obstructive 
sleep apnea (OSA) is the most common type of sleep apnea and is characterized by 
repeated episodes of complete or partial obstructions of the upper airway during sleep,  
OSA is usually associated with a reduction in blood oxygen saturation. 
The BMI Investigator is a computer human interface built in .Net which allows 
simultaneous query of structured data such as demographics, administrative codes, 
medications (coded in RxNorm), laboratory test results (coded in LOINC) and formerly 
unstructured data in clinical notes (coded in SNOMED CT).  The SNOMED CT codes are 
stored using Berkley DB and NoSQL Elastic Search, and the structured data is stored in 
SQL using the OMOP / OHDSI format.  We have integrated genomic data into the 
software platform and are working to integrate image features into the query engine.   
2. Methods 
We use the high throughput phenotyping – Natuaral Language Processor (HTP-NLP) 
developed at the University at Buffalo.[4].  The BMI Investigator application was written 
in .Net and was created using the user-centered design development method with a team 
of programmers, physicians, graduate students and faculty [5,6].  We tested the system on 
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a population of 212,343 patients in our outpatient practices at the UBMD practice plans 
age 18 and older.  The data for this trial was from 2010 to 2015.  The data used in the 
system was judged by the IRB to be IRB Exempt #587570.   The system allows users to 
use Boolean logic and parentheses to construct their queries.   
Genomic data is presented as gene abnormalities that are used in clinical medicine 
and polymorphisms that have been identified are stored in a separate set of tables and they 
are also used to match to our patients who are included in the precision oncology project 
[7].  In an exploratory analysis, which took five to ten minute, we entered four queries 
into the BMI Investigator (Rosacea, Rosacea and OSA, OSA, total eligible cases in the 
database) and used a Pearson Chi-Square test to compare the results. 
3. Results 
The dataset has 212,343 patients.  211,764 patients did not have Rosacea.  5443 patients 
had OSA without Rosacea.  580 patients had OSA with Rosacea and 51 patients had OSA 
with Rosacea.  The chance of OSA without Rosacea was 5443/211,764 (2.6%).  The 
chance of OSA with Rosacea was 51/580 (8.8%).  The Pearson Chi-Square test showed a 
p-value of <0.001.  The relative risk of OSA given Rosacea was 3.4 times those patients 
without Rosacea.  The number needed to test was only 12 to get one positive case. 
4. Conclusions 
The BMI investigator is an evolving tool linked to observational EHR data that has the 
ability to facilitate rapid retrospective research which can be clinically relevant.  In this 
case we have shown evidence that patients with Rosacea are at increased risk for 
Obstructive Sleep Apnea and with a low number needed to test (NNT) they should all be 
asked the screening questions for OSA and if positive they should be considered for 
polysomnography (a sleep study).  Many more studies and quality and safety projects are 
possible using the EHR based data and the BMI Investigators.   
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Safety and Drugs: How Do We Record 
Medication Consumption and Prescription 
in Electronic Medical Records?  
A Look on Aspirin 
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Abstract. Background: documentation of aspirin consumption is usually not 
complete and clear, probably because it´s a cheap drug that can be easily acquired. 
Objective: To evaluate the quality of the record of aspirin consumption 
documented in the electronic medical records (EMRs) of a Private University 
Hospital of Argentina. Design: Qualitative and quantitative descriptive exploratory 
study. Results: principal findings were that 86 % of the notes mentioned aspirin as 
a chronic prescription. 12% mentioned its temporary suspension. Numerous EMRs 
mentioned the use of an "antiplatelet" drug without specifying which, and didn´t 
specify abbreviations, consumed dose or when to start or stop aspirin. 
Conclusions: overall quality of aspirin related information registration in EMRs 
was poor. This is concerning since it’s a frequently prescribed drug, not exempt 
from adverse events. 
Keywords. Aspirin, record, EMR, consumption 
1. Background  
Although medication consumption is the first cause of adverse events [1][2], 
information about drugs taken by patients is often not documented in electronic 
medical records (EMRs). For example, aspirin consumption (dosage, initiation or 
suspension) is not usually complete and clear, probably because it´s a cheap drug that 
can be easily acquired over-the-counter. 
2. Objective  
To evaluate the quality of aspirin related consumption information documented in the 
EMR of a Private University Hospital of the Metropolitan Area of Buenos Aires, 
Argentina.   
3. Design  
 
We developed a keyword-based filter using expert knowledge, that allowed us to detect 
clinical notes in which aspirin was mentioned. We tested it on a manually annotated 
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sample of 2000 clinical notes, obtaining a sensitivity of 100% (95% CI 82.3 - 100) and 
a specificity of 100% (99.6 - 100). Using the filter, we obtained a sample of 1752 
clinical notes which contained at least one of the keywords. These notes were manually 
reviewed and classified according to the information on aspirin consumption that they 
contained in the following categories: current, chronic or temporary consumption of 
aspirin, definitive or temporary suspension, and indication to start it permanently or 
temporarily. We also performed a qualitative description of how professionals 
document its use. 
 
4. Results 
 
86% (95% CI 84.2 - 87.6) of the notes referred to the current use of aspirin as a chronic 
prescription, 12% (10.5 - 13.6) mentioned its temporary suspension, 6.9% (5.7 - 8.2) 
mentioned the indication of starting it daily, 1.4% (0.91 to 2.1) referred to a temporary 
initiation and 1.2% (0.7 to 1.8) a permanent suspension. Numerous records did not 
clarify the dose the patient consumed or when they should start or stop taking it. We 
noted abbreviations of aspirin (i.e. omission of letters) that had not been clarified 
previously and many records mentioned the use of an "antiplatelet" drug without 
specifying it.  
5. Discussion  
Registration errors were more severe in notes describing changes of aspirin use. We 
did not review the structured systems that document the use of drugs in EMR. We 
only focused on unstructured clinical notes where health professionals often write 
changes in pharmacological treatments. We wonder what would be the closest to an 
ideal model of medication reconciliation and if a single health record compatible with 
the different levels of care would be possible. 
6. Conclusions 
Although there is consensus that having a complete pharmacotherapeutic history of 
patients optimizes health decision-making, we found a poor quality of registration of 
an accessible and inexpensive drug such as aspirin, which is not exempt from adverse 
events and whose chronic use is frequent. 
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Service Personalization in IT-Supported 
Finnish Healthcare 
Olli KORHONEN a,1 , Vasiliki MYLONOPOULOU b, and Guido GIUNTI a
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Abstract. This paper reports a case study on the spontaneous personalization 
discussions emerged from interviews with healthcare professionals when asked 
about their work practices and the role of information technology (IT) during 
consultations. We thematically analyzed the personalization elements using an 
existing personalization framework to provide insights on the service 
personalization. Our results contribute to the better design of IT solutions that can 
support health services’ personalization.
Keywords. Personalization, Healthcare, Service Design, Case Study
1. Introduction
As the Healthcare User’s (HU) characteristics, medical condition, and personal 
preferences vary, they should be treated individually making Health Service
personalization (HSP) important. HS often take place between the healthcare 
professional (HP) and HU, supported by IT [7]. IT can act as facilitator for HSP,
providing data about HU’s particular characteristics [2] to be used by HP and HS during
HS delivery [5,7]. In service design, the users and their context are at its core [1]. This 
paper provides insights to the personalization field from a service design perspective [4]
by presenting personalization elements, emerged by the analysis of an interview study
[6] with a personalization framework [5].
2. Methods
We conducted 60 min semi-structured interviews with 6 HP working for more than 10 
years in different levels in the Finnish primary care on behavioral change. It was a 
convenience sample of 1 nurse, 2 medical doctors, and 3 nutritionists. They described
their practices, and the IT support in HS. The interview guide had 3 areas: HP
background, work practices, and IT use. The guide did not include personalization-
related questions. Authors independently thematically analyzed and later discussed the 
data related to personalization. To interpret our results, we used a personalization 
framework [5] related to the automation level IT provides for service personalization. 
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3. Results
Coercive personalization refers to predetermined regulations influencing the HS 
personalization e.g. different IT-solutions offered in Finnish primary healthcare. Within 
the interviews, HP referred to the coercive personalization elements implicitly as the 
support systems and restrictions that were placed on their daily work.
Data display personalization refers to IT enabled personalized data for the 
stakeholders to interpret and make personalization related decisions. The HP used digital 
and none-digital types of data display support to illustrate cases of optimal behavior (e.g. 
a good meal portion image) which they discuss with the HU in comparison to their data.
Data display support used also for progress monitoring during the behavioral change.
The HU’s (digital or paper-based) diary inputs lead to constructive discussions during 
consultation, helping HP to better understand and support their HU.
      Collaboration-based personalization refers to IT supported personalization 
between stakeholders, HP and HU. In this case, it was mainly generated verbally during 
the consultation but counted with the support by technologies. HP and HU discussed to 
provide information and create understanding on HU’s current and past behavior, context,
life situation, motivation, and social circle.
4. Discussion & Conclusion
The need for personalized solutions is frequently presented in the literature [3]. We 
applied the service design approach in healthcare setting, which is uncommon [4] as 
quantitative approaches are more valued than qualitative [8]. The use of a personalization 
framework [5] resulted in a better understanding of the HP views, which may help
improve IT solutions design. Limitations. The study conducted in Finland, the results 
may differ in a country with different culture and socioeconomic environment. The
sample was small, but due to HP’s different specialties and longtime experience, was 
considered representative of a primary healthcare setting.
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Serving Health Emergency Responders 
OpenWHO’s Global User Metrics  
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Melissa ATTIASa, Gaya GAMHEWAGEa 
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Abstract.  This poster presents some preliminary findings of the OpenWHO.org 
platform’s global use trends, in terms of the geographical distribution and 
occupational characteristics of its users. Assessment of user profiles is essential to 
measure the platform’s impact, most notably related to the attainment of its core 
mission: the provision of life-saving knowledge worldwide. A quantitative study 
was conducted on the global metrics of OpenWHO’s user statistics. Common user 
categories encompassed a wide range of professional bodies and occupations, both 
within public health and beyond, ranging from students and volunteers, to WHO 
staff, to members of international organizations and NGOs. Global tendencies in 
platform use confirm that that the mission of OpenWHO, to provide timely, up-to-
date and easy-to-understand lifesaving knowledge to healthcare workers based in-
country and responding to outbreaks at the front line, is being met. 
Keywords. Knowledge transfer, health emergencies, outbreaks, knowledge to 
action, online learning, knowledge resources, OpenWHO 
1. Introduction 
OpenWHO.org was launched in 2017 by the World Health Organization’s (WHO) 
Health Emergencies Programme (WHE). The free, self-paced and open-access online 
learning platform facilitates the transfer of the latest and most-relevant scientific, 
technical and operational knowledge to frontline responders. Planning for the worst-case 
scenario, a pandemic, the platform is designed to host millions of users simultaneously 
and provide an easy-to-access platform for WHO technical guidance.  
This study reveals some user profile characteristics that can be viewed against the 
global MOOC learner demographics. Veletsianos & Shepherdson (2016) highlight 
MOOC learners spanning over 194 countries with most users in North America and 
Europe and a majority being male, 20-40 years old, with a college degree or higher [1]. 
While OpenWHO user data does not collect educational background, the gross use by 
country and user profile seems to align with the global MOOC user profiles.    
2. Method  
Anonymous profile information of over 75 000 users was retrieved from the platform 
database in the format of spreadsheet. A quantitative analysis was conducted, primarily 
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focusing on user demographics and geographical presence, as well as affiliations given 
at the time of first enrollment. A separate analysis was conducted of the geographical 
information of users enrolled in the 12 most-visited courses, many of which were created 
in support of past or ongoing responses to global health emergencies.  
3.Results
As of September 2019, the platform had 75 000 unique users and 130 000 course 
enrolments in more than 70 courses, including courses in all UN official languages and 
15 other languages. User analysis reveals that OpenWHO is accessed by users in over 
190 countries. Half of the platform’s users (46%) are located in the five top countries:
the United States of America, India, Portugal, Nigeria and Saudi Arabia.  
Among the top 20 countries by users, four are experiencing ongoing WHO graded 
health emergencies – the Democratic Republic of the Congo, South Sudan, Pakistan and 
Nigeria – and five others are outbreak and epidemic-prone. The data on user location 
confirm that OpenWHO delivers lifesaving knowledge to those responding to health 
emergencies anywhere in the world. However, in the top countries list, a total of 11 
countries are high-income countries, mainly from North America and Europe. User 
profiles are majority male and aged 20-40.   
Results from the analysis of users’ professional profiles highlight the platform’s 
popularity among healthcare workers at the country level in low- and middle-income 
countries and countries with health events, while the student category is more popular in 
countries with no WHO-graded emergencies, such as the USA, India and Portugal. 
4.Discussion
Real-time health emergencies and outbreaks appear to be driving the platform’s 
popularity in its top countries. OpenWHO has also been successful in achieving yet 
another one of its aims, to make health-related technical knowledge more accessible to 
all, including any interested user, evidenced by the fact that the platform’s materials are 
being utilized by staff across ministries of health, the UN, humanitarian organizations 
and NGOs, as well as healthcare workers, government personnel, volunteers and students. 
This also shows a keen interest in online learning from countries on all continents.
5.Conclusion
OpenWHO’s user analytics suggest that the platform is reaching the world of health 
emergencies, as per its founding principle. Further analysis of user metrics will follow 
to understand the use of various languages on the platform and how use may be impacted 
by different types of health emergencies.
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Smartphone Applications for Range of 
Motion Measurement in Clinical Practice:  
A Systematic Review  
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a
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Abstract. The aim of this study was to investigate the validity and reliability of 
range of motion measurement via smartphone applications. This literature review 
included 26 articles after the selection process. The validity and reliability analysis 
showed good mean results (ICC or r >0.83). Thus, in clinical practice, 
photographic, goniometric and inclinometric smartphone applications can be used 
to measure joint angle, but with caution for cervical, hip and shoulder motions. 
Keywords. Range of motion – application – smartphone - validity – reliability 
1. Introduction 
Many smartphone applications have been launched in recent years for patient 
management in clinical practice, as well as range of motion tools.  However, before 
generalizing these tools, it is necessary to know the psychometrics qualities of these 
new smartphone applications. The aim of this study was to provide a systematic review 
about validity and reliability (intra and inter-raters) of range of motion measurement 
(upper-limbs, lower limbs and trunk movements) via smartphone application.  
2. Study 
2.1. Method 
The research was conducted, in English, using the following keywords such as « 
healthy subjects », « phone », « range of motion », validity », « reliability » et « 
repeatability » on the databases: PubMed/ Medline, ScienceDirect and Pedro. A 
synthesis was carried out and the qualities of each study was evaluated by the Qarel 
score.   
2.2. Results 
563 articles about smartphone applications used in healthy subjects were identified. 
Following the selection criteria, 26 articles were included which are six articles for 
cervical, thoracic and lumbar motions, 11 for lower limb and 9 for upper limb motions. 
____________________ 
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These studies included 818 healthy subjects. The mean Qarel score for all studies was 
7.36/12 (min:6/max:9). The synthesis showed that the for validity was good (r = 0.83 
[min:0.40, max:0.99]). The intra-rater reliability analysis showed an ICC=0.88 
(min:0.05 – max:0.99), investigated by 23 studies. The inter-rater reliability was 
assessed by 20 studies with a mean ICC result (ICC=0.85 [min:0.07 – max:0.99]). The 
results highlighted no difference between the type of applications (inclinometer or 
goniometer) and the phone system (iPhone vs. Android). 
2.3. Discussion  
This systematic review showed the existence of numerous studies on the psychometric 
qualities of smartphone applications to measure range of motion in clinical practice for 
healthy subjects. All studies presented a consistent methodology with the stated 
objective and tested validity prior to reliability. The data suggest that smartphone with 
the angle apps is a viable substitute for using a usual goniometer or an inclinometer 
when measuring angular changes that typically occur when examining range of motion 
and demonstrate the capacity of multiple examiners to accurately use smartphone-based 
angle apps. The trunk, upper limb and lower limb range of motion were assessed for 
validity and intra-rater reliability in healthy subjects. The inter-rater reliability has not 
been studied for hip movements. The best values were obtained for the wrist, the 
elbow, the ankle, the knee, the lumbar and thoracic range of motion, whatever 
application was used. No study at the time of the review was found on the finger 
movements. 
 
Figure 1. Synthesis of validity results. 
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Abstract. This study investigated the feasibility of a postpartum depression predic-
tor based on social media writings. The current broad use of social media networks
generates a large amount of digital data, which, when coupled with artificial intel-
ligence methods, have the potential to disclose significant health related insights.
In this paper we explore the use of machine learning for prediction of postpartum
depression on a corpus created from Reddit posts.
Keywords. postpartum depression, social media, machine learning, mental health,
women’s health
1. Introduction
Despite the widespread use of prenatal care and the increasing adoption of ante- and
post-partum depression screening tools, post partum depression (PPD) often goes undi-
agnosed or untreated. For example, Ko et. al [1] estimated nearly 50% of of pregnant
women who experienced a major depressive episode in the past year received treatment,
and Vesga-Lopez et al. [2] estimated the prevalence for untreated, postpartum mood dis-
orders to be 85%. Clearly, there is an opportunity to enhance existing screening tools and
protocols to detect PPD, and to promote better treatments. Here, this study considers the
use of social media as an early intervention tool by accelerating the potential diagnosis
of mothers at risk of PPD and thus the implementation of early interventions.
2. Methods
We build a corpus of postpartum depression related posts matched with control posts
using the Reddit API2. We collected public posts from PPD related subreddits, along
with posts from parenting subreddits as controls. We conducted this study as a binary
classification question. Prior to post classification, the preprocessing of the Reddit posts
followed standard approaches in text classification. The posts were lowercased and tok-
enized, after removing all non-alphabetic characters. Stopwords were filtered. We con-
sidered Bag of Words (BoW) features as predictors and we applied counts and tf-idf
based feature weighting. All experiments were managed using the scikit-learn machine
learning framework [3]. Additionally, our experiment targeted the relation between gen-
1Corresponding?Author:?alina.trifan@ua.pt?
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eralized depression and postpartum depression. For this purpose, we employed a model
previously trained on a dataset containing writings of depressed Reddit users, matched
with control users, the Reddit Self-reported Depression Dataset (RSDD) proposed by
Yates et al. [4].
3. Results
We performed experiments with two different estimators, under different configurations,
Passive Aggressive and Perceptron, as well as the model trained on RSDD. We present
the best results in Table 1. These results demonstrate that it is possible to distinguish
postpartum depression related context from generalized user writings with quite a high
degree of confidence. Moreover, as expected, there is a clear connection between the
writing style of people suffering from depression, independently of their age and sex,
and recent mothers that go through postpartum depression.
Table 1. Comparative results on classifying postpartum depression.
Method Prec. Rec. F1 Acc
Perceptron 0.83 0.87 0.85 0.89
Passive Aggressive (loss=sqrt hinge) 0.90 0.89 0.9 0.93
RSDD trained model 0.95 0.43 0.6 0.8
4. Conclusions
The preliminary results that we present in this paper serve as a motivation for safely
exploring social media networks as enablers of early risk interventions for mothers suf-
fering from postpartum depression. As future work, we will focus on extending the col-
lected corpus with more user histories and identifying psycholinguistics features that
differentiate the postpartum depression group from the control group within our corpus.
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Specification?and?Distribution?of
Vocabularies?Among?Consortial?Partners
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Abstract. Due to the variety of different software systems and disparate observa-
tional databases, the need for a uniform data representation rises. Common data
models (CDM) support the harmonisation of data. A powerful but compact soft-
ware setup and a minimum vocabulary set has been composed via Docker to facil-
itate analysis of data across ten university hospitals. The presented approach also
creates the possibility to use a concise database which is easy to deploy.
Keywords. vocabulary, OMOP, Docker, reproducible, data sharing
1. Introduction
To overcome the issues caused by heterogeneous databases, common data models
(CDM) support the harmonisation of data. As part of the MIRACUM initiative [1],
all data should be transformed into the Observational Medical Outcomes Partnership
(OMOP) CDM [2]. This yields a universal format and a corporate representation with
corresponding terminologies, vocabularies and coding schemes. The outcome of the im-
plementation is the utilisation and analysis of data across ten university hospitals and
the possibility to use the OHDSI suite of applications and exploration tools [3] in one
ready-made distribution.
2. Method
First, a minimal vocabulary for a provided synthetic test data was specified by down-
loading the full set of standardised vocabularies and based on local data and mappings
the actually needed concepts where determined. The next step comprised the enhance-
ment of the minimal vocabulary to meet the requirements of the core data. Based on
the work of Maier et al. [4] who integrated the ICD-10-GM (International Classifica-
tion of Diseases, German Modification) and the ”Operationen- und Prozedurenschlu¨ssel”
(surgery and procedure key) the vocabulary set was cleaned from unnecessary vocab-
ularies that have no relevance in Germany. Finally, a system was planed and realised
1Corresponding? Author:? ???????? ???????????????????????????????????
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using?Docker.?The? software? bundle? includes? the?OHDSI?WebAPI? [3]?which? contains?
all? services? that? can? be? called? from?Atlas? [3].?Additionally,? the? R?Methods? Library?
(https://github.com/OHDSI/Broadsea-MethodsLibrary)? and?Achilles? [3]?were? applied.?
The? databases?were? generated? reproducibly? via? scripts? and? shared? for? the? partners? as?
Docker?volumes?which?differ?in?the?setup?and?size?to?meet?different?requirements.
3.? Results
All? system?dependent?volumes?and? images?are?hosted? in?a?common? registry?and? self-
hosted?cloud? storage,? respectively.?The?developed? system?uses?a?Docker?compose?file?
which? is?derived?from? the?OHDSI?Broadsea?[5]? tool?set.?Thus,? the?whole?setup?can?be?
deployed? in?minutes?using?simple?docker?commands.?The?project? is?publicly?available?
via?GitLab?(https://gitlab.miracum.org/gruhlmi/ohdsi-omop-v5).
4.? Discussion
The? system? can? be? reproducibly? deployed.?Broadsea?was? chosen? as? a? basis? and? cus-
tomized?so?that?a?complete?database?with?all?needed?content?to?start?work?with?OMOP?is?
available?from?one?hand.?The?OMOP?CDM?was?selected?because?of?initial?experiences?
and?a?big?community.?The?compilation?of?the?provided?minimum?vocabulary?fits?the?re-
quirements?for?healthcare?research?in?Germany.?Hence,?every?consortial?member?can?start?
up?an?initial?database?with?optimal?memory?utilisation.?The?use?of?the?vocabulary?is?sub-
jected?to?the?license?agreement?and?expects?individual?responsibility?by?every?end?user.?
Apart?from?the?promising?approach?there?are?still?challenges?regarding?the?particularities?
of?German?classifications?and?procedures?and?the?mapping?to?standard?vocabularies.
5.? Conclusion
The?successful?realisation?of?the?objectives?yields?a?powerful?system?which?uses?OMOP?
as?starting?point?for?federated?healthcare?research?among?ten?MIRACUM?sites.?Further?
work?on?this?topic?will?include?the?upgrade?of?the?components?and?a?strategy?development?
to?update? the?vocabularies?automatically.?The?work? is?part?of? the?project?MIRACUM,?
funded?by?the?German?Ministry?of?Education?and?Research?(FKZ?01ZZ1801L).
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1. Introduction 
About 15% of patients with diabetes mellitus develop a diabetic foot syndrome (DFS) 
during their lifetime. Complications caused by DFS are the main reason for hospital 
admissions and amputations [1] [2]. The number of amputations in DFS patients is 
estimated at 40,000 per year and accounts for approximately 70% of all amputations 
performed in Germany. The total costs of treatment in Germany amount to 
approximately 2.5 billion euros per year. In order to reduce expenses, the DFS needs 
optimal care and treatment [3]. The data and information transfer is a decisive aspect in 
ensuring the quality of care and patient safety. The development and use of modern e-
health applications is therefore a promising approach for the interdisciplinary treatment 
of DFS. The iFoot research project focuses on an optimized approach to DFS medical 
and nursing care. In 2005 the German Federal Association for Statutory Health 
Insurance Physicians (Kassenärztliche Bundesvereinigung, KBV) introduced a 
specification for the electronic Disease Management Programme (eDMP) for patients 
with Diabetes mellitus type 1 and type 2. The aim of the eDMP is the structured 
treatment of chronically ill patients with the help of defined care processes based on 
defined therapy goals and to improve communication and care between service 
providers and the inpatient and outpatient sectors of the German health care system [4]. 
2. Methods  
Since the current specification of the eDMP Diabetes mellitus type 1 and type 2 does 
not provide the use of terminology standards, some excerpts of the eDMP are 
represented in this paper using the internationally recognized IT standards Fast 
Healthcare Interoperability Resources (FHIR) and the Systematized Nomenclature of 
Medicine Clinical Terms (SNOMED CT). FHIR is an international standard of Health 
Level Seven (HL7) for the exchange of digital health data [5]. SNOMED CT is a 
multilingual medical terminology system that is already used in over fifty countries for 
the electronic representation of clinically relevant terms [6]. In the context of this 
ongoing work, an example will be used to illustrate the possibility of mapping the 
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eDMP diabetes mellitus type 1 and type 2 according to the guidelines of the KBV with 
international standards. 
3. Results 
As an example, the mapping of the specified data fields for further risks for ulcus is 
carried out in an FHIR-Observation resource via SNOMED CT code 714664001 (At 
Risk of diabetic foot ulcer). Within the Observation.valueCodeableConcept element, it 
is possible to define the given values in coded form. For this purpose, the KBV defines 
the following seven concepts (Table 1): 
 
Table 1. Mapping examples from eDMP Diabetes mellitus to SNOMED CT 
            Code                                     Term Code System 
373066001 Yes     SNOMED CT 
373067005 No SNOMED CT 
229844004 
75134009 
396228006:363713009=255345002 
128926000:255234002=371087003 
128926000:255234002=180030006 
Deformity of foot 
Not examined for 
Hyperkeratosis with bleeding 
State after ulcer 
State after amputation 
SNOMED CT 
SNOMED CT 
SNOMED CT 
SNOMED CT 
SNOMED CT 
 
   
4. Discussion  
The current results of this ongoing work demonstrate that the use of FHIR and 
SNOMED CT is well suited and feasible for the annotation of the eDMP Diabetes 
mellitus type 1 and type 2 specification, although the annotation of the dataset poses 
some challenges due to a lack of information from KBV. Furthermore, as shown in 
Table 1, for more complex data elements (e.g. Hyperkeratosis with bleeding), post-
coordinated SNOMED CT concepts had to be built. By using standardized 
terminologies, future implementations of the eDMP for Diabetes mellitus could reduce 
redundancies in data collection and storage. Thus, eDMPs could become an integral 
part of an interoperable eHealth landscape in the German health care system. 
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Abstract. Through the development of a dashboard with participative 
methodology we present a centralized strategy to analyze and visualize EMRs data 
for the management of 15 public hospitals from Buenos Aires City. This approach 
could constitute an efficient option for public health systems from developing 
countries. 
Keywords. Electronic medical records, R software, data visualization, public 
health care. 
1. Introduction 
The availability and increasing amounts of data from electronic medical records 
(EMRs) give an important boost for information-based health service management. 
However, the exploitation of information to improve health care systems in low-
income countries is scarce [1]. In June 2016, the Ministry of Health of the city of 
Buenos Aires began to implement an EMR system at the primary healthcare level and 
progressively expanded into general hospitals [2]. Nevertheless, hospitals do not have 
human resources with the skills to conduct data analysis from EMRs. To minimize 
these technical barriers and support decision-making processes, AGISE1 designed a 
centralized and participative strategy to create dashboards for the management of 15 
public hospitals.  
2. Methods 
The centralized component of the strategy included the analysis and development of the 
dashboards. R software was chosen for statistical computing as it is open-source and 
free tool. The following libraries were used for visualization: highcharter, to create 
charts, leaflet, to create interactive maps, and rmarkdown, to render the dashboards. 
AGISE scheduled meetings with the managers of the three hospitals with the highest 
levels of EMR implementation in order to define and design new indicators and review 
testing versions in a participative manner. Unstructured individual exchanges with each 
manager were conducted for indicator prioritization and selection.  
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3. Results 
After reaching a consensus on what indicators and information should be included, the 
final version was elaborated and then distributed to the remaining hospitals. The 
dashboard contains an initial page (Fig.1) divided into four sections: Demographic 
Data (Fig.2), Registration, Outpatient Consultations, and Emergency Room 
Consultations (Figs.3 and 4). New versions of the design of the dashboard are 
incorporated on an ongoing basis as more hospital areas implement EMR systems. 
4. Discussion 
Although management frameworks recommend decentralized decision making for 
hospital autonomy and governance [3], the centralized and participative approach may 
have advantages in a context of low-qualified human resources for data analysis.  
5. Conclusion 
This action plan could constitute a good option for decision-making processes in public 
hospitals using EMR information with available resources in health systems from 
developing countries. Next steps will include evaluation of dashboard use and utility. 
 
          
          Figure 1. Initial page for each hospital.                     Figure 2. Demographic Data. 
 
        
Figure 3. Outpatient Consultations.           Figure 4. Outpatient Consultations. 
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Strengthening Behavior and Social 
Functioning Among Persons with Autism 
Spectrum Conditions 
Intelligence and Behavioral Activation: 
Protocol for the Well-Being and Health for 
Loved onEs with ASD (WHOLE) 
Psychosocial Pilot Randomized Controlled 
Trial 
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Abstract. Although a proportion of families and communities in low resource 
settings continue to provide care to loved ones with autism spectrum conditions, 
many of the affected persons remain undiagnosed and without access to proven 
therapies due to high treatment cost and cultural pressures, in particular. Use of 
conversational agents on mobile phones in combination with behavior activation 
home care may provide an innovative, culturally appropriate and affordable 
platform for strengthening behavior and social functioning outcomes, in addition to 
an opportunity for participation of the persons with autism spectrum conditions in 
the intervention development process.  We aim to assess the effectiveness of an 
intervention that incorporates artificial intelligence conversational agent 
technologies and behavioral activation therapy techniques. 
Keywords. Artificial Intelligence, Autism Spectrum Disorders, Conversational 
Agent, Chatbot, Psychosocial, Social functioning, Randomized Control Trial 
1. Introduction 
Autism Spectrum Disorders (ASD) are the fastest growing developmental disability [4, 
5] that affects approx. 1% of the world population [2] and impacts behavioral and social 
functioning deficits such as social motivation, social anxiety, social cognition, and social 
skills [3].  
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Autism policy and intervention research stakeholders advocate for psychosocial 
interventions that reduce core symptoms and improve adaptive skills; empower families 
and local communities; are applicable for low resource settings and actively incorporate 
persons with ASD in the research process and dissemination of findings [1], but 
interventions with such components remain underutilized. Therefore, this study aims to 
assess the feasibility of conducting a randomized control trial (RCT) evaluating the 
effectiveness of a behavior and social functioning intervention using artificial 
intelligence via a conversational agent or chatbot and behavioral activation with persons 
with Autism Spectrum Conditions.  
2. Methods and Analysis 
The Well-being and Health for Loved Ones with Autism Spectrum Conditions 
(WHOLE) intervention is a pilot, single-blinded, randomized controlled trial evaluated 
over 12 weeks, with 6 and 12-month follow-up periods to assess the feasibility, social 
and economic value of the intervention. Sixty youth/young persons will be recruited and 
randomized into intervention and control groups. Participants will be selected, in part, 
via the Emotional and Behavioral Screener instrument from the undiagnosed ASD 
population. Two separate pilot RCTs will be conducted in Saint Kitts & Nevis and 
Republic of China (Taiwan). Analysis of covariance (ANCOVA), descriptive statistics 
and social return on investment (SROI) analysis methods will be employed. 
References 
[1] Amaral, D. G., Anderson, G. M., Bailey, A., Bernier, R., Bishop, S., Blatt, G., Canal-Bedia, R., Charman, 
T., Dawson, G., de Vries, P. J., Dicicco-Bloom, E., Dissanayake, C., Kamio, Y., Kana, R., Khan, N. Z., 
Knoll, A., Kooy, F., Lainhart, J., Levitt, P., ? Whitehouse, A. (2019). Gaps in Current Autism Research: 
The Thoughts of the Autism Research Editorial Board and Associate Editors. Autism Research: Official 
Journal of the International Society for Autism Research, 12(5), 700–714. 
[2] De Luca, R., Leonardi, S., Portaro, S., Le Cause, M., De Domenico, C., Colucci, P. V., Pranio, F., 
Bramanti, P., & Calabrò, R. S. (2019). Innovative use of virtual reality in autism spectrum disorder: A 
case-study. Applied Neuropsychology. Child, 1–11. 
[3] Pallathra, A. A., Calkins, M. E., Parish-Morris, J., Maddox, B. B., Perez, L. S., Miller, J., Gur, R. C., 
Mandell, D. S., Schultz, R. T., & Brodkin, E. S. (2018). Defining behavioral components of social 
functioning in adults with autism spectrum disorder as targets for treatment. Autism Research: Official 
Journal of the International Society for Autism Research, 11(3), 488–502. 
[4] Price, S. (2019). Addressing Autism: Giving Physicians Tools. Texas Medicine, 115(12), 42–44. 
[5] Thabtah, F. (2018). Machine learning in autistic spectrum disorder behavioral research: A review and 
ways forward. Informatics for Health & Social Care, 1–20. 
P. Bowrin and U. Iqbal / Strengthening Behavior and Social Functioning Among Persons1400
TEDIS, a Comprehensive Data Model for 
In- epth Clinical Assessment of Patients 
Affected with Neuro-Developmental 
Disorders Including Autism 
Mohamed BEN SAID a, , Laurence ROBEL b, Pauline CHASTE c, Didier PERISSE d, 
Marie-Joelle OREVE e, Pascale ZYLBERBERG f, Anne PHILIPPE g, Catherine 
JOUSSELME h,  Stéphanie LACOSTE i, Mario SPERANZA e,  Ines HAFSAa, 
Fatouma CISSE a, Zoubair CHERQAOUI a and Jean-Philippe JAIS a 
a
 Paris Descartes University, Faculty of Medicine, Biostatistics Unit, Necker Hospital, 
APHP - Paris, France 
b Dept of Child Psychiatry, Necker Hospital, APHP, Paris, France 
c Dept of Child and Adolescent Psychiatry, Sainte Anne Hospital, Paris, France  
d Dept of Child and Adolescent Psychiatry, GH Pitié-Salpêtrière, APHP, Paris, France 
e Dept of Child and Adolescent Psychiatry, Versailles Hospital, Le Chesnay, France 
f UNIDEP, Jean Verdier Hospital – APHP - Bondy, France  
g Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163 – 
Paris Descartes University - Paris, France 
h Fondation Vallée, Paris Sud University, Gentilly, France 
i Dept of Child and Adolescent Psychiatry, GHEF Hospital – JOSSIGNY, France 
Abstract. TEDIS, an information system dedicated to patients affected with 
neuro-developmental disorders including autism, focuses on patient data generated 
during in-depth clinical assessment in nine expert centers in Ile-de-France region. 
Long term partnership involving methodologists and domain experts is necessary 
to support quality data production and analyses and to guarantee quality data and 
information governance in a domain characterized by frequent evolutions in 
clinical assessment instruments and in diagnostic criteria and classification. 
Keywords. Information model, data governance, information governance, DSM-5, 
ICD-11, Autism Spectrum Disorder, Neuro-Developmental Disorder.  
1. Introduction 
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized 
by persistent difficulties in social communication and interaction, alongside with 
restricted, repetitive behavior patterns and interests [1]. The diagnosis “ is still 
made solely on the basis of self/informant reports of behavior according to diagnostic 
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criteria in the Diagnostic and Statistical Manual of Mental Disorders [DSM-5] or the 
International Classification of Diseases [ICD-10]”[2]. Psychiatric experts from the 
nine “Centres de Diagnostic et d’Evaluation de l’autisme” or (CDE) in Ile-de-France 
region, gathered  with methodologists in a professional network to manage in a 
dedicated primary data source, valuable information resuming in-depth, 
multidisciplinary and psychopathological ASD’ patients’ assessment. The objectives 
are to improve knowledge about ASD disorders, follow-up patient cohorts and to 
improve patient care, decision making, and research. The process converged to the 
TEDIS project [3] supported by the regional public health agency, academic 
institutions and the regional ASD resources association.  
2. Methods 
An agreed-upon chart delimits the contours of the TEDIS project and defines policy for 
data information governance. An application system was developed to facilitate ASD’ 
patient data collection and quality control. Aggregated data are analyzed and described 
in an automatic feedback report [4]. Ethical authorizations facilitated Internet 
deployment via a Certified Health and Personal Data Internet Hosting Provider [5]. 
3. Results 
An active expert network federated around ASD’ patient data production, analyses and 
maintenance. Up-to-date, 978 controlled ASD patient records in TEDIS’ cohort 
provide a quality data source supporting research and public health decision making.  
4. Discussion / Conclusion 
Challenges need being addressed to maintain the professional network active to capture 
domain expertise, to  insure cohort progress and to keep the data model up-to-date with 
evolutions in diagnostic criteria (DSMIV/DSM-5) and classifications (ICD10/ICD11).  
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1. Introduction 
Telemedicine is often suggested as a promising approach to support patients with 
diabetes [1,2]. Telemedicine interventions in diabetes may include video consultations, 
text reminders, telemonitoring, etc. [3,4]. However, the effectiveness of diabetes-
related telemedicine interventions in regards to patient-related outcomes needs 
evaluation.  
The rapid development within telemedicine emphasizes the need for a new review. 
Moreover, previous systematic reviews describing the effectiveness of telemedicine in 
diabetes management focus on a specific type of telemedicine [5,6], a specific type of 
diabetes [7,8], specific comparators [2,6], or specific outcomes [2,9]. Thus, the present 
review has a broad scope with an eye to performing an exhaustive review within the 
field. The present systematic review and meta-analysis aims to evaluate the 
effectiveness of telemedicine interventions versus any comparator on diabetes-related 
outcomes among adult patients with diabetes. 
2. Method 
The present review considers studies that include adult subjects with a diagnosis of 
diabetes (type 1, 2, or gestational). Studies that evaluate telemedicine interventions are 
considered. These telemedicine interventions may include various technologies, and the 
remote communication may be managed by various health care professionals, trained 
peers, or be fully automatic. The review considers randomized controlled trials 
comparing a telemedicine intervention to any control that does not include telemedicine. 
The considered outcomes include all patient-diabetes related outcomes. Peer-reviewed 
full-text papers in English, Norwegian, Danish, and Swedish are considered. 
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A thorough search was performed in PubMed, CINAHL, EMBASE, and the 
Cochrane Library Central Register of Controlled Trials (CENTRAL). To provide an 
estimate of the treatment effect, the studies will be pooled via statistical meta-analysis.  
3. Results 
The search identified 11.759 potential papers. After removal of duplicates, 7.558 
papers remained. These papers underwent screening (title/abstract), and 941 remained 
for full text reading. This resulted in a final sample of 218 papers. Preliminary results 
indicate that effects are limited in regards to type 1 diabetes and gestational diabetes. 
However, the effect in regards to type 2 diabetes shows more promise. 
4. Discussion 
The review is strengthened by the fact that the search of literature is very exhaustive. 
An expected limitation is the limited heterogeneity between telemedicine studies, as the 
studies differ in use of technology, organizational setup, etc., which complicates the 
comparison of studies.  
5. Conclusion 
The present review may add value to the existing evidence base by providing an 
exhaustive review of telemedicine interventions in diabetes. Further results will follow. 
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Abstract. Automated dispensing cabinets in clinical wards may contribute to 
improving safety by reducing the likelihood of medications not being available 
when needed. However, achieving this safety benefit is dependent on a ‘back 
office’ sociotechnical infrastructure that combines semi-automated processes with 
mindful, resilient work practices.  
Keywords. Patient Safety, Hospital Drug Distribution Systems.  
1. Introduction  
Missed medication doses (omissions) are a common medication administration error 
and negatively impact the safety of hospital inpatients (e.g. [1, 2]). One reason leading 
to omissions is unavailability of medication on the ward at the time of need [3].  
Ward-based automated dispensing cabinets (ADCs) can assist with the 
management of ward medication stock (‘imprest’) and thus may reduce the number of 
doses omitted due to unavailability [4]. However, little is known about the ‘behind the 
scenes’ work that contributes to this effect. In this poster we describe and discuss the 
sociotechnical system that lies behind ward-based ADCs. This sociotechnical system 
usually remains invisible [5] to ADC users in clinical areas. 
2. Methods 
We draw on ethnographic research carried out in hospitals in the UK and in Australia. 
The UK study was conducted in an adult hospital in 2016-17, while the study in 
Australia is in progress. Both studies were wide-ranging, focused on clinicians’ 
medication work, with attention paid to medication activities carried out by pharmacy 
staff and technology such as ADCs. Activities were observed both in pharmacy areas 
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and clinical wards. We interviewed pharmacists and technicians, as well as pharmacy 
managers and IT staff. In this analysis, we focus on pharmacy processes for 
management of imprest medications in ADCs. Our analysis was influenced by the 
sensitivity to operations, preoccupation with failures and resourcefulness that 
characterize resilient activities in high-reliability organizations [6], and by the literature 
on infrastructures in organizations [7].   
3. Findings and discussion 
ADCs are one of the many information technologies (IT) hospital pharmacies have in 
place to manage medication stock. Such IT include stock management applications, or 
systems to connect with manufacturers and wholesalers’ catalogues. Some IT 
functionalities are automated: for example, the ADC alerts pharmacy staff of 
medications low in stock; a stock management system can be set up to automatically 
re-order routine stock from wholesalers.  
Effective use of these systems, however, cannot rely exclusively on automation 
that works on data about past use and embedded rules. Instead, it requires pharmacy 
staff to pay attention to any emerging risks associated with the availability (or lack 
thereof) of different types of medication, foreseeing supply chain conditions, and 
resourcefulness in solving problems or constraints.  
This is invisible, mindful [6] work of pharmacy staff behind the scenes of an 
ADC, that makes the replenishing of ADCs’ imprest medication stock look seamless 
from the clinical areas, most of the time.  
4. Conclusion 
The ‘backoffice’ of hospital ADCs is a sociotechnical infrastructure that combines 
semi-automated processes with mindful, resilient work practices. It is this combination, 
rather than the technology on its own, that is likely to reduce the frequency of omitted 
doses for hospital inpatients.  
References 
[1] C.N. Patel, M.D. Swartz, J.S. Tomasek, L.E. Vincent, W.E. Hallum, and J.B. Holcomb, The effects of 
missed doses of antibiotics on hospitalized patient outcomes, J S R  233 (2019), 276-283. 
[2] P. Rostami, C. Heal, A. Harrison, G. Parry, D.M. Ashcroft, and M.P. Tully, Prevalence, nature and risk 
factors for medication administration omissions in English NHS hospital inpatients: a retrospective 
multicentre study using Medication Safety Thermometer data, BMJ Open 9 (2019), e028170. 
[3] R.N. Keers, S.D. Williams, J. Cooke, and D.M. Ashcroft, Causes of Medication Administration Errors 
in Hospitals: a Systematic Review of Quantitative and Qualitative Evidence, Drug safety 36 (2013), 
1045-1067. 
[4] C.M. Boyle, D.J. Maxwell, S.E. Meguid, D. Ouaida, and I. Krass, Missed Doses An Evaluation in Two 
Drug Distribution Systems, The Australian Journal of Hospital Pharmacy 28 (1998), 413-416. 
[5] S.L. Star and A. Strauss, Layers of Silence, Arenas of Voice: The Ecology ofVisible and Invisible 
Work, Comput. Supported Coop. Work 8 (1999), 9-30. 
[6] K.E. Weick, K.M. Sutcliffe, and D. Obstfeld, Organizing for High Reliability: Processes of Collective 
Mindfulness, Research in Organizational Behavior (1999), 81-123. 
[7] S.L. Star, The Ethnography of Infrastructure, American Behavioral Scientist 43 (1999), 377-391. 
V. Lichtner et al. / The ‘Back Office’ of a Dispensing Cabinet1406
The Prevalence of Alcohol and Tobacco Use 
 of Noncommunicable 
Kampol KHEMTHONGa,1, Niruwan TURNBULL?b, Savittri 
Rattanopad SUWANLEE?c, Karl PELTZERd 
a,bFaculty of Public Health, Mahasarakham University, Thailand 
c
?Faculty of Humanities and Social sciences, Mahasarakham  
University, Thailand  
d
?Ton Duc Thang University, Ho Chi Minh City, Vietnam 
Abstract. Noncommunicable diseases (NCDs) were caused by risk factors also 
rising rapidly and killed more people. This study aimed to explore and determine 
the prevalence and distribution of alcohol and tobacco use as NCDs’s risk factors. 
We used a cross-sectional survey on Health dataset between October 2013 and 
April 2017 of people who were 13 years old and older. This study was investigated 
included demographics, alcohol consumption and tobacco use. This study found 
risk of NCDs 49.07%, The majority of risk factor were men (50.2 %), age_group 
were 40-59 years old(24.4%), The most were men having diabetes mellitus family 
(43.0%), hypertension family (17.9 %), alcohol consumption (26.9%), tobacco use 
(19.0%), most of the women were high blood pressure (23.0%), high blood sugar 
level (33.3%), overweight and obesity (23.4%), waist was over (22.5%) and high 
total cholesterol (21.4%), alcohol consumption among the gender 37.8%, most 
were male (26.9%), age_group mostly 45-59 years old (19.3 %), married (23.1%), 
agricultural (29.7%), primary school (29.7%). The prevalence of risk factors, most 
risk factors was tobacco use in men (18.9%), OR 16.789, (95%CI, p-value</001), 
alcohol consumption were men (26.9%), OR 3.934 (95%CI, p-value<.001). 
Keywords. Health Data Centre, Health Dataset, Risk Noncommunicable diseases 
1. Introduction 
Noncommunicable diseases (NCDs) are incurable  chronic diseases. People were death 
by NCDs caused a total of 41 million every year, up to 71% of all deaths globally, most 
death located in low and middle-income countries. The behavioural risk factors and 
metabolic factors are caused the major factors [1]. and underlying risk factors [1, 2]. 
Thailand had increased incidence of NCDs and death around 500,000 cases (71.0%) of 
all death[3]. Thai’s hospitals collected electronic health data records and linkage with 
Health Database Centre (HDC) [4] This study aimed to explore and determined alcohol 
consumption and tobacco use in the prevalence associated with the risk factors of 
NCDs[5]. 
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2. Methodology 
We used a cross-sectional survey and data from electronic health data records were 
verified quality to ensured from all hospitals on Health Data Centre (HDC) database of 
Si Sa Ket Provincial Public Health. This studied data contained demographics, physical 
measurements, biological measurement. This dataset excluded all cases with missing, 
duplicate, error information and a case that a physician had diagnosis be NCDs patient. 
We selected population by purposive sampling who was 13 years old and older.  
3. Results 
Found risk people 49.07 %, were men (50.2 %), age_group were 40-59 years 
old(24.4%)(mean 50.97, S.D. 21.747), men having diabetes mellitus (43.0%), 
hypertension family (17.9 %), alcohol consumption (26.9%), tobacco use (19.0%), 
most of the women were high blood pressure (23.0%), high blood sugar level (33.3%), 
overweight and obesity(23.4%), waist was over (22.5%) and high total cholesterol 
(21.4%). alcohol consumption among the gender 37.8%, mostly were male (26.9%), 
female(10.9%), the group of 45-59 years old (19.3 %), married (23.1%), agricultural 
(29.7%), primary school (29.7%). The prevalence of risk factors, most risk factors was 
tobacco use in men (18.9%), OR 16.789, (95%CI 16.399-17.188, p-value</001), 
alcohol consumption were men (26.9%), OR 3.934 (95%CI 3.885-3.983, p-value<.001). 
4. Discussion and Conclusion 
A large electronic health data were studied from the Health Data Centre (HDC), it was 
a linkage of all Health server database permitted for administrators to verified data and 
sharing.  We found a population that registered, but more cases were missing a health 
check data and electronic health data was an error, missing and duplicate. People who 
risk NCDs and the majority were men. Health evidence based on electronic health data 
could be support and provides health policy maker and effort to health personnel. 
References 
[1] World Health Organization. Noncommunicable diseases 2019 [updated [Internet]. 2019 [cited 2019 
May 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-
diseases. 
[2] Baldock K, Paquet C, Howard N, Coffee N, Hugo G, Taylor A, et al. Associations between resident 
perceptions of the local residential environment and metabolic syndrome. Journal of environmental and 
public health. 2012;2012. 
[3] World Health Organization. World Health Statistics 2015 (http://www. 
who.int/gho/publications/world_health_ statistics/2015/en). Accessed; 2015. 
[4] Ministry of Public Health. Health Data Center 2015 2015 [Available from: 
http://hdcservice.moph.go.th/hdc/main/index.php?sele_kpiyear=2015&level=1&sele_kpi=442f204be9d
6aec9da15786ad707d5a4. 
[5] World Health Organization. WHO | About 9 voluntary global targets. WHO. 2018. 
 
K. Khemthong et al. / The Prevalence of Alcohol and Tobacco Use Associated Risk Factor1408
Toward a Harmonized WHO Family of 
International Classifications Content Model 
Samson W. TU1a Csongor I. NYULASa Tania TUDORACHEa Mark A. MUSENa 
Andrea MARTINUZZIb Coen van GOOLc Vincenzo della MEAd Christopher G. 
CHUTEe Lucilla FRATTURAf Nick HARDIKERg Huib ten NAPELc Richard 
MADDENh  Ann-Helene ALMBORGi  Jeewani Anupama GINIGEj  Catherine SYKES,h 
Can CEKIKk Robert JAKOBk 
a Stanford University, USA, b IRCCS E. Medea Scientific Institute, Italy, cNational 
Institute for Public Health and the Environment, The Netherlands, dUniversity of 
Udine, Italy, eJohns Hopkins University, USA, fCentral Health Directorate, Friuli 
Venezia Giulia Region, Italy, gUniversity of Huddersfield, UK, hUniversity of Sydney, 
Australia, iNational Board of Health and Welfare, Sweden, jWestern Sydney University, 
Australia, kWorld Health Organization 
Abstract. An overarching WHO-FIC Content Model will allow uniform modeling 
of classifications in the WHO Family of International Classifications (WHO-FIC) 
and promote their joint use. We provide an initial conceptualization of such a model. 
Keywords. ICD, ICF, ICHI, Family of International Classifications 
1.Introduction 
The 11th revision of the International Statistical Classification of Diseases and Related 
Health Problems (ICD-11) represents a fundamental change in the methodology for 
developing new classifications at the World Health Organization (WHO). Major 
departures from past ICD revisions include an information model of ICD categories 
called the Content Model, the maintenance of all-inclusive knowledge about ICD-11 
content, called the Foundation, and the ability to create specialized classifications, called 
linearizations, for a range of use cases. 
In addition to ICD, the WHO-FIC reference classifications include the 
International Classification of Functioning, Disability, and Health (ICF)[1], and the 
emerging International Classification of Health Interventions (ICHI)[2]. The goal of this 
work is to develop a generalized WHO-FIC Content Model that defines the information 
structure of the entities in the classifications and their semantic roles. 
2.Method 
The Content Model defines the types of entities and relationships in the WHO-FIC 
Foundation. We analyzed the structure of ICD, ICF, and ICHI to determine an 
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overarching conceptualization. 
3.Results 
We conceptualize the generalized WHO-FIC Content Model as consisting of the 
following: (1) Codable entities in a classification: These are the categories that represent 
phenomena that a classification is designed to encode. For ICD, diseases, disorders, and 
injuries are examples of codable entities. For ICHI, health interventions are the codable 
entities. For ICF, functioning situations (defined in terms of ICF domains and the 
impairment/limitation/restriction qualifiers) and environmental factor roles, will be 
codable entities. (2) Structural component: These are the entities that help to define the 
meaning of codable entities. For ICHI, targets, actions, and means are the structural 
components of health interventions. For ICF, body structure, body function, activities 
and participation, and environmental factors are the structural components that help to 
define the functioning situations and environmental factor roles that ICF is designed to 
code. No structural component is defined for ICD at this time. (3) Defining qualifiers: In 
ICF, some attributes, such as the extent of impairment qualifier, are necessary for the 
definition of codable entities. (4) Extension codes: These are entities that can be used to 
refine the codable entities. (5) Properties of the classification entities: These include 
informational properties, such as title and definition, and post-coordination properties 
that represent axes along which the entities can be defined logically or specialized. 
In addition, a post-coordination model specifies how the structural components, 
defining qualifiers, and extension codes can be used, in conjunction with post- 
coordination properties, to define and refine codable entities. Finally, a linearization 
model specifies what entities and relationships are necessary to describe any linearization 
in the Foundation. It allows the specification of the entities that should be included in a 
linearization, the post-coordination axes are allowed or required in a given linearization, 
and constraints on the values of the post-coordination axes in a linearization. 
4.Discussion 
ICD and ICHI can easily be formulated in this framework. For ICF, the introduction of 
the concept of codable entities as composed from ICF domains and qualifiers formalizes 
what has been informally defined. The post-coordination model defines the semantic 
roles that each type of entity plays in the information model. In conclusion, the 
unification of WHO reference classifications in a common modeling framework is 
promising and provides a solid foundation for future enhancements of these 
classifications. 
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Abstract. A unified and integrated approach to represent mHealth apps and their 
characteristics is currently lacking. To fill this gap, the overall purpose of this 
project is to develop an ontology, to help address the objective of building 'trustful' 
mHealth apps. This paper is a brief presentation of the followed methods, and the 
preliminary results of the research, i.e. a first version of that ontology. 
Keywords. mHealth apps, ontology development process, Unified Modeling 
Language Class Diagrams, Web Ontology Language, Protégé 
1. Introduction 
Despite the continuous growth of mobile health applications (mHealth apps), the 
available ones are problematic, due to the lack of a unified framework, specially 
devised for their development and quality assessment [1]. This prevents a common 
adoption of mHealth apps in healthcare delivery, as they might be risky. Massive 
accreditation programmes of mHealth apps seem to be unfeasible [2], though 
assessment frameworks have been developed [3] and development of standards is in 
progress (e.g. HL7 cMHAFF [4]). Alternative strategies for quality assessment have to 
be explored, as well. Biomedical Informatics research has demonstrated a successful 
development of ontologies. As defined in Computer Science, they are sets of concepts 
and their relationships, to represent a domain, by sharing structured, computable 
knowledge (e.g. the Gene Ontology [5], for genes’ annotation). This project aimed to 
propose an ontology to help address the objective of building 'trustful' mHealth apps, 
sharing common understanding of the concepts, among people and applications.  
2. Method and Results 
We applied a combination of methods to develop an ontology for mHealth apps. The 
Design Science research methodology [6] has been involved as a main theory in the 
research process. We performed a literature search and analysis to identify features and 
characteristics of mHealth apps (search strings: “ontology development”, “mHealth”, 
“mHealth apps”, “mobile apps”, “content analysis”, “methodologies for ontology 
development”, sources: PubMed, Web of Science, and Google Scholar; time span: 
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2013-2017, language: English). The Unified Process for ONtology building (UPON) 
[7] and the Ontology Development 101 [8] guide have been applied for implementing 
the ontology. Protégé 5.2.0 and Astah UML have been used to represent the ontology 
by OWL 2.0 language and UML class diagrams, respectively. Finally, to identify 
subsumption relationships between classes, HermiT OWL Reasoner has been applied. 
Sixteen papers were selected and analysed. The developed ontology includes 13 
concepts and their relationships. Main concepts are “mHealth app” (with its features), 
“User”, “Development Process”, “Developer”, “Organisation”, “App Publisher”, and 
“App Documentation”, with sub-concepts. Main relationships are “use”, “assess”, 
recommend”, “develop”, “is_supported_by”, “regulate”, and “provide”. OWL 2.0 
format and UML class diagrams have been created, and consistency achieved.  
3. Discussion and Conclusion 
A first edition of an ontology for mHealth apps has been implemented, and its 
consistency achieved. Compared to past research [9], in this study mHealth apps and 
their development were the focuses, including OWL and UML format of the ontology.  
This work has certain limitations; firstly, only two researchers performed the 
development. Secondly, literature from 2013 to 2017 was considered to identify 
concepts and relationships. Future work addresses involving more researchers and 
including updated literature.  
4. Acknowledgments 
This research has been supported by the Health Informatics Centre (HIC), LIME 
Department, Karolinska Institutet, Stockholm, Sweden. 
References 
[1] C.K. Kao, D.M. Liebovitz, Consumer Mobile Health Apps: Current State, Barriers, and Future 
Directions, PM R. 9 (2017), S106-S115. 
[2] P. Wicks, E. Chiauzzi, 'Trust but verify'--five approaches to ensure safe medical apps, BMC Med. 13 
(2015), 205.  
[3] R. Nouri, S. R Niakan Kalhori, M. Ghazisaeedi, G. Marchand, M. Yasini, Criteria for assessing the 
quality of mHealth apps: a systematic review. J Am Med Inform Assoc 25 (2018), 1089-1098. 
[4] HL7 Consumer Mobile Health Application Functional Framework (cMHAFF), Release 1. [Online, June 
2018] Available at: https://www.hl7.org/implement/standards/product_brief.cfm?product_id=476 
[5] The Gene Ontology Consortium, The Gene Ontology Resource: 20 years and still GOing strong, 
Nucleic Acids Res. 47(D1) (2019)D330-D338.  
[6] K. Peffers, T. Tuunanen, C.E. Genglesr, at al., The design science research process: A model for 
producing and presenting information systems research, First International Conference on Design 
Science Research in Information Systems and Technology, 2006, 83-106. 
[7] A. De Nicola, M. Missikoff, R. Navigli, A Proposal for a Unified Process for Ontology Building: 
UPON, Lecture Notes in Computer Science, (2005)655–64. 
[8] N.F. Noy, D.L. McGuinness, Ontology Development 101: A Guide to Creating Your First Ontology, 
Stanford University, Stanford, CA, 2001. 
[9] J.D. Cameron, A. Ramaprasad, T. Syn, An ontology of and roadmap for mHealth research, Int J Med 
Inform 100 (2017),16-25. 
H. Derbouz Rouibete and S. Bonacina / Towards an Ontology for Trustful mHealth Apps1412
Towards Prediction of Type 1 Diabetes 
Patients Who Fail to Achieve Glycemic 
Target 
Morten Hasselstrøm JENSEN1a,b, Simon CICHOSZa, Ole HEJLESENa, Irl.B. 
HIRSCHc, Peter VESTERGAARDa,d 
aSteno Diabetes Center North Denmark, Aalborg University Hospital, Denmark  
bDepartment of Health Science and Technology, Aalborg University, Denmark 
c Department of Medicine, University of Washington, Seattle WA 
d Department of Clinical Medicine, Aalborg University, Denmark 
Abstract. In this study, we investigated which predictors from people with type 1 
diabetes at initiation of intensive treatment that increase the risk of not achieving 
glycemic target. Data from a clinical trial with type 1 diabetes people (n=460) were 
used in a logistic regression model to analyze the effect of the predictors on 
achievement of glycemic target. Results indicate that age, smoking, glycated 
hemoglobin, 1,5-anhydroglucitol and fluctuation from continuous glucose 
monitoring are predictors of achievement of glycemic target, which can be used in 
an algorithm to predict people who fail to achieve glycemic target. 
Keywords. Type 1 diabetes, prediction, continuous glucose monitoring 
1.Introduction 
Today’s guidelines, such as, American Diabetes Association’s Standards of Medical 
Care in Diabetes – 2019[1] recommend intensive treatment for diabetes patients to 
achieve a glycated hemoglobin (HbA1c) level of less than 7% (54 mmol/mol). However, 
it is challenging for people with type 1 diabetes to achieve this glycemic target, and a too 
aggressive treatment increases the risk of severe hypoglycemia[2]. Prediction at 
initiation of intensive treatment of those who will fail to achieve target would enable an 
alternative personalized treatment with the potential of being more effective and safer. 
This study sought to investigate which predictors from people with type 1 diabetes at 
initiation of intensive treatment that increase the risk of not achieving glycemic target. 
2.Method 
Data from people with type 1 diabetes (n=460) enrolled in the Onset 5® trial by Novo 
Nordisk. Participants were on average 43 years old, 57% male, had a diabetes duration 
of 24 years, a body mass index of 26 kg/m2 and an HbA1c of 7.5% (58.5 mmol/L) at 
baseline. 359 (78%) of the participants did not achieve HbA1c < 7% after 16 weeks of 
treatment. Time of randomization defined baseline and initiation of intensive insulin 
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treatment. A logistic regression model was constructed to analyze the effect of a variety 
of predictors at baseline on achievement of HbA1c < 7% (Y/N) after 16 weeks of 
treatment. Predictors at baseline included age (stratified in 18-25, 25-35, 35-50, 50-65 
and >65 years), gender, diabetes duration, body mass index, HbA1c, smoking status, 
fluctuation from continuous glucose monitoring, 1,5-anhydroglycitol (1,5-AG) and 
fasting plasma glucose. Odds ratios (OR) are presented with 95% confidence intervals 
(CI). 
3.Results 
Higher age resulted in an increased risk of not achieving target (50-65 vs 18-25 years 
OR: 3.5, 95% CI: 1.3-9.6). Not surprisingly, higher HbA1c at baseline increased the risk 
as well (OR: 14.7, 95% CI: 7.2-30.0). Being a smoker resulted in a 4-fold increased risk 
of not achieving target (OR: 4.0, 95% CI: 1.2-13.4). Increase in 1,5-AG resulted in a 
decreased risk (OR: 0.89, 95% CI: 0.87-1.01), whereas increased fluctuation in CGM 
increased the risk (OR: 1.34, 95% CI: 0.77-2.33), however, none of them were 
statistically significant. An analysis without fluctuation resulted in a statistically 
significant association between 1,5-AG and achieving glycemic target (OR: 0.87, 95% 
CI: 0.77-0.99). 
4.Discussion 
In this study, higher age affects ability to achieve glycemic target irrespective of diabetes 
duration. Furthermore, being smoker is associated with not achieving target, which is 
confirmed by Peng et al.[3]. Higher 1.5-AG level decreased the risk of not achieving 
target. Blood concentrations of 1,5-AG decreases during time of hyperglycemia, and a 
higher 1,5-AG level at baseline is thus a reflection of a better control with less glycemic 
variability. Furthermore, findings about fluctuation in CGM strengthen the indication of 
glycemic variability as a predictor of achievement of glycemic target. 
5.Conclusion 
Both age, smoking status, HbA1c, 1,5-AG and CGM fluctuation are at baseline for people 
with type 1 diabetes who succeed or fail to achieve glycemic target after 16 weeks of 
treatment. These are valuable findings prior to development of an algorithm to predict 
people who do not achieve glycemic target from intensive insulin treatment where 
alternative treatment options should thus be considered. 
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Abstract. openEHR and FHIR are two competing clinical data modeling and data 
exchange standards, that are commonly seen as mostly incompatible. However, the 
two have quite much in common and bridging approaches between the two worlds 
can serve the benefit of both communities. In the presented work, the data models 
of openEHR are translated into FHIR data models. 
1. Introduction 
FHIR and openEHR are two data model standards, which both have in common to use 
two-layer-modelling [1], i.e. they specify a meta-model, which is used to specify the 
domain model. If it were possible to translate openEHR models to FHIR models, many 
software components from the FHIR domain could be used to process openEHR data. 
Bosca [2] already described the possibility of using FHIR profiles as a reference model 
for openEHR and translating openEHR models to StructureDefinitions. The presented 
work analyzes to what extent an openEHR model can be generically and preferably 
without loss of information transformed into a FHIR model. 
2. Methods 
For the translation of an openEHR model all model parts of a given openEHR system 
(RM, archetypes, templates) are translated to StructureDefinitions. The set of 
StructureDefinitions representing the RM was created by hand. The ADL files of 
archetypes were parsed and all types inside fields were translated to individual 
elements of the translated StructureDefinition. The object-composition paradigm was 
realized by using BackboneElements. All elements of the anonymous class that 
represents a constrained archetypes element (as well as elements inherited from the RM 
type) were explicitly added to the BackboneElement. The identification of identifiable 
openEHR list elements was realized by incorporating the identifier into the path of the 
FHIR element. The cardinalities of elements were ignored and only the occurrences of 
the contained types were translated to FHIR. The translation of openEHR templates 
was realized by using the template format OET as translation source. The template files 
were parsed and for each contained archetype a FHIRPath constraint was added that 
required the existence of the element. All further constraints on the contained 
archetypes were also realized via FHIRPath constraints and added to the template 
model’s root element. The described translation methodology was implemented and 
applied on the models on the international CKM. 
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3. Result 
The translated archetypes and templates were successfully translated to 
StructureDefinitions and were validated without errors. By realizing the sub elements 
of archetypes as BackboneElements, the RM type of these elements was lost. 
4. Discussion 
The archetype translation was modeled using BackboneElements and by explicitly 
expanding the anonymous classes representing the archetype elements. The necessity to 
expand the anonymous classes make the logical models look quite bloated and complex 
when the used RM types themselves contain many elements (e.g. most RM types used 
in archetypes derive from LOCATABLE, which already adds 6 elements).  
The template translation was modeled alternatively using FHIRPath constraints to 
realize object-composition. This solution has the drawback that type checking could 
become complicated, because the actual elements are not explicitly defined. Although 
FHIR validators are capable of checking these constraints, this option moves the 
workload of conformance checking to the FHIRPath part of the validator, which could 
probably reduce performance. 
The OET format is commonly only used during template design time. It was 
developed for the Ocean Template Designer and is no official openEHR format. 
However, it has the advantage that all object-compositions and constraints on elements 
are still explicitly listed so they can be directly translated to FHIRPath constraints. 
When using FHIR it is forbidden to create a new set of custom profiles. It creates 
systems that are semantically incompatible with other FHIR systems not using those 
models. The presented work aims purely on the one-to-one model translations and 
semantic mappings are not its scope. 
5. Conclusion 
An approach was presented to translate openEHR archetypes and templates to FHIR 
logical models. The approach was tested on the models contained in the international 
openEHR model repository CKM. The authors consider the translation of openEHR 
models to FHIR models a difficult issue, because the two standards use different 
object-composition, derivation and constraining paradigms. Either the resulting models 
contain a very large number of elements or the number of resulting models becomes 
very large. 
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1. Introduction  
 
There are approximately 13.9 million ED visits in Canada each year. These visits can be 
overwhelming for patients and their loved ones. This study aimed to identify factors that 
diminish the ED experience for patients, guiding us to identify care barriers and informing 
us how to design and implement a person-centred app for patients visiting ED.  
2. Methods 
This mixed-methods study involved an online survey (n=125), focus groups (n=16) and 
individual interviews (n=14). Participants were patients and accompanying family or 
friends over 19 years who had visited any ED in BC in the past five years (June 2014 – 
June 2018). The survey, representing 169 visits to the ED, contained questions based on 
common care barriers identified in our pilot study[1] and past literature. 
3. Results 
Overall, 67.4% of interview patients were satisfied with the quality of care. However, we 
identified 5 ED care barrier themes presented below in order of prevalence of comments: 
Overall Experience (34.1%): 44.3% felt communication challenges with ED staff, and 
35.1% felt their care was unsatisfactory at one or more points during their visit. 
Wait times (25.7%): Most (35.8%) spent 1-3 hours waiting to see a doctor, and 18.2% 
spent more than 10 hours total in the ED.  
Discharge process (15.7%): 63.9% of the participants felt they were mentally and 
physically ready to manage their condition at home, whereas 36.1% were not. 
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Information Exchange (14.5%): Participants felt they did not receive enough 
information about amenities (74.6%), wait time (71.5%), wait reason (58.5%), who was 
going to be seeing them (56.6%), and aftercare instructions (52.4%).  
Process Flow (10.0%): 64.7% of these participants were unclear as to next steps as they 
progressed through the ED, and 35.3% desired improvement in efficiency.  
Use of Technology: When asked whether they felt an app would be helpful in their ED 
journeys, 47.5% of survey participants were sure they would use it, and 38.3% would 
decide depending on the functionality. Overall, 86.7% of interview participants wanted 
to use such an app if it existed, and those who were reluctant reported reasons such as 
security concerns and it being overwhelming to be a patient and expected to be on their 
phone. 
4. Discussion 
  
The care barriers identified were about timely communication, but were unrelated to the 
satisfactory quality of care experienced by the majority of patients. Suggested 
improvements that emerged were related to adjusting communication and administrative 
efforts, as follows: 
Improving physician-patient communication: Interpersonal skills during 
communication ensures patients feel being the focus of care, aided with practical solutions 
such as physician name tags and context-appropriate touch 
Improving patient experience of waiting: Electronic notifications to patients for their 
turn to see a physician untethers them from the waiting room. Furthermore, periodic 
checking to update patients of wait times or, “ED rounding,” can improve satisfaction, 
reduce frustrations, and decrease patients leaving prematurely. 
Improving patient anticipation of ED journey: Providing a general road map to 
prepare patients for their journeys through the ED and updating them on what they are 
waiting for can help decrease logistical confusion and ease unrest.  
Improving patient preparedness to manage their health post-discharge: Providing 
documentation of discharge summaries and home management information for patients 
to review at home can reduce anxiety, improve adherence to therapies and follow-up, and 
reduce unnecessary ED revisits. 
It is important to note that ED overcrowding, experienced by most EDs, can compromise 
communication over delivery of quality care as health professionals have finite time. 
Therefore, solutions that support better communication and improve ED flow would be 
ideal. 
5. Conclusion 
 
We are now developing an ED app based on the priority care barriers identified, which 
are likely similar in other EDs. We aspire to have this app to be useful and scalable to 
other locations to optimize person-centred care.  
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Abstract. The user interface of a mechanical ventilator is safety critical, as use 
errors can lead to patient harm. A systematic review was conducted to identify 
published usability issues and contributing factors that can lead to use errors. The 
findings were grouped in an Ishikawa diagram. Many of the problems mentioned 
based on inconsistent labeling and manufacturer-specific naming of ventilation 
modes. In the studies, usability was often measured quantitatively and did not allow 
any conclusions to be drawn about concrete problems. 
Keywords. Ventilators, mechanical; usability problems; patient safety 
1. Introduction 
Due to technological progress in the medical field, more and more functionalities of 
mechanical ventilators lead to an increase in complexity, which is reflected in the user 
interface. To reduce use-associated risks, the application of usability engineering to 
medical devices is subject to legal regulations [1]. Despite use of approved equipment, 
use errors caused by perception, cognition or action error can cause adverse events with 
potential patient harm. The aim of this work is the systematic analysis of published 
usability issues and contributing factors that can lead to use errors described in literature.  
2. Methods 
A systematic review according to the PRISMA reporting standard was carried out. In 
PubMed a search string consisting of a combination and synonyms of the terms 
"mechanical ventilation", "usability" and "risk" was used to find eligible publications. 
Articles were included if detailed information on usability issues and contributing factors 
as cause for reported incidents or possible use errors with mechanical ventilation devices 
was given. The selected articles were qualitatively analysed by two independent 
researcher. The findings were systematically listed in an Ishikawa diagram by the 
occurring main categories. 
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3. Results 
3.1. Study Selection  
The search strategy returned 379 articles. The titles and abstracts were assessed based on 
the inclusion and exclusion criteria leaving 31 studies for the full text screening. Two 
papers could not be obtained as full text. After reading the remaining articles, 19 papers 
were omitted due to exclusion criteria. There are 10 articles left after this procedure. 
3.2. Use Error Analysis 
The 10 articles eligible for inclusion deal with the usability evaluation of ventilators and 
approaches for alternative forms of presentation as well as the analysis of critical events. 
The main causes for use errors were inconsistent labelling of the ventilation settings and 
parameters across different devices (e.g. manufacturer / language specific terminology), 
aspects of the design (e.g. the position of the power switch, the design of interaction 
elements like buttons or the complexity of and divergent interaction models cross 
different devices) and the absence of experience and training according to manufacturer 
specification with the ventilators [2–5]. 
4. Discussion und Conclusion 
This review showed that there are several usability issues related to mechanical 
ventilation systems described and discussed in the current literature. The terms usability 
and user error were not used uniformly. Most of the articles have dealt with the usage of 
the devices, but not with the causes of the use errors. Many of the found usability 
problems were caused by inconsistent labelling across the devices and different 
manufacturers [2–4]. Therefore, the implementation of an internationally standardized 
nomenclature for ventilation modes and parameters is recommended [2–4]. Most of the 
studies focused on quantitative methods and statistical evaluations. Potential causes were 
given only as examples as explanation for the quantitative results in the discussion. For 
the analysis of use errors new testing methods and a systematic causal analysis should 
be performed. Further investigation on usability problems of mechanical ventilators and 
contributing factors is recommended. 
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Abstract. In medical emergency situations, the language barrier is often a problem 
for healthcare quality. To face this situation, we developed BabelDr, an innovative 
and reliable fixed phrase speech-enabled translator specialised for medical language. 
Majority of participants (>85%) showed a positive satisfaction level using BabelDr. 
Keywords. Fixed phrase speech-enabled translator, web application, user 
satisfaction, emergency settings 
1. Introduction 
Following the refugee crisis, European hospitals are increasingly confronted with 
patients who have no language in common with the medical staff. At the Geneva 
University Hospitals (HUG), 52% of the patients are foreigners and 8% speak no French 
at all. Miscommunication is a known threat to quality, security and equitability of 
medical care [1, 5]. Professional interpreters are not always available in emergency 
settings and considered to be expensive [2]. Generic technologies such as Google 
Translate (GT) are not reliable enough [3]. Medical fixed phrase translator lack of 
usability. In this context, the HUG in collaboration with the FTI, supported by the Private 
foundation of HUG, developed BabelDr, a speech-enabled fixed-phrase translator. Like 
other systems, it relies on pre-translated sentences, but includes speech recognition, 
allowing doctors to freely ask questions instead of searching for them in a list. Pretest 
showed that BabelDr is significantly more precise than GT and presents higher usability 
than MediBabble [4]. The aim of the present study is to evaluate BabelDr in real 
emergency settings. We focus on two aspects: global user satisfaction and the perceived 
quality of patient-doctor communication through the system, from the patient’s and 
doctor’s point of view. 
2. Method 
Patients were recruited between January and August 2019 in the outpatient emergency 
unit of the HUG. Inclusion criteria are: patients must speak a language available on 
BabelDr and must not have a French level sufficient for a standard diagnostic interview. 
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Patients are recruited in the outpatient emergency unit of the HUG. Exclusion criteria are 
patients who aren’t able to read in their language. Each doctor followed a short training 
before using BabelDr. Participants are enrolled during daytime, fill a consent form and 
receive instructions on how to interact with the tool. During the consultation, the use of 
the tool can be interrupted by the doctor or the patient. Doctors can use the speech 
recognition system or directly select sentences in a list to ask their questions and the 
patients are required to answer non-verbally. After the consultation, all participants 
(doctors and patients) fill in a satisfaction survey paragraph. 
3. Results 
In total, 22 patients (age: M=41.18, SD=17.44) are eligible for this study and speak: 
Spanish (9), Arabic (4), Farsi (6), Tigrinya (2) and Albanian (1). Results on the 
satisfaction level show predominantly a positive feedback from both patients and doctors 
(>85%). Regarding patient-doctor communication, 68.2% of patients thinks the system 
allows them to completely explain the reason for consulting and 90.1% of doctors think 
BabelDr allows them to understand the patient’s problem. 
4. Discussion 
We observe that most patients are able to communicate their reason to visit and doctors 
mostly understand the problem, suggesting that BabelDr is suitable for communication 
in emergency settings. User satisfaction is higher for patients than doctors, who can feel 
constrained by the available questions. Patients’ dissatisfaction is related to 
misunderstood translations (due to level of literacy, text-to-speech quality and dialects). 
5. Conclusion 
Based on the remarks of patients and doctors, we continue to develop the tool by 
expanding coverage and adding more languages. A bidirectional system, allowing 
patients to answer by selecting pictograms, is also in development. 
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Abstract. Multimorbidity increases care needs among people with chronic diseases. 
In order to support communication between patients, their informal caregivers and 
their healthcare teams, we developed CONCERTO+, a patient portal for chronic 
disease management in primary care. A user-centered design comprising 3 iterations 
with patients and informal caregivers was performed. Clinicians were also invited 
to provide feedback on the feasibility of the solution. Several improvements were 
brought to CONCERTO+, and it is now ready to be implemented in real-life setting. 
Keywords. Patient portal, Chronic disease management, User-centered design 
1.Introduction 
Chronic diseases are the leading cause of mortality in the world, and account for   
nearly 70% of deaths [1]. Interventions increasing patient involvement in their own 
care are associated with better health outcomes [2]. eHealth technologies have the 
potential to support chronic disease management by considering end-users’ needs, 
preferences, and capabilities. CONCERTO+ is an innovative solution to improve 
patient experience and includes personalized follow-up, health education, appointment 
management, and communication between patients, informal caregivers and primary 
healthcare teams. 
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2.Methods 
The development of CONCERTO+ was done through a collaborative approach between 
patients, caregivers, researchers, clinicians, designers, and IT developers who identified 
the functionalities to include. The solution was developed through 3 phases, based on 
user-centered design methods [3], and usability was assessed with patients. 
3.Results 
• Phase 1: Development of the 1st prototype by a design team based on a review of 
available solutions. Usability test performed with 10 patients and informal 
caregivers using think-aloud and eye-tracking methods. 
• Phase 2: Design of the 2nd prototype, addition of graphics and more functions. 
Usability tested with 9 people with a lower education level. Generally positive 
comments on CONCERTO+, and some improvements suggested. 
• Phase 3: 3rd prototype designed in response to the results of the 2nd usability test. A 
3rd usability test will be done to make the final adjustments to the solution. 
4.Discussion 
Users generally found CONCERTO+ intuitive and easy to navigate. After 2 iterations, 
only minor changes were brought to the design, although improvements are still possible 
in the final version. Chronic patients and their informal caregivers are willing to use 
CONCERTO+ to communicate with their primary healthcare team. 
5.Conclusion 
The final prototype will be translated into a fully interactive application with the support 
of our IT partners. A pilot trial will assess the feasibility of a large-scale study. 
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Abstract. Emergency Department (ED) overcrowding is a major global healthcare 
issue. In this paper, we used Long Short-Term Memory (LSTM) recurrent neural 
networks to build a model to predict ED wait time in the next 2 hours using a 
randomly generated patient timestamp dataset of a typical patient hospital journey. 
Compared with Linear Regression model, the average mean absolute error for the 
LSTM model is decreased by 15% (3 minutes) ?? ? ??????. The LSTM model 
statistically outperforms the LR model, however, both models could be practically 
useful in ED wait time prediction. 
Keywords. ED Overcrowding, ED Wait Time Prediction, Machine Learning, 
Linear Regression, Recurrent Neural Network, Long Short-Term Memory  
1. Introduction
Emergency Department (ED) overcrowding is a complex, systemic and global healthcare 
issue resulting in decreased care efficiency and worsening patient outcomes [1]. ED wait 
time, defined as the time to physician initial assessment, can support decision making to 
enhance patient experience and improve hospital resource allocation [1]. Very limited 
research studies explore the use of Long Short-Term Memory (LSTM) Recurrent Neural 
Networks [2] in Emergency Medicine research, while LSTM has been commonly used 
in fields such as Business consistently providing more accurate sequence predictions [3]. 
Comparatively, Linear Regression (LR) is a popular and simple prediction method, but 
such a method may not be accurate in the complex ED overcrowding problem. The aim 
of this paper is to preliminarily investigate the application of the LSTM method in ED 
overcrowding analysis by comparing the prediction accuracy of ED wait time in the next 
2 hours of an LSTM model and that of an LR model. 
2. Methods
A dataset was created to represent 50,000 patient instances of timestamp differences 
randomly generated over a pre-defined range uniformly. A sequence of five (5) 
timestamp differences were used to illustrate the six (6) timestamps in a patient journey, 
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including: patient arrival time, triage time, registered time, physician initial assessment 
time, ED exit time, and inpatient unit discharge time. The average ED wait time for the 
next 2 hours was calculated in minutes. Two models were built: 1) a single-layered LR 
model with an input array of 1 x 5 for the 5 timestamp differences; and 2) a single-layered 
LSTM model consisting of 5 input units corresponding to the 5 timestamp differences in 
the sequence with the final unit outputting to a linear regression layer. Both models were 
trained and validated with 80% of the data using 100-Fold Cross Validation and tested 
with the remaining 20% of the data. Both models include an early stopping to prevent 
overtraining and use mean absolute error (MAE) as loss function. A two-sample t-test 
was performed on the MAE values from the testing phase with a significant difference 
of ? ? ????? and 99% confidence level.  
3. Results
The LSTM model achieved a 15% (3 minutes) lower average MAE (p < 0.001), 
7.49? ????????????????? ? ???? ? ????? ? ????? (17 minutes) compared to  ?????
????????????????? ? ???? ? ?????? ????) (20 minutes) in the LR model. 
4. Discussion
Supported by Tax et al. 2017 [13], the LSTM outperforms the LR due to its ability to 
learn the relationships between each consecutive time-step. The 3-minute prediction 
difference between the 2 models suggests that either of the 2 models could be practically 
useful in wait time prediction. An ED wait time prediction model is a beneficial clinical 
decision support tool to provide patients control in their decision making of ED care [4], 
and improves care efficiency with proactive allocation of resources such as increasing 
workload nurses and overflow units [1]. A major limitation of the study is the use of 
randomly generated dataset without real patient flow and data quality representation.  
5. Conclusion
Though the LSTM model statistically outperforms the LR model, both models could be 
practically useful in wait time prediction. Next steps include using broader patient data 
variables from a level 1 trauma hospital to explore different LSTM and/or deep neural 
network architectures and compare with various accuracy evaluations. 
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